Citrus Sinensis ID: 017960

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360---
Protein Sequence
MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEccccccccccEEEccEEcccccEEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHccccccEEEEEEEEEccccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHEEEEEEEEEEccEEEEEEEEcccccEEEEEHHHHHHcccHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccccccEEEccccEEEEccccEEEcccccHHHHcHHHHHHHEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccHHHcccHHHHHccccHHHcc
Coil and Loop (DISEMBL)
mgntcrgsftgklyqgysqpedhsnnskrntnsdctnsdystpslnsqqlVSQEfskenpkkdnsaprispskkdnimrrgidnqtyyvlghktdNIRDLYTLGRklgqgqfgttyLCTEIATGIEFACKSIskrklisredvEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHslgvmhrdlkpenfllvnkdddfslkaidfglsvffkpgqiftdvvgspyyvapevllkhygpeadvwTAGVILYILLsgvppfwaetQQGIFDAVLKghidfesdpwplisDSAKDLIRKMLcsqpserltaHEVLCMYNLPVLF
Flexible Loop (DISEMBL)
mgntcrgsftgklyqgysqpedhsnnskrNTNSDCTNSDYSTPSLNSQQLVSQEfskenpkkdnsaprispskkdnimrrGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEfacksiskrklisredvEDVRREIQIMhhlaghkniVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQpserltahevLCMYNLPVLF
Low Complexity Region (SEG)
MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF
Disordered region (IsUnstruct)
*******************************************************************************RGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV**
Disordered Region (DISOPRED)
*******************************************************************************************HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF
Disordered Region (DISEMBL)
MGNTCRGSFTGKLYQGY****************************************************SPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF
Disordered Region (DISPRO)
****************************************************************************************VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	363	2.2.26 [Sep-21-2011]
A5A7I7	557	Calcium-dependent protein	N/A	no	0.953	0.621	0.801	1e-166
Q38871	556	Calcium-dependent protein	yes	no	0.958	0.625	0.808	1e-163
A5A7I8	535	Calcium-dependent protein	N/A	no	0.898	0.609	0.788	1e-163
Q38872	544	Calcium-dependent protein	no	no	0.931	0.621	0.793	1e-163
Q9SZM3	484	Calcium-dependent protein	no	no	0.763	0.572	0.884	1e-146
P53684	542	Calcium-dependent protein	no	no	0.809	0.542	0.763	1e-129
Q38870	646	Calcium-dependent protein	no	no	0.939	0.527	0.633	1e-128
Q06850	610	Calcium-dependent protein	no	no	0.746	0.444	0.771	1e-127
Q9ZV15	583	Calcium-dependent protein	no	no	0.975	0.607	0.573	1e-126
P53682	534	Calcium-dependent protein	no	no	0.878	0.597	0.653	1e-124

>sp|A5A7I7|CDPK4_SOLTU Calcium-dependent protein kinase 4 OS=Solanum tuberosum GN=CPK4 PE=2 SV=1

 Score =  585 bits (1508), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 286/357 (80%), Positives = 312/357 (87%), Gaps = 11/357 (3%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRN--TNSDCTNSDYSTPSLNSQQLVSQEFSKE 58
           MGNTCRGS  GK +QGY+QPED S ++  N  + +  ++SD  +P+ N+QQ         
Sbjct: 1   MGNTCRGSIGGKTFQGYTQPEDSSCSTNHNPSSGNSYSSSDNFSPTSNAQQ-------NS 53

Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
           N KK++S   +SP K    M R   NQ YYV+GH T NIRDLYTLGRKLGQGQFGTTYLC
Sbjct: 54  NHKKEHSLSLVSPRKAS--MNRSGSNQAYYVMGHMTPNIRDLYTLGRKLGQGQFGTTYLC 111

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
           TE +TG E+ACKSISKRKLIS+EDVEDVRREIQIMHHL+GH+NIVTIKGAYED L VHIV
Sbjct: 112 TENSTGAEYACKSISKRKLISKEDVEDVRREIQIMHHLSGHRNIVTIKGAYEDPLYVHIV 171

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           ME+C+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKD+
Sbjct: 172 MEICSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDN 231

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV
Sbjct: 232 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 291

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           PPFWAETQQGIFDAVLKGHIDF+SDPWPLIS+SAKDLIRKMLC QPSERLTAHEVLC
Sbjct: 292 PPFWAETQQGIFDAVLKGHIDFDSDPWPLISESAKDLIRKMLCMQPSERLTAHEVLC 348

Regulates the production of reactive oxygen species (ROS) by NADPH oxidase.
Solanum tuberosum (taxid: 4113)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q38871|CDPK5_ARATH Calcium-dependent protein kinase 5 OS=Arabidopsis thaliana GN=CPK5 PE=1 SV=1

 Score =  576 bits (1484), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 288/356 (80%), Positives = 317/356 (89%), Gaps = 8/356 (2%)

Query: 1   MGNTCRGSFTGKLYQG-YSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
           MGN+CRGSF  KL +G  ++PED+S  S  N +S   NSD+S    N+  +++QEFSK+N
Sbjct: 1   MGNSCRGSFKDKLDEGDNNKPEDYSKTSTTNLSS---NSDHSP---NAADIIAQEFSKDN 54

Query: 60  PKKDNSA-PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
              +NS  P +    ++ IMRR  DNQ YYVLGHKT NIRD+YTL RKLGQGQFGTTYLC
Sbjct: 55  NSNNNSKDPALVIPLREPIMRRNPDNQAYYVLGHKTPNIRDIYTLSRKLGQGQFGTTYLC 114

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
           TEIA+G+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGH +IVTIKGAYEDSL VHIV
Sbjct: 115 TEIASGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHGSIVTIKGAYEDSLYVHIV 174

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           MELCAGGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDD
Sbjct: 175 MELCAGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 234

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK YGPEADVWTAGVILYILLSGV
Sbjct: 235 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKRYGPEADVWTAGVILYILLSGV 294

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           PPFWAETQQGIFDAVLKG+IDFESDPWP+ISDSAKDLIR+ML S+P+ERLTAHEVL
Sbjct: 295 PPFWAETQQGIFDAVLKGYIDFESDPWPVISDSAKDLIRRMLSSKPAERLTAHEVL 350

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A5A7I8|CDPK5_SOLTU Calcium-dependent protein kinase 5 OS=Solanum tuberosum GN=CPK5 PE=2 SV=1

 Score =  573 bits (1478), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 280/355 (78%), Positives = 301/355 (84%), Gaps = 29/355 (8%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGN CRGSF GK +QGY QP+DHS +   N+N    NSD   P    Q LV+        
Sbjct: 1   MGNACRGSFGGKTFQGYPQPQDHSES---NSNPK-HNSDSPKPKKEQQPLVT-------- 48

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
                            M R   NQ+YYVLGHKT NIRDLYTLGRKLGQGQFGTTYLCTE
Sbjct: 49  -----------------MNRTSTNQSYYVLGHKTPNIRDLYTLGRKLGQGQFGTTYLCTE 91

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           +++GI++ACKSI+KRKLIS+EDVEDVRREIQIMHHLAGHKNIV+IKGAYED L VHIVME
Sbjct: 92  LSSGIDYACKSIAKRKLISKEDVEDVRREIQIMHHLAGHKNIVSIKGAYEDPLYVHIVME 151

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LC GGELFDRIIQRGHY+ERKAA+LT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 152 LCGGGELFDRIIQRGHYTERKAADLTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 211

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP
Sbjct: 212 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 271

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           FWAETQQGIFDAVLKGHIDF+SDPWPL+S+SAKDLIRKMLC +PSERLTAHEVLC
Sbjct: 272 FWAETQQGIFDAVLKGHIDFDSDPWPLLSESAKDLIRKMLCMRPSERLTAHEVLC 326

Regulates the production of reactive oxygen species (ROS) by NADPH oxidase.

Solanum tuberosum (taxid: 4113)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38872|CDPK6_ARATH Calcium-dependent protein kinase 6 OS=Arabidopsis thaliana GN=CPK6 PE=1 SV=1

 Score =  573 bits (1477), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 281/354 (79%), Positives = 309/354 (87%), Gaps = 16/354 (4%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGN+CRGSF  K+Y+G     +HS   + + ++  T S   +P+ +      Q+FSK+N 
Sbjct: 1   MGNSCRGSFKDKIYEG-----NHSRPEENSKSTTTTVSSVHSPTTD------QDFSKQN- 48

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
               + P +    K+ IMRR +DNQ+YYVLGHKT NIRDLYTL RKLGQGQFGTTYLCT+
Sbjct: 49  ----TNPALVIPVKEPIMRRNVDNQSYYVLGHKTPNIRDLYTLSRKLGQGQFGTTYLCTD 104

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           IATG+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct: 105 IATGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 164

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LCAGGELFDRII RGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 165 LCAGGELFDRIIHRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 224

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQIF DVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP
Sbjct: 225 SLKAIDFGLSVFFKPGQIFKDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 284

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           FWAETQQGIFDAVLKG+IDF++DPWP+ISDSAKDLIRKMLCS PSERLTAHEVL
Sbjct: 285 FWAETQQGIFDAVLKGYIDFDTDPWPVISDSAKDLIRKMLCSSPSERLTAHEVL 338

May play a role in signal transduction pathways that involve calcium as a second messenger. Functions in abscisic acid (ABA) regulation of guard cell S-type anion-and Ca(2+)-permeable channels and stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZM3|CDPKQ_ARATH Calcium-dependent protein kinase 26 OS=Arabidopsis thaliana GN=CPK26 PE=2 SV=1

 Score =  516 bits (1330), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 245/277 (88%), Positives = 261/277 (94%)

Query: 78  MRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           M+    NQ  YVLG KT +IRDLY+LG KLGQGQFGTTY+C EI+TG E+ACKSI+KRKL
Sbjct: 1   MKHSGGNQACYVLGQKTPSIRDLYSLGHKLGQGQFGTTYMCKEISTGREYACKSITKRKL 60

Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
           IS+EDVEDVRREIQIMHHLAG+KNIVTIKGAYED L VHIVMELC+GGELFDRIIQRGHY
Sbjct: 61  ISKEDVEDVRREIQIMHHLAGYKNIVTIKGAYEDPLYVHIVMELCSGGELFDRIIQRGHY 120

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           SERKAAEL +IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ
Sbjct: 121 SERKAAELIKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 180

Query: 258 IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
           IF DVVGSPYYVAPEVLLKHYGPEADVWTAGVILYIL+SGVPPFWAETQQGIFDAVLKGH
Sbjct: 181 IFEDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILVSGVPPFWAETQQGIFDAVLKGH 240

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           IDF+SDPWPLISDSAK+LIR MLCS+PSERLTAH+VL
Sbjct: 241 IDFDSDPWPLISDSAKNLIRGMLCSRPSERLTAHQVL 277

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53684|CDPKB_ORYSJ Calcium-dependent protein kinase isoform 11 OS=Oryza sativa subsp. japonica GN=CPK11 PE=2 SV=2

 Score =  460 bits (1184), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 226/296 (76%), Positives = 257/296 (86%), Gaps = 2/296 (0%)

Query: 61  KKDNSAPRISPSK--KDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
           K D++ P ++  K    +I+RRG+D  +  VLG KT ++R+ Y +GRKLGQGQFGTTYLC
Sbjct: 37  KFDDTWPEVNNFKPTAASILRRGLDPTSINVLGRKTADLREHYIIGRKLGQGQFGTTYLC 96

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
           TEI TG E+ACK+I KRKLI++EDVEDVRREIQIMHHL+GHKN+V IK  YED   VHIV
Sbjct: 97  TEINTGCEYACKTIPKRKLITKEDVEDVRREIQIMHHLSGHKNVVAIKDVYEDGQAVHIV 156

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           MELCAGGELFDRI ++GHYSERKAAEL RIIV +V  CHSLGVMHRDLKPENFLL++KDD
Sbjct: 157 MELCAGGELFDRIQEKGHYSERKAAELIRIIVSIVAMCHSLGVMHRDLKPENFLLLDKDD 216

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           D S+KAIDFGLSVFFKPGQ+FT++VGSPYYVAPEVL K YGPE+DVW+AGVILY+LLSGV
Sbjct: 217 DLSIKAIDFGLSVFFKPGQVFTELVGSPYYVAPEVLHKRYGPESDVWSAGVILYVLLSGV 276

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           PPFWAETQQGIFDAVLKGHIDF+SDPWP ISDSAKDLIRKML   PSERL AHEVL
Sbjct: 277 PPFWAETQQGIFDAVLKGHIDFQSDPWPKISDSAKDLIRKMLSHCPSERLKAHEVL 332

May play a role in signal transduction pathways that involve calcium as a second messenger.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38870|CDPK2_ARATH Calcium-dependent protein kinase 2 OS=Arabidopsis thaliana GN=CPK2 PE=1 SV=1

 Score =  457 bits (1175), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 218/344 (63%), Positives = 263/344 (76%), Gaps = 3/344 (0%)

Query: 12  KLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISP 71
           K+    S+ E     SKR       ++   T S +  +    E + E   +  + P+  P
Sbjct: 100 KVVPEESKQEVPPEESKREVVVQPESAKPETKSESKPETTKPETTSETKPETKAEPQ-KP 158

Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
                +   G+  +T  VL  KT+N ++ Y+LGRKLGQGQFGTT+LC E  TG E+ACKS
Sbjct: 159 KHMRRVSSAGL--RTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKS 216

Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
           ISKRKL++ EDVEDVRREIQIMHHLAGH N+++IKGAYED + VH+VMELC+GGELFDRI
Sbjct: 217 ISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRI 276

Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQRGHY+ERKAAEL R IVGV+EACHSLGVMHRDLKPENFL V++++D  LK IDFGLS+
Sbjct: 277 IQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSM 336

Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
           FFKP ++FTDVVGSPYYVAPEVL K YGPE+DVW+AGVI+YILLSGVPPFWAET+QGIF+
Sbjct: 337 FFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFE 396

Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            VL G +DF SDPWP IS+SAKDL+RKML   P  RLTAH+VLC
Sbjct: 397 QVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQVLC 440

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06850|CDPK1_ARATH Calcium-dependent protein kinase 1 OS=Arabidopsis thaliana GN=CPK1 PE=1 SV=1

 Score =  456 bits (1172), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 209/271 (77%), Positives = 237/271 (87%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +T  VL  KT+N ++ Y+LGRKLGQGQFGTT+LC E  TG EFACKSI+KRKL++ EDVE
Sbjct: 134 RTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVE 193

Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           DVRREIQIMHHLAGH N+++IKGAYED + VH+VME CAGGELFDRIIQRGHY+ERKAAE
Sbjct: 194 DVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAE 253

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           LTR IVGVVEACHSLGVMHRDLKPENFL V+K +D  LK IDFGLS+FFKP  +FTDVVG
Sbjct: 254 LTRTIVGVVEACHSLGVMHRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVG 313

Query: 265 SPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           SPYYVAPEVL K YGPEADVW+AGVI+YILLSGVPPFWAET+QGIF+ VL G +DF SDP
Sbjct: 314 SPYYVAPEVLRKRYGPEADVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDP 373

Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           WP IS+SAKDL+RKML   P +RLTAH+VLC
Sbjct: 374 WPSISESAKDLVRKMLVRDPKKRLTAHQVLC 404

May play a role in signal transduction pathways that involve calcium as a second messenger. Phosphorylates the Ca(2+)-ATPase ACA2 resulting in the inhibition of its calcium activation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZV15|CDPKK_ARATH Calcium-dependent protein kinase 20 OS=Arabidopsis thaliana GN=CPK20 PE=2 SV=1

 Score =  452 bits (1162), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 223/389 (57%), Positives = 279/389 (71%), Gaps = 35/389 (8%)

Query: 1   MGNTCRG----------SFTGKLYQGYSQPEDHSNNSK----RNTNSDCTNSDYSTPSLN 46
           MGNTC G          S +  +++   +P+D   +SK    R  N    N D S   ++
Sbjct: 1   MGNTCVGPNLNPNGFLQSVSAAVWRN-QKPDDSIKSSKDESSRKKNDKSVNGDDSNGHVS 59

Query: 47  SQ------------------QLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDN--QT 86
           S                   ++ ++E   +   ++   P   P KK+  M+R      Q 
Sbjct: 60  STVDPAPSTLPTPSTPPPPVKMANEEPPPKPITENKEDPNSKPQKKEAHMKRMASAGLQI 119

Query: 87  YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
             VLG KT+N++D+Y++GRKLGQGQFGTT+LC +  TG EFACK+I+KRKL + EDVEDV
Sbjct: 120 DSVLGRKTENLKDIYSVGRKLGQGQFGTTFLCVDKKTGKEFACKTIAKRKLTTPEDVEDV 179

Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           RREIQIMHHL+GH N++ I GAYED++ VH+VME+CAGGELFDRIIQRGHY+E+KAAEL 
Sbjct: 180 RREIQIMHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRGHYTEKKAAELA 239

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           RIIVGV+EACHSLGVMHRDLKPENFL V+ D++ +LK IDFGLSVFFKPG+ FTDVVGSP
Sbjct: 240 RIIVGVIEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKPGETFTDVVGSP 299

Query: 267 YYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           YYVAPEVL KHY  E DVW+AGVI+YILLSGVPPFW ET+QGIF+ VLKG +DF S+PWP
Sbjct: 300 YYVAPEVLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLKGDLDFISEPWP 359

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            +S+SAKDL+R+ML   P +R+T HEVLC
Sbjct: 360 SVSESAKDLVRRMLIRDPKKRMTTHEVLC 388

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53682|CDPK1_ORYSJ Calcium-dependent protein kinase isoform 1 OS=Oryza sativa subsp. japonica GN=SPK PE=2 SV=2

 Score =  443 bits (1140), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 211/323 (65%), Positives = 255/323 (78%), Gaps = 4/323 (1%)

Query: 35  CTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNI---MRRGIDNQTYYVLG 91
           C N  Y     NS +  +  F+      +++    S S + ++   +R+G+ N    VLG
Sbjct: 5   CQNGTYGNNYQNSNRFQNDRFASRYVDGNDTEDCYSGSSRASLAGALRQGL-NLKSPVLG 63

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +KT N+R+LYTLGR+LGQGQFG TYLCTEI+TG ++ACK+I K  L    D+EDVRREIQ
Sbjct: 64  YKTPNVRELYTLGRELGQGQFGKTYLCTEISTGCQYACKTILKSNLRCVSDIEDVRREIQ 123

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           IMHHL+G KNIVTIK  YED   VHIVMELCAGGELF +I +RGHYSERKAAEL +IIVG
Sbjct: 124 IMHHLSGQKNIVTIKDTYEDEQAVHIVMELCAGGELFSKIQKRGHYSERKAAELIKIIVG 183

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           ++E CHS GVMHRDLKPENFLL++ DD+FS+KAIDFGLSVFF+PGQ+F +VVGSPYY+AP
Sbjct: 184 IIETCHSHGVMHRDLKPENFLLLDADDEFSVKAIDFGLSVFFRPGQVFREVVGSPYYIAP 243

Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL K YGPEAD+WTAGVILY+LL+GVPPFWA+TQ GI++ VL G IDF+S+ WP ISDS
Sbjct: 244 EVLEKRYGPEADIWTAGVILYVLLTGVPPFWADTQSGIYEKVLDGRIDFKSNRWPRISDS 303

Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKDLI+KMLC  PSERL AHEVL
Sbjct: 304 AKDLIKKMLCPYPSERLKAHEVL 326

May play a role in signal transduction pathways that involve calcium as a second messenger.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
225428322	561	PREDICTED: calcium-dependent protein kin	0.969	0.627	0.878	0.0
147864481	561	hypothetical protein VITISV_017368 [Viti	0.969	0.627	0.873	0.0
224131906	560	calcium dependent protein kinase 6 [Popu	0.955	0.619	0.857	0.0
449454305	566	PREDICTED: calcium-dependent protein kin	0.969	0.621	0.852	1e-179
224104811	565	calcium dependent protein kinase 5 [Popu	0.955	0.614	0.846	1e-179
255559179	561	calcium-dependent protein kinase, putati	0.964	0.623	0.857	1e-177
20453015	558	calmodulin-like-domain protein kinase CP	0.958	0.623	0.839	1e-175
20453013	571	phloem calmodulin-like-domain protein ki	0.977	0.621	0.825	1e-174
402810032	449	calcium dependent protein kinase 6, part	0.969	0.783	0.814	1e-173
356551652	558	PREDICTED: calcium-dependent protein kin	0.950	0.618	0.813	1e-167

>gi|225428322|ref|XP_002282994.1| PREDICTED: calcium-dependent protein kinase 4 [Vitis vinifera]

 Score =  654 bits (1687), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 312/355 (87%), Positives = 331/355 (93%), Gaps = 3/355 (0%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGNTCRGSF GK +QGY QPE+ S  SKRN  SD +NSDYS  SLNSQQLVSQEF+KENP
Sbjct: 1   MGNTCRGSFRGKYFQGYGQPEEQST-SKRN--SDRSNSDYSPSSLNSQQLVSQEFAKENP 57

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
           KK+     +SP+ KD  MRRG+DNQ+YYVLGHKT NIRDLY+LGRKLGQGQFGTTYLCT+
Sbjct: 58  KKETRVSILSPTNKDGTMRRGVDNQSYYVLGHKTANIRDLYSLGRKLGQGQFGTTYLCTD 117

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           +ATGIE+ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct: 118 MATGIEYACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 177

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LCAGGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 178 LCAGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 237

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVL KHYGPEADVWTAGVILYILLSGVPP
Sbjct: 238 SLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLCKHYGPEADVWTAGVILYILLSGVPP 297

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           FWAETQQGIFDAVLKG IDFES+PWPLISDSAKDLIRKMLCS+P++RLTAHEVLC
Sbjct: 298 FWAETQQGIFDAVLKGFIDFESEPWPLISDSAKDLIRKMLCSRPADRLTAHEVLC 352

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864481|emb|CAN78387.1| hypothetical protein VITISV_017368 [Vitis vinifera]

 Score =  650 bits (1677), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 310/355 (87%), Positives = 330/355 (92%), Gaps = 3/355 (0%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGNTCRGSF GK +QGY QPE+ S  SKRN  SD +NSDYS  SLNSQQLVSQEF+KENP
Sbjct: 1   MGNTCRGSFRGKYFQGYGQPEEQST-SKRN--SDRSNSDYSPSSLNSQQLVSQEFAKENP 57

Query: 61  KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
           KK+     +SP+ KD  MRRG+DNQ+YYVLGHKT NIRDLY+LGRKLGQGQFGTT LCT+
Sbjct: 58  KKETRVSILSPTNKDGTMRRGVDNQSYYVLGHKTANIRDLYSLGRKLGQGQFGTTXLCTD 117

Query: 121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           +ATGIE+ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct: 118 MATGIEYACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 177

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           LCAGGELFDRIIQRGHYSER+AAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct: 178 LCAGGELFDRIIQRGHYSERRAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 237

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           SLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVL KHYGPEADVWTAGVILYILLSGVPP
Sbjct: 238 SLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLCKHYGPEADVWTAGVILYILLSGVPP 297

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           FWAETQQGIFDAVLKG IDFES+PWPLISDSAKDLIRKMLCS+P++RLTAHEVLC
Sbjct: 298 FWAETQQGIFDAVLKGFIDFESEPWPLISDSAKDLIRKMLCSRPADRLTAHEVLC 352

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224131906|ref|XP_002328137.1| calcium dependent protein kinase 6 [Populus trichocarpa] gi|222837652|gb|EEE76017.1| calcium dependent protein kinase 6 [Populus trichocarpa]

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 308/359 (85%), Positives = 331/359 (92%), Gaps = 12/359 (3%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS----NNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFS 56
           MGNTCRGSF GKLYQGY+QP++ S    +NSKRN +SD +NS+YS  SL  Q+L      
Sbjct: 1   MGNTCRGSFKGKLYQGYNQPDEQSTTTASNSKRNASSDHSNSEYSISSLTPQEL------ 54

Query: 57  KENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTY 116
             NPKKD++ P ISP+KKD IMRRG+DNQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTY
Sbjct: 55  --NPKKDSNLPLISPTKKDTIMRRGVDNQAYYVLGHKTANIRDLYTLGRKLGQGQFGTTY 112

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           LCT+I+TGIE+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VH
Sbjct: 113 LCTDISTGIEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDQLYVH 172

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IVMELC+GGELFDRIIQRGHY+ERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNK
Sbjct: 173 IVMELCSGGELFDRIIQRGHYTERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNK 232

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           DDDFSLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVLLK YGPEADVWTAGVILYILLS
Sbjct: 233 DDDFSLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLLKQYGPEADVWTAGVILYILLS 292

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           GVPPFWAETQQGIFDAVLKG+IDF+SDPWP+ISDSAKDLIRKMLCSQPSERLTAHEVLC
Sbjct: 293 GVPPFWAETQQGIFDAVLKGYIDFDSDPWPVISDSAKDLIRKMLCSQPSERLTAHEVLC 351

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449454305|ref|XP_004144896.1| PREDICTED: calcium-dependent protein kinase 4-like [Cucumis sativus] gi|449471982|ref|XP_004153460.1| PREDICTED: calcium-dependent protein kinase 4-like [Cucumis sativus] gi|449530458|ref|XP_004172212.1| PREDICTED: calcium-dependent protein kinase 4-like [Cucumis sativus]

 Score =  634 bits (1636), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 307/360 (85%), Positives = 329/360 (91%), Gaps = 8/360 (2%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSN-NSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
           MGNTCRGSF G ++QGYSQPED S  NSKRNTN   T++D+S  S+++  L+SQEF+KEN
Sbjct: 1   MGNTCRGSFKGNIFQGYSQPEDSSTPNSKRNTN---TSADHSPSSISTNNLISQEFAKEN 57

Query: 60  P--KKDN--SAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
               KDN  +   +SP+KKD  MR+  +NQ YYVLGHKT NIRDLYTLGRKLGQGQFGTT
Sbjct: 58  KIKSKDNDCNPTFLSPTKKDYTMRKSAENQAYYVLGHKTANIRDLYTLGRKLGQGQFGTT 117

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
           YLCTEI TGIE+ACKSISKRKLI++EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL V
Sbjct: 118 YLCTEITTGIEYACKSISKRKLIAKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLYV 177

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
           HIVMELC+GGELFDRIIQRGHYSERKAAELTRIIVGVVE CHSLGVMHRDLKPENFLLVN
Sbjct: 178 HIVMELCSGGELFDRIIQRGHYSERKAAELTRIIVGVVETCHSLGVMHRDLKPENFLLVN 237

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILL 295
           KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP ADVWTAGVILYILL
Sbjct: 238 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPAADVWTAGVILYILL 297

Query: 296 SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           SGVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDSAKDLIRKMLCS+PS+RLTAHEVLC
Sbjct: 298 SGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSAKDLIRKMLCSRPSDRLTAHEVLC 357

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104811|ref|XP_002313574.1| calcium dependent protein kinase 5 [Populus trichocarpa] gi|222849982|gb|EEE87529.1| calcium dependent protein kinase 5 [Populus trichocarpa]

 Score =  633 bits (1633), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 304/359 (84%), Positives = 327/359 (91%), Gaps = 12/359 (3%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS----NNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFS 56
           MGNTCRGSF G L+QGY+QP++ S    +NSKR+ +SD +NS++S  SL SQ+L      
Sbjct: 1   MGNTCRGSFKGILHQGYNQPDEQSTVTASNSKRHASSDHSNSEHSFSSLTSQELT----- 55

Query: 57  KENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTY 116
              PKKD++ P ISP+KKD IMRR +DNQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTY
Sbjct: 56  ---PKKDSNLPLISPTKKDTIMRRSVDNQAYYVLGHKTPNIRDLYTLGRKLGQGQFGTTY 112

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           LCTEI TG+++ACKSI KRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VH
Sbjct: 113 LCTEILTGMDYACKSICKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVH 172

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IVMELC+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNK
Sbjct: 173 IVMELCSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNK 232

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS
Sbjct: 233 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 292

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           GVPPFWAETQQGIFDAVLKG+IDF+SDPWPLISDSAKDLIRKMLCS PSERLTAHEVLC
Sbjct: 293 GVPPFWAETQQGIFDAVLKGYIDFDSDPWPLISDSAKDLIRKMLCSSPSERLTAHEVLC 351

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255559179|ref|XP_002520611.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223540210|gb|EEF41784.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  627 bits (1618), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 306/357 (85%), Positives = 328/357 (91%), Gaps = 7/357 (1%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNS--KRNTNSDCTNSDYSTPSLNSQQLVSQEFSKE 58
           MGNTCRGSF GKLYQGYSQPED S  S   RN +S+ +N+++S  S+      +QEF+K+
Sbjct: 1   MGNTCRGSFKGKLYQGYSQPEDQSTASHTNRNPSSNNSNTEHSPTSV-----TAQEFAKD 55

Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
           NPKKDN+ P ISP++KD IMRRG DNQ+YYVLGHKT NIRDLYTLGRKLGQGQFGTTYLC
Sbjct: 56  NPKKDNNFPLISPNRKDLIMRRGADNQSYYVLGHKTANIRDLYTLGRKLGQGQFGTTYLC 115

Query: 119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
            E +TG E+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIV
Sbjct: 116 VENSTGTEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDQLYVHIV 175

Query: 179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
           MELC+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDD
Sbjct: 176 MELCSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 235

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
           DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV
Sbjct: 236 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 295

Query: 299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           PPFWAETQQGIFDAVLKG+IDFESDPWPLISDSAKDLI KMLC +PS+RLTAHEVLC
Sbjct: 296 PPFWAETQQGIFDAVLKGYIDFESDPWPLISDSAKDLIHKMLCGRPSDRLTAHEVLC 352

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|20453015|gb|AAL68972.1| calmodulin-like-domain protein kinase CPK2 [Cucurbita maxima]

 Score =  620 bits (1600), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 299/356 (83%), Positives = 319/356 (89%), Gaps = 8/356 (2%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSN-NSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
           MGNTCRGSF G ++QGYSQPE+ S  N KRN N    +SD+S  S+N+  L+SQ F++EN
Sbjct: 1   MGNTCRGSFKGNIFQGYSQPEESSTPNFKRNING---SSDHSPSSINTNNLISQAFAEEN 57

Query: 60  PKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCT 119
             K       +  KKD  MR+  +NQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTYLCT
Sbjct: 58  KTKSKD----NDCKKDYTMRKSAENQAYYVLGHKTANIRDLYTLGRKLGQGQFGTTYLCT 113

Query: 120 EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM 179
           EI TGIE+ACKSISKRKLI++EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL VHIVM
Sbjct: 114 EIMTGIEYACKSISKRKLIAKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLYVHIVM 173

Query: 180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD 239
           ELC+GGELFDRIIQRGHYSERKAAELTRIIVGVVE CHSLGVMHRDLKPENFLLVNKDDD
Sbjct: 174 ELCSGGELFDRIIQRGHYSERKAAELTRIIVGVVETCHSLGVMHRDLKPENFLLVNKDDD 233

Query: 240 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
           FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP ADVWTAGVILYILLSGVP
Sbjct: 234 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPAADVWTAGVILYILLSGVP 293

Query: 300 PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           PFWAETQQGIFDAVLKGHIDF+SDPWPLISDSAKDLIRKMLCS+PS+RLTAHEVLC
Sbjct: 294 PFWAETQQGIFDAVLKGHIDFDSDPWPLISDSAKDLIRKMLCSRPSDRLTAHEVLC 349

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|20453013|gb|AAL68971.1| phloem calmodulin-like-domain protein kinase PCPK1 [Cucurbita maxima]

 Score =  616 bits (1588), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 299/362 (82%), Positives = 323/362 (89%), Gaps = 7/362 (1%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS---NNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSK 57
           MGNTCRGSF G ++QGYSQPED S   +    +++S  +NSD S  S+N+  L++QEFSK
Sbjct: 1   MGNTCRGSFKGNIFQGYSQPEDSSTLYSKRNNSSSSARSNSDISPTSINTHNLIAQEFSK 60

Query: 58  ENPKK----DNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFG 113
           EN  K    D +   +SP+KKD  MR+  +NQ YYVLGHKT NIRDLYTLGRKLGQGQFG
Sbjct: 61  ENKTKSKDNDYNQAFLSPTKKDFTMRKSAENQAYYVLGHKTANIRDLYTLGRKLGQGQFG 120

Query: 114 TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL 173
           TTYLCTEI TGIE+ACKSISKRKLI++EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL
Sbjct: 121 TTYLCTEITTGIEYACKSISKRKLIAKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL 180

Query: 174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL 233
            VHIVMELC+GGELFDRII RGHYSERKAAELTRIIVGVVE CHSLGVMHRDLKPENFLL
Sbjct: 181 YVHIVMELCSGGELFDRIIHRGHYSERKAAELTRIIVGVVETCHSLGVMHRDLKPENFLL 240

Query: 234 VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYI 293
           VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG PYYVAPEVLLKHYGP ADVWTAGVILYI
Sbjct: 241 VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGRPYYVAPEVLLKHYGPAADVWTAGVILYI 300

Query: 294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           LLSGVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDSAKD+IRKMLCS+PS+RLTAHEV
Sbjct: 301 LLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSAKDIIRKMLCSRPSDRLTAHEV 360

Query: 354 LC 355
           LC
Sbjct: 361 LC 362

Source: Cucurbita maxima

Species: Cucurbita maxima

Genus: Cucurbita

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|402810032|gb|AFR11236.1| calcium dependent protein kinase 6, partial [Chenopodium album]

 Score =  613 bits (1581), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 302/371 (81%), Positives = 325/371 (87%), Gaps = 19/371 (5%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHS---------------NNSKRNTNSDCTNSDYSTPSL 45
           MGNTCRGSF  K +QG +QPEDHS               N +KRN   D   SDYS  SL
Sbjct: 1   MGNTCRGSFGVKFHQGETQPEDHSVGNSNSNTNSNTTSSNTTKRN---DSDYSDYSPNSL 57

Query: 46  NSQQLVSQEFSKENPKKDNSAPRISPSKKDN-IMRRGIDNQTYYVLGHKTDNIRDLYTLG 104
            +QQLV+QEF+++NPKKD+++  + P  KDN  +R+  DNQ YYVLGHKT NIRDLYTLG
Sbjct: 58  RNQQLVNQEFAQDNPKKDHNSVVVVPMAKDNNTVRKQSDNQAYYVLGHKTANIRDLYTLG 117

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           RKLGQGQFGTTYLCTEI+TGIE+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVT
Sbjct: 118 RKLGQGQFGTTYLCTEISTGIEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVT 177

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           IKGAYED L VHIVMELC+GGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHR
Sbjct: 178 IKGAYEDPLYVHIVMELCSGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHR 237

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADV 284
           DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVLLK+YG EADV
Sbjct: 238 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLLKNYGFEADV 297

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDS KDLIRKMLCS P
Sbjct: 298 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSGKDLIRKMLCSNP 357

Query: 345 SERLTAHEVLC 355
            ERLTAH+VLC
Sbjct: 358 KERLTAHQVLC 368

Source: Chenopodium album

Species: Chenopodium album

Genus: Chenopodium

Family: Amaranthaceae

Order: Caryophyllales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551652|ref|XP_003544188.1| PREDICTED: calcium-dependent protein kinase 4-like [Glycine max]

 Score =  593 bits (1529), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 292/359 (81%), Positives = 313/359 (87%), Gaps = 14/359 (3%)

Query: 1   MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
           MGNTCRGS  GK  QG+SQPEDHS   KR+T        +S PS   QQ  +   +  N 
Sbjct: 1   MGNTCRGSLKGKYIQGFSQPEDHS---KRSTT-------HSDPSSTKQQDDNDNNNNNNN 50

Query: 61  KKDNSAPRISP----SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTY 116
             +N+    +     +K++ IMRRG+DNQ YYVLGHKT NIRDLYTLGRKLGQGQFGTTY
Sbjct: 51  NNNNNNNNNNNLPFNAKREAIMRRGLDNQAYYVLGHKTPNIRDLYTLGRKLGQGQFGTTY 110

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           LCTE +T IE+ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VH
Sbjct: 111 LCTENSTSIEYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVH 170

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IVMELC+GGELFDRIIQRGHY+ERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNK
Sbjct: 171 IVMELCSGGELFDRIIQRGHYTERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNK 230

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           DDDFSLKAIDFGLSVFFKPGQ+FTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS
Sbjct: 231 DDDFSLKAIDFGLSVFFKPGQVFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 290

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           GVPPFWAETQQGIFDAVLKGHIDF+SDPWPLISDS KDLIRKMLCSQPSERLTAH+VLC
Sbjct: 291 GVPPFWAETQQGIFDAVLKGHIDFDSDPWPLISDSGKDLIRKMLCSQPSERLTAHQVLC 349

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	363
TAIR|locus:2122063	556	CPK5 "calmodulin-domain protei	0.958	0.625	0.811	1.8e-151
TAIR|locus:2827528	544	CPK6 "calcium dependent protei	0.931	0.621	0.802	2.7e-148
TAIR|locus:2175503	610	CPK1 "calcium dependent protei	0.859	0.511	0.699	1.2e-119
TAIR|locus:2065021	583	CPK20 "calcium-dependent prote	0.917	0.571	0.642	2.9e-116
TAIR|locus:2075885	646	CPK2 "calmodulin-domain protei	0.922	0.518	0.642	3.1e-115
TAIR|locus:2039215	520	CPK25 "calcium-dependent prote	0.851	0.594	0.632	2.2e-105
TAIR|locus:2014691	495	CDPK2 "AT1G35670" [Arabidopsis	0.735	0.539	0.707	2e-102
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.732	0.508	0.669	6.9e-102
TAIR|locus:2177023	528	CPK17 "calcium-dependent prote	0.732	0.503	0.672	8.8e-102
TAIR|locus:2136917	501	CPK4 "calcium-dependent protei	0.735	0.532	0.707	1.4e-101

TAIR|locus:2122063 CPK5 "calmodulin-domain protein kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1478 (525.3 bits), Expect = 1.8e-151, P = 1.8e-151
 Identities = 289/356 (81%), Positives = 318/356 (89%)

Query:     1 MGNTCRGSFTGKLYQG-YSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKEN 59
             MGN+CRGSF  KL +G  ++PED+S  S  N +S   NSD+S P  N+  +++QEFSK+N
Sbjct:     1 MGNSCRGSFKDKLDEGDNNKPEDYSKTSTTNLSS---NSDHS-P--NAADIIAQEFSKDN 54

Query:    60 PKKDNSA-PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLC 118
                +NS  P +    ++ IMRR  DNQ YYVLGHKT NIRD+YTL RKLGQGQFGTTYLC
Sbjct:    55 NSNNNSKDPALVIPLREPIMRRNPDNQAYYVLGHKTPNIRDIYTLSRKLGQGQFGTTYLC 114

Query:   119 TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV 178
             TEIA+G+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGH +IVTIKGAYEDSL VHIV
Sbjct:   115 TEIASGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHGSIVTIKGAYEDSLYVHIV 174

Query:   179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
             MELCAGGELFDRIIQRGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDD
Sbjct:   175 MELCAGGELFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 234

Query:   239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGV 298
             DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK YGPEADVWTAGVILYILLSGV
Sbjct:   235 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKRYGPEADVWTAGVILYILLSGV 294

Query:   299 PPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             PPFWAETQQGIFDAVLKG+IDFESDPWP+ISDSAKDLIR+ML S+P+ERLTAHEVL
Sbjct:   295 PPFWAETQQGIFDAVLKGYIDFESDPWPVISDSAKDLIRRMLSSKPAERLTAHEVL 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
 Identities = 284/354 (80%), Positives = 308/354 (87%)

Query:     1 MGNTCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENP 60
             MGN+CRGSF  K+Y+G        N+S+   NS  T +  S  S++S     Q+FSK+N 
Sbjct:     1 MGNSCRGSFKDKIYEG--------NHSRPEENSKSTTTTVS--SVHSPT-TDQDFSKQNT 49

Query:    61 KKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTE 120
                   P +    K+ IMRR +DNQ+YYVLGHKT NIRDLYTL RKLGQGQFGTTYLCT+
Sbjct:    50 N-----PALVIPVKEPIMRRNVDNQSYYVLGHKTPNIRDLYTLSRKLGQGQFGTTYLCTD 104

Query:   121 IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
             IATG+++ACKSISKRKLIS+EDVEDVRREIQIMHHLAGHKNIVTIKGAYED L VHIVME
Sbjct:   105 IATGVDYACKSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVME 164

Query:   181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
             LCAGGELFDRII RGHYSERKAAELT+IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF
Sbjct:   165 LCAGGELFDRIIHRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 224

Query:   241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
             SLKAIDFGLSVFFKPGQIF DVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP
Sbjct:   225 SLKAIDFGLSVFFKPGQIFKDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 284

Query:   301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             FWAETQQGIFDAVLKG+IDF++DPWP+ISDSAKDLIRKMLCS PSERLTAHEVL
Sbjct:   285 FWAETQQGIFDAVLKGYIDFDTDPWPVISDSAKDLIRKMLCSSPSERLTAHEVL 338

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=RCA;IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006820 "anion transport" evidence=RCA

GO:0006862 "nucleotide transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0015696 "ammonium transport" evidence=RCA

GO:0015802 "basic amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0043269 "regulation of ion transport" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1151 (410.2 bits), Expect = 1.2e-119, Sum P(2) = 1.2e-119
 Identities = 219/313 (69%), Positives = 251/313 (80%)

Query:    44 SLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMR-RGIDNQTYYVLGHKTDNIRDLYT 102
             SL S+    QE   E   +    P   P K  ++ R      +T  VL  KT+N ++ Y+
Sbjct:    92 SLESKPETKQETKSETKPESKPDPPAKPKKPKHMKRVSSAGLRTESVLQRKTENFKEFYS 151

Query:   103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
             LGRKLGQGQFGTT+LC E  TG EFACKSI+KRKL++ EDVEDVRREIQIMHHLAGH N+
Sbjct:   152 LGRKLGQGQFGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVEDVRREIQIMHHLAGHPNV 211

Query:   163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
             ++IKGAYED + VH+VME CAGGELFDRIIQRGHY+ERKAAELTR IVGVVEACHSLGVM
Sbjct:   212 ISIKGAYEDVVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTIVGVVEACHSLGVM 271

Query:   223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA 282
             HRDLKPENFL V+K +D  LK IDFGLS+FFKP  +FTDVVGSPYYVAPEVL K YGPEA
Sbjct:   272 HRDLKPENFLFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPEVLRKRYGPEA 331

Query:   283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
             DVW+AGVI+YILLSGVPPFWAET+QGIF+ VL G +DF SDPWP IS+SAKDL+RKML  
Sbjct:   332 DVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVR 391

Query:   343 QPSERLTAHEVLC 355
              P +RLTAH+VLC
Sbjct:   392 DPKKRLTAHQVLC 404

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016020 "membrane" evidence=NAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2065021 CPK20 "calcium-dependent protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 1129 (402.5 bits), Expect = 2.9e-116, Sum P(2) = 2.9e-116
 Identities = 217/338 (64%), Positives = 262/338 (77%)

Query:    22 DHSNNSKRNTNSDCTNSDYSTPSLNSQQL-VSQEFSKENPKKDNSA-PRISPSKKDNIMR 79
             D SN    +T  D   S   TPS     + ++ E     P  +N   P   P KK+  M+
Sbjct:    52 DDSNGHVSST-VDPAPSTLPTPSTPPPPVKMANEEPPPKPITENKEDPNSKPQKKEAHMK 110

Query:    80 R--GIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
             R      Q   VLG KT+N++D+Y++GRKLGQGQFGTT+LC +  TG EFACK+I+KRKL
Sbjct:   111 RMASAGLQIDSVLGRKTENLKDIYSVGRKLGQGQFGTTFLCVDKKTGKEFACKTIAKRKL 170

Query:   138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
              + EDVEDVRREIQIMHHL+GH N++ I GAYED++ VH+VME+CAGGELFDRIIQRGHY
Sbjct:   171 TTPEDVEDVRREIQIMHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRGHY 230

Query:   198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +E+KAAEL RIIVGV+EACHSLGVMHRDLKPENFL V+ D++ +LK IDFGLSVFFKPG+
Sbjct:   231 TEKKAAELARIIVGVIEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKPGE 290

Query:   258 IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
              FTDVVGSPYYVAPEVL KHY  E DVW+AGVI+YILLSGVPPFW ET+QGIF+ VLKG 
Sbjct:   291 TFTDVVGSPYYVAPEVLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLKGD 350

Query:   318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             +DF S+PWP +S+SAKDL+R+ML   P +R+T HEVLC
Sbjct:   351 LDFISEPWPSVSESAKDLVRRMLIRDPKKRMTTHEVLC 388

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1136 (405.0 bits), Expect = 3.1e-115, P = 3.1e-115
 Identities = 217/338 (64%), Positives = 261/338 (77%)

Query:    18 SQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNI 77
             S+ E     SKR       ++   T S +  +    E + E   +  + P+  P     +
Sbjct:   106 SKQEVPPEESKREVVVQPESAKPETKSESKPETTKPETTSETKPETKAEPQ-KPKHMRRV 164

Query:    78 MRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
                G+  +T  VL  KT+N ++ Y+LGRKLGQGQFGTT+LC E  TG E+ACKSISKRKL
Sbjct:   165 SSAGL--RTESVLQRKTENFKEFYSLGRKLGQGQFGTTFLCLEKGTGNEYACKSISKRKL 222

Query:   138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
             ++ EDVEDVRREIQIMHHLAGH N+++IKGAYED + VH+VMELC+GGELFDRIIQRGHY
Sbjct:   223 LTDEDVEDVRREIQIMHHLAGHPNVISIKGAYEDVVAVHLVMELCSGGELFDRIIQRGHY 282

Query:   198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +ERKAAEL R IVGV+EACHSLGVMHRDLKPENFL V++++D  LK IDFGLS+FFKP +
Sbjct:   283 TERKAAELARTIVGVLEACHSLGVMHRDLKPENFLFVSREEDSLLKTIDFGLSMFFKPDE 342

Query:   258 IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
             +FTDVVGSPYYVAPEVL K YGPE+DVW+AGVI+YILLSGVPPFWAET+QGIF+ VL G 
Sbjct:   343 VFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIVYILLSGVPPFWAETEQGIFEQVLHGD 402

Query:   318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             +DF SDPWP IS+SAKDL+RKML   P  RLTAH+VLC
Sbjct:   403 LDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAHQVLC 440

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;NAS

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

TAIR|locus:2039215 CPK25 "calcium-dependent protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1023 (365.2 bits), Expect = 2.2e-105, Sum P(2) = 2.2e-105
 Identities = 196/310 (63%), Positives = 238/310 (76%)

Query:    47 SQQLVSQEFSKENPKKDNSAPRISPSKKDNIMR-RGIDNQTYYVLGHKTDNIRDLYTLGR 105
             SQ    ++ S E  KK   A   S  K  N+ R      Q   VL  KT ++++ Y LG 
Sbjct:    77 SQGQGGRKCSDEEYKKRAIACANSKRKAHNVRRLMSAGLQAESVLKTKTGHLKEYYNLGS 136

Query:   106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
             KLG GQFGTT++C E  TG E+ACKSI KRKL + EDVEDVRREI+IM HL G  N+++I
Sbjct:   137 KLGHGQFGTTFVCVEKGTGEEYACKSIPKRKLENEEDVEDVRREIEIMKHLLGQPNVISI 196

Query:   166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             KGAYEDS+ VH+VMELC GGELFDRI++RGHYSERKAA L ++I+GVV+ CHSLGVMHRD
Sbjct:   197 KGAYEDSVAVHMVMELCRGGELFDRIVERGHYSERKAAHLAKVILGVVQTCHSLGVMHRD 256

Query:   226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVW 285
             LKPENFL VN D+D  LKAIDFGLS+F KPG+ FTDVVGSPYY+APEVL K+YGPEAD+W
Sbjct:   257 LKPENFLFVNDDEDSPLKAIDFGLSMFLKPGENFTDVVGSPYYIAPEVLNKNYGPEADIW 316

Query:   286 TAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPS 345
             +AGV++Y+LLSG  PFW ET++ IF+ VL+G +D  SDPWP +S+SAKDLIRKML   P 
Sbjct:   317 SAGVMIYVLLSGSAPFWGETEEEIFNEVLEGELDLTSDPWPQVSESAKDLIRKMLERNPI 376

Query:   346 ERLTAHEVLC 355
             +RLTA +VLC
Sbjct:   377 QRLTAQQVLC 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2014691 CDPK2 "AT1G35670" [Arabidopsis thaliana (taxid:3702)]

 Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
 Identities = 189/267 (70%), Positives = 220/267 (82%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VL ++T  +RD Y LG+KLGQGQFGTTYLCTE +T   +ACKSI KRKL+ RED EDV R
Sbjct:    14 VLPYQTPRLRDHYLLGKKLGQGQFGTTYLCTEKSTSANYACKSIPKRKLVCREDYEDVWR 73

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             EIQIMHHL+ H N+V IKG YEDS+ VHIVME+C GGELFDRI+ +GH+SER+A +L + 
Sbjct:    74 EIQIMHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGHFSEREAVKLIKT 133

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             I+GVVEACHSLGVMHRDLKPENFL  +  DD  LKA DFGLSVF+KPGQ   DVVGSPYY
Sbjct:   134 ILGVVEACHSLGVMHRDLKPENFLFDSPKDDAKLKATDFGLSVFYKPGQYLYDVVGSPYY 193

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             VAPEVL K YGPE DVW+AGVILYILLSGVPPFWAET+ GIF  +L+G +DF+SDPWP I
Sbjct:   194 VAPEVLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKLDFKSDPWPTI 253

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVLC 355
             S++AKDLI KML   P +R++AHE LC
Sbjct:   254 SEAAKDLIYKMLERSPKKRISAHEALC 280

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=ISS;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:1901979 "regulation of inward rectifier potassium channel activity" evidence=IDA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 1010 (360.6 bits), Expect = 6.9e-102, P = 6.9e-102
 Identities = 178/266 (66%), Positives = 225/266 (84%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VLG   ++++  YTLG++LG+GQFG T+LCT+ ATG++FACK+I+KRKL+++ED+EDVRR
Sbjct:    56 VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRR 115

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             E+QIMHHL G  NIV +KGAYED   VH+VMELCAGGELFDRII +GHYSER AA L R 
Sbjct:   116 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 175

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             IV ++  CHS+GV+HRDLKPENFLL++KD++  LKA DFGLSVF+KPG++F D+VGS YY
Sbjct:   176 IVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 235

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             +APEVL + YGPEAD+W+ GV+LYILL GVPPFWAE++ GIF+A+L G +DF SDPWP+I
Sbjct:   236 IAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVI 295

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
             S  AKDL+RKML S P +RLTA +VL
Sbjct:   296 SPQAKDLVRKMLNSDPKQRLTAAQVL 321

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
 Identities = 179/266 (67%), Positives = 225/266 (84%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VLG   ++++  Y+LG++LG+GQFG T+LCT+ ATG +FACK+I+KRKL+++ED+EDVRR
Sbjct:    61 VLGRPMEDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRR 120

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             E+QIMHHL G  NIV +KGAYED   VH+VMELCAGGELFDRII +GHYSER AA L R 
Sbjct:   121 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 180

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             IV +V  CHS+GV+HRDLKPENFLL+NKD++  LKA DFGLSVF+KPG++F D+VGS YY
Sbjct:   181 IVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 240

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             +APEVL + YGPEAD+W+ GV+LYILL GVPPFWAE++ GIF+A+L+GH+DF SDPWP I
Sbjct:   241 IAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSI 300

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
             S  AKDL++KML S P +RLTA +VL
Sbjct:   301 SPQAKDLVKKMLNSDPKQRLTAAQVL 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2136917 CPK4 "calcium-dependent protein kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1007 (359.5 bits), Expect = 1.4e-101, P = 1.4e-101
 Identities = 189/267 (70%), Positives = 219/267 (82%)

Query:    89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
             VL ++T  +RD Y LG+KLGQGQFGTTYLCTE ++   +ACKSI KRKL+ RED EDV R
Sbjct:    13 VLPYETPRLRDHYLLGKKLGQGQFGTTYLCTEKSSSANYACKSIPKRKLVCREDYEDVWR 72

Query:   149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
             EIQIMHHL+ H N+V IKG YEDS+ VHIVME+C GGELFDRI+ +G +SER+AA+L + 
Sbjct:    73 EIQIMHHLSEHPNVVRIKGTYEDSVFVHIVMEVCEGGELFDRIVSKGCFSEREAAKLIKT 132

Query:   209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
             I+GVVEACHSLGVMHRDLKPENFL  +  DD  LKA DFGLSVF+KPGQ   DVVGSPYY
Sbjct:   133 ILGVVEACHSLGVMHRDLKPENFLFDSPSDDAKLKATDFGLSVFYKPGQYLYDVVGSPYY 192

Query:   269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
             VAPEVL K YGPE DVW+AGVILYILLSGVPPFWAET+ GIF  +L+G IDF+SDPWP I
Sbjct:   193 VAPEVLKKCYGPEIDVWSAGVILYILLSGVPPFWAETESGIFRQILQGKIDFKSDPWPTI 252

Query:   329 SDSAKDLIRKMLCSQPSERLTAHEVLC 355
             S+ AKDLI KML   P +R++AHE LC
Sbjct:   253 SEGAKDLIYKMLDRSPKKRISAHEALC 279

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
A5A7I8	CDPK5_SOLTU	2, ., 7, ., 1, 1, ., 1	0.7887	0.8980	0.6093	N/A	no
A5A7I7	CDPK4_SOLTU	2, ., 7, ., 1, 1, ., 1	0.8011	0.9531	0.6211	N/A	no
Q38871	CDPK5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8089	0.9586	0.6258	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00036285001	SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (561 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00027665001	SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (769 aa)						•			0.800
	GSVIVG00022728001	SubName- Full=Chromosome chr14 scaffold_27, whole genome shotgun sequence; (873 aa)						•			0.800
	GSVIVG00006233001	SubName- Full=Chromosome chr1 scaffold_166, whole genome shotgun sequence; (805 aa)						•			0.800
	GSVIVG00002525001	SubName- Full=Chromosome chr2 scaffold_132, whole genome shotgun sequence; (943 aa)						•			0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	363
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-98
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-90
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-64
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-61
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-57
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-54
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-51
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-51
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-51
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-51
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-46
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-46
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-44
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-44
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-42
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-40
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-39
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-38
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-38
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-38
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-38
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-37
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-35
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-35
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-35
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-34
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-33
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-33
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-33
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-33
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-32
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-32
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-32
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-31
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-31
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-31
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-31
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-31
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-30
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-30
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-30
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-30
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-30
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-30
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-30
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-29
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-29
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-29
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-29
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-29
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-28
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-28
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-28
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-28
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-28
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-28
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-28
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-27
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-27
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-27
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-27
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-27
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-27
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-27
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-27
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-27
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-26
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-26
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-26
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-26
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-26
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-26
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-25
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-25
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-25
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-25
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-25
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-25
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-24
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-24
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-24
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-24
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-23
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-23
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-23
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-23
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-22
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-22
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-22
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-22
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-21
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-21
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-21
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-21
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-21
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-20
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-20
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-19
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-19
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-18
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-17
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-17
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-16
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-15
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-14
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-12
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-09
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-09
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	8e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.001
pfam06293	206	pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/Waa	0.001
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  291 bits (747), Expect = 3e-98
 Identities = 117/256 (45%), Positives = 154/256 (60%), Gaps = 9/256 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +  KLG+G FG  YL  +  TG   A K I K+K+  ++D E + REI+I+  L  H 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKL-KHP 57

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +   +ED   +++VME C GG+LFD + +RG  SE +A    R I+  +E  HS G
Sbjct: 58  NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           ++HRDLKPEN LL   D+D  +K  DFGL+    PG+  T  VG+P Y+APEVLL K YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
              D+W+ GVILY LL+G PPF  + Q   +F  + K    F    W  IS  AKDLIRK
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIRK 233

Query: 339 MLCSQPSERLTAHEVL 354
           +L   P +RLTA E L
Sbjct: 234 LLVKDPEKRLTAEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  271 bits (696), Expect = 2e-90
 Identities = 114/261 (43%), Positives = 151/261 (57%), Gaps = 11/261 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L RKLG G FGT Y      TG   A K + KR   S++D    RREI+I+  L  H 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +  A+ED   +++VME C GG+LFD + + G  SE +A ++   I+  +E  HS G
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLLKH-- 277
           ++HRDLKPEN LL        +K  DFGL+    K     T  VG+P+Y+APEVLL    
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           YGP+ DVW+ GVILY LL+G PPF  E    Q  +   +L   ++F+   W   S+ AKD
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 335 LIRKMLCSQPSERLTAHEVLC 355
           LI+K L   PS+R TA E+L 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  205 bits (523), Expect = 2e-64
 Identities = 97/253 (38%), Positives = 143/253 (56%), Gaps = 18/253 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  +  TG  +A K + K+K+I R++VE    E  I+  +  H  IV + 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRIIVGVVEACHSLGVM 222
            A++    +++V+E   GGELF  + + G +SE      AAE    IV  +E  HSLG++
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE----IVLALEYLHSLGII 115

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-KHYGP 280
           +RDLKPEN LL   D D  +K  DFGL+         T+   G+P Y+APEVLL K YG 
Sbjct: 116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
             D W+ GV+LY +L+G PPF+AE ++ I++ +LK  + F       +S  A+DLI  +L
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF----LSPEARDLISGLL 228

Query: 341 CSQPSERLTAHEV 353
              P++RL +   
Sbjct: 229 QKDPTKRLGSGGA 241

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  198 bits (505), Expect = 2e-61
 Identities = 91/278 (32%), Positives = 132/278 (47%), Gaps = 37/278 (13%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ +G+G F T  L  E  T  E+A K + KR+LI  + V+ V+ E +++  L GH 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK----AAELTRIIVGVVEAC 216
            I+ +   ++D   ++ V+E    GEL   I + G   E+     AAE+   +    E  
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL----EYL 118

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI------------------ 258
           HS G++HRDLKPEN LL   D D  +K  DFG +    P                     
Sbjct: 119 HSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 259 ---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
              F   VG+  YV+PE+L  K  G  +D+W  G I+Y +L+G PPF    +   F  +L
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235

Query: 315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHE 352
           K    F     P     AKDLI K+L   P +RL  +E
Sbjct: 236 KLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNE 269

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  183 bits (468), Expect = 7e-57
 Identities = 93/252 (36%), Positives = 128/252 (50%), Gaps = 44/252 (17%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FGT YL  +  TG + A K I K    S   +E++ REI+I+  L  H NIV + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLN-HPNIVKLY 57

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
           G +ED   +++VME C GG L D + +  G  SE +   +   I+  +E  HS G++HRD
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--KHYGPEA 282
           LKPEN LL    D+  +K  DFGLS        +   +VG+P Y+APEVLL   +Y  ++
Sbjct: 118 LKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D+W+ GVILY L                                      KDLIRKML  
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200

Query: 343 QPSERLTAHEVL 354
            P +R +A E+L
Sbjct: 201 DPEKRPSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  179 bits (457), Expect = 2e-54
 Identities = 90/258 (34%), Positives = 130/258 (50%), Gaps = 24/258 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           + +G +G  +L  + +TG  +A K I K  +I +  V+ V  E  I+      ++   +K
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA---QSPYVVK 57

Query: 167 GAY----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
             Y    + +L   +VME   GG+L   +   G   E  A      IV  +E  HS G++
Sbjct: 58  LYYSFQGKKNLY--LVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQIF--------TDVVGSPYYVAPEV 273
           HRDLKP+N L+   D +  LK  DFGLS       QI           +VG+P Y+APEV
Sbjct: 116 HRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +L + +    D W+ G ILY  L G+PPF  ET + IF  +L G I++  D    +SD A
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA 230

Query: 333 KDLIRKMLCSQPSERLTA 350
            DLI K+L   P +RL A
Sbjct: 231 IDLISKLLVPDPEKRLGA 248

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  171 bits (435), Expect = 2e-51
 Identities = 75/263 (28%), Positives = 130/263 (49%), Gaps = 16/263 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + +++G+G FG  YL    + G  +  K I    + S ++ ED   E++I+  L  H 
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEAC 216
           NI+    ++E+   + IVME   GG+L  +I ++      + E +  +    +   ++  
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL 275
           HS  ++HRD+KP+N  L     +  +K  DFG+S V      +   VVG+PYY++PE+  
Sbjct: 120 HSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI-SDSAK 333
            K Y  ++D+W+ G +LY L +   PF  E    +   +LKG       P P   S   +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY----PPIPSQYSSELR 232

Query: 334 DLIRKMLCSQPSERLTAHEVLCM 356
           +L+  +L   P ER +  ++L  
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  171 bits (436), Expect = 5e-51
 Identities = 89/253 (35%), Positives = 140/253 (55%), Gaps = 19/253 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG G FG   L     +G  +A K +SK K++  + VE V  E +I+  +  H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK----AAELTRIIVGVVEAC 216
            +V + G+++D   +++VME   GGELF  + + G + E      AA+    +V  +E  
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ----VVLALEYL 117

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL- 275
           HSL +++RDLKPEN LL   D D  +K  DFG +   K    +T + G+P Y+APE++L 
Sbjct: 118 HSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR-TYT-LCGTPEYLAPEIILS 172

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           K YG   D W  G+++Y +L+G PPF+ +    I++ +L+G + F S      S  AKDL
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDL 228

Query: 336 IRKMLCSQPSERL 348
           IR +L    ++RL
Sbjct: 229 IRNLLQVDLTKRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  170 bits (433), Expect = 5e-51
 Identities = 88/261 (33%), Positives = 134/261 (51%), Gaps = 14/261 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +T G  LG+G FG+ YL  +  TG   A KS+ +    S E++E + REI+I+  L  H 
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQ-HP 59

Query: 161 NIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV   G+   E+   ++I +E  +GG L   + + G   E    + TR I+  +   HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK---PGQIFTDVVGSPYYVAPEVLL 275
            G++HRD+K  N L+   D D  +K  DFG +        G+    V G+PY++APEV+ 
Sbjct: 120 NGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAK 333
            + YG  AD+W+ G  +  + +G PP+          A+ K     E    P  +S+ AK
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSSGEPPEIPEHLSEEAK 234

Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           D +RK L   P +R TA E+L
Sbjct: 235 DFLRKCLRRDPKKRPTADELL 255

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  170 bits (433), Expect = 6e-51
 Identities = 89/247 (36%), Positives = 131/247 (53%), Gaps = 13/247 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG G FG   L    +    FA K + KR ++     E +  E +I+     H  IV + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++D   ++++ME C GGEL+  +  RG + E  A      +V   E  H+ G+++RDL
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVW 285
           KPEN LL   D +  +K +DFG +   K GQ      G+P YVAPE++L K Y    D W
Sbjct: 120 KPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176

Query: 286 TAGVILYILLSGVPPFWA--ETQQGIFDAVLKG--HIDFESDPWPLISDSAKDLIRKMLC 341
           + G++LY LL+G PPF    E    I++ +LKG   ++F   P   I  +AKDLI+++L 
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF---P-NYIDKAAKDLIKQLLR 232

Query: 342 SQPSERL 348
             P ERL
Sbjct: 233 RNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  158 bits (403), Expect = 1e-46
 Identities = 89/260 (34%), Positives = 127/260 (48%), Gaps = 16/260 (6%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+ +  K+G+G FG  Y      TG E A K I   KL S+E  E +  EIQI+     H
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCK-H 56

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHS 218
            NIV   G+Y     + IVME C+GG L D +       +E + A + + ++  +E  HS
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
            G++HRD+K  N LL     D  +K IDFGLS      +    +VG+PY++APEV+  K 
Sbjct: 117 NGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDFESDPWP-LISDSAKD 334
           Y  +AD+W+ G+    L  G PP+            L             P   SD  KD
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELP----PMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 335 LIRKMLCSQPSERLTAHEVL 354
            ++K L   P +R TA ++L
Sbjct: 230 FLKKCLQKNPEKRPTAEQLL 249

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  161 bits (407), Expect = 4e-46
 Identities = 95/279 (34%), Positives = 137/279 (49%), Gaps = 30/279 (10%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + RKLG+G FG  YL  +       A K ++K+     ++VE   REIQI+  L    
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACH 217
           NIV +   ++D   +++VME   GG L D + + G     SE +A  +   I+  +E  H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-------FTDVVGSPYYVA 270
           S G++HRD+KPEN LL    D   +K IDFGL+                +  VG+P Y+A
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 271 PEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW- 325
           PEVLL     +    +D+W+ G+ LY LL+G+PPF  E         LK  I     P  
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK-IILELPTPSL 235

Query: 326 ---------PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                     LIS +A DL++K+L   P  RL++   L 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  153 bits (390), Expect = 2e-44
 Identities = 81/288 (28%), Positives = 123/288 (42%), Gaps = 39/288 (13%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y +  ++G+G  G  +   +  TG   A K ++ R+L     + +   REI+ +     H
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQAC-QH 58

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHS 218
             +V +   +       +VME      L + +        E +     R+++  V   H+
Sbjct: 59  PYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG--QIFTDVVGSPYYVAPEVLL- 275
            G+MHRDLKP N L+     D  LK  DFGL+  F     ++++  V + +Y APE+L  
Sbjct: 118 NGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLK---------------- 315
            + Y P  D+W  G I   LL+G P F  E    Q  I    L                 
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234

Query: 316 GHIDF-ESDPWPL------ISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
             I F ES P PL       S  A DL++ +L   PS+RL+A E L  
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  153 bits (387), Expect = 3e-44
 Identities = 82/247 (33%), Positives = 127/247 (51%), Gaps = 7/247 (2%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + + +G FG+ YL  + +TG  FA K + K  +I++  V +V+ E  IM        +  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +  +++    +++VME   GG+    I   G   E  A +    +V  VE  H  G++HR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA-D 283
           D+KPEN L+   D    LK  DFGLS   + G      VG+P Y+APE +L     +  D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W+ G +++  L G PPF AET   +FD +L   I++  +     S  A DLI ++LC  
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235

Query: 344 PSERLTA 350
           P++RL A
Sbjct: 236 PAKRLGA 242

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  149 bits (379), Expect = 5e-42
 Identities = 87/277 (31%), Positives = 136/277 (49%), Gaps = 36/277 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG  +L  +  TG  +A K + K  +I R  +  VR E  I+   A    IV + 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADSPWIVKLY 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++D   +++VME   GG+L + +I++  + E  A      +V  +++ H LG +HRD+
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLS-------------------VFFKPGQIFTD------ 261
           KP+N L+   D D  +K  DFGL                    +F     +         
Sbjct: 128 KPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184

Query: 262 -----VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
                 VG+P Y+APEVL    YG E D W+ GVILY +L G PPF+++T Q  ++ ++ 
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244

Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHE 352
                   P P +S  A DLI ++LC  P +RL + E
Sbjct: 245 WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE 280

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  142 bits (360), Expect = 6e-40
 Identities = 82/289 (28%), Positives = 129/289 (44%), Gaps = 47/289 (16%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLA 157
           Y    KLG+G +G  Y   +  TG   A K I   +L + E+      +R EI ++  L 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTALR-EISLLKELK 56

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RII--QRGHYSERKAAELTRIIVGVV 213
            H NIV +         +++V E C      D  + +  + G  S      +   ++  +
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPE 272
             CHS  ++HRDLKP+N +L+N+D    LK  DFGL+  F  P + +T  V + +Y APE
Sbjct: 112 AYCHSHRILHRDLKPQN-ILINRDG--VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPE 168

Query: 273 VLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IFD-------------AV 313
           +LL  KHY    D+W+ G I   +++G P F  +++      IF                
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228

Query: 314 LKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           L  +      F         P +     DL+ KML   P++R++A E L
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  139 bits (353), Expect = 6e-39
 Identities = 85/264 (32%), Positives = 131/264 (49%), Gaps = 20/264 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+LY    K+G+G  G  Y  T+ ATG E A K +     + +++ E +  EI IM    
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCK 73

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H NIV    +Y     + +VME   GG L D I Q  ++      ++  +   V++   
Sbjct: 74  -HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ--NFVRMNEPQIAYVCREVLQGLE 130

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGSPYYVAPEV 273
             HS  V+HRD+K +N LL +KD   S+K  DFG +      +     VVG+PY++APEV
Sbjct: 131 YLHSQNVIHRDIKSDNILL-SKDG--SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDF-ESDPWPLISD 330
           + +  YGP+ D+W+ G++   +  G PP+  E   + +F    KG       + W   S 
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW---SP 244

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             KD + K L   P +R +A E+L
Sbjct: 245 EFKDFLNKCLVKDPEKRPSAEELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  139 bits (351), Expect = 1e-38
 Identities = 75/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G FG  +L  +  +   +A K ++  ++I  +  + V  E +++  ++ H  I+ + 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLF 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
               D   ++++ME   GGELF  +   G +S          IV  +E  HS  +++RDL
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVLL-KHYGPEADV 284
           KPEN LL   D +  +K  DFG   F K  +  T  + G+P Y+APEV+  K +    D 
Sbjct: 128 KPENILL---DKEGHIKLTDFG---FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDW 181

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G+++Y +L G PPF+ +   GI++ +L G ++F       +   AKDLI+K+L    
Sbjct: 182 WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH----LDLYAKDLIKKLLVVDR 237

Query: 345 SERL 348
           + RL
Sbjct: 238 TRRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  139 bits (352), Expect = 2e-38
 Identities = 85/249 (34%), Positives = 136/249 (54%), Gaps = 15/249 (6%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
           +G  LG G FG   +     TG  +A K + KR+++  + V+ V +E  I+  L+ H  I
Sbjct: 22  MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFI 80

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           V +  +++D   V+ ++E   GGELF  + + G +    A      +V   E  HS  ++
Sbjct: 81  VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +RDLKPEN LL   D+   +K  DFG   F K  P + FT + G+P Y+APEV+  K +G
Sbjct: 141 YRDLKPENLLL---DNKGHVKVTDFG---FAKKVPDRTFT-LCGTPEYLAPEVIQSKGHG 193

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D WT GV+LY  ++G PPF+ +T   I++ +L G + F +  W      A+DL++ +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGL 249

Query: 340 LCSQPSERL 348
           L +  ++RL
Sbjct: 250 LQTDHTKRL 258

Length = 329

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  136 bits (345), Expect = 4e-38
 Identities = 75/255 (29%), Positives = 123/255 (48%), Gaps = 18/255 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G FG   +  +  T   FA K ++K+K + +  V +V  E +I+  L  H 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HP 60

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEAC 216
            +V +  +++D   +++V++L  GG+L   + Q+  +SE    E  +     IV  +E  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE----EQVKFWICEIVLALEYL 116

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL- 275
           HS G++HRD+KP+N LL   D+   +   DF ++    P  + T   G+P Y+APEVL  
Sbjct: 117 HSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--WPLISDSAK 333
           + Y    D W+ GV  Y  L G  P+   ++               +D       S  A 
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQETADVLYPATWSTEAI 230

Query: 334 DLIRKMLCSQPSERL 348
           D I K+L   P +RL
Sbjct: 231 DAINKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 7e-38
 Identities = 79/257 (30%), Positives = 124/257 (48%), Gaps = 12/257 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  +G+G FG  Y    + TG   A K IS  K I  E ++ + +EI ++ +L  H 
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLK-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV   G+ E S  ++I++E    G L   I + G + E   A     ++  +   H  G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVL-LKHY 278
           V+HRD+K  N +L  KD    +K  DFG++       +    VVG+PY++APEV+ +   
Sbjct: 120 VIHRDIKAAN-ILTTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
              +D+W+ G  +  LL+G PP++       +F  V   H          IS   KD + 
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG----ISPELKDFLM 232

Query: 338 KMLCSQPSERLTAHEVL 354
           +     P+ R TA ++L
Sbjct: 233 QCFQKDPNLRPTAKQLL 249

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  136 bits (346), Expect = 9e-38
 Identities = 86/291 (29%), Positives = 136/291 (46%), Gaps = 49/291 (16%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHH 155
           Y  G+KLG+G +   Y   +  TG   A K I   KL  R++ +D       REI+++  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQE 58

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAG---GELFDRII--QRGHYSERKAAELTRIIV 210
           L  H NI+ +   +     +++V E         + D+ I          K+     + +
Sbjct: 59  LK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADI---KS--YMLMTL 112

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYV 269
             +E  HS  ++HRDLKP N L+     D  LK  DFGL+  F  P +  T  V + +Y 
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV---------- 313
           APE+L   +HYG   D+W+ G I   LL  VP    ++   Q G IF+A+          
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 314 ---LKGHIDFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
              L  +++F+  P       +P  SD A DL++++L   P++R+TA + L
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 1e-37
 Identities = 79/288 (27%), Positives = 119/288 (41%), Gaps = 44/288 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG 158
           Y    K+G+G +G  Y   +  TG   A K I  R      +       REI+++  L  
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELN- 56

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           H NI+ +   +     +++V E       +L     ++    E         ++  +  C
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFC 114

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL 275
           HS G++HRDLKPEN LL+N +    LK  DFGL+  F  P + +T  V + +Y APE+LL
Sbjct: 115 HSHGILHRDLKPEN-LLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171

Query: 276 --KHYGPEADVWTAGVILYILLSGVPPF-----------------------WAETQQGIF 310
             K Y    D+W+ G I   LLS  P F                       W +      
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231

Query: 311 DAVLKGHIDFESDPWPLI----SDSAKDLIRKMLCSQPSERLTAHEVL 354
           +            P P +    S  A DL+ +ML   P +R+TA + L
Sbjct: 232 NYKFS-FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 1e-35
 Identities = 87/278 (31%), Positives = 131/278 (47%), Gaps = 41/278 (14%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG+G  G  +L     TG  FA K + K+++I R  V+ V  E +I+  L  H  + T
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERK-----AAELTRIIVGVVEACHS 218
           +  +++    + +VM+ C GGELF     Q G     +     AAE    ++  +E  H 
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE----VLLALEYLHL 121

Query: 219 LGVMHRDLKPENFLL------VNKDDDFSLKAIDFGLSVFF---------KPGQIFTDV- 262
           LG+++RDLKPEN LL      +  D D S ++      V               I ++  
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 263 -----------VGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIF 310
                      VG+  Y+APEV+    +G   D WT G++LY +L G  PF    +   F
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241

Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL 348
             +LK  + F     P +S SA+DLIRK+L   PS+RL
Sbjct: 242 SNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 1e-35
 Identities = 81/245 (33%), Positives = 114/245 (46%), Gaps = 11/245 (4%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++GQG +G  +L  +  TG   A K + K  L    +V  V  E  I+      + +V +
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             A++D   +++ ME   GG+    +   G  SE  A      +   V+A H LG +HRD
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADV 284
           LKPENFL+   D    +K  DFGLS           VVGSP Y+APEVL  K Y    D 
Sbjct: 127 LKPENFLI---DASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWPLISDSAKDLIRKML 340
           W+ G +LY  L G PPF   T    ++ +       +     DP   +SD A DLI K++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 341 CSQPS 345
                
Sbjct: 242 NDPSR 246

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  131 bits (332), Expect = 3e-35
 Identities = 86/249 (34%), Positives = 129/249 (51%), Gaps = 20/249 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    ++   +A K +SK ++I R D      E  IM H A  + IV + 
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIVQLH 109

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHY--SERKAAELTRIIVGVVEACHSLGVMHR 224
            A++D   +++VME   GG+L + +    +Y   E+ A   T  +V  ++A HS+G +HR
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTD-VVGSPYYVAPEVLLK-----H 277
           D+KP+N LL   D    LK  DFG  +     G +  D  VG+P Y++PEVL       +
Sbjct: 167 DVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDSAKDL 335
           YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + F  D    IS  AKDL
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEISKQAKDL 281

Query: 336 IRKMLCSQP 344
           I   L  + 
Sbjct: 282 ICAFLTDRE 290

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  127 bits (320), Expect = 3e-34
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 20/266 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHL 156
           + L R LG G +G  +L  ++     G  +A K + K  ++ + +  E  R E Q++  +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++   GGELF  + QR H++E +       IV  ++  
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT--DVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F   +        G+  Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 275 LKH---YGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL 327
                 +    D W+ GV+ + LL+G  PF  +    +Q  I   +LK    F       
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT---- 234

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEV 353
           +S  A+D I+K+L   P +RL A+  
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGA 260

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  126 bits (318), Expect = 5e-34
 Identities = 74/261 (28%), Positives = 112/261 (42%), Gaps = 26/261 (9%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSI------SKRKLISREDVEDVRREIQIMHHLAGH 159
            LGQG  G  Y      TG  +A K I        RK +         RE++ +      
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL--------LRELKTLRS-CES 58

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS- 218
             +V   GA+     + IV+E   GG L D + + G   E   A + R I+  ++  H+ 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLL-K 276
             ++HRD+KP N LL+N   +  +K  DFG+S   +      +  VG+  Y++PE +  +
Sbjct: 119 RHIIHRDIKPSN-LLINSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-DFESDPWP--LISDSAK 333
            Y   AD+W+ G+ L     G  PF    Q   F+  L   I D      P    S   +
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE--LMQAICDGPPPSLPAEEFSPEFR 233

Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           D I   L   P +R +A E+L
Sbjct: 234 DFISACLQKDPKKRPSAAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 1e-33
 Identities = 82/289 (28%), Positives = 135/289 (46%), Gaps = 59/289 (20%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L  +  TG  +A K + K +++ +E V  VR E  I+   A +  +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VVEACHSLGVM 222
            +++D   ++++ME   GG++   ++++  ++E    E TR  +      +++ H LG +
Sbjct: 68  YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE----EETRFYIAETILAIDSIHKLGYI 123

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--------------PGQIFTD------- 261
           HRD+KP+N LL   D    +K  DFGL    K                  F D       
Sbjct: 124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 262 ------------------VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFW 302
                              VG+P Y+APEV L+  Y  E D W+ GVI+Y +L G PPF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 303 AETQQGIFDAVL--KGHIDFESD-PWPLISDSAKDLIRKMLCSQPSERL 348
           ++  Q  +  ++  K  + F  + P   +S  AKDLI+++ C     RL
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVP---LSPEAKDLIKRLCCE-AERRL 285

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  125 bits (315), Expect = 1e-33
 Identities = 83/269 (30%), Positives = 127/269 (47%), Gaps = 35/269 (13%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
            +G+G FGT       + G     K I    +  +E  + V  E+ I+  L  H NIV  
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS-EVNILRELK-HPNIVR- 63

Query: 166 KGAYED------SLCVHIVMELCAGGELFDRIIQRGHYSERKAAE---LTRIIVGVVEA- 215
              Y D      +  ++IVME C GG+L  ++IQ+    ERK  E   + RI+  ++ A 
Sbjct: 64  ---YYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKC-KKERKYIEEEFIWRILTQLLLAL 118

Query: 216 --CHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPY 267
             CH+       V+HRDLKP N  L   D + ++K  DFGL+        F    VG+PY
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175

Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           Y++PE L    Y  ++D+W+ G ++Y L +  PPF A  Q  +   + +G         P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF----RRIP 231

Query: 327 LI-SDSAKDLIRKMLCSQPSERLTAHEVL 354
              S    ++I+ ML   P +R +  E+L
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  125 bits (316), Expect = 2e-33
 Identities = 82/246 (33%), Positives = 125/246 (50%), Gaps = 14/246 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            +++  D LC   VME   GGELF  + +   +SE +A      IV  +   HS  V++R
Sbjct: 62  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           DLK EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232

Query: 343 QPSERL 348
            P +RL
Sbjct: 233 DPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 8e-33
 Identities = 83/263 (31%), Positives = 129/263 (49%), Gaps = 21/263 (7%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLAGHK 160
            G+ LGQG FG  YLC ++ TG E A K +         +++V  +  EIQ++ +L  H+
Sbjct: 6   RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HE 64

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            IV   G   D   + I ME   GG + D++   G  +E    + TR I+  VE  HS  
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM 124

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFG----LSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           ++HRD+K  N L   +D   ++K  DFG    L      G     V G+PY+++PEV+  
Sbjct: 125 IVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWA--ETQQGIFDAVLKGHIDFESDPW--PLISDS 331
             YG +ADVW+ G  +  +L+  PP WA  E    IF    +      ++P     +S  
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPQLPSHVSPD 235

Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           A++ +R+       +R +A E+L
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 8e-33
 Identities = 86/288 (29%), Positives = 130/288 (45%), Gaps = 44/288 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + ++LG G FG+ YL     TG   A K + K+K  S E+  ++R E++ +  L  H 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLR-EVKSLRKLNEHP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHS 218
           NIV +K  + ++  ++ V E    G L+  +  R    +SE     +   I+  +   H 
Sbjct: 59  NIVKLKEVFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G  HRDLKPEN L+   +    +K  DFGL+   +    +TD V + +Y APE+LL+  
Sbjct: 118 HGFFHRDLKPENLLVSGPE---VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRST 174

Query: 278 -YGPEADVWTAGVILYILLSGVPPF--WAETQQGIFD--AVLKGHIDFESDPWP------ 326
            Y    D+W  G I+  L +  P F   +E  Q ++   +VL G        WP      
Sbjct: 175 SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVL-GT--PTKQDWPEGYKLA 230

Query: 327 -----------------LI---SDSAKDLIRKMLCSQPSERLTAHEVL 354
                            LI   S  A DLI+ ML   P +R TA + L
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  121 bits (306), Expect = 2e-32
 Identities = 75/269 (27%), Positives = 120/269 (44%), Gaps = 20/269 (7%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L   +G G     Y    +    + A K I   K   +  V+++R+E+Q M     
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK--CQTSVDELRKEVQAMSQCN- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFD---RIIQRGHYSERKAAELTRIIVGVVEA 215
           H N+V    ++     + +VM   +GG L D       RG   E   A + + ++  +E 
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQIF----TDVVGSPYYVA 270
            HS G +HRD+K  N LL    +D S+K  DFG+S      G          VG+P ++A
Sbjct: 118 LHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 271 PEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH---IDFESDPW 325
           PEV+ +   Y  +AD+W+ G+    L +G  P+       +    L+     ++  +D  
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
              S S + +I   L   PS+R TA E+L
Sbjct: 235 KY-SKSFRKMISLCLQKDPSKRPTAEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  121 bits (306), Expect = 6e-32
 Identities = 86/272 (31%), Positives = 129/272 (47%), Gaps = 41/272 (15%)

Query: 110 GQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY 169
           G +G  YL     T   FA K I+K+ LI R  ++ V  E  I+   A +  +V++  ++
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSF 70

Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLGVMHRD 225
           E    + +VME   GG+    +   G        ++ R+     V  +E  H+ G++HRD
Sbjct: 71  ETKRHLCMVMEYVEGGDCATLLKNIGALP----VDMARMYFAETVLALEYLHNYGIVHRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFF--------------KPGQIFTD--VVGSPYYV 269
           LKP+N L+ +      +K  DFGLS                 K  + F D  V G+P Y+
Sbjct: 127 LKPDNLLITSMG---HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183

Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-- 326
           APEV+L+  YG   D W  G+ILY  L G  PF+ +T + +F  V+   I+     WP  
Sbjct: 184 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----WPEG 238

Query: 327 --LISDSAKDLIRKMLCSQPSERL---TAHEV 353
              +   A+DLI ++L   P ERL    A EV
Sbjct: 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEV 270

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  120 bits (302), Expect = 7e-32
 Identities = 79/261 (30%), Positives = 131/261 (50%), Gaps = 18/261 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +KLG+G +G+ Y    ++    +A K +    + S+++ ED   EI+I+  +  H 
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RIIVGVVE---A 215
           NI++ K A+ D   + IVME    G+L  + I +     +   E    RI + ++    A
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
            H   ++HRDLK  N LLV  D    +K  D G+S   K     T  +G+P+Y+APEV  
Sbjct: 119 LHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKKNMAKT-QIGTPHYMAPEVWK 174

Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI-SDSAK 333
              Y  ++D+W+ G +LY + +  PPF A + Q +   V +G    +  P P I S   +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQDLQ 230

Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           + IR ML  +P  R    ++L
Sbjct: 231 NFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  121 bits (306), Expect = 8e-32
 Identities = 74/258 (28%), Positives = 133/258 (51%), Gaps = 11/258 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISRED-VEDVRREIQIMHHL 156
           + L + LG G +G  +L  ++    TG  +A K + K  L+ +   VE  R E  ++ H+
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++  +GGE+F  + QR ++SE +    +  I+  +E  
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF--KPGQIFTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F  +  +      G+  Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
                +G   D W+ G++++ LL+G  PF  E ++     V +  +  +      I   A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 333 KDLIRKMLCSQPSERLTA 350
           +DL+ K+L   P +RL A
Sbjct: 239 QDLLHKLLRKDPKKRLGA 256

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  119 bits (300), Expect = 2e-31
 Identities = 82/270 (30%), Positives = 124/270 (45%), Gaps = 32/270 (11%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAG 158
            G K+G G FG  Y    + TG   A K I    +  K I     +++  E++++  L  
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-----KEIADEMKVLELLK- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H N+V   G       V+I ME C+GG L + +       E      T  ++  +   HS
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPYYVAPEV 273
            G++HRD+KP N  L   D +  +K  DFG +V  K      G+    + G+P Y+APEV
Sbjct: 118 HGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 274 L----LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ--GIFDAVLKGHIDFESDPWP- 326
           +     K +G  AD+W+ G ++  + +G  P W+E      I   V  GH      P P 
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVGAGH----KPPIPD 229

Query: 327 --LISDSAKDLIRKMLCSQPSERLTAHEVL 354
              +S   KD + + L S P +R TA E+L
Sbjct: 230 SLQLSPEGKDFLDRCLESDPKKRPTASELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  120 bits (302), Expect = 2e-31
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 62  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 120 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232

Query: 343 QPSERL 348
            P +RL
Sbjct: 233 DPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  120 bits (302), Expect = 7e-31
 Identities = 87/309 (28%), Positives = 139/309 (44%), Gaps = 66/309 (21%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + +G G FG   L  ++ T   +A K++ K  ++ R     V+ E  I+   A ++ +V 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  +++D   ++ VM+   GG++   +I+ G + E  A    AELT  I    E+ H +G
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAI----ESVHKMG 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL---------SVFFKPGQ-------------- 257
            +HRD+KP+N L+   D D  +K  DFGL         S +++ G               
Sbjct: 122 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 258 ---------------------IFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
                                +   +VG+P Y+APEVLL+  Y    D W+ GVILY +L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 296 SGVPPFWA----ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH 351
            G PPF A    ETQ  + +     HI  ++     +S  A DLI + LC    +RL  +
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAK----LSREASDLILR-LCCGAEDRLGKN 293

Query: 352 EVLCMYNLP 360
               +   P
Sbjct: 294 GADEIKAHP 302

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 8e-31
 Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 74/302 (24%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAG 158
            ++G+G +G  Y      TG   A K I       R + E         REI+++  L  
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI-------RMENEKEGFPITAIREIKLLQKL-R 56

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELF--------D--RIIQRG--HYSERKAAELT 206
           H NIV +K           ++     G ++        D   ++      ++E +     
Sbjct: 57  HPNIVRLKE----------IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM 106

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVG 264
           + ++  ++  HS G++HRD+K  N L+   ++D  LK  DFGL+  +       +T+ V 
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDF 320
           + +Y  PE+LL    YGPE D+W+ G IL  L  G P F   T+    + + +  G    
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223

Query: 321 ESDPWP---------------------------LISDSAKDLIRKMLCSQPSERLTAHEV 353
           E+  WP                           LI  SA DL+ K+L   P +R++A + 
Sbjct: 224 EN--WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281

Query: 354 LC 355
           L 
Sbjct: 282 LQ 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  117 bits (295), Expect = 8e-31
 Identities = 85/256 (33%), Positives = 125/256 (48%), Gaps = 12/256 (4%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           G  LG G FG+ Y    +  G  FA K  S++      +E V+ + +EI ++  L  H N
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPN 63

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           IV   G   +   ++I +EL  GG L   + + G + E      TR I+  +E  H    
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYG 279
           +HRD+K  N L+   D +  +K  DFG++             GSPY++APEV+ +   YG
Sbjct: 124 VHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRK 338
             AD+W+ G  +  + +G PP W++ +     AV K     E  P P  +SD AKD I K
Sbjct: 181 LAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 339 MLCSQPSERLTAHEVL 354
            L   PS R TA E+L
Sbjct: 238 CLQRDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  117 bits (295), Expect = 9e-31
 Identities = 80/251 (31%), Positives = 122/251 (48%), Gaps = 19/251 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG    C   ATG  +ACK + K++L  R+  +    E +I+      + IV++ 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLA 59

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVM 222
            A+E  D LC  +VM L  GG+L   I   G   + E +A      I+  +E  H   ++
Sbjct: 60  YAFETKDDLC--LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           +RDLKPEN LL   DD  +++  D GL+V  K G+      G+P Y+APEVL    Y   
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 282 ADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            D +  G  LY +++G  PF        ++ +    L+  +++        S  AKDL  
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK----FSPEAKDLCE 230

Query: 338 KMLCSQPSERL 348
            +L   P +RL
Sbjct: 231 ALLQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 2e-30
 Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 17/254 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVT 164
           +G+G FG  Y   +  T   +A K +SK++++++++V     E  I+      ++  IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +K +++    +++V +  +GGELF  + + G +SE +A      +V  +E  H   +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL--KHY 278
           DLKPEN LL   D    +   DFGLS   K             G+  Y+APEVLL  K Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
               D W+ GV+++ +  G  PF+AE  Q ++  +  G + F   P  ++SD  +  ++ 
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKG 231

Query: 339 MLCSQPSERLTAHE 352
           +L   P  RL AH 
Sbjct: 232 LLNRNPQHRLGAHR 245

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  117 bits (296), Expect = 2e-30
 Identities = 81/254 (31%), Positives = 135/254 (53%), Gaps = 18/254 (7%)

Query: 105 RKLGQGQFGTTYLC---TEIATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHK 160
           + LG+G +G  +     T   TG  FA K + K  ++ +++D    + E  I+  +  H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HP 60

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            IV +  A++    +++++E  +GGELF  + + G + E  A      I   +E  H  G
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPGQIFTDVVGSPYYVAPEVLLKH 277
           +++RDLKPEN LL   D    +K  DFGL   S+    G +     G+  Y+APE+L++ 
Sbjct: 121 IIYRDLKPENILL---DAQGHVKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175

Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +G   D W+ G ++Y +L+G PPF AE ++   D +LKG ++      P ++  A+DL+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231

Query: 337 RKMLCSQPSERLTA 350
           +K+L   PS RL A
Sbjct: 232 KKLLKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  116 bits (293), Expect = 3e-30
 Identities = 82/286 (28%), Positives = 129/286 (45%), Gaps = 41/286 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +  K+G+G F          TG  +A K + K+   S E V ++R EIQ +  L+ H 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHP 58

Query: 161 NIVTIKGAYEDSL--CVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVEACH 217
           NI+ +     D     + +V EL     L++ I  R     E++       ++  ++  H
Sbjct: 59  NILRLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFG--LSVFFKPGQIFTDVVGSPYYVAPEVLL 275
             G+ HRD+KPEN L+     D  LK  DFG    ++ KP   +T+ + + +Y APE LL
Sbjct: 118 RNGIFHRDIKPENILI----KDDILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLL 171

Query: 276 K--HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFD-------AVLK-----GH 317
              +YGP+ D+W  G + + +LS  P F    +      I D        VLK      H
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231

Query: 318 IDFESDP---------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +++              P  S    DL++K+L   P ER+TA + L
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  117 bits (294), Expect = 4e-30
 Identities = 85/266 (31%), Positives = 131/266 (49%), Gaps = 30/266 (11%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +  E ATG  +A K + K  L+++E V     E  I+  ++    I  ++
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDIL-SISNSPWIPQLQ 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKA----AELTRIIVGVVEACHSLG 220
            A++D   +++VME   GG+L   ++ R    + E  A    AEL   I  V    H +G
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSV----HQMG 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAPEVLLK-- 276
            +HRD+KPEN L+   D    +K  DFG +        + + + VG+P Y+APEVL    
Sbjct: 123 YVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 277 -----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLIS 329
                 YG E D W+ GVI Y ++ G  PF   T    ++ ++  +  + F  D  P +S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED--PKVS 237

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLC 355
               DLI+ +LC    ERL  +E LC
Sbjct: 238 SDFLDLIQSLLCG-QKERL-GYEGLC 261

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  116 bits (292), Expect = 4e-30
 Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 10/206 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A K ++ ++   +E + +   EI +M     H 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---EILVMRENK-HP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 136 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (289), Expect = 6e-30
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 28/267 (10%)

Query: 102 TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           TLG+KLG+G FG  Y            +E A K++ +    S + +E+  RE +IM  L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKL- 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H N+V + G   +   ++IVME   GG+L   +  R +  +   ++L    + +     
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGME 116

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG-SPY-YVAPE 272
              S   +HRDL   N L+    ++  +K  DFGLS        +    G  P  ++APE
Sbjct: 117 YLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173

Query: 273 VLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
            L +  +  ++DVW+ GV+L+ + + G  P+   + + + + +  G+        P   +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR------LPQPPN 227

Query: 331 SAKDLIRKML-C--SQPSERLTAHEVL 354
              +L   ML C    P +R T  E++
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  115 bits (290), Expect = 7e-30
 Identities = 74/261 (28%), Positives = 134/261 (51%), Gaps = 20/261 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHL 156
           + L + LG G +G  +L  +++   +G  +A K + K  ++ + +  E  R E Q++ H+
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++   GGELF  + QR  + E++    +  IV  +E  
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F   ++       G+  Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 275 L---KHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL 327
                 +    D W+ GV++Y LL+G  PF  +    +Q  I   +LK    +  +   L
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238

Query: 328 ISDSAKDLIRKMLCSQPSERL 348
               AKD+I+++L   P +RL
Sbjct: 239 ----AKDIIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 8e-30
 Identities = 78/256 (30%), Positives = 136/256 (53%), Gaps = 23/256 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +     TG  +A K ++K +++ R +    R E  ++ +    + I  + 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GDRRWITNLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLGVM 222
            A++D   +++VM+   GG+L   +     + +R   ++ R     +V  +++ H LG +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVL------ 274
           HRD+KP+N LL   D +  ++  DFG  +     G + ++V VG+P Y++PE+L      
Sbjct: 125 HRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDSA 332
              YGPE D W+ GV +Y +L G  PF+AE+    +  ++  K H  F  D    +S+ A
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSEEA 240

Query: 333 KDLIRKMLCSQPSERL 348
           KDLIR+++CS P  RL
Sbjct: 241 KDLIRRLICS-PETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 9e-30
 Identities = 87/293 (29%), Positives = 126/293 (43%), Gaps = 50/293 (17%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLA 157
            LG  +G+G +G    C   ATG   A K     K    ED EDV+    RE++++  L 
Sbjct: 5   VLGV-VGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQLR 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            H+NIV +K A+     +++V E       EL +     G             ++  +  
Sbjct: 59  -HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAY 115

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF--KPGQIFTDVVGSPYYVAPEV 273
           CHS  ++HRD+KPEN +LV++     LK  DFG +     +P    TD V + +Y APE+
Sbjct: 116 CHSHNIIHRDIKPEN-ILVSESG--VLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Query: 274 LLK--HYGPEADVWTAGVILYILLSGVPPF------------------WAETQQGIF--D 311
           L+   +YG   DVW  G I+  LL G P F                     + Q +F  +
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232

Query: 312 AVLKGHIDFE-SDPWPL-------ISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
               G    E S P  L       +S  A D ++  L   P ERLT  E+L  
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  115 bits (289), Expect = 9e-30
 Identities = 79/264 (29%), Positives = 130/264 (49%), Gaps = 37/264 (14%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T+ +TG + A K +  RK   RE + +   E+ IM     H NIV +
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HPNIVEM 81

Query: 166 KGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
             +Y   D L V  VME   GG L D I+     +E + A +   ++  +   H+ GV+H
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIH 138

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLKH 277
           RD+K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APEV+ + 
Sbjct: 139 RDIKSDSILLTS---DGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEVISRL 190

Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK--- 333
            YG E D+W+ G+++  ++ G PP++ E         L+       +  P + +  K   
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNLPPKLKNLHKVSP 243

Query: 334 ---DLIRKMLCSQPSERLTAHEVL 354
                + +ML   P++R TA E+L
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  115 bits (290), Expect = 2e-29
 Identities = 79/245 (32%), Positives = 127/245 (51%), Gaps = 12/245 (4%)

Query: 105 RKLGQGQFGTTYLCTEIATGIE-FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           R LG G FG   L T         A K   K K+I ++ V+ V  E +I++++  H   V
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCV 94

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
            + G+++D   +++V+E   GGE F  + +   +           IV + E   SL +++
Sbjct: 95  NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEA 282
           RDLKPEN LL   D D  +K  DFG +      + +T + G+P Y+APE+LL   +G  A
Sbjct: 155 RDLKPENLLL---DKDGFIKMTDFGFAKVVDT-RTYT-LCGTPEYIAPEILLNVGHGKAA 209

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D WT G+ +Y +L G PPF+A     I+  +L+G I F       + ++ K L++K+L  
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSH 265

Query: 343 QPSER 347
             ++R
Sbjct: 266 DLTKR 270

Length = 340

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  115 bits (290), Expect = 2e-29
 Identities = 75/255 (29%), Positives = 122/255 (47%), Gaps = 19/255 (7%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG+G FG   L     T   +A K + K  ++  +DVE    E +++     H  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 165 IKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +   +  +D L    VME   GG+L   I + G + E +A      IV  ++  H  G++
Sbjct: 61  LHSCFQTKDRLF--FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK----PGQIFTDVVGSPYYVAPEVLLKH- 277
           +RDLK +N LL   D +  +K  DFG+    K     G   +   G+P Y+APE+L    
Sbjct: 119 YRDLKLDNVLL---DSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQP 172

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YGP  D W  GV+LY +L+G  PF  + +  +F ++L+  + +    W  +S  AK +++
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--W--LSKEAKSILK 228

Query: 338 KMLCSQPSERLTAHE 352
             L   P +RL    
Sbjct: 229 SFLTKNPEKRLGCLP 243

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (284), Expect = 4e-29
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 27/267 (10%)

Query: 102 TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           TLG+KLG+G FG  Y  T         +E A K++ +    S + +E+  RE +IM  L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA--SEQQIEEFLREARIMRKL- 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G   +   + IVME   GG+L D + +     E   ++L    + +     
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGME 117

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG-SPY-YVAPE 272
              S   +HRDL   N L+    ++  +K  DFGLS        +    G  P  ++APE
Sbjct: 118 YLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174

Query: 273 VLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
            L +  +  ++DVW+ GV+L+ + + G  P+   +   + + + KG+        P   +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL------PKPPN 228

Query: 331 SAKDLIRKML-C--SQPSERLTAHEVL 354
              +L + ML C    P +R T  E++
Sbjct: 229 CPPELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 7e-29
 Identities = 85/307 (27%), Positives = 142/307 (46%), Gaps = 73/307 (23%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVT 164
           +G+G FG   L  +  TG  +A K++ K ++  ++ +  V+ E  +   LA   +  +V+
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV---LAESDSPWVVS 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLG 220
           +  +++D+  ++++ME   GG+L   +I+   +SE    ++TR      V  +EA H LG
Sbjct: 66  LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE----DVTRFYMAECVLAIEAVHKLG 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------------------KPG------ 256
            +HRD+KP+N L+   D    +K  DFGLS  F                  K        
Sbjct: 122 FIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 257 --------------QIFT----------DVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL 291
                         QI T            VG+P Y+APE+ L+  YG E D W+ G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 292 YILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL- 348
           +  L G PPF +E     +  ++  +  + F  D    +S  A+DLIR+++ +    RL 
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLITN-AENRLG 295

Query: 349 --TAHEV 353
              AHE+
Sbjct: 296 RGGAHEI 302

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  112 bits (282), Expect = 7e-29
 Identities = 80/249 (32%), Positives = 124/249 (49%), Gaps = 11/249 (4%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVS 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G   + E +A      I   +E  H   
Sbjct: 65  LAYAYETKDALC--LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 123 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G +LY +++G  PF    ++   + V +   + + +     S  A+ L + +
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239

Query: 340 LCSQPSERL 348
           LC  P ERL
Sbjct: 240 LCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  113 bits (284), Expect = 8e-29
 Identities = 74/246 (30%), Positives = 120/246 (48%), Gaps = 9/246 (3%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG   L     +G  +A K + K  ++  +DVE    E +I+     H  +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    +  VME   GG+L   I +   + E +A      I   +   H  G+++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           DLK +N LL   D +   K  DFG+       G+  +   G+P Y+APE+L +  YGP  
Sbjct: 121 DLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV+LY +L G  PF AE +  +F+A+L   + + +  W  +S  A D+++  +  
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTK 233

Query: 343 QPSERL 348
            P+ RL
Sbjct: 234 NPTMRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  114 bits (286), Expect = 1e-28
 Identities = 88/257 (34%), Positives = 133/257 (51%), Gaps = 22/257 (8%)

Query: 95  DNIRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           + IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      
Sbjct: 33  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E  IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  
Sbjct: 93  ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 150

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSP 266
           +V  ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207

Query: 267 YYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHID 319
            Y++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + 
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 267

Query: 320 FESDPWPLISDSAKDLI 336
           F  D    IS  AK+LI
Sbjct: 268 FPDD--NDISKEAKNLI 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-28
 Identities = 76/266 (28%), Positives = 135/266 (50%), Gaps = 25/266 (9%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-VEDVRREIQIMHHL-- 156
           LY     +G+G +G  Y    + TG   A K I+   L + +D V D++RE+ ++  L  
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQ 58

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEA 215
           +   NI    G+Y     + I+ME   GG +  R + + G  +E+  + + R ++  ++ 
Sbjct: 59  SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKY 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVL 274
            H +GV+HRD+K  N L+ N  +   +K  DFG++          +  VG+PY++APEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173

Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-LKGHID---FESDPWPLI 328
              K+Y  +AD+W+ G+ +Y + +G PP+   +    F A+ L         E + +   
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGY--- 227

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           S   ++ +   L  +P ERL+A E+L
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELL 253

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  112 bits (282), Expect = 2e-28
 Identities = 82/247 (33%), Positives = 128/247 (51%), Gaps = 15/247 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 62  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 120 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 176

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L 
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLSGLLK 232

Query: 342 SQPSERL 348
             P +RL
Sbjct: 233 KDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  112 bits (281), Expect = 2e-28
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 24/251 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E A+G  +A K + K  +I++++V     E +++ +   H  + ++K
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            +++  D LC   VME   GGELF  + +   +SE +       IV  ++  HS  +++R
Sbjct: 62  YSFQTKDRLC--FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLLKH- 277
           DLK EN +L   D D  +K  DFGL    K G   TD        G+P Y+APEVL  + 
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLC---KEG--ITDAATMKTFCGTPEYLAPEVLEDND 171

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YG   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F   P  L +D AK L+ 
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF---PRTLSAD-AKSLLS 227

Query: 338 KMLCSQPSERL 348
            +L   P++RL
Sbjct: 228 GLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-28
 Identities = 76/244 (31%), Positives = 122/244 (50%), Gaps = 10/244 (4%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG      +  T   +A K+I K  ++SR +V     E  ++  +     IV +K
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++    +++V+    GGELF  + + G +   +A   T  ++  +E  H   V++RDL
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL          T+   G+P Y+APE+LL H Y    D 
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           WT GV+LY +L+G+PPF+ E    ++  +L+  + F           AKDL+  +L   P
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRDP 232

Query: 345 SERL 348
           + RL
Sbjct: 233 TRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 2e-28
 Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 57/281 (20%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           +L+TL   +G+G FG  Y   +  T    A K I   +  + +++ED+++EIQ +     
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRS 58

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              I    G++     + I+ME C GG   D +++ G   E   A + R ++  +E  H 
Sbjct: 59  -PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FT-----DVVGSPYYVAPE 272
            G +HRD+K  N LL  + D   +K  DFG+S     GQ+  T       VG+P+++APE
Sbjct: 117 EGKIHRDIKAANILLSEEGD---VKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168

Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---- 327
           V+ +  Y  +AD+W+ G+    L  G PP                     SD  P+    
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPL--------------------SDLHPMRVLF 208

Query: 328 --------------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                          S   KD +   L   P ER +A E+L
Sbjct: 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 4e-28
 Identities = 87/276 (31%), Positives = 129/276 (46%), Gaps = 38/276 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           ++ Y L +++G G +G  Y   +IATG   A K I   KL   +D E +++EI ++    
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKE-C 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEA 215
            H NIV   G+Y     + IVME C GG L D I Q  RG  SE + A + R  +  +  
Sbjct: 58  RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAY 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYV 269
            H  G +HRD+K  N LL    +D  +K  DFG+S      Q+   +      +G+PY++
Sbjct: 117 LHETGKIHRDIKGANILLT---EDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWM 168

Query: 270 APEVLLKH----YGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDFESDP 324
           APEV        Y  + D+W  G+    L    PP +     + +F       I   + P
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LISKSNFP 222

Query: 325 WPLISDSAK------DLIRKMLCSQPSERLTAHEVL 354
            P + D  K      D I+K L   P +R TA ++L
Sbjct: 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLL 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (275), Expect = 6e-28
 Identities = 79/270 (29%), Positives = 130/270 (48%), Gaps = 33/270 (12%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           +++ +  KLG+G +G+ Y      TG   A K +        ED++++ +EI I+     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-----VEEDLQEIIKEISILKQ-CD 56

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEAC 216
              IV   G+Y  +  + IVME C  G + D  +I  +    E  AA L + + G+    
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE-YL 115

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT------DVVGSPYYVA 270
           HS   +HRD+K  N LL   +++   K  DFG+S     GQ+         V+G+P+++A
Sbjct: 116 HSNKKIHRDIKAGNILL---NEEGQAKLADFGVS-----GQLTDTMAKRNTVIGTPFWMA 167

Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDP--W 325
           PEV+ +  Y  +AD+W+ G+    +  G PP+ ++    + IF    K      SDP  W
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPY-SDIHPMRAIFMIPNKPPPTL-SDPEKW 225

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
              S    D ++K L   P ER +A ++L 
Sbjct: 226 ---SPEFNDFVKKCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  112 bits (281), Expect = 6e-28
 Identities = 89/297 (29%), Positives = 134/297 (45%), Gaps = 62/297 (20%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L  ++ T   +A K++ K+ +++R  V  V+ E  I+   A ++ +V 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  +++D   ++ VM+   GG++   +I+   + E  A    AELT  I    E+ H +G
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ESVHKMG 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--------------------PGQIFT 260
            +HRD+KP+N L+   D D  +K  DFGL   F+                    P  ++ 
Sbjct: 122 FIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 261 DV----------------------------VGSPYYVAPEVLL-KHYGPEADVWTAGVIL 291
           DV                            VG+P Y+APEVLL K Y    D W+ GVIL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 292 YILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL 348
           + +L G PPF A T       V+         P   +S  A DLI K+ CS   ERL
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA-EERL 294

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  109 bits (274), Expect = 1e-27
 Identities = 78/253 (30%), Positives = 124/253 (49%), Gaps = 11/253 (4%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V 
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVN 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ +  GG+L   I   G+  + E +A      I+  +E  H   
Sbjct: 65  LAYAYETKDALC--LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
            ++RDLKPEN LL   DD   ++  D GL+V    G+     VG+  Y+APEVL  + Y 
Sbjct: 123 TVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G ++Y ++ G  PF    ++   + V +  ++ E       S+ AK + + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239

Query: 340 LCSQPSERLTAHE 352
           L   P +RL   E
Sbjct: 240 LTKDPKQRLGCQE 252

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  108 bits (271), Expect = 2e-27
 Identities = 83/260 (31%), Positives = 130/260 (50%), Gaps = 17/260 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + R +G+G FG   L   + +  ++A K I  R   S   VED R+E  ++  +  H 
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI--RLPKSSSAVEDSRKEAVLLAKMK-HP 58

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGH-YSERKAAE-LTRIIVGVVEACH 217
           NIV  K ++E    ++IVME C GG+L  +I +QRG  + E    +   ++ +G V+  H
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG-VQHIH 117

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLK 276
              V+HRD+K +N  L     +  +K  DFG + +   PG      VG+PYYV PE+   
Sbjct: 118 EKRVLHRDIKSKNIFLTQ---NGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKD 334
             Y  ++D+W+ G ILY L +   PF A + + +   V +G       P P   S   + 
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY----KPLPSHYSYELRS 230

Query: 335 LIRKMLCSQPSERLTAHEVL 354
           LI++M    P  R +A  +L
Sbjct: 231 LIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  111 bits (278), Expect = 2e-27
 Identities = 85/293 (29%), Positives = 130/293 (44%), Gaps = 54/293 (18%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L  ++ T   +A K++ K+ ++ R  V  V+ E  I+   A ++ +V 
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +  +++D   ++ VM+   GG++   +I+ G + E  A      +   VE+ H +G +HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQIFTD---------- 261
           D+KP+N L+   D D  +K  DFGL   F+               Q   D          
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 262 -------------------------VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
                                    +VG+P Y+APEVLL+  Y    D W+ GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 296 SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL 348
            G PPF A+T       V+         P   +S  A DLI K LC  P +RL
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRL 294

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  108 bits (270), Expect = 2e-27
 Identities = 83/267 (31%), Positives = 135/267 (50%), Gaps = 24/267 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSI--SKRKLISREDVEDVRREIQIMHHLAG 158
           + LG+ LGQG FG  YLC +  TG E A K +        + ++V  +  EIQ++ +L  
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL- 62

Query: 159 HKNIVTIKGAYEDSL--CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           H+ IV   G   D +   + I ME   GG + D++   G  +E    + TR I+  V   
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK----PGQIFTDVVGSPYYVAPE 272
           HS  ++HRD+K  N L   +D   ++K  DFG S   +     G     V G+PY+++PE
Sbjct: 123 HSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDPW--PL 327
           V+  + YG +AD+W+ G  +  +L+  PP WAE +    IF    +      ++P   P 
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIATQ-----PTNPVLPPH 233

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +SD  +D ++++   +   R +A E+L
Sbjct: 234 VSDHCRDFLKRIFV-EAKLRPSADELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  110 bits (276), Expect = 2e-27
 Identities = 77/272 (28%), Positives = 124/272 (45%), Gaps = 41/272 (15%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L  +  TG  +A K + K  ++ +E V  +R E  I+   A    +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADSLWVVKMF 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++D L ++++ME   GG++   ++++   +E +        V  +++ H LG +HRD+
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPG------------------------------ 256
           KP+N LL   D    +K  DFGL    K                                
Sbjct: 128 KPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 257 ------QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
                 Q+    VG+P Y+APEV ++  Y    D W+ GVI+Y +L G PPF +ET Q  
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
           +  V+         P   IS+ AKDLI +  C
Sbjct: 245 YKKVMNWKETLIFPPEVPISEKAKDLILRFCC 276

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  110 bits (276), Expect = 3e-27
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 16/245 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + + +G+G FG   L    ++   +A K +SK ++I R D      E  IM   A   
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 103

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +  A++D   +++VME   GG+L + ++      E+ A   T  +V  ++A HS+G
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDV-VGSPYYVAPEVLLK-- 276
           ++HRD+KP+N LL   D    LK  DFG  +   + G +  D  VG+P Y++PEVL    
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 277 ---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDS 331
              +YG E D W+ GV L+ +L G  PF+A++  G +  ++  K  ++F  D    IS  
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE--ISKH 277

Query: 332 AKDLI 336
           AK+LI
Sbjct: 278 AKNLI 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  109 bits (274), Expect = 3e-27
 Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 20/254 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH--HLAGHKNIVT 164
           LG+G FG   L     TG  +A K++ K  +I+R++VE +  E +I    +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    V  VME  AGG+L    I    +SE +A      +V  ++  H   +++R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL-KHYG 279
           DLK +N LL   D +  +K  DFGL    K G  F D      G+P ++APEVL    Y 
Sbjct: 126 DLKLDNLLL---DTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDLIRK 338
              D W  GV++Y +L G  PF  + ++ +FD+++      +   +P  +S  A  ++R+
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSREAISIMRR 234

Query: 339 MLCSQPSERLTAHE 352
           +L   P  RL + E
Sbjct: 235 LLRRNPERRLGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  109 bits (273), Expect = 3e-27
 Identities = 71/244 (29%), Positives = 120/244 (49%), Gaps = 9/244 (3%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  ++  +DV+    E +I+   A H  +  + 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    +  VME   GG+L  +I +   + E ++      +   +   H  GV++RDL
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADV 284
           K +N LL   D +   K  DFG+       G   T   G+P Y+APE+L +  YGP  D 
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV++Y +++G PPF A+ +  +F+++L  H D     W  +S  A  +++  +   P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESIL--HDDVLYPVW--LSKEAVSILKAFMTKNP 235

Query: 345 SERL 348
           ++RL
Sbjct: 236 NKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  108 bits (271), Expect = 7e-27
 Identities = 70/248 (28%), Positives = 125/248 (50%), Gaps = 9/248 (3%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A G  +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HSL +++RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +  +  +   G+P Y+APEVL K  Y    D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +  + +    IS SA+ L+  +L    
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISVSARHLLEGLLQKDR 235

Query: 345 SERLTAHE 352
           ++RL A +
Sbjct: 236 TKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  107 bits (267), Expect = 1e-26
 Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 10/206 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT +   ++ATG E A K I+ +K   +E + +   EI +M  L  + 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN---EILVMKELK-NP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    ++     + +VME  AGG L D ++      E + A + R  +  +E  H+  
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL       S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 136 VIHRDIKSDNVLLGMDG---SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  108 bits (271), Expect = 1e-26
 Identities = 89/301 (29%), Positives = 132/301 (43%), Gaps = 62/301 (20%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR---REIQIMHHLA 157
           Y L + +G G +G      +  TG + A K IS       +D+ D +   REI+++ HL 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLRHLR 57

Query: 158 GHKNIVTIK-----GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE------LT 206
            H+NI+ +       + ED   V+IV EL    +L  ++I     S +   +      L 
Sbjct: 58  -HENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVI----KSPQPLTDDHIQYFLY 110

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDV 262
           +I+ G+ +  HS  V+HRDLKP N +LVN + D  LK  DFGL+             T+ 
Sbjct: 111 QILRGL-KYLHSANVIHRDLKPSN-ILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEY 166

Query: 263 VGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET---Q-QGIFDAVLKG 316
           V + +Y APE+LL    Y    D+W+ G I   LL+  P F       Q   I + +   
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226

Query: 317 H---IDFESD----------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
               + F +                 P     P  S  A DL+ KML   P +R+TA E 
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286

Query: 354 L 354
           L
Sbjct: 287 L 287

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  108 bits (270), Expect = 1e-26
 Identities = 80/284 (28%), Positives = 128/284 (45%), Gaps = 42/284 (14%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L  +  TG  +A K + K  ++ +E V  +R E  I+    G   +V + 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMF 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++D   ++++ME   GG++   ++++   SE          V  ++A H LG +HRD+
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPG------------------------------ 256
           KP+N LL   D    +K  DFGL    K                                
Sbjct: 128 KPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 257 ------QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
                 Q+    VG+P Y+APEV ++  Y    D W+ GVI+Y +L G PPF +ET Q  
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           +  V+         P   IS+ AKDLI +  C+    R+ ++ V
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILR-FCTDSENRIGSNGV 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 2e-26
 Identities = 79/290 (27%), Positives = 123/290 (42%), Gaps = 44/290 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMHHL--A 157
           Y    ++G+G +GT Y   ++ TG   A K +  R  +S E +     REI ++  L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIALLKQLESF 58

Query: 158 GHKNIVTI-----KGAYEDSLCVHIVMELC----AGGELFDRIIQRGHYSERKAAELTRI 208
            H NIV +         +  L + +V E      A      +  + G        +L R 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT--YLSKCPKPG-LPPETIKDLMRQ 115

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           ++  V+  HS  ++HRDLKP+N +LV  D    +K  DFGL+  +      T VV + +Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQN-ILVTSDG--QVKIADFGLARIYSFEMALTSVVVTLWY 172

Query: 269 VAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFD------------ 311
            APEVLL+  Y    D+W+ G I   L    P F   ++      IFD            
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232

Query: 312 --AVLKGHIDF-----ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             ++ +               P I +   DL++KML   P +R++A E L
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  105 bits (263), Expect = 2e-26
 Identities = 82/261 (31%), Positives = 129/261 (49%), Gaps = 18/261 (6%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSIS--KRKLISREDVEDVRREIQIMHHLAGHKN 161
           G+ LGQG FG  YLC ++ TG E A K +        + ++V  +  EIQ++ +L  H+ 
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HER 65

Query: 162 IVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           IV   G   D     + I ME   GG + D++   G  +E    + TR I+  +   HS 
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFG----LSVFFKPGQIFTDVVGSPYYVAPEVLL 275
            ++HRD+K  N L   +D   ++K  DFG    L      G     V G+PY+++PEV+ 
Sbjct: 126 MIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAK 333
            + YG +ADVW+ G  +  +L+  PP WAE +     A+ K      +   P  IS+ A+
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTNPQLPSHISEHAR 239

Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           D +  +   +   R +A E+L
Sbjct: 240 DFLGCIFV-EARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  105 bits (264), Expect = 3e-26
 Identities = 73/206 (35%), Positives = 108/206 (52%), Gaps = 10/206 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A   I +  L  +   E +  EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 77

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  105 bits (264), Expect = 6e-26
 Identities = 69/246 (28%), Positives = 123/246 (50%), Gaps = 9/246 (3%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A    +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HSL +++RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +     +   G+P Y+APEVL K  Y    D 
Sbjct: 123 KPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +  +    P I++SA+ L+  +L    
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235

Query: 345 SERLTA 350
           ++RL A
Sbjct: 236 TKRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  104 bits (260), Expect = 7e-26
 Identities = 67/259 (25%), Positives = 134/259 (51%), Gaps = 14/259 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   +K+G+G FG   L      G ++  K I+  K+  +E  E+ R+E+ ++ ++  H 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMK-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRG-HYSERKAAELTRIIVGVVEACHS 218
           NIV  + ++E++  ++IVM+ C GG+L+ +I  QRG  + E +  +    I   ++  H 
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-K 276
             ++HRD+K +N  L     D ++K  DFG++ V     ++    +G+PYY++PE+   +
Sbjct: 120 RKILHRDIKSQNIFLTK---DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR 176

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDL 335
            Y  ++D+W  G +LY + +    F A   + +   +++G       P     S   ++L
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY----PPVSSHYSYDLRNL 232

Query: 336 IRKMLCSQPSERLTAHEVL 354
           + ++    P +R + + +L
Sbjct: 233 VSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  104 bits (260), Expect = 1e-25
 Identities = 72/206 (34%), Positives = 111/206 (53%), Gaps = 10/206 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   +IATG E A K ++ ++   +E + +   EI +M     + 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN---EILVMRE-NKNP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  ++  HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 136 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  102 bits (257), Expect = 2e-25
 Identities = 75/260 (28%), Positives = 114/260 (43%), Gaps = 12/260 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   R LG+G FG   L            K ++  +L  +E   D   EI I+  L  H 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQ-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHS 218
           NI+     + D   + I ME   GG L+D+I+++    + E         IV  V   H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-K 276
            G++HRD+K  N  L  K     +K  DFG+S          + VVG+PYY++PE+    
Sbjct: 120 AGILHRDIKTLNIFL-TKAG--LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y  ++D+W  G +LY LL+    F A     +   +++G+       +   S     L+
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLV 233

Query: 337 RKMLCSQPSERLTAHEVLCM 356
             +L   P +R TA EVL  
Sbjct: 234 HSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  104 bits (260), Expect = 2e-25
 Identities = 71/253 (28%), Positives = 133/253 (52%), Gaps = 26/253 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +         FA K ++K +++ R +    R E  ++ +   ++ I T+ 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDNQWITTLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVVEACHSLGVM 222
            A++D   +++VM+   GG+L   +     + +R   ++ R     +V  +++ H L  +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAPEVLLK---- 276
           HRD+KP+N L+   D +  ++  DFG  +   + G + + V VG+P Y++PE+L      
Sbjct: 125 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 277 --HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL----ISD 330
              YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +P     +S+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVTDVSE 238

Query: 331 SAKDLIRKMLCSQ 343
            AKDLIR+++CS+
Sbjct: 239 DAKDLIRRLICSR 251

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  103 bits (257), Expect = 3e-25
 Identities = 77/262 (29%), Positives = 132/262 (50%), Gaps = 33/262 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   +  E  +G + A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQ-HQNVVEM 83

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + ++ME   GG L D I+ +   +E + A +   ++  +   HS GV+HRD
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLKH-Y 278
           +K ++ LL     D  +K  DFG        QI  DV      VG+PY++APEV+ +  Y
Sbjct: 143 IKSDSILLTL---DGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISRTPY 194

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK----- 333
           G E D+W+ G+++  ++ G PP+++++        ++        P P + ++ K     
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNAHKISPVL 247

Query: 334 -DLIRKMLCSQPSERLTAHEVL 354
            D + +ML  +P ER TA E+L
Sbjct: 248 RDFLERMLTREPQERATAQELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  103 bits (257), Expect = 3e-25
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 11/249 (4%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E +I+  +   + +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ +  GG+L   I   G+  + E++A      +   +E      
Sbjct: 65  LAYAYETKDALC--LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    G+     VG+  Y+APEV+  + Y 
Sbjct: 123 IVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G ++Y ++ G  PF    ++   + V +   + + +     S+ AK + R +
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239

Query: 340 LCSQPSERL 348
           L   P ERL
Sbjct: 240 LTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  102 bits (256), Expect = 4e-25
 Identities = 78/249 (31%), Positives = 129/249 (51%), Gaps = 12/249 (4%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG    C   ATG  +ACK ++K++L  R+  E    E +I+  +   + IV++ 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLA 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACHSLGVM 222
            A++    + +VM +  GG+L   I     +   + E +A   T  I+  +E  H   ++
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-KHYGP 280
           +RDLKPEN LL   D+D +++  D GL+V  K GQ  T    G+P ++APE+L  + Y  
Sbjct: 120 YRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDLIRKM 339
             D +  GV LY +++   PF A  ++ + +  LK  I  +S  +P   S ++K     +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 340 LCSQPSERL 348
           L   P +RL
Sbjct: 236 LAKDPEKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  103 bits (258), Expect = 5e-25
 Identities = 71/247 (28%), Positives = 123/247 (49%), Gaps = 15/247 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLGVMHRD 225
             ++    ++ VME   GG+L   I Q G + E  A      I +G+    HS G+++RD
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF-FLHSKGIIYRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGL---SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPE 281
           LK +N +L   D +  +K  DFG+   ++F   G+      G+P Y+APE++  + YG  
Sbjct: 127 LKLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV+LY +L+G PPF  E +  +F ++++ ++ +       +S  A  + + +L 
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLLT 237

Query: 342 SQPSERL 348
             P++RL
Sbjct: 238 KHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  101 bits (253), Expect = 1e-24
 Identities = 72/251 (28%), Positives = 130/251 (51%), Gaps = 11/251 (4%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 82

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEAD 283
           +K ++ LL +   D  +K  DFG      K       +VG+PY++APE++ +  YGPE D
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
           +W+ G+++  ++ G PP++ E        +++ ++  +      +S S K  + ++L   
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 344 PSERLTAHEVL 354
           P++R TA E+L
Sbjct: 258 PAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  101 bits (252), Expect = 2e-24
 Identities = 76/249 (30%), Positives = 125/249 (50%), Gaps = 11/249 (4%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64

Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G+  + E +A      I   +E  H   
Sbjct: 65  LAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    G+     VG+  Y+APEV+  + Y 
Sbjct: 123 IVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYT 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G ++Y ++ G  PF    ++   + V +   + + +     S++A+ + R++
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239

Query: 340 LCSQPSERL 348
           L   P  RL
Sbjct: 240 LTKDPGFRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  101 bits (253), Expect = 2e-24
 Identities = 73/271 (26%), Positives = 140/271 (51%), Gaps = 27/271 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D + + + +G+G FG   +     T   +A K ++K +++ R +    R E  ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VVE 214
            + I T+  A++D   +++VM+   GG+L   +     + +R   ++ R  +      + 
Sbjct: 60  CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIH 116

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAPE 272
           + H L  +HRD+KP+N LL   D +  ++  DFG  +   + G + + V VG+P Y++PE
Sbjct: 117 SIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 273 VL------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           +L      +  YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FP 230

Query: 327 L----ISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S+ AKDLI++++CS+   RL  + +
Sbjct: 231 SHITDVSEEAKDLIQRLICSR-ERRLGQNGI 260

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 99.5 bits (249), Expect = 3e-24
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 45/241 (18%)

Query: 105 RKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           +KLG+G FG  Y      +     E A K++ +    S E+ +D  +E ++M  L GH N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKL-GHPN 57

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK------AAELTRIIVGVVEA 215
           +V + G   +   +++V+E   GG+L D + +                +L    + +  A
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI--A 115

Query: 216 C-----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
                  S   +HRDL   N L+    +D  +K  DFGLS          DV    YY  
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSR---------DVYDDDYYRK 163

Query: 270 -----------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
                      APE L    +  ++DVW+ GV+L+ + + G  P+   + + + + + KG
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223

Query: 317 H 317
           +
Sbjct: 224 Y 224

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 99.7 bits (248), Expect = 5e-24
 Identities = 80/262 (30%), Positives = 132/262 (50%), Gaps = 33/262 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + TE  TG + A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYH-HENVVDM 84

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APEV+ +  Y
Sbjct: 144 IKSDSILLTS---DGRIKLSDFGFC-----AQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK--DLI 336
           G E D+W+ G+++  ++ G PP++ E         L+       +  P + DS K   ++
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPP-------LQAMRRIRDNLPPRVKDSHKVSSVL 248

Query: 337 RK----MLCSQPSERLTAHEVL 354
           R     ML  +PS+R TA E+L
Sbjct: 249 RGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  100 bits (250), Expect = 6e-24
 Identities = 70/251 (27%), Positives = 121/251 (48%), Gaps = 15/251 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L      G  +A K + K+ +++R++ + +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HS+ +++RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH-YGPE 281
           KPEN LL   D    +   DFGL    K G   +D      G+P Y+APEV+ K  Y   
Sbjct: 123 KPENILL---DSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  G +LY +L G+PPF+      ++D +L   +       P  S +A  ++ ++L 
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232

Query: 342 SQPSERLTAHE 352
                RL A E
Sbjct: 233 KDRQRRLGAKE 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.0 bits (244), Expect = 1e-23
 Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 25/273 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEF-ACKSIS-------KRKLISREDVEDVRREIQI 152
           Y +   LG G FG  Y   +   G    A K I+       K K    + + D+  E+ I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG---GELFDRIIQRG-HYSERKAAELTRI 208
           +     H NIV     + ++  ++IVM+L  G   GE F+ + ++   ++E +   +  I
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER---IWNI 118

Query: 209 IVGVVEACHSLG----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
            V +V A   L     ++HRDL P N +L   D    +   DFGL+   +P    T VVG
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD---KVTITDFGLAKQKQPESKLTSVVG 175

Query: 265 SPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
           +  Y  PE++    YG +ADVW  G ILY + +  PPF++     +   +++    +E  
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA--VYEPL 233

Query: 324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           P  + S+   D+I   L      R    +V  M
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 67/246 (27%), Positives = 119/246 (48%), Gaps = 9/246 (3%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    + G  +A K + K+ ++ +++   +  E  ++     H  +V + 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      +   +   HSL +++RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +P +  +   G+P Y+APEVL K  Y    D 
Sbjct: 123 KPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +          + +A DL+  +L    
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235

Query: 345 SERLTA 350
             RL A
Sbjct: 236 RRRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 44/277 (15%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHH 155
           DL  LG +LG G  G         TG   A K+I       +  +     + RE+ I+H 
Sbjct: 2   DLEYLG-ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-----ILRELDILHK 55

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVV 213
                 IV   GA+ ++  + I ME   GG L D+I++   G   ER    L +I V V+
Sbjct: 56  -CNSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERI---LGKIAVAVL 110

Query: 214 EAC----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGS 265
           +          ++HRD+KP N L+ ++     +K  DFG+S     GQ+   +    VG+
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGT 162

Query: 266 PYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ--GIFDAVLKGHIDFE- 321
             Y+APE +    Y  ++D+W+ G+ L  L +G  P+  E     GIF+ +L+  ++   
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE-LLQYIVNEPP 221

Query: 322 ----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
               S  +   S   +D +   L   P ER +  E+L
Sbjct: 222 PRLPSGKF---SPDFQDFVNLCLIKDPRERPSYKELL 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 97.2 bits (243), Expect = 2e-23
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 38/237 (16%)

Query: 102 TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            LG+KLG+G FG  Y  T       T  + A K++  ++  S E+ E+   E  IM  L 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL- 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G       ++IV E   GG+L D + + G   +    +L ++ + + +   
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGME 116

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N L+    ++  +K  DFGLS          D+    YY      
Sbjct: 117 YLESKNFVHRDLAARNCLV---TENLVVKISDFGLS---------RDIYEDDYYRKRGGG 164

Query: 270 -------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                  APE L    +  ++DVW+ GV+L+ + + G  P+   + + + + +  G+
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY 221

Length = 258

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 98.1 bits (244), Expect = 3e-23
 Identities = 72/247 (29%), Positives = 120/247 (48%), Gaps = 11/247 (4%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    +  VME   GG+L   I     +   +A      I+  ++  HS G+++R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLL-KHYGPEA 282
           DLK +N LL   D D  +K  DFG+      G   T    G+P Y+APE+LL + Y    
Sbjct: 121 DLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRKMLC 341
           D W+ GV+LY +L G  PF    ++ +F +     I  ++  +P  ++  AKD++ K+  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQS-----IRMDNPCYPRWLTREAKDILVKLFV 232

Query: 342 SQPSERL 348
            +P  RL
Sbjct: 233 REPERRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 96.6 bits (240), Expect = 4e-23
 Identities = 68/262 (25%), Positives = 125/262 (47%), Gaps = 19/262 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   R +G+G +G   L      G ++  K ++ R    RE  +   +E Q++  L  H 
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLK-HP 59

Query: 161 NIVTIKGAYEDSLC-VHIVMELCAGGELFDRII-QRGHY-SERKAAELTRIIVGVVEACH 217
           NIV  + ++E     ++IVM  C GG+L+ ++  Q+G    E +  E    I   ++  H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL- 275
              ++HRDLK +N  L   +    +K  D G++ V      + + ++G+PYY++PE+   
Sbjct: 120 EKHILHRDLKTQNVFLTRTN---IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK-- 333
           K Y  ++DVW  G  +Y + +    F A+    +   +++G +       P+  D +   
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP------PMPKDYSPEL 230

Query: 334 -DLIRKMLCSQPSERLTAHEVL 354
            +LI  ML  +P +R +   +L
Sbjct: 231 GELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 97.8 bits (243), Expect = 5e-23
 Identities = 70/245 (28%), Positives = 119/245 (48%), Gaps = 11/245 (4%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLGVMHRD 225
             ++    ++ VME   GG+L   I Q G + E +A      I VG+    H  G+++RD
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF-FLHRRGIIYRD 126

Query: 226 LKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEAD 283
           LK +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   D
Sbjct: 127 LKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVD 183

Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV+LY +L+G PPF  E +  +F ++++ ++ +       +S  A  + + ++   
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKH 239

Query: 344 PSERL 348
           PS+RL
Sbjct: 240 PSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.0 bits (239), Expect = 5e-23
 Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 14/259 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +  K+G+G FG  +     A    +A K I   K+ +R + E+   E +++  L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKL-DSS 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGH-YSERKAAEL-TRIIVGVVEACH 217
            I+    ++ D   ++IVME    G+L   + +QRG    E +      +I++G+    H
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL-AHLH 118

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL- 275
           S  ++HRD+K  N  L   D   ++K  D G++        F + +VG+PYY++PE+   
Sbjct: 119 SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           K Y  ++DVW  GV+LY   +G  PF A  Q  +   +++G     S  +   S     L
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMY---SQQLAQL 232

Query: 336 IRKMLCSQPSERLTAHEVL 354
           I + L     +R    ++L
Sbjct: 233 IDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 96.6 bits (240), Expect = 6e-23
 Identities = 75/254 (29%), Positives = 125/254 (49%), Gaps = 16/254 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG         TG  +ACK + K++L  +   +    E +I+  +     IV + 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 167 GAYEDSLCVHIVMELCAGGELFDRII---QRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
            A+E    + +VM L  GG+L   I    +RG   ER      +I  G++   HS+ +++
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH-LHSMDIVY 118

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           RD+KPEN LL   DD  + +  D GL+V  K G+  T   G+  Y+APE+L  + Y    
Sbjct: 119 RDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 283 DVWTAGVILYILLSGVPPF--WAE--TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           D +  G  +Y +++G  PF    E   ++ +    L+  + FE   +   ++ +KD+ R 
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNF---TEESKDICRL 232

Query: 339 MLCSQPSERLTAHE 352
            L  +P +RL + E
Sbjct: 233 FLAKKPEDRLGSRE 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 96.8 bits (241), Expect = 7e-23
 Identities = 71/262 (27%), Positives = 117/262 (44%), Gaps = 19/262 (7%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+T  R++G G FG  Y   ++ T    A K +S     S E  +D+ +E++ +  L  H
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-H 74

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            N +  KG Y       +VME C G   ++ +  + +    E + A +    +  +   H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           S   +HRD+K  N LL    +  ++K  DFG +    P   F   VG+PY++APEV+L  
Sbjct: 133 SHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAM 186

Query: 277 ---HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
               Y  + DVW+ G+    L    PP F       ++           S+ W   SD  
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYF 243

Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           ++ +   L   P +R ++ E+L
Sbjct: 244 RNFVDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 8e-23
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 24/220 (10%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            ++ L   +G+G +G  Y      TG   A K +   +    ++ E+++ E  I+   + 
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSN 61

Query: 159 HKNIVTIKGAY--EDSLCVH----IVMELCAGG---ELFDRIIQRGH-YSERKAAELTRI 208
           H NI T  GA+  ++         +VMELC GG   +L   + ++G    E   A + R 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPY 267
            +  +   H   V+HRD+K +N LL     +  +K +DFG+S          +  +G+PY
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 268 YVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPF 301
           ++APEV+     P+A      DVW+ G+    L  G PP 
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 72/269 (26%), Positives = 115/269 (42%), Gaps = 25/269 (9%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-------VEDVRREIQIMHHL 156
           G  +G+G +G  YL   + TG   A K +     I+          V+ +R EI+ +  L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NIV   G       + I +E   GG +   +   G + E+     T  ++  +   
Sbjct: 66  D-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV-----GSPYYVAP 271
           HS G++HRDLK +N L+   D D   K  DFG+S   K   I+ +       GS +++AP
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAP 179

Query: 272 EVL-LKH--YGPEADVWTAGVILYILLSGVPPFWA--ETQQGIFD-AVLKGHIDFESDPW 325
           EV+      Y  + D+W+ G ++  + +G  P W+  E    +F     +       D  
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEAIAAMFKLGNKRSAPPIPPDVS 238

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S  A D +       P  R TA E+L
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 29/269 (10%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSI---------SKRKLISREDVEDVRREIQIMH 154
           G  +G G FG+ YL    ++G   A K +           RK   R  ++ + REI ++ 
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRK---RSMLDALAREIALLK 61

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+NIV   G+  D+  ++I +E   GG +   +   G + E       R I+  + 
Sbjct: 62  ELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-------DVVGSPY 267
             H+ G++HRD+K  N L+ NK     +K  DFG+S   +   + T        + GS +
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKG---GIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 268 YVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPW 325
           ++APEV+ +  Y  +AD+W+ G ++  +L+G  PF   TQ Q IF        +  S+  
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSN-- 235

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             IS  A D + K      ++R TA E+L
Sbjct: 236 --ISSEAIDFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.1 bits (236), Expect = 1e-22
 Identities = 78/251 (31%), Positives = 122/251 (48%), Gaps = 19/251 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHHLA 157
           + LG+ LG+G FG  YLC +  TG E A K +      +  S+E V  +  EIQ++ +L 
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLR 62

Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            H  IV   G   D     + I +E   GG + D++   G  +E      TR I+  V  
Sbjct: 63  -HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSPYYVAP 271
            HS  ++HRD+K  N L   +D   ++K  DFG S         G     V G+PY+++P
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-IS 329
           EV+  + YG +ADVW+    +  +L+  PP WAE +     A+ K          P  +S
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYEA--MAAIFKIATQPTKPMLPDGVS 235

Query: 330 DSAKDLIRKML 340
           D+ +D ++++ 
Sbjct: 236 DACRDFLKQIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 68/264 (25%), Positives = 129/264 (48%), Gaps = 14/264 (5%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
             + + +K+G+GQF   Y    +  G   A K +   +++  +  +D  +EI ++  L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RIIVGV---V 213
           H N++    ++ ++  ++IV+EL   G+L  R+I+     +R   E T  +  V +   +
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPE 272
           E  HS  +MHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE
Sbjct: 120 EHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK-GHIDFESDPWPLISD 330
            + ++ Y  ++D+W+ G +LY + +   PF+ + +  ++    K    D+   P    S+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIEKCDYPPLPADHYSE 235

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             +DL+ + +   P +R     VL
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 95.5 bits (237), Expect = 3e-22
 Identities = 71/246 (28%), Positives = 122/246 (49%), Gaps = 13/246 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT-I 165
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++  L+G    +T +
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLGVMHR 224
              ++    ++ VME   GG+L  +I Q G + E  A      I +G+    HS G+++R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF-FLHSKGIIYR 125

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEA 282
           DLK +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   
Sbjct: 126 DLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV+LY +L+G  PF  E +  +F ++++ ++ +       +S  A  + + ++  
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTK 238

Query: 343 QPSERL 348
            P +RL
Sbjct: 239 HPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 75/253 (29%), Positives = 127/253 (50%), Gaps = 22/253 (8%)

Query: 107 LGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           LGQG FG  +L  +I     G  +A K + K  L  R+ V   + E  I+  +  H  IV
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEV-NHPFIV 61

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSL 219
            +  A++    ++++++   GG+LF R+ +   ++E       AEL       ++  HSL
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL----ALDHLHSL 117

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVL-LKH 277
           G+++RDLKPEN LL   D++  +K  DFGLS      +       G+  Y+APEV+  + 
Sbjct: 118 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ L+R
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLR 230

Query: 338 KMLCSQPSERLTA 350
            +    P+ RL A
Sbjct: 231 ALFKRNPANRLGA 243

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 94.2 bits (235), Expect = 5e-22
 Identities = 75/247 (30%), Positives = 111/247 (44%), Gaps = 51/247 (20%)

Query: 148 REIQIMHHLAGHKNIVTIK----GAYEDSLCVHIVMELCAGGE-----LFDRIIQRGHYS 198
           REI I+  L  H NIVT+K    G+  D   +++VME     E     L + + Q    S
Sbjct: 53  REINILLKL-QHPNIVTVKEVVVGSNLDK--IYMVMEYV---EHDLKSLMETMKQPFLQS 106

Query: 199 ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQ 257
           E K   L   ++  V   H   ++HRDLK  N LL N+     LK  DFGL+  +  P +
Sbjct: 107 EVKC--LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPLK 161

Query: 258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF--WAETQQ--GIFD 311
            +T +V + +Y APE+LL  K Y    D+W+ G I   LL+  P F   +E  Q   IF 
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221

Query: 312 AV---------------LKGHIDFESDP-WPL--------ISDSAKDLIRKMLCSQPSER 347
            +                     F   P   L        +SD+  DL+ ++L   P++R
Sbjct: 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKR 281

Query: 348 LTAHEVL 354
           ++A + L
Sbjct: 282 ISAEDAL 288

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.4 bits (234), Expect = 6e-22
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 15/265 (5%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           ++   L+T  R++G G FG  Y   ++ T    A K +S     S E  +D+ +E++ + 
Sbjct: 21  EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            +  H N +  KG Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 81  RIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL        +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASIASPANSF---VGTPYWMAPEVI 193

Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S+ W   S
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---S 250

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           D  ++ +   L   P +R T+ E+L
Sbjct: 251 DYFRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 97.1 bits (241), Expect = 7e-22
 Identities = 77/232 (33%), Positives = 115/232 (49%), Gaps = 34/232 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + +K+G G+FG  +L     T   F  K+IS R L  RE  + V  E+ +M  L  HK
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELK-HK 72

Query: 161 NIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVV 213
           NIV     +  + +  ++I+ME C  G+L  R IQ+     G   E    ++TR ++  +
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 214 EACHSLG-------VMHRDLKPENFLL----------VNKDDDFSLKAI----DFGLSVF 252
             CH+L        V+HRDLKP+N  L            + ++ + + I    DFGLS  
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 253 FKPGQIFTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPF 301
                +    VG+PYY +PE+LL   K Y  ++D+W  G I+Y L SG  PF
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.4 bits (232), Expect = 7e-22
 Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 29/272 (10%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHHL 156
            +T G  LG+G +GT Y C     G   A K +   +   L + ++ E ++ E+ ++  L
Sbjct: 1   EWTKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NIV   G   D   + I ME   GG +   + + G   E    + T+ I+  V   
Sbjct: 60  K-HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG-------LSVFFKPGQIFTDVVGSPYYV 269
           H+  V+HRD+K  N +L+       +K IDFG       + +      +   + G+PY++
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNG---IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ--GIFDAVLKGHIDFESDPWP 326
           APEV+ +  YG ++D+W+ G  ++ + +G PP  A   +   +F      +I       P
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMF------YIGAHRGLMP 228

Query: 327 LISDS----AKDLIRKMLCSQPSERLTAHEVL 354
            + DS    A D +   L     ER +A ++L
Sbjct: 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.0 bits (231), Expect = 9e-22
 Identities = 71/253 (28%), Positives = 117/253 (46%), Gaps = 10/253 (3%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G FG  +LC   A       K I   ++ ++++    + E Q++  L+ H NI+ 
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIE 63

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVM 222
               + +   + IVME   GG L + I +R +    E         I+  +   H+  ++
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPE 281
           HRDLK +N LL +K     +K  DFG+S           VVG+P Y++PE+   K Y  +
Sbjct: 124 HRDLKTQNILL-DKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
           +D+W  G +LY L S    F A     +   ++ G     SD +   S   + LI  ML 
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY---SPDLRQLILSMLN 238

Query: 342 SQPSERLTAHEVL 354
             PS+R    +++
Sbjct: 239 LDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 86/274 (31%), Positives = 128/274 (46%), Gaps = 30/274 (10%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D++ +  +LG G FG  Y      TG+  A K I   ++ S E++ED   EI I+  
Sbjct: 2   NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSE 58

Query: 156 LAGHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV 212
              H NIV +  AY  E+ L   I++E C GG L   +++     +E +   + R ++  
Sbjct: 59  CK-HPNIVGLYEAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGSPYYVAP 271
           +   HS  V+HRDLK  N LL    D   +K  DFG+S   K   Q     +G+PY++AP
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172

Query: 272 EVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           EV+         Y  +AD+W+ G+ L  L    PP        +   +LK      S+P 
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK------SEPP 226

Query: 326 PLI-----SDSAKDLIRKMLCSQPSERLTAHEVL 354
            L      S S  D ++  L   P +R TA E+L
Sbjct: 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 86/309 (27%), Positives = 131/309 (42%), Gaps = 75/309 (24%)

Query: 101 YTLGRKLGQGQFGTTYLC----TEIATGIEFACKSISK---RKLISREDVEDVRREIQIM 153
           Y L ++LGQG +G   +C     E +     A K I+    +K++++  +    RE++++
Sbjct: 2   YELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLL 55

Query: 154 HHLAGHKNIVTI-------KGAYEDSLCVHIVME------LCAGGELFDRIIQRGHYSER 200
            H  GHKNI  +        G + +      +ME      + +G  L D   Q   Y   
Sbjct: 56  RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY--- 112

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-- 258
                 +I+ G+ +  HS  V+HRDLKP N LLVN D +  LK  DFGL+  F       
Sbjct: 113 ------QILCGL-KYIHSANVLHRDLKPGN-LLVNADCE--LKICDFGLARGFSENPGEN 162

Query: 259 ---FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAE--------- 304
               T+ V + +Y APE++L  + Y    DVW+ G IL  LL   P F  +         
Sbjct: 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222

Query: 305 -------------------TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPS 345
                               Q  I          FES  +P  +  A DL+ K+L   P+
Sbjct: 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPT 281

Query: 346 ERLTAHEVL 354
           +R++  E L
Sbjct: 282 KRISVEEAL 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 15/247 (6%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L      G  FA K++ K  ++  +DVE    E +++     +  +  + 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    +  VME   GG+L   I  +G +   +A      IV  ++  HS G+++RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGL---SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           K +N +L   D D  +K  DFG+   +VF       +   G+P Y+APE+L    Y    
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTFSV 177

Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-WPLISDSAKDLIRKMLC 341
           D W+ GV+LY +L G  PF  + +  +F+++    +D    P W  I+  +KD++ K+  
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRW--ITKESKDILEKLFE 232

Query: 342 SQPSERL 348
             P+ RL
Sbjct: 233 RDPTRRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 88/307 (28%), Positives = 130/307 (42%), Gaps = 66/307 (21%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS--------KRKLISREDVEDVR 147
           ++   Y     +G+G +G     T   TG++ A K IS        +R L          
Sbjct: 2   DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL---------- 51

Query: 148 REIQIMHHLAGHKNIVTIK-----GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
           REI+I+     H+NI+ I       ++E    V+IV EL    +L+ ++I+  H S    
Sbjct: 52  REIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHI 108

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP----GQI 258
                 I+  ++  HS  V+HRDLKP N LL+N + D  LK  DFGL+    P       
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSN-LLLNTNCD--LKICDFGLARIADPEHDHTGF 165

Query: 259 FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF--------------- 301
            T+ V + +Y APE++L  K Y    D+W+ G IL  +LS  P F               
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225

Query: 302 ----WAETQQGIFDAVLKGHIDFESDPW----------PLISDSAKDLIRKMLCSQPSER 347
                 E    I     + +I  +S P+          P     A DL+ KML   P +R
Sbjct: 226 LGTPSQEDLNCIISLRARNYI--KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283

Query: 348 LTAHEVL 354
           +T  E L
Sbjct: 284 ITVEEAL 290

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 75/246 (30%), Positives = 117/246 (47%), Gaps = 13/246 (5%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   FA K++ K  ++  +DVE    E +++     H  +  + 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    +  VME   GG+L   I   G + E +A      I+  ++  H  G+++RDL
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLL-KHYGPEADV 284
           K +N LL   D D  +K  DFG+      G+       G+P Y+APE+L  + Y    D 
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW--PLISDSAKDLIRKMLCS 342
           W+ GV+LY +L G  PF  E +  +FD++L         P     IS  AKD + K+   
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILN------DRPHFPRWISKEAKDCLSKLFER 233

Query: 343 QPSERL 348
            P++RL
Sbjct: 234 DPTKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 64/187 (34%), Positives = 96/187 (51%), Gaps = 16/187 (8%)

Query: 177 IVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFL 232
           ++ME  +GG+L  +I QR      + E +   L   IV  ++  HS  +MHRDLK  N  
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201

Query: 233 LVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVL-LKHYGPEADVWTAG 288
           L+       +K  DFG S  +       + +   G+PYY+APE+   K Y  +AD+W+ G
Sbjct: 202 LMPTG---IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258

Query: 289 VILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDLIRKMLCSQPSER 347
           VILY LL+   PF   +Q+ I   VL G    + DP+P  +S   K L+  +L   P+ R
Sbjct: 259 VILYELLTLHRPFKGPSQREIMQQVLYG----KYDPFPCPVSSGMKALLDPLLSKNPALR 314

Query: 348 LTAHEVL 354
            T  ++L
Sbjct: 315 PTTQQLL 321

Length = 478

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.1 bits (226), Expect = 4e-21
 Identities = 68/264 (25%), Positives = 124/264 (46%), Gaps = 13/264 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLA 157
           +  G++LG G F + Y   ++ TG   A K ++  +  S E    VE +R+EI++M  L 
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL- 60

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H +I+ + GA  +    ++ +E  AGG +   + + G + E      T  ++  +   H
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-----FFKPGQIFTDVVGSPYYVAPE 272
              ++HRD+K  N L+ +      L+  DFG +          G+    ++G+  ++APE
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISD 330
           VL  + YG   DVW+ G ++  + +  PP+ AE        + K      +   P  +S 
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             +D+  + L  QP +R  + E+L
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 84/301 (27%), Positives = 133/301 (44%), Gaps = 56/301 (18%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK---RKLISREDVEDVRREIQIMHHLA 157
           Y   + +G G FG      +  TG   A K I K     ++++       RE++++ HL 
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR----TYRELKLLKHLR 67

Query: 158 GHKNIVTIKGAY----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
            H+NI+++   +    ED   ++ V EL   G    R++      ++        I+  +
Sbjct: 68  -HENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGL 121

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           +  HS GV+HRDLKP N +L+N++ D  LK  DFGL+    P    T  V + YY APE+
Sbjct: 122 KYVHSAGVVHRDLKPSN-ILINENCD--LKICDFGLARIQDPQ--MTGYVSTRYYRAPEI 176

Query: 274 LL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL----------------K 315
           +L  + Y  E D+W+AG I   +L G P F  +     F  +                 +
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236

Query: 316 GHIDF-----ESDPWPL------ISDSAKDLIRKMLCSQPSERLTA-----HEVLCMYNL 359
             + F     + +P P          SA DL+ KML   P +R++A     H  L  Y+ 
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296

Query: 360 P 360
           P
Sbjct: 297 P 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 90.0 bits (223), Expect = 8e-21
 Identities = 72/259 (27%), Positives = 128/259 (49%), Gaps = 13/259 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + +K+G+G FG  YL    +       K I   K+  +E  E  ++E+ ++  +  H 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMK-HP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRG-HYSERKA-AELTRIIVGVVEACH 217
           NIVT   +++++  + IVME C GG+L  RI  QRG  +SE +  +   +I +G ++  H
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLG-LKHIH 118

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL- 275
              ++HRD+K +N  L    +    K  DFG++       ++    VG+PYY++PE+   
Sbjct: 119 DRKILHRDIKSQNIFL--SKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           + Y  + D+W+ G +LY L +   PF       +   + +G+    S   P  S   + L
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS---PNFSRDLRSL 233

Query: 336 IRKMLCSQPSERLTAHEVL 354
           I ++    P +R +   +L
Sbjct: 234 ISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 91.2 bits (226), Expect = 9e-21
 Identities = 71/265 (26%), Positives = 114/265 (43%), Gaps = 15/265 (5%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+  +++    ++G G FG  Y  T   T    A K +S     + E  +D+ +E++ + 
Sbjct: 17  DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  KG Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 77  QLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL        +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPG---QVKLADFGSASKSSPANSF---VGTPYWMAPEVI 189

Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S+ W   +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---T 246

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           DS +  +   L   P ER  + E+L
Sbjct: 247 DSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 18/202 (8%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           K+G+G +G  + C    TG   A K     K +  ED   ++    REI+++  L  H N
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLK-HPN 61

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLG 220
           +V +   +     +H+V E C    + + + +      E    ++    +  V  CH   
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--KH 277
            +HRD+KPEN +L+ K     +K  DFG +     PG  +TD V + +Y APE+L+    
Sbjct: 121 CIHRDVKPEN-ILITKQG--QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177

Query: 278 YGPEADVWTAGVILYILLSGVP 299
           YGP  DVW  G +   LL+G P
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 87/298 (29%), Positives = 127/298 (42%), Gaps = 51/298 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           D Y    K+G+G +G  Y   +  TG     K ++ +K     D E +     REI ++ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQ 55

Query: 155 HLAGHKNIV---TIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--- 206
            L+    IV    ++   E +    +++V E     +L   +   G    R     T   
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114

Query: 207 ---RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV 262
              +++ GV   CH  GVMHRDLKP+N LLV+K     LK  D GL   F  P + +T  
Sbjct: 115 FMYQLLKGVAH-CHKHGVMHRDLKPQN-LLVDKQKGL-LKIADLGLGRAFSIPVKSYTHE 171

Query: 263 VGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFW--AETQQ--GIFD----- 311
           + + +Y APEVLL   HY    D+W+ G I   +    P F   +E QQ   IF      
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231

Query: 312 ------AVLKGHIDFESDPW---------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                  V K     E   W         P +S    DL++KML   P++R++A   L
Sbjct: 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 66/254 (25%), Positives = 121/254 (47%), Gaps = 12/254 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y  T +      A K +   +++  +  +D  +EI ++  L  H 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEAC 216
           N++    ++ +   ++IV+EL   G+L   I     Q+    ER   +    +   VE  
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVLL 275
           HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE + 
Sbjct: 123 HSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK-GHIDFESDPWPLISDSAK 333
           ++ Y  ++D+W+ G +LY + +   PF+ + +  +F    K    D+   P    S+  +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238

Query: 334 DLIRKMLCSQPSER 347
           +L+   +   P +R
Sbjct: 239 ELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 68/253 (26%), Positives = 124/253 (49%), Gaps = 18/253 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y  T +  G+  A K +    L+  +   D  +EI ++  L  H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRII-----QRGHYSERKAAELTRIIVGVVEA 215
           N++    ++ +   ++IV+EL   G+L  R+I     Q+    E+   +    +   +E 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVL 274
            HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            ++ Y  ++D+W+ G +LY + +   PF+ + +  ++    K     + D  PL SD   
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIE---QCDYPPLPSDHYS 234

Query: 334 DLIRKM--LCSQP 344
           + +R++  +C  P
Sbjct: 235 EELRQLVNMCINP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 89.1 bits (221), Expect = 3e-20
 Identities = 78/284 (27%), Positives = 120/284 (42%), Gaps = 46/284 (16%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           KLG+G + T Y      TG   A K I    L + E       REI +M  L  H+NIV 
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELK-HENIVR 62

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI------IVGVVEACHS 218
           +         + +V E     +L   +   G    R A +   +      ++  +  CH 
Sbjct: 63  LHDVIHTENKLMLVFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-- 275
             V+HRDLKP+N LL+NK  +  LK  DFGL+  F  P   F++ V + +Y AP+VLL  
Sbjct: 119 NRVLHRDLKPQN-LLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK-- 333
           + Y    D+W+ G I+  +++G P F     +     + +         WP IS   +  
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 334 -----------------------DLIRKMLCSQPSERLTAHEVL 354
                                  DL+ ++L   P  R++AH+ L
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 88.6 bits (219), Expect = 4e-20
 Identities = 85/276 (30%), Positives = 123/276 (44%), Gaps = 35/276 (12%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N ++ + L +++G G +G  Y    + TG   A K I   KL   ED   V++EI IM  
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEI-IMMK 61

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
              H NIV   G+Y     + I ME C GG L D     G  SE + A ++R  +  +  
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYV 269
            HS G MHRD+K  N LL    D+  +K  DFG+S      QI   +      +G+PY++
Sbjct: 122 LHSKGKMHRDIKGANILLT---DNGHVKLADFGVS-----AQITATIAKRKSFIGTPYWM 173

Query: 270 APEVLLKH----YGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDP 324
           APEV        Y    D+W  G+    L    PP F     + +F   L    +F+   
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQP-- 228

Query: 325 WPLISDSAK------DLIRKMLCSQPSERLTAHEVL 354
            P + D  K        ++  L   P +R TA ++L
Sbjct: 229 -PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 69/271 (25%), Positives = 114/271 (42%), Gaps = 20/271 (7%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 71  KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL        +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPG---LVKLGDFGSASIMAPANXF---VGTPYWMAPEVI 183

Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S  W   S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 240

Query: 330 DSAKDLIRKMLCSQPSERLTA-----HEVLC 355
           +  ++ +   L   P +R T+     H  + 
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 88.6 bits (219), Expect = 5e-20
 Identities = 83/293 (28%), Positives = 134/293 (45%), Gaps = 45/293 (15%)

Query: 78  MRRGID-NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK 136
           +RR +D N+ + ++G              +LG G FG  Y      TG   A K I  + 
Sbjct: 4   VRRDLDPNEVWEIIG--------------ELGDGAFGKVYKAKNKETGALAAAKVIETK- 48

Query: 137 LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI---IQ 193
             S E++ED   EI+I+     H  IV + GA+     + I++E C GG + D I   + 
Sbjct: 49  --SEEELEDYMVEIEILAT-CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELD 104

Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-F 252
           RG  +E +   + R ++  ++  HS+ ++HRDLK  N LL    D   +K  DFG+S   
Sbjct: 105 RG-LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKN 160

Query: 253 FKPGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            K  Q     +G+PY++APEV++        Y  +AD+W+ G+ L  +    PP      
Sbjct: 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVL 354
             +   + K      S+P  L   S      +D ++  L   P  R +A ++L
Sbjct: 221 MRVLLKIAK------SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 82/294 (27%), Positives = 132/294 (44%), Gaps = 46/294 (15%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y     +G G +G      +  TG + A K +S R   S    +   RE++++ H+
Sbjct: 13  VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELRLLKHM 71

Query: 157 AGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             H+N++ +   +      ED   V++V  L  G +L + I++    S+     L   I+
Sbjct: 72  D-HENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADL-NNIVKCQKLSDDHIQFLVYQIL 128

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS G++HRDLKP N + VN+D +  LK +DFGL+         T  V + +Y A
Sbjct: 129 RGLKYIHSAGIIHRDLKPSN-IAVNEDCE--LKILDFGLAR--HTDDEMTGYVATRWYRA 183

Query: 271 PEVLLK--HYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQGI 309
           PE++L   HY    D+W+ G I+  LL+G   F                     E  Q I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243

Query: 310 FDAVLKGHI---------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                + +I         DF  + +   +  A DL+ KML   P +R+TA E L
Sbjct: 244 SSESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 86.7 bits (214), Expect = 2e-19
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 26/265 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMH 154
           +L+T   K+G+G FG      E+  GI+   + +   K+I    + +++ED+++EI ++ 
Sbjct: 4   ELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  ++
Sbjct: 58  Q-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 115

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---IS 329
           + +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    S
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK------NNPPTLEGNYS 226

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
              K+ +   L  +PS R TA E+L
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 86.1 bits (213), Expect = 2e-19
 Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 26/267 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVEDVRREIQIMHHLA 157
           Y L ++LG+G FGT YL  +     E      K I   +L   E V+   +E Q++  L 
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKLD 60

Query: 158 GHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAE-LTRIIV 210
            H  IV    ++   D+ C  I+ E C G +L  ++ +  H     SE +  E   ++++
Sbjct: 61  -HPAIVKFHASFLERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGSPYYV 269
           G V   H   ++HRDLK +N  L N      LK  DFG+S        + T   G+PYY+
Sbjct: 118 G-VHYMHQRRILHRDLKAKNIFLKNN----LLKIGDFGVSRLLMGSCDLATTFTGTPYYM 172

Query: 270 APEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           +PE  LKH  Y  ++D+W+ G ILY +      F  +    +   +++G      + +  
Sbjct: 173 SPEA-LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYS- 230

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                  +++ ML   PS R +A E+L
Sbjct: 231 --RQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 86.3 bits (213), Expect = 3e-19
 Identities = 73/265 (27%), Positives = 129/265 (48%), Gaps = 26/265 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED----VEDVRREIQIMH 154
           +L+T   ++G+G FG      E+  GI+   + +   K+I  E+    +ED+++EI ++ 
Sbjct: 4   ELFTKLERIGKGSFG------EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G + E + A + + I+  ++
Sbjct: 58  Q-CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLD 115

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL  + D   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD-- 330
           + +  Y  +AD+W+ G+    L  G PP        +    +   I  +++P  L  +  
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP-----NSDMHPMRVLFLIP-KNNPPTLTGEFS 226

Query: 331 -SAKDLIRKMLCSQPSERLTAHEVL 354
              K+ I   L   PS R TA E+L
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.3 bits (213), Expect = 3e-19
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 17/209 (8%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED----VEDVRREIQIMH 154
           +L+T   ++G+G FG      E+  GI+   K +   K+I  E+    +ED+++EI ++ 
Sbjct: 4   ELFTKLERIGKGSFG------EVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLS 57

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  I    G+Y     + I+ME   GG   D +++ G   E   A + R I+  ++
Sbjct: 58  Q-CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLD 115

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL  + D   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPF 301
           + +  Y  +AD+W+ G+    L  G PP 
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 78/296 (26%), Positives = 121/296 (40%), Gaps = 52/296 (17%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG G  G  +   +       A K I      S   V+   REI+I+  L  H NIV 
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS---VKHALREIKIIRRLD-HDNIVK 66

Query: 165 I-----KGAYEDSLCVHIVMEL---CAGGELFD----RIIQRGHYSERKAAELTRIIVGV 212
           +         + +  V  + EL       E  +     ++++G  SE  A      ++  
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPY 267
           ++  HS  V+HRDLKP N + +N  +D  LK  DFGL+    P     G +   +V + +
Sbjct: 127 LKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKW 183

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAV-------- 313
           Y +P +LL   +Y    D+W AG I   +L+G P F      E  Q I ++V        
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243

Query: 314 ----------LKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                     ++        P     P ++  A D + ++L   P +RLTA E L 
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 86/300 (28%), Positives = 130/300 (43%), Gaps = 73/300 (24%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G +G         T  + A K I+     +R D +   REI+++ HL  H+N++ IK
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD-HENVIAIK 70

Query: 167 G--------AYEDSLCVHIVMELCAGGELFD----RIIQRGHYSERKAAELT-------- 206
                    A+ D   V+IV EL       D    +II       R +  L+        
Sbjct: 71  DIMPPPHREAFND---VYIVYEL------MDTDLHQII-------RSSQTLSDDHCQYFL 114

Query: 207 -RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVG 264
            +++ G+ +  HS  V+HRDLKP N LL+N + D  LK  DFGL+    + G   T+ V 
Sbjct: 115 YQLLRGL-KYIHSANVLHRDLKPSN-LLLNANCD--LKICDFGLARTTSEKGDFMTEYVV 170

Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVL----K 315
           + +Y APE+LL    Y    DVW+ G I   LL   P F  +    Q  +   +L    +
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230

Query: 316 GHIDFESDP--------------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             + F  +                     +P  +  A DL+ KML   PS+R+T  E L 
Sbjct: 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.9 bits (210), Expect = 7e-19
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 34/265 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G +G  Y   +++T +  A K I +R       V+ +  EI +  +L  H+NIV   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYL 71

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-----LTRIIVGVVEACHSLGV 221
           G+  ++    I ME   GG L    + R  +   K  E      T+ I+  ++  H   +
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSA--LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 222 MHRDLKPENFLLVNKDDDFS--LKAIDFGLS---VFFKP-GQIFTDVVGSPYYVAPEVL- 274
           +HRD+K +N +LVN    +S  +K  DFG S       P  + FT   G+  Y+APEV+ 
Sbjct: 130 VHRDIKGDN-VLVNT---YSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVID 182

Query: 275 --LKHYGPEADVWTAGVILYILLSGVPPFW--AETQQGIFD-AVLKGHIDFESDPWPLIS 329
              + YG  AD+W+ G  +  + +G PPF    E Q  +F   + K H +        +S
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES----LS 238

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
             AK+ I +     P +R +AH++L
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 85.9 bits (212), Expect = 8e-19
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 18/255 (7%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G+++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           DLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + YG   
Sbjct: 121 DLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 283 DVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
           D W  GV+++ +++G  PF            T+  +F  +L+  I         +S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAA 233

Query: 334 DLIRKMLCSQPSERL 348
            +++  L   P ERL
Sbjct: 234 SVLKSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 40/274 (14%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHK 160
            +LG+G  G+   C    TG+ FA       K I+ +   D++    RE++I        
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFA------LKTITTDPNPDLQKQILRELEINKSCK-SP 59

Query: 161 NIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVV 213
            IV   GA+  E S  + I ME C GG L D I ++     G   E+   ++   ++  +
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYV 269
              HS  ++HRD+KP N LL  K     +K  DFG+S     G++   +     G+ +Y+
Sbjct: 119 SYLHSRKIIHRDIKPSNILLTRKG---QVKLCDFGVS-----GELVNSLAGTFTGTSFYM 170

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI------DFES 322
           APE +  K Y   +DVW+ G+ L  +     PF  E +  +    L  +I      + + 
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230

Query: 323 DPWPLI--SDSAKDLIRKMLCSQPSERLTAHEVL 354
           +P   I  S+  KD I++ L   P+ R T  ++L
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 67/302 (22%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           D Y    K+G+G +G  Y   +  T    A K I     + +ED E V     REI ++ 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR----LEQED-EGVPSTAIREISLLK 56

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIV-----------MELCAGGELFDRIIQRGHYSERKAA 203
            +  H NIV ++        +++V           M+         R+I+          
Sbjct: 57  EMQ-HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIK---------T 106

Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDV 262
            L +I+ G+   CHS  V+HRDLKP+N L+  + +  +LK  DFGL+  F  P + FT  
Sbjct: 107 YLYQILRGIA-YCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHE 163

Query: 263 VGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK----- 315
           V + +Y APE+LL  +HY    D+W+ G I   +++  P F  +++    D + K     
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRIL 220

Query: 316 GHIDFESDP--------------W---------PLISDSAKDLIRKMLCSQPSERLTAHE 352
           G  + E+ P              W         P +  +  DL+ KML   PS+R+TA  
Sbjct: 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280

Query: 353 VL 354
            L
Sbjct: 281 AL 282

Length = 294

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 86/315 (27%), Positives = 135/315 (42%), Gaps = 62/315 (19%)

Query: 95  DNIRDLYT-LGRKLGQGQFGTTYLCTEIATGIEFACK-----SISKRKLISREDVEDV-- 146
            +I + Y   G  LG+G +G      +  TG   A K      IS      R+ V     
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 147 ----RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSER 200
                RE++IM+ +  H+NI+ +   Y +   +++VM++ A    ++ DR I R   S+ 
Sbjct: 64  HFTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI-RLTESQV 121

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------- 253
           K   L +I+ G+    H    MHRDL P N  + +K      K  DFGL+  +       
Sbjct: 122 KCI-LLQILNGL-NVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSD 176

Query: 254 --------KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA 303
                   +  +  T  V + +Y APE+L+  + Y    D+W+ G I   LL+G P F  
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236

Query: 304 ET---QQG-IFDAV-------------LKGHIDFE-------SDPWPLISDSAKDLIRKM 339
           E    Q G IF+ +             L  + +F           +P  SD A DL++ +
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSL 296

Query: 340 LCSQPSERLTAHEVL 354
           L   P ER++A E L
Sbjct: 297 LKLNPLERISAKEAL 311

Length = 335

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 80/294 (27%), Positives = 128/294 (43%), Gaps = 66/294 (22%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAGH 159
           K+G+G +G  Y   +  TG   A K I       R + ED        REI ++  L  H
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELN-H 57

Query: 160 KNIVTIKGAYEDSLCVHIV-----------MELCAGGELFDRIIQRGHYSERKAAELTRI 208
            NIV +         +++V           M+      L   +I+   Y         ++
Sbjct: 58  PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY---------QL 108

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY 267
           + G+   CHS  V+HRDLKP+N LL++++   +LK  DFGL+  F  P + +T  V + +
Sbjct: 109 LQGIA-YCHSHRVLHRDLKPQN-LLIDREG--ALKLADFGLARAFGVPVRTYTHEVVTLW 164

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFW--AETQQ--GIF-------DAVL 314
           Y APE+LL  + Y    D+W+ G I   +++  P F   +E  Q   IF       + V 
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224

Query: 315 KGHI---DFES-----------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            G     D++               P + +   DL+ KML   P++R++A   L
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 82.8 bits (205), Expect = 6e-18
 Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 28/231 (12%)

Query: 82  IDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           ID Q Y       D + DL  LG ++G G  G  Y      TG   A K +  R+  ++E
Sbjct: 5   IDGQKY-----PAD-LNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQM--RRTGNKE 55

Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSE 199
           + + +  ++ ++        IV   G +     V I MEL +     D++++R  G   E
Sbjct: 56  ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPE 113

Query: 200 RKAAELTRIIVGVVEACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
               ++T   V +V+A H L    GV+HRD+KP N LL   D   ++K  DFG+S     
Sbjct: 114 DILGKMT---VAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD 167

Query: 256 GQIFTDVVGSPYYVAPEVL-----LKHYGPEADVWTAGVILYILLSGVPPF 301
            +  T   G   Y+APE +        Y   ADVW+ G+ L  L +G  P+
Sbjct: 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 82.5 bits (203), Expect = 6e-18
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           ++ L   +G G +G  Y    + TG   A K +     ++ ++ E++++EI ++   + H
Sbjct: 7   IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHH 62

Query: 160 KNIVTIKGAY--------EDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAAELTRII 209
           +NI T  GA+        +D L   +VME C  G + D I   +     E   A + R I
Sbjct: 63  RNIATYYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVGSPY 267
           +  +   H   V+HRD+K +N LL    ++  +K +DFG+S       G+  T  +G+PY
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPY 176

Query: 268 YVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPF 301
           ++APEV+     P+A      D+W+ G+    +  G PP 
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 82.0 bits (202), Expect = 8e-18
 Identities = 80/271 (29%), Positives = 118/271 (43%), Gaps = 35/271 (12%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L +++G G +G  Y    + TG   A K I   KL   +D   +++EI  M     H 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEI-FMVKECKHC 66

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV   G+Y     + I ME C GG L D     G  SE + A + R  +  +   HS G
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVL 274
            MHRD+K  N LL +  D   +K  DFG++      +I   +      +G+PY++APEV 
Sbjct: 127 KMHRDIKGANILLTDNGD---VKLADFGVA-----AKITATIAKRKSFIGTPYWMAPEVA 178

Query: 275 LKH----YGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
                  Y    D+W  G+    L    PP F     + +F   L    +F+    P + 
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQP---PKLK 232

Query: 330 DSAK------DLIRKMLCSQPSERLTAHEVL 354
           D  K      + ++  L   P +R TA  +L
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 19/208 (9%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLA 157
            LG  +G+G +G    C    TG   A K     K +  ED + V+    REI+++  L 
Sbjct: 5   NLG-LVGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEAC 216
            H+N+V +   +     +++V E      L D      G    R    L +I+ G+ E C
Sbjct: 59  -HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI-EFC 116

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL 275
           HS  ++HRD+KPEN +LV++     +K  DFG +     PG+++TD V + +Y APE+L+
Sbjct: 117 HSHNIIHRDIKPEN-ILVSQSG--VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173

Query: 276 K--HYGPEADVWTAGVILYILLSGVPPF 301
               YG   D+W  G ++  +L+G P F
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 31/226 (13%)

Query: 97  IRD---LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +RD   ++ L   +G G +G  Y    + TG   A K +     ++ ++ E+++ EI ++
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINML 66

Query: 154 HHLAGHKNIVTIKGAY--------EDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAA 203
              + H+NI T  GA+        +D L   +VME C  G + D +   +     E   A
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKEDWIA 124

Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTD 261
            + R I+  +   H+  V+HRD+K +N LL    ++  +K +DFG+S       G+  T 
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT- 180

Query: 262 VVGSPYYVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPF 301
            +G+PY++APEV+     P+A      D+W+ G+    +  G PP 
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 22/206 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN---IV 163
           +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    +   IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 164 TIKGAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERK----AAELTRIIVGVVEACH 217
            +  A+   D L    +++L  GG+L   + Q G +SE +    AAE   II+G+ E  H
Sbjct: 61  CMSYAFHTPDKLS--FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE---IILGL-EHMH 114

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 115 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 170

Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 79/289 (27%), Positives = 129/289 (44%), Gaps = 56/289 (19%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 63

Query: 165 IKGAYEDSLCVHIV-----------MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           +         +++V           M+      +   +I+         + L +++ G+ 
Sbjct: 64  LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK---------SYLFQLLQGLA 114

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPE 272
             CHS  V+HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE
Sbjct: 115 -FCHSHRVLHRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170

Query: 273 VLL--KHYGPEADVWTAGVILYILLS--GVPPFWAETQQ--GIF-------DAVLKGHI- 318
           +LL  K+Y    D+W+ G I   +++   + P  +E  Q   IF       + V  G   
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230

Query: 319 --DFESD--PW---------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             D++     W         P + +  +DL+ +ML   P++R++A   L
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 24/271 (8%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  + + +  +LG G FG  Y      TG+  A K I  +   S E++ED   EI I+  
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILAS 58

Query: 156 LAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGV 212
              H NIV +  A  YE++L   I++E CAGG +   +++     +E +   + +  +  
Sbjct: 59  -CDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +   H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++AP
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172

Query: 272 EVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP- 324
           EV++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P 
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232

Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            W   S   KD ++K L      R T  ++L
Sbjct: 233 RW---SSEFKDFLKKCLEKNVDARWTTTQLL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 82/284 (28%), Positives = 120/284 (42%), Gaps = 55/284 (19%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQIMHH 155
           DL T+   LG G  G+      I TG   A K +   +K  +  +     + RE+QIMH 
Sbjct: 6   DLETI-SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-----RIIV 210
                 IV+  GA+ +   + + ME    G L DRI        +K   +      +I V
Sbjct: 60  -CRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIY-------KKGGPIPVEILGKIAV 110

Query: 211 GVVEACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV---- 262
            VVE    L     +MHRD+KP N +LVN      +K  DFG+S     G++   +    
Sbjct: 111 AVVEGLTYLYNVHRIMHRDIKPSN-ILVNSRGQ--IKLCDFGVS-----GELINSIADTF 162

Query: 263 VGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ--------GIFDAV 313
           VG+  Y++PE +    Y  ++DVW+ G+ +  L  G  PF              GI D  
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-- 220

Query: 314 LKGHIDFESDPWPLISDS----AKDLIRKMLCSQPSERLTAHEV 353
           L   I  E  P  L S       +D +   L   P+ER T  ++
Sbjct: 221 LLQQIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 16/253 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G +    L         +A K + K  +   ED++ V+ E  +    + +  +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++ +  + +V+E   GG+L   + ++    E  A      I   +   H  G+++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           DLK +N LL   D D  +K  D+G+      PG   +   G+P Y+APE+L  + YG   
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177

Query: 283 DVWTAGVILYILLSGVPPF-------WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           D W  GV+++ +++G  PF          T+  +F  +L+  I         +S  A  +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233

Query: 336 IRKMLCSQPSERL 348
           ++  L   P ERL
Sbjct: 234 LKGFLNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.8 bits (197), Expect = 8e-17
 Identities = 84/314 (26%), Positives = 123/314 (39%), Gaps = 81/314 (25%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           D + +  ++G+G +G  Y   +  TG   A K +       R D E         REI+I
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-------RLDNEKEGFPITAIREIKI 59

Query: 153 MHHLAGHKNIVTI----------------KGA------YEDSLCVHIVMELCAGGELFDR 190
           +  L  H+NIV +                KGA      Y D    H +M L   G +   
Sbjct: 60  LRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLV--- 111

Query: 191 IIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
                H+SE       + ++  +  CH    +HRD+K  N LL NK     +K  DFGL+
Sbjct: 112 -----HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLA 163

Query: 251 VFFKPG--QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
             +     + +T+ V + +Y  PE+LL  + YGP  DVW+ G IL  L +  P F A  +
Sbjct: 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223

Query: 307 QGIFDAVLKGHIDFESDPWP--------------------------LISDSAKDLIRKML 340
               + + +         WP                           I   A DL+  ML
Sbjct: 224 LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHML 283

Query: 341 CSQPSERLTAHEVL 354
              PS+R TA E L
Sbjct: 284 TLDPSKRCTAEEAL 297

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 16/203 (7%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN---IV 163
           +G+G FG  Y C +  TG  +A K + K+++  ++  E +    +IM  L    +   IV
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60

Query: 164 TIKGAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEACHSLG 220
            +  A+   D LC   +++L  GG+L   + Q G +SE++     T II+G+ E  H+  
Sbjct: 61  CMTYAFHTPDKLC--FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGL-EHMHNRF 117

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K   Y
Sbjct: 118 VVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAY 173

Query: 279 GPEADVWTAGVILYILLSGVPPF 301
              AD ++ G +L+ LL G  PF
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 46/284 (16%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           K+G+G +GT +      T    A K +        +D E V     REI ++  L  HKN
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK-HKN 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           IV +         + +V E C     + FD     G             ++  +  CHS 
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--K 276
            V+HRDLKP+N LL+NK+ +  LK  DFGL+  F  P + ++  V + +Y  P+VL   K
Sbjct: 119 NVLHRDLKPQN-LLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 277 HYGPEADVWTAGVILYILL-SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD----- 330
            Y    D+W+AG I   L  +G P F           + +       + WP +S      
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 331 --------------------SAKDLIRKMLCSQPSERLTAHEVL 354
                               + +DL++ +L   P +R++A E L
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 28/209 (13%)

Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG   LC        TG + A KS+        +   D  REI+I+  L  H+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLD-HE 66

Query: 161 NIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI---IVGVV 213
           NIV  KG  E     SL   ++ME    G L  R   + H  +     L      I   +
Sbjct: 67  NIVKYKGVCEKPGGRSLR--LIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YY 268
           +   S   +HRDL   N L+   + +  +K  DFGL+      + +   V  P     ++
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYY-YVKEPGESPIFW 178

Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLS 296
            APE L    +   +DVW+ GV LY L +
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 42/229 (18%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           D   LG +LG G  G         +G+      I  RKLI  E    +R    RE++++H
Sbjct: 2   DFEKLG-ELGAGNGGVVTKVLHRPSGL------IMARKLIHLEIKPAIRNQIIRELKVLH 54

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  IV   GA+     + I ME   GG L D+++       +KA  +   I+G + 
Sbjct: 55  E-CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVL-------KKAGRIPENILGKIS 105

Query: 215 ACHSLG---------VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--- 262
                G         +MHRD+KP N +LVN   +  +K  DFG+S     GQ+   +   
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSN-ILVNSRGE--IKLCDFGVS-----GQLIDSMANS 157

Query: 263 -VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
            VG+  Y++PE L   HY  ++D+W+ G+ L  +  G  P      + +
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 18/258 (6%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G +    L     T   +A K I K  +   ED++ V+ E  +    + H  +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           +   ++    +  V+E  +GG+L   + ++    E  A   +  I   +   H  G+++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           DLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + YG   
Sbjct: 121 DLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 283 DVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
           D W  GV+++ +++G  PF            T+  +F  +L+  I         +S  A 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAS 233

Query: 334 DLIRKMLCSQPSERLTAH 351
            +++  L   P ERL  H
Sbjct: 234 SVLKGFLNKDPKERLGCH 251

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 85/318 (26%), Positives = 135/318 (42%), Gaps = 54/318 (16%)

Query: 83  DNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           D+Q Y V +   T  +   Y   + +G G  G      +   GI  A K +S R   ++ 
Sbjct: 4   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQT 62

Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRG 195
             +   RE+ ++     HKNI+++   +      E+   V++VMEL        ++I   
Sbjct: 63  HAKRAYREL-VLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHME 119

Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+     
Sbjct: 120 LDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACT 175

Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS------------------ 296
             + T  V + YY APEV+L   Y    D+W+ G I+  L+                   
Sbjct: 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235

Query: 297 ---GVPP--FWAETQQGIFDAVLKG----HIDFES--DPWPLISDS---------AKDLI 336
              G P   F    Q  + + V        I FE     W   S+S         A+DL+
Sbjct: 236 EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295

Query: 337 RKMLCSQPSERLTAHEVL 354
            KML   P +R++  E L
Sbjct: 296 SKMLVIDPDKRISVDEAL 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 23/216 (10%)

Query: 147 RREIQIMHHLAGHKNIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           RRE  +   L  H NIV +   G     L +  V E   G  L + +   G      A E
Sbjct: 26  RRETALCARLY-HPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADGALP---AGE 80

Query: 205 LTRIIVGVVEA---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG----- 256
             R+++ V++A    H+ G++HRDLKP+N ++         K +DFG+     PG     
Sbjct: 81  TGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDAD 139

Query: 257 ----QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
                  T+V+G+P Y APE L  +   P +D++  G+I    L+G       +   I  
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILY 199

Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER 347
             L   +D    PW +       ++RK L   P +R
Sbjct: 200 QQL-SPVDVSLPPW-IAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 78/269 (28%), Positives = 123/269 (45%), Gaps = 36/269 (13%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G +G+ Y      TG+  A K I  R  +       +  E+ I+H  A    IV  
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHK-AVSPYIVDF 64

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR-----IIVGVVEACHSLG 220
            GA+     V++ ME    G L D++   G  +E    ++ R     ++ G+        
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLK 276
           ++HRD+KP N +LVN +    +K  DFG+S     G +   +    +G   Y+APE  +K
Sbjct: 124 IIHRDVKPTN-VLVNGNG--QVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE-RIK 174

Query: 277 HYGP--------EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL- 327
             GP        ++DVW+ G+ +  +  G  P+  ET   IF A L   +D   DP  L 
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVD--GDPPTLP 231

Query: 328 --ISDSAKDLIRKMLCSQPSERLTAHEVL 354
              SD A+D + K L   P+ R T  ++L
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 78/279 (27%), Positives = 120/279 (43%), Gaps = 44/279 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-------EIATGIEFACKSISKRKLISREDVEDVRREI 150
           R+  TLGR +G+GQFG  Y          +IA  ++  CK+ +     S    E   +E 
Sbjct: 5   REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK-TCKNCT-----SPSVREKFLQEA 58

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RI 208
            IM     H +IV + G   ++  V IVMEL   GEL         Y +     L    +
Sbjct: 59  YIMRQF-DHPHIVKLIGVITEN-PVWIVMELAPLGEL-------RSYLQVNKYSLDLASL 109

Query: 209 IVGVVEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
           I+   +         S   +HRD+   N L+ + D    +K  DFGLS + +    +   
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKAS 166

Query: 263 VGS-PY-YVAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHI 318
            G  P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----QGVKNNDVIGRI 221

Query: 319 DF-ESDPWP-LISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           +  E  P P     +   L+ K     PS+R    E+  
Sbjct: 222 ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 76.3 bits (188), Expect = 9e-16
 Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 47/290 (16%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIMHHLAG 158
           YT   K+G+G +G  Y      TG   A K I   +L S E+       REI ++  L  
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQ- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVME-LCAGGELFDRIIQRGHYSERKAAE--LTRIIVGVVEA 215
           H NIV ++        ++++ E L    + +   + +G Y + +  +  L +I+ G++  
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL-F 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CHS  V+HRDLKP+N L+   D+   +K  DFGL+  F  P +++T  V + +Y APEVL
Sbjct: 117 CHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173

Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFW--AETQQ--GIF-------DAVLKGHIDFE 321
           L    Y    D+W+ G I   + +  P F   +E  Q   IF       + V  G     
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG---VT 230

Query: 322 SDP--------W---------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           S P        W           + +   DL+ KML   P++R++A + L
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 78.0 bits (192), Expect = 9e-16
 Identities = 75/273 (27%), Positives = 124/273 (45%), Gaps = 26/273 (9%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH----- 155
           Y + R LG G  GT      ++ G  FA K +    + S  D    + E+  + +     
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFS 92

Query: 156 -LAGHKNIVTIKGAYEDS-LCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRII 209
            +  H++         ++ L + +V++    G+L   I  R      + E +A  L   +
Sbjct: 93  IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGS 265
           +  V   HS  ++HRD+K  N LL +      +K  DFG S  +    +  DV     G+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNG---LVKLGDFGFSKMYA-ATVSDDVGRTFCGT 208

Query: 266 PYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           PYYVAPE+   K Y  +AD+++ GV+LY LL+   PF  E  + +    L G      DP
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----DP 264

Query: 325 WP-LISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
            P  IS   ++++  +L S P  R ++ ++L M
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 46/221 (20%)

Query: 105 RKLGQGQFGTT---YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           ++LG G FG+        +    +E A K++ +  + + +   +  RE  +M  L  H  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQL-DHPC 57

Query: 162 IVTIKG-AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL-TRIIVGV--VEACH 217
           IV + G    + L   +VMEL   G L   + +R         EL  ++ +G+  +E+ H
Sbjct: 58  IVRLIGVCKGEPLM--LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA------P 271
               +HRDL   N LLVN+      K  DFG+S             GS YY A      P
Sbjct: 116 ---FVHRDLAARNVLLVNRH---QAKISDFGMSRALGA--------GSDYYRATTAGRWP 161

Query: 272 EVLLKHYGPE----------ADVWTAGVILYILLS-GVPPF 301
              LK Y PE          +DVW+ GV L+   S G  P+
Sbjct: 162 ---LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 80/305 (26%), Positives = 126/305 (41%), Gaps = 64/305 (20%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHL 156
           Y    K+GQG FG  +      T    A K +    L+  E  E       REI+I+  L
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKV----LMENEK-EGFPITALREIKILQLL 68

Query: 157 AGHKNIV-------TIKGAYE-DSLCVHIVMELCA---GGELFDRIIQRGHYSERKAAEL 205
             H+N+V       T    Y       ++V E C     G L ++ ++   ++  +  ++
Sbjct: 69  K-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK---FTLSEIKKV 124

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIF 259
            ++++  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      KP   +
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKP-NRY 180

Query: 260 TDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV--LK 315
           T+ V + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     +  L 
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240

Query: 316 GHIDFESDP-------------------------WPLISD-SAKDLIRKMLCSQPSERLT 349
           G I  E  P                          P + D  A DLI K+L   P++R+ 
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300

Query: 350 AHEVL 354
           A   L
Sbjct: 301 ADTAL 305

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 85/294 (28%), Positives = 132/294 (44%), Gaps = 55/294 (18%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  +++G G +G+     +  TG + A K +S R   S    +   RE+ ++ H+  H+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQ-HE 74

Query: 161 NIV------TIKGAYEDSLCVHIVMELCAGGELFDRI----IQRGHYSERKAAELTRIIV 210
           N++      T   + ++    ++VM        + +     I     SE K   L   ++
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMP-------YMQTDLQKIMGHPLSEDKVQYLVYQML 127

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS G++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y A
Sbjct: 128 CGLKYIHSAGIIHRDLKPGN-LAVNEDCE--LKILDFGLAR--HADAEMTGYVVTRWYRA 182

Query: 271 PEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAE------TQ-------------QGI 309
           PEV+L   HY    D+W+ G I+  +L+G   F  +      TQ             Q +
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242

Query: 310 FDAVLKGHI---------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            D   K +I         DF S  +P  S  A DL+ KML     +RLTA E L
Sbjct: 243 EDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 83/288 (28%), Positives = 125/288 (43%), Gaps = 47/288 (16%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN 161
           L R +G+G +G  Y   +  +G   A K +       R+ +     REI ++ +L  H N
Sbjct: 12  LNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLR-HPN 67

Query: 162 IVTIK----GAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           IV +K    G + DS  + +VME C      L D +     +SE +   L   ++  ++ 
Sbjct: 68  IVELKEVVVGKHLDS--IFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQY 123

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
            H   ++HRDLK  N LL +K     LK  DFGL+  +  P +  T  V + +Y APE+L
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKG---CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Query: 275 L--KHYGPEADVWTAGVILYILLSGVP--PFWAETQQ-----------------GIFDAV 313
           L    Y    D+W  G IL  LL+  P  P  +E +Q                 G  D  
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240

Query: 314 LKGHIDFESDPW-------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           L G       P+       P +S++   L+  +L   P +R TA E L
Sbjct: 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 31/230 (13%)

Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG  TD    + T+G+    G +G  Y  T    G   A K +     IS  D E++  E
Sbjct: 17  LGDPTDTWEIIETIGK----GTYGKVYKVTNKKDGSLAAVKILDP---ISDVD-EEIEAE 68

Query: 150 IQIMHHLAGHKNIVTIKGA-YEDSLCVH----IVMELCAGG---ELFDRIIQRGHYSERK 201
             I+  L  H N+V   G  Y+    V     +V+ELC GG   EL   ++  G   +  
Sbjct: 69  YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE- 127

Query: 202 AAELTRIIVGVV---EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI 258
            A ++ I+ G +   +  H+  ++HRD+K  N LL  +     +K +DFG+S      ++
Sbjct: 128 -AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG---GVKLVDFGVSAQLTSTRL 183

Query: 259 FTDV-VGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPF 301
             +  VG+P+++APEV+         Y    DVW+ G+    L  G PP 
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 56/291 (19%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-------REIQIM 153
           Y + R +G+G  G  YL  +       A K I       RED+ +         RE +I 
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-------REDLSENPLLKKRFLREAKIA 56

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--------RIIQRGHYSERKAAEL 205
             L  H  IV +     D   V+  M    G  L            + +    +      
Sbjct: 57  ADLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 206 TRI---IVGVVEACHSLGVMHRDLKPENFLL------------------VNKDDDFSLKA 244
             I   I   +E  HS GV+HRDLKP+N LL                  + ++D   +  
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 245 IDFGL--SVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA-DVWTAGVILYILLSGVPPF 301
            +  +  S    PG+I    VG+P Y+APE LL     E+ D++  GVILY +L+   P+
Sbjct: 176 DERNICYSSMTIPGKI----VGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Query: 302 WAETQQGIFDAVLKGHIDF--ESDPWPLISDSAKDLIRKMLCSQPSERLTA 350
             +  + I     +  I    E  P+  I      +  K L   P+ER ++
Sbjct: 232 RRKKGRKI---SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279

Length = 932

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 81/327 (24%), Positives = 128/327 (39%), Gaps = 88/327 (26%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIA--TGIEFACKSISKRKL----ISREDVEDVRREIQIM 153
            Y +   +G+G +G  Y         G E+A K     K     IS+       REI ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALL 56

Query: 154 HHLAGHKNIVTIKGAYEDS--LCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRII 209
             L  H+N+V++   + +     V+++ +        D  +II+   + + K   +   +
Sbjct: 57  RELK-HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIK--FHRQAKRVSIPPSM 109

Query: 210 V---------GVVEACHSLGVMHRDLKPENFLLV-NKDDDFSLKAIDFGLS-VFFKPGQI 258
           V         GV    HS  V+HRDLKP N L++    +   +K  D GL+ +F  P + 
Sbjct: 110 VKSLLWQILNGV-HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 259 FTD---VVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVP-------------P 300
             D   VV + +Y APE+LL  +HY    D+W  G I   LL+  P             P
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228

Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLI-------------------------------- 328
           F  +  + IF+  + G        WP I                                
Sbjct: 229 FQRDQLERIFE--VLGTPT--EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284

Query: 329 -SDSAKDLIRKMLCSQPSERLTAHEVL 354
                 DL+RK+L   P++R+TA E L
Sbjct: 285 PDSQGFDLLRKLLEYDPTKRITAEEAL 311

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.1 bits (183), Expect = 8e-15
 Identities = 54/173 (31%), Positives = 75/173 (43%), Gaps = 38/173 (21%)

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVVGSPYYVA 270
           HS  V+HRDLKP N LL   + D  +K  DFGL+             + TD V + +Y A
Sbjct: 124 HSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPF----------------WAETQQGI--- 309
           PE+LL    Y    D+W+ G IL  +L G P F                   + + I   
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 310 --------FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                    D++         +  P  SD A DL++K+L   P++RLTA E L
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 54/317 (17%)

Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 59

Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 60  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMEL 116

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 117 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 172

Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Query: 298 -----VPPFWAETQQGIFDAVLK----GHIDF-----------ESDPWPLISDSAKDLIR 337
                 P F  + Q  + + V        + F           +S+   L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292

Query: 338 KMLCSQPSERLTAHEVL 354
           KML   P++R++  E L
Sbjct: 293 KMLVIDPAKRISVDEAL 309

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 63/258 (24%)

Query: 148 REIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVME-----LCAGGELFDRIIQRGH 196
           RE+ +M  L  HKNI+      T + + E+   V++VME     LC       ++IQ   
Sbjct: 64  RELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLC-------QVIQMDL 115

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++V    D +LK +DFGL+      
Sbjct: 116 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSN-IVVK--SDCTLKILDFGLARTAGTS 171

Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL---------------------YIL 294
            + T  V + YY APEV+L   Y    D+W+ G I+                      I 
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231

Query: 295 LSGVPP--FWAETQQGIFDAVL-----KGH-ID--FESDPWPLISDS--------AKDLI 336
             G P   F +  Q  + + V       G+  +  F    +P  S+S        A+DL+
Sbjct: 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL 291

Query: 337 RKMLCSQPSERLTAHEVL 354
            KML   P +R++  + L
Sbjct: 292 SKMLVIDPEKRISVDDAL 309

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 17/199 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV--- 163
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 82

Query: 164 ---TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
              T   + E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 83  DVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 141 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 195

Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 196 NQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 17/213 (7%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y   +++G G +GT     +  TG + A K +  R   S    +   RE++++ H+
Sbjct: 13  VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHM 71

Query: 157 AGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             H+N++ +   +   L +      ++VM     G    ++++    SE +   L   ++
Sbjct: 72  K-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  H+ G++HRDLKP N L VN  +D  LK +DFGL+   +     T  V + +Y A
Sbjct: 129 KGLKYIHAAGIIHRDLKPGN-LAVN--EDCELKILDFGLAR--QTDSEMTGYVVTRWYRA 183

Query: 271 PEVLLK--HYGPEADVWTAGVILYILLSGVPPF 301
           PEV+L   HY    D+W+ G I+  +L+G P F
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 68/243 (27%), Positives = 97/243 (39%), Gaps = 34/243 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           RD  TL R LG G FG  Y           +E      +  +  S +D  D   E  IM 
Sbjct: 5   RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQ--RGHYSERKAAELTRIIV 210
               H+NIV + G   + L   I++EL AGG+L  F R  +      S     +L     
Sbjct: 65  KFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 211 GVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            V + C  L     +HRD+   N LL  K      K  DFG++          D+  + Y
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASY 174

Query: 268 Y------------VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           Y            + PE  L   +  + DVW+ GV+L+ + S G  P+   T Q + + V
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Query: 314 LKG 316
             G
Sbjct: 235 TGG 237

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 22/230 (9%)

Query: 69  ISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFA 128
           +S SK+DN       N     +G  T  +   Y   + +G G  G      +       A
Sbjct: 1   MSRSKRDN-------NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVA 53

Query: 129 CKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELC 182
            K +S R   ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL 
Sbjct: 54  IKKLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 183 AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL 242
                  ++IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +L
Sbjct: 112 DAN--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTL 165

Query: 243 KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL 291
           K +DFGL+       + T  V + YY APEV+L   Y    D+W+ G I+
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 48/285 (16%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKNI 162
           +G+G +G    C    T      + ++ +K    E+ E+V+    RE++++  L   +NI
Sbjct: 9   VGEGAYGVVLKCRHKETK-----EIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENI 62

Query: 163 VTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           V +K A+     +++V E       EL + +   G   E+  + + ++I   +  CH   
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLI-KAIHWCHKND 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLL-KH 277
           ++HRD+KPEN LL++ +D   LK  DFG +     G    +T+ V + +Y +PE+LL   
Sbjct: 121 IVHRDIKPEN-LLISHND--VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAET------------------QQGIFDAVLKGH-I 318
           YG   D+W+ G IL  L  G P F  E+                  Q  +F +  + H +
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237

Query: 319 DFESDPWP---------LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            F +   P         ++S    DL++ +L   P++R    + L
Sbjct: 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 64/268 (23%), Positives = 113/268 (42%), Gaps = 42/268 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKR--KLISREDV---EDVRREIQI 152
           R+ +TL RKLG G FG  +         E   K+  +   K++  +D+   +D ++E+Q 
Sbjct: 5   REEFTLERKLGSGYFGEVW---------EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQA 55

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY---SERKA---AELT 206
           +  L  HK+++++         V+I+ EL   G L         +    E +    A L 
Sbjct: 56  LKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASLI 107

Query: 207 RIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
            +   V E    L     +HRDL   N L+    +D   K  DFGL+   K     +   
Sbjct: 108 DMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDK 164

Query: 264 GSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF 320
             PY + APE      +  ++DVW+ G++LY + + G  P+       ++D +  G+   
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--- 221

Query: 321 ESDPWPL-ISDSAKDLIRKMLCSQPSER 347
              P P         ++ +   ++P +R
Sbjct: 222 -RMPCPAKCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 78/276 (28%), Positives = 112/276 (40%), Gaps = 48/276 (17%)

Query: 107 LGQGQFGTTY---LCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           LG G FG  Y       +  G   I  A K++  RK  + ++ ++  +E  +M +   H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNF-NHP 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER------KAAELTRIIVGVVE 214
           NIV + G    +   +I+MEL  GG+L   +  R    ER         EL  I + V +
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDVAK 117

Query: 215 ACHSLGVM---HRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPGQIFTDVVGSPYY- 268
            C  L  M   HRDL   N L+  K  D    +K  DFGL+          D+  S YY 
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSDYYR 168

Query: 269 -----------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLK 315
                      +APE LL   +  ++DVW+ GV+++ IL  G  P+ A   Q +   V  
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228

Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH 351
           G             D    L+       PSER T  
Sbjct: 229 GG---RLQKPENCPDKIYQLMTNCWAQDPSERPTFD 261

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 10/97 (10%)

Query: 262 VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF 320
           ++G+P Y+APE+LL K +GP  D W  GV L+  L+G+PPF  ET Q +F  +L   I  
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI-- 597

Query: 321 ESDPWP----LISDSAKDLIRKMLCSQPSERLTAHEV 353
              PWP     +S +A++ I  +L   P++R    E+
Sbjct: 598 ---PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKEL 631

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 85/312 (27%), Positives = 126/312 (40%), Gaps = 84/312 (26%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KRKLISREDVEDVRREIQ 151
           Y     +G G +G      +  +G + A K I          KR L          RE++
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----------RELK 56

Query: 152 IMHHLAGHKNIVTIKGAY----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
           I+ H   H NI+ I+        D   V++VM+L    +L   II   H  +    E  R
Sbjct: 57  ILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDL-MESDL-HHII---HSDQPLTEEHIR 110

Query: 208 -----IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG----LSVFFKPGQI 258
                ++ G+ +  HS  V+HRDLKP N LLVN+  D  L+  DFG    LS      + 
Sbjct: 111 YFLYQLLRGL-KYIHSANVIHRDLKPSN-LLVNE--DCELRIGDFGMARGLSSSPTEHKY 166

Query: 259 F-TDVVGSPYYVAPEVLLK--HYGPEADVWTAGVI-------------------LYILLS 296
           F T+ V + +Y APE+LL    Y    D+W+ G I                   L ++LS
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226

Query: 297 --GVPPFWAETQQGIFDAVLKGHI-----DFESD---PW----PLISDSAKDLIRKMLCS 342
             G P       + + + +    +     +       PW    P  S  A DL+ +ML  
Sbjct: 227 VLGSPS------EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF 280

Query: 343 QPSERLTAHEVL 354
            P ER+T  + L
Sbjct: 281 DPEERITVEQAL 292

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 76/318 (23%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREI 150
            +RD Y +  KLG+G FG  Y   +I TG   A K I    L+  E  +D       REI
Sbjct: 6   KLRD-YEILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNE--KDGFPITALREI 58

Query: 151 QIMHHLAGHKNIVTI--------KGAYEDSLCVHIVM-----ELCAGGELFDRIIQRGHY 197
           +I+  L  H N+V +          +      V++V      +L   G L +        
Sbjct: 59  KILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLEN---PSVKL 112

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPG 256
           +E +       ++  +   H   ++HRD+K  N L+ N+     LK  DFGL+  +  P 
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG---ILKIADFGLARPYDGPP 169

Query: 257 QI-----------FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA 303
                        +T++V + +Y  PE+LL  + Y    D+W  G +   + +  P    
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229

Query: 304 ETQ--QG--IFDAV----------------LKGHIDFESDP-------WPLISDSAKDLI 336
           ++   Q   IF                    +G   F + P         L  +   DL+
Sbjct: 230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL-DLL 288

Query: 337 RKMLCSQPSERLTAHEVL 354
            K+L   P +RLTA + L
Sbjct: 289 SKLLSLDPYKRLTASDAL 306

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 40/224 (17%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VRREIQIMHHLA 157
           Y +   +G+G +G      +  TG + A K I+       E V D   + REI+++  L 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND----VFEHVSDATRILREIKLLRLLR 57

Query: 158 GHKNIVTIKG--------AYEDSLCVHIVMELCAGGELFDRI-----IQRGHYSERKAAE 204
            H +IV IK          ++D   +++V EL    +L   I     +   H+       
Sbjct: 58  -HPDIVEIKHIMLPPSRREFKD---IYVVFEL-MESDLHQVIKANDDLTPEHHQ----FF 108

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFK--PGQIF-T 260
           L +++  + +  H+  V HRDLKP+N L    + D  LK  DFGL+ V F   P  IF T
Sbjct: 109 LYQLLRAL-KYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 164

Query: 261 DVVGSPYYVAPEV---LLKHYGPEADVWTAGVILYILLSGVPPF 301
           D V + +Y APE+       Y P  D+W+ G I   +L+G P F
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 2e-13
 Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 41/233 (17%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
            K+G+G FG  Y    +    E A K+   R  +  +      +E +I+     H NIV 
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQYD-HPNIVK 56

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT--RIIVGVVEAC------ 216
           + G       ++IVMEL  GG L         +  +K   LT  +++   ++A       
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRLTVKKLLQMSLDAAAGMEYL 109

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS---------VFFKPGQIFTDVVGSPY 267
            S   +HRDL   N L+    ++  LK  DFG+S         V     QI       P 
Sbjct: 110 ESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQI-------PI 159

Query: 268 -YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            + APE L    Y  E+DVW+ G++L+   S G  P+   + Q   + +  G+
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 44/286 (15%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV- 163
             +G G +G+     +     + A K +S R   S        RE++++ H+  H+N++ 
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMK-HENVIG 78

Query: 164 -----TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
                T   + E+   V++V  L  G +L + I++    S+     L   ++  ++  HS
Sbjct: 79  LLDVFTPATSIENFNEVYLVTNL-MGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N + VN  +D  L+ +DFGL+   +     T  V + +Y APE++L   
Sbjct: 137 AGIIHRDLKPSN-VAVN--EDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLNWM 191

Query: 277 HYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFDAVLKGHIDF------------ 320
           HY    D+W+ G I+  LL G   F    + +  + I + V     +             
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251

Query: 321 -ESDPWPLISDSAK----------DLIRKMLCSQPSERLTAHEVLC 355
            +S P     D  K          DL+ KML     +R++A E L 
Sbjct: 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 72/257 (28%), Positives = 109/257 (42%), Gaps = 23/257 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG G  GT Y    + T    A K I     I+ E  + +  E++I++       I+   
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDS-PYIIGFY 65

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH---SLGVMH 223
           GA+     + I  E   GG L         Y +     L RI V VV+      SL ++H
Sbjct: 66  GAFFVENRISICTEFMDGGSL-------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILH 118

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEA 282
           RD+KP N +LVN      +K  DFG+S       I    VG+  Y+APE +  + YG  +
Sbjct: 119 RDVKPSN-MLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 283 DVWTAGVILYILLSGVPPF-WAETQQGIFDAV--LKGHIDFESDPWP--LISDSAKDLIR 337
           DVW+ G+    L  G  P+   +  QG    +  L+  +D +    P    S+     I 
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234

Query: 338 KMLCSQPSERLTAHEVL 354
           + +  QP ER     ++
Sbjct: 235 QCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 73/279 (26%), Positives = 120/279 (43%), Gaps = 38/279 (13%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D + +   +G+G +G  +       G + A K +     I     E++  E  I+  L+ 
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73

Query: 159 HKNIVTIKGAYEDSLCVH-----IVMELCAGGELFDRI---IQRGHYSERK--AAELTRI 208
           H N+V   G Y      +     +V+ELC GG + D +   ++RG   E    A  L   
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPY 267
           ++G+ +  H    +HRD+K  N LL  +     +K +DFG+S      ++  +  VG+P+
Sbjct: 134 LMGL-QHLHVNKTIHRDVKGNNILLTTEG---GVKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 268 YVAPEV------LLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           ++APEV      L   Y    DVW+ G+    L  G PP  A+         ++      
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRALFKIP 242

Query: 322 SDPWP------LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +P P      L S+   D IRK L     +R T  ++L
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 75/296 (25%), Positives = 125/296 (42%), Gaps = 66/296 (22%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG--HKN 161
           ++G G +GT Y   +  +G   A KS+   ++ + ED   +   RE+ ++  L    H N
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSV---RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGE---------LFDRIIQ--RGHYSE--------RKA 202
           IV +             M++CA            +F+ + Q  R +  +           
Sbjct: 64  IVRL-------------MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETI 110

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
            +L R  +  ++  H+  ++HRDLKPEN L+ +      +K  DFGL+  +      T V
Sbjct: 111 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLARIYSCQMALTPV 167

Query: 263 VGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKG 316
           V + +Y APEVLL+  Y    D+W+ G I   +    P F   ++      IFD + L  
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227

Query: 317 HIDFESD------------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
             D+  D            P P+      I +S   L+ +ML   P +R++A   L
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 41/223 (18%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  +G G FG  Y    I T  + A K +        +D +   RE+ IM +L  H 
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNL-NHI 119

Query: 161 NIVTIKGAY--------EDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRI 208
           NI+ +K  Y        E ++ +++VME          I Q  H    +  R    L   
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEF---------IPQTVHKYMKHYARNNHALPLF 170

Query: 209 IVGVV--EAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           +V +   + C      HS  + HRDLKP+N L+    +  +LK  DFG +     GQ   
Sbjct: 171 LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFGSAKNLLAGQRSV 228

Query: 261 DVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
             + S +Y APE++L   +Y    D+W+ G I+  ++ G P F
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271

Length = 440

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 72/264 (27%), Positives = 118/264 (44%), Gaps = 29/264 (10%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGH 159
             ++G G  GT Y      TG  +A K I      + ED   VR    REI+I+     H
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYG----NHED--TVRRQICREIEILRD-VNH 131

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            N+V     ++ +  + +++E   GG L    I      E+  A++ R I+  +   H  
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLADVARQILSGIAYLHRR 187

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL---L 275
            ++HRD+KP N L+   +   ++K  DFG+S +  +        VG+  Y++PE +   L
Sbjct: 188 HIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 276 KH--Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
            H  Y G   D+W+ GV +     G  PF    +QG + A L   I     P    + S 
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDW-ASLMCAICMSQPPEAPATASR 302

Query: 333 --KDLIRKMLCSQPSERLTAHEVL 354
             +  I   L  +P++R +A ++L
Sbjct: 303 EFRHFISCCLQREPAKRWSAMQLL 326

Length = 353

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+      I  RKLI  E    +R    RE+Q++H       
Sbjct: 12  ELGAGNGGVVFKVSHKPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 64

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 125 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 176

Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.4 bits (162), Expect = 1e-12
 Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 21/228 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M  L+
Sbjct: 4   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLS 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H+ +V + G       ++IV E  + G L + + + G   +   ++L  +   V E   
Sbjct: 58  -HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ--PSQLLEMCKDVCEGMA 114

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---AP 271
              S   +HRDL   N L+   DD   +K  DFGLS +    + +T  VGS + V    P
Sbjct: 115 YLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 170

Query: 272 EVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           EVLL   +  ++DVW  GV+++ + S G  P+         + V +G 
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL 218

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 26/228 (11%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV---EDVRREIQIMHHLAG 158
           T  ++LG GQFG  +L  +    I+ A K I       RE     +D   E ++M  L+ 
Sbjct: 7   TFLKELGSGQFGVVHL-GKWRGKIDVAIKMI-------REGAMSEDDFIEEAKVMMKLS- 57

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H N+V + G       + IV E  A G L + + +R    +     L  +   V EA   
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEY 115

Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---APE 272
           L   G +HRDL   N  LV   +D  +K  DFGL+ +    Q +T   G+ + V    PE
Sbjct: 116 LESNGFIHRDLAARN-CLVG--EDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPE 171

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI 318
           V     +  ++DVW+ GV+++ + S G  P+   +   + ++V  G+ 
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 25/230 (10%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQI 152
           N ++L  LG  +G+G+FG   L      G + A K +       ++D    +    E  +
Sbjct: 4   NSKEL-KLGATIGKGEFGDVMLGD--YRGQKVAVKCL-------KDDSTAAQAFLAEASV 53

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL--TRIIV 210
           M  L  H N+V + G       ++IV E  A G L D +  RG      A +L     + 
Sbjct: 54  MTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YV 269
             +E       +HRDL   N L+    +D   K  DFGL+   K      D    P  + 
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLA---KEASQGQDSGKLPVKWT 166

Query: 270 APEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           APE L  K +  ++DVW+ G++L+ + S G  P+     + +   V KG+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY 216

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 49/179 (27%), Positives = 74/179 (41%), Gaps = 51/179 (28%)

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL----SVFFKPGQIFTDVVGSPYYVAP 271
           CH   V+HRDLKP+N L+  + +   LK  DFGL    SV   P + +++ V + +Y  P
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV---PSKTYSNEVVTLWYRPP 172

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES------D 323
           +VLL    Y    D+W  G I Y + +G P F      G  D   + H  F        +
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF-----PGSTDVEDQLHKIFRVLGTPTEE 227

Query: 324 PWPLIS----------------------------DSAKDLIRKMLCSQPSERLTAHEVL 354
            WP +S                               ++L  K L  +P +R++A E +
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 35/85 (41%), Positives = 47/85 (55%), Gaps = 7/85 (8%)

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF--FKPGQIFTDVVGSPYYVAPEVL 274
           HS G++HRD+KP N LLVN   +  LK  DFGL+        +  T  V + YY APE+L
Sbjct: 120 HSAGILHRDIKPGN-LLVN--SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176

Query: 275 L--KHYGPEADVWTAGVILYILLSG 297
           +  +HY    D+W+ G I   LL  
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 66.0 bits (162), Expect = 2e-12
 Identities = 71/270 (26%), Positives = 105/270 (38%), Gaps = 64/270 (23%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM-HHL-AGHKNIV 163
           KL  G+FG   +     T   F  K I  +              I+ M H L   + N +
Sbjct: 23  KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----------NAIEPMVHQLMKDNPNFI 72

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---G 220
            +  +        ++M+    G+LFD + + G  SE   AE+ +II  +VEA + L    
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE---AEVKKIIRQLVEALNDLHKHN 129

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-------YVAPEV 273
           ++H D+K EN L     D   L   D+GL            ++G+P        Y +PE 
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYL--CDYGLCK----------IIGTPSCYDGTLDYFSPEK 177

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-------- 324
           +  H Y    D W  GV+ Y LL+G  PF             K   D E D         
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPF-------------KEDEDEELDLESLLKRQQ 224

Query: 325 WPL-----ISDSAKDLIRKMLCSQPSERLT 349
             L     +S +A D ++ ML    + RLT
Sbjct: 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 36/222 (16%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G         +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 64

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-LTRIIVGVVEACHSL- 219
           IV   GA+     + I ME   GG L D++++    ++R   E L ++ + V+     L 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE---AKRIPEEILGKVSIAVLRGLAYLR 120

Query: 220 ---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPE 272
               +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172

Query: 273 VLL-KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIF 310
            L   HY  ++D+W+ G+ L  L  G   +PP  A+  + IF
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 75/290 (25%), Positives = 116/290 (40%), Gaps = 54/290 (18%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHK 160
            KLG+G + T Y       GI      +   K+IS +  E V     RE  ++  L  H 
Sbjct: 11  EKLGEGSYATVY------KGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HA 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHS 218
           NIV +         +  V E     +L   +IQ   G +       + +++ G+    H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGL-AYIHG 121

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL-- 275
             ++HRDLKP+N L+    +   LK  DFGL+     P Q ++  V + +Y  P+VLL  
Sbjct: 122 QHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF---ESDPWPLISD-- 330
             Y    D+W AG I   +L G P F   +   +F+ + K          D WP +S   
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSKLP 236

Query: 331 --------------------------SAKDLIRKMLCSQPSERLTAHEVL 354
                                      A+DL  +ML   P +R++A + L
Sbjct: 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 33/209 (15%)

Query: 107 LGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
           LG+G FG+  LC     +  TG   A K   K +  + E + D  REI+I+  L  H NI
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQ-HDNI 67

Query: 163 VTIKG-AYE-DSLCVHIVMELCAGGELFDRIIQRGHYSE-RKAAELTRIIVGVVEACHSL 219
           V  KG  Y      + +VME    G L D + +     + RK       I   +E   S 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-YY 268
             +HRDL   N L+ +   +  +K  DFGL+             +PG+       SP ++
Sbjct: 128 RYVHRDLATRNILVES---ENRVKIGDFGLTKVLPQDKEYYKVREPGE-------SPIFW 177

Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLS 296
            APE L +  +   +DVW+ GV+LY L +
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   LC        TG + A KS+          + D+++EI+I+ +L  H+
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 66

Query: 161 NIVTIKGAYEDSL--CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG   +     + ++ME    G L + + +  +    K  +  +  V + +    
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDY 124

Query: 219 LG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF---TDVVGSP-YYVAP 271
           LG    +HRDL   N L+ ++     +K  DFGL+   +  + +    D + SP ++ AP
Sbjct: 125 LGSRQYVHRDLAARNVLVESEH---QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 272 EVLL--KHYGPEADVWTAGVILYILLS 296
           E L+  K Y   +DVW+ GV LY LL+
Sbjct: 182 ECLIQSKFY-IASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 21/233 (9%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T +      T    A K I   +L   E       RE+ ++ +L  H NIVT
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKNLK-HANIVT 67

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE--LTRIIVGVVEACHSLGVM 222
           +        C+ +V E     +L   +   G+       +  + +++ G+   CH   ++
Sbjct: 68  LHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGL-SYCHKRKIL 125

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGL----SVFFKPGQIFTDVVGSPYYVAPEVLL--K 276
           HRDLKP+N L+  K +   LK  DFGL    SV   P + +++ V + +Y  P+VLL   
Sbjct: 126 HRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNEVVTLWYRPPDVLLGST 179

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
            Y    D+W  G ILY + +G P F   T +     + +       + WP I+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 59/255 (23%), Positives = 111/255 (43%), Gaps = 47/255 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLI----SREDVEDVRREIQI 152
           RD  TLG+ LG+G FG   +   +    +   ++++   K++    + +D+ D+  E+++
Sbjct: 14  RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI---- 208
           M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+    
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 209 ------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
                       +   +E   S   +HRDL   N L+   +    +K  DFGL+      
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLA------ 184

Query: 257 QIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFW 302
               DV    YY            +APE L    Y  ++DVW+ GV+++ I   G  P+ 
Sbjct: 185 ---RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241

Query: 303 AETQQGIFDAVLKGH 317
               + +F  + +GH
Sbjct: 242 GIPVEELFKLLKEGH 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 47/287 (16%)

Query: 106 KLGQGQFGTTYLCTEIATGIEF-ACKSISKRKLISREDVE-DVRREIQIMHHLAG--HKN 161
           ++G+G +G  +   ++  G  F A K +  R     E +     RE+ ++ HL    H N
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRV--RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 162 IVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +V +       +   E  L +   H+  +L       D++ + G  +E     + +++ G
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMFQLLRG 122

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           + +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + +Y AP
Sbjct: 123 L-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 272 EVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHID------ 319
           EVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D      
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238

Query: 320 -----FESDPW-------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                F S            I +  KDL+ K L   P++R++A+  L
Sbjct: 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 66/235 (28%), Positives = 104/235 (44%), Gaps = 25/235 (10%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T +      T    A K I   +L   E       RE+ ++  L  H NIVT
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIVT 68

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAE--LTRIIVGVVEACH 217
           +         VH    L    E  D+ +++     G+       +  L +I+ G+   CH
Sbjct: 69  LHD------IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA-YCH 121

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL- 275
              V+HRDLKP+N L+  + +   LK  DFGL+     P + +++ V + +Y  P+VLL 
Sbjct: 122 RRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
              Y  + D+W  G I + + SG P F   T +     + +       + WP IS
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 70/223 (31%), Positives = 112/223 (50%), Gaps = 24/223 (10%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           TLG  +G+G+FG   L  E  TG + A K+I K  + ++  +E    E  +M  L  HKN
Sbjct: 9   TLGEIIGEGEFGAV-LQGEY-TGQKVAVKNI-KCDVTAQAFLE----ETAVMTKLH-HKN 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G    +  ++IVMEL + G L + +  RG        +L +  + V E    L  
Sbjct: 61  LVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLES 118

Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVAPEVLLKH 277
             ++HRDL   N L+    +D   K  DFGL+   + G +  D    P  + APE  LKH
Sbjct: 119 KKLVHRDLAARNILV---SEDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEA-LKH 171

Query: 278 --YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             +  ++DVW+ GV+L+ + S G  P+   + + + + V KG+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY 214

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 21/218 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS---REDVEDVRREIQIMH 154
           R+  + G+ LG G FG     T        A   ++ + L       + E +  E++IM 
Sbjct: 34  RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGV 212
           HL  H+NIV + GA      + ++ E C  G+L + + ++     +       +  +   
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-------SVFFKPGQIFTDVVGS 265
           +    S   +HRDL   N LL +      +K  DFGL       S +   G     V   
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNYVVKGNARLPV--- 207

Query: 266 PYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
             ++APE +    Y  E+DVW+ G++L+ + S G  P+
Sbjct: 208 -KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 62.0 bits (150), Expect = 5e-11
 Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G FG  +     A     A KS   R+ +  +      +E +I+   + H NIV +
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYS-HPNIVRL 58

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII---VGVVEACHSLGVM 222
            G       ++IVMEL  GG+    +   G     K  EL +++      +E   S   +
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCI 116

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS------VFFKPGQIFTDVVGSPYYVAPEVL-L 275
           HRDL   N L+  K+    LK  DFG+S      V+   G +    V    + APE L  
Sbjct: 117 HRDLAARNCLVTEKN---VLKISDFGMSREEEDGVYASTGGMKQIPVK---WTAPEALNY 170

Query: 276 KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
             Y  E+DVW+ G++L+   S G  P+   + Q   +A+ +G
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 16/222 (7%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  ++LG GQFG  +L  +    I+ A K+I++  +      ED   E ++M  L+ H  
Sbjct: 7   TFMKELGSGQFGVVHL-GKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLS-HPK 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G       ++IV E    G L + + QR G  S+     + + +   +E      
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---APEVLL-K 276
            +HRDL   N L+        +K  DFG++ +    + +T   G+ + V    PEV    
Sbjct: 121 FIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFS 176

Query: 277 HYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            Y  ++DVW+ GV+++ +   G  PF  ++   + + + +G 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 30/209 (14%)

Query: 105 RKLGQGQFGTTYL-CTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   L C + A   TG   A K++ +     +++    ++EI I+  L  H+
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HE 66

Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-- 216
           NIV  KG   +     + ++ME    G L D       Y  +    L ++++   + C  
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119

Query: 217 ----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV---GSP-YY 268
               HS   +HRDL   N LL   D+D  +K  DFGL+     G  +  V     SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176

Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLS 296
            A E L ++ +   +DVW+ GV LY LL+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 67/264 (25%), Positives = 113/264 (42%), Gaps = 29/264 (10%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAG 158
           T+  KLG GQ+G  Y        +  A K++       +ED   VE+  +E  +M  +  
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTMEVEEFLKEAAVMKEIK- 60

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL----TRIIVGVVE 214
           H N+V + G        +I+ E    G L D  ++  +  E  A  L    T+I    +E
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSA-ME 118

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
                  +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + AP
Sbjct: 119 YLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 174

Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E L    +  ++DVW  GV+L+ I   G+ P+       +++ + KG   +  +      
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCP 231

Query: 330 DSAKDLIRKMLCSQPSERLTAHEV 353
               +L+R      PS+R +  E+
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 16/222 (7%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           TL +++G GQFG  +L   +    + A K+I +   +S ED  +   E Q+M  L+ H  
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKR-KVAIKTI-REGAMSEEDFIE---EAQVMMKLS-HPK 60

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG +S+     +   +   +    S  
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---APEVL-LK 276
           V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ + V   +PEV    
Sbjct: 121 VIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176

Query: 277 HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            Y  ++DVW+ GV+++ + S G  P+   +   + + +  G 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF 218

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 70/241 (29%), Positives = 106/241 (43%), Gaps = 31/241 (12%)

Query: 117 LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
           L  +  T   F  K + K    SRE +  +   +  M  L  HK IV+     EDS  V 
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCL--HKYIVS-----EDS--VF 61

Query: 177 IVMELCAGGELFDRIIQRGHYSE----RKAAELTRIIVGVVEACHSLGVMHRDLKPENFL 232
           +V++   GG+L+  I +  +  E    R AAE+    V  ++A H  G++ RDL P N L
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEM----VVALDALHREGIVCRDLNPNNIL 117

Query: 233 LVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEA-DVWTAGVIL 291
           L   DD   ++   F      +      + V    Y APEV       EA D W+ G IL
Sbjct: 118 L---DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEETEACDWWSLGAIL 172

Query: 292 YILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH 351
           + LL+G      +T      + +  H       W  +S+ A+ L++++L   P+ERL A 
Sbjct: 173 FELLTG------KTLVECHPSGINTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAG 224

Query: 352 E 352
            
Sbjct: 225 V 225

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 32/234 (13%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL----------ISREDVEDVRREIQ 151
            + + +G G+FG      E+ +G     K   KR++           + +   D   E  
Sbjct: 7   KIEKVIGAGEFG------EVCSG---RLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS 57

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRII 209
           IM     H NI+ ++G    S  V IV E    G L D  +++  G ++  +   + R I
Sbjct: 58  IMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGI 115

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGS-P 266
              ++    +G +HRDL   N +LVN   +   K  DFGLS   +  P   +T   G  P
Sbjct: 116 ASGMKYLSDMGYVHRDLAARN-ILVNS--NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172

Query: 267 Y-YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             + APE +  + +   +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 54/245 (22%), Positives = 101/245 (41%), Gaps = 46/245 (18%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV---EDVRREIQIMHHLAGHKNIV 163
           LG+G FG  Y           +  S++ + L    +    ++ R+E ++M  L  H NIV
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIV 71

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-------------ELTRIIV 210
            + G         ++ E  A G+L + +++   +S+  A              +   I +
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 211 GVVEACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            +      L     +HRDL   N  LV   +  ++K  DFGLS          D+  + Y
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARN-CLVG--EGLTVKISDFGLS---------RDIYSADY 179

Query: 268 Y------------VAPE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           Y            + PE +L   +  E+D+W+ GV+L+ + S G+ P++  + Q + + +
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239

Query: 314 LKGHI 318
               +
Sbjct: 240 RSRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 19/227 (8%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           T+ + +G G+FG          G   I+ A K++  +   S +   D   E  IM     
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFD- 63

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V I+ E    G L D+ + R +  +    +L  ++ G+      
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFL-RENDGKFTVGQLVGMLRGIASGMKY 121

Query: 219 LGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG--SPY-YVAPE 272
           L  M   HRDL   N +LVN +     K  DFGLS   +  +      G   P  + APE
Sbjct: 122 LSEMNYVHRDLAARN-ILVNSN--LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE 178

Query: 273 VL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            +  + +   +DVW+ G++++ ++S G  P+W  + Q +  AV  G+
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 47/255 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLI----SREDVEDVRREIQI 152
           R   TLG+ LG+G FG   +   I    +   K ++   K++    + +D+ D+  E+++
Sbjct: 11  RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEM 70

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI---- 208
           M  +  HKNI+ + GA      +++++E  + G L + +  R       + +  ++    
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 209 ------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
                       +   +E   S   +HRDL   N L+    +D  +K  DFGL+      
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLA------ 181

Query: 257 QIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFW 302
               DV    YY            +APE L    Y  ++DVW+ GV+L+ I   G  P+ 
Sbjct: 182 ---RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238

Query: 303 AETQQGIFDAVLKGH 317
               + +F  + +GH
Sbjct: 239 GIPVEELFKLLKEGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 32/263 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G++        ++  S  D  D   E++++  L  H NI+ + 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 167 GAYEDSLCVHIVMELCAGGELFD-----RII--------QRGHYSERKAAELTRIIVGVV 213
           GA E+   ++I +E    G L D     R++        + G  S   + +L +    V 
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    ++ + K  DFGLS    V+ K       V    
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPV---- 182

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y  ++DVW+ GV+L+ ++S G  P+   T   +++ + +G   +  + 
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRMEK 239

Query: 325 WPLISDSAKDLIRKMLCSQPSER 347
                D   +L+R+    +P ER
Sbjct: 240 PRNCDDEVYELMRQCWRDRPYER 262

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T Y      T    A K I   +L   E       RE+ ++  L  H NIVT
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIVT 68

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAEL--TRIIVGVVEACH 217
           +         +H    L    E  D+ +++     G+       +L   +++ G+   CH
Sbjct: 69  LHD------IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGL-NYCH 121

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL- 275
              V+HRDLKP+N L+  + +   LK  DFGL+     P + +++ V + +Y  P++LL 
Sbjct: 122 RRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAET 305
              Y  + D+W  G I Y + +G P F   T
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 33/221 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL  LG ++G+G FGT        +G   A K I  R  +  ++ + +  ++ ++   + 
Sbjct: 5   DLKDLG-EIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSD 61

Query: 159 HKNIVTIKGA-YEDSLCVHIVMELCAGG-ELFDRII---QRGHYSERKAAELTRIIVGVV 213
              IV   GA + +  C  I MEL     + F + +    +    E     L +I V  V
Sbjct: 62  CPYIVKFYGALFREGDCW-ICMELMDISLDKFYKYVYEVLKSVIPEEI---LGKIAVATV 117

Query: 214 EACH----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-----VG 264
           +A +     L ++HRD+KP N LL   D + ++K  DFG+S     GQ+   +      G
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGIS-----GQLVDSIAKTRDAG 169

Query: 265 SPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPF 301
              Y+APE +       Y   +DVW+ G+ LY + +G  P+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 47/255 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLIS---REDVEDVRREIQI 152
           RD   LG+ LG+G FG   +   I    E   +   ++ + L S    +D+ D+  E+++
Sbjct: 17  RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 76

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----------------GH 196
           M  +  HKNI+ + GA      +++++E  + G L + +  R                  
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
            S +        +   +E   S   +HRDL   N L+    +D  +K  DFGL+      
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA------ 187

Query: 257 QIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFW 302
               D+    YY            +APE L    Y  ++DVW+ GV+L+ I   G  P+ 
Sbjct: 188 ---RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244

Query: 303 AETQQGIFDAVLKGH 317
               + +F  + +GH
Sbjct: 245 GVPVEELFKLLKEGH 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 21/229 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-REDVEDVRREIQIMHHL 156
           R    L RKLG GQFG      E+  G+      ++ + L     D +D   E QIM  L
Sbjct: 5   RTSIQLLRKLGAGQFG------EVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL 58

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  ++ +         ++IV EL   G L +  +Q G     K  +L  +   V    
Sbjct: 59  R-HPKLIQLYAVCTLEEPIYIVTELMKYGSLLE-YLQGGAGRALKLPQLIDMAAQVASGM 116

Query: 217 HSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVA 270
             L      HRDL   N +LV   ++   K  DFGL+   K   I+    G+ +   + A
Sbjct: 117 AYLEAQNYIHRDLAARN-VLVG--ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTA 172

Query: 271 PE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           PE  L   +  ++DVW+ G++L  I+  G  P+   T   +   V +G+
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY 221

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + + + +G FG  YL  +      +A K + K  +I++  V  V+ E      LA  K
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE---RDALALSK 62

Query: 161 N--IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           +  IV +  + + +  V++VME   GG++   +   G++ E  A +    +   ++  H 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
            G++HRDLKP+N L+ N+     +K  DFGLS
Sbjct: 123 HGIIHRDLKPDNMLISNEG---HIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L RKLG GQFG  ++ T   T  + A K++    +      E   +E QIM  L 
Sbjct: 5   RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM----SPEAFLQEAQIMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E  + G L D  ++ G   + +  +L  +   + E   
Sbjct: 60  -HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD-FLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
              S   +HRDL   N L+    ++   K  DFGL+   +    +T   G+ +   + AP
Sbjct: 118 YLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAP 173

Query: 272 EVLLKHYGP---EADVWTAGVILY 292
           E     YG    ++DVW+ G++L 
Sbjct: 174 EAAN--YGRFTIKSDVWSFGILLT 195

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 43/225 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMH 154
           RD   L R+LG+G FG  +L  C  +    +    ++   K  +  D  +D  RE +++ 
Sbjct: 4   RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLT 63

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL----------FDRIIQR----GHYSER 200
           +   H+NIV   G   +     +V E    G+L             +       G  +  
Sbjct: 64  NF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           +  ++   I   +    S   +HRDL   N L+     D  +K  DFG+S          
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMS---------R 170

Query: 261 DVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY 292
           DV  + YY            + PE ++ + +  E+DVW+ GV+L+
Sbjct: 171 DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 44/282 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            DL  +  +LG+G +G       + TG   A K I  R  ++ ++ + +  ++ I     
Sbjct: 1   DDLEVI-EELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSV 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
                VT  GA      V I ME+      + + ++  +G         L +I V +V+A
Sbjct: 58  DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDI--LGKIAVSIVKA 115

Query: 216 CH----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV-----GSP 266
                  L V+HRD+KP N +L+N++     K  DFG+S     G +   V      G  
Sbjct: 116 LEYLHSKLSVIHRDVKPSN-VLINRNGQV--KLCDFGIS-----GYLVDSVAKTIDAGCK 167

Query: 267 YYVAPEVL-----LKHYGPEADVWTAGVILYILLSGVPPF--WAETQQGIFDAVLKGHID 319
            Y+APE +      K Y  ++DVW+ G+ +  L +G  P+  W    Q +   V      
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV------ 221

Query: 320 FESDPWPLI-----SDSAKDLIRKMLCSQPSERLTAHEVLCM 356
              +P P +     S   +D + K L     ER    E+L  
Sbjct: 222 --EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 42/231 (18%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI-------MHHLAGH 159
           LG+G FG  +  T +      A K+            ED+ +E++I       +     H
Sbjct: 3   LGKGNFGEVFKGT-LKDKTPVAVKTCK----------EDLPQELKIKFLSEARILKQYDH 51

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA---C 216
            NIV + G       ++IVMEL  GG+    +  R    E K  +L +  +         
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYL 109

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------VFFKPG--QIFTDVVGSPYY 268
            S   +HRDL   N L+    ++  LK  DFG+S      ++   G  QI         +
Sbjct: 110 ESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------W 160

Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            APE L    Y  E+DVW+ G++L+   S GV P+   T Q   + V KG+
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.1 bits (135), Expect = 6e-09
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 32/232 (13%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----REDVEDVRR-----EIQ 151
            + R LG G+FG      E+  G     K  SKR+L       R    D +R     E  
Sbjct: 8   KIERILGTGRFG------ELCRG---CLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
            +     H NIV ++G       + IV E  + G L D  +++ H  +  A +L  ++ G
Sbjct: 59  TLGQF-DHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRK-HEGQLVAGQLMGMLPG 115

Query: 212 VVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG-SP- 266
           +      L   G +H+ L     +LVN D     K   F      K   I+T + G SP 
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHK-VLVNSD--LVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
            + APE +   H+   +DVW+ G++++ ++S G  P+W  + Q +  AV  G
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 25/261 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T  + A K++    ++     E   +E QIM  L 
Sbjct: 5   RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMP----EAFLQEAQIMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E    G L D  ++ G     K  +L  +   + +   
Sbjct: 60  -HDKLVPLYAVVSEE-PIYIVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
               +  +HRDL+  N L+    D+   K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 117 YIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172

Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL-I 328
           E  L   +  ++DVW+ G++L  L++ G  P+     + + + V +G+      P P   
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY----RMPCPQGC 228

Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +S  +L++      P ER T
Sbjct: 229 PESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 55/292 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y        +       A K++++   +   +  +   E  +
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASV 62

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE------LT 206
           M     H ++V + G         +VMEL A G+L   +  R    E +         L 
Sbjct: 63  MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQ 119

Query: 207 RIIVGVVEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           + I    E         +   +HRDL   N  +V   +D ++K  DFG++          
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARN-CMVA--EDLTVKIGDFGMT---------R 167

Query: 261 DVVGSPYY------------VAPEVLLK-HYGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            +APE L    +  ++DVW+ GV+L+ +      P+   + 
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227

Query: 307 QGIFDAVLKG-HIDF-ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           + +   V+ G H+D  E+ P  L+     +L+R      P  R T  E++  
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLL-----ELMRMCWQYNPKMRPTFLEIVSS 274

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 59/215 (27%), Positives = 86/215 (40%), Gaps = 34/215 (15%)

Query: 106 KLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
           KLG G FG         +G   I  A K +   KL   + ++D  +E  IMH L  H+N+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLD-HENL 58

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLG 220
           + + G       + +V EL   G L DR+ +   GH+      +    I   +    S  
Sbjct: 59  IRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----------- 269
            +HRDL   N LL + D    +K  DFGL                 +YV           
Sbjct: 118 FIHRDLAARNILLASDD---KVKIGDFGLMRALP--------QNEDHYVMEEHLKVPFAW 166

Query: 270 -APEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
            APE L    +   +DVW  GV L+ + + G  P+
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 48/285 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD  TLG+ LG+G FG       +         +++ + L    + +D+ D+  E+++M 
Sbjct: 11  RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMK 70

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG--- 211
            +  HKNI+ + G       +++V+E  A G L D +  R    E  + +  R       
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 212 ---VVEACH----------SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI 258
              +V   +          S   +HRDL   N L+    +D  +K  DFGL+        
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA-------- 179

Query: 259 FTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAE 304
             D+    YY            +APE L    Y  ++DVW+ GV+L+ I   G  P+   
Sbjct: 180 -RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238

Query: 305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT 349
             + +F  + +G+     +     +     L+R      PS+R T
Sbjct: 239 PVEELFKLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQRPT 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 29/224 (12%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L  +G+                 T    A K I+     S+ED++ +++EI     L  H
Sbjct: 3   LTLIGKCFEDLMIVHLAKHK--PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-H 58

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR-IIVGVVEA--- 215
            NI+    ++     +++V  L A G   D +  + H+ E         I+  V+ A   
Sbjct: 59  PNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDY 116

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSP------ 266
            HS G +HR +K  + LL         K +  GL       K G+    V   P      
Sbjct: 117 IHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 267 -YYVAPEVL---LKHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
             +++PEVL   L+ Y  ++D+++ G+    L +G  PF  +  
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMP 214

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 40/231 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI---------EFACKSISKRKLISREDV----- 143
           R    L  KLG+GQFG  +LC   A G+         EF  + +     + R DV     
Sbjct: 4   RQQLRLKEKLGEGQFGEVHLCE--AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61

Query: 144 EDVRREIQIMHHLAGHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK 201
            D  +EI+IM  L  + NI+ + G    +D LC  ++ E    G+L   + QR   S   
Sbjct: 62  NDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLC--MITEYMENGDLNQFLSQREIESTFT 118

Query: 202 AAE------------LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            A             +   I   ++   SL  +HRDL   N L+    + +++K  DFG+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGM 175

Query: 250 SVFFKPGQIF----TDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           S     G  +      V+   +     +LL  +   +DVW  GV L+ + +
Sbjct: 176 SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L      G + A K I K    ++  +     E  +M  
Sbjct: 4   NMKEL-KLLQTIGKGEFGDVMLGDY--RGNKVAVKCI-KNDATAQAFLA----EASVMTQ 55

Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 56  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 113

Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 114 AMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 167

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS 296
           PE L  K +  ++DVW+ G++L+ + S
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 62/263 (23%), Positives = 108/263 (41%), Gaps = 32/263 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 167 GAYEDSLCVHIVMELCAGGELFD-----RII--------QRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D     R++             S   + +L      V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 175

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G   +  + 
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEK 232

Query: 325 WPLISDSAKDLIRKMLCSQPSER 347
                D   DL+R+    +P ER
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYER 255

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 34/275 (12%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 187

Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 244

Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVLCMYN 358
            PL   D   DL+R+    +P ER +  ++L   N
Sbjct: 245 -PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 64/261 (24%), Positives = 115/261 (44%), Gaps = 25/261 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 5   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVV 213
            H+ +V +     +   ++IV E  + G L D +  +G   +     +  ++   I   +
Sbjct: 60  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVA 270
                +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + A
Sbjct: 116 AYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTA 171

Query: 271 PE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           PE  L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P  
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPEC 228

Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +S  DL+ +    +P ER T
Sbjct: 229 PESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)

Query: 104 GRKLGQGQFGTTYLC--TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           G K+G+G +G  Y     +     E+A K I    +          REI ++  L  H N
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK-HPN 59

Query: 162 IVTIKGAY--EDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVG-----VV 213
           ++ ++  +       V ++ +  A  +L+  I   R   + +K  +L R +V      ++
Sbjct: 60  VIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118

Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFF----KPGQIFTDVVGS 265
           +  H L    V+HRDLKP N L++ +  +   +K  D G +  F    KP      VV +
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 266 PYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
            +Y APE+LL  +HY    D+W  G I   LL+  P F
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 18/171 (10%)

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ--RGHYSERKAAEL 205
           REI ++  L  H N+++++  +       + +           II+  R   + +K  +L
Sbjct: 47  REIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 105

Query: 206 TR-----IIVGVVEACHSLG---VMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFF--- 253
            R     ++  +++  H L    V+HRDLKP N L++ +  +   +K  D G +  F   
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 254 -KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
            KP      VV + +Y APE+LL  +HY    D+W  G I   LL+  P F
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 52.3 bits (125), Expect = 8e-08
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 20/228 (8%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++ K   +S E   +   E QIM  L 
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTL-KPGTMSPESFLE---EAQIMKKLR 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E  + G L D  ++ G     K   L  +   V     
Sbjct: 60  -HDKLVQLYAVVSEE-PIYIVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
               +  +HRDL+  N L+    D    K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 117 YIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172

Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E  L   +  ++DVW+ G++L  L++ G  P+     + + + V +G+
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY 220

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 21/212 (9%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D Y    KLG+G + T Y       G   A K I   +L   E       RE  ++  L 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI---RLQEEEGTPFTAIREASLLKGLK 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVME-----LCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
            H NIV +         + +V E     LC   +  D+    G + E     L +++ G+
Sbjct: 62  -HANIVLLHDIIHTKETLTLVFEYVHTDLC---QYMDKH-PGGLHPENVKLFLFQLLRGL 116

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAP 271
               H   ++HRDLKP+N L+    D   LK  DFGL+     P   +++ V + +Y  P
Sbjct: 117 -SYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
           +VLL    Y    D+W  G I   ++ GV  F
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 55/259 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIE---------FACKSISKRKLISREDVEDVRR 148
           RD   LG+ LG+G FG        A GI+          A K +      + +D+ D+  
Sbjct: 11  RDRLVLGKPLGEGCFGQVVRAE--AYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLIS 66

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+++M  +  HKNI+ + G       +++++E  A G L + +  R         ++T++
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 209 ----------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
                           +   +E   S   +HRDL   N +LV +D+   +K  DFGL+  
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN-VLVTEDN--VMKIADFGLA-- 181

Query: 253 FKPGQIFTDVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGV 298
                    V    YY            +APE L    Y  ++DVW+ G++++ I   G 
Sbjct: 182 -------RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234

Query: 299 PPFWAETQQGIFDAVLKGH 317
            P+     + +F  + +GH
Sbjct: 235 SPYPGIPVEELFKLLREGH 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 70/305 (22%), Positives = 127/305 (41%), Gaps = 34/305 (11%)

Query: 20  PEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMR 79
               +N+++R+ +     +  ST S  ++       +K+      +   ++P  K   + 
Sbjct: 44  TSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVT 103

Query: 80  RGIDNQT------YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS 133
             + NQ+      Y VLG   D     + +   LG+G FG      +       A K + 
Sbjct: 104 YALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR 163

Query: 134 KRKLISREDVEDVRREIQIMHHL-----AGHKNIVTIKGAYE-DSLCVHIVMELCAGGEL 187
                +R    D + EIQ M  +     A    ++ I+  ++ ++  + IVM    G  L
Sbjct: 164 NVPKYTR----DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK-YGPCL 218

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKD--------- 237
            D I++ G +S R  A++       ++  H+ L +MH DLKPEN L+   D         
Sbjct: 219 LDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278

Query: 238 ----DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILY 292
               D   ++  D G     +  +  T +V + +Y +PEV+L   +    D+W+ G I+Y
Sbjct: 279 ALPPDPCRVRICDLGGCCDERHSR--TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336

Query: 293 ILLSG 297
            L +G
Sbjct: 337 ELYTG 341

Length = 467

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 65/257 (25%), Positives = 113/257 (43%), Gaps = 54/257 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIE---FACKSISKRKLISREDVEDVRREIQI 152
           RD+  L R+LG+G FG  +L  C  ++   +    A K++    L +R+D +   RE ++
Sbjct: 5   RDI-VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ---REAEL 60

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELF--------DRIIQRGHYSERKAAE 204
           + +L  H++IV   G   D   + +V E    G+L         D +I       +   E
Sbjct: 61  LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 205 L---------TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
           L         ++I  G+V    S   +HRDL   N L+     +  +K  DFG+S     
Sbjct: 120 LGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGA---NLLVKIGDFGMS----- 170

Query: 256 GQIFTDVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPF 301
                DV  + YY            + PE ++ + +  E+DVW+ GVIL+ I   G  P+
Sbjct: 171 ----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Query: 302 WAETQQGIFDAVLKGHI 318
           +  +   + + + +G +
Sbjct: 227 FQLSNTEVIECITQGRV 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK---PGQIF 259
             + R ++  ++  H  G++HRD+K EN +LVN  +D  L   DFG + F +        
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFH 319

Query: 260 TDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY 292
             + G+    APEVL    Y P  D+W+AG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 26/81 (32%), Positives = 45/81 (55%), Gaps = 4/81 (4%)

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRD+K EN  +   +D   +   D G + F      F  + G+    APEVL +
Sbjct: 174 HAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR 230

Query: 277 -HYGPEADVWTAGVILYILLS 296
             Y  +AD+W+AG++L+ +L+
Sbjct: 231 DKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 60/253 (23%), Positives = 106/253 (41%), Gaps = 51/253 (20%)

Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           RD+  L  +LG+G FG  +L  C  +    +    ++   K  S    +D +RE +++  
Sbjct: 5   RDI-VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV 63

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE----------- 204
           L  H++IV   G   +   + +V E    G+L +R + R H  + K              
Sbjct: 64  LQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFL-RSHGPDAKILAGGEDVAPGQLT 120

Query: 205 -------LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
                   ++I  G+V    SL  +HRDL   N L+        +K  DFG+S       
Sbjct: 121 LGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLV---GQGLVVKIGDFGMS------- 169

Query: 258 IFTDVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWA 303
              D+  + YY            + PE +L + +  E+D+W+ GV+L+ I   G  P++ 
Sbjct: 170 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227

Query: 304 ETQQGIFDAVLKG 316
            +     + + +G
Sbjct: 228 LSNTEAIECITQG 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 21/229 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++        + A K++    +     V+    E  +M  L 
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEA 215
            H  +V +         ++I+ E  A G L D  +  + G     K  + +  I   +  
Sbjct: 60  -HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    +    K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 119 IERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 174

Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            +  ++G    ++DVW+ G++LY I+  G  P+   +   +  A+ +G+
Sbjct: 175 AI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 63/292 (21%)

Query: 105 RKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVE-DVRREIQIMHHLAGH 159
           R +GQG FG  +     A G+     F   ++   K  +  D++ D +RE  +M     H
Sbjct: 11  RDIGQGAFGRVFQAR--APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DH 67

Query: 160 KNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG------ 211
            NIV + G  A    +C  ++ E  A G+L + +  R   ++   +  T           
Sbjct: 68  PNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 212 ----VVEACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
                 + C +  V            +HRDL   N L+    ++  +K  DFGLS     
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLS----- 177

Query: 256 GQIFTDVVGSPYYVAPE-------------VLLKHYGPEADVWTAGVILYILLS-GVPPF 301
                ++  + YY A E             +    Y  E+DVW  GV+L+ + S G+ P+
Sbjct: 178 ----RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Query: 302 WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           +    + +   V  G++    D  PL      +L+R      PS+R +   +
Sbjct: 234 YGMAHEEVIYYVRDGNVLSCPDNCPL---ELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 25/237 (10%)

Query: 101 YTLGRKLGQGQFGT---TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +TLGR LG+G+FG+     L +E  +  + A K + K  + S  D+E+  RE   M    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58

Query: 158 GHKNI-----VTIKGAYEDSLCVHIV-MELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
            H N+     V+++   +  L + +V +     G+L   ++      E     L  ++  
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 212 VVEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           +++         S   +HRDL   N +L   +++ ++   DFGLS     G  +     S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 266 PY---YVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
                ++A E L  + Y   +DVW  GV ++ I+  G  P+       I++ ++KG+
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 43/223 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTY--LCTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 5   REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 62

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 63  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
           I    E    +  +      HRDL   N ++     DF++K  DFG++          D+
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RDI 169

Query: 263 VGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY 292
             + YY            +APE L    +   +D+W+ GV+L+
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 44/246 (17%)

Query: 103 LGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           L R+LG+G FG  +L  C  +    +    ++   K  S    +D  RE +++ +L  H+
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HE 67

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA-----AELTR-------- 207
           +IV   G   +   + +V E    G+L   +   G  +   A     AELT+        
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 208 -IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
            I  G+V    S   +HRDL   N L+    ++  +K  DFG+S          DV  + 
Sbjct: 128 QIAAGMVYLA-SQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYSTD 174

Query: 267 YY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDA 312
           YY            + PE ++ + +  E+DVW+ GV+L+ I   G  P++  +   + + 
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234

Query: 313 VLKGHI 318
           + +G +
Sbjct: 235 ITQGRV 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 3/95 (3%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           RD    G+ LG G FG     T    G E     ++ + L +    ++ E +  E++I+ 
Sbjct: 37  RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILS 96

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD 189
           HL  HKNIV + GA      V ++ E C  G+L +
Sbjct: 97  HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLN 131

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 43/233 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI------EFACKSISKRKLIS-----REDVE-- 144
           R   T   KLG+GQFG  +LC   A G+      +F+      + ++      RED    
Sbjct: 4   RKRLTFKEKLGEGQFGEVHLCE--AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61

Query: 145 ---DVRREIQIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
              D  +EI+IM  L    NI+ +       D LC  ++ E    G+L ++ + R    E
Sbjct: 62  ARNDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLC--MITEYMENGDL-NQFLSRHEPQE 117

Query: 200 RKAAELTRI------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF 247
                                I   ++   SL  +HRDL   N  LV K  ++++K  DF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN-CLVGK--NYTIKIADF 174

Query: 248 GLSVFFKPGQIF----TDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           G+S     G  +      V+   +     +LL  +   +DVW  GV L+ +L+
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 36/218 (16%)

Query: 105 RKLGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           R +G+G FG  Y  T I + G +  C   S  ++   E+VE   +E  IM   + H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVL 59

Query: 164 TIKG-AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG-- 220
           ++ G          +V+     G+L + I    H    K  +L    + V +    L   
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--DLIGFGLQVAKGMEYLASK 117

Query: 221 -VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY----------- 268
             +HRDL   N +L   D+ F++K  DFGL+          D+    YY           
Sbjct: 118 KFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNHTGAKLP 165

Query: 269 ---VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
              +A E L    +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 51/288 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    IA G+         A K++++   + RE +E +  E 
Sbjct: 5   REKITMSRELGQGSFGMVY--EGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 60

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE----LT 206
            +M     H ++V + G         ++MEL   G+L   +       E    +    L 
Sbjct: 61  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---------R 167

Query: 261 DVVGSPYY------------VAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY            ++PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +   V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 228 EQVLRFVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 55/239 (23%), Positives = 106/239 (44%), Gaps = 31/239 (12%)

Query: 102 TLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            LG+ LG+G+FG+     L  +  + ++ A K++ K  + +  ++E+   E   M     
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD- 59

Query: 159 HKNI-----VTIKGAYEDSLCVHIV-MELCAGGELFDRII--QRGHYSERKAAE-LTRII 209
           H N+     V  + +    +   +V +     G+L   ++  + G   E+   + L + +
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 210 VGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV------FFKPGQIFT 260
           V +   +E   +   +HRDL   N +L    +D ++   DFGLS       +++ G+I  
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 261 DVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
             V    ++A E L    Y  ++DVW  GV ++ I   G  P+       I+D +  G+
Sbjct: 177 MPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 30/178 (16%)

Query: 140 REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
           +   +++ RE +IMH L  +  IV + G  E +  + +VME+ +GG L         +  
Sbjct: 36  KSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMASGGPL-------NKFLS 86

Query: 200 RKAAELTRIIVGVVEACH--SLGV--------MHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            K  E+T  +  VVE  H  S+G+        +HRDL   N LLVN+      K  DFGL
Sbjct: 87  GKKDEIT--VSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGL 141

Query: 250 S-VFFKPGQIFTDVVGSPY---YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           S         +       +   + APE +    +   +DVW+ G+ ++   S G  P+
Sbjct: 142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 7/104 (6%)

Query: 98  RDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           RD   LGR LG G FG     T +  +   + ++ A K +  +      + + +  E++I
Sbjct: 36  RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKML--KSTARSSEKQALMSELKI 93

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH 196
           M HL  H NIV + GA      ++I+ E C  G+L D + +  H
Sbjct: 94  MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKH 137

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 13/115 (11%)

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + +++ G+    H +G++HRD+KPEN L+     D  +K IDFG +V    G  F  + G
Sbjct: 315 MRQVLTGL-RKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYG 370

Query: 265 --SPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPF-WAETQQGIFDAVLKG 316
              P Y  PE L+    P++        +  LLS   PF W   +  +FD+   G
Sbjct: 371 MLDPRYSPPEELVM---PQSCPRAPAPAMAALLS---PFAWLYGRPDLFDSYTAG 419

Length = 507

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 64/249 (25%), Positives = 100/249 (40%), Gaps = 75/249 (30%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-EFACKS--ISKRKLIS--------REDV--- 143
           R       KLG+GQFG  +LC   A G+ +F+ K+   +              R D    
Sbjct: 4   RQPLNFVEKLGEGQFGEVHLCE--ADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61

Query: 144 --EDVRREIQIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
             ED  +E++I+  L+   NI  + G    +  LC  ++ME    G+L         + +
Sbjct: 62  AREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLC--MIMEYMENGDL-------NQFLQ 111

Query: 200 RKAAEL-------------------TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           +  AE                    T+I  G+     SL  +HRDL   N  LV K  ++
Sbjct: 112 KHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LESLNFVHRDLATRN-CLVGK--NY 167

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYY------VAP-------EVLLKHYGPEADVWTA 287
           ++K  DFG+S          ++  S YY        P        VLL  +  ++DVW  
Sbjct: 168 TIKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 288 GVILYILLS 296
           GV L+ +L+
Sbjct: 219 GVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 18/102 (17%)

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + R ++  ++  H   ++HRD+K EN + +N   D  L   DFG + F  P     D+  
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAEN-IFINHPGDVCLG--DFGAACF--P----VDINA 237

Query: 265 SPYY--------VAPEVLLKH-YGPEADVWTAGVILYILLSG 297
           + YY         APE+L +  YGP  D+W+AG++L+ + + 
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 29/229 (12%)

Query: 104 GRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            + LG G FGT +    I  G    I  A K+I  R    R+  +++   +  M  L  H
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DH 68

Query: 160 KNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
             IV + G     +C    + +V +L   G L D +  R H        L    V + + 
Sbjct: 69  AYIVRLLG-----ICPGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKG 121

Query: 216 CHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYV 269
            + L    ++HR+L   N LL     D  ++  DFG++    P      +++      ++
Sbjct: 122 MYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 270 APE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           A E +L   Y  ++DVW+ GV ++ ++S G  P+       + D + KG
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 55/243 (22%), Positives = 100/243 (41%), Gaps = 46/243 (18%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFA-CKSISKRKLISR-EDVEDVRREIQIMHHLAGHKNIV 163
           +LG+  FG  Y       G++ A   +I   K I+  +   + ++E  +M  L  H NIV
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIV 70

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-----------------ELT 206
            + G       V ++ E    G+L + +I R  +S+   +                  + 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             I   +E   S   +H+DL   N L+    +   +K  D GLS          ++  + 
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLS---------REIYSAD 178

Query: 267 YY-VAPEVLLK------------HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           YY V P+ LL              +  ++D+W+ GV+L+ + S G+ P++  + Q + + 
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238

Query: 313 VLK 315
           V K
Sbjct: 239 VRK 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMH 154
           +R  Y +   L  G  G  ++CT+             ++K+I +     +   REI I+ 
Sbjct: 90  VRMQYNILSSLTPGSEGEVFVCTKHG--------DEQRKKVIVKAVTGGKTPGREIDILK 141

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMEL--CAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
            ++ H+ I+ +  AY     V +VM    C   +LF  + + G     +A  + R ++  
Sbjct: 142 TIS-HRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQRRLLEA 197

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-----FFKP---GQIFTDVVG 264
           +   H  G++HRD+K EN  L ++ ++  L   DFG +         P   G   T    
Sbjct: 198 LAYLHGRGIIHRDVKTENIFL-DEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETN 254

Query: 265 SPYYVAPEVLLKHYGPEADVWTAGVILY 292
           SP  +A    L  Y  + D+W+AG++L+
Sbjct: 255 SPELLA----LDPYCAKTDIWSAGLVLF 278

Length = 392

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 47/231 (20%)

Query: 106 KLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKL-----ISREDV-----EDVRREI 150
           KLG+GQFG  +LC E+        ++F       R L     I R D       D  +E+
Sbjct: 12  KLGEGQFGEVHLC-EVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 151 QIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGEL--------FDRIIQRGHYSER 200
           +I+  L    NI+ + G    ED LC  ++ E    G+L         D   + G+ +  
Sbjct: 71  KILSRLK-DPNIIRLLGVCVDEDPLC--MITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 201 KAAELTRI-----------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            A  L  I           I   ++   SL  +HRDL   N L+    ++ ++K  DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGM 184

Query: 250 SVFFKPG---QIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILYILLS 296
           S     G   +I    V    ++A E +L+  +   +DVW  GV L+ +L 
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 57/244 (23%), Positives = 109/244 (44%), Gaps = 42/244 (17%)

Query: 102 TLGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            LG+ LG+G+FG+       +  + ++ A K++ K  + +R ++ED   E   M     H
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEF-DH 59

Query: 160 KNIVTIKGAYEDSLCVH-----------IVMELCAGGEL-----FDRIIQRGHY--SERK 201
            N++ + G     +C+            +++     G+L     + R+     Y  ++  
Sbjct: 60  PNVMRLIG-----VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML 114

Query: 202 AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV------FFKP 255
              +T I  G+ E   S   +HRDL   N +L   +++ ++   DFGLS       +++ 
Sbjct: 115 VKFMTDIASGM-EYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQ 170

Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAV 313
           G+I    V    ++A E L    Y  ++DVW+ GV ++ I   G  P+       I+D +
Sbjct: 171 GRIAKMPVK---WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Query: 314 LKGH 317
            +G+
Sbjct: 228 RQGN 231

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 7/97 (7%)

Query: 98  RDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           RD   LGR LG G FG     T Y  +     ++ A K +      S +  + +  E++I
Sbjct: 36  RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK--QALMSELKI 93

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD 189
           M HL  H NIV + GA   S  ++I+ E C  G+L +
Sbjct: 94  MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVN 130

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 35/107 (32%), Positives = 46/107 (42%), Gaps = 11/107 (10%)

Query: 147 RREIQIMHHLAGHKNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
           RRE +IM      K  V +   Y  D     IVME   G  L D +I      E + +  
Sbjct: 47  RREARIMSRA--RKAGVNVPAVYFVDPENFIIVMEYIEGEPLKD-LINSNGMEELELSRE 103

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
              +VG +   HS G++H DL   N +L        L  IDFGL+ F
Sbjct: 104 IGRLVGKL---HSAGIIHGDLTTSNMIL--SGGKIYL--IDFGLAEF 143

Length = 211

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 59/262 (22%), Positives = 115/262 (43%), Gaps = 27/262 (10%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 5   RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 59

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 60  -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 117 FIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172

Query: 272 EVLLKHYGP---EADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           E +  ++G    ++DVW+ G++L  +++ G  P+   +   +  A+ +G+     +  P 
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP- 229

Query: 328 ISDSAKDLIRKMLCSQPSERLT 349
             +   +++ +   ++P ER T
Sbjct: 230 --EELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 31/116 (26%), Positives = 46/116 (39%), Gaps = 14/116 (12%)

Query: 139 SREDVEDVRREIQIMHHLAGHKNIV-TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY 197
           SRE   D  RE+ I+  LA     V  +  + E     +++ME   G  L +   +    
Sbjct: 31  SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKED 90

Query: 198 SERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              + AEL   +       H L    + H DL P N L+   DD   L  ID+  +
Sbjct: 91  IAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKR---KLISRED-----VEDVRREIQIMHHLA 157
           +LG G FGT      +  G+ +  K   K    K++  ++      +++ RE  +M  L 
Sbjct: 2   ELGSGNFGT------VKKGM-YKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL- 53

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            +  IV + G  E    + +VMEL   G L   + +  H +E+   EL   +   ++   
Sbjct: 54  DNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS---PY-YVAPEV 273
               +HRDL   N LLV +      K  DFGLS      + +         P  + APE 
Sbjct: 113 ETNFVHRDLAARNVLLVTQH---YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 274 LLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 56/258 (21%), Positives = 104/258 (40%), Gaps = 58/258 (22%)

Query: 103 LGRKLGQGQFGTTY--LCTEIA--TGIE-FACKSISKRKLISREDVEDVRREIQIMHHLA 157
           LG+ LG+G+FG         +    G    A K + +    S  ++ D+  E  ++  + 
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQR------GHYSERKAAELTR-- 207
            H +++ + GA      + +++E    G L  F R  ++      G    R ++ L    
Sbjct: 62  -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 208 ---IIVGVV-----EACH------SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
              + +G +     +          + ++HRDL   N L+    +   +K  DFGLS   
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLS--- 174

Query: 254 KPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
                  DV     YV            A E L  H Y  ++DVW+ GV+L+ +++ G  
Sbjct: 175 ------RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228

Query: 300 PFWAETQQGIFDAVLKGH 317
           P+     + +F+ +  G+
Sbjct: 229 PYPGIAPERLFNLLKTGY 246

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 39.7 bits (93), Expect = 8e-04
 Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 10/89 (11%)

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           ++   +L  +HR  K  N LL     D  LK    G   F  P Q   D    PY++APE
Sbjct: 24  LQCLGALRELHRQAKSGNILL---TWDGLLKL--DGSVAFKTPEQSRPD----PYFMAPE 74

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPP 300
           V+  + Y  +AD+++ G+ LY  L    P
Sbjct: 75  VIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 8/85 (9%)

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY-YVAPEVLL-KH 277
           +HRDL   N LL   +    +K  DFGL+  ++  P  +       P  ++APE +  K 
Sbjct: 196 IHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 14/111 (12%)

Query: 147 RREIQIMHHLAGHK---------NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH- 196
            RE +++  L               V + G Y+      ++ E   G +     + +   
Sbjct: 59  FREFRLLRRLREAGVPVPKPVAAGAVKVGGEYQ----ADLLTERLEGAQDLVTWLAQWAD 114

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF 247
            +E     L R +  ++   H  GV H DL   N LL   +  F +  IDF
Sbjct: 115 PAEELRRALWRAVGRLIARMHRAGVNHTDLNAHNILLDTGEGGFKVWLIDF 165

These lipopolysaccharide kinases are related to protein kinases pfam00069. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of S. enterica. Length = 206

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 26/94 (27%)

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV------------ 269
           +HRDL   N LL   +    +K  DFGL+          D+   P YV            
Sbjct: 195 IHRDLAARNILLSENN---VVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           APE +  K Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 25/84 (29%), Positives = 39/84 (46%), Gaps = 15/84 (17%)

Query: 198 SERKAAELTRIIVGVVEA---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG------ 248
            ER+   +  I+  ++ A    HS G++HRD+KP+N +       F  K ID G      
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLGAAADLR 307

Query: 249 LSVFFKPGQIFTDVVGSPYYVAPE 272
           + + + P +   D    P Y APE
Sbjct: 308 VGINYIPKEFLLD----PRYAAPE 327

Length = 566

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.1 bits (93), Expect = 0.001
 Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 6/87 (6%)

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--VGSPYYVA 270
           VE  H   ++HRD+K EN  L N D    L   DFG ++ F+  +   D   VG+    +
Sbjct: 280 VEYIHDKKLIHRDIKLENIFL-NCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNS 336

Query: 271 PEVLLKH-YGPEADVWTAGVILYILLS 296
           PE+L    Y    D+W+ G+IL  +LS
Sbjct: 337 PEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 27/85 (31%), Positives = 45/85 (52%), Gaps = 8/85 (9%)

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY-YVAPEVLL-KH 277
           +HRDL   N LL   +    +K  DFGL+  ++  P  +       P  ++APE +  + 
Sbjct: 201 IHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257

Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 37/164 (22%), Positives = 67/164 (40%), Gaps = 54/164 (32%)

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMH 223
           T+K   E +  VHIV ++ AG E                               S  V+H
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLS----------------------------SHHVVH 147

Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY------------VAP 271
           +DL   N L+ +K    ++K  D GL         F +V  + YY            ++P
Sbjct: 148 KDLATRNVLVFDK---LNVKISDLGL---------FREVYAADYYKLMGNSLLPIRWMSP 195

Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           E ++   +  ++D+W+ GV+L+ + S G+ P+   + Q + + +
Sbjct: 196 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	363
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
PRK12274	218	serine/threonine protein kinase; Provisional	99.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
PRK10345	210	hypothetical protein; Provisional	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.88
smart00090	237	RIO RIO-like kinase.	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.8
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.78
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.62
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
KOG3087	229	consensus Serine/threonine protein kinase [General	99.51
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.5
KOG1243	690	consensus Protein kinase [General function predict	99.43
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.26
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.24
COG4248	637	Uncharacterized protein with protein kinase and he	99.19
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.12
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.04
PRK09902	216	hypothetical protein; Provisional	98.9
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.89
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.8
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.79
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.74
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.69
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.67
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.65
PF01636	239	APH: Phosphotransferase enzyme family This family	98.62
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.59
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.55
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.53
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.5
PLN02876	822	acyl-CoA dehydrogenase	98.44
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.29
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.18
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.17
PRK10593	297	hypothetical protein; Provisional	98.17
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.13
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.09
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.08
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.04
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.0
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.86
KOG2270	520	consensus Serine/threonine protein kinase involved	97.84
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.68
PRK05231	319	homoserine kinase; Provisional	97.67
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.66
PLN02236	344	choline kinase	97.51
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.33
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.33
PLN02756	418	S-methyl-5-thioribose kinase	97.27
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.2
PRK12396	409	5-methylribose kinase; Reviewed	97.15
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.11
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.09
PRK11768	325	serine/threonine protein kinase; Provisional	96.9
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.81
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.72
PTZ00384	383	choline kinase; Provisional	96.66
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.65
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.15
PRK06148	1013	hypothetical protein; Provisional	96.13
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.05
COG2334	331	Putative homoserine kinase type II (protein kinase	95.92
PTZ00296	442	choline kinase; Provisional	95.73

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-65  Score=456.47  Aligned_cols=265  Identities=38%  Similarity=0.616  Sum_probs=245.9

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh----hhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR----EDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ..+.+.|.+.+.||+|+||.|-+|.++.+|+.||||++.++.....    .....+.+|+++|++|+ |||||+++++|+
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~f~  246 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDFFE  246 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeeeee
Confidence            3477889999999999999999999999999999999988765442    23345689999999998 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      ..+..||||||++||+|++.+..++.+.+...+.+++||+.|+.|||++||+||||||+|||+..+.++..+||+|||+|
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999999999999999999999999999999999999999999999999987777899999999999


Q ss_pred             eecCCCCccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCcccCCCCC
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPW  325 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  325 (363)
                      +....+....+.||||.|.|||++.+    .+..++|+||+||+||-+++|.+||.+..... +.++|.++.+.+.+..|
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            99988889999999999999999973    25568999999999999999999998877665 99999999999999999


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ..+++++++||.+||..||++|||+.|+|+||||+
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            99999999999999999999999999999999996

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-60  Score=444.90  Aligned_cols=254  Identities=37%  Similarity=0.565  Sum_probs=242.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      .+|+.++.||+|||+.||++++..+|+.||+|++.+.........+++.+||++.+.|. |||||+++++|++.+.+|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            46999999999999999999999999999999999988888888999999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-C
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~  257 (363)
                      .|+|..++|.+++++++.++|.+++.+++||+.||.|||+++|||||||..|+++   +++.+|||+|||+|.....+ +
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCccc
Confidence            9999999999999999999999999999999999999999999999999999999   88999999999999998744 6


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ...+.||||.|.|||++.+ .++..+||||+||+||-||.|++||....-++.+..|......++.    .++.++++||
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI  249 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI  249 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence            7788999999999999985 5999999999999999999999999999999999999999887776    5899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+||++||.+|||+++||+|+||.
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhh
Confidence            999999999999999999999993

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-59  Score=414.93  Aligned_cols=257  Identities=33%  Similarity=0.592  Sum_probs=238.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.++||+|+||+||.++.+.+++.+|+|++++.........+....|..+|..++ ||.||+++-.|++...+|+|
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEEE
Confidence            45999999999999999999999999999999999988877778899999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec-CCCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~-~~~~  257 (363)
                      +||+.||.|+.+|.+.+.|++..++.++..|+.||.|||++|||||||||+|||+   |.+|+++|+|||+++.. ..+.
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccCCC
Confidence            9999999999999999999999999999999999999999999999999999999   99999999999999854 4445


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ...+++||+.|||||++.+ .|+.++|.||||+++|||++|.+||.+.+...+.+.|.+++.....   ..++.++++||
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardll  257 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDLL  257 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHHH
Confidence            5667899999999999985 6999999999999999999999999999999999999998843332   24789999999


Q ss_pred             HHhcccCcCCCC----CHHHHhcCCCcccC
Q 017960          337 RKMLCSQPSERL----TAHEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~----s~~evL~~~~~~~~  362 (363)
                      +++|..||++|.    ++.++-+|+||..+
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            999999999995    78999999999753

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-59  Score=412.34  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=229.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-eEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-CVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~i  177 (363)
                      ++.+.++.||+|+.|+||+|.|+.+++.+|+|++....  +.+..+++.+|+++++... ||+||.+||+|.... .++|
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEe
Confidence            34667889999999999999999999999999995432  6677889999999999996 999999999999988 5999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||.||+|.+.+...+++++.....++.++++||.|||+ .+||||||||+|||+   +..|.|||||||.+....+.
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh
Confidence            99999999999999988999999999999999999999995 999999999999999   88899999999999987655


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-----CHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                       ...+++||..|||||.+.+ .|+.++||||||++++|+++|+.||...     ...+++..|..+..+..+..  .+|+
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~--~fS~  309 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG--EFSP  309 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc--cCCH
Confidence             6688999999999999985 6999999999999999999999999764     56678888887654333322  4899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++++||..||++||.+|+|++|+++|||+..
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence            9999999999999999999999999999964

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-58  Score=421.07  Aligned_cols=257  Identities=36%  Similarity=0.606  Sum_probs=239.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      .+|..++.||+|+|++|++|.++.+++.||||++.++....+...+.+.+|-.+|.+|.+||.|++|+-.|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            35999999999999999999999999999999999888877777888999999999998899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      +||+++|+|+++|.+.+.|++..++.++.+|+.||+|||++|||||||||+|||+   |+++++||.|||.|+.+.+...
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhc
Confidence            9999999999999999999999999999999999999999999999999999999   9999999999999987753221


Q ss_pred             --------------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC
Q 017960          259 --------------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (363)
Q Consensus       259 --------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  323 (363)
                                    ..+++||..|.+||+|.. ..++.+|+|+||||||+|+.|.+||.+.++--+++.|..-.+.++. 
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~-  308 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE-  308 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC-
Confidence                          145899999999999985 5889999999999999999999999999999999999998887775 


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                         .+++.+++||+++|..||.+|+|+++|-+||||..+
T Consensus       309 ---~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  309 ---GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             ---CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence               578999999999999999999999999999999653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-57  Score=407.65  Aligned_cols=261  Identities=35%  Similarity=0.604  Sum_probs=237.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .....+-+..|+++|+.++ |||||.+++++...+.+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEE
Confidence            34569999999999999999999999999999999987665 6677788999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC---ccEEEeecCcceec
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD---FSLKAIDFGLSVFF  253 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~---~~~kl~DFG~a~~~  253 (363)
                      +|||||.||+|.+++++.+.+++..++.++.||+.||++||+++||||||||+|||+.....+   -.+||+|||+|+..
T Consensus        86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            999999999999999999999999999999999999999999999999999999999764222   68999999999999


Q ss_pred             CCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      .++....+.+|++.|||||++. .+|+.|+|+||+|+++|+|++|+.||...+..+++..+.++....+..+ ..+++.+
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~  244 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPL  244 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCch
Confidence            9988889999999999999996 6899999999999999999999999999999999998888765544332 2456777


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+|+...|..+|..|.+..+-+.++++.
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~  272 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLA  272 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcc
Confidence            8999999999999999999999888764

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-59  Score=391.35  Aligned_cols=264  Identities=39%  Similarity=0.718  Sum_probs=248.9

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .|.+.|.+-+.||+|.|+.||++.+..+|+.+|+|++...++ .....+.+.+|+.|-+.|+ ||||+++.+.+.+....
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~   85 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   85 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcC-CCcEeehhhhhccccee
Confidence            466789999999999999999999999999999999976665 4447889999999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |||+|++.|++|..-+.++..+++..+..+++||++||.|+|.+||||||+||+|+|+...+..--+||+|||+|.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999999999998888877789999999999999999999999999999999999998877788999999999999987


Q ss_pred             CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      +......+|||.|||||++.+ .|+..+|||+-|++||-|+.|.+||++.....+++.|.++...++.+.|+.+++++++
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            777788999999999999984 6999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |+++||..||.+|+|+.|+|.|||+..
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcc
Confidence            999999999999999999999999863

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.8e-58  Score=395.14  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=225.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|+...++|+|+||+||+|+++.+|+.||||++..+. .++.-.+-..+||++|++|. |||+|.++++|..+..+++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEE
Confidence            45888899999999999999999999999999996543 24445566789999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CC
Q 017960          179 MELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~  256 (363)
                      +|||+ .++++.|.+.. .++...+..++.|++.|+.|+|++++|||||||+||||   ..++.+||||||+|+... ++
T Consensus        80 FE~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   80 FEYCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             eeecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCc
Confidence            99995 47777777653 48999999999999999999999999999999999999   788899999999999887 77


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc---------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------------  319 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------  319 (363)
                      ..++.++.|++|+|||.+.+  +|+..+||||+||++.||++|.+.|.+.++-+.+..|.+.--.               
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            88999999999999999985  6999999999999999999999999999988877666552111               


Q ss_pred             ----cC--------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ----FE--------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ----~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                          ++        +..++.++.-+.+|+++||+.||++|++..|+|.|++|..+
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence                01        11245677889999999999999999999999999998643

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-57  Score=386.58  Aligned_cols=254  Identities=32%  Similarity=0.570  Sum_probs=240.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|+..+.||.|+||+|.+++++.+|..+|+|++.+.......+++...+|..+|+.+. ||+++++++.|.+.+.+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEE
Confidence            34889999999999999999999999999999999988888888899999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||++||.|+.++++.++|++..++.++.+|+.||+|||+++|++|||||+|||+   |.+|.+||.|||+|+.....  
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--  197 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--
Confidence            9999999999999999999999999999999999999999999999999999999   99999999999999987644  


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ..+.||||.|+|||++. +.|+.++|.||||+++|||+.|.+||...+...++++|..+...++.    .+++++++||.
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLK  273 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHH
Confidence            56799999999999998 57999999999999999999999999999999999999999998875    58999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          338 KMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       338 ~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      ++|+.|-.+|.     ...+|..|+||..+
T Consensus       274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             HHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            99999999994     56799999999753

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.5e-56  Score=411.13  Aligned_cols=259  Identities=33%  Similarity=0.543  Sum_probs=237.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|+++++||+|+||.||+|+.+.+|..+|+|++++.......+++.++.|-.+|.... +|+||+++-.|++...+|+|
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEecCCCeeEEE
Confidence            56999999999999999999999999999999999999888899999999999999965 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC---
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP---  255 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~---  255 (363)
                      |||++||++..+|.+.+.|++..++.++.+++.|++.||+.|+|||||||+|+||   |..|++||+|||++.-...   
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999   9999999999999853211   


Q ss_pred             -------------------CC-c-------------------------cccCccCCcccccccccc-cCCCcccHHHHHH
Q 017960          256 -------------------GQ-I-------------------------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGV  289 (363)
Q Consensus       256 -------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~  289 (363)
                                         .. .                         ..+.+|||.|+|||++.+ .|+..+|+|||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                               00 0                         123589999999999985 5999999999999


Q ss_pred             HHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccC
Q 017960          290 ILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCMYNLPVL  362 (363)
Q Consensus       290 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~evL~~~~~~~~  362 (363)
                      ||||||.|.+||.+.+..+..+.|...+..+..+.-..+++++.|||.+||+ ||++|.   +++||-+||||..+
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            9999999999999999999999999988666555556788999999999999 999998   59999999999754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-57  Score=411.20  Aligned_cols=260  Identities=31%  Similarity=0.446  Sum_probs=227.2

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-e
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-C  174 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~  174 (363)
                      .+.++|.++++||.|+||.||+|+.+.++..||||.++++.. ..++. .-.||++.|++|..||||+++.+++.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            356789999999999999999999999999999999976543 33322 23579999999988999999999998888 9


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      +|+||||| ..+|+.+++.++ .|++..++.|+.||++||+|+|++|++|||+||+|||+   .....+||+|||+|+..
T Consensus        85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREV  160 (538)
T ss_pred             EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEeccccccccc
Confidence            99999999 569999987654 59999999999999999999999999999999999999   55668999999999999


Q ss_pred             CCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC--------
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD--------  323 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------  323 (363)
                      .....++.++.|++|+|||++.+  -|+.+.|+||+|||++|+++-++.|.|.++.+.+.+|..-.-.....        
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            88889999999999999999984  59999999999999999999999999999888777776521111111        


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          324 ------------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       324 ------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                        ..+.++.++.+||.+||.+||++||||.++|+||||+.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~  296 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV  296 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence                              12347889999999999999999999999999999975

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-56  Score=417.96  Aligned_cols=254  Identities=38%  Similarity=0.645  Sum_probs=240.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      .-|++++.||.|+.|.|-+|++..+|+.+|||++.+...........+.+||-+|+.|. ||||+.++++|+++.++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEE
Confidence            34999999999999999999999999999999998876556677788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      .||++||.|++++.++|++++.++.++++||+.|+.|||..+|+||||||+|+|+   |....+||+|||+|....++..
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCcc
Confidence            9999999999999999999999999999999999999999999999999999999   7777899999999999888999


Q ss_pred             cccCccCCccccccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ..+.||+|+|+|||++.+. | +.++||||.|||||.||+|.+||.+++...++.++.+|.+..+.    .++.++++||
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdLL  243 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDLL  243 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHHH
Confidence            9999999999999999964 4 78999999999999999999999999999999999999988774    6899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+||..||.+|+|++||++|||+.
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhh
Confidence            999999999999999999999985

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-55  Score=406.87  Aligned_cols=268  Identities=58%  Similarity=0.973  Sum_probs=252.1

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ....+.+.|++.+.||.|.||.||+|.++.+|+.+|+|++.+.........+.+.+|+.+|+++.+|||||.++++|++.
T Consensus        29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~  108 (382)
T KOG0032|consen   29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP  108 (382)
T ss_pred             ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence            34556778999999999999999999999999999999999888766667789999999999999899999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC-CccEEEeecCcce
Q 017960          173 LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSV  251 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~~kl~DFG~a~  251 (363)
                      ..+++|||+|.||.|++.+.+. .+++..+..+++|++.|+.|||+.||+||||||+|+|+...++ ++.+|++|||+|.
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999999999999887 4999999999999999999999999999999999999976543 4689999999999


Q ss_pred             ecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ....+......+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||++.........+.++.+.+..+.|+.++.
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            988877888999999999999999 6899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+++||.+||..||.+|+|+.++|+|||+..
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence            9999999999999999999999999999864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-55  Score=406.73  Aligned_cols=258  Identities=41%  Similarity=0.659  Sum_probs=234.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh--hhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.|++++.||+|+||+|+.|.+..++..||+|++.+......  ...+.+.+|+.++++++.||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34569999999999999999999999999999998766432211  2355677999999999889999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC-ccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~-~~~kl~DFG~a~~~  253 (363)
                      +|+|||||.||+|++++...+++.+..+..+++||+.|++|||++||+||||||+|||+   +.+ +.+||+|||++...
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999   666 89999999999987


Q ss_pred             -CCCCccccCccCCcccccccccc-c-C-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC-
Q 017960          254 -KPGQIFTDVVGSPYYVAPEVLLK-H-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI-  328 (363)
Q Consensus       254 -~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-  328 (363)
                       ..+....+.+||+.|+|||++.+ . | +.++||||+|++||.|++|+.||...+...++..+.++.+.++..    + 
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~~  247 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----LL  247 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----cC
Confidence             46677889999999999999985 4 6 488999999999999999999999999999999999998877653    4 


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++++++|+.+||..||.+|+|+.+++.|+||+.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999999975

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-54  Score=394.09  Aligned_cols=256  Identities=30%  Similarity=0.464  Sum_probs=225.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~  175 (363)
                      .+.|+.+++||+|+||.||+|++..+|+.||+|.+..... ......-..+||.||++|. ||||+++.+...+.  ..+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCceE
Confidence            3669999999999999999999999999999999986553 3444566789999999998 99999999988765  789


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |+|+|||+. +|.-++... -.|++.+++.+++||+.||+|||++||+|||||.+||||   |.+|.+||+|||+|+++.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence            999999954 787776653 369999999999999999999999999999999999999   899999999999999775


Q ss_pred             CCC--ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC----
Q 017960          255 PGQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP----  326 (363)
Q Consensus       255 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----  326 (363)
                      ...  .+++.+.|.+|+|||++.+  .|+.++|+||.||||.||+.|++.|.|.++.+.++.|.+-.-......|+    
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            543  5788899999999999985  59999999999999999999999999999999999987744333333332    


Q ss_pred             ---------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          327 ---------------------LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       327 ---------------------~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                           .++..+.+|+..||..||.+|.||.++|.+.||
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence                                 367789999999999999999999999999999

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-53  Score=401.80  Aligned_cols=256  Identities=29%  Similarity=0.483  Sum_probs=238.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.++||+|+||+|+++..+.+++.+|||++++........++..+.|..|+....+||.+++++..|+...++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            56999999999999999999999999999999999999999999999999999999988899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~  257 (363)
                      |||+.||++ .++.+.+.|++..+..++..|+.||.|||++||||||||.+|||+   |.+|++||+|||+++... .+.
T Consensus       448 mey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  448 MEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCCCCC
Confidence            999999994 445556789999999999999999999999999999999999999   999999999999998765 556


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ...+++|||.|||||++.+ .|+.++|.|||||+|||||.|..||.+++++++++.|......++.    .++.++.+++
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~il  599 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAIM  599 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHHH
Confidence            7788999999999999995 6999999999999999999999999999999999999998776654    5899999999


Q ss_pred             HHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          337 RKMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +++|.+||++|..     +.+|..||||..+
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            9999999999984     5899999999764

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4e-55  Score=372.27  Aligned_cols=261  Identities=36%  Similarity=0.639  Sum_probs=243.1

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      +-..|.-.+.||.|..++|.+|.++.+|.++|+|++......     ..+..+.-..|+.||+++.+||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            445577889999999999999999999999999998643221     123355678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ...+++|+|+|+.|.|+|+|...-.++++..+.|++||++|++|||..+||||||||+|||+   +++..+||+|||+|+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFAC  171 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceee
Confidence            99999999999999999999998889999999999999999999999999999999999999   889999999999999


Q ss_pred             ecCCCCccccCccCCccccccccc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCC
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  324 (363)
                      .+.+++.....||||+|+|||.+.       ..|+..+|+|++|+|||-|+.|.+|||...+.-++..|..+++.|..+.
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe  251 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE  251 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence            999999999999999999999984       2489999999999999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      |..++.+.++||.+||+.||.+|+|++|+|.||||.
T Consensus       252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            999999999999999999999999999999999994

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-53  Score=377.47  Aligned_cols=262  Identities=30%  Similarity=0.462  Sum_probs=225.3

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec---
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---  171 (363)
                      ..+...|...+.||+|+||.|+.|.++.+|+.||||.+.. .+.+....++..+|+++|++++ |+||+.+.+++..   
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR   95 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence            3455567778999999999999999999999999999963 4557778899999999999999 9999999999865   


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                        -+.+|+|+|+| +.+|...++.+..+++..+..++.||+.||.|+|+.+|+||||||.|+|+   +.+..+||||||+
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGL  171 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccc
Confidence              45799999999 66787777777779999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCC---CCccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-----
Q 017960          250 SVFFKP---GQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----  319 (363)
Q Consensus       250 a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----  319 (363)
                      |+....   ....+.++.|++|+|||++.  ..|+.+.||||+||||.||++|++.|.|...-..+..|..-...     
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            998753   45568899999999999987  46999999999999999999999999887766555555431111     


Q ss_pred             ------------------cCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ------------------FES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ------------------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                        .+.    ..++.+++.+.+|+++||..||.+|+|++|+|+||++..+
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                              111    1246788999999999999999999999999999998653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-53  Score=359.67  Aligned_cols=257  Identities=31%  Similarity=0.474  Sum_probs=223.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|...++||+|.||.||+|++..+|+.||||.++.....+.- .....+||+.|+.++ |+||+.++++|...+.+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-NRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-cHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEE
Confidence            4688899999999999999999999999999999876543222 345778999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      +||++ .+|...++.. ..++..+++.++.+++.||+|||++.|+||||||.|+|+   +.+|.+||+|||+|+.+... 
T Consensus        80 fEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   80 FEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             EEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCC
Confidence            99995 4888777654 358999999999999999999999999999999999999   88999999999999987644 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC---------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW---------  325 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------  325 (363)
                      ...+..+.|++|+|||.+.+  .|+..+|+||.|||+.||+-|.+.|.|.++-+.+..|.+.--...++.|         
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            34445588999999999984  6999999999999999999999999999999988888774443333333         


Q ss_pred             ---------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          326 ---------------PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       326 ---------------~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                     +..++++.||+.+||..||.+|+|+.|+|+|+||..
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                           335678899999999999999999999999999964

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-55  Score=371.36  Aligned_cols=247  Identities=28%  Similarity=0.477  Sum_probs=217.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeE-EEecCCe-EE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKG-AYEDSLC-VH  176 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~-~~~~~~~-~~  176 (363)
                      ..|++.++||.|+||+||++.+..+|..+|.|.+.-.. .+....+.+..|+.+|++|+ |||||++++ .|.+++. ++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhH
Confidence            34999999999999999999999999999999997443 36667788999999999998 999999998 5555555 99


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          177 IVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHS--LG--VMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      ||||||.+|+|...+++    .+.+++..++.++.|++.||..+|+  ..  |+||||||.||++   +.+|.+||+|||
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfG  173 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFG  173 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccch
Confidence            99999999999988854    3459999999999999999999999  44  9999999999999   889999999999


Q ss_pred             cceecCCCCc-cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          249 LSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       249 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      +++.+..... ..+.+|||.||+||.+. ..|+.++||||+||++|||+.-..||.+.+-.++-++|.++..+..+  ..
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~~  251 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--DE  251 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--HH
Confidence            9998876543 45789999999999998 46999999999999999999999999999999999999998654222  13


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHH
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHE  352 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~e  352 (363)
                      .+|.++..||..|+..||+.||+...
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t~~  277 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDTVP  277 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCcch
Confidence            57899999999999999999998533

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.3e-54  Score=395.25  Aligned_cols=253  Identities=30%  Similarity=0.523  Sum_probs=233.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+... .....+.+.+|+++++.|+ ||||+.++++|+...++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEE
Confidence            358889999999999999999999999999999987654 5556778999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      .|||.| +|+..|...+.++++.+..++.+++.||.|||+++|+|||+||.|||+   +.++.+|+||||+|+....+. 
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce
Confidence            999976 999999999999999999999999999999999999999999999999   889999999999999876554 


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ..+...|||.|||||++.+ .|+..+|+|||||++|||+.|++||.......+.+.|......++.    .++..+++||
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl  231 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFL  231 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHH
Confidence            5567889999999999985 5999999999999999999999999999999999999887665544    6899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+|.+||.+|++..+++.|+|.+.
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhh
Confidence            9999999999999999999999753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-52  Score=380.37  Aligned_cols=257  Identities=33%  Similarity=0.547  Sum_probs=225.0

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh-----------hhHHHHHHHHHHHHHhcCCCceeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-----------EDVEDVRREIQIMHHLAGHKNIVTI  165 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~h~niv~~  165 (363)
                      .-+.|++++.||+|.||.|-+|++..+++.||||++.+......           ...+++.+||.+|++|. |||||++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~L  173 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKL  173 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEE
Confidence            44679999999999999999999999999999999976544321           22468999999999998 9999999


Q ss_pred             eEEEec--CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccE
Q 017960          166 KGAYED--SLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (363)
Q Consensus       166 ~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~  242 (363)
                      +++..+  .+.+|||+|||..|.+.+ ....+. +++.+++.++++++.||+|||.+|||||||||+|+||   +++|++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g~V  249 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDGTV  249 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCCcE
Confidence            999865  567999999999888743 434444 8999999999999999999999999999999999999   888999


Q ss_pred             EEeecCcceecCC------CCccccCccCCcccccccccc---c--CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHH
Q 017960          243 KAIDFGLSVFFKP------GQIFTDVVGSPYYVAPEVLLK---H--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFD  311 (363)
Q Consensus       243 kl~DFG~a~~~~~------~~~~~~~~gt~~y~aPE~~~~---~--~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  311 (363)
                      ||+|||.+.....      +......+|||.|+|||.+.+   .  .+.+.||||+||+||.|+.|..||.+....++++
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            9999999987632      223445789999999999874   2  4678999999999999999999999999999999


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       312 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +|....+.++..+  .+.+++++||.+||++||++|++..+|..|||..
T Consensus       330 KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  330 KIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             HHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence            9999988877653  5789999999999999999999999999999974

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-53  Score=379.12  Aligned_cols=253  Identities=33%  Similarity=0.475  Sum_probs=213.0

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--eEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--CVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--~~~i  177 (363)
                      .|..++.||+|+||.||++.++.+|...|||.+....   ....+.+.+|+.+|++|+ |||||+++|......  .++|
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEe
Confidence            3777899999999999999999999999999997652   222678999999999999 999999999754444  6999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC-CccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~~kl~DFG~a~~~~~  255 (363)
                      .|||+++|+|.+++.+.+ .+++..+..+++||++||+|||++|||||||||+|||+   +. ++.+||+|||++.....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccccc
Confidence            999999999999999877 79999999999999999999999999999999999999   66 68999999999987653


Q ss_pred             ----CCccccCccCCcccccccccccC--CCcccHHHHHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          256 ----GQIFTDVVGSPYYVAPEVLLKHY--GPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       256 ----~~~~~~~~gt~~y~aPE~~~~~~--~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                          ........||+.|||||++....  ..++|||||||++.||+||..||.. .......-.+......  +.....+
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~--P~ip~~l  248 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL--PEIPDSL  248 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC--CCCCccc
Confidence                12234688999999999998432  3499999999999999999999977 3333333333333311  1233458


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++++++||.+|+..||++||||.++|.|+|+..
T Consensus       249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            999999999999999999999999999999853

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-53  Score=375.52  Aligned_cols=258  Identities=38%  Similarity=0.638  Sum_probs=243.3

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      -..+...+|++.+.||+|.||+|-+|.+...|+.||||.+++.+..++.+.-.+++||+||..|. ||||+.++++|+..
T Consensus        47 hkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENk  125 (668)
T KOG0611|consen   47 HKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENK  125 (668)
T ss_pred             cccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCC
Confidence            34456778999999999999999999999999999999999999989999999999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          173 LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +.+.|||||..+|.|++++.+.+.+++.+++.+++||+.|+.|+|+++++|||||.+|||+   |.++.+||+|||++..
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNL  202 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999   8999999999999999


Q ss_pred             cCCCCccccCccCCccccccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          253 FKPGQIFTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      +..+....++||++.|.+||++++. | ++.+|-||||++||-|+.|.+||.|.....+.++|.++.+..+.     -+.
T Consensus       203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PS  277 (668)
T KOG0611|consen  203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPS  277 (668)
T ss_pred             hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCc
Confidence            9999999999999999999999964 4 78999999999999999999999999999999999998765443     467


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+.-||+.||..||++|.|..+|..|-|+
T Consensus       278 dA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             hHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence            78999999999999999999999999886

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-52  Score=389.00  Aligned_cols=256  Identities=32%  Similarity=0.480  Sum_probs=225.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +....|...++||+|+.|.||.|....+++.||||.+..+..   ...+-+.+|+.+|+.++ |+|||++++.|...+.+
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhcc-chHHHHHHHHhccccee
Confidence            345678889999999999999999999999999999987643   33467889999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |+||||++||+|.+.+.. ..+++.++..|++.++.||+|||.+||||||||.+|||+   +.++.+||+|||++..+..
T Consensus       346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeecccc
Confidence            999999999999887654 358999999999999999999999999999999999999   7888999999999988766


Q ss_pred             CC-ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ...+.+|||+|||||++. ..|+++.||||||++++||+-|++||...+.-..+..|...... .......+|++++
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P-~lk~~~klS~~~k  500 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-KLKNPEKLSPELK  500 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC-CcCCccccCHHHH
Confidence            55 456789999999999998 57999999999999999999999999877766666655543322 2333457899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +||.+||+.|+++|+++.|+|+||||+
T Consensus       501 dFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  501 DFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            999999999999999999999999985

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-53  Score=353.53  Aligned_cols=254  Identities=32%  Similarity=0.553  Sum_probs=236.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|-||.||.|+.+.++-.||+|++-++.........++.+|++|-..|+ ||||++++++|.+....|++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEE
Confidence            45999999999999999999999999999999998887666666678999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRII--QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||..+|+|+..|.  ...++++.....++.|++.||.|+|..++|||||||+|+|+   +..+.+||+|||.+...+ .
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-S  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-C
Confidence            99999999999998  56779999999999999999999999999999999999999   778899999999998865 4


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      ....+.+||..|.+||...+ .++..+|+|++|++.||++.|.+||......+.++.|.+-.+.++    ..++.++.||
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence            45567999999999999985 699999999999999999999999999999999999999888777    3689999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |.+||.++|.+|....|++.|||+.+
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHh
Confidence            99999999999999999999999865

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-52  Score=364.22  Aligned_cols=258  Identities=26%  Similarity=0.351  Sum_probs=222.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~  175 (363)
                      .+.|+....|++|+||.||+|+++.+++.||+|.++....... .--.-.+||.+|.+++ |||||.+..+...  -+.+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcC-CCCeeeeEEEEecccccee
Confidence            3569999999999999999999999999999999987653221 1224578999999998 9999999987754  4569


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |||||||+. +|...+...+ +|...+++.++.|++.|++|||.+.|+||||||+|+|+   ...|.+||+|||+|+.+.
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhc
Confidence            999999965 8888887755 79999999999999999999999999999999999999   888999999999999876


Q ss_pred             CC-CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCC----
Q 017960          255 PG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL----  327 (363)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----  327 (363)
                      .. ..++..+.|.+|+|||++.+  .|+.++|+||+|||+.||+++++.|.|..+.+.++.|.+-.-......|+.    
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            44 46788899999999999984  599999999999999999999999999999999888876333222222221    


Q ss_pred             ------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          328 ------------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       328 ------------------------~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                              +++...+|+..+|..||.+|.||.|+|+|.||..
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence                                    4578899999999999999999999999999965

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-51  Score=377.37  Aligned_cols=253  Identities=29%  Similarity=0.489  Sum_probs=226.3

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+...+++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEE
Confidence            5889999999999999999999999999999997654434445677889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--T  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC--c
Confidence            999999999999988889999999999999999999999999999999999999   77889999999999865432  2


Q ss_pred             ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....|++.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..+...++.    .+++.+++||.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~  231 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKK  231 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHH
Confidence            34678999999999874 5899999999999999999999999998888888888877655443    468899999999


Q ss_pred             hcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          339 MLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       339 ~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      ||+.||.+|++     +.++++|+|+..+
T Consensus       232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         232 LLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            99999999995     9999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-51  Score=365.29  Aligned_cols=257  Identities=33%  Similarity=0.503  Sum_probs=233.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||.|.-|+||+|....++..+|+|++.+..........++..|-+||..+. ||.++.+|..|+.+...|++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence            45899999999999999999999999999999999988877888889999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-
Q 017960          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-  255 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-  255 (363)
                      ||||+||+|..+++++  +.|++..++.++..++.||+|||-+|||+|||||+||||   .++|++.|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence            9999999998877664  459999999999999999999999999999999999999   8999999999998643210 


Q ss_pred             --------------------------------C-C-----------------------ccccCccCCcccccccccc-cC
Q 017960          256 --------------------------------G-Q-----------------------IFTDVVGSPYYVAPEVLLK-HY  278 (363)
Q Consensus       256 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~-~~  278 (363)
                                                      . .                       ...+++||-.|.|||++.+ ..
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                       0123689999999999996 58


Q ss_pred             CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCC----HHHHh
Q 017960          279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT----AHEVL  354 (363)
Q Consensus       279 ~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~evL  354 (363)
                      +.++|.|+|||++|||+.|..||.|.+..+.+..|......++..+  .++..++|||+++|.+||.+|+.    |.||-
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999999999999999999999999999988888764  68899999999999999999998    99999


Q ss_pred             cCCCccc
Q 017960          355 CMYNLPV  361 (363)
Q Consensus       355 ~~~~~~~  361 (363)
                      +||||+-
T Consensus       391 ~HpFF~g  397 (459)
T KOG0610|consen  391 RHPFFEG  397 (459)
T ss_pred             cCccccC
Confidence            9999974

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-51  Score=379.89  Aligned_cols=248  Identities=30%  Similarity=0.399  Sum_probs=214.2

Q ss_pred             eeecceecccCCeEEEEEEEccCCcE-EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-eEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIE-FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-CVHIV  178 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~iv  178 (363)
                      ..+.+.||.|+||+||+|.+  .|+. ||||++......... .+.|.+|+.+|.+++ |||||+++|++.+.. .++||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             hhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEE
Confidence            44566799999999999994  5556 999999866554433 789999999999998 999999999998887 79999


Q ss_pred             EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-cEecCCCCCceEeeeCCCCc-cEEEeecCcceecC
Q 017960          179 MELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLG-VMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFK  254 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~-iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~~  254 (363)
                      |||+++|+|.+++..  .+.++...+..++.+|+.||.|||+++ ||||||||+|||+   +.++ ++||+|||+++...
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceeec
Confidence            999999999999988  578999999999999999999999999 9999999999999   7776 99999999998866


Q ss_pred             CC-CccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PG-QIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .. ...+...||+.|||||++.+   .|+.++||||||++||||+||+.||.+.........+.........+  ..+++
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~  273 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPP  273 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCH
Confidence            44 34455789999999999984   49999999999999999999999999988866666665443322222  23789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+..|+.+||+.||.+||++.+++..+
T Consensus       274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l  300 (362)
T KOG0192|consen  274 HLSSLMERCWLVDPSRRPSFLEIVSRL  300 (362)
T ss_pred             HHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence            999999999999999999999998743

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-51  Score=381.40  Aligned_cols=253  Identities=31%  Similarity=0.553  Sum_probs=227.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++++. ||||+++++++.+.+..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEE
Confidence            55999999999999999999999999999999997655444455678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC--
Confidence            9999999999999988889999999999999999999999999999999999999   78889999999999876433  


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.......+.+..+...++.    .++.++.+||.
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~  247 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVK  247 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHH
Confidence            234678999999999874 5899999999999999999999999998888888888877654432    47889999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCccc
Q 017960          338 KMLCSQPSERLT-----AHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s-----~~evL~~~~~~~  361 (363)
                      +||+.||.+|++     +++++.|+||..
T Consensus       248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        248 GLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            999999999997     799999999964

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.4e-51  Score=381.03  Aligned_cols=249  Identities=33%  Similarity=0.531  Sum_probs=222.2

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998655444555677889999999998 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~~  263 (363)
                      ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   788899999999987532 223344567


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||.+.........+..+...++    ..+++++.+||.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999974 599999999999999999999999998888888888777655443    35789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCCccc
Q 017960          343 QPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       343 dp~~R~-----s~~evL~~~~~~~  361 (363)
                      ||++||     ++.++++|+||..
T Consensus       233 dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.2e-51  Score=383.79  Aligned_cols=257  Identities=30%  Similarity=0.494  Sum_probs=222.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++.++. |+||+++++.+.+...+|+||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEEE
Confidence            5889999999999999999999999999999997655444555678889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccccc
Confidence            999999999999988899999999999999999999999999999999999999   788899999999987542110  


Q ss_pred             ----------------------------------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCC
Q 017960          258 ----------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFW  302 (363)
Q Consensus       258 ----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~  302 (363)
                                                        .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                              0124579999999999874 59999999999999999999999999


Q ss_pred             CcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcC---CCCCHHHHhcCCCccc
Q 017960          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPS---ERLTAHEVLCMYNLPV  361 (363)
Q Consensus       303 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~R~s~~evL~~~~~~~  361 (363)
                      +....+....+.........+....+++++++||.+|+. +|.   .||++.|+++|+||..
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         238 SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence            988888888887644333333333578999999999876 444   4689999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.2e-51  Score=371.69  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=217.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++++. |++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            778899999999999999999999999999997654433344456789999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |+++++|.+.+...  ..+++..+..++.|++.||+|||+.||+||||||+|||+   ++++.+||+|||++........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCe
Confidence            99999998877543  358999999999999999999999999999999999999   7788999999999988655555


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....||..|+|||++. ..++.++|||||||++|||++|+.||.+.........+..............+++++.+||.
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  237 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR  237 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence            55678999999999997 46999999999999999999999999876543322222221111122223457899999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          338 KMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       338 ~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +||+.||.+||+     ++++++|+||..+
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            999999999997     8999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-51  Score=383.12  Aligned_cols=257  Identities=29%  Similarity=0.529  Sum_probs=224.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||+||+|.+..+++.||||++.+...........+.+|+.++..+. ||||+++++++.+.+.+|+||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEE
Confidence            5899999999999999999999999999999997654444455677889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccccc
Confidence            999999999999888889999999999999999999999999999999999999   888999999999987543211  


Q ss_pred             -------------------------------------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCC
Q 017960          258 -------------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP  299 (363)
Q Consensus       258 -------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~  299 (363)
                                                           .....+||+.|+|||++.+ .++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                 0113469999999999874 69999999999999999999999


Q ss_pred             CCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCccc
Q 017960          300 PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT---AHEVLCMYNLPV  361 (363)
Q Consensus       300 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~evL~~~~~~~  361 (363)
                      ||.+....+....+..............+++++.+||.+||. +|.+|++   +.+++.|+||..
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            999888887777777654433333334578999999999997 9999998   999999999964

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=378.17  Aligned_cols=256  Identities=30%  Similarity=0.437  Sum_probs=225.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..++ ||||+++++++.+.+..|+||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999998665434445677889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....  ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--cc
Confidence            999999999999888889999999999999999999999999999999999999   7888999999999976543  33


Q ss_pred             ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC----CCCCHHHHH
Q 017960          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW----PLISDSAKD  334 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~~~~~  334 (363)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+....+.........+..    ..+++++.+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence            45679999999999874 6899999999999999999999999988887777776654332222221    256899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||..+|.+||++.+++.|+||..
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            999999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-50  Score=377.82  Aligned_cols=253  Identities=32%  Similarity=0.530  Sum_probs=225.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      +.|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEEE
Confidence            45999999999999999999876655 689999997655444555678889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC-
Confidence            99999999999999988889999999999999999999999999999999999999   78889999999999875432 


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                       .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.......+.+..+...++    ..+++++.++|
T Consensus       185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  259 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHLM  259 (340)
T ss_pred             -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHH
Confidence             245679999999999874 589999999999999999999999999888888888887765443    34789999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      ++||+.||.+|+     +++++++||||..
T Consensus       260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999999995     8999999999975

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-50  Score=382.87  Aligned_cols=260  Identities=29%  Similarity=0.404  Sum_probs=220.0

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-----CceeEEeE
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-----KNIVTIKG  167 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~niv~~~~  167 (363)
                      ..+.+.-+|++.+.||+|+||.|.+|.+..+++.||||++++.    .....+...|+.+|..|++|     -|||++++
T Consensus       180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            3344555899999999999999999999999999999999864    35567788899999999844     48999999


Q ss_pred             EEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEe
Q 017960          168 AYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (363)
Q Consensus       168 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~  245 (363)
                      +|...+++|||+|++ ..+|+++++.+.  .++...++.++.||+.||.+||++||||+||||+||||...+.. .|||+
T Consensus       256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVI  333 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVI  333 (586)
T ss_pred             ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEE
Confidence            999999999999999 679999998764  48899999999999999999999999999999999999765444 89999


Q ss_pred             ecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-------
Q 017960          246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-------  317 (363)
Q Consensus       246 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------  317 (363)
                      |||+|+......  .+++.++.|+|||++.+ .|+.+.||||||||++||++|.+.|.|.++.+.+..|..-.       
T Consensus       334 DFGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  334 DFGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             ecccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999999865433  37899999999999996 69999999999999999999999999998887766664310       


Q ss_pred             --------cccCC-----------C---------------------CCC------------CCCHHHHHHHHHhcccCcC
Q 017960          318 --------IDFES-----------D---------------------PWP------------LISDSAKDLIRKMLCSQPS  345 (363)
Q Consensus       318 --------~~~~~-----------~---------------------~~~------------~~~~~~~~li~~~l~~dp~  345 (363)
                              ..+..           .                     ..+            .-...+.+||.+||.+||+
T Consensus       412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~  491 (586)
T KOG0667|consen  412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA  491 (586)
T ss_pred             HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence                    00000           0                     000            0124679999999999999


Q ss_pred             CCCCHHHHhcCCCcc
Q 017960          346 ERLTAHEVLCMYNLP  360 (363)
Q Consensus       346 ~R~s~~evL~~~~~~  360 (363)
                      +|+|+.++|+|+|+.
T Consensus       492 ~R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  492 ERITPAQALNHPFLT  506 (586)
T ss_pred             hcCCHHHHhcCcccc
Confidence            999999999999996

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-52  Score=358.45  Aligned_cols=257  Identities=39%  Similarity=0.656  Sum_probs=233.8

Q ss_pred             ccccceee-cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe----
Q 017960           96 NIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----  170 (363)
Q Consensus        96 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----  170 (363)
                      .+.++|.+ -++||-|-.|.|..|.++.+++.+|+|++...        .+.++|+++--..++|||||.++++|+    
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            35566777 45899999999999999999999999988532        567889998888889999999999885    


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      ...++.||||.++||.|+..+..++.  |++.++..|++||+.|+.|||+.+|.||||||+|+|.+....+..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence            45678999999999999999988776  9999999999999999999999999999999999999887888999999999


Q ss_pred             cceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcC----HHHHHHHHHcCCcccCCC
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESD  323 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~  323 (363)
                      +|+.........+.+-||.|.|||++. ..|+..+|+||+||+||-|++|.+||+...    ..++...|..+.+.|+.+
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            999877666777888999999999998 469999999999999999999999997654    357889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .|..+|++++++|+++|..+|.+|.|.++++.|+|+.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence            9999999999999999999999999999999999984

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=364.38  Aligned_cols=257  Identities=30%  Similarity=0.421  Sum_probs=226.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++...||.|..++||+|+...+++.||||++..++..  ...+.+.+|+..++.+. ||||++++..|..+..+|+|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEEe
Confidence            4599999999999999999999999999999999877653  33789999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |.||.+|++++.+...  ..+++..+..|+++++.||.|||.+|.||||||+.||||   +.+|.|||+|||.+..+..+
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeeccc
Confidence            9999999999998764  348999999999999999999999999999999999999   99999999999987655332


Q ss_pred             C-----ccccCccCCccccccccc---ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC------C
Q 017960          257 Q-----IFTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE------S  322 (363)
Q Consensus       257 ~-----~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------~  322 (363)
                      .     .+...+||+.|||||++.   ..|+.|+||||||++..||.+|..||.....-+++-.-.++..+..      .
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            1     125679999999999976   3599999999999999999999999988888777776666665422      2


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +....++..++++|..||.+||.+|||+.++|+|.||+.
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~  298 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKK  298 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhh
Confidence            223456788999999999999999999999999999964

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.9e-50  Score=382.03  Aligned_cols=258  Identities=30%  Similarity=0.493  Sum_probs=220.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+++.+. ||||+++++++.+.+.+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            4889999999999999999999999999999998765555566778999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC---
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~---  256 (363)
                      ||++||+|.+++.+.+.+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   78889999999987532100   


Q ss_pred             ---------------------------------------------CccccCccCCcccccccccc-cCCCcccHHHHHHH
Q 017960          257 ---------------------------------------------QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVI  290 (363)
Q Consensus       257 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~i  290 (363)
                                                                   ......+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123579999999999874 58999999999999


Q ss_pred             HHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc--CcCCCCCHHHHhcCCCccc
Q 017960          291 LYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS--QPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       291 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dp~~R~s~~evL~~~~~~~  361 (363)
                      +|||++|..||...........+.........+....+++++.+||.+|++.  +|..|+++.+++.|+||..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            9999999999988777666666654333333333446889999999996654  4555999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-52  Score=360.13  Aligned_cols=265  Identities=35%  Similarity=0.597  Sum_probs=238.2

Q ss_pred             cccccceee-cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           95 DNIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        95 ~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..|.+.|++ .+.||+|+|+.|-.|....++.+||||++.+.   ......++.+|++++.+.++|+||++++++|+++.
T Consensus        73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            346677877 67899999999999999999999999999876   44556889999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .+|+|||-|.||+|+.++.++..|++.++..+.+.|+.||.+||.+||.||||||+|||....+.-..+|||||.+....
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999977666678999999987544


Q ss_pred             CCC--------CccccCccCCccccccccc---c---cCCCcccHHHHHHHHHHHHhCCCCCCCcC--------------
Q 017960          254 KPG--------QIFTDVVGSPYYVAPEVLL---K---HYGPEADVWTAGVILYILLSGVPPFWAET--------------  305 (363)
Q Consensus       254 ~~~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~Di~slG~il~ell~g~~pf~~~~--------------  305 (363)
                      .-.        ....+.+|+..|||||+..   +   .|+.++|.||||+|||.|++|.+||.|..              
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~  309 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV  309 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence            221        1234578899999999874   3   39999999999999999999999996543              


Q ss_pred             -HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          306 -QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       306 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                       +..+++.|..+.+.|+...|..+|.++++||..+|..|+.+|.++.+++.|||++..
T Consensus       310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence             357899999999999999999999999999999999999999999999999999753

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-50  Score=371.79  Aligned_cols=247  Identities=31%  Similarity=0.524  Sum_probs=220.2

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++. ||||+++++++.+.+..++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999999999999999997655445556678889999999997 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCccC
Q 017960          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGS  265 (363)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt  265 (363)
                      |.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......+||
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCC
Confidence            99999888889999999999999999999999999999999999999   7888999999999875432 2233456799


Q ss_pred             Ccccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCc
Q 017960          266 PYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP  344 (363)
Q Consensus       266 ~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  344 (363)
                      +.|+|||++.+ .++.++|||||||++|||++|..||.+....+....+......++    ..+++++.+||.+||+.||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence            99999999885 599999999999999999999999998888888888877655443    3578999999999999999


Q ss_pred             CCCC---CHHHHhcCCCccc
Q 017960          345 SERL---TAHEVLCMYNLPV  361 (363)
Q Consensus       345 ~~R~---s~~evL~~~~~~~  361 (363)
                      .+||   ++.++|.||||..
T Consensus       233 ~~R~~~~~~~e~l~hp~~~~  252 (312)
T cd05585         233 TRRLGYNGAQEIKNHPFFSQ  252 (312)
T ss_pred             HHcCCCCCHHHHHcCCCcCC
Confidence            9997   5899999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-50  Score=382.08  Aligned_cols=257  Identities=32%  Similarity=0.529  Sum_probs=222.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence            4889999999999999999999999999999997655444556678899999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC---
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~---  256 (363)
                      |||++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   88899999999997532100   


Q ss_pred             ---------------------------------------------CccccCccCCccccccccc-ccCCCcccHHHHHHH
Q 017960          257 ---------------------------------------------QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVI  290 (363)
Q Consensus       257 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~i  290 (363)
                                                                   ......+||+.|+|||++. ..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         0012357899999999987 469999999999999


Q ss_pred             HHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCccc
Q 017960          291 LYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT---AHEVLCMYNLPV  361 (363)
Q Consensus       291 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~evL~~~~~~~  361 (363)
                      +|||++|+.||.+....+....+.........+....+++++.++|.+|+ .||.+|++   +.+++.|+||..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            99999999999988877777666654444444444568999999999986 59999997   999999999965

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-50  Score=381.79  Aligned_cols=257  Identities=29%  Similarity=0.495  Sum_probs=220.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.+++++. ||||+++++++.+...+|+||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEEE
Confidence            5889999999999999999999999999999997654434455678899999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||++|++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+|||+   +.++.+||+|||+++......  
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   788899999999986321100  


Q ss_pred             ----------------------------------------------ccccCccCCcccccccccc-cCCCcccHHHHHHH
Q 017960          258 ----------------------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVI  290 (363)
Q Consensus       258 ----------------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~i  290 (363)
                                                                    .....+||+.|+|||++.+ .++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                          0012469999999999874 69999999999999


Q ss_pred             HHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCccc
Q 017960          291 LYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER---LTAHEVLCMYNLPV  361 (363)
Q Consensus       291 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---~s~~evL~~~~~~~  361 (363)
                      +|||++|..||.+....+.+..+.........+....++.++.+||.+||. +|.+|   +++.|++.|+||..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            999999999998888777777776543333323333578999999999998 76665   59999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.4e-50  Score=373.24  Aligned_cols=249  Identities=31%  Similarity=0.522  Sum_probs=220.6

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998665445556678889999999998 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~  263 (363)
                      ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccccccccc
Confidence            9999999888889999999999999999999999999999999999999   7888999999999875322 22334567


Q ss_pred             cCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......++    ..+++++.+||.+||++
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK  232 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence            999999999987 4689999999999999999999999988887777777766555443    35789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCCccc
Q 017960          343 QPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       343 dp~~R~-----s~~evL~~~~~~~  361 (363)
                      ||++|+     ++.++++|+||..
T Consensus       233 dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         233 DPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999997     8999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.2e-50  Score=372.05  Aligned_cols=249  Identities=33%  Similarity=0.534  Sum_probs=220.8

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++ ||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999999999999999998655444555677889999999998 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~  263 (363)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   7888999999999875322 22334567


Q ss_pred             cCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++. ..++.++|||||||++|||++|+.||...........+......++    ..+++++.+||.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            999999999987 4689999999999999999999999998888888777776655443    35789999999999999


Q ss_pred             CcCCCC-----CHHHHhcCCCccc
Q 017960          343 QPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       343 dp~~R~-----s~~evL~~~~~~~  361 (363)
                      ||.+|+     ++.++++|+||..
T Consensus       233 dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcCCCcCC
Confidence            999998     9999999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.4e-50  Score=372.04  Aligned_cols=251  Identities=30%  Similarity=0.510  Sum_probs=221.9

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999997654434455677888999998876799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~~  263 (363)
                      ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   788899999999987542 223334567


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......++    ..+++++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence            9999999999874 589999999999999999999999999998888888887665433    24789999999999999


Q ss_pred             CcCCCCCH------HHHhcCCCcccC
Q 017960          343 QPSERLTA------HEVLCMYNLPVL  362 (363)
Q Consensus       343 dp~~R~s~------~evL~~~~~~~~  362 (363)
                      ||++||++      ++++.|+||..+
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999998      999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-50  Score=378.43  Aligned_cols=257  Identities=33%  Similarity=0.582  Sum_probs=226.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..+. ||||+++++++.+.+..++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEEE
Confidence            5899999999999999999999999999999998655444455678899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcc
Confidence            999999999999888889999999999999999999999999999999999999   788899999999997654332  


Q ss_pred             ----------------------------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH
Q 017960          258 ----------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQG  308 (363)
Q Consensus       258 ----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  308 (363)
                                                  ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                        2234578999999999884 69999999999999999999999999888777


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCC-HHHHhcCCCccc
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT-AHEVLCMYNLPV  361 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s-~~evL~~~~~~~  361 (363)
                      ....+.........+....+++++.+||.+||. ||.+|++ +.+++.|+|+..
T Consensus       238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            777777633223333334479999999999997 9999999 999999999965

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-49  Score=369.99  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=225.0

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+..|+.++..+.+|++|+.+++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            38889999999999999999999999999999986554444556778899999999985677999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~  258 (363)
                      ||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   778899999999987532 2233


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+......++    ..+++++.++|.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  233 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK  233 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            445679999999999884 589999999999999999999999999888888888877655443    357899999999


Q ss_pred             HhcccCcCCCCCH-----HHHhcCCCccc
Q 017960          338 KMLCSQPSERLTA-----HEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s~-----~evL~~~~~~~  361 (363)
                      +||..||.+|++.     +++++|+||..
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999999999976     89999999865

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-50  Score=380.56  Aligned_cols=257  Identities=30%  Similarity=0.501  Sum_probs=222.0

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++++. ||||+++++.+.+.+.+++||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999997654434445677889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC---
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~---  256 (363)
                      ||+++++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|......   
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   78889999999997532100   


Q ss_pred             -----------------------------------------CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHH
Q 017960          257 -----------------------------------------QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYIL  294 (363)
Q Consensus       257 -----------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~el  294 (363)
                                                               ......+||+.|+|||++.+ .++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                     00123579999999999974 589999999999999999


Q ss_pred             HhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCccc
Q 017960          295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCMYNLPV  361 (363)
Q Consensus       295 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~evL~~~~~~~  361 (363)
                      ++|+.||.+....+....+..............+++++.++|.+|+ .+|.+|+   ++.+++.|+||..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            9999999988877776666654444444444568999999999977 5999999   9999999999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5e-50  Score=355.13  Aligned_cols=258  Identities=28%  Similarity=0.405  Sum_probs=222.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc-eeEEeEEEecCC----
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-IVTIKGAYEDSL----  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~----  173 (363)
                      ..|+..++||+|+||+||+|+++.+|+.||+|.+...... +..-....+|+.+|+.|+ |+| |+.+++++...+    
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            3477888999999999999999999999999999765431 223345789999999998 999 999999998877    


Q ss_pred             --eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          174 --CVHIVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       174 --~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                        .+++|+||+ .-+|..++....    .++...++.+++||+.||+|||+++|+||||||.||||   ++.|.+||+||
T Consensus        89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeecc
Confidence              899999999 568988887654    47888999999999999999999999999999999999   78999999999


Q ss_pred             CcceecC-CCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCC
Q 017960          248 GLSVFFK-PGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       248 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  324 (363)
                      |+|+... +...++..++|.+|+|||++.+  .|+...||||+|||++||++++..|.+..+.+.+..|.+-.-...+..
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9998776 4556888899999999999985  599999999999999999999999999999888888876433333333


Q ss_pred             CC--------------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          325 WP--------------------------LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       325 ~~--------------------------~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      |+                          ..+++..+++.+||+.+|.+|.|+..+|.|++|+.+
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            32                          223578999999999999999999999999999754

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-49  Score=369.65  Aligned_cols=250  Identities=27%  Similarity=0.477  Sum_probs=221.8

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      ++||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999997654444555667888999998876799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~  263 (363)
                      ++|...+...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccc
Confidence            9999999888889999999999999999999999999999999999999   7888999999999876432 23344567


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+..+.+......++    ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence            8999999999874 689999999999999999999999999998888888887665433    24789999999999999


Q ss_pred             CcCCCC-------CHHHHhcCCCccc
Q 017960          343 QPSERL-------TAHEVLCMYNLPV  361 (363)
Q Consensus       343 dp~~R~-------s~~evL~~~~~~~  361 (363)
                      ||++|+       ++.++++|+||..
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            999999       9999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-49  Score=376.01  Aligned_cols=258  Identities=31%  Similarity=0.472  Sum_probs=224.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+.+.+++|
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEE
Confidence            46999999999999999999999999999999997654434445566788999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       122 ~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         122 MEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCCCc
Confidence            999999999987754 468999999999999999999999999999999999999   888999999999998764332 


Q ss_pred             -ccccCccCCcccccccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          258 -IFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                       .....+||+.|+|||++.+     .++.++|||||||++|||++|..||.+......+..+.........+....++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence             2235679999999999863     3789999999999999999999999998888888888765544443444467999


Q ss_pred             HHHHHHHhcccCcCC--CCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSE--RLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~--R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||+.+|.+  |+++.+++.|+||..
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            999999999999988  999999999999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-49  Score=368.16  Aligned_cols=255  Identities=26%  Similarity=0.430  Sum_probs=225.4

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+..|++|+++++++.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            37889999999999999999999999999999987554444455677888888888877899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~  258 (363)
                      ||+++|+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||++..... ...
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCc
Confidence            999999999999888889999999999999999999999999999999999999   8888999999999976432 233


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ....+||+.|+|||++. ..++.++|||||||++|||++|..||.+.........+......++.    .++.++.+|+.
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~  233 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK  233 (323)
T ss_pred             cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence            44567999999999988 46999999999999999999999999998888888888876654443    47899999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCccc
Q 017960          338 KMLCSQPSERLT-----AHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s-----~~evL~~~~~~~  361 (363)
                      +||+.||.+|++     ..+++.|+||..
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            999999999998     489999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.6e-49  Score=362.96  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=212.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||.|+||.||+|.+..++..||+|++....  .......+.+|+.++++++ ||||+++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEE
Confidence            35999999999999999999999999999999986543  2223356778999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+.+ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC
Confidence            999965 8988887654 47899999999999999999999999999999999999   77889999999999764322 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc--------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF--------------  320 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------  320 (363)
                      .......+++.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+.+..+.+.....              
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            23345678999999998863  58999999999999999999999998877666555543311100              


Q ss_pred             -----CC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          321 -----ES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       321 -----~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                           +.       ...+.+++++++||.+||+.||.+|||++|+|+|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                 00       0123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.1e-50  Score=370.78  Aligned_cols=249  Identities=32%  Similarity=0.530  Sum_probs=220.5

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|++++..+. ||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765445555677889999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccC
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~  262 (363)
                      ++|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccc
Confidence            9999999888889999999999999999999997 799999999999999   788899999999987533 22333456


Q ss_pred             ccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          263 VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       263 ~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      .||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......++    ..+++++.+||.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            7999999999987 4689999999999999999999999998888888887776655443    2478999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCCCccc
Q 017960          342 SQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       342 ~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      .||++|+     ++.++++|+||..
T Consensus       233 ~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            9999997     9999999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-52  Score=373.20  Aligned_cols=253  Identities=27%  Similarity=0.412  Sum_probs=224.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|...+.||+|+||.||+|.+..+++.||+|++....  ....++.+..|+.+|..++ ++||.++|+.|..+..++|+|
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHHH
Confidence            4777799999999999999999999999999997665  5566788999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      |||.||++.+.+...+.+.+..+..++++++.||.|||..+.+|||||+.|||+   ..+|.+||+|||.+.........
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE---eccCcEEEEecceeeeeechhhc
Confidence            999999999999888888999999999999999999999999999999999999   67799999999999887655433


Q ss_pred             -ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          260 -TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       260 -~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                       .+++||+.|||||++.. .|+.++||||||++++||++|.+||....+...+-.|-+...+...   ..+++.+++|+.
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEFV~  244 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEFVE  244 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHHHH
Confidence             67899999999999985 6999999999999999999999999887775544444443322222   257899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCccc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .||++||+.||+|.++|+|.|++.
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHh
Confidence            999999999999999999999853

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.5e-49  Score=368.37  Aligned_cols=250  Identities=26%  Similarity=0.448  Sum_probs=215.0

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      ++||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+.+||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765445555677889999999997799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec-CCCCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~-~~~~~~~~~~  263 (363)
                      ++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++... .........+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   77889999999998753 2233345578


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---------CHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---------TQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ||+.|+|||++.+ .++.++|+|||||++|+|++|+.||...         ......+.+.......+    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~  233 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAS  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHH
Confidence            9999999999884 5899999999999999999999999531         11223444555443332    34789999


Q ss_pred             HHHHHhcccCcCCCCC------HHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLT------AHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s------~~evL~~~~~~~  361 (363)
                      ++|.+||+.||.+|++      +.++++|+||..
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-49  Score=370.96  Aligned_cols=257  Identities=30%  Similarity=0.464  Sum_probs=223.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. |+||+++++++.+.+..++||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEEE
Confidence            5889999999999999999999999999999998765444555677889999999887 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||+++++|.+++.+. +.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCCc
Confidence            999999999999776 679999999999999999999999999999999999999   7888999999999987654332


Q ss_pred             --cccCccCCccccccccc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          259 --FTDVVGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       259 --~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                        .....||+.|+|||++.       ..++.++|||||||++|||++|..||........+..+.........+..+.++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence              23357899999999985       247889999999999999999999998888777777776544322223334578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +++.+||.+||+ ||.+||++.+++.|+||..
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            999999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-49  Score=374.55  Aligned_cols=257  Identities=30%  Similarity=0.497  Sum_probs=222.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..+. ||+|+++++.+.+.+.+|+||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEE
Confidence            5889999999999999999999999999999997654444555678889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||++|++|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......  
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccccc
Confidence            999999999999888889999999999999999999999999999999999999   788899999999986432110  


Q ss_pred             ----------------------------------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCC
Q 017960          258 ----------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFW  302 (363)
Q Consensus       258 ----------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~  302 (363)
                                                        .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                              0123579999999999874 69999999999999999999999999


Q ss_pred             CcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCccc
Q 017960          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCMYNLPV  361 (363)
Q Consensus       303 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~evL~~~~~~~  361 (363)
                      +.........+.........+....+++++++||.+|+ .||.+|+   ++.+++.|+||..
T Consensus       238 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         238 SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence            88888888777754332222222347899999999987 5999998   5899999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.4e-49  Score=365.48  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=217.6

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.++.+++.||+|++.+..............|..++..+.+||||+++++++.+.+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997654333344566778888888765699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~~  263 (363)
                      ++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccC
Confidence            9999999888889999999999999999999999999999999999999   788899999999987532 222344577


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||.+.......+.+......++    ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER  233 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999984 699999999999999999999999998888888887766543332    24789999999999999


Q ss_pred             CcCCCCCH-HHHhcCCCcccC
Q 017960          343 QPSERLTA-HEVLCMYNLPVL  362 (363)
Q Consensus       343 dp~~R~s~-~evL~~~~~~~~  362 (363)
                      ||.+|+++ ++++.|+||..+
T Consensus       234 dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCCC
Confidence            99999998 588899999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3e-49  Score=373.22  Aligned_cols=259  Identities=30%  Similarity=0.458  Sum_probs=222.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+. ||||+++++++.+...+|+
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEE
Confidence            456999999999999999999999999999999997654434445567889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|.......
T Consensus       121 v~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         121 VMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecccCC
Confidence            9999999999998865 468999999999999999999999999999999999999   788899999999998764332


Q ss_pred             c--cccCccCCcccccccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          258 I--FTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       258 ~--~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .  ....+||+.|+|||++.+     .++.++|||||||++|||++|..||.+......+..+.........+....++.
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence            2  235679999999999863     278999999999999999999999999888888888876544333333345789


Q ss_pred             HHHHHHHHhcccCcCC--CCCHHHHhcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSE--RLTAHEVLCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~--R~s~~evL~~~~~~~  361 (363)
                      .++++|.+||..++.+  |+++.|+++|+||..
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            9999999999865544  899999999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.6e-49  Score=364.59  Aligned_cols=250  Identities=30%  Similarity=0.471  Sum_probs=216.8

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+.+||||+++++++.....+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333444566677888887665699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-CccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~  263 (363)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... ......+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   78889999999999764322 3334567


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+....+......++    ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence            9999999999874 589999999999999999999999999888888887766543332    34789999999999999


Q ss_pred             CcCCCCCH-HHHhcCCCccc
Q 017960          343 QPSERLTA-HEVLCMYNLPV  361 (363)
Q Consensus       343 dp~~R~s~-~evL~~~~~~~  361 (363)
                      ||.+||++ .++++|+|+..
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             CHHHcCCChHHHHcCcccCC
Confidence            99999986 58889999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.3e-49  Score=365.12  Aligned_cols=250  Identities=28%  Similarity=0.498  Sum_probs=220.9

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+.+||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765444555677888999999886799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~  263 (363)
                      ++|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++..... .......+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCccccee
Confidence            9999999888889999999999999999999999999999999999999   7888999999999875322 22334467


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      |++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++    ..++.++.+||.+||+.
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK  233 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence            8999999999874 689999999999999999999999998888888887776655433    24789999999999999


Q ss_pred             CcCCCCCH-----HHHhcCCCccc
Q 017960          343 QPSERLTA-----HEVLCMYNLPV  361 (363)
Q Consensus       343 dp~~R~s~-----~evL~~~~~~~  361 (363)
                      ||.+||++     .++++|+|+..
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCC
Confidence            99999999     99999999965

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-49  Score=361.60  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=211.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEE
Confidence            58999999999999999999999999999999975432 3344567889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||++++.+.........+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence            999887665544445678999999999999999999999999999999999999   778899999999998754322  


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-----------------
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----------------  319 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------------  319 (363)
                      ......|++.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+......                 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            2334678999999999874 5899999999999999999999999877655443332221000                 


Q ss_pred             --cCC---------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 --FES---------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 --~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                        .+.         .....++.++.+||.+||+.||++|||++++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              000         0012367889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7e-49  Score=361.22  Aligned_cols=258  Identities=26%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.+. ||||+++++++.+....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc--ccccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEE
Confidence            356999999999999999999999999999999986543  2222346778999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-
Q 017960          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-  255 (363)
                      ||||+. ++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||++..... 
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCC
Confidence            999995 6788877654 568999999999999999999999999999999999999   7788999999999876432 


Q ss_pred             CCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCcc-------------
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHID-------------  319 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~-------------  319 (363)
                      ........+++.|+|||++.+  .++.++|||||||++|+|++|..||.+... .+.+..+......             
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            223345678999999999863  489999999999999999999999976533 2222222110000             


Q ss_pred             -cCCCC--------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 -FESDP--------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 -~~~~~--------------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                       +....              ....++++.+||.+||+.||++|||+.|+|+|+||..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence             00000              01245788999999999999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9e-49  Score=363.91  Aligned_cols=252  Identities=30%  Similarity=0.476  Sum_probs=218.2

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHH---HhcCCCceeEEeEEEecCCeEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH---HLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      |++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.++.   .+. ||||+++++++...+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCEEEE
Confidence            678899999999999999999999999999997654434445567777777664   444 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-C
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-G  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~  256 (363)
                      ||||+++++|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence            9999999999887754 578999999999999999999999999999999999999   7888999999999875322 2


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      ......+|++.|+|||++.+ .++.++|||||||++|||++|..||.+....+....+......++    ..+++++.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l  231 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI  231 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            23345679999999999874 589999999999999999999999999888888888877655433    3478999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCCCccc
Q 017960          336 IRKMLCSQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       336 i~~~l~~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      |.+||+.||.+||     ++.++++|+||..
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            9999999999999     7999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-48  Score=363.34  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=223.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|+.++..+.+|++|+++++++.+.+.+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            67789999999999999999999999999999765443444566788899999988767889999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-Ccc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~  259 (363)
                      |+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... ...
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCccc
Confidence            99999999999888889999999999999999999999999999999999999   78889999999998764322 223


Q ss_pred             ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.......+.+......++    ..+++++.+++.+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  234 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKG  234 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHH
Confidence            4567899999999987 4589999999999999999999999999888888888877665443    3478999999999


Q ss_pred             hcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          339 MLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       339 ~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      ||+.||.+|++     .+++++|+||..+
T Consensus       235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         235 LMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            99999999997     5799999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-48  Score=356.98  Aligned_cols=257  Identities=29%  Similarity=0.444  Sum_probs=218.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.++||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++ ||||+++++.+.+.+.+++|||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEEe
Confidence            788999999999999999999999999999997654333344456788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCc
Confidence            99999998887654  358999999999999999999999999999999999999   7788999999999987655444


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....|++.|+|||++. ..++.++||||+||++|||++|..||.+.......+.+..............+++.+.+||.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICR  237 (285)
T ss_pred             cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHH
Confidence            45567899999999987 45899999999999999999999999876654433333222111122223457899999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCccc
Q 017960          338 KMLCSQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      +||+.||++||     ++++++.|+||..
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            99999999999     9999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.8e-49  Score=367.65  Aligned_cols=255  Identities=30%  Similarity=0.496  Sum_probs=214.9

Q ss_pred             ceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .|++.+.||+|+||.||+|++.   .+++.||+|++.+.... .....+.+..|+.++.++++||+|+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            3889999999999999998864   47889999999754322 2234567889999999997799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   7788999999999976432


Q ss_pred             CC--ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcC----HHHHHHHHHcCCcccCCCCCCC
Q 017960          256 GQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       256 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|||++|..||....    .......+......    ....
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~  233 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP----FPSF  233 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC----CCCC
Confidence            22  2234679999999999874  37889999999999999999999996432    23333444433322    2235


Q ss_pred             CCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      +++++.+||.+||+.||++||     +++++++|+|+..
T Consensus       234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            789999999999999999999     8899999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.5e-48  Score=377.03  Aligned_cols=259  Identities=25%  Similarity=0.325  Sum_probs=205.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc-----CCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-----GHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~~~~  171 (363)
                      ..++|++.++||+|+||+||+|.+..+++.||||++....    ........|+.+++.++     +|.++++++++|..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4577999999999999999999999999999999996421    22345567888887775     24568999998875


Q ss_pred             C-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCC------------
Q 017960          172 S-LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKD------------  237 (363)
Q Consensus       172 ~-~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~------------  237 (363)
                      . ..+++|||++ |++|.+++.+.+.+++..+..++.||+.||+|||+ .|||||||||+|||+...+            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            4 5789999998 88999999888889999999999999999999998 5999999999999994321            


Q ss_pred             -CCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Q 017960          238 -DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK  315 (363)
Q Consensus       238 -~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  315 (363)
                       +...+||+|||.+....  ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+.+
T Consensus       282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence             12259999999886432  23356789999999999885 599999999999999999999999987776555444332


Q ss_pred             CCcccCC---------------------C---------------CC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          316 GHIDFES---------------------D---------------PW--PLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       316 ~~~~~~~---------------------~---------------~~--~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....++.                     .               .+  ...++.+.+||.+||+.||++|||+.|+|+||
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            1110000                     0               00  01135678999999999999999999999999


Q ss_pred             CcccC
Q 017960          358 NLPVL  362 (363)
Q Consensus       358 ~~~~~  362 (363)
                      ||...
T Consensus       440 ~~~~~  444 (467)
T PTZ00284        440 YVLKY  444 (467)
T ss_pred             ccccc
Confidence            99765

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=364.05  Aligned_cols=261  Identities=34%  Similarity=0.571  Sum_probs=239.0

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+...|.+.+.||+|-|++|-+|++..+|+.||||++.+.++. ......+..|+..|+.++ |||||++|++.....
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQT   90 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccc
Confidence            345677899999999999999999999999999999999988764 344567888999999887 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      .+|+|+|+=.+|+|++++.+. ..+.+..+.++++||+.|+.|+|+.++|||||||+||.+.  .+-|-|||.|||++..
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNK  168 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeecccccc
Confidence            999999999999999999764 4589999999999999999999999999999999999886  5678999999999999


Q ss_pred             cCCCCccccCccCCcccccccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          253 FKPGQIFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      +.+++..++.||+..|.|||++.+ .| .+++||||||+|||-|++|++||...++.+.+-.|...++..+.    .++.
T Consensus       169 f~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~  244 (864)
T KOG4717|consen  169 FQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSK  244 (864)
T ss_pred             CCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhH
Confidence            999999999999999999999996 46 56899999999999999999999999999999999988877654    5899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ++++||..||..||.+|.+.++|..+.|++..
T Consensus       245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             HHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            99999999999999999999999999999863

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-50  Score=354.92  Aligned_cols=252  Identities=30%  Similarity=0.436  Sum_probs=215.0

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-----Ce
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----LC  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----~~  174 (363)
                      .|+-.+++|.|+||.||+|....+++.||||.+-....       --.+|+++|+.+. |||||++.-+|...     -+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhH
Confidence            37788999999999999999999999999998854432       2346999999997 99999999888532     24


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          175 VHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      ..+||||++ .+|.+.++.    +..++...++-+..||++||.|||+.||+||||||.|||++  .+.+.+||||||+|
T Consensus        97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcc
Confidence            568999995 589888875    56789999999999999999999999999999999999994  34589999999999


Q ss_pred             eecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc---------
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------  319 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------  319 (363)
                      +....++...++..|+.|+|||.+.+  .|+.+.||||.||+++||+-|++.|.|.+..+.+..|.+---.         
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            99988888888999999999999984  6999999999999999999999999999888877777551110         


Q ss_pred             -----------cCCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 -----------FESDP-----WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 -----------~~~~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                 +....     ....++++.+|+.++|..+|.+|.++.|+|.|+||..+
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence                       00111     23468999999999999999999999999999999764

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-48  Score=364.04  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=214.0

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765545556677889999998886699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~~  263 (363)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... .........
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCcccccc
Confidence            9999999888889999999999999999999999999999999999999   888899999999987532 223334567


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---------CHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---------TQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||...         ......+.+......++    ..++.++.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  233 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAA  233 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHH
Confidence            9999999999874 5899999999999999999999999521         12223444444443332    35789999


Q ss_pred             HHHHHhcccCcCCCCC------HHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLT------AHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s------~~evL~~~~~~~  361 (363)
                      +||.+||+.||++||+      +.++++|+||..
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999999999998      589999999965

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.5e-49  Score=365.56  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=210.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-----Ce
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----LC  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----~~  174 (363)
                      +|++.+.||+|+||.||+|.+..++..||||.+..... ......++.+|+.+++.++ ||||+++++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCce
Confidence            48899999999999999999999999999999864321 3334567889999999998 99999999987543     35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +|+||||+ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccc
Confidence            89999999 56899999888889999999999999999999999999999999999999   888899999999997543


Q ss_pred             CCC----ccccCccCCccccccccc---ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHc------------
Q 017960          255 PGQ----IFTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK------------  315 (363)
Q Consensus       255 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~------------  315 (363)
                      ...    ......||+.|+|||++.   ..++.++|||||||++|||++|+.||.+.........+..            
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            221    223467899999999986   3589999999999999999999999977654333222111            


Q ss_pred             ---------------CCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          316 ---------------GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       316 ---------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                     .........++.+++++.++|.+||+.||++|||+.|+|+|+||..
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence                           0000111123457889999999999999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-48  Score=361.26  Aligned_cols=251  Identities=27%  Similarity=0.441  Sum_probs=216.6

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||+||+|.+..+++.||||++.+..............|..++..+.+||||+++++++.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997654323344556777888888765599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~  263 (363)
                      ++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++..... ........
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeec
Confidence            9999999887889999999999999999999999999999999999999   7788999999999875422 22334567


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+..+.+......++    ..++.++.+||.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~  233 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR  233 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence            8999999999874 589999999999999999999999998888888777765543322    24789999999999999


Q ss_pred             CcCCCCCHH-HHhcCCCcccC
Q 017960          343 QPSERLTAH-EVLCMYNLPVL  362 (363)
Q Consensus       343 dp~~R~s~~-evL~~~~~~~~  362 (363)
                      ||++||++. +++.|+||..+
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCC
Confidence            999999996 89999998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-48  Score=368.56  Aligned_cols=258  Identities=31%  Similarity=0.458  Sum_probs=222.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+...+++|
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999997654434445566788999999987 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||++|++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       122 ~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         122 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCc
Confidence            999999999988765 458999999999999999999999999999999999999   788899999999998764332 


Q ss_pred             -ccccCccCCcccccccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          258 -IFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                       .....+||+.|+|||++..     .++.++|||||||++|||++|..||.+.+....+..+..............++.+
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence             2235679999999999863     2789999999999999999999999998888888888765544343444568999


Q ss_pred             HHHHHHHhcccCcCC--CCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSE--RLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~--R~s~~evL~~~~~~~  361 (363)
                      +++||.+||..++.+  |+++.++++|+||..
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            999999999854443  789999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-48  Score=362.95  Aligned_cols=249  Identities=29%  Similarity=0.511  Sum_probs=215.5

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHH-HHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI-MHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+..|... ++.++ ||||+++++.+.+.+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            469999999999999999999999999976544333444556666554 56676 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccC
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV  262 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~  262 (363)
                      +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   7888999999999875322 2333456


Q ss_pred             ccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      .||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+..+.+........    +.+++++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence            79999999999874 589999999999999999999999998888888888877654433    3578999999999999


Q ss_pred             cCcCCCCCH----HHHhcCCCccc
Q 017960          342 SQPSERLTA----HEVLCMYNLPV  361 (363)
Q Consensus       342 ~dp~~R~s~----~evL~~~~~~~  361 (363)
                      .||.+||++    .+++.|+||..
T Consensus       233 ~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcCCCcCC
Confidence            999999987    69999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.2e-48  Score=360.45  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=216.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..++..||+|++....  .....+++.+|++++++++ ||||+++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEE
Confidence            356999999999999999999999999999999987542  3445678999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||+   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence            999999999999998888899999999999999999999986 69999999999999   77889999999998765432


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc----------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------------  319 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------  319 (363)
                       ......|++.|+|||++.+ .++.++|||||||++|||++|+.||......++...+......                
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             3345678999999999884 5999999999999999999999999765554433222110000                


Q ss_pred             ----------------------------cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          320 ----------------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       320 ----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                                  .+......+++++++||.+||.+||++|||+.|+|+|+|+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                                        000011236789999999999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-48  Score=361.20  Aligned_cols=249  Identities=33%  Similarity=0.559  Sum_probs=217.4

Q ss_pred             ceecccCCeEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          105 RKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      +.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+++.+. ||||+++++++..++.+|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEe
Confidence            67999999999999864   47889999999764321 2233456788999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCcc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~  259 (363)
                      |+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcc
Confidence            99999999999888889999999999999999999999999999999999999   7888999999999875432 2233


Q ss_pred             ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.........+..+....+    +.+++++.+||.+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  233 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKK  233 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            44679999999999874 588999999999999999999999998888888888877765443    3578999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCCCccc
Q 017960          339 MLCSQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       339 ~l~~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      ||+.||++||     ++.+++.|+|+..
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            9999999999     8999999999864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.2e-48  Score=354.33  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=209.1

Q ss_pred             ceeecceecccCCeEEEEEEEcc-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEe-----c
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYE-----D  171 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~-----~  171 (363)
                      +|++.+.||+|+||.||+|.+.. .+..||+|.+..... .......+.+|+.+++.+.  .||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            58999999999999999999854 467899999865432 2223345667888877764  4999999999875     3


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                      ...+++||||+. ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccc
Confidence            456899999995 6898888653  348999999999999999999999999999999999999   7788999999999


Q ss_pred             ceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES------  322 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------  322 (363)
                      +.............||+.|+|||++. ..++.++|||||||++|||++|.+||.+....+.+..+.........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            98765554455667899999999987 46899999999999999999999999988877766666532111000      


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          323 -----------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       323 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                       ...+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             0113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.9e-48  Score=361.10  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=207.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++ |+||+++++++...+.+++|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEE
Confidence            44888899999999999999999999999999986443  3445577899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||+++++|...    ....+..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++....... 
T Consensus       151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence            999999988543    245778889999999999999999999999999999999   788899999999998754322 


Q ss_pred             ccccCccCCcccccccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ......||..|+|||++..      ..+.++|||||||++|||++|+.||......+....+..............++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2345678999999998742      2456899999999999999999999744332222222111111122233467899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||+.||++||++.|+|+|+|+..
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            999999999999999999999999999853

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.9e-48  Score=360.04  Aligned_cols=251  Identities=25%  Similarity=0.444  Sum_probs=214.8

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++.+||||+.+++++.+.+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998765545556677889999999997799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~~  263 (363)
                      ++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ........+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceeccc
Confidence            9999999888889999999999999999999999999999999999999   778899999999987532 233345578


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-------CHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-------TQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..||...       ........+.......+    ..++..+.++
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~l  233 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHV  233 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence            9999999999874 6899999999999999999999999532       22234444444333222    3578999999


Q ss_pred             HHHhcccCcCCCCC------HHHHhcCCCcccC
Q 017960          336 IRKMLCSQPSERLT------AHEVLCMYNLPVL  362 (363)
Q Consensus       336 i~~~l~~dp~~R~s------~~evL~~~~~~~~  362 (363)
                      |.+||+.||.+|++      +.+++.|+||..+
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            99999999999998      5799999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=346.10  Aligned_cols=257  Identities=32%  Similarity=0.533  Sum_probs=239.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      -+.|...++||+|.||+|-+|+.+.+++.||+|++++........+..-..|-.+|+..+ ||.+..+.-.|+..+.+|+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEE
Confidence            356889999999999999999999999999999999988888888888889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec-CCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~-~~~  256 (363)
                      ||||..||.|+.+|.+...+++...+.+...|+.||.|||+.+||+||||.+|+|+   |++|++||.|||+++.. ..+
T Consensus       246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccccc
Confidence            99999999999999999999999999999999999999999999999999999999   99999999999999753 455


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      ....++||||.|+|||++.. .|+.++|.|.+|++||||++|++||+......+++.|....+.++.    .++++++.|
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL  398 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL  398 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence            66788999999999999985 6999999999999999999999999999999999999998887775    589999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          336 IRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       336 i~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      +..+|.+||.+|.     .+.||.+|.||..+
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            9999999999997     68999999998653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-49  Score=362.42  Aligned_cols=244  Identities=27%  Similarity=0.413  Sum_probs=212.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.+++++.||+|.||.||.|... ....||+|.++....    ..+.|.+|+++|++|+ |++||++++++..+..+|||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM----SPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc----ChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEE
Confidence            44777899999999999999963 334899999976432    2356779999999999 99999999999998899999


Q ss_pred             EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+.|+|.++|..  .+.+...+.+.++.||++|++||+++++|||||...||||   +++..+||+|||+|+...++
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCC
Confidence            999999999999987  4568999999999999999999999999999999999999   88999999999999955443


Q ss_pred             CccccCcc---CCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          257 QIFTDVVG---SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       257 ~~~~~~~g---t~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      . +....|   ...|.|||.+. +.++.+||||||||+||||+| |+.||.+.+..++++.+.++.-   .+....+|++
T Consensus       357 ~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR---lp~P~~CP~~  432 (468)
T KOG0197|consen  357 E-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR---LPRPEGCPDE  432 (468)
T ss_pred             c-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc---CCCCCCCCHH
Confidence            3 322222   34699999998 679999999999999999999 9999999999999999999854   3444579999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      +.+++..||+.+|++|||++.+..
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999986654

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-48  Score=358.84  Aligned_cols=259  Identities=28%  Similarity=0.495  Sum_probs=219.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..+. |+||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence            35899999999999999999999999999999997654444455667889999999987 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||++|++|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence            999999999999976 4568999999999999999999999999999999999999   788899999999987654333


Q ss_pred             cc--ccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-CCCCCC
Q 017960          258 IF--TDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLI  328 (363)
Q Consensus       258 ~~--~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~  328 (363)
                      ..  ....||+.|+|||++.      ..++.++|||||||++|+|++|+.||.+....+....+......+.. .....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  236 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV  236 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence            21  2346899999999986      24788999999999999999999999888777777776654322221 223457


Q ss_pred             CHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSE--RLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~--R~s~~evL~~~~~~~  361 (363)
                      ++++++||++||+.++++  |+++.+++.|+||..
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            899999999999765544  889999999999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-48  Score=352.09  Aligned_cols=251  Identities=29%  Similarity=0.434  Sum_probs=208.9

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||+|+||+||+|.+..+++.||+|.+.+.........+.+..|+.+++.+. |+||+++.+++......++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999999999999999997654444445567889999999997 9999999999999999999999999999


Q ss_pred             hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-cccc
Q 017960          187 LFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-IFTD  261 (363)
Q Consensus       187 L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~~~~  261 (363)
                      |...+..    ...+++..+..++.||+.||.|||++||+||||||+||++   ++++.+||+|||++....... ....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccc
Confidence            9877743    3458999999999999999999999999999999999999   778899999999997654432 2334


Q ss_pred             CccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhc
Q 017960          262 VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML  340 (363)
Q Consensus       262 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l  340 (363)
                      ..||+.|+|||++. ..++.++|||||||++|||++|+.||...........+..............+++++.+++.+||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            57899999999988 46899999999999999999999999765432222222222111122222357899999999999


Q ss_pred             ccCcCCCC-----CHHHHhcCCCccc
Q 017960          341 CSQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       341 ~~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      +.||++||     +++++++|+||..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            99999999     8899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-49  Score=364.63  Aligned_cols=249  Identities=29%  Similarity=0.493  Sum_probs=216.6

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      ||+|+||+||+|.+..+++.||+|++.+..............|..++..+.  +||||+.+++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999997654434444555667777777664  699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~  263 (363)
                      ++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..... .......+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            9999999888889999999999999999999999999999999999999   7788999999999875322 23344567


Q ss_pred             cCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          264 GSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       264 gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      ||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+..+...++.   ..+++++.+||.+||+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~  234 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence            9999999999863  4899999999999999999999999998888888888776654443   2478999999999999


Q ss_pred             cCcCCCC----CHHHHhcCCCccc
Q 017960          342 SQPSERL----TAHEVLCMYNLPV  361 (363)
Q Consensus       342 ~dp~~R~----s~~evL~~~~~~~  361 (363)
                      .||++||    ++.++++|+|+..
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCccccC
Confidence            9999998    7999999999964

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-49  Score=363.77  Aligned_cols=254  Identities=30%  Similarity=0.508  Sum_probs=230.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe-EEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC-VHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-~~i  177 (363)
                      +.|..++++|+|+||.+++++++.++..+++|.+..... ..........|+.+++++. |||||.+.+.|.+++. ++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~-t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL-TEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc-CchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence            459999999999999999999999999999999987665 3344457889999999998 9999999999999888 999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||+||+||+|.+.+.+.+  .++++.+..|+.|++.|+.|||+++|+|||||+.||++   ..+..|||+|||+|+...+
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCC
Confidence            999999999999997654  58999999999999999999999999999999999999   6777889999999999887


Q ss_pred             CC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ...+.+||+.||.||++.+ .|+.++|||||||++|||++-+.+|.+.+-..+..+|.+.......   ...+.+++
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~  235 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR  235 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence            76 6778999999999999985 6999999999999999999999999999999999999988743333   35789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+|..||..+|..||++.++|.+|.++
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            999999999999999999999998765

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4e-48  Score=359.73  Aligned_cols=249  Identities=27%  Similarity=0.475  Sum_probs=215.2

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHH-HHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI-MHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      +.||+|+||+||+|.+..+++.||+|++.+...........+..|... ++.++ ||||+++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence            469999999999999999999999999976544344445566666654 55576 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccC
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~  262 (363)
                      +++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||++.... ........
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   788899999999987532 22333456


Q ss_pred             ccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      +||+.|+|||++.+ .++.++|||||||++|||++|..||......+..+.+........    +.++.++.++|.+||.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence            79999999999874 589999999999999999999999998888888888776654332    3578999999999999


Q ss_pred             cCcCCCCCH----HHHhcCCCccc
Q 017960          342 SQPSERLTA----HEVLCMYNLPV  361 (363)
Q Consensus       342 ~dp~~R~s~----~evL~~~~~~~  361 (363)
                      .||.+||++    .++++|+||..
T Consensus       233 ~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         233 KDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             cCHHhcCCCCCCHHHHhcCCCcCC
Confidence            999999977    59999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-48  Score=359.95  Aligned_cols=248  Identities=29%  Similarity=0.484  Sum_probs=217.1

Q ss_pred             ceecccCCeEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          105 RKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      +.||+|+||.||++++.   .+++.||+|++.+... .......+..|+.++++++ ||||+++++++.+.+.+|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcC
Confidence            57999999999999863   5789999999976432 2233456788999999998 99999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-Cccc
Q 017960          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFT  260 (363)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~  260 (363)
                      +++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++...... ....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCcee
Confidence            9999999999888889999999999999999999999999999999999999   78889999999998765433 2334


Q ss_pred             cCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHh
Q 017960          261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (363)
Q Consensus       261 ~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  339 (363)
                      ...|++.|+|||++.+ .++.++|||||||++|||++|+.||.+.........+.+.....+    ..+++++.+||.+|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence            5678999999999874 589999999999999999999999998888888888877655433    34789999999999


Q ss_pred             cccCcCCCCC-----HHHHhcCCCccc
Q 017960          340 LCSQPSERLT-----AHEVLCMYNLPV  361 (363)
Q Consensus       340 l~~dp~~R~s-----~~evL~~~~~~~  361 (363)
                      |+.||++||+     +.+++.|+|+..
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            9999999999     778999999965

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.3e-48  Score=358.39  Aligned_cols=249  Identities=28%  Similarity=0.498  Sum_probs=212.9

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ-IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+. ||||+++++++.+.+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999997654323333344555554 456676 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccC
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~  262 (363)
                      +++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ........
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccc
Confidence            99999999888889999999999999999999999999999999999999   778899999999987532 22234456


Q ss_pred             ccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      +||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.++.+.......    .+.+++++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~  232 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSARHLLEGLLQ  232 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC----CCCCCHHHHHHHHHHcc
Confidence            79999999999874 58999999999999999999999999988888888777654433    24678999999999999


Q ss_pred             cCcCCCCCHH----HHhcCCCccc
Q 017960          342 SQPSERLTAH----EVLCMYNLPV  361 (363)
Q Consensus       342 ~dp~~R~s~~----evL~~~~~~~  361 (363)
                      .||.+|+++.    ++++|+|+..
T Consensus       233 ~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         233 KDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             cCHHHCCCCCCCHHHHhcCcccCC
Confidence            9999999876    8999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-47  Score=357.34  Aligned_cols=259  Identities=26%  Similarity=0.465  Sum_probs=220.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.++||+|+||.||++.+..+++.||+|++.+...........+..|+.++..+. |++|+++++++.+.+.+++||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEEE
Confidence            5899999999999999999999999999999997644334444556888999999887 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||+++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCCc
Confidence            99999999999977 4678999999999999999999999999999999999999   7888999999999876533322


Q ss_pred             --cccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-CCCCCCC
Q 017960          259 --FTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLIS  329 (363)
Q Consensus       259 --~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~  329 (363)
                        ....+||+.|+|||++.      ..++.++|||||||++|||++|+.||.+....+.+..+......+.. .....++
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence              23457999999999885      24889999999999999999999999988888888877665432221 2234578


Q ss_pred             HHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccC
Q 017960          330 DSAKDLIRKMLCSQPSE--RLTAHEVLCMYNLPVL  362 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~--R~s~~evL~~~~~~~~  362 (363)
                      +++.+||.+||+.++++  |+++.++++|+||..+
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            99999999999776554  7899999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.7e-48  Score=357.21  Aligned_cols=249  Identities=28%  Similarity=0.485  Sum_probs=213.5

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ-IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      ++||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.++ ||||+++++++.+.+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999999999999999997654333334455666655 566776 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCCccccC
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDV  262 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~  262 (363)
                      +++|...+.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.... ........
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccc
Confidence            99999999888889999999999999999999999999999999999999   788899999999987532 22233456


Q ss_pred             ccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          263 VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       263 ~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      .||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+.....+.+.......+    +..+.++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~  232 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH  232 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence            78999999999874 589999999999999999999999999888888888776654333    3468899999999999


Q ss_pred             cCcCCCCCH----HHHhcCCCccc
Q 017960          342 SQPSERLTA----HEVLCMYNLPV  361 (363)
Q Consensus       342 ~dp~~R~s~----~evL~~~~~~~  361 (363)
                      .||.+|+++    .++++|+|+..
T Consensus       233 ~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         233 KDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCHhhcCCCCCCHHHHhCCCCcCC
Confidence            999999875    59999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.7e-48  Score=372.09  Aligned_cols=252  Identities=27%  Similarity=0.385  Sum_probs=205.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----  172 (363)
                      ...|++++.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++ ||||+++++++...     
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcC-CCCCcceeeeEeecccccC
Confidence            356999999999999999999999999999999885432       23457999999998 99999999877432     


Q ss_pred             ---CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC-ccEEE
Q 017960          173 ---LCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKA  244 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~-~~~kl  244 (363)
                         ..+++||||+++ +|.+++.    ....+++..+..++.||+.||.|||++||+||||||+|||+   +.+ +.+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl---~~~~~~vkL  212 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI---DPNTHTLKL  212 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE---cCCCCceee
Confidence               247799999964 7766664    24568999999999999999999999999999999999999   543 47999


Q ss_pred             eecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc----
Q 017960          245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI----  318 (363)
Q Consensus       245 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----  318 (363)
                      +|||+|.............||+.|+|||++.+  .|+.++|||||||++|||++|.+||.+....+.+..+.+...    
T Consensus       213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99999987665555556788999999998864  589999999999999999999999988776655554433110    


Q ss_pred             -------------ccCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          319 -------------DFESD--------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       319 -------------~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                   .++..        .....++++++||.+||..||.+|||+.|+|.||||..
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                         00000        01135789999999999999999999999999999864

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-47  Score=349.24  Aligned_cols=254  Identities=31%  Similarity=0.485  Sum_probs=214.4

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++++++ |++|+.+++.+.+.+..++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEEE
Confidence            677889999999999999999999999999987654444444566788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCcc
Confidence            99999999888653  358999999999999999999999999999999999999   7788999999999987655444


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH---HHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQG---IFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .....|+..|+|||++. ..++.++|||||||++|+|++|..||.......   .........   .......+++++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  234 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---QEEYSEKFSPDARS  234 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---hhhcCccCCHHHHH
Confidence            45567899999999987 458999999999999999999999997654321   222221111   11122357889999


Q ss_pred             HHHHhcccCcCCCCC-----HHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLT-----AHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s-----~~evL~~~~~~~  361 (363)
                      |+.+||+.||.+|||     +.|+++|+||..
T Consensus       235 li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         235 LCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            999999999999999     999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-48  Score=364.99  Aligned_cols=251  Identities=18%  Similarity=0.313  Sum_probs=206.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ...|++.+.||+|+||.||+|.+..+++.||+|....         ..+.+|+.++++|+ ||||++++++|......++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEE
Confidence            3569999999999999999999999999999996532         34678999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|...... 
T Consensus       161 v~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccc
Confidence            99999 57899998888889999999999999999999999999999999999999   77889999999999653221 


Q ss_pred             -CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcC-----------
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-------QGIFDAVLKG-----------  316 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~i~~~-----------  316 (363)
                       .......||+.|+|||++.+ .++.++|||||||++|||++|..||.....       ...+..+...           
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence             22345679999999999874 699999999999999999999988754321       1111111110           


Q ss_pred             ---------------CcccCC--CC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          317 ---------------HIDFES--DP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       317 ---------------~~~~~~--~~---~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                     ....+.  ..   ...++.++.+||.+||+.||.+|||+.|+|+|+||+.+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                           000000  00   11346789999999999999999999999999999764

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-47  Score=357.07  Aligned_cols=259  Identities=27%  Similarity=0.468  Sum_probs=220.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|+.++..+. |++|+++++++.+.+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            46999999999999999999999999999999997644334444566888999999887 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence            999999999999977 4678999999999999999999999999999999999999   788899999999997764433


Q ss_pred             cc--ccCccCCcccccccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC-CCCCCCC
Q 017960          258 IF--TDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-SDPWPLI  328 (363)
Q Consensus       258 ~~--~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~  328 (363)
                      ..  ....||+.|+|||++.+      .++.++|||||||++|+|++|+.||......+.+..+......+. ...+..+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV  236 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence            22  23578999999998863      478899999999999999999999998887777777766443222 1223457


Q ss_pred             CHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSE--RLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~--R~s~~evL~~~~~~~  361 (363)
                      ++++.+||.+||+.++++  |++++++++|+||..
T Consensus       237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            899999999999977655  579999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-47  Score=359.56  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=210.1

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++ ||||+++++++...   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   95 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCc
Confidence            45677999999999999999999999999999999986543 23445667889999999998 99999999998644   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ..+|+||||+.+ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCC
Confidence               357999999965 6766653  347899999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC------------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG------------  316 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~------------  316 (363)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+...            
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            986554444556788999999999874 6999999999999999999999999876544333222111            


Q ss_pred             ----------CcccC----------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          317 ----------HIDFE----------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       317 ----------~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                .....                .......++++++||.+||+.||++|||+.|+|.|+|+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                      00000                0011124678999999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4e-47  Score=346.54  Aligned_cols=258  Identities=29%  Similarity=0.441  Sum_probs=218.8

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++ |+||+.+.+.+..++..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEE
Confidence            677889999999999999999999999999997654433444556788999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCCc
Confidence            99999998888653  358999999999999999999999999999999999999   7778999999999977654444


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....|+..|+|||.+. ..++.++|+|||||++|+|++|..||.+.........+..............++.++.+|+.
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            45668899999999987 46899999999999999999999999877655444444332222222233457899999999


Q ss_pred             HhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          338 KMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       338 ~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +||+.||++||+     +.+++.|+||..+
T Consensus       238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            999999999999     8999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-47  Score=348.05  Aligned_cols=255  Identities=26%  Similarity=0.379  Sum_probs=208.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEec-----C
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYED-----S  172 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~-----~  172 (363)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.+++.+.  +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            48899999999999999999999999999999875432 2222334567787777764  49999999998764     3


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          173 LCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      ...+++|||+. ++|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcc
Confidence            45899999996 5888888664  348999999999999999999999999999999999999   77889999999999


Q ss_pred             eecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc----------
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------  319 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  319 (363)
                      .............+|..|+|||++. ..++.++|||||||++|+|++|.+||.+....+.+..+......          
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            8765544445567899999999987 46899999999999999999999999887766555544321100          


Q ss_pred             ------cC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 ------FE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 ------~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                            +.       ....+.++.++.+||.+||+.||++|||+.|++.|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                  00       01123567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.5e-48  Score=345.02  Aligned_cols=254  Identities=39%  Similarity=0.623  Sum_probs=215.1

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++++.||+|+||+||+|.+..+++.||+|++..... .........+|+.++++++ ||||+++++++......++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhcccccc-cccccccccccccccccccccc
Confidence            7889999999999999999999999999999986543 2222234456999999996 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec-CCCCcc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~-~~~~~~  259 (363)
                      |+.+++|.+++...+.+++..+..++.||+.||.+||+.||+|+||||+||++   ++++.++|+|||.+... ......
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99999999999888889999999999999999999999999999999999999   88889999999999863 334455


Q ss_pred             ccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          260 TDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ....++..|+|||++.  ..++.++||||||+++|+|++|..||....   .......................+.++.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            6678899999999987  468999999999999999999999998773   33333333333222222222223489999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +|.+||+.||++||++.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.1e-47  Score=357.76  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=213.0

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--  172 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.+. ||||+++++++...  
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~   97 (364)
T cd07875          20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS   97 (364)
T ss_pred             hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcC-CCCccccceeeccccc
Confidence            345678999999999999999999999999999999986533 23445567889999999997 99999999987543  


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          173 ----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       173 ----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                          ...|+||||+. ++|...+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        98 ~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG  171 (364)
T cd07875          98 LEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  171 (364)
T ss_pred             ccccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCC
Confidence                35799999995 477776643  47899999999999999999999999999999999999   778899999999


Q ss_pred             cceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc--------
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID--------  319 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  319 (363)
                      ++.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......        
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9987655444556788999999999874 5899999999999999999999999887766555544321100        


Q ss_pred             --------------cC----------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          320 --------------FE----------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       320 --------------~~----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                    +.                .......+.++++||.+||+.||.+|||+.|+|+|+|+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                          00                0001123467899999999999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-47  Score=352.08  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=212.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.+.....  ......+.+|+.++++++ ||||+++++++...+..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEE
Confidence            459999999999999999999999999999999865432  223346778999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCc
Confidence            999964 8888776544 47899999999999999999999999999999999999   77889999999999764332 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc----------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI----------------  318 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------  318 (363)
                      .......+++.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.+...                
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            22334567899999998863  589999999999999999999999987776555444432110                


Q ss_pred             ---ccCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          319 ---DFES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       319 ---~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                         .++.       ...+.+++++.+||.+||+.||.+|||+.|+|.|+||..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence               0000       1123578899999999999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.3e-47  Score=357.85  Aligned_cols=259  Identities=26%  Similarity=0.412  Sum_probs=211.1

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||.+.... ........+.+|+.+++.++ ||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhC-CCchhceeeeeeccccc
Confidence            45678999999999999999999999999999999986543 23445677889999999997 99999999988643   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ...++||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcc
Confidence               357999999955 67666643  47899999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-----------  317 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  317 (363)
                      +.............+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+....           
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            987655444556788999999999874 58999999999999999999999998766544333221110           


Q ss_pred             -----------ccc----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          318 -----------IDF----------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       318 -----------~~~----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                 ..+                ........+.++++||.+||+.||++|||+.|+|+|+|+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                       000                000112245678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.8e-47  Score=344.61  Aligned_cols=249  Identities=27%  Similarity=0.448  Sum_probs=208.1

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||+|+||.||++.+..+|+.||+|.+.............+..|+++++++. ||||+++++++......++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999999999999999997544333333445667999999997 9999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCcc
Q 017960          187 LFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG  264 (363)
Q Consensus       187 L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  264 (363)
                      |.+++...+  .+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|||++.............|
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCC
Confidence            988876543  47889999999999999999999999999999999999   7788999999999987665544455678


Q ss_pred             CCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH----HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHh
Q 017960          265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ----GIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (363)
Q Consensus       265 t~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  339 (363)
                      +..|+|||++. ..++.++|||||||++|||++|..||......    .............   ....+++++.+||.+|
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~  233 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF---EHQNFTEESKDICRLF  233 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc---ccccCCHHHHHHHHHH
Confidence            99999999987 45999999999999999999999999764332    2233333222222   1235789999999999


Q ss_pred             cccCcCCCCCH----HHHhcCCCcccC
Q 017960          340 LCSQPSERLTA----HEVLCMYNLPVL  362 (363)
Q Consensus       340 l~~dp~~R~s~----~evL~~~~~~~~  362 (363)
                      |+.||++||++    ++++.|+||+.+
T Consensus       234 L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             hccCHhhCCCCccchhhhhcChhhcCC
Confidence            99999999999    778899999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7e-47  Score=352.50  Aligned_cols=257  Identities=23%  Similarity=0.339  Sum_probs=214.1

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..++..+|+|++....  .......+.+|+++++.++ ||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEE
Confidence            356999999999999999999999999999999886542  3445677899999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+++++|.+++...+.+++..+..++.+++.||.|||+. +|+||||||+|||+   +.++.+||+|||++..... 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~-  156 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID-  156 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh-
Confidence            999999999999998888899999999999999999999975 79999999999999   7788999999999876432 


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHc---CCc--------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK---GHI--------------  318 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~--------------  318 (363)
                      .......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+..   +..              
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence            22344578999999999874 589999999999999999999999976554333221110   000              


Q ss_pred             -----------------------c--cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          319 -----------------------D--FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       319 -----------------------~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                             .  .+......++.++++||.+||+.||++|||+.|++.|+|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~  304 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  304 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence                                   0  000001135688999999999999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.6e-47  Score=359.80  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=213.2

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-----eE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----CV  175 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~~  175 (363)
                      |++++.||+|+||.||+|.+..+++.||||.+.... ......+++.+|+.+++.++ ||||+++++++....     ..
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence            778899999999999999999999999999986432 23345567889999999998 999999999998776     78


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence            99999995 6888888887889999999999999999999999999999999999999   7888999999999986543


Q ss_pred             CC--ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------------
Q 017960          256 GQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG---------------  316 (363)
Q Consensus       256 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~---------------  316 (363)
                      ..  ......+++.|+|||++.+  .++.++|||||||++|||++|+.||.+......+..+...               
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            22  2334567899999999874  4899999999999999999999999887766555444321               


Q ss_pred             --------CcccCC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          317 --------HIDFES-----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       317 --------~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                              ....+.     ......++++.+||.+||+.||++|||+.|+|.|+|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                    000000     112345789999999999999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-47  Score=355.25  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=203.1

Q ss_pred             ccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|++.+.||+|+||.||+|.+.     .++..||||++....  .......+.+|+.++.++.+||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            467999999999999999999752     345689999986432  3344567899999999995599999999988654


Q ss_pred             -CeEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 017960          173 -LCVHIVMELCAGGELFDRIIQR---------------------------------------------------------  194 (363)
Q Consensus       173 -~~~~iv~e~~~~~~L~~~l~~~---------------------------------------------------------  194 (363)
                       ..+++||||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999988652                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc---cccCccCC
Q 017960          195 -----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSP  266 (363)
Q Consensus       195 -----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~  266 (363)
                           ..+++..+..++.||+.||+|||+.||+||||||+|||+   ++++.+||+|||++........   .....++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 236778889999999999999999999999999999999   7788999999999976533221   12234567


Q ss_pred             ccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHH-HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccC
Q 017960          267 YYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (363)
Q Consensus       267 ~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  343 (363)
                      .|+|||++. ..++.++|||||||++|||++ |..||.+..... ....+..+...   .....+++++.+|+.+||+.|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~d  317 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM---RAPENATPEIYRIMLACWQGD  317 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHccCC
Confidence            899999987 459999999999999999997 999997755433 33333333221   112357889999999999999


Q ss_pred             cCCCCCHHHHhcCC
Q 017960          344 PSERLTAHEVLCMY  357 (363)
Q Consensus       344 p~~R~s~~evL~~~  357 (363)
                      |++|||+.|+++.+
T Consensus       318 p~~RPs~~el~~~l  331 (338)
T cd05102         318 PKERPTFSALVEIL  331 (338)
T ss_pred             hhhCcCHHHHHHHH
Confidence            99999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.2e-47  Score=367.91  Aligned_cols=252  Identities=28%  Similarity=0.406  Sum_probs=218.6

Q ss_pred             cceeecceecccCCeEEEEEEEccC-CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ..|.+.+.||+|+||.||+|.+..+ +..||+|.+...   .......+.+|+.+++.++ ||||+++++++...+..||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEEE
Confidence            3499999999999999999998777 788999976433   3445567888999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ||||++|++|.+++..    ...+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceec
Confidence            9999999999887754    3468999999999999999999999999999999999999   77889999999999876


Q ss_pred             CCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          254 KPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       254 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      ....   .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+.+..+..+.....   ...++
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s  296 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVS  296 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCC
Confidence            4332   2345679999999999874 599999999999999999999999998888888888776654321   13578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +++.+||.+||..||++||++.++|.++|+.
T Consensus       297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence            9999999999999999999999999998875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-49  Score=359.47  Aligned_cols=260  Identities=33%  Similarity=0.533  Sum_probs=236.2

Q ss_pred             cccceee--cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           97 IRDLYTL--GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        97 ~~~~y~~--~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      |...|++  .++||+|.||+||-|+++.+|+.||||++.+..+... ....+++|+.||..+. ||.||.+.-.|+..+.
T Consensus       560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~-HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLH-HPGIVNLECMFETPER  637 (888)
T ss_pred             HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence            4445666  5899999999999999999999999999988776443 3478999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          175 VHIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +++|||-+ .|++++.+..  .+++++.....++.||+.||.|||-++|+|+||||+|||+...+.--.+||||||+|+.
T Consensus       638 vFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  638 VFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             EEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence            99999999 5577777643  57899999999999999999999999999999999999997765556899999999999


Q ss_pred             cCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          253 FKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      +.......+.+|||.|+|||++. +.|+..-|+||.|+|+|--++|..||.  .++++.++|.+..+.++..+|..++.+
T Consensus       717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~eis~~  794 (888)
T KOG4236|consen  717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEISPE  794 (888)
T ss_pred             cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhcCHH
Confidence            98888888999999999999998 569999999999999999999999994  346788999999999999999999999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++|||..+|+..-.+|.|.+..|.|+|++.
T Consensus       795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             HHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            999999999999999999999999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-48  Score=358.83  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=215.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+...++..||+|.||+||+|.+.+   .||||++..... +.+..+.|++|+.++++.+ |.||+-+.|++..... .
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-A  463 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-e
Confidence            33557789999999999999999766   699999976654 5668899999999999999 9999999999988877 9


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec--
Q 017960          177 IVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF--  253 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~--  253 (363)
                      ||+-+|+|-+|+.+++-. ..|.....+.|++|+++|+.|||.++|||||||..||++   .+++.|||+|||++..-  
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeee
Confidence            999999999999999753 468999999999999999999999999999999999999   88899999999998652  


Q ss_pred             -CCCCccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-CCCCC
Q 017960          254 -KPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPL  327 (363)
Q Consensus       254 -~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~  327 (363)
                       ..........|...|||||+++.    .|+..+|||||||++|||++|.+||...+.+.++-.+-+|...... .....
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence             33445556677889999999972    4999999999999999999999999977777777666666433222 22345


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      ++.++++|+..||..++++||.+.+||.
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            6789999999999999999999999998

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-46  Score=367.74  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=220.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC---
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL---  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---  173 (363)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..+. |+||+++++.+....   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccC
Confidence            34579999999999999999999999999999999976543 4555677889999999997 999999988775432   


Q ss_pred             -----eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEE
Q 017960          174 -----CVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       174 -----~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                           .+++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.+|+||||||+|||+   +.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence                 378999999999999988653    458999999999999999999999999999999999999   77889999


Q ss_pred             eecCcceecCCC---CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc
Q 017960          245 IDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       245 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                      +|||++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+..+....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999999765432   22345679999999999984 59999999999999999999999999888888887777655432


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                         ..+.+++++.+|+.+||+.||.+||++.+++.|+|++.
T Consensus       265 ---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        265 ---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             ---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence               22457899999999999999999999999999998754

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-46  Score=341.18  Aligned_cols=253  Identities=34%  Similarity=0.606  Sum_probs=225.0

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+.+|+++++++. ||||+++++++.+....++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEE
Confidence            5889999999999999999999999999999997655444555678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|+||++   +.++.+||+|||++......  .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--C
Confidence            999999999999888889999999999999999999999999999999999999   77889999999999876544  3


Q ss_pred             ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....+++.|+|||.+. ..++.++||||||+++|+|++|..||...........+..+...++.    .++..+.++|.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~  231 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRN  231 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHHH
Confidence            4457889999999887 45889999999999999999999999887777777777665544332    468999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          339 MLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       339 ~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      ||..||.+|+     +++|++.|+|+..+
T Consensus       232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HccCCHHHccCcccCCHHHHHcCcccccC
Confidence            9999999999     99999999998653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-46  Score=355.23  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             ccccceeecceecccCCeEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .+..+|++.+.||+|+||.||+|...  .++..||+|.+...        ....+|+.++++++ ||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTIS-HRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcC-CCCccceeeeEeeCC
Confidence            34567999999999999999999754  34578999988543        23457999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..+++||++ +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       160 ~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        160 TVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCcccccc
Confidence            999999999 46898988777889999999999999999999999999999999999999   78889999999999765


Q ss_pred             CCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH---HHHHHHHcC----CcccCC
Q 017960          254 KPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ---GIFDAVLKG----HIDFES  322 (363)
Q Consensus       254 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~i~~~----~~~~~~  322 (363)
                      .....   .....||+.|+|||++. ..|+.++|||||||++|||++|+.||.+....   ..+..+.+.    ...++.
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            43321   23467999999999987 46999999999999999999999999765421   112211110    000000


Q ss_pred             -----------------------CC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          323 -----------------------DP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       323 -----------------------~~---~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                             +.   ...++.++.+||.+||..||++|||+.|+|.||||..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence                                   00   0134678899999999999999999999999999964

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-46  Score=333.91  Aligned_cols=254  Identities=30%  Similarity=0.473  Sum_probs=216.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .|++.+.||+|++|.||+|.+..+++.||+|.+.......  ......+.+|+.+++++. ||||+++++++.+....++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEEE
Confidence            4888999999999999999998999999999987543221  223467889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||++   ++++.++|+|||++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccccc
Confidence            99999999999999888889999999999999999999999999999999999999   778899999999987654322


Q ss_pred             cc----ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          258 IF----TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       258 ~~----~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..    ....++..|+|||.+.+ .++.++||||||+++|||++|+.||...........+.......  .....++.++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPDA  236 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHHH
Confidence            11    33567889999999984 58999999999999999999999997766555544444332221  1223578999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .++|.+||..+|++|||+.+++.|+||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.1e-46  Score=343.29  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=212.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.++ ||||+++++++...+..++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEE
Confidence            45999999999999999999999999999999986543  2223346778999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+. ++|...+... ..+++..+..++.||+.||.|||+.||+|+||||+||++   +.++.+||+|||++...... 
T Consensus        83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC
Confidence            99996 5888888654 458999999999999999999999999999999999999   77889999999998764322 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc---------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------------  319 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------  319 (363)
                      .......+++.|+|||++.+  .++.++|||||||++|+|++|++||.+....+....+......               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            22334567889999998864  4788999999999999999999999877665544433221100               


Q ss_pred             ----cCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ----FES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ----~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                          .+.       ...+.+++++.+||.+||+.||.+|||+.|+|.|+||+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                000       0113468899999999999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.7e-46  Score=339.87  Aligned_cols=243  Identities=17%  Similarity=0.226  Sum_probs=209.9

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec----CCeEEEEEe
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SLCVHIVME  180 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~iv~e  180 (363)
                      ..||+|++|.||+|..  +|+.||||.+.+.........+.+.+|+.+|++++ ||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999985  78899999997654444444678889999999998 9999999999876    457899999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      |+++|+|.+++...+.+++.....++.+++.||.|||+ .+++||||||+|||+   ++++.+||+|||++.......  
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence            99999999999888889999999999999999999998 599999999999999   788899999999987654322  


Q ss_pred             ccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ....++..|+|||++.+   .++.++|||||||++|||++|..||.+....+....+.........+  ..+++++.+|+
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li  255 (283)
T PHA02988        178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV  255 (283)
T ss_pred             ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence            34568899999999863   68999999999999999999999999888888888776554433222  25789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCC
Q 017960          337 RKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+||+.||++|||+.|++..+
T Consensus       256 ~~cl~~dp~~Rps~~ell~~l  276 (283)
T PHA02988        256 EACTSHDSIKRPNIKEILYNL  276 (283)
T ss_pred             HHHhcCCcccCcCHHHHHHHH
Confidence            999999999999999999754

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-46  Score=376.99  Aligned_cols=261  Identities=31%  Similarity=0.510  Sum_probs=216.3

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--C
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--S  172 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~  172 (363)
                      +.+.+.|++++.||.|+||+||+|.+..++..||+|++..... .......+..|+.++..|. |||||+++++|..  .
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCC
Confidence            3445679999999999999999999999999999999875543 4445678899999999998 9999999998854  4


Q ss_pred             CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEecCCCCCceEeeeC-----
Q 017960          173 LCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSL-------GVMHRDLKPENFLLVNK-----  236 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~-------~iiHrDlkp~NIll~~~-----  236 (363)
                      ..+||||||+++++|.++|..    .+.+++..++.|+.||+.||.|||+.       +||||||||+||||...     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            679999999999999998865    25699999999999999999999995       49999999999999431     


Q ss_pred             ---------CCCccEEEeecCcceecCCCCccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCc
Q 017960          237 ---------DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAE  304 (363)
Q Consensus       237 ---------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~  304 (363)
                               +....+||+|||++.............||+.|+|||++.+   .++.++|||||||+||||++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     2234699999999987655544556789999999999852   4899999999999999999999999765


Q ss_pred             CHHH-HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          305 TQQG-IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       305 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .... ++..+... ..   .+....+.++.+||..||..+|.+||++.|+|.++|+..
T Consensus       247 ~~~~qli~~lk~~-p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        247 NNFSQLISELKRG-PD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             CcHHHHHHHHhcC-CC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            5433 33333322 21   222356899999999999999999999999999999864

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.3e-46  Score=335.56  Aligned_cols=254  Identities=28%  Similarity=0.405  Sum_probs=212.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++++. ||||+++++++......++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEE
Confidence            346999999999999999999999999999999986442   233456788999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||++   ++++.+||+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecccc
Confidence            99999999999999888889999999999999999999999999999999999999   778889999999998654322


Q ss_pred             -ccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-CCCCCCCHH
Q 017960          258 -IFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLISDS  331 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~  331 (363)
                       ......++..|+|||.+.    ..++.++|+|||||++|||++|..||...........+.......+. .....++.+
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence             223456889999999874    24788999999999999999999999655543333322222222111 112246789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      +.+||.+||+.||++||+++++|+++|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-46  Score=352.58  Aligned_cols=258  Identities=24%  Similarity=0.402  Sum_probs=211.0

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++ ||||+++++++...   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccc
Confidence            355779999999999999999999999999999999865321 3334566789999999998 99999999987543   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ...+++||++ +++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~  164 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGL  164 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcc
Confidence               4578999998 778877664 4569999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc--------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID--------  319 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  319 (363)
                      +.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+......        
T Consensus       165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            987543  2345678999999999874  5899999999999999999999999876655444433221100        


Q ss_pred             ---------------cCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ---------------FES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ---------------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                     .+.    ..+...++.+.+||.+||+.||.+|||+.|+|.|+||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                           000    0112456778999999999999999999999999999653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=339.22  Aligned_cols=267  Identities=27%  Similarity=0.395  Sum_probs=218.3

Q ss_pred             eecccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-----cee
Q 017960           89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-----NIV  163 (363)
Q Consensus        89 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-----niv  163 (363)
                      .+-...+.+..+|++.+.+|+|.||.|..|.+..++..||||+++.-    ....+..+-|+++|.++..+.     -+|
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            34456677889999999999999999999999999999999999642    334567778999999995332     488


Q ss_pred             EEeEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC----
Q 017960          164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----  237 (363)
Q Consensus       164 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~----  237 (363)
                      ++.++|...++.|||+|.+ |.|+++++..++  +++...++.+++||++++++||+++++|.||||+|||+.+.+    
T Consensus       155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  155 QMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             eeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEE
Confidence            8999999999999999998 889999998764  488999999999999999999999999999999999995321    


Q ss_pred             -------------CCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC
Q 017960          238 -------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA  303 (363)
Q Consensus       238 -------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~  303 (363)
                                   ++..++|+|||.|+...  +.....+.|..|+|||++.+ .|+.++||||+||||+||++|...|++
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                         24579999999999854  34477899999999999997 699999999999999999999999988


Q ss_pred             cCHHHHH---HHHHcC------------------CcccCCCCCC---------------------CCCHHHHHHHHHhcc
Q 017960          304 ETQQGIF---DAVLKG------------------HIDFESDPWP---------------------LISDSAKDLIRKMLC  341 (363)
Q Consensus       304 ~~~~~~~---~~i~~~------------------~~~~~~~~~~---------------------~~~~~~~~li~~~l~  341 (363)
                      ....+.+   +.|...                  .+.+++....                     ....++.|||++||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            7766533   333221                  1111100000                     011358899999999


Q ss_pred             cCcCCCCCHHHHhcCCCcccC
Q 017960          342 SQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       342 ~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .||.+|+|+.|+|.||||..+
T Consensus       392 fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  392 FDPARRITLREALSHPFFARL  412 (415)
T ss_pred             cCccccccHHHHhcCHHhhcC
Confidence            999999999999999999753

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.3e-46  Score=334.63  Aligned_cols=254  Identities=30%  Similarity=0.417  Sum_probs=213.8

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.++..   .......+.+|+.+++.++ ||||+++++.+...+..++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEE
Confidence            34689999999999999999999999999999998654   2234456788999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.+||+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc
Confidence            99999999999999888889999999999999999999999999999999999999   778899999999987653221


Q ss_pred             -ccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-CCCCCCCHH
Q 017960          258 -IFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLISDS  331 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~  331 (363)
                       ......|+..|+|||.+.    ..++.++|+|||||++|+|++|..||...................+. .....++..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS  240 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence             223457899999999873    34889999999999999999999999765544433333333322211 111246789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      +.++|.+||..||++||++.++++|+|
T Consensus       241 ~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         241 FHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3e-45  Score=328.21  Aligned_cols=251  Identities=26%  Similarity=0.425  Sum_probs=219.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |.+.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++ ||||+++++++.+.+..++|||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEEE
Confidence            7788999999999999999999999999999875443 3455678899999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |+++++|.+++...  ..+++..+..++.+++.||.|||+.|++|+||||+||++   +.++.++|+|||++....... 
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence            99999999998764  568999999999999999999999999999999999999   777899999999988765433 


Q ss_pred             ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......+++.|+|||++. +.++.++|+||||+++|+|++|..||...........+..+......   ..++.++.++|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i  233 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQLI  233 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHHH
Confidence            223456888999999987 45899999999999999999999999888877777777665433222   25788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+||+.+|++||++.++++++|+
T Consensus       234 ~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         234 DQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.9e-47  Score=353.64  Aligned_cols=254  Identities=37%  Similarity=0.630  Sum_probs=236.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ..|.+.+.||+|.|++|.+|++..++..||||++.+... +......+.+|+++|+.|. |||||+++.+.+....+|+|
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeEEE
Confidence            459999999999999999999999999999999988766 3444455999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||+.+|.+++++.+.+.+.+..+..++.|+..|++|||+++|||||||++|||+   +.+..+||+|||++..+..+..
T Consensus       134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeeccccc
Confidence            9999999999999999999999999999999999999999999999999999999   8888899999999999998888


Q ss_pred             cccCccCCccccccccccc--CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ..+.+|++.|.|||++.+.  -++++|+||+|+++|-|+.|.+||.+.+-.++...+..+++.++.    .++.++.+||
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~lL  286 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDLL  286 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHHHH
Confidence            8999999999999999853  578999999999999999999999999999998888888877665    4788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +++|.++|.+|++.+++.++.|.-.
T Consensus       287 rk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  287 RKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             HHhhccCccccCCHHHhhhhcccch
Confidence            9999999999999999999999743

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-45  Score=338.95  Aligned_cols=255  Identities=24%  Similarity=0.307  Sum_probs=213.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+....  ......++.+|++++++++ ||||+++++.+.+.+.+++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEe
Confidence            5889999999999999999999999999999986432  3445567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+|||+   ++++.+||+|||++...... .
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-M  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccc-c
Confidence            999999999999888889999999999999999999997 699999999999999   77889999999998765332 2


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-----------------
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-----------------  320 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------------  320 (363)
                      .....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+.......                 
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            345678999999999874 58899999999999999999999997655433332221110000                 


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          321 -----------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       321 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                       +..+...++.++.+|+.+||..||++||++.+++.|+|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                             00011236788999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=344.57  Aligned_cols=260  Identities=30%  Similarity=0.452  Sum_probs=231.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|..-++||+|+||.||-|+.+.+|+.||.|.+.+.............+|-.+|.+++ .+.||.+--+|+..+.+++|
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEE
Confidence            45888899999999999999999999999999987766555555667889999999998 89999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |..|+||+|.-+|...+  .|++..+..++.+|+.||++||+.+||+|||||+|||+   |+.|+++|+|+|+|..+..+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEecCCC
Confidence            99999999998887766  69999999999999999999999999999999999999   99999999999999999999


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      +.....+||.+|||||++.+ .|+...|.|||||++|||+.|+.||.......-.+.+.+.....+.+....+|+++++|
T Consensus       341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl  420 (591)
T KOG0986|consen  341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL  420 (591)
T ss_pred             CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence            98888999999999999984 59999999999999999999999997766554444454444444444445789999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          336 IRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       336 i~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      .+.+|.+||.+|.     .+++|-+||+|..+
T Consensus       421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            9999999999997     67899999999754

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.9e-46  Score=342.99  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=193.0

Q ss_pred             cceecccCCeEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCeEEEEE
Q 017960          104 GRKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCVHIVM  179 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~iv~  179 (363)
                      +++||+|+||+||+|.++  .+++.||+|.+....     ....+.+|+.++++++ ||||+++++++..  ...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999965  467889999986432     1245678999999998 9999999998854  55789999


Q ss_pred             eccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC-CCCccEEEeecCc
Q 017960          180 ELCAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-DDDFSLKAIDFGL  249 (363)
Q Consensus       180 e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~-~~~~~~kl~DFG~  249 (363)
                      ||+ +++|.+++...         ..+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            998 45888776532         248899999999999999999999999999999999999542 3557899999999


Q ss_pred             ceecCCCC----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH---------HHHHHHH
Q 017960          250 SVFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------GIFDAVL  314 (363)
Q Consensus       250 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~---------~~~~~i~  314 (363)
                      +.......    ......+|+.|+|||++.+  .++.++||||+||++|+|++|++||......         ..+..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654321    2345678999999999874  4899999999999999999999999643321         1111111


Q ss_pred             cCCc-------------c-------------c--------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          315 KGHI-------------D-------------F--------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       315 ~~~~-------------~-------------~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ....             .             .        ........+.++.+||.+||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            1000             0             0        000011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.2e-45  Score=334.60  Aligned_cols=256  Identities=27%  Similarity=0.448  Sum_probs=212.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+. ||||+++++++......++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEE
Confidence            358999999999999999999998999999999865432 2223456789999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||++++.|...+.....+++..+..++.||+.||.|||+.|++||||||+||++   +.++.+||+|||++....... 
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence            9999988887776666679999999999999999999999999999999999999   777899999999998765433 


Q ss_pred             ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc-----------------
Q 017960          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-----------------  318 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  318 (363)
                      ......++..|+|||.+.+  .++.++||||||+++|+|++|..||.+....+....+.....                 
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            3334567889999999863  488999999999999999999999987765544433322100                 


Q ss_pred             --ccCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          319 --DFES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       319 --~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                        ..+.        ..++.++..+.+||.+||+.||++||++.|++.|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              0000        0123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-45  Score=339.34  Aligned_cols=256  Identities=34%  Similarity=0.522  Sum_probs=221.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.+.........+.+..|+++++.+. |+||+++++.+.+....++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEE
Confidence            5889999999999999999999999999999998765444456678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhcccccc
Confidence            999999999988754  468999999999999999999999999999999999999   778899999999986543211


Q ss_pred             ------------------------------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH
Q 017960          258 ------------------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ  306 (363)
Q Consensus       258 ------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~  306 (363)
                                                    ......|+..|+|||++.+ .++.++||||||+++|+|++|..||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          1113467889999999874 589999999999999999999999988887


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCC----HHHHhcCCCccc
Q 017960          307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT----AHEVLCMYNLPV  361 (363)
Q Consensus       307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~evL~~~~~~~  361 (363)
                      ...+..+......++..  ..+++++.++|.+||..||++||+    +.++|.|+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            77777666555443332  237899999999999999999999    999999999864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.7e-45  Score=329.95  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=214.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC------hhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS------REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+.......      ....+.+.+|+.+++++. ||||+++++++.+..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            3778899999999999999998899999999886543322      123467889999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..+++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||++   ++++.++|+|||.+...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCccc
Confidence            999999999999999999888889999999999999999999999999999999999999   78889999999998766


Q ss_pred             CCCC-------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          254 KPGQ-------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       254 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      ....       ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||.+.........+.....   ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~  233 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIP  233 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCC
Confidence            4221       1123457889999999874 588999999999999999999999987665555444443221   1222


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ..++.++.++|.+||++||++||++.++++++||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            3578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.4e-45  Score=333.53  Aligned_cols=258  Identities=27%  Similarity=0.419  Sum_probs=217.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||.|+||.||+|.+..++..||+|.+...   .....+.+.+|+.+++.+. ||||+++++.+...+.++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEE
Confidence            456799999999999999999999999999999998653   4555678889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +||||+++++|...+.+ ...+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccc
Confidence            99999999999887754 4568999999999999999999999999999999999999   7788999999999875432


Q ss_pred             C-CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          256 G-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      . .......++..|+|||.+.      ..++.++|+|||||++|+|++|..||...........+...... .......+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  241 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKW  241 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCccc
Confidence            2 2233456788999999884      23788999999999999999999999876665555555433221 11112356


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      +.++.++|.+||+.||++||++.++++|+|+..+
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            7899999999999999999999999999999754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.9e-45  Score=335.96  Aligned_cols=257  Identities=31%  Similarity=0.486  Sum_probs=221.3

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++ ||||+++++.+...+..++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEEE
Confidence            4888999999999999999999999999999987654333445667889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++.......  
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCccc
Confidence            999999999999888889999999999999999999999999999999999999   778899999999886421100  


Q ss_pred             --------------ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          258 --------------IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       258 --------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                                    ......++..|+|||.+. ..++.++|+|||||++|||++|..||.+....+....+..+....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  237 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence                          011245678899999887 46899999999999999999999999988888877777766544443


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCccc
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLT---AHEVLCMYNLPV  361 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s---~~evL~~~~~~~  361 (363)
                      ... .++.++.++|.+||+.||++||+   +.++|+++|+..
T Consensus       238 ~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         238 GDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            322 57899999999999999999997   799999999853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-45  Score=347.63  Aligned_cols=250  Identities=20%  Similarity=0.309  Sum_probs=200.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ..|++.+.||+|+||.||+|.+..++..||+|+..+.         ....|+.++++++ ||||+++++++......++|
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEE
Confidence            3599999999999999999999999999999975432         2346899999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||++ .++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc
Confidence            9999 4588888765 4568999999999999999999999999999999999999   778899999999997644434


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-----------HHHHHHHHcCCc---ccCC
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-----------QGIFDAVLKGHI---DFES  322 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~-----------~~~~~~i~~~~~---~~~~  322 (363)
                      ......||+.|+|||++.+ .++.++|||||||++|||+++..|+.....           ..+.+.+.....   .++.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  291 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR  291 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence            4455679999999999874 699999999999999999986555432211           011111111000   0000


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 --------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 --------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                                .....++.++.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                                      0011356778899999999999999999999999999864

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-46  Score=341.58  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ..|++.++||+||.+.||++.. .+...||+|.+.... .+...+.-+.+|+..|.+|.+|.+|++++++-..++.+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            4599999999999999999995 555567777664332 26677889999999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||= ..+|..+|.+... ++...++.+..|++.|+.++|++||||.||||.|+|+.    .|.+||+|||.|..+..+.
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCccc
Confidence            9985 5689988887655 34468999999999999999999999999999999994    5689999999998877654


Q ss_pred             ---ccccCccCCcccccccccc------------cCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcccC
Q 017960          258 ---IFTDVVGSPYYVAPEVLLK------------HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE  321 (363)
Q Consensus       258 ---~~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~  321 (363)
                         ...+.+||..||+||.+..            ..+.++||||||||||+|+.|++||..-. ...-+..|......++
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE  593 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence               3356899999999999851            15678999999999999999999994432 3344445544433222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+..+. ..+++++++.||..||++||+..++|+|+|++.
T Consensus       594 fp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  594 FPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            222221 245999999999999999999999999999976

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-46  Score=315.25  Aligned_cols=253  Identities=25%  Similarity=0.313  Sum_probs=220.8

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      .+.+..||.|+.|.|+++..+.+|...|||.+.+..  +.+..+++...+.++.....+|+||+.+|+|..+..++|.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            556778999999999999999999999999997654  667778899999988877678999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          181 LCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      .| +..+..++.+ .+++++..+-++...++.||.||-+ +||||||+||+|||+   |+.|.+||||||.+..+-+...
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc
Confidence            98 4455555544 4679999999999999999999975 689999999999999   9999999999999998888888


Q ss_pred             cccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .+...|-+.|||||.+.    ..|+.++||||||++++||.||..||.+. .+.+++-.+.+...+ ..+.-..+++.++
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-~L~~~~gFSp~F~  326 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-LLPGHMGFSPDFQ  326 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-CCCcccCcCHHHH
Confidence            88889999999999996    25999999999999999999999999874 566888888875442 2222234899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +|+..||.+|+.+||...++|+|+|+.
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhcCccee
Confidence            999999999999999999999999985

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.7e-45  Score=325.82  Aligned_cols=252  Identities=30%  Similarity=0.452  Sum_probs=220.9

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||.|+||.||.+++..+++.+++|.+..... ......++.+|+.++++++ |+||+++++++.+.+..+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEE
Confidence            48899999999999999999999999999999865433 3455667889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.+||+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEccccc
Confidence            999999999998765  458999999999999999999999999999999999999   777889999999998764433


Q ss_pred             -ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                       ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+....+..+......   ..++.++.++
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISL  232 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence             3345678999999999874 5889999999999999999999999888877777777766543322   4578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      |.+||+.+|++||++.++|+++|+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-45  Score=349.60  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=205.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|++++.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.+.+|+||+++++++...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            35699999999999999999986443     3579999997543  3344567889999999995599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 017960          173 LCVHIVMELCAGGELFDRIIQR----------------------------------------------------------  194 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~----------------------------------------------------------  194 (363)
                      +..++||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988542                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc---
Q 017960          195 ------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF---  259 (363)
Q Consensus       195 ------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~---  259 (363)
                                  .++++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++.........   
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcceeec
Confidence                        136788899999999999999999999999999999999   77889999999999765433221   


Q ss_pred             ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ....++..|+|||++. ..++.++|||||||++|||++ |..||....................  ....+++++.+++.
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~  349 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMK  349 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHH
Confidence            1223456799999887 469999999999999999997 9999977655444333333322222  12346899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCC
Q 017960          338 KMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~  357 (363)
                      +||+.||++|||+.++++.+
T Consensus       350 ~cl~~dp~~RPs~~~l~~~l  369 (374)
T cd05106         350 MCWNLEPTERPTFSQISQLI  369 (374)
T ss_pred             HHcCCChhhCcCHHHHHHHH
Confidence            99999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3e-45  Score=337.14  Aligned_cols=254  Identities=22%  Similarity=0.317  Sum_probs=205.1

Q ss_pred             ccceeecceecccCCeEEEEEEEcc----------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA----------------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN  161 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n  161 (363)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++.+++ |||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~n   80 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLK-DPN   80 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcC-CCC
Confidence            3569999999999999999997532                34579999986543  3445678999999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 017960          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-------------------HYSERKAAELTRIIVGVVEACHSLGVM  222 (363)
Q Consensus       162 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~i~~~l~~~l~~lH~~~ii  222 (363)
                      |+++++++.+.+..++||||+++++|.+++....                   .+++..+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   357788999999999999999999999


Q ss_pred             ecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh--
Q 017960          223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--  296 (363)
Q Consensus       223 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~--  296 (363)
                      ||||||+|||+   ++++.+||+|||++........   .....++..|+|||++. +.++.++|||||||++|||++  
T Consensus       161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            99999999999   7788999999999976543322   12334577899999887 569999999999999999986  


Q ss_pred             CCCCCCCcCHHHHHHHHHcC----CcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          297 GVPPFWAETQQGIFDAVLKG----HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       297 g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +..||.+....+....+...    .........+.++..+.+|+.+||+.||.+|||+.+|.+.+
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l  302 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL  302 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence            66788776666655444321    11111112235788999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-45  Score=349.26  Aligned_cols=253  Identities=21%  Similarity=0.365  Sum_probs=205.2

Q ss_pred             ccceeecceecccCCeEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|++++.||+|+||.||+|.+     ..++..||||+++...  .....+.+.+|+.++..+.+||||+++++++.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            34699999999999999999974     3456789999986443  2334567889999999995599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG---------------------------------------------------------  195 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~---------------------------------------------------------  195 (363)
                      +..++|||||++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999886432                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          196 ------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       196 ------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                                        .+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++.......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcc
Confidence                              36788899999999999999999999999999999999   677889999999998654332


Q ss_pred             cc---ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHH-HHHHHHcCCcccCCCCCCCCCHH
Q 017960          258 IF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       258 ~~---~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ..   ....++..|+|||++.+ .++.++|||||||++|||++ |..||....... ..+.+..+. ...  .....+.+
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~  345 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-RML--SPECAPSE  345 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-cCC--CCCCCCHH
Confidence            21   12334567999999874 69999999999999999998 899997665443 334333332 111  12346789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      +.+||.+||+.||++|||+.|+++.+.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~l~  372 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQLIE  372 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.3e-45  Score=333.42  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=208.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.+. ||||+++++++.+++..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEE
Confidence            38889999999999999999999999999999865432 2333467888999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          180 ELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||++ ++|.+++...   ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCC
Confidence            9996 5888877543   458999999999999999999999999999999999999   78889999999998765322


Q ss_pred             -CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc---------------
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI---------------  318 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------------  318 (363)
                       .......+++.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.....               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             22234467889999998863  478999999999999999999999987665433322211100               


Q ss_pred             ----------ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          319 ----------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       319 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                .........+++++.+||.+||+.||++|||+.+++.|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                      00011123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-45  Score=336.57  Aligned_cols=254  Identities=25%  Similarity=0.426  Sum_probs=207.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++ ||||+++++++.+....++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEE
Confidence            48889999999999999999999999999999865432 2233456778999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-C
Q 017960          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~  257 (363)
                      ||+. ++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++...... .
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC
Confidence            9996 578887765 5678999999999999999999999999999999999999   77889999999999765432 2


Q ss_pred             ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCC-CcCHHHHHHHHHcCCcc---------------
Q 017960          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHID---------------  319 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~---------------  319 (363)
                      ......++..|+|||.+.+  .++.++|||||||++|+|++|..||. +....+.++.+.+....               
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            2334567889999998864  37999999999999999999988864 33433333333221000               


Q ss_pred             --cC--------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 --FE--------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 --~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                        +.        ....+.+++++.+||.+||+.||.+|||+.+++.|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              00        01123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.3e-45  Score=330.96  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=208.3

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.++||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++++. ||||+++++.+...+..++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEE
Confidence            4788899999999999999999999999999986542  3445567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||+   +.++.++|+|||++...... ..
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~  150 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IA  150 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cc
Confidence            99999988543    357899999999999999999999999999999999999   77889999999999765432 33


Q ss_pred             ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-------QGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ....++..|+|||.+.+ .++.++|+|||||++|+|++|..||.....       ......+.....  ........+++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  228 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEK  228 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC--CCCCCCcCCHH
Confidence            45678999999999874 589999999999999999999999964321       122222222211  11122346789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.++|.+||+.||++||+++|+++|+|+..
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence            999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=364.08  Aligned_cols=247  Identities=34%  Similarity=0.494  Sum_probs=209.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEE-Eec------
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA-YED------  171 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~-~~~------  171 (363)
                      .+++|.+.|.+|||+.||+|.+...+..||+|++-..   ++...+.+++||.+|+.|++|+|||.++|. ...      
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3588999999999999999999888899999988543   778889999999999999999999999993 221      


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeec
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      .-.++|.||||.||.|.+++..+  ..|++.++++|+.++++|+.+||.+.  |||||||-+||||   ..++..|||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcc
Confidence            23588999999999999999753  45999999999999999999999998  9999999999999   78889999999


Q ss_pred             CcceecCCCC-cc---------ccCccCCccccccccc---c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHH
Q 017960          248 GLSVFFKPGQ-IF---------TDVVGSPYYVAPEVLL---K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (363)
Q Consensus       248 G~a~~~~~~~-~~---------~~~~gt~~y~aPE~~~---~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i  313 (363)
                      |.|+...... ..         -....|+.|+|||.+.   + ..++|+|||+|||+||.||....||.+...-    .|
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aI  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AI  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eE
Confidence            9987543221 10         1134689999999985   2 4899999999999999999999999765432    35


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+.+.++..  +.++..+.+||+.||+.||.+||++-+++...
T Consensus       267 lng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  267 LNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             EeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            6666666543  57899999999999999999999999998754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.1e-45  Score=333.35  Aligned_cols=249  Identities=21%  Similarity=0.351  Sum_probs=213.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      .|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.++..++ ||||+++++++.....
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~   82 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCCc
Confidence            5889999999999999999976655     679999886432  3445567899999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC
Q 017960          175 VHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~  238 (363)
                      .+++|||+++++|.+++...                ..+++..+..++.|++.||.|||+.|++||||||+||++   ++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence            99999999999999998764                457889999999999999999999999999999999999   77


Q ss_pred             CccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 017960          239 DFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i  313 (363)
                      ++.+||+|||++.......   ......+++.|+|||.+. ..++.++|||||||++|||++ |..||.+....+....+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8899999999997653322   123345678899999887 568999999999999999998 99999998888888887


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+.....   ...+++++.+|+.+||+.||++||++.|+++++
T Consensus       240 ~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l  280 (283)
T cd05048         240 RSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRL  280 (283)
T ss_pred             HcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            76554322   245789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-47  Score=375.11  Aligned_cols=257  Identities=30%  Similarity=0.488  Sum_probs=228.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|+++++||+|+||.|.+++++.+++.||+|++.+.....+....-|..|-.+|..-. .+-|++++-+|++..++|+
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence            366999999999999999999999999999999998766555666677888888888665 8999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      ||||++||+|..++.+.+++++..++.++..|+.||+.||+.|+|||||||+|||+   |..|++||+|||.+-.+..+ 
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCCC
Confidence            99999999999999988899999999999999999999999999999999999999   99999999999998776633 


Q ss_pred             C-ccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CcccCCCCCCC
Q 017960          257 Q-IFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPL  327 (363)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~  327 (363)
                      . .....+|||.|.+||++.      +.|++.+|.||+||++|||+.|..||+..+-.+.+..|..-  .+.||  ....
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~  307 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD  307 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence            3 234578999999999995      34999999999999999999999999999999999999875  44555  3345


Q ss_pred             CCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLT---AHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s---~~evL~~~~~~~  361 (363)
                      +|+++++||+++++ +|+.|..   ++++-.||||..
T Consensus       308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            99999999999987 5667877   999999999964

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4e-45  Score=329.99  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=210.4

Q ss_pred             cceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ..|++.+.||+|+||.||+|.++   ..+..||+|.++...  .......+.+|+..+.+++ ||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCc
Confidence            35899999999999999999865   345689999987542  3444567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++... +.+++..+..++.||+.||+|||++|++||||||+|||+   +.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCccccccc
Confidence            9999999999999988764 568999999999999999999999999999999999999   778899999999876543


Q ss_pred             CCCccc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQIFT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ......  ...++..|+|||.+. ..++.++|||||||++|||++ |..||.+....+..+.+..+...   +....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  235 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---PAPRNCPN  235 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCH
Confidence            222221  233457899999887 569999999999999999775 99999998888888877665322   22345789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      .+.+++.+||+.+|.+||++.++++.
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~~  261 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHSI  261 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=351.42  Aligned_cols=238  Identities=26%  Similarity=0.412  Sum_probs=208.5

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .+-||.|+.|.||+|+  ..++.||||+++..          -..+|+-|++|+ ||||+.|.|+|....++|||||||.
T Consensus       129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~el----------kETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGR--LHNETVAVKKVREL----------KETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhccCcccceeeee--ccCceehhHHHhhh----------hhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccc
Confidence            5679999999999999  66789999988522          235788999998 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCc
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV  263 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  263 (363)
                      .|-|++.|+....++......|..+|+.|+.|||.+.|||||||.-||||   ..+..|||+|||.++.+..-...-.++
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---eccceEEeccccchHhhhhhhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999   445589999999999887776777899


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||..|||||++.+ ..+.|+|||||||+|||||||..||.......++--+-...+..+  ....+++.++-||+.||+-
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kqcw~s  350 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQCWNS  350 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc--CcccCchHHHHHHHHHHhc
Confidence            9999999999985 589999999999999999999999977665554443333333222  2246889999999999999


Q ss_pred             CcCCCCCHHHHhcCCCc
Q 017960          343 QPSERLTAHEVLCMYNL  359 (363)
Q Consensus       343 dp~~R~s~~evL~~~~~  359 (363)
                      .|.+||++.++|.|+-+
T Consensus       351 KpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  351 KPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CCCCCccHHHHHHHHhh
Confidence            99999999999999865

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=351.88  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=224.3

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|.=.+.||.|+||.||-|.+..+.+.||||.+......+.+....+.+|+.+|++|. |||++.+.|+|-.....|+||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHHH
Confidence            3555788999999999999999999999999998888888888999999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||| -|+-.|.+. ..+++.+.++..|+.+.+.||.|||+++.||||||..|||+   .+.|.|||+|||+|....+   
T Consensus       106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc---
Confidence            999 457777774 35678999999999999999999999999999999999999   8899999999999987654   


Q ss_pred             cccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ..+++|||.|||||++.    ++|+-++||||||++..||...++|++..+....+.-|-+...+...  .+.+++.+.+
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~~F~~  256 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDYFRN  256 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHHHHHH
Confidence            45789999999999986    57999999999999999999999999998887777777665433222  3457899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      |+..||++-|.+|||..++|+|+|+.
T Consensus       257 Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  257 FVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             HHHHHHhhCcccCCcHHHHhhcchhc
Confidence            99999999999999999999999974

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.3e-44  Score=324.48  Aligned_cols=251  Identities=25%  Similarity=0.468  Sum_probs=214.2

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-CCeEEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~iv~  179 (363)
                      |++.+.||.|++|.||++.+..+++.||+|.+..... .....+.+.+|+.++++++ |+|++++++.+.. ...++++|
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEEe
Confidence            8899999999999999999999999999999865432 3445667889999999997 9999999998764 45689999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      ||+++++|.+++...  ..+++.++..++.+++.||.+||+.||+||||||+||++   +.++.++|+|||++...... 
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccC
Confidence            999999999988763  458999999999999999999999999999999999999   77889999999999765432 


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      .......+++.|+|||++.+ .++.++|+||||+++|+|++|+.||...........+..+....   ....+++++.++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  233 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGEL  233 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHH
Confidence            22334568899999999874 58899999999999999999999998777666666665554321   223578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      |.+||+.||++||++.++++|+||
T Consensus       234 i~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         234 IATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.3e-45  Score=340.45  Aligned_cols=255  Identities=20%  Similarity=0.237  Sum_probs=205.8

Q ss_pred             ecceeccc--CCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          103 LGRKLGQG--QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       103 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      ++++||+|  +|++||++.++.+|+.||+|.+..... .....+.+.+|+.+++.++ ||||+++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEe
Confidence            46789999  789999999999999999999965432 3344567888999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          181 LCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       181 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.++++|||.+....... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhccccccc
Confidence            99999999988653  458999999999999999999999999999999999999   777899999998654322111 


Q ss_pred             -------ccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-----
Q 017960          258 -------IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-----  322 (363)
Q Consensus       258 -------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----  322 (363)
                             ......++..|+|||++.+   .++.++|||||||++|||++|..||..............+......     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence                   1112346678999999863   4899999999999999999999999765554433333322211000     


Q ss_pred             -------------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 -------------------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 -------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                                           .....+++++.+||.+||+.||++|||++|+|+|+||..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                                 0011346789999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-45  Score=332.19  Aligned_cols=256  Identities=32%  Similarity=0.446  Sum_probs=218.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||.|+||.||+|.+..++..+|+|.+...   .....+.+.+|+.++++++ ||||+++++.+......++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEE
Confidence            45699999999999999999999889999999998643   4455678889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccc
Confidence            99999999999988764 568999999999999999999999999999999999999   77889999999988654322


Q ss_pred             -CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          257 -QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                       .......+++.|+|||.+.      ..++.++|+||||+++|+|++|..||...........+........ .....++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWS  235 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCC
Confidence             2233456889999999874      2367899999999999999999999988776666666655432211 1223578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .++.++|.+||+.||.+||++.++|+|+|+..
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence            89999999999999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-45  Score=327.98  Aligned_cols=251  Identities=32%  Similarity=0.514  Sum_probs=214.6

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||.|+||.||+|.+..+++.||+|.+.+...........+..|..++....+|+||+++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999999999999999987654333333445556666655554599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCcc
Q 017960          185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG  264 (363)
Q Consensus       185 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  264 (363)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||++   ++++.+||+|||++.....   .....+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCC
Confidence            9999999888889999999999999999999999999999999999999   7788999999999876433   234567


Q ss_pred             CCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccC
Q 017960          265 SPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (363)
Q Consensus       265 t~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  343 (363)
                      +..|+|||.+.+ .++.++||||||+++|+|++|..||...........+......++......+++++.++|.+||+.|
T Consensus       156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  235 (260)
T cd05611         156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD  235 (260)
T ss_pred             CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence            889999999874 4799999999999999999999999888887777777766655554444568899999999999999


Q ss_pred             cCCCCC---HHHHhcCCCccc
Q 017960          344 PSERLT---AHEVLCMYNLPV  361 (363)
Q Consensus       344 p~~R~s---~~evL~~~~~~~  361 (363)
                      |++||+   +.|+|.|+||..
T Consensus       236 p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         236 PAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             HHHccCCCcHHHHHcChHhhc
Confidence            999995   579999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.4e-45  Score=327.92  Aligned_cols=255  Identities=29%  Similarity=0.407  Sum_probs=217.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||.|+||+||+|....++..+|+|++.....  ......+.+|+.+++.++ |+||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEE
Confidence            358999999999999999999888999999999865432  225678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          179 MELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||++++++|.+.+...   ..+++..+..++.|++.||.+||+.||+||||+|+||++   ++++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhcc
Confidence            9999999999998764   458999999999999999999999999999999999999   7778999999999876543


Q ss_pred             CCc-----cccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCC--CC
Q 017960          256 GQI-----FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--WP  326 (363)
Q Consensus       256 ~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~  326 (363)
                      ...     .....++..|+|||.+..  .++.++|+||||+++|+|++|..||.......................  +.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            322     133468899999999873  589999999999999999999999987766665655555432221111  23


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+++++.+++.+||..||++||++.++++||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            578899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-45  Score=330.63  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=218.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+....  .......+.+|+.+++.+. |+||+++++.+.+....++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEE
Confidence            35888999999999999999999999999999986543  3445567889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-C
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~  257 (363)
                      +||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||++   ++++.++|+|||++...... .
T Consensus        78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc
Confidence            9999999999988765 78999999999999999999999999999999999999   77889999999999876543 2


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.........  ...++.++.+++
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  231 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFV  231 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHH
Confidence            3345678889999999874 5899999999999999999999999876665555555444322111  112788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||..||++|||+.++++|+|+..
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcC
Confidence            9999999999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.2e-45  Score=333.50  Aligned_cols=256  Identities=31%  Similarity=0.467  Sum_probs=215.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ...+|++.+.||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.+. |+||+++++.+......+
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEEE
Confidence            4457999999999999999999999999999999987543   233567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+++++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccc
Confidence            99999999999998754 468999999999999999999999999999999999999   77889999999998764332


Q ss_pred             C-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      . ......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||...........+...... .......++..+.+
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  248 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD  248 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC-CCCCccccCHHHHH
Confidence            2 2234578899999998874 5889999999999999999999999877654443333322211 11122357889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +|.+||..||++||++.++++++|+..
T Consensus       249 li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6e-45  Score=329.45  Aligned_cols=253  Identities=25%  Similarity=0.419  Sum_probs=210.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----  172 (363)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+..|+.++.++.+|+||+++++++...     
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            356888999999999999999999999999999986532    23456788999999996699999999998653     


Q ss_pred             -CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 -LCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 -~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                       ..++++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+|+||||||+||++   ++++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCC
Confidence             4689999999999999988763  358999999999999999999999999999999999999   7788999999999


Q ss_pred             ceecCCC-CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          250 SVFFKPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       250 a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      +...... .......|+..|+|||++.      ..++.++|||||||++|||++|..||...........+....  ...
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~  235 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APR  235 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CCC
Confidence            9765332 2233467889999999885      248889999999999999999999997655544444333322  122


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .....++.++.+||.+||..||.+|||+.++++|+||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            2223578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8e-45  Score=330.65  Aligned_cols=255  Identities=28%  Similarity=0.423  Sum_probs=215.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..++..+|+|.+...   .....+.+.+|+++++.+. ||||+++++.+...+..++|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEE
Confidence            3478899999999999999999999999999998643   3455677889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+++++|...+.. ...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc
Confidence            999999999887765 4568999999999999999999999999999999999999   77889999999998654322 


Q ss_pred             CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          257 QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .......++..|+|||++.      ..++.++|||||||++|+|++|..||......+....+........ .....++.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSS  236 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-CCccccCH
Confidence            1233456889999999873      2378899999999999999999999987776666555554432211 11234788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++.+||.+||+.||.+||++.++++|+|+..
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence            9999999999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.2e-45  Score=327.66  Aligned_cols=250  Identities=35%  Similarity=0.575  Sum_probs=217.0

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++ ||||+++++.+.+....+++|||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            699999999999998889999999998765544556678999999999997 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCC
Q 017960          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP  266 (363)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~  266 (363)
                      |.+++.+...+++..+..++.||+.||.|||+.+++|+||+|+||++   +.++.++|+|||++.............+++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCc
Confidence            99999888789999999999999999999999999999999999999   778899999999998765543344567889


Q ss_pred             ccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcC--HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccC
Q 017960          267 YYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (363)
Q Consensus       267 ~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  343 (363)
                      .|+|||.+. ..++.++|+||||+++|+|++|..||....  .......+..+......+  ...++++.++|.+||+.|
T Consensus       157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence            999999987 458999999999999999999999997766  556666665322222111  234789999999999999


Q ss_pred             cCCCCC-----HHHHhcCCCcccC
Q 017960          344 PSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       344 p~~R~s-----~~evL~~~~~~~~  362 (363)
                      |++||+     +.|+++|+||..+
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhhhCC
Confidence            999999     9999999999753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=355.35  Aligned_cols=258  Identities=28%  Similarity=0.413  Sum_probs=223.9

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +..+.|+|+..||.|+||.||+|..+.++-..|-|+|...   +.+..+.+.-||.||..+. ||+||++++.|...+.+
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkL  104 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKL  104 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCce
Confidence            3456688999999999999999999988888899988543   6788899999999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +|+.|||.||-+...+.. ...+++.++..+++|++.||.|||+++|||||||..|||+   .-+|.++|+|||.+....
T Consensus       105 wiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccch
Confidence            999999999988766655 4469999999999999999999999999999999999999   778899999999875432


Q ss_pred             -CCCccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          255 -PGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       255 -~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                       ......++.|||+|||||+..      ..|++++||||||++|.||..+.+|-...+...++-.|.+...+-... ...
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS~  260 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PSH  260 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cch
Confidence             223445789999999999874      359999999999999999999999998888877777777655433222 235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++..+.||+.+||.+||..||++.++|+|||++.
T Consensus       261 Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  261 WSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             hhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            7889999999999999999999999999999974

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.5e-45  Score=332.23  Aligned_cols=251  Identities=31%  Similarity=0.471  Sum_probs=210.9

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||+|+||+||+|.+..+++.||+|.+.+...........+..|+.+++.++ ||||+++++.+...+..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999999999999999997654333344556778999999998 9999999999999999999999999999


Q ss_pred             hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCcc
Q 017960          187 LFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG  264 (363)
Q Consensus       187 L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  264 (363)
                      |.+++....  .+++..+..++.|++.||.|||+.|++||||+|+||++   ++++.++|+|||.+.............+
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccC
Confidence            999987765  68999999999999999999999999999999999999   7788999999999876654444445667


Q ss_pred             CCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccC
Q 017960          265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ  343 (363)
Q Consensus       265 t~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  343 (363)
                      +..|+|||.+. +.++.++||||||+++|+|++|+.||...........+..............+++++.++|.+||+.|
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            88999999987 45899999999999999999999999765442222223332222233333457899999999999999


Q ss_pred             cCCCC-----CHHHHhcCCCccc
Q 017960          344 PSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       344 p~~R~-----s~~evL~~~~~~~  361 (363)
                      |.+||     ++.+++.|+||..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     8999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.8e-45  Score=330.37  Aligned_cols=252  Identities=29%  Similarity=0.442  Sum_probs=219.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++ ||||+++++.+.+....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence            3889999999999999999998899999999998765545456788999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      ||+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++   ++++.++|+|||++.........
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCccc
Confidence            999999999999887789999999999999999999999999999999999999   78889999999999876555444


Q ss_pred             ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH---HHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      ....++..|+|||.+.. .++.++|+||||+++|+|++|..||.....   ...........    ......++.++.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  232 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD----VLYPATWSTEAIDA  232 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccc----ccCcccCcHHHHHH
Confidence            55678889999999874 589999999999999999999999987663   33333222221    22223578999999


Q ss_pred             HHHhcccCcCCCCCH--HHHhcCCCc
Q 017960          336 IRKMLCSQPSERLTA--HEVLCMYNL  359 (363)
Q Consensus       336 i~~~l~~dp~~R~s~--~evL~~~~~  359 (363)
                      |.+||+.||.+||++  +|+++|+||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-45  Score=326.20  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=216.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|++....   ....+.+.+|+.+++.++ ||||+++++++.....+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEE
Confidence            356999999999999999999998899999999997543   235678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||++   ++++.+||+|||++......
T Consensus        78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhh
Confidence            99999999999988776 789999999999999999999999999999999999999   77889999999998765432


Q ss_pred             C-ccccCccCCccccccccc-c---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-CCCCCCCH
Q 017960          257 Q-IFTDVVGSPYYVAPEVLL-K---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-DPWPLISD  330 (363)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~-~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~  330 (363)
                      . ......++..|+|||.+. .   .++.++|+||||+++|+|++|..||.+.........+....+.... .....++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence            2 233457888999999886 3   5888999999999999999999999877665555544444222111 11224578


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ++.++|.+||+.||.+|||+.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-44  Score=323.67  Aligned_cols=253  Identities=27%  Similarity=0.404  Sum_probs=218.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++ ||||+++++.+...+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEE
Confidence            48889999999999999999999999999999976543 3345678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||+++++|.+++...  ..+++..+..++.+++.||.|||++|++|+||+|+||++.  +++..+||+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc
Confidence            999999999999764  3489999999999999999999999999999999999993  234578999999998776554


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......++..|+|||.+.+ .++.++||||||+++|+|++|..||.+.........+.......   ....+++++.+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li  233 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLI  233 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHH
Confidence            4445678899999999874 58899999999999999999999998877776666665543321   1234789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+||+.||++|||+.|++.|||+
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-45  Score=332.94  Aligned_cols=256  Identities=25%  Similarity=0.327  Sum_probs=213.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+....  .......+.+|+.+++++. ||||+++++.+...+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEE
Confidence            35889999999999999999998899999999886432  3445578899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          179 MELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |||+++++|..++...   ..+++..+..++.+|+.||.|||+ .+|+||||||+||++   +.++.+||+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCccccc
Confidence            9999999998877653   368999999999999999999997 599999999999999   778899999999987653


Q ss_pred             CCCccccCccCCcccccccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .. ......+++.|+|||.+.+       .++.++|+|||||++|+|++|..||...........+............+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence            32 2334567889999998852       258899999999999999999999976555444433322111112222335


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++.++.+||.+||+.+|++||++.+++.|+|+..
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~  267 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK  267 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence            7899999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.4e-44  Score=325.90  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=212.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeecccc---CChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +|++.+.||.|+||.||+|.+ .+++.+|+|.+.....   ........+.+|+.++++++ |+||+++++++.+.+..+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            378899999999999999985 5788999998864321   12334567899999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-  255 (363)
                      ++|||+++++|.+++.+.+.+++..+..++.|++.||+|||+.+|+|+||+|+||++   ++++.++|+|||++..... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhhc
Confidence            999999999999999887889999999999999999999999999999999999999   7888999999999875421 


Q ss_pred             ------CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          256 ------GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       256 ------~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                            ........++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+....... ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  234 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPDSF  234 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCCCC
Confidence                  112234568889999999874 58899999999999999999999997765544443333321111 1222357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +.++.++|.+||+.+|++||++.+++.|+||
T Consensus       235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-44  Score=331.73  Aligned_cols=255  Identities=31%  Similarity=0.477  Sum_probs=216.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ..+|++.+.||.|++|.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++ ||||+++++++......++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEE
Confidence            356999999999999999999999999999999986542   233567889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |+||+++++|.+++.. ..+++.++..++.+++.||.|||+.|++||||||+||++   +.++.+||+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccc
Confidence            9999999999887754 468999999999999999999999999999999999999   778899999999987654332


Q ss_pred             c-cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 I-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 ~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      . .....++..|+|||.+.+ .++.++|||||||++|+|++|..||.+.........+...... .......+++.+.+|
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  248 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIFRDF  248 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHHHHH
Confidence            2 234568889999999874 5899999999999999999999999887765554444433221 122234578899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |.+||..||.+||++.+++.|+|+..
T Consensus       249 i~~~l~~dp~~Rpt~~~il~~~~~~~  274 (296)
T cd06655         249 LNRCLEMDVEKRGSAKELLQHPFLKL  274 (296)
T ss_pred             HHHHhhcChhhCCCHHHHhhChHhhh
Confidence            99999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-44  Score=329.83  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=213.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+++++. ||||+++++++......++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEe
Confidence            48899999999999999999999999999999876432 2344567889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      ||+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||++   +.++.++|+|||++....... 
T Consensus        79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC
Confidence            999 9999998865 3568999999999999999999999999999999999999   778899999999988765432 


Q ss_pred             -ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc----------------
Q 017960          258 -IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI----------------  318 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----------------  318 (363)
                       ......++..|+|||.+.+  .++.++||||||+++|||++|.+||.+......+..+.....                
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             2345678999999998863  478999999999999999999888877666554444332110                


Q ss_pred             ---ccCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          319 ---DFES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       319 ---~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                         .+..       ...+..+.++.+||.+||+.||++||++.++|.|+||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence               0000       01234678999999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-44  Score=326.21  Aligned_cols=253  Identities=25%  Similarity=0.440  Sum_probs=212.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++ ||||+++++++.+.+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            35899999999999999999999999999999887654445566678899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          179 MELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence            999999999887753    3447899999999999999999999999999999999999   778889999999988754


Q ss_pred             CCCc-cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCH--HHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQI-FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .... .....+++.|+|||.+. ..++.++|+||||+++|||++|..||.....  ......+.....  +......++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC--CCCChhhcCH
Confidence            3321 23456888999999887 4588999999999999999999999965432  344444443322  2222235678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+.++|.+||+.+|++||++.++++.+
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~~  262 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQIA  262 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence            999999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=340.61  Aligned_cols=265  Identities=24%  Similarity=0.332  Sum_probs=210.1

Q ss_pred             CCCCcceeeecccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC
Q 017960           81 GIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK  160 (363)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~  160 (363)
                      ....+++.++..++++|.    -..+||+|+||.||+|.. .++..||||.+.......   ..+|.+|+.++.+++ ||
T Consensus        61 ~~~~fs~~el~~AT~~Fs----~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~-H~  131 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFS----ESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLR-HP  131 (361)
T ss_pred             CcceeeHHHHHHHHhCCc----hhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCC-Cc
Confidence            344566677777776655    457899999999999995 566899999876543211   345999999999999 99


Q ss_pred             ceeEEeEEEecCC-eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cEecCCCCCceEee
Q 017960          161 NIVTIKGAYEDSL-CVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLLV  234 (363)
Q Consensus       161 niv~~~~~~~~~~-~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---iiHrDlkp~NIll~  234 (363)
                      |+|+++|+|.+.+ ..++|+||+++|+|.++|....  .++|..+.+|+.+++.||+|||+..   ||||||||+|||+ 
T Consensus       132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL-  210 (361)
T KOG1187|consen  132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL-  210 (361)
T ss_pred             CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE-
Confidence            9999999999998 5999999999999999998765  8999999999999999999999854   9999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCC-CCccccC-ccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcC---HHH
Q 017960          235 NKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET---QQG  308 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~  308 (363)
                        |+++.+||+|||+|..... ....... .||.+|+|||.+. +..+.++||||||++|.||++|+.+.....   ...
T Consensus       211 --D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  211 --DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             --CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence              9999999999999977654 3333333 8999999999987 679999999999999999999998875432   111


Q ss_pred             HHH----HHHcCCcccCCCC-C--CCCC-----HHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFD----AVLKGHIDFESDP-W--PLIS-----DSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~----~i~~~~~~~~~~~-~--~~~~-----~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.+    .+.++......++ .  ...+     ..+..+..+|++.+|.+||++.||++.+
T Consensus       289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L  349 (361)
T KOG1187|consen  289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL  349 (361)
T ss_pred             HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence            222    2222222111111 1  1222     2366888899999999999999998765

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-44  Score=332.68  Aligned_cols=257  Identities=31%  Similarity=0.460  Sum_probs=214.9

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +...+|++.+.||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++ |+||+++++++......
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEE
Confidence            34567999999999999999999999999999999986543   233467889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccC
Confidence            999999999999998754 468999999999999999999999999999999999999   7788999999999876543


Q ss_pred             CC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ......+++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.........+..... ........++..+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  246 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPERLSAVFR  246 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC-CCCCCccccCHHHH
Confidence            32 2234568889999999874 588999999999999999999999977654333322222211 11112235778899


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +|+.+||..||++||++.++++|+|+..
T Consensus       247 ~li~~~l~~~p~~Rps~~~il~~~~~~~  274 (297)
T cd06656         247 DFLNRCLEMDVDRRGSAKELLQHPFLKL  274 (297)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCchhcc
Confidence            9999999999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-44  Score=328.73  Aligned_cols=251  Identities=27%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             eecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEecCCeEEEEEeccC
Q 017960          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++.+.  +||+|+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999997654333332333445554444432  49999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCc
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV  263 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  263 (363)
                      +++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+|||+   ++++.++|+|||++....... .....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcC
Confidence            99999999888889999999999999999999999999999999999999   788899999999987654322 23457


Q ss_pred             cCCccccccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          264 GSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       264 gt~~y~aPE~~~-~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      |+..|+|||.+. + .++.++||||+||++|+|++|..||........ ..+..............+++++.++|.+||+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ  235 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence            899999999886 3 489999999999999999999999965432211 1111111122222334578999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCCCccc
Q 017960          342 SQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       342 ~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      .||.+|+     +++++++|+||+.
T Consensus       236 ~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         236 RDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             CCHHHhcCCCCCCHHHHHhCccccC
Confidence            9999999     6999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-44  Score=330.76  Aligned_cols=257  Identities=27%  Similarity=0.369  Sum_probs=208.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe----
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC----  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~----  174 (363)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            358899999999999999999999999999998865422 223345788899999999868999999999877665    


Q ss_pred             -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC-CccEEEeec
Q 017960          175 -VHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDF  247 (363)
Q Consensus       175 -~~iv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~~kl~DF  247 (363)
                       .|+||||+++ +|.+++...     ..+++..+..++.||+.||.|||++||+||||||+||++   +. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~---~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---ecCCCeEEEeec
Confidence             8999999975 788887643     347999999999999999999999999999999999999   55 789999999


Q ss_pred             CcceecCCC-CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc----
Q 017960          248 GLSVFFKPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF----  320 (363)
Q Consensus       248 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----  320 (363)
                      |++...... .......+++.|+|||++.+  .++.++||||||+++|+|++|..||.+.........+.......    
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            998765322 22334467889999998863  47999999999999999999999998776655444333211000    


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          321 --------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       321 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                                          .....+.++.++.+||.+||..||++||++.|+|.|+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                0011235788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9e-45  Score=332.86  Aligned_cols=257  Identities=28%  Similarity=0.422  Sum_probs=213.4

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+......  .......+..|+.+++.++ |+||+++++++.+.+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            378889999999999999999889999999999765432  1223456778999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||++   +.++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCC
Confidence            99999 889999987766 79999999999999999999999999999999999999   77889999999999876443


Q ss_pred             -CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC------------
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE------------  321 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------------  321 (363)
                       .......+++.|+|||.+.+  .++.++|+|||||++|||++|.+||.+....+.+..+........            
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence             22334456788999998853  578999999999999999999888877666555544432210000            


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 ------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 ------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                  ...+...+.++.++|.+||++||++|||+.|+|.|+||..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence                        0011345788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-44  Score=328.43  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=208.2

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe-----c
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-----D  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-----~  171 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+.+||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4567999999999999999999999999999999875432    223567789999999966999999999873     4


Q ss_pred             CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          172 SLCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      ++..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+|+||||||+||++   ++++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~df  168 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVDF  168 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEccC
Confidence            5679999999999999887753    3468899999999999999999999999999999999999   77788999999


Q ss_pred             CcceecCCCC-ccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc
Q 017960          248 GLSVFFKPGQ-IFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       248 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                      |++....... ......|++.|+|||++.      ..++.++|||||||++|||++|..||...........+...... 
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-  247 (286)
T cd06638         169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP-  247 (286)
T ss_pred             CceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC-
Confidence            9998654332 223456899999999874      23788999999999999999999999776554443333222111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .......++.++.+||.+||+.||++|||+.|+++|+|+
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            111112357889999999999999999999999999996

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.6e-44  Score=322.63  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=214.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+..|+.+++.++ |+||+++++.+...+.+++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEE
Confidence            48889999999999999999988999999999876543 2456788999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc-
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~-  258 (363)
                      ||+++++|.+++.....+++..+..++.+++.||.|||+.||+|+||+|+||++   ++++.+||+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence            999999999999887778999999999999999999999999999999999999   7788999999999887644322 


Q ss_pred             ----cccCccCCcccccccccc-c---CCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCcccCCCCCCCCC
Q 017960          259 ----FTDVVGSPYYVAPEVLLK-H---YGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       259 ----~~~~~gt~~y~aPE~~~~-~---~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                          .....++..|+|||.+.. .   ++.++||||||+++|+|++|..||...... .....+.. ......+....++
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS  234 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence                123567889999999873 3   789999999999999999999999655322 22222222 2222222333468


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +.+.++|.+||+.||.+||++.+++.|+|+
T Consensus       235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         235 PEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-44  Score=333.39  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcE--EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .|++.+.||+|+||.||+|.+..++..  +|+|.+..  .........+.+|+.++.++.+||||+++++++.+.+..++
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            488899999999999999998877765  46666542  22445567888999999999559999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc
Q 017960          178 VMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      ||||+++++|.+++...+                .+++..+..++.||+.||+|||++||+||||||+|||+   ++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence            999999999999987543                47889999999999999999999999999999999999   77889


Q ss_pred             EEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcc
Q 017960          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHID  319 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  319 (363)
                      +||+|||++.............++..|+|||.+.. .++.++|||||||++|||++ |..||.+....+..+.+....  
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--  240 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--  240 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--
Confidence            99999999864321111122234567999998874 58999999999999999998 999998887777776664432  


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                       .......+++++.+||.+||+.+|++||++.++|..+
T Consensus       241 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l  277 (303)
T cd05088         241 -RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  277 (303)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence             1112234688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-44  Score=325.18  Aligned_cols=256  Identities=27%  Similarity=0.403  Sum_probs=212.9

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-------ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-------SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+......       .....+.+.+|+.+++.++ ||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            378889999999999999999889999999988542211       1122456888999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          173 LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+++++||||+|+||++   +.++.++|+|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeecccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999   7788999999999876


Q ss_pred             cCCCC---ccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CcccCCCC
Q 017960          253 FKPGQ---IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDP  324 (363)
Q Consensus       253 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~  324 (363)
                      .....   ......++..|+|||.+..   .++.++|+||||+++|+|++|..||...........+...  ...++...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43211   1233567889999999863   3789999999999999999999999655544333333222  22222333


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+.++.++.++|.+||.+||++||++.++|+|+|+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            34678999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-44  Score=328.36  Aligned_cols=250  Identities=22%  Similarity=0.370  Sum_probs=213.1

Q ss_pred             cceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +.|.+.+.||+|+||.||+|.+..     ++..||+|.+....  ..+..+.+.+|+++++.+. |+||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCC
Confidence            358889999999999999998643     45789999986542  3335678999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC
Q 017960          174 CVHIVMELCAGGELFDRIIQRG--------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~  239 (363)
                      ..++||||+++++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||++   +.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCC
Confidence            9999999999999999987542              37889999999999999999999999999999999999   778


Q ss_pred             ccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHH
Q 017960          240 FSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL  314 (363)
Q Consensus       240 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~  314 (363)
                      +.+||+|||++........   .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+....+..+.+.
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9999999999976433221   12334567899999987 468999999999999999998 999999888888888887


Q ss_pred             cCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+......   ..++.++.+++.+||+.||++||++.|+++.+
T Consensus       239 ~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l  278 (280)
T cd05049         239 QGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERL  278 (280)
T ss_pred             cCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence            66543322   35789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.8e-44  Score=322.18  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=217.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe--cCCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~~~~~~i  177 (363)
                      +|++.+.||.|+||.||+|.+..++..||+|.+..... .....+++..|+.+++.++ ||||+++++.+.  .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEE
Confidence            37888999999999999999999999999999875433 4555678899999999998 999999999775  3556899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACH-----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH-----~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      +|||+++++|.+++..    ...+++..+..++.||+.||.|||     +.+++|+||+|+||++   ++++.+||+|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccc
Confidence            9999999999998865    356899999999999999999999     8999999999999999   778899999999


Q ss_pred             cceecCCCCc-cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          249 LSVFFKPGQI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       249 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      ++........ .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.........+.+..+.....   ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  232 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI---PY  232 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC---cc
Confidence            9987654443 345678999999999874 588999999999999999999999988877777777766544322   23


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .++.++.+++.+||+.+|++||++.+||+|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            568899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-44  Score=348.16  Aligned_cols=250  Identities=18%  Similarity=0.305  Sum_probs=204.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....         ..+.+|+.+|++|+ |+||+++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEE
Confidence            3469999999999999999999999999999996421         23567999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||++ .++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       238 v~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccc
Confidence            99999 56888888664 468999999999999999999999999999999999999   77889999999999865432


Q ss_pred             C---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCCccc----
Q 017960          257 Q---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--------QQGIFDAVLKGHIDF----  320 (363)
Q Consensus       257 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~----  320 (363)
                      .   ......||..|+|||++.+ .++.++|||||||+||||++|..|+....        ...+.+.+.......    
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            2   1234579999999999874 59999999999999999999876654321        223333333322110    


Q ss_pred             -----------------------CCCCC---CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          321 -----------------------ESDPW---PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       321 -----------------------~~~~~---~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                             ....|   ..++.++.+||.+||+.||.+|||+.|+|+|+||+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                   00011   135568999999999999999999999999999974

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.3e-44  Score=328.73  Aligned_cols=252  Identities=30%  Similarity=0.457  Sum_probs=207.5

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVHIV  178 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~iv  178 (363)
                      |++.+.||+|+||.||+|.+..++..||+|.+..... ... .....+|+.++.++.+|+||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6778899999999999999999999999999865432 222 233457899999997799999999999887  889999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||++ ++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||++   +. +.+||+|||++.......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCC
Confidence            99996 5888888763 568999999999999999999999999999999999999   66 899999999998765554


Q ss_pred             ccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC------------------
Q 017960          258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------------------  317 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------  317 (363)
                      ......++..|+|||.+.  +.++.++|||||||++|||++|..||.+.+..+....+....                  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            445567889999999775  347899999999999999999999998776655444443211                  


Q ss_pred             cccCCC-------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          318 IDFESD-------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       318 ~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ..++..       ..+.++.++.++|.+||+.||++||++.++++|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000000       012467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=352.39  Aligned_cols=248  Identities=28%  Similarity=0.410  Sum_probs=212.9

Q ss_pred             eecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCC
Q 017960          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG  185 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~  185 (363)
                      +||+|.||+||.|+|..+...+|||.+..+   .....+-+..||.+-++|+ |.|||+++|.+.+++.+-|.||-++||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            699999999999999999999999999654   4455678899999999999 999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-Ccccc
Q 017960          186 ELFDRIIQR-GHY--SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTD  261 (363)
Q Consensus       186 ~L~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~  261 (363)
                      +|.++|... |++  .+..+..+.+||++||.|||++.|||||||-+||||+  .-.|.+||+|||.++....- ....+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccc
Confidence            999998764 676  8899999999999999999999999999999999995  45789999999999876543 34457


Q ss_pred             CccCCccccccccc---ccCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          262 VVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       262 ~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      +.||..|||||++.   +.|+.++|||||||++.||.||++||..... +..+-  .-+.+...++....++.+++.||.
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--kVGmyKvHP~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--KVGMYKVHPPIPEELSAEAKNFIL  813 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--hhcceecCCCCcHHHHHHHHHHHH
Confidence            88999999999997   3599999999999999999999999964332 22222  223333334444467889999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCccc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +|+.+||.+||++.++|..||++.
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~  837 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQH  837 (1226)
T ss_pred             HHcCCCcccCccHHHhccCccccc
Confidence            999999999999999999999863

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.3e-44  Score=321.00  Aligned_cols=252  Identities=25%  Similarity=0.495  Sum_probs=218.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEE
Confidence            48899999999999999999999999999999865433 3344567899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||+.+++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++.......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcch
Confidence            9999999999887643  57899999999999999999999999999999999999   777889999999997654332


Q ss_pred             -ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                       ......+++.|+|||++.+ .++.++|+|||||++|+|++|..||......+....+..+.....   ...++.++.++
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  232 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNL  232 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHH
Confidence             2234567889999999874 588999999999999999999999988777777777766554322   23568899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      |.+||+.+|++||++.++|.|+||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.5e-44  Score=321.51  Aligned_cols=250  Identities=30%  Similarity=0.487  Sum_probs=215.4

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||.|+||.||++.+..++..+|+|.+....  .....+.+.+|+.+++.+. |+||+++++.+.+.+.++++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            3788999999999999999999999999999986543  3345678889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||+++++|.+.+...  ..+++..+..++.||+.||.|||++||+|+||||+||++   ++++.++|+|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeecccc
Confidence            999999999888653  357999999999999999999999999999999999999   778899999999997664332


Q ss_pred             -ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                       ......+++.|+|||++.+ .++.++|+||||+++|+|++|..||...........+..+......   ..++.++.+|
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence             2334678899999999874 5899999999999999999999999887777776666655443222   3478899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCC
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      |.+||+.||++||++.+++..-.
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~~~  254 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSRGS  254 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhccC
Confidence            99999999999999999997643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.1e-44  Score=321.02  Aligned_cols=254  Identities=31%  Similarity=0.425  Sum_probs=216.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeecccc--CChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      +|+..+.||+|+||.||+|.+..++..|++|.+.....  ......+.+.+|+.+++.++ |+||+++++++.+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence            37778999999999999999988999999999865432  12345678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      +|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||++   +.++.+||+|||.+.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceeccccc
Confidence            99999999999999888789999999999999999999999999999999999999   778899999999988765444


Q ss_pred             ccccCccCCccccccccc-cc-CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLL-KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      ......++..|+|||.+. .. ++.++|+||||+++|+|++|..||...........+.....  .......+++++.++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  234 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE--LPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--CCCcCCCcCHHHHHH
Confidence            345567889999999886 34 89999999999999999999999976665444444333111  112223578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +.+||+.+|++||++.+++.|+|+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.7e-44  Score=326.53  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=211.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----  172 (363)
                      ..+.|++.+.||+|+||.||+|.+..+++.+|+|.+....    .....+.+|+.++.++.+||||+++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            4567999999999999999999999999999999986432    22356778999999996699999999998643    


Q ss_pred             -CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          173 -LCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       173 -~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                       ...++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++||||||+||++   ++++.+||+||
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~df  172 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDF  172 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeec
Confidence             468999999999999988753    4568999999999999999999999999999999999999   77888999999


Q ss_pred             CcceecCCCC-ccccCccCCcccccccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc
Q 017960          248 GLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       248 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                      |++....... ......++..|+|||.+..      .++.++|||||||++|||++|+.||...........+.+.....
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~  252 (291)
T cd06639         173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT  252 (291)
T ss_pred             ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence            9987654322 2234568889999998752      26889999999999999999999998776655555554432211


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      . .....++.++.+||.+||+.||++||++.+++.|+||+
T Consensus       253 ~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 L-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             C-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            1 11124567899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.4e-44  Score=323.00  Aligned_cols=254  Identities=30%  Similarity=0.453  Sum_probs=209.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~  175 (363)
                      .|++.+.||+|+||.||+|.+..++..||+|.+......  .......+.+|+.+++.++ ||||+++++.+.+  ...+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEE
Confidence            488899999999999999999999999999998654321  2334567889999999998 9999999998865  4678


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +++|||+++++|.+++...+.+++.....++.|++.||.|||+.+|+||||||+||++   +.++.+||+|||++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccccc
Confidence            9999999999999999888889999999999999999999999999999999999999   7788999999999875432


Q ss_pred             C----CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          256 G----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       256 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .    .......++..|+|||.+.+ .++.++|||||||++|||++|+.||...........+.....  .......+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHISE  236 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhcCH
Confidence            1    11223557889999999874 589999999999999999999999976654444433332211  1111234678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+.++| +||..+|++||+++|++.||||+
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            889998 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-44  Score=324.58  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=211.8

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----  173 (363)
                      .++|++.+.||+|++|.||+|.+..+++.+++|++....    ...+.+.+|+.+++++.+|+||+++++++.+..    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            467999999999999999999998899999999986542    234678899999999966999999999997644    


Q ss_pred             --eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          174 --CVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       174 --~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                        .+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCC
Confidence              48999999999999988765    3578999999999999999999999999999999999999   77889999999


Q ss_pred             CcceecCCCC-ccccCccCCcccccccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc
Q 017960          248 GLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       248 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                      |++....... ......++..|+|||++..      .++.++||||||+++|+|++|..||...........+.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  237 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT  237 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence            9987654322 2334568899999998742      37889999999999999999999997665555555554433221


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      . .....++.++.+||.+||..||++|||+.++++|+|+
T Consensus       238 ~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            1 1112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.6e-45  Score=330.50  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=211.8

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+++++.++ ||||+++++++......++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEEE
Confidence            58899999999999999999988999999999865432 2234567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-Cc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~  258 (363)
                      ||+++++|.++......+++..+..++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||++...... ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccc
Confidence            999998888777666679999999999999999999999999999999999999   77889999999998765433 23


Q ss_pred             cccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc------------------
Q 017960          259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI------------------  318 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  318 (363)
                      .....++..|+|||++.+  .++.++||||||+++|||++|++||......+....+.....                  
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            344567889999999863  478899999999999999999999976654433322221000                  


Q ss_pred             -ccCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          319 -DFES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       319 -~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                       ..+.        ..++.++..+.+|+.+||+.||++||++.++++|+||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             0000        1134578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-44  Score=326.54  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=208.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec------C
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------S  172 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~  172 (363)
                      +.|++.+.||.|+||.||+|.+..+++.+|+|++...    ......+..|+.+++++.+|+||+++++++..      .
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            4688999999999999999999999999999998643    23446788899999999679999999998853      5


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          173 LCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      ..++++|||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+|+||+|+||++   ++++.++|+|||++
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~  168 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVS  168 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcch
Confidence            6789999999999999988653  347888999999999999999999999999999999999   77889999999998


Q ss_pred             eecCCC-CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC
Q 017960          251 VFFKPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (363)
Q Consensus       251 ~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  323 (363)
                      ...... .......|++.|+|||.+.      ..++.++|+|||||++|||++|..||...........+.....  ...
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~  246 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--PKL  246 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--CCC
Confidence            754321 2233467889999999875      2478899999999999999999999976655444443333221  111


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ....++.++.+||.+||+.||.+||++.|+|+|+||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.7e-44  Score=339.21  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=210.4

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.+. ||||+++++++...   
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   90 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSL   90 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCc
Confidence            45678999999999999999999999999999999986432 23445567888999999997 99999999988643   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ...|+||||+. ++|.+.+...  +++..+..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||+
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~  164 (353)
T cd07850          91 EEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  164 (353)
T ss_pred             cccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCcc
Confidence               35799999995 5888877544  8999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-----------  317 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  317 (363)
                      +.............+++.|+|||.+.+ .++.++|||||||++|+|++|+.||...........+....           
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            987654444445678899999999874 68999999999999999999999997766544433332110           


Q ss_pred             -----------cccCCC-----------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          318 -----------IDFESD-----------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       318 -----------~~~~~~-----------------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                 ......                 .....++++.+||.+||+.||++|||+.|+|.|+|+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                       000000                 01124567899999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.7e-44  Score=321.18  Aligned_cols=253  Identities=30%  Similarity=0.475  Sum_probs=210.3

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeecccc--CChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~  175 (363)
                      .|++.+.||+|+||.||+|.+..++..||+|.+.....  ......+.+.+|+.+++++. ||||+++++++.+  ...+
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCceE
Confidence            48899999999999999999999999999998864321  12344678899999999997 9999999998866  3568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +++|||+++++|.+++...+.+++..+..++.|++.||.|||+.+|+|+||||+||++   +.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccccc
Confidence            8999999999999999887788999999999999999999999999999999999999   7788999999999875432


Q ss_pred             C----CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          256 G----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       256 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .    .......++..|+|||.+.+ .++.++|||||||++|+|++|+.||...........+.....  .......++.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVSD  236 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhCH
Confidence            1    12234568889999999874 589999999999999999999999977655544444332211  1112235678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+.++|.+||. +|++||++.++++|+|+
T Consensus       237 ~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         237 HCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             HHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            89999999995 99999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.9e-44  Score=331.43  Aligned_cols=257  Identities=27%  Similarity=0.386  Sum_probs=211.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~  175 (363)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++ |+||+++++++.+.  +.+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            3459999999999999999999999999999999865432 1222335667999999998 99999999998754  568


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||++   ++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecC
Confidence            99999995 578888765 3568999999999999999999999999999999999999   778899999999998765


Q ss_pred             CC-CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc-------------
Q 017960          255 PG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-------------  318 (363)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------  318 (363)
                      .. .......+++.|+|||.+.+  .++.++|||||||++|||++|..||.+.+..+.+..+.....             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            33 22333456788999999863  489999999999999999999999988887776665544211             


Q ss_pred             ------ccCCCC-------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          319 ------DFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       319 ------~~~~~~-------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                            ......       ....++++.+||.+||++||.+|||+.++|.|+||.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                  000000       123578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-44  Score=321.48  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=212.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..++..+|+|.+....     ..+.+.+|+.+++.+. ||||+++++.+.+....+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEE
Confidence            46899999999999999999998889999999986432     2678999999999996 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      +||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++   ++++.++|+|||++.......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCc
Confidence            999999999998875 4568999999999999999999999999999999999999   778899999999988764433


Q ss_pred             -ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 -IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                       ......++..|+|||++.+ .++.++||||||+++|+|++|+.||...........+...... .......++.++.++
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF  232 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence             2334557889999999874 5899999999999999999999999776554444333322111 111123467899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      |.+||+.||++|||+.|+|+|+||
T Consensus       233 i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-44  Score=341.84  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=205.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .+.|+++++||+|+||.||+|.+...     +..||||++....  .....+.+.+|+.++.++..||||+++++++.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            45699999999999999999986433     3469999986543  3444578999999999996699999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 017960          173 LCVHIVMELCAGGELFDRIIQR----------------------------------------------------------  194 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~----------------------------------------------------------  194 (363)
                      +..|+|||||++|+|.+++.+.                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999888642                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC
Q 017960          195 --------------------------------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK  236 (363)
Q Consensus       195 --------------------------------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~  236 (363)
                                                            ..+++..+..++.||+.||.|||+.+|+||||||+|||+   
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---
Confidence                                                  136778889999999999999999999999999999999   


Q ss_pred             CCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHH-H
Q 017960          237 DDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI-F  310 (363)
Q Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~-~  310 (363)
                      ++++.+||+|||++........   .....++..|+|||.+. ..++.++|||||||++|||++ |..||........ .
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            7778899999999986543221   12334677899999887 458999999999999999997 9999977554333 3


Q ss_pred             HHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       311 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+..+ ...  .....++.++.+++.+||+.||++||++.++.+.+
T Consensus       351 ~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l  394 (400)
T cd05105         351 NKIKSG-YRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV  394 (400)
T ss_pred             HHHhcC-CCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence            333333 221  12235789999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-44  Score=324.13  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=211.3

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC---ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      |+..+.||+|++|.||+|.+..+++.||+|++......   .....+.+.+|+.++++++ |+||+++++++.+.+..++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEEE
Confidence            77889999999999999999999999999998654321   1224578899999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc-cEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~~~~  256 (363)
                      ||||+++++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||++   +.++ .+||+|||.+......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~---~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEcccccccccccc
Confidence            99999999999999888889999999999999999999999999999999999999   5443 6999999998765432


Q ss_pred             C-----ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-cccCCCCCCCCC
Q 017960          257 Q-----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH-IDFESDPWPLIS  329 (363)
Q Consensus       257 ~-----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~  329 (363)
                      .     ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.+.. ..........++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1     1123467889999999874 58999999999999999999999996544332222222111 111122223578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +++.+++.+||..||++||++.+++.|+||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-44  Score=332.81  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=191.5

Q ss_pred             cceecccCCeEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe--cCCeEEEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCVHIVM  179 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~~~~~~iv~  179 (363)
                      +.+||+|+||.||+|.+..  ++..||+|.+....     ....+.+|+.++++++ ||||+++++++.  .....++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEE
Confidence            4689999999999999654  56789999886432     1245778999999998 999999999884  456789999


Q ss_pred             eccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC-CCCccEEEeecCc
Q 017960          180 ELCAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-DDDFSLKAIDFGL  249 (363)
Q Consensus       180 e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~-~~~~~~kl~DFG~  249 (363)
                      ||+. ++|.+.+...         ..+++..+..++.||+.||.|||+.||+||||||+|||+... +.++.+||+|||+
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            9985 5787776421         247889999999999999999999999999999999999532 3567899999999


Q ss_pred             ceecCCCC----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH---------HHHHHHH
Q 017960          250 SVFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------GIFDAVL  314 (363)
Q Consensus       250 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~---------~~~~~i~  314 (363)
                      +.......    ......+|+.|+|||++.+  .++.++|||||||++|||++|.+||......         .....+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF  238 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence            98654322    2234578999999999864  4899999999999999999999999643321         1111110


Q ss_pred             cCC--------------c------------cc--------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          315 KGH--------------I------------DF--------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       315 ~~~--------------~------------~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ...              .            ..        ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000              0            00        000011235678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-44  Score=327.47  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=212.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+++++.++ ||||+++++.+...+.+++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEE
Confidence            45899999999999999999999999999999886542  3445678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||+++++|.+++...+.+++..+..++.+++.||.|||+ .+++||||||+||++   ++++.++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-
Confidence            9999999999998887889999999999999999999997 689999999999999   77889999999998654322 


Q ss_pred             ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-----------HHHHHHHcCCcccCCCCC
Q 017960          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-----------GIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~  325 (363)
                      ......|+..|+|||.+. ..++.++|+|||||++|+|++|..||......           +....+......  ....
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RLPS  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CCCc
Confidence            223457899999999886 56899999999999999999999999765432           222333222111  0111


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ..++.++.+||.+||+.||++|||+.|+++++|+.
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            23678999999999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.7e-44  Score=323.31  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=201.3

Q ss_pred             cceeeccee--cccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           99 DLYTLGRKL--GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        99 ~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.|++.+.+  |.|+||.||++.++.++..+|+|.+.......        .|+.....+.+||||+++++.+...+..+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            446666655  99999999999999999999999987543211        12222332335999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc-cEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~~~  255 (363)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||++   +.++ .++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY---DRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---eCCCCeEEEecCccceecCC
Confidence            999999999999999887789999999999999999999999999999999999999   5555 899999999877543


Q ss_pred             CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHH-HHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIF-DAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .   ....++..|+|||++.+ .++.++||||||+++|+|++|..||......... ..+... .......++.+++.+.
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-QQKKLPFIKNVSKNAN  238 (267)
T ss_pred             C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-hcccCCcccccCHHHH
Confidence            2   23467899999999874 6899999999999999999999999755443321 111111 1222233446899999


Q ss_pred             HHHHHhcccCcCCCCC-HHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLT-AHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s-~~evL~~~~~~~  361 (363)
                      +||.+||+.||.+||+ ++++|+|+||..
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            9999999999999996 699999999863

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-44  Score=324.67  Aligned_cols=252  Identities=21%  Similarity=0.326  Sum_probs=209.2

Q ss_pred             cccceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++ ||||+++++++.+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence            34669999999999999999998642     35679999885432  3344567889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRG----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+.|++||||||+||++   ++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCC
Confidence            999999999999999999886532          25678899999999999999999999999999999999   77889


Q ss_pred             EEEeecCcceecCCCCcc---ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcC
Q 017960          242 LKAIDFGLSVFFKPGQIF---TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG  316 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~  316 (363)
                      ++|+|||++.........   ....++..|+|||++. +.++.++|||||||++|||++ |..||.+.......+.+...
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998765433221   1234567899999987 468999999999999999999 78999888877777776665


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .....   ...+++.+.+++.+||+.||++|||+.|+++++
T Consensus       238 ~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  275 (277)
T cd05062         238 GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  275 (277)
T ss_pred             CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence            43222   235788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.8e-44  Score=325.45  Aligned_cols=253  Identities=27%  Similarity=0.418  Sum_probs=215.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ..|+..+.||.|+||.||+|.+..++..||+|.+....  .......+.+|+.+++++. ||||+++++.+.+....++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEE
Confidence            35888899999999999999998999999999987543  3445678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||+++++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence            999999999998764 568999999999999999999999999999999999999   778889999999997654433 


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......++..|+|||.+.+ .++.++|+|||||++|||++|..||...........+.....   ......++..+.+++
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li  233 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEFI  233 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHHH
Confidence            2233467889999999874 589999999999999999999999987776655554433322   122234678899999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||+.+|++||++.+++.|+|+..
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhh
Confidence            9999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=327.92  Aligned_cols=255  Identities=28%  Similarity=0.429  Sum_probs=211.8

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+++++.+. |+||+++++++...+..++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence            58999999999999999999999999999998865432 3344578899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||++++.+.....+...+++..+..++.||+.||.|||+.+++|+||+|+||++   ++++.+||+|||++.......  
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence            999886666555555679999999999999999999999999999999999999   788899999999988765443  


Q ss_pred             ccccCccCCccccccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc-----------------
Q 017960          258 IFTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-----------------  318 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  318 (363)
                      ......++..|+|||++. . .++.++||||||+++|+|++|..||.+....+....+.....                 
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            344567889999999987 4 588999999999999999999999977655443333221000                 


Q ss_pred             --ccCC---------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          319 --DFES---------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       319 --~~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                        ....         .....++.++.+||++||+.||++||++.+++.++||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              0000         0011247899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.2e-44  Score=326.42  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=210.4

Q ss_pred             cceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +.|.+.+.||+|+||.||++.+.     .++..+|+|.+...   .......+.+|+.+++++. ||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCC
Confidence            45889999999999999999852     34567999988643   3445678999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          174 CVHIVMELCAGGELFDRIIQRG-------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      ..++||||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+||++   ++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence            9999999999999999987543             38999999999999999999999999999999999999   7888


Q ss_pred             cEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHc
Q 017960          241 SLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~  315 (363)
                      .+||+|||++........   .....++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976533221   12234567899999987 458999999999999999998 9999988888888888877


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.....   ...++.++.+|+.+||++||.+|||+.+++..
T Consensus       238 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~  275 (288)
T cd05093         238 GRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL  275 (288)
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            654322   23478899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=329.17  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=216.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      -|.++++||+|+||.||+|.++.+|..+|||.+..     ..+.+++.+|+.+++++. .|+||++||.|.....+||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeeh
Confidence            47788999999999999999999999999999864     356788999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||..|++.+.+.. ++++++.++..+++..+.||+|||...-||||||..|||+   +.+|+.||+|||.|..+.+.. 
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH
Confidence            99999999998864 5679999999999999999999999999999999999999   889999999999998765332 


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ...+..|||-|||||++.. .|+.++||||||++..||..|++||........+-.|-.. .+........++.++.||+
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC-CCCCCCChHhhhhHHHHHH
Confidence            2356889999999999986 6999999999999999999999999665543222222111 1111111235688999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++||-+.|++|-|+.++++|+|++.
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhhhhcC
Confidence            9999999999999999999999864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=336.14  Aligned_cols=258  Identities=31%  Similarity=0.466  Sum_probs=207.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----  172 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|.+....  ......++.+|+.++++++ ||||+++++++...    
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFES   79 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccc
Confidence            4577999999999999999999999999999999986422  2334567888999999998 99999999987543    


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          173 -LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       173 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                       ...++||||+. ++|...+. ...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECccccee
Confidence             35899999995 57877664 4578999999999999999999999999999999999999   788899999999987


Q ss_pred             ecCCCC----ccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--------
Q 017960          252 FFKPGQ----IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH--------  317 (363)
Q Consensus       252 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------  317 (363)
                      ......    ......|++.|+|||.+.  ..++.++|||||||++|+|++|+.||.+.........+....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            654322    123356889999999875  358999999999999999999999997665433322221100        


Q ss_pred             --------------cccC-C----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          318 --------------IDFE-S----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       318 --------------~~~~-~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                    .... .    ...+..++++.+||.+||+.||.+|||+.+++.|+|+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                          0000 0    0123467889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6e-44  Score=324.15  Aligned_cols=254  Identities=25%  Similarity=0.343  Sum_probs=211.0

Q ss_pred             cceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +.|.+.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++ |+||+++++++.+..
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERL   82 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCC
Confidence            458899999999999999999877     77889999885432  3444567889999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          174 CVHIVMELCAGGELFDRIIQRG-------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                      ..++||||+++++|.+++...+       .+++..+..++.||+.||.|||+++++||||||+||++..+++...+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999999987653       478999999999999999999999999999999999995444445799999


Q ss_pred             cCcceecCCCCcc---ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          247 FGLSVFFKPGQIF---TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       247 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      ||++.........   .....+..|+|||++. ..++.++|||||||++|||++ |..||.+....+..+.+......  
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--  240 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL--  240 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--
Confidence            9999865322211   1223346799999987 469999999999999999997 99999888877777666544221  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                       .....++.++.+++.+||+.||++||++.++++++.
T Consensus       241 -~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 -DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             122457899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-44  Score=324.59  Aligned_cols=253  Identities=25%  Similarity=0.333  Sum_probs=213.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||.|++|.||+|.+..+++.+|+|.+....  ......++.+|+++++.+. ||||+++++.+...+..++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEE
Confidence            4788899999999999999999999999999987643  2345677889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||++   ++++.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHH
Confidence            999999999998776 778999999999999999999999 999999999999999   778899999999987653322


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc-----CHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .. ...++..|+|||.+.+ .++.++||||||+++|+|++|..||...     ......+.+.......  .....++++
T Consensus       156 ~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  232 (265)
T cd06605         156 AK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR--LPSGKFSPD  232 (265)
T ss_pred             hh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC--CChhhcCHH
Confidence            22 2678889999999874 5899999999999999999999999654     2223333333322111  111127889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.++|.+||..||++|||+.+++.|+||+.
T Consensus       233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.2e-44  Score=319.74  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=208.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|..+ ++..+|+|.+....    .....+.+|+.++++++ ||||+++++++.+....++||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEEE
Confidence            4888999999999999999864 45689999876432    22356888999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||.+........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCce
Confidence            999999999988753 568999999999999999999999999999999999999   7788999999999876543322


Q ss_pred             cc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          259 FT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       259 ~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ..  ...++..|+|||.+. ..++.++|+||||+++|||++ |+.||......+....+..+......   ...+.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~  232 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYE  232 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHH
Confidence            21  223456899999987 468999999999999999999 99999888888888888775432222   246789999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCC
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+||+.||++||++.++++.+
T Consensus       233 li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHHhh
Confidence            99999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.1e-44  Score=327.96  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=207.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.|++.+.||+|+||.||+|.+..++.  .+++|.++..  ......+.+.+|+.++.++.+||||+++++++.+.+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            458899999999999999999877765  4688877532  234456778999999999966999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          177 IVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      ++|||+++++|.+++....                .+++..+..++.|++.||+|||+.||+||||||+|||+   ++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCC
Confidence            9999999999999986532                47889999999999999999999999999999999999   7788


Q ss_pred             cEEEeecCcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCc
Q 017960          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  318 (363)
                      .+||+|||++..............+..|+|||.+. ..++.++|||||||++|||++ |..||.+.........+..+..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~  236 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  236 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence            99999999986432211111222345799999887 458999999999999999997 9999998888777777765432


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .   .....++.++.+||.+||+.||.+||++.++++.+
T Consensus       237 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  272 (297)
T cd05089         237 M---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL  272 (297)
T ss_pred             C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            1   12235789999999999999999999999997753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.8e-44  Score=324.38  Aligned_cols=254  Identities=25%  Similarity=0.278  Sum_probs=204.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.....  .....++..|+.++.+..+||||+++++++...+..+++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            58899999999999999999999999999999875432  2223456667776555545999999999999999999999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          180 ELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       180 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ||++ ++|.+.+..    ...+++..+..++.||+.||.|||++ +++||||||+||++   +.++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccc
Confidence            9995 678776654    24589999999999999999999997 99999999999999   788899999999998764


Q ss_pred             CCCccccCccCCcccccccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      .........++..|+|||.+.+     .++.++|+|||||++|+|++|..||... ...+....+..+...  ..+...+
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  233 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP--QLPAEKF  233 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC--CCCcccc
Confidence            4333344678889999998752     4788999999999999999999999642 222333333332111  1111247


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.++.++|.+||..+|++||++.+++.|+|+..
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence            899999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-44  Score=326.10  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=204.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|++|.||+|.+..+++.||+|.+.....  ......+.+|+.+++.++ |+||+++++++.+....++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEE
Confidence            469999999999999999999988999999999865432  122345678999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++...... 
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC
Confidence            999964 898888664 468999999999999999999999999999999999999   77889999999998654321 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcc--------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHID--------------  319 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~--------------  319 (363)
                      .......++..|+|||.+.+  .++.++||||+|+++|+|++|+.||.+.. ..+....+.+....              
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            22233456888999998863  48899999999999999999999997654 22222222110000              


Q ss_pred             -----cC-------CCCCCCCC--HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 -----FE-------SDPWPLIS--DSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 -----~~-------~~~~~~~~--~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                           ..       ....+.++  .++.++|.+||+.||++|||+.++|.|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                 00       00011234  788999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-43  Score=327.32  Aligned_cols=255  Identities=27%  Similarity=0.427  Sum_probs=215.0

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ....|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCeEE
Confidence            3455889999999999999999998899999999987554445556678899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +||||+. +++.+.+.. .+.+++..+..++.|++.||.|||+.||+||||+|+||++   ++++.++|+|||++.....
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence            9999996 577776654 4568999999999999999999999999999999999999   7888999999999876543


Q ss_pred             CCccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .   ....+++.|+|||++.    +.++.++||||||+++|||++|..||.+.........+......  ......++.+
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  242 (307)
T cd06607         168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLSSNDWSDY  242 (307)
T ss_pred             C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC--CCCchhhCHH
Confidence            2   3456788999999874    35889999999999999999999999887766655544433211  1111246789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.++|.+||+.||++||++.+++.|+|+..
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.5e-45  Score=355.39  Aligned_cols=247  Identities=23%  Similarity=0.404  Sum_probs=216.4

Q ss_pred             ceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+..+.||+|+||+||+|+-.     .....||||.++...  +....++|++|++++..|+ |||||+++|++.+++.
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDP  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCe
Confidence            3566789999999999999843     234569999997554  5557789999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          175 VHIVMELCAGGELFDRIIQRG--------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      +++|+|||..|+|.++|....              +++..+.+.|+.||+.|++||-++.+|||||-..|+||   .++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccce
Confidence            999999999999999996532              27789999999999999999999999999999999999   8999


Q ss_pred             cEEEeecCcceecCCCCcccc---CccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHc
Q 017960          241 SLKAIDFGLSVFFKPGQIFTD---VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~  315 (363)
                      .|||+|||+++..-..+.+.-   ..-..+|||||.+. +.|+.+|||||+||+|||+++ |..||++...+++++.+..
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999987654444332   22356899999877 789999999999999999999 9999999999999999999


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017960          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      +..   .+....+|.++.+|+..||+.+|.+||++.||=.
T Consensus       721 g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  721 GQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             CCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            987   3344578999999999999999999999999854

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=345.42  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=222.3

Q ss_pred             eecceecccCCeEEEEEEEccCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--eEEEE
Q 017960          102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--CVHIV  178 (363)
Q Consensus       102 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--~~~iv  178 (363)
                      +...+||+|+|-+||+|.|..+|..||--.++-..+ ......+++..|+.+|+.|. ||||++++++|.+..  .+.+|
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeee
Confidence            446789999999999999999999998766544333 25566799999999999998 999999999997655  48899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +|++..|+|..++++.+.++.+.++.|++||+.||.|||++.  |||||||-+||+|+  +..|.|||+|+|+|+.....
T Consensus       122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence            999999999999999999999999999999999999999986  99999999999996  56789999999999986544


Q ss_pred             CccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                       .....+|||.|||||.....|+..+||||||++|+||+|+..||..+. ...+++++..|..+-.....  -.+++++|
T Consensus       200 -~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--~dPevr~f  276 (632)
T KOG0584|consen  200 -HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--KDPEVREF  276 (632)
T ss_pred             -ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--CCHHHHHH
Confidence             445589999999999999999999999999999999999999998764 45788888888765444333  36899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |.+||.. ..+|+|+.|+|.++||..
T Consensus       277 IekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhChhhcc
Confidence            9999999 899999999999999964

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.6e-44  Score=327.30  Aligned_cols=256  Identities=23%  Similarity=0.253  Sum_probs=207.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|+..+.||+|+||.||++.+..+++.||+|.+.....  ......+.+|+.++.++.+|+||+++++++......+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            36677899999999999999999999999999875432  2445678899999999977999999999999999999999


Q ss_pred             eccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          180 ELCAGGELFDRI---I--QRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       180 e~~~~~~L~~~l---~--~~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ||+. +++.+..   .  ....+++..+..++.+++.||+|||+. +|+||||||+||++   +.++.+||+|||++...
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQL  158 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHh
Confidence            9985 4554432   2  235689999999999999999999974 99999999999999   77889999999999765


Q ss_pred             CCCCccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCc-ccCCCCCCC
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHI-DFESDPWPL  327 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~-~~~~~~~~~  327 (363)
                      ..........++..|+|||.+..    .++.++|||||||++|+|++|+.||..... .+....+..+.. .........
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            54444445578899999999873    489999999999999999999999965432 122222222211 111222234


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++.++.+||.+||+.||++|||+++++.|+|+..
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            7899999999999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.4e-44  Score=322.87  Aligned_cols=251  Identities=25%  Similarity=0.464  Sum_probs=210.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||+|+||.||+|.+..++..+|||.+.............+.+|+.+++.+. ||||+++++++.+.+..+++|
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEEE
Confidence            5888999999999999999999999999999887654445555678899999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          180 ELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       180 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhcccc
Confidence            99999999988863    3458999999999999999999999999999999999999   7788999999999876543


Q ss_pred             CC-ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCH--HHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .. ......++..|+|||.+. ..++.++|+||||+++|+|++|..||.+...  ....+.+....  .+......++++
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  236 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEE  236 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccHH
Confidence            32 223456889999999987 4588999999999999999999999975543  23333333222  222223457889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.++|.+||+.||++|||+.+|++.
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~~  261 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYDV  261 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHHH
Confidence            9999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.2e-44  Score=318.87  Aligned_cols=244  Identities=25%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+. ||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccC
Confidence            36999999999999999999999999886432  3455677899999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccc---
Q 017960          185 GELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT---  260 (363)
Q Consensus       185 ~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~---  260 (363)
                      ++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++..........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccccCC
Confidence            99999987644 58999999999999999999999999999999999999   778889999999987644322111   


Q ss_pred             cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          261 DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       261 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....+..|+|||.+. +.++.++||||||+++|||++ |..||...........+......   .....++..+.+|+.+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~  231 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMER  231 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHH
Confidence            112245699999987 468999999999999999998 99999777766666665543221   1223568899999999


Q ss_pred             hcccCcCCCCCHHHHhcCC
Q 017960          339 MLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~  357 (363)
                      ||+.||++|||+.++++.+
T Consensus       232 ~l~~~p~~Rps~~~~~~~l  250 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQEL  250 (252)
T ss_pred             HcCCChhhCcCHHHHHHHH
Confidence            9999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.2e-44  Score=326.09  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=208.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||.|++|.||+|.+..+++.||||.+..... .......+.+|++++++++ ||||+++++++.+.+..++|||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEee
Confidence            7889999999999999999999999999998864332 2233457889999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-C
Q 017960          181 LCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (363)
Q Consensus       181 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~  257 (363)
                      |+. ++|.+++..  ...+++..+..++.|++.||+|||+.+++|+||+|+||++   ++++.+||+|||++...... .
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc
Confidence            995 688888865  3468999999999999999999999999999999999999   78889999999998765332 2


Q ss_pred             ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc----------------
Q 017960          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID----------------  319 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------  319 (363)
                      ......++..|+|||.+.+  .++.++||||||+++|+|++|+.||.+.........+......                
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            2334457889999998864  3688999999999999999999999876654433332221000                


Q ss_pred             --cC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 --FE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 --~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                        ++       ....+.+++++.++|.+||+.||.+|||+.+++.|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              00       01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.8e-44  Score=358.89  Aligned_cols=251  Identities=28%  Similarity=0.346  Sum_probs=204.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.++||+|+||.||+|.+..+++.||+|++...........+++.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            46999999999999999999999999999999997654434455678999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          179 MELCAGGELFDRIIQR-----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      |||++|++|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||+   +.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence            9999999999988641           234567788999999999999999999999999999999   78889999999


Q ss_pred             CcceecCCCC-------------------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH
Q 017960          248 GLSVFFKPGQ-------------------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ  307 (363)
Q Consensus       248 G~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~  307 (363)
                      |++.......                   .....+||+.|+|||++.+ .++.++|||||||++|||++|..||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9997652110                   0112568999999999874 5899999999999999999999999775544


Q ss_pred             HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017960          308 GIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL  354 (363)
Q Consensus       308 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL  354 (363)
                      ......... ......+...+++.+.+++.+||..||++|++..+.+
T Consensus       238 ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        238 KISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             hhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            332221111 1111122346789999999999999999998765544

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.9e-44  Score=327.94  Aligned_cols=255  Identities=28%  Similarity=0.394  Sum_probs=210.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVH  176 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~  176 (363)
                      +.|++.+.||.|+||.||+|.+..+++.+|+|.+..... .......+.+|+.++++++ ||||+++++++...  ...+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc-cccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEE
Confidence            358899999999999999999998999999999975433 2233346678999999998 99999999998877  8999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +||||+. ++|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||++   +.++.+||+|||++.....
T Consensus        83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS  158 (293)
T ss_pred             EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence            9999996 58988887644 58999999999999999999999999999999999999   7788999999999987654


Q ss_pred             C-CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-------------
Q 017960          256 G-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-------------  319 (363)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------  319 (363)
                      . .......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||...........+......             
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            3 23344567889999998864  3689999999999999999999999877666555444321100             


Q ss_pred             -------------cCCCCCCC--CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 -------------FESDPWPL--ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 -------------~~~~~~~~--~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                   .....++.  +++.+.++|++||+.||++|||+.|+|.|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         00011122  47889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.3e-44  Score=323.81  Aligned_cols=250  Identities=20%  Similarity=0.327  Sum_probs=209.5

Q ss_pred             cceeecceecccCCeEEEEEEEc----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.|++.+.||+|+||.||+|...    .++..||+|.+....  .......+.+|+.+++.++ ||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCc
Confidence            34888999999999999999853    455789999986432  3445577889999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC
Q 017960          175 VHIVMELCAGGELFDRIIQR-----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~  237 (363)
                      .++||||+++++|.+++...                 ..+++..+..++.|++.||.|||++||+||||||+|||+   +
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---G  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---c
Confidence            99999999999999988532                 236788899999999999999999999999999999999   7


Q ss_pred             CCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHH
Q 017960          238 DDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA  312 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~  312 (363)
                      +++.+||+|||++.......   ......++..|+|||.+. ..++.++|||||||++|||++ |..||.+.......+.
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            78899999999997653322   122344567799999987 468999999999999999998 9999988777777776


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       313 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.......   ....+++++.+++.+||+.||++||++.++++++
T Consensus       239 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  280 (283)
T cd05090         239 VRKRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL  280 (283)
T ss_pred             HHcCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence            66544321   2235789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.9e-44  Score=320.19  Aligned_cols=247  Identities=23%  Similarity=0.350  Sum_probs=210.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+...    ......+.+|+.+++.+. |+||+++++++...+.++++|
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEEE
Confidence            488889999999999999999999999999998643    233567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++   ++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccce
Confidence            999999999988654  358899999999999999999999999999999999999   778899999999998764432


Q ss_pred             ccc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          258 IFT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       258 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ...  ...++..|+|||.+. ..++.++|||||||++|||++ |..||.+....+....+.....   ......++.++.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  235 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPKVY  235 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHH
Confidence            211  122356799999887 468999999999999999998 9999988887777777665421   222345789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++|.+||+.||++||++.++++.+
T Consensus       236 ~li~~cl~~~p~~Rp~~~~l~~~l  259 (263)
T cd05052         236 ELMRACWQWNPSDRPSFAEIHQAF  259 (263)
T ss_pred             HHHHHHccCCcccCCCHHHHHHHH
Confidence            999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-44  Score=322.81  Aligned_cols=254  Identities=27%  Similarity=0.472  Sum_probs=213.9

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEecCCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~i  177 (363)
                      .|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++.+.  .|||++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            3778899999999999999999999999999986532  3344567889999999996  59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||++   ++++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence            9999999999988755 478999999999999999999999999999999999999   778899999999998765433


Q ss_pred             -ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          258 -IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......|+..|+|||.+.+  .++.++|+||||+++|+|++|..||.+.........+.....  +.-....++.++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  233 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--PRLEDNGYSKLLRE  233 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCC--CCCCcccCCHHHHH
Confidence             2334568889999998863  478999999999999999999999977665544443332211  11111236789999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++.+||+.||++||++.+++.++|++.
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhc
Confidence            999999999999999999999999965

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.6e-44  Score=320.06  Aligned_cols=253  Identities=26%  Similarity=0.351  Sum_probs=218.4

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||.|++|.||+|.+..+++.||+|++.....  ......+.+|+..+.+++ |+||+++++.+......++||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEE
Confidence            48889999999999999999999999999999875432  245678999999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||++   +.++.++|+|||.+........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence            999999999999888889999999999999999999999 999999999999999   7788999999999987654333


Q ss_pred             c-ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCcccCCCCCCC-CCHHH
Q 017960          259 F-TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKGHIDFESDPWPL-ISDSA  332 (363)
Q Consensus       259 ~-~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~~~~~  332 (363)
                      . ....++..|+|||.+.. .++.++|+||||+++|+|++|..||...   ...+....+.......   .... ++..+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  232 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---LPAEEFSPEF  232 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC---CCcccCCHHH
Confidence            2 24567889999999874 5889999999999999999999999766   3444555554332221   1123 78899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .++|.+||..+|++||++.++++++|++.
T Consensus       233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         233 RDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-43  Score=325.33  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=210.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCC----------------cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCce
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG----------------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI  162 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni  162 (363)
                      ++|++.+.||+|+||.||+|.+...+                ..||+|.+....  .....+.+.+|+.++++++ ||||
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i   81 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLS-DPNI   81 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcC-CCCE
Confidence            46899999999999999999876543                458999986543  3455678999999999998 9999


Q ss_pred             eEEeEEEecCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCce
Q 017960          163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (363)
Q Consensus       163 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NI  231 (363)
                      +++++++..+...+++|||+.+++|.+++....           .+++..+..++.|++.||.|||++||+||||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            999999999999999999999999999987765           689999999999999999999999999999999999


Q ss_pred             EeeeCCCCccEEEeecCcceecCCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh--CCCCCCCcC
Q 017960          232 LLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS--GVPPFWAET  305 (363)
Q Consensus       232 ll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~--g~~pf~~~~  305 (363)
                      ++   ++++.++|+|||++.......   ......++..|+|||.+.+ .++.++|||||||++|||++  |..||....
T Consensus       162 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         162 LV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99   777899999999987654332   1223456778999999874 69999999999999999998  788997777


Q ss_pred             HHHHHHHHHcC----CcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          306 QQGIFDAVLKG----HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       306 ~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+..+...    ...........++.++.+++.+||+.||++|||+.++++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L  294 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL  294 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence            66666655432    11111122235678999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-44  Score=328.79  Aligned_cols=256  Identities=28%  Similarity=0.461  Sum_probs=214.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|.....||+|+||.||++.+..++..||||.+...   .....+.+.+|+.+++.++ |+||+++++.+...+..+
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~   95 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELW   95 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEE
Confidence            344566677899999999999999899999999998643   3344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+++++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||++   ++++.++|+|||++......
T Consensus        96 lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          96 VVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccc
Confidence            9999999999988774 4568999999999999999999999999999999999999   77789999999998754322


Q ss_pred             C-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      . ......++..|+|||.+.+ .++.++|+||||+++|||++|..||...........+..... ........++..+.+
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  250 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRG  250 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHH
Confidence            2 2234568899999999874 689999999999999999999999987776665555443221 111222346889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +|.+||..||.+|||+.++++++||..
T Consensus       251 li~~~l~~~P~~Rpt~~~il~~~~~~~  277 (292)
T cd06658         251 FLDLMLVREPSQRATAQELLQHPFLKL  277 (292)
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhhc
Confidence            999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-43  Score=321.87  Aligned_cols=249  Identities=28%  Similarity=0.393  Sum_probs=201.9

Q ss_pred             eecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHh--cCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL--AGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .||+|+||.||+|.+..+++.||+|.+.+..............|..+++.+  ..||+|+.+++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999899999999999765433222222333444433332  149999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCc
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV  263 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  263 (363)
                      |++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.+||+|||++...... ......
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc-CCcCcC
Confidence            99999999888889999999999999999999999999999999999999   77889999999998765332 223457


Q ss_pred             cCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          264 GSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       264 gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      |+..|+|||.+.+  .++.++||||+|+++|+|++|+.||.+..   .............    .....++.++.+++.+
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~li~~  232 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----ELPDSFSPELRSLLEG  232 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC----CCCCcCCHHHHHHHHH
Confidence            8999999999873  48999999999999999999999997663   2222222222221    1223468999999999


Q ss_pred             hcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          339 MLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       339 ~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      ||..||.+||     ++.++++|+|+..+
T Consensus       233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            9999999999     99999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-44  Score=334.83  Aligned_cols=259  Identities=30%  Similarity=0.413  Sum_probs=211.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----  172 (363)
                      +.++|++.+.||+|+||+||+|.+..+++.||||.+..... .......+.+|+.+++.+. |+||+++++++...    
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~   80 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREA   80 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCccchHHheecccccc
Confidence            44579999999999999999999999999999999865322 3334567788999999997 99999999987644    


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          173 -LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       173 -~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                       ...++||||+ +++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||++   +.++.+||+|||++.
T Consensus        81 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~  156 (337)
T cd07858          81 FNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR  156 (337)
T ss_pred             cCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccc
Confidence             3589999999 46899988888889999999999999999999999999999999999999   778899999999998


Q ss_pred             ecCCC-CccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC------------
Q 017960          252 FFKPG-QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG------------  316 (363)
Q Consensus       252 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~------------  316 (363)
                      ..... .......++..|+|||.+.  ..++.++|||||||++|+|++|+.||.+.........+...            
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            65433 2334456788999999876  35899999999999999999999999765443322222110            


Q ss_pred             -----------CcccC----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          317 -----------HIDFE----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       317 -----------~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                 .....    ....+.+++++.+||.+||+.||++|||+.++|+|+|+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                       00000    0112457899999999999999999999999999999964

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-44  Score=327.99  Aligned_cols=253  Identities=27%  Similarity=0.402  Sum_probs=213.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+....  .....+.+.+|+.+++++. ||||+++++++...+..++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEEE
Confidence            45888899999999999999998899999999986443  3345678899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||++   ++++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch
Confidence            999999999887754 568999999999999999999999999999999999999   777899999999997654332 


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......++..|+|||.+.+ .++.++|+|||||++|||++|..||...........+......   .....++.++.++|
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li  233 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEFV  233 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHHH
Confidence            2223467889999999874 5899999999999999999999999766555544444333221   11124678899999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||+.+|++||++.+++.|+|+..
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHH
Confidence            9999999999999999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.1e-44  Score=329.51  Aligned_cols=249  Identities=21%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIE----FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..|++.+.||+|+||.||+|.+..++..    ||+|.+....  .....+++.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-C
Confidence            3489999999999999999997666654    8999886432  3445678889999999997 99999999988765 5


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++++||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||+   ++++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence            67999999999999999874 458899999999999999999999999999999999999   77889999999999876


Q ss_pred             CCCCcc---ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          254 KPGQIF---TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       254 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ......   ....++..|+|||.+. ..++.++|||||||++|||++ |..||.+....+....+..+. ..+.  .+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~  236 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPIC  236 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCCC
Confidence            543321   1223456799999987 468999999999999999998 999998877666555444332 2222  2356


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.++.+++.+||..||++||++.+++..+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l  265 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIEF  265 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            78999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-43  Score=318.68  Aligned_cols=247  Identities=22%  Similarity=0.343  Sum_probs=209.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.++||+|+||.||+|.+ .++..||+|.+....    ...+.+.+|+.+++.++ |+||+++++.+.+.+..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc----hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEE
Confidence            5699999999999999999986 456789999876432    23568899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.+++||||||+||++   ++++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCC
Confidence            9999999999988653  457889999999999999999999999999999999999   78889999999999876433


Q ss_pred             Cc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 QI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..  .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+.........+.....   .+....++.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR---MPRMENCPDEL  233 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHH
Confidence            21  12234566899999887 468999999999999999998 9999988877777777665432   22234578999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+++.+||+.+|++||+++++++.+
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~i~~~l  258 (261)
T cd05072         234 YDIMKTCWKEKAEERPTFDYLQSVL  258 (261)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHHH
Confidence            9999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5e-44  Score=333.69  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=203.1

Q ss_pred             ccceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-  171 (363)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|++....  .....+.+.+|+.++.++.+|+||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            4579999999999999999997433     45789999986432  334456788999999999559999999998754 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR---------------------------------------------------------  194 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~---------------------------------------------------------  194 (363)
                      +..++++|||+++++|.+++...                                                         
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            56788999999999999888542                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc---cccCccCCc
Q 017960          195 ----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPY  267 (363)
Q Consensus       195 ----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~  267 (363)
                          ..+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++........   .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                257889999999999999999999999999999999999   7778999999999986533221   122345678


Q ss_pred             cccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHH-HHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCc
Q 017960          268 YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIF-DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP  344 (363)
Q Consensus       268 y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  344 (363)
                      |+|||++. ..++.++|||||||++|||++ |..||.+....+.+ ..+..+.. ..  .....++++.+++.+||+.+|
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~~cl~~~p  317 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-MR--APEYATPEIYSIMLDCWHNNP  317 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-CC--CCccCCHHHHHHHHHHccCCh
Confidence            99999887 469999999999999999998 99999775443333 33333222 11  123567899999999999999


Q ss_pred             CCCCCHHHHhcCC
Q 017960          345 SERLTAHEVLCMY  357 (363)
Q Consensus       345 ~~R~s~~evL~~~  357 (363)
                      ++||++.|+++++
T Consensus       318 ~~RPs~~ell~~l  330 (337)
T cd05054         318 EDRPTFSELVEIL  330 (337)
T ss_pred             hhCcCHHHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.5e-44  Score=320.28  Aligned_cols=250  Identities=35%  Similarity=0.549  Sum_probs=218.2

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||.|+||.||+|.+..+++.+|+|.+...........+.+.+|+.++++++ ||||+++++.+......|++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999998889999999997654434456778999999999998 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC---------
Q 017960          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---------  257 (363)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---------  257 (363)
                      |.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||++.......         
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccc
Confidence            99999887789999999999999999999999999999999999999   778899999999987643321         


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......++..|+|||.+.. .++.++|+||||+++|+|++|..||......+....+..+....+..  ..++.++.+++
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i  234 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI  234 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence            2234567889999998874 58899999999999999999999998888888887777655443322  22589999999


Q ss_pred             HHhcccCcCCCCCH---HHHhcCCCcccC
Q 017960          337 RKMLCSQPSERLTA---HEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s~---~evL~~~~~~~~  362 (363)
                      .+||+.+|++|||+   .++|+++||..+
T Consensus       235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            99999999999999   999999999765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-43  Score=327.24  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=203.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----  173 (363)
                      .+.|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++ ||||+++++++....    
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccccc
Confidence            3459999999999999999999999999999999865432 2222345678999999997 999999999886543    


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          174 ----CVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       174 ----~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                          ..++||||+. ++|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||++   +.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg  164 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFG  164 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCC
Confidence                4699999995 58887776543 68999999999999999999999999999999999999   788899999999


Q ss_pred             cceecCCCC-----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          249 LSVFFKPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       249 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      ++.......     ......++..|+|||.+.+  .++.++||||||+++|||++|+.||.+.........+..-....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            997653322     1223457788999998764  378899999999999999999999987765544333322110000


Q ss_pred             CCC----------------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          322 SDP----------------------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       322 ~~~----------------------------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+.                            ....++.+.+||.+||+.||++|||++++|+|+||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000                            01135678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=339.63  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=216.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc---E-EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI---E-FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ++..+.++||+|+||.||+|..+..+.   . ||+|..............++.+|.++++.++ |||||+++|+......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEEP  235 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCc
Confidence            345667999999999999999766432   3 8999887645557888999999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ++||||+|.||+|.++|.+.+. ++..+...++.+.+.||+|||++++|||||-.+|+|+   ..++.+||+|||+++..
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCC
Confidence            9999999999999999998874 9999999999999999999999999999999999999   77778999999998764


Q ss_pred             CCCCccc-cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          254 KPGQIFT-DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       254 ~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ..-.... ...-...|+|||.+. +.|+.++|||||||++||+++ |..||.+....++...|.......+.+  ...+.
T Consensus       313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p~  390 (474)
T KOG0194|consen  313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTPK  390 (474)
T ss_pred             cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCHH
Confidence            3111111 122456899999998 569999999999999999999 899999999999999996554433333  25688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ++..++.+||..||++||++.++.+.
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~~  416 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKKK  416 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHHH
Confidence            99999999999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=341.54  Aligned_cols=248  Identities=34%  Similarity=0.495  Sum_probs=217.1

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.+.|++...+|.|+|+.|-.+.+..+++..++|++.++.       ....+|+.++....+||||+++.+++.+..
T Consensus       317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cCCcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCc
Confidence            3356788999999999999999999999999999999997652       234457878888888999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..|+|||++.|+.+.+.+.....+. .++..|+++|+.|+.|||++|+|||||||+|||+.  ++.++++|+|||.+...
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhC
Confidence            9999999999999988887776666 88889999999999999999999999999999994  36778999999999887


Q ss_pred             CCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCcccCCCCCCCCCHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ...  ..+.+-|..|.|||++. ..|+.++|+||||++||+|++|+.||...... ++...+..+.+.      ..+|++
T Consensus       467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~  538 (612)
T KOG0603|consen  467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDE  538 (612)
T ss_pred             chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHH
Confidence            654  44556788999999998 46999999999999999999999999766655 566666555443      468999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +++||.+||+.||.+|+++.+++.|+|+
T Consensus       539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  539 AKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHHhccCChhhCcChhhhccCcch
Confidence            9999999999999999999999999998

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.6e-44  Score=323.55  Aligned_cols=253  Identities=35%  Similarity=0.596  Sum_probs=220.9

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++.+||||+++++++...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            58899999999999999999999999999999977554445556778899999999977999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||++   +.++.++|+|||++.......  
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcccc
Confidence            999999999999988889999999999999999999999999999999999999   778899999999987654322  


Q ss_pred             -------------------ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC
Q 017960          258 -------------------IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH  317 (363)
Q Consensus       258 -------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~  317 (363)
                                         ......++..|+|||++. ..++.++|+||||++++++++|..||........+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE  238 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence                               112345788999999887 458899999999999999999999998877666666665444


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCc
Q 017960          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTA----HEVLCMYNL  359 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~----~evL~~~~~  359 (363)
                      ..++    ..+++.+.+||.+||+.||.+||++    .+++.|+||
T Consensus       239 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         239 YSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            3333    3468999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-44  Score=322.30  Aligned_cols=246  Identities=29%  Similarity=0.405  Sum_probs=203.6

Q ss_pred             eecceecccCCeEEEEEEEc----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          102 TLGRKLGQGQFGTTYLCTEI----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       102 ~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ++.+.||.|+||.||+|...    ..+..|+||.+...  ......+.+.+|++.+++++ ||||+++++++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccc-ccccccccccccccccccc
Confidence            35678999999999999987    45678999999543  24556789999999999996 9999999999998888999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|+||+++|||+   ++++.+||+|||++.....
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence            99999999999999886  678999999999999999999999999999999999999   7788999999999987632


Q ss_pred             CCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          256 GQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       256 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ...   .........|+|||.+. ..++.++||||||+++|||++ |+.||......+....+.++....   ....++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence            221   22344667899999997 458999999999999999999 789998888888888886654422   2235789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      .+.++|.+||..||++|||+.++++.
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~~  258 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQE  258 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHhc
Confidence            99999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-43  Score=318.73  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=211.2

Q ss_pred             cceeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +.|++.+.||+|+||+||+|.+..+   ...||+|.+....  .......+.+|+.+++.++ ||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCce
Confidence            4588999999999999999997654   4579999886543  3445667889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +++|||+++++|.+++... +.+++..+..++.|++.||.|||+++|+|+||||+||++   ++++.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhccc
Confidence            9999999999999998764 468999999999999999999999999999999999999   778899999999998764


Q ss_pred             CC-Cccc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          255 PG-QIFT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       255 ~~-~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      .. ....  ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.........+.+......   +....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---PPPMDCP  234 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            21 1111  223456899999987 468999999999999999998 99999888877777777654322   1223578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.+.+|+.+||+.+|++||++.++++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l  262 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVSTL  262 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            9999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-43  Score=317.51  Aligned_cols=243  Identities=23%  Similarity=0.285  Sum_probs=204.1

Q ss_pred             eecccCCeEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          106 KLGQGQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .||+|+||.||+|.+  ..++..+|+|++.... ......+.+.+|+.+++.+. ||||+++++++. ....++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecCC
Confidence            589999999999964  4567889999986443 23445678899999999997 999999999875 456789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc----
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----  259 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~----  259 (363)
                      +++|.+++...+.+++..+..++.|++.||.|||++||+||||||.||++   ++++.+||+|||++.........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeec
Confidence            99999999888889999999999999999999999999999999999999   77889999999999765433221    


Q ss_pred             ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ....++..|+|||.+. ..++.++|+|||||++|||++ |..||......+....+.++...   .....+++++.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~  232 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---ECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHHH
Confidence            1223357899999887 458899999999999999998 99999888777777777765432   122357899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCC
Q 017960          338 KMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~  357 (363)
                      +||+.||++||++.+|...+
T Consensus       233 ~~~~~~p~~Rp~~~~i~~~l  252 (257)
T cd05116         233 LCWTYGVDERPGFAVVELRL  252 (257)
T ss_pred             HHhccCchhCcCHHHHHHHH
Confidence            99999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.2e-43  Score=320.86  Aligned_cols=253  Identities=28%  Similarity=0.459  Sum_probs=214.8

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|...+.||+|++|.||+|.+..+++.+|+|.+...   .....+.+.+|+.+++.+. ||||+++++++...+..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEEE
Confidence            455567999999999999999899999999988543   3334566889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-c
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~  258 (363)
                      ||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||++   +.++.++|+|||.+....... .
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCcc
Confidence            99999999998876 678999999999999999999999999999999999999   778899999999886543322 2


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+........ .....++..+.++|.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  250 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFLD  250 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHHH
Confidence            233568899999999874 589999999999999999999999988776666666655432221 122347889999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCccc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||+.||++||++.++++|+|+..
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~  274 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAK  274 (285)
T ss_pred             HHcccChhhCcCHHHHccCccccc
Confidence            999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-43  Score=324.14  Aligned_cols=258  Identities=28%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.++++++ ||||+++++++.+....++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEE
Confidence            358999999999999999999999999999999865432 2233456888999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||++ ++|.+++.....  +++..+..++.||+.||+|||+++++||||+|+||+++  ..++.+||+|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCC
Confidence            99995 588887765443  57888999999999999999999999999999999994  23457999999999764322


Q ss_pred             -CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-------------
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------------  320 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------------  320 (363)
                       .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||......+....+.......             
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence             22334567889999998864  47899999999999999999999998776655544432210000             


Q ss_pred             --------CC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          321 --------ES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       321 --------~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                              ..    ...+.+++++.++|.+||+.||++||++.++++|+||..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence                    00    012356889999999999999999999999999999964

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9e-44  Score=323.81  Aligned_cols=249  Identities=19%  Similarity=0.321  Sum_probs=210.5

Q ss_pred             ceeecceecccCCeEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      .|++.+.||+|+||.||+|.+..+     +..||+|.+....  .....+.+.+|+.++..+. ||||+++++++.+...
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCc
Confidence            488899999999999999987543     5789999986442  3344567889999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC
Q 017960          175 VHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~  238 (363)
                      .++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||++   ++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence            99999999999999888532                247888899999999999999999999999999999999   77


Q ss_pred             CccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 017960          239 DFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i  313 (363)
                      ++.+||+|||++........   .....+++.|+|||.+. +.++.++|||||||++|||++ |..||.+....+..+.+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            78899999999876533221   12344577899999886 568999999999999999998 88999888888888888


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ........   ...++..+.+|+.+||+.+|++||++++++..+
T Consensus       240 ~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l  280 (283)
T cd05091         240 RNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL  280 (283)
T ss_pred             HcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence            77654322   235789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.8e-43  Score=317.39  Aligned_cols=253  Identities=25%  Similarity=0.459  Sum_probs=212.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.++..........+.+.+|+++++++. |+||+++++.+.+.+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence            45899999999999999999998899999999987655445555778999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          179 MELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |||+++++|.+++..    ...+++..+..++.+++.||.|||+.||+||||+|+||++   +.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence            999999999988864    3458999999999999999999999999999999999999   778899999999987654


Q ss_pred             CCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--HHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ... ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||....  .....+.+..+...  ..+...++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence            322 2234568889999998874 58999999999999999999999996543  22344444433221  112235678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.++|.+||+.+|++|||+.++++.+
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~~~  262 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQVA  262 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=323.12  Aligned_cols=253  Identities=27%  Similarity=0.399  Sum_probs=208.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+..+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEe
Confidence            5678899999999999999999999999999875432 2233456788999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-C
Q 017960          181 LCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~  257 (363)
                      |+ +++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||++   ++++.++|+|||++...... .
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          79 FL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc
Confidence            99 468999887765  68999999999999999999999999999999999999   77889999999998764322 2


Q ss_pred             ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc-----------------
Q 017960          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI-----------------  318 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  318 (363)
                      ......++..|+|||++.+  .++.++|+||||+++|+|++|..||...........+.+...                 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            2234456889999998863  478999999999999999999999987665443333322100                 


Q ss_pred             --------ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          319 --------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       319 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                              .......+.++.++.++|.+||+.||++|||+.|++.|+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                    00011134567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-43  Score=320.38  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=210.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.+. ||||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCC
Confidence            456999999999999999999976443     789999986432  3344567889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccE
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~  242 (363)
                      ...++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+|+||||||+||++   +.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence            99999999999999999886532          36778999999999999999999999999999999999   788899


Q ss_pred             EEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCC
Q 017960          243 KAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH  317 (363)
Q Consensus       243 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  317 (363)
                      ||+|||++........   .....++..|+|||.+. +.++.++|||||||++|||++ |..||.+.......+.+..+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            9999999876543321   12344677899999887 468999999999999999998 999998888877777776443


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....   ...++.++.++|.+||+.+|++|||+.+++..+
T Consensus       239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  275 (277)
T cd05032         239 HLDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL  275 (277)
T ss_pred             CCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence            2211   234689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-43  Score=320.10  Aligned_cols=256  Identities=27%  Similarity=0.379  Sum_probs=209.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~i  177 (363)
                      .|+..+.||.|++|.||+|.+..+++.+|+|.+....  ......++.+|++++++++ ||||+++++++.+  .+.+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEE
Confidence            5888999999999999999999999999999987543  3345677899999999997 9999999998854  447899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ||||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||++   ++++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccc
Confidence            9999999999887643    3458899999999999999999999999999999999999   77788999999998764


Q ss_pred             CCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCc-----CHHHHHHHHHcCCcccCC-CCC-
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDFES-DPW-  325 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~-~~~-  325 (363)
                      .... .....++..|+|||.+. ..++.++|||||||++|+|++|..||...     ...+....+......... ... 
T Consensus       156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd06621         156 VNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN  234 (287)
T ss_pred             cccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence            3322 22456788999999887 46899999999999999999999999765     223444444332211111 111 


Q ss_pred             -CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          326 -PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       326 -~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                       ..+++++.+||.+||..||.+|||+.|+++|+|+...
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence             1346789999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-43  Score=316.40  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=212.0

Q ss_pred             ceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          105 RKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      +.||+|+||.||+|.+...   +..||+|.+.....  ....+.+.+|+..+..++ |+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEe
Confidence            4699999999999998766   88999999976542  225678999999999998 99999999999999999999999


Q ss_pred             cCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          182 CAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       182 ~~~~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +++++|.+++...         ..+++..+..++.|++.||+|||++|++||||||+||++   +.++.+||+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccc
Confidence            9999999999875         678999999999999999999999999999999999999   7788999999999987


Q ss_pred             cCCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          253 FKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       253 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .....   ......++..|+|||.+.. .++.++||||||+++|+|++ |..||.........+.+..+...   .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  231 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEY  231 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence            65432   2334567889999998874 68999999999999999999 69999888888888877764322   22235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++++.+++.+||+.||.+|||+.|+++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-43  Score=324.19  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=210.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ++|++.+.||+|+||.||++.+....     ..+|+|.+....  .......+.+|+.++.++.+|+||+++++++...+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            56899999999999999999876433     689999986542  34455678899999999955999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC
Q 017960          174 CVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~  237 (363)
                      .++++|||+++++|.+++...                +.+++..+..++.|++.||.|||+.+|+||||||+||++   +
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---T  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---c
Confidence            999999999999999998642                357899999999999999999999999999999999999   7


Q ss_pred             CCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHH
Q 017960          238 DDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA  312 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~  312 (363)
                      +++.+||+|||++........   .....++..|+|||.+. ..++.++|||||||++|||++ |..||.+....+..+.
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            788999999999986543321   11223456799999877 468999999999999999997 9999988887777777


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       313 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +..+...   ......+.++.+|+.+||+.||++|||+.++++.+
T Consensus       247 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l  288 (293)
T cd05053         247 LKEGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL  288 (293)
T ss_pred             HHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            6655322   12235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3e-43  Score=321.73  Aligned_cols=254  Identities=26%  Similarity=0.379  Sum_probs=202.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.++ |+||+++++++......++|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEE
Confidence            459999999999999999999999999999999865432  222345678999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.||+|+||||+||++   +.++.+||+|||++...... 
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCC
Confidence            99995 677776654 3557889999999999999999999999999999999999   77889999999998754322 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcC--------------Ccc
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKG--------------HID  319 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~--------------~~~  319 (363)
                      .......+++.|+|||.+.+  .++.++||||||+++|+|++|..||.+.... +.+..+...              ...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            22334567889999999864  4788999999999999999999999765432 111111100              000


Q ss_pred             cCCC------------CCC--CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 FESD------------PWP--LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 ~~~~------------~~~--~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +...            .+.  ..+.++.+++.+||..||.+|||+.|++.|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            0000            000  125689999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-43  Score=325.28  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=209.7

Q ss_pred             ccceeecceecccCCeEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      .++|.+++.||+|+||.||+|.+..       +...+|+|.+....  .......+.+|+.+++.+.+||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3569999999999999999998643       23469999987542  34455678899999999966999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                      ..+..++||||+++++|.+++....                .+++..+..++.|++.||+|||++|++||||||+||++ 
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-  173 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-  173 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence            9999999999999999999997642                37889999999999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHH
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~  309 (363)
                        ++++.+||+|||++........   .....++..|+|||++.+ .++.++|||||||++|||++ |..||.+....+.
T Consensus       174 --~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         174 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             --cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence              7788999999999876543221   112234568999998874 58999999999999999998 8999988877777


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+.+.....   .+....++.++.+|+.+||..+|++||++.++++.+
T Consensus       252 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l  296 (307)
T cd05098         252 FKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  296 (307)
T ss_pred             HHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            776665432   122235789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.9e-43  Score=321.68  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=208.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||.|++|.||+|.+..++..||+|.+....  .......+.+|+.++++++ |+||+++++.+.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc--cccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEE
Confidence            3888999999999999999999999999999987543  2233456778999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          180 ELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||||+||++   ++++.++|+|||++......
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCC
Confidence            99975 888887654   358999999999999999999999999999999999999   77889999999998754322


Q ss_pred             -CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-----------
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-----------  322 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------  322 (363)
                       .......++..|++||.+.+  .++.++||||||+++|+|++|..||.+....+....+.........           
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             22234567889999998864  4789999999999999999999999877665554443321100000           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          323 --------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       323 --------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                    ...+.++.++.++|.+||+.||.+||++.+++.|+||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                          0012357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.2e-43  Score=323.46  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=208.4

Q ss_pred             cccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||+|.+....  .....+.+.+|+.+++++.+||||+++++++..
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            4467999999999999999999752     345689999886543  334457889999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                      .+..+++|||+.+++|.+++....  .+++.++..++.+++.||.|||+++|+|+||||+|||+   ++++.++|+|||+
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~  187 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL  187 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence            999999999999999999987643  38999999999999999999999999999999999999   7788999999999


Q ss_pred             ceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCC
Q 017960          250 SVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       250 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  324 (363)
                      +........   .....++..|+|||.+. ..++.++|||||||++|||++ |..||......+.+..........  ..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~  265 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQ  265 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CC
Confidence            976543221   12234567899999887 468999999999999999998 999998766555444443332221  12


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....++++.+++.+||+.+|++|||+.|+++.+
T Consensus       266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l  298 (302)
T cd05055         266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI  298 (302)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            234688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-43  Score=322.34  Aligned_cols=255  Identities=29%  Similarity=0.510  Sum_probs=212.9

Q ss_pred             eeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      |++.+.||.|+||.||+|.+.   .+|..||+|++...... .....+.+.+|+.++.++.+|+||+.+++.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            788999999999999999875   47899999998754321 22334678899999999977999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||+   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecccc
Confidence            999999999999999888889999999999999999999999999999999999999   77889999999999765433


Q ss_pred             C--ccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCH----HHHHHHHHcCCcccCCCCCCC
Q 017960          257 Q--IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       257 ~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .  ......|+..|+|||.+..   .++.++||||||+++|+|++|..||.....    ....+.+......+    ...
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~  234 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQE  234 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Ccc
Confidence            2  2234568899999999863   478899999999999999999999964332    33334433333222    234


Q ss_pred             CCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          328 ISDSAKDLIRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      +++.+.+++.+||..||++||     ++.+++.|+|++.+
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            788999999999999999997     89999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.9e-43  Score=320.01  Aligned_cols=256  Identities=23%  Similarity=0.313  Sum_probs=209.9

Q ss_pred             ccceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|++.+.||+|+||.||+|..+.     .+..||+|.+....  .......+.+|+.+++.+. ||||+++++++.+.
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~   81 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKG   81 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC
Confidence            4579999999999999999997542     34579999886432  2334456788999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccE
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~  242 (363)
                      ...++||||+++++|.+++...+          .++...+..++.||+.||.|||+++|+||||||+||++   ++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence            99999999999999999997532          24567889999999999999999999999999999999   778899


Q ss_pred             EEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCC
Q 017960          243 KAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH  317 (363)
Q Consensus       243 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  317 (363)
                      +|+|||++........   .....++..|+|||.+. +.++.++|+|||||++|||++ |..||.+....+..+.+..+.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876433221   11234467899999987 468999999999999999998 789998888777777766554


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------CCCcccC
Q 017960          318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC------MYNLPVL  362 (363)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~------~~~~~~~  362 (363)
                      ....   ....++++.+++.+||+.||++|||+.++++      ++||..+
T Consensus       239 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         239 YLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            3221   1245789999999999999999999999998      7777543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-43  Score=317.87  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=206.9

Q ss_pred             eeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe---
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC---  174 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---  174 (363)
                      |++++.||+|+||.||+|....+   +..||+|.+..... .......+.+|+..++.+. ||||+++++++.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence            56788999999999999997654   47899999875332 3455678999999999997 9999999998765443   


Q ss_pred             ---EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEe
Q 017960          175 ---VHIVMELCAGGELFDRIIQR------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (363)
Q Consensus       175 ---~~iv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~  245 (363)
                         .+++|||+++++|...+...      ..+++..+..++.|++.||.|||+.+++||||||+||++   ++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEEC
Confidence               79999999999998887442      358999999999999999999999999999999999999   778899999


Q ss_pred             ecCcceecCCCCcc---ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCccc
Q 017960          246 DFGLSVFFKPGQIF---TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       246 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                      |||++.........   ....++..|+|||.+. ..++.++|||||||++|||++ |..||.+....+..+.+..+....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999875433221   1123456899999987 458999999999999999999 999998888878877777654322


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                         ....+++++.+++.+||+.||++|||+.|+++++
T Consensus       236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l  269 (273)
T cd05035         236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL  269 (273)
T ss_pred             ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence               2235789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.3e-43  Score=315.69  Aligned_cols=247  Identities=23%  Similarity=0.353  Sum_probs=208.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||+|.+.. +..+|+|.+....    ...+.+.+|+.+++++. ||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEE
Confidence            348899999999999999998643 4569999886432    22356889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||++   ++++.+||+|||.+.......
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCc
Confidence            9999999999988764 468999999999999999999999999999999999999   778899999999987654433


Q ss_pred             ccc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          258 IFT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       258 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ...  ...++..|+|||.+. ..++.++|||||||++|+|++ |..||......+....+..+......   ...++.+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            211  223456799999987 468999999999999999998 99999887777777777665433222   24678999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.+||+.||.+||++.+++..+
T Consensus       232 ~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         232 AIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHHHhh
Confidence            999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-43  Score=319.16  Aligned_cols=248  Identities=21%  Similarity=0.275  Sum_probs=206.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ++|++.+.||+|+||+||+|.+..++.    .||+|++....  .......+.+|+.+++.+. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~~   82 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-ST   82 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-CC
Confidence            458899999999999999999877776    48999886443  4445567889999999997 9999999998865 45


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .+++|||+++|+|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||+   ++++.+||+|||++...
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCceeec
Confidence            78999999999999998764 568999999999999999999999999999999999999   67778999999999876


Q ss_pred             CCCCcc---ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          254 KPGQIF---TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       254 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ......   ....++..|+|||.+. ..++.++|||||||++|||++ |..||...........+..+...   .....+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~  236 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL---PQPPIC  236 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC---CCCccC
Confidence            433221   1223466899999987 468999999999999999998 99999877766666665554322   122457


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.++.+++.+||+.||++||++.+++..
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.9e-43  Score=318.77  Aligned_cols=253  Identities=27%  Similarity=0.416  Sum_probs=214.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||.|+||.||+|.+..+++.||+|.+....  .......+.+|+.++.++. ||||+++++++.++...++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEE
Confidence            45788899999999999999998899999999886443  2344567889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||+++++|.+++.. ..+++..+..++.+++.|+.+||+.|++|+||+|+||++   +.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh
Confidence            999999999888754 568999999999999999999999999999999999999   778899999999987654332 


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......++..|+|||.+.. .++.++|+|||||++|+|++|..||...........+......   .....++.++.++|
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i  233 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFV  233 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC---CCCcccCHHHHHHH
Confidence            2233567889999999874 5888999999999999999999999776665555555443221   11234688999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||+.+|.+||++.++++|+|+..
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~~~~~~~  258 (277)
T cd06641         234 EACLNKEPSFRPTAKELLKHKFIVR  258 (277)
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhh
Confidence            9999999999999999999999853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=320.30  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=211.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVHIV  178 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~iv  178 (363)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+. |+|++++++++...  ...++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEE
Confidence            677889999999999999999899999999997653 23334467888999999998 99999999999888  899999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||++ ++|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||++   ++++.+||+|||++.......
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          79 FEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             ecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCC
Confidence            99996 4888888665 578999999999999999999999999999999999999   788899999999998765433


Q ss_pred             --ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCC---------
Q 017960          258 --IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP---------  324 (363)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---------  324 (363)
                        ......++..|+|||.+.+  .++.++||||||+++|||++|..||...........+.+.........         
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence              2344567888999998763  488999999999999999999999988776665555443211111000         


Q ss_pred             -----------------CCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          325 -----------------WPL-ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       325 -----------------~~~-~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                       ... ++.++.++|.+||+.||.+||++.++++++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                             111 37889999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-45  Score=325.09  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=234.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|..+.+||+|+||+|.+|..+.+.+.+|||++++....+..+++--..|-++|.....-|.+++++..|+.-+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            47788999999999999999999999999999998877777777777788888887666789999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec-CCCCc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~-~~~~~  258 (363)
                      ||+.||+|.-++++-+++.+..+..++..|+-||-+||++|||+||||.+||++   +.+|++||+|||+++.. -.+..
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccCCcc
Confidence            999999999999999999999999999999999999999999999999999999   99999999999999763 34556


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ..+++|||.|+|||++. ..|+..+|.||+|++||||+.|.+||.+..+.+++..|......++.    .+|.++.++..
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ick  582 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAICK  582 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHHHH
Confidence            67899999999999987 67999999999999999999999999999999999999998887775    48999999999


Q ss_pred             HhcccCcCCCCCH-----HHHhcCCCcccC
Q 017960          338 KMLCSQPSERLTA-----HEVLCMYNLPVL  362 (363)
Q Consensus       338 ~~l~~dp~~R~s~-----~evL~~~~~~~~  362 (363)
                      ..|.+.|.+|...     ++|-.|+||..+
T Consensus       583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  583 GLLTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             HHhhcCCccccCCCCccccchhhCcchhhc
Confidence            9999999999843     688889998654

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-43  Score=315.13  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=208.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|++|.||+|.+. +++.||+|.+....    ...+.+.+|+.++++++ ||||+++++++...+..++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeee
Confidence            356899999999999999999964 45689999986532    22456889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||||+++++|.+++....  .+++..+..++.|++.||.+||+.||+||||||+||++   ++++.+||+|||++.....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccC
Confidence            999999999999987654  68999999999999999999999999999999999999   7788999999999987653


Q ss_pred             CCccc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQIFT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .....  ....+..|+|||.+. ..++.++||||||+++|||++ |+.||.+.........+......   .....++..
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---PCPPGCPKE  232 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHH
Confidence            22111  112235799999887 468999999999999999999 99999888877777776554221   122357899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.+++.+||+.||++||++.+++..+
T Consensus       233 ~~~li~~~l~~~P~~Rp~~~~l~~~l  258 (261)
T cd05068         233 LYDIMLDCWKEDPDDRPTFETLQWKL  258 (261)
T ss_pred             HHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.5e-43  Score=324.95  Aligned_cols=252  Identities=29%  Similarity=0.464  Sum_probs=213.4

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |.....||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++..+. ||||+++++.+..++..++|||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEEEe
Confidence            555668999999999999998899999999986543   233466889999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-cc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-IF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~~  259 (363)
                      |+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||++   +.++.+||+|||++....... ..
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~  174 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKR  174 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccccc
Confidence            9999999886644 568999999999999999999999999999999999999   788899999999987543322 22


Q ss_pred             ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....++..|+|||.+.+ .++.++|||||||++|||++|..||...........+...... .......++.++.++|.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDFLER  253 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHHHHH
Confidence            34678899999999874 6899999999999999999999999877766666655443222 222334578899999999


Q ss_pred             hcccCcCCCCCHHHHhcCCCccc
Q 017960          339 MLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||+.+|++||++.++++|+|+..
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhcc
Confidence            99999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.6e-43  Score=312.28  Aligned_cols=252  Identities=28%  Similarity=0.492  Sum_probs=219.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+++++.++ |||++++.+.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEE
Confidence            48889999999999999999988999999999875432 3455678899999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          180 ELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       180 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||+++++|.+.+...    ..+++..+..++.+++.||.+||+.|++|+||+|+||++   ++++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeeccc
Confidence            999999999988764    678999999999999999999999999999999999999   7778999999999987644


Q ss_pred             CC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ......+++.|+|||.+.+ .++.++|+||+|+++++|++|..||.....................   ..++.++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  232 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP---SQYSSELR  232 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            33 3334578889999998874 5899999999999999999999999887777777776655432222   25789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +++.+||..+|++||++.++|+++||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=288.74  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=220.0

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|...++||+|.||+||+|++..+++.||+|.++.... ++..-....+||.+|+.|. |.|||+++++...+..+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelk-hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence            36667899999999999999999999999999976542 2233456789999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          180 ELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       180 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      ||| ..+|..+... ++.+..+.++.++.|++.||.++|++++.||||||.|+||   +.+|.+||+|||+++.+.-.- 
T Consensus        81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCceE
Confidence            999 5577777655 5779999999999999999999999999999999999999   889999999999998765443 


Q ss_pred             ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC-------
Q 017960          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL-------  327 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-------  327 (363)
                      .+...+.|.+|++|.++.+  -|+...|+||.|||+.|+.. |++.|.+....+.+..|.+..-...++.|+.       
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            4566778999999999985  49999999999999999987 8888999988888888877544444444432       


Q ss_pred             ------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          328 ------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       328 ------------------~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                        ++..-++|++++|.-+|..|++++++|+|++|..+
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                              23456899999999999999999999999999754

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.5e-43  Score=317.88  Aligned_cols=248  Identities=22%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             eecceecccCCeEEEEEEEccCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec------CC
Q 017960          102 TLGRKLGQGQFGTTYLCTEIATGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------SL  173 (363)
Q Consensus       102 ~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~~  173 (363)
                      .+++.||+|+||.||+|.+..++.  .||+|.+.... ......+.+.+|+.+++.++ |+||+++++++..      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCC
Confidence            467899999999999999877765  68999886532 24556778899999999997 9999999997643      23


Q ss_pred             eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          174 CVHIVMELCAGGELFDRIIQ------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      ..+++|||+++++|.+++..      ...+++..+..++.||+.||.|||+++|+||||||+|||+   ++++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCC
Confidence            57899999999999887743      1347899999999999999999999999999999999999   77889999999


Q ss_pred             CcceecCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          248 GLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       248 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      |++........   .....+++.|+|||.+.+ .++.++|||||||++|||++ |..||.+.......+.+..+....  
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--  234 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK--  234 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            99987643322   122345678999999874 58999999999999999999 899998877777777776654321  


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                       ..+.++..+.++|.+||+.||++|||+.++++.+
T Consensus       235 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  268 (272)
T cd05075         235 -QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL  268 (272)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence             1235788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.3e-43  Score=315.17  Aligned_cols=252  Identities=27%  Similarity=0.477  Sum_probs=214.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|.+.+.||.|+||.||+|.+..++..+|+|.+..... .....+.+.+|+.+++.++ |+||+++++.+......++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEE
Confidence            37889999999999999999999999999999876432 2234567889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC-ccEEEeecCcceecCCC
Q 017960          180 ELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~-~~~kl~DFG~a~~~~~~  256 (363)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||||+||++   +++ ..+||+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL---SKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---cCCCCeEEecccccchhccCC
Confidence            9999999999887643  47899999999999999999999999999999999999   544 45799999998765433


Q ss_pred             C-ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 Q-IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      . ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||......+....+.......   ..+.++.++.+
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRS  232 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHH
Confidence            2 223356888999999887 458999999999999999999999998777666666555544322   22357889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +|.+||..+|++|||+.++++++||
T Consensus       233 ~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         233 LISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.6e-43  Score=321.35  Aligned_cols=248  Identities=22%  Similarity=0.380  Sum_probs=209.0

Q ss_pred             ceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      .|.+.+.||+|+||.||+|.+..     ++..+++|.+...   .....+.+.+|+.++++++ |+||+++++++.....
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   81 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCc
Confidence            48889999999999999998543     4556889987543   3344567889999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC
Q 017960          175 VHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~  238 (363)
                      .++||||+++++|.+++...+                .+++..+..++.||+.||.|||++||+||||||+|||+   ++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence            999999999999999986542                37889999999999999999999999999999999999   77


Q ss_pred             CccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 017960          239 DFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i  313 (363)
                      ++.++|+|||++.......   ......++..|+|||.+. ..++.++|||||||++|||++ |..||......+..+.+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            8899999999997653322   122345678899999887 468999999999999999998 99999888877777777


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+.....   ...++.++.+++.+||+.||.+||++.++++.+
T Consensus       239 ~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l  279 (291)
T cd05094         239 TQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL  279 (291)
T ss_pred             hCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            66544322   234688999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.1e-43  Score=315.42  Aligned_cols=248  Identities=28%  Similarity=0.409  Sum_probs=202.1

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      ..||+|+||.||+|.+..++..||+|.+...   .....+.+.+|+.+++.++ |+||+++++++...+..++|+||+++
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~   89 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPG   89 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCCC
Confidence            5799999999999999899999999988654   3345678899999999998 99999999999999999999999999


Q ss_pred             CChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-ccc
Q 017960          185 GELFDRIIQR-GHY--SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-IFT  260 (363)
Q Consensus       185 ~~L~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~~~  260 (363)
                      ++|.+++... ..+  ++..+..++.||+.||.|||+.||+||||||+||++.  ..++.++|+|||++....... ...
T Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccc
Confidence            9999998764 445  7888999999999999999999999999999999993  225689999999987654322 223


Q ss_pred             cCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          261 DVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       261 ~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ...++..|+|||.+.+   .++.++|+||||+++|+|++|..||............ .............+++++.+|+.
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHHH
Confidence            3467889999999863   3889999999999999999999999654322111110 11011111122357889999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +||+.+|++|||+.+++.||||
T Consensus       247 ~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-43  Score=315.25  Aligned_cols=246  Identities=25%  Similarity=0.374  Sum_probs=206.4

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|+||.||+|.+. ++..+|+|++.+...    ....+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEE
Confidence            4888999999999999999875 566899998864322    2346778999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++   ++++.+||+|||++........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecccccc
Confidence            999999999998764 468999999999999999999999999999999999999   7788999999999976543322


Q ss_pred             cc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          259 FT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       259 ~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ..  ...++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+......   .....++.++.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---YRPKLAPTEVYT  232 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence            11  112345799999887 568999999999999999999 89999887777777766654221   222357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCC
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+||+.+|++|||+.++++.+
T Consensus       233 li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         233 IMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHhcCChhhCcCHHHHHHHh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.4e-43  Score=323.71  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=209.8

Q ss_pred             cccceeecceecccCCeEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~  169 (363)
                      ..++|.+.+.||+|+||.||+|.+..       ....+|+|.+....  .......+.+|+.+++++.+||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34679999999999999999998532       34579999886432  3445677889999999996699999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEe
Q 017960          170 EDSLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (363)
Q Consensus       170 ~~~~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll  233 (363)
                      .+.+..+++|||+++++|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999998653                247889999999999999999999999999999999999


Q ss_pred             eeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHH
Q 017960          234 VNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (363)
Q Consensus       234 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~  308 (363)
                         ++++.+||+|||++........   .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+
T Consensus       168 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 ---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             ---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence               7778999999999976543221   11223346799999987 458999999999999999999 899998888888


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+..+...   .....++.++.+++.+||+.||++|||+.++++.+
T Consensus       245 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l  290 (314)
T cd05099         245 LFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL  290 (314)
T ss_pred             HHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            77777655321   12235688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.8e-44  Score=331.80  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=210.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe----cCC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----DSL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~  173 (363)
                      .+.|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++++. ||||+++++++.    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence            4679999999999999999999999999999999875432 2344567888999999998 999999999875    345


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..++||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   ++++.+||+|||++...
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL  157 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence            7899999995 6899988877889999999999999999999999999999999999999   78889999999999765


Q ss_pred             CCCC-----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----------
Q 017960          254 KPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG----------  316 (363)
Q Consensus       254 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~----------  316 (363)
                      ....     ......++..|+|||.+.+  .++.++|||||||++|||++|+.||.+.........+...          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            3322     1234578899999998863  4899999999999999999999999766543322221110          


Q ss_pred             ------------Ccc-cCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          317 ------------HID-FESD----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       317 ------------~~~-~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                  ... ....    ..+.++.++.++|.+||+.||++||++.+++.|+|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence                        000 0000    12346889999999999999999999999999999953

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-43  Score=317.05  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             ceecccCCeEEEEEEEccCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEecc
Q 017960          105 RKLGQGQFGTTYLCTEIATGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      +.||+|+||.||+|.+..++.  .+|+|.+....  .....+.+.+|+.++.++.+||||+++++++...+..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            369999999999999887776  46888775322  34456688899999999966999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          183 AGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       183 ~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                      ++++|.+++....                .+++..+..++.|++.||+|||+.|++||||||+||++   ++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECC
Confidence            9999999987543                37889999999999999999999999999999999999   7888999999


Q ss_pred             cCcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCC
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  324 (363)
                      ||++..............+..|+|||++. ..++.++|||||||++|||++ |..||.+....+....+.....   .+.
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC---CCC
Confidence            99986432111111223356799999887 458999999999999999997 9999988777777776655321   112


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...++.++.+|+.+||+.||.+|||+.+++..+
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  265 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  265 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence            234688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-43  Score=343.25  Aligned_cols=262  Identities=21%  Similarity=0.256  Sum_probs=195.8

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCc-EEEEE--------------EeeccccCChhhHHHHHHHHHHHHHhcCC
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGI-EFACK--------------SISKRKLISREDVEDVRREIQIMHHLAGH  159 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~~h  159 (363)
                      +.+.++|++++.||+|+||+||+|..+.... .++.|              .+.+...........+.+|+.+|+++. |
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-H  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-C
Confidence            3456789999999999999999987543322 22222              111111112334567889999999998 9


Q ss_pred             CceeEEeEEEecCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       160 ~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                      |||+++++++...+..|+|+|++ +++|.+++...     .......+..++.||+.||.|||++|||||||||+|||+ 
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl-  300 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-  300 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-
Confidence            99999999999999999999998 56787776542     223467788999999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCCc--cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC---H-H
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---Q-Q  307 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~---~-~  307 (363)
                        +.++.+||+|||++........  .....||..|+|||++.+ .++.++|||||||++|||++|..++.+..   . .
T Consensus       301 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 --NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             --CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence              7788999999999987654322  234679999999999874 59999999999999999999886543322   1 1


Q ss_pred             HHHHHHHcCC---cccC------------------CC------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          308 GIFDAVLKGH---IDFE------------------SD------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       308 ~~~~~i~~~~---~~~~------------------~~------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+.+.+....   ..++                  ..      ....++.++.++|.+||+.||.+|||+.|+|.|+||.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            2222111100   0000                  00      0013566788999999999999999999999999986


Q ss_pred             c
Q 017960          361 V  361 (363)
Q Consensus       361 ~  361 (363)
                      .
T Consensus       459 ~  459 (501)
T PHA03210        459 A  459 (501)
T ss_pred             c
Confidence            4

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-43  Score=326.18  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=202.7

Q ss_pred             ceeecceecccCCeEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~  175 (363)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+...........+.+.+|+.+++.++ ||||+++++++.+.  ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            37888999999999999999988  89999999997643223334467788999999998 99999999999888  889


Q ss_pred             EEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC----CccEEEee
Q 017960          176 HIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD----DFSLKAID  246 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~----~~~~kl~D  246 (363)
                      ++||||++ ++|.+.+...     ..+++..+..++.||+.||.|||+.+|+||||||+||++   +.    ++.+||+|
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~---~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV---MGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEE---cCCCCccceEEECC
Confidence            99999996 4777766432     268899999999999999999999999999999999999   55    88999999


Q ss_pred             cCcceecCCCCc----cccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH---------HHH
Q 017960          247 FGLSVFFKPGQI----FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQG---------IFD  311 (363)
Q Consensus       247 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---------~~~  311 (363)
                      ||++........    .....++..|+|||++.+  .++.++|||||||++|+|++|+.||.+.....         .+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999886533221    223567889999998764  48999999999999999999999997554321         111


Q ss_pred             HHHcCC----------------c-----ccCCCCC------------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          312 AVLKGH----------------I-----DFESDPW------------PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       312 ~i~~~~----------------~-----~~~~~~~------------~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      .+....                .     .......            ...+.++.++|.+||+.||++|||+.|++.|+|
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            110000                0     0000011            145678999999999999999999999999999


Q ss_pred             c
Q 017960          359 L  359 (363)
Q Consensus       359 ~  359 (363)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-45  Score=305.90  Aligned_cols=250  Identities=28%  Similarity=0.362  Sum_probs=207.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-----CC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----SL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-----~~  173 (363)
                      ++|++.+.||+|||+-||+++...++..||+|.+...   ..+..+...+|++.-+++. ||||++++++...     ..
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCce
Confidence            5799999999999999999999999999999999765   4567789999999999998 9999999987633     34


Q ss_pred             eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeec
Q 017960          174 CVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      ..||++.|...|+|.+.+...    ..+++.++..|+.+|++||++||+..  ++||||||.|||+   .+.+.++|.||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D~  173 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMDL  173 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe---cCCCceEEEec
Confidence            599999999999999988652    36899999999999999999999999  9999999999999   67889999999


Q ss_pred             CcceecCCC----C------ccccCccCCccccccccc-c---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH--HHHH
Q 017960          248 GLSVFFKPG----Q------IFTDVVGSPYYVAPEVLL-K---HYGPEADVWTAGVILYILLSGVPPFWAETQQ--GIFD  311 (363)
Q Consensus       248 G~a~~~~~~----~------~~~~~~gt~~y~aPE~~~-~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~  311 (363)
                      |+++...-.    .      ...+...|..|+|||.+. +   ..+.++|||||||+||.|+.|..||.....+  .+.-
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            998764211    0      112334588999999986 2   3789999999999999999999999432221  1223


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       312 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+..+.+.++...  .+|+.+.+||+.||+.||.+||++.+++.+.
T Consensus       254 Av~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~  297 (302)
T KOG2345|consen  254 AVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKL  297 (302)
T ss_pred             eeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence            3344455555443  3899999999999999999999999998754

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.8e-43  Score=327.62  Aligned_cols=260  Identities=27%  Similarity=0.389  Sum_probs=212.2

Q ss_pred             cccceee-cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChh-----------hHHHHHHHHHHHHHhcCCCceeE
Q 017960           97 IRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----------DVEDVRREIQIMHHLAGHKNIVT  164 (363)
Q Consensus        97 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~  164 (363)
                      +.++|.. .+.||.|+||.||+|.+..+++.||||++.........           ....+.+|+.+++.++ |+||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence            4566764 57899999999999999999999999998654322110           0124778999999998 999999


Q ss_pred             EeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEE
Q 017960          165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       165 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                      +++++...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~~~kl  160 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKI  160 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCCCEEE
Confidence            9999999999999999996 6899999888889999999999999999999999999999999999999   77889999


Q ss_pred             eecCcceecCCC---------------CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH
Q 017960          245 IDFGLSVFFKPG---------------QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQ  307 (363)
Q Consensus       245 ~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~  307 (363)
                      +|||++......               .......++..|+|||.+.+  .++.++|+|||||++|+|++|..||.+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998765411               11223456788999999874  4789999999999999999999999888776


Q ss_pred             HHHHHHHcCCcccCC------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          308 GIFDAVLKGHIDFES------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       308 ~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+..+.........                        ...+..+.++.++|.+||+.||++||+++|+|.|+|+..
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~  318 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS  318 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence            655544331110000                        011245788999999999999999999999999999964

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.7e-43  Score=319.94  Aligned_cols=257  Identities=24%  Similarity=0.293  Sum_probs=210.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|+||.||+|.+..+++.||||.+.+..  .......+..|+.++.++.+||||+++++++.+....++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            356899999999999999999998889999999997543  223345667788877777679999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +|||+ ++++.+.+.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||++   ++++.+||+|||++.....
T Consensus        92 v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          92 CMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             Eeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccC
Confidence            99998 4577666654 4568999999999999999999997 699999999999999   7788999999999876654


Q ss_pred             CCccccCccCCcccccccccc-----cCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcccCCCCCCCCC
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      ........++..|+|||.+.+     .++.++||||||+++|+|++|+.||.... ..+.+..+........ .....++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  246 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFS  246 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCC
Confidence            443444567889999999863     27889999999999999999999996533 2344444444432211 1112468


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +++.+|+.+||+.||++||++.+++.|+|+..
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            89999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-43  Score=322.01  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=210.1

Q ss_pred             ccceeecceecccCCeEEEEEEEc-------cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEI-------ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      .++|.+.+.||+|+||.||+|.+.       .++..||+|.+....  .......+.+|+.+++.+.+||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            456999999999999999999753       234579999886432  34456788999999999955999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                      .....++||||+++++|.+++...                ..++...+..++.||+.||.|||++||+||||||+||++ 
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili-  170 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV-  170 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE-
Confidence            999999999999999999998763                236778899999999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHH
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~  309 (363)
                        ++++.+||+|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+.
T Consensus       171 --~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         171 --TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             --cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence              7788999999999987643221   122345678999999874 58999999999999999998 8899988888888


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+.+.......   ....++.++.+||.+||..+|++|||+.++++.+
T Consensus       249 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l  293 (304)
T cd05101         249 FKLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL  293 (304)
T ss_pred             HHHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence            77776553221   2235789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-42  Score=309.30  Aligned_cols=250  Identities=33%  Similarity=0.473  Sum_probs=214.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||+|++|.||+|.+..+++.+++|++.....   .....+.+|+.+++.+. |+||+++++.+......++++|
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEe
Confidence            7788999999999999999988999999999975432   45678899999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc
Q 017960          181 LCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~  259 (363)
                      |+++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++   ++++.++|+|||.+.........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  154 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKAR  154 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeeccccccccccccc
Confidence            99999999988776 578999999999999999999999999999999999999   77889999999999876554333


Q ss_pred             ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....++..|+|||.+.. .++.++|+||||+++|+|++|..||...........+....... ......++.++.++|.+
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHHHHHH
Confidence            45678899999999874 58899999999999999999999998775544444444322211 11112347899999999


Q ss_pred             hcccCcCCCCCHHHHhcCCC
Q 017960          339 MLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~~  358 (363)
                      ||+.||++|||+.++|+|+|
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.7e-43  Score=317.71  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIE----FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.|++.+.||+|+||+||+|.+..++..    +++|.+....  ......++..|+..+.++. ||||+++++++. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GAS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCc
Confidence            4588899999999999999998777764    6667664221  2334567888888999997 999999999875 455


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++++||+++++|.+++... +.+++..+..++.||+.||.|||+.+++||||||+|||+   ++++.+||+|||++...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLL  159 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceec
Confidence            78899999999999999764 568999999999999999999999999999999999999   78889999999999865


Q ss_pred             CCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          254 KPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       254 ~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ....   ......++..|+|||.+. +.++.++|||||||++|||++ |..||.+.......+.+..+......   ..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~  236 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QIC  236 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCC
Confidence            4332   123345677899999987 569999999999999999998 99999888777766666554432221   246


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.++.+++.+||..||++|||+.|+++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         237 TIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            7889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.2e-43  Score=315.71  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=209.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+|++.+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+.+|+.+++++. ||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCcc
Confidence            358899999999999999999765443   69999886432  3445678899999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++... +.+++.++..++.|++.||.|||+.|++||||||+|||+   +.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence            9999999999999998764 458999999999999999999999999999999999999   778899999999998654


Q ss_pred             CCCcc----ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQIF----TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      .....    ....++..|+|||.+. +.++.++|+|||||++||+++ |..||.+....+....+..+..   .+....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  234 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---LPAPMDC  234 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---CCCCCCC
Confidence            33211    1122356799999987 468999999999999999886 9999988877777777765422   1222357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++++.+++.+||+.+|.+||++.++++.+
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  263 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVSIL  263 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence            88999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.8e-43  Score=318.24  Aligned_cols=249  Identities=20%  Similarity=0.354  Sum_probs=208.6

Q ss_pred             cceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .+|.+.++||+|+||.||+|...     .++..+|+|.+...   .......+.+|+++++.++ |+||+++++++.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCC
Confidence            34788899999999999999742     35668999987643   3455678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC
Q 017960          174 CVHIVMELCAGGELFDRIIQRG---------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~  238 (363)
                      ..+++|||+++++|.+++...+               .+++..+..++.||+.||.|||+.|++||||||+|||+   ++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence            9999999999999999987643               47889999999999999999999999999999999999   77


Q ss_pred             CccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 017960          239 DFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i  313 (363)
                      ++.+||+|||++........   .....+++.|+|||.+. ..++.++|||||||++|||++ |.+||......+....+
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            88999999999876543221   12233467899999887 468999999999999999998 99999887777777777


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+...   .....+++.+.+||.+||+.||++||++.++++.+
T Consensus       238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l  278 (280)
T cd05092         238 TQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL  278 (280)
T ss_pred             HcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            655432   12235789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-43  Score=321.65  Aligned_cols=253  Identities=23%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             cceeecceecccCCeEEEEEEEccC--------------CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIAT--------------GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT  164 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~  164 (363)
                      ++|++.+.||+|+||.||+|.+..+              ...||+|.+....  .......+.+|++++++++ |+||++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLK-NPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence            5699999999999999999986543              2358999986532  3445667999999999998 999999


Q ss_pred             EeEEEecCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceE
Q 017960          165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRG------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFL  232 (363)
Q Consensus       165 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIl  232 (363)
                      +++++...+..++||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886532            3678889999999999999999999999999999999


Q ss_pred             eeeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCcCH
Q 017960          233 LVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--GVPPFWAETQ  306 (363)
Q Consensus       233 l~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~--g~~pf~~~~~  306 (363)
                      +   ++++.+||+|||++........   .....++..|+|||++. +.++.++|||||||++|+|++  |..||.....
T Consensus       162 l---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         162 V---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             E---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9   7788899999999976543321   12234467899999887 569999999999999999988  6788877766


Q ss_pred             HHHHHHHHcC----CcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          307 QGIFDAVLKG----HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       307 ~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ......+...    .........+.+++.+.+|+.+||..||++|||+.+|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l  293 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL  293 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            6655544321    11111122335689999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.9e-43  Score=316.08  Aligned_cols=248  Identities=22%  Similarity=0.371  Sum_probs=208.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      .|++.+.||+|+||.||+|.+..++.   .||||.+....  .......+..|+.+++.+. ||||+++++++.++...+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceE
Confidence            48899999999999999999877665   59999986532  4555678999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||++   +.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence            999999999999988763 568999999999999999999999999999999999999   7788999999999876543


Q ss_pred             CCcc---ccCc---cCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          256 GQIF---TDVV---GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       256 ~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ....   ....   .+..|+|||.+. ..++.++|||||||++|||++ |..||......+....+....   ..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~  235 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLPPPMD  235 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---cCCCccc
Confidence            2211   1111   234799999987 468999999999999999886 999998888777777765432   1222245


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ++.++.+++.+||..+|++||++.+++..
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            78899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=336.83  Aligned_cols=256  Identities=32%  Similarity=0.504  Sum_probs=238.6

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      ++++..||-|+||.|=++........+|+|++++....+..+.+.+..|-.+|..++ .|.||++|..|.+..++|++||
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhHH
Confidence            667788999999999999876666679999999998888888899999999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT  260 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~  260 (363)
                      -|-||.|...|..++.|.+..++.++..+++|++|||++|||+|||||+|+++   +.+|.+||.|||+|+.+..+....
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCCcee
Confidence            99999999999999999999999999999999999999999999999999999   999999999999999999998889


Q ss_pred             cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHh
Q 017960          261 DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (363)
Q Consensus       261 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  339 (363)
                      +++|||.|.|||++. +..+.++|.||||+++|||++|.+||.+.++...+..|.++.-.+..+  ..++..+.+||+++
T Consensus       578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~L  655 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKKL  655 (732)
T ss_pred             eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHHH
Confidence            999999999999887 568999999999999999999999999999999999999987665554  46889999999999


Q ss_pred             cccCcCCCCC-----HHHHhcCCCcccC
Q 017960          340 LCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       340 l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +..+|.+|..     ..||-+|-||.-|
T Consensus       656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  656 CRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             HhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            9999999985     7899999998643

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-43  Score=316.97  Aligned_cols=248  Identities=21%  Similarity=0.331  Sum_probs=211.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ..|++.++||.|+||.||+|.+.. +..+|+|.+...   .......+.+|+.+++.++ ||||+++++++.+....++|
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEEE
Confidence            458999999999999999999877 889999998654   2334567889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||+++++|.+++...  ..+++..+..++.||+.||.|||+.||+|+||||+||++   ++++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCc
Confidence            9999999999998753  458999999999999999999999999999999999999   77889999999999765433


Q ss_pred             Cc-cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          257 QI-FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       257 ~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+....+.+..+.....   ......+++++.
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---MPCPAKCPQEIY  234 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---CCCCCCCCHHHH
Confidence            21 12234566899999887 468999999999999999998 8999988887777777765422   122246789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.+||+.||.+|||+.++++.+
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~~L  258 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALREEL  258 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.3e-43  Score=319.54  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=206.1

Q ss_pred             eeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      |++.+.||+|+||.||+|.+..     ....+|+|.+....  .......+.+|+.+++.+. ||||+++++.+...+..
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPL   78 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCCc
Confidence            7788999999999999998653     23568998886443  3444678899999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCce
Q 017960          176 HIVMELCAGGELFDRIIQR------------------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NI  231 (363)
                      +++|||+.+++|.+++...                        ..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999987642                        2467889999999999999999999999999999999


Q ss_pred             EeeeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCH
Q 017960          232 LLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQ  306 (363)
Q Consensus       232 ll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~  306 (363)
                      |+   ++++.+||+|||++........   .....++..|+|||.+. ..++.++||||||+++|||++ |..||.+...
T Consensus       159 ll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         159 LV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             EE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99   7788999999999976533221   12234567899999876 458999999999999999998 9999988887


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+.+.....   ......++.++.+++.+||+.||++||++.++++.+
T Consensus       236 ~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l  283 (290)
T cd05045         236 ERLFNLLKTGYR---MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL  283 (290)
T ss_pred             HHHHHHHhCCCC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence            777776655421   122245789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.6e-45  Score=314.22  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=204.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-CC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~  173 (363)
                      ..|++++.||+|.||.||+|..+.++    +.+|+|.++.++.... .-....+|+.+++.|+ ||||+.+..+|.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELK-HPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhc-CCcchhHHHHHhccCc
Confidence            34899999999999999999755443    2689999876543221 2246778999999998 9999999999877 88


Q ss_pred             eEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC-CCCccEEEeec
Q 017960          174 CVHIVMELCAGGELFDRIIQR-----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-DDDFSLKAIDF  247 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~-~~~~~~kl~DF  247 (363)
                      .+++++||.+. +|...++..     ..++...++.|+.||+.|+.|||++-|+||||||.||||..+ .+.|.|||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999965 788877532     358999999999999999999999999999999999999432 23589999999


Q ss_pred             CcceecCCCC----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCH---------HHHHHH
Q 017960          248 GLSVFFKPGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ---------QGIFDA  312 (363)
Q Consensus       248 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~---------~~~~~~  312 (363)
                      |+++.+.+.-    .....+.|.+|+|||.+.+  +|+.+.||||+|||+.||++-.+.|.+...         .+.++.
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999875431    2345678999999999984  699999999999999999999988855322         233344


Q ss_pred             HHcCCcccCCCCCC---------------------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          313 VLKGHIDFESDPWP---------------------------------LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       313 i~~~~~~~~~~~~~---------------------------------~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      |..-.-......|+                                 .-++...+|+.+||..||.+|+|+.++|+|++|
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            43321111122221                                 123558899999999999999999999999998


Q ss_pred             cc
Q 017960          360 PV  361 (363)
Q Consensus       360 ~~  361 (363)
                      ..
T Consensus       341 ~~  342 (438)
T KOG0666|consen  341 TE  342 (438)
T ss_pred             cc
Confidence            53

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.9e-43  Score=351.91  Aligned_cols=149  Identities=26%  Similarity=0.428  Sum_probs=138.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.++||+|+||.||+|.+..+++.||||++.............+..|+.++..++ ||||+++++++.....+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEEE
Confidence            45999999999999999999999999999999998765555666678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      |||+.|++|.+++...+.+++..++.++.||+.||.|||+++||||||||+|||+   +.++.+||+|||++.
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999999999999999999999   778899999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-42  Score=309.38  Aligned_cols=252  Identities=33%  Similarity=0.493  Sum_probs=215.1

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCVHIV  178 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~iv  178 (363)
                      |.+.+.||+|++|.||+|.+..+++.|++|++..... .....+.+.+|+.+++++. ||||+++++.+...  ...+++
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEE
Confidence            7788999999999999999988999999999875533 2455778999999999998 99999999999988  899999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEecccccc
Confidence            9999999999999887789999999999999999999999999999999999999   7788999999999988765543


Q ss_pred             ---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          259 ---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       259 ---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                         .....++..|+|||.+.. .++.++||||||+++|+|++|..||.... .......+.....  .......++.++.
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~  234 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE--PPEIPEHLSEEAK  234 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC--CcCCCcccCHHHH
Confidence               345678889999999874 48999999999999999999999997655 2222222221111  1112234689999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ++|.+||..||++||++.+++.|+||
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.8e-43  Score=321.60  Aligned_cols=255  Identities=32%  Similarity=0.471  Sum_probs=212.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||++.+..++..||+|.+...   .....+.+.+|+.+++.++ ||||+++++.+...+..++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEE
Confidence            46799999999999999999998889999999998543   2233567889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++.......
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceecccccc
Confidence            9999999999988765 357899999999999999999999999999999999999   778899999999887654332


Q ss_pred             -ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 -IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                       ......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+..... ........++..+.++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l  248 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDF  248 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHHH
Confidence             223456888999999887 4589999999999999999999999977655443333322211 1111223467889999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |.+||..+|++||++.+++.|+||+.
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~  274 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKI  274 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhc
Confidence            99999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.9e-43  Score=325.06  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=209.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccC-------CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ..+|++++.||+|+||.||+|.+...       ...||+|.+....  .....+.+.+|+.+++++.+||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            34699999999999999999986432       2368999886432  34456788999999999955999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                      ..+..+++|||+++++|.+++.+..                .++...+..++.|++.||.|||++||+||||||+|||+ 
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill-  167 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV-  167 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE-
Confidence            9999999999999999999987532                36778899999999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHH
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~  309 (363)
                        ++++.+||+|||+++.......   .....++..|+|||++.+ .++.++||||||+++|||++ |..||.+....+.
T Consensus       168 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         168 --TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             --cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence              7778999999999986543221   122234567999999874 58999999999999999998 8999988888888


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+..+...   +....++.++.+|+.+||+.+|++||++.+++.++
T Consensus       246 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         246 FKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            7777654322   12235688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=311.35  Aligned_cols=253  Identities=29%  Similarity=0.444  Sum_probs=211.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccc--cCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK--LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~  175 (363)
                      .|++.+.||+|+||.||+|.+..++..||+|.+....  .........+.+|+.++++++ |+||+++++.+.+.  ..+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCEE
Confidence            5889999999999999999999999999999875432  112345678899999999998 99999999988654  568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +++|||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccccc
Confidence            8999999999999999887789999999999999999999999999999999999999   7788899999999976432


Q ss_pred             C----CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          256 G----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       256 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .    .......++..|+|||.+.+ .++.++|+|||||++|+|++|+.||...........+.....  .......+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~  236 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVSD  236 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccCH
Confidence            1    12234568899999999874 588999999999999999999999987665554444433221  1222346789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ++.++|.+||. +|..||++.+++.|||.
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=308.72  Aligned_cols=252  Identities=29%  Similarity=0.445  Sum_probs=217.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|++++.+++ |+|++++++++.+.+..+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEE
Confidence            37889999999999999999988999999999976543 3356678999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc-
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~-  258 (363)
                      ||+++++|.+++...+.+++..+..++.|++.||.+||+.||+||||+|+||++   +.++.++|+|||.+........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence            999999999999888889999999999999999999999999999999999999   6778999999999987654332 


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....++..|+|||.+.+ .++.++||||||+++|+|++|..||..................   .....+++++.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence            234567889999998873 4889999999999999999999999776654444444332221   122357899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +||..+|++||++.+++.++||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999996

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.8e-42  Score=320.17  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=214.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++ |||++++++++.+....++
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEEE
Confidence            344777788999999999999999999999999997655445555677889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+. +++.+.+.. ...+++..+..++.||+.||.|||++|++|+||+|+||++   ++++.+||+|||++....  
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~--  172 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSS--  172 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccC--
Confidence            999995 577777755 4568999999999999999999999999999999999999   777899999999986532  


Q ss_pred             CccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                       ......++..|+|||.+.    +.++.++|||||||++|+|++|..||...........+......  ......++..+
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  249 (313)
T cd06633         173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDSF  249 (313)
T ss_pred             -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHHH
Confidence             223467888999999974    35888999999999999999999999877665555555443322  12223467889


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+|+.+||+.+|.+||++.+++.|+|+..
T Consensus       250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         250 RGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-42  Score=310.74  Aligned_cols=248  Identities=27%  Similarity=0.423  Sum_probs=212.2

Q ss_pred             eeecceecccCCeEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +++.+.||.|+||.||+|.+...+    ..||+|.+....  .....+.+..|+.++..+. |+||+++++++.+.+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeE
Confidence            356789999999999999988766    899999986543  2335678999999999996 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++|||+++++|.+++.....  +++..+..++.|++.||.+||+.|++|+||||+||++   ++++.++|+|||++....
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecc
Confidence            99999999999999876544  8999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCCcccc--CccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQIFTD--VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~~~~--~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .......  ..++..|+|||.+. ..++.++|+||||+++|+|++ |..||.........+.+........   ...++.
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  231 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPP  231 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCH
Confidence            4432222  33678899999886 458999999999999999998 8999988887777777776654322   234789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+++.+||+.||++|||+.|+++.+
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            999999999999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.7e-43  Score=332.74  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=205.1

Q ss_pred             ccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .+.|.+++.||+|+||.||+|.+.     ..++.||+|++....  .....+.+.+|+.++.++.+||||+++++++...
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            345888999999999999999854     345689999996543  3334567889999999997799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG---------------------------------------------------------  195 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~---------------------------------------------------------  195 (363)
                      ...++||||+++|+|.+++.+.+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999986532                                                         


Q ss_pred             -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          196 -----------------------------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       196 -----------------------------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                                                               .+++..+..++.||+.||.|||+.+|+||||||+|||+ 
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl-  272 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI-  272 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE-
Confidence                                                     24566788899999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHH
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~  309 (363)
                        ++++.+||+|||++........   .....++..|+|||.+. ..++.++||||||+++|||++ |..||......+.
T Consensus       273 --~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         273 --CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             --eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence              6778999999999976432221   12345678899999987 458999999999999999998 8999976655554


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...........  .....++.++.+|+.+||+.+|.+||++.|++..+
T Consensus       351 ~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L  396 (401)
T cd05107         351 FYNAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV  396 (401)
T ss_pred             HHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            43333322211  12235789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-42  Score=320.40  Aligned_cols=253  Identities=27%  Similarity=0.438  Sum_probs=214.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ...|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.+. |||++++++++.+....++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEEE
Confidence            344788899999999999999998999999999987654444555678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+.| +|.+.+.. ...+++..+..++.+++.||.|||+.||+||||+|+||++   +.++.+||+|||++......
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc
Confidence            9999964 77777654 4568999999999999999999999999999999999999   77889999999998764332


Q ss_pred             CccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                         ....++..|+|||.+.    +.++.++|||||||++|+|++|..||...........+........  ....+++.+
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  253 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYF  253 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHH
Confidence               3456888999999874    3588999999999999999999999988776666666555433221  223567899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .++|.+||+.+|.+||++.++++++|+.
T Consensus       254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         254 RNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             HHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            9999999999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-43  Score=328.18  Aligned_cols=256  Identities=30%  Similarity=0.436  Sum_probs=216.0

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-----e
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----C  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~  174 (363)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++ |+||+++++++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccc
Confidence            4889999999999999999998889999999986532 12445578899999999998 999999999987765     7


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      .|++|||++ ++|.+.+.+...+++..+..++.+|+.||.+||+.||+||||||+|||+   +.++.++|+|||++....
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVD  154 (330)
T ss_pred             eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeec
Confidence            899999996 5898888887789999999999999999999999999999999999999   777899999999998765


Q ss_pred             CCC----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC-----
Q 017960          255 PGQ----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD-----  323 (363)
Q Consensus       255 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-----  323 (363)
                      ...    ......++..|+|||++.+  .++.++|+||||+++|+|++|..||.+....+.+..+..........     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            443    2345667889999999873  58999999999999999999999998877666555544321111100     


Q ss_pred             ----------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          324 ----------------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       324 ----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                            ..+.++.++.+||.+||++||.+||++.+++.|+||..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                                  12346788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-42  Score=313.41  Aligned_cols=250  Identities=21%  Similarity=0.366  Sum_probs=209.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +.|+..+.||+|+||.||+|.+..++.   .+|+|.+....  .....+.+..|+.++++++ ||||+++.+++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCc
Confidence            357888999999999999999876654   69999886432  3444677889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||++   ++++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence            9999999999999988764 568999999999999999999999999999999999999   778899999999987654


Q ss_pred             CCCc--cc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQI--FT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~--~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ....  ..  ....+..|+|||.+. +.++.++|||||||++|||++ |..||......+....+.....   .+....+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~  235 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR---LPAPMDC  235 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC---CCCCCCC
Confidence            3221  11  112345799999887 468999999999999999997 9999988888777777765422   1222347


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.++.+++.+||..+|++||++.+|++.+
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l  264 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVNLL  264 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            88999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.8e-43  Score=327.90  Aligned_cols=257  Identities=29%  Similarity=0.422  Sum_probs=207.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----  172 (363)
                      +..+|++.+.||.|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++ ||||+++++++...    
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL   78 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence            4567999999999999999999999999999999986543   244567889999999997 99999999876543    


Q ss_pred             ----------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccE
Q 017960          173 ----------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (363)
Q Consensus       173 ----------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~  242 (363)
                                ...++||||++ ++|.+.+. .+.+++..+..++.||+.||.|||+.||+||||||+||+++  .+++.+
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~  154 (342)
T cd07854          79 TEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVL  154 (342)
T ss_pred             ccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceE
Confidence                      35899999996 58877765 35689999999999999999999999999999999999994  245679


Q ss_pred             EEeecCcceecCCCC----ccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC
Q 017960          243 KAIDFGLSVFFKPGQ----IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG  316 (363)
Q Consensus       243 kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~  316 (363)
                      ||+|||.+.......    ......++..|+|||.+.  ..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999997653221    112345788999999875  35889999999999999999999999877665544443321


Q ss_pred             Ccc----------------------cCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          317 HID----------------------FES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       317 ~~~----------------------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ...                      ...    ...+.++.++.+||.+||+.||.+|||+.++|.|+||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            100                      000    012357789999999999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.7e-43  Score=328.06  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=201.4

Q ss_pred             ccceeecceecccCCeEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-  171 (363)
                      .++|++++.||+|+||.||+|.+     ..+++.||||++....  .......+.+|+.++.++.+||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35799999999999999999984     3467889999996543  334456788999999999769999999998754 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--------------------------------------------------------
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRG--------------------------------------------------------  195 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~--------------------------------------------------------  195 (363)
                      +...+++|||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            456899999999999999886421                                                        


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc---ccc
Q 017960          196 -----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTD  261 (363)
Q Consensus       196 -----------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~  261 (363)
                                 .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcchhhcCC
Confidence                       35778888999999999999999999999999999999   7788999999999876532221   112


Q ss_pred             CccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHH-HHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          262 VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       262 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ..++..|+|||.+. ..++.++||||||+++|+|++ |..||...... .....+..+.. ...  ...+++++.+++.+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~  317 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRA--PDYTTPEMYQTMLD  317 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCC--CCCCCHHHHHHHHH
Confidence            33456799999886 468999999999999999997 99999765433 33333333322 111  12367899999999


Q ss_pred             hcccCcCCCCCHHHHhcCC
Q 017960          339 MLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~  357 (363)
                      ||+.||++|||+.|+++++
T Consensus       318 cl~~~p~~Rps~~eil~~l  336 (343)
T cd05103         318 CWHGEPSQRPTFSELVEHL  336 (343)
T ss_pred             HccCChhhCcCHHHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=310.33  Aligned_cols=245  Identities=38%  Similarity=0.653  Sum_probs=216.0

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||.|+||.||++.+..+++.+|+|++.+...........+..|+.+++.++ |+||+++++.+..+...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999998889999999998765545556778999999999998 9999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-CccccCccC
Q 017960          187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGS  265 (363)
Q Consensus       187 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt  265 (363)
                      |.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||++   +.++.++|+|||++...... .......++
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCC
Confidence            99999888889999999999999999999999999999999999999   77889999999999776443 233456778


Q ss_pred             Ccccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCc
Q 017960          266 PYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP  344 (363)
Q Consensus       266 ~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  344 (363)
                      ..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+......++    ..++.++.++|++||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence            89999999874 578899999999999999999999987776666777666443332    2458999999999999999


Q ss_pred             CCCCCH---HHHhcCCCc
Q 017960          345 SERLTA---HEVLCMYNL  359 (363)
Q Consensus       345 ~~R~s~---~evL~~~~~  359 (363)
                      ++||++   .+++.|+||
T Consensus       233 ~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         233 TKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             hhCCCcccHHHHHhCCCC
Confidence            999999   999999997

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=315.95  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEecCCe----
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLC----  174 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~----  174 (363)
                      |++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++  .||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6778999999999999999988899999999975432 2223345667888887775  49999999999987776    


Q ss_pred             -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          175 -VHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       175 -~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                       .+++|||+. ++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||++   ++++.+||+|||++.
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcce
Confidence             999999996 48988887643  48999999999999999999999999999999999999   777899999999998


Q ss_pred             ecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-----cC----
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----FE----  321 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~----  321 (363)
                      ............++..|+|||.+.+ .++.++|+|||||++|+|++|.+||.+....+....+......     +.    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            7655444445567889999999874 5899999999999999999999999888776666555431110     00    


Q ss_pred             --------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          322 --------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       322 --------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                    ....+.+++.+.++|.+||+.||.+||++.+++.|+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                          00112356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-42  Score=313.36  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=204.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.++||+|+||.||+|.+..+ ..||+|++.....    ..+.+.+|+.+++++. ||||+++++.+.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEE
Confidence            35699999999999999999987655 4699999875332    2357889999999997 9999999998754 55899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+++||||||+||++   ++++.+||+|||.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccc
Confidence            99999999999999753  347899999999999999999999999999999999999   7788999999999976643


Q ss_pred             CCcc--ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQIF--TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ....  ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+....+....+......   .....++..
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPES  231 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---CCccccCHH
Confidence            3221  1234567899999886 468999999999999999999 89999888777777766544211   112357899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.+++.+||++||++||++.++++.
T Consensus       232 l~~li~~~l~~~p~~Rp~~~~~~~~  256 (262)
T cd05071         232 LHDLMCQCWRKEPEERPTFEYLQAF  256 (262)
T ss_pred             HHHHHHHHccCCcccCCCHHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-42  Score=311.24  Aligned_cols=242  Identities=22%  Similarity=0.308  Sum_probs=200.6

Q ss_pred             eecccCCeEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          106 KLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.++++++ ||||+++++++. ....++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            3899999999999765  445579999886542  3445577999999999997 999999999875 457899999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc----
Q 017960          184 GGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI----  258 (363)
Q Consensus       184 ~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~----  258 (363)
                      +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||+   +.++.+||+|||++........    
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccceec
Confidence            9999998875 4568999999999999999999999999999999999999   7788999999999976543321    


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....++..|+|||.+. ..++.++|||||||++|||++ |..||......+....+..+...   ......++++.++|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  231 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYALM  231 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHH
Confidence            11122356899999887 468999999999999999996 99999888887777777665432   12235689999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCC
Q 017960          337 RKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+||..||++||++.++++.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~~l  252 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEERM  252 (257)
T ss_pred             HHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-42  Score=311.78  Aligned_cols=243  Identities=24%  Similarity=0.328  Sum_probs=204.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEE-ecCCeEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY-EDSLCVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-~~~~~~~i  177 (363)
                      +.|++.+.||+|+||.||+|..  .+..||+|.+...     ...+.+.+|+.++++++ |+|++++++++ .+.+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEE
Confidence            3588999999999999999984  5788999988532     23467889999999997 99999999975 45677999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +|||+++++|.+++...+  .+++..+..++.|++.||.|||++|++||||||+||++   ++++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccc
Confidence            999999999999987654  37899999999999999999999999999999999999   7888999999999876433


Q ss_pred             CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..  ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||......+....+.++..   ......+++.+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (256)
T cd05082         155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVY  229 (256)
T ss_pred             cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHH
Confidence            22  23344668999998874 58999999999999999997 9999988777777776655432   222346789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.+||+.||++|||+.++++.+
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~~l  253 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLREQL  253 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHH
Confidence            999999999999999999998754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-42  Score=311.13  Aligned_cols=243  Identities=23%  Similarity=0.339  Sum_probs=203.6

Q ss_pred             ceecccCCeEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          105 RKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      +.||+|+||.||+|....++   ..+|+|.+......  ...+++.+|+.+++.+. ||||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEe
Confidence            46999999999999876555   78999998765432  45567899999999997 999999999775 4568999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc-c
Q 017960          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-T  260 (363)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~-~  260 (363)
                      +++++|.+++.....+++..+..++.|++.||.|||..+++|+||||+|||+   +.++.+||+|||++......... .
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcccc
Confidence            9999999999888889999999999999999999999999999999999999   77889999999999765433221 1


Q ss_pred             ---cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          261 ---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       261 ---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                         ...++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+......   .....++..+.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l  230 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSI  230 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHH
Confidence               112245799999887 468999999999999999998 99999887777777776655321   2234578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCC
Q 017960          336 IRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~  357 (363)
                      |.+||+.||++||++.++++.+
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~~l  252 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELESTF  252 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHHHH
Confidence            9999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=311.14  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=209.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||.|+||.||+|..  .++.||+|.+....    ...+++.+|+.+++.+. |+||+++++++.+....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS----TAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch----hHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEE
Confidence            3588899999999999999985  47899999986542    24678899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||++   +.++.+||+|||.+......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccc
Confidence            99999999999997765  68999999999999999999999999999999999999   77889999999999876322


Q ss_pred             CccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .  .....+..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+.....   ......+++++.+
T Consensus       156 ~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (256)
T cd05039         156 Q--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYK  230 (256)
T ss_pred             c--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHH
Confidence            2  2334456799999887 568899999999999999997 9999988877777766655422   1222357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCC
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +|.+||..+|++||++.++++.+
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~~l  253 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLREQL  253 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHHHH
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-42  Score=310.57  Aligned_cols=251  Identities=29%  Similarity=0.467  Sum_probs=217.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+..... .......+.+|+.+++.++ |+||+++++++.+....++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEe
Confidence            37889999999999999999999999999999875443 3345567889999999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          180 ELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       180 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhcc
Confidence            99999999998866    3568999999999999999999999999999999999999   6678899999999987654


Q ss_pred             CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      . ......++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...........+..+......   ..++.++.+
T Consensus       156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd08530         156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQN  231 (256)
T ss_pred             C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHH
Confidence            4 3344568889999999874 5888999999999999999999999888777766666655443222   257889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ++.+||+.+|++||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-42  Score=317.22  Aligned_cols=250  Identities=22%  Similarity=0.335  Sum_probs=209.5

Q ss_pred             cceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++++. ||||+++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~~   81 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-HPNIVKLLGVCAVGK   81 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCC
Confidence            458899999999999999998743     67789999986432  3444567889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCce
Q 017960          174 CVHIVMELCAGGELFDRIIQRG----------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NI  231 (363)
                      ..++||||+++++|.+++....                      .+++..+..++.|++.||.|||+.+++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999999986432                      367888999999999999999999999999999999


Q ss_pred             EeeeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCH
Q 017960          232 LLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQ  306 (363)
Q Consensus       232 ll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~  306 (363)
                      ++   ++++.++|+|||++........   ......+..|+|||.+. ..++.++|||||||++|||++ |..||.+...
T Consensus       162 l~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         162 LV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             Ee---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99   7788999999999876432221   12233456799999887 569999999999999999997 8899988887


Q ss_pred             HHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+....+..+.....   ...++.++.+||.+||+.||++|||+.|+++.+
T Consensus       239 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l  286 (288)
T cd05050         239 EEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRIL  286 (288)
T ss_pred             HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            777777766553221   235689999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.1e-43  Score=320.37  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=208.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----  173 (363)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++ ||||+++++++.+..    
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhh
Confidence            4569999999999999999999999999999999865432 2223356778999999997 999999999887654    


Q ss_pred             ------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          174 ------CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       174 ------~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                            .+++|+||+++ ++...+... ..+++..+..++.|++.||.|||+.||+|+||||+||++   ++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCc
Confidence                  79999999965 777766653 468999999999999999999999999999999999999   7888999999


Q ss_pred             cCcceecCCCC--ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          247 FGLSVFFKPGQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       247 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      ||++.......  ......++..|+|||.+.+  .++.++|||||||++|+|++|+.||......+.+..+.+.......
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99998654332  2233456788999998863  4789999999999999999999999876665555444332110000


Q ss_pred             --------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          323 --------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       323 --------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                                ..+..++..+.++|.+||+.||.+||++.+++.|+|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                      1123468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=316.63  Aligned_cols=253  Identities=30%  Similarity=0.429  Sum_probs=209.6

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||.|++|+||+|....+++.||||.+..... . .......+|+..++++.+|+||+++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            6778999999999999999988899999999865432 1 2223455789999999779999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          181 LCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |+ +++|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|+||++   ++++.++|+|||++........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC
Confidence            99 789999887764  68999999999999999999999999999999999999   7888999999999987765545


Q ss_pred             cccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC---------------
Q 017960          259 FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE---------------  321 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------------  321 (363)
                      .....++..|+|||++.  ..++.++|+||||+++++|++|..||......+....+........               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            55667889999999885  3489999999999999999999999977665544433322100000               


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          322 -----------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       322 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                                 ....+..+.++.++|.+||+.||++||++.|++.++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       00112336789999999999999999999999999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-43  Score=328.53  Aligned_cols=261  Identities=27%  Similarity=0.435  Sum_probs=214.8

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ....+.++|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++.+. ||||+++.+++...
T Consensus         9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   86 (343)
T cd07851           9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPA   86 (343)
T ss_pred             ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcc
Confidence            33456778999999999999999999999999999999886432 23344567888999999997 99999999987665


Q ss_pred             Ce------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          173 LC------VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       173 ~~------~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                      ..      .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.++|+|
T Consensus        87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~d  161 (343)
T cd07851          87 SSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILD  161 (343)
T ss_pred             ccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcc
Confidence            54      89999999 7799887765 568999999999999999999999999999999999999   7788999999


Q ss_pred             cCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC---
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE---  321 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  321 (363)
                      ||++......  .....++..|+|||.+.+  .++.++|||||||++|+|++|+.||.+....+.+..+........   
T Consensus       162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         162 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9999875432  345577889999998864  578999999999999999999999987766655554433211000   


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          322 ------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       322 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                              ......+++++.+||.+||+.||++|||+.+|+.|+||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence                                    00112358899999999999999999999999999999753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-42  Score=311.57  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=205.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+.....    ..+.+.+|+.++++++ |+||+++++++. ....+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~-~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLR-HDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcC-CCceEEEEeEEC-CCCcE
Confidence            3457999999999999999999864 566799999875432    2356889999999997 999999999875 45688


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++|||+++++|.+++...  ..+++..+..++.+++.||.|||+.||+||||||+||++   ++++.++|+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeecc
Confidence            999999999999988753  358999999999999999999999999999999999999   778899999999997654


Q ss_pred             CCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ....  .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+..+.+......   +.....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPI  230 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCH
Confidence            3321  11233456799999887 468999999999999999999 99999888877777777654221   12235788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+|+.+||++||++|||+.++++.+
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l  257 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQSFL  257 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.7e-43  Score=326.28  Aligned_cols=261  Identities=29%  Similarity=0.421  Sum_probs=211.3

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CC
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SL  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~  173 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++++.+||||+++++++..  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            45677999999999999999999998899999999886432 2333456677899999999449999999998864  34


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..++||||+. ++|..++... .+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||.+...
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSL  157 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhcc
Confidence            6899999996 5898887665 78899999999999999999999999999999999999   88899999999998765


Q ss_pred             CCCC------ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--------
Q 017960          254 KPGQ------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH--------  317 (363)
Q Consensus       254 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------  317 (363)
                      ....      ......++..|+|||.+.+  .++.++||||||+++|+|++|+.||.+.........+....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            4322      2234568899999998753  58899999999999999999999997665544333322211        


Q ss_pred             -------------------cccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          318 -------------------IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       318 -------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                         ........+.++.++.++|.+||+.||++|||+.++++++|+..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                               001111223468899999999999999999999999999998653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.3e-42  Score=315.07  Aligned_cols=256  Identities=34%  Similarity=0.474  Sum_probs=217.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||+|++|.||+|.+..++..||+|++.....    ..+.+.+|+++++.+. |+||+++++.+......+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCK-HPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEEE
Confidence            45568899999999999999999988899999999865432    4567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +++||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||++   +.++.++|+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhcc
Confidence            9999999999999998876 79999999999999999999999999999999999999   7788999999998865433


Q ss_pred             CC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+....... ......++.++.
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~  247 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEFK  247 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHHH
Confidence            22 2233457889999998874 58999999999999999999999998776655555544333221 112234788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++|.+||+.+|.+||++.+++.++|+..
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            9999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.8e-43  Score=325.47  Aligned_cols=252  Identities=17%  Similarity=0.233  Sum_probs=201.2

Q ss_pred             ceeccc--CCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEecc
Q 017960          105 RKLGQG--QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       105 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      ..||+|  +||+||+|++..+++.||+|++..... .....+.+.+|+.+++.++ ||||++++++|...+..++||||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEecc
Confidence            456666  999999999999999999999875433 3445678899999999898 999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc-
Q 017960          183 AGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-  259 (363)
Q Consensus       183 ~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~-  259 (363)
                      .+++|.+++.+.  ..+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.++++|||.+......... 
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccc
Confidence            999999988764  348999999999999999999999999999999999999   77789999999865332111100 


Q ss_pred             -------ccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC--------
Q 017960          260 -------TDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE--------  321 (363)
Q Consensus       260 -------~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------  321 (363)
                             ....++..|+|||++.+   .++.++|||||||++|+|++|..||.+.................+        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   11234567999999874   378999999999999999999999977655444333322211000        


Q ss_pred             -----------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 -----------------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 -----------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                                         ......+++++.+||.+||+.||++|||+.|+|+|+||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                               0011235678999999999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-42  Score=310.74  Aligned_cols=248  Identities=22%  Similarity=0.309  Sum_probs=207.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.++||+|+||.||+|.. .+++.||+|.+....    .....+.+|+.+++++. |+||+++++++. .+..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC----CcHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcE
Confidence            456799999999999999999985 567889999986433    23467889999999998 999999999864 45689


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++|||+.+++|.+++...  ..+++.++..++.|++.||+|||+.|++||||||+||++   ++++.++|+|||++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIE  153 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecC
Confidence            999999999999988653  358899999999999999999999999999999999999   778899999999997765


Q ss_pred             CCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ....  .....++..|+|||.+. ..++.++||||||+++|||++ |+.||.+....+....+......   +.....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC---CCCCCCCH
Confidence            3221  12334567899999987 458999999999999999999 99999888877777766554321   22235688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.++|.+||+.+|++||++++++..+
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l  257 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRSVL  257 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHh
Confidence            999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.8e-42  Score=310.26  Aligned_cols=247  Identities=24%  Similarity=0.348  Sum_probs=204.8

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|++|.||+|.+..+ ..+|+|.+....    ...+.+.+|+.+++.+. |+||+++++++. .+..++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEE
Confidence            35699999999999999999987554 469999876432    22356888999999998 999999999875 456889


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +|||+.+++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||++   ++++.++|+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccC
Confidence            999999999999997643  47899999999999999999999999999999999999   7888999999999976543


Q ss_pred             CCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ...  .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+.....   ......++..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPES  231 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHH
Confidence            321  12234567899999887 468999999999999999999 9999988887777776655421   1222357899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.+++.+||.+||++||+++++++.+
T Consensus       232 ~~~li~~~l~~~p~~Rp~~~~i~~~l  257 (260)
T cd05069         232 LHELMKLCWKKDPDERPTFEYIQSFL  257 (260)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHHH
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.6e-42  Score=317.26  Aligned_cols=252  Identities=27%  Similarity=0.455  Sum_probs=212.5

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |....+||+|+||.||++....+++.||+|.+...   .......+.+|+.+++.+. |+||+++++.+...+..++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEe
Confidence            44457899999999999999999999999988543   3344567889999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-cc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-IF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~~  259 (363)
                      |+++++|.+++. .+.+++..+..++.|++.||.|||+.|++|+||+|+||++   ++++.++|+|||++....... ..
T Consensus        98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657          98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccccc
Confidence            999999988664 4568999999999999999999999999999999999999   778899999999987654322 22


Q ss_pred             ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....+++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.........+..... ........+++++.+++.+
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHHH
Confidence            3456788999999886 4588999999999999999999999987776665555543322 1222234578999999999


Q ss_pred             hcccCcCCCCCHHHHhcCCCccc
Q 017960          339 MLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||+.||.+||++.+++.|+||..
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~  275 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAK  275 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhc
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.1e-42  Score=313.44  Aligned_cols=252  Identities=19%  Similarity=0.338  Sum_probs=211.8

Q ss_pred             cceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +.|++.+.||+|+||.||+|+.+.     +.+.||+|.+....  .....+.+.+|+.++++++ |+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCC
Confidence            458889999999999999999653     34679999886432  3335678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEE
Q 017960          174 CVHIVMELCAGGELFDRIIQRG---------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                      ..++||||+++++|.+++....         .+++..+..++.||+.||.|||+.+|+||||||+||++   +.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEE
Confidence            9999999999999999997765         68999999999999999999999999999999999999   77889999


Q ss_pred             eecCcceecCCCC--ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCccc
Q 017960          245 IDFGLSVFFKPGQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       245 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                      +|||++.......  ......++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9999986543221  223345567899999886 458899999999999999998 889998777777777776555433


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ..  ...++..+.+++.+||+.||.+||++.+++..++
T Consensus       239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            32  2357899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-42  Score=315.34  Aligned_cols=250  Identities=25%  Similarity=0.331  Sum_probs=197.2

Q ss_pred             cce-eecceecccCCeEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--
Q 017960           99 DLY-TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--  171 (363)
Q Consensus        99 ~~y-~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--  171 (363)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+....  .......+.+|+.+++.++ ||||+++++++..  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence            445 889999999999998764    34577899999986542  2334567889999999997 9999999998765  


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ...+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+   ++++.+||+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~  155 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK  155 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccc
Confidence            34689999999999999988654 58999999999999999999999999999999999999   777899999999998


Q ss_pred             ecCCCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH--HHH------------HH
Q 017960          252 FFKPGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ--GIF------------DA  312 (363)
Q Consensus       252 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~------------~~  312 (363)
                      .......    .....++..|+|||.+. ..++.++||||||+++|||++|..||......  +..            ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            6543321    12234566799999887 46899999999999999999999998543211  000            00


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       313 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .......  ......++.++.+++.+||+.||++|||+++++..+
T Consensus       236 ~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l  278 (283)
T cd05080         236 LLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL  278 (283)
T ss_pred             hhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            0001111  111234678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-42  Score=324.44  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=211.0

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--  173 (363)
                      .+.++|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.++++++ ||||+++++++....  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSL   89 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCccc
Confidence            46778999999999999999999999999999999986432 23334567889999999998 999999999987543  


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          174 ----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       174 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                          .+++||||+ +++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||++   +.++.++|+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~  164 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGL  164 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeccc
Confidence                468999999 778877665 4578999999999999999999999999999999999999   7788999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------  320 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------  320 (363)
                      +......  .....+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.........+.+.....       
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9765332  234567889999998874  48899999999999999999999998766544443332211100       


Q ss_pred             ----------------C----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          321 ----------------E----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       321 ----------------~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                      .    ...++.+++++.++|.+||+.||++|||+.+++.|+||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence                            0    0112357788999999999999999999999999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-42  Score=318.37  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=213.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|...+.||.|+||.||+|.+..++..+|+|.+............++.+|+.+++.++ |+|++++++++......+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence            3445888899999999999999999999999999987544434455677889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +||||+. +++.+.+.. ...+++..+..++.|++.||.|||+.+++||||+|+||++   +.++.++|+|||++.....
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC
Confidence            9999996 578777654 4568999999999999999999999999999999999999   7788999999999876543


Q ss_pred             CCccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .   ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||...........+........  ....++..
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  242 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY  242 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHH
Confidence            2   3456788999999874    3588899999999999999999999977665555444444332211  12357789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||+.+|++||++.+++.++|+..
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            999999999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=350.76  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=215.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +..++.+.||+|+||.||.|.-....     ..||||.+.+..  +.+...+|.+|..+|+.+. |||||+++|++.+..
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCCC
Confidence            45778899999999999999865433     248888886543  7788899999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                      ..+|++|||+||+|..+|++.       ..++......++.+|+.|+.||+++++|||||...|+|+   +....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcc
Confidence            999999999999999999875       248899999999999999999999999999999999999   7889999999


Q ss_pred             cCcceecCCCCccccC---ccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          247 FGLSVFFKPGQIFTDV---VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      ||+|+.+.....+...   .-...|||||.+. +.++.++|||||||++||++| |..||.+....+++..+..+.   .
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R  922 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R  922 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c
Confidence            9999955444433211   2235799999998 579999999999999999999 999999999999988666655   3


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      .++.+.+++.+.+++..||+.+|++||++..+++.
T Consensus       923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q  957 (1025)
T KOG1095|consen  923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ  957 (1025)
T ss_pred             cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence            44446799999999999999999999999999873

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-45  Score=364.50  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=221.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.-++.-+..||.|.||.||.|.+..+|+..|+|.+.-.... ....+.+.+|..++..+. |||+|+++|+-...+..+
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhcc-CccccccCceeecHHHHH
Confidence            444577788999999999999999999999999998655432 445678899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |.||||++|+|.+.+...+..++.....+..|++.|+.|||++|||||||||+||++   +.+|.+|++|||.|..+.++
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence            999999999999999888888889999999999999999999999999999999999   88899999999999887654


Q ss_pred             C-----ccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCcccCCCCCC
Q 017960          257 Q-----IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       257 ~-----~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      .     .....+||+.|||||++.+    ....+.|||||||++.||+||+.||.. ++.-.++-.+-.+..+..++   
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~--- 1464 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE--- 1464 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch---
Confidence            2     2346789999999999974    367799999999999999999999954 34456666666666554443   


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .++.+..+||..||..||..|.++.|+|+|-|-
T Consensus      1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence            389999999999999999999999999998664

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-42  Score=316.61  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=203.3

Q ss_pred             ccceeecceecccCCeEEEEEEEcc----------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA----------------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN  161 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n  161 (363)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+....  .......+.+|+.+++.++ |+|
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~-~~~   80 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLK-DPN   80 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCC
Confidence            3569999999999999999986432                34579999986442  3445678899999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCc
Q 017960          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-----------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPEN  230 (363)
Q Consensus       162 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~N  230 (363)
                      |+++++++...+..++||||+.+++|.+++....           .+++..+..++.|++.||+|||+.||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999887642           35677899999999999999999999999999999


Q ss_pred             eEeeeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCc
Q 017960          231 FLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--GVPPFWAE  304 (363)
Q Consensus       231 Ill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~--g~~pf~~~  304 (363)
                      ||+   ++++.++|+|||++........   .....++..|+|||... +.++.++|||||||++|||++  |..||...
T Consensus       161 ili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         161 CLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            999   7788999999999976543321   11233457899999766 569999999999999999998  78899776


Q ss_pred             CHHHHHHHHHc----CCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          305 TQQGIFDAVLK----GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       305 ~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+.......    .......+....+++.+.+|+.+||+.||.+||++.+|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l  294 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL  294 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            66555443321    001111112234678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.3e-42  Score=321.98  Aligned_cols=257  Identities=28%  Similarity=0.399  Sum_probs=207.7

Q ss_pred             ceeecceecccCCeEEEEEEEccC--CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec----CC
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SL  173 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~  173 (363)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+.... ......+.+.+|+.+++++.+||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            378899999999999999999888  8899999986432 1233456788899999999779999999986532    24


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..++++||+ +++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||++   ++++.+||+|||++...
T Consensus        80 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceec
Confidence            578999998 46899998888889999999999999999999999999999999999999   77889999999999765


Q ss_pred             CCCC-----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc--------
Q 017960          254 KPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--------  318 (363)
Q Consensus       254 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------  318 (363)
                      ....     ......|+..|+|||.+.+  .++.++||||||+++|+|++|..||.+......+..+.....        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4322     1233578999999998763  589999999999999999999999977654443332221100        


Q ss_pred             -------------------ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          319 -------------------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       319 -------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                         ......++..+.++.+|+.+||+.||.+|||+.+++.++|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~  297 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI  297 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence                               0001122346789999999999999999999999999999853

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.3e-42  Score=308.94  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=205.1

Q ss_pred             ceecccCCeEEEEEEEcc-CC--cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          105 RKLGQGQFGTTYLCTEIA-TG--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      +.||+|++|.||+|.+.. .+  ..||+|.+......  ...+.+.+|+.++++++ ||||+++++.+.+ ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEe
Confidence            468999999999999765 33  36999999765432  56678999999999998 9999999999988 889999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          182 CAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       182 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      +++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||++   +.++.+||+|||++.......  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc
Confidence            99999999997754  68999999999999999999999999999999999999   777899999999998764322  


Q ss_pred             --ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          258 --IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                        ......++..|+|||.+.. .++.++|||||||++|+|++ |..||......+....+........  ....++..+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence              1123456778999999874 68999999999999999998 9999988777777776664322222  1234688999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.+||+.+|++||++.++++.+
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHHHh
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=315.00  Aligned_cols=253  Identities=30%  Similarity=0.464  Sum_probs=210.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+..... .......+.+|+.+++++. |+||+++++++......++|||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEe
Confidence            5677899999999999999988999999999865432 3344567889999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-c
Q 017960          181 LCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~  258 (363)
                      |+++ +|.+.+... ..+++..+..++.||+.||.|||+.+|+|+||||+||++   ++++.++|+|||.+....... .
T Consensus        79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCccc
Confidence            9965 888877663 578999999999999999999999999999999999999   778899999999998765443 3


Q ss_pred             cccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-----------------
Q 017960          259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----------------  319 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----------------  319 (363)
                      .....++..|+|||.+.+  .++.++|+||||+++|+|++|+.||.+....+....+......                 
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            344567889999998863  5899999999999999999999999877765544443221000                 


Q ss_pred             --cC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 --FE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 --~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                        ++       ....+.++.++.++|.+||++||.+||++.+++.|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence              00       01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.6e-42  Score=312.75  Aligned_cols=251  Identities=22%  Similarity=0.264  Sum_probs=208.4

Q ss_pred             ccceeecceecccCCeEEEEEEEcc----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-C
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-S  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~  172 (363)
                      .++|++.+.||+|+||.||+|.+..    ++..||+|.+....  .......+.+|+.+++.+. ||||+++++++.. .
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCC
Confidence            3569999999999999999999765    35789999886332  4555778899999999997 9999999998765 5


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEE
Q 017960          173 LCVHIVMELCAGGELFDRIIQR--------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                      ...++++||+++++|.+++...        ..+++..+..++.|++.||+|||+++++||||||+||++   ++++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEE
Confidence            7789999999999999988653        358899999999999999999999999999999999999   77789999


Q ss_pred             eecCcceecCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcc
Q 017960          245 IDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHID  319 (363)
Q Consensus       245 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  319 (363)
                      +|||+++.......   .....++..|+|||.+.+ .++.++|||||||++||+++ |+.||......+....+..+.. 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-  237 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR-  237 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC-
Confidence            99999976543321   122345667999998874 58999999999999999999 9999988777776666555422 


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .  .....+++++.+++.+||+.||++|||+.++++.+
T Consensus       238 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  273 (280)
T cd05043         238 L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCL  273 (280)
T ss_pred             C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            1  12235689999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.3e-43  Score=352.17  Aligned_cols=255  Identities=33%  Similarity=0.462  Sum_probs=208.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS----  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----  172 (363)
                      ...+|+..+.||+||||.||+|+++-+|+.||||+|....  +.....++.+|++.|.+|. |||||+++..|.+.    
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcc
Confidence            3455889999999999999999999999999999997654  5666788999999999998 99999998877210    


Q ss_pred             --------------------------------------------------------------------------------
Q 017960          173 --------------------------------------------------------------------------------  172 (363)
Q Consensus       173 --------------------------------------------------------------------------------  172 (363)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 017960          173 -----------------------------------LCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVEAC  216 (363)
Q Consensus       173 -----------------------------------~~~~iv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~~l~~~l~~l  216 (363)
                                                         ..+||-||||+...+.+.+.++... .....+.++++|++||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                               1368999999875555555444333 4788999999999999999


Q ss_pred             HhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-------------------CCCccccCccCCcccccccccc-
Q 017960          217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------------PGQIFTDVVGSPYYVAPEVLLK-  276 (363)
Q Consensus       217 H~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-  276 (363)
                      |++|||||||||.||++   +++..|||+|||+|+...                   +....+..+||.-|+|||++.+ 
T Consensus       714 H~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99999999999999999   788899999999998721                   1124567899999999999972 


Q ss_pred             ---cCCCcccHHHHHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHH
Q 017960          277 ---HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHE  352 (363)
Q Consensus       277 ---~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~e  352 (363)
                         .|+.|+|+||||++|+||+.   ||.. ......+..+.++.++.+..-+..--+.-..+|++||++||.+||||.|
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence               59999999999999999996   5643 3344566777777666653323233356688999999999999999999


Q ss_pred             HhcCCCcc
Q 017960          353 VLCMYNLP  360 (363)
Q Consensus       353 vL~~~~~~  360 (363)
                      +|..-|++
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999987

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.3e-42  Score=305.43  Aligned_cols=243  Identities=25%  Similarity=0.325  Sum_probs=203.3

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      ++||+|+||.||+|.. .++..+|+|.+....  .......+.+|+.+++.+. ||||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~   76 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPG   76 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCC
Confidence            3699999999999985 568899999886442  3344557889999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccc--c
Q 017960          185 GELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT--D  261 (363)
Q Consensus       185 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~--~  261 (363)
                      ++|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||++   ++++.+||+|||++..........  .
T Consensus        77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccccCCC
Confidence            9999988654 457899999999999999999999999999999999999   778899999999987644332211  1


Q ss_pred             CccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHh
Q 017960          262 VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM  339 (363)
Q Consensus       262 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~  339 (363)
                      ..++..|+|||.+. +.++.++||||||+++|++++ |..||.+.........+..+...   .....++.++.+++.+|
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~  230 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHH
Confidence            23356799999987 468999999999999999998 99999888777766666554321   22235789999999999


Q ss_pred             cccCcCCCCCHHHHhcCC
Q 017960          340 LCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       340 l~~dp~~R~s~~evL~~~  357 (363)
                      |+.+|++||++.++++.+
T Consensus       231 l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         231 WDYKPENRPKFSELQKEL  248 (250)
T ss_pred             cccCcccCCCHHHHHHHh
Confidence            999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-42  Score=307.72  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=209.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+. .+..||||.+....    ...+.+.+|+.+++++. |+||+++++++......+
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceE
Confidence            3467999999999999999999964 55789999987533    23467889999999998 999999999999989999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||+++++|.+++....  .+++..+..++.+++.||.|||++|++|+||||+||++   ++++.+||+|||++....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceecc
Confidence            9999999999999987643  58999999999999999999999999999999999999   778899999999998764


Q ss_pred             CCCcc--ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQIF--TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .....  ....++..|+|||.+. ..++.++|+||||+++|+|++ |+.||.+.......+.+..+...   ......+.
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPNCPE  231 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            32211  1223456799999887 458999999999999999998 99999888877777777654321   11234688


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+++.+||+.+|++||+++++++.+
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~~l  258 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQSFL  258 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHH
Confidence            999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-42  Score=323.40  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=209.2

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+.+.+|+.++++++ ||||+++++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL   91 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecccc
Confidence            45678999999999999999999999999999999986532 13334567888999999998 99999999987543   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||++   ++++.+||+|||+
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~  166 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGL  166 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccc
Confidence               3478899887 7888776654 468999999999999999999999999999999999999   7788999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc--------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID--------  319 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------  319 (363)
                      +.....  ......++..|+|||.+.+  .++.++|||||||++|+|++|+.||...........+......        
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         167 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             cccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            876432  2334577899999998764  4889999999999999999999999776654444433221100        


Q ss_pred             ---------------cCC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ---------------FES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ---------------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                     .+.    ......++++.+||.+||+.||.+||++.+++.|+||+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                           000    0112357889999999999999999999999999999753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.4e-42  Score=315.28  Aligned_cols=255  Identities=30%  Similarity=0.485  Sum_probs=209.6

Q ss_pred             eeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccCC-hhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLIS-REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      |++.+.||+|++|.||+|.+.   .+++.||||.+.+..... ....+.+.+|+.++.++++||||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            788899999999999999864   467889999987543222 2334678899999999977999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+.+++|.+++.....+++..+..++.|++.||.|||+.+++||||+|.||++   +.++.++|+|||++......
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccccc
Confidence            999999999999999887889999999999999999999999999999999999999   77889999999998765433


Q ss_pred             Cc--cccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCH----HHHHHHHHcCCcccCCCCCCC
Q 017960          257 QI--FTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ..  .....++..|+|||.+.+   ..+.++|+||||+++|+|++|..||.....    .+..+.+.....    .....
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~  234 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP----PFPKT  234 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC----CCCcc
Confidence            21  223467889999999863   268899999999999999999999954322    233333333322    22234


Q ss_pred             CCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcccC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLT---AHEVLCMYNLPVL  362 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s---~~evL~~~~~~~~  362 (363)
                      ++.++.++|.+||+.||++|||   +.++|+|+|++.+
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            7889999999999999999998   5677999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.9e-42  Score=319.03  Aligned_cols=256  Identities=25%  Similarity=0.349  Sum_probs=205.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-----  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----  172 (363)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+++++.++ ||||+++++++.+.     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcC-CCCccchhhheeccccccc
Confidence            4569999999999999999999999999999999865432 2222345678999999998 99999999987443     


Q ss_pred             ---CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                         ..+++||||+. ++|...+.. ...+++..+..++.||+.||.|||++||+|+||||+||++   ++++.++|+|||
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg  160 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFG  160 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCc
Confidence               35799999995 467776654 3469999999999999999999999999999999999999   788899999999


Q ss_pred             cceecCCCC------------ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHH
Q 017960          249 LSVFFKPGQ------------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL  314 (363)
Q Consensus       249 ~a~~~~~~~------------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~  314 (363)
                      ++.......            ..+...+++.|+|||.+.+  .++.++|||||||++|||++|.+||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            987653221            1123456888999998763  48899999999999999999999998777665555443


Q ss_pred             cCCcccCC--------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          315 KGHIDFES--------------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       315 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ........                          ..+..+++++.++|.+||..||.+|||+.+++.|+||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            21110000                          0112345788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-42  Score=324.23  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=207.7

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      .+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.+. ||||+++++++...   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~   89 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSG   89 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcC-CCCccchhheecccccC
Confidence            345679999999999999999999999999999999865322 2333456889999999997 99999999988654   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ..+++|+||+. .+|...+  ...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||+
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~  163 (342)
T cd07879          90 DEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGL  163 (342)
T ss_pred             CCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCC
Confidence               34699999995 4666554  3468999999999999999999999999999999999999   7788999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC----------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH----------  317 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  317 (363)
                      +.....  ......++..|+|||.+.+  .++.++|||||||++|||++|+.||.+......+..+....          
T Consensus       164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            876432  2234567889999999864  48899999999999999999999998776554444333210          


Q ss_pred             -------------cccCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          318 -------------IDFESD----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       318 -------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                   ......    .++..+.++.+||.+||+.||.+||++.+++.|+||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                         000000    123467889999999999999999999999999999753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.4e-42  Score=309.49  Aligned_cols=249  Identities=26%  Similarity=0.346  Sum_probs=206.8

Q ss_pred             cceeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++|.+.+.||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.+++.+. ||||+++++++.+ ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCc
Confidence            4588899999999999999987544   3468999885432  3455678999999999998 9999999998875 457


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++.... .+++..+..++.+++.||.|||+.|++||||||+||++   +.++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeecc
Confidence            89999999999999997644 58999999999999999999999999999999999999   677899999999998765


Q ss_pred             CCCccc--cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQIFT--DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ......  ...++..|+|||.+. ..++.++||||||+++|||++ |..||.+....+....+.++...   .....++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~  235 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCPP  235 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCH
Confidence            443222  223346799999887 468999999999999999986 99999888877777666654322   22345789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.++|.+||..+|++|||+.++++.+
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l  262 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQL  262 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=309.56  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=208.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ++|++.+.||+|+||.||+|.+..++.    .+|+|.+....  .......+.+|+.+++.+. ||||+++++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cc
Confidence            458899999999999999999876665    58999876543  3445678889999999997 9999999998887 78


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+++++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||++   ++++.+||+|||.+...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcccccc
Confidence            89999999999999998764 468999999999999999999999999999999999999   77889999999999876


Q ss_pred             CCCCccc---cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          254 KPGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       254 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      .......   ...++..|+|||.+. ..++.++|+||||+++|||++ |..||.+....+....+..+....   .....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  236 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP---QPPIC  236 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC---CCCCC
Confidence            4332211   122356799999886 568999999999999999998 999998888777777776543221   12346


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.++.+++.+||..||++||++.++++.
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~  264 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELINE  264 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            7899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.1e-42  Score=308.77  Aligned_cols=247  Identities=21%  Similarity=0.294  Sum_probs=194.9

Q ss_pred             ceecccCCeEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEecc
Q 017960          105 RKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      +.||+|+||.||+|...  .++..+|+|.+....  .......+.+|+.++++++ ||||+++++++.+....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECC
Confidence            36999999999999854  345679999886543  2334457888999999998 999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          183 AGGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       183 ~~~~L~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ++++|.+++....     ..++..+..++.|++.||+|||+.+++||||||+||++   +.++.+||+|||++.......
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcc
Confidence            9999999986532     35667888999999999999999999999999999999   778899999999987543322


Q ss_pred             c---cccCccCCcccccccccc--------cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHc-CCcccCCCC
Q 017960          258 I---FTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK-GHIDFESDP  324 (363)
Q Consensus       258 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~  324 (363)
                      .   .....++..|+|||++.+        .++.++|+||||+++|||++ |..||......+....... .........
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence            1   123456788999998852        25789999999999999996 9999977665554433222 222222221


Q ss_pred             -CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       325 -~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                       ....++.+.+++.+|+ .+|++|||++||+..+-
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence             1246788999999998 68999999999997653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.6e-42  Score=305.74  Aligned_cols=246  Identities=25%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+.||.|+||.||+|.+. ++..+|+|.+.....    ....+.+|+++++++. ||||+++++++......++||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEE
Confidence            4888899999999999999874 467899998864332    2356888999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||+++++|.+++... +.+++..+..++.+++.||+|||+.+++||||||+||++   +.++.+||+|||.+........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc
Confidence            999999999988764 468999999999999999999999999999999999999   7788999999999876543221


Q ss_pred             --cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          259 --FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       259 --~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        .....++..|+|||.+. +.++.++||||||+++|||++ |..||.........+.+..+......   ...+.++.+
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYE  232 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHH
Confidence              11223456899999887 568999999999999999998 99999888777777777654322221   246889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCC
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      |+.+||+.+|++|||+.++++.+
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHhh
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-41  Score=306.41  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=207.0

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+ ..+..+|+|.+...    ......+.+|+.+++.+. |+||+++++.+.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCC----hhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeE
Confidence            456799999999999999999985 45667999988643    233567889999999997 9999999999887 7789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||.+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeecc
Confidence            999999999999998763  347888999999999999999999999999999999999   778899999999997654


Q ss_pred             CCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ....  .....++..|+|||.+. +.++.++|+|||||++|++++ |..||.+.........+..+...   +.....+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  230 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPE  230 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCcccCCH
Confidence            3321  11233456799999987 458999999999999999998 99999888777777666554321   22245789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+++.+||+.+|++||++.+++..+
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~~L  257 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQSVL  257 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHHH
Confidence            999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-43  Score=329.46  Aligned_cols=259  Identities=31%  Similarity=0.510  Sum_probs=226.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ..|..++.||-|+||+|.++....+...||+|.+.+.....+.++..++.|-.||.... .+-||+|+-.|++++.+|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEE
Confidence            35888999999999999999998999999999999888888888889999999999987 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC----
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK----  254 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~----  254 (363)
                      |||++||++..+|.+.+-|.+..++.++..|..|+++.|+.|+|||||||+||||   |.+|++||.|||+++-+.    
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence            9999999999999999999999999999999999999999999999999999999   999999999999986431    


Q ss_pred             -----CCCc----------------------------------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHH
Q 017960          255 -----PGQI----------------------------------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYIL  294 (363)
Q Consensus       255 -----~~~~----------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~el  294 (363)
                           .+..                                  ....+||+.|+|||++.+ .|+..+|.||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 1100                                  013579999999999984 699999999999999999


Q ss_pred             HhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccC
Q 017960          295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCMYNLPVL  362 (363)
Q Consensus       295 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~evL~~~~~~~~  362 (363)
                      +.|+.||-..+.-+....+..............+++++.++|.++++ +++.|.   .++||-.|+||+-+
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence            99999998877766666666655555555566799999999998654 566776   57789999999754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.5e-42  Score=317.29  Aligned_cols=256  Identities=30%  Similarity=0.452  Sum_probs=207.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-CCeE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCV  175 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~  175 (363)
                      +.++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .....+.+..|+.+++.++ ||||+++.+++.. ....
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLEDI   85 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCcE
Confidence            56779999999999999999999999999999998865322 2334567889999999998 9999999998865 5678


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +++|||+ +++|.+.+. ...+++..+..++.||+.||.|||+.||+||||+|+||++   ++++.++|+|||.+.....
T Consensus        86 ~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          86 YFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCC
Confidence            9999998 668877665 3467889999999999999999999999999999999999   7888999999999876432


Q ss_pred             CCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG-----------------  316 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------  316 (363)
                        ......++..|+|||.+.+  .++.++|||||||++|+|++|..||.+.........+.+.                 
T Consensus       161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence              2234567889999998764  5899999999999999999999999766543222211110                 


Q ss_pred             ---------Ccc-cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          317 ---------HID-FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       317 ---------~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                               ... ......+.+++++.++|.+||+.+|++||++.+++.++|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~  293 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP  293 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence                     000 000112356789999999999999999999999999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=304.17  Aligned_cols=243  Identities=25%  Similarity=0.345  Sum_probs=203.7

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      ++||.|+||.||+|.+.. ++.||+|.+....  .......+.+|+.+++++. |+||+++++++.+....++||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL--PPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCC
Confidence            469999999999999876 9999999886543  2245678999999999998 99999999999999999999999999


Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc---c
Q 017960          185 GELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF---T  260 (363)
Q Consensus       185 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~---~  260 (363)
                      ++|.+++... ..+++..+..++.+++.||.|||+++++||||||+||++   +.++.+||+|||++.........   .
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccc
Confidence            9999998663 457899999999999999999999999999999999999   77889999999999765422211   1


Q ss_pred             cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          261 DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       261 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ....+..|+|||.+. +.++.++|+||||+++|+|++ |..||...........+..... .  .....++.++.+++.+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~  230 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-M--PAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-C--CCCccCCHHHHHHHHH
Confidence            122355799999887 468999999999999999999 8999988777666666654321 1  1223578899999999


Q ss_pred             hcccCcCCCCCHHHHhcCC
Q 017960          339 MLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~  357 (363)
                      ||+.+|++||++.|+++.+
T Consensus       231 ~l~~~p~~Rp~~~ell~~l  249 (251)
T cd05041         231 CWAYDPENRPSFSEIYNEL  249 (251)
T ss_pred             HhccChhhCcCHHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.6e-42  Score=317.31  Aligned_cols=254  Identities=20%  Similarity=0.237  Sum_probs=199.7

Q ss_pred             eecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       102 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      .+++.+|.|  |.||.+++..+++.||||++..... .......+.+|+.+++.++ |+||+++++++.+.+..+++|||
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEec
Confidence            344445444  4555556567999999999976422 4556788999999999998 99999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          182 CAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       182 ~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||++   +.++.+||+|||.+.......  
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccccc
Confidence            9999999988753  458899999999999999999999999999999999999   777899999999886543221  


Q ss_pred             ------ccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC-------
Q 017960          258 ------IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-------  321 (363)
Q Consensus       258 ------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------  321 (363)
                            ......++..|+|||++..   .++.++|+|||||++|||++|..||..............+.....       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                  1223456778999999863   488999999999999999999999976554433222221111000       


Q ss_pred             -----------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          322 -----------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       322 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                             ......++.++.+|+.+||+.||++|||+.++|+|+||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                                   00001234678999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-42  Score=312.82  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=200.1

Q ss_pred             ceeecceecccCCeEEEEEEE----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--C
Q 017960          100 LYTLGRKLGQGQFGTTYLCTE----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--L  173 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~  173 (363)
                      .|++.+.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+. ||||+++++++...  .
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCC
Confidence            378899999999999999973    4578899999986442  3445578999999999997 99999999988775  6


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ..++||||++|++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccc
Confidence            7899999999999999886643 58999999999999999999999999999999999999   7788999999999986


Q ss_pred             cCCCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcC---------------HHHHHHH
Q 017960          253 FKPGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET---------------QQGIFDA  312 (363)
Q Consensus       253 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~---------------~~~~~~~  312 (363)
                      ......    .....++..|+|||.+. ..++.++|||||||++|||+++..|+....               .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            543321    12345667899999887 458999999999999999999876642211               0111122


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       313 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +..+.   ..+....++.++.+|+.+||+.||++||++.++++.+
T Consensus       239 ~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  280 (284)
T cd05079         239 LEEGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF  280 (284)
T ss_pred             HHcCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            22221   1122345789999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.9e-42  Score=306.14  Aligned_cols=242  Identities=28%  Similarity=0.382  Sum_probs=204.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.+.||+|+||.||++.  .+++.||+|.+...     .....+.+|+.++++++ ||||+++++++... ..+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-----chHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcEEE
Confidence            358999999999999999987  57889999998543     12357889999999998 99999999988665 47999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceecccc
Confidence            99999999999987643  47899999999999999999999999999999999999   77889999999998764322


Q ss_pred             CccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        ......+..|+|||.+. +.++.++|+|||||++|+|++ |..||......+....+.++...   .....+++++.+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  228 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM---EPPEGCPADVYV  228 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC---CCCCcCCHHHHH
Confidence              22334456899999887 468999999999999999997 99999888877777776654321   223457899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCC
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+||+.+|++||++.+++..+
T Consensus       229 li~~~l~~~p~~Rp~~~~l~~~l  251 (254)
T cd05083         229 LMTSCWETEPKKRPSFHKLREKL  251 (254)
T ss_pred             HHHHHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999998754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-41  Score=307.88  Aligned_cols=245  Identities=20%  Similarity=0.296  Sum_probs=194.8

Q ss_pred             eecccCCeEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          106 KLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.+. ||||+++++.+......++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeCC
Confidence            59999999999996432  34568888775432  3444567889999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          184 GGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       184 ~~~L~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      +++|.+++....     ..++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchh
Confidence            999999987643     24677889999999999999999999999999999999   7888999999999865432221


Q ss_pred             ---cccCccCCccccccccc--------ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCC-cccCCC-C
Q 017960          259 ---FTDVVGSPYYVAPEVLL--------KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH-IDFESD-P  324 (363)
Q Consensus       259 ---~~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~-~  324 (363)
                         .....++..|+|||++.        ..++.++|||||||++|||++ |..||......+....+.... ...+.. .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL  235 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence               12234567799999874        246889999999999999999 888998777666655544432 222222 1


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+++.+.+++..|+ .||++|||+.+|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            2357788999999998 5999999999999865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=312.13  Aligned_cols=253  Identities=30%  Similarity=0.462  Sum_probs=210.8

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |++.+.||+|++|.||+|++..+++.||+|++.... ......+.+..|+.+++.+. |+||+++++++.+....++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEec
Confidence            566788999999999999999999999999997653 12334467788999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-c
Q 017960          181 LCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~  258 (363)
                      |++ ++|.+++.+. ..+++..+..++.+++.||.|||+.||+||||+|+||++   ++++.++|+|||++....... .
T Consensus        79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCccc
Confidence            996 5899999876 579999999999999999999999999999999999999   778899999999987654332 3


Q ss_pred             cccCccCCccccccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc------------------
Q 017960          259 FTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI------------------  318 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  318 (363)
                      .....++..|+|||.+. . .++.++|||||||++|||++|..||.+....+.+..+.....                  
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            33455678899999886 3 689999999999999999999999987776555444332100                  


Q ss_pred             ccC-------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          319 DFE-------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       319 ~~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .++       ...++.++.++.++|.+||..||.+||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            000       01123457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-42  Score=310.61  Aligned_cols=241  Identities=21%  Similarity=0.251  Sum_probs=192.7

Q ss_pred             ceecccCCeEEEEEEEccCCc-------EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      +.||.|+||.||+|.+...+.       .+|+|.+...   .....+.+..|+.+++.+. ||||+++++++......++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEE
Confidence            369999999999999765443       4888877543   2344567888999999997 9999999999999899999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC-----CccEEEeecCcce
Q 017960          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-----DFSLKAIDFGLSV  251 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~-----~~~~kl~DFG~a~  251 (363)
                      ||||+++++|..++...+ .+++..+..++.||+.||.|||++||+||||||+||++..++.     ...++++|||++.
T Consensus        77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999999987654 5899999999999999999999999999999999999953221     1237999999987


Q ss_pred             ecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCC-CCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      .....   ....++..|+|||.+.+  .++.++||||||+++|+|++|. .||.......... ........+    ...
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~----~~~  228 (258)
T cd05078         157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP----APK  228 (258)
T ss_pred             ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCC----CCC
Confidence            65432   23567889999999874  4899999999999999999984 6665544433332 222222222    235


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.++.+||.+||+.||++|||++++++.+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         229 WTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            67899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-41  Score=306.73  Aligned_cols=242  Identities=18%  Similarity=0.206  Sum_probs=191.2

Q ss_pred             ceecccCCeEEEEEEEcc------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960          105 RKLGQGQFGTTYLCTEIA------------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      +.||+|+||.||+|+...            ....||+|.+...   .......+..|+.++..+. ||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            368999999999998432            2235888887543   2334557888999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC----CCccEEEeec
Q 017960          173 LCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----DDFSLKAIDF  247 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~----~~~~~kl~DF  247 (363)
                      ...++||||+++++|..++.. ...+++..+..++.||+.||+|||+.+|+||||||+|||+....    ....++++||
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999999887765 35689999999999999999999999999999999999994311    1123899999


Q ss_pred             CcceecCCCCccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHH-hCCCCCCCcCHHHHHHHHHcCCcccCCCC
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILL-SGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  324 (363)
                      |++.....   .....++..|+|||.+.  ..++.++|||||||++|||+ +|..||......+... ........    
T Consensus       157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~----  228 (262)
T cd05077         157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCML----  228 (262)
T ss_pred             CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccC----
Confidence            99865432   23456788899999886  35899999999999999998 5888887655443322 22222211    


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ....++++.+||.+||+.||.+||++.+++++++
T Consensus       229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1234678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-41  Score=305.38  Aligned_cols=244  Identities=25%  Similarity=0.362  Sum_probs=197.3

Q ss_pred             ceecccCCeEEEEEEEcc---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe-cCCeEEEEEe
Q 017960          105 RKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-DSLCVHIVME  180 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~~~~iv~e  180 (363)
                      +.||+|+||.||+|.+..   .+..||+|.+....  .....+.+.+|+.+++.++ ||||+++++++. .++..+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998653   34579999875322  3445678889999999997 999999999765 4566899999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          181 LCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       181 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      |+.+++|.+++... ...++..+..++.|++.||.|||+.+++||||||+|||+   ++++.+||+|||++.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce
Confidence            99999999998764 346778889999999999999999999999999999999   778899999999987543221  


Q ss_pred             ---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          258 ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       258 ---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                         ......++..|+|||.+. ..++.++|||||||++|||++ |.+||......+....+..+.....   ...+++.+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPL  231 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHH
Confidence               112334567899999886 468999999999999999999 5677777776666666655432211   12467899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+++.+||..+|++||++.+++..+
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~~l  256 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVSRI  256 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHHHH
Confidence            9999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-41  Score=309.38  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=197.7

Q ss_pred             ceeecceecccCCeEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CC
Q 017960          100 LYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SL  173 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~  173 (363)
                      .|++.+.||+|+||.||+|.    +..++..||+|.+...   .....+.+.+|+.+++.++ ||||+++++++..  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCC
Confidence            58889999999999999997    3457889999998643   3455678899999999998 9999999997643  45


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||++..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~  157 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKV  157 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccc
Confidence            689999999999999998764 458999999999999999999999999999999999999   7788999999999987


Q ss_pred             cCCCCcc----ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH----------------HHHH
Q 017960          253 FKPGQIF----TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ----------------GIFD  311 (363)
Q Consensus       253 ~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~----------------~~~~  311 (363)
                      .......    ....++..|+|||.+.+ .++.++||||||+++|||++|..|+......                ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            6433221    11223456999999874 5899999999999999999987775332211                0111


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       312 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                       +......  ......++.++.+||.+||..+|++|||+.++++.+
T Consensus       238 -~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05081         238 -LLKNNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV  280 (284)
T ss_pred             -HHhcCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence             1111111  112235788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.6e-41  Score=305.29  Aligned_cols=252  Identities=26%  Similarity=0.426  Sum_probs=210.6

Q ss_pred             eeecceecccCCeEEEEEEEcc-CCcEEEEEEeecccc-------CChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKL-------ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      |++.+.||+|+||.||+|.+.. .++.+|+|.+.....       .......++..|+.++.+..+||||+++++++.+.
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            7888999999999999999877 678999998854321       13344566788999887644499999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          173 LCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      +..+++|||+++++|.+.+..    ...+++..++.++.|++.||.|||+ .+++|+||+|+||++   +.++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEecc
Confidence            999999999999999887743    3468999999999999999999996 789999999999999   77889999999


Q ss_pred             CcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      |.+.............++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.........  ..
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~  236 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--EG  236 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--cc
Confidence            99987655444456678899999999874 5899999999999999999999999877766666666554433211  22


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+++++.++|.+||+.||++||++.|+..++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~  267 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAMI  267 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence            4688999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.5e-42  Score=308.69  Aligned_cols=247  Identities=25%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             ceecccCCeEEEEEEEccCC------cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATG------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.||+|+||.||+|++....      +.+|+|.+.+..  .......+.+|+.+++.+. ||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEE
Confidence            36999999999999976443      679999886432  2344567889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC--CCccEEEeecCc
Q 017960          179 MELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--DDFSLKAIDFGL  249 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~~kl~DFG~  249 (363)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++  ....++|+|||+
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999998642       2378899999999999999999999999999999999994322  223899999999


Q ss_pred             ceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCC
Q 017960          250 SVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       250 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  324 (363)
                      +........   .....++..|+|||.+. +.++.++|||||||++|||++ |..||......+....+..+...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~  234 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QK  234 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CC
Confidence            876533221   11234567899999887 468999999999999999998 99999877776666665543321   22


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...++..+.++|.+||.++|.+||+++++++.+
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  267 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL  267 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence            245789999999999999999999999998764

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-41  Score=309.18  Aligned_cols=240  Identities=18%  Similarity=0.192  Sum_probs=191.5

Q ss_pred             eecccCCeEEEEEEEccC------------------------CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc
Q 017960          106 KLGQGQFGTTYLCTEIAT------------------------GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN  161 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n  161 (363)
                      +||+|+||.||+|....+                        ...||+|++...   .......+.+|+.+++.++ |||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~-h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVS-HIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCC-CCC
Confidence            699999999999974321                        235888888543   2233457888999999998 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC----
Q 017960          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK----  236 (363)
Q Consensus       162 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~----  236 (363)
                      |+++++++.+....++||||+++++|..++.. .+.+++..+..++.||+.||+|||+.||+||||||+|||+...    
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999888865 4568999999999999999999999999999999999999531    


Q ss_pred             CCCccEEEeecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHH-hCCCCCCCcCHHHHHHHH
Q 017960          237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILL-SGVPPFWAETQQGIFDAV  313 (363)
Q Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell-~g~~pf~~~~~~~~~~~i  313 (363)
                      .....+||+|||++......   ....++..|+|||.+.+  .++.++|||||||++|||+ +|..||............
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence            12235899999988653222   23456788999998863  4899999999999999985 699999876655443332


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .. ....+    ...++++.++|.+||+.+|++|||+.++|+.+
T Consensus       235 ~~-~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         235 EK-KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             Hh-ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            22 21111    12457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-44  Score=304.17  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=213.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-------
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-------  171 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-------  171 (363)
                      ..|+-..+||+|.||.||+|+.+.+++.||+|++-.+.. ....-....+|+++|..|. |+|++.+++.|..       
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCccc
Confidence            347778899999999999999999999999998754322 1122345678999999998 9999999987742       


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 -SLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 -~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                       ...+|+||++|+. +|.-.|... -+++..++..+++++..||.|+|+..|+|||+||+|+||   +.++.+||+|||+
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGl  170 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGL  170 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecccc
Confidence             3459999999954 787777554 569999999999999999999999999999999999999   8899999999999


Q ss_pred             ceecCCC-----CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          250 SVFFKPG-----QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       250 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      ++.+...     ..++..+.|.+|++||.+.+  .|+++.|||+.||+|.||++|.+.+.+.+....+..|..-.-.+..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9655322     23566778999999999884  6999999999999999999999999999988887777654444444


Q ss_pred             CCCCCC-------------------------------CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          323 DPWPLI-------------------------------SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       323 ~~~~~~-------------------------------~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +.||.+                               ++++.+|+.+||..||.+|++++++|.|.||.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            444321                               34788999999999999999999999999984

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-41  Score=311.70  Aligned_cols=249  Identities=20%  Similarity=0.282  Sum_probs=203.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.|+..+.||+|+||.||+|.+..++.    .||+|.+....  .......+.+|+.+++.+. ||||+++++++... .
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-C
Confidence            347888999999999999999877776    46888775432  3334457889999999997 99999999988654 4


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccccc
Confidence            678999999999999987644 58899999999999999999999999999999999999   77788999999999865


Q ss_pred             CCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          254 KPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       254 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      .....   .....++..|+|||.+. ..++.++||||||+++|||++ |..||.+.......+.+..+... +  ..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL-P--QPPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-C--CCCCC
Confidence            43321   12234567899999887 468999999999999999997 99999877766665555543322 1  22356


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +..+.+++.+||..+|++||++.++++.+
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l  265 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAEF  265 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            78999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=332.61  Aligned_cols=245  Identities=28%  Similarity=0.421  Sum_probs=200.1

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC------e
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL------C  174 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~------~  174 (363)
                      +...+.||+||||.||+++++.+|+.||||.+.+..  .....+++.+|+++|++|. |+|||+++++-++..      .
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCccccc
Confidence            566788999999999999999999999999997654  5566789999999999998 999999999866544      4


Q ss_pred             EEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC-CCccEEEeecCcc
Q 017960          175 VHIVMELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLS  250 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~~kl~DFG~a  250 (363)
                      ..+|||||.||+|...|.+.   ..+++.+.+.++..+..||.|||++||+||||||.||++.... .....||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            68999999999999999753   3489999999999999999999999999999999999995432 4457899999999


Q ss_pred             eecCCCCccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-----HHHHHHHcCCcc----
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-----GIFDAVLKGHID----  319 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~~----  319 (363)
                      +..+++....+.+||+.|.+||.+.  +.|+..+|.|||||++|+++||..||......     -+...+.+....    
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            9999999999999999999999998  45999999999999999999999999543222     223333221110    


Q ss_pred             ----------cC--CCC----CCCCCHHHHHHHHHhcccCcCCCC
Q 017960          320 ----------FE--SDP----WPLISDSAKDLIRKMLCSQPSERL  348 (363)
Q Consensus       320 ----------~~--~~~----~~~~~~~~~~li~~~l~~dp~~R~  348 (363)
                                +.  .+.    .+.+-..+...+..+|..+|++|.
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                      00  000    011123456788899999999998

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=300.85  Aligned_cols=256  Identities=25%  Similarity=0.445  Sum_probs=227.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|.+.++||+|+|++|.+++.+.+.+.||+|+++++.+...+++.-+..|-.+..+.++||.+|-++.+|+....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            45899999999999999999999999999999999988888888888899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee-cCCCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~-~~~~~  257 (363)
                      .||++||+|.-++.+.++++++.++.+...|+.||.|||+.|||+||||.+|||+   |..|++||.|+|+++. +.++.
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCCc
Confidence            9999999999999999999999999999999999999999999999999999999   9999999999999876 35667


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCC-------C-cCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFW-------A-ETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~-------~-~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ...+++|||.|.|||++++ .|+..+|.|+||++|+||+.|+.||.       . .++.=+++.|....+.++.    .+
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----sl  482 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SL  482 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----ee
Confidence            7888999999999999995 69999999999999999999999993       1 2222345555555544432    46


Q ss_pred             CHHHHHHHHHhcccCcCCCC------CHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSERL------TAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~------s~~evL~~~~~~~  361 (363)
                      +-.+..+++..|++||.+|.      .+.++-.|+||..
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            77888999999999999996      4678888888864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=308.15  Aligned_cols=265  Identities=26%  Similarity=0.421  Sum_probs=211.8

Q ss_pred             cccccccc-cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcC-------CCce
Q 017960           91 GHKTDNIR-DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-------HKNI  162 (363)
Q Consensus        91 ~~~~~~~~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-------h~ni  162 (363)
                      ..+++.|. .+|.+.++||-|-|++||+|+|....+.||+|+++-    .+...+....||++|++++.       ..+|
T Consensus        69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V  144 (590)
T KOG1290|consen   69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCV  144 (590)
T ss_pred             eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence            35677777 899999999999999999999999999999999863    34556778899999999983       2479


Q ss_pred             eEEeEEEe----cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeee
Q 017960          163 VTIKGAYE----DSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVN  235 (363)
Q Consensus       163 v~~~~~~~----~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~  235 (363)
                      |+|++.|.    .+.++|||+|++ |.+|+.+|...  +.++...+++|++||+.||.|||+ .||||.||||+|||+..
T Consensus       145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS  223 (590)
T ss_pred             eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence            99999996    456899999999 88999999875  348999999999999999999996 69999999999999943


Q ss_pred             CC------------------------------------------------------------------------------
Q 017960          236 KD------------------------------------------------------------------------------  237 (363)
Q Consensus       236 ~~------------------------------------------------------------------------------  237 (363)
                      .+                                                                              
T Consensus       224 ~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~  303 (590)
T KOG1290|consen  224 TEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESY  303 (590)
T ss_pred             cccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccc
Confidence            31                                                                              


Q ss_pred             --------------------------------------------------------------------------------
Q 017960          238 --------------------------------------------------------------------------------  237 (363)
Q Consensus       238 --------------------------------------------------------------------------------  237 (363)
                                                                                                      
T Consensus       304 n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~  383 (590)
T KOG1290|consen  304 NNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPD  383 (590)
T ss_pred             ccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCC
Confidence                                                                                            


Q ss_pred             -----CCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC------
Q 017960          238 -----DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET------  305 (363)
Q Consensus       238 -----~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~------  305 (363)
                           .+..|||+|||-|+...  ..++..+.|+.|+|||++.+ .|++.+||||++|++|||+||...|....      
T Consensus       384 ~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r  461 (590)
T KOG1290|consen  384 IPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR  461 (590)
T ss_pred             CCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence                 01247899999888753  56778889999999999986 69999999999999999999999984322      


Q ss_pred             HHHHHHHHHc------------CCcc-------------cCCCCCC---------CCC----HHHHHHHHHhcccCcCCC
Q 017960          306 QQGIFDAVLK------------GHID-------------FESDPWP---------LIS----DSAKDLIRKMLCSQPSER  347 (363)
Q Consensus       306 ~~~~~~~i~~------------~~~~-------------~~~~~~~---------~~~----~~~~~li~~~l~~dp~~R  347 (363)
                      +++.+..|..            ++..             -....|+         .++    .++.+||.-||+.+|++|
T Consensus       462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR  541 (590)
T KOG1290|consen  462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR  541 (590)
T ss_pred             cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence            1222222211            1100             0011222         122    467899999999999999


Q ss_pred             CCHHHHhcCCCcccC
Q 017960          348 LTAHEVLCMYNLPVL  362 (363)
Q Consensus       348 ~s~~evL~~~~~~~~  362 (363)
                      |||.++|+|||+..+
T Consensus       542 ~tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  542 PTAAQCLKHPWLNPV  556 (590)
T ss_pred             ccHHHHhcCccccCC
Confidence            999999999999653

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-41  Score=304.28  Aligned_cols=236  Identities=18%  Similarity=0.200  Sum_probs=191.7

Q ss_pred             ceecccCCeEEEEEEEccCC----------cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960          105 RKLGQGQFGTTYLCTEIATG----------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.||+|+||.||+|.+..++          ..+++|.+....    .....+.+|+.+++.+. ||||+++++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCC-CcchhheeeEEec-CC
Confidence            46999999999999987766          357788765432    12578889999999997 9999999999888 77


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc-------cEEEee
Q 017960          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-------SLKAID  246 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-------~~kl~D  246 (363)
                      .++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++   +.++       .+||+|
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill---~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV---ARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEE---ecCccccCCceeEEeCC
Confidence            899999999999999998766 68999999999999999999999999999999999999   4444       799999


Q ss_pred             cCcceecCCCCccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      ||++.....   .....++..|+|||.+..   .++.++||||||+++|+|++ |..||................ ..+.
T Consensus       152 fg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~  227 (259)
T cd05037         152 PGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RLPM  227 (259)
T ss_pred             CCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-CCCC
Confidence            999986543   223456778999999873   48999999999999999999 688886654433333322111 1111


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                          .....+.++|.+||..+|.+|||+.++++.+
T Consensus       228 ----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         228 ----PDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                1237899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=300.83  Aligned_cols=251  Identities=24%  Similarity=0.259  Sum_probs=212.4

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      ...||.|+||+|++..++.+|+..|||.++...  .+...+++..|.+...+-.++||||+++|....++..||.||+| 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-  145 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-  145 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence            567999999999999999999999999997654  45567889999999888888999999999999999999999999 


Q ss_pred             CCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          184 GGELFDRI-----IQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       184 ~~~L~~~l-----~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ..||..+-     .+...++++.+..|....+.||.||-+ .+|||||+||+|||+   +..|.+||||||.+..+.++-
T Consensus       146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHH
Confidence            55663322     235679999999999999999999975 689999999999999   899999999999998876655


Q ss_pred             ccccCccCCccccccccc--c-cCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcccCCCCC--CCCCHH
Q 017960          258 IFTDVVGSPYYVAPEVLL--K-HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPW--PLISDS  331 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~--~-~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~--~~~~~~  331 (363)
                      ..+..+|-..|||||.+.  + .|+.++||||||++|||+.||+.||.+-. ..+.+..+..+.++......  -.++..
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~  302 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS  302 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence            566678999999999986  3 49999999999999999999999996533 34555666666655433221  247889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +..+|..||-+|-..||+..++++++|+.
T Consensus       303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  303 MVRFINTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             HHHHHHHHhhcccccCcchhhhhcCchhh
Confidence            99999999999999999999999999875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-41  Score=304.82  Aligned_cols=252  Identities=27%  Similarity=0.412  Sum_probs=208.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      +|.+.+.||+|+||.||+|.+...+..+++|+++.....  .......+..|+.+++.++ ||||+++++++.+....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            488899999999999999998887777777776543221  2223446778999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ||||+++++|.+.+..    ...+++..+..++.|++.||.|||+.|++|+||+|+||++   ++ +.++|+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili---~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL---KN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEe---ec-CCEeecccCceeec
Confidence            9999999999888753    3568999999999999999999999999999999999999   43 45999999998775


Q ss_pred             CCCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          254 KPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       254 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+..+.....   ...++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL---PETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC---cchhcHH
Confidence            4332 2334567889999998864 588899999999999999999999987766666665554432221   2356789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +.++|.+||+.||++||++.++++|+|+
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.1e-41  Score=309.16  Aligned_cols=252  Identities=15%  Similarity=0.148  Sum_probs=189.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhH--------HHHHHHHHHHHHhcCCCceeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDV--------EDVRREIQIMHHLAGHKNIVT  164 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~~h~niv~  164 (363)
                      ...++|++.++||+|+||.||+|.+..+   +..+|+|+............        .....++..+..+. |++|++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCc
Confidence            3456799999999999999999998777   66778876433221110000        11122333444455 999999


Q ss_pred             EeEEEecCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          165 IKGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       165 ~~~~~~~~~----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      +++.+....    ..++++|++ ..++.+.+......++..+..++.|++.||.|||+.+|+||||||+|||+   +.++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~~  163 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGNN  163 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCC
Confidence            998765443    457888887 45677766665557889999999999999999999999999999999999   7778


Q ss_pred             cEEEeecCcceecCCCC--------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-H--
Q 017960          241 SLKAIDFGLSVFFKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ-G--  308 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~--  308 (363)
                      .++|+|||+|.......        ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.... .  
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999999997653221        1123468999999999874 5999999999999999999999999776322 2  


Q ss_pred             ------HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 ------IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                            ....+..+..     ..+..++++.+++..|+..+|++||+++++++.+
T Consensus       244 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                  1222222222     2235689999999999999999999999998753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7.7e-43  Score=319.80  Aligned_cols=276  Identities=22%  Similarity=0.332  Sum_probs=230.4

Q ss_pred             cccCCCCcceeeecccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc
Q 017960           78 MRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA  157 (363)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~  157 (363)
                      +...|++..-++-....+.+..+|.+....|+|-|++|..|.+...|..||||+|..    ++...+.-.+|+++|++|.
T Consensus       411 L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn----NE~M~KtGl~EleiLkKL~  486 (752)
T KOG0670|consen  411 LQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN----NEVMHKTGLKELEILKKLN  486 (752)
T ss_pred             cccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec----chHHhhhhhHHHHHHHHhh
Confidence            344566655555556777888999999999999999999999999999999999976    4455677788999999997


Q ss_pred             C-----CCceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCC
Q 017960          158 G-----HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKPE  229 (363)
Q Consensus       158 ~-----h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~  229 (363)
                      .     .-+++.++..|...+++|||+|.+ ..+|.+.|.+.|.   +....+..++.||+-||..|-..||+|.||||+
T Consensus       487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPD  565 (752)
T KOG0670|consen  487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPD  565 (752)
T ss_pred             ccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCcc
Confidence            2     458999999999999999999998 6799999988664   788999999999999999999999999999999


Q ss_pred             ceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH
Q 017960          230 NFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQG  308 (363)
Q Consensus       230 NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  308 (363)
                      ||||+  .....+||||||.|.....+. .+.+..+.-|+|||++.+ .|+...|+||.||+||||+||+..|.|.+...
T Consensus       566 NiLVN--E~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~  642 (752)
T KOG0670|consen  566 NILVN--ESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ  642 (752)
T ss_pred             ceEec--cCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence            99995  445689999999998876544 456677888999999997 69999999999999999999999999998887


Q ss_pred             HHHHHHcCCcccCCCCC-------------------------------------------------CCCC-------HHH
Q 017960          309 IFDAVLKGHIDFESDPW-------------------------------------------------PLIS-------DSA  332 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~-------------------------------------------------~~~~-------~~~  332 (363)
                      ++.....-.-.++...+                                                 +.++       ..+
T Consensus       643 MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~  722 (752)
T KOG0670|consen  643 MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQL  722 (752)
T ss_pred             HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHH
Confidence            77655442222221100                                                 0011       357


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||.+||..||++|+|..++|.||||+.
T Consensus       723 rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  723 RDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            89999999999999999999999999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.2e-42  Score=289.32  Aligned_cols=255  Identities=27%  Similarity=0.489  Sum_probs=211.5

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCe
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLC  174 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~  174 (363)
                      -.+.|++.+++|+|.++.||.|....+++.++||++++-      ..+.+.+|+++|..|++||||++++++..+  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            346699999999999999999999999999999999643      357899999999999999999999998865  456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ..+|+||+++.+... |  -..++...+..++.+|+.||.|+|+.||+|||+||.|++|+  .+...++|+|+|+|.+..
T Consensus       110 paLiFE~v~n~Dfk~-l--y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQ-L--YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             chhHhhhhccccHHH-H--hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcC
Confidence            789999997765543 3  23578899999999999999999999999999999999995  345689999999999999


Q ss_pred             CCCccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCC-CcCHHHHHHHHHc-------------CCc
Q 017960          255 PGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLK-------------GHI  318 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~-------------~~~  318 (363)
                      ++..+.-.+.++.|-.||.+.  ..|+..-|+|||||+|+.|+..+.||. |....+.+-.|.+             -.+
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            999888889999999999997  469999999999999999999999985 3333333322221             111


Q ss_pred             ccC--------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          319 DFE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       319 ~~~--------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ...                    .+....+++++.|||.++|..|.++|+|++|++.||||..+
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            111                    01112356999999999999999999999999999999654

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=301.26  Aligned_cols=246  Identities=20%  Similarity=0.290  Sum_probs=194.5

Q ss_pred             eecccCCeEEEEEEEccCC--cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          106 KLGQGQFGTTYLCTEIATG--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .||+|+||.||+|.....+  ..+++|.+....  .....+.+.+|+.+++.++ ||||+++++.+.+....++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCC
Confidence            5999999999999754332  346666664432  3344678899999999997 9999999999999999999999999


Q ss_pred             CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          184 GGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       184 ~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      +++|.+++.+.    ..+++..+..++.||+.||+|||+.+++||||||+|||+   +.++.+||+|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh
Confidence            99999998754    235677888999999999999999999999999999999   778899999999986432211  


Q ss_pred             -ccccCccCCcccccccccc--------cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCc-ccC-CCCC
Q 017960          258 -IFTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI-DFE-SDPW  325 (363)
Q Consensus       258 -~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~-~~~-~~~~  325 (363)
                       ......++..|+|||++..        .++.++|||||||++|||++ |..||......+.+..+.++.. ... ....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence             1234567889999998742        35789999999999999997 5778877777666666544332 211 1122


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ..+++.+.+++..|| .+|++||+++++++.+.
T Consensus       236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            346888999999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7e-41  Score=302.98  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             eeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC----
Q 017960          101 YTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----  173 (363)
                      |++.+.||+|+||.||+|.+.   .+++.||||++.... ......+++.+|+.+++.+. ||||+++++++....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence            567889999999999999864   357899999986543 24455678899999999998 999999999875432    


Q ss_pred             --eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEe
Q 017960          174 --CVHIVMELCAGGELFDRIIQR------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (363)
Q Consensus       174 --~~~iv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~  245 (363)
                        ..++++||+.+++|.+++...      ..++...+..++.|++.||+|||+.||+||||||+||++   +.++.+||+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEEC
Confidence              347889999999998876432      147889999999999999999999999999999999999   778899999


Q ss_pred             ecCcceecCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCccc
Q 017960          246 DFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       246 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                      |||++.....+..   .....+++.|++||.+.. .++.++|||||||++|+|++ |..||.+....+....+.......
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999886543321   122344578999998874 58899999999999999999 899998877777776666543221


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                         ..+..++.+.+++.+||+.+|++|||+.+++..+
T Consensus       236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l  269 (273)
T cd05074         236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL  269 (273)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence               1235678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.6e-41  Score=305.11  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=202.0

Q ss_pred             cceeecceecccCCeEEEEEEEc----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--C
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--S  172 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~  172 (363)
                      +.|++.+.||+|+||.||+|...    .++..+|+|.+.....  ....+.+.+|+.+++.+. |+||+++++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCC
Confidence            34778899999999999999854    3478999999975432  235678999999999997 9999999999877  6


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ...+++|||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||++   +.++.++|+|||.+.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~  157 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK  157 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccc
Confidence            67999999999999999987654 58999999999999999999999999999999999999   778899999999998


Q ss_pred             ecCCCCcc----ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH---------------HHHH
Q 017960          252 FFKPGQIF----TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ---------------GIFD  311 (363)
Q Consensus       252 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---------------~~~~  311 (363)
                      ........    ....++..|+|||.+. ..++.++||||||+++|||++|..|+......               ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76533221    1223456799999887 46899999999999999999999998543221               1222


Q ss_pred             HHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       312 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+.. ....+  ....++.++.+|+.+||+.+|++|||+.|+++.+
T Consensus       238 ~~~~-~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l  280 (284)
T cd05038         238 LLKE-GERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV  280 (284)
T ss_pred             HHHc-CCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            2222 21111  1234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.6e-41  Score=297.83  Aligned_cols=228  Identities=24%  Similarity=0.317  Sum_probs=188.5

Q ss_pred             cCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCChHH
Q 017960          110 GQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD  189 (363)
Q Consensus       110 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~  189 (363)
                      |.+|.||+|.+..+++.||+|.+....        ...+|...+.... ||||+++++++.+....++||||++|++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999999999999999997542        1223444444444 9999999999999999999999999999999


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCccc
Q 017960          190 RIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV  269 (363)
Q Consensus       190 ~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~  269 (363)
                      ++.+...+++..+..++.|++.||.|||+.||+||||||+||++   +.++.++|+|||.+......  .....++..|+
T Consensus        75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccc--cccCCcCcccc
Confidence            99887789999999999999999999999999999999999999   77888999999987654332  23445677899


Q ss_pred             cccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCC
Q 017960          270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL  348 (363)
Q Consensus       270 aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  348 (363)
                      |||.+. ..++.++|+||+|+++|||++|+.|+......     + ......  .....+++.+.++|.+||+.||++||
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTL--NIPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-cccccc--CCcccCCHHHHHHHHHHccCCHHHhc
Confidence            999987 45899999999999999999999887543221     0 000011  11234788999999999999999999


Q ss_pred             CH-----HHHhcCCCc
Q 017960          349 TA-----HEVLCMYNL  359 (363)
Q Consensus       349 s~-----~evL~~~~~  359 (363)
                      ++     +++++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            86     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=316.10  Aligned_cols=248  Identities=27%  Similarity=0.423  Sum_probs=212.3

Q ss_pred             cceeecceecccCCeEEEEEEEcc--CC--cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIA--TG--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +..++.+.||.|.||.||+|....  .|  -.||||..+...  .....+.|..|..+|+.+. ||||++++|++.+. .
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfd-HphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCC-Ccchhheeeeeecc-c
Confidence            446678899999999999998432  23  358888876543  5566889999999999998 99999999988765 5


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .|||||+++-|.|.++|+.+. .++......++.||+.||.|||+.++|||||...|||+   .....|||+|||+++..
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRYL  541 (974)
T ss_pred             eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhhc
Confidence            899999999999999998764 58899999999999999999999999999999999999   55668999999999998


Q ss_pred             CCCCccccCcc--CCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          254 KPGQIFTDVVG--SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       254 ~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      .+...+..-.|  ..-|||||.++ ++++.++|||-||++|||++. |..||.+-...+++-.+.+|.-   .+..+.+|
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---lP~P~nCP  618 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---LPCPPNCP  618 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC---CCCCCCCC
Confidence            87776654444  34699999998 889999999999999999877 9999999888888877777653   33345789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.+..|+.+||..||.+||.+.++...
T Consensus       619 p~LYslmskcWayeP~kRPrftei~~~  645 (974)
T KOG4257|consen  619 PALYSLMSKCWAYEPSKRPRFTEIKAI  645 (974)
T ss_pred             hHHHHHHHHHhccCcccCCcHHHHHHH
Confidence            999999999999999999999888653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-42  Score=327.30  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=219.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ...|.++||.|.||.||+|..+..+   ..||||.++...  .+.+...|..|..||-++. ||||+++.|+......++
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeE
Confidence            3677899999999999999987666   459999996543  6777789999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||+|||++|+|..+|+. .+.|+..++.-+++.|+.|+.||.+.++|||||...||||   +.+..+|++|||+++.+.+
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeeccc
Confidence            99999999999999976 4679999999999999999999999999999999999999   8999999999999998755


Q ss_pred             CC--ccccCcc--CCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          256 GQ--IFTDVVG--SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       256 ~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      +.  .+++.-|  ..+|.|||.+. +.++.++||||+|++|||.++ |+.|||....+++++.|.++-   ..++...+|
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPpPmDCP  860 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPPPMDCP  860 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCCCCCCc
Confidence            44  2222222  46899999887 789999999999999999887 999999999999999998874   334445789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+.+|+..||++|-.+||.+.+|+.++
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~l  888 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVSTL  888 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence            9999999999999999999999998754

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=307.75  Aligned_cols=254  Identities=22%  Similarity=0.346  Sum_probs=212.1

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      .++...++++||+|-||.|.+|.- ..+..||||.++...  .......|.+|+++|.+|+ ||||+.++++|..++.++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchH
Confidence            345678899999999999999993 456899999997665  4455689999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +|+||+++|+|..++.+..  .+.......|+.||+.|++||.+.++|||||.+.|+|+   +.++++||+|||+++.+-
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccc
Confidence            9999999999999998763  23456677799999999999999999999999999999   999999999999999765


Q ss_pred             CCCccc---cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCcCHHHHHHHHHcCCc----ccCCCC
Q 017960          255 PGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS--GVPPFWAETQQGIFDAVLKGHI----DFESDP  324 (363)
Q Consensus       255 ~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~--g~~pf~~~~~~~~~~~i~~~~~----~~~~~~  324 (363)
                      .+..+.   ..+-..+|||||.+. ++++.++|+|+||++|||+++  ...||....+++..+....-..    ..-...
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccC
Confidence            554432   234567899999766 889999999999999999765  7889988887777665533111    111223


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+.++.++.+++.+||..|..+||+++++..++
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l  801 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFL  801 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence            356889999999999999999999999987654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=306.93  Aligned_cols=263  Identities=29%  Similarity=0.459  Sum_probs=220.9

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC----ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe-
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-  170 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-  170 (363)
                      .+.++|-+..+||+|+|+.||+|.+....++||||+-...+..    .+...+...+|..|-+.|. ||.||+++++|. 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyfsl  538 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYFSL  538 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeeeee
Confidence            4668899999999999999999999999999999987543321    2233456789999999998 999999999995 


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      +.+.+|-|+|||+|.+|..+|+..+.+++++++.|+.||+.||.||.+..  |||-||||.|||+.+.+..|.+||.|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            56679999999999999999999999999999999999999999999875  9999999999999887889999999999


Q ss_pred             cceecCCCC--------ccccCccCCccccccccc-c----cCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHH--
Q 017960          249 LSVFFKPGQ--------IFTDVVGSPYYVAPEVLL-K----HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDA--  312 (363)
Q Consensus       249 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~----~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~--  312 (363)
                      +++.+.++.        ......||.+|++||.+. +    ..+.++||||+|||+|..+.|+.||...- ..++++.  
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            999876543        234578999999999875 3    37899999999999999999999995432 3333322  


Q ss_pred             HH-cCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          313 VL-KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       313 i~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |. .....|+..  +.++.++++||++||..--++|+...++.++++|..
T Consensus       699 IlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  699 ILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            22 233334433  578999999999999999999999999999998853

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-41  Score=316.04  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=213.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +..++.++||+|+||+|++|.+...+   ..||||.++.....  .....|.+|+.+|.+|+ |+|++++||+..+ ...
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chh
Confidence            44677899999999999999987533   46999999765432  25688999999999998 9999999998877 678


Q ss_pred             EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          176 HIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .+|||++++|+|.+.|.+  ...|.......++.||+.|+.||.++++|||||-..|||+.   ....|||+|||+.+.+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceecc
Confidence            899999999999999987  34588899999999999999999999999999999999994   4568999999999988


Q ss_pred             CCCCccccCc----cCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          254 KPGQIFTDVV----GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       254 ~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ..++.+....    ....|+|||.+. +.++.++|||++||++|||++ |+.||.|.....+++.|..+..   ....+.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er---LpRPk~  339 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER---LPRPKY  339 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc---CCCCCC
Confidence            7665443322    245699999998 679999999999999999999 8999999999999999885543   233356


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      +++++.+++..||.++|++|||+..|.+...+
T Consensus       340 csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            89999999999999999999999988654433

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=309.27  Aligned_cols=243  Identities=25%  Similarity=0.388  Sum_probs=215.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      ..+..+||-|.||.||.|.++.-.-.||||.++.    +...+++|..|..+|+.+. |||+|+++|+|..+..+|||+|
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEe
Confidence            5566789999999999999999999999999864    4456789999999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          181 LCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||..|+|+++|.+-.  .++.-....++.||..|++||..+++|||||...|+|+   .++..|||+|||+++.+..+. 
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDT-  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDT-  419 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCc-
Confidence            999999999998743  36778889999999999999999999999999999999   888899999999999876543 


Q ss_pred             cccCcc---CCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          259 FTDVVG---SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       259 ~~~~~g---t~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ++.-.|   ...|.|||-+. ..++.++|||+||++|||+.| |-.||.+.....++..+.++-   ..+....+++.+.
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy---RM~~PeGCPpkVY  496 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY---RMDGPEGCPPKVY  496 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---cccCCCCCCHHHH
Confidence            333333   45699999887 779999999999999999998 999999999999998888764   3344457999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~  355 (363)
                      +|++.||+++|.+||++.|+-+
T Consensus       497 eLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHhcCCcccCccHHHHHH
Confidence            9999999999999999988754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=316.82  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=218.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-----C
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----S  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-----~  172 (363)
                      .+.|++.+.||.|.+|.||+++++.+++.+|+|+.....    ..-+++..|..+|+.+..|||++.++++|..     +
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            455899999999999999999999999999999987643    3346677899999999999999999999853     5


Q ss_pred             CeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          173 LCVHIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      +.+|+|||||.||+..|+++.  ...+.|..+..|++.++.|+.+||.+.+||||||-.|||+   ++++.|||+|||.+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVS  170 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeee
Confidence            689999999999999998865  4568999999999999999999999999999999999999   78889999999999


Q ss_pred             eecCCCC-ccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC
Q 017960          251 VFFKPGQ-IFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (363)
Q Consensus       251 ~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  323 (363)
                      ....... ...+.+||+.|||||++.      ..|+..+|+||||++..||.-|.+|+.+......+-.|-+.. +....
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLk  249 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLK  249 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Ccccc
Confidence            8765432 345689999999999985      138889999999999999999999998877655554443322 22233


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+..++.++.+||..||.+|-.+||++.++|+|||++.
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            35567899999999999999999999999999999863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.1e-39  Score=315.69  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=174.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccC----CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEE-----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIAT----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA-----  168 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~-----  168 (363)
                      .+.|++.+.||+|+||.||+|.+..+    +..||+|.+.....     .+....|  .+.... +.++..++..     
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~  202 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRAC-PNSCADFVYGFLEPV  202 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhc-hhhHHHHHHhhhccc
Confidence            35699999999999999999999888    89999998754221     1111111  111111 2222222221     


Q ss_pred             -EecCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 017960          169 -YEDSLCVHIVMELCAGGELFDRIIQRGH--------------------YSERKAAELTRIIVGVVEACHSLGVMHRDLK  227 (363)
Q Consensus       169 -~~~~~~~~iv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlk  227 (363)
                       .......++||||+.+++|.+++.....                    .....+..++.||+.||.|||+.+|+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             2456679999999999999998865421                    1234467899999999999999999999999


Q ss_pred             CCceEeeeCCCCccEEEeecCcceecCCC--CccccCccCCccccccccc-c----------------------cCCCcc
Q 017960          228 PENFLLVNKDDDFSLKAIDFGLSVFFKPG--QIFTDVVGSPYYVAPEVLL-K----------------------HYGPEA  282 (363)
Q Consensus       228 p~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~----------------------~~~~~~  282 (363)
                      |+|||++  ++++.+||+|||+|.....+  .......+++.|+|||.+. .                      .+..++
T Consensus       283 P~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        283 PQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             HHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999993  23578999999999765432  2234568899999999653 1                      133466


Q ss_pred             cHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-------CC----------CCCCCCCHHHHHHHHHhcccCcC
Q 017960          283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------ES----------DPWPLISDSAKDLIRKMLCSQPS  345 (363)
Q Consensus       283 Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~~~~~~~li~~~l~~dp~  345 (363)
                      |||||||+||||+++..++... .......+.......       ..          +..........+||.+||+.||.
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999999999987765321 111111111111000       00          00111234466999999999999


Q ss_pred             CCCCHHHHhcCCCccc
Q 017960          346 ERLTAHEVLCMYNLPV  361 (363)
Q Consensus       346 ~R~s~~evL~~~~~~~  361 (363)
                      +|||+.++|+||||..
T Consensus       440 kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        440 QRISAKAALAHPYFDR  455 (566)
T ss_pred             cCCCHHHHhCCcCcCC
Confidence            9999999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.5e-38  Score=279.82  Aligned_cols=242  Identities=46%  Similarity=0.709  Sum_probs=208.1

Q ss_pred             CCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCChHHH
Q 017960          111 QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR  190 (363)
Q Consensus       111 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~  190 (363)
                      +||.||+|.+..+++.+|+|++........  .+.+.+|++.+++++ |+||+++++.+......+++|||+.+++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            589999999988899999999875532221  678999999999996 99999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccc
Q 017960          191 IIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA  270 (363)
Q Consensus       191 l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~a  270 (363)
                      +.....++...+..++.+++.++.+||+.+++|+||+|.||++   ++++.++|+|||.+.............++..|++
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  154 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA  154 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence            8877668999999999999999999999999999999999999   7778999999999988765545556778899999


Q ss_pred             ccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCC
Q 017960          271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL  348 (363)
Q Consensus       271 PE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  348 (363)
                      ||.+. ..++.++||||||+++++|++|..||.. .......+.+......... ....++.++.+++.+||..+|++||
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhcc
Confidence            99987 5688999999999999999999999977 5555555555544433222 1122788999999999999999999


Q ss_pred             CHHHHhcCCCc
Q 017960          349 TAHEVLCMYNL  359 (363)
Q Consensus       349 s~~evL~~~~~  359 (363)
                      ++.++++++||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            99999999996

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=285.72  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=212.0

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      ....+|.-.+.+|.|+- .|..|.|.-.++.||+|.+... +......++..+|..++..+. |+||++++.+|...   
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccH
Confidence            34456888899999998 8888999999999999998765 555667789999999999998 99999999998543   


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ...|+|||++ ..+|...+.  -.+.-..+..++.|++.|+.|||+.||+||||||+||++   ..+..+||+|||+
T Consensus        91 ~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   91 EEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGL  164 (369)
T ss_pred             HHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchh
Confidence               4589999999 568877775  346789999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc---------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------  319 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------  319 (363)
                      |+.....-..+.++.|+.|+|||++.+ .|.+.+||||+||++.||++|...|.|...-+.+.++....-.         
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            988666556778899999999999985 5999999999999999999999999877655444433321000         


Q ss_pred             ----------------------cCCCCC-------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          320 ----------------------FESDPW-------PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       320 ----------------------~~~~~~-------~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                                            ++...|       +.-...+++|+.+||..||++|.|++++|+||++.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                  000001       11234689999999999999999999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=285.87  Aligned_cols=255  Identities=24%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-----eE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----CV  175 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~~  175 (363)
                      .+-.+.||.|+||+||.+.|..+|+.||+|++.. .+.+....+++.+|+++|..++ |.|++..++..+...     .+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHH
Confidence            4446889999999999999999999999998864 2334555688999999999998 999999988765433     47


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |+++|++ ..+|...+.....++...++-++.||+.||.|||+.+|.||||||.|+|+   +.+..+||||||+++....
T Consensus       133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccch
Confidence            7889998 45787777777889999999999999999999999999999999999999   8899999999999988754


Q ss_pred             CC--ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------------
Q 017960          256 GQ--IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG---------------  316 (363)
Q Consensus       256 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~---------------  316 (363)
                      ++  ..+..+.|-+|+|||++.+  +|+.+.||||.|||+.||+..+..|...+..+.++.|..-               
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            43  4455677889999999984  6999999999999999999999999877766655555431               


Q ss_pred             --------CcccCC-CCC------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          317 --------HIDFES-DPW------PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       317 --------~~~~~~-~~~------~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                              ....+. ..+      ....-+..+++.+||.+||++|++..+++.|+++..
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence                    111000 000      112246789999999999999999999999998754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.7e-38  Score=303.04  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=188.8

Q ss_pred             ccceeecceecccCCeEEEEEEEc----------------cCCcEEEEEEeeccccCChh-----------hHHHHHHHH
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEI----------------ATGIEFACKSISKRKLISRE-----------DVEDVRREI  150 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~  150 (363)
                      .+.|++.++||+|+||+||+|.+.                ..++.||||.+.........           ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            467999999999999999999742                34567999998643211000           112234577


Q ss_pred             HHHHHhcCCCc-----eeEEeEEEec--------CCeEEEEEeccCCCChHHHHHhcC----------------------
Q 017960          151 QIMHHLAGHKN-----IVTIKGAYED--------SLCVHIVMELCAGGELFDRIIQRG----------------------  195 (363)
Q Consensus       151 ~~l~~l~~h~n-----iv~~~~~~~~--------~~~~~iv~e~~~~~~L~~~l~~~~----------------------  195 (363)
                      .++.+++ |.+     +++++++|..        .+..++||||+++++|.+++....                      
T Consensus       224 ~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        224 YMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            7777776 443     4667776642        456899999999999998886421                      


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcccc--CccCCccccc
Q 017960          196 --HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD--VVGSPYYVAP  271 (363)
Q Consensus       196 --~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~--~~gt~~y~aP  271 (363)
                        .+++..+..++.|++.+|.|||+.+|+||||||+|||+   +.++.+||+|||++.....+.....  ..+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence              23466788999999999999999999999999999999   7778999999999976543332222  2347899999


Q ss_pred             cccccc---------------------CC--CcccHHHHHHHHHHHHhCCC-CCCCcCHH-----------HHHHHHHcC
Q 017960          272 EVLLKH---------------------YG--PEADVWTAGVILYILLSGVP-PFWAETQQ-----------GIFDAVLKG  316 (363)
Q Consensus       272 E~~~~~---------------------~~--~~~Di~slG~il~ell~g~~-pf~~~~~~-----------~~~~~i~~~  316 (363)
                      |.+...                     |+  .+.||||+||++|+|++|.. ||.+....           .....+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            987521                     11  24799999999999999886 66432111           111112222


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcccCc---CCCCCHHHHhcCCCcccCC
Q 017960          317 HIDFESDPWPLISDSAKDLIRKMLCSQP---SERLTAHEVLCMYNLPVLF  363 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~l~~dp---~~R~s~~evL~~~~~~~~~  363 (363)
                      ..  ....+...++..++|+.+||..+|   .+|+|+.|+|+|+||..-|
T Consensus       460 ~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~~  507 (507)
T PLN03224        460 KY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPEF  507 (507)
T ss_pred             CC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCCC
Confidence            22  233456678999999999999866   6899999999999998765

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=314.46  Aligned_cols=247  Identities=30%  Similarity=0.430  Sum_probs=198.2

Q ss_pred             eeecceecccCCeE-EEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          101 YTLGRKLGQGQFGT-TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      |.-.+++|.|+.|+ ||+|.  ..++.||||.+..      +....+.+|+..|+.-..|||||++++.-.+....||+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal  582 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL  582 (903)
T ss_pred             eccHHHcccCCCCcEEEEEe--eCCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence            44467899999875 89998  7889999998843      345678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC--CCCccEEEeecCcceec
Q 017960          180 ELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK--DDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~--~~~~~~kl~DFG~a~~~  253 (363)
                      |+| ..+|.+++...+.    ......+.++.|++.||++||+.+||||||||.||||..+  +....++|+|||+++.+
T Consensus       583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            999 5699999977411    1114467889999999999999999999999999999754  23468999999999988


Q ss_pred             CCCCc----cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhC-CCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          254 KPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       254 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ..+..    .....||.+|+|||++.. .-+.++|||||||++|+.++| ..||......  -..|.++......-. +.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~-~~  738 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE-PL  738 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec-cC
Confidence            76642    356789999999999984 467799999999999999985 8999544332  233444443322111 11


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ...++.+||.+|+++||..||+|.+||.||+|
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLF  770 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence            12289999999999999999999999999998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=257.57  Aligned_cols=212  Identities=26%  Similarity=0.325  Sum_probs=181.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +....+..||+|++|.|=+.++..+|...|+|.+....  .....++..+|+.+..+...+|.+|.++|.+......+|.
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            44555678999999999999999999999999997654  4555678889999999888899999999999999999999


Q ss_pred             EeccCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          179 MELCAGGELFDR----IIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       179 ~e~~~~~~L~~~----l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ||.| ..||..+    +.+.+.+++..+-+|+..++.||.|||++ .+||||+||+|||+   +.+|.+|+||||.+..+
T Consensus       124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYL  199 (282)
T ss_pred             HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceee
Confidence            9999 5566433    34567799999999999999999999975 89999999999999   89999999999999888


Q ss_pred             CCCCccccCccCCccccccccc-----ccCCCcccHHHHHHHHHHHHhCCCCCC-CcCHHHHHHHHHcC
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLL-----KHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKG  316 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~~  316 (363)
                      .++-..+-..|-..|||||.+.     ..|+.++||||||++++||.+++.||. ..++.+.++++...
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            7665555577888999999986     259999999999999999999999995 34566667766654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-37  Score=303.40  Aligned_cols=248  Identities=23%  Similarity=0.399  Sum_probs=210.1

Q ss_pred             eeecceecccCCeEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .++.+.||+|+||.|++|.-..       ....||||..+...  .....+.+..|+++|+.+..|+||+.+.+++...+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            4567799999999999997331       14579999987654  33677899999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC
Q 017960          174 CVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~  237 (363)
                      .+++|+||+..|+|.+++.+.+                .++......++.||+.|++||++.++|||||-..|||+   .
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---T  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---c
Confidence            9999999999999999998766                38889999999999999999999999999999999999   7


Q ss_pred             CCccEEEeecCcceecCCCCcccc--Ccc--CCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcC-HHHHH
Q 017960          238 DDFSLKAIDFGLSVFFKPGQIFTD--VVG--SPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAET-QQGIF  310 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~-~~~~~  310 (363)
                      ++..+||+|||+|+.......+..  ..+  ...|||||.+.. .|+.++||||||++|||+++ |..||.+.. ..++.
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            778999999999987655444432  222  345999999985 69999999999999999999 999998855 66677


Q ss_pred             HHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       311 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.+..|.-...   ...+++++.++++.||+.+|++||++.++.+.
T Consensus       533 ~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~  575 (609)
T KOG0200|consen  533 EFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEF  575 (609)
T ss_pred             HHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            76777654322   23579999999999999999999999998764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-37  Score=327.16  Aligned_cols=240  Identities=24%  Similarity=0.265  Sum_probs=185.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|...+.||+|+||.||+|.+..++..||||.+.....       ....|++.+++++ |||||++++++.+....++||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEEE
Confidence            45667889999999999999989999999998864321       1124688899997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||+++|+|.+++.   .+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++..++. ||.+..... 
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT-  834 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc-
Confidence            9999999999985   3789999999999999999999   6799999999999999   666667765 665543221 


Q ss_pred             CccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCH--HHHHHHHHc---C-Cc----ccCC-CC
Q 017960          257 QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLK---G-HI----DFES-DP  324 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i~~---~-~~----~~~~-~~  324 (363)
                        .....+|+.|+|||++. ..++.++|||||||++|||++|+.||.....  ....+....   . ..    .... ..
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence              12346789999999987 4699999999999999999999999843211  111111110   0 00    0000 00


Q ss_pred             CC---CCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          325 WP---LISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       325 ~~---~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..   ....++.+++.+||+.||++|||+.|+++.+
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L  948 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL  948 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence            00   1123577899999999999999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=291.32  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=208.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      .+..++||+|+||+||+|.+...|+    +||+|++....  ......++..|+-+|.+|. |||++++++++.... +.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HH
Confidence            3446899999999999999887765    58888875433  4455678999999999998 999999999987766 88


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||++|+++|+|.++++. +..+..+..+.|..||++||.|||+++++||||-..||||   .....+||.|||+|+....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCc
Confidence            99999999999999976 4568999999999999999999999999999999999999   6666899999999998765


Q ss_pred             CCc-cccC--ccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          256 GQI-FTDV--VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       256 ~~~-~~~~--~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      +.. +...  .-.+.|||-|.+. +.|+.++|||||||++||++| |..||.+....++-+.+.++.-   ....+.++-
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---LsqPpiCti  927 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---LSQPPICTI  927 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---CCCCCCccH
Confidence            542 2222  2245689999887 579999999999999999999 9999999999999888887764   333456889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      ++.-++.+||..|++.||+++++..
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999988754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=273.56  Aligned_cols=242  Identities=25%  Similarity=0.342  Sum_probs=187.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc-CCCceeEEeEEEecCC----eE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-GHKNIVTIKGAYEDSL----CV  175 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~~----~~  175 (363)
                      .++.++||+|.||.||+|+  -+++.||||++.      ....+.+.+|-.|..... .|+||++|+++-....    .+
T Consensus       212 l~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhhHHHhhcCccceeehhh--ccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            5567899999999999999  566899999995      345567777777766532 4999999999876544    79


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEecCCCCCceEeeeCCCCccEEEee
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---------GVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~---------~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                      +||+||.+.|+|.++|..+ .+++.....++.-+++||+|||+-         .|+|||||..||||   ..|+.+.|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeec
Confidence            9999999999999999765 579999999999999999999963         59999999999999   8899999999


Q ss_pred             cCcceecCCCCc---cccCccCCcccccccccccC--C-----CcccHHHHHHHHHHHHhCCC------------CCC--
Q 017960          247 FGLSVFFKPGQI---FTDVVGSPYYVAPEVLLKHY--G-----PEADVWTAGVILYILLSGVP------------PFW--  302 (363)
Q Consensus       247 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--~-----~~~Di~slG~il~ell~g~~------------pf~--  302 (363)
                      ||+|..+.++..   ....+||.+|||||++.+..  .     .+.||||+|.+||||++.-.            ||.  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            999988865542   23478999999999997542  2     35899999999999998532            221  


Q ss_pred             ---CcCHHHHHHHHHcCCccc-CCCCCCC--CCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017960          303 ---AETQQGIFDAVLKGHIDF-ESDPWPL--ISDSAKDLIRKMLCSQPSERLTAHEVL  354 (363)
Q Consensus       303 ---~~~~~~~~~~i~~~~~~~-~~~~~~~--~~~~~~~li~~~l~~dp~~R~s~~evL  354 (363)
                         .....++...+.+.+... ..+.|..  -..-+.+.+..||+.||+.|.|+.=|-
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence               122234444443332211 1112221  224688999999999999999986443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=5.6e-37  Score=275.95  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=202.6

Q ss_pred             ccccccceeecceecccCCeEEEEEEEcc---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ...+.+.|.++++||+|.|++||++.+..   ..+.||+|.+....     ...++.+|+++|..+.++.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            33455679999999999999999999887   78899999986543     23679999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      .++...+|+||++.....++..   .++...+..+++.++.||.++|.+|||||||||.|+|.+.  ..++-.|+|||+|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~--~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR--RTQRGVLVDFGLA  180 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc--ccCCceEEechhH
Confidence            9999999999998887776653   3678999999999999999999999999999999999963  4557889999998


Q ss_pred             eecC-----------------C--CC--------------------------ccccCccCCcccccccccc--cCCCccc
Q 017960          251 VFFK-----------------P--GQ--------------------------IFTDVVGSPYYVAPEVLLK--HYGPEAD  283 (363)
Q Consensus       251 ~~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~D  283 (363)
                      ....                 +  +.                          ......||++|+|||++.+  .-+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7210                 0  00                          0113479999999999984  5789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCcCHH-HHHHHH--------------HcCC--c-----------------cc---------
Q 017960          284 VWTAGVILYILLSGVPPFWAETQQ-GIFDAV--------------LKGH--I-----------------DF---------  320 (363)
Q Consensus       284 i~slG~il~ell~g~~pf~~~~~~-~~~~~i--------------~~~~--~-----------------~~---------  320 (363)
                      |||.|+|+.-+++++.||...... +.+..+              .-+.  .                 ..         
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            999999999999999999432221 000000              0011  0                 00         


Q ss_pred             ----CCCCC-CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          321 ----ESDPW-PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       321 ----~~~~~-~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                          ....+ ...+..+.+|+.+||..||.+|+|++++|+|+||..
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence                00011 123457899999999999999999999999999954

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=291.90  Aligned_cols=258  Identities=28%  Similarity=0.402  Sum_probs=226.3

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +.+++|++...+|.|+||.||+++++.+++..|+|+++..   ......-+..|+-+++..+ ||||+.+++.+.....+
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCC-CcChHHHHhhhhhhcCc
Confidence            4567799999999999999999999999999999999765   3455677888999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +|.||||.||+|.+.-+-.+++++.++...++..+.+|+|||+.|=+|||||-.|||+   .+.+.+|++|||.+..+..
T Consensus        88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhh
Confidence            9999999999999988788899999999999999999999999999999999999999   7888999999999866543


Q ss_pred             C-CccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC-CCCCCC
Q 017960          256 G-QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD-PWPLIS  329 (363)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~  329 (363)
                      . ....++.||+.|||||+..    +.|...+|||++|+...|+-.-.+|.........+..+.+..++.+.- .-...+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            2 1234689999999999874    469999999999999999999888987877777777777766654432 223467


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +.+-+|++.+|.++|++||+++.+|.|+|..
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs  275 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVS  275 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence            8899999999999999999999999999874

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=267.18  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=190.7

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHH--hcCCCceeEEeEEEecCC
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH--LAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~~~  173 (363)
                      .+..+.++.+.||+|.||.||+|.  ..|+.||||++.-+.      ...+.+|.+|.+.  |+ |+||+.|++.-..+.
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd------E~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~  278 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD------ERSWFRETEIYQTVMLR-HENILGFIAADNKDN  278 (513)
T ss_pred             hhhheeEEEEEecCccccceeecc--ccCCceEEEEecccc------hhhhhhHHHHHHHHHhc-cchhhhhhhccccCC
Confidence            356678999999999999999999  568899999996432      2456666666554  66 999999998764432


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecCCCCCceEeeeCCCCcc
Q 017960          174 ----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL--------GVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       174 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~--------~iiHrDlkp~NIll~~~~~~~~  241 (363)
                          .+++|++|.+.|||+|+|.+ ..++.....+++.-++.||++||-.        .|.|||||..||||   .+++.
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~  354 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT  354 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCc
Confidence                58999999999999999987 5789999999999999999999953        49999999999999   88999


Q ss_pred             EEEeecCcceecCCCC-----ccccCccCCcccccccccccCC-------CcccHHHHHHHHHHHHhC----------CC
Q 017960          242 LKAIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLLKHYG-------PEADVWTAGVILYILLSG----------VP  299 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~Di~slG~il~ell~g----------~~  299 (363)
                      +.|+|+|+|.......     ..+..+||.+|||||++.....       ..+||||||.++||++-.          .+
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            9999999998765432     2356799999999999974322       358999999999998752          46


Q ss_pred             CCCC-----cCHHHHHHHHHcCCcccCC-CCCCCCC--HHHHHHHHHhcccCcCCCCCHHHHhc
Q 017960          300 PFWA-----ETQQGIFDAVLKGHIDFES-DPWPLIS--DSAKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       300 pf~~-----~~~~~~~~~i~~~~~~~~~-~~~~~~~--~~~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      ||.+     ...+++.+-+.-.+..... ..|...+  ..+..+++.||..||.-|.|+-.+-+
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            7743     2334444444433333222 2232211  35678899999999999999866543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=281.29  Aligned_cols=199  Identities=32%  Similarity=0.510  Sum_probs=177.7

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhH-----HHHHHHHHHHHHhc--CCCceeEEeEEEecCC
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV-----EDVRREIQIMHHLA--GHKNIVTIKGAYEDSL  173 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~  173 (363)
                      |...+.+|+|+||.|++|.++.+...|+||.+.++...-....     -.+-.||+||..|.  .|+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            8999999999999999999999999999999987654432222     23567999999997  4899999999999999


Q ss_pred             eEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELC-AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~-~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      .+||+||.- +|.+|++++.....+++.++..|++|++.|+++||+.||||||||-+||.+   +.+|.+||+|||.|..
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSAAY  719 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccchhh
Confidence            999999986 456899999999999999999999999999999999999999999999999   8999999999999987


Q ss_pred             cCCCCccccCccCCccccccccccc--CCCcccHHHHHHHHHHHHhCCCCCCC
Q 017960          253 FKPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWA  303 (363)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~il~ell~g~~pf~~  303 (363)
                      ... ..+..++||..|.|||++.+.  .+..-|||+||++||-++..+.||+.
T Consensus       720 ~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            654 456779999999999999864  47889999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-36  Score=255.17  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=207.1

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeE-EEecC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKG-AYEDS  172 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~-~~~~~  172 (363)
                      .-.+.+.|.+.+.||+|.||.+.+|.++.+++.+++|.+.+..    .....|.+|..---.|..|.||+.-++ .|+..
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            3356788999999999999999999999999999999997643    345788899888778888999999876 47888


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          173 LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +.+++++||++.|+|...+...| +.+.....++.|++.||.|||++++||||||.+||||-..| ..++||||||..+.
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRK  172 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccc
Confidence            89999999999999988776643 68999999999999999999999999999999999997644 34899999999875


Q ss_pred             cCCCCccccCccCCccccccccc----c--cCCCcccHHHHHHHHHHHHhCCCCCCCcC----HHHHHHHHHcCCcccCC
Q 017960          253 FKPGQIFTDVVGSPYYVAPEVLL----K--HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFES  322 (363)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~  322 (363)
                      .+.  .....--+..|.+||...    +  ...+.+|+|.||+++|.++||.+||....    ..-.+....++.....+
T Consensus       173 ~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P  250 (378)
T KOG1345|consen  173 VGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP  250 (378)
T ss_pred             cCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence            432  222222355699999875    2  25788999999999999999999996332    22344555555555556


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCc
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSER---LTAHEVLCMYNL  359 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R---~s~~evL~~~~~  359 (363)
                      ..+..+++.+..+.++-|.++|++|   .++..-...+|.
T Consensus       251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            6677789999999999999999999   444444445554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=6.9e-33  Score=239.08  Aligned_cols=210  Identities=44%  Similarity=0.713  Sum_probs=185.3

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      ||+|++|.||++.+..+++.+++|++.......  ....+.+|+..++.+. |++|+++++++......+++||++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999988789999999997543211  4578999999999998 9999999999999999999999999899


Q ss_pred             hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC-CccEEEeecCcceecCCCC-ccccCc
Q 017960          187 LFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPGQ-IFTDVV  263 (363)
Q Consensus       187 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~~kl~DFG~a~~~~~~~-~~~~~~  263 (363)
                      |.+++... ..++...+..++.+++.++.+||+.|++|+||+|.||++   +. ++.++|+|||.+....... ......
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhccc
Confidence            99988765 468999999999999999999999999999999999999   55 6789999999998765432 133456


Q ss_pred             cCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcc
Q 017960          264 GSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC  341 (363)
Q Consensus       264 gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~  341 (363)
                      +...|++||.+..  .++.+.|+|++|+++++|                                   ..+.+++.+|++
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            7889999999874  688999999999999999                                   678999999999


Q ss_pred             cCcCCCCCHHHHhcCC
Q 017960          342 SQPSERLTAHEVLCMY  357 (363)
Q Consensus       342 ~dp~~R~s~~evL~~~  357 (363)
                      .||++||++.++++++
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-32  Score=238.99  Aligned_cols=211  Identities=45%  Similarity=0.716  Sum_probs=183.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |.+.+.||.|++|.||+|.+..+++.+|+|.+......  ...+.+.+|+..+++++ |+|++++++.+......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEe
Confidence            56778999999999999999888999999999765322  35678899999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC--
Q 017960          181 LCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--  257 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~--  257 (363)
                      ++++++|.+++..... +++..+..++.+++.++.+||+.+++|+||+|.||++   +.++.++|+|||.+.......  
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc
Confidence            9999999999987766 8999999999999999999999999999999999999   677899999999998775543  


Q ss_pred             ccccCccCCcccccccc-c-ccCCCcccHHHHHHHHHHHHhCCCCCCC--cCHHHHHHHHHcCC
Q 017960          258 IFTDVVGSPYYVAPEVL-L-KHYGPEADVWTAGVILYILLSGVPPFWA--ETQQGIFDAVLKGH  317 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~-~-~~~~~~~Di~slG~il~ell~g~~pf~~--~~~~~~~~~i~~~~  317 (363)
                      ......++..|++||.+ . ..++.++|+|+||+++++|++|+.||..  .....+.+.+..+.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            33456778899999998 4 4578899999999999999999999977  44446777776654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-33  Score=247.21  Aligned_cols=250  Identities=20%  Similarity=0.260  Sum_probs=208.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe-c
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-D  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~  171 (363)
                      ++++++..++-+|.||.||.|.++..     .+.|.+|.++...  ++.++..+..|-..+..+. |||+..+.++.. +
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~  359 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIED  359 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCc-CCCccceeEEEeec
Confidence            45688888999999999999976543     3457778776544  6677888999999999998 999999999874 5


Q ss_pred             CCeEEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEE
Q 017960          172 SLCVHIVMELCAGGELFDRIIQ--------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                      ....++++.++.-|+|..+|..        ...++..+...++.|++.|++|||+.|+||.||...|.+|   ++...+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVk  436 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVK  436 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEE
Confidence            5678899999988999998872        1236778889999999999999999999999999999999   8889999


Q ss_pred             EeecCcceecCCCCccc---cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCc
Q 017960          244 AIDFGLSVFFKPGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       244 l~DFG~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  318 (363)
                      |+|=.+++..-+.....   .......||+||.+. ..|+.++|+||||++||||+| |+.||...++.++...+++|.-
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR  516 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR  516 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence            99999988765544321   112245699999987 579999999999999999999 9999999999999998888753


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                         ....-++|+++..++..||..+|++||+++|+...
T Consensus       517 ---laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~c  551 (563)
T KOG1024|consen  517 ---LAQPFNCPDELFTVMACCWALLPEERPSFSQLVIC  551 (563)
T ss_pred             ---ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence               22234689999999999999999999999998764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=1.7e-32  Score=282.64  Aligned_cols=196  Identities=18%  Similarity=0.188  Sum_probs=146.6

Q ss_pred             CceeEEeEEE-------ecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCce
Q 017960          160 KNIVTIKGAY-------EDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (363)
Q Consensus       160 ~niv~~~~~~-------~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NI  231 (363)
                      +||+.++++|       .....++.+||++ +++|.+++.. ...+++.++..+++||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5777788877       2334678889987 6799999965 34589999999999999999999999999999999999


Q ss_pred             Eeee----------------CCCCccEEEeecCcceecCCCC-----------------ccccCccCCccccccccc-cc
Q 017960          232 LLVN----------------KDDDFSLKAIDFGLSVFFKPGQ-----------------IFTDVVGSPYYVAPEVLL-KH  277 (363)
Q Consensus       232 ll~~----------------~~~~~~~kl~DFG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~  277 (363)
                      ||..                .+.++.+||+|||+++......                 .....+||+.|||||++. ..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            9942                1234567788888776421100                 011246889999999987 46


Q ss_pred             CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       278 ~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      |+.++|||||||+||||++|..|+....  .....+.....  +. ......++..+++.+||++||.+||++.|+|+|+
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PP-QILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Ch-hhhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999998875322  22222222111  11 1111245678999999999999999999999999


Q ss_pred             Cccc
Q 017960          358 NLPV  361 (363)
Q Consensus       358 ~~~~  361 (363)
                      |+..
T Consensus       267 ~~~~  270 (793)
T PLN00181        267 FINE  270 (793)
T ss_pred             hhhh
Confidence            9853

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-29  Score=229.22  Aligned_cols=253  Identities=24%  Similarity=0.298  Sum_probs=195.5

Q ss_pred             ceeecceecccCCeEEEEEEEccCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHHhc---CCCceeEEeEEE-ecCCe
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISREDVEDVRREIQIMHHLA---GHKNIVTIKGAY-EDSLC  174 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---~h~niv~~~~~~-~~~~~  174 (363)
                      .|++.+.||+|+||.||.|.+..++ ..+|+|.........   ...+..|+.++..+.   +..++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            6999999999999999999987775 679999886543211   126778999999887   246999999999 58888


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC--CCccEEEeecCcc
Q 017960          175 VHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--DDFSLKAIDFGLS  250 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~~kl~DFG~a  250 (363)
                      .||||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||+|++++...  +...+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999998 99999977544  5799999999999999999999999999999999999996432  1257999999999


Q ss_pred             e--ecC-CCC-------c-cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc
Q 017960          251 V--FFK-PGQ-------I-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       251 ~--~~~-~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  318 (363)
                      +  ... ...       . .....||..|+++.+..+ ..+.+.|+||++.++.||+.|.+||.+.........+.+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  321 111       1 223559999999998875 689999999999999999999999976654333333322222


Q ss_pred             ccCCC-CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          319 DFESD-PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       319 ~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ..... .....+.++..+...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            22211 223356778888888888899999988877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.1e-31  Score=260.16  Aligned_cols=259  Identities=27%  Similarity=0.410  Sum_probs=202.1

Q ss_pred             cce-eecceecccCCeEEEEEEEccCCcEEEEEEeecc--ccCChhhH-HHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLY-TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKR--KLISREDV-EDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~-~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.| ....++|.|++|.|+.+......+.++.|.+...  ........ ..+..|+.+-..|. |||++..+..+.+...
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~  395 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG  395 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc
Confidence            334 4577899999999999887777777777765422  11122222 23777888888887 9999888877766666


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ..-.||||++ +|+..+...+.++..++..+++||+.|+.|+|+.||.|||+||+|+++   ..++.+||+|||.+....
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFR  471 (601)
T ss_pred             chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeec
Confidence            6666999999 999999988899999999999999999999999999999999999999   788899999999987654


Q ss_pred             CCC-----ccccCccCCcccccccccc-cCCC-cccHHHHHHHHHHHHhCCCCCCCcCHHHHH--HHHHcCCcc---cCC
Q 017960          255 PGQ-----IFTDVVGSPYYVAPEVLLK-HYGP-EADVWTAGVILYILLSGVPPFWAETQQGIF--DAVLKGHID---FES  322 (363)
Q Consensus       255 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~-~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~i~~~~~~---~~~  322 (363)
                      .+.     .....+|+..|+|||++.+ .|.+ ..||||.|+++..|++|+.||......+..  .........   -+.
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            332     3356789999999999984 5765 589999999999999999999644433221  111111111   112


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ..+..++.+.+.+|.+||++||.+|.|+++|++.+|++.+
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            2344678899999999999999999999999999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=210.34  Aligned_cols=249  Identities=21%  Similarity=0.263  Sum_probs=199.5

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .....|+++++||.|+||.+|.|....+|+.||||+-....     ...++..|..+.+.|++...|+.+..++.+...-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            34567999999999999999999999999999999876433     2346778999999999889999999999999999


Q ss_pred             EEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      .+|||++ |.+|.+++. ....++..+++.++.|++.-++|+|..++|||||||+|.|.+-......+.|+|||+|+...
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 999988775 45679999999999999999999999999999999999999655556689999999998764


Q ss_pred             CCC--------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH---HHHHHHHHcCCcccCC
Q 017960          255 PGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFES  322 (363)
Q Consensus       255 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~  322 (363)
                      +..        ......||.+|.+-....+ .-+.+.|+-|+|.+|.++.-|.+||.+...   ..-++.|...+...+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            332        2345679999998776664 468899999999999999999999987543   3445555554443332


Q ss_pred             C-CCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017960          323 D-PWPLISDSAKDLIRKMLCSQPSERLTA  350 (363)
Q Consensus       323 ~-~~~~~~~~~~~li~~~l~~dp~~R~s~  350 (363)
                      + ....+|.|+.-.+.-|=..--++-|..
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            2 234667777777776665555555544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=1.5e-27  Score=219.14  Aligned_cols=252  Identities=38%  Similarity=0.579  Sum_probs=207.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEeEEEecCCeEEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~iv~  179 (363)
                      |++.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.++..+. |+ +|+.+.+.+......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            677889999999999999976   789999997765544345778999999999998 66 8999999998888889999


Q ss_pred             eccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc-cEEEeecCcceecCC
Q 017960          180 ELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKP  255 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~~~  255 (363)
                      +++.++++.+.+....   .++......++.|++.++.|+|+.+++|||+||+||++   +... .++++|||.+.....
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCC
Confidence            9999999997776654   78999999999999999999999999999999999999   6666 799999999976544


Q ss_pred             CC-------ccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCH----HHHHHHHHcCCcc-
Q 017960          256 GQ-------IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQ----QGIFDAVLKGHID-  319 (363)
Q Consensus       256 ~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~-  319 (363)
                      ..       ......|+..|+|||.+..    .+....|+||+|++++++++|..||.....    ......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            33       3467789999999999874    588899999999999999999999876653    4555555554433 


Q ss_pred             cCCCCCCCC----CHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 FESDPWPLI----SDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .........    ...+.+++.+++..+|..|.+..+...+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~  278 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL  278 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHh
Confidence            222211111    2578999999999999999999988776443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-28  Score=216.04  Aligned_cols=245  Identities=19%  Similarity=0.300  Sum_probs=194.4

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|+++++||+|+||+.+.|++..+++.||||.-...     ....++..|....+.|.+.++|..++-+..++.+..+||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            499999999999999999999999999999987543     234678889999999988999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC--CCCccEEEeecCcceecCCC
Q 017960          180 ELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK--DDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       180 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~--~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |++ |.||.|++. ..+.|+.+.+..++.|++.-++|+|++.+|+|||||+|+||+..  .+...+.|+|||+|+...+.
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            999 899988775 45679999999999999999999999999999999999999532  23457999999999987654


Q ss_pred             Cc--------cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCcccC-CC
Q 017960          257 QI--------FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFE-SD  323 (363)
Q Consensus       257 ~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~  323 (363)
                      ..        ..+..||.+||+-.... ++-+.+.|+-|||-++.++|-|.+||.|..   .++-+++|-..+-.-+ ..
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~  262 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV  262 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence            32        34568999999988666 458999999999999999999999997654   3445555543322111 11


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCH
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTA  350 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~  350 (363)
                      ....+|.++..-+.-.=..+-.+-|..
T Consensus       263 Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  263 LCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             HHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            233466666666655555555555544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.3e-29  Score=212.83  Aligned_cols=160  Identities=26%  Similarity=0.321  Sum_probs=127.1

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCc
Q 017960          185 GELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV  263 (363)
Q Consensus       185 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  263 (363)
                      |+|.+++... ..+++..+..++.|++.||.|||+.+      ||+|||+   +.++.+|+  ||++......    ...
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~----~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE----QSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc----cCC
Confidence            6889988764 45999999999999999999999999      9999999   78888999  9999875432    236


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCcccCCC---CCCCCCH--HHHHHH
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESD---PWPLISD--SAKDLI  336 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~---~~~~~~~--~~~~li  336 (363)
                      ||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+..+..........   ....++.  ++.++|
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            8999999999974 699999999999999999999999966543 23333333322211111   1112333  699999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+||..||.+||++.|+++|+|+
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHH
Confidence            99999999999999999999876

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.2e-27  Score=221.83  Aligned_cols=165  Identities=19%  Similarity=0.178  Sum_probs=129.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEcc-CCcEEEEEEeecccc--CChhhHHHHHHHHHHHHHhcCCCceeE-EeEEEec
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKL--ISREDVEDVRREIQIMHHLAGHKNIVT-IKGAYED  171 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~-~~~~~~~  171 (363)
                      .+.+.|++.+.||+|+||+||+|.+.. +++.||||++.....  ........+.+|+++|++++ |+||+. ++++   
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~---   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT---   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc---
Confidence            355679999999999999999998776 677789998753211  12334567999999999998 999885 5432   


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC-CCCceEeeeCCCCccEEEeecCcc
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL-KPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDl-kp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                       +..|+||||++|++|.. +.   ...   ...++.+++.||.|||+.||+|||| ||+|||+   +.++.+||+|||+|
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQLA  159 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECccc
Confidence             45799999999998862 21   111   2567899999999999999999999 9999999   67788999999999


Q ss_pred             eecCCCCc---------cccCccCCccccccccc
Q 017960          251 VFFKPGQI---------FTDVVGSPYYVAPEVLL  275 (363)
Q Consensus       251 ~~~~~~~~---------~~~~~gt~~y~aPE~~~  275 (363)
                      ........         .....++..|+|||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            87644321         13456788899999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-29  Score=237.88  Aligned_cols=241  Identities=27%  Similarity=0.422  Sum_probs=207.2

Q ss_pred             eecccCCeEEEEEEE---ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEecc
Q 017960          106 KLGQGQFGTTYLCTE---IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      .+|+|+||.|+++..   ...+.-+|+|+..+......... ....|-.++...++||.+++++-.++.+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998752   24566799998876654443333 56678888888888999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccC
Q 017960          183 AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV  262 (363)
Q Consensus       183 ~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~  262 (363)
                      .||.|+..+.....+.+.....+...++-|++++|+.+|+|||+|++||++   +.+|++++.|||+++..-..+..   
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhhc---
Confidence            999999999888889999999999999999999999999999999999999   99999999999999876544332   


Q ss_pred             ccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          263 VGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       263 ~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      +||..|||||++. ....+.|.||||++++||++|..||.+    ++...|.+.....+.    .++.++++++..++..
T Consensus       154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR  224 (612)
T ss_pred             ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence            9999999999998 667899999999999999999999977    677777776655554    4678899999999999


Q ss_pred             CcCCCCC-----HHHHhcCCCcccC
Q 017960          343 QPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       343 dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +|.+|.-     +.|+++|++++.+
T Consensus       225 ~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  225 NPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             CHHHHhccCcchhHHHhccchheee
Confidence            9999984     4788999988754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=8e-26  Score=193.06  Aligned_cols=142  Identities=23%  Similarity=0.225  Sum_probs=110.7

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhh-----------------------HHHHHHHHHHHHHhcCCC
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-----------------------VEDVRREIQIMHHLAGHK  160 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~h~  160 (363)
                      ...||+|+||.||+|.+. +|+.||||+++.........                       ......|+.++.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            467999999999999986 89999999997543211110                       123345999999997 77


Q ss_pred             ceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecCCCCCceEeeeCCCC
Q 017960          161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-HSLGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       161 niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~l-H~~~iiHrDlkp~NIll~~~~~~  239 (363)
                      ++..........  .+|||||++|+++.......+.++...+..++.|++.+|.++ |+.||+||||||+|||+   + +
T Consensus        80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli---~-~  153 (190)
T cd05147          80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY---H-D  153 (190)
T ss_pred             CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---E-C
Confidence            764433322222  379999998877765545567789999999999999999999 79999999999999999   4 3


Q ss_pred             ccEEEeecCcceec
Q 017960          240 FSLKAIDFGLSVFF  253 (363)
Q Consensus       240 ~~~kl~DFG~a~~~  253 (363)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            57999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=5.9e-26  Score=202.20  Aligned_cols=234  Identities=26%  Similarity=0.349  Sum_probs=155.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcC---------CCceeEEeEEEe
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG---------HKNIVTIKGAYE  170 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~niv~~~~~~~  170 (363)
                      .+..++.||.|+++.||.+.+..+++.+|||+............+.+++|......+.+         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35678899999999999999999999999999876664455567778877765555432         223333333321


Q ss_pred             ---------cC---C-----eEEEEEeccCCCChHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhCCcEecCC
Q 017960          171 ---------DS---L-----CVHIVMELCAGGELFDRII---QRGH----YSERKAAELTRIIVGVVEACHSLGVMHRDL  226 (363)
Q Consensus       171 ---------~~---~-----~~~iv~e~~~~~~L~~~l~---~~~~----~~~~~~~~i~~~l~~~l~~lH~~~iiHrDl  226 (363)
                               ..   .     ..+++|+-+ .++|.+.+.   ....    +.......+..|++..+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     236778877 557766643   2222    223344566689999999999999999999


Q ss_pred             CCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccccc---------cCCCcccHHHHHHHHHHHHhC
Q 017960          227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---------HYGPEADVWTAGVILYILLSG  297 (363)
Q Consensus       227 kp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~Di~slG~il~ell~g  297 (363)
                      +|+|+++   +.+|.++|+||+......  ........+..|.+||....         .++.+.|.|+||+++|.|++|
T Consensus       172 ~~~nfll---~~~G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLL---DQDGGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE----TTS-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEE---cCCCCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999   889999999999877643  22222445678999997742         378899999999999999999


Q ss_pred             CCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 017960          298 VPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER  347 (363)
Q Consensus       298 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  347 (363)
                      +.||...........        .......+|+.+++||..+|++||.+|
T Consensus       247 ~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999965543221111        122233689999999999999999998

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=6.9e-26  Score=196.07  Aligned_cols=174  Identities=16%  Similarity=0.160  Sum_probs=135.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHH------HHHHHHHHHHhcCCCceeEEeEEE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAGHKNIVTIKGAY  169 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~~h~niv~~~~~~  169 (363)
                      .+.++|++.++||.|+||.||++..  ++..+|||++.......+.....      +.+|+..+.++. |++|..+.+++
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~  104 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFY  104 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEee
Confidence            4678899999999999999999764  56789999997655444444344      579999999997 99999999886


Q ss_pred             ecC--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc
Q 017960          170 EDS--------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       170 ~~~--------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      ...        ...+++|||++|.+|.+..    .+++    ....+++.+|..+|+.|++|||+||+||++   ++++ 
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~~g-  172 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SKNG-  172 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eCCC-
Confidence            533        3578999999999997763    2333    346699999999999999999999999999   5666 


Q ss_pred             EEEeecCcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHH
Q 017960          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILL  295 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell  295 (363)
                      ++|+|||............           .++. +.|..++|+||||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            9999999887643222111           1222 45788999999999987664

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=8.1e-25  Score=185.55  Aligned_cols=188  Identities=21%  Similarity=0.245  Sum_probs=141.9

Q ss_pred             ecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC-hhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       103 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      +...|++|+||+||.+.  ..+..++.+.+....... ......+.+|+++|++|.+|++|++++++    +..+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            46789999999999877  477788877665432111 11123578999999999867999999886    346899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCC-CCCceEeeeCCCCccEEEeecCcceecCCCCcc-
Q 017960          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL-KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-  259 (363)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDl-kp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~-  259 (363)
                      +.|.+|...+..       ....++.|++.+|.++|++||+|||| ||+|||+   +.++.++|+|||+|......... 
T Consensus        80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcchHH
Confidence            999888654311       12457889999999999999999999 7999999   67788999999999865543310 


Q ss_pred             -----c--------cCccCCccccccccc--ccCC-CcccHHHHHHHHHHHHhCCCCCCCcCH
Q 017960          260 -----T--------DVVGSPYYVAPEVLL--KHYG-PEADVWTAGVILYILLSGVPPFWAETQ  306 (363)
Q Consensus       260 -----~--------~~~gt~~y~aPE~~~--~~~~-~~~Di~slG~il~ell~g~~pf~~~~~  306 (363)
                           .        -...++.|++|+...  ...+ ...+.++.|+-+|.++|+..+++++.+
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                 0        012467778887543  3444 567999999999999999999877653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.92  E-value=1.1e-25  Score=222.60  Aligned_cols=219  Identities=34%  Similarity=0.537  Sum_probs=172.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ..|..++.|..|+||.||.++|+.+.+.+|+| +.+...        +.+.  ++... +.|.+|               
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a-~npfvv---------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFA-GNPFVV---------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--ccccc-CCccee---------------
Confidence            45888999999999999999999999999995 433221        1111  22222 244444               


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC--
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG--  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--  256 (363)
                            |+=...++.-++++...        +.+++|||+-||+|||+||+|.+|   ..-|++|+.|||++...-..  
T Consensus       136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhcc
Confidence                  23233344444544443        678999999999999999999999   77889999999997643110  


Q ss_pred             ------C--------ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          257 ------Q--------IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       257 ------~--------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                            .        .....+||+.|.|||++. ..|+..+|+|++|+|+||++-|..||.+++.++++..+....+.++
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence                  0        113468999999999987 5699999999999999999999999999999999999999998888


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccC
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERL---TAHEVLCMYNLPVL  362 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~evL~~~~~~~~  362 (363)
                      +..+ .++++++++|..+|+.+|..|.   .+-++-+|.||+.+
T Consensus       279 E~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  279 EEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             ccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            8744 5789999999999999999996   67788888888754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-26  Score=225.80  Aligned_cols=245  Identities=23%  Similarity=0.290  Sum_probs=179.9

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccc-cCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK-LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      .|...+.||++.|=+|.+|++ ..| .|+||++-+.. ..+-....+...|++ .... ++||++++.-+.......|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~-~eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKD-REG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccC-CCc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence            467788999999999999995 555 49999987654 334444555556666 3334 499999999888888888999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec--CCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF--KPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~--~~~  256 (363)
                      -+|. ..+|+|.+..+..+..-+.+.|+.||+.||.-+|+.||+|+|||.+||||   .....+.|+||..-+..  ..+
T Consensus       100 Rqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  100 RQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence            9998 55999999888888999999999999999999999999999999999999   66678999999875432  111


Q ss_pred             C--ccccC----ccCCcccccccccc-----------c-CCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCC
Q 017960          257 Q--IFTDV----VGSPYYVAPEVLLK-----------H-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH  317 (363)
Q Consensus       257 ~--~~~~~----~gt~~y~aPE~~~~-----------~-~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~  317 (363)
                      .  .++-+    ..-..|.|||.+..           . .+++.||||+||+++||++ |++||.-   ..++. ...+.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~a-Yr~~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLA-YRSGN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHh-HhccC
Confidence            1  11111    12235999998742           1 4678999999999999988 7888821   11111 01110


Q ss_pred             cccCCCCCC-CCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          318 IDFESDPWP-LISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       318 ~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ...++.... --+..++.+|..|++.||.+|.++++.|+.
T Consensus       252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            000000000 013468999999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=2.2e-24  Score=184.61  Aligned_cols=144  Identities=19%  Similarity=0.155  Sum_probs=113.6

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh-----------------------hhHHHHHHHHHHHHHhcCCC
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-----------------------EDVEDVRREIQIMHHLAGHK  160 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~~h~  160 (363)
                      .+.||+|+||.||+|.+. +|+.||||++........                       .....+..|...+.++. |+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            468999999999999976 899999999976421100                       00223468999999998 88


Q ss_pred             ceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCC
Q 017960          161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       161 niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~  239 (363)
                      +|.....+....  .++||||++|+++.........++...+..++.|++.++.++|+ .||+||||||+|||+   + +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~-~  153 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H-D  153 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E-C
Confidence            875544443332  47999999887665444445678889999999999999999999 999999999999999   5 5


Q ss_pred             ccEEEeecCcceecCC
Q 017960          240 FSLKAIDFGLSVFFKP  255 (363)
Q Consensus       240 ~~~kl~DFG~a~~~~~  255 (363)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            7899999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.6e-24  Score=192.05  Aligned_cols=193  Identities=27%  Similarity=0.351  Sum_probs=140.7

Q ss_pred             CCCceeEEeEEEec---------------------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 017960          158 GHKNIVTIKGAYED---------------------------SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV  210 (363)
Q Consensus       158 ~h~niv~~~~~~~~---------------------------~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~  210 (363)
                      .|||||.+.++|.+                           ...+|+||... ..+|..++-.+ ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            59999999998844                           23689999887 45887777544 457788889999999


Q ss_pred             HHHHHHHhCCcEecCCCCCceEeeeCCC-CccEEEeecCcceecCCC-------CccccCccCCccccccccccc-----
Q 017960          211 GVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPG-------QIFTDVVGSPYYVAPEVLLKH-----  277 (363)
Q Consensus       211 ~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~~kl~DFG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~-----  277 (363)
                      +|+.|||++||.|||+|.+|||+.-+++ --.+.|+|||++--....       ...-..-|....||||+....     
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            9999999999999999999999965333 336889999987543221       112234567789999998732     


Q ss_pred             --CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017960          278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL  354 (363)
Q Consensus       278 --~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL  354 (363)
                        --.++|.|+.|.+.||+++...||++..+.. ++.-.-...+.+ .....+++.+++|+..+|+.||.+|+++.=+-
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhhCC-CCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence              1247899999999999999999998743321 111111111111 11235788999999999999999999875443

>PRK10345 hypothetical protein; Provisional

Probab=99.89  E-value=1.7e-22  Score=174.20  Aligned_cols=138  Identities=18%  Similarity=0.209  Sum_probs=107.4

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc----CCCceeEEeEEEecCC---e-E
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA----GHKNIVTIKGAYEDSL---C-V  175 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~~~---~-~  175 (363)
                      .+.||+|+||.||.  +..++.. +||++....   ....+.+.+|+.+++.+.    .||||++++++++++.   . +
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            46899999999995  6666655 699886542   223467899999999994    3899999999998863   4 3


Q ss_pred             EEEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcEecCCCCCceEeeeCC-CCccEEEeecCcc
Q 017960          176 HIVMEL--CAGGELFDRIIQRGHYSERKAAELTRIIVGVV-EACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLS  250 (363)
Q Consensus       176 ~iv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l-~~lH~~~iiHrDlkp~NIll~~~~-~~~~~kl~DFG~a  250 (363)
                      .+||||  +.+++|.+++.+. .+++.  ..++.+++.++ +|||+++|+||||||+|||+...+ .+..++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            478999  5578999999653 46555  35577777776 999999999999999999996433 3458999995444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.8e-23  Score=208.15  Aligned_cols=197  Identities=23%  Similarity=0.300  Sum_probs=159.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|.|.+.||+|+||+||+|.+.. |+.||+|+-+....-.-.-..+++..++ +.   --+.|..+...+...+..++
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~---~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ---MLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh---hhcchHHHHHHHccCCccee
Confidence            3569999999999999999999755 9999999876543211111122322222 11   13567777777777888899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeee----CCCCccEEEeecCcceec
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~----~~~~~~~kl~DFG~a~~~  253 (363)
                      |+||.+.|+|.+++...+.+++..+..++.|++..++.||..+|||+||||+|.||..    +.+...++|+|||.|..+
T Consensus       772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM  851 (974)
T ss_pred             eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence            9999999999999998888999999999999999999999999999999999999953    233557999999998543


Q ss_pred             ---CCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCC
Q 017960          254 ---KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP  299 (363)
Q Consensus       254 ---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~  299 (363)
                         .++..+...++|-.+-.+|...+ .|++.+|.|.|+.+++-|+.|+.
T Consensus       852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence               45557778889999999999985 59999999999999999999865

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=6.4e-23  Score=190.70  Aligned_cols=244  Identities=23%  Similarity=0.286  Sum_probs=170.8

Q ss_pred             eeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEe------EEEe-
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK------GAYE-  170 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~------~~~~-  170 (363)
                      +.+.+..+..+++.+........   .+.++-+.....   +........+++-.+.....|+..+..-      ..+. 
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~  322 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR  322 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence            45556677777777766553332   233333333221   2133445555666665555344443322      0111 


Q ss_pred             ----cCCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEE
Q 017960          171 ----DSLCVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       171 ----~~~~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                          ...++||.|++|.-.+|.+||.++..   .+....+.++.|++.|++|   +|.+|||+||.||+.   ..+..+|
T Consensus       323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~k  396 (516)
T KOG1033|consen  323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLK  396 (516)
T ss_pred             cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhh
Confidence                13368999999999999999976543   5778899999999999999   999999999999999   5666899


Q ss_pred             EeecCcceecCCCC-------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHH
Q 017960          244 AIDFGLSVFFKPGQ-------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL  314 (363)
Q Consensus       244 l~DFG~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~  314 (363)
                      |.|||+........       ..+..+||..||+||.+.+ .|+.++||||||++|+||+. -..++   .....+..+.
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r  473 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIR  473 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhh
Confidence            99999998765554       5567899999999999995 69999999999999999998 33333   2234455555


Q ss_pred             cCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .+.++  +..+.. .++-.+|+.+||.+.|.+||++.+.--+.|+
T Consensus       474 ~g~ip--~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  474 DGIIP--PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             cCCCC--hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            55443  111122 2455799999999999999988777766664

>smart00090 RIO RIO-like kinase

Probab=99.88  E-value=5.5e-22  Score=175.06  Aligned_cols=146  Identities=21%  Similarity=0.147  Sum_probs=114.6

Q ss_pred             ceeecceecccCCeEEEEEE-EccCCcEEEEEEeeccccCC-------------------h--hhHHHHHHHHHHHHHhc
Q 017960          100 LYTLGRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLIS-------------------R--EDVEDVRREIQIMHHLA  157 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~~-------------------~--~~~~~~~~E~~~l~~l~  157 (363)
                      .|.+.+.||+|+||.||+|. +..+|+.||+|++.......                   .  .....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 67899999999987543110                   0  01234678999999997


Q ss_pred             CCC--ceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cEecCCCCCceEee
Q 017960          158 GHK--NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG-VMHRDLKPENFLLV  234 (363)
Q Consensus       158 ~h~--niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~-iiHrDlkp~NIll~  234 (363)
                       +.  .++++++.    ...++||||++|.+|.........+....+..++.|++.++.+||+.| |+||||||+||++ 
T Consensus       109 -~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli-  182 (237)
T smart00090      109 -EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV-  182 (237)
T ss_pred             -hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE-
Confidence             43  34444442    234899999998888665544555677778899999999999999999 9999999999999 


Q ss_pred             eCCCCccEEEeecCcceecC
Q 017960          235 NKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~  254 (363)
                        + ++.++|+|||.+....
T Consensus       183 --~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 --H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             --E-CCCEEEEEChhhhccC
Confidence              5 6689999999987643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-22  Score=173.15  Aligned_cols=239  Identities=19%  Similarity=0.248  Sum_probs=184.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      ..+..+|.+.-.|..|+|++.  |..+++|++..+.. ....-..|..|.-.|+-++ ||||+.+++.+.....+.++..
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence            345667889999999999954  44677888765544 2233356788888888887 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEe--ecCcceecC
Q 017960          181 LCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFK  254 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~--DFG~a~~~~  254 (363)
                      ||+.|+|+..|+....  .+..++..++.+++.|+.|||+..  |----|....+++   |++...+|+  |--++... 
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe-  343 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE-  343 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec-
Confidence            9999999999987654  577899999999999999999975  3344578888999   887777763  43333221 


Q ss_pred             CCCccccCccCCccccccccccc----CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .     ...-.|.||+||.+.+.    --.++|+|||++++|||.|.+.||..-...+.--++.-....  ....+.++.
T Consensus       344 ~-----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~  416 (448)
T KOG0195|consen  344 V-----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISR  416 (448)
T ss_pred             c-----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccH
Confidence            1     12236789999999742    335789999999999999999999776665544444332222  223357899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHh
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVL  354 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL  354 (363)
                      .+..|+.-|++.||.+||.++.++
T Consensus       417 hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999999998765

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.7e-20  Score=162.04  Aligned_cols=137  Identities=30%  Similarity=0.354  Sum_probs=113.6

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-----EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      +.||+|++|.||+|.+  .+..+++|+.........     ....++.+|+.++..+. |++|+....++......+++|
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            5799999999999985  777899998654322111     12346788999999998 888887777777778889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ||++|++|.+.+....   . ....++.+++.+|.++|+.|++|+|++|.|||+   + ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence            9999999998886532   2 888999999999999999999999999999999   4 56799999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=5.9e-20  Score=158.45  Aligned_cols=134  Identities=28%  Similarity=0.311  Sum_probs=106.7

Q ss_pred             eecccCCeEEEEEEEccCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      .||+|+||.||+|.  .++..+++|.........     .....++.+|+.++..+. |+++.....++......++|||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            48999999999998  567889999865432211     112467789999999998 7765555445556666789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||++   + ++.++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcCC
Confidence            9999999887754321       889999999999999999999999999999   5 678999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.7e-22  Score=197.93  Aligned_cols=257  Identities=31%  Similarity=0.472  Sum_probs=208.6

Q ss_pred             eeecceecccCCeEEEEEEEcc-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      |.+.+.||+|+|+.|-.+.... ....+|+|.+.... ......+....|..+-+.+.+|.|++.+++........++++
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            6777889999999999887643 34457777775443 244556677778888888888999999999999999999999


Q ss_pred             eccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCCCceEeeeCCCCc-cEEEeecCcceecCC
Q 017960          180 ELCAGGELFDRI-IQRG-HYSERKAAELTRIIVGVVEACH-SLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKP  255 (363)
Q Consensus       180 e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~~l~~~l~~lH-~~~iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~~~  255 (363)
                      +|..|+++++-+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.++   +..+ .++++|||+|.....
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccccc
Confidence            999999999888 5554 6788899999999999999999 9999999999999999   6666 899999999987655


Q ss_pred             -CC---ccccCcc-CCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCcccCCCCCCC
Q 017960          256 -GQ---IFTDVVG-SPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       256 -~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  327 (363)
                       ..   .....+| ++.|+|||...+  ...+..|+||.|+++.-+++|..||....... .+.........+...+|..
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             22   2345678 999999999986  46788999999999999999999996544332 1122222222334556778


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++....+++.+++..+|..|.+..++-..+|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8999999999999999999999999999999853

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.83  E-value=5.8e-20  Score=158.40  Aligned_cols=139  Identities=23%  Similarity=0.255  Sum_probs=107.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh-------------------hhHHHHHHHHHHHHHhcCCC-
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-------------------EDVEDVRREIQIMHHLAGHK-  160 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~h~-  160 (363)
                      |.+.+.||+|+||.||+|.. .+|+.||||++........                   ........|+.++..+. |+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            77789999999999999986 4799999998764321000                   01123678899999987 66 


Q ss_pred             -ceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC
Q 017960          161 -NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       161 -niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~  239 (363)
                       .++..++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||++   +++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~  161 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD  161 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence             4444443    234589999999998865432      14567788999999999999999999999999999   778


Q ss_pred             ccEEEeecCcceecC
Q 017960          240 FSLKAIDFGLSVFFK  254 (363)
Q Consensus       240 ~~~kl~DFG~a~~~~  254 (363)
                      +.++|+|||.+....
T Consensus       162 ~~~~liDfg~~~~~~  176 (198)
T cd05144         162 EKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcEEEEECCccccCC
Confidence            899999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=4.3e-20  Score=174.82  Aligned_cols=198  Identities=23%  Similarity=0.316  Sum_probs=156.7

Q ss_pred             HHhcCCCceeEEeEEEecCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-EecCCCCCce
Q 017960          154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGV-MHRDLKPENF  231 (363)
Q Consensus       154 ~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~i-iHrDlkp~NI  231 (363)
                      +.+. |.|+.+++|.+.++...++|.+||..|+|.|.+.. .-.+++.-...++++|+.||.|+|...| .|+.+++.|.
T Consensus         2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4566 99999999999999999999999999999999977 3457778888899999999999998876 9999999999


Q ss_pred             EeeeCCCCccEEEeecCcceecCCC---CccccCccCCccccccccccc--------CCCcccHHHHHHHHHHHHhCCCC
Q 017960          232 LLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH--------YGPEADVWTAGVILYILLSGVPP  300 (363)
Q Consensus       232 ll~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~Di~slG~il~ell~g~~p  300 (363)
                      ++   +....+||+|||+.......   .......-...|.|||.+...        .+.+.||||||++++|+++...|
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99   89999999999998765321   111122234569999999742        46779999999999999999999


Q ss_pred             CCCcC----HHHHHHHHHc-CCcccCCCCC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017960          301 FWAET----QQGIFDAVLK-GHIDFESDPW--PLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       301 f~~~~----~~~~~~~i~~-~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      |....    ..++...+.+ +...+.+..+  ...++++..+++.||..+|..||+++++-.
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            95422    2345555555 3322332222  145668999999999999999999988754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=3.1e-19  Score=176.26  Aligned_cols=140  Identities=24%  Similarity=0.264  Sum_probs=111.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..|...+.||+|+||+||+|....  ..+++|+.......     .....+++.+|+.++..++ |++|+....++....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCC
Confidence            345668899999999999998543  34455443222111     1123467889999999998 999988877777777


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..++||||++|++|.+.+.        ....++.+++.+|.+||+.|++||||||+|||+   + ++.++|+|||++...
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl---~-~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV---R-DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE---E-CCcEEEEeCcccccC
Confidence            7899999999999988774        457789999999999999999999999999999   3 457999999999763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.80  E-value=4.5e-19  Score=151.32  Aligned_cols=140  Identities=21%  Similarity=0.227  Sum_probs=99.7

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHH---------------------HHHHHHHHHHHhcCC-Cc
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE---------------------DVRREIQIMHHLAGH-KN  161 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h-~n  161 (363)
                      .+.||+|+||.||+|.+. +++.||||++............                     ....|...+..+..+ ..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999975 8999999998653321111111                     124567777776522 23


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCC
Q 017960          162 IVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       162 iv~~~~~~~~~~~~~iv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~  239 (363)
                      +.+.++.    ...++||||++++.+.. .+... .. ...+..++.+++.++.++|. .||+||||||+||++   + +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~-~  150 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D-D  150 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-C
Confidence            4444443    23589999998854321 11111 11 16788999999999999999 999999999999999   5 6


Q ss_pred             ccEEEeecCcceecC
Q 017960          240 FSLKAIDFGLSVFFK  254 (363)
Q Consensus       240 ~~~kl~DFG~a~~~~  254 (363)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            789999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.1e-18  Score=165.45  Aligned_cols=258  Identities=22%  Similarity=0.253  Sum_probs=201.9

Q ss_pred             ccccceeecceecc--cCCeEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           96 NIRDLYTLGRKLGQ--GQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        96 ~~~~~y~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      .+...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.. ........+=.+|+.-.+.+..|++.++.+..++.
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence            34556777889999  99999999987  788899999974322 11222334455678777888889999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCcEecCCCCCceEeeeCCCC-ccEEEe
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVG----VVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAI  245 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~----~l~~lH~~~iiHrDlkp~NIll~~~~~~-~~~kl~  245 (363)
                      .+..++-+|+| +.+|..+...... ++...++..+.+...    ||.++|..+++|-|+||.||+.   .++ ...+++
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~---~~~~~s~~~~  265 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT---TSDWTSCKLT  265 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec---ccccceeecC
Confidence            99999999999 6788888776555 888999999999999    9999999999999999999999   566 789999


Q ss_pred             ecCcceecCCCCccc------cCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc
Q 017960          246 DFGLSVFFKPGQIFT------DVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID  319 (363)
Q Consensus       246 DFG~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  319 (363)
                      |||+...+..+....      ...|...|++||.+.+.++...|+|++|.++.+-.++-.+........ ...+.++.  
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~--  342 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGY--  342 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccccccc--
Confidence            999998876654221      225677899999999999999999999999999988766653321110 11111111  


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+.+.....+.++...+..|++.+|-.|++++.++.+.++..
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            233333455677888999999999999999999999887753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.76  E-value=1.1e-17  Score=148.01  Aligned_cols=139  Identities=22%  Similarity=0.296  Sum_probs=104.6

Q ss_pred             cceec-ccCCeEEEEEEEccCCcEEEEEEeecccc----------CChhhHHHHHHHHHHHHHhcCCCce--eEEeEEEe
Q 017960          104 GRKLG-QGQFGTTYLCTEIATGIEFACKSISKRKL----------ISREDVEDVRREIQIMHHLAGHKNI--VTIKGAYE  170 (363)
Q Consensus       104 ~~~lG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~  170 (363)
                      ...|| .|+.|+||.+..  .+..++||.+.....          .......++.+|+.++.+|. |++|  +..+++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~  112 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARV  112 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeee
Confidence            35687 889999999884  477899998854221          01123457889999999998 7774  66776543


Q ss_pred             cC-C---eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEe
Q 017960          171 DS-L---CVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (363)
Q Consensus       171 ~~-~---~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~  245 (363)
                      .. .   ..++|||+++| .+|.+.+.. ..+++..    +.+|+.+|.+||+.||+||||||.|||+   +.++.++|+
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LI  184 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLI  184 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEE
Confidence            32 2   23599999997 588777654 4455543    5789999999999999999999999999   666689999


Q ss_pred             ecCcceec
Q 017960          246 DFGLSVFF  253 (363)
Q Consensus       246 DFG~a~~~  253 (363)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988763

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=3e-17  Score=134.23  Aligned_cols=133  Identities=24%  Similarity=0.305  Sum_probs=111.2

Q ss_pred             ecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeEEEecCCeEEEEEec
Q 017960          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       103 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      +.+.||.|.++.||++...  +..+++|.......     ...+.+|+.++..++.+ .++++++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            3567999999999999953  37899998865421     45788999999999834 6899999988888889999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ++|..+...       +......++.+++.++.++|..   +++|+|++|.||++   ++.+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEecccccC
Confidence            988777543       5667788899999999999985   69999999999999   5567899999998865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=2.6e-17  Score=163.87  Aligned_cols=258  Identities=29%  Similarity=0.385  Sum_probs=204.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.+.+.+-+-+|+++.++.+.-..++...+.|+............+....+-.++-.-+ +|.++...-.+.-....+++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcchh
Confidence            44677778999999999999987888677777654433323333444444444443333 67777666556667789999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC---
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP---  255 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~---  255 (363)
                      ++|+.+++|...|+..+..+...++..+..+..++++||...++|||++|.|+|+   ..+++.++.|||.......   
T Consensus       883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccccC
Confidence            9999999999999888888888889999999999999999999999999999999   7888999999984321100   


Q ss_pred             ---C--------------------------CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC
Q 017960          256 ---G--------------------------QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET  305 (363)
Q Consensus       256 ---~--------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~  305 (363)
                         .                          .......+|+.|.+||.+.+ .....+|+|++|++++|.++|.+||....
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence               0                          00123568999999999884 58889999999999999999999999999


Q ss_pred             HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCCCccc
Q 017960          306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAH---EVLCMYNLPV  361 (363)
Q Consensus       306 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~---evL~~~~~~~  361 (363)
                      .+..++.+.++...++.-+. ..+.++++++.+.|..+|.+|..+.   ++-.|++++.
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~-~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPE-EGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred             hhhhhhccccCCCCCCCCcc-ccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence            99999999988877665443 4688999999999999999999887   8888888764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.62  E-value=1.7e-15  Score=147.07  Aligned_cols=144  Identities=20%  Similarity=0.273  Sum_probs=92.7

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC--------------------------C-h----hhHHH----
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--------------------------S-R----EDVED----  145 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~-~----~~~~~----  145 (363)
                      |.. +.||+|++|.||+|+.+.+|+.||||++++....                          . .    +..+.    
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            555 7899999999999998877999999999754210                          0 0    11122    


Q ss_pred             --HHHHHHHHHHhc---CCCceeEEeEEE-ecCCeEEEEEeccCCCChHHH--HHhcCC----CCHHHHHHHHHHHHHHH
Q 017960          146 --VRREIQIMHHLA---GHKNIVTIKGAY-EDSLCVHIVMELCAGGELFDR--IIQRGH----YSERKAAELTRIIVGVV  213 (363)
Q Consensus       146 --~~~E~~~l~~l~---~h~niv~~~~~~-~~~~~~~iv~e~~~~~~L~~~--l~~~~~----~~~~~~~~i~~~l~~~l  213 (363)
                        +.+|...+.+++   .+...+.+=.++ ......+|||||+.|+.+.+.  +...+.    +.+..+..++.|+    
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi----  276 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV----  276 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH----
Confidence              333444444443   122222222222 224456799999999999763  333331    2333333344443    


Q ss_pred             HHHHhCCcEecCCCCCceEeeeCCCCc----cEEEeecCcceecCC
Q 017960          214 EACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDFGLSVFFKP  255 (363)
Q Consensus       214 ~~lH~~~iiHrDlkp~NIll~~~~~~~----~~kl~DFG~a~~~~~  255 (363)
                         ...|++|+|+||.||++   +.++    .++++|||++...+.
T Consensus       277 ---f~~GffHaDpHPGNIlv---~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ---FRDGFFHADMHPGNIFV---SYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ---HhCCeeeCCCChHHeEE---ecCCCCCCeEEEEecceEEECCH
Confidence               46899999999999999   5555    899999999987643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.60  E-value=2.1e-14  Score=121.83  Aligned_cols=143  Identities=12%  Similarity=0.075  Sum_probs=103.1

Q ss_pred             cceecccCCeEEEEEEEcc------CCcEEEEEEeeccccC-------------------ChhhHHHH----HHHHHHHH
Q 017960          104 GRKLGQGQFGTTYLCTEIA------TGIEFACKSISKRKLI-------------------SREDVEDV----RREIQIMH  154 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~-------------------~~~~~~~~----~~E~~~l~  154 (363)
                      ...||.|--+.||.|....      .+..+|||+.+.....                   .......+    .+|...|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3569999999999998543      3579999987431110                   01112233    38999999


Q ss_pred             HhcCC-CceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecCCCCCceE
Q 017960          155 HLAGH-KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-HSLGVMHRDLKPENFL  232 (363)
Q Consensus       155 ~l~~h-~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~l-H~~~iiHrDlkp~NIl  232 (363)
                      ++... -+++.++++    ..-+|||||+.+..+.....+...++......+..+++.+|..| |+.||||+||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            99732 467777764    45679999996654432222333456667788899999999998 8999999999999999


Q ss_pred             eeeCCCCccEEEeecCcceecC
Q 017960          233 LVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       233 l~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +   + ++.++|+|||.+....
T Consensus       158 ~---~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 W---H-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             E---E-CCcEEEEECCCceeCC
Confidence            9   3 3579999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=1.1e-14  Score=139.77  Aligned_cols=144  Identities=19%  Similarity=0.200  Sum_probs=98.5

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---------------------------h----hHH------HHH
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---------------------------E----DVE------DVR  147 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----~~~------~~~  147 (363)
                      +.||.|++|.||+|+. .+|+.||||+.++.....-                           .    ...      .+.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5799999999999995 5899999999854311000                           0    000      244


Q ss_pred             HHHHHHHHhc----CCCceeEEeEEEecCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 017960          148 REIQIMHHLA----GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVG-VVEACHSLGV  221 (363)
Q Consensus       148 ~E~~~l~~l~----~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~-~l~~lH~~~i  221 (363)
                      +|...+.++.    ++++|.-..-++......++||||++|++|.+..... ...   ....++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            4555555553    2344332222233344578999999999998766432 112   23456666665 4678999999


Q ss_pred             EecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       222 iHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +|+|+||.||++   ++++.++|+|||++.....
T Consensus       279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            999999999999   7788999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=5.7e-15  Score=140.32  Aligned_cols=251  Identities=20%  Similarity=0.195  Sum_probs=185.4

Q ss_pred             cccceeecceecccCCeEEEEEEEc-cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ...+|-.+..||.|.|+.|+.+... .++..|++|.+.+.......+ ..-..|+.+...+..|.+++.....|......
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3455788899999999999998755 677889999886554333222 23445777777777799999999988888888


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||--|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+  ++..++.|||+++...-
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhccccccccccce
Confidence            8999999999886666444557889999999999999999999999999999999999532  28899999999874211


Q ss_pred             CCccccCccCCccc-ccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          256 GQIFTDVVGSPYYV-APEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       256 ~~~~~~~~gt~~y~-aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      .  .....+.-++. .+|++..  .+..+.|++|||..+.+.+++...-+...   ....+..+..    ...+....++
T Consensus       420 ~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~----p~~~~~~~~~  490 (524)
T KOG0601|consen  420 S--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDT----PNLPGLKLQL  490 (524)
T ss_pred             e--cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccc----cCCCchHHhh
Confidence            1  11122233444 3666653  47889999999999999999875432211   1112222221    1223345788


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ..+.+.++.+++..|+.+.++..+.-+
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchh
Confidence            999999999999999999998887655

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.55  E-value=2.8e-14  Score=119.59  Aligned_cols=129  Identities=20%  Similarity=0.159  Sum_probs=95.5

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      ++.|+.|.++.||++..  .+..|++|+......    ....+.+|+.+++.+.+...+++++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            35789999999999984  477899998754321    12345789999999873333455655443  23579999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          184 GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV-----MHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       184 ~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~i-----iHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      |.++...        ......++.+++.+|..||+.++     +|+|++|.||++   + ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~---~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL---D-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE---E-CCeEEEEecccccC
Confidence            9887543        11123456889999999999985     999999999999   4 45799999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=1.5e-14  Score=127.76  Aligned_cols=236  Identities=17%  Similarity=0.184  Sum_probs=157.0

Q ss_pred             eEEEEEEEccCCcEEEEEEeeccccCChhhH-HHHHHHHHHHHHhcCCCceeEEeEEEec-----CCeEEEEEeccCCCC
Q 017960          113 GTTYLCTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMHHLAGHKNIVTIKGAYED-----SLCVHIVMELCAGGE  186 (363)
Q Consensus       113 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-~~~~~E~~~l~~l~~h~niv~~~~~~~~-----~~~~~iv~e~~~~~~  186 (363)
                      -.||++.+...|.+|+--.++.....+.... +....-...|-++- |.|||+++.+|.+     .....++.||+..|+
T Consensus        80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs  158 (458)
T KOG1266|consen   80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGS  158 (458)
T ss_pred             HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchh
Confidence            3577777777776665443322111111111 11222233444555 9999999999865     345788999999999


Q ss_pred             hHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecCcceecCCC----
Q 017960          187 LFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG----  256 (363)
Q Consensus       187 L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~----  256 (363)
                      |..+|++.    ..+....+.+|+.||+.||.|||+..  |+|+++.-+-|++   ..++-+|+.---.... ...    
T Consensus       159 ~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ap~s~-h~s~~~~  234 (458)
T KOG1266|consen  159 LKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSVAPDST-HPSVNST  234 (458)
T ss_pred             HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEecccCcccc-chhhhhh
Confidence            99988763    34788999999999999999999985  9999999999999   6777788743211111 100    


Q ss_pred             --CccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCC-CcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 --QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 --~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                        ....-..+-++|.|||.=. ...+.++|||+||....||.-+..--. .......-..+.+-.+...       ...-
T Consensus       235 ~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lq  307 (458)
T KOG1266|consen  235 REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQ  307 (458)
T ss_pred             hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------Cccc
Confidence              0111234567899999765 467889999999999999988765421 2111122222222111111       1223


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ++++.+||+..|..||+|+++|.|+-+-
T Consensus       308 r~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  308 RGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             cCcCcccccCCCCCCcchhhhhcCceee
Confidence            5789999999999999999999998653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.51  E-value=3.2e-13  Score=110.58  Aligned_cols=148  Identities=22%  Similarity=0.227  Sum_probs=112.3

Q ss_pred             ecceecccCCeEEEEEEEccCCcEEEEEEeecc-----ccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKR-----KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       103 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ...+|-+|+-+.|+++.  ..|+...||.=...     .+...-...+..+|+++|.++. --.|.-..-+|.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            35678899999999998  67878777753222     2222333567889999999987 5566655556777777789


Q ss_pred             EEeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          178 VMELCAG-GELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       178 v~e~~~~-~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      +|||++| .++.+++....  .........++++|-+.+.-||.++|||+||..+||++..++....+.++|||++...
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9999977 36777775532  2333444789999999999999999999999999999987677777799999998653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=5.3e-13  Score=109.77  Aligned_cols=135  Identities=27%  Similarity=0.287  Sum_probs=101.0

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChh-----hHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      ..+++|+-+.+|.+..  -|..+++|.=.++....++     ...+..+|..++.++. --.|...+-++.+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            3588999999999964  4445677654332222222     2456788999999987 445555555566677778999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ||++|..|.+.+...       ...+++.+-..+.-||..||+|+||.++||++.   . +.+.++|||++...
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~---~-~~i~~IDfGLg~~s  141 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS---G-GRIYFIDFGLGEFS  141 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe---C-CcEEEEECCccccc
Confidence            999998888888654       366777888888999999999999999999994   2 24999999999763

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=1.8e-12  Score=124.81  Aligned_cols=182  Identities=15%  Similarity=0.143  Sum_probs=135.3

Q ss_pred             eeecceecccCCeEEE-EEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          101 YTLGRKLGQGQFGTTY-LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy-~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      |.+ ...+-++.+ +| .|..+.++.+|.|...+...   ......+.+.++-|+.++ ||||+++++.++.....|||+
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEe
Confidence            444 333334444 34 46667889999999887553   244567788889999998 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH-SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |.+.  .|...+.+.+   ...+..-+.||+.||.+|| +.+++|++|.-..|+|   +..|..||++|..+........
T Consensus        89 ErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~  160 (690)
T KOG1243|consen   89 ERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA  160 (690)
T ss_pred             eccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc
Confidence            9884  5666666543   7788888999999999997 6789999999999999   8899999999998755332211


Q ss_pred             -cccCccCCcccccccccccCCCcccHHHHHHHHHHHHhC
Q 017960          259 -FTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSG  297 (363)
Q Consensus       259 -~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g  297 (363)
                       ......--.|..|+.+... .-..|.|-|||+++|++.|
T Consensus       161 ~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  161 PAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence             0111111235556554311 1356999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=8.8e-12  Score=108.93  Aligned_cols=141  Identities=28%  Similarity=0.401  Sum_probs=103.2

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeEEEecC---CeEEEEEe
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDS---LCVHIVME  180 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~---~~~~iv~e  180 (363)
                      +.||.|..+.||++.. .+|+.+++|+.......  .....+..|.++++.+..+ ..+++++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEe-cCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            5689999999999985 34688999987643221  1345788999999999732 3467777766553   36789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS------------------------------------------  218 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~------------------------------------------  218 (363)
                      |++|.++.+.+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999887664421 345666666677777777766663                                          


Q ss_pred             --------------CCcEecCCCCCceEeeeCCC--CccEEEeecCccee
Q 017960          219 --------------LGVMHRDLKPENFLLVNKDD--DFSLKAIDFGLSVF  252 (363)
Q Consensus       219 --------------~~iiHrDlkp~NIll~~~~~--~~~~kl~DFG~a~~  252 (363)
                                    ..++|+|++|.||++   +.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLF---HPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEE---cCCCCcEEEEEecccccc
Confidence                          246999999999999   44  56789999998865

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.27  E-value=2.5e-10  Score=107.15  Aligned_cols=212  Identities=16%  Similarity=0.222  Sum_probs=154.1

Q ss_pred             CCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe----cCCeEEEEEeccCC-C
Q 017960          111 QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----DSLCVHIVMELCAG-G  185 (363)
Q Consensus       111 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~~~~iv~e~~~~-~  185 (363)
                      --.+.|+|....+|..|++|+++-.....   ......-++.++++. |+|||++.++|.    .+..+++|++|.++ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            34678999999999999999994322211   123344577888998 999999999986    35678999999976 4


Q ss_pred             ChHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          186 ELFDRIIQ---------------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       186 ~L~~~l~~---------------~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      +|.+....               ....++..++.++.||..||.++|+.|+..+-|.|.+||+   +.+.+++|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccce
Confidence            67665422               1236789999999999999999999999999999999999   55557888877776


Q ss_pred             eecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCC-CCCcCHHHH-HHHHHcCCcccCCCCCCCC
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP-FWAETQQGI-FDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~  328 (363)
                      .....+..             |-+.  --.+-|.-.||.+++.|.||..- +........ ++.|.           ..+
T Consensus       441 Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y  494 (655)
T KOG3741|consen  441 DVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY  494 (655)
T ss_pred             eeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence            65543320             1111  12467999999999999999654 222222222 33332           246


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.+++++|.-+...++++ -+.++++.+
T Consensus       495 S~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  495 STDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            889999999999998886 677777653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.26  E-value=2.3e-10  Score=102.50  Aligned_cols=143  Identities=22%  Similarity=0.180  Sum_probs=98.2

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccC----C----hhhHHHHHHHHHHHHHhcCCCce--eEEeEEEec-----
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLI----S----REDVEDVRREIQIMHHLAGHKNI--VTIKGAYED-----  171 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~----~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~-----  171 (363)
                      +-......|+++.  ..|+.|.||........    .    ......+.+|...+.+|. .-+|  +.++.+++.     
T Consensus        30 v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         30 FRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCc
Confidence            3333444466655  46778999966332200    0    011124778999998886 3333  333444433     


Q ss_pred             CCeEEEEEeccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeee----CCCCccEEE
Q 017960          172 SLCVHIVMELCAGG-ELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKA  244 (363)
Q Consensus       172 ~~~~~iv~e~~~~~-~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~----~~~~~~~kl  244 (363)
                      ....++|||++++. +|.+++..  ....+......++.+++..+.-||..||+|+|+++.|||+..    .+++..+.|
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            23578999999875 78887753  344567788899999999999999999999999999999953    123578999


Q ss_pred             eecCccee
Q 017960          245 IDFGLSVF  252 (363)
Q Consensus       245 ~DFG~a~~  252 (363)
                      +||+.+..
T Consensus       187 IDl~r~~~  194 (268)
T PRK15123        187 IDLHRAQI  194 (268)
T ss_pred             EECCcccc
Confidence            99998854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.24  E-value=8e-11  Score=99.64  Aligned_cols=130  Identities=25%  Similarity=0.233  Sum_probs=82.9

Q ss_pred             EEEEEEEccCCcEEEEEEeeccccC----------------------C-hhhHHHHHHHHHHHHHhcCC-CceeEEeEEE
Q 017960          114 TTYLCTEIATGIEFACKSISKRKLI----------------------S-REDVEDVRREIQIMHHLAGH-KNIVTIKGAY  169 (363)
Q Consensus       114 ~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~-~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~  169 (363)
                      .||.|.. .+|..+|||+.+.....                      . ........+|...|.++... -++++++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899985 67889999987532110                      0 11134578899999999833 2567776542


Q ss_pred             ecCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          170 EDSLCVHIVMELCA--GGELFDRIIQRGHYSERKAAELTRIIVGVVEA-CHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       170 ~~~~~~~iv~e~~~--~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~-lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                          ..+|||||++  |..+.. +... .++......++.+++..+.. +|+.||+|+||.+.|||+   +++ .+.|+|
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv---~~~-~~~iID  149 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILV---DDG-KVYIID  149 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEE---ETT-CEEE--
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEe---ecc-eEEEEe
Confidence                3469999997  544433 3322 12245667777888885544 689999999999999999   444 799999


Q ss_pred             cCcceecC
Q 017960          247 FGLSVFFK  254 (363)
Q Consensus       247 FG~a~~~~  254 (363)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.19  E-value=1.2e-09  Score=100.19  Aligned_cols=242  Identities=17%  Similarity=0.232  Sum_probs=163.1

Q ss_pred             eecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEE-------ecCCe
Q 017960          102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY-------EDSLC  174 (363)
Q Consensus       102 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-------~~~~~  174 (363)
                      ..++.||+|+-+.+|..-...   .-+-|++.....   ...   ...+..|...-.||-+-.=+.|=       .....
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Ppp---a~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPP---AAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchhh---chhheeecCCCc---hHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            356789999999999755222   234567654421   111   11233334443455433311111       12223


Q ss_pred             EEEEEeccCCCChHHHHH----hc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          175 VHIVMELCAGGELFDRII----QR---GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~----~~---~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      ..++|..+.|..--..+.    ++   ..+.+.-+...++.|+.+...||..|.+-+|+.++|+|+   .+++.|.|.|=
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence            678888887653222221    22   236788899999999999999999999999999999999   78889999987


Q ss_pred             CcceecCCCCccccCccCCccccccccc-c-----cCCCcccHHHHHHHHHHHHhC-CCCCCCcCHH----HHHH-HHHc
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLL-K-----HYGPEADVWTAGVILYILLSG-VPPFWAETQQ----GIFD-AVLK  315 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~Di~slG~il~ell~g-~~pf~~~~~~----~~~~-~i~~  315 (363)
                      ..-....++..+...+|...|.+||.-. +     .-+...|.|.||+++++|+.| +.||.|....    .-++ .|..
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            7666656677778889999999999865 2     256789999999999999886 9999653221    1111 2333


Q ss_pred             CCccc------------CCCCCCCCCHHHHHHHHHhccc--CcCCCCCHHHHhc
Q 017960          316 GHIDF------------ESDPWPLISDSAKDLIRKMLCS--QPSERLTAHEVLC  355 (363)
Q Consensus       316 ~~~~~------------~~~~~~~~~~~~~~li~~~l~~--dp~~R~s~~evL~  355 (363)
                      +.+.+            ...+|..+++++..|..+|+..  ++.-|||++..+.
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~a  295 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVA  295 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHH
Confidence            32222            1234557889999999999875  4678999976553

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.15  E-value=2.6e-10  Score=99.54  Aligned_cols=139  Identities=22%  Similarity=0.251  Sum_probs=104.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeecccc-----------------CC--hhhHHHHHHHHHHHHHhcCC-C
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-----------------IS--REDVEDVRREIQIMHHLAGH-K  160 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------------~~--~~~~~~~~~E~~~l~~l~~h-~  160 (363)
                      +.++..||-|--|.||.|.+ ..|.++|||.-+....                 .+  -.......+|.++|.+|..+ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            56788999999999999996 5899999997421100                 01  11234577899999999743 3


Q ss_pred             ceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       161 niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      .|+..+++    +.-.+|||+++|..|...-     +.......++..|++-+..+-..||||+|+.+-||++   +++|
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~dg  239 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TEDG  239 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecCC
Confidence            67777663    5667999999987775422     2355666667777777766669999999999999999   8888


Q ss_pred             cEEEeecCccee
Q 017960          241 SLKAIDFGLSVF  252 (363)
Q Consensus       241 ~~kl~DFG~a~~  252 (363)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=3.5e-11  Score=116.42  Aligned_cols=148  Identities=18%  Similarity=0.251  Sum_probs=108.3

Q ss_pred             HHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCcc-----c-----cCccCCcccccccccc-c
Q 017960          210 VGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----T-----DVVGSPYYVAPEVLLK-H  277 (363)
Q Consensus       210 ~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~-~  277 (363)
                      +.|+.|+|. .++||+.|.|++|.+   +..+..||+.|+++....++..+     .     -......|.|||++.. .
T Consensus       109 ~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  109 ADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            389999996 589999999999999   88889999999998776542211     1     1123457999999985 5


Q ss_pred             CCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017960          278 YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE-SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       278 ~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      -+.++|+||+|+++|-+.. |...+......... .......... .-....++.++++-|.+++..++..||++.+++.
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence            7889999999999999984 55555433222211 1111111111 1111468999999999999999999999999999


Q ss_pred             CCCccc
Q 017960          356 MYNLPV  361 (363)
Q Consensus       356 ~~~~~~  361 (363)
                      .+||+.
T Consensus       265 ~~ff~D  270 (700)
T KOG2137|consen  265 IPFFSD  270 (700)
T ss_pred             ccccCC
Confidence            999853

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=3e-09  Score=92.08  Aligned_cols=111  Identities=22%  Similarity=0.283  Sum_probs=85.6

Q ss_pred             HHHHHHHHHHHHHhcC-CCceeEEeEEEecC----CeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 017960          143 VEDVRREIQIMHHLAG-HKNIVTIKGAYEDS----LCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVGVVEAC  216 (363)
Q Consensus       143 ~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~----~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~l  216 (363)
                      ..+..+|...+..|.. .-.++..+++.+..    ...++|+|++++. +|.+.+......+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3467888888888762 12344555555442    2458999999874 7888887655577888899999999999999


Q ss_pred             HhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       217 H~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      |+.||+|+|++|.|||+..++....+.|+||+-+...
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999955444458999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.90  E-value=3.4e-08  Score=84.29  Aligned_cols=143  Identities=14%  Similarity=0.099  Sum_probs=99.6

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHHhcCC-CceeEEeEEEec----CCeEEEE
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLIS---REDVEDVRREIQIMHHLAGH-KNIVTIKGAYED----SLCVHIV  178 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~----~~~~~iv  178 (363)
                      -|+||-+.|+...  ..|..+-+|.-......+   +.....+.+|+..|.+|... -.++++......    .-.-+||
T Consensus        26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence            4678999999877  344468888764221111   23457889999999998721 124444422111    2246799


Q ss_pred             EeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          179 MELCAG-GELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       179 ~e~~~~-~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +|-+.| .+|.+++...  .+.+......++.+++.++.-||+.|+.|+|+-+.||++... ++..++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence            997744 4787777552  345778888999999999999999999999999999999421 123499999986653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.89  E-value=3.8e-08  Score=84.30  Aligned_cols=142  Identities=20%  Similarity=0.235  Sum_probs=92.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHH------HHHHHHHHHHHhc--CCCceeEEeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE------DVRREIQIMHHLA--GHKNIVTIKGA  168 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~------~~~~E~~~l~~l~--~h~niv~~~~~  168 (363)
                      +...|++.+++-......|.+-.  .+|..+++|....+....+....      ...+++..+.++.  +......++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            45668888888777777676655  77889999987654322221111      1234455455554  12233332222


Q ss_pred             E-----ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEE
Q 017960          169 Y-----EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       169 ~-----~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                      .     ......+++|||++|..|.+...    +++    .++..+.+++.-||+.|+.|+|..|.|+++   .++ .++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv---~~~-~i~  174 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV---SNN-GIR  174 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE---ECC-cEE
Confidence            2     22345678999999988865431    222    345667788999999999999999999999   433 499


Q ss_pred             EeecCccee
Q 017960          244 AIDFGLSVF  252 (363)
Q Consensus       244 l~DFG~a~~  252 (363)
                      ++||+....
T Consensus       175 iID~~~k~~  183 (229)
T PF06176_consen  175 IIDTQGKRM  183 (229)
T ss_pred             EEECccccc
Confidence            999986654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.80  E-value=3.9e-08  Score=95.42  Aligned_cols=143  Identities=20%  Similarity=0.223  Sum_probs=94.9

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccC--------------------------C-hhhH----H------HHH
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--------------------------S-REDV----E------DVR  147 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------~-~~~~----~------~~~  147 (363)
                      +.|+.++-|.||+|+. .+|+.||||+.++.-..                          . ...+    +      .+.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5799999999999996 55999999996532110                          0 0001    1      234


Q ss_pred             HHHHHHHHhc----CCCceeEEeEEEecCCeEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 017960          148 REIQIMHHLA----GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAAELTRIIVGV-VEACHSLG  220 (363)
Q Consensus       148 ~E~~~l~~l~----~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~~l~~~-l~~lH~~~  220 (363)
                      +|...+.+++    +.++|.-..-+++....-.++|||++|..+.+..  .. ..++.+.+   +..++.+ +.-+=..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence            4555555554    3455444444455566778999999998887763  33 33443333   3333332 23334589


Q ss_pred             cEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       221 iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++|.|.+|.||++   +.++.+.+.|||+....++
T Consensus       286 ffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence            9999999999999   7789999999999877654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.79  E-value=1.3e-07  Score=82.99  Aligned_cols=135  Identities=16%  Similarity=0.148  Sum_probs=84.4

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEeEEEecCCeEEEEEeccC
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      ..||+|..+.||+.    .+..+++|......     ....+.+|.++++.+.... .+.+++++....+...+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            46899999999984    24467888875422     2345788999999987332 25778888888888899999998


Q ss_pred             CCC-hH--------------HHH-------Hhc--CCCCHH-HHHHHHHHH----------HH-HHHHHH----hCCcEe
Q 017960          184 GGE-LF--------------DRI-------IQR--GHYSER-KAAELTRII----------VG-VVEACH----SLGVMH  223 (363)
Q Consensus       184 ~~~-L~--------------~~l-------~~~--~~~~~~-~~~~i~~~l----------~~-~l~~lH----~~~iiH  223 (363)
                      |.. +.              ..+       +.-  ...... ....+..++          .. ...+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 11              111       100  001111 011111111          11 112222    124789


Q ss_pred             cCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          224 RDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       224 rDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +|+.|.||++   ++++ +.|+||+.+..
T Consensus       158 gD~~~~Nii~---~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLIT---SGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEE---cCCC-cEEEechhcCc
Confidence            9999999999   6666 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.74  E-value=1.7e-07  Score=81.26  Aligned_cols=141  Identities=18%  Similarity=0.124  Sum_probs=94.1

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh--------------------hhHH-HHHHHHHHHHHhcC-CCce
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--------------------EDVE-DVRREIQIMHHLAG-HKNI  162 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--------------------~~~~-~~~~E~~~l~~l~~-h~ni  162 (363)
                      ..|++|--+.||+|. ..++..+|+|++......-.                    ..+. =..+|...|+++.. +-.+
T Consensus        54 g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            356777778899998 37788999999864322111                    0111 13567888887762 3445


Q ss_pred             eEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCcc
Q 017960          163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       163 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      ++.+++.    ...+||||+.....---..+.-.+...++..+..++++.+.-|-. .++||+||..-|||+   . ++.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~---~-~~~  204 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV---H-DGE  204 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE---E-CCe
Confidence            5555543    346999999443111001111223444788888888888887765 999999999999999   5 668


Q ss_pred             EEEeecCcceecC
Q 017960          242 LKAIDFGLSVFFK  254 (363)
Q Consensus       242 ~kl~DFG~a~~~~  254 (363)
                      +.|+|||-|....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999887654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.69  E-value=2.8e-07  Score=81.93  Aligned_cols=75  Identities=16%  Similarity=0.130  Sum_probs=55.1

Q ss_pred             ecccCC-eEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCC
Q 017960          107 LGQGQF-GTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG  185 (363)
Q Consensus       107 lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~  185 (363)
                      |-.|.. +.||++..  .+..+.||+.....      ...+.+|+.+++.+..+--+++++++....+..++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            445555 78999873  34688888775321      3456789999999976656778888877777789999999987


Q ss_pred             ChHH
Q 017960          186 ELFD  189 (363)
Q Consensus       186 ~L~~  189 (363)
                      ++..
T Consensus        78 ~l~~   81 (244)
T cd05150          78 PAAA   81 (244)
T ss_pred             cHhH
Confidence            7653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.67  E-value=1.7e-07  Score=96.16  Aligned_cols=203  Identities=20%  Similarity=0.157  Sum_probs=146.9

Q ss_pred             HHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE----EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 017960          144 EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL  219 (363)
Q Consensus       144 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~----iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~  219 (363)
                      .....|+..+.++. |+|++.++.+..+.....    +..|+|...++...+..-+..+....+.+..+++.||.|+|+.
T Consensus       227 ~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  227 QTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            34455677777787 999999998876544333    4457888899999999889999999999999999999999999


Q ss_pred             CcEecCCCCCceEeeeCCCCccEEEe--ecCcceecCCCCccccCccCCccccccccccc---CCCcccHHHHHHHHHHH
Q 017960          220 GVMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH---YGPEADVWTAGVILYIL  294 (363)
Q Consensus       220 ~iiHrDlkp~NIll~~~~~~~~~kl~--DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~Di~slG~il~el  294 (363)
                      ...|.-+...-..-...+..+.+.++  ||+.+..............+..+.+||.....   .....|+|.+|.++..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            66665554442222222566677777  99988877665555555566778888887643   33447999999999999


Q ss_pred             HhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       295 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ..|..+-..   ......+...          ....+..+++.+|+.-++++|+++.+++.|+++.
T Consensus       386 ~~~~~i~~~---~~~~~~~l~~----------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  386 SQGEDISEK---SAVPVSLLDV----------LSTSELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             hhcCccccc---ccchhhhhcc----------ccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            887655211   0111111110          1112678999999999999999999999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.65  E-value=1.6e-09  Score=104.22  Aligned_cols=183  Identities=19%  Similarity=0.200  Sum_probs=136.8

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc-eeEEeEEEecCCeEEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-IVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~~~iv~  179 (363)
                      |....-+++|+++++++.+...+...+ .+.+...        ....-++++|.+++ ||| .+..++-++.+...+++|
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHcc-CCCCcccccccCCcccccchhh
Confidence            444556889999999998865555444 6666432        34556889999997 999 777777778888999999


Q ss_pred             eccCCC-ChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          180 ELCAGG-ELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       180 e~~~~~-~L~~-~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      +++.++ +... .....-.+..-+...+.+.-+.+++++|+.-=+|||    ||+..    +...+..||+....+....
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcccCccc
Confidence            999777 2211 111111234445566667777889999998778999    88873    3578999999988776655


Q ss_pred             ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCC
Q 017960          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF  301 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf  301 (363)
                      ..+...+++.++|||+.. +.+....|+|++|.-..++.-|.+|-
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            566788999999999877 56999999999999878888777774

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.62  E-value=8.2e-07  Score=77.92  Aligned_cols=79  Identities=24%  Similarity=0.217  Sum_probs=56.6

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeEEE---ecCCeEEEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAY---EDSLCVHIVM  179 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~---~~~~~~~iv~  179 (363)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.|..+ .-+..++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            3579999999999999533  59999987532     4456788999999988744 2356666643   2344579999


Q ss_pred             eccCCCChHH
Q 017960          180 ELCAGGELFD  189 (363)
Q Consensus       180 e~~~~~~L~~  189 (363)
                      ++++|..+..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999887766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=3.9e-07  Score=74.90  Aligned_cols=132  Identities=26%  Similarity=0.298  Sum_probs=91.1

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      -++.+.||+|.+|.||+|.  ..|..+|+|+-..     ......+..|.++|..+.+-.--.+++.+..+    ++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEee--ccCceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            3456789999999999999  5566999997653     23456788999999999854445566665433    35699


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCC-CC-ceEeeeCCCCccEEEeecCcceecC
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLK-PE-NFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlk-p~-NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |+.|.+|.+.-...   +..+    ...++++---|-..||-|..|. |. ||++    .+..+.|+||..|+.-.
T Consensus        93 ~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k~  157 (201)
T COG2112          93 YIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhhcc
Confidence            99998886654321   2222    2344444445677899999886 33 5555    23379999999998543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.55  E-value=1.8e-06  Score=73.29  Aligned_cols=129  Identities=22%  Similarity=0.277  Sum_probs=90.9

Q ss_pred             cceeecceecccCC-eEEEEEEEccCCcEEEEEEeeccccC---------C--h-------hhHHHHHHHHHHHHHhc--
Q 017960           99 DLYTLGRKLGQGQF-GTTYLCTEIATGIEFACKSISKRKLI---------S--R-------EDVEDVRREIQIMHHLA--  157 (363)
Q Consensus        99 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~---------~--~-------~~~~~~~~E~~~l~~l~--  157 (363)
                      ..++.++.||.|+- |.||+++  ..|+.||+|++..-...         .  .       ....-|..|.....+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            45888999999999 9999998  67889999993210000         0  0       22345778888888776  


Q ss_pred             CCCce--eEEeEEEecC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 017960          158 GHKNI--VTIKGAYEDS------------------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH  217 (363)
Q Consensus       158 ~h~ni--v~~~~~~~~~------------------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH  217 (363)
                      ++.++  |+.+|+..-.                  ....||.||.+...         .++...    +.+|..-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            34555  8999987211                  12467888876543         223333    455666678899


Q ss_pred             hCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       218 ~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      +.||+-+|+++.|..=        -||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC--------CEEEecccC
Confidence            9999999999999763        589999965

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=9.1e-07  Score=85.82  Aligned_cols=143  Identities=18%  Similarity=0.210  Sum_probs=89.5

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCC----------------------------hhhHHH------HHHHH
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----------------------------REDVED------VRREI  150 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~~~------~~~E~  150 (363)
                      +.||.-+.|.||+|+.+. |+.||||+-++.-...                            .+..+.      |.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999654 9999999864322110                            011111      33333


Q ss_pred             HHHHHhc---CCCc------eeEEeEEEecCCeEEEEEeccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHH-HHHHh
Q 017960          151 QIMHHLA---GHKN------IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVV-EACHS  218 (363)
Q Consensus       151 ~~l~~l~---~h~n------iv~~~~~~~~~~~~~iv~e~~~~~~L~~--~l~~~~~~~~~~~~~i~~~l~~~l-~~lH~  218 (363)
                      +...+++   .|-+      |++++  +.-.....++||||+|..+.+  .+.+.+ ++...   ++..+.++. +-|=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHh
Confidence            3333332   1434      33333  233446789999999987644  344433 45553   334444432 23346


Q ss_pred             CCcEecCCCCCceEeeeC-CCCccEEEeecCcceecC
Q 017960          219 LGVMHRDLKPENFLLVNK-DDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       219 ~~iiHrDlkp~NIll~~~-~~~~~~kl~DFG~a~~~~  254 (363)
                      .|++|+|=+|.||++.++ ..++.+.+.|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            789999999999999642 357789999999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.50  E-value=6.9e-06  Score=70.19  Aligned_cols=134  Identities=22%  Similarity=0.292  Sum_probs=95.7

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeecccc-------------CChhhHHHHHHHHHHHHHhc-----CCCceeEEe
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-------------ISREDVEDVRREIQIMHHLA-----GHKNIVTIK  166 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~  166 (363)
                      ..||+|+.-.||.  + .......||+......             .......+..+|+.-...+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5799999999995  2 4455678998876540             01122455666666555554     378899999


Q ss_pred             EEEecCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          167 GAYEDSLCVHIVMELCAG------GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       167 ~~~~~~~~~~iv~e~~~~------~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      |+.+++....+|+|.+.+      .+|.+++.+ +.+++    .+...+-+...||-+++|+.+|++|.||++...++..
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998743      357776643 44555    3344445556788999999999999999997765555


Q ss_pred             -cEEEee
Q 017960          241 -SLKAID  246 (363)
Q Consensus       241 -~~kl~D  246 (363)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             788888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.44  E-value=3.1e-06  Score=88.13  Aligned_cols=81  Identities=22%  Similarity=0.312  Sum_probs=56.7

Q ss_pred             cceecccCCeEEEEEEEccCC--cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCce--eEEeEEEecC---CeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATG--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI--VTIKGAYEDS---LCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~~---~~~~  176 (363)
                      .+.++.|.++.+|+......+  ..+++|+......  ......+.+|..+++.|..|.+|  ++++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            467899999999998754332  4677776643221  11234678999999999655554  7777777654   4678


Q ss_pred             EEEeccCCCC
Q 017960          177 IVMELCAGGE  186 (363)
Q Consensus       177 iv~e~~~~~~  186 (363)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.29  E-value=6e-06  Score=72.99  Aligned_cols=73  Identities=18%  Similarity=0.133  Sum_probs=46.3

Q ss_pred             ceecccCCe-EEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC--CceeEEeEEEecC---CeEEEE
Q 017960          105 RKLGQGQFG-TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDS---LCVHIV  178 (363)
Q Consensus       105 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~---~~~~iv  178 (363)
                      +.|+.|+.. .||+..     ..+++|+....     .....+.+|.+++..|.++  --+..+++.....   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            457767666 599752     25777865431     1235788999999988743  1344555443332   235889


Q ss_pred             EeccCCCCh
Q 017960          179 MELCAGGEL  187 (363)
Q Consensus       179 ~e~~~~~~L  187 (363)
                      |++++|.++
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.18  E-value=1.9e-05  Score=69.71  Aligned_cols=76  Identities=13%  Similarity=0.200  Sum_probs=49.9

Q ss_pred             cceecccCCeEEEEEEEcc-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEecc
Q 017960          104 GRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      ++.|..|-...||++.... .+..|++|+.....   . ..-...+|+.++..+..+.-.++++..+..    .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---E-LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---c-ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence            3568888889999987432 35789999775321   1 112234688899888644445666554332    3799999


Q ss_pred             CCCCh
Q 017960          183 AGGEL  187 (363)
Q Consensus       183 ~~~~L  187 (363)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            88765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.17  E-value=4.9e-05  Score=71.88  Aligned_cols=80  Identities=15%  Similarity=0.146  Sum_probs=55.9

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccC----ChhhHHHHHHHHHHHHHhcCC--CceeEEeEEEecCCeEEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~iv  178 (363)
                      +.||.|.+..||++.....++.|+||.-......    .....++...|.+.|..+..+  ..+++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999997533358999985422110    123456788899988887543  457778776  34557899


Q ss_pred             EeccCCCC
Q 017960          179 MELCAGGE  186 (363)
Q Consensus       179 ~e~~~~~~  186 (363)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99997643

>PRK10593 hypothetical protein; Provisional

Probab=98.17  E-value=4.5e-05  Score=69.85  Aligned_cols=77  Identities=10%  Similarity=0.047  Sum_probs=56.3

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC--CceeEEeEEEec---CCeEEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYED---SLCVHIV  178 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~---~~~~~iv  178 (363)
                      .+.||.|..+.||.... .++ .+.+|..+.     ......+..|...|+.|..+  -.++++++++..   .+..+||
T Consensus        19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         19 VECISEQPYAALWALYD-SQG-NPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eeecCCccceeEEEEEc-CCC-CEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            46799999999999863 333 577777432     11235788999999999754  368888887754   3668999


Q ss_pred             EeccCCCCh
Q 017960          179 MELCAGGEL  187 (363)
Q Consensus       179 ~e~~~~~~L  187 (363)
                      ||+++|.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999988654

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.13  E-value=2.9e-06  Score=76.31  Aligned_cols=138  Identities=22%  Similarity=0.240  Sum_probs=98.4

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeec-----------------cccCChhh--HHHHHHHHHHHHHhcCCC
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK-----------------RKLISRED--VEDVRREIQIMHHLAGHK  160 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~-----------------~~~~~~~~--~~~~~~E~~~l~~l~~h~  160 (363)
                      .+.+++.||-|--+.||.+-+ ..|.+.++|+-+.                 +...+.-.  .-...+|...|+.|..|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            477889999999999999985 6788999986321                 11001111  124567999999887443


Q ss_pred             -ceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC
Q 017960          161 -NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       161 -niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~  239 (363)
                       -|++.++    .+.-++|||++.|..|...-+      ...+..+...+...+.-|..+|+||+|+.-=||++   +++
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd  238 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD  238 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence             2444444    456789999999888754321      22344555666677778899999999999999999   778


Q ss_pred             ccEEEeecCcce
Q 017960          240 FSLKAIDFGLSV  251 (363)
Q Consensus       240 ~~~kl~DFG~a~  251 (363)
                      ..++++||--..
T Consensus       239 ~~i~vIDFPQmv  250 (465)
T KOG2268|consen  239 DKIVVIDFPQMV  250 (465)
T ss_pred             CCEEEeechHhh
Confidence            889999997543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.09  E-value=2.7e-07  Score=96.71  Aligned_cols=207  Identities=20%  Similarity=0.131  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHHHhcCCCceeEEeEEEe--cCCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHH
Q 017960          143 VEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCVHIVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEAC  216 (363)
Q Consensus       143 ~~~~~~E~~~l~~l~~h~niv~~~~~~~--~~~~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~l  216 (363)
                      .+....|...++... |+++.....-..  +....++.++|+.+|.+++.+.+.-    .+...-+....++.+.+..-+
T Consensus      1273 kemll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             HHhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            444555555555666 998888766553  3445789999999999999987642    233444444445546666666


Q ss_pred             HhC-----CcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CCccccCccCCcccccccccc-cCCCcccHHHHHH
Q 017960          217 HSL-----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGV  289 (363)
Q Consensus       217 H~~-----~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~  289 (363)
                      |+.     -.+|+++|+.|.+|   ..+..+|++++|+.+...+ .......++++.|++|++..+ .++.++|+|..|+
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred             hhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            653     27899999999999   6677899999999994333 234455677889999999886 5888899999999


Q ss_pred             HHHHHHhCCCCCCCcCHHHHHHHHHcCCcc----cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          290 ILYILLSGVPPFWAETQQGIFDAVLKGHID----FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       290 il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+|++.-|..+|..     ..+.+.++...    +..+.  ..|.++-.....+|-+.-..||.-..++..+.+.
T Consensus      1429 ~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHhcccHHHHH-----HHHHHHcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            99999999888733     23333333221    11111  1234444455555666666788877777766554

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.08  E-value=1.5e-05  Score=67.82  Aligned_cols=100  Identities=21%  Similarity=0.246  Sum_probs=79.3

Q ss_pred             HHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 017960          147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR---IIQRGHYSERKAAELTRIIVGVVEACHS---LG  220 (363)
Q Consensus       147 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~---l~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~  220 (363)
                      ..|.-+++.+.+.+++++++|+|-    .++|.||...+++...   +.+-...++..+.+|+.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999986689999999882    2568899976666421   2222245899999999999999999987   45


Q ss_pred             cEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       221 iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      +.-.|++|+|+-+   ++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence            8889999999999   77889999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.04  E-value=3.1e-05  Score=69.37  Aligned_cols=134  Identities=20%  Similarity=0.157  Sum_probs=77.5

Q ss_pred             ecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCC
Q 017960          107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE  186 (363)
Q Consensus       107 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~  186 (363)
                      +..|-.+.+|+..  .++..+++|......   ....-...+|..+++.+..+.-.++++....    -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            5668888999887  556788898764321   1110124678999999874433345554432    268999998865


Q ss_pred             hHH--------------HH---HhcC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCcEecCCC
Q 017960          187 LFD--------------RI---IQRG----HYSE-RKAAELTRII---------VGVVEACHS--------LGVMHRDLK  227 (363)
Q Consensus       187 L~~--------------~l---~~~~----~~~~-~~~~~i~~~l---------~~~l~~lH~--------~~iiHrDlk  227 (363)
                      +..              .+   +...    +++. ..+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            421              11   1111    1111 1122222111         111222221        258999999


Q ss_pred             CCceEeeeCCCCccEEEeecCcceec
Q 017960          228 PENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       228 p~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      |.||++   ++++ +.|+||..|...
T Consensus       155 ~~Nil~---~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVV---TPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEE---eCCC-CEEEeccccCcC
Confidence            999999   4444 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.00  E-value=6.5e-05  Score=68.75  Aligned_cols=138  Identities=20%  Similarity=0.204  Sum_probs=82.9

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEeEE------EecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGA------YEDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~------~~~~~~~~  176 (363)
                      .+.|..|....+|+..  .++..+++|+...      .....+..|+.++..|..+- .+++++..      ....+..+
T Consensus        19 i~~i~~G~~n~~y~v~--~~~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          19 FEGISAGIENTNYFVT--TDSGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             eecccCccccceEEEE--eCCCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            4568888888999986  3445789998753      12345677888888886321 24454431      12345678


Q ss_pred             EEEeccCCCChHH----H---H-------Hhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 017960          177 IVMELCAGGELFD----R---I-------IQR-GHYSE--------RKAA------------ELTRIIVGVVEACHS---  218 (363)
Q Consensus       177 iv~e~~~~~~L~~----~---l-------~~~-~~~~~--------~~~~------------~i~~~l~~~l~~lH~---  218 (363)
                      +|+++++|..+..    .   +       +.. ..+..        ....            .....+..++.++.+   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999998866421    1   1       110 00000        0000            011122334444443   


Q ss_pred             ----CCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          219 ----LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       219 ----~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                          .+++|+|+.|.||++   +++..+.|+||+.+..
T Consensus       171 ~~~~~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~~  205 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLF---DGDELSGVIDFYFACT  205 (296)
T ss_pred             hcCCCcCCccCcCcccEEE---eCCceEEEeehhhhcC
Confidence                479999999999999   6666678999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.89  E-value=0.00011  Score=67.46  Aligned_cols=76  Identities=14%  Similarity=0.155  Sum_probs=49.8

Q ss_pred             ceecccCCeEEEEEEEcc------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960          105 RKLGQGQFGTTYLCTEIA------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|..|-...||++....      .++.+++|+.....    .......+|..++..+..+.-..++++.+..    .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence            456677778899887432      25789999875431    1223557788888888744444566665542    358


Q ss_pred             EeccCCCChH
Q 017960          179 MELCAGGELF  188 (363)
Q Consensus       179 ~e~~~~~~L~  188 (363)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.86  E-value=0.0002  Score=66.03  Aligned_cols=139  Identities=19%  Similarity=0.207  Sum_probs=80.9

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeEEE------ecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAY------EDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~------~~~~~~~  176 (363)
                      .+.++.|....||++.. .++ .+++|+.....  .   ...+..|+.++..|..+ -.+++++...      ...+..+
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            56678888889999873 344 67889775421  1   23455677888887522 1244444321      2245678


Q ss_pred             EEEeccCCCChH----H-------H---HHh-cCCCC--------HHHHH---------------HHHHHHHHHHHHHHh
Q 017960          177 IVMELCAGGELF----D-------R---IIQ-RGHYS--------ERKAA---------------ELTRIIVGVVEACHS  218 (363)
Q Consensus       177 iv~e~~~~~~L~----~-------~---l~~-~~~~~--------~~~~~---------------~i~~~l~~~l~~lH~  218 (363)
                      +++||++|..+.    .       .   ++. ...++        .....               .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999885431    1       1   111 00010        00000               001123334555532


Q ss_pred             -------CCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          219 -------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       219 -------~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                             .+++|+|+++.||++   ++++.+.|+||+.+..
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLF---DGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEE---ECCceEEEeecccccC
Confidence                   589999999999999   5556678999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.84  E-value=0.00026  Score=65.05  Aligned_cols=143  Identities=24%  Similarity=0.254  Sum_probs=95.3

Q ss_pred             ecceecccCCeEEEEEEEccCCcEEEEEEeeccccC----------------------ChhhHHH-HHHHHHHHHHhcCC
Q 017960          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----------------------SREDVED-VRREIQIMHHLAGH  159 (363)
Q Consensus       103 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~-~~~E~~~l~~l~~h  159 (363)
                      +..-|..|--+-||-|. ..+|..+|||+++..-+.                      .+..++- ...|+..|+++. .
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~  225 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-N  225 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-h
Confidence            44567888889999998 578889999997532211                      1111222 346888888887 3


Q ss_pred             CceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEecCCCCCceEeeeCCC
Q 017960          160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC-HSLGVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       160 ~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~l-H~~~iiHrDlkp~NIll~~~~~  238 (363)
                      ..|.-.--...  ..-.+||+++.......-..+.-.++...+..+-.+++.-+.-| |.+++||.||.--|+|+    .
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h  299 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H  299 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence            33322111111  12358999994332222223344577778888888888877665 67899999999999999    3


Q ss_pred             CccEEEeecCcceec
Q 017960          239 DFSLKAIDFGLSVFF  253 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~  253 (363)
                      +|.+.|+|-+-+...
T Consensus       300 dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEH  314 (520)
T ss_pred             CCEEEEEEccccccC
Confidence            678999999877654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.68  E-value=0.00047  Score=62.41  Aligned_cols=31  Identities=29%  Similarity=0.411  Sum_probs=24.9

Q ss_pred             CcEecCCCCCceEeeeCCCCc-cEEEeecCcceec
Q 017960          220 GVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFF  253 (363)
Q Consensus       220 ~iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~  253 (363)
                      .++|+|++|.|||+   ++++ ..-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv---~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILI---DEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEE---eCCCCEEEEECcHhcccC
Confidence            48999999999999   5434 4569999988763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK05231 homoserine kinase; Provisional

Probab=97.67  E-value=0.0014  Score=60.67  Aligned_cols=75  Identities=17%  Similarity=0.196  Sum_probs=45.0

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeE------EEecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKG------AYEDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~------~~~~~~~~~  176 (363)
                      .+.|+.|....+|+... .+| .+++|++. ..  .   .+.+..|+.++..|..+ -.+++++.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~~--~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFE-RL--T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEe-CCC-cEEEEEec-cC--C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            35577788889999873 333 78899874 11  2   23344566666666421 11333332      122355678


Q ss_pred             EEEeccCCCC
Q 017960          177 IVMELCAGGE  186 (363)
Q Consensus       177 iv~e~~~~~~  186 (363)
                      +++||++|..
T Consensus        99 ~l~~~l~G~~  108 (319)
T PRK05231         99 AIVTFLEGKW  108 (319)
T ss_pred             EEEEecCCCC
Confidence            9999998864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.66  E-value=0.00072  Score=62.82  Aligned_cols=77  Identities=14%  Similarity=0.052  Sum_probs=51.4

Q ss_pred             eecccCCeEEEEEEEccCCcEEEEEEeecccc----CChhhHHHHHHHHHHHHHhcCC-C-ceeEEeEEEecCCeEEEEE
Q 017960          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKL----ISREDVEDVRREIQIMHHLAGH-K-NIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~iv~  179 (363)
                      .||.|....||++.+...++.|+||.-.....    ...-...+...|...|+..... | .+++++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            47999999999999743336899997543221    1234456777888888876542 3 4556654  3445566899


Q ss_pred             eccCC
Q 017960          180 ELCAG  184 (363)
Q Consensus       180 e~~~~  184 (363)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.51  E-value=0.00086  Score=62.77  Aligned_cols=139  Identities=12%  Similarity=0.136  Sum_probs=82.0

Q ss_pred             ceecccCCeEEEEEEEcc----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      +.|-.|-...+|++....    .++.|++|+.....   ...+.+ ..|..+++.+..+.--.++++.+...    .|+|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e  113 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEE  113 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence            456568888999986422    34689999875432   222233 67888998887555555677766433    5789


Q ss_pred             ccCCCChHHH----------H-------HhcC------CCCHHHHHHHHHHH-----------------HHHHHHH----
Q 017960          181 LCAGGELFDR----------I-------IQRG------HYSERKAAELTRII-----------------VGVVEAC----  216 (363)
Q Consensus       181 ~~~~~~L~~~----------l-------~~~~------~~~~~~~~~i~~~l-----------------~~~l~~l----  216 (363)
                      |+++.++...          +       ++..      .....++..+..++                 ...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9987665311          1       1110      01122233332221                 1111112    


Q ss_pred             ----HhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          217 ----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       217 ----H~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                          +...++|+|+++.|||+.  ++++.+.|+||..|...
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASYN  232 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcccc
Confidence                123589999999999994  22467999999988653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.33  E-value=0.0025  Score=58.36  Aligned_cols=145  Identities=18%  Similarity=0.242  Sum_probs=82.2

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeEEEecCC--eEEEEEe
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSL--CVHIVME  180 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~--~~~iv~e  180 (363)
                      .+.+..|..-.+|....  +++.+++. .. .............+|..+++.+..- .-+...++.+.++.  ..|.||+
T Consensus        30 v~~~~~G~sn~t~~~~~--~~~~~vlR-~P-~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          30 VEEISGGWSNDTFRLGD--TGQKYVLR-KP-PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             eeeccCCcccceEEEec--CCceEEEe-cC-CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            34444454445555553  37788887 32 1222334456778899999887531 23344555565554  6799999


Q ss_pred             ccCCCCh---------H---------HHHHhc--------------CCCCHHHHHHHHHHH--------------HHHHH
Q 017960          181 LCAGGEL---------F---------DRIIQR--------------GHYSERKAAELTRII--------------VGVVE  214 (363)
Q Consensus       181 ~~~~~~L---------~---------~~l~~~--------------~~~~~~~~~~i~~~l--------------~~~l~  214 (363)
                      |++|..+         .         +.|..-              +.+...++..+..+.              .....
T Consensus       106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~  185 (321)
T COG3173         106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK  185 (321)
T ss_pred             EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence            9988322         1         111110              001111222222222              12244


Q ss_pred             HHHhC--------CcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          215 ACHSL--------GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       215 ~lH~~--------~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +++.+        .++|+|+++.||++   ++...+=|.||+++...++
T Consensus       186 Wl~~~~p~~~~~~~lvHGD~~~gNlii---~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         186 WLEANRPPWAGPPVLVHGDYRPGNLII---DPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHhcCCCcCCCceeeeCCcccCCEEE---eCCCeeEEEeccccccCCc
Confidence            55433        48999999999999   5555688999999987544

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.33  E-value=0.0018  Score=60.30  Aligned_cols=139  Identities=17%  Similarity=0.150  Sum_probs=78.8

Q ss_pred             ceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          105 RKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      +.|..|-...+|++.....   +..|++|+.....   .. .-.-.+|..+++.+..+.--+++++++. .+   +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---Ce-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence            4455577788998864332   3378899875432   11 1223568888888874444456666653 22   58899


Q ss_pred             cCCCChHH----------HH-------HhcC-C----C-CHHHHHHHHHHH----------------------HHHHHHH
Q 017960          182 CAGGELFD----------RI-------IQRG-H----Y-SERKAAELTRII----------------------VGVVEAC  216 (363)
Q Consensus       182 ~~~~~L~~----------~l-------~~~~-~----~-~~~~~~~i~~~l----------------------~~~l~~l  216 (363)
                      ++|..|..          .+       +... +    . ....+..+..++                      ..-+..+
T Consensus        92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  171 (330)
T PLN02421         92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL  171 (330)
T ss_pred             hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence            97765421          11       1111 0    1 122232222222                      1111111


Q ss_pred             ----HhC----CcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          217 ----HSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       217 ----H~~----~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                          ...    -++|.|+.+.|||+.  ++++.++++||..|...
T Consensus       172 ~~~~~~~~~~~v~CHnDl~~~NiL~~--~~~~~l~lID~EYag~n  214 (330)
T PLN02421        172 KEITDSLKAPVVFAHNDLLSGNLMLN--EDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HHHhccCCCCeEEEECCCCcccEEEe--CCCCcEEEEcccccCCC
Confidence                111    279999999999994  23467999999988653

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.27  E-value=0.0045  Score=58.61  Aligned_cols=77  Identities=12%  Similarity=0.064  Sum_probs=52.8

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCC----hhhHHHHHHHHHHHHHhcCC--CceeEEeEEEecCCeEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~i  177 (363)
                      .+.||.|....||+..+  .+..++||.-.......    .....+...|...|+.+...  ..+++++.++.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            46789999999999885  34569999765322211    12456666777777766522  478888887663  4568


Q ss_pred             EEeccCC
Q 017960          178 VMELCAG  184 (363)
Q Consensus       178 v~e~~~~  184 (363)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999976

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.20  E-value=0.0011  Score=63.44  Aligned_cols=164  Identities=20%  Similarity=0.178  Sum_probs=102.5

Q ss_pred             HHHHHHHHHHHHhcCCCceeEEeEEEecC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcE
Q 017960          144 EDVRREIQIMHHLAGHKNIVTIKGAYEDS-LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM  222 (363)
Q Consensus       144 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ii  222 (363)
                      .++.-..++++.+. |+|...++++-... ....+|||++ +.+|.+.+..+. +-.....                  .
T Consensus        27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~   85 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A   85 (725)
T ss_pred             HHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence            34556677888887 99999999877543 3478899999 779988876543 2111110                  2


Q ss_pred             ecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCC
Q 017960          223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFW  302 (363)
Q Consensus       223 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~  302 (363)
                      |+= -+-||          ++++| -++..   .   ....               .+++||||+|.++.++.-|...|.
T Consensus        86 ~~~-~~~~~----------~~~td-~~~t~---~---~~~~---------------~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   86 HGV-LHLNI----------IYITD-HFLTK---Y---PSPI---------------GPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             ccc-ceehh----------hhccc-ccccc---C---CCCC---------------CcchhhhhHHHHHHHHHHhhHHHH
Confidence            221 11122          23333 11100   0   1111               249999999999999999988876


Q ss_pred             CcCHHHHHHHHHcCCcccCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          303 AETQQGIFDAVLKGHIDFESD--------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       303 ~~~~~~~~~~i~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .....+..+.+.+-.......        ..-.++.....++.+|+-..|..||...++.++.-|.+
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e  199 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE  199 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence            655555555444422111000        00135667789999999999999999888888776643

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.15  E-value=0.0039  Score=58.80  Aligned_cols=79  Identities=15%  Similarity=0.148  Sum_probs=54.0

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccC---ChhhHHHHHHHHHHHHHhcCC-C-ceeEEeEEEecCCeEEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SREDVEDVRREIQIMHHLAGH-K-NIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~iv  178 (363)
                      .+.||.|.-.-||++.+...+..|+||.-......   ..-..++...|...|+.+... | .+++++.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            45789999999999997433567999975322211   234467888899988877532 3 4666664  344556789


Q ss_pred             EeccCC
Q 017960          179 MELCAG  184 (363)
Q Consensus       179 ~e~~~~  184 (363)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.11  E-value=0.0022  Score=58.29  Aligned_cols=74  Identities=15%  Similarity=0.120  Sum_probs=49.6

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEecCCeEEEEEec
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      .+.+|.|....+|+..  .+++.+.||+-...      ....+..|..-|+.|.  .--.+++++++....+..++||||
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            4678999999999988  78889999987522      2356788888888884  245688899988877778999999


Q ss_pred             cCCC
Q 017960          182 CAGG  185 (363)
Q Consensus       182 ~~~~  185 (363)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.09  E-value=0.012  Score=54.12  Aligned_cols=30  Identities=33%  Similarity=0.495  Sum_probs=24.9

Q ss_pred             CCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       219 ~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      .+++|+|+.+.||++   +. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~---~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILL---KD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEE---eC-CcEEEEECccccc
Confidence            478999999999999   44 4588999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.90  E-value=0.025  Score=52.50  Aligned_cols=72  Identities=14%  Similarity=0.047  Sum_probs=43.5

Q ss_pred             cCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEe---E--EEecCCeEEEEEeccC
Q 017960          110 GQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIK---G--AYEDSLCVHIVMELCA  183 (363)
Q Consensus       110 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~---~--~~~~~~~~~iv~e~~~  183 (363)
                      +.-..||+.. ..++..+++|+.....    .....+..|+..+..|..+. .++...   |  ....++..+.++++++
T Consensus        36 s~eN~vy~v~-~~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFG-DEDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEe-cCCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            3446789887 3566789999875321    23456677888888876321 122211   1  1233466788999998


Q ss_pred             CCC
Q 017960          184 GGE  186 (363)
Q Consensus       184 ~~~  186 (363)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.81  E-value=0.0039  Score=53.98  Aligned_cols=56  Identities=18%  Similarity=0.135  Sum_probs=33.5

Q ss_pred             CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCCh
Q 017960          124 GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL  187 (363)
Q Consensus       124 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~L  187 (363)
                      ++.|+|++....    ....-.-..|..+++.+..+-.-+++++.+..+    .|+||++|..|
T Consensus         2 ~~~~~~Ri~g~~----t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEG----TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESC----GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred             CCEEEEEeCCCC----cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence            457888887653    123345567888888887555556777765433    57799876543

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.72  E-value=0.0076  Score=56.45  Aligned_cols=62  Identities=16%  Similarity=0.157  Sum_probs=44.3

Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEecCCCCCceEeeeC
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-CHSLGVMHRDLKPENFLLVNK  236 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~-lH~~~iiHrDlkp~NIll~~~  236 (363)
                      ...++-+|..|.++..++...+ .++.....++.-...|+-- +--.+++|.|+.|.||++..+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            3456777888888888776543 3555666777666666543 344579999999999999653

>PTZ00384 choline kinase; Provisional

Probab=96.66  E-value=0.017  Score=54.82  Aligned_cols=76  Identities=20%  Similarity=0.187  Sum_probs=47.0

Q ss_pred             cceecccCCeEEEEEEEccC-CcE-----EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIAT-GIE-----FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~-~~~-----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|..|-...+|++..... +..     |.+.....    .....-.-.+|+.+++.|..+..-.++++.+..    ++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~  126 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT  126 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence            34565688889999874332 122     33333211    111111235689999999866667778777653    58


Q ss_pred             EEeccCCCCh
Q 017960          178 VMELCAGGEL  187 (363)
Q Consensus       178 v~e~~~~~~L  187 (363)
                      +.||++|.+|
T Consensus       127 l~efIeGr~l  136 (383)
T PTZ00384        127 IQEWVEGNTM  136 (383)
T ss_pred             EEEEeccccC
Confidence            9999988765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.65  E-value=0.043  Score=50.54  Aligned_cols=30  Identities=27%  Similarity=0.368  Sum_probs=26.9

Q ss_pred             CcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       220 ~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +++|+|+.+.|||+   ++++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence            79999999999999   7777899999998865

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.15  E-value=0.029  Score=51.91  Aligned_cols=105  Identities=14%  Similarity=0.205  Sum_probs=70.8

Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       170 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      .+..+.|++|++- |+++.- +   ......++..++.+.+..++-+..+ .+=|||+...||||   + +|.|.|+||-
T Consensus       296 de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfk  366 (488)
T COG5072         296 DETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFK  366 (488)
T ss_pred             CCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEee
Confidence            3445678888885 666532 2   2235788888888888877776654 58899999999999   6 8899999999


Q ss_pred             cceecCCCCccccCccCCcccccccccccCCCcccHHHH
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTA  287 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~sl  287 (363)
                      +++...+..    .+.....-.|-.+.+.-+.+-+||-+
T Consensus       367 lsRl~~~q~----~isy~rldhp~lF~G~dd~QFeIYrl  401 (488)
T COG5072         367 LSRLSYSQG----IISYNRLDHPDLFNGVDDYQFEIYRL  401 (488)
T ss_pred             eeecccCCc----eeeccccCchhhhcCccceeeeHHHH
Confidence            998533222    11122334455555544666677664

>PRK06148 hypothetical protein; Provisional

Probab=96.13  E-value=0.091  Score=56.32  Aligned_cols=78  Identities=15%  Similarity=0.228  Sum_probs=44.6

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC------CceeEEe-E----EEec-C
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH------KNIVTIK-G----AYED-S  172 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h------~niv~~~-~----~~~~-~  172 (363)
                      +.|+ |..-.+|+.. ..++..+++|+.....     ....+..|...|..|..+      |.++.-. +    .... .
T Consensus        31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~  103 (1013)
T PRK06148         31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD  103 (1013)
T ss_pred             eecC-CcCCceEEEE-eCCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence            4564 4457788877 3567789999986432     123344566667666532      2333221 1    1111 2


Q ss_pred             C--eEEEEEeccCCCChHH
Q 017960          173 L--CVHIVMELCAGGELFD  189 (363)
Q Consensus       173 ~--~~~iv~e~~~~~~L~~  189 (363)
                      +  ..+.+++|++|..+.+
T Consensus       104 G~~~~vrLl~~l~G~~l~~  122 (1013)
T PRK06148        104 GEPRLLRLLSWLPGTPLAE  122 (1013)
T ss_pred             CceEEEEEEeccCCCcHHh
Confidence            2  4677899999876644

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.05  E-value=0.085  Score=45.87  Aligned_cols=75  Identities=16%  Similarity=0.152  Sum_probs=51.7

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcC--CCceeEEeEEEecCCeEEEEEecc
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      +.+..|.--..|...  .....+.||.=      ..+....+..|+.-|..+..  --.+.+++.+.....+.|+||||+
T Consensus        22 ~~v~gG~inea~~v~--dg~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L   93 (286)
T COG3001          22 EEVSGGDINEAWRLR--DGTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL   93 (286)
T ss_pred             cccCCccccceeEee--cCCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence            345445545555544  23346778754      34455778888888877762  346888999999999999999999


Q ss_pred             CCCCh
Q 017960          183 AGGEL  187 (363)
Q Consensus       183 ~~~~L  187 (363)
                      +-+.+
T Consensus        94 ~~~~~   98 (286)
T COG3001          94 PTGPL   98 (286)
T ss_pred             cCCCC
Confidence            87554

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.92  E-value=0.14  Score=47.41  Aligned_cols=136  Identities=20%  Similarity=0.277  Sum_probs=77.6

Q ss_pred             eecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC--c---eeEEeEEE--ecC--CeEE
Q 017960          106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK--N---IVTIKGAY--EDS--LCVH  176 (363)
Q Consensus       106 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--n---iv~~~~~~--~~~--~~~~  176 (363)
                      .|.+ .-..||+... .+|.. ++|+....     .....+..|+..+..|..+.  -   +...-|-.  .-.  ...+
T Consensus        33 ~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a  104 (331)
T COG2334          33 GLNS-EENSNFRVQT-EDGRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA  104 (331)
T ss_pred             cccc-ccCceEEEEe-cCCCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence            3444 4567998883 44444 99988653     23456777888888887331  1   22222211  112  3778


Q ss_pred             EEEeccCCCChHH-----HH----------Hh-cCC-----------CCHH----H---------HHHHHHHHHHHHHHH
Q 017960          177 IVMELCAGGELFD-----RI----------IQ-RGH-----------YSER----K---------AAELTRIIVGVVEAC  216 (363)
Q Consensus       177 iv~e~~~~~~L~~-----~l----------~~-~~~-----------~~~~----~---------~~~i~~~l~~~l~~l  216 (363)
                      -+++|++|..+..     ++          +. ...           ..+.    .         -.....++...++.+
T Consensus       105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~  184 (331)
T COG2334         105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL  184 (331)
T ss_pred             EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence            8999998876651     11          10 000           1111    0         011122333334444


Q ss_pred             Hh--------CC--cEecCCCCCceEeeeCCCCc-cEEEeecCccee
Q 017960          217 HS--------LG--VMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVF  252 (363)
Q Consensus       217 H~--------~~--iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~  252 (363)
                      .+        .+  +||+|+.|.||++   +.+. .+-++|||-+..
T Consensus       185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         185 LARLPAHLPALGDQIIHGDLHPDNVLF---DDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HhhchhhCCcccceeeecCCCccceeE---cCCCCeeeEEEcccccc
Confidence            32        34  9999999999999   5544 488999997754

>PTZ00296 choline kinase; Provisional

Probab=95.73  E-value=0.11  Score=50.29  Aligned_cols=76  Identities=9%  Similarity=0.054  Sum_probs=46.7

Q ss_pred             cceecccCCeEEEEEEEcc--------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960          104 GRKLGQGQFGTTYLCTEIA--------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++.|..|-.-.+|++....        .++.|.+++.....   .... .-..|..+++.+..+.--.++++.+. +   
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g---  181 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G---  181 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C---
Confidence            4567778788899987432        14678898875432   1112 23457778777774433345666553 2   


Q ss_pred             EEEEeccCCCCh
Q 017960          176 HIVMELCAGGEL  187 (363)
Q Consensus       176 ~iv~e~~~~~~L  187 (363)
                      +.|.||++|.+|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            357899987644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	363
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-57
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-57
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-57
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-57
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-57
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-56
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-56
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-53
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-53
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-52
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-52
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-52
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-52
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-52
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-52
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-51
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-51
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-50
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-50
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-50
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-50
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-49
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-49
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-48
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-48
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-48
3soa_A	444	Full-Length Human Camkii Length = 444		6e-48
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-48
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-48
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-48
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-48
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-48
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-48
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-47
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-47
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-47
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-47
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-47
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-47
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-47
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-47
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-47
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-47
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-47
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-47
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-47
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-47
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-47
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-47
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-46
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-46
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-46
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-46
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-45
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-45
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-45
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-44
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-44
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-42
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-41
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-40
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-39
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-39
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-39
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-39
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-38
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-38
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-38
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-38
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-38
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-38
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-38
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-38
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-38
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-38
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-38
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-38
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-38
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-38
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-38
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-37
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-37
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-37
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-37
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-36
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-36
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-36
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-35
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-35
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-35
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-35
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-35
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-35
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-35
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-35
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-35
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-35
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-35
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-35
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-35
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-35
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-35
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-35
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-35
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-35
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-34
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-34
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-34
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-34
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-33
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-33
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-33
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-33
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-33
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-33
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-33
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-32
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-32
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-32
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-32
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-32
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-32
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-32
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-32
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-32
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-32
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-32
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-32
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-32
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-32
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-32
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-32
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-32
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-32
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-32
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-31
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-31
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-31
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-31
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-31
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-31
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-31
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-31
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-31
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-31
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-31
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-31
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-31
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-31
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-31
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-31
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-31
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-31
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-31
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-31
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-31
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-31
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-31
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-31
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-31
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-31
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-31
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-31
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-31
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-31
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-31
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-31
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-31
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-31
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-31
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-31
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-31
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-31
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-30
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-30
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-30
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-30
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-30
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-30
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-30
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-30
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-30
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-30
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-30
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-30
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-30
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-30
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-30
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-30
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-30
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-30
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-30
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-30
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-30
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-30
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-30
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-30
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-30
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-30
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-30
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-30
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-30
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-30
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-30
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-30
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-30
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-30
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-30
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-30
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-29
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-29
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-29
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-29
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-29
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-29
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-29
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-29
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-29
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-29
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-29
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-29
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-29
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-29
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-29
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-29
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-29
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-29
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-29
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-29
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-29
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-28
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-28
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-28
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-27
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-27
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-27
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-27
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-27
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-27
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-27
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-27
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-27
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-27
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-26
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-26
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-26
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-26
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-26
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-26
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-26
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-25
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-25
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-25
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-25
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-25
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-25
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-25
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-25
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-25
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-25
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-25
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-24
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-24
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-24
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-24
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-24
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-24
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-24
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-23
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-23
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-23
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-23
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-23
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-22
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-22
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-22
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-21
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-21
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-21
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-21
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-21
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-21
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-21
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-21
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-21
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-21
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-21
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-21
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-21
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-21
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-21
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-21
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-21
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-21
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-21
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-21
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-20
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-20
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-20
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-20
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-20
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-20
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-20
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-20
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-20
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-20
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-19
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-19
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-19
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-19
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-17
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-17
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-17
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-16
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-16
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-16
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-16
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-15
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-15
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-15
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-15
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-15
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-14
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-14
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-14
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-14
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-14
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-14
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-14
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-14
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-14
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-14
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-14
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-14
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-14
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-14
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		6e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-14
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-12
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		9e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		9e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-11
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-11
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-11
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		7e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		7e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		8e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		8e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-11
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		9e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-09
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-08
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-08
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-08
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		5e-08
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		6e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-04
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-04
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-04
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-04
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-04
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-04
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-04

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 117/263 (44%), Positives = 156/263 (59%), Gaps = 1/263 (0%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 79  LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 198 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKDLIRKML   PS R++A + L
Sbjct: 258 AKDLIRKMLTYVPSMRISARDAL 280

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 117/263 (44%), Positives = 156/263 (59%), Gaps = 1/263 (0%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 42  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 101
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 102 LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 160
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 161 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 220
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 221 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 280
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKDLIRKML   PS R++A + L
Sbjct: 281 AKDLIRKMLTYVPSMRISARDAL 303

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 117/263 (44%), Positives = 156/263 (59%), Gaps = 1/263 (0%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 43  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 102
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 103 LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 161
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 162 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 221
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 222 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 281
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKDLIRKML   PS R++A + L
Sbjct: 282 AKDLIRKMLTYVPSMRISARDAL 304

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  219 bits (557), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 117/263 (44%), Positives = 156/263 (59%), Gaps = 1/263 (0%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 25  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 84
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 85  LLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 143
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 144 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 203
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 204 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 263
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKDLIRKML   PS R++A + L
Sbjct: 264 AKDLIRKMLTYVPSMRISARDAL 286

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  218 bits (556), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 159/270 (58%), Gaps = 4/270 (1%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +  Y  G    +I   YTL   +G+G +G   +  +  T I  A K I K  +   EDV+
Sbjct: 12  ENLYFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVD 68
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
             ++EI+IM  L  H NI+ +   +ED+  +++VMELC GGELF+R++ +  + E  AA 
Sbjct: 69  RFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR 127
Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + + ++  V  CH L V HRDLKPENFL +    D  LK IDFGL+  FKPG++    VG
Sbjct: 128 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 187
Query: 265 SPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           +PYYV+P+VL   YGPE D W+AGV++Y+LL G PPF A T   +   + +G   F    
Sbjct: 188 TPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKD 247
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           W  +S  A+ LIR++L   P +R+T+ + L
Sbjct: 248 WLNVSPQAESLIRRLLTKSPKQRITSLQAL 277

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  216 bits (551), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 108/264 (40%), Positives = 157/264 (59%), Gaps = 4/264 (1%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
           G    +I   YTL   +G+G +G   +  +  T I  A K I K  +   EDV+  ++EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +IM  L  H NI+ +   +ED+  +++VMELC GGELF+R++ +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             V  CH L V HRDLKPENFL +    D  LK IDFGL+  FKPG++    VG+PYYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 271 PEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           P+VL   YGPE D W+AGV++Y+LL G PPF A T   +   + +G   F    W  +S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSP 236
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
            A+ LIR++L   P +R+T+ + L
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQAL 260

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  216 bits (550), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 116/263 (44%), Positives = 154/263 (58%), Gaps = 1/263 (0%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + RE+Q
Sbjct: 19  HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI  +   +ED    ++V E+  GGELFD II R  +SE  AA + R ++ 
Sbjct: 79  LLKQL-DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY+AP
Sbjct: 138 GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAP 197
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +S+S
Sbjct: 198 EVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKDLIRK L   PS R++A + L
Sbjct: 258 AKDLIRKXLTYVPSXRISARDAL 280

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 110/248 (44%), Positives = 147/248 (59%), Gaps = 2/248 (0%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG    C +  T  E+A K I+K    ++ D   + RE++++  L  H NI+ + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-DHPNIMKLF 87
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
              EDS   +IV EL  GGELFD II+R  +SE  AA + + +   +   H   ++HRDL
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWT 286
           KPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+APEVL   Y  + DVW+
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWS 207
Query: 287 AGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSE 346
           AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD AKDLIRKML   PS 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 347 RLTAHEVL 354
           R+TA + L
Sbjct: 268 RITATQCL 275

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 104/262 (39%), Positives = 155/262 (59%), Gaps = 4/262 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++I+ ++     LG G F    L  E ATG  FA K I K+ L  +E    +  EI +
Sbjct: 16  QAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES--SIENEIAV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  +  H+NIV ++  YE    +++VM+L +GGELFDRI+++G Y+E+ A+ L R ++  
Sbjct: 74  LRKIK-HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA 132
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V   H +G++HRDLKPEN L  ++D++  +   DFGLS     G + +   G+P YVAPE
Sbjct: 133 VYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE 192
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDS 252
Query: 332 AKDLIRKMLCSQPSERLTAHEV 353
           AKD IR ++   P++R T  + 
Sbjct: 253 AKDFIRNLMEKDPNKRYTCEQA 274

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 111/254 (43%), Positives = 149/254 (58%), Gaps = 2/254 (0%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +  T  E+A K I+K    ++ D   + RE++++  L  H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-DHP 81
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +   +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP 280
           ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+APEVL   Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
           + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD AKDLIRKML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 341 CSQPSERLTAHEVL 354
              PS R+TA + L
Sbjct: 262 TFHPSLRITATQCL 275

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 111/254 (43%), Positives = 149/254 (58%), Gaps = 2/254 (0%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +  T  E+A K I+K    ++ D   + RE++++  L  H 
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL-DHP 81
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +   +   H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP 280
           ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+APEVL   Y  
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE 201
Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
           + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD AKDLIRKML
Sbjct: 202 KCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKML 261
Query: 341 CSQPSERLTAHEVL 354
              PS R+TA + L
Sbjct: 262 TFHPSLRITATQCL 275

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  203 bits (516), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 153/263 (58%), Gaps = 4/263 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K+ L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKD IR ++   P +R T  + L
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  202 bits (514), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 152/263 (57%), Gaps = 4/263 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K  L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKD IR ++   P +R T  + L
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  202 bits (514), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 152/263 (57%), Gaps = 4/263 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K  L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKD IR ++   P +R T  + L
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 107/263 (40%), Positives = 152/263 (57%), Gaps = 4/263 (1%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K  L  +E    +  EI +
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG--SMENEIAV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 70  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 128
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 129 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 188
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKD IR ++   P +R T  + L
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 106/258 (41%), Positives = 149/258 (57%), Gaps = 1/258 (0%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y   +KLG G +G   LC +  TG E A K I K  + +  +   +  E+ ++  L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NI+ +   +ED    ++VME+  GGELFD II R  +SE  AA + + ++      
Sbjct: 62  -DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H   ++HRDLKPEN LL +K  D  +K +DFGLS  F+ G    + +G+ YY+APEVL K
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y  + DVW+ GVILYILL G PPF  +T Q I   V KG   F+   W  +SD AK L+
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 337 RKMLCSQPSERLTAHEVL 354
           + ML  +PS+R++A E L
Sbjct: 241 KLMLTYEPSKRISAEEAL 258

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  200 bits (508), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 106/258 (41%), Positives = 149/258 (57%), Gaps = 1/258 (0%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + D Y   +KLG G +G   LC +  TG E A K I K  + +  +   +  E+ ++  L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H NI+ +   +ED    ++VME+  GGELFD II R  +SE  AA + + ++      
Sbjct: 79  -DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H   ++HRDLKPEN LL +K  D  +K +DFGLS  F+ G    + +G+ YY+APEVL K
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 197
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y  + DVW+ GVILYILL G PPF  +T Q I   V KG   F+   W  +SD AK L+
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 257
Query: 337 RKMLCSQPSERLTAHEVL 354
           + ML  +PS+R++A E L
Sbjct: 258 KLMLTYEPSKRISAEEAL 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  195 bits (496), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 106/261 (40%), Positives = 154/261 (59%), Gaps = 4/261 (1%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y L   +G+G F     C ++ TG E+A K I+ +KL +R D + + RE +I   
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSAR-DHQKLEREARICR- 58
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+   + I+  V  
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVL 274
           CH +GV+HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK
Sbjct: 179 RKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           +LI +ML   P++R+TAHE L
Sbjct: 239 NLINQMLTINPAKRITAHEAL 259

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  194 bits (494), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 108/261 (41%), Positives = 153/261 (58%), Gaps = 4/261 (1%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y L  +LG+G F     C +I TG E+A K I+ +KL +R D + + RE +I   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR-DHQKLEREARICR- 58
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+   + I+  V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVL 274
           CH  G++HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           DLI KML   P++R+TA E L
Sbjct: 239 DLINKMLTINPAKRITASEAL 259

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  194 bits (494), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 106/263 (40%), Positives = 156/263 (59%), Gaps = 6/263 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           +T NIR  +     LG G F   +L  +  TG  FA K I K        +E+   EI +
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAV 59
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  +  H+NIVT++  YE +   ++VM+L +GGELFDRI++RG Y+E+ A+ + + ++  
Sbjct: 60  LKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H  G++HRDLKPEN L +  +++  +   DFGLS   + G I +   G+P YVAPE
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPE 177
Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ ET+  +F+ + +G+ +FES  W  IS+S
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKD I  +L   P+ER T  + L
Sbjct: 238 AKDFICHLLEKDPNERYTCEKAL 260

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  194 bits (492), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 108/267 (40%), Positives = 155/267 (58%), Gaps = 4/267 (1%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG +    + +Y L  +LG+G F     C ++  G E+A K I+ +KL +R D + + RE
Sbjct: 13  LGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSAR-DHQKLERE 71
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
            +I   L  H NIV +  +  +    +++ +L  GGELF+ I+ R +YSE  A+   + I
Sbjct: 72  ARICR-LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 130
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYY 268
           +  V  CH +GV+HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y
Sbjct: 131 LEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 190
Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           ++PEVL K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT 250
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
           ++  AKDLI KML   PS+R+TA E L
Sbjct: 251 VTPEAKDLINKMLTINPSKRITAAEAL 277

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 103/262 (39%), Positives = 152/262 (58%), Gaps = 2/262 (0%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K  ++ ++Y   +KLG G +G   LC +  T +E A K I K   +S      +  E+ +
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAV 89
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  L  H NI+ +   +ED    ++VME   GGELFD II R  ++E  AA + + ++  
Sbjct: 90  LK-LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V   H   ++HRDLKPEN LL +K+ D  +K +DFGLS  F+  +   + +G+ YY+APE
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208
Query: 273 VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           VL K Y  + DVW+ GVIL+ILL+G PPF  +T Q I   V KG   F+S  W  +S+ A
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           KDLI++ML      R++A + L
Sbjct: 269 KDLIKQMLQFDSQRRISAQQAL 290

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  193 bits (490), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 108/261 (41%), Positives = 153/261 (58%), Gaps = 4/261 (1%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y L  +LG+G F     C +I TG E+A K I+ +KL +R D + + RE +I   
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR-DHQKLEREARICR- 58
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+   + I+  V  
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVL 274
           CH  G++HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL 178
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK
Sbjct: 179 RKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           DLI KML   P++R+TA E L
Sbjct: 239 DLINKMLTINPAKRITASEAL 259

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 100/257 (38%), Positives = 146/257 (56%), Gaps = 3/257 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 86
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 338 KMLCSQPSERLTAHEVL 354
            ML   P +R+TA + L
Sbjct: 267 SMLTVNPKKRITADQAL 283

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 104/256 (40%), Positives = 149/256 (58%), Gaps = 4/256 (1%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L  +LG+G F     C ++  G E+A   I+ +KL +R D + + RE +I   L  H 
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICR-LLKHP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +  +  +    +++ +L  GGELF+ I+ R +YSE  A+   + I+  V  CH +G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HR+LKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL K  Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           G   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AKDLI K
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250
Query: 339 MLCSQPSERLTAHEVL 354
           ML   PS+R+TA E L
Sbjct: 251 MLTINPSKRITAAEAL 266

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 111/294 (37%), Positives = 157/294 (53%), Gaps = 11/294 (3%)
Query: 71  PSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK 130
            S ++N+  +GI       +  K   I + Y   RKLG G +G   LC E     E A K
Sbjct: 8   SSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIK 67
Query: 131 SISKRKL----ISREDV------EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
            I K +      S ++       E++  EI ++  L  H NI+ +   +ED    ++V E
Sbjct: 68  VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYLVTE 126
Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
              GGELF++II R  + E  AA + + I+  +   H   ++HRD+KPEN LL NK+   
Sbjct: 127 FYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186
Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP 300
           ++K +DFGLS FF       D +G+ YY+APEVL K Y  + DVW+ GVI+YILL G PP
Sbjct: 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP 246
Query: 301 FWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           F  +  Q I   V KG   F+ + W  ISD AK+LI+ ML    ++R TA E L
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 100/257 (38%), Positives = 146/257 (56%), Gaps = 3/257 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 63
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 338 KMLCSQPSERLTAHEVL 354
            ML   P +R+TA + L
Sbjct: 244 SMLTVNPKKRITADQAL 260

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 61
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 62  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 61
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 62  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 100/257 (38%), Positives = 146/257 (56%), Gaps = 3/257 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 62
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 242
Query: 338 KMLCSQPSERLTAHEVL 354
            ML   P +R+TA + L
Sbjct: 243 SMLTVNPKKRITADQAL 259

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 100/257 (38%), Positives = 146/257 (56%), Gaps = 3/257 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +  +LG+G F     C    TG+EFA K I+ +KL +R D + + RE +I   L  
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ- 63
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +  CHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEVL K  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  AK LI 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 338 KMLCSQPSERLTAHEVL 354
            ML   P +R+TA + L
Sbjct: 244 SMLTVNPKKRITADQAL 260

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 105/270 (38%), Positives = 151/270 (55%), Gaps = 8/270 (2%)
Query: 87  YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           Y++ G   D + D + +  +LG+G     Y C +  T   +A K + K       D + V
Sbjct: 41  YWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIV 95
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           R EI ++  L+ H NI+ +K  +E    + +V+EL  GGELFDRI+++G+YSER AA+  
Sbjct: 96  RTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + I+  V   H  G++HRDLKPEN L      D  LK  DFGLS   +   +   V G+P
Sbjct: 155 KQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214
Query: 267 YYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP 324
            Y APE+L    YGPE D+W+ G+I YILL G  PF+ E   Q +F  +L     F S  
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           W  +S +AKDL+RK++   P +RLT  + L
Sbjct: 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 156/267 (58%), Gaps = 6/267 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK-LISREDV--EDVRRE 149
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+   SR  V  E++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           + I+  +  H NI+T+   YE+   V +++EL +GGELFD + Q+   SE +A    + I
Sbjct: 66  VSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + +  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            S+ AKD IRK+L  +  +RLT  E L
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 157/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S+ AKD IRK+L  +  +RLT  E L
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 157/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S+ AKD IRK+L  +  +RLT  E L
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 157/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S+ AKD IRK+L  +  +RLT  E L
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 157/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S+ AKD IRK+L  +  +RLT  E L
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  185 bits (469), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 102/270 (37%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG G+F     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 157/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           K   + D Y +G +LG GQF     C E +TG+E+A K I KR+       +SRE++E  
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    
Sbjct: 64  -REVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S+ AKD IRK+L  +  +RLT  E L
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEAL 271

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 158/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V ++ EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 102/270 (37%), Positives = 158/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +N+ D Y  G +LG G F     C E +TG+++A K I KR+       +SRED+E  
Sbjct: 5   RQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE-- 62
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  
Sbjct: 63  -REVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + 
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S  AKD IR++L   P +R+T  + L
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 99/277 (35%), Positives = 150/277 (54%), Gaps = 16/277 (5%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVR-- 147
           H T    + Y     LG+G       C    T  E+A K   ++     S E+V+++R  
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 148 --REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
             +E+ I+  ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
            R ++ V+ A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G+
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGT 186
Query: 266 PYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
           P Y+APE++          YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+ 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            F S  W   SD+ KDL+ + L  QP +R TA E L 
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 99/277 (35%), Positives = 149/277 (53%), Gaps = 16/277 (5%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVR-- 147
           H T    + Y     LG+G       C    T  E+A K   ++     S E+V+++R  
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 148 --REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
             +E+ I+  ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
            R ++ V+ A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+    V G+
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLRSVCGT 186
Query: 266 PYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
           P Y+APE++          YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+ 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246
Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            F S  W   SD+ KDL+ + L  QP +R TA E L 
Sbjct: 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 99/266 (37%), Positives = 157/266 (59%), Gaps = 12/266 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDVRREI 150
           + D Y +G +LG GQF     C +  TG E+A K I KR+L      +SRE++E   RE+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE---REV 59
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            I+  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  + I+
Sbjct: 60  NILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
             V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+P +V
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           APE++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + +   
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           S+ AKD IR++L   P  R+T  + L
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSL 264

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 146/262 (55%), Gaps = 16/262 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACK--SISKRKLISREDVEDVR----REIQIMHHLAGHK 160
           LG+G       C    T  E+A K   ++     S E+V+++R    +E+ I+  ++GH 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++ R ++ V+ A H L 
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL----- 275
           ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G+P Y+APE++      
Sbjct: 132 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 188
Query: 276 --KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
               YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+  F S  W   SD+ K
Sbjct: 189 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 334 DLIRKMLCSQPSERLTAHEVLC 355
           DL+ + L  QP +R TA E L 
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALA 270

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 98/270 (36%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDV 146
           + +++ D Y +G +LG GQF     C +  TG E+A K I KR+L      +SRE++E  
Sbjct: 6   RQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE-- 63
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
            RE+ I+  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  
Sbjct: 64  -REVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           + I+  V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+
Sbjct: 122 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 181
Query: 266 PYYVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P +VAPE++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + 
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 241
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   S+ AKD IR++L   P  R+   + L
Sbjct: 242 FSNTSELAKDFIRRLLVKDPKRRMXIAQSL 271

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 98/266 (36%), Positives = 156/266 (58%), Gaps = 12/266 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL------ISREDVEDVRREI 150
           + D Y +G +LG GQF     C +  TG E+A K I KR+L      +SRE++E   RE+
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE---REV 80
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            I+  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  + I+
Sbjct: 81  NILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 139
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
             V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+P +V
Sbjct: 140 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 199
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           APE++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + +   
Sbjct: 200 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 259
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           S+ AKD IR++L   P  R+   + L
Sbjct: 260 SELAKDFIRRLLVKDPKRRMXIAQSL 285

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 96/260 (36%), Positives = 144/260 (55%), Gaps = 15/260 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +G+G       C   ATG EFA K +    + +S E +E+VR    RE  I+  +AGH +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           I+T+  +YE S  + +V +L   GELFD + ++   SE++   + R ++  V   H+  +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221
Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL------ 275
           +HRDLKPEN LL   DD+  ++  DFG S   +PG+   ++ G+P Y+APE+L       
Sbjct: 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
              YG E D+W  GVIL+ LL+G PPFW   Q  +   +++G   F S  W   S + KD
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 335 LIRKMLCSQPSERLTAHEVL 354
           LI ++L   P  RLTA + L
Sbjct: 339 LISRLLQVDPEARLTAEQAL 358

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 100/258 (38%), Positives = 145/258 (56%), Gaps = 4/258 (1%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L  +LG+G F     C +     E+A K I+ +KL +R D + + RE +I   L  
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR-DHQKLEREARICR-LLK 88
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +  +  +    ++V +L  GGELF+ I+ R +YSE  A+     I+  V   H 
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH 277
             ++HRDLKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y++PEVL K 
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD 208
Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  ++  AK+LI
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 268
Query: 337 RKMLCSQPSERLTAHEVL 354
            +ML   P++R+TA + L
Sbjct: 269 NQMLTINPAKRITADQAL 286

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 149/264 (56%), Gaps = 10/264 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHHL 156
           D+Y L   +G+G F     C    TG +FA K +   K  S   +  ED++RE  I H L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGV 212
             H +IV +   Y     +++V E   G +L   I++R      YSE  A+   R I+  
Sbjct: 84  K-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +  CH   ++HRD+KPEN LL +K++   +K  DFG+++   + G +    VG+P+++AP
Sbjct: 143 LRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 272 EVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F+ ++KG        W  IS+
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISE 261
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
           SAKDL+R+ML   P+ER+T +E L
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEAL 285

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 95/259 (36%), Positives = 138/259 (53%), Gaps = 15/259 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL    + LG+G F     C    +   FA K ISKR         + ++EI  +    G
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEG 64
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV +   + D L   +VMEL  GGELF+RI ++ H+SE +A+ + R +V  V   H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGSPYYVAPEVLLKH 277
           +GV+HRDLKPEN L  +++D+  +K IDFG +    P  Q       + +Y APE+L ++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQ-------GIFDAVLKGHIDFESDPWPLIS 329
            Y    D+W+ GVILY +LSG  PF +  +         I   + KG   FE + W  +S
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 330 DSAKDLIRKMLCSQPSERL 348
             AKDLI+ +L   P++RL
Sbjct: 245 QEAKDLIQGLLTVDPNKRL 263

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 149/272 (54%), Gaps = 9/272 (3%)
Query: 87  YYVLGHKTDNIRDLYTLGRK--LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           + ++  K   +   YT+ +   LG G+FG  + C E ATG++ A K I  R +   +D E
Sbjct: 75  HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKE 131
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAA 203
           +V+ EI +M+ L  H N++ +  A+E    + +VME   GGELFDRII   +  +E    
Sbjct: 132 EVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
              + I   +   H + ++H DLKPEN L VN+D    +K IDFGL+  +KP +      
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNF 249
Query: 264 GSPYYVAPEVLLKHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           G+P ++APEV+   +     D+W+ GVI Y+LLSG+ PF  +      + +L    D E 
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + +  IS+ AK+ I K+L  + S R++A E L
Sbjct: 310 EEFQDISEEAKEFISKLLIKEKSWRISASEAL 341

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 146/264 (55%), Gaps = 10/264 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHHL 156
           D+Y L   +G+G F     C    TG +FA K +   K  S   +  ED++RE  I H L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGV 212
             H +IV +   Y     +++V E   G +L   I++R      YSE  A+   R I+  
Sbjct: 86  K-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +  CH   ++HRD+KP   LL +K++   +K   FG+++   + G +    VG+P+++AP
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 204
Query: 272 EVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F+ ++KG        W  IS+
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISE 263
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
           SAKDL+R+ML   P+ER+T +E L
Sbjct: 264 SAKDLVRRMLMLDPAERITVYEAL 287

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 147/263 (55%), Gaps = 8/263 (3%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            I DL+   RKLG G FG  +L  E ++G+E   K+I+K +  S+  +E +  EI+++  
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKS 76
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ---RGH-YSERKAAELTRIIVG 211
           L  H NI+ I   +ED   ++IVME C GGEL +RI+    RG   SE   AEL + ++ 
Sbjct: 77  L-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   HS  V+H+DLKPEN L  +      +K IDFGL+  FK  +  T+  G+  Y+AP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EV  +    + D+W+AGV++Y LL+G  PF   + + +         ++  +  PL +  
Sbjct: 196 EVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL-TPQ 254
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           A DL+++ML   P  R +A +VL
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVL 277

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 146/264 (55%), Gaps = 10/264 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHHL 156
           D+Y L   +G+G F     C    TG +FA K +   K  S   +  ED++RE  I H L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGV 212
             H +IV +   Y     +++V E   G +L   I++R      YSE  A+   R I+  
Sbjct: 84  K-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +  CH   ++HRD+KP   LL +K++   +K   FG+++   + G +    VG+P+++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 272 EVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F+ ++KG        W  IS+
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISE 261
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
           SAKDL+R+ML   P+ER+T +E L
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEAL 285

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 99/265 (37%), Positives = 142/265 (53%), Gaps = 19/265 (7%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT +EFA K I K K        D   EI+I+     
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  H+
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 219 LGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +  S++  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ GV+LY +L+G  PF     +T + I   +  G        W  +S
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           D+AKDL+ KML   P +RLTA  VL
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVL 276

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 143/265 (53%), Gaps = 19/265 (7%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT +E+A K I K K        D   EI+I+     
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQ 79
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  HS
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 219 LGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +   L+  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 196
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFW---AETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ G++LY +L+G  PF    ++T + I   +  G        W  +S
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVS 256
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           ++AKDL+ KML   P +RLTA +VL
Sbjct: 257 ETAKDLVSKMLHVDPHQRLTAKQVL 281

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 142/256 (55%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A + I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G    +  GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVL 354
            L   PS+R T  +++
Sbjct: 247 FLILNPSKRGTLEQIM 262

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 143/265 (53%), Gaps = 19/265 (7%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT +E+A K I K K        D   EI+I+     
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK-------RDPSEEIEILLRYGQ 79
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  HS
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHS 139
Query: 219 LGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +   L+  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFG---FAKQLRAENGLLMTPCYTANFVAPEV 196
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFW---AETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ G++LY +L+G  PF    ++T + I   +  G        W  +S
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVS 256
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           ++AKDL+ KML   P +RLTA +VL
Sbjct: 257 ETAKDLVSKMLHVDPHQRLTAKQVL 281

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 141/256 (55%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVL 354
            L   PS+R T  +++
Sbjct: 247 FLILNPSKRGTLEQIM 262

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 141/256 (55%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVL 354
            L   PS+R T  +++
Sbjct: 247 FLILNPSKRGTLEQIM 262

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 141/256 (55%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A + I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVL 354
            L   PS+R T  +++
Sbjct: 247 FLILNPSKRGTLEQIM 262

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 156/310 (50%), Gaps = 19/310 (6%)
Query: 57  KENPKKDNS--APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGT 114
           K  P  +NS  A  +S +K        +D+Q+ Y        +RD Y + + LG G  G 
Sbjct: 96  KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVY-----PKALRDEYIMSKTLGSGACGE 150
Query: 115 TYLCTEIATGIEFACKSISKRKLI---SRED--VEDVRREIQIMHHLAGHKNIVTIKGAY 169
             L  E  T  + A + ISKRK     +RE     +V  EI+I+  L  H  I+ IK  +
Sbjct: 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 209
Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPE 229
            D+   +IV+EL  GGELFD+++      E         ++  V+  H  G++HRDLKPE
Sbjct: 210 -DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE 268
Query: 230 NFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVW 285
           N LL ++++D  +K  DFG S       +   + G+P Y+APEVL+      Y    D W
Sbjct: 269 NVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 328
Query: 286 TAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           + GVIL+I LSG PPF    TQ  + D +  G  +F  + W  +S+ A DL++K+L   P
Sbjct: 329 SLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388
Query: 345 SERLTAHEVL 354
             R T  E L
Sbjct: 389 KARFTTEEAL 398

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 107/310 (34%), Positives = 156/310 (50%), Gaps = 19/310 (6%)
Query: 57  KENPKKDNS--APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGT 114
           K  P  +NS  A  +S +K        +D+Q+ Y        +RD Y + + LG G  G 
Sbjct: 110 KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVY-----PKALRDEYIMSKTLGSGACGE 164
Query: 115 TYLCTEIATGIEFACKSISKRKLI---SRED--VEDVRREIQIMHHLAGHKNIVTIKGAY 169
             L  E  T  + A + ISKRK     +RE     +V  EI+I+  L  H  I+ IK  +
Sbjct: 165 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 223
Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPE 229
            D+   +IV+EL  GGELFD+++      E         ++  V+  H  G++HRDLKPE
Sbjct: 224 -DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE 282
Query: 230 NFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK----HYGPEADVW 285
           N LL ++++D  +K  DFG S       +   + G+P Y+APEVL+      Y    D W
Sbjct: 283 NVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 342
Query: 286 TAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           + GVIL+I LSG PPF    TQ  + D +  G  +F  + W  +S+ A DL++K+L   P
Sbjct: 343 SLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 402
Query: 345 SERLTAHEVL 354
             R T  E L
Sbjct: 403 KARFTTEEAL 412

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 141/256 (55%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEVL 354
            L   PS+R T  +++
Sbjct: 247 FLILNPSKRGTLEQIM 262

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 141/256 (55%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++IM  L  H 
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVL-NHP 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 127 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L++K
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKK 239
Query: 339 MLCSQPSERLTAHEVL 354
            L   PS+R T  +++
Sbjct: 240 FLILNPSKRGTLEQIM 255

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRED--VEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +S+ A DL++K+L   P  R T  E L
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRED--VEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +S+ A DL++K+L   P  R T  E L
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRED--VEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 67  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +S+ A DL++K+L   P  R T  E L
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEAL 272

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRED--VEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 68  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +S+ A DL++K+L   P  R T  E L
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEAL 273

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 140/268 (52%), Gaps = 12/268 (4%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---SRE--DVEDVRREIQ 151
           +RD Y + + LG G  G   L  E  T  + A K ISKRK     +RE     +V  EI+
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I+  L  H  I+ IK  + D+   +IV+EL  GGELFD+++      E         ++ 
Sbjct: 74  ILKKL-NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 272 EVLLK----HYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP 326
           EVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +S+ A DL++K+L   P  R T  E L
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEAL 279

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 98/265 (36%), Positives = 139/265 (52%), Gaps = 19/265 (7%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y +   +G G +     C   AT  EFA K I K K        D   EI+I+     
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   I   VE  H+
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 219 LGVMHRDLKPENFLLVNKDDD-FSLKAIDFGLSVFFKPGQIFTDVVGSPYY----VAPEV 273
            GV+HRDLKP N L V++  +  S++  DFG   F K  +    ++ +P Y    VAPEV
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFG---FAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFESDPWPLIS 329
           L +  Y    D+W+ GV+LY  L+G  PF     +T + I   +  G        W  +S
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           D+AKDL+ K L   P +RLTA  VL
Sbjct: 252 DTAKDLVSKXLHVDPHQRLTAALVL 276

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/270 (37%), Positives = 142/270 (52%), Gaps = 21/270 (7%)
Query: 97  IRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           + D Y L ++ LG G  G    C    TG + A K +         D    R+E+     
Sbjct: 7   VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQ 58
Query: 156 LAGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRII 209
            +G  +IV I   YE+      C+ I+ME   GGELF RI +RG   ++ER+AAE+ R I
Sbjct: 59  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 118
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              ++  HS  + HRD+KPEN L  +K+ D  LK  DFG +       + T    +PYYV
Sbjct: 119 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYV 177
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK----GHIDFESDP 324
           APEVL  + Y    D+W+ GVI+YILL G PPF++ T Q I   + +    G   F +  
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           W  +S+ AK LIR +L + P+ERLT  + +
Sbjct: 238 WSEVSEDAKQLIRLLLKTDPTERLTITQFM 267

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 100/270 (37%), Positives = 142/270 (52%), Gaps = 21/270 (7%)
Query: 97  IRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           + D Y L ++ LG G  G    C    TG + A K +         D    R+E+     
Sbjct: 26  VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQ 77
Query: 156 LAGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRII 209
            +G  +IV I   YE+      C+ I+ME   GGELF RI +RG   ++ER+AAE+ R I
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              ++  HS  + HRD+KPEN L  +K+ D  LK  DFG +       + T    +PYYV
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY-TPYYV 196
Query: 270 APEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK----GHIDFESDP 324
           APEVL  + Y    D+W+ GVI+YILL G PPF++ T Q I   + +    G   F +  
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           W  +S+ AK LIR +L + P+ERLT  + +
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFM 286

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 93/256 (36%), Positives = 140/256 (54%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L +   ++ + RE++IM  L  H 
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    ++++ME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 132 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L+++
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKR 244
Query: 339 MLCSQPSERLTAHEVL 354
            L   P +R T  +++
Sbjct: 245 FLVLNPIKRGTLEQIM 260

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 92/256 (35%), Positives = 140/256 (54%), Gaps = 11/256 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L +   ++ + RE++IM  L  H 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    ++++ME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+    K+ 
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+ + +D  ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYMSTD-CENLLKR 247
Query: 339 MLCSQPSERLTAHEVL 354
            L   P +R T  +++
Sbjct: 248 FLVLNPIKRGTLEQIM 263

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 134/264 (50%), Gaps = 7/264 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ 
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQT 101
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVG 211
           M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R +  
Sbjct: 102 MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 160
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + AP
Sbjct: 161 GLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 219
Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS+
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 279
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             KD IRK+L + P+ R+T H+ L
Sbjct: 280 DGKDFIRKLLLADPNTRMTIHQAL 303

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 134/264 (50%), Gaps = 7/264 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ 
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQT 207
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVG 211
           M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R +  
Sbjct: 208 MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + AP
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS+
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             KD IRK+L + P+ R+T H+ L
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQAL 409

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/257 (36%), Positives = 138/257 (53%), Gaps = 13/257 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 73
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 133 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 189
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 245
Query: 338 KMLCSQPSERLTAHEVL 354
           +ML   P  R++ HE++
Sbjct: 246 RMLIVNPLNRISIHEIM 262

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 94/255 (36%), Positives = 137/255 (53%), Gaps = 11/255 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K +L S   ++ + RE++I   L  H 
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIXKVL-NHP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++V E  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+    K+ 
Sbjct: 134 IVHRDLKAENLLL---DADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G       P+   +D  ++L++K
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI---PFYXSTD-CENLLKK 246
Query: 339 MLCSQPSERLTAHEV 353
            L   PS+R T  ++
Sbjct: 247 FLILNPSKRGTLEQI 261

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/257 (36%), Positives = 138/257 (53%), Gaps = 13/257 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 72
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 132 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 188
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 244
Query: 338 KMLCSQPSERLTAHEVL 354
           +ML   P  R++ HE++
Sbjct: 245 RMLIVNPLNRISIHEIM 261

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/257 (36%), Positives = 138/257 (53%), Gaps = 13/257 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 63
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 123 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 179
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 235
Query: 338 KMLCSQPSERLTAHEVL 354
           +ML   P  R++ HE++
Sbjct: 236 RMLIVNPLNRISIHEIM 252

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 93/257 (36%), Positives = 138/257 (53%), Gaps = 13/257 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y + + LG+G FG   L     TG + A K I+K K++++ D++  + REI  +  L  H
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINK-KVLAKSDMQGRIEREISYLR-LLRH 67
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +    +    + +V+E  AG ELFD I+QR   SE++A    + I+  VE CH  
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--H 277
            ++HRDLKPEN LL   D+  ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 127 KIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 183
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ GVILY++L    PF  E+   +F  +  G           +S  A  LI+
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 239
Query: 338 KMLCSQPSERLTAHEVL 354
           +ML   P  R++ HE++
Sbjct: 240 RMLIVNPLNRISIHEIM 256

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/218 (39%), Positives = 121/218 (55%), Gaps = 7/218 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   + TG E A K I K +L +   ++ + RE++IM  L  H 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-NPTSLQKLFREVRIMKIL-NHP 74
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    +++VME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHY 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       GSP Y APE+    K+ 
Sbjct: 135 IVHRDLKAENLLL---DGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG 316
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 138/269 (51%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 65
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T+   +PYYVA
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVA 185
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 274

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 117
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 118 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 237
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 238 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 297
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 298 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 326

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 111
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 320

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 67
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 276

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 71
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 72  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 191
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 192 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 251
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 252 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 280

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 72
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 73  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 192
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 193 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 252
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 253 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 281

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 65
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 66  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 185
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 186 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 245
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 246 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 274

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 73
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 74  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 193
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 194 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 253
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 254 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 282

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 66
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 67  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 186
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 187 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 246
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 247 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 275

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 81
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 82  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 201
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 202 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 261
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 262 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 290

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 67
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 187
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W
Sbjct: 188 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 247
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +S+  K LIR +L ++P++R+T  E +
Sbjct: 248 SEVSEEVKMLIRNLLKTEPTQRMTITEFM 276

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 92/256 (35%), Positives = 136/256 (53%), Gaps = 13/256 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGH 159
           Y +   LG+G FG   L T   T  + A K IS R+L+ + D+   V REI  +  L  H
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLK-LLRH 68
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            +I+ +         + +V+E  AGGELFD I+++   +E +     + I+  +E CH  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL--LKH 277
            ++HRDLKPEN LL   DD+ ++K  DFGLS     G       GSP Y APEV+    +
Sbjct: 128 KIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
            GPE DVW+ G++LY++L G  PF  E    +F  V    +    D    +S  A+ LIR
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCVYVMPD---FLSPGAQSLIR 240
Query: 338 KMLCSQPSERLTAHEV 353
           +M+ + P +R+T  E+
Sbjct: 241 RMIVADPMQRITIQEI 256

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 91/289 (31%), Positives = 141/289 (48%), Gaps = 33/289 (11%)
Query: 96  NIRDLYTLGRKL-GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
              D+Y L  +L G+G +        +  G E+A K I K+   SR  V    RE++ ++
Sbjct: 9   KFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV---FREVETLY 65
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
              G+KNI+ +   +ED    ++V E   GG +   I ++ H++ER+A+ + R +   ++
Sbjct: 66  QCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALD 125
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV--------GSP 266
             H+ G+ HRDLKPEN L  + +    +K  DF L    K     T +         GS 
Sbjct: 126 FLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 267 YYVAPEVL------LKHYGPEADVWTAGVILYILLSGVPPF---------WAE------T 305
            Y+APEV+         Y    D+W+ GV+LYI+LSG PPF         W         
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           Q  +F+++ +G  +F    W  IS  AKDLI K+L     +RL+A +VL
Sbjct: 246 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVL 294

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 135/264 (51%), Gaps = 7/264 (2%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K  ++ D Y +  +LG G FG  + C E ATG  F  K I+    +   D   V+ EI I
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISI 101
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVG 211
           M+ L  H  ++ +  A+ED   + +++E  +GGELFDRI    +  SE +     R    
Sbjct: 102 MNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            ++  H   ++H D+KPEN +   K    S+K IDFGL+    P +I      +  + AP
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
Query: 272 EVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           E++ +   G   D+W  GV+ Y+LLSG+ PF  E        V +   +F+ D +  +S 
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
            AKD I+ +L  +P +RLT H+ L
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDAL 303

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 92/255 (36%), Positives = 135/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  +RREIQ +  L  H 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHP 76
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +         + +VME  +GGELFD I + G   E+++  L + I+  V+ CH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL--LKHY 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+    + 
Sbjct: 137 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYA 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W++GVILY LL G  PF  +    +F  +  G   F +  +  ++ S   L++ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249
Query: 339 MLCSQPSERLTAHEV 353
           ML   P +R T  ++
Sbjct: 250 MLQVDPMKRATIKDI 264

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  ++REIQ +  L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +           +VME  +GGELFD I + G   E +A  L + I+  V+ CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+   D  GSP Y APEV+    + 
Sbjct: 132 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYA 188
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ GVILY LL G  PF  E    +F  + +G + +  +    ++ S   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGVFYIPE---YLNRSVATLLMH 244
Query: 339 MLCSQPSERLTAHEV 353
           ML   P +R T  ++
Sbjct: 245 MLQVDPLKRATIKDI 259

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 131/267 (49%), Gaps = 19/267 (7%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVELHWRA 111
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IV E   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PYYVA
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPW 325
           PEVL  + Y    D W+ GVI YILL G PPF++        G    +  G  +F +  W
Sbjct: 232 PEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEW 291
Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHE 352
             +S+  K LIR +L ++P++R T  E
Sbjct: 292 SEVSEEVKXLIRNLLKTEPTQRXTITE 318

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 92/255 (36%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  ++REIQ +  L  H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +           +VME  +GGELFD I + G   E +A  L + I+  V+ CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+    + 
Sbjct: 132 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ GVILY LL G  PF  E    +F  + +G + +  +    ++ S   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI-RGGVFYIPE---YLNRSVATLLMH 244
Query: 339 MLCSQPSERLTAHEV 353
           ML   P +R T  ++
Sbjct: 245 MLQVDPLKRATIKDI 259

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    GE++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 246 LKHNPSQRPMLREVL 260

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 99/324 (30%), Positives = 151/324 (46%), Gaps = 60/324 (18%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISRED 142
           +  Y  G     ++  Y L   +GQG +G   +  E  T    A K ++K K+  I+ +D
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI----------- 191
           VE ++ E+++M  L  H NI  +   YED   + +VMELC GG L D++           
Sbjct: 72  VERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130
Query: 192 ---------------------------------IQRGHYSERKAAELTRIIVGVVEACHS 218
                                            +QR    E+  + + R I   +   H+
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR----EKLISNIMRQIFSALHYLHN 186
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFK--PGQIF--TDVVGSPYYVAPEV 273
            G+ HRD+KPENFL  + +  F +K +DFGLS  F+K   G+ +  T   G+PY+VAPEV
Sbjct: 187 QGICHRDIKPENFLF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 274 LL---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           L    + YGP+ D W+AGV+L++LL G  PF           VL   + FE+  + ++S 
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSP 305
Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
            A+DL+  +L     ER  A   L
Sbjct: 306 LARDLLSNLLNRNVDERFDAMRAL 329

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 85/266 (31%), Positives = 139/266 (52%), Gaps = 10/266 (3%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG K     + + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           ++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     +
Sbjct: 63  VEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSV-HAPSSRRTTLCGTLDYL 177
Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            PE++  + +  + D+W+ GV+ Y  L G+PPF A T Q  +  + +    F       +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FV 233
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           ++ A+DLI ++L    S+RLT  EVL
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVL 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 246 LKHNPSQRPMLREVL 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 242 LKHNPSQRPMLREVL 256

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/255 (32%), Positives = 134/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    TD+ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 136/258 (52%), Gaps = 12/258 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D + +GR LG+G+FG  YL  E       A K + K +L  +E VE  +RREI+I  HL 
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLR 73
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H NI+ +   + D   +++++E    GEL+  + + G + E+++A     +   +  CH
Sbjct: 74  -HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 132
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K 276
              V+HRD+KPEN L+  K +   LK  DFG SV   P      + G+  Y+ PE++  K
Sbjct: 133 ERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +  + D+W AGV+ Y  L G+PPF + +       ++   + F     P +SD +KDLI
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI 244
Query: 337 RKMLCSQPSERLTAHEVL 354
            K+L   P +RL    V+
Sbjct: 245 SKLLRYHPPQRLPLKGVM 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 139/257 (54%), Gaps = 11/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +G  LG+G F   Y    I TG+E A K I K+ +     V+ V+ E++I H    H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI-HCQLKHP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
           +I+ +   +EDS  V++V+E+C  GE+   +  R   +SE +A      I+  +   HS 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH- 277
           G++HRDL   N LL     + ++K  DFGL+   K P +    + G+P Y++PE+  +  
Sbjct: 132 GILHRDLTLSNLLLTR---NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +G E+DVW+ G + Y LL G PPF  +T +   + V+    D+E   +  +S  AKDLI 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDLIH 244
Query: 338 KMLCSQPSERLTAHEVL 354
           ++L   P++RL+   VL
Sbjct: 245 QLLRRNPADRLSLSSVL 261

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P     D+ G+  Y+ PE++  + + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYLPPEMIEGRMHD 210
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 266
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 267 LKHNPSQRPMLREVL 281

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    GE++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLXGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 246 LKHNPSQRPMLREVL 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 134/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T++ G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 94
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 155 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 210
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 266
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 267 LKHNPSQRPMLREVL 281

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 85
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 146 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 201
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 257
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 258 LKHNPSQRPMLREVL 272

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 138/266 (51%), Gaps = 10/266 (3%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG K     + + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE
Sbjct: 3   LGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRRE 62
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           ++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     +
Sbjct: 63  VEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+
Sbjct: 122 ANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSV-HAPSSRRDTLCGTLDYL 177
Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            PE++  + +  + D+W+ GV+ Y  L G+PPF A T Q  +  + +    F       +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD----FV 233
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           ++ A+DLI ++L    S+RLT  EVL
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVL 259

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 84/266 (31%), Positives = 138/266 (51%), Gaps = 11/266 (4%)
Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           LG +   + D + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE
Sbjct: 3   LGSRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           ++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     +
Sbjct: 62  VEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
              +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P     D+ G+  Y+
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDDLCGTLDYL 176
Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            PE++  + +  + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FV 232
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           ++ A+DLI ++L   PS+R    EVL
Sbjct: 233 TEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 137/267 (51%), Gaps = 10/267 (3%)
Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            +G K     + + +GR LG+G+FG  YL  E  +    A K + K +L        +RR
Sbjct: 2   AMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 61
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     
Sbjct: 62  EVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +   +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y
Sbjct: 121 LANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDY 176
Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           + PE++  + +  + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----F 232
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +++ A+DLI ++L   PS+R    EVL
Sbjct: 233 VTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 244 LKHNPSQRPMLREVL 258

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F TT L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 246 LKHNPSQRPMLREVL 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 73
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE +  + + 
Sbjct: 134 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEXIEGRXHD 189
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 245
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 246 LKHNPSQRPXLREVL 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 67
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 127
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 128 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 239
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 240 LKHNPSQRPMLREVL 254

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 244 LKHNPSQRPMLREVL 258

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 135/258 (52%), Gaps = 12/258 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D + + R LG+G+FG  YL  E       A K + K +L  +E VE  +RREI+I  HL 
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLR 72
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H NI+ +   + D   +++++E    GEL+  + + G + E+++A     +   +  CH
Sbjct: 73  -HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K 276
              V+HRD+KPEN L+  K +   LK  DFG SV   P      + G+  Y+ PE++  K
Sbjct: 132 ERKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +  + D+W AGV+ Y  L G+PPF + +       ++   + F     P +SD +KDLI
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLI 243
Query: 337 RKMLCSQPSERLTAHEVL 354
            K+L   P +RL    V+
Sbjct: 244 SKLLRYHPPQRLPLKGVM 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  +FG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 186
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 242
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 243 LKHNPSQRPMLREVL 257

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 263 EKLLVLDATKRLGCEEM 279

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + DS  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 67
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 127
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 128 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 185 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 240
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 241 EKLLVLDATKRLGCEEM 257

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 69
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 130 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 187 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 242
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 243 EKLLVLDATKRLGCEEM 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 131 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 188 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 243
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 244 EKLLVLDATKRLGCEEM 260

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 74
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 134
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 135 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 192 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 247
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 248 EKLLVLDATKRLGCEEM 264

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 241
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 242 EKLLVLDATKRLGCEEM 258

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 267 EKLLVLDATKRLGCEEM 283

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 10/265 (3%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
           G K     + + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE+
Sbjct: 1   GKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     + 
Sbjct: 61  EIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 119
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             +  CHS  V+HRD+KPEN LL +  +   LK  DFG S    P    T + G+  Y+ 
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSC-HAPSSRRTTLSGTLDYLP 175
Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           PE++  + +  + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       ++
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVT 231
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           + A+DLI ++L   PS+R    EVL
Sbjct: 232 EGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E       A K + K +L        +RRE++I  HL  H 
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 126 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 237
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 238 LKHNPSQRPMLREVL 252

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 129/257 (50%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 95
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 155
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 156 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF +  +P     A+DL+
Sbjct: 213 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFP----KARDLV 268
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 269 EKLLVLDATKRLGCEEM 285

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 89
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 149
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 150 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 207 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 262
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 263 EKLLVLDATKRLGCEEM 279

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 131 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMHD 186
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 242
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 243 LKHNPSQRPMLREVL 257

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 133/255 (52%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  +FG SV   P    T + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIANFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 244 LKHNPSQRPMLREVL 258

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/257 (33%), Positives = 130/257 (50%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDV-VGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P   Q   +  VG+  YV+PE+L  K
Sbjct: 151 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 263
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 264 EKLLVLDATKRLGCEEM 280

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 137/267 (51%), Gaps = 11/267 (4%)
Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            +G +   + D + +GR LG+G+FG  YL  E  +    A K + K +L        +RR
Sbjct: 2   AMGSRQWALED-FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E++I  HL  H NI+ + G + D+  V++++E    G ++  + +   + E++ A     
Sbjct: 61  EVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +   +  CHS  V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y
Sbjct: 120 LANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDY 175
Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           + PE++  + +  + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----F 231
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +++ A+DLI ++L   PS+R    EVL
Sbjct: 232 VTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRDTLCGTLDYLPPEMIEGRMHD 185
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 241
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 242 LKHNPSQRPMLREVL 256

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 93
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 153
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 154 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 211 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 266
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 267 EKLLVLDATKRLGCEEM 283

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 97
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 158 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 215 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 270
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 271 EKLLVLDATKRLGCEEM 287

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 137/251 (54%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  +++E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFGL+   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 71
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 132 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 243
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 244 LKHNPSQRPMLREVL 258

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 10/255 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 68
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL +  +   LK  DFG SV   P      + G+  Y+ PE++  + + 
Sbjct: 129 VIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 240
Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 241 LKHNPSQRPMLREVL 255

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 136/251 (54%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +T + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 136/251 (54%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 85
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +T + G+P Y+APE++L K 
Sbjct: 146 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKG 200
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 201 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 256
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 257 NLLQVDLTKRF 267

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 136/251 (54%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 137/251 (54%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  +++E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    ++  DFGL+   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 127/257 (49%), Gaps = 12/257 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     G L   I + G + E      T  IV  +E  H  G
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF    +P     A+DL+
Sbjct: 210 SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLV 265
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L    ++RL   E+
Sbjct: 266 EKLLVLDATKRLGCEEM 282

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/245 (32%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G  +T + G+P Y+APE++L K Y    D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GATWT-LCGTPEYLAPEIILSKGYNKAVD 241
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 297
Query: 344 PSERL 348
            ++R 
Sbjct: 298 LTKRF 302

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + +G G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 90/291 (30%), Positives = 142/291 (48%), Gaps = 33/291 (11%)
Query: 94  TDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           +    D+Y L    LG+G       C  + T  E+A K I K+    R  V    RE+++
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---FREVEM 63
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           ++   GH+N++ +   +E+    ++V E   GG +   I +R H++E +A+ + + +   
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--------VG 264
           ++  H+ G+ HRDLKPEN L  + +    +K  DFGL    K     + +         G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCG 183
Query: 265 SPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPF---------W------A 303
           S  Y+APEV+         Y    D+W+ GVILYILLSG PPF         W       
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             Q  +F+++ +G  +F    W  IS +AKDLI K+L     +RL+A +VL
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  FA K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  FA K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 134/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 92
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 93  LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 152
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D+   ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 153 DLKPENLLI---DEQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 207
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 208 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 263
Query: 344 PSERL 348
            ++R 
Sbjct: 264 LTKRF 268

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LAGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  FA K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +  ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LXGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +  ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 106
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 107 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 167 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 221
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 277
Query: 344 PSERL 348
            ++R 
Sbjct: 278 LTKRF 282

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 207
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 263
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 264 NLLQVDLTKRF 274

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 133/251 (52%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG G FG   L     TG  +A K + K+K++  + +E    E +I   +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++V+E   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + +G G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GG++F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + +G G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GG++F  + + G +SE  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 120
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 181 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 235
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 236 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 291
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 292 NLLQVDLTKRF 302

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 130/237 (54%), Gaps = 11/237 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKML 340
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLL 273

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G +SE  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 134/251 (53%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 160 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 214
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 270
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 271 NLLQVDLTKRF 281

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 130/259 (50%), Gaps = 10/259 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I     E+V+REI I H    
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSLR 72
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 73  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 132
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLLK  
Sbjct: 133 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 251
Query: 335 LIRKMLCSQPSERLTAHEV 353
           LI ++  + P++R++  E+
Sbjct: 252 LISRIFVADPAKRISIPEI 270

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G ++E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 8/256 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G+FG  + C E ++   +  K +     +   D   V++EI I++ +A H+
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILN-IARHR 61
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSL 219
           NI+ +  ++E    + ++ E  +G ++F+RI       +ER+       +   ++  HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYG 279
            + H D++PEN +   +    ++K I+FG +   KPG  F  +  +P Y APEV      
Sbjct: 122 NIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 280 PEA-DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             A D+W+ G ++Y+LLSG+ PF AET Q I + ++     F+ + +  IS  A D + +
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 339 MLCSQPSERLTAHEVL 354
           +L  +   R+TA E L
Sbjct: 241 LLVKERKSRMTASEAL 256

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 133/251 (52%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L   + TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 100
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +  ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN ++   D    +K  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 161 LDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 215
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 271
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 272 NLLQVDLTKRF 282

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 130/259 (50%), Gaps = 10/259 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I     E+V+REI I H    
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK   FG S          D VG+P Y+APEVLLK  
Sbjct: 134 MQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEV 353
           LI ++  + P++R++  E+
Sbjct: 253 LISRIFVADPAKRISIPEI 271

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 141/291 (48%), Gaps = 33/291 (11%)
Query: 94  TDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           +    D+Y L    LG+G       C  + T  E+A K I K+    R  V    RE+++
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---FREVEM 63
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           ++   GH+N++ +   +E+    ++V E   GG +   I +R H++E +A+ + + +   
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASA 123
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--------VG 264
           ++  H+ G+ HRDLKPEN L  + +    +K  DF L    K     + +         G
Sbjct: 124 LDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 265 SPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPF---------W------A 303
           S  Y+APEV+         Y    D+W+ GVILYILLSG PPF         W       
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             Q  +F+++ +G  +F    W  IS +AKDLI K+L     +RL+A +VL
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 133/245 (54%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN ++   D    ++  DFG +   K G+ +  + G+P Y+APE+++ K Y    D
Sbjct: 166 DLKPENLII---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIIISKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 126
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 127 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 187 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 241
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 297
Query: 344 PSERL 348
            ++R 
Sbjct: 298 LTKRF 302

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 100
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 160
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 161 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 215
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 216 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 271
Query: 344 PSERL 348
            ++R 
Sbjct: 272 LTKRF 276

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G + E  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+AP ++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPAIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 133/251 (52%), Gaps = 11/251 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   + LG G FG   L     TG  +A K + K+K++  + +E    E +I+  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 92
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              +V ++ +++D+  +++VME   GGE+F  + + G + E  A      IV   E  HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
           L +++RDLKPEN L+   D    ++  DFG +   K G+ +  + G+P Y+APE++L K 
Sbjct: 153 LDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKG 207
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R
Sbjct: 208 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLR 263
Query: 338 KMLCSQPSERL 348
            +L    ++R 
Sbjct: 264 NLLQVDLTKRF 274

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 130/259 (50%), Gaps = 10/259 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I+     +V+REI I H    
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIA----ANVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLLK  
Sbjct: 134 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEV 353
           LI ++  + P++R++  E+
Sbjct: 253 LISRIFVADPAKRISIPEI 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 144/294 (48%), Gaps = 14/294 (4%)
Query: 81  GIDNQTYYVLGHKTDNIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS 139
           G+D  T  +     +N  + Y L  ++LG+G+F     C   +TG E+A K + KR+   
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-G 68
Query: 140 REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHY 197
           ++   ++  EI ++        ++ +   YE++  + +++E  AGGE+F   +       
Sbjct: 69  QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           SE     L + I+  V   H   ++H DLKP+N LL +      +K +DFG+S       
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 258 IFTDVVGSPYYVAPEVLLKHYGP---EADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
              +++G+P Y+APE+L  +Y P     D+W  G+I Y+LL+   PF  E  Q  +  + 
Sbjct: 189 ELREIMGTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246
Query: 315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTA-----HEVLCMYNLPVLF 363
           + ++D+  + +  +S  A D I+ +L   P +R TA     H  L  ++   LF
Sbjct: 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/245 (31%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +     +V 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
           ++ +++D+  +++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++R
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEAD 283
           DLKPEN L+   D    ++  DFG +   K G+ +  + G+P  +APE++L K Y    D
Sbjct: 166 DLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEALAPEIILSKGYNKAVD 220
Query: 284 VWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
            W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KDL+R +L   
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLLQVD 276
Query: 344 PSERL 348
            ++R 
Sbjct: 277 LTKRF 281

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/268 (31%), Positives = 127/268 (47%), Gaps = 38/268 (14%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I D     + LG G  G         T  +FA K +        +D    RRE+++    
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 67
Query: 157 AGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIV 210
           +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ + I 
Sbjct: 68  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             ++  HS+ + HRD+KPEN L  +K  +  LK  DFG                     A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------A 167
Query: 271 PEVLLKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWP 326
            E   + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +  W 
Sbjct: 168 KETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +S+  K LIR +L ++P++R+T  E +
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFM 255

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 89/259 (34%), Positives = 129/259 (49%), Gaps = 10/259 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +  +    A K I + + I     E+V+REI I H    
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID----ENVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V  CH+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK   FG S            VG+P Y+APEVLLK  
Sbjct: 134 MQVCHRDLKLENTLL-DGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEV 353
           LI ++  + P++R++  E+
Sbjct: 253 LISRIFVADPAKRISIPEI 271

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/270 (34%), Positives = 132/270 (48%), Gaps = 14/270 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y L + +G G FG   L  +       A K I + + I     E+V+REI I H    
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKID----ENVKREI-INHRSLR 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + IVME  +GGELF+RI   G +SE +A    + ++  V   H+
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHA 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + V HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLLK  
Sbjct: 134 MQVAHRDLKLENTLL-DGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG--HIDFESDPWPLISDSAKD 334
           + G  ADVW+ GV LY++L G  PF    +   F   +    ++ +    +  IS   + 
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 335 LIRKMLCSQPSERLTAHEV----LCMYNLP 360
           LI ++  + P++R++  E+      + NLP
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 128/256 (50%), Gaps = 10/256 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 102
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+   D+ G+P Y+APEVL K  +
Sbjct: 163 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 275
Query: 339 MLCSQPSERLTAHEVL 354
           ML + P+ R +  E+L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 128/256 (50%), Gaps = 10/256 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 86
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+   D+ G+P Y+APEVL K  +
Sbjct: 147 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 259
Query: 339 MLCSQPSERLTAHEVL 354
           ML + P+ R +  E+L
Sbjct: 260 MLHADPTLRPSVAELL 275

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 133/257 (51%), Gaps = 12/257 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLA 157
           D + +GR LG+G+FG  YL  E  +    A K + K + I +E VE  +RREI+I  HL 
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ-IEKEGVEHQLRREIEIQAHL- 80
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H NI+ +   + D   +++++E    GEL+  + +   + E++ A +   +   +  CH
Sbjct: 81  HHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K 276
              V+HRD+KPEN   +       LK  DFG SV   P      + G+  Y+ PE++  +
Sbjct: 141 GKKVIHRDIKPEN---LLLGLKGELKIADFGWSV-HAPSLRRKTMCGTLDYLPPEMIEGR 196
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +  + D+W  GV+ Y LL G PPF + +    +  ++K  + F +     +   A+DLI
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPAS----VPTGAQDLI 252
Query: 337 RKMLCSQPSERLTAHEV 353
            K+L   PSERL   +V
Sbjct: 253 SKLLRHNPSERLPLAQV 269

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 74
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 75  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 132
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 133 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 189
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 190 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 245
Query: 343 QPSERL 348
            P +RL
Sbjct: 246 DPKQRL 251

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL 348
            P +RL
Sbjct: 243 DPKQRL 248

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL 348
            P +RL
Sbjct: 243 DPKQRL 248

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 127/256 (49%), Gaps = 10/256 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 102
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+    + G+P Y+APEVL K  +
Sbjct: 163 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 275
Query: 339 MLCSQPSERLTAHEVL 354
           ML + P+ R +  E+L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL 348
            P +RL
Sbjct: 243 DPKQRL 248

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 242
Query: 343 QPSERL 348
            P +RL
Sbjct: 243 DPKQRL 248

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 127/256 (49%), Gaps = 10/256 (3%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y  GR LG+G F   Y  T++ T   FA K + K  L+     E +  EI I H    + 
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI-HKSLDNP 102
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++V   G +ED   V++V+E+C    L +   +R   +E +A    R  +  V+  H+  
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-Y 278
           V+HRDLK  N  L   +DD  +K  DFGL+   +  G+    + G+P Y+APEVL K  +
Sbjct: 163 VIHRDLKLGNLFL---NDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             E D+W+ G ILY LL G PPF     +  +  + K            I+  A  LIR+
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRH----INPVASALIRR 275
Query: 339 MLCSQPSERLTAHEVL 354
           ML + P+ R +  E+L
Sbjct: 276 MLHADPTLRPSVAELL 291

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 76
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 77  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 134
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 135 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 191
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 192 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 247
Query: 343 QPSERL 348
            P +RL
Sbjct: 248 DPKQRL 253

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 82/246 (33%), Positives = 126/246 (51%), Gaps = 14/246 (5%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
            A++  D LC   VME   GGELF  + +   ++E +A      IV  +E  HS  V++R
Sbjct: 72  YAFQTHDRLC--FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEA 282
           D+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL  + YG   
Sbjct: 130 DIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAV 186
Query: 283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS 342
           D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  +L  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 242
Query: 343 QPSERL 348
            P +RL
Sbjct: 243 DPKQRL 248

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 135/264 (51%), Gaps = 22/264 (8%)
Query: 95  DNIRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           + IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E  IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTD-VVGSP 266
           +V  ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 267 YYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHID 319
            Y++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + 
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 298
Query: 320 FESDPWPLISDSAKDLIRKMLCSQ 343
           F  D    IS  AK+LI   L  +
Sbjct: 299 FPDD--NDISKEAKNLICAFLTDR 320

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 135/264 (51%), Gaps = 22/264 (8%)
Query: 95  DNIRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           + IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      
Sbjct: 59  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E  IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  
Sbjct: 119 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 176
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTD-VVGSP 266
           +V  ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 267 YYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHID 319
            Y++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + 
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293
Query: 320 FESDPWPLISDSAKDLIRKMLCSQ 343
           F  D    IS  AK+LI   L  +
Sbjct: 294 FPDD--NDISKEAKNLICAFLTDR 315

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 90/265 (33%), Positives = 125/265 (47%), Gaps = 22/265 (8%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D Y   + +G G FG   L  +  T    A K I +   I     E+V+REI I H    
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREI-INHRSLR 74
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NIV  K        + I+ME  +GGEL++RI   G +SE +A    + ++  V  CHS
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
           + + HRDLK EN LL +      LK  DFG S            VG+P Y+APEVLL+  
Sbjct: 135 MQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 277 HYGPEADVWTAGVILYILLSGVPPF--------WAETQQGIFDAVLKGHIDFESDPWPLI 328
           + G  ADVW+ GV LY++L G  PF        + +T Q I         D        I
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR------I 247
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEV 353
           S     LI ++  + P+ R++  E+
Sbjct: 248 SPECCHLISRIFVADPATRISIPEI 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 135/264 (51%), Gaps = 22/264 (8%)
Query: 95  DNIRDL------YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           + IRDL      Y + + +G+G FG   L    +T   +A K +SK ++I R D      
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E  IM   A    +V +  A++D   +++VME   GG+L + ++      E+ A   T  
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTD-VVGSP 266
           +V  ++A HS+G +HRD+KP+N LL   D    LK  DFG  +   K G +  D  VG+P
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 267 YYVAPEVLLK-----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHID 319
            Y++PEVL       +YG E D W+ GV LY +L G  PF+A++  G +  ++  K  + 
Sbjct: 239 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 298
Query: 320 FESDPWPLISDSAKDLIRKMLCSQ 343
           F  D    IS  AK+LI   L  +
Sbjct: 299 FPDD--NDISKEAKNLICAFLTDR 320

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 124/249 (49%), Gaps = 11/249 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + R LG G FG  +L      G  +A K + K  ++  + VE    E ++M  +  H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE-RLMLSIVTHP 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            I+ + G ++D+  + ++M+   GGELF  + +   +    A      +   +E  HS  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL-LKHYG 279
           +++RDLKPEN LL   D +  +K  DFG + +     +   + G+P Y+APEV+  K Y 
Sbjct: 127 IIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W+ G+++Y +L+G  PF+       ++ +L   + F     P  ++  KDL+ ++
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRL 237
Query: 340 LCSQPSERL 348
           +    S+RL
Sbjct: 238 ITRDLSQRL 246

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 127/247 (51%), Gaps = 15/247 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 74
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 75  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 132
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 133 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 189
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 190 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 245
Query: 342 SQPSERL 348
             P +RL
Sbjct: 246 KDPKQRL 252

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 127/247 (51%), Gaps = 15/247 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 75
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 76  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 133
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 134 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 190
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 246
Query: 342 SQPSERL 348
             P +RL
Sbjct: 247 KDPKQRL 253

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 127/247 (51%), Gaps = 15/247 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 214
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 215 YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 273 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 329
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 385
Query: 342 SQPSERL 348
             P +RL
Sbjct: 386 KDPKQRL 392

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 127/247 (51%), Gaps = 15/247 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 76
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 77  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 134
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 135 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRA 191
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 247
Query: 342 SQPSERL 348
             P +RL
Sbjct: 248 KDPKQRL 254

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 127/247 (51%), Gaps = 15/247 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 217
Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMH 223
            +++  D LC   VME   GGELF  + +   +SE +A      IV  ++  HS   V++
Sbjct: 218 YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 275
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
           RDLK EN +L   D D  +K  DFGL     K G       G+P Y+APEVL  + YG  
Sbjct: 276 RDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA 332
Query: 282 ADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLC 341
            D W  GV++Y ++ G  PF+ +  + +F+ +L   I F     P     AK L+  +L 
Sbjct: 333 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP----EAKSLLSGLLK 388
Query: 342 SQPSERL 348
             P +RL
Sbjct: 389 KDPKQRL 395

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 14/268 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLC--MYNLPV 361
           + K+L   PS R+T  ++     YN P+
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 14/268 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLC--MYNLPV 361
           + K+L   PS R+T  ++     YN P+
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 14/268 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLC--MYNLPV 361
           + K+L   PS R+T  ++     YN P+
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 14/268 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEVLC--MYNLPV 361
           + K+L   PS R+T  ++     YN P+
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 141/278 (50%), Gaps = 22/278 (7%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR- 140
           +T  + GH      + + L + LG G +G  +L  +I+   TG  +A K + K  ++ + 
Sbjct: 40  RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 99
Query: 141 EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER 200
           +  E  R E Q++ H+     +VT+  A++    +H++++   GGELF  + QR  ++E 
Sbjct: 100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH 159
Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-- 258
           +       IV  +E  H LG+++RD+K EN LL   D +  +   DFGLS  F   +   
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETER 216
Query: 259 FTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFD 311
             D  G+  Y+AP+++      +    D W+ GV++Y LL+G  PF  +    +Q  I  
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
Query: 312 AVLKGHIDFESDPWPL-ISDSAKDLIRKMLCSQPSERL 348
            +LK        P+P  +S  AKDLI+++L   P +RL
Sbjct: 277 RILKS-----EPPYPQEMSALAKDLIQRLLMKDPKKRL 309

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 256
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 257 TARPTINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 144 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 200
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 201 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 256
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 257 TARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 87
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 148 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDV 204
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 205 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 260
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 261 TARPTINELL 270

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 131/268 (48%), Gaps = 14/268 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEVLC--MYNLPV 361
           + K+L   PS R+T  ++     YN P+
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 242 LHKILVENPSARITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 242 LHKILVENPSARITIPDI 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 242 LHKILVENPSARITIPDI 259

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 242 LHKILVENPSARITIPDI 259

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 63
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 124 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 240 LHKILVENPSARITIPDI 257

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 242 LHKILVENPSARITIPDI 259

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 105
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 166 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 222
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 223 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 278
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 279 TARPTINELL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 107
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 168 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 280
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 281 TARPTINELL 290

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NAMLNHE 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 242 LHKILVENPSARITIPDI 259

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/252 (32%), Positives = 131/252 (51%), Gaps = 16/252 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y + + +G+G FG   L    A+   +A K +SK ++I R D      E  IM   A   
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSP 135
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +  A++D   +++VME   GG+L + ++      E+ A   T  +V  ++A HS+G
Sbjct: 136 WVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 194
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTD-VVGSPYYVAPEVLLK-- 276
           ++HRD+KP+N LL   D    LK  DFG  +   + G +  D  VG+P Y++PEVL    
Sbjct: 195 LIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 277 ---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFESDPWPLISDS 331
              +YG E D W+ GV L+ +L G  PF+A++  G +  ++  K  + F  D    IS  
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPED--AEISKH 309
Query: 332 AKDLIRKMLCSQ 343
           AK+LI   L  +
Sbjct: 310 AKNLICAFLTDR 321

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/250 (33%), Positives = 125/250 (50%), Gaps = 10/250 (4%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H+++V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 81
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V+HRDL
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           K  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL K  +  E DV
Sbjct: 142 KLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W+ G I+Y LL G PPF     +  +  + K            I+  A  LI+KML + P
Sbjct: 199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH----INPVAASLIQKMLQTDP 254
Query: 345 SERLTAHEVL 354
           + R T +E+L
Sbjct: 255 TARPTINELL 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 126/258 (48%), Gaps = 12/258 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G  G   L     T    A K +  ++ +  +  E++++EI I + +  H+
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICI-NKMLNHE 64
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLLKH 277
           + HRD+KPEN LL  +D+   LK  DFGL+  F+     ++   + G+  YVAPE+L + 
Sbjct: 125 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 278 --YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             +    DVW+ G++L  +L+G  P W +      +           +PW  I  +   L
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 336 IRKMLCSQPSERLTAHEV 353
           + K+L   PS R+T  ++
Sbjct: 241 LHKILVENPSARITIPDI 258

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 124/246 (50%), Gaps = 9/246 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A  + +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
            +++ +  ++ V++   GGELF  + +   + E +A      I   +   HSL +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADV 284
           KPEN LL   D    +   DFGL     +     +   G+P Y+APEVL K  Y    D 
Sbjct: 166 KPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  G +LY +L G+PPF++     ++D +L   +  +    P I++SA+ L+  +L    
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 278
Query: 345 SERLTA 350
           ++RL A
Sbjct: 279 TKRLGA 284

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 138/262 (52%), Gaps = 26/262 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+ + + + +G+G FG   +         FA K ++K +++ R +    R E  ++ +  
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-G 131
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVV 213
             K I T+  A++D   +++VM+   GG+L   +     + +R   E+ R     +V  +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIAI 188
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDV-VGSPYYVAP 271
           ++ H L  +HRD+KP+N L+   D +  ++  DFG  +   + G + + V VG+P Y++P
Sbjct: 189 DSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 272 EVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           E+L         YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---F 302
Query: 326 PL----ISDSAKDLIRKMLCSQ 343
           P     +S++AKDLIR+++CS+
Sbjct: 303 PTQVTDVSENAKDLIRRLICSR 324

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 133/258 (51%), Gaps = 14/258 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLI-SREDVEDVRREIQIMH 154
           + + L R LG+G +G  +   ++    TG  FA K + K  ++ + +D    + E  I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            +  H  IV +  A++    +++++E  +GGELF ++ + G + E  A      I   + 
Sbjct: 77  EVK-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEV 273
             H  G+++RDLKPEN +L ++     +K  DFGL       G +     G+  Y+APE+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQG---HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L++  +    D W+ G ++Y +L+G PPF  E ++   D +LK  ++      P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEA 248
Query: 333 KDLIRKMLCSQPSERLTA 350
           +DL++K+L    + RL A
Sbjct: 249 RDLLKKLLKRNAASRLGA 266

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 133/258 (51%), Gaps = 14/258 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLI-SREDVEDVRREIQIMH 154
           + + L R LG+G +G  +   ++    TG  FA K + K  ++ + +D    + E  I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            +  H  IV +  A++    +++++E  +GGELF ++ + G + E  A      I   + 
Sbjct: 77  EVK-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEV 273
             H  G+++RDLKPEN +L ++     +K  DFGL       G +     G+  Y+APE+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQG---HVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEI 192
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L++  +    D W+ G ++Y +L+G PPF  E ++   D +LK  ++      P ++  A
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEA 248
Query: 333 KDLIRKMLCSQPSERLTA 350
           +DL++K+L    + RL A
Sbjct: 249 RDLLKKLLKRNAASRLGA 266

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 120/252 (47%), Gaps = 9/252 (3%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG   L     TG  +A K + K  ++  +DVE    E +I+     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H  +  +   ++    +  VME   GG+L   I +   + E +A      I+  +   H 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLLKH 277
            G+++RDLK +N LL   D +   K  DFG+       G       G+P Y+APE+L + 
Sbjct: 143 KGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            YGP  D W  GV+LY +L G  PF AE +  +F+A+L   + + +  W  + + A  ++
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LHEDATGIL 255
Query: 337 RKMLCSQPSERL 348
           +  +   P+ RL
Sbjct: 256 KSFMTKNPTMRL 267

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 112/206 (54%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 77
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   +++VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 77
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 78
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 138 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNE 220

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 77
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HRD+K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 111/206 (53%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT   K+GQG  GT Y   ++ATG E A + ++ ++   +E + +   EI +M     + 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRE-NKNP 78
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E  HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-FTDVVGSPYYVAPEVLL-KHY 278
           V+HR++K +N LL     D S+K  DFG      P Q   + +VG+PY++APEV+  K Y
Sbjct: 138 VIHRNIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 279 GPEADVWTAGVILYILLSGVPPFWAE 304
           GP+ D+W+ G++   ++ G PP+  E
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNE 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 135/259 (52%), Gaps = 14/259 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   +K+G+G FG   L      G ++  K I+  ++ S+E  E+ RRE+ ++ ++  H 
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMK-HP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRG-HYSERKAAELTRIIVGVVEACHS 218
           NIV  + ++E++  ++IVM+ C GG+LF RI  Q+G  + E +  +    I   ++  H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-K 276
             ++HRD+K +N  L     D +++  DFG++ V     ++    +G+PYY++PE+   K
Sbjct: 144 RKILHRDIKSQNIFLTK---DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISDSAKDL 335
            Y  ++D+W  G +LY L +    F A + + +   ++ G       P  L  S   + L
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLRSL 256
Query: 336 IRKMLCSQPSERLTAHEVL 354
           + ++    P +R + + +L
Sbjct: 257 VSQLFKRNPRDRPSVNSIL 275

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 124/251 (49%), Gaps = 11/251 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +   ++    +  VME   GG+L   I     +   +A      I+  ++  HS G
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D D  +K  DFG+      G   T+   G+P Y+APE+LL + Y
Sbjct: 139 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKY 195
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-WPLISDSAKDLIR 337
               D W+ GV+LY +L G  PF  + ++ +F ++    +D    P W  +   AKDL+ 
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMDNPFYPRW--LEKEAKDLLV 250
Query: 338 KMLCSQPSERL 348
           K+   +P +RL
Sbjct: 251 KLFVREPEKRL 261

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 33/262 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   L  E  +G + A K +  RK   RE + +   E+ IM     H N+V +
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQ-HFNVVEM 107
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + ++ME   GG L D I+ +   +E + A +   ++  +   H+ GV+HRD
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLKH-Y 278
           +K ++ LL     D  +K  DFG        QI  DV      VG+PY++APEV+ +  Y
Sbjct: 167 IKSDSILLTL---DGRVKLSDFGFC-----AQISKDVPKRKXLVGTPYWMAPEVISRSLY 218
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK----- 333
             E D+W+ G+++  ++ G PP+++       D+ ++        P P + +S K     
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFS-------DSPVQAMKRLRDSPPPKLKNSHKVSPVL 271
Query: 334 -DLIRKMLCSQPSERLTAHEVL 354
            D + +ML   P ER TA E+L
Sbjct: 272 RDFLERMLVRDPQERATAQELL 293

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 124/251 (49%), Gaps = 11/251 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +   ++    +  VME   GG+L   I     +   +A      I+  ++  HS G
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 139
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D D  +K  DFG+      G   T +  G+P Y+APE+LL + Y
Sbjct: 140 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP-WPLISDSAKDLIR 337
               D W+ GV+LY +L G  PF  + ++ +F ++    +D    P W  +   AKDL+ 
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMDNPFYPRW--LEKEAKDLLV 251
Query: 338 KMLCSQPSERL 348
           K+   +P +RL
Sbjct: 252 KLFVREPEKRL 262

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 213
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 273 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 324
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 383
Query: 339 MLCSQPSERLTAHEVL 354
           +L   P++R TA E+L
Sbjct: 384 LLVRDPAQRATAAELL 399

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 119/244 (48%), Gaps = 9/244 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++  L     +  + 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    ++ VME   GG+L   I Q G + E +A      I   +   H  G+++RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADV 284
           K +N +L   D +  +K  DFG+       G    +  G+P Y+APE++  + YG   D 
Sbjct: 147 KLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW 203
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV+LY +L+G PPF  E +  +F ++++ ++ +       +S  A  + + ++   P
Sbjct: 204 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSICKGLMTKHP 259
Query: 345 SERL 348
           ++RL
Sbjct: 260 AKRL 263

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 136
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 196 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 247
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 306
Query: 339 MLCSQPSERLTAHEVL 354
           +L   P++R TA E+L
Sbjct: 307 LLVRDPAQRATAAELL 322

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 29/260 (11%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + TE  TG + A K +  RK   RE + +   E+ IM     H N+V +
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYH-HDNVVDM 107
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APEV+ +  Y
Sbjct: 167 IKSDSILLTS---DGRIKLSDFGFC-----AQVSKEVPKRKXLVGTPYWMAPEVISRLPY 218
Query: 279 GPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           G E D+W+ G+++  ++ G PP++ E      + I D++     D        +S   + 
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHK-----VSSVLRG 273
Query: 335 LIRKMLCSQPSERLTAHEVL 354
            +  ML  +PS+R TA E+L
Sbjct: 274 FLDLMLVREPSQRATAQELL 293

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 93
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 153 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 204
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 205 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 263
Query: 339 MLCSQPSERLTAHEVL 354
           +L   P++R TA E+L
Sbjct: 264 LLVRDPAQRATAAELL 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 91
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 151 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 202
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 203 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 261
Query: 339 MLCSQPSERLTAHEVL 354
           +L   P++R TA E+L
Sbjct: 262 LLVRDPAQRATAAELL 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 86
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 146 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 197
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 198 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 256
Query: 339 MLCSQPSERLTAHEVL 354
           +L   P++R TA E+L
Sbjct: 257 LLVRDPAQRATAAELL 272

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G+G  G   + T  ++G   A K +  RK   RE + +   E+ IM     H+N+V +
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQ-HENVVEM 82
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
             +Y     + +VME   GG L D I+     +E + A +   ++  +   H+ GV+HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV------VGSPYYVAPEVLLK-HY 278
           +K ++ LL +   D  +K  DFG        Q+  +V      VG+PY++APE++ +  Y
Sbjct: 142 IKSDSILLTH---DGRVKLSDFGFC-----AQVSKEVPRRKXLVGTPYWMAPELISRLPY 193
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ G+++  ++ G PP++ E        +++ ++         +S S K  + +
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDR 252
Query: 339 MLCSQPSERLTAHEVL 354
           +L   P++R TA E+L
Sbjct: 253 LLVRDPAQRATAAELL 268

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 128/256 (50%), Gaps = 16/256 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVE-DVRREIQIMHHL 156
           + L + LGQG FG  +L  +I+       +A K + K  L  R+ V   + R+I +    
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE--- 82
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    ++++++   GG+LF R+ +   ++E         +   ++  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLL 275
           HSLG+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ 
Sbjct: 143 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255
Query: 335 LIRKMLCSQPSERLTA 350
           L+R +    P+ RL A
Sbjct: 256 LLRMLFKRNPANRLGA 271

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 137/262 (52%), Gaps = 26/262 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+ + + + +G+G FG   +     T   +A K ++K +++ R +    R E  ++ +  
Sbjct: 89  REDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-G 147
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VV 213
             + I  +  A++D   +++VM+   GG+L   +     + ++   ++ R  +G     +
Sbjct: 148 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEMVLAI 204
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAP 271
           ++ H L  +HRD+KP+N LL   D +  ++  DFG  +     G + + V VG+P Y++P
Sbjct: 205 DSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISP 261
Query: 272 EVL------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           E+L      +  YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---F 318
Query: 326 PL----ISDSAKDLIRKMLCSQ 343
           P     +S+ AKDLI++++CS+
Sbjct: 319 PSHVTDVSEEAKDLIQRLICSR 340

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 137/262 (52%), Gaps = 26/262 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+ + + + +G+G FG   +     T   +A K ++K +++ R +    R E  ++ +  
Sbjct: 73  REDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN-G 131
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG----VV 213
             + I  +  A++D   +++VM+   GG+L   +     + ++   ++ R  +G     +
Sbjct: 132 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEMVLAI 188
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAP 271
           ++ H L  +HRD+KP+N LL   D +  ++  DFG  +     G + + V VG+P Y++P
Sbjct: 189 DSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISP 245
Query: 272 EVL------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           E+L      +  YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+   +
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---F 302
Query: 326 PL----ISDSAKDLIRKMLCSQ 343
           P     +S+ AKDLI++++CS+
Sbjct: 303 PSHVTDVSEEAKDLIQRLICSR 324

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 128/256 (50%), Gaps = 16/256 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVE-DVRREIQIMHHL 156
           + L + LGQG FG  +L  +I+       +A K + K  L  R+ V   + R+I +    
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE--- 82
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    ++++++   GG+LF R+ +   ++E         +   ++  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLL 275
           HSLG+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ 
Sbjct: 143 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255
Query: 335 LIRKMLCSQPSERLTA 350
           L+R +    P+ RL A
Sbjct: 256 LLRMLFKRNPANRLGA 271

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 128/256 (50%), Gaps = 16/256 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIE---FACKSISKRKLISREDVE-DVRREIQIMHHL 156
           + L + LGQG FG  +L  +I+       +A K + K  L  R+ V   + R+I +    
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE--- 83
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             H  IV +  A++    ++++++   GG+LF R+ +   ++E         +   ++  
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLL 275
           HSLG+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ 
Sbjct: 144 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ 
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 256
Query: 335 LIRKMLCSQPSERLTA 350
           L+R +    P+ RL A
Sbjct: 257 LLRMLFKRNPANRLGA 272

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 191
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 245
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 246 R----VSSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 190
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 244
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 245 R----VSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 131/254 (51%), Gaps = 16/254 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           + L + LGQG FG  +L  ++    +G  +A K + K  L  R+ V   + E  I+  + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKMERDILADV- 87
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA-ELTRIIVGVVEAC 216
            H  +V +  A++    ++++++   GG+LF R+ +   ++E      L  + +G+ +  
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGL-DHL 146
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAPEVLL 275
           HSLG+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ 
Sbjct: 147 HSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
           +  +   AD W+ GV+++ +L+G  PF  + ++     +LK  +         +S  A+ 
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTEAQS 259
Query: 335 LIRKMLCSQPSERL 348
           L+R +    P+ RL
Sbjct: 260 LLRALFKRNPANRL 273

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 218
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 272
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 273 R----VSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 35  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 210
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 264
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 265 R----VSSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 258 R----VSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 191
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 245
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 246 R----VSXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 15  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 74
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 75  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 134
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 190
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 244
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 245 R----VSXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 43  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 102
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 103 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 162
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 218
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 272
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 273 R----VSXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 130/262 (49%), Gaps = 24/262 (9%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 158 -GHKNIVTIKGAYE--DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            G   ++ +   +E  DS  V I+  +    +LFD I +RG   E  A      ++  V 
Sbjct: 70  SGFSGVIRLLDWFERPDSF-VLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 215 ACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
            CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEW 184
Query: 274 LLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S  
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSE 234
Query: 332 AKDLIRKMLCSQPSERLTAHEV 353
            + LIR  L  +PS+R T  E+
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEI 256

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 48  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 107
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 108 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 167
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 223
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 277
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 278 R----VSXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 124/249 (49%), Gaps = 11/249 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G   + E +A      I   +E  H   
Sbjct: 249 LAYAYETKDALC--LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G +LY +++G  PF    ++   + V +   +   +     S  A+ L  ++
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 340 LCSQPSERL 348
           LC  P+ERL
Sbjct: 424 LCKDPAERL 432

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 136/271 (50%), Gaps = 33/271 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD + + + +G+G F    +     TG  +A K ++K  ++ R +V   R E  ++ +  
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-G 118
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----IVGVV 213
             + I  +  A++D   +++VME   GG+L   + +   + ER  AE+ R     IV  +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAI 175
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAP 271
           ++ H LG +HRD+KP+N LL   D    ++  DFG  +  +  G + + V VG+P Y++P
Sbjct: 176 DSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 272 EVL--------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL--KGHIDFE 321
           E+L           YGPE D W  GV  Y +  G  PF+A++    +  ++  K H+   
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL- 291
Query: 322 SDPWPLISDS----AKDLIRKMLCSQPSERL 348
               PL+ +     A+D I+++LC  P  RL
Sbjct: 292 ----PLVDEGVPEEARDFIQRLLCP-PETRL 317

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/249 (32%), Positives = 124/249 (49%), Gaps = 11/249 (4%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R LG+G FG    C   ATG  +ACK + K+++  R+       E QI+  +   + +V+
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 248
Query: 165 IKGAYE--DSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLG 220
           +  AYE  D+LC  +V+ L  GG+L   I   G   + E +A      I   +E  H   
Sbjct: 249 LAYAYETKDALC--LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W  G +LY +++G  PF    ++   + V +   +   +     S  A+ L  ++
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 340 LCSQPSERL 348
           LC  P+ERL
Sbjct: 424 LCKDPAERL 432

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 236
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 237 QHLIRWCLALRPSDRPTFEEI 257

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 258 R----VSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 258 R----VSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 22/262 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHH 155
           Y+    LG G FG  +   +     E   K I K K++    +ED     V  EI I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           +  H NI+ +   +E+     +VME    G +LF  I +     E  A+ + R +V  V 
Sbjct: 86  VE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
                 ++HRD+K EN ++    +DF++K IDFG + + + G++F    G+  Y APEVL
Sbjct: 145 YLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +   + GPE ++W+ GV LY L+    PF  E ++ +  A+          P  L+S   
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAI---------HPPYLVSKEL 251
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
             L+  +L   P  R T  +++
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLV 273

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 259 R----VSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 236
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 237 QHLIRWCLALRPSDRPTFEEI 257

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 259 R----VSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 185
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 235
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 236 QHLIRWCLALRPSDRPTFEEI 256

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 28  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 87
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 88  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 147
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 203
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 257
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 258 R----VSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 259 R----VSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 29  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 88
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 89  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 148
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 204
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F  
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQ 258
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +PS+R T  E+
Sbjct: 259 R----VSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 186
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 236
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 237 QHLIRWCLALRPSDRPTFEEI 257

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 184
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 234
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 235 QHLIRWCLALRPSDRPTFEEI 255

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSSEC 231
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 131/271 (48%), Gaps = 22/271 (8%)
Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-- 148
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R  
Sbjct: 16  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 75
Query: 149 -EIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 76  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 135
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDG 191
Query: 265 SPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES 322
           +  Y  PE +  H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F  
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ 245
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                +S   + LIR  L  +P +R T  E+
Sbjct: 246 R----VSXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSXEC 231
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 7/216 (3%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I + Y +  KLG G   T YL  +    I+ A K+I        E ++   RE+     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           + H+NIV++    E+  C ++VME   G  L + I   G  S   A   T  I+  ++  
Sbjct: 69  S-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVL 274
           H + ++HRD+KP+N L+   D + +LK  DFG++       +     V+G+  Y +PE  
Sbjct: 128 HDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 275 LKHYGPE-ADVWTAGVILYILLSGVPPFWAETQQGI 309
                 E  D+++ G++LY +L G PPF  ET   I
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 208
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S   
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VSXEC 258
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 259 QHLIRWCLALRPSDRPTFEEI 279

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 127/283 (44%), Gaps = 37/283 (13%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---------------------- 138
           YTL  ++G+G +G   L         +A K +SK+KLI                      
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 139 -SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM--ELCAGGELFDRIIQRG 195
             R  +E V +EI I+  L  H N+V +    +D    H+ M  EL   G + + +    
Sbjct: 75  QPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             SE +A    + ++  +E  H   ++HRD+KP N L+    +D  +K  DFG+S  FK 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEFKG 189
Query: 256 GQ-IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIF 310
              + ++ VG+P ++APE L +      G   DVW  GV LY  + G  PF  E    + 
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
             +    ++F   P   I++  KDLI +ML   P  R+   E+
Sbjct: 250 SKIKSQALEFPDQPD--IAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 124/263 (47%), Gaps = 22/263 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VRREIQIMHHLA 157
           Y LG  LG+G FGT +    +   ++ A K I + +++    + D      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 158 ---GHKNIVTIKGAYEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
              GH  ++ +   +E      +V+E      +LFD I ++G   E  +      +V  +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           + CHS GV+HRD+K EN L+  +      K IDFG        + +TD  G+  Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLH-DEPYTDFDGTRVYSPPEW 209
Query: 274 LLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           + +H  +   A VW+ G++LY ++ G  PF  E  Q I +A L     F +     +S  
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILEAELH----FPAH----VSPD 259
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
              LIR+ L  +PS R +  E+L
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEIL 282

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 127/261 (48%), Gaps = 22/261 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR---EIQIMHHLA 157
           Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +  R   E+ ++  ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 158 -GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
            G   ++ +   +E      +++E      +LFD I +RG   E  A      ++  V  
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 216 CHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           CH+ GV+HRD+K EN L+ +N+ +   LK IDFG     K   ++TD  G+  Y  PE +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWI 181
Query: 275 LKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             H  +G  A VW+ G++LY ++ G  PF  + +      ++ G + F       +S   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIGGQVFFRQR----VSSEC 231
Query: 333 KDLIRKMLCSQPSERLTAHEV 353
           + LIR  L  +PS+R T  E+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEI 252

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/264 (31%), Positives = 136/264 (51%), Gaps = 12/264 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +   R LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVE 214
            + IV++  A+E    + +VM +  GG++   I         + E +A   T  IV  +E
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+
Sbjct: 304 HLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDS 331
           LL + Y    D +  GV LY +++   PF A  ++ + +  LK  +  ++  +P   S +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYPDKFSPA 419
Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           +KD    +L   P +RL   +  C
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSC 443

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 13/257 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D + + R +G+G FG   +  +  T   +A K ++K+K + R +V +V +E+QIM  L  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE- 73
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H  +V +  +++D   + +V++L  GG+L   + Q  H+ E         +V  ++   +
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
             ++HRD+KP+N LL   D+   +   DF ++         T + G+  Y+APE+     
Sbjct: 134 QRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 278 ---YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--WPLISDSA 332
              Y    D W+ GV  Y LL G  P+   +     + V        + P  W   S   
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW---SQEM 247
Query: 333 KDLIRKMLCSQPSERLT 349
             L++K+L   P +R +
Sbjct: 248 VSLLKKLLEPNPDQRFS 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 114/244 (46%), Gaps = 9/244 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    ++ VME   GG+L   I Q G + E  A      I   +    S G+++RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADV 284
           K +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   D 
Sbjct: 469 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV+LY +L+G  PF  E +  +F ++++ ++ +       +S  A  + + ++   P
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 581
Query: 345 SERL 348
            +RL
Sbjct: 582 GKRL 585

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 114/244 (46%), Gaps = 9/244 (3%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
             ++    ++ VME   GG+L   I Q G + E  A      I   +    S G+++RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 227 KPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADV 284
           K +N +L   D +  +K  DFG+       G       G+P Y+APE++  + YG   D 
Sbjct: 148 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 285 WTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQP 344
           W  GV+LY +L+G  PF  E +  +F ++++ ++ +       +S  A  + + ++   P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 260
Query: 345 SERL 348
            +RL
Sbjct: 261 GKRL 264

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 47/285 (16%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           K+G+G +G  + C    TG     + ++ +K +  ED   ++    REI+++  L  H N
Sbjct: 10  KIGEGSYGVVFKCRNRDTG-----QIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPN 63
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V +   +     +H+V E C    L   DR  QRG   E     +T   +  V  CH  
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY-QRG-VPEHLVKSITWQTLQAVNFCHKH 121
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL--K 276
             +HRD+KPEN L+        +K  DFG +     P   + D V + +Y +PE+L+   
Sbjct: 122 NCIHRDVKPENILITKHS---VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAET--------QQGIFDAVLKGHIDFES------ 322
            YGP  DVW  G +   LLSGVP +  ++        ++ + D + +    F +      
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 323 ----DP---------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
               DP         +P IS  A  L++  L   P+ERLT  ++L
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 131/307 (42%), Gaps = 65/307 (21%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR---REIQIMHH 155
           D + + R  GQG FGT  L  E +TG+  A K +          ++D R   RE+QIM  
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----------IQDPRFRNRELQIMQD 72
Query: 156 LA--GHKNIVTIKGAY-------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           LA   H NIV ++  +          + +++VME     +   R   R +Y  + A    
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCC-RNYYRRQVAPPPI 129
Query: 207 RIIVGVVEACHSLG--------VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI 258
            I V + +   S+G        V HRD+KP N +LVN+ D  +LK  DFG +    P + 
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADG-TLKLCDFGSAKKLSPSEP 187
Query: 259 FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK- 315
               + S YY APE++   +HY    D+W+ G I   ++ G P F  +   G    +++ 
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 316 --------------GHIDFE-----SDPWPLI--------SDSAKDLIRKMLCSQPSERL 348
                          H D +       PW  +        +  A DL+  +L   P ER+
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 349 TAHEVLC 355
             +E LC
Sbjct: 308 KPYEALC 314

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 118/262 (45%), Gaps = 18/262 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 131 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 187
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 243
Query: 330 DSAKDLIRKMLCSQPSERLTAH 351
             A  +++  L   P ERL  H
Sbjct: 244 VKAASVLKSFLNKDPKERLGCH 265

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 118/262 (45%), Gaps = 18/262 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 127 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 183
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 239
Query: 330 DSAKDLIRKMLCSQPSERLTAH 351
             A  +++  L   P ERL  H
Sbjct: 240 VKAASVLKSFLNKDPKERLGCH 261

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 118/262 (45%), Gaps = 18/262 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A + + K  +   ED++ V+ E  +    + H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 174 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 286
Query: 330 DSAKDLIRKMLCSQPSERLTAH 351
             A  +++  L   P ERL  H
Sbjct: 287 VKAASVLKSFLNKDPKERLGCH 308

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 123/253 (48%), Gaps = 18/253 (7%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y    +  G+  A K +    L+  +   D  +EI ++  L  H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 92
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRII-----QRGHYSERKAAELTRIIVGVVEA 215
           N++    ++ +   ++IV+EL   G+L  R+I     Q+    ER   +    +   +E 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-DVVGSPYYVAPEVL 274
            HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            ++ Y  ++D+W+ G +LY + +   PF+ + +  ++    K     + D  PL SD   
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCKKIE---QCDYPPLPSDHYS 264
Query: 334 DLIRKM--LCSQP 344
           + +R++  +C  P
Sbjct: 265 EELRQLVNMCINP 277

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 133/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++   +    I    +   K +   K         ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KNKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 117/259 (45%), Gaps = 18/259 (6%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L R +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +V +   ++    +  V+E   GG+L   + ++    E  A   +  I   +   H  G
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGL-SVFFKPGQIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N LL   D +  +K  D+G+     +PG   +   G+P Y+APE+L  + Y
Sbjct: 142 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 279 GPEADVWTAGVILYILLSGVPPF---------WAETQQGIFDAVLKGHIDFESDPWPLIS 329
           G   D W  GV+++ +++G  PF            T+  +F  +L+  I         +S
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----MS 254
Query: 330 DSAKDLIRKMLCSQPSERL 348
             A  +++  L   P ERL
Sbjct: 255 VKAASVLKSFLNKDPKERL 273

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 132/276 (47%), Gaps = 37/276 (13%)
Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T    +++ +  KLG+G +G+ Y      TG   A K +         D++++ +EI IM
Sbjct: 24  TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIM 78
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV 212
                  ++V   G+Y  +  + IVME C  G + D I  R    +E + A + +  +  
Sbjct: 79  QQ-CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-------VVGS 265
           +E  H +  +HRD+K  N LL   + +   K  DFG++     GQ+ TD       V+G+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVA-----GQL-TDXMAKRNXVIGT 188
Query: 266 PYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
           P+++APEV+ +  Y   AD+W+ G+    +  G PP+ A+         ++      ++P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY-ADIHP------MRAIFMIPTNP 241
Query: 325 WP------LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            P      L SD+  D +++ L   P +R TA ++L
Sbjct: 242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLL 277

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 15/265 (5%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 50  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 110 KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL    +   +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 169 YLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVI 222
Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S  W   S
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 279
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           +  ++ +   L   P +R T+  +L
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLL 304

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 20/219 (9%)
Query: 149 EIQIMHHLAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII----QRGHYSERKA 202
           E+ ++  L  H NIV       D  +  ++IVME C GG+L   I     +R +  E   
Sbjct: 55  EVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 203 AELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +   +   ++ CH        V+HRDLKP N  L  K +   +K  DFGL+      +
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDE 170
Query: 258 IFT-DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            F  + VG+PYY++PE + +  Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           G   F   P+   SD   ++I +ML  +   R +  E+L
Sbjct: 231 GK--FRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 15/265 (5%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 71  KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL    +   +K  DFG +    P   F   VG+PY++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVI 183
Query: 275 LK----HYGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           L      Y  + DVW+ G+    L    PP F       ++          +S  W   S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 240
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
           +  ++ +   L   P +R T+  +L
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLL 265

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 149 EIQIMHHLAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII----QRGHYSERKA 202
           E+ ++  L  H NIV       D  +  ++IVME C GG+L   I     +R +  E   
Sbjct: 55  EVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 203 AELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +   +   ++ CH        V+HRDLKP N  L  K +   +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDT 170
Query: 258 IFTDV-VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            F    VG+PYY++PE + +  Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           G   F   P+   SD   ++I +ML  +   R +  E+L
Sbjct: 231 GK--FRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 149 EIQIMHHLAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII----QRGHYSERKA 202
           E+ ++  L  H NIV       D  +  ++IVME C GG+L   I     +R +  E   
Sbjct: 55  EVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 203 AELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
             +   +   ++ CH        V+HRDLKP N  L  K +   +K  DFGL+       
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDT 170
Query: 258 IFTDV-VGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            F    VG+PYY++PE + +  Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           G   F   P+   SD   ++I +ML  +   R +  E+L
Sbjct: 231 GK--FRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 135/293 (46%), Gaps = 45/293 (15%)
Query: 78  MRRGID-NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK 136
           +RR +D N+ + ++G              +LG G FG  Y      TG   A K I  + 
Sbjct: 11  VRRDLDPNEVWEIVG--------------ELGDGAFGKVYKAKNKETGALAAAKVIETK- 55
Query: 137 LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI---IQ 193
             S E++ED   EI+I+     H  IV + GAY     + I++E C GG + D I   + 
Sbjct: 56  --SEEELEDYIVEIEILA-TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELD 111
Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF- 252
           RG  +E +   + R ++  +   HS  ++HRDLK  N L+  + D   ++  DFG+S   
Sbjct: 112 RG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKN 167
Query: 253 FKPGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            K  Q     +G+PY++APEV++        Y  +AD+W+ G+ L  +    PP      
Sbjct: 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVL 354
             +   + K      SDP  L++ S      +D ++  L   P  R +A ++L
Sbjct: 228 MRVLLKIAK------SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 135/293 (46%), Gaps = 45/293 (15%)
Query: 78  MRRGID-NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK 136
           +RR +D N+ + ++G              +LG G FG  Y      TG   A K I  + 
Sbjct: 3   VRRDLDPNEVWEIVG--------------ELGDGAFGKVYKAKNKETGALAAAKVIETK- 47
Query: 137 LISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI---IQ 193
             S E++ED   EI+I+     H  IV + GAY     + I++E C GG + D I   + 
Sbjct: 48  --SEEELEDYIVEIEILA-TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELD 103
Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF- 252
           RG  +E +   + R ++  +   HS  ++HRDLK  N L+  + D   ++  DFG+S   
Sbjct: 104 RG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKN 159
Query: 253 FKPGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
            K  Q     +G+PY++APEV++        Y  +AD+W+ G+ L  +    PP      
Sbjct: 160 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 219
Query: 307 QGIFDAVLKGHIDFESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVL 354
             +   + K      SDP  L++ S      +D ++  L   P  R +A ++L
Sbjct: 220 MRVLLKIAK------SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 266

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 55/293 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMH 154
           Y    K+G+G +G  Y   + + G   A K I       R D ED        REI ++ 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-------RLDAEDEGIPSTAIREISLLK 74
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII---QRGHYSERKAAELTRIIVG 211
            L  H NIV++        C+ +V E         +++   + G    +    L +++ G
Sbjct: 75  ELH-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
           V   CH   ++HRDLKP+N LL+N D   +LK  DFGL+  F  P + +T  V + +Y A
Sbjct: 132 VAH-CHQHRILHRDLKPQN-LLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPF-----------------------WAET 305
           P+VL+  K Y    D+W+ G I   +++G P F                       W + 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 306 QQGIFDAVLKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           Q+          + FE  PW    P       DL+  MLC  P++R++A + +
Sbjct: 248 QELPLWKQRTFQV-FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGH 159
           Y +G  LG+G +G      +  T    A K + K+KL    + E +V++EIQ++  L  H
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65
Query: 160 KNIVTIKGAY--EDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           KN++ +      E+   +++VME C  G  E+ D + ++     +      ++I G+ E 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL-EY 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP---GQIFTDVVGSPYYVAPE 272
            HS G++H+D+KP N LL       +LK    G++    P           GSP +  PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGG---TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 273 V---LLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           +   L    G + D+W+AGV LY + +G+ PF  +    +F+ + KG      D  P +S
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 330 DSAKDLIRKMLCSQPSERLTAHEV 353
               DL++ ML  +P++R +  ++
Sbjct: 242 ----DLLKGMLEYEPAKRFSIRQI 261

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 55/293 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMH 154
           Y    K+G+G +G  Y   + + G   A K I       R D ED        REI ++ 
Sbjct: 23  YQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-------RLDAEDEGIPSTAIREISLLK 74
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII---QRGHYSERKAAELTRIIVG 211
            L  H NIV++        C+ +V E         +++   + G    +    L +++ G
Sbjct: 75  ELH-HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
           V   CH   ++HRDLKP+N LL+N D   +LK  DFGL+  F  P + +T  V + +Y A
Sbjct: 132 VAH-CHQHRILHRDLKPQN-LLINSDG--ALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPF-----------------------WAET 305
           P+VL+  K Y    D+W+ G I   +++G P F                       W + 
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 306 QQGIFDAVLKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           Q+          + FE  PW    P       DL+  MLC  P++R++A + +
Sbjct: 248 QELPLWKQRTFQV-FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           ++ L   +G G +G  Y    + TG   A K +     ++ ++ E++++EI ++   + H
Sbjct: 25  IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHH 80
Query: 160 KNIVTIKGAY--------EDSLCVHIVMELCAGGELFDRI--IQRGHYSERKAAELTRII 209
           +NI T  GA+        +D L   +VME C  G + D I   +     E   A + R I
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVGSPY 267
           +  +   H   V+HRD+K +N LL    ++  +K +DFG+S       G+  T  +G+PY
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPY 194
Query: 268 YVAPEVLLKHYGPEA------DVWTAGVILYILLSGVPPF 301
           ++APEV+     P+A      D+W+ G+    +  G PP 
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 140/322 (43%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +   T  +   Y   + +G G  G      +   GI  A K +S R  
Sbjct: 3   KSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ ++     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYREL-VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           I      ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IHMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPF--------W 302
                 + T  V + YY APEV+L   Y    D+W+ G I+  L+ G   F        W
Sbjct: 175 TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQW 234
Query: 303 AE------TQQGIFDAVLKGHID--FESDP-------------WPLISDS---------A 332
            +      T    F A L+  +    E+ P             W   S+S         A
Sbjct: 235 NKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P +R++  E L
Sbjct: 295 RDLLSKMLVIDPDKRISVDEAL 316

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++VG+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLVGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ GVI+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 109/252 (43%), Gaps = 39/252 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L +KLG+G +G  +   +  TG   A K I      +  D +   REI I+  L+GH+
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGHE 69
Query: 161 NIVTIKGAYE-----DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NIV +          D   V   ME      +   I++  H        +   ++ V++ 
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH-----KQYVVYQLIKVIKY 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---------------------- 253
            HS G++HRD+KP N LL   + +  +K  DFGLS  F                      
Sbjct: 125 LHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 254 KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
               I TD V + +Y APE+LL    Y    D+W+ G IL  +L G P F   +     +
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 312 AVLKGHIDFESD 323
            ++ G IDF S+
Sbjct: 242 RII-GVIDFPSN 252

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 89/171 (52%), Gaps = 17/171 (9%)
Query: 186 ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKA 244
           +LFD I +RG   E  A      ++  V  CH+ GV+HRD+K EN L+ +N+ +   LK 
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKL 199
Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFW 302
           IDFG     K   ++TD  G+  Y  PE +  H  +G  A VW+ G++LY ++ G  PF 
Sbjct: 200 IDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258
Query: 303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
            + +      +++G + F       +S   + LIR  L  +PS+R T  E+
Sbjct: 259 HDEE------IIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 28/262 (10%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G +G  Y   +++  +  A K I +R   SR   + +  EI +  HL  HKNIV   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYS-QPLHEEIALHKHLK-HKNIVQYL 85
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-----LTRIIVGVVEACHSLGV 221
           G++ ++  + I ME   GG L    + R  +   K  E      T+ I+  ++  H   +
Sbjct: 86  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 222 MHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLLKH- 277
           +HRD+K +N L+    + +S  LK  DFG S         T+   G+  Y+APE++ K  
Sbjct: 144 VHRDIKGDNVLI----NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 278 --YGPEADVWTAGVILYILLSGVPPFW--AETQQGIFD-AVLKGHIDFESDPWPLISDSA 332
             YG  AD+W+ G  +  + +G PPF+   E Q  +F   + K H +        +S  A
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES----MSAEA 255
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           K  I K     P +R  A+++L
Sbjct: 256 KAFILKCFEPDPDKRACANDLL 277

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 156 LAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV 212
              H NIV +  A  YE++L   I++E CAGG +   +++     +E +   + +  +  
Sbjct: 91  -CDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +   H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++AP
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 272 EVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP- 324
           EV++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P 
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            W   S + KD ++K L      R T  ++L
Sbjct: 265 RW---SSNFKDFLKKCLEKNVDARWTTSQLL 292

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++VG+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLVGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ GVI+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 156 LAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV 212
              H NIV +  A  YE++L   I++E CAGG +   +++     +E +   + +  +  
Sbjct: 91  -CDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +   H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++AP
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 272 EVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP- 324
           EV++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P 
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            W   S + KD ++K L      R T  ++L
Sbjct: 265 RW---SSNFKDFLKKCLEKNVDARWTTSQLL 292

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 124/263 (47%), Gaps = 28/263 (10%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G +G  Y   +++  +  A K I +R   SR   + +  EI +  HL  HKNIV   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYS-QPLHEEIALHKHLK-HKNIVQYL 71
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-----LTRIIVGVVEACHSLGV 221
           G++ ++  + I ME   GG L    + R  +   K  E      T+ I+  ++  H   +
Sbjct: 72  GSFSENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 222 MHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEVLLKH- 277
           +HRD+K +N L+    + +S  LK  DFG S         T+   G+  Y+APE++ K  
Sbjct: 130 VHRDIKGDNVLI----NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 278 --YGPEADVWTAGVILYILLSGVPPFW--AETQQGIFD-AVLKGHIDFESDPWPLISDSA 332
             YG  AD+W+ G  +  + +G PPF+   E Q  +F   + K H +        +S  A
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES----MSAEA 241
Query: 333 KDLIRKMLCSQPSERLTAHEVLC 355
           K  I K     P +R  A+++L 
Sbjct: 242 KAFILKCFEPDPDKRACANDLLV 264

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 142/329 (43%), Gaps = 54/329 (16%)
Query: 72  SKKDNIMRRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK 130
           +K  N+ +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K
Sbjct: 34  AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAG 184
            +S R   ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL   
Sbjct: 94  KLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 151
Query: 185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA 244
                ++IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK 
Sbjct: 152 N--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205
Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG 297
           +DFGL+       + T  V + YY APEV+L   Y    D+W+ G I+       IL  G
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 298 -----------------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP------ 326
                             P F  + Q  + + V        L     F    +P      
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325
Query: 327 -LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            L +  A+DL+ KML   P++R++  + L
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDAL 354

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 142/329 (43%), Gaps = 54/329 (16%)
Query: 72  SKKDNIMRRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK 130
           +K  N+ +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K
Sbjct: 34  AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAG 184
            +S R   ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL   
Sbjct: 94  KLS-RPFQNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 151
Query: 185 GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA 244
                ++IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK 
Sbjct: 152 N--LCQVIQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205
Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG 297
           +DFGL+       + T  V + YY APEV+L   Y    D+W+ G I+       IL  G
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 298 -----------------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP------ 326
                             P F  + Q  + + V        L     F    +P      
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325
Query: 327 -LISDSAKDLIRKMLCSQPSERLTAHEVL 354
            L +  A+DL+ KML   P++R++  + L
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDAL 354

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI I+  
Sbjct: 34  NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILAS 90
Query: 156 LAGHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV 212
              H NIV +  A  YE++L   I++E CAGG +   +++     +E +   + +  +  
Sbjct: 91  -CDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV-FFKPGQIFTDVVGSPYYVAP 271
           +   H   ++HRDLK  N L     D   +K  DFG+S    +  Q     +G+PY++AP
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 272 EVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP- 324
           EV++      + Y  +ADVW+ G+ L  +    PP        +   + K      + P 
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            W   S + KD ++K L      R T  ++L
Sbjct: 265 RW---SSNFKDFLKKCLEKNVDARWTTSQLL 292

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLXGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 295 RDLLSKMLVIDPAKRISVDDAL 316

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 295 RDLLSKMLVIDPAKRISVDDAL 316

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/319 (26%), Positives = 139/319 (43%), Gaps = 54/319 (16%)
Query: 82  IDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR 140
           +D+Q Y V +   T  +   Y   + +G G  G      +   GI  A K +S R   ++
Sbjct: 4   MDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQ 62
Query: 141 EDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQR 194
              +   RE+ ++     HKNI+++   +      E+   V++VMEL        ++I  
Sbjct: 63  THAKRAYREL-VLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHM 119
Query: 195 GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
               ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+    
Sbjct: 120 ELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAS 175
Query: 255 PGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPF--------WAE- 304
              + T  V + YY APEV+L   Y    D+W+ G I+  L+ G   F        W + 
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 235
Query: 305 -----TQQGIFDAVLKGHID--FESDP-------------WPLISDS---------AKDL 335
                T    F A L+  +    E+ P             W   S+S         A+DL
Sbjct: 236 IEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDL 295
Query: 336 IRKMLCSQPSERLTAHEVL 354
           + KML   P +R++  E L
Sbjct: 296 LSKMLVIDPDKRISVDEAL 314

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++VG+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLVGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLXGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 295 RDLLSKMLVIDPAKRISVDDAL 316

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 127/307 (41%), Gaps = 58/307 (18%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIM 153
           NI   + L   LG+G +G     T   TG   A K I    + L +   +    REI+I+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKIL 63
Query: 154 HHLAGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            H   H+NI+TI       ++E+   V+I+ EL        R+I     S+         
Sbjct: 64  KHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---------- 258
            +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+                  
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 259 -FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFD 311
             T+ V + +Y APEV+L    Y    DVW+ G IL  L    P F    +      IF 
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 312 AVLKGHID--------------------FESDP----WPLISDSAKDLIRKMLCSQPSER 347
            +   H D                    + + P    +P ++    DL+++ML   P++R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 348 LTAHEVL 354
           +TA E L
Sbjct: 298 ITAKEAL 304

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMKXV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 295 RDLLSKMLVIDPAKRISVDDAL 316

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 127/307 (41%), Gaps = 58/307 (18%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIM 153
           NI   + L   LG+G +G     T   TG   A K I    + L +   +    REI+I+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKIL 63
Query: 154 HHLAGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            H   H+NI+TI       ++E+   V+I+ EL        R+I     S+         
Sbjct: 64  KHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---------- 258
            +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+                  
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 259 -FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFD 311
             T+ V + +Y APEV+L    Y    DVW+ G IL  L    P F    +      IF 
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 312 AVLKGHID--------------------FESDP----WPLISDSAKDLIRKMLCSQPSER 347
            +   H D                    + + P    +P ++    DL+++ML   P++R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 348 LTAHEVL 354
           +TA E L
Sbjct: 298 ITAKEAL 304

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 134/272 (49%), Gaps = 29/272 (10%)
Query: 95  DNIRD---LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVR 147
           +NI D   L+T   ++G+G FG      E+  GI+   + +   K+I    + +++ED++
Sbjct: 16  NNIADPEELFTKLERIGKGSFG------EVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ 69
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
           +EI ++        +    G+Y     + I+ME   GG   D +++ G + E + A + +
Sbjct: 70  QEITVLSQ-CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLK 127
Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSP 266
            I+  ++  HS   +HRD+K  N LL  + D   +K  DFG++      QI  +  VG+P
Sbjct: 128 EILKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTP 184
Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           +++APEV+ +  Y  +AD+W+ G+    L  G PP        +   + K      ++P 
Sbjct: 185 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK------NNPP 238
Query: 326 PLISD---SAKDLIRKMLCSQPSERLTAHEVL 354
            L+ D   S K+ I   L   PS R TA E+L
Sbjct: 239 TLVGDFTKSFKEFIDACLNKDPSFRPTAKELL 270

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 54/287 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAGHKNI 162
           K+G+G +G  Y       G  FA K I     + +ED        REI I+  L  H NI
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIR----LEKEDEGIPSTTIREISILKELK-HSNI 62
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEA 215
           V +   Y+    +H    L    E  D+ +++       G  S    + L +++ G+   
Sbjct: 63  VKL---YD---VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-Y 115
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  V + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +  K Y    D+W+ G I   +++G P F   ++      + +      S  WP +++  
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 333 K-------------------------DLIRKMLCSQPSERLTAHEVL 354
           K                         DL+ KML   P++R+TA + L
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 129/287 (44%), Gaps = 54/287 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAGHKNI 162
           K+G+G +G  Y       G  FA K I     + +ED        REI I+  L  H NI
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIR----LEKEDEGIPSTTIREISILKELK-HSNI 62
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEA 215
           V +   Y+    +H    L    E  D+ +++       G  S    + L +++ G+   
Sbjct: 63  VKL---YD---VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-Y 115
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  V + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +  K Y    D+W+ G I   +++G P F   ++      + +      S  WP +++  
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 333 K-------------------------DLIRKMLCSQPSERLTAHEVL 354
           K                         DL+ KML   P++R+TA + L
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 4   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 62
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 63  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 119
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 120 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 235
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 295
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 296 RDLLSKMLVIDPAKRISVDDAL 317

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 295 RDLLSKMLVIDPAKRISVDDAL 316

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 2   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 60
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 61  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 117
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 118 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 173
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 174 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 233
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 234 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 293
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 294 RDLLSKMLVIDPAKRISVDDAL 315

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 235 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 295 RDLLSKMLVIDPAKRISVDDAL 316

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD Y L   +G G               + A K I+  K   +  ++++ +EIQ M    
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-C 70
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD---RIIQRGHYS-----ERKAAELTRII 209
            H NIV+   ++     + +VM+L +GG + D    I+ +G +      E   A + R +
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG------QIFTDVV 263
           +  +E  H  G +HRD+K  N LL    +D S++  DFG+S F   G      ++    V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 264 GSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           G+P ++APEV+  ++ Y  +AD+W+ G+    L +G  P+       +        +  +
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ 241
Query: 322 SDPWPLISDSAKDL---------IRKM--LCSQ--PSERLTAHEVL 354
           +DP P +    +D           RKM  LC Q  P +R TA E+L
Sbjct: 242 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 138/322 (42%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           +  +DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 4   KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF 62
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++
Sbjct: 63  QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQV 119
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 120 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 + T  V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 235
Query: 298 ----------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSA 332
                      P F  + Q  + + V        L     F    +P       L +  A
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 295
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML   P++R++  + L
Sbjct: 296 RDLLSKMLVIDPAKRISVDDAL 317

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 54/287 (18%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAGHKNI 162
           K+G+G +G  Y       G  FA K I     + +ED        REI I+  L  H NI
Sbjct: 9   KIGEGTYGVVYKAQN-NYGETFALKKIR----LEKEDEGIPSTTIREISILKELK-HSNI 62
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-------GHYSERKAAELTRIIVGVVEA 215
           V +   Y+    +H    L    E  D+ +++       G  S    + L +++ G+   
Sbjct: 63  VKL---YD---VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-Y 115
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  + + +Y AP+VL
Sbjct: 116 CHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +  K Y    D+W+ G I   +++G P F   ++      + +      S  WP +++  
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 333 K-------------------------DLIRKMLCSQPSERLTAHEVL 354
           K                         DL+ KML   P++R+TA + L
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD Y L   +G G               + A K I+  K   +  ++++ +EIQ M    
Sbjct: 9   RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQ-C 65
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFD---RIIQRGHYS-----ERKAAELTRII 209
            H NIV+   ++     + +VM+L +GG + D    I+ +G +      E   A + R +
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG------QIFTDVV 263
           +  +E  H  G +HRD+K  N LL    +D S++  DFG+S F   G      ++    V
Sbjct: 126 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 264 GSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           G+P ++APEV+  ++ Y  +AD+W+ G+    L +G  P+       +        +  +
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ 236
Query: 322 SDPWPLISDSAKDL---------IRKM--LCSQ--PSERLTAHEVL 354
           +DP P +    +D           RKM  LC Q  P +R TA E+L
Sbjct: 237 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 10/214 (4%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLA 157
           D Y    KLG+G +G  Y   +  T    A K I  R     E V     RE+ ++  L 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI--RLEHEEEGVPGTAIREVSLLKELQ 91
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+NI+ +K     +  +H++ E  A  +L   + +    S R        ++  V  CH
Sbjct: 92  -HRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 218 SLGVMHRDLKPENFLLVNKDDDFS--LKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVL 274
           S   +HRDLKP+N LL   D   +  LK  DFGL+  F  P + FT  + + +Y  PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
           L  +HY    D+W+   I   +L   P F  +++
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 60/306 (19%)
Query: 93  KTDNIRDL-YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           KT   R++ YT  + +G G FG  +    + +  E A K + + K           RE+Q
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN-------RELQ 84
Query: 152 IMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAA 203
           IM  +  H N+V +K  +      +D + +++V+E           + R   HY++ K  
Sbjct: 85  IMR-IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP------ETVYRASRHYAKLKQT 137
Query: 204 ELTRII-------VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
               +I       +  +   HS+G+ HRD+KP+N LL        LK IDFG +     G
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAG 195
Query: 257 QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
           +     + S YY APE++    +Y    D+W+ G ++  L+ G P F  E+       ++
Sbjct: 196 EPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII 255
Query: 315 K------------------GHIDFESDPWPL-------ISDSAKDLIRKMLCSQPSERLT 349
           K                   H   +  P P            A DLI ++L   PS RLT
Sbjct: 256 KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
Query: 350 AHEVLC 355
           A E LC
Sbjct: 316 AIEALC 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M  +  HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 310 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 248
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 308
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 309 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 364
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 310 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++ R +G+G FG  Y C +  TG  +A K + K++ I  +  E +    +IM  L    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVSTG 249
Query: 161 N---IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           +   IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK- 276
           +  V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL K 
Sbjct: 310 NRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKG 365
Query: 277 -HYGPEADVWTAGVILYILLSGVPPF 301
             Y   AD ++ G +L+ LL G  PF
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 126/307 (41%), Gaps = 58/307 (18%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIM 153
           NI   + L   LG+G +G     T   TG   A K I    + L +   +    REI+I+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKIL 63
Query: 154 HHLAGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            H   H+NI+TI       ++E+   V+I+ EL        R+I     S+         
Sbjct: 64  KHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQ 120
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---------- 258
            +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+                  
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 259 -FTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF----WAETQQGIFD 311
              + V + +Y APEV+L    Y    DVW+ G IL  L    P F    +      IF 
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 312 AVLKGHID--------------------FESDP----WPLISDSAKDLIRKMLCSQPSER 347
            +   H D                    + + P    +P ++    DL+++ML   P++R
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 348 LTAHEVL 354
           +TA E L
Sbjct: 298 ITAKEAL 304

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 136/318 (42%), Gaps = 54/318 (16%)
Query: 83  DNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           DNQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++ 
Sbjct: 1   DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQT 59
Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRG 195
             +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ  
Sbjct: 60  HAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME 116
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+     
Sbjct: 117 LDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGT 172
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG----------- 297
             + T  V + YY APEV+L   Y    D+W+ G I+       IL  G           
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232
Query: 298 ------VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLI 336
                  P F  + Q  + + V        L     F    +P       L +  A+DL+
Sbjct: 233 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 292
Query: 337 RKMLCSQPSERLTAHEVL 354
            KML   P++R++  + L
Sbjct: 293 SKMLVIDPAKRISVDDAL 310

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 128/286 (44%), Gaps = 47/286 (16%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHHLAGHKN 161
           LG+GQF T Y   +  T    A K I   KL  R + +D       REI+++  L+ H N
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQELS-HPN 73
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----SERKAAELTRIIVGVVEACH 217
           I+ +  A+     + +V +        + II+        S  KA  L  + +  +E  H
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYML--MTLQGLEYLH 129
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL- 275
              ++HRDLKP N LL   D++  LK  DFGL+  F  P + +   V + +Y APE+L  
Sbjct: 130 QHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFG 186
Query: 276 -KHYGPEADVWTAGVILYILLSGVP--PFWAETQQ--GIFDAV-------------LKGH 317
            + YG   D+W  G IL  LL  VP  P  ++  Q   IF+ +             L  +
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246
Query: 318 IDFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           + F+S P       +    D   DLI+ +    P  R+TA + L M
Sbjct: 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 135/317 (42%), Gaps = 54/317 (17%)
Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 59
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 60  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMEL 116
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 117 DHERMSYLLYQMLXGI-KHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLARTAGTS 172
Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 298 -----VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLIR 337
                 P F  + Q  + + V        L     F    +P       L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 338 KMLCSQPSERLTAHEVL 354
           KML   P++R++  + L
Sbjct: 293 KMLVIDPAKRISVDDAL 309

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +  +LG G FG         TG + A K    R+ +S ++ E    EIQIM  L  H 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 161 NIVTIKGAYEDSL-------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           N+V+ +    D L          + ME C GG+L   + Q  +    K   +  ++  + 
Sbjct: 73  NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 214 EAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
            A    H   ++HRDLKPEN +L         K ID G +     G++ T+ VG+  Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPF---WAETQ 306
           PE+L  K Y    D W+ G + +  ++G  PF   W   Q
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +  +LG G FG         TG + A K    R+ +S ++ E    EIQIM  L  H 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKKL-NHP 73
Query: 161 NIVTIKGAYEDSL-------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           N+V+ +    D L          + ME C GG+L   + Q  +    K   +  ++  + 
Sbjct: 74  NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 132
Query: 214 EAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
            A    H   ++HRDLKPEN +L         K ID G +     G++ T+ VG+  Y+A
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 271 PEVL-LKHYGPEADVWTAGVILYILLSGVPPF---WAETQ 306
           PE+L  K Y    D W+ G + +  ++G  PF   W   Q
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 232

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 80  RGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS 139
           RG  NQ      H   +  +L+T   ++G+G FG      E+  GI+   K +   K+I 
Sbjct: 6   RGFANQ------HSRVDPEELFTKLDRIGKGSFG------EVYKGIDNHTKEVVAIKIID 53
Query: 140 ----REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
                +++ED+++EI ++        I    G+Y  S  + I+ME   GG   D +++ G
Sbjct: 54  LEEAEDEIEDIQQEITVLSQ-CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPG 111
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              E   A + R I+  ++  HS   +HRD+K  N LL  + D   +K  DFG++     
Sbjct: 112 PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTD 168
Query: 256 GQIFTD-VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPP 300
            QI  +  VG+P+++APEV+ +  Y  +AD+W+ G+    L  G PP
Sbjct: 169 TQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           KLG G + T Y      TG+  A K +   KL S E       REI +M  L  H+NIV 
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELK-HENIVR 67
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI------IVGVVEACHS 218
           +         + +V E     +L   +  R   +  +  EL  +      ++  +  CH 
Sbjct: 68  LYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL-- 275
             ++HRDLKP+N LL+NK     LK  DFGL+  F  P   F+  V + +Y AP+VL+  
Sbjct: 127 NKILHRDLKPQN-LLINKRG--QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 276 KHYGPEADVWTAGVILYILLSGVPPF 301
           + Y    D+W+ G IL  +++G P F
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 4   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 62
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 63  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 119
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 120 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 175
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 + T  V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 175 TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 135/317 (42%), Gaps = 54/317 (17%)
Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 2   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 60
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 61  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMEL 117
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 118 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 173
Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 233
Query: 298 -----VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLIR 337
                 P F  + Q  + + V        L     F    +P       L +  A+DL+ 
Sbjct: 234 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 293
Query: 338 KMLCSQPSERLTAHEVL 354
           KML   P++R++  + L
Sbjct: 294 KMLVIDPAKRISVDDAL 310

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 135/317 (42%), Gaps = 54/317 (17%)
Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTH 59
Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M     HKNI+++   +      E+   V++VMEL        ++IQ   
Sbjct: 60  AKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMEL 116
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
             ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 117 DHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 172
Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------------ 297
            + T  V + YY APEV+L   Y    D+W+ G I+       IL  G            
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 298 -----VPPFWAETQQGIFDAV--------LKGHIDFESDPWP-------LISDSAKDLIR 337
                 P F  + Q  + + V        L     F    +P       L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292
Query: 338 KMLCSQPSERLTAHEVL 354
           KML   P++R++  + L
Sbjct: 293 KMLVIDPAKRISVDDAL 309

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIM 153
            +L+T   K+G+G FG      E+  GI+   + +   K+I      +++ED+++EI ++
Sbjct: 26  EELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 79
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                   +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  +
Sbjct: 80  SQ-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 137
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPE 272
           +  HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APE
Sbjct: 138 DYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 194
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---I 328
           V+ +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNY 248
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           S   K+ +   L  +PS R TA E+L
Sbjct: 249 SKPLKEFVEACLNKEPSFRPTAKELL 274

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 128/265 (48%), Gaps = 26/265 (9%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMH 154
           +L+T   K+G+G FG      E+  GI+   + +   K+I    + +++ED+++EI ++ 
Sbjct: 7   ELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  ++
Sbjct: 61  Q-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 118
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-VGSPYYVAPEV 273
             HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 175
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---IS 329
           + +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    S
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNYS 229
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
              K+ +   L  +PS R TA E+L
Sbjct: 230 KPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIM 153
            +L+T   K+G+G FG      E+  GI+   + +   K+I      +++ED+++EI ++
Sbjct: 21  EELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                   +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  +
Sbjct: 75  SQ-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 132
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPE 272
           +  HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APE
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE 189
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---I 328
           V+ +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNY 243
Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
           S   K+ +   L  +PS R TA E+L
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELL 269

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 107
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 162
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 220
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E 
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 107
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 162
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E 
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 109
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 164
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 165 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 222
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 282
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E 
Sbjct: 283 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 336

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 101
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 156
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 157 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 214
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 274
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E 
Sbjct: 275 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 328

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 111
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 166
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 167 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 224
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 284
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E 
Sbjct: 285 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 338

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 26/265 (9%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS----REDVEDVRREIQIMH 154
           +L+T   K+G+G FG      E+  GI+   + +   K+I      +++ED+++EI ++ 
Sbjct: 7   ELFTKLEKIGKGSFG------EVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
                  +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  ++
Sbjct: 61  Q-CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLD 118
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEV 273
             HS   +HRD+K  N LL    +   +K  DFG++      QI  +  VG+P+++APEV
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEV 175
Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---IS 329
           + +  Y  +AD+W+ G+    L  G PP        +   + K      ++P  L    S
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------NNPPTLEGNYS 229
Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
              K+ +   L  +PS R TA E+L
Sbjct: 230 KPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 152
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 207
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 208 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 266 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 325
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E 
Sbjct: 326 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 379

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 78
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 133
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 134 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 191
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 192 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 251
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEV 353
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E 
Sbjct: 252 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 305

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 85
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 140
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 259 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 311

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++   +    I    + A K +   K         ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKK------IKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N L+ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 16/227 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 5   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 63
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 64  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 120
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 121 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 176
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSG 297
                 +    V + YY APEV+L   Y    D+W+ G I+  ++ G
Sbjct: 177 TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 86
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 141
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 142 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 199
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 259
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 260 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 312

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 81
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 136
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 137 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 194
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 254
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 255 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 307

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 8   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 66
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 67  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 123
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 124 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 179
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL 291
                 + T  V + YY APEV+L   Y    D+W+ G I+
Sbjct: 180 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIM 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 85
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 140
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 198
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 258
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 259 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 311

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 92
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 147
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 148 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 205
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 265
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 266 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 318

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+ L   LGQG     +      TG  FA K  +    +   DV+   RE +++  L  H
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NH 66
Query: 160 KNIVTIKGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           KNIV +    E++   H  ++ME C  G L+  + +  +      +E   ++  VV   +
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSL-KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
            L   G++HR++KP N + V  +D  S+ K  DFG +   +  + F  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 274 L---------LKHYGPEADVWTAGVILYILLSGVPPF 301
                      K YG   D+W+ GV  Y   +G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           L+ L   LGQG     +      TG  FA K  +    +   DV+   RE +++  L  H
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREFEVLKKL-NH 66
Query: 160 KNIVTIKGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
           KNIV +    E++   H  ++ME C  G L+  + +  +      +E   ++  VV   +
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSL-KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
            L   G++HR++KP N + V  +D  S+ K  DFG +   +  + F  + G+  Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 274 L---------LKHYGPEADVWTAGVILYILLSGVPPF 301
                      K YG   D+W+ GV  Y   +G  PF
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 74
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 129
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 130 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 187
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 247
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 248 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 300

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 77
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 132
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 133 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 190
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 250
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 251 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 303

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 123/282 (43%), Gaps = 41/282 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  +G + A K +S R   S    +   RE+ ++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQ-HENVIGLL 107
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMH 223
             +  +  +    +           +Q+     +SE K   L   ++  ++  HS GV+H
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVH 167
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPE 281
           RDLKP N L VN  +D  LK +DFGL+         T  V + +Y APEV+L   HY   
Sbjct: 168 RDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 282 ADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHI---- 318
            D+W+ G I+  +L+G   F                     E  Q + D   K +I    
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282
Query: 319 -----DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                DF +  +P  S  A DL+ KML     +RLTA + L 
Sbjct: 283 QTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 35  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 88
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 145
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 83  DNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
           DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R   ++ 
Sbjct: 1   DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQT 59
Query: 142 DVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
             +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++IQ  
Sbjct: 60  HAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQME 116
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+     
Sbjct: 117 LDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGT 172
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL 291
             + T  V + YY APEV+L   Y    D+W+ G I+
Sbjct: 173 SFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIM 209

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 247 IREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 35  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 88
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 145
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 34  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 87
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 144
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 202
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 123/282 (43%), Gaps = 41/282 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  +G + A K +S R   S    +   RE+ ++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQ-HENVIGLL 89
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQR---GHYSERKAAELTRIIVGVVEACHSLGVMH 223
             +  +  +    +           +Q+     +SE K   L   ++  ++  HS GV+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVH 149
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPE 281
           RDLKP N L VN  +D  LK +DFGL+         T  V + +Y APEV+L   HY   
Sbjct: 150 RDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 282 ADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAVLKGHI---- 318
            D+W+ G I+  +L+G   F                     E  Q + D   K +I    
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264
Query: 319 -----DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                DF +  +P  S  A DL+ KML     +RLTA + L 
Sbjct: 265 QTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 41  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 94
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++ Q    ++         I+  ++ 
Sbjct: 95  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDY 151
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 152 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 209
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 210 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 269
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 270 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 324

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL          T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVNEDSE--LKILDFGLCR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 122/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++     E   R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV- 163
           R +G G +G+     +     + A K +S R   S        RE++++ HL  H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLK-HENVIG 91
Query: 164 -----TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
                T   + ED   V++V  L   G   + I++    S+     L   ++  ++  HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N   V  ++D  L+ +DFGL+   +  +  T  V + +Y APE++L   
Sbjct: 150 AGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 277 HYGPEADVWTAGVILYILLSGVPPF 301
           HY    D+W+ G I+  LL G   F
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVNEDSE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 203 NQTVDIWSVGCIMAELLTG 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 87/322 (27%), Positives = 135/322 (41%), Gaps = 54/322 (16%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL------YILLSG------- 297
                 +    V + YY APEV+L   Y    D+W+ G I+       IL  G       
Sbjct: 175 TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQW 234
Query: 298 ----------VPPFWAETQQGIFDAV-------------LKGHIDFESDPW--PLISDSA 332
                      P F  + Q  + + V             L   + F +D     L +  A
Sbjct: 235 NKVIEQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 294
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +DL+ KML    S+R++  E L
Sbjct: 295 RDLLSKMLVIDASKRISVDEAL 316

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVNEDSE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++REI+I+ +L 
Sbjct: 36  QDDYQLVRKLGRGKY------SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR 89
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+T+    +D  S    +V E     + F ++  R   ++         I+  ++ 
Sbjct: 90  GGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--RQTLTDYDIRFYMYEILKALDY 146
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS+G+MHRD+KP N ++ ++     L+ ID+GL+ F+ PGQ +   V S Y+  PE+L+
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++D + K +I+
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 264
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A D + K+L      RLTA E +
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 319

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 101
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V++V  L  G +L+ ++++  H S          I+  ++ 
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHL-MGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 277 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 329

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 133/313 (42%), Gaps = 47/313 (15%)
Query: 81  GIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR 140
           G+  +   V G   D +   YT  + +G+G +G      +       A K IS  +   +
Sbjct: 26  GVPGEVEMVKGQPFD-VGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE--HQ 82
Query: 141 EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC-----VHIVMELCAGGELFDRIIQRG 195
              +   REIQI+     H+N++ I+     S       V+IV +L    +L+  +  + 
Sbjct: 83  TYCQRTLREIQILLRFR-HENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQ 140
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             ++     L +I+ G+ +  HS  V+HRDLKP N LL+N   D  LK  DFGL+    P
Sbjct: 141 LSNDHICYFLYQILRGL-KYIHSANVLHRDLKPSN-LLINTTCD--LKICDFGLARIADP 196
Query: 256 GQ----IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
                   T+ V + +Y APE++L  K Y    D+W+ G IL  +LS  P F  +     
Sbjct: 197 EHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 256
Query: 310 FDAVL-----------------KGHIDFESDP----------WPLISDSAKDLIRKMLCS 342
            + +L                 K     +S P          +P     A DL+ +ML  
Sbjct: 257 LNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTF 316
Query: 343 QPSERLTAHEVLC 355
            P++R+T  E L 
Sbjct: 317 NPNKRITVEEALA 329

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 98
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 157 IIHRDLKPSN-LAVNEDXE--LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 211
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 212 NQTVDIWSVGCIMAELLTG 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 121/293 (41%), Gaps = 56/293 (19%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT  + +G G FG  Y      +G   A K + + K           RE+QIM  L  H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKL-DHC 73
Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV-- 212
           NIV ++      G  +D + +++V++         R+ +  HYS R    L  I V +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVY--RVAR--HYS-RAKQTLPVIYVKLYM 128
Query: 213 ------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
                 +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+     + S 
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSXICSR 186
Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--------- 315
           YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K         
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 316 ------GHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHE 352
                  + +F     ++ PW     P     A  L  ++L   P+ RLT  E
Sbjct: 247 IREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV--- 163
           +G G +G+     ++ +G++ A K +S R   S    +   RE++++ H+  H+N++   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 116
Query: 164 ---TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
              T   + E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 117 DVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 174
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 175 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 229
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 230 NMTVDIWSVGCIMAELLTG 248

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKNI 162
           +G+G +G    C    TG     + ++ +K +  +D + V+    REI+++  L  H+N+
Sbjct: 33  VGEGSYGMVMKCRNKDTG-----RIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENL 86
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           V +    +     ++V E      L D  +   G   +     L +II G+   CHS  +
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI-GFCHSHNI 145
Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           +HRD+KPEN L+        +K  DFG +     PG+++ D V + +Y APE+L+    Y
Sbjct: 146 IHRDIKPENILVSQSG---VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 279 GPEADVWTAGVILYILLSGVPPF 301
           G   DVW  G ++  +  G P F
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLF 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 99
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 158 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 213 NQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 99
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 158 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 213 NQTVDIWSVGCIMAELLTG 231

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 85
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 144 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 198
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 199 NQTVDIWSVGCIMAELLTG 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 86
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 145 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 199
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 200 NQTVDIWSVGCIMAELLTG 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 203 NQTVDIWSVGCIMAELLTG 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 203 NQTVDIWSVGCIMAELLTG 221

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 94
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 153 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 207
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 208 NQTVDIWSVGCIMAELLTG 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNAMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGXVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 98
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 157 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 211
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 212 NQTVDIWSVGCIMAELLTG 230

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 92
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 151 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 205
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 206 NQTVDIWSVGCIMAELLTG 224

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 89
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 148 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 202
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 203 NQTVDIWSVGCIMAELLTG 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV- 163
           R +G G +G+     +     + A K +S R   S        RE++++ HL  H+N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLK-HENVIG 91
Query: 164 -----TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
                T   + ED   V++V  L   G   + I++    S+     L   ++  ++  HS
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N   V  ++D  L+ +DFGL+   +  +  T  V + +Y APE++L   
Sbjct: 150 AGIIHRDLKPSN---VAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 204
Query: 277 HYGPEADVWTAGVILYILLSGVPPF 301
           HY    D+W+ G I+  LL G   F
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 84
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 143 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 197
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 198 NQTVDIWSVGCIMAELLTG 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 84
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 143 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 197
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 198 NQTVDIWSVGCIMAELLTG 216

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 106
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 165 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 219
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 220 NQTVDIWSVGCIMAELLTG 238

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 107
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 166 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 220
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 221 NQTVDIWSVGCIMAELLTG 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV- 163
           R +G G +G+     +     + A K +S R   S        RE++++ HL  H+N++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLK-HENVIG 83
Query: 164 -----TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
                T   + ED   V++V  L   G   + I++    S+     L   ++  ++  HS
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-- 276
            G++HRDLKP N   V  ++D  L+ +DFGL+   +  +  T  V + +Y APE++L   
Sbjct: 142 AGIIHRDLKPSN---VAVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWM 196
Query: 277 HYGPEADVWTAGVILYILLSGVPPF 301
           HY    D+W+ G I+  LL G   F
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 110
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 169 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 223
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 224 NQTVDIWSVGCIMAELLTG 242

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +SK    S    +   RE++++ H+  H+N++ + 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELRLLKHMK-HENVIGLL 99
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 158 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 212
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 213 NQTVDIWSVGCIMAELLTG 231

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 16/221 (7%)
Query: 79  RRGIDNQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           R   DN  Y V +G  T  +   Y   + +G G  G      +       A K +S R  
Sbjct: 3   RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF 61
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRI 191
            ++   +   RE+ +M     HKNI+      T + + E+   V+IVMEL        ++
Sbjct: 62  QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQV 118
Query: 192 IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
           IQ     ER +  L +++ G+ +  HS G++HRDLKP N ++     D +LK +DFGL+ 
Sbjct: 119 IQMELDHERMSYLLYQMLCGI-KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 174
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVIL 291
                 +    V + YY APEV+L   Y    D+W+ G I+
Sbjct: 175 TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIM 215

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFR-HE 83
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGI 258
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K+G+G FG  Y           A K ++    I+ E++
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 73
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++M     H+N+V + G   D   + +V      G L DR+           
Sbjct: 74  KQQFDQEIKVMAK-CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQT 189
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
            + + +VG+  Y+APE L     P++D+++ GV+L  +++G+P
Sbjct: 190 VMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYXQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D+GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDYGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 83
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 258
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 89
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 148 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 205 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 264
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 265 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 317

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 81
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 140 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 197 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 256
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 257 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K+G+G FG  Y           A K ++    I+ E++
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 73
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++M     H+N+V + G   D   + +V      G L DR+           
Sbjct: 74  KQQFDQEIKVMAK-CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQT 189
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
            +   +VG+  Y+APE L     P++D+++ GV+L  +++G+P
Sbjct: 190 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 40/239 (16%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
            + +++ +  K+G+G F + YL T ++  G E   + I+ + LI       +  E+Q + 
Sbjct: 18  QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPE---EKIALKHLIPTSHPIRIAAELQCLT 74
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
              G  N++ +K  +  +  V I M         D I+    + E +   L   +   ++
Sbjct: 75  VAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLD-ILNSLSFQEVREYMLN--LFKALK 131
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL------------------------- 249
             H  G++HRD+KP NFL   +   ++L  +DFGL                         
Sbjct: 132 RIHQFGIVHRDVKPSNFLYNRRLKKYAL--VDFGLAQGTHDTKIELLKFVQSEAQQERCS 189
Query: 250 ----SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFW 302
               S+     Q      G+P + APEVL K  +     D+W+AGVI   LLSG  PF+
Sbjct: 190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 66/294 (22%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAGH 159
           K+G+G +GT +      T    A K +       R D +D        REI ++  L  H
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELK-H 60
Query: 160 KNIVTIKGAYEDSLCVHIVMELC----------AGGELFDRIIQRGHYSERKAAELTRII 209
           KNIV +         + +V E C            G+L   I++         + L +++
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK---------SFLFQLL 111
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYY 268
            G+   CHS  V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + ++  V + +Y
Sbjct: 112 KGL-GFCHSRNVLHRDLKPQN-LLINRNGE--LKLADFGLARAFGIPVRCYSAEVVTLWY 167
Query: 269 VAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA-----ETQQGIFDAV-------- 313
             P+VL   K Y    D+W+AG I   L +   P +      +  + IF  +        
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 314 --LKGHIDFESDPW-----------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +    D++  P            P ++ + +DL++ +L   P +R++A E L
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 119/293 (40%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 79
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD------ 323
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +L      E +      
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCII 254
Query: 324 -----------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                            PW    P     A DL+ KML   P +R+   + L 
Sbjct: 255 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 307

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 86
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 261
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 262 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 314

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 87
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 146 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 262
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 263 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 315

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 78
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 137 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 253
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 254 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 306

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 101
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 277 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 329

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K+G+G FG  Y           A K ++    I+ E++
Sbjct: 10  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 67
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++M     H+N+V + G   D   + +V      G L DR+           
Sbjct: 68  KQQFDQEIKVMAK-CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 127 HMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQX 183
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
            +   +VG+  Y+APE L     P++D+++ GV+L  +++G+P
Sbjct: 184 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 110
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 169 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMXGYVATRWYRAPEIMLNWMHY 223
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 224 NQTVDIWSVGCIMAELLTG 242

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 79
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 138 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 254
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 255 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 307

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFR-HE 83
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 142 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 199 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 258
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 259 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 311

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 107
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 166 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 220
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 221 NQTVDIWSVGCIMAELLTG 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 97
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 98  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 155
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 156 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 210
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 211 NQTVDIWSVGCIMAELLTG 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 93
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 152 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 206
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 207 NQTVDIWSVGCIMAELLTG 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 29/269 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++     D+V   H+    DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----DSVAYQHV--REDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSER 347
            P       +S     ++ K L   P  R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 106
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 165 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 219
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 220 NQTVDIWSVGCIMAELLTG 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+         T  V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKGHIDFESDPWP-----L 327
            HY  ++D+W+ G+ L  +  G   +PP  A+       A+ +      ++P P     +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV 237
Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            S   +D + K L   P+ER    +++
Sbjct: 238 FSLEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 121/292 (41%), Gaps = 46/292 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + ++             PW    P     A DL+ KML   P +R+   + L
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A + IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P        T+ V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 111/286 (38%), Gaps = 63/286 (22%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G FG  +       G  +  + +       + + E   RE++ +  L  H NIV   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRV-------KYNNEKAEREVKALAKL-DHVNIVHYN 71
Query: 167 GAYE----------DSL-------------------CVHIVMELCAGGELFDRIIQRGHY 197
           G ++          DSL                   C+ I ME C  G L   I +R   
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 131
Query: 198 SERK--AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
              K  A EL   I   V+  HS  ++HRDLKP N  LV   D   +K  DFGL    K 
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV---DTKQVKIGDFGLVTSLKN 188
Query: 256 GQIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILYILLS------GVPPFWAETQQG 308
               T   G+  Y++PE +  + YG E D++  G+IL  LL           F+ + + G
Sbjct: 189 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 248
Query: 309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           I   +                   K L++K+L  +P +R    E+L
Sbjct: 249 IISDIF--------------DKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 31/263 (11%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 84
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 145 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 196
Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP-WP--LISDS 331
            HY  ++D+W+ G+ L  +  G  P  + +    IF+  L  +I  E  P  P  + S  
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFE--LLDYIVNEPPPKLPSGVFSLE 254
Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
            +D + K L   P+ER    +++
Sbjct: 255 FQDFVNKCLIKNPAERADLKQLM 277

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK + FGL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILGFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 27/259 (10%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPL 131
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   + ++G   E +A       +  +E  HS  ++H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 191
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG +V  +P  +  D++      G+  ++APEV+L +  
Sbjct: 192 VKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL--- 335
             + DVW++  ++  +L+G  P+   TQ   F   L   I  E  P   I  S   L   
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPW---TQ--FFRGPLCLKIASEPPPVREIPPSCAPLTAQ 304
Query: 336 -IRKMLCSQPSERLTAHEV 353
            I++ L  +P  R++A E+
Sbjct: 305 AIQEGLRKEPIHRVSAAEL 323

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 133/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++RE++I+ +L 
Sbjct: 37  QDDYQLVRKLGRGKY------SEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR 90
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+ +    +D  S    +V E     + F ++ Q    ++         ++  ++ 
Sbjct: 91  GGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDY 147
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS G+MHRD+KP N ++ ++     L+ ID+GL+ F+ P Q +   V S Y+  PE+L+
Sbjct: 148 CHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLV 205
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFWAETQ--------------QGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++  + K HID
Sbjct: 206 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHID 265
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A DL+ K+L     +RLTA E +
Sbjct: 266 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAM 320

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 33/262 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+  ++    VG+  Y++PE L  
Sbjct: 129 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDEMANEFVGTRSYMSPERLQG 180
Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD---PWPLISDSA 332
            HY  ++D+W+ G+ L  +  G  P        IF+  L  +I  E     P  + S   
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYP---RPPMAIFE--LLDYIVNEPPPKLPSAVFSLEF 235
Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +D + K L   P+ER    +++
Sbjct: 236 QDFVNKCLIKNPAERADLKQLM 257

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 47/292 (16%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG 158
           Y    ++G+G +G  +   ++  G  F   ++ + ++ + E+   +   RE+ ++ HL  
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 159 --HKNIVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELT 206
             H N+V +       +   E  L +   H+  +L       D++ + G  +E     + 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMF 127
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           +++ G+ +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + 
Sbjct: 128 QLLRGL-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTL 183
Query: 267 YYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHIDF 320
           +Y APEVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 321 ESD------------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
             D              P+      I +  KDL+ K L   P++R++A+  L
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 133/295 (45%), Gaps = 49/295 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +D Y L RKLG+G++      +E+   I          K++     + ++RE++I+ +L 
Sbjct: 42  QDDYQLVRKLGRGKY------SEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLR 95
Query: 158 GHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           G  NI+ +    +D  S    +V E     + F ++ Q    ++         ++  ++ 
Sbjct: 96  GGTNIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDY 152
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
           CHS G+MHRD+KP N ++ ++     L+ ID+GL+ F+ P Q +   V S Y+  PE+L+
Sbjct: 153 CHSKGIMHRDVKPHNVMIDHQQK--KLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLV 210
Query: 276 KH--YGPEADVWTAGVILYILLSGVPPFWAETQ--------------QGIFDAVLKGHID 319
            +  Y    D+W+ G +L  ++    PF+                  + ++  + K HID
Sbjct: 211 DYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHID 270
Query: 320 FE--------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +                    S+   L+S  A DL+ K+L     +RLTA E +
Sbjct: 271 LDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAM 325

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 184 TAVDIWSLGCIF 195

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDAGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 186 TAVDIWSLGCIF 197

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 73
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 74  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 132
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 133 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 190 TAVDIWSLGCIF 201

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
            +  K+G G FGT +       G + A K + ++   + E V +  RE+ IM  L  H N
Sbjct: 40  NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLR-HPN 95
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHS 218
           IV   GA      + IV E  + G L+  + + G      ER+   +   +   +   H+
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 219 LG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
               ++HRDLK  N L+   D  +++K  DFGLS       + +    G+P ++APEVL 
Sbjct: 156 RNPPIVHRDLKSPNLLV---DKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 276 KHYGPE-ADVWTAGVILYILLSGVPPF 301
                E +DV++ GVIL+ L +   P+
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW 239

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 184 TAVDIWSLGCIF 195

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 70
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 71  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 129
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 130 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 187 TAVDIWSLGCIF 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 73
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 74  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 132
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 133 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 190 TAVDIWSLGCIF 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 182 TAVDIWSLGCIF 193

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDRGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 182 TAVDIWSLGCIF 193

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL-SFCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 85
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P         + V + +Y AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 120/293 (40%), Gaps = 46/293 (15%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+     H+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HE 86
Query: 161 NIVTIKG-----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           NI+ I         E    V+IV +L    +L+ ++++  H S          I+  ++ 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLY-KLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYVAP 271
            HS  V+HRDLKP N LL    D   LK  DFGL+    P         + V + +Y AP
Sbjct: 145 IHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-----------LKGHI 318
           E++L  K Y    D+W+ G IL  +LS  P F  +      + +           L   I
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 261
Query: 319 DFESD------------PW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++             PW    P     A DL+ KML   P +R+   + L 
Sbjct: 262 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 314

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG+  A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +D GL+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDGGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 83
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 142 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMAGFVATRWYRAPEIMLNWMHY 196
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 197 NQTVDIWSVGCIMAELLTG 215

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 127
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 188 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 239
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 283

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 108/273 (39%), Gaps = 50/273 (18%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G FG  +       G  +  K +       + + E   RE++ +  L  H NIV   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKL-DHVNIVHYN 70
Query: 167 GAYE----------------DSLCVHIVMELCAGGELFDRIIQRGHYSERK--AAELTRI 208
           G ++                 + C+ I ME C  G L   I +R      K  A EL   
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           I   V+  HS  +++RDLKP N  LV   D   +K  DFGL    K         G+  Y
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRXRSKGTLRY 187
Query: 269 VAPE-VLLKHYGPEADVWTAGVILYILLS------GVPPFWAETQQGIFDAVLKGHIDFE 321
           ++PE +  + YG E D++  G+IL  LL           F+ + + GI   +        
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF------- 240
Query: 322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                      K L++K+L  +P +R    E+L
Sbjct: 241 -------DKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 45/244 (18%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK-RKLISRE-DVEDVRREIQIM----- 153
           Y+LG+ LG G FG      +I +G  FA K + +  +  +RE D+  V   + I+     
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 154 -----------------HHLAGHKN--------IVTIKGAYEDSLCVHIVMELCAGGELF 188
                            H+  G KN         V +  +    L  +++ME     +  
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL--NVIMEYVP--DTL 124
Query: 189 DRIIQRGHYSERK-AAELTRIIV----GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK 243
            ++++    S R     L  I +      V   HSLG+ HRD+KP+N L+ +KD+  +LK
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLK 182
Query: 244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
             DFG +    P +     + S +Y APE++L    Y P  D+W+ G +   L+ G P F
Sbjct: 183 LCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
Query: 302 WAET 305
             ET
Sbjct: 243 SGET 246

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 47/292 (16%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG 158
           Y    ++G+G +G  +   ++  G  F   ++ + ++ + E+   +   RE+ ++ HL  
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 159 --HKNIVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELT 206
             H N+V +       +   E  L +   H+  +L       D++ + G  +E     + 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMF 127
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           +++ G+ +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + 
Sbjct: 128 QLLRGL-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTL 183
Query: 267 YYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHIDF 320
           +Y APEVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D+
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 321 ESD------------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
             D              P+      I +  KDL+ K L   P++R++A+  L
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 107
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L   G   + I++    ++     L   I+  ++  HS  
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DFGL+            V + +Y APE++L   HY
Sbjct: 166 IIHRDLKPSN-LAVN--EDCELKILDFGLAR--HTDDEMXGXVATRWYRAPEIMLNWMHY 220
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 221 NQTVDIWSVGCIMAELLTG 239

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 131/287 (45%), Gaps = 47/287 (16%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG--HKN 161
           ++G+G +G  +   ++  G  F   ++ + ++ + E+   +   RE+ ++ HL    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 162 IVTI-------KGAYEDSLCV---HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +V +       +   E  L +   H+  +L       D++ + G  +E     + +++ G
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           + +  HS  V+HRDLKP+N L+ +      +K  DFGL+  +      T VV + +Y AP
Sbjct: 133 L-DFLHSHRVVHRDLKPQNILVTSSG---QIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 272 EVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQG-IFDAV-LKGHIDFESD-- 323
           EVLL+  Y    D+W+ G I   +    P F   +   Q G I D + L G  D+  D  
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 324 ----------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                       P+      I +  KDL+ K L   P++R++A+  L
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 186 TAVDIWSLGCIF 197

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 185 TAVDIWSLGCIF 196

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKPEN LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPEN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 184 TAVDIWSLGCIF 195

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 92/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E  +    +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 185 TAVDIWSLGCIF 196

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 129/294 (43%), Gaps = 66/294 (22%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQIMHHLAGH 159
           K+G+G +GT +      T    A K +       R D +D        REI ++  L  H
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELK-H 60
Query: 160 KNIVTIKGAYEDSLCVHIVMELC----------AGGELFDRIIQRGHYSERKAAELTRII 209
           KNIV +         + +V E C            G+L   I++         + L +++
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK---------SFLFQLL 111
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYY 268
            G+   CHS  V+HRDLKP+N LL+N++ +  LK  +FGL+  F  P + ++  V + +Y
Sbjct: 112 KGL-GFCHSRNVLHRDLKPQN-LLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 269 VAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA-----ETQQGIFDAV-------- 313
             P+VL   K Y    D+W+AG I   L +   P +      +  + IF  +        
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 314 --LKGHIDFESDPW-----------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +    D++  P            P ++ + +DL++ +L   P +R++A E L
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 116/286 (40%), Gaps = 41/286 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH------- 159
           LGQG FG             +A K I      + E +  +  E+ ++  L          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 160 -----KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER-KAAELTRIIVGVV 213
                +N V    A +    + I ME C  G L+D I       +R +   L R I+  +
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQI-- 258
              HS G++HRDLKP N  +   D+  ++K  DFGL+                 PG    
Sbjct: 130 SYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 259 FTDVVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLK 315
            T  +G+  YVA EVL    HY  + D+++ G+I + +   + PF    ++  I   +  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILKKLRS 243
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV 361
             I+F  D         K +IR ++   P++R  A  +L    LPV
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y  +  + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 66  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 125 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 38  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 92
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 93  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 152 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 93
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 94  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 153 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 126 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G  +  +   +G+  A      RKLI  E    +R    RE+Q++H       
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 92
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT-RIIVGVVEACHSLG 220
           IV   GA+     + I ME   GG L   + + G   E+   +++  +I G+        
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLL- 275
           +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y++PE L  
Sbjct: 153 IMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQG 204
Query: 276 KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIFDAVLKG 316
            HY  ++D+W+ G+ L  +  G   +PP  A+  + +F   ++G
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 44/296 (14%)
Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            +G K+    + + L  K+G G+FG+ + C +   G  +A K  SK+ L    D ++  R
Sbjct: 2   AMGMKSRYTTEFHEL-EKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALR 59
Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTR 207
           E+     L  H ++V    A+ +   + I  E C GG L D I +     S  K AEL  
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 208 IIVGV---VEACHSLGVMHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFF 253
           +++ V   +   HS+ ++H D+KP N  +              +DD++   + F +    
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 254 KPGQIFTDVV--GSPYYVAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WA 303
              +I +  V  G   ++A EVL ++Y   P+AD++   + + +  +G  P       W 
Sbjct: 180 HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWH 238
Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER-----LTAHEVL 354
           E +QG    + +           ++S    +L++ M+   P  R     L  H VL
Sbjct: 239 EIRQGRLPRIPQ-----------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 29/269 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSER 347
            P       +S     ++ K L   P  R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 71  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 130 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 44/295 (14%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            +R +Y   + +G G +G      +  TG + A K +  R   S    +   RE++++ H
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80
Query: 156 LAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           +  H+N++ +   +      +D    ++VM     G    ++++     E +   L   +
Sbjct: 81  MR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 137
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  +   H+ G++HRDLKP N L VN  +D  LK +DFGL+   +        V + +Y 
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGN-LAVN--EDCELKILDFGLAR--QADSEMXGXVVTRWYR 192
Query: 270 APEVLLK--HYGPEADVWTAGVILYILL---------------------SGVPP--FWAE 304
           APEV+L    Y    D+W+ G I+  ++                     +G PP  F   
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 305 TQQGIFDAVLKGHIDFESDPWPLI----SDSAKDLIRKMLCSQPSERLTAHEVLC 355
            Q       +KG  + E   +  I    S  A +L+ KML     +R+TA E L 
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 16  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 71  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 130 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPY 214

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++     + + ++  + E+ ++     H N
Sbjct: 13  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRK-TRHVN 67
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 68  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 126
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 127 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPY 211

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 31/201 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA--------- 215
           +         +++V E           + +   +   A+ LT I + ++++         
Sbjct: 66  LLDVIHTENKLYLVFEH----------VHQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 216 --CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPE 272
             CHS  V+HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE
Sbjct: 116 AFCHSHRVLHRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 273 VLL--KHYGPEADVWTAGVIL 291
           +LL  K+Y    D+W+ G I 
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIF 193

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 29/269 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSER 347
            P       +S     ++ K L   P  R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 15  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 69
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  +      +  +K  ++ R     ++  H+  
Sbjct: 70  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 128
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 129 IIHRDLKSNNIFL---HEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPL 150
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   + ++G   E +A       +  +E  HS  ++H D
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 210
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG +V  +P  +   ++      G+  ++APEV+L +  
Sbjct: 211 VKADNVLLSSDGSHAAL--CDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL--- 335
             + DVW++  ++  +L+G  P+   TQ   F   L   I  E  P   I  S   L   
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPW---TQ--FFRGPLCLKIASEPPPVREIPPSCAPLTAQ 323
Query: 336 -IRKMLCSQPSERLTAHEV 353
            I++ L  +P  R++A E+
Sbjct: 324 AIQEGLRKEPIHRVSAAEL 342

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G G +G+     +  TG   A K +S R   S    +   RE++++ H+  H+N++ + 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMK-HENVIGLL 87
Query: 167 GAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +      E+   V++V  L  G +L + I++    ++     L   I+  ++  HS  
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HY 278
           ++HRDLKP N L VN  +D  LK +DF L+         T  V + +Y APE++L   HY
Sbjct: 146 IIHRDLKPSN-LAVN--EDCELKILDFYLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 200
Query: 279 GPEADVWTAGVILYILLSG 297
               D+W+ G I+  LL+G
Sbjct: 201 NQTVDIWSVGCIMAELLTG 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 66  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 125 IIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 185 TAVDIWSLGCIF 196

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 29/269 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSER 347
            P       +S     ++ K L   P  R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A   I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A   I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +T  V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 182 TAVDIWSLGCIF 193

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 182 TAVDIWSLGCIF 193

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 186 TAVDIWSLGCIF 197

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 68
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 69  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 127
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 128 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 185 TAVDIWSLGCIF 196

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 81
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y  +  + IV + C G  L+  +      +  +K  ++ R     ++  H+  
Sbjct: 82  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 141 IIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 66
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 125
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 126 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 183 TAVDIWSLGCIF 194

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     L  H ++V  
Sbjct: 14  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 72
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV---VEACHSLGV 221
             A+ +   + I  E C GG L D I +     S  K AEL  +++ V   +   HS+ +
Sbjct: 73  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 132
Query: 222 MHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFFKPGQIFTDVV--GSPYY 268
           +H D+KP N  +              +DD++   + F +       +I +  V  G   +
Sbjct: 133 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRF 192
Query: 269 VAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WAETQQGIFDAVLKGHIDF 320
           +A EVL ++Y   P+AD++   + + +  +G  P       W E +QG    + +     
Sbjct: 193 LANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQWHEIRQGRLPRIPQ----- 246
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSER-----LTAHEVL 354
                 ++S    +L++ M+   P  R     L  H VL
Sbjct: 247 ------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 279

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 39  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 93
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 94  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 153 IIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 65
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 124
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 125 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 182 TAVDIWSLGCIF 193

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 70
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 71  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 129
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 130 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 187 TAVDIWSLGCIF 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 186 TAVDIWSLGCIF 197

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 184 TAVDIWSLGCIF 195

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 67
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 68  LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 126
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 127 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 184 TAVDIWSLGCIF 195

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 31  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 85
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 86  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 145 IIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPY 229

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D  +Y  + H  D++   Y + + +G+G FG      +       A K +   K   R+ 
Sbjct: 83  DQGSYVQVPH--DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 143 VEDVRREIQIMHHLAGHK-----NIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
            E    EI+I+ HL         N++ +     + + +C+   +      EL  +   +G
Sbjct: 141 AE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            +S     +    I+  ++A H   ++H DLKPEN LL  +     +K IDFG S + + 
Sbjct: 197 -FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-GIKVIDFGSSCY-EH 253
Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVP 299
            +++T  + S +Y APEV+L   YG   D+W+ G IL  LL+G P
Sbjct: 254 QRVYT-XIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     L  H ++V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV---VEACHSLGV 221
             A+ +   + I  E C GG L D I +     S  K AEL  +++ V   +   HS+ +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 222 MHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFFKPGQIFTDVV--GSPYY 268
           +H D+KP N  +              +DD++   + F +       +I +  V  G   +
Sbjct: 135 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRF 194
Query: 269 VAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WAETQQGIFDAVLKGHIDF 320
           +A EVL ++Y   P+AD++   + + +  +G  P       W E +QG    + +     
Sbjct: 195 LANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRIPQ----- 248
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSER-----LTAHEVL 354
                 ++S    +L++ M+   P  R     L  H VL
Sbjct: 249 ------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     L  H ++V  
Sbjct: 16  KIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 74
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGV---VEACHSLGV 221
             A+ +   + I  E C GG L D I +     S  K AEL  +++ V   +   HS+ +
Sbjct: 75  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL 134
Query: 222 MHRDLKPENFLLVNK-----------DDDFSLKAIDFGLSVFFKPGQIFTDVV--GSPYY 268
           +H D+KP N  +              +DD++   + F +       +I +  V  G   +
Sbjct: 135 VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRF 194
Query: 269 VAPEVLLKHYG--PEADVWTAGVILYILLSGVPPF------WAETQQGIFDAVLKGHIDF 320
           +A EVL ++Y   P+AD++   + + +  +G  P       W E +QG    + +     
Sbjct: 195 LANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRIPQ----- 248
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSER-----LTAHEVL 354
                 ++S    +L++ M+   P  R     L  H VL
Sbjct: 249 ------VLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 281

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+T+ GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 81
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  +      +  +K  ++ R     ++  H+  
Sbjct: 82  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 141 IIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + ED+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEEDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 18/225 (8%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D  +Y  + H  D++   Y + + +G+G FG      +       A K +   K   R+ 
Sbjct: 83  DQGSYVQVPH--DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 143 VEDVRREIQIMHHLAGHK-----NIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
            E    EI+I+ HL         N++ +     + + +C+   +      EL  +   +G
Sbjct: 141 AE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            +S     +    I+  ++A H   ++H DLKPEN LL  +     +K IDFG S + + 
Sbjct: 197 -FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-GIKVIDFGSSCY-EH 253
Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVP 299
            +++T  + S +Y APEV+L   YG   D+W+ G IL  LL+G P
Sbjct: 254 QRVYT-XIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+G+++G G FGT Y         + A K ++      ++ ++  + E+ ++     H N
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQ-LQAFKNEVGVLRK-TRHVN 65
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           I+   G Y     + IV + C G  L+  + I    +   K  ++ R     ++  H+  
Sbjct: 66  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV---FFKPGQIFTDVVGSPYYVAPEVLLKH 277
           ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++APEV+   
Sbjct: 125 IIHRDLKSNNIFL---HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 278 ----YGPEADVWTAGVILYILLSGVPPF 301
               Y  ++DV+  G++LY L++G  P+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY 209

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 31/201 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA--------- 215
           +         +++V E           + +   +   A+ LT I + ++++         
Sbjct: 70  LLDVIHTENKLYLVFEF----------LHQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 216 --CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPE 272
             CHS  V+HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE
Sbjct: 120 AFCHSHRVLHRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 273 VLL--KHYGPEADVWTAGVIL 291
           +LL  K+Y    D+W+ G I 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIF 197

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 29/269 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 26  HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL--RADLARDPSFYLRFRREAQNA 83
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 84  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 142
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N ++   +   ++K +DFG++      G   T    V+G+
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 253
Query: 325 WPL------ISDSAKDLIRKMLCSQPSER 347
            P       +S     ++ K L   P  R
Sbjct: 254 IPPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 113/269 (42%), Gaps = 29/269 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIM 153
           ++ D Y LG  LG G     +L  ++    + A K +  R  ++R+       RRE Q  
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNA 66
Query: 154 HHLAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H  IV +    E         +IVME   G  L D +   G  + ++A E+    
Sbjct: 67  AAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTD---VVGS 265
              +   H  G++HRD+KP N L+   +   ++K +DFG++      G        V+G+
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 266 PYYVAPE-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
             Y++PE          +DV++ G +LY +L+G PPF  ++   +       +     DP
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236
Query: 325 WPL------ISDSAKDLIRKMLCSQPSER 347
            P       +S     ++ K L   P  R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 18/225 (8%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D  +Y  + H  D++   Y + + +G+G FG      +       A K +   K   R+ 
Sbjct: 83  DQGSYVQVPH--DHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 143 VEDVRREIQIMHHLAGHK-----NIVTI--KGAYEDSLCVHIVMELCAGGELFDRIIQRG 195
            E    EI+I+ HL         N++ +     + + +C+   +      EL  +   +G
Sbjct: 141 AE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG 196
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            +S     +    I+  ++A H   ++H DLKPEN LL  +     +K IDFG S +   
Sbjct: 197 -FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRS-GIKVIDFGSSCY--E 252
Query: 256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVP 299
            Q     + S +Y APEV+L   YG   D+W+ G IL  LL+G P
Sbjct: 253 HQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 15/223 (6%)
Query: 86  TYYVLGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
           ++Y L + T+N   R +   G K G+G FG  Y           A K ++    I+ E++
Sbjct: 7   SFYELKNVTNNFDERPISVGGNKXGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEEL 64
Query: 144 -EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
            +   +EI++      H+N+V + G   D   + +V      G L DR+           
Sbjct: 65  KQQFDQEIKVXAKCQ-HENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 203 AELTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL---SVFFKPG 256
               +I  G    +   H    +HRD+K  N LL   D+ F+ K  DFGL   S  F   
Sbjct: 124 HXRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQX 180
Query: 257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVP 299
              + +VG+  Y APE L     P++D+++ GV+L  +++G+P
Sbjct: 181 VXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           TL   +G G FG  Y    I   +          + IS + +E+VR+E ++   L  H N
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLK-HPN 67
Query: 162 IVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS- 218
           I+ ++G    E +LC  +VME   GG L +R++                I   +   H  
Sbjct: 68  IIALRGVCLKEPNLC--LVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 219 --LGVMHRDLKPENFLLVNK--DDDFS---LKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
             + ++HRDLK  N L++ K  + D S   LK  DFGL+  +      +   G+  ++AP
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-AAGAYAWMAP 183
Query: 272 EVL-LKHYGPEADVWTAGVILYILLSGVPPF 301
           EV+    +   +DVW+ GV+L+ LL+G  PF
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               + +         ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 45/281 (16%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED--VRREIQIMHHLAGHKNI 162
           R L +G F   Y   ++ +G E+A K     +L+S E+ ++  + +E+  M  L+GH NI
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALK-----RLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 163 VTIKGAY----EDSLCVH----IVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGV 212
           V    A     E+S        ++ ELC G   E   ++  RG  S     ++       
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 213 VEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-----------KPGQIF 259
           V+  H     ++HRDLK EN LL N+    ++K  DFG +              +   + 
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG---TIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 260 TDVV--GSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV 313
            ++    +P Y  PE++  +     G + D+W  G ILY+L     PF    + G    +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRI 261
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G   +   P          LIR ML   P ERL+  EV+
Sbjct: 262 VNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 32/234 (13%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL----------ISREDVEDVRREIQ 151
           T+ R +G G+FG      E+ +G     K   KR+L           + +   D   E  
Sbjct: 25  TIERVIGAGEFG------EVCSG---RLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEAS 75
Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRII 209
           IM     H NI+ ++G    S  V IV E    G L D  +++  G ++  +   + R I
Sbjct: 76  IMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGI 133
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGS-P 266
              ++    +G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G  P
Sbjct: 134 SAGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 267 Y-YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             + APE +  + +   +DVW+ G++++ ++S G  P+W  T Q +  AV +G+
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGY 244

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 91/192 (47%), Gaps = 13/192 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHLAGHKNIVT 164
           K+G+G +G  Y      TG   A K I  R     E V     REI ++  L  H NIV 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKI--RLDTETEGVPSTAIREISLLKEL-NHPNIVK 69
Query: 165 IKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           +         +++V E       +  D     G       + L +++ G+   CHS  V+
Sbjct: 70  LLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA-FCHSHRVL 128
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP+N LL+N +   ++K  DFGL+  F  P + +   V + +Y APE+LL  K+Y 
Sbjct: 129 HRDLKPQN-LLINTEG--AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 280 PEADVWTAGVIL 291
              D+W+ G I 
Sbjct: 186 TAVDIWSLGCIF 197

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 66/301 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 78
Query: 162 IVTI-----KGAYEDSLC---VHIVMELC----AGGELFDRIIQRGHYSERKAAELTRII 209
           +V +       A   + C   +++V + C    AG  L   ++ +   SE K   + +++
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK--RVMQML 134
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVV 263
           +  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
            + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 322 SDPWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEV 353
            + WP + +                             A DLI K+L   P++R+ + + 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 354 L 354
           L
Sbjct: 311 L 311

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI--------------IQRGHYSER 200
           HL  H+NIV + GA      V ++ E C  G+L + +              I     S R
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPG 256
                +  +   +    S   +HRD+   N LL N    K  DF L       S +   G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
                V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 NARLPV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 36/222 (16%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMHHLAGHKN 161
           +LG G  G         +G+      I  RKLI  E    +R    RE+Q++H       
Sbjct: 23  ELGAGNGGVVTKVQHRPSGL------IMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPY 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE-LTRIIVGVVEACHSL- 219
           IV   GA+     + I ME   GG L D++++    ++R   E L ++ + V+     L 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE---AKRIPEEILGKVSIAVLRGLAYLR 131
Query: 220 ---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPE 272
               +MHRD+KP N L+ ++ +   +K  DFG+S     GQ+   +    VG+  Y+APE
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMAPE 183
Query: 273 VLL-KHYGPEADVWTAGVILYILLSG---VPPFWAETQQGIF 310
            L   HY  ++D+W+ G+ L  L  G   +PP  A+  + IF
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 115/286 (40%), Gaps = 41/286 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH------- 159
           LGQG FG             +A K I      + E +  +  E+ ++  L          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 160 -----KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER-KAAELTRIIVGVV 213
                +N V    A +    + I ME C    L+D I       +R +   L R I+  +
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQI-- 258
              HS G++HRDLKP N  +   D+  ++K  DFGL+                 PG    
Sbjct: 130 SYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 259 FTDVVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLK 315
            T  +G+  YVA EVL    HY  + D+++ G+I + +   + PF    ++  I   +  
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILKKLRS 243
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV 361
             I+F  D         K +IR ++   P++R  A  +L    LPV
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 26/239 (10%)
Query: 73  KKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI 132
           +K+ I  RG  + +YY     ++ +     L  ++G G FGT Y       G      ++
Sbjct: 15  EKNKIRPRGQRDSSYYWEIEASEVM-----LSTRIGSGSFGTVY------KGKWHGDVAV 63
Query: 133 SKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
              K++  + E  +  R E+ ++     H NI+   G Y     + IV + C G  L+  
Sbjct: 64  KILKVVDPTPEQFQAFRNEVAVLRK-TRHVNILLFMG-YMTKDNLAIVTQWCEGSSLYKH 121
Query: 191 I-IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
           + +Q   +   +  ++ R     ++  H+  ++HRD+K  N  L    +  ++K  DFGL
Sbjct: 122 LHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGL 178
Query: 250 SVF---FKPGQIFTDVVGSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPF 301
           +     +   Q      GS  ++APEV+       +  ++DV++ G++LY L++G  P+
Sbjct: 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 27/227 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI--------------IQRGHYSER 200
           HL  H+NIV + GA      V ++ E C  G+L + +              I     S R
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPG 256
                +  +   +    S   +HRD+   N LL N    K  DF L       S +   G
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
                V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 NARLPV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 119/283 (42%), Gaps = 58/283 (20%)
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI--------------KGAYEDSLCVH 176
           +I K  L   + V+   REI+I+  L  H NIV +               G+  +   V+
Sbjct: 40  AIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           IV E          ++++G   E  A      ++  ++  HS  V+HRDLKP N L +N 
Sbjct: 99  IVQEYMETD--LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT 155
Query: 237 DDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGV 289
            +D  LK  DFGL+    P     G +   +V + +Y +P +LL   +Y    D+W AG 
Sbjct: 156 -EDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 290 ILYILLSG-------------------VPPFWAETQQGIFDAV---LKGHIDFESDP--- 324
           I   +L+G                   +P    E +Q +   +   ++  +     P   
Sbjct: 214 IFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ 273
Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVL-----CMYNLPV 361
             P IS  A D + ++L   P +RLTA E L      +Y+ P+
Sbjct: 274 LLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 66/301 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 77
Query: 162 IVTI-----KGAYEDSLC---VHIVMELC----AGGELFDRIIQRGHYSERKAAELTRII 209
           +V +       A   + C   +++V + C    AG  L   ++ +   SE K   + +++
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK--RVMQML 133
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVV 263
           +  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
            + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +      
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249
Query: 322 SDPWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEV 353
            + WP + +                             A DLI K+L   P++R+ + + 
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 354 L 354
           L
Sbjct: 310 L 310

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 66/301 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 78
Query: 162 IVTI-----KGAYEDSLC---VHIVMELC----AGGELFDRIIQRGHYSERKAAELTRII 209
           +V +       A   + C   +++V + C    AG  L   ++ +   SE K   + +++
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK--RVMQML 134
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVV 263
           +  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
            + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 322 SDPWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEV 353
            + WP + +                             A DLI K+L   P++R+ + + 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 354 L 354
           L
Sbjct: 311 L 311

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 237
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             I+F   P        +D+++  L   P +R++  E+L 
Sbjct: 238 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 273

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 66/301 (21%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE----DVRREIQIMHHLAGHKN 161
           K+GQG FG  +      TG + A K     K++   + E       REI+I+  L  H+N
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ-LLKHEN 78
Query: 162 IVTI-----KGAYEDSLC---VHIVMELC----AGGELFDRIIQRGHYSERKAAELTRII 209
           +V +       A   + C   +++V + C    AG  L   ++ +   SE K   + +++
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIK--RVMQML 134
Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF------KPGQIFTDVV 263
           +  +   H   ++HRD+K  N L+     D  LK  DFGL+  F      +P +    VV
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 264 GSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
            + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +      
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 322 SDPWPLISD----------------------------SAKDLIRKMLCSQPSERLTAHEV 353
            + WP + +                             A DLI K+L   P++R+ + + 
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 354 L 354
           L
Sbjct: 311 L 311

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 86
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 256
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             I+F   P        +D+++  L   P +R++  E+L 
Sbjct: 257 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 123/276 (44%), Gaps = 32/276 (11%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 114
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
                           P++DVW+ G ILY +  G  PF     Q I + + K H   + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 284
Query: 324 ---PWPLISDS-AKDLIRKMLCSQPSERLTAHEVLC 355
               +P I +   +D+++  L   P +R++  E+L 
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +  +   + +D+ D+  E+
Sbjct: 19  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM 76
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 77  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 136
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 193
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 253
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 254 FKLLKEGH 261

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 108/246 (43%), Gaps = 29/246 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACK--SISKRKLIS---REDVEDVRREIQI 152
           RD   LG+ LG+G FG   L   I    +   +   ++ + L S    +D+ D+  E+++
Sbjct: 16  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 75
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSERK 201
           M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E +
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 202 AAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
            +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+      
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHI 192
Query: 257 QIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
             +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +F 
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252
Query: 312 AVLKGH 317
            + +GH
Sbjct: 253 LLKEGH 258

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 38/286 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 125
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 242
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302
Query: 310 FDAVLKGH-IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           F  + +GH +D  S+     ++    ++R    + PS+R T  +++
Sbjct: 303 FKLLKEGHRMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLV 344

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 114
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 284
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             I+F   P        +D+++  L   P +R++  E+L 
Sbjct: 285 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 37  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 96
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----SERKAAELTRIIV 210
           HL  H+NIV + GA      V ++ E C  G+L + + ++        + +  EL  ++ 
Sbjct: 97  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 156
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPGQIFT 260
              +    +  +      HRD+   N LL N    K  DF L       S +   G    
Sbjct: 157 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 261 DVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
            V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 217 PV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 40/184 (21%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 155 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 211
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW--------------AETQQGIFD 311
           +  PE+L  L+ Y    D+W+ G +   ++    PF+                   G+  
Sbjct: 212 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNA 271
Query: 312 AVLKGHIDFE-----------SDPW---------PLISDSAKDLIRKMLCSQPSERLTAH 351
            + K  I+ +             PW          L+S  A D + K+L     ERLTA 
Sbjct: 272 YLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTAL 331
Query: 352 EVLC 355
           E + 
Sbjct: 332 EAMT 335

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/276 (23%), Positives = 123/276 (44%), Gaps = 32/276 (11%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 114
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
                           P++DVW+ G ILY +  G  PF     Q I + + K H   + +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 284
Query: 324 ---PWPLISDS-AKDLIRKMLCSQPSERLTAHEVLC 355
               +P I +   +D+++  L   P +R++  E+L 
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 137
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 254
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 315 FKLLKEGH 322

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 86
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 256
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             I+F   P        +D+++  L   P +R++  E+L 
Sbjct: 257 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 23  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 80
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 81  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 197
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 257
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 258 FKLLKEGH 265

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 23/223 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----SERKAAELTRIIV 210
           HL  H+NIV + GA      V ++ E C  G+L + + ++        + +  EL  ++ 
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFKPGQIFT 260
              +    +  +      HRD+   N LL N    K  DF L       S +   G    
Sbjct: 165 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 261 DVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
            V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 PVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 21  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 78
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENN---VMKIADFGLARDIN 195
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 255
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 256 FKLLKEGH 263

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 20  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 77
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 78  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 137
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 194
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 254
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 255 FKLLKEGH 262

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 69
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 186
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 247 FKLLKEGH 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
                           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    ++  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMRIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 26  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 83
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 200
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 260
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 261 FKLLKEGH 268

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 13  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 70
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 71  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 130 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 240
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             I+F   P        +D+++  L   P +R++  E+L 
Sbjct: 241 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 276

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 135 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 136 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 192
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 193 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 229

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 135 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 228

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 104
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----------------GHYS 198
           HL  H+NIV + GA      V ++ E C  G+L + + ++                   S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 199 ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN----KDDDFSLKAIDFGLSVFFK 254
            R     +  +   +    S   +HRD+   N LL N    K  DF L       S +  
Sbjct: 165 SRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 224
Query: 255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPF 301
            G     V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 225 KGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 269

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPL 129
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   I Q G   E +A       +  +E  H+  ++H D
Sbjct: 130 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 189
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG ++  +P  +   ++      G+  ++APEV++ K  
Sbjct: 190 VKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 279 GPEADVWTAGVILYILLSGVPPF 301
             + D+W++  ++  +L+G  P+
Sbjct: 248 DAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
                           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
           +Y++ +++G G     +        I +A K ++  +    + ++  R EI  ++ L  H
Sbjct: 9   IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 66
Query: 160 KNIVTIKGAYE-DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            + +     YE     +++VME C   +L   + ++      +     + ++  V   H 
Sbjct: 67  SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVL- 274
            G++H DLKP NFL+V    D  LK IDFG++   +P     +    VG+  Y+ PE + 
Sbjct: 126 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 275 -----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH------ 317
                           P++DVW+ G ILY +  G  PF     Q I + + K H      
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-----QQIINQISKLHAIIDPN 236
Query: 318 --IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             I+F   P        +D+++  L   P +R++  E+L 
Sbjct: 237 HEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 272

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 27  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 84
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-----------GHYSE 199
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R            H  E
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPE 144
Query: 200 RKAAELTRI-----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV--- 251
            + +    +     +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIH 201
Query: 252 FFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
                +  T+      ++APE L  + Y  ++DVW+ GV+L+ I   G  P+     + +
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 261
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 262 FKLLKEGH 269

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 57/97 (58%), Gaps = 6/97 (6%)
Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++  ++ CHS G+MHRD+KP N ++   D +   L+ ID+GL+ F+ PG+ +   V S Y
Sbjct: 134 LLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFW 302
           +  PE+L  L+ Y    D+W+ G +   ++    PF+
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 227

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 108/247 (43%), Gaps = 19/247 (7%)
Query: 81  GIDNQT---YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           G+D  T   Y+    K +  R   T+  KLG GQ+G  Y+       +  A K++ +  +
Sbjct: 11  GVDLGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM 70
Query: 138 ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRG 195
               +VE+  +E  +M  +  H N+V + G        +IV E    G L D  R   R 
Sbjct: 71  ----EVEEFLKEAAVMKEIK-HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE 125
Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             +      +   I   +E       +HRDL   N L+    ++  +K  DFGLS     
Sbjct: 126 EVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHVVKVADFGLSRLMT- 181
Query: 256 GQIFTDVVGSPY---YVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIF 310
           G  +T   G+ +   + APE L  + +  ++DVW  GV+L+ I   G+ P+       ++
Sbjct: 182 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 241
Query: 311 DAVLKGH 317
           D + KG+
Sbjct: 242 DLLEKGY 248

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  FT   G+ +   + APE L  
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAY 184
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK---DYRMERPEGCPEKVYE 241
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++   + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAG--HKN 161
           ++G G +GT Y   +  +G   A KS+             +   RE+ ++  L    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 162 IVTIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           +V +      S     + V +V E          D+    G  +E    +L R  +  ++
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLD 134
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             H+  ++HRDLKPEN L+ +     ++K  DFGL+  +      T VV + +Y APEVL
Sbjct: 135 FLHANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 275 LKH-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKGHIDFESD----- 323
           L+  Y    D+W+ G I   +    P F   ++      IFD + L    D+  D     
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251
Query: 324 -------PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                  P P+      + +S   L+ +ML   P +R++A   L
Sbjct: 252 GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGAVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 27/273 (9%)
Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI-RDLYTLGRKLGQGQFGTTYL 117
           N K+   +  +S S+ D+      +  TY +   +   I R+   LGR +G+GQFG  + 
Sbjct: 349 NEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQ 408
Query: 118 CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI 177
              ++        +I   K  + + V +   +  +      H +IV + G   ++  V I
Sbjct: 409 GIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWI 467
Query: 178 VMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEACHSLGVM------HRDLKPEN 230
           +MELC  GEL      R     RK + +L  +I+   +   +L  +      HRD+   N
Sbjct: 468 IMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 231 FLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPEVL-LKHYGPEADVWTA 287
            L+ + D    +K  DFGLS + +    +    G  P  ++APE +  + +   +DVW  
Sbjct: 522 VLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 288 GVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIE 606

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAEL 205
           RE+Q++     H N++      +D    +I +ELCA   L + + Q+   H        L
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT-LQEYVEQKDFAHLGLEPITLL 124
Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFKPGQ----IF 259
            +   G+    HSL ++HRDLKP N L+   +    +KA+  DFGL      G+      
Sbjct: 125 QQTTSGLAH-LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 260 TDVVGSPYYVAPEVLLKHYGPE----ADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
           + V G+  ++APE+L +          D+++AG + Y ++S G  PF    Q+     +L
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NIL 241
Query: 315 KGHIDFES-DPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            G    +   P       A++LI KM+   P +R +A  VL
Sbjct: 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 118/268 (44%), Gaps = 29/268 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+  TL ++LG GQFG   L  +     + A K I +  +   ED  +  +E Q M  L+
Sbjct: 7   REEITLLKELGSGQFGVVKL-GKWKGQYDVAVKMIKEGSM--SED--EFFQEAQTMMKLS 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V   G       ++IV E  + G L + +   G     K  E ++++    + C 
Sbjct: 62  -HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCE 115
Query: 218 SLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---Y 268
            +  +      HRDL   N L+   D D  +K  DFG++ +    Q +   VG+ +   +
Sbjct: 116 GMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKW 171
Query: 269 VAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
            APEV     Y  ++DVW  G++++ + S G  P+   T   +   V +GH  +      
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH--- 228
Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
           L SD+   ++       P +R T  ++L
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLL 256

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 31/254 (12%)
Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           I DL  LG ++G G  G  +      TG   A K +  R+  ++E+ + +  ++ ++   
Sbjct: 24  INDLENLG-EMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKS 80
Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVE 214
                IV   G +  +  V I MEL   G   +++ +R  G   ER   ++T   V +V+
Sbjct: 81  HDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMT---VAIVK 135
Query: 215 ACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
           A + L    GV+HRD+KP N LL   D+   +K  DFG+S      +      G   Y+A
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMA 192
Query: 271 PEVL------LKHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLK-------G 316
           PE +         Y   ADVW+ G+ L  L +G  P+   +T   +   VL+       G
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252
Query: 317 HIDFESDPWPLISD 330
           H+ F  D    + D
Sbjct: 253 HMGFSGDFQSFVKD 266

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 277
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HR+L   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 338 NFIHRNLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 450
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 451 LMRACWQWNPSDRPSFAEI 469

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPL 115
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   I Q G   E +A       +  +E  H+  ++H D
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG ++  +P  +   ++      G+  ++APEV++ K  
Sbjct: 176 VKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 279 GPEADVWTAGVILYILLSGVPPF 301
             + D+W++  ++  +L+G  P+
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 105/248 (42%), Gaps = 33/248 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD  TLG+ LG+G FG   +   +          +  A K +      + +D+ D+  E+
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEM 91
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI-- 208
           ++M  +  HKNI+ + GA      +++++   + G L + +  R       + ++ R+  
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 209 --------------IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                         +   +E   S   +HRDL   N L+   +    +K  DFGL+    
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN---VMKIADFGLARDIN 208
Query: 255 PGQIFTDVVGSPY---YVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGI 309
               +           ++APE L  + Y  ++DVW+ GV+++ I   G  P+     + +
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 310 FDAVLKGH 317
           F  + +GH
Sbjct: 269 FKLLKEGH 276

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 135
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 19  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 75
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 134 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 238

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGFVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 46  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 102
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 161 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 265

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 54/279 (19%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +  Y  G K  ++ D Y +   +G+G +G  YL  +  T    A K ++ R      D +
Sbjct: 12  ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCK 70
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLC----VHIVMELCAGG--ELFDRIIQRGHYS 198
            + REI I++ L     I        D L     ++IV+E+      +LF   I      
Sbjct: 71  RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--E 128
Query: 199 ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF----- 253
           E     L  +++G     H  G++HRDLKP N LL   + D S+K  DFGL+        
Sbjct: 129 EHIKTILYNLLLGE-NFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKD 184
Query: 254 -----------KPG-------QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYI 293
                      +PG       +  T  V + +Y APE++L  ++Y    D+W+ G I   
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244
Query: 294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           LL+                +L+ HI+  ++ +PL   S+
Sbjct: 245 LLN----------------MLQSHINDPTNRFPLFPGSS 267

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 19  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 75
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 134 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 238

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 36  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 92
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGLS   +  P   +T   G     + +P
Sbjct: 151 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 255

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 134/318 (42%), Gaps = 63/318 (19%)
Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T ++ D Y +   +G G +G         TG + A K I     +   + +   RE++I+
Sbjct: 49  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKIL 107
Query: 154 HHLAGHKNIVTIKG------AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
            H   H NI+ IK        Y +   V++V++L        +II   H S+    E  R
Sbjct: 108 KHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQII---HSSQPLTLEHVR 161
Query: 208 I----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ---I 258
                ++  ++  HS  V+HRDLKP N LLVN  ++  LK  DFG++  +   P +    
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSN-LLVN--ENCELKIGDFGMARGLCTSPAEHQYF 218
Query: 259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVI---------------------LYILL 295
            T+ V + +Y APE++L    Y    D+W+ G I                     L +++
Sbjct: 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278
Query: 296 SGVPPFWAETQQGIFDAVLKGHIDF----ESDPW----PLISDSAKDLIRKMLCSQPSER 347
            G P       Q +    ++ +I      +  PW    P     A  L+ +ML  +PS R
Sbjct: 279 LGTPS--PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSAR 336
Query: 348 LTA-----HEVLCMYNLP 360
           ++A     H  L  Y+ P
Sbjct: 337 ISAAAALRHPFLAKYHDP 354

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 18/219 (8%)
Query: 107 LGQGQFG---TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +G G+FG   + +L       I  A K++  +   + +   D   E  IM     H N++
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQF-DHPNVI 97
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVM 222
            ++G    S  V I+ E    G L   + Q  G ++  +   + R I   ++    +  +
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK---PGQIFTDVVGSPY---YVAPEVL-L 275
           HRDL   N L+   + +   K  DFGLS F +       +T  +G      + APE +  
Sbjct: 158 HRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 276 KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           + +   +DVW+ G++++ ++S G  P+W  T Q + +A+
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 253

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 186
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIV 163
           R +G G+FG          G      +I   K+  + +   D   E  IM     H N+V
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQF-DHPNVV 107
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGV 221
            ++G       V IV+E    G L D  +++  G ++  +   + R I   +     +G 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY 166
Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGS--PYYVAPEVL-LK 276
           +HRDL   N L+   + +   K  DFGLS   +  P  ++T   G     + APE +  +
Sbjct: 167 VHRDLAARNILV---NSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 277 HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            +   +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 265

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G FG  +   +  TG + A K +          +E  R E  +         IV +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPL 131
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRD 225
            GA  +   V+I MEL  GG L   I Q G   E +A       +  +E  H+  ++H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 191
Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV------GSPYYVAPEVLL-KHY 278
           +K +N LL +     +L   DFG ++  +P  +   ++      G+  ++APEV++ K  
Sbjct: 192 VKADNVLLSSDGSRAAL--CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 279 GPEADVWTAGVILYILLSGVPPF 301
             + D+W++  ++  +L+G  P+
Sbjct: 250 DAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   LGR +G+GQFG  +    ++        +I   K  + + V +   +  +     
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEAC 216
            H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I+   +  
Sbjct: 69  DHPHIVKLIGVITENP-VWIIMELCTLGEL------RSFLQVRKYSLDLASLILYAYQLS 121
Query: 217 HSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-Y 268
            +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G  P  +
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 269 VAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           +APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 37  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 90
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 91  LTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 143
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 200
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 254

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 134/318 (42%), Gaps = 63/318 (19%)
Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T ++ D Y +   +G G +G         TG + A K I     +   + +   RE++I+
Sbjct: 50  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKIL 108
Query: 154 HHLAGHKNIVTIKG------AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
            H   H NI+ IK        Y +   V++V++L        +II   H S+    E  R
Sbjct: 109 KHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQII---HSSQPLTLEHVR 162
Query: 208 I----IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ---I 258
                ++  ++  HS  V+HRDLKP N LLVN  ++  LK  DFG++  +   P +    
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSN-LLVN--ENCELKIGDFGMARGLCTSPAEHQYF 219
Query: 259 FTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVI---------------------LYILL 295
            T+ V + +Y APE++L    Y    D+W+ G I                     L +++
Sbjct: 220 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279
Query: 296 SGVPPFWAETQQGIFDAVLKGHIDF----ESDPW----PLISDSAKDLIRKMLCSQPSER 347
            G P       Q +    ++ +I      +  PW    P     A  L+ +ML  +PS R
Sbjct: 280 LGTPS--PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSAR 337
Query: 348 LTA-----HEVLCMYNLP 360
           ++A     H  L  Y+ P
Sbjct: 338 ISAAAALRHPFLAKYHDP 355

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 33/288 (11%)
Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
           +KK  ++      +  +VL H+     DL  LG ++G+G FG  +     A     A KS
Sbjct: 93  TKKSGVVLHRAVPKDKWVLNHE-----DL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146
Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
              R+ +  +      +E +I+   + H NIV + G       ++IVMEL  GG+    +
Sbjct: 147 C--RETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 192 IQRGHYSERKAAELTRII---VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
              G  +  +   L +++      +E   S   +HRDL   N L+  K+    LK  DFG
Sbjct: 204 RTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFG 258
Query: 249 LS------VFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPP 300
           +S      V+   G +    V    + APE L    Y  E+DVW+ G++L+   S G  P
Sbjct: 259 MSREEADGVYAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 301 FWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRKMLCSQPSER 347
           +   + Q   + V KG       P P L  D+   L+ +    +P +R
Sbjct: 316 YPNLSNQQTREFVEKGG----RLPCPELCPDAVFRLMEQCWAYEPGQR 359

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 71
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG---SP-YYVA 270
              +   +HRDL   N L+ N++    +K  DFGL+      + F  V     SP ++ A
Sbjct: 129 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGV 298
           PE L +  +   +DVW+ GV+LY L + +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMHHLAGHKNIVTI 165
           LG+G FG  +          +A K I   +L +RE   E V RE++ +  L  H  IV  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI---RLPNRELAREKVMREVKALAKLE-HPGIVRY 68
Query: 166 KGAYEDS------------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             A+ +             + ++I M+LC    L D +  R    ER+ +    I + + 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 214 EAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL----------SVFFKPGQIF- 259
           EA    HS G+MHRDLKP N      D    +K  DFGL               P   + 
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 260 --TDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
             T  VG+  Y++PE +  + Y  + D+++ G+IL+ LL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 59
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 60  LTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 112
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 223

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 40/240 (16%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 62
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRII 209
             M     H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I
Sbjct: 63  LTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGEL------RSFLQVRKYSLDLASLI 114
Query: 210 VGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
           +   +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASK 171
Query: 264 GS-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           G  P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++G+G FG  +    +      A KS+    S+ +    E  ++ +RE+ IM +L  H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +      + 
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ 139
Query: 221 -----VMHRDLKPENFLLVNKDDDFSL--KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
                ++HRDL+  N  L + D++  +  K  DFGLS   +     + ++G+  ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 274 L---LKHYGPEADVWTAGVILYILLSGVPPF 301
           +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   +      +   I   +E     
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 14  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 67
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 68  LTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 120
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 231

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 9   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 63  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS +   +  PEV
Sbjct: 122 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 177
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 12  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 65
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 66  LTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 118
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 175
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 229

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 19/220 (8%)
Query: 90  LGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
           LG+ +  I  +DL T  ++LG GQFG      +     + A K I +  +   E +E   
Sbjct: 14  LGYGSWEIDPKDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE--- 68
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELT 206
            E ++M +L+ H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ 
Sbjct: 69  -EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + +   +E   S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSK 182
Query: 267 Y---YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +   +  PEVL+   +  ++D+W  GV+++ + S G  P+
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 98  RDLYTLGRKLGQGQFGTT----YLCTE---IATGIEFACKSISKRKLISREDVEDVRREI 150
           R+   LGR +G+GQFG      Y+  E   +A  I+  CK+ +     S    E   +E 
Sbjct: 11  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCT-----SDSVREKFLQEA 64
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
             M     H +IV + G   ++  V I+MELC  GEL    +Q   YS     +L  +I+
Sbjct: 65  LTMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYS----LDLASLIL 117
Query: 211 GVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              +   +L  +      HRD+   N L+ + D    +K  DFGLS + +    +    G
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTYYKASKG 174
Query: 265 S-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
             P  ++APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 27/273 (9%)
Query: 59  NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI-RDLYTLGRKLGQGQFGTTYL 117
           N K+   +  +S S+ D+      +  TY +   +   I R+   LGR +G+GQFG  + 
Sbjct: 349 NEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQ 408
Query: 118 CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI 177
              ++        +I   K  + + V +   +  +      H +IV + G   ++  V I
Sbjct: 409 GIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWI 467
Query: 178 VMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEACHSLGVM------HRDLKPEN 230
           +MELC  GEL      R     RK + +L  +I+   +   +L  +      HRD+   N
Sbjct: 468 IMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 521
Query: 231 FLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPEVL-LKHYGPEADVWTA 287
            L+   D    +K  DFGLS + +    +    G  P  ++APE +  + +   +DVW  
Sbjct: 522 VLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 288 GVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 579 GVCMWEILMHGVKPF-----QGVKNNDVIGRIE 606

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 38/282 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIV 163
           ++G G +GT Y   +  +G   A KS+          +  VR E+ ++  L    H N+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 164 TIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            +      S     + V +V E          D+    G  +E    +L R  +  ++  
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLDFL 128
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRDLKPEN L+ +     ++K  DFGL+  +        VV + +Y APEVLL+
Sbjct: 129 HANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQ 185
Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQ----GIFDAV-LKGHIDFESD------- 323
             Y    D+W+ G I   +    P F   ++      IFD + L    D+  D       
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 245
Query: 324 -----PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                P P+      + +S   L+ +ML   P +R++A   L
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   +      +   I   +E     
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 132 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAY 187
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 19/220 (8%)
Query: 90  LGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
           LG+ +  I  +DL T  ++LG GQFG      +     + A K I +  +   E +E   
Sbjct: 5   LGYGSWEIDPKDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE--- 59
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELT 206
            E ++M +L+ H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ 
Sbjct: 60  -EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 117
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + +   +E   S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS 
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSK 173
Query: 267 Y---YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +   +  PEVL+   +  ++D+W  GV+++ + S G  P+
Sbjct: 174 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 4   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 57
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 58  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS +   +  PEV
Sbjct: 117 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 172
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 112/286 (39%), Gaps = 41/286 (14%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH------- 159
           LGQG FG             +A K I      + E +  +  E+ ++  L          
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVXLLASLNHQYVVRYYA 69
Query: 160 -----KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER-KAAELTRIIVGVV 213
                +N V    A +    + I  E C    L+D I       +R +   L R I+  +
Sbjct: 70  AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------------PGQI-- 258
              HS G++HR+LKP N  +   D+  ++K  DFGL+                 PG    
Sbjct: 130 SYIHSQGIIHRNLKPXNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 259 FTDVVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLK 315
            T  +G+  YVA EVL    HY  + D ++ G+I +     + PF    ++  I   +  
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF---EXIYPFSTGXERVNILKKLRS 243
Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV 361
             I+F  D         K +IR ++   P++R  A  +L    LPV
Sbjct: 244 VSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQFG  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   S      +   I   +E     
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L  
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 184
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK---DYRMERPEGCPEKVYE 241
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 12  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 71  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 126
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 8   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 62  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 120
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T  VGS +   +  PEV
Sbjct: 121 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 176
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   +      +   I   +E     
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 133 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAY 188
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 245
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 246 LMRACWQWNPSDRPSFAEI 264

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 316
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   +      +   I   +E     
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 376
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HR+L   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 377 NFIHRNLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 432
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 489
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 490 LMRACWQWNPSDRPSFAEI 508

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 74
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 134 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
              +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVY 246
Query: 334 DLIRKMLCSQPSERLTAHEV 353
           +L+R      PS+R +  E+
Sbjct: 247 ELMRACWQWNPSDRPSFAEI 266

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 135 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 190
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 38/282 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIV 163
           ++G G +GT Y   +  +G   A KS+          +  VR E+ ++  L    H N+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 164 TIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            +      S     + V +V E          D+    G  +E    +L R  +  ++  
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLDFL 128
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRDLKPEN L+ +     ++K  DFGL+  +        VV + +Y APEVLL+
Sbjct: 129 HANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQ 185
Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV-LKGHIDFESD------- 323
             Y    D+W+ G I   +    P F   ++      IFD + L    D+  D       
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 245
Query: 324 -----PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                P P+      + +S   L+ +ML   P +R++A   L
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 29  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 83
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 143 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 198
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
              +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   
Sbjct: 199 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVY 255
Query: 334 DLIRKMLCSQPSERLTAHEV 353
           +L+R      PS+R +  E+
Sbjct: 256 ELMRACWQWNPSDRPSFAEI 275

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGL+   +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 21/260 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 130 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 185
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
              +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVY 242
Query: 334 DLIRKMLCSQPSERLTAHEV 353
           +L+R      PS+R +  E+
Sbjct: 243 ELMRACWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   +      +   I   +E     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 191
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 248
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 68
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   S      +   I   +E     
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 128
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L  
Sbjct: 129 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 184
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK---DYRMERPEGCPEKVYE 241
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 242 LMRACWQWNPSDRPSFAEI 260

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   LGR +G+GQFG  +    ++        +I   K  + + V +   +  +     
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEAC 216
            H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I+   +  
Sbjct: 69  DHPHIVKLIGVITENP-VWIIMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLS 121
Query: 217 HSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-Y 268
            +L  +      HRD+   N L+   D    +K  DFGLS + +    +    G  P  +
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSATD---CVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 269 VAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           +APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   +      +   I   +E     
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 133 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 188
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 70
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-- 219
           +V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A   L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL- 274
              +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L 
Sbjct: 130 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 185
Query: 275 LKHYGPEADVWTAGVILY-ILLSGVPPF 301
              +  ++DVW  GV+L+ I   G+ P+
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 72
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   +      +   I   +E     
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 132
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G  +T   G+ +   + APE L  
Sbjct: 133 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 188
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPF 301
             +  ++DVW  GV+L+ I   G+ P+
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 62/267 (23%)
Query: 83  DNQTYYV------LGHKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKS 131
           DN+ +YV         K +  R+    G+ LG G FG     T Y  ++    I+ A K 
Sbjct: 23  DNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM 82
Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
           + K K  S E  E +  E+++M  L  H+NIV + GA   S  ++++ E C  G+L + +
Sbjct: 83  L-KEKADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
Query: 192 -IQRGHYSE--------RKAAELTRIIVGVVE--ACHSLGV------------MHRDLKP 228
             +R  +SE        ++  E   + V   E   C +  V            +HRDL  
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200
Query: 229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV------------APEVLLK 276
            N L+ +      +K  DFGL+          D++    YV            APE L +
Sbjct: 201 RNVLVTHGK---VVKICDFGLA---------RDIMSDSNYVVRGNARLPVKWMAPESLFE 248
Query: 277 H-YGPEADVWTAGVILYILLS-GVPPF 301
             Y  ++DVW+ G++L+ + S GV P+
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVNPY 275

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/296 (22%), Positives = 124/296 (41%), Gaps = 49/296 (16%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--------------EDV 146
           Y + R L QG+F    LC +      +A K   K  L  + D               +D 
Sbjct: 33  YRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDR--IIQRGHYSERKA 202
           + E+QI+  +      +T +G   +   V+I+ E      +  FD    +   +Y+    
Sbjct: 91  KNELQIITDIKNEY-CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 203 AELTRIIVGVVEACHSL-----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
            ++ + I+  V    S       + HRD+KP N L+   D +  +K  DFG S +    +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDKK 206
Query: 258 IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAV 313
           I     G+  ++ PE       + G + D+W+ G+ LY++   V PF  + +   +F+ +
Sbjct: 207 I-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 314 LKGHIDFESDP----WPL-----------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
              +I++  D     +PL           +S+   D ++  L   P+ER+T+ + L
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 18  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 77  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 132
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 189
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 18  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 77  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 132
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 38/282 (13%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIV 163
           ++G G +GT Y   +  +G   A KS+          +  VR E+ ++  L    H N+V
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRLEAFEHPNVV 69
Query: 164 TIKGAYEDS-----LCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            +      S     + V +V E          D+    G  +E    +L R  +  ++  
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE-TIKDLMRQFLRGLDFL 128
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
           H+  ++HRDLKPEN L+ +     ++K  DFGL+  +        VV + +Y APEVLL+
Sbjct: 129 HANCIVHRDLKPENILVTSGG---TVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQ 185
Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQ----GIFDAV-LKGHIDFESD------- 323
             Y    D+W+ G I   +    P F   ++      IFD + L    D+  D       
Sbjct: 186 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 245
Query: 324 -----PWPL------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                P P+      + +S   L+ +ML   P +R++A   L
Sbjct: 246 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R+LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 74
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L + + +   + ER    K  + T  I   +E
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK---HKERIDHIKLLQYTSQICKGME 131
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 132 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 187
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 8   KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 67  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 105/228 (46%), Gaps = 20/228 (8%)
Query: 102 TLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           ++ + +G G+FG   +C+   ++ +  E +    + +   + +   D   E  IM     
Sbjct: 48  SIDKVVGAGEFGE--VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-D 104
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           H NI+ ++G    S  V IV E    G L D  + R H ++    +L  ++ G+      
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 219 L---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAP 271
           L   G +HRDL   N L+   + +   K  DFGL    +  P   +T   G     + +P
Sbjct: 163 LSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 8   KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 67  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHXVMQEHRKVPFA 179
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 12  KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 70
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 71  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 126
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 183
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   LGR +G+GQFG  +    ++        +I   K  + + V +   +  +     
Sbjct: 9   RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK-AAELTRIIVGVVEAC 216
            H +IV + G   ++  V I+MELC  GEL      R     RK + +L  +I+   +  
Sbjct: 69  DHPHIVKLIGVITENP-VWIIMELCTLGEL------RSFLQVRKFSLDLASLILYAYQLS 121
Query: 217 HSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-Y 268
            +L  +      HRD+   N L+ + D    +K  DFGLS + +         G  P  +
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 269 VAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHID 319
           +APE +  + +   +DVW  GV ++ IL+ GV PF     QG+ +  + G I+
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF-----QGVKNNDVIGRIE 226

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 26/266 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           +DL  L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 8   KDLRLL-EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H+N++ + G    +  + +V EL   G L DR+  R H        L+R  V V E
Sbjct: 67  SL-DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 215 A---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPY- 267
                 S   +HRDL   N LL  +D    +K  DFGL           +  +    P+ 
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 268 YVAPEVL-LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           + APE L  + +   +D W  GV L+ + +    +  E   G+  + +   ID E +  P
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFT----YGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 327 LISDSAKDLIRKML---CSQPSERLT 349
              D  +D+   M+     +P +R T
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG       +    ++  K ++ +++ S  + +    E++ +  +  H NIV + 
Sbjct: 17  VGRGAFG-------VVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLY 68
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSL-- 219
           GA  + +C  +VME   GG L++  +  G     +Y+   A          V   HS+  
Sbjct: 69  GACLNPVC--LVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
             ++HRDLKP N LLV       LK  DFG +   +     T+  GS  ++APEV    +
Sbjct: 125 KALIHRDLKPPNLLLVAGGT--VLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSN 180
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK---D 334
           Y  + DV++ G+IL+ +++   PF  E     F  +   H        PLI +  K    
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRP---PLIKNLPKPIES 236
Query: 335 LIRKMLCSQPSERLTAHEVL 354
           L+ +     PS+R +  E++
Sbjct: 237 LMTRCWSKDPSQRPSMEEIV 256

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 25/232 (10%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKNIVT 164
           KLG+G + T Y      T    A K I   +L   E       RE+ ++  L  H NIVT
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLK-HANIVT 64
Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQR-----GHYSERKAAELT--RIIVGVVEACH 217
           +         +H    L    E  D+ +++     G+       +L   +++ G+   CH
Sbjct: 65  LHD------IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA-YCH 117
Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL- 275
              V+HRDLKP+N L+  + +   LK  DFGL+     P + + + V + +Y  P++LL 
Sbjct: 118 RQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
              Y  + D+W  G I Y + +G P F   T +     + +       + WP
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           D   E  IM     H NI+ ++G         IV E    G L D  + R H  +    +
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFL-RTHDGQFTIMQ 152
Query: 205 LTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIF 259
           L  ++ GV   +     LG +HRDL   N L+   D +   K  DFGLS   +  P   +
Sbjct: 153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 260 TDVVGSP--YYVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLK 315
           T   G     + APE +  + +   +DVW+ GV+++ +L  G  P+W  T + +  +V +
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
Query: 316 GH 317
           G+
Sbjct: 270 GY 271

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG       +    ++  K ++ +++ S  + +    E++ +  +  H NIV + 
Sbjct: 16  VGRGAFG-------VVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLY 67
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG-----HYSERKAAELTRIIVGVVEACHSL-- 219
           GA  + +C  +VME   GG L++  +  G     +Y+   A          V   HS+  
Sbjct: 68  GACLNPVC--LVMEYAEGGSLYN--VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 220 -GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KH 277
             ++HRDLKP N LLV       LK  DFG +   +     T+  GS  ++APEV    +
Sbjct: 124 KALIHRDLKPPNLLLVAGGT--VLKICDFGTACDIQ--THMTNNKGSAAWMAPEVFEGSN 179
Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK---D 334
           Y  + DV++ G+IL+ +++   PF  E     F  +   H        PLI +  K    
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPF-DEIGGPAFRIMWAVHNGTRP---PLIKNLPKPIES 235
Query: 335 LIRKMLCSQPSERLTAHEVL 354
           L+ +     PS+R +  E++
Sbjct: 236 LMTRCWSKDPSQRPSMEEIV 255

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 78
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 135
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 136 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 191
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFTYI 221

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
           +KK  ++      +  +VL H+     DL  LG ++G+G FG  +     A     A KS
Sbjct: 93  TKKSGVVLHRAVPKDKWVLNHE-----DL-VLGEQIGRGNFGEVFSGRLRADNTLVAVKS 146
Query: 132 ISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI 191
              R+ +  +      +E +I+   + H NIV + G       ++IVMEL  GG+    +
Sbjct: 147 C--RETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 192 IQRGHYSERKAAELTRII---VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
              G  +  +   L +++      +E   S   +HRDL   N L+  K+    LK  DFG
Sbjct: 204 RTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFG 258
Query: 249 LS------VFFKPGQIFTDVVGSPYYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPP 300
           +S      V    G +    V    + APE L    Y  E+DVW+ G++L+   S G  P
Sbjct: 259 MSREEADGVXAASGGLRQVPVK---WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 301 FWAETQQGIFDAVLKGHIDFESDPWP-LISDSAKDLIRKMLCSQPSER 347
           +   + Q   + V KG       P P L  D+   L+ +    +P +R
Sbjct: 316 YPNLSNQQTREFVEKGG----RLPCPELCPDAVFRLMEQCWAYEPGQR 359

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 74
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG    +    + ++ME    G L D +  + H       +L +    + +    
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEY 132
Query: 219 LGV---MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYVA 270
           LG    +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ A
Sbjct: 133 LGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYA 188
Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGV 298
           PE L +  +   +DVW+ GV+LY L + +
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 70
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 127
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 128 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 183
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFTYI 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 25/243 (10%)
Query: 58  ENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYL 117
           E P+  ++ PR      D+     I NQ + V   K D++  +  LGR    G +G    
Sbjct: 21  EQPQTSSTPPR----DLDSKACISIGNQNFEV---KADDLEPIMELGR----GAYGVVEK 69
Query: 118 CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI 177
              + +G   A K I  R  ++ ++ + +  ++ I          VT  GA      V I
Sbjct: 70  MRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 127
Query: 178 VMEL--CAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLL 233
            MEL   +  + + ++I +G    E    ++   IV  +E  HS L V+HRD+KP N L+
Sbjct: 128 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI 187
Query: 234 VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL-----LKHYGPEADVWTAG 288
              +    +K  DFG+S +       T   G   Y+APE +      K Y  ++D+W+ G
Sbjct: 188 ---NALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 244
Query: 289 VIL 291
           + +
Sbjct: 245 ITM 247

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++G+G FG  +    +      A KS+    S+ +    E  ++ +RE+ IM +L  H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +      + 
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ 139
Query: 221 -----VMHRDLKPENFLLVNKDDDFSL--KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
                ++HRDL+  N  L + D++  +  K  DFG S   +     + ++G+  ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 274 L---LKHYGPEADVWTAGVILYILLSGVPPF 301
           +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 110/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 71
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I++E    G L D  R   R   +      +   I   +E     
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 131
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L  
Sbjct: 132 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 187
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 244
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 245 LMRACWQWNPSDRPSFAEI 263

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 74
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 131
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 132 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 187
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFTYI 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 71
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 129 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 184
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 69
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 126
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 127 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 182
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYELFTYI 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 75
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 132
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 133 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 188
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 189 APESLTESKFSVASDVWSFGVVLYELFTYI 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 71
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 129 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 184
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYI 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 102
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 159
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 160 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 215
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYI 245

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 76
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 133
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 134 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 189
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFTYI 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 77
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 134
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 135 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 190
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFTYI 220

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 36/236 (15%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMH 154
           R+    G+ LG G FG     T    G E A   ++ + L S    ++ E +  E++IM 
Sbjct: 30  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMS 89
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY----------------- 197
           HL  H+NIV + GA      V ++ E C  G+L + + ++                    
Sbjct: 90  HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK 149
Query: 198 SERKAAELTRIIVGVVEACHSLGVM------HRDLKPENFLLVN----KDDDFSLKAIDF 247
            + +  EL  ++    +    +  +      HRD+   N LL N    K  DF L     
Sbjct: 150 EDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
             S +   G     V     ++APE +    Y  ++DVW+ G++L+ + S G+ P+
Sbjct: 210 NDSNYIVKGNARLPV----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 89
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 146
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 147 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 202
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLSGV 298
           APE L +  +   +DVW+ GV+LY L + +
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFTYI 232

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSI----SKRKLISREDVEDVRREIQIMHHLAGHK 160
           +++G+G FG  +    +      A KS+    S+ +    E  ++ +RE+ IM +L  H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHP 83
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +      + 
Sbjct: 84  NIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ 139
Query: 221 -----VMHRDLKPENFLLVNKDDDFSL--KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
                ++HRDL+  N  L + D++  +  K  DF LS   +     + ++G+  ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 274 L---LKHYGPEADVWTAGVILYILLSGVPPF 301
           +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 89
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 146
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP-----YYV 269
              +   +HRDL   N L+ N++    +K  DFGL+    P       V  P     ++ 
Sbjct: 147 YLGTKRYIHRDLATRNILVENEN---RVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWY 202
Query: 270 APEVLLK-HYGPEADVWTAGVILYILLS 296
           APE L +  +   +DVW+ GV+LY L +
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 109/259 (42%), Gaps = 19/259 (7%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T+  KLG GQ+G  Y        +  A K++ +  +    +VE+  +E  +M  +  H N
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIK-HPN 75
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +V + G        +I+ E    G L D  R   R   +      +   I   +E     
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 135
Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL-L 275
             +HRDL   N L+    ++  +K  DFGLS     G   T   G+ +   + APE L  
Sbjct: 136 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAY 191
Query: 276 KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
             +  ++DVW  GV+L+ I   G+ P+       +++ + K   D+  +      +   +
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYE 248
Query: 335 LIRKMLCSQPSERLTAHEV 353
           L+R      PS+R +  E+
Sbjct: 249 LMRACWQWNPSDRPSFAEI 267

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 107 LGQGQFG---TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +G G+FG   + +L       I  A K++  +   + +   D   E  IM     H N++
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQF-DHPNVI 71
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVM 222
            ++G    S  V I+ E    G L   + Q  G ++  +   + R I   ++    +  +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK---PGQIFTDVVGSPY---YVAPEVL-L 275
           HR L   N L+   + +   K  DFGLS F +       +T  +G      + APE +  
Sbjct: 132 HRALAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 276 KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           + +   +DVW+ G++++ ++S G  P+W  T Q + +A+
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 202
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 90  LGHKTDNI--RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
           LG+ +  I  +DL T  ++LG GQFG      +     + A K I +  +   E +E   
Sbjct: 14  LGYGSWEIDPKDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE--- 68
Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELT 206
            E ++M +L+ H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ 
Sbjct: 69  -EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + +   +E   S   +HRDL   N L+   +D   +K  DFGLS +    +  T  VGS 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEE-TSSVGSK 182
Query: 267 Y---YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +   +  PEVL+   +  ++D+W  GV+++ + S G  P+
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 105 RKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           ++LG+G FG+  +C     +  TG   A K +      + E + D  REI+I+  L  H 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HD 72
Query: 161 NIVTIKGAYEDS--LCVHIVMELCAGGELFDRIIQRGHYSER----KAAELTRIIVGVVE 214
           NIV  KG    +    + ++ME    G L D + +   + ER    K  + T  I   +E
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 129
Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG---SP-YYVA 270
              +   +HR+L   N L+ N++    +K  DFGL+      + +  V     SP ++ A
Sbjct: 130 YLGTKRYIHRNLATRNILVENEN---RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
Query: 271 PEVLLK-HYGPEADVWTAGVILYILLSGV 298
           PE L +  +   +DVW+ GV+LY L + +
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFTYI 215

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 202
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LGRK+G G FG  YL T+IA G E A K    +    +  +E      +I   + G  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-----KIYKMMQGGV 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            I TI+    +     +VMEL      +LF+   ++  +S +    L   ++  +E  HS
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              +HRD+KP+NFL+        +  IDFGL+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +DL T  ++LG GQFG      +     + A K I +  +   E +E    E ++M +L+
Sbjct: 9   KDL-TFLKELGTGQFGVVKY-GKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLS 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H+ +V + G       + I+ E  A G L + + +  H +  ++  E+ + +   +E  
Sbjct: 63  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEV 273
            S   +HRDL   N L+   +D   +K  DFGLS +    + +T   GS +   +  PEV
Sbjct: 122 ESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE-YTSSRGSKFPVRWSPPEV 177
Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           L+   +  ++D+W  GV+++ + S G  P+
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL---- 156
           Y L RKLG G F T +L  ++      A K +   K+ + E  ED   EI+++  +    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAED---EIKLLQRVNDAD 76
Query: 157 ------AGHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL--- 205
                  G  +I+ +   +  +    VH+VM     GE    +I++  Y  R    +   
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVK 134
Query: 206 ---TRIIVGVVEACHSLGVMHRDLKPENFLLV---NKDDDFSLKAIDFGLSVFFKPGQIF 259
               ++++G+       G++H D+KPEN L+    + ++   +K  D G + ++   + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG 297
           T+ + +  Y +PEVLL   +G  AD+W+   +++ L++G
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL---- 156
           Y L RKLG G F T +L  ++      A K +   K+ + E  ED   EI+++  +    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAED---EIKLLQRVNDAD 76
Query: 157 ------AGHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL--- 205
                  G  +I+ +   +  +    VH+VM     GE    +I++  Y  R    +   
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVK 134
Query: 206 ---TRIIVGVVEACHSLGVMHRDLKPENFLLV---NKDDDFSLKAIDFGLSVFFKPGQIF 259
               ++++G+       G++H D+KPEN L+    + ++   +K  D G + ++   + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 192
Query: 260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG 297
           T+ + +  Y +PEVLL   +G  AD+W+   +++ L++G
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LGRK+G G FG  YL T+IA G E A K    +    +  +E      +I   + G  
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-----KIYKMMQGGV 63
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            I TI+    +     +VMEL      +LF+   ++  +S +    L   ++  +E  HS
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              +HRD+KP+NFL+        +  IDFGL+
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 63  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 122
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 123 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 239
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   LC        TG + A KS+          + D+++EI+I+ +L  H+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 83
Query: 161 NIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG    +    + ++ME    G L + + +      +    L + +   V+ C  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQLKYAVQICKG 138
Query: 219 LGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---KPGQIFTDVVGSP-YY 268
           +  +      HRDL   N L+   + +  +K  DFGL+      K      D   SP ++
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 269 VAPEVLLK-HYGPEADVWTAGVILYILLS 296
            APE L++  +   +DVW+ GV L+ LL+
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 205
Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 262
Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVLCMYN 358
            PL   D   DL+R+    +P ER +  ++L   N
Sbjct: 263 -PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 28  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 87
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 204
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 105 RKLGQGQFGTTYLCTEIA----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           R LG+G FG   LC        TG + A KS+          + D+++EI+I+ +L  H+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HE 71
Query: 161 NIVTIKG-AYED-SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           NIV  KG   ED    + ++ME    G L + + +      +    L + +   V+ C  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KNKINLKQQLKYAVQICKG 126
Query: 219 LGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---KPGQIFTDVVGSP-YY 268
           +  +      HRDL   N L+   + +  +K  DFGL+      K      D   SP ++
Sbjct: 127 MDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 269 VAPEVLLK-HYGPEADVWTAGVILYILLS 296
            APE L++  +   +DVW+ GV L+ LL+
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HRDL   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 195
Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 196 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 252
Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVLCMYN 358
            PL   D   DL+R+    +P ER +  ++L   N
Sbjct: 253 -PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 286

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 27  RDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 86
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGV 212
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K  E        
Sbjct: 87  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 213 VE--ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPG 256
           +E   C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPD 203
Query: 257 QIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
            +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + ++ E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 35/254 (13%)
Query: 72  SKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKS 131
           S ++N+  +G D++  +    K   + + + + RK+G G FG   LC  I     +A K 
Sbjct: 9   SGRENLYFQG-DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKV 67
Query: 132 ISKRKLISRE-DVE-DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD 189
           +   K  +R   +E D+ ++IQ       +      K  Y D +C  ++ E   G  L++
Sbjct: 68  VRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC--LIFE-PLGPSLYE 124
Query: 190 RIIQRGHYSERKAAELTRIIVGVVEACHSLGVM---HRDLKPENFLL------------- 233
            II R +Y+     ++    + +++A + L  M   H DLKPEN LL             
Sbjct: 125 -IITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 234 ---------VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEAD 283
                    + +     +K IDFG + F         ++ +  Y APEV+L   +   +D
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSD 241
Query: 284 VWTAGVILYILLSG 297
           +W+ G +L  L +G
Sbjct: 242 MWSFGCVLAELYTG 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 35/262 (13%)
Query: 83  DNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACK 130
           D    Y    KT +I DL        TL R LG G FG  Y           + ++ A K
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
           ++ +  + S +D  D   E  I+  L  H+NIV   G    SL   I++EL AGG+L   
Sbjct: 68  TLPE--VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 124
Query: 191 IIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNK 236
           + +        S     +L  +   +   C  L     +HRD+   N LL       V K
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 184
Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
             DF +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + 
Sbjct: 185 IGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 296 S-GVPPFWAETQQGIFDAVLKG 316
           S G  P+ +++ Q + + V  G
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG 262

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + ++ E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIYKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
           D   E  IM     H NI+ ++G         IV E    G L D  + R H  +    +
Sbjct: 96  DFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFL-RTHDGQFTIMQ 152
Query: 205 LTRIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIF 259
           L  ++ GV   +     LG +HRDL   N L+   D +   K  DFGLS   +  P    
Sbjct: 153 LVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 260 TDVVGS-PY-YVAPEVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLK 315
           T   G  P  + APE +  + +   +DVW+ GV+++ +L  G  P+W  T + +  +V +
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
Query: 316 GH 317
           G+
Sbjct: 270 GY 271

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I+MEL AGG+L   + +  
Sbjct: 86  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 143
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 204 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 259
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 70
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I+MEL AGG+L   + +  
Sbjct: 71  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 189 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 245 PYPSKSNQEVLEFVTSG 261

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+  L  H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 86  -VCSEQDELDFLMEALIISKL-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 204 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 259
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 90  LGHKTDNIRDLYTL-GRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLISREDVEDV 146
           L  + + + DL+   G K+G+G +G  Y         +  +A K I    +         
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-----SA 65
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQ--RGHYSERKAAE 204
            REI ++  L  H N+++++  +       + +           II+  R   + +K  +
Sbjct: 66  CREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 205 LTR-----IIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFF-- 253
           L R     ++  +++  H L    V+HRDLKP N L++ +  +   +K  D G +  F  
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 254 --KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF 301
             KP      VV + +Y APE+LL  +HY    D+W  G I   LL+  P F
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 43/297 (14%)
Query: 48  QQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL------- 100
           Q+L + +   ++P+      ++S  +   IM    D    Y    KT +I DL       
Sbjct: 7   QELQAMQMELQSPEY-----KLSKLRTSTIM---TDYNPNYSFAGKTSSISDLKEVPRKN 58
Query: 101 YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            TL R LG G FG  Y           + ++ A K++ +  + S +D  D   E  I+  
Sbjct: 59  ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISK 116
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVG 211
              H+NIV   G    SL   I++EL AGG+L   + +        S     +L  +   
Sbjct: 117 F-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 212 VVEACHSLG---VMHRDLKPENFLL-------VNKDDDFSLKAIDFGLSVFFKPGQIFTD 261
           +   C  L     +HRD+   N LL       V K  DF +    +  S + K G     
Sbjct: 176 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 235
Query: 262 VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           V     ++ PE  ++  +  + D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 236 V----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 288

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDP 202
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 38/277 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 12  KLSKLRTSTIM---TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 68
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 69  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 125
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 126 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 185
Query: 229 ENFLL-------VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGP 280
            N LL       V K  DF +    +  S + K G     V     ++ PE  ++  +  
Sbjct: 186 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTS 241
Query: 281 EADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           + D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 242 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 278

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 35/262 (13%)
Query: 83  DNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACK 130
           D    Y    KT +I DL        TL R LG G FG  Y           + ++ A K
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
           ++ +  + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   
Sbjct: 68  TLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 124
Query: 191 IIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNK 236
           + +        S     +L  +   +   C  L     +HRD+   N LL       V K
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 184
Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
             DF +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + 
Sbjct: 185 IGDFGMAQDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 296 S-GVPPFWAETQQGIFDAVLKG 316
           S G  P+ +++ Q + + V  G
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG 262

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 320
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 321 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 379 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 434
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 491
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 492 SLHDLMCQCWRKEPEERPT 510

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 38/277 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 2   KLSKLRTSTIM---TDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 58
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 59  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 115
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 116 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 175
Query: 229 ENFLL-------VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGP 280
            N LL       V K  DF +    +  S + K G     V     ++ PE  ++  +  
Sbjct: 176 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTS 231
Query: 281 EADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
           + D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 232 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 268

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG          G+         ++  S++D  D   E++++  L  H NI+ + 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 167 GAYEDSLCVHIVMELCAGGELFDRI-------------IQRGHYSERKAAELTRIIVGVV 213
           GA E    +++ +E    G L D +             I     S   + +L      V 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 214 EACHSLG---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----VFFKPGQIFTDVVGSP 266
                L     +HR+L   N L+    +++  K  DFGLS    V+ K       V    
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 202
Query: 267 YYVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDP 324
            ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G+   E   
Sbjct: 203 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEK-- 259
Query: 325 WPL-ISDSAKDLIRKMLCSQPSERLTAHEVLCMYN 358
            PL   D   DL+R+    +P ER +  ++L   N
Sbjct: 260 -PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 293

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+  K    + ++ E    E  IM 
Sbjct: 7   REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 64
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGV 212
           +L  H +IV + G  E+     I+MEL   GEL       GHY ER   + ++  +++  
Sbjct: 65  NL-DHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYS 115
Query: 213 VEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGS 265
           ++ C       S+  +HRD+   N L+ + +    +K  DFGLS + +    +   V   
Sbjct: 116 LQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRL 172
Query: 266 PY-YVAPEVL-LKHYGPEADVWTAGVILYILLS--GVPPFWAETQQGI 309
           P  +++PE +  + +   +DVW   V ++ +LS    P FW E +  I
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 28/229 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG               C++++ + L    +  +   +  E++I+ 
Sbjct: 17  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 76
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA--ELTRIIV 210
           H+  H N+V + GA  +    + ++ E C  G L   +  +R  +   K A  +L +  +
Sbjct: 77  HIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 211 GVVE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKP 255
            +    C+S  V            +HRDL   N LL  K+    +K  DFGL+  +   P
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVKICDFGLARDIXKDP 193
Query: 256 GQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
             +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 32/273 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+  K    + ++ E    E  IM 
Sbjct: 23  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 80
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGV 212
           +L  H +IV + G  E+     I+MEL   GEL       GHY ER   + ++  +++  
Sbjct: 81  NL-DHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYS 131
Query: 213 VEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGS 265
           ++ C       S+  +HRD+   N L+ + +    +K  DFGLS + +    +   V   
Sbjct: 132 LQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 266 PY-YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFES 322
           P  +++PE +  + +   +DVW   V ++ +LS G  PF+    + +   + KG    + 
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 248
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           D  P +  +   L+ +     PS+R    E++C
Sbjct: 249 DLCPPVLYT---LMTRCWDYDPSDRPRFTELVC 278

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 32/273 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+  K    + ++ E    E  IM 
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMK 68
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGV 212
           +L  H +IV + G  E+     I+MEL   GEL       GHY ER   + ++  +++  
Sbjct: 69  NL-DHPHIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYS 119
Query: 213 VEAC------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGS 265
           ++ C       S+  +HRD+   N L+ + +    +K  DFGLS + +    +   V   
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 266 PY-YVAPEVL-LKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFES 322
           P  +++PE +  + +   +DVW   V ++ +LS G  PF+    + +   + KG    + 
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236
Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           D  P +  +   L+ +     PS+R    E++C
Sbjct: 237 DLCPPVLYT---LMTRCWDYDPSDRPRFTELVC 266

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G G+FG          G    C +I   K   + +   D   E  IM     H NI+ +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 95
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMH 223
           +G       V I+ E    G L D  +++  G ++  +   + R I   ++    +  +H
Sbjct: 96  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVH 154
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAPEVL-LKHY 278
           RDL   N L+   + +   K  DFG+S   +  P   +T   G     + APE +  + +
Sbjct: 155 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 279 GPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
              +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 212 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 251

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 4   YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 62
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 63  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 120
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 121 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 181 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 236
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 237 PYPSKSNQEVLEFVTSG 253

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 108/262 (41%), Gaps = 35/262 (13%)
Query: 83  DNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACK 130
           D    Y    KT +I DL        TL R LG G FG  Y           + ++ A K
Sbjct: 8   DYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 67
Query: 131 SISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDR 190
           ++ +  + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   
Sbjct: 68  TLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 124
Query: 191 IIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNK 236
           + +        S     +L  +   +   C  L     +HRD+   N LL       V K
Sbjct: 125 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 184
Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILL 295
             DF +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + 
Sbjct: 185 IGDFGMARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 296 S-GVPPFWAETQQGIFDAVLKG 316
           S G  P+ +++ Q + + V  G
Sbjct: 241 SLGYMPYPSKSNQEVLEFVTSG 262

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 11/189 (5%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           ++G+G F T Y   +  T +E A   +  RKL ++ + +  + E + +  L  H NIV  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEXLKGLQ-HPNIVRF 90
Query: 166 KGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             ++E ++    C+ +V EL   G L   + +      +      R I+  ++  H+   
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 221 -VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYG 279
            ++HRDLK +N  +       S+K  D GL+   K       V+G+P + APE   + Y 
Sbjct: 151 PIIHRDLKCDNIFITGPTG--SVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKYD 207
Query: 280 PEADVWTAG 288
              DV+  G
Sbjct: 208 ESVDVYAFG 216

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 70
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 71  -VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 128
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 189 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 245 PYPSKSNQEVLEFVTSG 261

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 105/259 (40%), Gaps = 16/259 (6%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +LG G +G  +       G  +A K  S       +D      E+     +  H   V +
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHR 224
           + A+E+   +++  ELC G  L       G    E +     R  +  +   HS G++H 
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADV 284
           D+KP N  L  +      K  DFGL V            G P Y+APE+L   YG  ADV
Sbjct: 182 DVKPANIFLGPRG---RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADV 238
Query: 285 WTAGV-ILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQ 343
           ++ G+ IL +  +   P   E  Q +    L    +F +     +S   + ++  ML   
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFTAG----LSSELRSVLVMMLEPD 292
Query: 344 PSERLTAHEVLCMYNLPVL 362
           P  R TA  +L    LPVL
Sbjct: 293 PKLRATAEALLA---LPVL 308

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 36/276 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 36  KLSKLRTSTIM---TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 92
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 93  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 149
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209
Query: 229 ENFLLVNKDDDFSLKAIDFGLSV------FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
            N LL         K  DFG++       +++ G      V    ++ PE  ++  +  +
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSK 266
Query: 282 ADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
            D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 267 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 35/257 (13%)
Query: 88  YVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL-----CTEIATGIEFACKSISKR 135
           Y    KT +I DL        TL R LG G FG  Y           + ++ A K++ + 
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE- 85
Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
            + S +D  D   E  I+     H+NIV   G    SL   I++EL AGG+L   + +  
Sbjct: 86  -VYSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETR 143
Query: 195 ---GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLL-------VNKDDDFS 241
                 S     +L  +   +   C  L     +HRD+   N LL       V K  DF 
Sbjct: 144 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVP 299
           +    +  S + K G     V     ++ PE  ++  +  + D W+ GV+L+ + S G  
Sbjct: 204 MARDIYRASYYRKGGCAMLPV----KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 259
Query: 300 PFWAETQQGIFDAVLKG 316
           P+ +++ Q + + V  G
Sbjct: 260 PYPSKSNQEVLEFVTSG 276

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 36/276 (13%)
Query: 68  RISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL-------YTLGRKLGQGQFGTTYL--- 117
           ++S  +   IM    D    Y    KT +I DL        TL R LG G FG  Y    
Sbjct: 13  KLSKLRTSTIM---TDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQV 69
Query: 118 --CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
                  + ++ A K++ +  + S +D  D   E  I+     H+NIV   G    SL  
Sbjct: 70  SGMPNDPSPLQVAVKTLPE--VCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 126
Query: 176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKP 228
            I++EL AGG+L   + +        S     +L  +   +   C  L     +HRD+  
Sbjct: 127 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 186
Query: 229 ENFLLVNKDDDFSLKAIDFGLSV------FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPE 281
            N LL         K  DFG++       +++ G      V    ++ PE  ++  +  +
Sbjct: 187 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK---WMPPEAFMEGIFTSK 243
Query: 282 ADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG 316
            D W+ GV+L+ + S G  P+ +++ Q + + V  G
Sbjct: 244 TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 279

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 237
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 238 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 296 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 408
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 121/294 (41%), Gaps = 48/294 (16%)
Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           +  Y  GH        Y   +KLG+G F    L   +  G  +A K I   +   ++D E
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDRE 71
Query: 145 DVRREIQIMHHLAGHKNIVTI-------KGAYEDSLCVHIVMELCAGGELF---DRIIQR 194
           + +RE   MH L  H NI+ +       +GA  ++    +++     G L+   +R+  +
Sbjct: 72  EAQREAD-MHRLFNHPNILRLVAYCLRERGAKHEAW---LLLPFFKRGTLWNEIERLKDK 127
Query: 195 GHY-SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
           G++ +E +   L   I   +EA H+ G  HRDLKP N LL    D+     +D G     
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLG----- 179
Query: 254 KPGQIFTDVVGSPY------YVAPEVLLKHYGPE-------------ADVWTAGVILYIL 294
              Q    V GS        + A    + +  PE              DVW+ G +LY +
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239
Query: 295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPW-PLISDSAKDLIRKMLCSQPSER 347
           + G  P+    Q+G  D+V     +  S P  P  S +   L+  M+   P +R
Sbjct: 240 MFGEGPYDMVFQKG--DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 237
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 238 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 296 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 408
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 63
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSL- 219
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 120
Query: 220 --GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 121 EASVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G G+FG          G    C +I   K   + +   D   E  IM     H NI+ +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 80
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMH 223
           +G       V I+ E    G L D  +++  G ++  +   + R I   ++    +  +H
Sbjct: 81  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 139
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAPEVL-LKHY 278
           RDL   N L+   + +   K  DFG+S   +  P   +T   G     + APE +  + +
Sbjct: 140 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 279 GPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
              +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 197 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 236

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 14/220 (6%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G G+FG          G    C +I   K   + +   D   E  IM     H NI+ +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHL 74
Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMH 223
           +G       V I+ E    G L D  +++  G ++  +   + R I   ++    +  +H
Sbjct: 75  EGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVH 133
Query: 224 RDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--PGQIFTDVVGSP--YYVAPEVL-LKHY 278
           RDL   N L+   + +   K  DFG+S   +  P   +T   G     + APE +  + +
Sbjct: 134 RDLAARNILV---NSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 279 GPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
              +DVW+ G++++ ++S G  P+W  + Q +  A+ +G+
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY 230

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI-SKRKLISREDVEDVRREIQIMHHLA 157
           D Y +   +G+G FG      +       A K I +K+  +++  +E    E+   H   
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 158 GHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGV 212
               IV +K    + + LC+   M      +L      RG   + + + A ++   ++ +
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
             A   L ++H DLKPEN LL N     ++K +DFG S   + GQ     + S +Y +PE
Sbjct: 155 --ATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSC--QLGQRIYQXIQSRFYRSPE 209
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           VLL   Y    D+W+ G IL  + +G P F
Sbjct: 210 VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 239

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI-SKRKLISREDVEDVRREIQIMHHLA 157
           D Y +   +G+G FG      +       A K I +K+  +++  +E    E+   H   
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 158 GHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGV 212
               IV +K    + + LC+   M      +L      RG   + + + A ++   ++ +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
             A   L ++H DLKPEN LL N     ++K +DFG S   + GQ     + S +Y +PE
Sbjct: 174 --ATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSC--QLGQRIYQXIQSRFYRSPE 228
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           VLL   Y    D+W+ G IL  + +G P F
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLS-HPK 61
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 118
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 119 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 174
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 12/210 (5%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI-SKRKLISREDVEDVRREIQIMHHLA 157
           D Y +   +G+G FG      +       A K I +K+  +++  +E    E+   H   
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 158 GHKNIVTIKG--AYEDSLCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGV 212
               IV +K    + + LC+   M      +L      RG   + + + A ++   ++ +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
             A   L ++H DLKPEN LL N     ++K +DFG S   + GQ     + S +Y +PE
Sbjct: 174 --ATPELSIIHCDLKPENILLCNPKRX-AIKIVDFGSSC--QLGQRIYQXIQSRFYRSPE 228
Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           VLL   Y    D+W+ G IL  + +G P F
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLF 258

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 237
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSER-KAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 238 -HEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 296 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 351
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 408
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 409 SLHDLMCQCWRKEPEERPT 427

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 66
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 123
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 124 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 179
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 180 SFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 106 KLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH L  +  IV
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYIV 73
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVM 222
            + G  +    + +VME+  GG L   ++ +R        AEL   +   ++       +
Sbjct: 74  RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY---YVAPEVL-LKH 277
           HRDL   N LLVN+      K  DFGLS         +T      +   + APE +  + 
Sbjct: 133 HRDLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           +   +DVW+ GV ++  LS G  P+
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 63
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 120
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 121 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 176
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG                ++++ + L    +  +   +  E++I+ 
Sbjct: 28  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 87
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGV 212
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K  +L +  + +
Sbjct: 88  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTL 147
Query: 213 -------------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ 257
                        +E   S   +HRDL   N LL  K+    +K  DFGL+  +   P  
Sbjct: 148 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKICDFGLARDIXKDPDX 204
Query: 258 IFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +      ED   E ++M  L+ H  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPK 64
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 121
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 122 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 177
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 30/215 (13%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +   G       I K   + R   E  R EIQ++ HL    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRY-CEAARSEIQVLEHLNTTD 72
Query: 161 NIVTIKGA-----YEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGVV 213
              T +       +E    + IV EL  G   +D I + G    R     ++   I   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFEL-LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 214 EACHSLGVMHRDLKPENFLLVNKD-----------DDFSL-----KAIDFGLSVFFKPGQ 257
              HS  + H DLKPEN L V  D           D+ +L     K +DFG + +    +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DDE 189
Query: 258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVIL 291
             + +V + +Y APEV+L   +    DVW+ G IL
Sbjct: 190 HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IVME  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 184 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGNM----SPEAFLQEAQVMKKLR 238
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 239 -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL    +  + +T   G+ +   + APE
Sbjct: 297 VERMNYVHRDLRAANILV---GENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPE 352
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 409
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 410 SLHDLMCQCWRKDPEERPT 428

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LGRK+G G FG  YL   IA+G E A K    +    +  +E      +    + G  
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIES-----KFYKMMQGGV 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
            I +IK    +     +VMEL      +LF+   ++  +S +    L   ++  +E  HS
Sbjct: 66  GIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
              +HRD+KP+NFL+        +  IDFGL+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 10  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 64
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 65  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 123 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 178
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 235
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 236 SLHDLMCQCWRKEPEERPT 254

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR-------EIQIM 153
           + LGRK+G G FG  YL T I T  E A K            +E+V+        E +I 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYESKIY 56
Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVG 211
             L G   I  ++    +     +VM+L      +LF+   ++   S +    L   ++ 
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK--------PGQIFTDVV 263
            VE  HS   +HRD+KP+NFL+        +  IDFGL+  ++        P +   ++ 
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 264 GSPYYVAPEVLLKHYGPEA----DVWTAGVILYILLSGVPPFWAETQQG 308
           G+  Y +   +  H G E     D+ + G +L   L G  P W   + G
Sbjct: 175 GTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAG 219

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 14  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E    G L D +  + G Y    +  +++  I   +  
Sbjct: 69  -HEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 127 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 182
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 239
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV+E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 59/284 (20%)
Query: 85  QTYYVLGHKTDNIR--DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           +  Y  G    N++  D Y +   +G+G +G  YL  +       A K ++ R      D
Sbjct: 12  ENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-RMFEDLID 70
Query: 143 VEDVRREIQIMHHLAG------HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH 196
            + + REI I++ L        H  I+       D L  +IV+E+ A  +L         
Sbjct: 71  CKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDEL--YIVLEI-ADSDLKKLFKTPIF 127
Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------ 250
            +E+    +   ++   +  H  G++HRDLKP N LL   + D S+K  DFGL+      
Sbjct: 128 LTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSD 184
Query: 251 -------------VFFKPG-------QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAG 288
                           +PG       +  T  V + +Y APE++L  ++Y    D+W+ G
Sbjct: 185 KDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTG 244
Query: 289 VILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
            I   LL+                ++K HI+  ++ +PL   S+
Sbjct: 245 CIFAELLN----------------MMKSHINNPTNRFPLFPGSS 272

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           T  +++G GQFG  +L   +    + A K+I +  +   ED  D   E ++M  L+ H  
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIKEGSM--SED--DFIEEAEVMMKLS-HPK 83
Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +V + G   +   + +V E    G L D +  QRG ++   A  L  + + V E    L 
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEGMAYLE 140
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPEVL 274
              V+HRDL   N L+    ++  +K  DFG++ F    Q +T   G+ +   + +PEV 
Sbjct: 141 EACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVF 196
Query: 275 -LKHYGPEADVWTAGVILYILLS 296
               Y  ++DVW+ GV+++ + S
Sbjct: 197 SFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 111/247 (44%), Gaps = 40/247 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+L  LG+ LG+G+FG+     L  E  T ++ A K++ K    S+ ++E+   E   M 
Sbjct: 33  RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMK 91
Query: 155 HLAGHKNIVTIKGAYEDSLCVH----------IVMELCAGGELFDRIIQRGHYSERKAAE 204
             + H N++ + G     +C+           +++     G+L   ++     +  K   
Sbjct: 92  DFS-HPNVIRLLG-----VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 205 LTRIIVGVVEACHSL------GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV------F 252
           L  ++  +V+    +        +HRDL   N +L    DD ++   DFGLS       +
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDY 202
Query: 253 FKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIF 310
           ++ G+I    V    ++A E L  + Y  ++DVW  GV ++ I   G+ P+       ++
Sbjct: 203 YRQGRIAKMPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 311 DAVLKGH 317
           D +L GH
Sbjct: 260 DYLLHGH 266

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN-IV 163
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L  H + IV
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--HSDFIV 74
Query: 164 TIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             +G         + +VME    G L D  +QR H +   A+ L      + +    LG 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYLGS 132
Query: 221 --VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-Y 267
              +HRDL   N L+   + +  +K  DFGL+          V  +PGQ       SP +
Sbjct: 133 RRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ-------SPIF 182
Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLS 296
           + APE L  + +  ++DVW+ GV+LY L +
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 102/250 (40%), Gaps = 44/250 (17%)
Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISRE 141
           D+   +++ H  D +++ Y +   LG+G FG    C +   G    A K I   +     
Sbjct: 17  DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK-- 74
Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV------MELCAGGEL-----FDR 190
             E  R EI ++         +  K     +LCV +         +C   EL     FD 
Sbjct: 75  --EAARLEINVLEK-------INEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDF 125
Query: 191 IIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------- 237
           +    +  Y   +   +   +   V+  H   + H DLKPEN L VN D           
Sbjct: 126 LKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKR 185
Query: 238 DDFSLKA-----IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVIL 291
           D+ S+K+     +DFG + F    +  + +V + +Y APEV+L+  +    DVW+ G I+
Sbjct: 186 DERSVKSTAVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCII 243
Query: 292 YILLSGVPPF 301
           +    G   F
Sbjct: 244 FEYYVGFTLF 253

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +GR++G+G FG  +  T +    + A K   +R      D   +R E +    LAG  
Sbjct: 11  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 65
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
            I  +    ++ L   +V++L  G  L D +   G  +S +  A   + ++  V++ H  
Sbjct: 66  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 124
Query: 220 GVMHRDLKPENFLL--VNKDDDFSLKAIDFGLSVFFK 254
            +++RD+KP+NFL+   N  +   +  +DFG+  F++
Sbjct: 125 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 161

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +GR++G+G FG  +  T +    + A K   +R      D   +R E +    LAG  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 66
Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
            I  +    ++ L   +V++L  G  L D +   G  +S +  A   + ++  V++ H  
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 220 GVMHRDLKPENFLL--VNKDDDFSLKAIDFGLSVFFK 254
            +++RD+KP+NFL+   N  +   +  +DFG+  F++
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN-IV 163
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L  H + IV
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--HSDFIV 75
Query: 164 TIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             +G         + +VME    G L D  +QR H +   A+ L      + +    LG 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYLGS 133
Query: 221 --VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-Y 267
              +HRDL   N L+   + +  +K  DFGL+          V  +PGQ       SP +
Sbjct: 134 RRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ-------SPIF 183
Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLS 296
           + APE L  + +  ++DVW+ GV+LY L +
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 14  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E    G L D +  + G Y    +  +++  I   +  
Sbjct: 69  -HEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 127 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-WTARQGAKFPIKWTAPE 182
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 239
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 240 SLHDLMCQCWRKEPEERPT 258

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHLAGHKN-IV 163
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L  H + IV
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL--HSDFIV 87
Query: 164 TIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG- 220
             +G         + +VME    G L D  +QR H +   A+ L      + +    LG 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYLGS 145
Query: 221 --VMHRDLKPENFLLVNKDDDFSLKAIDFGLS----------VFFKPGQIFTDVVGSP-Y 267
              +HRDL   N L+   + +  +K  DFGL+          V  +PGQ       SP +
Sbjct: 146 RRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQ-------SPIF 195
Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLS 296
           + APE L  + +  ++DVW+ GV+LY L +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 8   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 63  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 121 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 176
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 233
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 234 SLHDLMCQCWRKDPEERPT 252

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 90/225 (40%), Gaps = 30/225 (13%)
Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG    C +   G       I K   + R   E  R EIQ++ HL    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRY-CEAARSEIQVLEHLNTTD 72
Query: 161 NIVTIKGA-----YEDSLCVHIVMELCAGGELFDRIIQRGHYSER--KAAELTRIIVGVV 213
              T +       +E    + IV EL  G   +D I + G    R     ++   I   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFEL-LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 214 EACHSLGVMHRDLKPENFLLVNKD-----------DDFSL-----KAIDFGLSVFFKPGQ 257
              HS  + H DLKPEN L V  D           D+ +L     K +DFG + +    +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--DDE 189
Query: 258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPF 301
             + +V   +Y APEV+L   +    DVW+ G IL     G   F
Sbjct: 190 HHSTLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 23/238 (9%)
Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           G  LG+G FG     T   TG     K + +      E      +E+++M  L  H N++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVL 70
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVM 222
              G       ++ + E   GG L   I      Y   +     + I   +   HS+ ++
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 223 HRDLKPENFLLVNKDD----DFSL-------KAIDFGLSVFFKPGQIFT-DVVGSPYYVA 270
           HRDL   N L+    +    DF L       K    GL    KP +     VVG+PY++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGV---PPFWAETQQGIFDAVLKGHIDFESDP 324
           PE++  + Y  + DV++ G++L  ++  V   P +   T    F   ++G +D    P
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--FGLNVRGFLDRYCPP 246

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 6   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 60
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 61  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 119 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 174
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 231
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 232 SLHDLMCQCWRKDPEERPT 250

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 25/233 (10%)
Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL  LG ++G+G +G+        +G   A K I  R  +  ++ + +  ++ ++   + 
Sbjct: 23  DLKDLG-EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE---LTRIIVGVVEA 215
              IV   GA        I MEL +    FD+  +  +           L +I +  V+A
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 216 CH----SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +    +L ++HRD+KP N LL   D   ++K  DFG+S         T   G   Y+AP
Sbjct: 138 LNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
Query: 272 EVL-----LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD---AVLKG 316
           E +      + Y   +DVW+ G+ LY L +G  P+       +FD    V+KG
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKG 245

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG                ++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTR-- 207
           H+  H N+V + GA  +    + +++E C  G L   +  + +    Y +     LT   
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 208 ------IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIF 259
                  +   +E   S   +HRDL   N LL  K+    +K  DFGL+  ++  P  + 
Sbjct: 146 LIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKIXDFGLARDIYKDPDYVR 202
Query: 260 TDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
                 P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 106 KLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH L  +  IV
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYIV 399
Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVM 222
            + G  + +  + +VME+  GG L   ++ +R        AEL   +   ++       +
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY---YVAPEVL-LKH 277
           HR+L   N LLVN+      K  DFGLS         +T      +   + APE +  + 
Sbjct: 459 HRNLAARNVLLVNRH---YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 278 YGPEADVWTAGVILYILLS-GVPPF 301
           +   +DVW+ GV ++  LS G  P+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 7/176 (3%)
Query: 175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV 234
           +++   L  G +L   + ++G  +  +A  + R I   ++A H+ G  HRD+KPEN L+ 
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV- 167
Query: 235 NKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVIL 291
              DDF+   +DFG++      ++    + VG+ YY APE   + H    AD++    +L
Sbjct: 168 -SADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVL 225
Query: 292 YILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSER 347
           Y  L+G PP+  + Q  +  A +   I   S   P I  +   +I +     P +R
Sbjct: 226 YECLTGSPPYQGD-QLSVXGAHINQAIPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++  +  LGR    G +G       + +G   A K I  R  ++ ++ + +  ++ I
Sbjct: 5   KADDLEPIMELGR----GAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDI 58
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMEL--CAGGELFDRIIQRGH-YSERKAAELTRII 209
                     VT  GA      V I MEL   +  + + ++I +G    E    ++   I
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 210 VGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG---- 264
           V  +E  HS L V+HRD+KP N L+   +    +K  DFG+S     G +  DV      
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGIS-----GYLVDDVAKDIDA 170
Query: 265 ------SPYYVAPEVLLKHYGPEADVWTAGVIL 291
                 +P  + PE+  K Y  ++D+W+ G+ +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE-DVRREIQIMHHL-----AGH 159
           +LG+G FG+  LC     G         K+   S  D + D +REIQI+  L       +
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           + +    G  E    + +VME    G L D  +QR H +   A+ L      + +    L
Sbjct: 74  RGVSYGPGRPE----LRLVMEYLPSGCLRD-FLQR-HRARLDASRLLLYSSQICKGMEYL 127
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF---KPGQIFTDVVGSP-YYVAPE 272
           G    +HRDL   N L+   + +  +K  DFGL+      K   +  +   SP ++ APE
Sbjct: 128 GSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 273 VLLKH-YGPEADVWTAGVILYILLS 296
            L  + +  ++DVW+ GV+LY L +
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 15  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 72
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 73  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++        + K 
Sbjct: 132 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKG 188
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 189 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 244
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P  R T  E++
Sbjct: 245 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL---ISREDVEDVRREIQIMH 154
           RD   LG+ LG+G FG                ++++ + L    +  +   +  E++I+ 
Sbjct: 26  RDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILI 85
Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGV 212
           H+  H N+V + GA  +    + +++E C  G L   +  +R  +   K  +L +  + +
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK--DLYKDFLTL 143
Query: 213 VE-ACHSLGV------------MHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQ 257
               C+S  V            +HRDL   N LL  K+    +K  DFGL+  ++  P  
Sbjct: 144 EHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKN---VVKICDFGLARDIYKDPDY 200
Query: 258 IFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           +       P  ++APE +  + Y  ++DVW+ GV+L+ + S G  P+
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  + 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKIR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 119/286 (41%), Gaps = 47/286 (16%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          D+
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMT---------RDI 180
Query: 263 VGSPYY------------VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQG 308
             + YY            +APE L    +   +D+W+ GV+L+ + S    P+   + + 
Sbjct: 181 YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 240
Query: 309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   V+ G    + D  P   +   DL+R      P  R T  E++
Sbjct: 241 VLKFVMDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC--- 216
           KN V         + ++I M+LC    L D + +R    +R+      I + + EA    
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDV---------V 263
           HS G+MHRDLKP N      D    +K  DFGL       +    + T +         V
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDD---VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV 237
Query: 264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILL 295
           G+  Y++PE +   +Y  + D+++ G+IL+ LL
Sbjct: 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV+E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  +  T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL   N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLAAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++        + K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKG 189
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 190 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P  R T  E++
Sbjct: 246 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 72  -HEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 185
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 242
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +     P ER T
Sbjct: 243 SLHDLMCQCWRKDPEERPT 261

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 48/293 (16%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 30  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 81
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 82  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 257 QI-----FTDVVGSPYYVAPEVL----LKHYGPEADVWTAGVILYILLS-GVPPFWAETQ 306
           Q        +  G+  + APE+L     +      D+++ G + Y +LS G  PF  +  
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 307 QGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVL 354
           +     +++G   F  D    + D      A DLI +M+   P +R TA +VL
Sbjct: 260 RE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 48/293 (16%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 30  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 81
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 82  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 257 QI-----FTDVVGSPYYVAPEVL----LKHYGPEADVWTAGVILYILLS-GVPPFWAETQ 306
           Q        +  G+  + APE+L     +      D+++ G + Y +LS G  PF  +  
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 307 QGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVL 354
           +     +++G   F  D    + D      A DLI +M+   P +R TA +VL
Sbjct: 260 RE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 21/259 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++    +      E   +E Q+M  L 
Sbjct: 7   RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLR 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSE-RKAAELTRIIVGVVEA 215
            H+ +V +     +   + IV E  + G L D +  + G Y    +  ++   I   +  
Sbjct: 62  -HEKLVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
              +  +HRDL+  N L+    ++   K  DFGL+   +  +  T   G+ +   + APE
Sbjct: 120 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEX-TARQGAKFPIKWTAPE 175
Query: 273 -VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPE 232
Query: 331 SAKDLIRKMLCSQPSERLT 349
           S  DL+ +    +P ER T
Sbjct: 233 SLHDLMCQCWRKEPEERPT 251

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 24/280 (8%)
Query: 74  KDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS 133
           K  +M   +  Q  +       N+++L  L + +G+G+FG   L       +   C    
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC---- 223
Query: 134 KRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRII 192
              + +    +    E  +M  L  H N+V + G   E+   ++IV E  A G L D + 
Sbjct: 224 ---IKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 193 QRGHYSERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
            RG  S      L +  + V EA   L     +HRDL   N L+    +D   K  DFGL
Sbjct: 280 SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGL 335
Query: 250 SVFFKPGQIFTDVVGSPY-YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQ 306
           +   K      D    P  + APE L  K +  ++DVW+ G++L+ + S G  P+     
Sbjct: 336 T---KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
Query: 307 QGIFDAVLKGH-IDFESDPWPLISDSAKDLIRKMLCSQPS 345
           + +   V KG+ +D      P + D  K+       ++P+
Sbjct: 393 KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPT 432

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKG 189
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 190 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P+ R T  E++
Sbjct: 246 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HR+L   N ++ +   DF++K  DFG++        + K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKG 189
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 190 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P+ R T  E++
Sbjct: 246 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
           +IVME   G  L     Q+   +E  A  L   I+  +   HS+G+++ DLKPEN +L  
Sbjct: 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLE--ILPALSYLHSIGLVYNDLKPENIMLTE 217
Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILL 295
           +     LK ID G          F  + G+P + APE++        D++T G  L  L 
Sbjct: 218 E----QLKLIDLGAVSRINS---FGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALT 270
Query: 296 SGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHE 352
             +P     T+ G +   L      E DP     DS   L+R+ +   P +R T  E
Sbjct: 271 LDLP-----TRNGRYVDGLP-----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAE 317

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 17  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 74
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 75  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HR+L   N ++ +   DF++K  DFG++        + K 
Sbjct: 134 IQMAAEIADGMAYLNAKKFVHRNLAARNCMVAH---DFTVKIGDFGMTRDIYETDYYRKG 190
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 191 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 246
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P+ R T  E++
Sbjct: 247 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L       +   C       + +    +    E  +M  
Sbjct: 19  NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 70
Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 71  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 128
Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 182
Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           PE L  K +  ++DVW+ G++L+ + S G  P+
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 13  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 70
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 71  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          K 
Sbjct: 130 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKG 186
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 187 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P  R T  E++
Sbjct: 243 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 47/245 (19%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRRE 149
           H    I D Y +   +G G +G  ++C E    +E    +I K  R      D + + RE
Sbjct: 46  HSDWQIPDRYEIRHLIGTGSYG--HVC-EAYDKLEKRVVAIKKILRVFEDLIDCKRILRE 102
Query: 150 IQIMHHLAGHKNIV-----TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAA 203
           I I++ L  H ++V      I    E    +++V+E+      F ++ +   Y +E    
Sbjct: 103 IAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIK 159
Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------------V 251
            L   ++  V+  HS G++HRDLKP N L+   + D S+K  DFGL+            +
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 252 FFKPGQIFTDVVGSP----------------YYVAPEVLL--KHYGPEADVWTAGVILYI 293
              P +   ++V  P                +Y APE++L  ++Y    DVW+ G I   
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276
Query: 294 LLSGV 298
           LL+ +
Sbjct: 277 LLNMI 281

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 37/281 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATG---IEFACKSISKRKLISREDVEDVRREIQI 152
           R+  TL R+LGQG FG  Y     +I  G      A K++++   + RE +E +  E  +
Sbjct: 16  REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFL-NEASV 73
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----RKAAELTRI 208
           M     H ++V + G         +VMEL A G+L   +      +E    R    L  +
Sbjct: 74  MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 209 IVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFFKP 255
           I    E    +  +      HRDL   N ++ +   DF++K  DFG++          K 
Sbjct: 133 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTVKIGDFGMTRDIXETDXXRKG 189
Query: 256 GQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           G+    V     ++APE L    +   +D+W+ GV+L+ + S    P+   + + +   V
Sbjct: 190 GKGLLPV----RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245
Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + G    + D  P   +   DL+R      P  R T  E++
Sbjct: 246 MDGGYLDQPDNCP---ERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L       +   C       + +    +    E  +M  
Sbjct: 4   NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 55
Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 56  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 113
Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 114 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 167
Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPF 301
           PE L  K +  ++DVW+ G++L+ + S G  P+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 52/297 (17%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 12  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 63
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 257 QI-----FTDVVGSPYYVAPEVL--------LKHYGPEADVWTAGVILYILLS-GVPPFW 302
           Q        +  G+  + APE+L         +      D+++ G + Y +LS G  PF 
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 303 AETQQGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVL 354
            +  +     +++G   F  D    + D      A DLI +M+   P +R TA +VL
Sbjct: 242 DKYSRE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 52/297 (17%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS-KRKLISREDVEDVRREIQIMH 154
           ++++L    + LG G  GT      +  G  F  + ++ KR LI   D+  +  EI+++ 
Sbjct: 12  SLKNLVVSEKILGYGSSGTV-----VFQG-SFQGRPVAVKRMLIDFCDIALM--EIKLLT 63
Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS--------ERKAAELT 206
               H N++    +      ++I +ELC        +++  + S        E     L 
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVFFKPG 256
           R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL      G
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 257 QI-----FTDVVGSPYYVAPEVL--------LKHYGPEADVWTAGVILYILLS-GVPPFW 302
           Q        +  G+  + APE+L         +      D+++ G + Y +LS G  PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 303 AETQQGIFDAVLKGHIDFESDPWPLISD-----SAKDLIRKMLCSQPSERLTAHEVL 354
            +  +     +++G   F  D    + D      A DLI +M+   P +R TA +VL
Sbjct: 242 DKYSRE--SNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 29/270 (10%)
Query: 101 YTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISK-----RKLISRED---VEDVRREIQ 151
           YT+ R +  G +G   +C  + + GI  A K +       R +    D    + V REI+
Sbjct: 24  YTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 152 IMHHLAGHKNIVTIKGAY----EDSLC-VHIVMELCAGGELFDRII--QRGHYSERKAAE 204
           +++H   H NI+ ++  +    E ++  +++V EL        ++I  QR   S +    
Sbjct: 82  LLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQY 138
Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
               I+  +   H  GV+HRDL P N LL + +D   +   DF L+         T  V 
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTHYVT 195
Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDF 320
             +Y APE+++  K +    D+W+AG ++  + +    F   T     + +++  G    
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTA 350
           E D     S SA+D +R  L + P+   TA
Sbjct: 256 E-DVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 29/270 (10%)
Query: 101 YTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSI-----SKRKLISRED---VEDVRREIQ 151
           YT+ R +  G +G   +C  + + GI  A K +       R +    D    + V REI+
Sbjct: 24  YTVQRFISSGSYGA--VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 152 IMHHLAGHKNIVTIKGAY----EDSLC-VHIVMELCAGGELFDRII--QRGHYSERKAAE 204
           +++H   H NI+ ++  +    E ++  +++V EL        ++I  QR   S +    
Sbjct: 82  LLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQY 138
Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
               I+  +   H  GV+HRDL P N LL + +D   +   DF L+         T  V 
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTHYVT 195
Query: 265 SPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK--GHIDF 320
             +Y APE+++  K +    D+W+AG ++  + +    F   T     + +++  G    
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTA 350
           E D     S SA+D +R  L + P+   TA
Sbjct: 256 E-DVVMFSSPSARDYLRNSLSNVPARAWTA 284

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 96
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 213
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 214 LARHIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 17/227 (7%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++        + A K++    +     V+    E  +M  L 
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ 65
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII--QRGHYSERKAAELTRIIVGVVEA 215
            H  +V +         ++I+ E  A G L D +   + G     K  + +  I   +  
Sbjct: 66  -HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    +    K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 125 IERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 180
Query: 273 VL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            +    +  +++VW+ G++LY I+  G  P+   T   +  A+ +G+
Sbjct: 181 AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGY 227

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 105 RKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
           R +G+G FG  Y      +    I+ A KS+S+  +   + VE   RE  +M  L  H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGLLMRGL-NHPN 83
Query: 162 IVTIKGAYEDSLCV-HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           ++ + G       + H+++     G+L   I  R         +L    + V      L 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 221 ---VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY--------- 268
               +HRDL   N +L   D+ F++K  DFGL+          D++   YY         
Sbjct: 142 EQKFVHRDLAARNCML---DESFTVKVADFGLA---------RDILDREYYSVQQHRHAR 189
Query: 269 -----VAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
                 A E L  + +  ++DVW+ GV+L+ LL+ G PP+
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 20/228 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L ++LG GQFG  ++ T      + A K++    +      E    E QIM  L 
Sbjct: 8   RESLQLIKRLGNGQFGEVWMGT-WNGNTKVAIKTLKPGTM----SPESFLEEAQIMKKLK 62
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA-- 215
            H  +V +     +   ++IV E    G L D  ++ G     K   L  +   V     
Sbjct: 63  -HDKLVQLYAVVSEE-PIYIVTEYMNKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 216 -CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
               +  +HRDL+  N L+ N       K  DFGL+   +  +  T   G+ +   + AP
Sbjct: 120 YIERMNYIHRDLRSANILVGN---GLICKIADFGLARLIEDNEX-TARQGAKFPIKWTAP 175
Query: 272 E-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E  L   +  ++DVW+ G++L  L++ G  P+     + + + V +G+
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY 223

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 17/227 (7%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L ++LG GQFG  ++        + A K++    +     V+    E  +M  L 
Sbjct: 12  RESIKLVKRLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQ 66
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII--QRGHYSERKAAELTRIIVGVVEA 215
            H  +V +         ++I+ E  A G L D +   + G     K  + +  I   +  
Sbjct: 67  -HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 125
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    +    K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 126 IERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 181
Query: 273 VL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
            +    +  ++DVW+ G++LY I+  G  P+   T   +  A+ +G+
Sbjct: 182 AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGY 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 73
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 190
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 191 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 116/267 (43%), Gaps = 28/267 (10%)
Query: 101 YTLGRKLGQGQFGT---TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           +TLGR LG+G+FG+     L  E  + ++ A K + K  +I+  D+E+  RE   M    
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF- 82
Query: 158 GHKNI-----VTIKGAYEDSLCV-HIVMELCAGGELFDRIIQR---GHYSERKAAELTRI 208
            H ++     V+++   +  L +  +++     G+L   ++      +        L R 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 209 IVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
           +V +   +E   S   +HRDL   N +L    +D ++   DFGLS     G  +     S
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 266 PY---YVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDF 320
                ++A E L  + Y   +DVW  GV ++ I+  G  P+       I++ ++ G+   
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN--- 256
Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSER 347
                P   +   DL+ +   + P +R
Sbjct: 257 RLKQPPECMEEVYDLMYQCWSADPKQR 283

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 34  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 91
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 92  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 151
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 152 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 208
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 209 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 266

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 32  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 89
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 90  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 149
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 150 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 206
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 207 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 264

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++  +  LGR    G +G       + +G   A K I  R  ++ ++ + +  ++ I
Sbjct: 32  KADDLEPIXELGR----GAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDI 85
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMEL--CAGGELFDRIIQRGH-YSERKAAELTRII 209
                     VT  GA      V I  EL   +  + + ++I +G    E    ++   I
Sbjct: 86  SXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 145
Query: 210 VGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG---- 264
           V  +E  HS L V+HRD+KP N L+   +    +K  DFG+S     G +  DV      
Sbjct: 146 VKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKXCDFGIS-----GYLVDDVAKDIDA 197
Query: 265 ------SPYYVAPEVLLKHYGPEADVWTAGV 289
                 +P  + PE+  K Y  ++D+W+ G+
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGI 228

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 92  HKTDNIRDLYTLGRKLGQGQFG-----TTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           HK +  R+  + G+ LG G FG     T Y   +    +  A K +     ++    E +
Sbjct: 39  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EAL 96
Query: 147 RREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAA-- 203
             E++++ +L  H NIV + GA        ++ E C  G+L + +  +R  +   K +  
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 204 ---------------ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                            +  +   +    S   +HRDL   N LL +       K  DFG
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFG 213
Query: 249 LSVFFKPGQIFTDVVGSPY----YVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           L+   K    +  V G+      ++APE +    Y  E+DVW+ G+ L+ L S G  P+
Sbjct: 214 LARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 271

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 52/242 (21%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQI 152
           D +++ Y +   LG+G FG    C + A G     KS    K+I    +  E  R EI +
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINV 69
Query: 153 MHHLAGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDR----IIQRGHYSERKA 202
           +         +  K      LCV      +    +C   EL  +     ++  ++   + 
Sbjct: 70  L-------KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF---QP 119
Query: 203 AELTRIIVGVVEACHSLGVMHR------DLKPENFLLVNKD----------------DDF 240
             L  +     + CH+L  +H       DLKPEN L VN +                 + 
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP 299
           S++  DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    G  
Sbjct: 180 SIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
Query: 300 PF 301
            F
Sbjct: 238 LF 239

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 52/242 (21%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQI 152
           D +++ Y +   LG+G FG    C + A G     KS    K+I    +  E  R EI +
Sbjct: 24  DWLQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINV 78
Query: 153 MHHLAGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDR----IIQRGHYSERKA 202
           +         +  K      LCV      +    +C   EL  +     ++  ++   + 
Sbjct: 79  L-------KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF---QP 128
Query: 203 AELTRIIVGVVEACHSLGVMHR------DLKPENFLLVNKD----------------DDF 240
             L  +     + CH+L  +H       DLKPEN L VN +                 + 
Sbjct: 129 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 188
Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP 299
           S++  DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    G  
Sbjct: 189 SIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 246
Query: 300 PF 301
            F
Sbjct: 247 LF 248

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/241 (21%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAGHKNI 162
           +LG+ +FG  Y             ++++ + L  + +    E+ R E  +   L  H N+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNV 91
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----------RKAAE------LT 206
           V + G       + ++   C+ G+L + ++ R  +S+          + A E      L 
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             I   +E   S  V+H+DL   N L+ +K    ++K  D GL         F +V  + 
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGL---------FREVYAAD 199
Query: 267 YY------------VAPE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           YY            +APE ++   +  ++D+W+ GV+L+ + S G+ P+   + Q + + 
Sbjct: 200 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259
Query: 313 V 313
           +
Sbjct: 260 I 260

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 52/242 (21%)
Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQI 152
           D +++ Y +   LG+G FG    C + A G     KS    K+I    +  E  R EI +
Sbjct: 47  DWLQERYEIVGNLGEGTFGKVVECLDHARG-----KSQVALKIIRNVGKYREAARLEINV 101
Query: 153 MHHLAGHKNIVTIKGAYEDSLCV------HIVMELCAGGELFDR----IIQRGHYSERKA 202
           +         +  K      LCV      +    +C   EL  +     ++  ++   + 
Sbjct: 102 L-------KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF---QP 151
Query: 203 AELTRIIVGVVEACHSLGVMHR------DLKPENFLLVNKD----------------DDF 240
             L  +     + CH+L  +H       DLKPEN L VN +                 + 
Sbjct: 152 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 211
Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVP 299
           S++  DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    G  
Sbjct: 212 SIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 269
Query: 300 PF 301
            F
Sbjct: 270 LF 271

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 187 RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 241
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 242 -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 299 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 354
Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           E +    +  ++DVW+ G++L  I+  G  P+   +   +  A+ +G+
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           N+++L  L + +G+G+FG   L       +   C       + +    +    E  +M  
Sbjct: 10  NMKELKLL-QTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQ 61
Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 62  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 119
Query: 215 ACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY-YVA 270
           A   L     +HRDL   N L+    +D   K  DFGL+   K      D    P  + A
Sbjct: 120 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTA 173
Query: 271 PEVLLKH-YGPEADVWTAGVILYILLS 296
           PE L +  +  ++DVW+ G++L+ + S
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/241 (21%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRREIQIMHHLAGHKNI 162
           +LG+ +FG  Y             ++++ + L  + +    E+ R E  +   L  H N+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNV 74
Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE----------RKAAE------LT 206
           V + G       + ++   C+ G+L + ++ R  +S+          + A E      L 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             I   +E   S  V+H+DL   N L+ +K    ++K  D GL         F +V  + 
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGL---------FREVYAAD 182
Query: 267 YY------------VAPE-VLLKHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           YY            +APE ++   +  ++D+W+ GV+L+ + S G+ P+   + Q + + 
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 313 V 313
           +
Sbjct: 243 I 243

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 57/292 (19%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIAT---GIEFACKSISKRKLISREDVEDVRREIQI 152
           RD+  L R+LG+G FG  +L  C  ++     +  A K++    L +R+D +   RE ++
Sbjct: 15  RDI-VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ---REAEL 70
Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELF--------DRIIQRGHYSERKAAE 204
           + +L  H++IV   G   D   + +V E    G+L         D +I       +   E
Sbjct: 71  LTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 205 L---------TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
           L         ++I  G+V    S   +HRDL   N L+     +  +K  DFG+S     
Sbjct: 130 LGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLV---GANLLVKIGDFGMS----- 180
Query: 256 GQIFTDVVGSPYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPF 301
                DV  + YY            + PE ++ + +  E+DVW+ GVIL+ I   G  P+
Sbjct: 181 ----RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236
Query: 302 WAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           +  +   + + + +G +       P       D++      +P +RL   E+
Sbjct: 237 FQLSNTEVIECITQGRVLERPRVCP---KEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 14  RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 68
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 69  -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+   +  + +T   G+ +   + AP
Sbjct: 126 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 181
Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           E +    +  ++DVW+ G++L  I+  G  P+   +   +  A+ +G+
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 106/247 (42%), Gaps = 44/247 (17%)
Query: 102 TLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            L R+LG+G FG  +L  C  +    +    ++   K  S    +D  RE +++ +L  H
Sbjct: 16  VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-H 74
Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA-----AELTR------- 207
           ++IV   G   +   + +V E    G+L   +   G  +   A      ELT+       
Sbjct: 75  EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134
Query: 208 --IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
             I  G+V    S   +HRDL   N L+    ++  +K  DFG+S          DV  +
Sbjct: 135 QQIAAGMVYLA-SQHFVHRDLATRNCLV---GENLLVKIGDFGMS---------RDVYST 181
Query: 266 PYY------------VAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
            YY            + PE ++ + +  E+DVW+ GV+L+ I   G  P++  +   + +
Sbjct: 182 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241
Query: 312 AVLKGHI 318
            + +G +
Sbjct: 242 CITQGRV 248

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 14  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 69
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAA--ELT 206
            +M     H ++V + G         ++MEL   G+L  + R ++    +    A   L+
Sbjct: 70  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 129 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 185
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 186 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 242 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 24  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 79
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAA--ELT 206
            +M     H ++V + G         ++MEL   G+L  + R ++    +    A   L+
Sbjct: 80  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 195
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 196 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 252 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 17  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 72
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 73  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 188
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 189 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 245 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 46  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 101
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 102 SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 161 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 217
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 218 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 273
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 274 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 11  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 66
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 67  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 182
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 183 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 239 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 18  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 73
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 74  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 189
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 190 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 246 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 24  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 79
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 80  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 195
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 196 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 252 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 15  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 70
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 71  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 130 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 186
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 187 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 243 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 17  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 72
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 73  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++        + 
Sbjct: 132 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 188
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 189 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 245 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++    +     VE    E  +M  L 
Sbjct: 181 RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQ 235
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V +         ++I+ E  A G L D  ++    S++   +L      + E   
Sbjct: 236 -HDKLVKLHAVVTKE-PIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 218 SL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAP 271
            +     +HRDL+  N L+         K  DFGL+            VG+ +   + AP
Sbjct: 293 FIEQRNYIHRDLRAANILV---SASLVCKIADFGLA-----------RVGAKFPIKWTAP 338
Query: 272 EVL-LKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
           E +    +  ++DVW+ G++L  I+  G  P+   +   +  A+ +G+
Sbjct: 339 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 386

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 11  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 66
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 67  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N  +    +DF++K  DFG++        + 
Sbjct: 126 KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMTRDIYETDYYR 182
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 183 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 239 FVMEGGLLDKPDNCP---DMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 36/281 (12%)
Query: 64  NSAPRISPSKKDNIMRRG--IDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYL--CT 119
            S   +SP++      +G  I+N  Y+         R    L  +LG+G FG  +L  C 
Sbjct: 4   GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63
Query: 120 EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM 179
            +    +    ++   K  S    +D +RE +++  L  H++IV   G   +   + +V 
Sbjct: 64  NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVF 122
Query: 180 ELCAGGELFDRIIQRGHYSERKA------------------AELTRIIVGVVEACHSLGV 221
           E    G+L +R + R H  + K                   A  +++  G+V     L  
Sbjct: 123 EYMRHGDL-NRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHF 179
Query: 222 MHRDLKPENFL----LVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE-VLLK 276
           +HRDL   N L    LV K  DF +    +    +   G+    +   P    PE +L +
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP----PESILYR 235
Query: 277 HYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKG 316
            +  E+DVW+ GV+L+ I   G  P++  +     D + +G
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 9   REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 64
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 65  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 124 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 180
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 181 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 237 FVMEGGLLDKPDNCP---DMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           RD+  L  +LG+G FG  +L  C  +    +    ++   K  S    +D +RE +++  
Sbjct: 18  RDI-VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 76
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA------------- 202
           L  H++IV   G   +   + +V E    G+L +R + R H  + K              
Sbjct: 77  LQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFL-RSHGPDAKLLAGGEDVAPGPLG 133
Query: 203 -----AELTRIIVGVVEACHSLGVMHRDLKPENFL----LVNKDDDFSLKAIDFGLSVFF 253
                A  +++  G+V     L  +HRDL   N L    LV K  DF +    +    + 
Sbjct: 134 LGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 192
Query: 254 KPGQIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
             G+    +   P    PE +L + +  E+DVW+ GV+L+ I   G  P++  +     D
Sbjct: 193 VGGRTMLPIRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 248
Query: 312 AVLKG 316
            + +G
Sbjct: 249 CITQG 253

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYL--CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           RD+  L  +LG+G FG  +L  C  +    +    ++   K  S    +D +RE +++  
Sbjct: 12  RDI-VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 70
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA------------- 202
           L  H++IV   G   +   + +V E    G+L +R + R H  + K              
Sbjct: 71  LQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFL-RSHGPDAKLLAGGEDVAPGPLG 127
Query: 203 -----AELTRIIVGVVEACHSLGVMHRDLKPENFL----LVNKDDDFSLKAIDFGLSVFF 253
                A  +++  G+V     L  +HRDL   N L    LV K  DF +    +    + 
Sbjct: 128 LGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 186
Query: 254 KPGQIFTDVVGSPYYVAPE-VLLKHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
             G+    +   P    PE +L + +  E+DVW+ GV+L+ I   G  P++  +     D
Sbjct: 187 VGGRTMLPIRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 242
Query: 312 AVLKG 316
            + +G
Sbjct: 243 CITQG 247

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGI-------EFACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y    +A G+         A K++++   + RE +E +  E 
Sbjct: 18  REKITMSRELGQGSFGMVY--EGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL-NEA 73
Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            +M     H ++V + G         ++MEL   G+L   +       E         L+
Sbjct: 74  SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 207 RIIVGVVEACHSLGVM------HRDLKPENFLLVNKDDDFSLKAIDFGLS-------VFF 253
           ++I    E    +  +      HRDL   N ++    +DF++K  DFG++          
Sbjct: 133 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETDXXR 189
Query: 254 KPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFD 311
           K G+    V     +++PE L    +   +DVW+ GV+L+ I      P+   + + +  
Sbjct: 190 KGGKGLLPV----RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V++G +  + D  P   D   +L+R      P  R +  E++
Sbjct: 246 FVMEGGLLDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 12/89 (13%)
Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV---VGSPYYVAPEV 273
           H   + HRD K +N LL     D +    DFGL+V F+PG+   D    VG+  Y+APEV
Sbjct: 140 HKPSIAHRDFKSKNVLL---KSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 274 L--LKHYGPEA----DVWTAGVILYILLS 296
           L    ++  +A    D++  G++L+ L+S
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  Y    +A G   A K + + +    E     + E++++  +A H+N++ ++
Sbjct: 46  LGRGGFGKVY-KGRLADGTLVAVKRLKEERXQGGE--LQFQTEVEMIS-MAVHRNLLRLR 101
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGH------YSERKAAELTRIIVGVVEACHSL- 219
           G         +V    A G +   + +R        + +R+     RI +G       L 
Sbjct: 102 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ-----RIALGSARGLAYLH 156
Query: 220 -----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF--FKPGQIFTDVVGSPYYVAPE 272
                 ++HRD+K  N LL   D++F     DFGL+    +K   +   V G+  ++APE
Sbjct: 157 DHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPE 213
Query: 273 VLLKHYGPE-ADVWTAGVILYILLSGVPPF 301
            L      E  DV+  GV+L  L++G   F
Sbjct: 214 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 95
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 96  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 148
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 149 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMAL 205
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 155
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 156 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 208
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 209 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 94
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 95  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 147
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 148 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 204
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 97
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 98  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 150
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 151 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 207
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 239

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 101
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 102 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 154
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 155 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 211
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 243

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 22  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 76
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 77  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 135 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 190
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 191 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 246
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 247 -EELYQLMRLCWKERPEDRPT 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 7   RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 61
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 62  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 120 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 175
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 176 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 231
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 232 -EELYQLMRLCWKERPEDRPT 251

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 114
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 115 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 167
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 168 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 225 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 256

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 115
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 116 LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 168
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 169 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 225
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 226 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 257

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 18  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 72
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 73  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 131 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 186
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 187 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 242
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 243 -EELYQLMRLCWKERPEDRPT 262

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  Y    +A G   A K + + +    E     + E++++  +A H+N++ ++
Sbjct: 38  LGRGGFGKVY-KGRLADGXLVAVKRLKEERTQGGE--LQFQTEVEMIS-MAVHRNLLRLR 93
Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGH------YSERKAAELTRIIVGVVEACHSL- 219
           G         +V    A G +   + +R        + +R+     RI +G       L 
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ-----RIALGSARGLAYLH 148
Query: 220 -----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF--FKPGQIFTDVVGSPYYVAPE 272
                 ++HRD+K  N LL   D++F     DFGL+    +K   +   V G   ++APE
Sbjct: 149 DHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE 205
Query: 273 VLLKHYGPE-ADVWTAGVILYILLSGVPPF 301
            L      E  DV+  GV+L  L++G   F
Sbjct: 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 95
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 96  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 148
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 149 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 206 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 237

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 17  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 71
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 72  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 130 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 185
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 186 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 241
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 242 -EELYQLMRLCWKERPEDRPT 261

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +  +      +    E  +M  L 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQ 66
Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 67  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY---YVAPE 272
                 +HRDL+  N L+    D  S K  DFGL+   +  + +T   G+ +   + APE
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 180
Query: 273 VLLKHYGP---EADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            +  +YG    ++DVW+ G++L  I+  G  P+   T   +   + +G+     D  P  
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-- 236
Query: 329 SDSAKDLIRKMLCSQPSERLT 349
            +    L+R     +P +R T
Sbjct: 237 -EELYQLMRLCWKERPEDRPT 256

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 96
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 97  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 149
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 150 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 206
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 88
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 89  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 141
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 142 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 198
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 199 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 230

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 85  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 143 LEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 85  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 142
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 143 LEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 200 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 91
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 92  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 144
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 145 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 368 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 427
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 428 L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 485
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 486 LEESNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 542
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 543 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 23  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 82
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 83  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 140
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 141 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 197
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 198 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 94
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 95  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 147
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 148 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 107 LGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
           +G+G FG  Y  T +   G +  C   S  ++    +V     E  IM   + H N++++
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSL 93
Query: 166 KGAYEDSLCVH------IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            G     +C+       +V+     G+L + I    H    K  +L    + V +    L
Sbjct: 94  LG-----ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYL 146
Query: 220 G---VMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPY---YVAP 271
                +HRDL   N +L   D+ F++K  DFGL+  ++ K      +  G+     ++A 
Sbjct: 147 ASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 272 EVL-LKHYGPEADVWTAGVILYILLS-GVPPF 301
           E L  + +  ++DVW+ GV+L+ L++ G PP+
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 426
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 427 L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 484
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 485 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 541
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 542 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 98  RDLYTL-GRKLGQGQFGTTYL-CTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           R L TL  ++LG G FGT      ++   ++     I K +       +++  E  +M  
Sbjct: 9   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 68
Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           L  +  IV + G  E    + +VME+   G L   + Q  H  ++   EL   +   ++ 
Sbjct: 69  L-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 126
Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVAP 271
                 +HRDL   N LLV +      K  DFGLS   +  + +    T       + AP
Sbjct: 127 LEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 183
Query: 272 EVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
           E +  + +  ++DVW+ GV+++   S G  P+
Sbjct: 184 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	363
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-172
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-171
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-171
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-171
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-171
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-169
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-169
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-168
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-168
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-167
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-167
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-167
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-166
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-166
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-165
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-165
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-165
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-164
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-163
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-162
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-162
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-162
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-161
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-161
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-158
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-157
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-157
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-157
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-154
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-153
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-147
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-145
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-143
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-89
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-88
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-88
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-86
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-84
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-83
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-83
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-82
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-81
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-80
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-80
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-79
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-79
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-78
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-78
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-78
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-78
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-77
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-77
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-76
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-76
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-76
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-76
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-75
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-75
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-75
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-75
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-71
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-70
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-70
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-68
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-64
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-64
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-63
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-60
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-60
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-58
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-58
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-55
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-54
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-52
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-52
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-51
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-51
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-51
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-50
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-47
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-47
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-47
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-47
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-47
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-46
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-46
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-46
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-45
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-45
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-45
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-45
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-45
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-44
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-44
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-43
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-42
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-42
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-41
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-41
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-41
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-39
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-39
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-38
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-38
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-37
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-37
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-36
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-36
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-35
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-35
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-34
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-33
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-33
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-33
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-33
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-32
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-32
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-32
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-32
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-31
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-31
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-31
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-30
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-29
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-29
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-29
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-29
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-28
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-28
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-28
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-28
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-25
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-23
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-23
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-22
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-22
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-20
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-20
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-20
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  481 bits (1240), Expect = e-172
 Identities = 104/291 (35%), Positives = 155/291 (53%), Gaps = 8/291 (2%)

Query: 66  APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI 125
            P ++       M RG +      + + +    D Y +  +LG+G F     C    TG+
Sbjct: 1   GPHMASMTGGQQMGRGSE-----FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGL 55

Query: 126 EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG 185
           EFA K I+ +KL S  D + + RE +I   L  H NIV +  + ++    ++V +L  GG
Sbjct: 56  EFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGG 113

Query: 186 ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI 245
           ELF+ I+ R  YSE  A+   + I+  +  CHS G++HR+LKPEN LL +K    ++K  
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173

Query: 246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAE 304
           DFGL++     + +    G+P Y++PEVL K  Y    D+W  GVILYILL G PPFW E
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233

Query: 305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            Q  ++  +  G  D+ S  W  ++  AK LI  ML   P +R+TA + L 
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  478 bits (1232), Expect = e-171
 Identities = 111/264 (42%), Positives = 151/264 (57%), Gaps = 2/264 (0%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +      + Y +   LG+G FG    C +  T  E+A K I+K    + +D   + RE++
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVE 73

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +  
Sbjct: 74  LLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD 
Sbjct: 193 EVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252

Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           AKDLIRKML   PS R+TA + L 
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLE 276

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  477 bits (1229), Expect = e-171
 Identities = 108/265 (40%), Positives = 157/265 (59%), Gaps = 4/265 (1%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
           G    +I   YTL   +G+G +G   +  +  T I  A K I K  +   EDV+  ++EI
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEI 57

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +IM  L  H NI+ +   +ED+  +++VMELC GGELF+R++ +  + E  AA + + ++
Sbjct: 58  EIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             V  CH L V HRDLKPENFL +    D  LK IDFGL+  FKPG++    VG+PYYV+
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 271 PEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           P+VL   YGPE D W+AGV++Y+LL G PPF A T   +   + +G   F    W  +S 
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLC 355
            A+ LIR++L   P +R+T+ + L 
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALE 261

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  480 bits (1237), Expect = e-171
 Identities = 102/362 (28%), Positives = 158/362 (43%), Gaps = 21/362 (5%)

Query: 6   RGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNS 65
             S     +    +          N N +   +   +   +  Q      S     +   
Sbjct: 7   HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQ------SANLLAEAKK 60

Query: 66  APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI 125
                P   +N+  + +  +               Y     +G+G       C   ATG 
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120

Query: 126 EFACKSISKRKLIS-----REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME 180
           EFA K +             E  E  RRE  I+  +AGH +I+T+  +YE S  + +V +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF 240
           L   GELFD + ++   SE++   + R ++  V   H+  ++HRDLKPEN LL   DD+ 
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNM 237

Query: 241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL-------LKHYGPEADVWTAGVILYI 293
            ++  DFG S   +PG+   ++ G+P Y+APE+L          YG E D+W  GVIL+ 
Sbjct: 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297

Query: 294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           LL+G PPFW   Q  +   +++G   F S  W   S + KDLI ++L   P  RLTA + 
Sbjct: 298 LLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357

Query: 354 LC 355
           L 
Sbjct: 358 LQ 359

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  476 bits (1228), Expect = e-171
 Identities = 100/263 (38%), Positives = 146/263 (55%), Gaps = 3/263 (1%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +    D Y +  +LG+G F     C    TG+EFA K I+ +KL S  D + + RE +I 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARIC 59

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             L  H NIV +  + ++    ++V +L  GGELF+ I+ R  YSE  A+   + I+  +
Sbjct: 60  RKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 118

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
             CHS G++HR+LKPEN LL +K    ++K  DFGL++     + +    G+P Y++PEV
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178

Query: 274 LLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L K  Y    D+W  GVILYILL G PPFW E Q  ++  +  G  D+ S  W  ++  A
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238

Query: 333 KDLIRKMLCSQPSERLTAHEVLC 355
           K LI  ML   P +R+TA + L 
Sbjct: 239 KSLIDSMLTVNPKKRITADQALK 261

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  474 bits (1223), Expect = e-169
 Identities = 101/268 (37%), Positives = 156/268 (58%), Gaps = 6/268 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRRE 149
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+  S       ED+ RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           + I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  + I
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + +  
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            S  AKD IR++L   P +R+T  + L 
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  479 bits (1234), Expect = e-169
 Identities = 111/264 (42%), Positives = 150/264 (56%), Gaps = 2/264 (0%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +      + Y +   LG+G FG    C +  T  E+A K I+K      +D   + RE++
Sbjct: 15  YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVE 73

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           ++  L  H NI+ +    EDS   +IV EL  GGELFD II+R  +SE  AA + + +  
Sbjct: 74  LLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H   ++HRDLKPEN LL +K+ D  +K IDFGLS  F+      D +G+ YY+AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 272 EVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           EVL   Y  + DVW+AGVILYILLSG PPF+ + +  I   V  G   F+   W  ISD 
Sbjct: 193 EVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252

Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           AKDLIRKML   PS R+TA + L 
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLE 276

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  475 bits (1225), Expect = e-168
 Identities = 104/267 (38%), Positives = 149/267 (55%), Gaps = 4/267 (1%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREI 150
                   + Y L  +LG+G F     C ++  G E+A   I+ +KL S  D + + RE 
Sbjct: 3   TITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREA 61

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +I   L  H NIV +  +  +    +++ +L  GGELF+ I+ R +YSE  A+   + I+
Sbjct: 62  RICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL 120

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYV 269
             V  CH +GV+HR+LKPEN LL +K    ++K  DFGL++  +   Q +    G+P Y+
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180

Query: 270 APEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           +PEVL K  YG   D+W  GVILYILL G PPFW E Q  ++  +  G  DF S  W  +
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLC 355
           +  AKDLI KML   PS+R+TA E L 
Sbjct: 241 TPEAKDLINKMLTINPSKRITAAEALK 267

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  476 bits (1228), Expect = e-168
 Identities = 117/267 (43%), Positives = 157/267 (58%), Gaps = 1/267 (0%)

Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            + H T    D Y   R LG+G FG   LC +  TG E A K ISKR++  + D E + R
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+Q++  L  H NI+ +   +ED    ++V E+  GGELFD II R  +SE  AA + R 
Sbjct: 76  EVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 134

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           ++  +   H   ++HRDLKPEN LL +K  D +++ IDFGLS  F+  +   D +G+ YY
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194

Query: 269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           +APEVL   Y  + DVW+ GVILYILLSG PPF    +  I   V KG   FE   W  +
Sbjct: 195 IAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLC 355
           S+SAKDLIRKML   PS R++A + L 
Sbjct: 255 SESAKDLIRKMLTYVPSMRISARDALD 281

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  468 bits (1206), Expect = e-167
 Identities = 97/265 (36%), Positives = 154/265 (58%), Gaps = 6/265 (2%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRREIQI 152
            + D Y +G +LG GQF     C +  TG E+A K I KR+L S       E++ RE+ I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  +  H NI+T+   +E+   V +++EL +GGELFD + ++   +E +A +  + I+  
Sbjct: 62  LREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120

Query: 213 VEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           V   HS  + H DLKPEN +L++K+  +  +K IDFG++   + G  F ++ G+P +VAP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           E++  +  G EAD+W+ GVI YILLSG  PF  ET+Q     +   + DF+ + +   S+
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLC 355
            AKD IR++L   P  R+T  + L 
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLE 265

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  468 bits (1206), Expect = e-167
 Identities = 76/279 (27%), Positives = 136/279 (48%), Gaps = 5/279 (1%)

Query: 81  GIDNQTYYVLGHKTDNIRDLYTL-GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS 139
           G+D  T  +     +N  + Y L  ++LG+G+F     C   +TG E+A K + KR+   
Sbjct: 10  GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-G 68

Query: 140 REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHY 197
           ++   ++  EI ++        ++ +   YE++  + +++E  AGGE+F   +       
Sbjct: 69  QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           SE     L + I+  V   H   ++H DLKP+N LL +      +K +DFG+S       
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188

Query: 258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG 316
              +++G+P Y+APE+L         D+W  G+I Y+LL+   PF  E  Q  +  + + 
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248

Query: 317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           ++D+  + +  +S  A D I+ +L   P +R TA   L 
Sbjct: 249 NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  474 bits (1223), Expect = e-167
 Identities = 110/299 (36%), Positives = 155/299 (51%), Gaps = 11/299 (3%)

Query: 67  PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIE 126
                S ++N+  +GI       +  K   I + Y   RKLG G +G   LC E     E
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 127 FACKSISKRKLIS----------REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH 176
            A K I K +              +  E++  EI ++  L  H NI+ +   +ED    +
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFY 122

Query: 177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK 236
           +V E   GGELF++II R  + E  AA + + I+  +   H   ++HRD+KPEN LL NK
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182

Query: 237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLS 296
           +   ++K +DFGLS FF       D +G+ YY+APEVL K Y  + DVW+ GVI+YILL 
Sbjct: 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLC 242

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           G PPF  +  Q I   V KG   F+ + W  ISD AK+LI+ ML    ++R TA E L 
Sbjct: 243 GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  464 bits (1196), Expect = e-166
 Identities = 91/268 (33%), Positives = 145/268 (54%), Gaps = 8/268 (2%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           +    I DL+   RKLG G FG  +L  E ++G+E   K+I+K +   +  +E +  EI+
Sbjct: 15  YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIE 72

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTR 207
           ++  L  H NI+ I   +ED   ++IVME C GGEL +RI+         SE   AEL +
Sbjct: 73  VLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            ++  +   HS  V+H+DLKPEN L  +      +K IDFGL+  FK  +  T+  G+  
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191

Query: 268 YVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           Y+APEV  +    + D+W+AGV++Y LL+G  PF   + + +         ++  +  P 
Sbjct: 192 YMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP- 250

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           ++  A DL+++ML   P  R +A +VL 
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLH 278

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  464 bits (1197), Expect = e-166
 Identities = 100/278 (35%), Positives = 149/278 (53%), Gaps = 16/278 (5%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRK--LISREDVEDVR- 147
            H T    + Y     LG+G       C    T  E+A K I        S E+V+++R 
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 148 ---REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
              +E+ I+  ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  +
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           + R ++ V+ A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCG 185

Query: 265 SPYYVAPEVL-------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
           +P Y+APE++          YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             F S  W   SD+ KDL+ + L  QP +R TA E L 
Sbjct: 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  465 bits (1199), Expect = e-165
 Identities = 106/302 (35%), Positives = 156/302 (51%), Gaps = 8/302 (2%)

Query: 56  SKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
             +   ++     +S                Y++ G   D + D + +  +LG+G     
Sbjct: 10  GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
           Y C +  T   +A K + K       D + VR EI ++  L+ H NI+ +K  +E    +
Sbjct: 70  YRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEI 123

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
            +V+EL  GGELFDRI+++G+YSER AA+  + I+  V   H  G++HRDLKPEN L   
Sbjct: 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYIL 294
              D  LK  DFGLS   +   +   V G+P Y APE+L    YGPE D+W+ G+I YIL
Sbjct: 184 PAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL 243

Query: 295 LSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
           L G  PF+ E   Q +F  +L     F S  W  +S +AKDL+RK++   P +RLT  + 
Sbjct: 244 LCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

Query: 354 LC 355
           L 
Sbjct: 304 LQ 305

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  470 bits (1212), Expect = e-165
 Identities = 104/289 (35%), Positives = 159/289 (55%), Gaps = 2/289 (0%)

Query: 67  PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIE 126
              S  +++   +  +       +  K  ++ ++Y   +KLG G +G   LC +  T +E
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 127 FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGE 186
            A K I K  + S      +  E+ ++  L  H NI+ +   +ED    ++VME   GGE
Sbjct: 65  RAIKIIRKTSV-STSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGE 122

Query: 187 LFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID 246
           LFD II R  ++E  AA + + ++  V   H   ++HRDLKPEN LL +K+ D  +K +D
Sbjct: 123 LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVD 182

Query: 247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQ 306
           FGLS  F+  +   + +G+ YY+APEVL K Y  + DVW+ GVIL+ILL+G PPF  +T 
Sbjct: 183 FGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           Q I   V KG   F+S  W  +S+ AKDLI++ML      R++A + L 
Sbjct: 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  463 bits (1193), Expect = e-165
 Identities = 100/269 (37%), Positives = 154/269 (57%), Gaps = 6/269 (2%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRR 148
            K   + D Y +G +LG GQF     C E +TG+E+A K I KR+  +       E++ R
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+ I+  +  H N++T+   YE+   V +++EL +GGELFD + Q+   SE +A    + 
Sbjct: 65  EVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPY 267
           I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+P 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             S+ AKD IRK+L  +  +RLT  E L 
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALR 272

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  463 bits (1193), Expect = e-164
 Identities = 99/285 (34%), Positives = 150/285 (52%), Gaps = 12/285 (4%)

Query: 81  GIDNQTYYVLGHKTD--NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI 138
           GI      +L    D     D+Y L   +G+G F     C    TG +FA K +   K  
Sbjct: 4   GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63

Query: 139 SRE--DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH 196
           S      ED++RE  I H L  H +IV +   Y     +++V E   G +L   I++R  
Sbjct: 64  SSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD 122

Query: 197 ----YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV- 251
               YSE  A+   R I+  +  CH   ++HRD+KP   LL +K++   +K   FG+++ 
Sbjct: 123 AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 252 FFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIF 310
             + G +    VG+P+++APEV+ +  YG   DVW  GVIL+ILLSG  PF+  T++ +F
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLF 241

Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + ++KG        W  IS+SAKDL+R+ML   P+ER+T +E L 
Sbjct: 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  459 bits (1182), Expect = e-163
 Identities = 101/269 (37%), Positives = 154/269 (57%), Gaps = 6/269 (2%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRR 148
            K   + D Y +G +LG GQF     C E +TG+E+A K I KR+  +       E++ R
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           E+ I+  +  H NI+T+   YE+   V +++EL +GGELFD + Q+   SE +A    + 
Sbjct: 65  EVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKPGQIFTDVVGSPY 267
           I+  V   H+  + H DLKPEN +L++K+     +K IDFGL+   + G  F ++ G+P 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP 326
           +VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     +     DF+ + + 
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             S+ AKD IRK+L  +  +RLT  E L 
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALR 272

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  457 bits (1177), Expect = e-162
 Identities = 95/273 (34%), Positives = 140/273 (51%), Gaps = 13/273 (4%)

Query: 89  VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
            L   +    D Y +   +G G +     C   AT +EFA K I K K        D   
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTE 64

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
           EI+I+     H NI+T+K  Y+D   V++V EL  GGEL D+I+++  +SER+A+ +   
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFKP-GQIFTDVVGSP 266
           I   VE  H+ GV+HRDLKP N L V++  +   ++  DFG +   +    +      + 
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184

Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFES 322
            +VAPEVL +  Y    D+W+ GV+LY +L+G  PF     +T + I   +  G      
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             W  +SD+AKDL+ KML   P +RLTA  VL 
Sbjct: 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  455 bits (1172), Expect = e-162
 Identities = 104/264 (39%), Positives = 154/264 (58%), Gaps = 6/264 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           +T NIR  +     LG G F   +L  +  TG  FA K I K        +E    EI +
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAV 59

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  +  H+NIVT++  YE +   ++VM+L +GGELFDRI++RG Y+E+ A+ + + ++  
Sbjct: 60  LKKIK-HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H  G++HRDLKPEN L +  +++  +   DFGLS   + G   +   G+P YVAPE
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPE 177

Query: 273 VLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL +  Y    D W+ GVI YILL G PPF+ ET+  +F+ + +G+ +FES  W  IS+S
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237

Query: 332 AKDLIRKMLCSQPSERLTAHEVLC 355
           AKD I  +L   P+ER T  + L 
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALS 261

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  454 bits (1171), Expect = e-162
 Identities = 96/275 (34%), Positives = 140/275 (50%), Gaps = 18/275 (6%)

Query: 93  KTDNIRDLYTLG---RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           K       Y L    + LG+G F     C    +   FA K ISKR         + ++E
Sbjct: 2   KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKE 55

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           I  +    GH NIV +   + D L   +VMEL  GGELF+RI ++ H+SE +A+ + R +
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDVVGSPYY 268
           V  V   H +GV+HRDLKPEN L  +++D+  +K IDFG +    P  Q       + +Y
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175

Query: 269 VAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ-------GIFDAVLKGHIDF 320
            APE+L ++ Y    D+W+ GVILY +LSG  PF +  +         I   + KG   F
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           E + W  +S  AKDLI+ +L   P++RL    +  
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  452 bits (1165), Expect = e-161
 Identities = 87/293 (29%), Positives = 139/293 (47%), Gaps = 33/293 (11%)

Query: 93  KTDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
            +    D+Y L    LG+G       C  + T  E+A K I K+          V RE++
Sbjct: 6   FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVE 62

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +++   GH+N++ +   +E+    ++V E   GG +   I +R H++E +A+ + + +  
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV--------V 263
            ++  H+ G+ HRDLKPEN L  + +    +K  DF L    K     + +         
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 264 GSPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPFWAE------------- 304
           GS  Y+APEV+         Y    D+W+ GVILYILLSG PPF                
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242

Query: 305 --TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
              Q  +F+++ +G  +F    W  IS +AKDLI K+L     +RL+A +VL 
Sbjct: 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  452 bits (1165), Expect = e-161
 Identities = 72/262 (27%), Positives = 132/262 (50%), Gaps = 8/262 (3%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            + + Y +   LG+G+FG  + C E ++   +  K +  +      D   V++EI I++ 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNI 57

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVE 214
              H+NI+ +  ++E    + ++ E  +G ++F+RI       +ER+       +   ++
Sbjct: 58  A-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  + H D++PEN +   +    ++K I+FG +   KPG  F  +  +P Y APEV 
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 275 L-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
                    D+W+ G ++Y+LLSG+ PF AET Q I + ++     F+ + +  IS  A 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235

Query: 334 DLIRKMLCSQPSERLTAHEVLC 355
           D + ++L  +   R+TA E L 
Sbjct: 236 DFVDRLLVKERKSRMTASEALQ 257

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  448 bits (1153), Expect = e-158
 Identities = 99/333 (29%), Positives = 149/333 (44%), Gaps = 27/333 (8%)

Query: 36  TNSDYSTPS--LNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHK 93
           +NS   +P     +     Q  +   P      P   P +      +        +   K
Sbjct: 3   SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSG------LQIKK 56

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
              I D     + LG G  G         T  +FA K +              RRE+++ 
Sbjct: 57  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELH 108

Query: 154 HHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTR 207
              +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ +
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 168

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            I   ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +PY
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228

Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFES 322
           YVAPEVL    Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             W  +S+  K LIR +L ++P++R+T  E + 
Sbjct: 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  445 bits (1147), Expect = e-157
 Identities = 90/306 (29%), Positives = 139/306 (45%), Gaps = 7/306 (2%)

Query: 52  SQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQ 111
           S        K          +  D              +  K  ++ D Y +  +LG G 
Sbjct: 4   SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63

Query: 112 FGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED 171
           FG  + C E ATG  F  K I+        D   V+ EI IM+ L  H  ++ +  A+ED
Sbjct: 64  FGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLH-HPKLINLHDAFED 119

Query: 172 SLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPEN 230
              + +++E  +GGELFDRI    +  SE +     R     ++  H   ++H D+KPEN
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179

Query: 231 FLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGV 289
            +   K    S+K IDFGL+    P +I      +  + APE++  +  G   D+W  GV
Sbjct: 180 IMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV 238

Query: 290 ILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLT 349
           + Y+LLSG+ PF  E        V +   +F+ D +  +S  AKD I+ +L  +P +RLT
Sbjct: 239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298

Query: 350 AHEVLC 355
            H+ L 
Sbjct: 299 VHDALE 304

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  445 bits (1146), Expect = e-157
 Identities = 99/336 (29%), Positives = 160/336 (47%), Gaps = 9/336 (2%)

Query: 24  SNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGID 83
            +    N       +     S +      + +S  +  +         S     +     
Sbjct: 12  VDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPA 71

Query: 84  NQTYYVLGHKTDNIRDLYTLGRK--LGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
              + ++  K   +   YT+ +   LG G+FG  + C E ATG++ A K I  R +   +
Sbjct: 72  PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---K 128

Query: 142 DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSER 200
           D E+V+ EI +M+ L  H N++ +  A+E    + +VME   GGELFDRII   +  +E 
Sbjct: 129 DKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
                 + I   +   H + ++H DLKPEN L VN+D    +K IDFGL+  +KP +   
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLK 246

Query: 261 DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID 319
              G+P ++APEV+         D+W+ GVI Y+LLSG+ PF  +      + +L    D
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD 306

Query: 320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            E + +  IS+ AK+ I K+L  + S R++A E L 
Sbjct: 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  451 bits (1163), Expect = e-157
 Identities = 99/326 (30%), Positives = 146/326 (44%), Gaps = 7/326 (2%)

Query: 32  NSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLG 91
            S              ++   + +  +   K         S  DN +           + 
Sbjct: 90  QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
            K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQ 206

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIV 210
            M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R + 
Sbjct: 207 TMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + A
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 324

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           PEV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS
Sbjct: 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLC 355
           +  KD IRK+L + P+ R+T H+ L 
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALE 410

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  435 bits (1121), Expect = e-154
 Identities = 95/270 (35%), Positives = 136/270 (50%), Gaps = 12/270 (4%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVRREI 150
            +RD Y + + LG G  G   L  E  T  + A K ISKRK             +V  EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +I+  L  H  I+ IK  ++     +IV+EL  GGELFD+++      E         ++
Sbjct: 67  EILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
             V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 271 PEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFESDPW 325
           PEVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  + W
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             +S+ A DL++K+L   P  R T  E L 
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALR 274

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  434 bits (1118), Expect = e-153
 Identities = 100/279 (35%), Positives = 141/279 (50%), Gaps = 21/279 (7%)

Query: 89  VLGHKTDNIRDLYTLGRK-LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR 147
               K   + D Y L ++ LG G  G    C    TG + A K +              R
Sbjct: 18  GPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KAR 69

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERK 201
           +E+      +G  +IV I   YE+      C+ I+ME   GGELF RI +RG   ++ER+
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129

Query: 202 AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD 261
           AAE+ R I   ++  HS  + HRD+KPEN L  +K+ D  LK  DFG +       + T 
Sbjct: 130 AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT- 188

Query: 262 VVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQ----GIFDAVLKG 316
              +PYYVAPEVL    Y    D+W+ GVI+YILL G PPF++ T Q    G+   +  G
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248

Query: 317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
              F +  W  +S+ AK LIR +L + P+ERLT  + + 
Sbjct: 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  422 bits (1087), Expect = e-147
 Identities = 94/273 (34%), Positives = 136/273 (49%), Gaps = 12/273 (4%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVR 147
               +RD Y + + LG G  G   L  E  T  + A + ISKRK             +V 
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
            EI+I+  L  H  I+ IK  ++     +IV+EL  GGELFD+++      E        
Sbjct: 189 TEIEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            ++  V+  H  G++HRDLKPEN LL ++++D  +K  DFG S       +   + G+P 
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306

Query: 268 YVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFES 322
           Y+APEVL+      Y    D W+ GVIL+I LSG PPF    TQ  + D +  G  +F  
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           + W  +S+ A DL++K+L   P  R T  E L 
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  414 bits (1067), Expect = e-145
 Identities = 95/321 (29%), Positives = 142/321 (44%), Gaps = 52/321 (16%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL--ISRED 142
           +  Y  G     ++  Y L   +GQG +G   +  E  T    A K ++K K+  I+ +D
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71

Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH------ 196
           VE ++ E+++M  L  H NI  +   YED   + +VMELC GG L D++           
Sbjct: 72  VERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKC 130

Query: 197 ----------------------------------YSERKAAELTRIIVGVVEACHSLGVM 222
                                               E+  + + R I   +   H+ G+ 
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-----GQIFTDVVGSPYYVAPEVL--- 274
           HRD+KPENFL    +  F +K +DFGLS  F           T   G+PY+VAPEVL   
Sbjct: 191 HRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
            + YGP+ D W+AGV+L++LL G  PF           VL   + FE+  + ++S  A+D
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARD 309

Query: 335 LIRKMLCSQPSERLTAHEVLC 355
           L+  +L     ER  A   L 
Sbjct: 310 LLSNLLNRNVDERFDAMRALQ 330

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  405 bits (1043), Expect = e-143
 Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 38/273 (13%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K   I D     + LG G  G         T  +FA K +              RRE+++
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVEL 63

Query: 153 MHHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELT 206
               +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+ 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           + I   ++  HS+ + HRD+KPEN L  +K  +  LK  DFG                  
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------- 166

Query: 267 YYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFES 322
              A E   + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F +
Sbjct: 167 ---AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             W  +S+  K LIR +L ++P++R+T  E + 
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  295 bits (757), Expect = 1e-97
 Identities = 67/266 (25%), Positives = 113/266 (42%), Gaps = 21/266 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +     LG G  GT      +    + A K I        E      RE+Q++     H 
Sbjct: 26  FCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSL 219
           N++      +D    +I +ELC    L + + Q+   +   +   L +     +   HSL
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAI--DFGLSVFFKPGQ----IFTDVVGSPYYVAPEV 273
            ++HRDLKP N L+   +    +KA+  DFGL      G+      + V G+  ++APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 274 LL----KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           L     ++     D+++AG + Y ++S G  PF    Q+     +    +D    P    
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH-PEKHE 256

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
              A++LI KM+   P +R +A  VL
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVL 282

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  294 bits (755), Expect = 3e-97
 Identities = 66/299 (22%), Positives = 114/299 (38%), Gaps = 44/299 (14%)

Query: 90  LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           + +   ++++L    + LG G  GT         G   A K +           +    E
Sbjct: 6   IPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALME 58

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYS-------ERKA 202
           I+++     H N++    +      ++I +ELC    L D +  +           E   
Sbjct: 59  IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------DDFSLKAIDFGLSVF 252
             L R I   V   HSL ++HRDLKP+N L+              ++  +   DFGL   
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 253 FKPGQ-----IFTDVVGSPYYVAPEVLL--------KHYGPEADVWTAGVILYILLS-GV 298
              GQ        +  G+  + APE+L         +      D+++ G + Y +LS G 
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 299 PPFWAETQQGIFDAVLKGHIDF---ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            PF  +  +     +++G       +      +   A DLI +M+   P +R TA +VL
Sbjct: 238 HPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  270 bits (691), Expect = 4e-89
 Identities = 63/299 (21%), Positives = 113/299 (37%), Gaps = 43/299 (14%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
               L+ L   LGQG     +      TG  FA K  +         V+   RE +++  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKK 63

Query: 156 LAGHKNIVTIKGAYEDSLCVHI--VMELCAGGELFDRIIQRGH---YSERKAAELTRIIV 210
           L  HKNIV +    E++   H   +ME C  G L+  + +  +     E +   + R +V
Sbjct: 64  LN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 211 GVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           G +      G++HR++KP N +  + +D     K  DFG +   +  + F  + G+  Y+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 270 APEVL---------LKHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKG 316
            P++           K YG   D+W+ GV  Y   +G  PF         + +   ++ G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 317 ---------------HIDFESD--PWPLISDSAKD----LIRKMLCSQPSERLTAHEVL 354
                           ID+  D      +S   +     ++  +L +   +     +  
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  266 bits (683), Expect = 3e-88
 Identities = 88/265 (33%), Positives = 132/265 (49%), Gaps = 11/265 (4%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
               + R  Y  GR LG+G F   +  ++  T   FA K + K  L+     E +  EI 
Sbjct: 9   VDPRSRRR-YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           I   LA H+++V   G +ED+  V +V+ELC    L +   +R   +E +A    R IV 
Sbjct: 68  IHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVA 270
             +  H   V+HRDLK  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+A
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           PEVL  K +  E DVW+ G I+Y LL G PPF     +  +  + K   ++       I+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--IN 239

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
             A  LI+KML + P+ R T +E+L
Sbjct: 240 PVAASLIQKMLQTDPTARPTINELL 264

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  268 bits (686), Expect = 4e-88
 Identities = 94/315 (29%), Positives = 141/315 (44%), Gaps = 29/315 (9%)

Query: 42  TPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLY 101
            P+   +  V    +   P     A  I     D                    + R  Y
Sbjct: 3   APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD------------------PRSRRR-Y 43

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
             GR LG+G F   +  ++  T   FA K + K  L+     E +  EI I   LA H++
Sbjct: 44  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQH 102

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGV 221
           +V   G +ED+  V +V+ELC    L +   +R   +E +A    R IV   +  H   V
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 162

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +HRDLK  N  L   ++D  +K  DFGL+   +  G+    + G+P Y+APEVL  K + 
Sbjct: 163 IHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            E DVW+ G I+Y LL G PPF     +  +  + K   ++       I+  A  LI+KM
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQKM 275

Query: 340 LCSQPSERLTAHEVL 354
           L + P+ R T +E+L
Sbjct: 276 LQTDPTARPTINELL 290

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  264 bits (676), Expect = 6e-86
 Identities = 64/299 (21%), Positives = 114/299 (38%), Gaps = 43/299 (14%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
               L+ L   LGQG     +      TG  FA K  +    +   DV    RE +++  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKK 63

Query: 156 LAGHKNIVTIKGAYEDSLCVHI--VMELCAGGELFDRIIQRGH---YSERKAAELTRIIV 210
           L  HKNIV +    E++   H   +ME C  G L+  + +  +     E +   + R +V
Sbjct: 64  LN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 211 GVVEACHSLGVMHRDLKPENFLL-VNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           G +      G++HR++KP N +  + +D     K  DFG +   +  + F  + G+  Y+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 270 APEVL---------LKHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKG 316
            P++           K YG   D+W+ GV  Y   +G  PF         + +   ++ G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 317 ---------------HIDFESD--PWPLISDSAKD----LIRKMLCSQPSERLTAHEVL 354
                           ID+  D      +S   +     ++  +L +   +     +  
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  256 bits (657), Expect = 2e-84
 Identities = 86/257 (33%), Positives = 138/257 (53%), Gaps = 11/257 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +G  LG+G F   Y    I TG+E A K I K+ +     V+ V+ E++I   L  H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HP 71

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSL 219
           +I+ +   +EDS  V++V+E+C  GE+   +  R   +SE +A      I+  +   HS 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEVLL-KH 277
           G++HRDL   N LL     + ++K  DFGL+   K P +    + G+P Y++PE+     
Sbjct: 132 GILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +G E+DVW+ G + Y LL G PPF  +T +   + V+    D+E   +  +S  AKDLI 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDLIH 244

Query: 338 KMLCSQPSERLTAHEVL 354
           ++L   P++RL+   VL
Sbjct: 245 QLLRRNPADRLSLSSVL 261

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  254 bits (650), Expect = 4e-83
 Identities = 68/289 (23%), Positives = 112/289 (38%), Gaps = 41/289 (14%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
               +     LGQG FG             +A K I   +    E +  +  E+ ++  L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59

Query: 157 AGHKNIVTIKGAYED-------------SLCVHIVMELCAGGELFDRIIQRGHYSER-KA 202
             H+ +V    A+ +                + I ME C  G L+D I       +R + 
Sbjct: 60  N-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-------- 254
             L R I+  +   HS G++HRDLKP N  +   D+  ++K  DFGL+            
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 255 -------PGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAET 305
                       T  +G+  YVA EVL    HY  + D+++ G+I + ++   P      
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +  I   +    I+F  D         K +IR ++   P++R  A  +L
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  252 bits (647), Expect = 7e-83
 Identities = 81/255 (31%), Positives = 131/255 (51%), Gaps = 10/255 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E       A K + K +L        +RREI+I  HL  H 
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HP 74

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ +   + D   +++++E    GEL+  + + G + E+++A     +   +  CH   
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN L+        LK  DFG SV     +  T + G+  Y+ PE++  K + 
Sbjct: 135 VIHRDIKPENLLM---GYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPEMIEGKTHD 190

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W AGV+ Y  L G+PPF + +       ++    D +  P+  +SD +KDLI K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLISKL 246

Query: 340 LCSQPSERLTAHEVL 354
           L   P +RL    V+
Sbjct: 247 LRYHPPQRLPLKGVM 261

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  252 bits (645), Expect = 1e-82
 Identities = 79/255 (30%), Positives = 131/255 (51%), Gaps = 10/255 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HP 69

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL        LK  DFG SV     +    + G+  Y+ PE++  + + 
Sbjct: 130 VIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 185

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F    +  +++ A+DLI ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP--DF--VTEGARDLISRL 241

Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 242 LKHNPSQRPMLREVL 256

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  248 bits (635), Expect = 3e-81
 Identities = 93/256 (36%), Positives = 130/256 (50%), Gaps = 10/256 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  ++REIQ +     H 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HP 71

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +           +VME  +GGELFD I + G   E +A  L + I+  V+ CH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+  + Y 
Sbjct: 132 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W+ GVILY LL G  PF  E    +F  +  G   F    +  ++ S   L+  
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLMH 244

Query: 339 MLCSQPSERLTAHEVL 354
           ML   P +R T  ++ 
Sbjct: 245 MLQVDPLKRATIKDIR 260

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  249 bits (636), Expect = 3e-80
 Identities = 47/345 (13%), Positives = 86/345 (24%), Gaps = 48/345 (13%)

Query: 49  QLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLG 108
           +   +       +       +  +    +  +  +     +L            L   L 
Sbjct: 16  KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERK----LKLVEPLR 71

Query: 109 QGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL------------ 156
            G     +L  ++    +FA K  +     SR ++E +         L            
Sbjct: 72  VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131

Query: 157 -----------AGHKNIVTIKGAYED--SLCVHIVMELCAG------GELFDRIIQRGHY 197
                              +    +D       ++M   +         L    + RG  
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
                  LT  ++ +     S G++H    P+N  +     D  L   D       K G 
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALW--KVGT 246

Query: 258 IFTDVVGSPYYVAPEVLLKH---YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL 314
                     Y   E L      +    + W  G+ +Y +     PF   T         
Sbjct: 247 RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306

Query: 315 KGHIDFESDPWPL-----ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                  +D         + D  K LI + L      RL   E +
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  246 bits (631), Expect = 6e-80
 Identities = 91/256 (35%), Positives = 139/256 (54%), Gaps = 11/256 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L + +G+G F    L   I TG E A K I K + ++   ++ + RE++IM  L  H 
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILN-HP 74

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +    E    ++++ME  +GGE+FD ++  G   E++A    R IV  V+ CH   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           ++HRDLK EN LL   D D ++K  DFG S  F  G       G+P Y APE+   K Y 
Sbjct: 135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ GVILY L+SG  PF  +  + + + VL+G   +    +  +S   ++L+++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLKR 247

Query: 339 MLCSQPSERLTAHEVL 354
            L   P +R T  +++
Sbjct: 248 FLVLNPIKRGTLEQIM 263

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  253 bits (648), Expect = 9e-79
 Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 33/288 (11%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
               + +  +LG G FG         TG + A K   +    S ++ E    EIQIM  L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL 69

Query: 157 AGHKNIVTIKGAYEDSLCVH------IVMELCAGGELFDRIIQRGH---YSERKAAELTR 207
             H N+V+ +   +    +       + ME C GG+L   + Q  +     E     L  
Sbjct: 70  N-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            I   +   H   ++HRDLKPEN +L         K ID G +     G++ T+ VG+  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW- 325
           Y+APE+L  K Y    D W+ G + +  ++G  PF    Q   +   ++   +     + 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248

Query: 326 -------------------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                               +++   +  ++ ML     +R T  +  
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  246 bits (630), Expect = 4e-78
 Identities = 92/256 (35%), Positives = 135/256 (52%), Gaps = 10/256 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y LG  LG G FG   +     TG + A K ++++K+ S + V  +RREIQ +     H 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +         + +VME  +GGELFD I + G   E+++  L + I+  V+ CH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           V+HRDLKPEN LL   D   + K  DFGLS     G+      GSP Y APEV+  + Y 
Sbjct: 137 VVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE D+W++GVILY LL G  PF  +    +F  +  G   F +  +  ++ S   L++ 
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249

Query: 339 MLCSQPSERLTAHEVL 354
           ML   P +R T  ++ 
Sbjct: 250 MLQVDPMKRATIKDIR 265

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  243 bits (621), Expect = 6e-78
 Identities = 40/298 (13%), Positives = 81/298 (27%), Gaps = 58/298 (19%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--- 157
              G  LGQ         T+  TG  F        +      ++ ++ E+  +  L    
Sbjct: 75  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134

Query: 158 ---------------------GHKNIVTIKGAYED--SLCVHIVMELCA------GGELF 188
                                  K ++ ++    D   L    +           G  L 
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194

Query: 189 DRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                          +LT  ++ ++ + H  G++H  L+P + +L   D    +    F 
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFE 251

Query: 249 LSVFFKPGQIFTDVVGSPYYVAPEVLL------------KHYGPEADVWTAGVILYILLS 296
             V             S  +  PE+                     D W  G+++Y +  
Sbjct: 252 HLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
              P   +   G  + + +   +        I    + L+   L     +RL   + +
Sbjct: 309 ADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAM 358

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  241 bits (618), Expect = 6e-78
 Identities = 91/256 (35%), Positives = 134/256 (52%), Gaps = 11/256 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   LG+G FG   L T   T  + A K IS++ L   +    V REI  +  L  H 
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HP 69

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           +I+ +         + +V+E  AGGELFD I+++   +E +     + I+  +E CH   
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           ++HRDLKPEN LL   DD+ ++K  DFGLS     G       GSP Y APEV+  K Y 
Sbjct: 129 IVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           GPE DVW+ G++LY++L G  PF  E    +F  V      +    +  +S  A+ LIR+
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIRR 241

Query: 339 MLCSQPSERLTAHEVL 354
           M+ + P +R+T  E+ 
Sbjct: 242 MIVADPMQRITIQEIR 257

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  240 bits (615), Expect = 8e-78
 Identities = 60/270 (22%), Positives = 114/270 (42%), Gaps = 24/270 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH- 159
           Y++ +++G G     +          +A K ++  +    + ++  R EI  ++ L  H 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
             I+ +         +++VME C   +L   + ++      +     + ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL- 275
           G++H DLKP NFL+V+      LK IDFG++   +P     +    VG+  Y+ PE +  
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 276 -----------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP 324
                          P++DVW+ G ILY +  G  PF     Q I         + E + 
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEF 261

Query: 325 WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             +     +D+++  L   P +R++  E+L
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  237 bits (608), Expect = 3e-77
 Identities = 75/260 (28%), Positives = 125/260 (48%), Gaps = 14/260 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I   L  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-K 276
           + HRD+KPEN LL   D+  +LK  DFGL+  F+      +   + G+  YVAPE+L  +
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 277 HY-GPEADVWTAGVILYILLSGVPPF-WAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
            +     DVW+ G++L  +L+G  P+         +    +       +PW  I  +   
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240

Query: 335 LIRKMLCSQPSERLTAHEVL 354
           L+ K+L   PS R+T  ++ 
Sbjct: 241 LLHKILVENPSARITIPDIK 260

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  239 bits (611), Expect = 6e-77
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 22/262 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIMHH 155
           Y+    LG G FG  +   +     E   K I K K++    +ED     V  EI I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           +  H NI+ +   +E+     +VME   +G +LF  I +     E  A+ + R +V  V 
Sbjct: 86  VE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
                 ++HRD+K EN ++    +DF++K IDFG + + + G++F    G+  Y APEVL
Sbjct: 145 YLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVL 201

Query: 275 L-KHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +   Y GPE ++W+ GV LY L+    PF         +  ++            +S   
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEA--AIHPPYL--VSKEL 251

Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
             L+  +L   P  R T  +++
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLV 273

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  237 bits (607), Expect = 1e-76
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 22/273 (8%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VR 147
           G   +     Y LG  LG+G FGT +    +   ++ A K I + +++    + D     
Sbjct: 23  GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82

Query: 148 REIQIM---HHLAGHKNIVTIKGAYEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAA 203
            E+ ++       GH  ++ +   +E      +V+E      +LFD I ++G   E  + 
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR 142

Query: 204 ELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
                +V  ++ CHS GV+HRD+K EN +L++       K IDFG          +TD  
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDEN-ILIDL-RRGCAKLIDFGSGALLHDEP-YTDFD 199

Query: 264 GSPYYVAPEVLL-KHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE 321
           G+  Y  PE +    Y    A VW+ G++LY ++ G  PF  E  Q I +A      +  
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILEA------ELH 251

Query: 322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                 +S     LIR+ L  +PS R +  E+L
Sbjct: 252 FPAH--VSPDCCALIRRCLAPKPSSRPSLEEIL 282

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  237 bits (608), Expect = 2e-76
 Identities = 78/261 (29%), Positives = 128/261 (49%), Gaps = 16/261 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++ +  +  E++++EI I   L  H+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN-HE 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD---VVGSPYYVAPEVLL-K 276
           + HRD+KPEN LL   D+  +LK  DFGL+  F+          + G+  YVAPE+L  +
Sbjct: 126 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 277 HY-GPEADVWTAGVILYILLSGVPPF--WAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            +     DVW+ G++L  +L+G  P+   +++ Q   D   K       +PW  I  +  
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TYLNPWKKIDSAPL 239

Query: 334 DLIRKMLCSQPSERLTAHEVL 354
            L+ K+L   PS R+T  ++ 
Sbjct: 240 ALLHKILVENPSARITIPDIK 260

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  236 bits (604), Expect = 3e-76
 Identities = 83/286 (29%), Positives = 124/286 (43%), Gaps = 41/286 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---------------------- 138
           YTL  ++G+G +G   L         +A K +SK+KLI                      
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 139 -SREDVEDVRREIQIMHHLAGHKNIVT----IKGAYEDSLCVHIVMELCAGGELFDRIIQ 193
             R  +E V +EI I+  L  H N+V     +    ED L  ++V EL   G + + +  
Sbjct: 75  QPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHL--YMVFELVNQGPVME-VPT 130

Query: 194 RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
               SE +A    + ++  +E  H   ++HRD+KP N L+    +D  +K  DFG+S  F
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV---GEDGHIKIADFGVSNEF 187

Query: 254 KPGQIFTD-VVGSPYYVAPEVL---LKHY-GPEADVWTAGVILYILLSGVPPFWAETQQG 308
           K         VG+P ++APE L    K + G   DVW  GV LY  + G  PF  E    
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247

Query: 309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +   +       E    P I++  KDLI +ML   P  R+   E+ 
Sbjct: 248 LHSKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  236 bits (605), Expect = 4e-76
 Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 20/271 (7%)

Query: 91  GHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VR 147
           G + + +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +   V 
Sbjct: 35  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94

Query: 148 REIQIMHHLA-GHKNIVTIKGAYEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAEL 205
            E+ ++  ++ G   ++ +   +E      +++E      +LFD I +RG   E  A   
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
              ++  V  CH+ GV+HRD+K EN +L++  +   LK IDFG     K    +TD  G+
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDEN-ILIDL-NRGELKLIDFGSGALLKDTV-YTDFDGT 211

Query: 266 PYYVAPEVLL-KHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
             Y  PE +    Y G  A VW+ G++LY ++ G  PF  E  + I              
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG------QVFFR 263

Query: 324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
               +S   + LIR  L  +PS+R T  E+ 
Sbjct: 264 QR--VSSECQHLIRWCLALRPSDRPTFEEIQ 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  236 bits (603), Expect = 2e-75
 Identities = 61/276 (22%), Positives = 117/276 (42%), Gaps = 27/276 (9%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
             R  Y++ +++G G     +          +A K ++  +    + ++  R EI  ++ 
Sbjct: 7   KGRI-YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNK 63

Query: 156 LAGH-KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H   I+ +         +++VME C   +L   + ++      +     + ++  V 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAP 271
             H  G++H DLKP NFL+V+      LK IDFG++   +P     +    VG+  Y+ P
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 272 EVLL------------KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHI 318
           E +                 P++DVW+ G ILY +  G  PF     Q     A++  + 
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238

Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           + E     +     +D+++  L   P +R++  E+L
Sbjct: 239 EIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  236 bits (603), Expect = 2e-75
 Identities = 86/260 (33%), Positives = 122/260 (46%), Gaps = 14/260 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   + +G G FG   L  +  T    A K I +   I     E+V+REI     L  H 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLR-HP 76

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV  K        + I+ME  +GGEL++RI   G +SE +A    + ++  V  CHS+ 
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHY- 278
           + HRDLK EN  L++      LK  DFG S            VG+P Y+APEVLL + Y 
Sbjct: 137 ICHRDLKLEN-TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIF----DAVLKGHIDFESDPWPLISDSAKD 334
           G  ADVW+ GV LY++L G  PF    +   +      +L        D    IS     
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCH 253

Query: 335 LIRKMLCSQPSERLTAHEVL 354
           LI ++  + P+ R++  E+ 
Sbjct: 254 LISRIFVADPATRISIPEIK 273

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  235 bits (601), Expect = 3e-75
 Identities = 62/327 (18%), Positives = 123/327 (37%), Gaps = 50/327 (15%)

Query: 71  PSKKDNIMRRGIDNQTYYVLGHKTDNIR-DLYTLGRKLGQGQFGTTYLCTEIATGIEFAC 129
           P      +     N  Y     K  +   + Y + R L QG+F    LC +      +A 
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYAL 59

Query: 130 KSISKRKLI--------------SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
           K   K  L                +   +D + E+QI+  +  ++  +T +G   +   V
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEV 118

Query: 176 HIVMELCAGGELFDRIIQRGH--------YSERKAAELTRIIVGVVEACHS-LGVMHRDL 226
           +I+ E      +                    +    + + ++      H+   + HRD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL---LKHYGPEAD 283
           KP N L+   D +  +K  DFG S +    +I     G+  ++ PE       + G + D
Sbjct: 179 KPSNILM---DKNGRVKLSDFGESEYMVDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVD 234

Query: 284 VWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDF---------------ESDPWPL 327
           +W+ G+ LY++   V PF  + +   +F+ +   +I++                +     
Sbjct: 235 IWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +S+   D ++  L   P+ER+T+ + L
Sbjct: 295 LSNEDIDFLKLFLRKNPAERITSEDAL 321

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  236 bits (603), Expect = 6e-75
 Identities = 69/349 (19%), Positives = 134/349 (38%), Gaps = 47/349 (13%)

Query: 22  DHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRG 81
            H ++S           + +      Q + S +   ++  K +S      S  + I  +G
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASS------SANECISVKG 55

Query: 82  IDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE 141
                              Y++ +++G G     +          +A K ++  +    +
Sbjct: 56  RI-----------------YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQ 96

Query: 142 DVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSER 200
            ++  R EI  ++ L  H   I+ +         +++VME C   +L   + ++      
Sbjct: 97  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPW 155

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--- 257
           +     + ++  V   H  G++H DLKP NFL+V+      LK IDFG++   +P     
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDTTSV 211

Query: 258 IFTDVVGSPYYVAPEVLL------------KHYGPEADVWTAGVILYILLSGVPPFWAET 305
           +    VG+  Y+ PE +                 P++DVW+ G ILY +  G  PF    
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

Query: 306 QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            Q I         + E +   +     +D+++  L   P +R++  E+L
Sbjct: 272 NQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  221 bits (566), Expect = 7e-71
 Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 21/269 (7%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           + Y +   +G G +G        + G     K +    + +  + + +  E+ ++  L  
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK- 63

Query: 159 HKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGV 212
           H NIV       D  +  ++IVME C GG+L   I +    R +  E     +   +   
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 213 VEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSP 266
           ++ CH        V+HRDLKP N  L   D   ++K  DFGL+        F    VG+P
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 267 YYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           YY++PE +    Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +G        +
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
              SD   ++I +ML  +   R +  E+L
Sbjct: 241 ---SDELNEIITRMLNLKDYHRPSVEEIL 266

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  222 bits (567), Expect = 1e-70
 Identities = 71/265 (26%), Positives = 126/265 (47%), Gaps = 20/265 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-VRREIQIMHHLAGH 159
           Y +G  LG+G +G      +  T    A K + K+KL    + E  V++EIQ++  L  H
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-H 65

Query: 160 KNIVTIKG--AYEDSLCVHIVMELCAGG--ELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
           KN++ +      E+   +++VME C  G  E+ D + +   +   +A      ++  +E 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF---FKPGQIFTDVVGSPYYVAPE 272
            HS G++H+D+KP N LL       +LK    G++     F          GSP +  PE
Sbjct: 125 LHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 273 VL--LKHY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           +   L  + G + D+W+AGV LY + +G+ PF  +    +F+ + KG   +         
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--CG 237

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
               DL++ ML  +P++R +  ++ 
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIR 262

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  221 bits (565), Expect = 3e-70
 Identities = 68/316 (21%), Positives = 117/316 (37%), Gaps = 23/316 (7%)

Query: 41  STPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDL 100
           S   L ++ L  Q   +  P++ +     S + + +        ++++         +  
Sbjct: 9   SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQ-SPGYDPSRPESFF---------QQS 58

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +    +LG G +G  +       G  +A K  S       +D      E+     +  H 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVEACHSL 219
             V ++ A+E+   +++  ELC G  L       G    E +     R  +  +   HS 
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYG 279
           G++H D+KP N  L         K  DFGL V            G P Y+APE+L   YG
Sbjct: 177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG 233

Query: 280 PEADVWTAGVILYILLSGVP-PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
             ADV++ G+ +  +   +  P   E  Q +    L             +S   + ++  
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLVM 287

Query: 339 MLCSQPSERLTAHEVL 354
           ML   P  R TA  +L
Sbjct: 288 MLEPDPKLRATAEALL 303

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  217 bits (555), Expect = 2e-68
 Identities = 66/263 (25%), Positives = 130/263 (49%), Gaps = 14/263 (5%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           + Y   +K+G+G FG   L      G ++  K I+  ++ S ++ E+ RRE+ ++ ++  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK- 81

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEAC 216
           H NIV  + ++E++  ++IVM+ C GG+LF RI  +    + E +  +    I   ++  
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           H   ++HRD+K +N  L     D +++  DFG++             +G+PYY++PE+  
Sbjct: 142 HDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-LISDSAK 333
            K Y  ++D+W  G +LY L +    F A + + +   ++ G       P     S   +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLR 254

Query: 334 DLIRKMLCSQPSERLTAHEVLCM 356
            L+ ++    P +R + + +L  
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEK 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  204 bits (522), Expect = 7e-64
 Identities = 63/276 (22%), Positives = 103/276 (37%), Gaps = 30/276 (10%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   +KLG+G F    L   +  G  +A K I       ++D E+ +RE  +      H 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHP 86

Query: 161 NIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGV 212
           NI+ +               +++     G L++ I +        +E +   L   I   
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG----------QIFTDV 262
           +EA H+ G  HRDLKP N LL    D+     +D G                  Q +   
Sbjct: 147 LEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 263 VGSPYYVAPEVL-LKHY---GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
             +  Y APE+  ++ +       DVW+ G +LY ++ G  P+    Q+G     L    
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQN 262

Query: 319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                  P  S +   L+  M+   P +R     +L
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  207 bits (529), Expect = 8e-64
 Identities = 40/295 (13%), Positives = 80/295 (27%), Gaps = 51/295 (17%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-- 157
               G  LGQ         T+  TG  F        +      ++ ++ E+  +  L   
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 158 ----------------------GHKNIVTIKGAYED--SLCVHIVMELCAG------GEL 187
                                   K ++ ++    D   L    +              L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF 247
                           +LT  ++ ++ + H  G++H  L+P + +L   D    +    F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGF 255

Query: 248 GLSVFFKPGQIF--TDVVGSPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVP 299
              V      +         P   A  +L              D WT G+ +Y +     
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 300 PFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           P   +   G  + + +   +        I    + L+   L     +RL   + +
Sbjct: 316 PNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAM 362

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  202 bits (516), Expect = 3e-63
 Identities = 74/285 (25%), Positives = 109/285 (38%), Gaps = 40/285 (14%)

Query: 91  GHKTDNIRDL--YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRR 148
           G  T + R    +     +G G FG  +       G  +  K +           E   R
Sbjct: 1   GAHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAER 53

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSL----------------CVHIVMELCAGGELFDRII 192
           E++ +  L  H NIV   G ++                   C+ I ME C  G L   I 
Sbjct: 54  EVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112

Query: 193 QR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS 250
           +R      +  A EL   I   V+  HS  +++RDLKP N  L    D   +K  DFGL 
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLV 169

Query: 251 VFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
              K     T   G+  Y++PE +  + YG E D++  G+IL  LL       A      
Sbjct: 170 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKF 227

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           F  +  G I        +     K L++K+L  +P +R    E+L
Sbjct: 228 FTDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  196 bits (500), Expect = 2e-60
 Identities = 85/258 (32%), Positives = 129/258 (50%), Gaps = 20/258 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
             V +   ++D   ++  +     GEL   I + G + E       AE    IV  +E  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----IVSALEYL 146

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTD-VVGSPYYVAPEV 273
           H  G++HRDLKPEN LL   ++D  ++  DFG +  +  +  Q   +  VG+  YV+PE+
Sbjct: 147 HGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L  K     +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF   P       A
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKA 259

Query: 333 KDLIRKMLCSQPSERLTA 350
           +DL+ K+L    ++RL  
Sbjct: 260 RDLVEKLLVLDATKRLGC 277

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  196 bits (501), Expect = 2e-60
 Identities = 70/300 (23%), Positives = 111/300 (37%), Gaps = 50/300 (16%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           QT  +   +         + R L +G F   Y   ++ +G E+A K +        E   
Sbjct: 21  QTVELGELR-------LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNR 70

Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLC--------VHIVMELCAGGELFDRIIQR-- 194
            + +E+  M  L+GH NIV    A                ++ ELC  G+L + + +   
Sbjct: 71  AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMES 129

Query: 195 -GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
            G  S     ++       V+  H     ++HRDLK EN LL    +  ++K  DFG + 
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSAT 186

Query: 252 FFKPGQIFTD-------------VVGSPYYVAPEVLL----KHYGPEADVWTAGVILYIL 294
                  ++                 +P Y  PE++        G + D+W  G ILY+L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

Query: 295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                PF    +      ++ G       P          LIR ML   P ERL+  EV+
Sbjct: 247 CFRQHPFEDGAKL----RIVNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  195 bits (497), Expect = 5e-60
 Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 14/262 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + +K+G+GQF   Y    +  G+  A K +    L+  +   D  +EI ++  L  H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HP 92

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEAC 216
           N++    ++ +   ++IV+EL   G+L   I           ER   +    +   +E  
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGSPYYVAPEVL- 274
           HS  VMHRD+KP N  +        +K  D GL  FF         +VG+PYY++PE + 
Sbjct: 153 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAVLKGHIDFESDPWPLISDSA 332
              Y  ++D+W+ G +LY + +   PF+ +      +   + +   D+   P    S+  
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSEEL 267

Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           + L+   +   P +R     V 
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVY 289

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  190 bits (485), Expect = 2e-58
 Identities = 67/283 (23%), Positives = 105/283 (37%), Gaps = 40/283 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG+G FG  +          +A K I           E V RE++ +  L  H 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HP 63

Query: 161 NIVTIKGAYED------------SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI 208
            IV    A+ +             + ++I M+LC    L D +  R    ER+ +    I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 209 IVGVVEA---CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-------------VF 252
            + + EA    HS G+MHRDLKP N        D  +K  DFGL                
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 253 FKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD 311
                  T  VG+  Y++PE +    Y  + D+++ G+IL+ LL   P      +     
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLT 238

Query: 312 AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            V           +         +++ ML   P ER  A  ++
Sbjct: 239 DVRNLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  192 bits (489), Expect = 2e-58
 Identities = 53/279 (18%), Positives = 96/279 (34%), Gaps = 36/279 (12%)

Query: 99  DLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
            L  +   LG+G F   Y  T     +     +F  K           +     + ++ +
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERL 121

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRI----- 208
                    +    A+       +V EL + G L + I    +  E+   +   I     
Sbjct: 122 KPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNK--------DDDFSLKAIDFGLSV---FFKPGQ 257
           ++ ++E  H   ++H D+KP+NF+L N         D    L  ID G S+    F  G 
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLK 315
           IFT    +  +   E+L  K +  + D +     +Y +L G       E  +   + + +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300

Query: 316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                  D W        +    ML       L + ++L
Sbjct: 301 RL--PHLDMW-------NEFFHVMLNIPDCHHLPSLDLL 330

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  185 bits (472), Expect = 3e-55
 Identities = 90/315 (28%), Positives = 140/315 (44%), Gaps = 32/315 (10%)

Query: 45  LNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG 104
           L+    +  +      +K+ +        KD I +          +        D Y + 
Sbjct: 26  LDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINK----------IRDLRMKAED-YEVV 74

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           + +G+G FG   L    +T   +A K +SK ++I R D      E  IM   A    +V 
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSPWVVQ 133

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  A++D   +++VME   GG+L   ++      E+ A    AE    +V  ++A HS+G
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAE----VVLALDAIHSMG 188

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVLLK-- 276
            +HRD+KP+N LL   D    LK  DFG  +     G +  D  VG+P Y++PEVL    
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245

Query: 277 ---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
              +YG E D W+ GV LY +L G  PF+A++  G +  ++             IS  AK
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305

Query: 334 DLIRKMLCSQPSERL 348
           +LI   L      RL
Sbjct: 306 NLICAFLTD-REVRL 319

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  181 bits (462), Expect = 2e-54
 Identities = 78/254 (30%), Positives = 134/254 (52%), Gaps = 21/254 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG G FG   L     +G  +A K + K+K++  + +E    E +I+  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
            +V ++ +++D+  +++VME  AGGE+F  + + G +SE  A    A+    IV   E  
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ----IVLTFEYL 157

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           HSL +++RDLKPEN L+   D    ++  DFG +   K  +  T  + G+P  +APE++L
Sbjct: 158 HSLDLIYRDLKPENLLI---DQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIIL 211

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
            K Y    D W  GV++Y + +G PPF+A+    I++ ++ G + F S      S   KD
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKD 267

Query: 335 LIRKMLCSQPSERL 348
           L+R +L    ++R 
Sbjct: 268 LLRNLLQVDLTKRF 281

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  175 bits (447), Expect = 2e-52
 Identities = 72/254 (28%), Positives = 125/254 (49%), Gaps = 21/254 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + R LG G FG  +L      G  +A K + K  ++  + VE    E  ++  +  H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HP 66

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
            I+ + G ++D+  + ++M+   GGELF  + +   +    A    AE    +   +E  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----VCLALEYL 122

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           HS  +++RDLKPEN LL   D +  +K  DFG +   K     T  + G+P Y+APEV+ 
Sbjct: 123 HSKDIIYRDLKPENILL---DKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVS 176

Query: 276 KH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
              Y    D W+ G+++Y +L+G  PF+       ++ +L   + F   P P  ++  KD
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKD 232

Query: 335 LIRKMLCSQPSERL 348
           L+ +++    S+RL
Sbjct: 233 LLSRLITRDLSQRL 246

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  175 bits (446), Expect = 9e-52
 Identities = 66/255 (25%), Positives = 118/255 (46%), Gaps = 23/255 (9%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT 164
           R +G+G FG   +  +  T   +A K ++K+K + R +V +V +E+QIM  L  H  +V 
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVN 79

Query: 165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
           +  +++D   + +V++L  GG+L   + Q  H+ E        E    +V  ++   +  
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE----LVMALDYLQNQR 135

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--- 277
           ++HRD+KP+N LL   D+   +   DF ++         T + G+  Y+APE+       
Sbjct: 136 IIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192

Query: 278 -YGPEADVWTAGVILYILLSGVPPFW---AETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            Y    D W+ GV  Y LL G  P+    + + + I        + +   P    S    
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY---P-SAWSQEMV 248

Query: 334 DLIRKMLCSQPSERL 348
            L++K+L   P +R 
Sbjct: 249 SLLKKLLEPNPDQRF 263

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  175 bits (445), Expect = 2e-51
 Identities = 72/258 (27%), Positives = 123/258 (47%), Gaps = 25/258 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G F    +     TG  +A K ++K  ++ R +V   R E  ++ +    + I  + 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRRWITQLH 127

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKA----AELTRIIVGVVEACHSLGV 221
            A++D   +++VME   GG+L   + + G       A    AE    IV  +++ H LG 
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE----IVMAIDSVHRLGY 183

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQIFTDV-VGSPYYVAPEVLLK--- 276
           +HRD+KP+N LL   D    ++  DFG  +  +  G + + V VG+P Y++PE+L     
Sbjct: 184 VHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240

Query: 277 -----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL-ISD 330
                 YGPE D W  GV  Y +  G  PF+A++    +  ++              + +
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300

Query: 331 SAKDLIRKMLCSQPSERL 348
            A+D I+++LC  P  RL
Sbjct: 301 EARDFIQRLLCP-PETRL 317

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  179 bits (456), Expect = 6e-51
 Identities = 79/354 (22%), Positives = 142/354 (40%), Gaps = 28/354 (7%)

Query: 6   RGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNS 65
           R   + +++  Y   E  + +   + ++   +             + Q + +E  +    
Sbjct: 101 RLVCSREIFDTYIMKELLACSHPFSKSA-IEHVQGHLVKKQVPPDLFQPYIEEICQNLRG 159

Query: 66  APRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI 125
                  + D   R     Q   V  +    + D     R +G+G FG  Y C +  TG 
Sbjct: 160 DVFQKFIESDKFTRFC---QWKNVELNIHLTMNDFSVH-RIIGRGGFGEVYGCRKADTGK 215

Query: 126 EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVTIKGAYEDSLCVHIVMELCA 183
            +A K + K+++  ++       E  ++  ++      IV +  A+     +  +++L  
Sbjct: 216 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 275

Query: 184 GGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD 239
           GG+L   + Q G +SE       AE    I+  +E  H+  V++RDLKP N LL   D+ 
Sbjct: 276 GGDLHYHLSQHGVFSEADMRFYAAE----IILGLEHMHNRFVVYRDLKPANILL---DEH 328

Query: 240 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSG 297
             ++  D GL+  F   +     VG+  Y+APEVL K   Y   AD ++ G +L+ LL G
Sbjct: 329 GHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

Query: 298 VPPFWAET---QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL 348
             PF       +  I    L   ++         S   + L+  +L    + RL
Sbjct: 388 HSPFRQHKTKDKHEIDRMTLTMAVELPDS----FSPELRSLLEGLLQRDVNRRL 437

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  174 bits (443), Expect = 8e-51
 Identities = 75/256 (29%), Positives = 130/256 (50%), Gaps = 23/256 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   +         FA K ++K +++ R +    R E  ++ +    K I T+ 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSKWITTLH 140

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQ-RGHYSERKA----AELTRIIVGVVEACHSLGV 221
            A++D   +++VM+   GG+L   + +      E  A    AE    +V  +++ H L  
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE----MVIAIDSVHQLHY 196

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDV-VGSPYYVAPEVLL---- 275
           +HRD+KP+N L+   D +  ++  DFG      + G + + V VG+P Y++PE+L     
Sbjct: 197 VHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253

Query: 276 --KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW-PLISDSA 332
               YGPE D W+ GV +Y +L G  PF+AE+    +  ++     F+       +S++A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313

Query: 333 KDLIRKMLCSQPSERL 348
           KDLIR+++CS    RL
Sbjct: 314 KDLIRRLICS-REHRL 328

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  170 bits (432), Expect = 1e-50
 Identities = 56/281 (19%), Positives = 107/281 (38%), Gaps = 32/281 (11%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
                +    K+G G+FG+ + C +   G  +A K  SK+ L    D ++  RE+     
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAV 66

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVG 211
           L  H ++V    A+ +   + I  E C GG L D I +      ++ E +  +L   +  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI----------------DFGLSVFFKP 255
            +   HS+ ++H D+KP N  +       +                    D G       
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 256 GQIFTDVVGSPYYVAPEVLLKH--YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV 313
            Q+     G   ++A EVL ++  + P+AD++   + +       P      Q   +  +
Sbjct: 187 PQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240

Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +G +          S    +L++ M+   P  R +A  ++
Sbjct: 241 RQGRLPRIPQVL---SQEFTELLKVMIHPDPERRPSAMALV 278

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  163 bits (415), Expect = 1e-47
 Identities = 83/255 (32%), Positives = 129/255 (50%), Gaps = 24/255 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H  +  +K
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 71

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLGVM 222
            A++    +  VME   GGELF  + +   ++E +A    AE    IV  +E  HS  V+
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE----IVSALEYLHSRDVV 127

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH- 277
           +RD+K EN +L   D D  +K  DFGL    K G      +    G+P Y+APEVL  + 
Sbjct: 128 YRDIKLENLML---DKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YG   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F   P   +S  AK L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---P-RTLSPEAKSLLA 237

Query: 338 KMLCSQPSERLTAHE 352
            +L   P +RL    
Sbjct: 238 GLLKKDPKQRLGGGP 252

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  163 bits (415), Expect = 1e-47
 Identities = 75/255 (29%), Positives = 123/255 (48%), Gaps = 23/255 (9%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H  +  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLGVM 222
             ++    +  VME   GG+L   I     +   +A    AE   II+G ++  HS G++
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE---IILG-LQFLHSKGIV 140

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL-KH 277
           +RDLK +N LL   D D  +K  DFG+    K   +         G+P Y+APE+LL + 
Sbjct: 141 YRDLKLDNILL---DKDGHIKIADFGMC---KENMLGDAKTNTFCGTPDYIAPEILLGQK 194

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           Y    D W+ GV+LY +L G  PF  + ++ +F ++   +  +   P   +   AKDL+ 
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---P-RWLEKEAKDLLV 250

Query: 338 KMLCSQPSERLTAHE 352
           K+   +P +RL    
Sbjct: 251 KLFVREPEKRLGVRG 265

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  163 bits (415), Expect = 2e-47
 Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 27/257 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     T   +A K + K  +I  +DVE    E +++        +  + 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
             +   D L    VME   GG+L   I Q G + E  A    AE    I   +    S G
Sbjct: 88  SCFQTMDRLY--FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----IAIGLFFLQSKG 141

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLK 276
           +++RDLK +N +L   D +  +K  DFG+    K             G+P Y+APE++  
Sbjct: 142 IIYRDLKLDNVML---DSEGHIKIADFGMC---KENIWDGVTTKTFCGTPDYIAPEIIAY 195

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             YG   D W  GV+LY +L+G  PF  E +  +F ++++ ++ +   P   +S  A  +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAI 251

Query: 336 IRKMLCSQPSERLTAHE 352
            + ++   P +RL    
Sbjct: 252 CKGLMTKHPGKRLGCGP 268

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  163 bits (414), Expect = 3e-47
 Identities = 77/257 (29%), Positives = 120/257 (46%), Gaps = 27/257 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG   L     TG  +A K + K  ++  +DVE    E +I+     H  +  + 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
             +   D L    VME   GG+L   I +   + E +A    AE    I+  +   H  G
Sbjct: 91  CCFQTPDRLF--FVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----IISALMFLHDKG 144

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLK 276
           +++RDLK +N LL   D +   K  DFG+    K G           G+P Y+APE+L +
Sbjct: 145 IIYRDLKLDNVLL---DHEGHCKLADFGMC---KEGICNGVTTATFCGTPDYIAPEILQE 198

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             YGP  D W  GV+LY +L G  PF AE +  +F+A+L   + +   P   + + A  +
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---P-TWLHEDATGI 254

Query: 336 IRKMLCSQPSERLTAHE 352
           ++  +   P+ RL +  
Sbjct: 255 LKSFMTKNPTMRLGSLT 271

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  160 bits (407), Expect = 4e-47
 Identities = 57/259 (22%), Positives = 112/259 (43%), Gaps = 14/259 (5%)

Query: 103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNI 162
              ++G+G F T Y   +  T +E A   +  RKL ++ + +  + E +++  L  H NI
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNI 87

Query: 163 VTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           V    ++E ++    C+ +V EL   G L   + +      +      R I+  ++  H+
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 219 LG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK 276
               ++HRDLK +N  +       S+K  D GL+   +       V+G+P ++APE+  +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYEE 204

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDSAKDL 335
            Y    DV+  G+ +  + +   P+        I+  V  G     +    +     K++
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEI 262

Query: 336 IRKMLCSQPSERLTAHEVL 354
           I   +     ER +  ++L
Sbjct: 263 IEGCIRQNKDERYSIKDLL 281

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  168 bits (426), Expect = 7e-47
 Identities = 84/356 (23%), Positives = 143/356 (40%), Gaps = 24/356 (6%)

Query: 4   TCRGSFTGKLYQGYSQPEDHSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKD 63
           T R  F G L  G S+ +    +      S      ++ P        ++E  ++  +  
Sbjct: 251 TSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAK 310

Query: 64  NSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIAT 123
                 +P +K        DN            + D +     LG+G FG   L     T
Sbjct: 311 IGQGTKAPEEKTANTISKFDNNG----NRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGT 365

Query: 124 GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY--EDSLCVHIVMEL 181
              +A K + K  +I  +DVE    E +++        +  +   +   D L    VME 
Sbjct: 366 DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY--FVMEY 423

Query: 182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS 241
             GG+L   I Q G + E  A      I   +    S G+++RDLK +N +L   D +  
Sbjct: 424 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGH 480

Query: 242 LKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS 296
           +K  DFG+    K             G+P Y+APE++  + YG   D W  GV+LY +L+
Sbjct: 481 IKIADFGMC---KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537

Query: 297 GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHE 352
           G  PF  E +  +F ++++ ++ +   P   +S  A  + + ++   P +RL    
Sbjct: 538 GQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMTKHPGKRLGCGP 589

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  166 bits (421), Expect = 1e-46
 Identities = 79/257 (30%), Positives = 122/257 (47%), Gaps = 23/257 (8%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG    C   ATG  +ACK + K+++  R+       E QI+      + +V++ 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-EKVNSRFVVSLA 250

Query: 167 GAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKA----AELTRIIVGVVEACHSLG 220
            AYE    + +V+ L  GG+L   I   G   + E +A    AE   I  G +E  H   
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE---ICCG-LEDLHRER 306

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   DD   ++  D GL+V    GQ     VG+  Y+APEV+  + Y 
Sbjct: 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363

Query: 280 PEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
              D W  G +LY +++G  PF        ++ +   V +   ++        S  A+ L
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER----FSPQARSL 419

Query: 336 IRKMLCSQPSERLTAHE 352
             ++LC  P+ERL    
Sbjct: 420 CSQLLCKDPAERLGCRG 436

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  162 bits (411), Expect = 5e-46
 Identities = 86/315 (27%), Positives = 146/315 (46%), Gaps = 30/315 (9%)

Query: 53  QEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG-----RKL 107
           +E++       +   + + ++ D       DN     +       +   T+      + L
Sbjct: 97  EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL 156

Query: 108 GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKG 167
           G+G FG   L  E ATG  +A K + K  ++++++V     E +++ + + H  +  +K 
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKY 215

Query: 168 AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHS-LGVM 222
           +++    +  VME   GGELF  + +   +SE +A    AE    IV  ++  HS   V+
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE----IVSALDYLHSEKNVV 271

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH- 277
           +RDLK EN +L   D D  +K  DFGL    K G      +    G+P Y+APEVL  + 
Sbjct: 272 YRDLKLENLML---DKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPEVLEDND 325

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           YG   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F   P   +   AK L+ 
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---P-RTLGPEAKSLLS 381

Query: 338 KMLCSQPSERLTAHE 352
            +L   P +RL    
Sbjct: 382 GLLKKDPKQRLGGGS 396

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  160 bits (406), Expect = 5e-46
 Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 27/257 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G FG   L    A  + +A K + K+ ++ +++ + +  E  ++     H  +V + 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSLG 220
            ++   D L    V++   GGELF  + +   + E +A    AE    I   +   HSL 
Sbjct: 106 FSFQTADKLY--FVLDYINGGELFYHLQRERCFLEPRARFYAAE----IASALGYLHSLN 159

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLK 276
           +++RDLKPEN LL   D    +   DFGL    K             G+P Y+APEVL K
Sbjct: 160 IVYRDLKPENILL---DSQGHIVLTDFGLC---KENIEHNSTTSTFCGTPEYLAPEVLHK 213

Query: 277 H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
             Y    D W  G +LY +L G+PPF++     ++D +L   +       P I++SA+ L
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---K-PNITNSARHL 269

Query: 336 IRKMLCSQPSERLTAHE 352
           +  +L    ++RL A +
Sbjct: 270 LEGLLQKDRTKRLGAKD 286

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  160 bits (406), Expect = 1e-45
 Identities = 74/320 (23%), Positives = 128/320 (40%), Gaps = 33/320 (10%)

Query: 54  EFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG-----RKLG 108
            +   +   D   P          M  GI+ +   +   ++        L      R +G
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61

Query: 109 QGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA 168
           +G +    L     T   +A + + K  +   ED++ V+ E  +    + H  +V +   
Sbjct: 62  RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121

Query: 169 Y--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDL 226
           +  E  L    V+E   GG+L   + ++    E  A   +  I   +   H  G+++RDL
Sbjct: 122 FQTESRLF--FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV----GSPYYVAPEVLLKH-YGPE 281
           K +N LL   D +  +K  D+G+    K G    D      G+P Y+APE+L    YG  
Sbjct: 180 KLDNVLL---DSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233

Query: 282 ADVWTAGVILYILLSGVPPFW---------AETQQGIFDAVLKGHIDFESDPWPLISDSA 332
            D W  GV+++ +++G  PF            T+  +F  +L+  I     P   +S  A
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSVKA 289

Query: 333 KDLIRKMLCSQPSERLTAHE 352
             +++  L   P ERL  H 
Sbjct: 290 ASVLKSFLNKDPKERLGCHP 309

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  162 bits (412), Expect = 1e-45
 Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 30/262 (11%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           LG+G FG  + C   ATG  +ACK ++K++L  R+  +    E +I+      + IV++ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL-AKVHSRFIVSLA 251

Query: 167 GAYE--DSLCVHIVMELCAGGELFDRIIQRGH----YSERKA----AELTRIIVGVVEAC 216
            A+E    LC  +VM +  GG++   I         + E +A    A+   I+ G +E  
Sbjct: 252 YAFETKTDLC--LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ---IVSG-LEHL 305

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-VVGSPYYVAPEVLL 275
           H   +++RDLKPEN LL   DDD +++  D GL+V  K GQ  T    G+P ++APE+LL
Sbjct: 306 HQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPLISD 330
            + Y    D +  GV LY +++   PF A       + +   VL+  + +        S 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK----FSP 418

Query: 331 SAKDLIRKMLCSQPSERLTAHE 352
           ++KD    +L   P +RL   +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRD 440

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  158 bits (401), Expect = 2e-45
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 28/262 (10%)

Query: 107 LGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK 166
           +G+G +    L     T   +A K + K  +   ED++ V+ E  +    + H  +V + 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 167 GAY--EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHR 224
             +  E  L    V+E   GG+L   + ++    E  A   +  I   +   H  G+++R
Sbjct: 77  SCFQTESRLF--FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEVLLKH-YG 279
           DLK +N LL   D +  +K  D+G+    K G    D      G+P Y+APE+L    YG
Sbjct: 135 DLKLDNVLL---DSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 188

Query: 280 PEADVWTAGVILYILLSGVPPFW---------AETQQGIFDAVLKGHIDFESDPWPLISD 330
              D W  GV+++ +++G  PF            T+  +F  +L+  I     P   +S 
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---P-RSLSV 244

Query: 331 SAKDLIRKMLCSQPSERLTAHE 352
            A  +++  L   P ERL  H 
Sbjct: 245 KAASVLKSFLNKDPKERLGCHP 266

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  156 bits (398), Expect = 3e-45
 Identities = 74/255 (29%), Positives = 127/255 (49%), Gaps = 22/255 (8%)

Query: 107 LGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
           LGQG FG  +L  +I+       +A K + K  L  R+ V   + E  I+     H  IV
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVE-VNHPFIV 89

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHSL 219
            +  A++    ++++++   GG+LF R+ +   ++E       AE    +   ++  HSL
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE----LALALDHLHSL 145

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
           G+++RDLKPEN LL   D++  +K  DFGLS       +      G+  Y+APEV+ +  
Sbjct: 146 GIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR 337
           +   AD W+ GV+++ +L+G  PF  + ++     +LK  +     P   +S  A+ L+R
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLR 258

Query: 338 KMLCSQPSERLTAHE 352
            +    P+ RL A  
Sbjct: 259 MLFKRNPANRLGAGP 273

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  155 bits (395), Expect = 8e-45
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 22/256 (8%)

Query: 107 LGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHLAGHKNI 162
           LG+G +G  +   ++    TG  FA K + K  ++   +D    + E  I+     H  I
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-VKHPFI 83

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEACHS 218
           V +  A++    +++++E  +GGELF ++ + G + E  A    AE   I + +    H 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE---ISMAL-GHLHQ 139

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLKH 277
            G+++RDLKPEN +L   +    +K  DFGL       G +     G+  Y+APE+L++ 
Sbjct: 140 KGIIYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196

Query: 278 -YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            +    D W+ G ++Y +L+G PPF  E ++   D +LK  ++    P P ++  A+DL+
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---P-PYLTQEARDLL 252

Query: 337 RKMLCSQPSERLTAHE 352
           +K+L    + RL A  
Sbjct: 253 KKLLKRNAASRLGAGP 268

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  155 bits (393), Expect = 3e-44
 Identities = 81/321 (25%), Positives = 146/321 (45%), Gaps = 29/321 (9%)

Query: 45  LNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLG 104
           +       +E    +     ++       +  +  +            +   I + + L 
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-FELL 59

Query: 105 RKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISR-EDVEDVRREIQIMHHLAGHK 160
           + LG G +G  +L  +I+   TG  +A K + K  ++ + +  E  R E Q++ H+    
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA----AELTRIIVGVVEAC 216
            +VT+  A++    +H++++   GGELF  + QR  ++E +      E    IV  +E  
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----IVLALEHL 175

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--VFFKPGQIFTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS        +   D  G+  Y+AP+++
Sbjct: 176 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232

Query: 275 LKH---YGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL 327
                 +    D W+ GV++Y LL+G  PF  +    +Q  I   +LK    +   P   
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---P-QE 288

Query: 328 ISDSAKDLIRKMLCSQPSERL 348
           +S  AKDLI+++L   P +RL
Sbjct: 289 MSALAKDLIQRLLMKDPKKRL 309

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  153 bits (389), Expect = 7e-44
 Identities = 67/340 (19%), Positives = 129/340 (37%), Gaps = 44/340 (12%)

Query: 24  SNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGID 83
           S +S +  +       +S+ S   Q+L  +    E          +    ++ +      
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEV------ 57

Query: 84  NQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV 143
                             T   ++G+G FG  +   +  TG + A K +          +
Sbjct: 58  ---------------HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV---------RL 93

Query: 144 EDVR-REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA 202
           E  R  E+     L+    IV + GA  +   V+I MEL  GG L   I Q G   E +A
Sbjct: 94  EVFRVEELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT-- 260
                  +  +E  H+  ++H D+K +N +L++ D        DFG ++  +P  +    
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADN-VLLSSDGS-RAALCDFGHALCLQPDGLGKSL 210

Query: 261 ----DVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVL 314
                + G+  ++APEV++      + D+W++  ++  +L+G  P+    +         
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270

Query: 315 KGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +     E  P    +      I++ L  +P  R +A E+ 
Sbjct: 271 EPPPIREIPPS--CAPLTAQAIQEGLRKEPVHRASAMELR 308

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  151 bits (383), Expect = 2e-43
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 26/264 (9%)

Query: 104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIV 163
              LG+G +G  Y   +++  +  A K I           + +  EI +  HL  HKNIV
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLK-HKNIV 82

Query: 164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----YSERKAAELTRIIVGVVEACHSL 219
              G++ ++  + I ME   GG L   +++        +E+     T+ I+  ++  H  
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
            ++HRD+K +N L+        LK  DFG S              G+  Y+APE++ K  
Sbjct: 142 QIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 278 --YGPEADVWTAGVILYILLSGVPPFW--AETQQGIFDAVLKGHIDFESDPWPL---ISD 330
             YG  AD+W+ G  +  + +G PPF+   E Q  +F       +        +   +S 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF------KVGMFKVHPEIPESMSA 253

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
            AK  I K     P +R  A+++L
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLL 277

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  150 bits (381), Expect = 4e-42
 Identities = 83/341 (24%), Positives = 141/341 (41%), Gaps = 62/341 (18%)

Query: 56  SKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
           S        +  +++P    N + +          G   +     YT  + +G G FG  
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIK-----VLASDGKTGEQREIAYTNCKVIGNGSFGVV 56

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK------GAY 169
           +    + +  E A K +        +D     RE+QIM  +  H N+V +K      G  
Sbjct: 57  FQAKLVESD-EVAIKKV-------LQDKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDK 107

Query: 170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--------VEACHSLGV 221
           +D + +++V+E     E   R  +  HY++ K   +  +++ +        +   HS+G+
Sbjct: 108 KDEVFLNLVLEYV--PETVYRASR--HYAKLKQ-TMPMLLIKLYMYQLLRSLAYIHSIGI 162

Query: 222 MHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYG 279
            HRD+KP+N LL++      LK IDFG +     G+     + S YY APE++    +Y 
Sbjct: 163 CHRDIKPQN-LLLDPPSG-VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYT 220

Query: 280 PEADVWTAGVILYILLSGVPPFWAET--QQ--GIFD-----------AVLKGHIDF---- 320
              D+W+ G ++  L+ G P F  E+   Q   I              +   +++     
Sbjct: 221 TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQ 280

Query: 321 -ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
               P+     P     A DLI ++L   PS RLTA E LC
Sbjct: 281 IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  148 bits (375), Expect = 6e-42
 Identities = 62/326 (19%), Positives = 108/326 (33%), Gaps = 81/326 (24%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRK----------------- 136
           +   + +G+G FG  +               I    + +++ K                 
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 137 -------------------------------LISREDVEDVRREIQIMHHLAGHKNIVTI 165
                                          L S   ++    +I+ M   +  KN V  
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFS-TKNTVGQ 126

Query: 166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA---CHSLGVM 222
                  + ++I M+LC    L D + +R    +R+      I + + EA    HS G+M
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLS-------------VFFKPGQIFTDVVGSPYYV 269
           HRDLKP N        D  +K  DFGL                       T  VG+  Y+
Sbjct: 187 HRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           +PE +   +Y  + D+++ G+IL+ LL          +  I   V           +   
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKF---PLLFTQK 298

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVL 354
                 +++ ML   P+ER  A +++
Sbjct: 299 YPQEHMMVQDMLSPSPTERPEATDII 324

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  145 bits (369), Expect = 3e-41
 Identities = 78/308 (25%), Positives = 134/308 (43%), Gaps = 27/308 (8%)

Query: 58  ENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGH--KTDNIRDLYTLGRKLGQGQFGTT 115
            +    +S   +               Q    L       + R L     K+G+G  G  
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIV 61

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
            L  E  +G + A K +    L  ++  E +  E+ IM     H N+V +  +Y     +
Sbjct: 62  CLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEEL 117

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
            ++ME   GG L D I+ +   +E + A +   ++  +   H+ GV+HRD+K ++ LL  
Sbjct: 118 WVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL-- 174

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTD------VVGSPYYVAPEVLL-KHYGPEADVWTAG 288
              D  +K  DFG        QI  D      +VG+PY++APEV+    Y  E D+W+ G
Sbjct: 175 -TLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG 228

Query: 289 VILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE-SDPWPLISDSAKDLIRKMLCSQPSE 346
           +++  ++ G PP+++++  Q +           + S      S   +D + +ML   P E
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV---SPVLRDFLERMLVRDPQE 285

Query: 347 RLTAHEVL 354
           R TA E+L
Sbjct: 286 RATAQELL 293

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  144 bits (366), Expect = 6e-41
 Identities = 81/273 (29%), Positives = 129/273 (47%), Gaps = 31/273 (11%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
             + +  YT   K+GQG  GT Y   ++ATG E A + +    L  +   E +  EI +M
Sbjct: 15  VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVM 71

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                + NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +
Sbjct: 72  RENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQAL 129

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD------VVGSPY 267
           E  HS  V+HRD+K +N LL     D S+K  DFG        QI  +      +VG+PY
Sbjct: 130 EFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPY 181

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP- 324
           ++APEV+  K YGP+ D+W+ G++   ++ G PP+  E   + ++       I     P 
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTPE 235

Query: 325 ---WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                 +S   +D + + L     +R +A E+L
Sbjct: 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  144 bits (366), Expect = 8e-41
 Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 38/268 (14%)

Query: 102 TLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            +   +G+G FG        A     + A K     ++ S  + +    E++ +  +  H
Sbjct: 11  EVEEVVGRGAFGVVCK----AKWRAKDVAIK-----QIESESERKAFIVELRQLSRVN-H 60

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC--- 216
            NIV + GA  + +C  +VME   GG L++ +          AA      +   +     
Sbjct: 61  PNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 217 HSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           HS+    ++HRDLKP N LLV       LK  DFG +   +     T+  GS  ++APEV
Sbjct: 119 HSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEV 174

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFW--AETQQGIFDAVLKGHIDFESDPWPLISD 330
               +Y  + DV++ G+IL+ +++   PF         I  AV  G         P +  
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-------RPPLIK 227

Query: 331 SA----KDLIRKMLCSQPSERLTAHEVL 354
           +     + L+ +     PS+R +  E++
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  143 bits (362), Expect = 7e-40
 Identities = 70/324 (21%), Positives = 124/324 (38%), Gaps = 28/324 (8%)

Query: 38  SDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI 97
           S Y     +   + + E        D            +     +  +         D+ 
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFK---------DDP 52

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
             L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ +  L 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H N +  +G Y       +VME C G       + +    E + A +T   +  +   H
Sbjct: 113 -HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--TDVVGSPYYVAPEVLL 275
           S  ++HRD+K  N LL    +   +K  DFG +       +      VG+PY++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILL---SEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVIL 223

Query: 276 ----KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISD 330
                 Y  + DVW+ G+    L    PP +       ++          +S  W   S+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SE 280

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             ++ +   L   P +R T+  +L
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLL 304

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (354), Expect = 2e-39
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR----EDVEDVRREIQIMHHLA 157
              +++G+G FG  +    +      A KS+            E  ++ +RE+ IM +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G   +     +VME    G+L+ R++ + H    K +   R+++ +     
Sbjct: 82  -HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIE 136

Query: 217 --HSLG--VMHRDLKPENFLLVNKD--DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVA 270
              +    ++HRDL+  N  L + D       K  DFGLS         + ++G+  ++A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMA 194

Query: 271 PEVLL---KHYGPEADVWTAGVILYILLSGVPPF 301
           PE +    + Y  +AD ++  +ILY +L+G  PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  143 bits (362), Expect = 3e-39
 Identities = 88/351 (25%), Positives = 137/351 (39%), Gaps = 72/351 (20%)

Query: 57  KENPKKDNSAPRISPSKKDNIMRRGIDNQTYYV-----LGHKTDNIRDL-YTLGRKLGQG 110
           +     ++  P   PS   ++      + +         G   D  +++ YT  + +G G
Sbjct: 6   RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65

Query: 111 QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIK---- 166
            FG  Y      +G   A K +        +D     RE+QIM  L  H NIV ++    
Sbjct: 66  SFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKL-DHCNIVRLRYFFY 117

Query: 167 --GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--------VEAC 216
             G  +D + +++V++     E   R+ +  HYS  K   L  I V +        +   
Sbjct: 118 SSGEKKDEVYLNLVLDYV--PETVYRVAR--HYSRAKQ-TLPVIYVKLYMYQLFRSLAYI 172

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL- 275
           HS G+ HRD+KP+N LL++ D    LK  DFG +     G+     + S YY APE++  
Sbjct: 173 HSFGICHRDIKPQN-LLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQG---------IFD-----------AVL 314
              Y    DVW+AG +L  LL G P F      G         I              + 
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIF-----PGDSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 315 KGHIDF-----ESDPW-----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
             + +F     ++ PW     P     A  L  ++L   P+ RLT  E   
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  138 bits (350), Expect = 1e-38
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 36/275 (13%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
             +  +L+T   K+G+G FG  +   +  T    A K I   +  + +++ED+++EI ++
Sbjct: 17  KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVL 74

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
                   +    G+Y     + I+ME   GG   D +++ G   E + A + R I+  +
Sbjct: 75  SQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGL 132

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF------TDVVGSPY 267
           +  HS   +HRD+K  N LL    +   +K  DFG++     GQ+          VG+P+
Sbjct: 133 DYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPF 184

Query: 268 YVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAET-QQGIFD------AVLKGHID 319
           ++APEV+ +  Y  +AD+W+ G+    L  G PP       + +F         L+G+  
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN-- 242

Query: 320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                +   S   K+ +   L  +PS R TA E+L
Sbjct: 243 -----Y---SKPLKEFVEACLNKEPSFRPTAKELL 269

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  137 bits (348), Expect = 4e-38
 Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 36/277 (12%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            ++ L   +G G +G  Y    + TG   A K +     ++ ++ E++++EI ++   + 
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 159 HKNIVTIKGAYEDSLCVH------IVMELCAGGELFD--RIIQRGHYSERKAAELTRIIV 210
           H+NI T  GA+             +VME C  G + D  +  +     E   A + R I+
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI------FTDVVG 264
             +   H   V+HRD+K +N LL    ++  +K +DFG+S      Q+          +G
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVS-----AQLDRTVGRRNTFIG 191

Query: 265 SPYYVAPEVLLKH------YGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGH 317
           +PY++APEV+         Y  ++D+W+ G+    +  G PP       + +F       
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
              +S  W   S   +  I   L    S+R    +++
Sbjct: 252 PRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLM 285

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  136 bits (345), Expect = 8e-38
 Identities = 70/284 (24%), Positives = 117/284 (41%), Gaps = 38/284 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           RD Y L   +G G               + A K I+  K   +  ++++ +EIQ M    
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCH 71

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV--EA 215
            H NIV+   ++     + +VM+L +GG + D I       E K+  L    +  +  E 
Sbjct: 72  -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 216 C------HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-------- 261
                  H  G +HRD+K  N LL    +D S++  DFG+S       + T         
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVS-----AFLATGGDITRNKV 182

Query: 262 ---VVGSPYYVAPEVL--LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG 316
               VG+P ++APEV+  ++ Y  +AD+W+ G+    L +G  P+       +    L+ 
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242

Query: 317 ------HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                     + +       S + +I   L   P +R TA E+L
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  137 bits (347), Expect = 9e-38
 Identities = 73/302 (24%), Positives = 132/302 (43%), Gaps = 57/302 (18%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
             +D Y L RKLG+G++   +    I    +     +   K++     + ++REI+I+ +
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVV---V---KILKPVKKKKIKREIKILEN 86

Query: 156 LAGHKNIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           L G  NI+T+        +   +L    V         F ++ Q    ++         I
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNT-----DFKQLYQT--LTDYDIRFYMYEI 139

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  ++ CHS+G+MHRD+KP N ++++ +    L+ ID+GL+ F+ PGQ +   V S Y+ 
Sbjct: 140 LKALDYCHSMGIMHRDVKPHN-VMIDHEH-RKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA---ETQQ-----------GIFDAV 313
            PE+L+  + Y    D+W+ G +L  ++    PF+       Q            ++D +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257

Query: 314 LKGHIDFESD-----------PW---------PLISDSAKDLIRKMLCSQPSERLTAHEV 353
            K +I+ +              W          L+S  A D + K+L      RLTA E 
Sbjct: 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317

Query: 354 LC 355
           + 
Sbjct: 318 ME 319

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  134 bits (340), Expect = 5e-37
 Identities = 70/280 (25%), Positives = 120/280 (42%), Gaps = 46/280 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            +++ +  +LG G FG  Y      TG   A K I      S E++ED   EI+I+    
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCD 74

Query: 158 GHKNIVTIKGAY--EDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGVVE 214
            H  IV + GAY  +  L   I++E C GG +   +++     +E +   + R ++  + 
Sbjct: 75  -HPYIVKLLGAYYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF------TDVVGSPYY 268
             HS  ++HRDLK  N L+     +  ++  DFG+S      +           +G+PY+
Sbjct: 132 FLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYW 183

Query: 269 VAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE 321
           +APEV++        Y  +AD+W+ G+ L  +    PP       + +        I   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKS 237

Query: 322 SDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             P       W   S   +D ++  L   P  R +A ++L
Sbjct: 238 DPPTLLTPSKW---SVEFRDFLKIALDKNPETRPSAAQLL 274

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  134 bits (339), Expect = 8e-37
 Identities = 69/281 (24%), Positives = 114/281 (40%), Gaps = 43/281 (15%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            I DL  LG  +G G  G  +      TG   A K +  R+  ++E+ + +  ++ ++  
Sbjct: 23  EINDLENLGE-MGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLK 79

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
                 IV   G +  +  V I MEL        +   +G   ER   ++T  IV  +  
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139

Query: 216 CHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----TDVVGSPYYV 269
                GV+HRD+KP N LL   D+   +K  DFG+S     G++          G   Y+
Sbjct: 140 LKEKHGVIHRDVKPSNILL---DERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYM 191

Query: 270 APEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDA----------V 313
           APE +         Y   ADVW+ G+ L  L +G  P+  +  +  F+           +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPL 249

Query: 314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           L GH+ F        S   +  ++  L     +R   +++L
Sbjct: 250 LPGHMGF--------SGDFQSFVKDCLTKDHRKRPKYNKLL 282

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  133 bits (337), Expect = 1e-36
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 27/271 (9%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           T    +++ +  KLG+G +G+ Y      TG   A K +         D++++ +EI IM
Sbjct: 24  TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-----VESDLQEIIKEISIM 78

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY-SERKAAELTRIIVGV 212
                  ++V   G+Y  +  + IVME C  G + D I  R    +E + A + +  +  
Sbjct: 79  QQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF------TDVVGSP 266
           +E  H +  +HRD+K  N LL   + +   K  DFG++     GQ+         V+G+P
Sbjct: 138 LEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVA-----GQLTDTMAKRNTVIGTP 189

Query: 267 YYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFE-SD 323
           +++APEV+ +  Y   AD+W+ G+    +  G PP+      + IF         F   +
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPE 249

Query: 324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            W   SD+  D +++ L   P +R TA ++L
Sbjct: 250 LW---SDNFTDFVKQCLVKSPEQRATATQLL 277

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  133 bits (336), Expect = 2e-36
 Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 28/259 (10%)

Query: 102 TLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
            +  K+G G FGT +     A   G + A K + ++     E V +  RE+ IM  L  H
Sbjct: 40  NIKEKIGAGSFGTVHR----AEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-H 93

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC--- 216
            NIV   GA      + IV E  + G L+  + + G   +        +   V +     
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 217 HSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEV 273
           H+    ++HR+LK  N L+   D  +++K  DFGLS +            G+P ++APEV
Sbjct: 154 HNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           L  +    ++DV++ GVIL+ L +   P+       +  AV              I  + 
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------LEIPRNL 264

Query: 333 ----KDLIRKMLCSQPSER 347
                 +I     ++P +R
Sbjct: 265 NPQVAAIIEGCWTNEPWKR 283

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  131 bits (331), Expect = 1e-35
 Identities = 76/290 (26%), Positives = 118/290 (40%), Gaps = 43/290 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHL 156
           + Y    K+G+G +G  + C    TG   A K          + V      REI+++  L
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQL 59

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGVVE 214
             H N+V +   +     +H+V E C        DR   +    E     +T   +  V 
Sbjct: 60  K-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVN 116

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAPEV 273
            CH    +HRD+KPEN +L+ K     +K  DFG + +   P   + D V + +Y +PE+
Sbjct: 117 FCHKHNCIHRDVKPEN-ILITKHSV--IKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 274 LL--KHYGPEADVWTAGVILYILLSGVPPF--WAETQQ--GIF-------DAVLKGHIDF 320
           L+    YGP  DVW  G +   LLSGVP +   ++  Q   I            +     
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233

Query: 321 E----------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +                   +P IS  A  L++  L   P+ERLT  ++L
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  131 bits (331), Expect = 2e-35
 Identities = 82/290 (28%), Positives = 124/290 (42%), Gaps = 43/290 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIM 153
             Y     LG+GQF T Y   +  T    A K I   KL  R + +D       REI+++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVG 211
             L+ H NI+ +  A+     + +V +        +          S  KA     + + 
Sbjct: 67  QELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQ 123

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
            +E  H   ++HRDLKP N LL   D++  LK  DFGL+  F  P + +T  V + +Y A
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180

Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET--QQ--GIFDAV----------- 313
           PE+L   + YG   D+W  G IL  LL  VP    ++   Q   IF+ +           
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240

Query: 314 --LKGHIDFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
             L  ++ F+S P       +    D   DLI+ +    P  R+TA + L
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  129 bits (326), Expect = 4e-35
 Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 35/264 (13%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           T+G+++G G FGT Y       G    + A K +      + + ++  + E+ ++     
Sbjct: 27  TVGQRIGSGSFGTVYK------GKWHGDVAVKML-NVTAPTPQQLQAFKNEVGVLRKTR- 78

Query: 159 HKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
           H NI+   G      L   IV + C G  L+  +    H SE K      I +    A  
Sbjct: 79  HVNILLFMGYSTAPQLA--IVTQWCEGSSLYHHL----HASETKFEMKKLIDIARQTARG 132

Query: 217 ----HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS---VFFKPGQIFTDVVGSPYYV 269
               H+  ++HRDLK  N  L    +D ++K  DFGL+     +     F  + GS  ++
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 270 APEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDP 324
           APEV+       Y  ++DV+  G++LY L++G  P+     +  I + V +G +  +   
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

Query: 325 WPLISDSA-KDLIRKMLCSQPSER 347
                    K L+ + L  +  ER
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDER 273

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 7e-35
 Identities = 60/282 (21%), Positives = 107/282 (37%), Gaps = 48/282 (17%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
            +G  +G+G+FG  Y       G    E A + I   +  + + ++  +RE+        
Sbjct: 36  EIGELIGKGRFGQVYH------GRWHGEVAIRLI-DIERDNEDQLKAFKREVMAYRQTR- 87

Query: 159 HKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEA 215
           H+N+V   GA      L   I+  LC G  L+  +   +      K  ++ + IV  +  
Sbjct: 88  HENVVLFMGACMSPPHLA--IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI------FTDVVGSPYYV 269
            H+ G++H+DLK +N       D+  +   DFGL       Q            G   ++
Sbjct: 146 LHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201

Query: 270 APEVL----------LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID 319
           APE++             +   +DV+  G I Y L +   PF  +  + I   +  G   
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK- 260

Query: 320 FESDPWPLISDSA-----KDLIRKMLCSQPSERLTAHEVLCM 356
                 P +S         D++      +  ER T  +++ M
Sbjct: 261 ------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  128 bits (324), Expect = 1e-34
 Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 40/279 (14%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           DL  LG ++G+G +G+        +G   A K I  R  +  ++ + +  ++ ++   + 
Sbjct: 23  DLKDLG-EIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA---AELTRIIVGVVEA 215
              IV   GA        I MEL +    FD+  +  +           L +I +  V+A
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 216 CHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----TDVVGSP 266
            + L     ++HRD+KP N +L+++  +   K  DFG+S     GQ+      T   G  
Sbjct: 138 LNHLKENLKIIHRDIKPSN-ILLDRSGNI--KLCDFGIS-----GQLVDSIAKTRDAGCR 189

Query: 267 YYVAPEVL-----LKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--- 318
            Y+APE +      + Y   +DVW+ G+ LY L +G  P+       +FD +    +   
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLT--QVVKG 245

Query: 319 ---DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                 +      S S  + +   L    S+R    E+L
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  126 bits (320), Expect = 2e-34
 Identities = 39/219 (17%), Positives = 83/219 (37%), Gaps = 28/219 (12%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIM 153
           + + L     KL +   G  +         G +   K +  R   +R+   D   E   +
Sbjct: 8   DFKQL-NFLTKLNENHSGELWK----GRWQGNDIVVKVLKVRDWSTRK-SRDFNEECPRL 61

Query: 154 HHLAGHKNIVTIKGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
              + H N++ + GA +     H  ++      G L++ ++  G       ++  +  + 
Sbjct: 62  RIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALD 119

Query: 212 VVEAC---HSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
           +       H+L   +    L   + ++   D+D + +     +   F+        + +P
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQ----SPGRMYAP 172

Query: 267 YYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPF 301
            +VAPE L K         AD+W+  V+L+ L++   PF
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  128 bits (323), Expect = 2e-34
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 47/292 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
           + Y     +G+G +G    C    TG   A K     K +  +D + V+    REI+++ 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLK 79

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVGV 212
            L  H+N+V +    +     ++V E       +  +          +   +    I+  
Sbjct: 80  QLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIING 136

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVAP 271
           +  CHS  ++HRD+KPEN +LV++     +K  DFG +     PG+++ D V + +Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPEN-ILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWA--ETQQ--GIFDAV------------ 313
           E+L+    YG   DVW  G ++  +  G P F    +  Q   I   +            
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253

Query: 314 -LKGHIDFESDPW----------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                                  P +S+   DL +K L   P +R    E+L
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (319), Expect = 3e-34
 Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 42/282 (14%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
               DL  +   LG+G +G       + +G   A K I  R  ++ ++ + +  ++ I  
Sbjct: 4   VKADDLEPIME-LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISM 60

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE--LTRIIVGV 212
                   VT  GA      V I MEL       D+  ++     +   E  L +I V +
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 213 VEACHSL----GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-----TDVV 263
           V+A   L     V+HRD+KP N +L+N       K  DFG+S     G +          
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSN-VLINALGQV--KMCDFGIS-----GYLVDDVAKDIDA 170

Query: 264 GSPYYVAPEVLL-----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI 318
           G   Y+APE +      K Y  ++D+W+ G+ +  L     P+  ++    F  +    +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLK--QV 226

Query: 319 ------DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                    +D +   S    D   + L     ER T  E++
Sbjct: 227 VEEPSPQLPADKF---SAEFVDFTSQCLKKNSKERPTYPELM 265

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  127 bits (321), Expect = 5e-34
 Identities = 77/294 (26%), Positives = 120/294 (40%), Gaps = 48/294 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           D Y    KLG+G +G  Y   +  T    A K I       R + E+        RE+ +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-------RLEHEEEGVPGTAIREVSL 86

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +  L  H+NI+ +K     +  +H++ E     +L   + +    S R        ++  
Sbjct: 87  LKELQ-HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLING 144

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFS---LKAIDFGLSVFF-KPGQIFTDVVGSPYY 268
           V  CHS   +HRDLKP+N LL++  D      LK  DFGL+  F  P + FT  + + +Y
Sbjct: 145 VNFCHSRRCLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203

Query: 269 VAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVLK 315
             PE+LL  +HY    D+W+   I   +L   P F  +++      IF       D    
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263

Query: 316 GH---------------IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           G                   +     L+ D   DL+  ML   P +R++A   L
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (321), Expect = 7e-34
 Identities = 67/302 (22%), Positives = 113/302 (37%), Gaps = 57/302 (18%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG 158
           D +    +LG G  G  +  +   +G+  A K I     I       + RE+Q++H    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI--HLEIKPAIRNQIIRELQVLHECN- 89

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              IV   GA+     + I ME   GG L   + + G   E+   +++  ++  +     
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 219 -LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV----VGSPYYVAPEV 273
              +MHRD+KP N +LVN   +   K  DFG+S     GQ+   +    VG+  Y++PE 
Sbjct: 150 KHKIMHRDVKPSN-ILVNSRGEI--KLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 201

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL------------------ 314
           L   HY  ++D+W+ G+ L  +  G  P      + +                       
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 315 --KGHIDFESDPWPLI--------------------SDSAKDLIRKMLCSQPSERLTAHE 352
                   +S P   I                    S   +D + K L   P+ER    +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

Query: 353 VL 354
           ++
Sbjct: 322 LM 323

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  125 bits (315), Expect = 2e-33
 Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 28/219 (12%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
             G  LG+G FG     T   TG     K + +      E      +E+++M  L  H N
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68

Query: 162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC---HS 218
           ++   G       ++ + E   GG L   I  +   S+   ++       +       HS
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS---------------VFFKPGQIFTDVV 263
           + ++HRDL   N  LV   ++ ++   DFGL+               +     +    VV
Sbjct: 127 MNIIHRDLNSHN-CLV--RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF 301
           G+PY++APE++  + Y  + DV++ G++L  ++  V   
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  124 bits (313), Expect = 3e-33
 Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 50/293 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
             Y    K+G+G +GT +      T    A K +       R D +D        REI +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICL 54

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIV 210
           +  L  HKNIV +         + +V E C     + FD           K+      ++
Sbjct: 55  LKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLL 111

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYV 269
             +  CHS  V+HRDLKP+N LL+N++ +  LK  +FGL+  F  P + ++  V + +Y 
Sbjct: 112 KGLGFCHSRNVLHRDLKPQN-LLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWA---ETQQ--GIF-------DAVLK 315
            P+VL   K Y    D+W+AG I   L +   P +       Q   IF       +    
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 316 GHI---DFESDP-----------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                 D++  P            P ++ + +DL++ +L   P +R++A E L
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (325), Expect = 4e-33
 Identities = 62/267 (23%), Positives = 95/267 (35%), Gaps = 41/267 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCT-EIATGIEFACKSISKRKLISREDVEDV---RREIQIMHHL 156
           Y +   +  G  G  YL       G     K      L+   D E       E Q +  +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEV 136

Query: 157 AGHKNIVTI-----KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
             H +IV I               +IVME   G  L             +A      I+ 
Sbjct: 137 V-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD---VVGSPYY 268
            +   HS+G+++ DLKPEN +++ ++    LK ID G                + G+P +
Sbjct: 194 ALSYLHSIGLVYNDLKPEN-IMLTEE---QLKLIDLGAV------SRINSFGYLYGTPGF 243

Query: 269 VAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
            APE++        D++T G  L  L   +P        G+           E DP    
Sbjct: 244 QAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKT 293

Query: 329 SDSAKDLIRKMLCSQPSER-LTAHEVL 354
            DS   L+R+ +   P +R  TA E+ 
Sbjct: 294 YDSYGRLLRRAIDPDPRQRFTTAEEMS 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  125 bits (315), Expect = 5e-33
 Identities = 85/318 (26%), Positives = 130/318 (40%), Gaps = 75/318 (23%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           ++    D + + R  GQG FGT  L  E +TG+  A K +        +D     RE+QI
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-------IQDPRFRNRELQI 69

Query: 153 MHHLA--GHKNIVTIKGAY-------EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA 203
           M  LA   H NIV ++  +          + +++VME     +   R  +  +Y  R+  
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCR--NYYRRQV- 124

Query: 204 ELTRIIVGV--------VEACH--SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF 253
               I++ V        +   H  S+ V HRD+KP N +LVN+ D  +LK  DFG +   
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEAD-GTLKLCDFGSAKKL 182

Query: 254 KPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG--- 308
            P +     + S YY APE++   +HY    D+W+ G I   ++ G P F     +G   
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-----RGDNS 237

Query: 309 ------IFDAVL----------------------KGHIDFE---SDPWPLISDSAKDLIR 337
                 I   VL                         I +    SD     +  A DL+ 
Sbjct: 238 AGQLHEIVR-VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296

Query: 338 KMLCSQPSERLTAHEVLC 355
            +L   P ER+  +E LC
Sbjct: 297 ALLQYLPEERMKPYEALC 314

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  124 bits (313), Expect = 6e-33
 Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 49/292 (16%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIM 153
           + Y    KLG+G + T Y      T    A K I       R + E+       RE+ ++
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLL 54

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIVG 211
             L  H NIVT+         + +V E       +  D      +    K       ++ 
Sbjct: 55  KDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL--FLFQLLR 111

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYVA 270
            +  CH   V+HRDLKP+N LL+N+  +  LK  DFGL+     P + + + V + +Y  
Sbjct: 112 GLAYCHRQKVLHRDLKPQN-LLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 271 PEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVLKGH 317
           P++LL    Y  + D+W  G I Y + +G P F   T +     IF       +    G 
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228

Query: 318 IDFE---------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +  E                   P +     DL+ K+L  +   R++A + +
Sbjct: 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  122 bits (309), Expect = 2e-32
 Identities = 69/299 (23%), Positives = 111/299 (37%), Gaps = 54/299 (18%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED-----VRREIQIM 153
             +    KLG G + T Y      TG+  A K +       + D E+       REI +M
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLM 57

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG-----ELFDRIIQRGHYSERKAAELTRI 208
             L  H+NIV +         + +V E          +                      
Sbjct: 58  KELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 209 IVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPY 267
           ++  +  CH   ++HRDLKP+N LL+NK     LK  DFGL+  F  P   F+  V + +
Sbjct: 117 LLQGLAFCHENKILHRDLKPQN-LLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLW 173

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVL 314
           Y AP+VL+  + Y    D+W+ G IL  +++G P F     +     IF       +++ 
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233

Query: 315 KGHID-------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                                    +      +  +  D +  +L   P  RL+A + L
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (310), Expect = 4e-32
 Identities = 52/318 (16%), Positives = 99/318 (31%), Gaps = 72/318 (22%)

Query: 99  DLYTLGRKLGQGQ--FGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
             Y L   +G+G     T  L     TG     + I+     S E V  ++ E+ +    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLF 83

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD--RIIQRGHYSERKAAELTRIIVGVVE 214
             H NIV  +  +     + +V    A G   D          +E   A + + ++  ++
Sbjct: 84  N-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-------------TD 261
             H +G +HR +K  + L+     D  +       +       +                
Sbjct: 143 YIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSN-----LSMISHGQRQRVVHDFPKY 194

Query: 262 VVGSPYYVAPEVL---LKHYGPEADVWTAGVILYILLSGVPPF----------------- 301
            V    +++PEVL   L+ Y  ++D+++ G+    L +G  PF                 
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 302 -------------------WAETQQGIFDAVLKGHIDFESDPWPLI------SDSAKDLI 336
                               +    G+ D++        +   P        S      +
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314

Query: 337 RKMLCSQPSERLTAHEVL 354
            + L   P  R +A  +L
Sbjct: 315 EQCLQRNPDARPSASTLL 332

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (305), Expect = 4e-32
 Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 19/264 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-VEDVRREIQIMHHLAGH 159
           Y +  KLG G   T YL  +    I+ A K         +E+ ++   RE+     L+ H
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLS-H 70

Query: 160 KNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           +NIV++    E+  C ++VME   G  L + I   G  S   A   T  I+  ++  H +
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD--VVGSPYYVAPE-VLLK 276
            ++HRD+KP+N L+   D + +LK  DFG++       +     V+G+  Y +PE    +
Sbjct: 131 RIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-----SDPWPLISDS 331
                 D+++ G++LY +L G PPF  ET   I    +K HI        +D    I  S
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI---AIK-HIQDSVPNVTTDVRKDIPQS 243

Query: 332 AKDLIRKMLCSQPSER-LTAHEVL 354
             ++I +      + R  T  E+ 
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMK 267

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  120 bits (304), Expect = 4e-32
 Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 102 TLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAG 158
           TL   +G G FG  Y     A   G E A K+          + +E+VR+E ++   L  
Sbjct: 10  TLEEIIGIGGFGKVYR----AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK- 64

Query: 159 HKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           H NI+ ++G    E +LC  +VME   GG L   +             L    V +    
Sbjct: 65  HPNIIALRGVCLKEPNLC--LVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGM 118

Query: 217 ---HSLG---VMHRDLKPENFLLVNKD------DDFSLKAIDFGLSVFFKPGQIFTDVVG 264
              H      ++HRDLK  N +L+ +        +  LK  DFGL+  +          G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSN-ILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAG 176

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF 301
           +  ++APEV+    +   +DVW+ GV+L+ LL+G  PF
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  121 bits (305), Expect = 5e-32
 Identities = 79/292 (27%), Positives = 123/292 (42%), Gaps = 50/292 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           + Y    K+G+G +G  Y       G  FA K I       R + ED        REI I
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI-------RLEKEDEGIPSTTIREISI 53

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIV 210
           +  L  H NIV +         + +V E       +L D           K+      ++
Sbjct: 54  LKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS--FLLQLL 110

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYV 269
             +  CH   V+HRDLKP+N LL+N++ +  LK  DFGL+  F  P + +T  + + +Y 
Sbjct: 111 NGIAYCHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAV---------- 313
           AP+VL+  K Y    D+W+ G I   +++G P F   ++      IF  +          
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 314 ---LKG-HIDFESDP-------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
              L     +F              + +S  DL+ KML   P++R+TA + L
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  120 bits (304), Expect = 7e-32
 Identities = 68/294 (23%), Positives = 113/294 (38%), Gaps = 45/294 (15%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-----REIQIM 153
             Y    ++G G +GT Y   +  +G   A KS+   ++ +             RE+ ++
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALL 65

Query: 154 HHL--AGHKNIVTIK-----GAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAE 204
             L    H N+V +         +  + V +V E          D+    G        +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           L R  +  ++  H+  ++HRDLKPEN +LV       +K  DFGL+  +      T VV 
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPEN-ILVTSGGT--VKLADFGLARIYSYQMALTPVVV 181

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DA 312
           + +Y APEVLL   Y    D+W+ G I   +    P F   ++      IF       + 
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

Query: 313 VLKGHI---DFESDPW---------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                +        P          P + +S   L+ +ML   P +R++A   L
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (303), Expect = 1e-31
 Identities = 70/304 (23%), Positives = 121/304 (39%), Gaps = 42/304 (13%)

Query: 60  PKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCT 119
               +         + + M    +++     G         Y L R +G+G  G  Y   
Sbjct: 3   SSHHHHHHSSGLVPRGSHMDGTAESREGTQFGP--------YRLRRLVGRGGMGDVYEAE 54

Query: 120 EIATGIEFACKSISKRKLISREDVEDV------RREIQIMHHLAGHKNIVTI--KGAYED 171
           +       A K      L+S     D       +RE +    L    ++V I   G  + 
Sbjct: 55  DTVRERIVALK------LMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDG 107

Query: 172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF 231
            L  ++ M L  G +L   + ++G  +  +A  + R I   ++A H+ G  HRD+KPEN 
Sbjct: 108 QL--YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165

Query: 232 LLVNKDDDFSLKAIDFGLSVFFKPGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTA 287
           L+     D     +DFG++      ++ T   + VG+ YY+APE     H    AD++  
Sbjct: 166 LV---SADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYAL 221

Query: 288 GVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWPLISDSAKDLIRKMLCSQ 343
             +LY  L+G PP+  +       +V+  HI+      S   P I  +   +I + +   
Sbjct: 222 TCVLYECLTGSPPYQGDQL-----SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKN 276

Query: 344 PSER 347
           P +R
Sbjct: 277 PEDR 280

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  118 bits (299), Expect = 5e-31
 Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 51/293 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED------VRREIQI 152
           + Y    K+G+G +G  Y   + + G   A K I       R D ED        REI +
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-------RLDAEDEGIPSTAIREISL 72

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKAAELTRIIV 210
           +  L  H NIV++        C+ +V E       ++ D        S+ K       ++
Sbjct: 73  LKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI--YLYQLL 129

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-VFFKPGQIFTDVVGSPYYV 269
             V  CH   ++HRDLKP+N LL+N D    LK  DFGL+  F  P + +T  V + +Y 
Sbjct: 130 RGVAHCHQHRILHRDLKPQN-LLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYR 186

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF-------DAVLKG 316
           AP+VL+  K Y    D+W+ G I   +++G P F   T       IF             
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246

Query: 317 HI---DFESDP------------WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                 ++                P       DL+  MLC  P++R++A + +
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  119 bits (300), Expect = 9e-31
 Identities = 75/338 (22%), Positives = 127/338 (37%), Gaps = 96/338 (28%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI---SKRKLISREDVEDVRREIQ 151
           +     Y+LG+ LG G FG      +I +G  FA K +    + K           RE+ 
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------RELD 52

Query: 152 IMHHLAGHKNIVTIK--------------------------------------GAYEDSL 173
           IM  L  H NI+ +                                            + 
Sbjct: 53  IMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--------VEACHSLGVMHRD 225
            ++++ME     +   ++++   +       +   ++ +        V   HSLG+ HRD
Sbjct: 112 YLNVIMEYV--PDTLHKVLK--SFIRSGR-SIPMNLISIYIYQLFRAVGFIHSLGICHRD 166

Query: 226 LKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEAD 283
           +KP+N LLVN  D+ +LK  DFG +    P +     + S +Y APE++L    Y P  D
Sbjct: 167 IKPQN-LLVNSKDN-TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSID 224

Query: 284 VWTAGVILYILLSGVPPFWAET--QQ--GIFDAVL----KGHIDF-------------ES 322
           +W+ G +   L+ G P F  ET   Q   I   ++    K  +               ++
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKA 283

Query: 323 DPWPLI-----SDSAKDLIRKMLCSQPSERLTAHEVLC 355
             W  I        A DL+ ++L  +P  R+  +E + 
Sbjct: 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  120 bits (302), Expect = 1e-30
 Identities = 86/369 (23%), Positives = 145/369 (39%), Gaps = 79/369 (21%)

Query: 41  STPSLNSQQLVSQEFSKE-NPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRD 99
           S P+L+ +    Q F K+ +         +S SK DN         + + +  +      
Sbjct: 10  SEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKR------ 63

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KRKLISREDVEDVRREI 150
            Y   + +G G  G      +       A K +S         KR            RE+
Sbjct: 64  -YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----------REL 112

Query: 151 QIMHHLAGHKNIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
            +M  +  HKNI+++          E+   V++VMEL     L  ++IQ     ER +  
Sbjct: 113 VLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANL-CQVIQMELDHERMSYL 169

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           L +++ G+ +  HS G++HRDLKP N ++V  D    LK +DFGL+       + T  V 
Sbjct: 170 LYQMLCGI-KHLHSAGIIHRDLKPSN-IVVKSDCT--LKILDFGLARTAGTSFMMTPYVV 225

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF-------------------WAE 304
           + YY APEV+L   Y    D+W+ G I+  ++     F                     E
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285

Query: 305 TQQGI------------------FDAVLKGHIDF-ESDPWPLISDSAKDLIRKMLCSQPS 345
             + +                  F  +    +   +S+   L +  A+DL+ KML   P+
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345

Query: 346 ERLTAHEVL 354
           +R++  + L
Sbjct: 346 KRISVDDAL 354

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  116 bits (292), Expect = 1e-29
 Identities = 71/337 (21%), Positives = 124/337 (36%), Gaps = 80/337 (23%)

Query: 87  YY--VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           Y+    G    + R  Y L RKLG G F T +L  ++      A K I +   +  E  E
Sbjct: 7   YHPAFKGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAE 63

Query: 145 DVRREIQIMHHL----------AGHKNIV------TIKGAYEDSLCVHIVMELCAGGELF 188
           D   EI+++  +           G  +I+        KG     +   +V E+  G  L 
Sbjct: 64  D---EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV--MVFEVL-GENLL 117

Query: 189 DRIIQRGH--YSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDD---DFSL 242
             I +  H         ++++ ++  ++  H   G++H D+KPEN L+   D       +
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177

Query: 243 KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPF 301
           K  D G + +    + +T+ + +  Y +PEVLL   +G  AD+W+   +++ L++G   F
Sbjct: 178 KIADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

Query: 302 WAETQQGIFDAV--------LKGHID-------------FESD----------PWPLISD 330
             +                 L G +              F S            WPL   
Sbjct: 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 295

Query: 331 SAK-------------DLIRKMLCSQPSERLTAHEVL 354
             +             D +  ML   P +R  A  ++
Sbjct: 296 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  115 bits (291), Expect = 2e-29
 Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 59/302 (19%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y   + +G G  G      +       A K +S R   ++   +   RE+ +M  +  HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCV-NHK 84

Query: 161 NIVTIK---------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           NI+ +            ++D   V+IVMEL     L  ++IQ     ER +  L +++ G
Sbjct: 85  NIIGLLNVFTPQKSLEEFQD---VYIVMEL-MDANL-CQVIQMELDHERMSYLLYQMLCG 139

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           + +  HS G++HRDLKP N ++V  D    LK +DFGL+       + T  V + YY AP
Sbjct: 140 I-KHLHSAGIIHRDLKPSN-IVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQGI-- 309
           EV+L   Y    D+W+ G I+  ++ G   F                     E  + +  
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 310 ----------------FDAVLKGHIDFESDP-WPLISDSAKDLIRKMLCSQPSERLTAHE 352
                           F+ +    +         L +  A+DL+ KML    S+R++  E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315

Query: 353 VL 354
            L
Sbjct: 316 AL 317

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  114 bits (286), Expect = 2e-29
 Identities = 33/251 (13%), Positives = 67/251 (26%), Gaps = 36/251 (14%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y L    G       +   + A   + A   +  + ++  + +++       +  +    
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +           +V E   GG L +        S   A    + +    +A H  G
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGP 280
           V      P   + V+ D                  G +   V+  P  +          P
Sbjct: 150 VALSIDHPSR-VRVSID------------------GDV---VLAYPATMPDA------NP 181

Query: 281 EADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWPLISDSAKDLI 336
           + D+   G  LY LL    P      +       +     +    +D    I      + 
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-DTAGQPIEPADIDRDIPFQISAVA 240

Query: 337 RKMLCSQPSER 347
            + +      R
Sbjct: 241 ARSVQGDGGIR 251

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (286), Expect = 3e-29
 Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 24/269 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED-VEDVRREIQIMHHLAGH 159
           Y LG  LG G     +L  ++    + A K + +  L          RRE Q    L  H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN-H 71

Query: 160 KNIVTI--KGAYEDSLCVH--IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEA 215
             IV +   G  E        IVME   G  L D +   G  + ++A E+       +  
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTD---VVGSPYYVAP 271
            H  G++HRD+KP N ++       ++K +DFG++      G   T    V+G+  Y++P
Sbjct: 132 SHQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 272 E-VLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE----SDPWP 326
           E          +DV++ G +LY +L+G PPF  ++   +     + H+  +    S    
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---AYQ-HVREDPIPPSARHE 244

Query: 327 LISDSAKDLIRKMLCSQPSER-LTAHEVL 354
            +S     ++ K L   P  R  TA E+ 
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMR 273

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  113 bits (285), Expect = 9e-29
 Identities = 74/307 (24%), Positives = 122/307 (39%), Gaps = 64/307 (20%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR----REIQIMH 154
             Y    K+GQG FG  +      TG + A K     K++   + E       REI+I+ 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ 71

Query: 155 HLAGHKNIVTIKG--------AYEDSLCVHIVMELC----AGGELFDRIIQRGHYSERKA 202
            L  H+N+V +                 +++V + C    AG  L   ++ +   SE K 
Sbjct: 72  LLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKR 128

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-----KPGQ 257
             + ++++  +   H   ++HRD+K  N L+     D  LK  DFGL+  F         
Sbjct: 129 --VMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IF- 310
            +T+ V + +Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     I  
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243

Query: 311 ------DAVLKGHI---DFESD--------------PWPLISDSAKDLIRKMLCSQPSER 347
                   V         +E                   +    A DLI K+L   P++R
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303

Query: 348 LTAHEVL 354
           + + + L
Sbjct: 304 IDSDDAL 310

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  112 bits (283), Expect = 2e-28
 Identities = 66/327 (20%), Positives = 122/327 (37%), Gaps = 61/327 (18%)

Query: 78  MRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL 137
           M+   +     ++      ++  YT+ R +  G +G      + + GI  A K +     
Sbjct: 2   MQAKGEAAMRDLIAE-LHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVS 59

Query: 138 ISR-----EDVEDVR---REIQIMHHLAGHKNIVTIK--------GAYEDSLCVHIVMEL 181
             R      D    +   REI++++H   H NI+ ++         A      +++V EL
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHK---LYLVTEL 115

Query: 182 CAGGELFDRIIQRGHYS---ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
               +L  ++I         +     +  I++G+    H  GV+HRDL P N +L+  ++
Sbjct: 116 -MRTDL-AQVIHDQRIVISPQHIQYFMYHILLGL-HVLHEAGVVHRDLHPGN-ILLADNN 171

Query: 239 DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLS 296
           D  +   DF L+         T  V   +Y APE+++  K +    D+W+AG ++  + +
Sbjct: 172 D--ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 297 GVPPF-------------------WAETQQGIFDAVLKGHID-----FESDPW----PLI 328
               F                     E          + ++        +  W    P  
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA 289

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLC 355
              A DLI KML   P  R++  + L 
Sbjct: 290 DPVALDLIAKMLEFNPQRRISTEQALR 316

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  112 bits (282), Expect = 2e-28
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 45/290 (15%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y     +G G +G+     +  +G + A K +S R   S    +   RE+ ++ H+  H+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQ-HE 83

Query: 161 NIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           N++ +        +  +    ++VM      +L  +I+      E+    + +++ G+ +
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDL-QKIMGLKFSEEKIQYLVYQMLKGL-K 140

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS GV+HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y APEV+
Sbjct: 141 YIHSAGVVHRDLKPGN-LAVNEDCE--LKILDFGLARHADAE--MTGYVVTRWYRAPEVI 195

Query: 275 L--KHYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQGIFDAV 313
           L   HY    D+W+ G I+  +L+G   F                     E  Q + D  
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 314 LKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            K +I          +    P  S  A DL+ KML     +RLTA + L 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  112 bits (282), Expect = 3e-28
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 44/295 (14%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            + + Y     +G G +G+     +  TG+  A K +S R   S    +   RE++++ H
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKH 84

Query: 156 LAGHKNIVTIK------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           +  H+N++ +        + E+   V++V  L  G +L + I++    ++     L   I
Sbjct: 85  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADL-NNIVKCQKLTDDHVQFLIYQI 141

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  ++  HS  ++HRDLKP N L VN+D +  LK +DFGL+         T  V + +Y 
Sbjct: 142 LRGLKYIHSADIIHRDLKPSN-LAVNEDCE--LKILDFGLARHTAD--EMTGYVATRWYR 196

Query: 270 APEVLL--KHYGPEADVWTAGVILYILLSGVPPF-------------------WAETQQG 308
           APE++L   HY    D+W+ G I+  LL+G   F                    AE  + 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 309 IFDAVLKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
           I     + +I          +       +  A DL+ KML     +R+TA + L 
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  112 bits (282), Expect = 3e-28
 Identities = 72/328 (21%), Positives = 121/328 (36%), Gaps = 83/328 (25%)

Query: 97  IRDLYT-LGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVED-VRREIQI 152
           + DL+   G K+G+G +G  Y     +     ++A K I          +     REI +
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG------TGISMSACREIAL 71

Query: 153 MHHLAGHKNIVTIKGAYEDSL--CVHIVMELCAGGELFD--RII--QRGHYSERKAAELT 206
           +  L  H N+++++  +       V ++ +        D   II   R   + +K  +L 
Sbjct: 72  LRELK-HPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLP 126

Query: 207 RIIV---------GVVEACHSLGVMHRDLKPENFLLVNKDDDFS--LKAIDFGLS-VFFK 254
           R +V         G+    H+  V+HRDLKP N +LV  +      +K  D G + +F  
Sbjct: 127 RGMVKSLLYQILDGI-HYLHANWVLHRDLKPAN-ILVMGEGPERGRVKIADMGFARLFNS 184

Query: 255 PGQIFTD---VVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 309
           P +   D   VV + +Y APE+LL  +HY    D+W  G I   LL+  P F    +   
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244

Query: 310 FDAVLKG----HI-------------DFESDPW--------------------------P 326
                       I             D +  P                            
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVL 354
                A  L++K+L   P +R+T+ + +
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAM 332

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  111 bits (280), Expect = 4e-28
 Identities = 73/298 (24%), Positives = 127/298 (42%), Gaps = 50/298 (16%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            +R +Y   + +G G +G      +  TG + A K +  R   S    +   RE++++ H
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKH 80

Query: 156 LAGHKNIVTIK---------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELT 206
           +  H+N++ +            + D    ++VM    G +L  ++++     E +   L 
Sbjct: 81  MR-HENVIGLLDVFTPDETLDDFTD---FYLVMPF-MGTDL-GKLMKHEKLGEDRIQFLV 134

Query: 207 RIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             ++  +   H+ G++HRDLKP N L VN+D +  LK +DFGL+         T  V + 
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGN-LAVNEDCE--LKILDFGLARQADSE--MTGYVVTR 189

Query: 267 YYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF-------------------WAET 305
           +Y APEV+L    Y    D+W+ G I+  +++G   F                    AE 
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249

Query: 306 QQGIFDAVLKGHID----FESDPW----PLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
            Q +     K ++      E   +       S  A +L+ KML     +R+TA E L 
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  110 bits (278), Expect = 5e-28
 Identities = 64/296 (21%), Positives = 110/296 (37%), Gaps = 51/296 (17%)

Query: 99  DLYTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISKRKLISREDVED------VRREIQ 151
             Y    ++G+G +G  +   ++   G   A K +       R    +        RE+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVA 63

Query: 152 IMHHL--AGHKNIVTIK-----GAYEDSLCVHIVMELCAG--GELFDRIIQRGHYSERKA 202
           ++ HL    H N+V +         +    + +V E          D++           
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETI 122

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
            ++   ++  ++  HS  V+HRDLKP+N +LV       +K  DFGL+  +      T V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQN-ILVTSSGQ--IKLADFGLARIYSFQMALTSV 179

Query: 263 VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA--ETQQ--GIF------- 310
           V + +Y APEVLL   Y    D+W+ G I   +    P F    +  Q   I        
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239

Query: 311 DAVLKGHI---DFESDPW---------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           +      +                     I +  KDL+ K L   P++R++A+  L
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  108 bits (273), Expect = 2e-27
 Identities = 76/306 (24%), Positives = 122/306 (39%), Gaps = 54/306 (17%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++   Y   + LG G  G  +   +       A K I          V+   REI+I+  
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRR 64

Query: 156 LAGHKNIVTIK--------------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK 201
           L  H NIV +               G+  +   V+IV E     +L   ++++G   E  
Sbjct: 65  L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDL-ANVLEQGPLLEEH 121

Query: 202 AAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP----GQ 257
           A      ++  ++  HS  V+HRDLKP N L +N  +D  LK  DFGL+    P      
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPHYSHKG 179

Query: 258 IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPF-------------- 301
             ++ + + +Y +P +LL   +Y    D+W AG I   +L+G   F              
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239

Query: 302 -----WAETQQGIFDAV---LKGHIDFESDPW----PLISDSAKDLIRKMLCSQPSERLT 349
                  E +Q +   +   ++  +     P     P IS  A D + ++L   P +RLT
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299

Query: 350 AHEVLC 355
           A E L 
Sbjct: 300 AEEALS 305

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  108 bits (272), Expect = 7e-27
 Identities = 84/329 (25%), Positives = 126/329 (38%), Gaps = 63/329 (19%)

Query: 73  KKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSI 132
              + M          V G    ++   YT    +G+G +G      +    +  A K I
Sbjct: 2   HHHHHMAAAAAAGPEMVRGQ-VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60

Query: 133 S--------KRKLISREDVEDVRREIQIMHHLAGHKNIVTIK-----GAYEDSLCVHIVM 179
           S        +R L          REI+I+     H+NI+ I         E    V+IV 
Sbjct: 61  SPFEHQTYCQRTL----------REIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQ 109

Query: 180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD 239
           +L    +L  ++++  H S          I+  ++  HS  V+HRDLKP N LL+N   D
Sbjct: 110 DL-METDL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN-LLLNTTCD 166

Query: 240 FSLKAIDFGLSVFFKP----GQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYI 293
             LK  DFGL+    P        T+ V + +Y APE++L  K Y    D+W+ G IL  
Sbjct: 167 --LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224

Query: 294 LLSGVPPF-------------------WAETQQGIFDAVLKGHID----FESDPW----P 326
           +LS  P F                     E    I +   + ++         PW    P
Sbjct: 225 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 284

Query: 327 LISDSAKDLIRKMLCSQPSERLTAHEVLC 355
                A DL+ KML   P +R+   + L 
Sbjct: 285 NADSKALDLLDKMLTFNPHKRIEVEQALA 313

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  107 bits (270), Expect = 2e-26
 Identities = 77/366 (21%), Positives = 135/366 (36%), Gaps = 84/366 (22%)

Query: 55  FSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGT 114
           F   N KK     +      +N    G D+     +    D++   Y + + +G+G FG 
Sbjct: 60  FLGLNAKK----RQGMTGGPNN---GGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQ 112

Query: 115 TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-----KNIVTIKGA- 168
                +       A K +   K   R+       EI+I+ HL         N++ +    
Sbjct: 113 VVKAYDHKVHQHVALKMVRNEKRFHRQ----AAEEIRILEHLRKQDKDNTMNVIHMLENF 168

Query: 169 -YEDSLCVHIVMELCAGGELFDRIIQRGHY---SERKAAELTRIIVGVVEACHSLGVMHR 224
            + + +C  +  EL     L++ +I++  +   S     +    I+  ++A H   ++H 
Sbjct: 169 TFRNHIC--MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224

Query: 225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEAD 283
           DLKPEN LL  +     +K IDFG S  ++  +++T +  S +Y APEV+L   YG   D
Sbjct: 225 DLKPENILLKQQ-GRSGIKVIDFG-SSCYEHQRVYTYIQ-SRFYRAPEVILGARYGMPID 281

Query: 284 VWTAGVILYILLSGVPPFWAETQQ----------GIFDAVL-------KGHIDFESDPWP 326
           +W+ G IL  LL+G P    E +           G+    L       K  +  +  P  
Sbjct: 282 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 341

Query: 327 LISDSAKD--------------------------------------LIRKMLCSQPSERL 348
               +  D                                       +++ L   P+ R+
Sbjct: 342 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401

Query: 349 TAHEVL 354
           T  + L
Sbjct: 402 TPGQAL 407

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  104 bits (261), Expect = 7e-26
 Identities = 63/300 (21%), Positives = 102/300 (34%), Gaps = 56/300 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHL 156
           RD+ TL   +G+G++G  +  +    G   A K        SR++    R  E+     L
Sbjct: 8   RDI-TLLECVGKGRYGEVWRGS--WQGENVAVK-----IFSSRDEKSWFRETELYNTVML 59

Query: 157 AGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIV-- 210
             H+NI+    +   S        ++      G L+D  +Q           +   I   
Sbjct: 60  R-HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASG 117

Query: 211 ------GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-- 262
                  +        + HRDLK +N L+     +      D GL+V         DV  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 263 ---VGSPYYVAPEVL-------LKHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFD 311
              VG+  Y+APEVL               D+W  G++L+ +   +      E  +  F 
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234

Query: 312 AVLKGHIDFESDPW--------PLISDSA---------KDLIRKMLCSQPSERLTAHEVL 354
            V+     FE            P I +             L+++     PS RLTA  + 
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  103 bits (260), Expect = 3e-25
 Identities = 87/319 (27%), Positives = 123/319 (38%), Gaps = 80/319 (25%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS--------KRKLISREDVEDVR 147
           NI   + L   LG+G +G     T   TG   A K I          R L          
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL---------- 57

Query: 148 REIQIMHHLAGHKNIVTIK--------GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
           REI+I+ H   H+NI+TI           + +   V+I+ EL    +L  R+I     S+
Sbjct: 58  REIKILKHFK-HENIITIFNIQRPDSFENFNE---VYIIQEL-MQTDL-HRVISTQMLSD 111

Query: 200 RKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS--------- 250
                     +  V+  H   V+HRDLKP N LL+N + D  LK  DFGL+         
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN-LLINSNCD--LKVCDFGLARIIDESAAD 168

Query: 251 --VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAET- 305
                       + V + +Y APEV+L    Y    DVW+ G IL  L    P F     
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228

Query: 306 --Q-QGIFDAVLKGHIDFESDPWPLISDSAK--------------------------DLI 336
             Q   IF  +  G    ++D   + S  A+                          DL+
Sbjct: 229 RHQLLLIFGII--GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLL 286

Query: 337 RKMLCSQPSERLTAHEVLC 355
           ++ML   P++R+TA E L 
Sbjct: 287 QRMLVFDPAKRITAKEALE 305

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  103 bits (258), Expect = 4e-25
 Identities = 62/300 (20%), Positives = 101/300 (33%), Gaps = 56/300 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR-REIQIMHHL 156
           R +  L   +G+G+FG  +       G E A K        SRE+    R  EI     L
Sbjct: 42  RTI-VLQESIGKGRFGEVWRGK--WRGEEVAVK-----IFSSREERSWFREAEIYQTVML 93

Query: 157 AGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIV-- 210
             H+NI+    A            +V +    G LFD  + R   +     +L       
Sbjct: 94  R-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASG 151

Query: 211 ------GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV-- 262
                  +V       + HRDLK +N L+     + +    D GL+V         D+  
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 263 ---VGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFD 311
              VG+  Y+APEVL              AD++  G++ + +          E  Q  + 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 312 AVLKGHIDFESDPW--------PLISDSA---------KDLIRKMLCSQPSERLTAHEVL 354
            ++      E            P I +             ++R+   +  + RLTA  + 
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  101 bits (254), Expect = 9e-25
 Identities = 59/302 (19%), Positives = 102/302 (33%), Gaps = 63/302 (20%)

Query: 102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN 161
            L     +G+FG  +           A K    +     +       E+  +  +  H+N
Sbjct: 27  QLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMK-HEN 79

Query: 162 IVTIKGA------YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV--- 212
           I+   GA       +  L   ++      G L D  ++    S     EL  I   +   
Sbjct: 80  ILQFIGAEKRGTSVDVDLW--LITAFHEKGSLSD-FLKANVVSWN---ELCHIAETMARG 133

Query: 213 ----------VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD- 261
                     ++  H   + HRD+K +N LL    ++ +    DFGL++ F+ G+   D 
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDT 190

Query: 262 --VVGSPYYVAPEVLLKHYGPE------ADVWTAGVILYILLSGVPPFW--AETQQGIFD 311
              VG+  Y+APEVL      +       D++  G++L+ L S         +     F+
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 312 AVLKGHIDFES---------------DPWPLISDSAK--DLIRKMLCSQPSERLTAHEVL 354
             +  H   E                D W   +  A   + I +        RL+A  V 
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

Query: 355 CM 356
             
Sbjct: 311 ER 312

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  101 bits (254), Expect = 3e-24
 Identities = 82/350 (23%), Positives = 127/350 (36%), Gaps = 117/350 (33%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KRKLISREDVEDV 146
           ++   Y L +KLG+G +G  +   +  TG   A K I          +R           
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--------- 56

Query: 147 RREIQIMHHLAGHKNIVTIK-----GAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERK 201
            REI I+  L+GH+NIV +          D   V++V +     +L   +I        +
Sbjct: 57  -REIMILTELSGHENIVNLLNVLRADNDRD---VYLVFDY-METDL-HAVI--------R 102

Query: 202 AAELTR---------IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS-- 250
           A  L           +I  + +  HS G++HRD+KP N +L+N +    +K  DFGLS  
Sbjct: 103 ANILEPVHKQYVVYQLIKVI-KYLHSGGLLHRDMKPSN-ILLNAECH--VKVADFGLSRS 158

Query: 251 --------------------VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAG 288
                                F     I TD V + +Y APE+LL    Y    D+W+ G
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

Query: 289 VILYILLSGVPPF------------------------------------------WAETQ 306
            IL  +L G P F                                              Q
Sbjct: 219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQ 278

Query: 307 QGIFDAVLKGHIDFES-DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC 355
               D   K        +P    ++ A DL+ K+L   P++R++A++ L 
Sbjct: 279 SNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  100 bits (251), Expect = 3e-24
 Identities = 55/302 (18%), Positives = 104/302 (34%), Gaps = 60/302 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVR-REIQIMH 154
           + +  + +++G+G++G  ++        G + A K        + E+    R  EI    
Sbjct: 37  KQI-QMVKQIGKGRYGEVWM----GKWRGEKVAVK-----VFFTTEEASWFRETEIYQTV 86

Query: 155 HLAGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            +  H+NI+    A            ++ +    G L+D  ++      +   +L    V
Sbjct: 87  LMR-HENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSV 144

Query: 211 --------GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
                    +        + HRDLK +N L+     + +    D GL+V F       D+
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI 201

Query: 263 -----VGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGV----------PP 300
                VG+  Y+ PEVL              AD+++ G+IL+ +               P
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261

Query: 301 FWAETQQGIFDAVLKGHIDFESD----PWPLISDSA----KDLIRKMLCSQPSERLTAHE 352
           +            ++  +  +      P    SD        L+ +     P+ RLTA  
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

Query: 353 VL 354
           V 
Sbjct: 322 VK 323

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  100 bits (252), Expect = 4e-24
 Identities = 61/251 (24%), Positives = 102/251 (40%), Gaps = 22/251 (8%)

Query: 67  PRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIE 126
              S  K+  +   G D+  Y  +    +   D Y +   +G+G FG      +      
Sbjct: 22  SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEW 81

Query: 127 FACKSISKRKLISREDVEDVRREIQIMHHLAGH-----KNIVTIKGA--YEDSLCVHIVM 179
            A K I  +K    +     + E++++  +  H       IV +K    + + LC  +V 
Sbjct: 82  VAIKIIKNKKAFLNQ----AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC--LVF 135

Query: 180 ELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHS--LGVMHRDLKPENFLLVN 235
           E+     L+D +        S     +  + +   +    +  L ++H DLKPEN LL N
Sbjct: 136 EML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYIL 294
                ++K +DFG S     GQ     + S +Y +PEVLL   Y    D+W+ G IL  +
Sbjct: 195 -PKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251

Query: 295 LSGVPPFWAET 305
            +G P F    
Sbjct: 252 HTGEPLFSGAN 262

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 58/237 (24%), Positives = 92/237 (38%), Gaps = 34/237 (14%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
            +   LG ++G+G FG  +     A     A KS   R+ +  +      +E +I+    
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQY- 169

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H NIV + G       ++IVMEL  GG+    +  R   +  +   L +++        
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGME 227

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N L+    +   LK  DFG+S          +     Y       
Sbjct: 228 YLESKCCIHRDLAARNCLV---TEKNVLKISDFGMS---------REEADGVYAASGGLR 275

Query: 270 -------APEVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGH 317
                  APE L    Y  E+DVW+ G++L+     G  P+   + Q   + V KG 
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG 332

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 67/359 (18%), Positives = 114/359 (31%), Gaps = 84/359 (23%)

Query: 70  SPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFAC 129
             S     +    D++  +    K   + + + + RK+G G FG   LC  I     +A 
Sbjct: 6   HHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAV 65

Query: 130 KSI-SKRKLISREDVEDVRREIQIMHHLAGH----KNIVTIKGA--YEDSLCVHIVMELC 182
           K + + +K          + E  I+  +        NIV   G   Y D +C  ++ E  
Sbjct: 66  KVVRNIKKY-----TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC--LIFEPL 118

Query: 183 AGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--- 237
            G  L++ I +  +  +           I+  +     + + H DLKPEN LL +     
Sbjct: 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177

Query: 238 -------------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH- 277
                                  +K IDFG + F         ++ +  Y APEV+L   
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG 235

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQ----------GIFDAVL-------KGHIDF 320
           +   +D+W+ G +L  L +G   F                      +        G    
Sbjct: 236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYV 295

Query: 321 ESDPWPL------------------------ISDSA-KDLIRKMLCSQPSERLTAHEVL 354
             D   L                        I      D +  +L   P+ R +  E+L
Sbjct: 296 NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 97.9 bits (244), Expect = 9e-23
 Identities = 76/377 (20%), Positives = 129/377 (34%), Gaps = 133/377 (35%)

Query: 85  QTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSIS---------KR 135
           +  Y  G K  ++ D Y +   +G+G +G  YL  +  T    A K ++         KR
Sbjct: 12  ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR 71

Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIK--------GAYEDSLCVHIVMELCAGGEL 187
            L          REI I++ L     I+ +           +++   ++IV+E+ A  +L
Sbjct: 72  IL----------REITILNRL-KSDYIIRLYDLIIPDDLLKFDE---LYIVLEI-ADSDL 116

Query: 188 FDRIIQRGHYSERKAAELTR---------IIVGVVEACHSLGVMHRDLKPENFLLVNKDD 238
             ++        +    LT          +++G     H  G++HRDLKP N  L+N+D 
Sbjct: 117 -KKLF-------KTPIFLTEEHIKTILYNLLLGE-NFIHESGIIHRDLKPAN-CLLNQDC 166

Query: 239 DFSLKAIDFGLS-----------------------VFFKPGQIFTDVVGSPYYVAPEVLL 275
              +K  DFGL+                             +  T  V + +Y APE++L
Sbjct: 167 S--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224

Query: 276 --KHYGPEADVWTAGVILYILLS-----------------GVPPFWAETQQGIFDAVLKG 316
             ++Y    D+W+ G I   LL+                 G   F     +       K 
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284

Query: 317 HID----------------------------------FESDPW----PLISDSAKDLIRK 338
           + D                                   +        P ISD   +L+  
Sbjct: 285 NRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344

Query: 339 MLCSQPSERLTAHEVLC 355
           ML   P++R+T  + L 
Sbjct: 345 MLKFNPNKRITIDQALD 361

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 96.5 bits (240), Expect = 2e-22
 Identities = 66/368 (17%), Positives = 114/368 (30%), Gaps = 118/368 (32%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D     Y + RKLG G F T +L  +I      A K + K    +    E    EI+++ 
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKS---AEHYTETALDEIRLLK 88

Query: 155 HLA-------GHKNIV------TIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY---S 198
            +          + +V       I G     +C  +V E+  G  L    I + +Y    
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVFEV-LGHHLLK-WIIKSNYQGLP 144

Query: 199 ERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKD-------------------- 237
                ++ + ++  ++  H+   ++H D+KPEN LL   +                    
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 238 --------------------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
                                     +   +K  D G + +    + FT+ + +  Y + 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSL 262

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD---------AVL------- 314
           EVL+   Y   AD+W+   + + L +G   F   + +              +L       
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322

Query: 315 -----KGHIDFESD----------PWPLIS-------------DSAKDLIRKMLCSQPSE 346
                     F             PW L                   D +  ML   P +
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382

Query: 347 RLTAHEVL 354
           R TA E L
Sbjct: 383 RATAAECL 390

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 63/319 (19%), Positives = 116/319 (36%), Gaps = 41/319 (12%)

Query: 23  HSNNSKRNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGI 82
           H +  +R + +        +P L+    + +  +    K  +       +   +I    +
Sbjct: 12  HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71

Query: 83  DNQTYYVLGHKTDNIRDLY-TLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLI 138
           + +    + H       L       +G+G FG  Y  T +      I  A KS+   ++ 
Sbjct: 72  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRIT 129

Query: 139 SREDVEDVRREIQIMHHLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHY 197
              +V     E  IM   + H N++++ G          +V+     G+L + I  R   
Sbjct: 130 DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNET 186

Query: 198 SERKAAELTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                 +L    + V +    L      HRDL   N +L   D+ F++K  DFGL+    
Sbjct: 187 HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLA---- 239

Query: 255 PGQIFTDVVGSPYYV--------------APEVLLKH-YGPEADVWTAGVILYILLS-GV 298
                 D+    +                A E L    +  ++DVW+ GV+L+ L++ G 
Sbjct: 240 -----RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294

Query: 299 PPFWAETQQGIFDAVLKGH 317
           PP+       I   +L+G 
Sbjct: 295 PPYPDVNTFDITVYLLQGR 313

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 70/338 (20%), Positives = 115/338 (34%), Gaps = 75/338 (22%)

Query: 83  DNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           D + + V     D +++ Y +   LG+G FG    C + A G       I +     RE 
Sbjct: 4   DKEGHLVC-RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62

Query: 143 VEDVRREIQIMHHLA-----GHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRG 195
               R EI ++  +           V +     +   +C  I  EL  G   F+ + +  
Sbjct: 63  A---RLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC--IAFELL-GKNTFEFLKENN 116

Query: 196 H--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD---------------- 237
              Y       +   +   +   H   + H DLKPEN L VN +                
Sbjct: 117 FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 238 DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS 296
            + S++  DFG + F    +  T +V + +Y  PEV+L+  +    DVW+ G IL+    
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Query: 297 GVPPFWAETQQ----------GIFD------AVLKGHIDFESDPWPLISDSAK------- 333
           G   F     +          G            + +       W   S   +       
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294

Query: 334 -----------------DLIRKMLCSQPSERLTAHEVL 354
                            DL+R+ML   P++R+T  E L
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 59/325 (18%), Positives = 95/325 (29%), Gaps = 90/325 (27%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRRE 149
            DN+     L   +G+G++G  Y  +     +A             K+ S  + ++   E
Sbjct: 12  LDNL----KLLELIGRGRYGAVYKGSLDERPVAV------------KVFSFANRQNFINE 55

Query: 150 IQIMHHLAG--HKNIVTIKGA-------YEDSLCVHIVMELCAGGELFDRIIQRGHYSER 200
             I   +    H NI                     +VME    G L   +         
Sbjct: 56  KNIYR-VPLMEHDNIARFIVGDERVTADGRMEYL--LVMEYYPNGSLXKYL----SLHTS 108

Query: 201 KAAELTRIIVGVV------------EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                 R+   V                +   + HRDL   N L+    +D +    DFG
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFG 165

Query: 249 LSVFFKPGQIF---------TDVVGSPYYVAPEVL--------LKHYGPEADVWTAGVIL 291
           LS+     ++             VG+  Y+APEVL         +    + D++  G+I 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 292 YILLSG----VPPFWAETQQGIFDAVLKGHIDFES---------------DPWPLISDSA 332
           + +        P       Q  F   +  H  FE                + W   S + 
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285

Query: 333 ---KDLIRKMLCSQPSERLTAHEVL 354
              K+ I          RLTA    
Sbjct: 286 RSLKETIEDCWDQDAEARLTAQXAE 310

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.9 bits (234), Expect = 7e-22
 Identities = 54/249 (21%), Positives = 95/249 (38%), Gaps = 43/249 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
              +TLGR LG+G+FG+        E  + ++ A K + K  +I+  D+E+  RE   M 
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMK 80

Query: 155 HLAGHKNIVTIKGA------YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKA---AEL 205
               H ++  + G               +++     G+L   ++               L
Sbjct: 81  EF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 206 TRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV 262
            R +V +      L      HRDL   N +L    +D ++   DFGLS           +
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLS---------RKI 187

Query: 263 VGSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQG 308
               YY             A E L  + Y   +DVW  GV ++ +++ G  P+       
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

Query: 309 IFDAVLKGH 317
           I++ ++ G+
Sbjct: 248 IYNYLIGGN 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 93.9 bits (234), Expect = 7e-22
 Identities = 75/334 (22%), Positives = 116/334 (34%), Gaps = 75/334 (22%)

Query: 87  YYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDV 146
           + +     D +   Y +   LG+G FG    C +   G       I K      E     
Sbjct: 3   HLIC-QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--- 58

Query: 147 RREIQIMHHLA-----GHKNIVTIKGA--YEDSLCVHIVMELCAGGELFDRIIQRGH--Y 197
           R EIQ++ HL           V +     +   +C  IV EL  G   +D I + G   +
Sbjct: 59  RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC--IVFELL-GLSTYDFIKENGFLPF 115

Query: 198 SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD----------------DDFS 241
                 ++   I   V   HS  + H DLKPEN L V  D                 +  
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPP 300
           +K +DFG + +    +  + +V + +Y APEV+L   +    DVW+ G IL     G   
Sbjct: 176 IKVVDFGSATY--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 301 FWAETQQ----------GIFDAVL------KGHIDFESDPWPLISDSAK----------- 333
           F     +          G     +      + +   +   W   S + +           
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293

Query: 334 -------------DLIRKMLCSQPSERLTAHEVL 354
                        DLI+KML   P++R+T  E L
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 64/309 (20%), Positives = 114/309 (36%), Gaps = 66/309 (21%)

Query: 46  NSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGR 105
           + +   +Q+ +       + + +    +K +   +           H    I D Y +  
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKP---TASMPRPHSDWQIPDRYEIRH 59

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAGHKNIV 163
            +G G +G      +       A K I +   +  + ++  R  REI I++ L  H ++V
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRL-NHDHVV 115

Query: 164 TIK-----GAYEDSLCVHIVMELC---------AGGELFDRIIQRGHYSERKAAELTRII 209
            +         E    +++V+E+              L +  I+   Y          ++
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY---------NLL 166

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS------------------- 250
           VGV +  HS G++HRDLKP N  LVN+D    +K  DFGL+                   
Sbjct: 167 VGV-KYVHSAGILHRDLKPAN-CLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 251 ---------VFFKPGQIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVP 299
                          +  T  V + +Y APE++L  ++Y    DVW+ G I   LL+ + 
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 300 PFWAETQQG 308
              A     
Sbjct: 283 ENVAYHADR 291

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.4 bits (230), Expect = 1e-21
 Identities = 45/244 (18%), Positives = 76/244 (31%), Gaps = 39/244 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYL-------CTEIATGIEFACKSISKRKLISREDVEDVRREI 150
            +       LGQG F   +                E   K +       R   E      
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAA 63

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            +M  L+ HK++V   G         +V E    G L   +  + + +         +  
Sbjct: 64  SMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAK 120

Query: 211 GVVEACH---SLGVMHRDLKPENFLLVNKDDDFSL-----KAIDFGLSVFFKPGQIFTDV 262
            +  A H      ++H ++  +N LL+ ++D  +      K  D G+S+          V
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI---------TV 171

Query: 263 VGSPYY------VAPEVLL--KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           +           V PE +   K+     D W+ G  L+ + S G  P  A   Q      
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

Query: 314 LKGH 317
              H
Sbjct: 232 EDRH 235

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 18/228 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R   T+  KLG GQ+G  Y        +  A K++ +       +VE+  +E  +M  + 
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 274

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC- 216
            H N+V + G        +I+ E    G L D + +     E  A  L  +   +  A  
Sbjct: 275 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAME 332

Query: 217 --HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---AP 271
                  +HR+L   N L+    ++  +K  DFGLS     G  +T   G+ + +   AP
Sbjct: 333 YLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 388

Query: 272 EVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E L    +  ++DVW  GV+L+ + + G+ P+       +++ + K +
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 436

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 91.7 bits (228), Expect = 6e-21
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 42/248 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R   TL R LG G FG  Y      +G+         A K++   ++ S +D  D   E 
Sbjct: 70  RKNITLIRGLGHGAFGEVYEG--QVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEA 125

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            I+     H+NIV   G    SL   I++EL AGG+L   + +      + ++    +L 
Sbjct: 126 LIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 207 RIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
            +   +   C  L      HRD+   N LL         K  DFG++          D+ 
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIY 235

Query: 264 GSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
            + YY              PE  ++  +  + D W+ GV+L+ + S G  P+ +++ Q +
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295

Query: 310 FDAVLKGH 317
            + V  G 
Sbjct: 296 LEFVTSGG 303

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 58/248 (23%), Positives = 100/248 (40%), Gaps = 42/248 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT---EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+L  LG+ LG+G+FG+        E  T ++ A K++ K    S+ ++E+   E   M 
Sbjct: 33  RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMK 91

Query: 155 HLAGHKNIVTIKGA--YEDSLCVH---IVMELCAGGELFDRIIQRGHYSERKA---AELT 206
               H N++ + G      S  +    +++     G+L   ++     +  K      L 
Sbjct: 92  DF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 207 RIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
           + +V +      L      HRDL   N +L    DD ++   DFGLS           + 
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLS---------KKIY 198

Query: 264 GSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
              YY             A E L    Y  ++DVW  GV ++ + + G+ P+       +
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

Query: 310 FDAVLKGH 317
           +D +L GH
Sbjct: 259 YDYLLHGH 266

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 42/248 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R   TL R LG G FG  Y      +G+         A K++   ++ S +D  D   E 
Sbjct: 29  RKNITLIRGLGHGAFGEVYEGQ--VSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEA 84

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA----ELT 206
            I+     H+NIV   G    SL   I+MEL AGG+L   + +      + ++    +L 
Sbjct: 85  LIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 207 RIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVV 263
            +   +   C  L      HRD+   N LL         K  DFG++          D+ 
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---------RDIY 194

Query: 264 GSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
            + YY              PE  ++  +  + D W+ GV+L+ + S G  P+ +++ Q +
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254

Query: 310 FDAVLKGH 317
            + V  G 
Sbjct: 255 LEFVTSGG 262

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 89.7 bits (223), Expect = 1e-20
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 7/159 (4%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + + Y LGRK+G G FG  YL T+IA G E A K    +    +     +  E +I   +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMM 61

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEA 215
            G   I TI+    +     +VMEL  G  L D        +S +    L   ++  +E 
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            HS   +HRD+KP+NFL+        +  IDFGL+  ++
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 57/243 (23%), Positives = 92/243 (37%), Gaps = 40/243 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
             +      +G+G FG  Y   L       I  A KS+   ++    +V     E  IM 
Sbjct: 24  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 81

Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
               H N++++ G          +V+     G+L + I  R         +L    + V 
Sbjct: 82  DF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVA 138

Query: 214 EACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +    L      HRDL   N +L   D+ F++K  DFGL+          D+    YY  
Sbjct: 139 KGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLA---------RDMYDKEYYSV 186

Query: 270 -------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
                        A E L    +  ++DVW+ GV+L+ L++ G PP+       I   +L
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246

Query: 315 KGH 317
           +G 
Sbjct: 247 QGR 249

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 21/232 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIM 153
              +   + LG G FGT Y    I  G    I  A K +  R+  S +  +++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             +  + ++  + G    S  V ++ +L   G L D +  R H     +  L    V + 
Sbjct: 72  ASVD-NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIA 127

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +  +      ++HRDL   N L+        +K  DFGL+      +      G    + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184

Query: 270 --APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             A E +L + Y  ++DVW+ GV ++ L++ G  P+       I   + KG 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 36/236 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T  ++LG GQFG            + A K I +         ++   E ++M +L+
Sbjct: 23  PKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLS 77

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+ +V + G       + I+ E  A G L + +  R      +  +L  +   V EA  
Sbjct: 78  -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAME 134

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N  LVN  D   +K  DFGLS           V+   Y       
Sbjct: 135 YLESKQFLHRDLAARN-CLVN--DQGVVKVSDFGLS---------RYVLDDEYTSSVGSK 182

Query: 270 ------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                  PEVL+   +  ++D+W  GV+++ + S G  P+   T     + + +G 
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 238

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 88.4 bits (220), Expect = 2e-20
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 36/236 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T  +++G GQFG  +L   +    + A K+I +         ED   E ++M  L+
Sbjct: 7   PSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIRE----GAMSEEDFIEEAEVMMKLS 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V + G   +   + +V E    G L D +  R       A  L  + + V E   
Sbjct: 62  -HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMA 118

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
                 V+HRDL   N  LV   ++  +K  DFG++           V+   Y       
Sbjct: 119 YLEEACVIHRDLAARN-CLVG--ENQVIKVSDFGMT---------RFVLDDQYTSSTGTK 166

Query: 270 ------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                 +PEV     Y  ++DVW+ GV+++ + S G  P+   +   + + +  G 
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.5 bits (220), Expect = 3e-20
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 18/228 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R   T+  KLG GQ+G  Y        +  A K++ +       +VE+  +E  +M  + 
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 67

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H N+V + G        +I+ E    G L D  ++  +  E  A  L  +   +  A  
Sbjct: 68  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAME 125

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---AP 271
                  +HRDL   N  LV   ++  +K  DFGLS     G  +T   G+ + +   AP
Sbjct: 126 YLEKKNFIHRDLAARN-CLVG--ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 181

Query: 272 EVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           E L    +  ++DVW  GV+L+ + + G+ P+       +++ + K +
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.0 bits (219), Expect = 4e-20
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 36/236 (15%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+  TL ++LG GQFG   L        + A K I +         ++  +E Q M  L+
Sbjct: 7   REEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKE----GSMSEDEFFQEAQTMMKLS 61

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H  +V   G       ++IV E  + G L + +  R H    + ++L  +   V E   
Sbjct: 62  -HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 218 ---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV----- 269
              S   +HRDL   N  LV+   D  +K  DFG++           V+   Y       
Sbjct: 119 FLESHQFIHRDLAARN-CLVD--RDLCVKVSDFGMT---------RYVLDDQYVSSVGTK 166

Query: 270 ------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                 APEV     Y  ++DVW  G++++ + S G  P+   T   +   V +GH
Sbjct: 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 7/155 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + LGRK+G G FG  YL T I T  E A K  + +    +     +  E +I   L G  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKIYRILQGGT 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            I  ++    +     +VM+L  G  L D         S +    L   ++  VE  HS 
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
             +HRD+KP+NFL+        +  IDFGL+  ++
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 87.6 bits (218), Expect = 6e-20
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 30/231 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHH 155
                L + +G+G+FG   L      G + A K I       + D   +    E  +M  
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-------KNDATAQAFLAEASVMTQ 70

Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 71  LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 128

Query: 215 ACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
           A         +HRDL   N +LV+  +D   K  DFGL+      +  +        V  
Sbjct: 129 AMEYLEGNNFVHRDLAARN-VLVS--EDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 180

Query: 270 -APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            APE L  K +  ++DVW+ G++L+ + S G  P+     + +   V KG+
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 52/251 (20%), Positives = 96/251 (38%), Gaps = 48/251 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+  T+ R+LGQG FG  Y     A G+         A K++   +  S  +  +   E 
Sbjct: 24  REKITMSRELGQGSFGMVYEGV--AKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEA 79

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA------- 203
            +M       ++V + G         ++MEL   G+L   +                   
Sbjct: 80  SVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 204 ELTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
           ++ ++   + +    L      HRDL   N ++    +DF++K  DFG++          
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMT---------R 186

Query: 261 DVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAETQ 306
           D+  + YY             +PE L    +   +DVW+ GV+L+ I      P+   + 
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246

Query: 307 QGIFDAVLKGH 317
           + +   V++G 
Sbjct: 247 EQVLRFVMEGG 257

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 52/232 (22%), Positives = 87/232 (37%), Gaps = 21/232 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIM 153
                  + LG G FGT +    I  G    I    K I       R+  + V   +  +
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAI 69

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             L  H +IV + G    S  + +V +    G L D +  R H        L    V + 
Sbjct: 70  GSLD-HAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIA 125

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +  +     G++HR+L   N LL        ++  DFG++    P         +   + 
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182

Query: 270 --APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             A E +    Y  ++DVW+ GV ++ L++ G  P+       + D + KG 
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 87.3 bits (217), Expect = 8e-20
 Identities = 63/242 (26%), Positives = 88/242 (36%), Gaps = 43/242 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
                L  KLG G FG              +  A K +    L   E ++D  RE+  MH
Sbjct: 17  EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76

Query: 155 HLAGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
            L  H+N++ + G     +     + +V EL   G L DR+  R H        L+R  V
Sbjct: 77  SLD-HRNLIRLYG-----VVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAV 128

Query: 211 GVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            V E    L      HRDL   N LL  +D    +K  DFGL                 +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALPQ--------NDDH 177

Query: 268 YV------------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV 313
           YV            APE L  + +   +D W  GV L+ + + G  P+       I   +
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

Query: 314 LK 315
            K
Sbjct: 238 DK 239

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 86.9 bits (216), Expect = 9e-20
 Identities = 59/245 (24%), Positives = 95/245 (38%), Gaps = 49/245 (20%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   L R LG+G FG  Y           I  A K+   +K  + ++ E    E  IM 
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMK 68

Query: 155 HLAGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
           +L  H +IV + G     +       I+MEL   GEL   +    + +  K   L    +
Sbjct: 69  NLD-HPHIVKLIG-----IIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSL 120

Query: 211 GVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            + +A     S+  +HRD+   N L+        +K  DFGLS           +    Y
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLS---------RYIEDEDY 168

Query: 268 YV-----------APEVLLKHYG---PEADVWTAGVILYILLS-GVPPFWAETQQGIFDA 312
           Y            +PE +  ++      +DVW   V ++ +LS G  PF+    + +   
Sbjct: 169 YKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226

Query: 313 VLKGH 317
           + KG 
Sbjct: 227 LEKGD 231

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 30/231 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV--EDVRREIQIMHH 155
                L + +G+G+FG   L      G + A K I       + D   +    E  +M  
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-------KNDATAQAFLAEASVMTQ 242

Query: 156 LAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
           L  H N+V + G   E+   ++IV E  A G L D +  RG  S      L +  + V E
Sbjct: 243 LR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCE 300

Query: 215 ACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS--PY-Y 268
           A   L      HRDL   N L+    +D   K  DFGL+      +  +       P  +
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLT-----KEASSTQDTGKLPVKW 352

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
            APE L  K +  ++DVW+ G++L+ + S G  P+     + +   V KG+
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 60/243 (24%), Positives = 90/243 (37%), Gaps = 45/243 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   LGR +G+GQFG  +     +     +  A K+   +   S    E   +E   M 
Sbjct: 14  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMR 71

Query: 155 HLAGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIV 210
               H +IV + G     +     V I+MELC  GEL   +  +        A L     
Sbjct: 72  QFD-HPHIVKLIG-----VITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAY 123

Query: 211 GVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
            +  A   L      HRD+   N L+     +  +K  DFGLS           +  S Y
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLS---------RYMEDSTY 171

Query: 268 YV-----------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
           Y            APE +  + +   +DVW  GV ++ +L  GV PF       +   + 
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

Query: 315 KGH 317
            G 
Sbjct: 232 NGE 234

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 50/229 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+    G+ LG G FG     T  A G+         A K +  +     ++ E +  E+
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEAT--AFGLGKEDAVLKVAVKML--KSTAHADEKEALMSEL 100

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD------RIIQRGHYSERKAAE 204
           +IM HL  H+NIV + GA      V ++ E C  G+L +      R+++         + 
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 205 LT-----RIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
            +          V +      S   +HRD+   N LL    +    K  DFGL+      
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLA------ 211

Query: 257 QIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY 292
               D++    Y+            APE +    Y  ++DVW+ G++L+
Sbjct: 212 ---RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 60/234 (25%), Positives = 88/234 (37%), Gaps = 44/234 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
                   +LG+G FG+  LC        TG   A K +   +    +   D +REIQI+
Sbjct: 22  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQIL 78

Query: 154 HHLAGHKNIVTIKG----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L     IV  +G        SL   +VME    G L D +  + H +   A+ L    
Sbjct: 79  KAL-HSDFIVKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFL--QRHRARLDASRLLLYS 133

Query: 210 VGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             + +    LG     HRDL   N L+   + +  +K  DFGL+            +   
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLP--------LDKD 182

Query: 267 YYVAPE---VLLKHYGPEA----------DVWTAGVILYILLS-GVPPFWAETQ 306
           YYV  E     +  Y PE+          DVW+ GV+LY L +          +
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 51/239 (21%), Positives = 96/239 (40%), Gaps = 33/239 (13%)

Query: 98  RDLYTLGRKLGQGQFGT----TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
               T  + +G G+FG         +     +  A K++  +   + +   D   E  IM
Sbjct: 43  PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIM 100

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
              + H NI+ ++G       + I+ E    G L   +  R    E    +L  ++ G+ 
Sbjct: 101 GQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIA 157

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
                  ++  +HRDL   N +LVN   +   K  DFGLS      ++  D   + Y   
Sbjct: 158 AGMKYLANMNYVHRDLAARN-ILVN--SNLVCKVSDFGLS------RVLEDDPEATYTTS 208

Query: 270 ---------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                    APE +  + +   +DVW+ G++++ +++ G  P+W  +   +  A+  G 
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 267

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 54/233 (23%), Positives = 82/233 (35%), Gaps = 54/233 (23%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+  + G+ LG G FG     T  A G+         A K +  +      + E +  E+
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEAT--AYGLIKSDAAMTVAVKML--KPSAHLTEREALMSEL 77

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD---------------RIIQRG 195
           +++ +L  H NIV + GA        ++ E C  G+L +                 I   
Sbjct: 78  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 196 HYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
                   +L      V +      S   +HRDL   N LL         K  DFGL+  
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLA-- 192

Query: 253 FKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY 292
                   D+     YV            APE +    Y  E+DVW+ G+ L+
Sbjct: 193 -------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 73/309 (23%), Positives = 115/309 (37%), Gaps = 38/309 (12%)

Query: 29  RNTNSDCTNSDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYY 88
           R  N    +          + L S      N K+   +  +S S+ D+      +  TY 
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378

Query: 89  VLGHKTDNI-RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVE 144
           +   +   I R+   LGR +G+GQFG  +     +     +  A K+   +   S    E
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVRE 436

Query: 145 DVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAE 204
              +E   M     H +IV + G   ++  V I+MELC  GEL   +  +        A 
Sbjct: 437 KFLQEALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL--QVRKFSLDLAS 492

Query: 205 LTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD 261
           L      +  A   L      HRD+   N +LV+   +  +K  DFGLS           
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARN-VLVS--SNDCVKLGDFGLS---------RY 540

Query: 262 VVGSPYYV-----------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQG 308
           +  S YY            APE +  + +   +DVW  GV ++ +L  GV PF       
Sbjct: 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

Query: 309 IFDAVLKGH 317
           +   +  G 
Sbjct: 601 VIGRIENGE 609

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 21/232 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIM 153
              +   + LG G FGT Y    I  G    I  A K +  R+  S +  +++  E  +M
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71

Query: 154 HHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
             +  + ++  + G    S  V ++ +L   G L D +  R H     +  L    V + 
Sbjct: 72  ASVD-NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIA 127

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
           +  +      ++HRDL   N L+        +K  DFGL+      +      G    + 
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184

Query: 270 --APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             A E +L + Y  ++DVW+ GV ++ L++ G  P+       I   + KG 
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +      R LG+G FG   LC        TG + A KS+  +       + D+++EI+I+
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEIL 77

Query: 154 HHLAGHKNIVTIKGAYEDSLC--VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
            +L  H+NIV  KG   +     + ++ME    G L + +    + ++    +  +  V 
Sbjct: 78  RNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQ 134

Query: 212 VVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           + +    LG     HRDL   N L+   + +  +K  DFGL+   +            YY
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE--------TDKEYY 183

Query: 269 V------------APEVLLKH-YGPEADVWTAGVILYILLS 296
                        APE L++  +   +DVW+ GV L+ LL+
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 34/239 (14%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
                + + +G G  G      L       +  A K++  +   +     D   E  IM 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMG 105

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
               H NI+ ++G         IV E    G L   +  R H  +    +L  ++ GV  
Sbjct: 106 QFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGA 162

Query: 215 ACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
                  LG +HRDL   N L+   D +   K  DFGLS   +             Y   
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP-------DAAYTTT 212

Query: 270 ---------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                    APE +  + +   +DVW+ GV+++ +L+ G  P+W  T + +  +V +G+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 84.7 bits (210), Expect = 7e-19
 Identities = 38/161 (23%), Positives = 77/161 (47%), Gaps = 9/161 (5%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           +   Y +GR++G+G FG  +  T +    + A K   +R    +     +R E +    L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYKLL 62

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEA 215
           AG   I  +    ++ L   +V++L  G  L D   +    +S +  A   + ++  V++
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFK 254
            H   +++RD+KP+NFL+   +   +  +  +DFG+  F++
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 56/260 (21%), Positives = 95/260 (36%), Gaps = 59/260 (22%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
                  ++LG+G FG+  +C     +  TG   A K +   +  + E + D  REI+I+
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEIL 65

Query: 154 HHLAGHKNIVTIKG----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H NIV  KG    A   +L   ++ME    G L D +  + H       +L +  
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYL--QKHKERIDHIKLLQYT 120

Query: 210 VGVVEAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             + +      +   +HRDL   N L+   +++  +K  DFGL+                
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLP--------QDKE 169

Query: 267 YYV------------APEVLL-KHYGPEADVWTAGVILYILLS----------------G 297
           ++             APE L    +   +DVW+ GV+LY L +                G
Sbjct: 170 FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229

Query: 298 VPPFWAETQQGIFDAVLKGH 317
                      + + +    
Sbjct: 230 NDKQGQMIVFHLIELLKNNG 249

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 28/232 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +         +    E  +M  L 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQ 66

Query: 158 GHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
            H+ +V +             ++I+ E    G L D +       +    +L  +   + 
Sbjct: 67  -HQRLVRLYAV-----VTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIA 119

Query: 214 EACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS--PY- 267
           E          +HRDL+  N +LV+  D  S K  DFGL+   +    +T   G+  P  
Sbjct: 120 EGMAFIEERNYIHRDLRAAN-ILVS--DTLSCKIADFGLARLIE-DNEYTAREGAKFPIK 175

Query: 268 YVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           + APE +    +  ++DVW+ G++L  +++ G  P+   T   +   + +G+
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 18/227 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T        A K++           E   +E Q+M  L 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLR 237

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+ +V +     +   ++IV E  + G L D +         +  +L  +   +     
Sbjct: 238 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMA 294

Query: 218 SLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPE 272
            +  M   HRDL+  N L+    ++   K  DFGL+   +  +         P  + APE
Sbjct: 295 YVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G+
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 398

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 60/243 (24%), Positives = 97/243 (39%), Gaps = 40/243 (16%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMH 154
           R +    R +G+G FG  Y    I      I+ A KS+   ++   + VE   RE  +M 
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMR 77

Query: 155 HLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
            L  H N++ + G         H+++     G+L   I  R         +L    + V 
Sbjct: 78  GLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVA 134

Query: 214 EACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV- 269
                L      HRDL   N +L   D+ F++K  DFGL+          D++   YY  
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLA---------RDILDREYYSV 182

Query: 270 -------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVL 314
                        A E L  + +  ++DVW+ GV+L+ LL+ G PP+       +   + 
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

Query: 315 KGH 317
           +G 
Sbjct: 243 QGR 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 62/259 (23%), Positives = 106/259 (40%), Gaps = 55/259 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF---------ACKSISKRKLISREDVEDVRR 148
           RD  TLG+ LG+G FG   +    A GI+          A K +  +   + +D+ D+  
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAE--AVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVS 89

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRG 195
           E+++M  +  HKNI+ + GA      +++++E  + G L             +   I R 
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 196 HYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
              +    +L      +        S   +HRDL   N L+    ++  +K  DFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLA-- 204

Query: 253 FKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGV 298
                   D+    YY             APE L    Y  ++DVW+ GV+++ I   G 
Sbjct: 205 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257

Query: 299 PPFWAETQQGIFDAVLKGH 317
            P+     + +F  + +GH
Sbjct: 258 SPYPGIPVEELFKLLKEGH 276

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 61/259 (23%), Positives = 106/259 (40%), Gaps = 55/259 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF---------ACKSISKRKLISREDVEDVRR 148
           RD  TLG+ LG+G FG   +    A GI+          A K +  +   + +D+ D+  
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAE--AVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVS 135

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-----RIIQRGHYSERKAA 203
           E+++M  +  HKNI+ + GA      +++++E  + G L +     R     +  +    
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 204 --------ELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF 252
                   +L      +        S   +HRDL   N L+    ++  +K  DFGL+  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLA-- 250

Query: 253 FKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGV 298
                   D+    YY             APE L    Y  ++DVW+ GV+++ I   G 
Sbjct: 251 -------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303

Query: 299 PPFWAETQQGIFDAVLKGH 317
            P+     + +F  + +GH
Sbjct: 304 SPYPGIPVEELFKLLKEGH 322

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 62/240 (25%), Positives = 96/240 (40%), Gaps = 37/240 (15%)

Query: 98  RDLYTLGR-KLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           RD   +   +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH
Sbjct: 8   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMH 65

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  +  IV + G  +    + +VME+  GG L   +   G   E   + +  ++  V  
Sbjct: 66  QLD-NPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSM 121

Query: 215 ACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
               L      HRDL   N LLVN+      K  DFGLS                YY   
Sbjct: 122 GMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALG--------ADDSYYTAR 170

Query: 270 ----------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                     APE +  + +   +DVW+ GV ++  LS G  P+       +   + +G 
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 43/223 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
                  ++LG+G FG+  +C     +  TG   A K +   +  + E + D  REI+I+
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEIL 96

Query: 154 HHLAGHKNIVTIKG----AYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
             L  H NIV  KG    A   +L   ++ME    G L D +  + H       +L +  
Sbjct: 97  KSLQ-HDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYL--QKHKERIDHIKLLQYT 151

Query: 210 VGVVEAC---HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSP 266
             + +      +   +HRDL   N L+   +++  +K  DFGL+                
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLP--------QDKE 200

Query: 267 YYV------------APEVLLKH-YGPEADVWTAGVILYILLS 296
           YY             APE L +  +   +DVW+ GV+LY L +
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 32/238 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
               ++ + +G G+FG      L       I  A K++  +   + +   D   E  IM 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMG 101

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
               H NI+ ++G    S  V IV E    G L   +  R H ++    +L  ++ G+  
Sbjct: 102 QFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIAS 158

Query: 215 ACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-- 269
                  +G +HRDL   N +L+N   +   K  DFGL       ++  D   + Y    
Sbjct: 159 GMKYLSDMGYVHRDLAARN-ILIN--SNLVCKVSDFGLG------RVLEDDPEAAYTTRG 209

Query: 270 --------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                   +PE +  + +   +DVW+ G++L+ ++S G  P+W  + Q +  AV +G+
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY 267

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 36/157 (22%), Positives = 62/157 (39%), Gaps = 9/157 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +G+K+G G FG   L   + T    A K +   K         +  E +    L    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK----SRAPQLHLEYRFYKQLGSGD 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFD-RIIQRGHYSERKAAELTRIIVGVVEACHSL 219
            I  +           +V+EL  G  L D   +    +S +    +   ++  +E  HS 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 220 GVMHRDLKPENFLL--VNKDDDFSLKAIDFGLSVFFK 254
            +++RD+KPENFL+          +  IDF L+  + 
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 18/227 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T        A K++           E   +E Q+M  L 
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLR 320

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH 217
            H+ +V +     +   ++IV E  + G L D +         +  +L  +   +     
Sbjct: 321 -HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMA 377

Query: 218 SLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS-PY-YVAPE 272
            +  M   HRDL+  N L+    ++   K  DFGL+   +  +         P  + APE
Sbjct: 378 YVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
             L   +  ++DVW+ G++L  L + G  P+     + + D V +G+
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 481

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 60/261 (22%), Positives = 98/261 (37%), Gaps = 59/261 (22%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG        A GI+        A K +  ++  +  +   +  E+
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKML--KEGATHSEHRALMSEL 81

Query: 151 QIMHHLAGHKNIVTIKGA---YEDSLCVHIVMELCAGGEL-------------FDRIIQR 194
           +I+ H+  H N+V + GA       L   +++E C  G L             +    + 
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 195 GHYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV 251
            +        L      V +      S   +HRDL   N LL    +   +K  DFGL+ 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLA- 195

Query: 252 FFKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSG 297
                    D+   P YV            APE +    Y  ++DVW+ GV+L+ I   G
Sbjct: 196 --------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247

Query: 298 VPPFWA-ETQQGIFDAVLKGH 317
             P+   +  +     + +G 
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGT 268

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.2 bits (206), Expect = 3e-18
 Identities = 63/221 (28%), Positives = 87/221 (39%), Gaps = 40/221 (18%)

Query: 98  RDLYTLGRKLGQGQFGTTYLC----TEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
           +      R LG+G FG   L     T   TG   A K++  +     +     ++EI I+
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDIL 87

Query: 154 HHLAGHKNIVTIKGAYEDSLC--VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
             L  H++I+  KG  ED+    + +VME    G L D +    H      A+L      
Sbjct: 88  RTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRH--SIGLAQLLLFAQQ 142

Query: 212 VVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           + E    L      HRDL   N LL   D+D  +K  DFGL+             G  YY
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVP--------EGHEYY 191

Query: 269 VAPE---VLLKHYGPEA----------DVWTAGVILYILLS 296
              E     +  Y PE           DVW+ GV LY LL+
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 82.7 bits (205), Expect = 4e-18
 Identities = 55/242 (22%), Positives = 86/242 (35%), Gaps = 44/242 (18%)

Query: 99  DLYTLGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
            L    ++LG G FGT               A K + K +       +++  E  +M  L
Sbjct: 17  LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL 75

Query: 157 AGHKNIVTIKGAYEDSLC----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
             +  IV + G     +C      +VME+   G L   + Q  H        +  ++  V
Sbjct: 76  D-NPYIVRMIG-----ICEAESWMLVMEMAELGPLNKYLQQNRHVK---DKNIIELVHQV 126

Query: 213 VEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
                 L      HRDL   N LLV +      K  DFGLS   +  +         YY 
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADE--------NYYK 175

Query: 270 ------------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK 315
                       APE +    +  ++DVW+ GV+++   S G  P+       +   + K
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

Query: 316 GH 317
           G 
Sbjct: 236 GE 237

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 22/229 (9%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L +KLG GQFG  ++ T      + A K++          VE    E  +M  L 
Sbjct: 187 RESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKP----GSMSVEAFLAEANVMKTLQ 241

Query: 158 GHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            H  +V +     ++ +   I+ E  A G L D +      S++   +L      + E  
Sbjct: 242 -HDKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGM 297

Query: 217 HSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---A 270
             +      HRDL+  N L+         K  DFGL+   +    +T   G+ + +   A
Sbjct: 298 AFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTA 353

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
           PE +    +  ++DVW+ G++L  +++ G  P+   +   +  A+ +G+
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.2 bits (206), Expect = 7e-18
 Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 51/257 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKR---KLI----SREDVEDVRREI 150
           RD   LG+ LG+G FG   L    A G++    +   +   K++    + +D+ D+  E+
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRGHY 197
           ++M  +  HKNI+ + GA      +++++E  + G L             +         
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 198 SERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            +  + +L      V        S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLA---- 238

Query: 255 PGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGVPP 300
                 D+    YY             APE L    Y  ++DVW+ GV+L+ I   G  P
Sbjct: 239 -----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

Query: 301 FWAETQQGIFDAVLKGH 317
           +     + +F  + +GH
Sbjct: 294 YPGVPVEELFKLLKEGH 310

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 40/182 (21%), Positives = 68/182 (37%), Gaps = 24/182 (13%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM 153
            D   + + LG+K+G G FG  YL        + A   +     +  ++   +  E++  
Sbjct: 32  DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFY 87

Query: 154 HHLAGHKNIVTIK----------------GAYEDSLCVH--IVMELCAGGELFDRIIQRG 195
             +A    I                    G  E     +  +VME   G +L     Q G
Sbjct: 88  QRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG 146

Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
            + +    +L   ++ V+E  H    +H D+K  N LL  K+ D  +   D+GLS  + P
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSYRYCP 205

Query: 256 GQ 257
             
Sbjct: 206 NG 207

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 36/238 (15%)

Query: 99  DLYTLGRKLGQGQFGTTY--LCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           +L     +LG G FG+    +       I+ A K +  ++   + D E++ RE QIMH L
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL 393

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
             +  IV + G  +    + +VME+  GG L   +   G   E   + +  ++  V    
Sbjct: 394 -DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGM 449

Query: 217 HSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV---- 269
             L      HR+L   N LLVN+      K  DFGLS                YY     
Sbjct: 450 KYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALG--------ADDSYYTARSA 498

Query: 270 --------APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGH 317
                   APE +  + +   +DVW+ GV ++  LS G  P+       +   + +G 
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 49/252 (19%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT--EIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            +       +G+G FG        +    ++ A K +  ++  S++D  D   E++++  
Sbjct: 24  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCK 81

Query: 156 LAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFD-------------RIIQRGHYSERKA 202
           L  H NI+ + GA E    +++ +E    G L D               I     S   +
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 203 AELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF 259
            +L      V            +HRDL   N L+    +++  K  DFGLS         
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLS--------- 189

Query: 260 TDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY-ILLSGVPPFWAET 305
               G   YV            A E L    Y   +DVW+ GV+L+ I+  G  P+   T
Sbjct: 190 ---RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246

Query: 306 QQGIFDAVLKGH 317
              +++ + +G+
Sbjct: 247 CAELYEKLPQGY 258

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 59/260 (22%), Positives = 100/260 (38%), Gaps = 59/260 (22%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R    L R+LG+G FG  +L       +         A K++   K  +    +D +RE 
Sbjct: 14  RRDIVLKRELGEGAFGKVFLAE--CYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREA 68

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRGHY 197
           +++ +L  H++IV   G   D   + +V E    G+L                   R   
Sbjct: 69  ELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 198 SERKAAELTRIIVGVVEACHSLGVM---HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
            E   +++  I   +      L      HRDL   N  LV    +  +K  DFG+S    
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN-CLVG--ANLLVKIGDFGMS---- 180

Query: 255 PGQIFTDVVGSPYYV------------APEVLLKHYG---PEADVWTAGVILYILLS-GV 298
                 DV  + YY              PE ++  Y     E+DVW+ GVIL+ + + G 
Sbjct: 181 -----RDVYSTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGK 233

Query: 299 PPFWAETQQGIFDAVLKGHI 318
            P++  +   + + + +G +
Sbjct: 234 QPWFQLSNTEVIECITQGRV 253

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 54/256 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R    L  +LG+G FG  +L       +         A K++   K  S    +D +RE 
Sbjct: 40  RRDIVLKWELGEGAFGKVFLA--ECHNLLPEQDKMLVAVKAL---KEASESARQDFQREA 94

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAA------- 203
           +++  L  H++IV   G   +   + +V E    G+L   +   G  ++  A        
Sbjct: 95  ELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153

Query: 204 -----ELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
                +L  +   V         L  +HRDL   N  LV       +K  DFG+S     
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN-CLVG--QGLVVKIGDFGMS----- 205

Query: 256 GQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPF 301
                D+  + YY              PE +L   +  E+DVW+ GV+L+ + + G  P+
Sbjct: 206 ----RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261

Query: 302 WAETQQGIFDAVLKGH 317
           +  +     D + +G 
Sbjct: 262 YQLSNTEAIDCITQGR 277

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 79.7 bits (197), Expect = 7e-17
 Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 61/239 (25%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R+    G+ LG G FG     T  A GI         A K +  ++     + E +  E+
Sbjct: 44  RENLEFGKVLGSGAFGKVMNAT--AYGISKTGVSIQVAVKML--KEKADSSEREALMSEL 99

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL--FDRIIQRGHYSERKAAELTRI 208
           ++M  L  H+NIV + GA   S  ++++ E C  G+L  + R  +R  +SE +     + 
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR-SKREKFSEDEIEYENQK 158

Query: 209 IVGVVEACHSL----------------------GVMHRDLKPENFLLVNKDDDFSLKAID 246
            +   E  + L                        +HRDL   N L+        +K  D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICD 215

Query: 247 FGLSVFFKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVILY 292
           FGL+          D++    YV            APE L +  Y  ++DVW+ G++L+
Sbjct: 216 FGLA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 63/308 (20%), Positives = 112/308 (36%), Gaps = 69/308 (22%)

Query: 63  DNSAPRISPSKKDNIMRRGIDNQTY----YVLGHKTDNI---RDLYTLGRKLGQGQFGTT 115
           +++A  ++    + ++ R   N  Y     +L  K  ++   R+     R +G+G FG  
Sbjct: 4   ESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRV 63

Query: 116 YLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGA 168
           +     A G+         A K +  ++  S +   D +RE  +M     + NIV + G 
Sbjct: 64  FQA--RAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF-DNPNIVKLLGV 118

Query: 169 YEDSLCVHIVMELCAGGEL---------------------FDRIIQRGHYSERKAAELTR 207
                 + ++ E  A G+L                         +          AE   
Sbjct: 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178

Query: 208 IIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
           I   V            +HRDL   N L+    ++  +K  DFGLS          ++  
Sbjct: 179 IARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLS---------RNIYS 226

Query: 265 SPYYV------------APEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWAETQQGIF 310
           + YY              PE +  + Y  E+DVW  GV+L+ + S G+ P++    + + 
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286

Query: 311 DAVLKGHI 318
             V  G+I
Sbjct: 287 YYVRDGNI 294

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 56/267 (20%), Positives = 99/267 (37%), Gaps = 66/267 (24%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           R    LG+ LG+G+FG     T  A  ++        A K +  ++  S  ++ D+  E 
Sbjct: 22  RKNLVLGKTLGEGEFGKVVKAT--AFHLKGRAGYTTVAVKML--KENASPSELRDLLSEF 77

Query: 151 QIMHHLAGHKNIVTIKGA--YEDSLCVHIVMELCAGGEL--------------------- 187
            ++  +  H +++ + GA   +  L   +++E    G L                     
Sbjct: 78  NVLKQV-NHPHVIKLYGACSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKA 244
               +           +L      + +       + ++HRDL   N L+    +   +K 
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKI 191

Query: 245 IDFGLSVFFKPGQIFTDVVGSPYYV------------APEVLLKH-YGPEADVWTAGVIL 291
            DFGLS          DV     YV            A E L  H Y  ++DVW+ GV+L
Sbjct: 192 SDFGLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

Query: 292 Y-ILLSGVPPFWAETQQGIFDAVLKGH 317
           + I+  G  P+     + +F+ +  GH
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNLLKTGH 269

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 49/257 (19%), Positives = 92/257 (35%), Gaps = 54/257 (21%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
                   +LG+ +FG  Y       G          A K++  +        E+ R E 
Sbjct: 8   LSAVRFMEELGEDRFGKVYKGH--LFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEA 63

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGEL-------------FDRIIQRGHY 197
            +   L  H N+V + G       + ++   C+ G+L                   R   
Sbjct: 64  MLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122

Query: 198 SERKAAELTRIIVGVVEACH---SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
           S  +  +   ++  +        S  V+H+DL   N +LV   D  ++K  D GL     
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN-VLVY--DKLNVKISDLGLF---- 175

Query: 255 PGQIFTDVVGSPYYV------------APEVLL-KHYGPEADVWTAGVILYILLS-GVPP 300
                 +V  + YY             APE ++   +  ++D+W+ GV+L+ + S G+ P
Sbjct: 176 -----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 301 FWAETQQGIFDAVLKGH 317
           +   + Q + + +    
Sbjct: 231 YCGYSNQDVVEMIRNRQ 247

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.6 bits (173), Expect = 9e-14
 Identities = 35/190 (18%), Positives = 71/190 (37%), Gaps = 37/190 (19%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLC-----TEIATGIEFACKSISKRKLISREDVEDVRR 148
           TD     + +G  +GQG FG  YL        + +      K       +   D   +  
Sbjct: 30  TDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK-------VEPSDNGPLFT 82

Query: 149 EIQIMHHLAGHKNIVTIK----------------GAYEDSLCVH--IVMELCAG---GEL 187
           E++     A  + I                    G ++ +   +  ++M+   G    ++
Sbjct: 83  ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKI 141

Query: 188 FDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF 247
           ++       +S +   +L+  I+ ++E  H    +H D+K  N LL  K+ D  +  +D+
Sbjct: 142 YEA--NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDY 198

Query: 248 GLSVFFKPGQ 257
           GL+  + P  
Sbjct: 199 GLAYRYCPEG 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 30/181 (16%), Positives = 60/181 (33%), Gaps = 21/181 (11%)

Query: 94  TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGI--------EFACKSISKRKLISREDVED 145
           TD     + L     +   G  Y     +T          +F+ K  +K   +  E    
Sbjct: 37  TDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFF 96

Query: 146 VRR----EIQIMHHLAG--HKNIVTIK--GAYEDSLCVHIVMELCAGGELFD--RIIQRG 195
            R     ++     L       I T    G ++D     +V+    G  L     +  + 
Sbjct: 97  QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSL-GRSLQSALDVSPKH 154

Query: 196 HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             SER   ++   ++  +E  H    +H ++  EN  + + +D   +    +G +  + P
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV-DPEDQSQVTLAGYGFAFRYCP 213

Query: 256 G 256
            
Sbjct: 214 S 214

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 60/252 (23%), Positives = 99/252 (39%), Gaps = 69/252 (27%)

Query: 86  TYYVLGHKTDNIRD--LYTLGRKLGQGQFGTTY---LCTEIATGIEFACKSISKRKLISR 140
           ++Y L + T+N  +  +   G K+G+G FG  Y   +          A K     KL + 
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVK-----KLAAM 65

Query: 141 EDVEDV------RREIQIMHHLAGHKNIVTIKG----------AYE----DSLCVHIVME 180
            D+          +EI++M     H+N+V + G           Y      SL       
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDR---- 120

Query: 181 LCAGGELFDRIIQRGHYSERKAAEL---TR--IIVGV---VEACHSLGVMHRDLKPENFL 232
                 L                 L    R  I  G    +   H    +HRD+K  N L
Sbjct: 121 ------LSCL---------DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL 165

Query: 233 LVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGV 289
           L   D+ F+ K  DFGL+   +      + + +VG+  Y+APE L     P++D+++ GV
Sbjct: 166 L---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGV 222

Query: 290 ILYILLSGVPPF 301
           +L  +++G+P  
Sbjct: 223 VLLEIITGLPAV 234

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 12/100 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEF-------ACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG        A GI+        A K +  ++  +  +   +  E+
Sbjct: 21  RDRLKLGKPLGRGAFGQVIEAD--AFGIDKTATCRTVAVKML--KEGATHSEHRALMSEL 76

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLC-VHIVMELCAGGELFD 189
           +I+ H+  H N+V + GA       + +++E C  G L  
Sbjct: 77  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 30/97 (30%), Positives = 41/97 (42%), Gaps = 26/97 (26%)

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV-------- 269
           S   +HRDL   N LL    +   +K  DFGL+          D+   P YV        
Sbjct: 211 SRKCIHRDLAARNILL---SEKNVVKICDFGLA---------RDIYKDPDYVRKGDARLP 258

Query: 270 ----APEVLLKH-YGPEADVWTAGVILY-ILLSGVPP 300
               APE +    Y  ++DVW+ GV+L+ I   G  P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)

Query: 106 KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTI 165
            LG+G FG  Y    +A G   A K + K +     +++  + E++++     H+N++ +
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRL-KEERTQGGELQ-FQTEVEMISMAV-HRNLLRL 92

Query: 166 KGAYEDSLCVH-----IVMELCAGGELFDRIIQRGHYSERKAAELT-----RIIVGVV-- 213
           +G      C+      +V    A G +   +             L      RI +G    
Sbjct: 93  RG-----FCMTPTERLLVYPYMANGSVASCL----RERPESQPPLDWPKRQRIALGSARG 143

Query: 214 -----EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--IFTDVVGSP 266
                + C    ++HRD+K  N LL   D++F     DFGL+         + T V G+ 
Sbjct: 144 LAYLHDHCD-PKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 267 YYVAPEVLLKHYGPE-ADVWTAGVILYILLSGVPPF 301
            ++APE L      E  DV+  GV+L  L++G   F
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 61/268 (22%), Positives = 105/268 (39%), Gaps = 47/268 (17%)

Query: 86  TYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED 145
               L   T+N          +G G FG  Y    +  G + A K   +R   S + +E+
Sbjct: 30  PLVDLEEATNNFDH----KFLIGHGVFGKVYKGV-LRDGAKVALK---RRTPESSQGIEE 81

Query: 146 VRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAEL 205
              EI+ +     H ++V++ G  ++   + ++ +    G L   +    + S+     +
Sbjct: 82  FETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL----YGSDLPTMSM 136

Query: 206 T-----RIIVGV---VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ 257
           +      I +G    +   H+  ++HRD+K  N LL   D++F  K  DFG+S       
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELD 193

Query: 258 ---IFTDVVGSPYYVAPEVLLKHYGPE-ADVWTAGVILYILLSGVPPF------------ 301
              + T V G+  Y+ PE  +K    E +DV++ GV+L+ +L                  
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

Query: 302 -WAETQQ------GIFDAVLKGHIDFES 322
            WA           I D  L   I  ES
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPES 281

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 2e-08
 Identities = 43/249 (17%), Positives = 76/249 (30%), Gaps = 68/249 (27%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE-----DVEDVRREIQI 152
            +      K+G+G FG  +    IA     A K I+               E++  EI I
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 153 MHHLAGH--------------KNIVTIKGAYEDSLC------------------------ 174
              L+                 ++  ++G+Y   L                         
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV 234
           + IV+E   GG   +++  +        + L ++   +  A  SL   HRDL   N LL 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 235 N---------------KDDDFSLKA--IDFGLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK 276
                                 L+   ID+ LS   + G  +F D       +  ++   
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD-----VSMDEDLFTG 251

Query: 277 HYGPEADVW 285
               + D++
Sbjct: 252 DGDYQFDIY 260

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 1e-04
 Identities = 50/338 (14%), Positives = 91/338 (26%), Gaps = 135/338 (39%)

Query: 38  SDYSTPSLNSQQLVSQEFSKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNI 97
           ++   PS+ ++  + Q   ++    DN         K N+ R                 +
Sbjct: 100 TEQRQPSMMTRMYIEQ---RDRLYNDNQ-----VFAKYNVSRL-----------QPYLKL 140

Query: 98  RD-LYTL--GRKL---GQGQFGTTYLCTEIATGIEFACKSISKRKLISRE----DVEDVR 147
           R  L  L   + +   G    G T++  +        C S   +  +  +    ++++  
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALD-------VCLSYKVQCKMDFKIFWLNLKNCN 193

Query: 148 REIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTR 207
               ++  L                L   I     +  +    I  R H  +   AEL R
Sbjct: 194 SPETVLEMLQ--------------KLLYQIDPNWTSRSDHSSNIKLRIHSIQ---AELRR 236

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPY 267
           ++              +  +  N LLV          +                      
Sbjct: 237 LL------------KSKPYE--NCLLV----------LL--------------------- 251

Query: 268 YVAPEVLLKHYGPEADVWTAGVILY------ILLSGVPPFWAETQ-QGIFDAV---LKGH 317
                          +V  A           ILL+        T+ + + D +      H
Sbjct: 252 ---------------NVQNAKAWNAFNLSCKILLT--------TRFKQVTDFLSAATTTH 288

Query: 318 IDFESDPWPLISDSAKDLIRKML-CSQ---PSERLTAH 351
           I  +     L  D  K L+ K L C     P E LT +
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	363
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.97
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.95
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.82
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.56
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.33
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.33
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.13
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.93
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.92
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.71
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.58
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.55
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.4
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.32
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.26
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.03
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.91
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.85
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.82
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.82
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.81
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.8
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.67
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.55
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.83
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.11
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.59
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.37
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.3
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	83.64
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	81.13

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-67  Score=481.19  Aligned_cols=256  Identities=32%  Similarity=0.543  Sum_probs=234.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+++|++|+ |||||+++++|++.+.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEE
Confidence            45999999999999999999999999999999998765544555788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC--
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG--  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--  256 (363)
                      ||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....  
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCC
Confidence            9999999999999999999999999999999999999999999999999999999   88899999999999986533  


Q ss_pred             -CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.+..+++..+.++.+.++.    .+++++++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~d  263 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARD  263 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHH
Confidence             23456899999999999985 6999999999999999999999999999999999999988776543    58999999


Q ss_pred             HHHHhcccCcCCCCCHHH------HhcCCCcccC
Q 017960          335 LIRKMLCSQPSERLTAHE------VLCMYNLPVL  362 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~e------vL~~~~~~~~  362 (363)
                      ||.+||.+||++|||++|      +++||||+.+
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            999999999999999988      5889999754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.5e-67  Score=469.39  Aligned_cols=254  Identities=37%  Similarity=0.624  Sum_probs=215.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++.+.........+++.+|+.+++.++ |||||++++++.+.+.+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            46999999999999999999999999999999998766555566778999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||| +|+|.+++.+.+.+++.++..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|+.......
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence            9999 78999999999999999999999999999999999999999999999999   8889999999999988766666


Q ss_pred             cccCccCCcccccccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ..+.+||+.|||||++.+ .| +.++|||||||++|+|++|+.||.+.+...+++.+..+...++    ..+++++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            677899999999999985 34 6899999999999999999999999999999999988876544    35899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||++||++|||++|+|+|+||+.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHccCChhHCcCHHHHHcCccccc
Confidence            9999999999999999999999963

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-66  Score=477.21  Aligned_cols=256  Identities=28%  Similarity=0.454  Sum_probs=229.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||+|+||+||+|.++.+|+.||||++......   ..+.+.+|+.+|+.|+ |||||+++++|.+.+.+|
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            346699999999999999999999999999999999765432   2356789999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||||+||+|.+++.+ +.+++.++..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....
T Consensus       148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCC
Confidence            99999999999998865 579999999999999999999999999999999999999   88899999999999876543


Q ss_pred             -CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.+..+.+..+..... .....+..+++++++
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  302 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  302 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHH
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHH
Confidence             34567899999999999984 699999999999999999999999999999888888876532 233345678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||..||++|||+.|+|+||||+.
T Consensus       303 li~~~L~~dP~~R~ta~e~l~Hp~~~~  329 (346)
T 4fih_A          303 FLDRLLVRDPAQRATAAELLKHPFLAK  329 (346)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence            999999999999999999999999964

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-66  Score=479.38  Aligned_cols=254  Identities=25%  Similarity=0.493  Sum_probs=224.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|++|+ |||||+++++|++.+.+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999976554 4556788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+||+|.+++...+  .+++.+++.|+.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.....
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCC
Confidence            99999999999997543  47899999999999999999999999999999999999   88899999999999876543


Q ss_pred             C-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 Q-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      . .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.+..+++..+..+....   .+..+++++++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~  255 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHH
Confidence            2 3456789999999999985 59999999999999999999999999999999999998876542   23468999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ||.+||++||++|||+.|+|+|+||+
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhh
Confidence            99999999999999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-64  Score=458.96  Aligned_cols=254  Identities=22%  Similarity=0.360  Sum_probs=221.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec----CCeEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SLCVH  176 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~  176 (363)
                      |++.+.||+|+||+||+|.++.++..||+|++..... .....+++.+|+.+|++|+ |||||+++++|.+    ...+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEE
Confidence            4778899999999999999999999999999976543 5556788999999999998 9999999999865    45689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ||||||+||+|.+++.+.+.+++..+..++.||+.||+|||++|  ||||||||+|||++  +.++.+||+|||+|+...
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCC
Confidence            99999999999999999999999999999999999999999999  99999999999993  246899999999998643


Q ss_pred             CCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                       .....+.+||+.|||||++.+.|+.++|||||||+||||+||+.||.+.. ...+...+..+..+.  .....+++++.
T Consensus       184 -~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~  260 (290)
T 3fpq_A          184 -ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIPEVK  260 (290)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCHHHH
T ss_pred             -CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC--CCCccCCHHHH
Confidence             34456789999999999998889999999999999999999999997654 445556555543321  12245789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||.+||.+||++|||+.|+|+||||+.
T Consensus       261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-64  Score=478.65  Aligned_cols=256  Identities=28%  Similarity=0.458  Sum_probs=230.0

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||+|+||+||+|.++.+|+.||||++.....   ...+.+.+|+.+|+.|+ |||||+++++|.+.+.+|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEE
Confidence            45679999999999999999999999999999999976543   23456889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||||+||+|.+++.. +.+++.++..++.||+.||+|||++|||||||||+||||   +.++.+||+|||+|......
T Consensus       225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSS
T ss_pred             EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCC
Confidence            99999999999998764 569999999999999999999999999999999999999   88899999999999876543


Q ss_pred             -CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+..... .....+..+++++++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             34567899999999999984 699999999999999999999999999999888888876533 233445678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||..||++|||+.|+|+|+||+.
T Consensus       380 li~~~L~~dP~~R~ta~ell~Hp~~~~  406 (423)
T 4fie_A          380 FLDRLLVRDPAQRATAAELLKHPFLAK  406 (423)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence            999999999999999999999999964

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-65  Score=465.79  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=221.9

Q ss_pred             cceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++|++++.||+|+||+||+|++.   .+++.||||++.+.... .....++.+|+.+|++|+ |||||++++++++.+.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCC-CTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEE
Confidence            46999999999999999999874   46789999999765432 223346888999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |||||||+||+|.+++.+.+.+++.++..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence            9999999999999999999999999999999999999999999999999999999999   8889999999999986543


Q ss_pred             -CCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 -GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                       .....+.+||+.|||||++. ..|+.++|||||||+||||++|+.||.+.+..+++..+.+....++    ..+|++++
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  254 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ  254 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence             33456789999999999998 4699999999999999999999999999999999999988776544    35899999


Q ss_pred             HHHHHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          334 DLIRKMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +||.+||++||++|||     ++|+++||||+.+
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999998     5899999999753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-63  Score=459.12  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=219.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|++.++||+|+||+||+|+++.+|+.||||++.....        ..+|+.+++.|+ |||||++++++.+.+.+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLS-SPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            458899999999999999999999999999999976532        236999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc-cEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+||+|.+++.+.+.+++.++..++.||+.||+|||++|||||||||+|||+   +.++ .+||+|||+|+......
T Consensus       129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC----
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999999999999999999999999999999999999999999999999   6666 69999999998765432


Q ss_pred             c------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          258 I------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       258 ~------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .      ....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+.....+...+........ ..++.+++
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  284 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAP  284 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCH
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCH
Confidence            1      234689999999999985 599999999999999999999999998888788888877654432 23457899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHH-------------hcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEV-------------LCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~ev-------------L~~~~~~~  361 (363)
                      ++.+||.+||.+||++|||+.|+             |+|||+..
T Consensus       285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~  328 (336)
T 4g3f_A          285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE  328 (336)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence            99999999999999999999998             57899865

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-62  Score=461.40  Aligned_cols=261  Identities=25%  Similarity=0.369  Sum_probs=225.8

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec----
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----  171 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----  171 (363)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ......+++.+|+.+|+.|+ |||||++++++..    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  128 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPY  128 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcC-CCCcceEeeeeeccccc
Confidence            35678999999999999999999999999999999997543 24556678899999999998 9999999998753    


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                        .+.+|||||||+ |+|.+++...+.+++..+..+++||+.||.|||++|||||||||+|||+   +.++.+||+|||+
T Consensus       129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGl  204 (398)
T 4b99_A          129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGM  204 (398)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTT
T ss_pred             ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecce
Confidence              467999999995 6899999988999999999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCC-----CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          250 SVFFKPG-----QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       250 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      |+.....     ....+.+||+.|||||++.+  .|+.++||||+||++|||++|++||.+.+..+.+..|.........
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9865322     23456899999999999874  4799999999999999999999999999998888887653322111


Q ss_pred             C---------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 D---------------------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 ~---------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .                           .++.+++++++||.+||..||++|||+.|+|+||||+.+
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            1                           123578999999999999999999999999999999753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.9e-61  Score=438.48  Aligned_cols=248  Identities=21%  Similarity=0.362  Sum_probs=216.3

Q ss_pred             cceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ++|.+.+.||+|+||+||+|++.     .++..||||++...   +....+++.+|+.+|++|+ |||||++++++.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCC
Confidence            56999999999999999999865     35788999999653   4556788999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          174 CVHIVMELCAGGELFDRIIQR-------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      .++||||||++|+|.++|...             ..+++.++..++.||+.||.|||+++||||||||+|||+   ++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCC
Confidence            999999999999999999764             358999999999999999999999999999999999999   8889


Q ss_pred             cEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHc
Q 017960          241 SLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~  315 (363)
                      .+||+|||+|+.......   .....||+.|||||++. +.|+.++|||||||+||||+| |+.||.+.+..++...+.+
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986544332   22356899999999998 569999999999999999998 9999999999999999888


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +....   ....+|+++.+||.+||+.||++|||+.||+..
T Consensus       246 ~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~  283 (299)
T 4asz_A          246 GRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTL  283 (299)
T ss_dssp             TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            76432   224689999999999999999999999999653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.7e-60  Score=444.67  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=211.9

Q ss_pred             cccccceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..+.++|++.+.||+|+||+||+|+++   .+++.||||.+.+..     ...++.+|+++|+.+.+||||++++++|.+
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            346788999999999999999999875   457889999986532     245688999999999779999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      .+.+|||||||+|++|.+++   +.+++.+++.++.||+.||+|||++|||||||||+|||++  .+.+.+||+|||+|+
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQ  166 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred             CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCc
Confidence            99999999999999999988   3589999999999999999999999999999999999994  233799999999997


Q ss_pred             ecCCCC-----------------------------ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCC
Q 017960          252 FFKPGQ-----------------------------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPP  300 (363)
Q Consensus       252 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~p  300 (363)
                      ......                             ...+.+||+.|||||++.+  .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            654321                             2245689999999999874  489999999999999999999999


Q ss_pred             CCCc-CHHHHHHHHHcC--------------------------------------C------------cccCCCCCCCCC
Q 017960          301 FWAE-TQQGIFDAVLKG--------------------------------------H------------IDFESDPWPLIS  329 (363)
Q Consensus       301 f~~~-~~~~~~~~i~~~--------------------------------------~------------~~~~~~~~~~~~  329 (363)
                      |... +..+.+..+..-                                      .            .....+.+..++
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            9644 333333333210                                      0            001112355789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ++++|||.+||+.||++|+|++|+|+||||+.+
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-60  Score=439.92  Aligned_cols=249  Identities=21%  Similarity=0.346  Sum_probs=211.5

Q ss_pred             cceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ++|.+.++||+|+||+||+|++.     .+++.||||++...   +....++|.+|+.+|++|+ |||||++++++.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            45888999999999999999864     36789999999643   4566788999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC
Q 017960          174 CVHIVMELCAGGELFDRIIQR---------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~  238 (363)
                      .+|||||||++|+|.+++...               +++++.++..|+.||+.||.|||+++||||||||+|||+   ++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence            999999999999999998753               358999999999999999999999999999999999999   78


Q ss_pred             CccEEEeecCcceecCCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHH
Q 017960          239 DFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAV  313 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i  313 (363)
                      ++.+||+|||+|+......   .....+||+.|||||++.+ .|+.++|||||||+||||+| |+.||.+....+++..+
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            8999999999998764332   2345679999999999984 69999999999999999999 99999999999988888


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .++...   +....+++++.+|+.+||+.||++|||+.||++++
T Consensus       274 ~~g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L  314 (329)
T 4aoj_A          274 TQGREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL  314 (329)
T ss_dssp             HHTCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred             HcCCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            876432   22346899999999999999999999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-60  Score=435.76  Aligned_cols=252  Identities=27%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-----
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-----  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----  173 (363)
                      ++|++++.||+|+||+||+|+++.+++.||||++....  .....+++.+|+.+|++|+ |||||+++++|.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            35999999999999999999999999999999997543  4555678999999999998 999999999987544     


Q ss_pred             -------eEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEE
Q 017960          174 -------CVHIVMELCAGGELFDRIIQRGHY---SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       174 -------~~~iv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                             .+|||||||+||+|.+++...+.+   .+..+..++.||+.||+|||++|||||||||+|||+   +.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEE
Confidence                   479999999999999999876653   456788999999999999999999999999999999   7888999


Q ss_pred             EeecCcceecCCCCc-------------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-H
Q 017960          244 AIDFGLSVFFKPGQI-------------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ-G  308 (363)
Q Consensus       244 l~DFG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~  308 (363)
                      |+|||+|+.......             .++.+||+.|||||++.+ .|+.++|||||||++|||++   ||.+.... .
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987654321             234689999999999985 69999999999999999996   88654322 2


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .+..+....++   +.+...++++.+||.+||++||++|||+.|+|+|+||+.+
T Consensus       236 ~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          236 TLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            33344433321   1122346778999999999999999999999999999754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-60  Score=433.28  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +++++.+.||+|+||+||+|++..   .||||+++... .+....+.+.+|+.++++|+ |||||++++++.+ +.++||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEE
Confidence            458889999999999999998532   69999986543 35666788999999999998 9999999998755 568999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      ||||+||+|.++|... +.+++.++..|+.||+.||+|||+++||||||||+|||+   ++++.+||+|||+|+..... 
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCC
Confidence            9999999999999764 579999999999999999999999999999999999999   78899999999999865432 


Q ss_pred             --CccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHH-HcCCccc-CCCCCCCC
Q 017960          257 --QIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV-LKGHIDF-ESDPWPLI  328 (363)
Q Consensus       257 --~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i-~~~~~~~-~~~~~~~~  328 (363)
                        ......+||+.|||||++.+    .|+.++|||||||+||||+||+.||.+.........+ ..+.... ....+..+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  266 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC  266 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence              23456789999999999852    4899999999999999999999999886655444444 4332221 12334578


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++++.+||.+||+.||++|||+.||++++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            99999999999999999999999987654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6e-60  Score=467.35  Aligned_cols=262  Identities=35%  Similarity=0.557  Sum_probs=240.5

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.+-++|++++.||+|+||+||+|.++.+|+.||+|++.+.   .....+.+.+|+.+|+.|+ |||||+++++|.+...
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCE
Confidence            34557899999999999999999999999999999999764   3445678899999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      +|||||||+||+|++++.. .+.+++.++..+++||+.||+|||++||+||||||+|||+.. +..+.+||+|||+|+..
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEEC
T ss_pred             EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEc
Confidence            9999999999999999864 467999999999999999999999999999999999999943 23478999999999998


Q ss_pred             CCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........+||+.|||||++.+ .|+.++|||||||+||||++|..||.+.+..+.+..+......++...+..+++++
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  387 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG  387 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            87777778899999999999985 59999999999999999999999999999999999999988887777778899999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++||.+||+.||.+|||+.|+|+|+||+.
T Consensus       388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          388 KDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence            99999999999999999999999999974

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.2e-60  Score=434.26  Aligned_cols=250  Identities=20%  Similarity=0.333  Sum_probs=217.4

Q ss_pred             cceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..+++.+.||+|+||+||+|...     .+++.||||++....  .....++|.+|+.++++|+ |||||+++|++.+.+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECC
Confidence            34788899999999999999853     467889999996543  3445678999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC
Q 017960          174 CVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~  237 (363)
                      .++||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+||||   +
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---Y  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---C
Confidence            999999999999999999653                358999999999999999999999999999999999999   8


Q ss_pred             CCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHH
Q 017960          238 DDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA  312 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~  312 (363)
                      +++.+||+|||+|+......   .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+.+..++...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            88999999999998654332   234568999999999988 579999999999999999998 8999999999999998


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       313 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +..+....   ....+++++.+|+.+||+.||++|||+.||++++
T Consensus       260 i~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L  301 (308)
T 4gt4_A          260 IRNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL  301 (308)
T ss_dssp             HHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            88765432   2346899999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8e-59  Score=458.36  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=220.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHH---HHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE---IQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+|   +.+++.+. |||||+++++|++.+.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEECCEE
Confidence            569999999999999999999999999999999976544333333344444   45555555 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |||||||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.+|++||+|||+|+....
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecCC
Confidence            9999999999999999999999999999999999999999999999999999999999   8899999999999988755


Q ss_pred             CCccccCccCCccccccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH---HHHHHHHHcCCcccCCCCCCCCCH
Q 017960          256 GQIFTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .. ..+.+||+.|||||++. + .|+.++|||||||+||||++|.+||.+...   ..+...+......++    ..+++
T Consensus       345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~  419 (689)
T 3v5w_A          345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSP  419 (689)
T ss_dssp             CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCH
Confidence            43 45679999999999996 3 599999999999999999999999976433   345555655544433    46899


Q ss_pred             HHHHHHHHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          331 SAKDLIRKMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      ++++||.+||++||.+|++     ++||++||||+.+
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999998     7999999999754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-58  Score=431.42  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=213.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATG-----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-  171 (363)
                      .++|++++.||+|+||+||+|.+...+     +.||||.+....  .....+.+.+|+.+|.++.+|||||+++++|.+ 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            467999999999999999999976543     579999986543  445567899999999999856999999999865 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeee
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN  235 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~  235 (363)
                      .+.++||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+|||+  
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--  218 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  218 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence            56789999999999999999753                347899999999999999999999999999999999999  


Q ss_pred             CCCCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCH-HHH
Q 017960          236 KDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQ-QGI  309 (363)
Q Consensus       236 ~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~-~~~  309 (363)
                       ++++.+||+|||+|+....+.   .....+||+.|||||++. +.|+.++|||||||+||||+| |..||.+... ..+
T Consensus       219 -~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          219 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             -CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             -CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             888999999999998765433   223567899999999998 569999999999999999998 9999988654 444


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+..+...   .....+++++.+||.+||+.||++|||+.||++|+
T Consensus       298 ~~~i~~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L  342 (353)
T 4ase_A          298 CRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  342 (353)
T ss_dssp             HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            5555554321   22245799999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.3e-56  Score=418.06  Aligned_cols=264  Identities=38%  Similarity=0.634  Sum_probs=239.7

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ...+.+.|++++.||+|+||.||+|.++.+|+.||+|++.+......   ...+.+.+|+.+++.+. ||||+++++++.
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~   85 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYE   85 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEE
Confidence            44577889999999999999999999999999999999976543221   23578899999999998 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc----cEEEee
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAID  246 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~----~~kl~D  246 (363)
                      +...+++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   ++++    .+||+|
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll---~~~~~~~~~vkl~D  162 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML---LDKNIPIPHIKLID  162 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---SCTTSSSCCEEECC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---eCCCCCccCEEEEe
Confidence            999999999999999999999888889999999999999999999999999999999999999   4444    799999


Q ss_pred             cCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      ||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....+.+..+......++...+
T Consensus       163 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  242 (361)
T 2yab_A          163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF  242 (361)
T ss_dssp             CSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             cCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence            999998776666677889999999999984 6999999999999999999999999999999999999988877766666


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+++++++||.+||..||.+|||+.|+|+||||..
T Consensus       243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            778999999999999999999999999999999974

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-55  Score=407.97  Aligned_cols=255  Identities=36%  Similarity=0.605  Sum_probs=233.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.+... .....+++.+|+.+++.++ ||||+++++++...+..|+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEE
Confidence            3569999999999999999999999999999999976543 5566778999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....+.
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSC
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCCC
Confidence            99999999999999988999999999999999999999999999999999999999   888999999999998877666


Q ss_pred             ccccCccCCcccccccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+..+....+..+....+.    .+++++.+|
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  244 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENL  244 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence            6777899999999999974 44 57899999999999999999999999999999999888765443    478999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |.+||..||.+|||+.|+|+|+|+..
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcC
Confidence            99999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.9e-56  Score=415.65  Aligned_cols=265  Identities=38%  Similarity=0.698  Sum_probs=242.1

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.+.|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  101 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEES  101 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            34566789999999999999999999999999999999976543 4556678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..|+||||++|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++...
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999999999988888999999999999999999999999999999999999965445567999999999887


Q ss_pred             CCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..........||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.........+..+...++...+..+++++
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            66665667889999999999985 69999999999999999999999999999999999999988887777777899999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+||.+||+.||++|||+.++|+|+|+.
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~  289 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWIC  289 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence            9999999999999999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2e-55  Score=423.19  Aligned_cols=264  Identities=39%  Similarity=0.688  Sum_probs=239.8

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~   84 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK-HPNIVRLHDSISEEGH   84 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCE
Confidence            3567789999999999999999999999999999999976543 3445678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      .++||||+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+....+++.+||+|||++....
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999999999999999999999999999999999999999999999999999654467899999999998765


Q ss_pred             CCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          255 PGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       255 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.........+..+...++...+..+++++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            433 3456789999999999985 69999999999999999999999999999999999999999888888888999999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+||.+||+.||.+|||+.|+|+|||+.
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence            9999999999999999999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-55  Score=412.38  Aligned_cols=257  Identities=29%  Similarity=0.506  Sum_probs=228.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+.........+.+.+|..++..+.+||||+++++++.+.+.+|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            45999999999999999999999999999999998754444555678889999999986799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~  257 (363)
                      |||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|.... ...
T Consensus       103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccCCc
Confidence            9999999999999998899999999999999999999999999999999999999   888999999999998643 233


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..+++..+..+...++.    .+++++.+||
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  255 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATGIL  255 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            4456789999999999984 5999999999999999999999999999999999999988766543    4789999999


Q ss_pred             HHhcccCcCCCCCH------HHHhcCCCcccC
Q 017960          337 RKMLCSQPSERLTA------HEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s~------~evL~~~~~~~~  362 (363)
                      .+||+.||.+||++      .|+++|+||..+
T Consensus       256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            99999999999998      899999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.6e-55  Score=404.82  Aligned_cols=256  Identities=32%  Similarity=0.520  Sum_probs=230.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+.+|+|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999997654333445678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~  257 (363)
                      |||++|++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCC
Confidence            9999999999999988899999999999999999999999999999999999999   888999999999998633 334


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.........+......++    ..+++++.+||
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  236 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            4566789999999999984 699999999999999999999999999998888888887765544    35799999999


Q ss_pred             HHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          337 RKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      .+||+.||.+||     ++.|+++|+||..+
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            999999999999     99999999999653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-55  Score=406.02  Aligned_cols=260  Identities=28%  Similarity=0.520  Sum_probs=235.3

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   76 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIAR-HRNILHLHESFESMEEL   76 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEE
Confidence            3567899999999999999999999999999999998643    344567889999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++....
T Consensus        77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECC
Confidence            99999999999999997654 6999999999999999999999999999999999999942 126899999999999887


Q ss_pred             CCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .+.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+......+....++.+++++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            7666677789999999999985 489999999999999999999999999999999999998887776666678899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||.+||..||.+|||+.|+|+||||+.
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            9999999999999999999999999854

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-55  Score=403.86  Aligned_cols=249  Identities=22%  Similarity=0.256  Sum_probs=193.1

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----  173 (363)
                      .++|.+.+.||+|+||+||+|++  +|+.||||++....    ........|+..+.+++ |||||++++++.+.+    
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~   74 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCce
Confidence            35689999999999999999985  68899999986432    11222345666667787 999999999997654    


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecCCCCCceEeeeCCCCccEEEe
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL--------GVMHRDLKPENFLLVNKDDDFSLKAI  245 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~--------~iiHrDlkp~NIll~~~~~~~~~kl~  245 (363)
                      .+|||||||++|+|.+++... .+++..+..++.|++.||+|||++        +||||||||+|||+   +.++.+||+
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~  150 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred             EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEE
Confidence            589999999999999998754 689999999999999999999987        99999999999999   889999999


Q ss_pred             ecCcceecCCCCc-----cccCccCCcccccccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCc---------
Q 017960          246 DFGLSVFFKPGQI-----FTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAE---------  304 (363)
Q Consensus       246 DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~ell~g~~pf~~~---------  304 (363)
                      |||+|+.......     ....+||+.|||||++.+       .|+.++|||||||+||||+||..||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            9999987654332     224689999999999864       3678999999999999999997765221         


Q ss_pred             ------CHHHHHHHHHcCCcccCCCC-C--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          305 ------TQQGIFDAVLKGHIDFESDP-W--PLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       305 ------~~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                            ........+.........+. +  ...++.+.+|+.+||+.||++|||+.||++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  292 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                  12334444443332211111 1  11235788999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=402.50  Aligned_cols=263  Identities=39%  Similarity=0.651  Sum_probs=235.6

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..+.+.|++.+.||+|+||.||+|.+..+++.||+|++.+......   ...+.+.+|+.+++.++ ||||+++++++.+
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            3566789999999999999999999999999999999976543221   23578899999999998 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc----cEEEeec
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDF  247 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~----~~kl~DF  247 (363)
                      ....++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++    .+||+||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll---~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML---LDRNVPKPRIKIIDF  162 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---SCSSSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEE---ecCCCCCCCEEEEEC
Confidence            99999999999999999999888889999999999999999999999999999999999999   4444    7999999


Q ss_pred             CcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      |++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+....+.
T Consensus       163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (326)
T 2y0a_A          163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  242 (326)
T ss_dssp             TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             CCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence            9998876666666778999999999987 469999999999999999999999999999888888888776665554456


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+++++.+||.+||+.||++|||+.|+|+|+||..
T Consensus       243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            78999999999999999999999999999999964

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1e-54  Score=424.84  Aligned_cols=268  Identities=38%  Similarity=0.651  Sum_probs=240.1

Q ss_pred             ccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      .....+.++|++++.||+|+||+||+|.++.++..||+|++.+... .......+.+|+.+++.+. ||||+++++++.+
T Consensus        30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  107 (494)
T 3lij_A           30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLD-HPNIMKLYDFFED  107 (494)
T ss_dssp             CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe
Confidence            3445677889999999999999999999999999999999976543 2233567889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ...+++|||||++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999999999999999988899999999999999999999999999999999999999654556779999999998


Q ss_pred             ecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+....+..+...+..+.|..++++
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            87766666778899999999999888999999999999999999999999999999999999999888887778889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||+.||.+|||+.|+|+|||++.
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            999999999999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-55  Score=427.90  Aligned_cols=269  Identities=43%  Similarity=0.706  Sum_probs=247.8

Q ss_pred             ccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      .....+.++|++.+.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.+++++. ||||+++++++.+
T Consensus        19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~   97 (484)
T 3nyv_A           19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFED   97 (484)
T ss_dssp             CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            344567788999999999999999999999999999999998765544556788999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ...+++||||+.+++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999999999999988899999999999999999999999999999999999999655567899999999998


Q ss_pred             ecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ...........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+....+..+...+..+.|..++++
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             EcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            87766666677899999999999888999999999999999999999999999999999999999888777777889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +++||.+||+.||.+|||+.|+|+|||++.
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            999999999999999999999999999863

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-54  Score=409.09  Aligned_cols=257  Identities=25%  Similarity=0.449  Sum_probs=225.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.++||+|+||+||+|+++.+++.||||++.+.........+.+.+|..++.++.+||||+++++++.+...+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            45999999999999999999999999999999998776555555677889999999986699999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee-cCCCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF-FKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~-~~~~~  257 (363)
                      |||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+. .....
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccCCC
Confidence            9999999999999988899999999999999999999999999999999999999   8889999999999986 33444


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---------CHHHHHHHHHcCCcccCCCCCCC
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---------TQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||...         ....+.+.+......++    ..
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~  284 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS  284 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----TT
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----Cc
Confidence            5667899999999999984 6999999999999999999999999532         23345666666655444    35


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCcccC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTA------HEVLCMYNLPVL  362 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~------~evL~~~~~~~~  362 (363)
                      +++++.+||.+||+.||.+||++      .|+++|+||..+
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            79999999999999999999985      799999999754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.9e-54  Score=388.90  Aligned_cols=264  Identities=38%  Similarity=0.696  Sum_probs=241.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEE
Confidence            467889999999999999999999999999999999976543 5566778999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++||||+++++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||++..++..+.+||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999999999999888899999999999999999999999999999999999995544455699999999988776


Q ss_pred             CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+..+...++...+..+++++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHH
Confidence            666667789999999999884 5899999999999999999999999999999999999988888777777789999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||++|||+.|+|+|+||..
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICN  267 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccC
Confidence            999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-54  Score=424.15  Aligned_cols=269  Identities=39%  Similarity=0.640  Sum_probs=239.5

Q ss_pred             ccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh----------hhHHHHHHHHHHHHHhcCCCc
Q 017960           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR----------EDVEDVRREIQIMHHLAGHKN  161 (363)
Q Consensus        92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~n  161 (363)
                      .....+.++|++++.||+|+||+||+|.+..+++.||+|++.+......          ...+.+.+|+.++++++ |||
T Consensus        29 ~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn  107 (504)
T 3q5i_A           29 KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPN  107 (504)
T ss_dssp             EECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTT
T ss_pred             ccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCC
Confidence            3455677889999999999999999999999999999999976543211          34577899999999997 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc
Q 017960          162 IVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       162 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      |+++++++.+...+++|||||+|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+..++....
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999999999999998889999999999999999999999999999999999999954333447


Q ss_pred             EEEeecCcceecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      +||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+....+..+...+.
T Consensus       188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99999999998776666677889999999999988899999999999999999999999999999999999999887777


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ...|..+++++++||.+||+.||.+|||+.|+|+|+|++.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            6667789999999999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.1e-55  Score=425.15  Aligned_cols=265  Identities=42%  Similarity=0.696  Sum_probs=240.6

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||||++.+... .......+.+|+.++++++ ||||+++++++.+...
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCE
Confidence            4577889999999999999999999999999999999975433 2234577899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +++|||||.+++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999999999988899999999999999999999999999999999999999665567789999999998776


Q ss_pred             CCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ........+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+....+.+..+..+...+..+.+..+++++++
T Consensus       176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             CC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            66666678899999999999988999999999999999999999999999999999999999888877777889999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||.+|||+.++|+|||++.
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.4e-54  Score=402.90  Aligned_cols=257  Identities=27%  Similarity=0.435  Sum_probs=230.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+.+||||+++++++.+...+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            45999999999999999999999999999999997654333344667889999999885599999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~  257 (363)
                      |||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++..... ..
T Consensus        97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCC
Confidence            9999999999999988899999999999999999999999999999999999999   8889999999999986432 23


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..++...+......++    ..+++++.+||
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  249 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLL  249 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHHH
Confidence            4456789999999999984 599999999999999999999999999999999998887765443    35789999999


Q ss_pred             HHhcccCcCCCCCHH-HHhcCCCcccC
Q 017960          337 RKMLCSQPSERLTAH-EVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~-evL~~~~~~~~  362 (363)
                      .+||+.||++||++. ++++|+||..+
T Consensus       250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          250 VKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHhcCCHhHcCCChHHHHcCccccCC
Confidence            999999999999998 99999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.6e-54  Score=390.43  Aligned_cols=263  Identities=41%  Similarity=0.753  Sum_probs=240.0

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.++|++.+.||+|+||.||+|.+..++..||+|++.....   ...+.+.+|+.++++++ ||||+++++++.+...
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTD   80 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCe
Confidence            4567789999999999999999999999999999999976532   33577899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+..++.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999999999988889999999999999999999999999999999999999665677899999999998877


Q ss_pred             CCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .........||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+..+...++...+..+++++.+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES  240 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred             CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence            66666778899999999999888999999999999999999999999999999999888888776665555678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||.+|||+.++|+|+||+.
T Consensus       241 li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          241 LIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-53  Score=398.30  Aligned_cols=257  Identities=25%  Similarity=0.438  Sum_probs=227.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|+++.+++.||||++.+.........+.+.+|+.++.++.+||||+++++++.+...+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            45999999999999999999999999999999998876666677788999999999985699999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~  257 (363)
                      |||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ...
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccccccCCCC
Confidence            9999999999999988899999999999999999999999999999999999999   888999999999998632 334


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC---------cCHHHHHHHHHcCCcccCCCCCCC
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA---------ETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .....+||+.|+|||++.+ .++.++|||||||++|||++|..||..         .....+...+......++    ..
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~  241 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS  241 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TT
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CC
Confidence            4566789999999999984 699999999999999999999999965         233445666666655443    35


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCcccC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTA------HEVLCMYNLPVL  362 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~------~evL~~~~~~~~  362 (363)
                      ++.++.+||.+||+.||.+||++      .|+++|+||..+
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            78999999999999999999995      899999999753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-54  Score=395.35  Aligned_cols=254  Identities=27%  Similarity=0.517  Sum_probs=230.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEEE
Confidence            45999999999999999999999999999999997654333345677889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....  .
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--V  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--C
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC--c
Confidence            9999999999999988899999999999999999999999999999999999999   8889999999999987543  3


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+.......+......++    ..+++++.+||.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  235 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  235 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            346789999999999884 699999999999999999999999999998888888888765544    357899999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          338 KMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       338 ~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      +||..||.+||     +++++++|+||..+
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            99999999999     99999999999754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.1e-54  Score=402.61  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=230.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.++.+++.||||++.+.........+.+..|..++..+.+||+|+++++++.+.+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            45999999999999999999999999999999998754333445677889999999886699999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~  257 (363)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.... ...
T Consensus       100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccccCCc
Confidence            9999999999999988899999999999999999999999999999999999999   888999999999998643 233


Q ss_pred             ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....+||+.|+|||++. ..++.++|||||||++|||++|..||.+....+++..+......++.    .+++++.+||
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  252 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC  252 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred             ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence            455678999999999997 46999999999999999999999999999999999999887765543    5799999999


Q ss_pred             HHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          337 RKMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      .+||+.||.+||+     +.++++|+||..+
T Consensus       253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999994     6999999999753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.8e-54  Score=403.86  Aligned_cols=266  Identities=35%  Similarity=0.611  Sum_probs=228.4

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ...+.+.|++.+.||+|+||.||+|.++.+++.||||++.......  ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus        19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~   97 (351)
T 3c0i_A           19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSS   97 (351)
T ss_dssp             -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            3456778999999999999999999999999999999997543211  123577899999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      .+.+|+|||||+|++|.+.+...    ..+++..+..++.||+.||.|||++||+||||||+|||+..++....+||+||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence            99999999999999998887643    24899999999999999999999999999999999999955444556999999


Q ss_pred             CcceecCCCCc-cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          248 GLSVFFKPGQI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       248 G~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      |++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. .......+..+........+
T Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH
T ss_pred             cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc
Confidence            99987654432 445789999999999984 5999999999999999999999999875 45667777777665555455


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+++++.+||.+||..||++|||+.|+|+|+|+..
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            678999999999999999999999999999999853

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-53  Score=402.75  Aligned_cols=263  Identities=33%  Similarity=0.551  Sum_probs=236.0

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.+.|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++.++ ||||+++++++.+..
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKY  121 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSS
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCC
Confidence            344667899999999999999999999999999999999754   2344567899999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      .+++||||+.|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++..
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEeccccee
Confidence            9999999999999999887654 6899999999999999999999999999999999999942 2356899999999998


Q ss_pred             cCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          253 FKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ...........||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+....+......+....+..++++
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  280 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE  280 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHH
Confidence            766665666789999999999984 5899999999999999999999999999988888888888777777777789999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||..||.+|||+.|+|+|+|+..
T Consensus       281 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (387)
T 1kob_A          281 AKDFIKNLLQKEPRKRLTVHDALEHPWLKG  310 (387)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence            999999999999999999999999999963

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=399.13  Aligned_cols=262  Identities=39%  Similarity=0.670  Sum_probs=215.5

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.+.|++.+.||+|+||.||+|.+..+++.||||++....     ..+.+.+|+.++++++ ||||+++++++.+..
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPT  121 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCC-CCCCcceeeeEecCC
Confidence            3456778999999999999999999999999999999997532     3456889999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++...
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999999999988888999999999999999999999999999999999999954445889999999999876


Q ss_pred             CCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCcccCCCCCCCCCHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQG-IFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ..........||+.|+|||++.+ .++.++|||||||++|||++|..||.+..... ....+......+....+..++.+
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            65555566789999999999885 59999999999999999999999997665544 67777777666666666788999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||+.||++|||+.|+|+|+||..
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999999964

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-54  Score=410.39  Aligned_cols=260  Identities=31%  Similarity=0.449  Sum_probs=228.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|+
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEE
Confidence            356999999999999999999999999999999997643322233345788999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|.......
T Consensus       147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTS
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccCC
Confidence            9999999999998865 468999999999999999999999999999999999999   888999999999998765443


Q ss_pred             --ccccCccCCcccccccccc-c----CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          258 --IFTDVVGSPYYVAPEVLLK-H----YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~-~----~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                        .....+||+.|+|||++.+ .    |+.++|||||||++|||++|..||.+.+..+.+..+.........+.+..+++
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  302 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK  302 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCH
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccH
Confidence              2346789999999999873 2    78999999999999999999999999999999999887654444444557899


Q ss_pred             HHHHHHHHhcccCcCC--CCCHHHHhcCCCcccC
Q 017960          331 SAKDLIRKMLCSQPSE--RLTAHEVLCMYNLPVL  362 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~--R~s~~evL~~~~~~~~  362 (363)
                      ++++||.+||..+|.+  |++++||++|+||+.+
T Consensus       303 ~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            9999999999999988  9999999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-53  Score=398.90  Aligned_cols=254  Identities=30%  Similarity=0.528  Sum_probs=231.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.+++.+. ||||+++++++.+...+|+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEE
Confidence            356999999999999999999999999999999997654433445678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||++|++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus       119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceeccCC-
Confidence            99999999999999988899999999999999999999999999999999999999   88899999999999876433 


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                       ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+.+..+..+...++    ..+++++.+||
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  269 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLL  269 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHH
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence             345789999999999874 699999999999999999999999999999999999988866544    35799999999


Q ss_pred             HHhcccCcCCCCC-----HHHHhcCCCccc
Q 017960          337 RKMLCSQPSERLT-----AHEVLCMYNLPV  361 (363)
Q Consensus       337 ~~~l~~dp~~R~s-----~~evL~~~~~~~  361 (363)
                      .+||+.||.+||+     +.|+++|+||..
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            9999999999998     999999999965

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.8e-54  Score=400.72  Aligned_cols=260  Identities=37%  Similarity=0.608  Sum_probs=229.1

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.+.|++.+.||+|+||.||+|.++.+++.||||++.+...       ...+|++++.++.+||||+++++++.+..
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            34567889999999999999999999999999999999976532       23468888988866999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC-CCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~~kl~DFG~a~~  252 (363)
                      ..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+ ..+.+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999999999999888899999999999999999999999999999999999984322 234699999999987


Q ss_pred             cCCC-CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCC---cCHHHHHHHHHcCCcccCCCCCCC
Q 017960          253 FKPG-QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWA---ETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       253 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+   ....++...+..+.+.+....+..
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            6443 34456789999999999985 589999999999999999999999975   456778888888888877777788


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +++++.+||.+||..||++|||+.++|+|+||.
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            999999999999999999999999999999984

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2e-53  Score=386.68  Aligned_cols=263  Identities=35%  Similarity=0.587  Sum_probs=225.4

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.++|++.+.||+|+||.||+|.+..++..||+|++....  .....+.+.+|+.+++.++ ||||+++++++.+...
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCe
Confidence            356678999999999999999999999999999999997654  3334678899999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          175 VHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      .++||||+++++|.+.+..    ...+++..+..++.||+.||.|||+.||+||||||+|||+...+.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999998854    367999999999999999999999999999999999999965555678999999999


Q ss_pred             eecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......+.... ..+++
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  253 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTP  253 (285)
T ss_dssp             CC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCH
T ss_pred             eecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccccc-CcCCH
Confidence            87766555667789999999999988899999999999999999999999999888877777666554443322 34789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus       254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            9999999999999999999999999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-53  Score=400.25  Aligned_cols=257  Identities=26%  Similarity=0.455  Sum_probs=228.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ ||||++++++|.+...+|+
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEE
Confidence            366999999999999999999999999999999997655444455678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTC
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeeccCCC
Confidence            99999999999999988889999999999999999999999999999999999999   888999999999999877666


Q ss_pred             ccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          258 IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .....+||+.|+|||++..    .|+.++|||||||++|||++|..||...   ........+......++    ..+++
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~  245 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQ  245 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCH
Confidence            6778899999999999862    4899999999999999999999999743   33455555555544333    35789


Q ss_pred             HHHHHHHHhcccCcCCCCC-HHHHhcCCCcccC
Q 017960          331 SAKDLIRKMLCSQPSERLT-AHEVLCMYNLPVL  362 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s-~~evL~~~~~~~~  362 (363)
                      ++.+||.+||+.||.+||+ +.+++.|+||..+
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            9999999999999999998 9999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.8e-53  Score=387.19  Aligned_cols=257  Identities=30%  Similarity=0.456  Sum_probs=223.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++.....   ...+.+.+|+.+++.++ ||||+++++++...+..
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEE
Confidence            345679999999999999999999999999999999976543   23467889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCC
Confidence            9999999999999988764 68999999999999999999999999999999999999   7888999999999987654


Q ss_pred             CC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....... ......+++.+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  247 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSAIFR  247 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CSCGGGSCHHHH
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CCCccccCHHHH
Confidence            33 3445789999999999874 69999999999999999999999998887776665555433221 122345789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||.+||+.||++|||+.|+|+|+||+.
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~  275 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKI  275 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhcc
Confidence            9999999999999999999999999964

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.5e-53  Score=400.54  Aligned_cols=259  Identities=37%  Similarity=0.607  Sum_probs=226.3

Q ss_pred             ccceee--cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           98 RDLYTL--GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        98 ~~~y~~--~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.|.+  .+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.++++++ ||||+++++++.+.+..
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  161 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDI  161 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEE
Confidence            344555  67899999999999999999999999999764   3345678999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+.. +.++.+||+|||++....
T Consensus       162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecC
Confidence            9999999999999988664 46899999999999999999999999999999999999954 345789999999999877


Q ss_pred             CCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .........||+.|+|||++. ..++.++|||||||++|||++|..||.+....+.+..+......+....+..+++++.
T Consensus       241 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  320 (373)
T 2x4f_A          241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK  320 (373)
T ss_dssp             TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred             CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence            666666678999999999987 4589999999999999999999999999999999998888777666666678899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||.+||+.||.+|||+.|+|+|+||..
T Consensus       321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          321 EFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            9999999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.1e-53  Score=394.13  Aligned_cols=270  Identities=27%  Similarity=0.496  Sum_probs=234.9

Q ss_pred             ccccccccceeec-ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           92 HKTDNIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        92 ~~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ...+.+.++|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+.+||||+++++++.
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            3455678889997 899999999999999999999999999976543 33446788999999999987899999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      +....++||||+.+++|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||+.....++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            999999999999999999988543  568999999999999999999999999999999999999433337899999999


Q ss_pred             cceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+....+..
T Consensus       180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence            999876655556678999999999988 4689999999999999999999999999999888888888877777777778


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      +++++.+||.+||+.||++|||+.++|+|+||+.+
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            99999999999999999999999999999999753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.5e-53  Score=391.50  Aligned_cols=264  Identities=38%  Similarity=0.645  Sum_probs=235.5

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..+.+.|++.+.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.+++.+. ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            3466789999999999999999999999999999999976543221   13578999999999998 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc----cEEEeec
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDF  247 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~----~~kl~DF  247 (363)
                      ....++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++    .+||+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~---~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML---LDKNIPIPHIKLIDF  163 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---SCTTSSSCCEEECCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE---ecCCCCcCCEEEccC
Confidence            99999999999999999999888889999999999999999999999999999999999999   5555    7999999


Q ss_pred             CcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      |++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......++...+.
T Consensus       164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            9998877665566778999999999987 468999999999999999999999999999888888888776655444445


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .+++++.+||.+||+.||++|||+.|+|+|+||..+
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            688999999999999999999999999999999753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-54  Score=402.49  Aligned_cols=256  Identities=35%  Similarity=0.586  Sum_probs=223.2

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++ ||||+++++++......+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   85 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIV   85 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEE
Confidence            3456999999999999999999999999999999997654323333467899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+ +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++.....+
T Consensus        86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTTTS
T ss_pred             EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceeccCC
Confidence            999999 78999999988899999999999999999999999999999999999999   88889999999999887766


Q ss_pred             CccccCccCCccccccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.........+.......    ...+++++.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~  237 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM----PDFLSPGAQS  237 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC----CTTSCHHHHH
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC----cccCCHHHHH
Confidence            666778899999999999853 4 789999999999999999999997765544433333322222    2357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||.+|||+.|+++||||..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            999999999999999999999999853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-53  Score=409.92  Aligned_cols=261  Identities=27%  Similarity=0.472  Sum_probs=227.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.++||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..+. ||||++++++|.+...+|+
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEE
Confidence            467999999999999999999999999999999997643322233345888999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||++||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence            9999999999999987 5679999999999999999999999999999999999999   88899999999999876544


Q ss_pred             Cc--cccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC-CCCC
Q 017960          257 QI--FTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD-PWPL  327 (363)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~  327 (363)
                      ..  ....+||+.|+|||++.      +.|+.++|||||||++|||++|+.||.+.+..+.+..+......+..+ .+..
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  308 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD  308 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCC
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccccc
Confidence            32  23468999999999986      358999999999999999999999999999988888887643222222 2346


Q ss_pred             CCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccC
Q 017960          328 ISDSAKDLIRKMLCSQPSE--RLTAHEVLCMYNLPVL  362 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~--R~s~~evL~~~~~~~~  362 (363)
                      +++++++||.+||+.+|++  |++++|+++||||..+
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            8999999999999999988  9999999999999643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.7e-53  Score=402.96  Aligned_cols=257  Identities=36%  Similarity=0.599  Sum_probs=214.7

Q ss_pred             ccccceeec-ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec---
Q 017960           96 NIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (363)
Q Consensus        96 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---  171 (363)
                      .+.+.|.+. +.||+|+||+||+|.+..+++.||||++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            344567776 7899999999999999999999999998632        3567899988777679999999999875   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          172 -SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       172 -~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                       ...+|||||||+||+|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence             667999999999999999998653  59999999999999999999999999999999999999543337899999999


Q ss_pred             cceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH----HHHHHHHcCCcccCCC
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ----GIFDAVLKGHIDFESD  323 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~  323 (363)
                      ++............+||+.|+|||++. ..|+.++|||||||++|||++|..||.+....    .....+..+...++..
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            998876555566788999999999997 46999999999999999999999999765533    2556677777777766


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+..+++++.+||.+||+.||.+|||+.|+|+|+||.
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            7778999999999999999999999999999999984

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-53  Score=395.09  Aligned_cols=259  Identities=37%  Similarity=0.638  Sum_probs=207.9

Q ss_pred             cccceeec---ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           97 IRDLYTLG---RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        97 ~~~~y~~~---~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +.++|++.   +.||+|+||.||+|.+..+++.||||++.+.      ....+.+|+.+++.+.+||||+++++++.+..
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            34456664   7899999999999999999999999999643      24567889999999988999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+...+.+..+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            99999999999999999999889999999999999999999999999999999999999965444558999999999875


Q ss_pred             CCC-CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC-------HHHHHHHHHcCCcccCCCC
Q 017960          254 KPG-QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET-------QQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       254 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~  324 (363)
                      ... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..       ..+....+..+...+....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred             CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence            443 23456678999999999984 69999999999999999999999997643       3567777877777666665


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +..+++++.+||.+||+.||.+|||+.|+++|+|++.
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence            6678999999999999999999999999999999964

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.4e-53  Score=398.36  Aligned_cols=256  Identities=27%  Similarity=0.506  Sum_probs=219.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHH-HHhcCCCceeEEeEEEecCCeEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIM-HHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ++|++.+.||+|+||.||+|+++.+++.||||++.+...........+.+|..++ +.+. ||||+++++++.+.+.+|+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEEEE
Confidence            4599999999999999999999999999999999877655555566777787774 5565 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~  256 (363)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.... ..
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccccCC
Confidence            99999999999999988899999999999999999999999999999999999999   888999999999998632 33


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.+..++++.+......++    +.+++++.+|
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~l  269 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHL  269 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHH
Confidence            44566789999999999984 599999999999999999999999999999999999888765543    3589999999


Q ss_pred             HHHhcccCcCCCCCH----HHHhcCCCcccC
Q 017960          336 IRKMLCSQPSERLTA----HEVLCMYNLPVL  362 (363)
Q Consensus       336 i~~~l~~dp~~R~s~----~evL~~~~~~~~  362 (363)
                      |.+||+.||.+||++    .++++|+||..+
T Consensus       270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            999999999999987    699999999753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-53  Score=388.98  Aligned_cols=264  Identities=33%  Similarity=0.546  Sum_probs=220.3

Q ss_pred             cccccceeec-ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           95 DNIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        95 ~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..+.+.|++. +.||+|+||.||+|.+..+++.||||++....   ......+.+|+.++.++.+||||+++++++.+.+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3466779985 78999999999999999999999999997542   2345678999999999766999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .+++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++....+||+|||++...
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999999999998888999999999999999999999999999999999999944333345999999998765


Q ss_pred             CCCC--------ccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcC--------------
Q 017960          254 KPGQ--------IFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAET--------------  305 (363)
Q Consensus       254 ~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~--------------  305 (363)
                      ....        .....+||+.|+|||++.      ..++.++|||||||++|+|++|..||.+..              
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            3221        123456899999999986      348999999999999999999999997654              


Q ss_pred             -HHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          306 -QQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       306 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                       .......+..+...++...+..+++++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus       245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  301 (316)
T 2ac3_A          245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG  301 (316)
T ss_dssp             HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred             HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence             23456667766665554444568999999999999999999999999999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-53  Score=403.43  Aligned_cols=260  Identities=27%  Similarity=0.466  Sum_probs=225.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.+.........+.+.+|..++..+. ||||+++++++.+.+.+|+
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEEE
Confidence            467999999999999999999999999999999997644333344456889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccCC
Confidence            999999999999998754 79999999999999999999999999999999999999   88899999999999876544


Q ss_pred             Cc--cccCccCCccccccccc--------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC-CC
Q 017960          257 QI--FTDVVGSPYYVAPEVLL--------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD-PW  325 (363)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~  325 (363)
                      ..  ....+||+.|+|||++.        ..|+.++|||||||++|||++|+.||.+.+..+.+..+.........+ ..
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  295 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD  295 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence            32  23468999999999986        248999999999999999999999999999888888887643222222 12


Q ss_pred             CCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCcccC
Q 017960          326 PLISDSAKDLIRKMLCSQPSER---LTAHEVLCMYNLPVL  362 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R---~s~~evL~~~~~~~~  362 (363)
                      ..+++++++||.+||+ +|.+|   ++++|+++|+||..+
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            4689999999999999 99998   599999999999753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-52  Score=381.46  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=217.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++ ||||+++++++.+....++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEE
Confidence            469999999999999999999999999999999976543 4445677889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+.+ ++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc
Confidence            999965 66666554 5779999999999999999999999999999999999999   78889999999999876433 


Q ss_pred             CccccCccCCcccccccccc-c-CCCcccHHHHHHHHHHHHhCCCC-CCCcCHHHHHHHHHcCCcccCC-----------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPP-FWAETQQGIFDAVLKGHIDFES-----------  322 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~ell~g~~p-f~~~~~~~~~~~i~~~~~~~~~-----------  322 (363)
                      .......||+.|+|||++.+ . ++.++|||||||++|+|++|..| |.+....+....+.+.......           
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            33455688999999999874 3 89999999999999999988777 4555666666665442111111           


Q ss_pred             --------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 --------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 --------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                    ...+.+++++.+||.+||+.||++|||+.|+|+|+||..+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                          1123578899999999999999999999999999999865

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-52  Score=386.66  Aligned_cols=262  Identities=26%  Similarity=0.428  Sum_probs=217.1

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .+.+.++|++.+.||+|+||+||+|.+. +++.||+|++..... .......+.+|+.++++++ ||||+++++++.+..
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   92 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELH-HPNIVSLIDVIHSER   92 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSS
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCC
Confidence            4456788999999999999999999984 589999999965432 3344577889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ..++||||+++ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARA  168 (311)
T ss_dssp             CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCcee
Confidence            99999999964 888887664 458999999999999999999999999999999999999   7888999999999987


Q ss_pred             cCCC-CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC------
Q 017960          253 FKPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD------  323 (363)
Q Consensus       253 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~------  323 (363)
                      .... .......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+..........      
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence            6433 33455688999999999864  58999999999999999999999998877776666554311111110      


Q ss_pred             --------------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          324 --------------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       324 --------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                          ..+.+++++.+||.+||+.||++|||+.|+|+||||+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                                023467899999999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.9e-53  Score=408.58  Aligned_cols=257  Identities=31%  Similarity=0.513  Sum_probs=220.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++ ||||+++++++.+.+.+++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEE
Confidence            466999999999999999999999999999999998765445555677889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-C
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-P  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~  255 (363)
                      ||||+++++|.+++...+.+++..+..++.||+.||+|||+ .||+||||||+|||+   +.++.+||+|||+|.... .
T Consensus       226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceeccCC
Confidence            99999999999999988899999999999999999999998 999999999999999   788899999999997633 2


Q ss_pred             CCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .......+||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.........+......++    ..+++++.+
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~  378 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKS  378 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHH
Confidence            33455678999999999987 4699999999999999999999999999999888888887766544    357899999


Q ss_pred             HHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          335 LIRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       335 li~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      ||.+||+.||.+||     ++.|+++|+||..+
T Consensus       379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            99999999999999     99999999999754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.8e-52  Score=379.37  Aligned_cols=265  Identities=36%  Similarity=0.647  Sum_probs=237.3

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC------ChhhHHHHHHHHHHHHHhcCCCceeEEeEE
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI------SREDVEDVRREIQIMHHLAGHKNIVTIKGA  168 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~niv~~~~~  168 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++......      .....+.+.+|+.+++++.+||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34567799999999999999999999999999999999754311      123356788999999999779999999999


Q ss_pred             EecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          169 YEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       169 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      +......++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg  169 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFG  169 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEeccc
Confidence            99999999999999999999999988889999999999999999999999999999999999999   788899999999


Q ss_pred             cceecCCCCccccCccCCccccccccc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      ++.............+++.|+|||++.       ..++.++||||||+++|+|++|..||.+.........+..+...+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 1phk_A          170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  249 (298)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence            998877666666778999999999884       2478999999999999999999999999988888888888877776


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .+.+..+++++.+||.+||+.||.+|||+.|+|+|+||+..
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            66667789999999999999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-53  Score=399.91  Aligned_cols=262  Identities=29%  Similarity=0.444  Sum_probs=212.0

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-  173 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++.+. ........++.+|+.+++.+.+||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            34567899999999999999999999999999999998643 3356667888999999999988999999999997544 


Q ss_pred             -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 -CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 -~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                       .+|+||||++ ++|...+.. +.+++..+..++.||+.||+|||+.||+||||||+|||+   +.++.+||+|||+|+.
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS  158 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence             7899999996 588887765 578999999999999999999999999999999999999   8888999999999986


Q ss_pred             cCC----------------------CCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH
Q 017960          253 FKP----------------------GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQG  308 (363)
Q Consensus       253 ~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  308 (363)
                      ...                      .......+||+.|+|||++.+  .|+.++|||||||++|||++|++||.+....+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            532                      122345689999999999874  58999999999999999999999999988877


Q ss_pred             HHHHHHcCCcccC-------------------------------------------CCCCCCCCHHHHHHHHHhcccCcC
Q 017960          309 IFDAVLKGHIDFE-------------------------------------------SDPWPLISDSAKDLIRKMLCSQPS  345 (363)
Q Consensus       309 ~~~~i~~~~~~~~-------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~  345 (363)
                      .+..+........                                           ......+++++.+||.+||+.||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            7766653111000                                           001125789999999999999999


Q ss_pred             CCCCHHHHhcCCCcccC
Q 017960          346 ERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       346 ~R~s~~evL~~~~~~~~  362 (363)
                      +|||+.|+|+||||..+
T Consensus       319 ~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          319 KRISANDALKHPFVSIF  335 (388)
T ss_dssp             GSCCHHHHTTSTTTTTT
T ss_pred             cCCCHHHHhCCHHHHHh
Confidence            99999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-52  Score=394.63  Aligned_cols=264  Identities=36%  Similarity=0.638  Sum_probs=235.6

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-C----hhhHHHHHHHHHHHHHhcCCCceeEEeEEE
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-S----REDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~  169 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .    ....+.+.+|+.+++++.+||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            34557799999999999999999999889999999998754321 1    223467889999999995699999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          170 EDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       170 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                      ......++||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~  246 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGF  246 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCc
Confidence            9999999999999999999999888889999999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      +.............||+.|+|||++.+       .++.++|||||||++|+|++|..||.+.........+..+...+..
T Consensus       247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS  326 (365)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            988776666677889999999998852       4889999999999999999999999998888888888887766655


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+..++.++.+||.+||+.||++|||+.++|+|+||+.
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            555678999999999999999999999999999999963

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-53  Score=408.86  Aligned_cols=257  Identities=35%  Similarity=0.583  Sum_probs=232.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++ ||||+++++++...+.++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            3456999999999999999999999999999999997654333344678999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....+
T Consensus        93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcccc
Confidence            999999999999999888889999999999999999999999999999999999999   88889999999999987766


Q ss_pred             CccccCccCCccccccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.........+..+....+    ..+++++.+
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  245 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVIS  245 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHH
Confidence            666778999999999999853 4 7899999999999999999999999888888888888765433    357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||.+|||+.|+++|+||..
T Consensus       246 Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          246 LLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             HHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            999999999999999999999999853

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3e-52  Score=382.90  Aligned_cols=263  Identities=25%  Similarity=0.350  Sum_probs=217.5

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHHhc--CCCceeEEeEEEe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLA--GHKNIVTIKGAYE  170 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~  170 (363)
                      ..+.++|++.+.||+|+||+||+|.+..+++.||||++.......  ......+.+|+.+++.+.  +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            345678999999999999999999999999999999997543211  112245667777777665  4999999999997


Q ss_pred             cCC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEE
Q 017960          171 DSL-----CVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       171 ~~~-----~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                      ...     ..++||||+. ++|.+++.....  +++..+..++.||+.||+|||++||+||||||+|||+   +.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEE
Confidence            755     5899999995 599999987654  8999999999999999999999999999999999999   7888999


Q ss_pred             EeecCcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       244 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      |+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+.........
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99999998776666666788999999999987 56999999999999999999999999998888877776543221111


Q ss_pred             CC-----------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          323 DP-----------------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       323 ~~-----------------------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..                       .+.+++++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            11                       1357899999999999999999999999999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4e-52  Score=385.60  Aligned_cols=257  Identities=29%  Similarity=0.512  Sum_probs=216.9

Q ss_pred             ccceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+++.++ ||||+++++++...+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCC
Confidence            356999999999999999999975   68899999999765322 2234566889999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC---
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCccccc
Confidence            999999999999999999988889999999999999999999999999999999999999   78889999999999764


Q ss_pred             CC-CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          254 KP-GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       254 ~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .. .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......++    +.++++
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~  247 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQE  247 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHH
Confidence            32 233456789999999999874 689999999999999999999999999998888888887765443    357899


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          332 AKDLIRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      +.+||.+||..||++||     ++.|+++|+||..+
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            99999999999999999     89999999999753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-52  Score=384.94  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=207.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEE
Confidence            46999999999999999999999999999999997543  2333467889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          179 MELCAGGELFDRIIQR------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      |||++ ++|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCcccee
Confidence            99997 5999988654      358999999999999999999999999999999999999   7888999999999987


Q ss_pred             cCCC-CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-------
Q 017960          253 FKPG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-------  322 (363)
Q Consensus       253 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-------  322 (363)
                      .... .......||+.|+|||++.+  .++.++|||||||++|||++|+.||.+....+....+.........       
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            6432 33455688999999999874  5899999999999999999999999998887777666542111000       


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017960          323 -----------------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF  363 (363)
Q Consensus       323 -----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~~  363 (363)
                                             .....++.++.+||.+||+.||++|||+.|+|+|+||..++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence                                   01124788999999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-52  Score=388.28  Aligned_cols=257  Identities=29%  Similarity=0.498  Sum_probs=217.5

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            55679999999999999999999999999999999965432  223467889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceeccC
Confidence            999999999999999888889999999999999999999999999999999999999   78889999999999765322


Q ss_pred             ---CccccCccCCcccccccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCcccCCCCCCCCCH
Q 017960          257 ---QIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       257 ---~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                         .......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||.+.... ...........  ....+..+++
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  236 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS  236 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--cCCccccCCH
Confidence               22346789999999999874 3 477899999999999999999999766543 22333333222  2233456899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++.+||.+||+.||.+|||+.|+++|+||..
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence            9999999999999999999999999999964

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.8e-52  Score=420.65  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=233.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.++.+++.||||++.+.........+.+..|..++..+.+||+|+++++++.+.+.+|||
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            56999999999999999999999999999999998654434445677889999999887799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC-CCC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~-~~~  257 (363)
                      |||++||+|.+++...+.+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|.... .+.
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTC
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccccCCc
Confidence            9999999999999998899999999999999999999999999999999999999   888999999999998643 334


Q ss_pred             ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....+||+.|+|||++. ..|+.++|||||||+||||++|..||.+.+..+++..+......++.    .+++++.+||
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li  573 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC  573 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHH
Confidence            456788999999999998 46999999999999999999999999999999999999988766553    5899999999


Q ss_pred             HHhcccCcCCCCCH-----HHHhcCCCcccC
Q 017960          337 RKMLCSQPSERLTA-----HEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s~-----~evL~~~~~~~~  362 (363)
                      .+||+.||++||++     +||++|+||..+
T Consensus       574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            99999999999997     999999999754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.8e-52  Score=381.47  Aligned_cols=263  Identities=39%  Similarity=0.671  Sum_probs=232.3

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++ ||||+++++++.+..
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIK-HENIVTLEDIYESTT   79 (304)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCC-CCCeeehhhhcccCC
Confidence            3456778999999999999999999999999999999997543   223456889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++...+.++.+||+|||++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999999999999988888999999999999999999999999999999999999965566789999999999764


Q ss_pred             CCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      .. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+..+...+....+..+++++
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          160 QN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CC-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            43 23345678999999999974 58999999999999999999999999999888899988887777666667889999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||.+||+.||.+|||+.|+|+|+||..
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999853

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-52  Score=380.46  Aligned_cols=265  Identities=42%  Similarity=0.696  Sum_probs=237.8

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.+...
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCe
Confidence            3466789999999999999999999999999999999975443 3345678899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      .++||||+++++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||++..++.++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888889999999999999999999999999999999999999654455689999999998766


Q ss_pred             CCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .........+|+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+..+...+..+.+..+++++.+
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            55545556789999999999888999999999999999999999999999988888888888776666666678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||++|||+.|+|+|+||+.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-52  Score=412.83  Aligned_cols=258  Identities=31%  Similarity=0.505  Sum_probs=226.9

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+|+.++ ||||+++++++.+.+.+|
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEEE
Confidence            3466999999999999999999999999999999997654433344567889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||++||+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceecc
Confidence            99999999999999977544  9999999999999999999999999999999999999   888999999999999877


Q ss_pred             CCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC----HHHHHHHHHcCCcccCCCCCCCCC
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      .+......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+..    ...+...+......++    ..++
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s  413 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFS  413 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCC
Confidence            6666667899999999999985 69999999999999999999999998753    3445555555433332    4689


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          330 DSAKDLIRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      +++.+||.+||+.||.+||     ++.|+++|+||..+
T Consensus       414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            9999999999999999999     89999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-52  Score=378.79  Aligned_cols=261  Identities=37%  Similarity=0.647  Sum_probs=227.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++........   ...+.+.+|+.++++++ ||||+++++++.+..
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence            45679999999999999999999999999999999976543221   23678999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc----cEEEeecCc
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF----SLKAIDFGL  249 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~----~~kl~DFG~  249 (363)
                      ..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++    .+||+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIML---LDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---SCSSSSSCCEEECCCTT
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEE---ecCCCCCCceEEEeccc
Confidence            999999999999999999888889999999999999999999999999999999999999   4444    899999999


Q ss_pred             ceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      +.............+++.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+......+....+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence            98876655556678999999999987 46899999999999999999999999999888888888777655544444568


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++++.+||.+||+.||++|||+.++|+|+|++.
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            899999999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-52  Score=405.61  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=212.8

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--  172 (363)
                      ..+.++|++++.||+|+||+||+|.+..+++.||||++.+. .......+++.+|+.+++.++ ||||+++++++...  
T Consensus        58 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  135 (464)
T 3ttj_A           58 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKT  135 (464)
T ss_dssp             EEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCS
T ss_pred             eeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCc
Confidence            34567899999999999999999999999999999999754 335566788999999999997 99999999999654  


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          173 ----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       173 ----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                          ..+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus       136 ~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG  209 (464)
T 3ttj_A          136 LEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFG  209 (464)
T ss_dssp             TTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCC
T ss_pred             cccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEE
Confidence                467999999965 5766664  358999999999999999999999999999999999999   888899999999


Q ss_pred             cceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-------
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------  320 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------  320 (363)
                      +|............+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+.+.....       
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9988766666677899999999999984 69999999999999999999999999988777766664421100       


Q ss_pred             ---------------CCCCC----CC------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          321 ---------------ESDPW----PL------------ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       321 ---------------~~~~~----~~------------~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                     ....+    +.            .++++.+||.+||..||++|||+.|+|+||||...
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                           00000    00            14679999999999999999999999999999753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-52  Score=404.84  Aligned_cols=261  Identities=26%  Similarity=0.382  Sum_probs=201.4

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe-----
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-----  170 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-----  170 (363)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++.+. .......+++.+|+.+|++++ ||||+++++++.     
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  127 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVE  127 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCcc
Confidence            3557899999999999999999999999999999999653 335566788999999999997 999999999984     


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      ....+|+||||+ +++|.+++.....+++..+..++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla  203 (458)
T 3rp9_A          128 KFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA  203 (458)
T ss_dssp             TCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccc
Confidence            336799999998 67999999888889999999999999999999999999999999999999   88889999999999


Q ss_pred             eecCCC----------------------------CccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHh----
Q 017960          251 VFFKPG----------------------------QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLS----  296 (363)
Q Consensus       251 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~----  296 (363)
                      +.....                            ......+||+.|+|||++.  ..|+.++|||||||+||||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            875422                            1234568899999999864  459999999999999999999    


Q ss_pred             -------CCCCCCCcCH--------------------HHHHHHHHcC----------------------Cc-----ccCC
Q 017960          297 -------GVPPFWAETQ--------------------QGIFDAVLKG----------------------HI-----DFES  322 (363)
Q Consensus       297 -------g~~pf~~~~~--------------------~~~~~~i~~~----------------------~~-----~~~~  322 (363)
                             |+++|.+...                    .+.+..+...                      .+     ....
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   6777765431                    1111111110                      00     0001


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ..++.+++++.+||.+||..||++|||+.|+|+||||..+
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            1245678999999999999999999999999999999764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.1e-52  Score=392.81  Aligned_cols=260  Identities=20%  Similarity=0.252  Sum_probs=217.7

Q ss_pred             ccceeecceeccc--CCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           98 RDLYTLGRKLGQG--QFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        98 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .++|++.+.||+|  +||.||+|.+..+++.||||++..... .....+.+.+|+.+++.++ ||||+++++++.+.+.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEE
Confidence            3569999999999  999999999999999999999976543 4566788999999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          176 HIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence            9999999999999999775  679999999999999999999999999999999999999   78889999999998654


Q ss_pred             CCC--------CccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc--
Q 017960          254 KPG--------QIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF--  320 (363)
Q Consensus       254 ~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--  320 (363)
                      ...        .......||+.|+|||++.+   .++.++|||||||++|||++|+.||.+.........+..+....  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            221        11223478999999999874   58999999999999999999999998766555444333222110  


Q ss_pred             ----------------------------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          321 ----------------------------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       321 ----------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                                                              .......+++++.+||.+||+.||++|||+.|+|+|+||.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                                                    0012235788999999999999999999999999999997


Q ss_pred             cC
Q 017960          361 VL  362 (363)
Q Consensus       361 ~~  362 (363)
                      .+
T Consensus       339 ~~  340 (389)
T 3gni_B          339 QI  340 (389)
T ss_dssp             GC
T ss_pred             HH
Confidence            53

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-52  Score=380.14  Aligned_cols=255  Identities=31%  Similarity=0.510  Sum_probs=216.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC-----------------------hhhHHHHHHHHHHHHH
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----------------------REDVEDVRREIQIMHH  155 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~  155 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.+.....                       ....+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            56999999999999999999999999999999997654221                       1224578899999999


Q ss_pred             hcCCCceeEEeEEEec--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEe
Q 017960          156 LAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (363)
Q Consensus       156 l~~h~niv~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll  233 (363)
                      ++ ||||+++++++.+  ....++||||+++++|.+++ ..+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus        93 l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           93 LD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             CC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            97 9999999999986  67899999999999997754 34579999999999999999999999999999999999999


Q ss_pred             eeCCCCccEEEeecCcceecCCCC-ccccCccCCccccccccccc----CCCcccHHHHHHHHHHHHhCCCCCCCcCHHH
Q 017960          234 VNKDDDFSLKAIDFGLSVFFKPGQ-IFTDVVGSPYYVAPEVLLKH----YGPEADVWTAGVILYILLSGVPPFWAETQQG  308 (363)
Q Consensus       234 ~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~il~ell~g~~pf~~~~~~~  308 (363)
                         +.++.+||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|..||.+.....
T Consensus       171 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          171 ---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             ---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence               788899999999998765432 34557899999999999742    4778999999999999999999999888877


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ....+......++.  .+.+++++.+||.+||+.||++|||+.|+|+||||.
T Consensus       248 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          248 LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            77777766554432  346899999999999999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.7e-53  Score=404.09  Aligned_cols=264  Identities=35%  Similarity=0.585  Sum_probs=218.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-----REDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.+.....     ......+.+|+.+|++++ ||||+++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEEe
Confidence            45678999999999999999999999999999999997654321     122335789999999997 999999999875


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      . ...++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++.+..+||+|||++
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence            4 458999999999999999988888999999999999999999999999999999999999965555667999999999


Q ss_pred             eecCCCCccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCcccCCCCC
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  325 (363)
                      ............+||+.|+|||++.    ..|+.++|||||||++|+|++|..||.+... ......+..+...+....+
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            8876665666788999999999985    3578899999999999999999999976543 3455666666665555555


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+++++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            678999999999999999999999999999999964

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.7e-52  Score=393.26  Aligned_cols=254  Identities=34%  Similarity=0.489  Sum_probs=206.5

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.....    ..+.+.+|+.+++.++ ||||+++++++.+...++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEE
Confidence            34579999999999999999999999999999999975432    2256789999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc--cEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF--SLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~--~~kl~DFG~a~~~~  254 (363)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++  .+||+|||++....
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill---~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE---CSSSSCCEEECCCCCC----
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCceEEEeecCcccccc
Confidence            999999999999999888899999999999999999999999999999999999999   5444  49999999998655


Q ss_pred             CCCccccCccCCcccccccccc-cCCC-cccHHHHHHHHHHHHhCCCCCCCcCH----HHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLK-HYGP-EADVWTAGVILYILLSGVPPFWAETQ----QGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~-~~Di~slG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      .........||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+...    ......+......++  ....+
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  247 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP--DDIRI  247 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--TTSCC
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--CcCCC
Confidence            4445566789999999999874 4544 48999999999999999999976544    344444544443332  23357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ++++.+||.+||+.||++|||+.|+++|+||.
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  279 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFL  279 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence            89999999999999999999999999999984

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.2e-52  Score=375.86  Aligned_cols=254  Identities=32%  Similarity=0.550  Sum_probs=223.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.++++++ ||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEE
Confidence            56999999999999999999999999999999997654333344567899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||+++++|.+.+.....+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...... .
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCCcc-c
Confidence            9999999999999988889999999999999999999999999999999999999   88889999999998664332 3


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++    ..+++++.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  239 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS  239 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence            345688999999999874 589999999999999999999999999988888888877655443    347899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCccc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||+.||.+|||+.|+|+|+||..
T Consensus       240 ~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          240 RLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             HHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHhccChhhCCCHHHHhhCccccC
Confidence            999999999999999999999853

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-52  Score=380.46  Aligned_cols=257  Identities=23%  Similarity=0.298  Sum_probs=214.2

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.+.++|++.++||+|+||+||+|.+..+++.||||++..... ......+...|+..+..+.+||||+++++++.+.+.
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            4456789999999999999999999999999999999865432 344455666777777777569999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEEC
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeec
Confidence            99999999 779988887654 59999999999999999999999999999999999999   78889999999999887


Q ss_pred             CCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      ..........||+.|+|||++.+.++.++|||||||++|||++|..|+.+..   ....+..+...  ......+++++.
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~l~  282 (311)
T 3p1a_A          208 GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLP--PEFTAGLSSELR  282 (311)
T ss_dssp             C------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCC--HHHHTTSCHHHH
T ss_pred             ccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCC--cccccCCCHHHH
Confidence            6655556678999999999998889999999999999999999977765533   23333333221  112235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||.+||+.||++|||+.|+|+||||+.
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.7e-52  Score=378.08  Aligned_cols=256  Identities=27%  Similarity=0.406  Sum_probs=213.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEE
Confidence            4699999999999999999998 6789999999965432 2233467889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+.+ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC--
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc
Confidence            999965 898888764 679999999999999999999999999999999999999   78889999999999765432 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES------------  322 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------------  322 (363)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+.+.......            
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            23345678999999999864  4899999999999999999999999988877766665432110000            


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          323 -------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       323 -------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                   .....+++++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                         012357899999999999999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.2e-52  Score=379.93  Aligned_cols=260  Identities=28%  Similarity=0.457  Sum_probs=217.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++++++ ||||+++++++.+.+..++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHL   79 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEE
Confidence            356999999999999999999999999999999986543 24455677889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence            99999999998888878889999999999999999999999999999999999999   78889999999999876533 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc---------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------------  319 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------  319 (363)
                      .......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+....+....+.+....               
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            33456688999999999874  5899999999999999999999999988877666554431100               


Q ss_pred             ----cCCC--------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ----FESD--------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ----~~~~--------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                          .+..        .++.+++++.+||.+||+.||.+|||+.|+|+|+||+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence                0000        124578899999999999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-52  Score=389.48  Aligned_cols=264  Identities=34%  Similarity=0.573  Sum_probs=226.1

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+....  .....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  100 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccC
Confidence            34667899999999999999999999999999999999764321  3445678999999999998 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 017960          173 LCVHIVMELCAGGELFDRIIQ----------------------------------------RGHYSERKAAELTRIIVGV  212 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~~l~~~  212 (363)
                      +..++||||++|++|.+++..                                        ...+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999998742                                        1113577889999999999


Q ss_pred             HHHHHhCCcEecCCCCCceEeeeCCCCc--cEEEeecCcceecCCCC-----ccccCccCCccccccccc---ccCCCcc
Q 017960          213 VEACHSLGVMHRDLKPENFLLVNKDDDF--SLKAIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLL---KHYGPEA  282 (363)
Q Consensus       213 l~~lH~~~iiHrDlkp~NIll~~~~~~~--~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~  282 (363)
                      |.|||++||+||||||+|||+   +.++  .+||+|||++.......     ......||+.|+|||++.   ..++.++
T Consensus       181 l~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQGICHRDIKPENFLF---STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTTEECCCCCGGGEEE---SCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCCccccCCChhhEEE---ecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            999999999999999999999   4444  89999999998653211     234567999999999986   3589999


Q ss_pred             cHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          283 DVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       283 Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      |||||||++|||++|..||.+....+....+......+....+..+++++.+||.+||+.||.+|||+.++|+|+||..+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            99999999999999999999999998888888887776666666789999999999999999999999999999999754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7e-52  Score=384.21  Aligned_cols=263  Identities=27%  Similarity=0.416  Sum_probs=212.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+.+|+.++++++ ||||+++++++.+...++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEE
Confidence            34569999999999999999999999999999999975432 3334567789999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC--CCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK--DDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~--~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+  +..+.+||+|||++....
T Consensus       110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9999996 5999999998889999999999999999999999999999999999999532  245569999999998654


Q ss_pred             CC-CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC-----
Q 017960          255 PG-QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP-----  326 (363)
Q Consensus       255 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-----  326 (363)
                      .. .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+....+...........++     
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            32 33455678999999999874  48999999999999999999999999888877776665432111111110     


Q ss_pred             ---------------------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          327 ---------------------LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       327 ---------------------~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                           .+++++.+||.+||+.||.+|||+.|+|+|+||...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                                 167899999999999999999999999999999753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.3e-51  Score=371.53  Aligned_cols=257  Identities=34%  Similarity=0.485  Sum_probs=231.2

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEE
Confidence            4567999999999999999999999999999999998766556667788999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceecccC
Confidence            999999999999999888889999999999999999999999999999999999999   78889999999999876432


Q ss_pred             -CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+    ..+++++.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  244 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS  244 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHHH
Confidence             33445678999999999874 589999999999999999999999999888888877777654433    357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||++|||+.|+++|+||..
T Consensus       245 li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHHHcccChhhCcCHHHHhhChheec
Confidence            999999999999999999999999854

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-51  Score=385.81  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=220.6

Q ss_pred             ccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc----CCCceeEEeE
Q 017960           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA----GHKNIVTIKG  167 (363)
Q Consensus        92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~  167 (363)
                      .....+.++|++.+.||+|+||+||+|.+..+++.||||++..    .......+..|+.+++.+.    +||||+++++
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            3455677889999999999999999999999999999999964    3445567788999999996    5999999999


Q ss_pred             EEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC---------
Q 017960          168 AYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK---------  236 (363)
Q Consensus       168 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~---------  236 (363)
                      ++...+..++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+...         
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence            999999999999999 999999998754  48999999999999999999999999999999999999421         


Q ss_pred             -------------CCCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCC
Q 017960          237 -------------DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFW  302 (363)
Q Consensus       237 -------------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~  302 (363)
                                   ..++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                         1267899999999987543  3356789999999999884 69999999999999999999999999


Q ss_pred             CcCHHHHHHHHHcCCcccCCC---------------------CCC---------------------CCCHHHHHHHHHhc
Q 017960          303 AETQQGIFDAVLKGHIDFESD---------------------PWP---------------------LISDSAKDLIRKML  340 (363)
Q Consensus       303 ~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~~~~~~~li~~~l  340 (363)
                      +....+....+.......+..                     .++                     ..++.+.+||.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            888777666654432211100                     000                     12367889999999


Q ss_pred             ccCcCCCCCHHHHhcCCCcc
Q 017960          341 CSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       341 ~~dp~~R~s~~evL~~~~~~  360 (363)
                      +.||++|||+.|+|+|+||+
T Consensus       341 ~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CSSGGGSCCHHHHTTSGGGC
T ss_pred             cCChhhCCCHHHHhcCcccC
Confidence            99999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-51  Score=395.77  Aligned_cols=263  Identities=26%  Similarity=0.400  Sum_probs=212.2

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-  172 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-  172 (363)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++... .......+++.+|+.+|++++ ||||+++++++... 
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCC
Confidence            344677899999999999999999999999999999999753 335566788999999999998 99999999998766 


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          173 ----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       173 ----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                          ..+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFG  174 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFG  174 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCC
Confidence                57999999995 6999999888889999999999999999999999999999999999999   888999999999


Q ss_pred             cceecCCCC-----------------------ccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCC-----
Q 017960          249 LSVFFKPGQ-----------------------IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGV-----  298 (363)
Q Consensus       249 ~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~-----  298 (363)
                      +|+......                       .....+||+.|+|||++.  ..|+.++|||||||++|||++|.     
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  254 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN  254 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence            998764332                       235678999999999864  45999999999999999999843     


Q ss_pred             ------CCCCCcC-----------------HHHHHHHHHc------------------------CCcccCC---CCCCCC
Q 017960          299 ------PPFWAET-----------------QQGIFDAVLK------------------------GHIDFES---DPWPLI  328 (363)
Q Consensus       299 ------~pf~~~~-----------------~~~~~~~i~~------------------------~~~~~~~---~~~~~~  328 (363)
                            ++|.+..                 ..+.+..+..                        .......   ..++.+
T Consensus       255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
T 3n9x_A          255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI  334 (432)
T ss_dssp             SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred             ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence                  3443332                 0111111111                        0000000   012468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ++++.+||.+||..||++|||+.|+|+||||..+
T Consensus       335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999999999754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-52  Score=386.02  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=221.9

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-  173 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++++++ ||||+++++++.... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETP   86 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEET
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccCC
Confidence            456778999999999999999999999999999999998765556666788999999999997 999999999987544 


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          174 ---CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       174 ---~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                         ..|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA  163 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccCc
Confidence               349999999999999999988899999999999999999999999999999999999999   77789999999999


Q ss_pred             eecCCCC----ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          251 VFFKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      .......    ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......................
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH  243 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence            8654332    2234578999999999874 6899999999999999999999999998887777766665544333334


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ..+++++.+||.+||+.||++||++.++|.++|+.
T Consensus       244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            56899999999999999999999999999988874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-51  Score=385.06  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=216.4

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-  172 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-  172 (363)
                      ...+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+.+++.++ ||||+++++++... 
T Consensus        20 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           20 AWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDE   97 (367)
T ss_dssp             EECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCS
T ss_pred             eeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCC
Confidence            3346678999999999999999999999999999999986532 35556778999999999998 99999999999765 


Q ss_pred             -----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          173 -----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       173 -----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                           ..+|+||||+ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Df  172 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDF  172 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEee
Confidence                 3469999999 8899888765 578999999999999999999999999999999999999   78889999999


Q ss_pred             CcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-----
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-----  320 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----  320 (363)
                      |++.....  .....++|+.|+|||++.+  .++.++|||||||++|||++|+.||.+....+.+..+.+.....     
T Consensus       173 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99987543  3456789999999999874  59999999999999999999999999888777666654321110     


Q ss_pred             ------------------C----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          321 ------------------E----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       321 ------------------~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                        .    ...++.+++++.+||.+||..||++|||+.|+|+||||..+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                              0    01234678999999999999999999999999999999764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.5e-51  Score=378.63  Aligned_cols=257  Identities=34%  Similarity=0.485  Sum_probs=231.2

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+. ||||+++++++.+.+..+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEE
Confidence            4467999999999999999999999999999999998766656677788999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecccC
Confidence            999999999999999888889999999999999999999999999999999999999   78889999999999876432


Q ss_pred             -CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+    ..+++++.+
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  270 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS  270 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred             cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHH
Confidence             33445678999999999874 589999999999999999999999998888888777777655433    357899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||++|||+.|+|+|+||..
T Consensus       271 li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.4e-52  Score=383.65  Aligned_cols=264  Identities=36%  Similarity=0.596  Sum_probs=220.7

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+++.+. ||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence            4567899999999999999999999999999999999754321     1223346889999999997 999999999987


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      ... .++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..++.+..+||+|||++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            665 8999999999999999988888999999999999999999999999999999999999954444556999999999


Q ss_pred             eecCCCCccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCcccCCCCC
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  325 (363)
                      .............||+.|+|||++.    ..++.++|||||||++|+|++|..||...... .....+..+...+....+
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8876555555677999999999974    35899999999999999999999999765433 445555555544433334


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+++++.+||.+||+.||++|||+.++|+|+||..
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            568999999999999999999999999999999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-51  Score=374.45  Aligned_cols=258  Identities=28%  Similarity=0.423  Sum_probs=218.9

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+++.+|+.++++++ ||||+++++++.+.+
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~   84 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDD   84 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSS
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCC
Confidence            4456788999999999999999999999999999999997666556677789999999999998 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ..++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcccc
Confidence            999999999999999999988899999999999999999999999999999999999999   78889999999999765


Q ss_pred             CCCC--ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-CCCCCCCCC
Q 017960          254 KPGQ--IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-ESDPWPLIS  329 (363)
Q Consensus       254 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~  329 (363)
                      ....  ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+................. .....+.++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP  241 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence            4332  2334679999999999874 58999999999999999999999999888776655555443322 122345689


Q ss_pred             HHHHHHHHHhcccCcCCCC-CHHHHhc
Q 017960          330 DSAKDLIRKMLCSQPSERL-TAHEVLC  355 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~-s~~evL~  355 (363)
                      +.+.++|.+||..||.+|| +++++++
T Consensus       242 ~~l~~li~~~l~~dp~~R~~~~~~l~~  268 (294)
T 4eqm_A          242 QSLSNVILRATEKDKANRYKTIQEMKD  268 (294)
T ss_dssp             HHHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHHHhcCCHhHccccHHHHHH
Confidence            9999999999999999999 5555544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.1e-51  Score=371.02  Aligned_cols=257  Identities=36%  Similarity=0.577  Sum_probs=219.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++ ||||+++++++.+....+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEE
Confidence            4467999999999999999999999999999999997654333344678899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCCC-
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccCCC
Confidence            999999999999999888889999999999999999999999999999999999999   78889999999999877655


Q ss_pred             CccccCccCCccccccccccc-C-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLKH-Y-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      .......+++.|+|||++.+. + +.++||||||+++|+|++|..||...........+..+....+    ..++.++.+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~  240 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVAT  240 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHH
Confidence            555567889999999999854 3 6899999999999999999999998888888888777654433    347899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ||.+||+.||++|||+.|+++|+||+.
T Consensus       241 li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHHhChhhcc
Confidence            999999999999999999999999964

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-52  Score=383.63  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=210.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEE
Confidence            46999999999999999999999999999999996543  1112224557999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...... 
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC----
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc
Confidence            99996 58988887654 58999999999999999999999999999999999999   78889999999999765432 


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCC----------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP----------  324 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----------  324 (363)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+.+.........          
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            23445678999999999874  589999999999999999999999999888877777655322211111          


Q ss_pred             ----------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          325 ----------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       325 ----------------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                      .+.+++++.+||.+||+.||.+|||+.|+|+||||..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                            13468899999999999999999999999999999754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.3e-51  Score=370.80  Aligned_cols=253  Identities=32%  Similarity=0.560  Sum_probs=226.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEE
Confidence            56999999999999999999999999999999997654323334567899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... .
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECSSS-C
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCccc-c
Confidence            9999999999999988889999999999999999999999999999999999999   78889999999999765432 3


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++    ..+++++.+||.
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  244 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLIS  244 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHH
Confidence            345678999999999884 589999999999999999999999998888888888777655433    357899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCcc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +||+.||.+|||+.++++|+||.
T Consensus       245 ~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             HHhhcCHhhCCCHHHHhhCHHHH
Confidence            99999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-51  Score=403.49  Aligned_cols=257  Identities=31%  Similarity=0.487  Sum_probs=225.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|+||.||+|+++.+++.||||++.+...........+.+|+.++++++ ||||+++++++.+...+|+
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEEEE
Confidence            366999999999999999999999999999999997654433345678899999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          178 VMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ||||++|++|.+++...    ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceeeec
Confidence            99999999999998764    369999999999999999999999999999999999999   88899999999999886


Q ss_pred             CCCCc-cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc----CHHHHHHHHHcCCcccCCCCCCC
Q 017960          254 KPGQI-FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE----TQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       254 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ..... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+.    ....+...+......++    ..
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~  415 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK  415 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence            55443 344689999999999985 5999999999999999999999999775    34566666666554443    35


Q ss_pred             CCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +++++.+||.+||+.||.+||+     +.+++.|+||..+
T Consensus       416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            8999999999999999999995     5899999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.6e-52  Score=384.27  Aligned_cols=253  Identities=29%  Similarity=0.492  Sum_probs=219.5

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHHhcCCCceeEEeEEE
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-----EDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~  169 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||++........     .....+.+|+.++++++ ||||+++++++
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~   98 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF   98 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            3466789999999999999999999999999999999976543221     13346778999999997 99999999999


Q ss_pred             ecCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          170 EDSLCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       170 ~~~~~~~iv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      .+.+.+++||||+.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg  175 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFG  175 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeecc
Confidence            9999999999999766 999999888889999999999999999999999999999999999999   788899999999


Q ss_pred             cceecCCCCccccCccCCcccccccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      ++.............||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.....      ....    ......
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~----~~~~~~  245 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEA----AIHPPY  245 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTT----CCCCSS
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhh----ccCCCc
Confidence            9998776666667889999999999874 34 7899999999999999999999965322      1111    112223


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+++++.+||.+||+.||++|||+.++|+|+|+..
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~  280 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ  280 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence            57899999999999999999999999999999964

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-50  Score=367.73  Aligned_cols=257  Identities=22%  Similarity=0.358  Sum_probs=220.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec----CC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~  173 (363)
                      ...|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++ ||||+++++++..    ..
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCc
Confidence            3458999999999999999999999999999999976543 5566788999999999997 9999999998865    46


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      .+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.|  |+||||||+|||+.  ++++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence            68999999999999999998888999999999999999999999999  99999999999993  267799999999997


Q ss_pred             ecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCcccCCCCCCCCCH
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      .... .......||+.|+|||++.+.++.++|||||||++|+|++|..||.+... ......+..+....  ......++
T Consensus       181 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  257 (290)
T 1t4h_A          181 LKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIP  257 (290)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCH
T ss_pred             cccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc--ccCCCCCH
Confidence            6443 33455779999999999988899999999999999999999999987444 44444444432221  11234678


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++.+||.+||+.||.+|||+.|+|+|+||+.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            9999999999999999999999999999974

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.1e-51  Score=381.54  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=218.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec------
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------  171 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++ ||||+++++++..      
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC-----
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccc
Confidence            4579999999999999999999999999999999865543 2333456789999999998 9999999999876      


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          172 --SLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                        .+.+++||||+.+ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg  169 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFG  169 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCT
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccch
Confidence              4568999999965 777777654 569999999999999999999999999999999999999   788899999999


Q ss_pred             cceecCCC-----CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          249 LSVFFKPG-----QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       249 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      ++......     .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99875422     23345678999999999874  489999999999999999999999999888887777765433333


Q ss_pred             CCCCCC----------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 SDPWPL----------------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 ~~~~~~----------------------------~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ...++.                            .++++.+||.+||+.||++|||+.|+|+|+||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            333322                            2678999999999999999999999999999964

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-50  Score=374.98  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=221.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|...+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.+++.++ ||||+++++++...+..++||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEE
Confidence            4777889999999999999999899999999997543   234567889999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-c
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-I  258 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-~  258 (363)
                      ||+++++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++....... .
T Consensus       122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc
Confidence            99999999987754 568999999999999999999999999999999999999   788899999999998765432 3


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.........+....... ......+++++.+||.
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-CTTGGGSCHHHHHHHH
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-cCccccCCHHHHHHHH
Confidence            356789999999999874 58999999999999999999999999888877777776554322 1222357899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCccc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||+.||++|||+.|+|+|+||..
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             HHccCChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999953

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-51  Score=370.14  Aligned_cols=255  Identities=33%  Similarity=0.553  Sum_probs=198.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...........+++.+|+.++++++ ||||+++++++.+.+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEEE
Confidence            45999999999999999999999999999999997654323334578899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...... 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCCC
Confidence            9999999999998765 568999999999999999999999999999999999999   78889999999999876432 


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                      .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......    ....++.++.+|
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l  242 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE----MPSFLSIEAKDL  242 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC----CCTTSCHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC----CccccCHHHHHH
Confidence            22335678999999999874 5899999999999999999999999876655554444333222    223578999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          336 IRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |.+||+.||++|||+.++|+|+||..
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccC
Confidence            99999999999999999999999964

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-51  Score=380.25  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC---
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL---  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---  173 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.++++++ ||||++++++|.+..   
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence            4467999999999999999999999999999999997543  3445678999999999997 999999999986543   


Q ss_pred             ------------------------------------------------------eEEEEEeccCCCChHHHHHhcCC---
Q 017960          174 ------------------------------------------------------CVHIVMELCAGGELFDRIIQRGH---  196 (363)
Q Consensus       174 ------------------------------------------------------~~~iv~e~~~~~~L~~~l~~~~~---  196 (363)
                                                                            ..++|||||++++|.+++.....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987644   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-------------ccccCc
Q 017960          197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-------------IFTDVV  263 (363)
Q Consensus       197 ~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-------------~~~~~~  263 (363)
                      .++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......             ......
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            4566789999999999999999999999999999999   778899999999998765432             223467


Q ss_pred             cCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          264 GSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       264 gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      ||+.|+|||++.+ .++.++|||||||++|||++|..|+..  .......+.......   .+...++++.+||.+||+.
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~  312 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPL---LFTQKYPQEHMMVQDMLSP  312 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHHCS
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCc---ccccCChhHHHHHHHHccC
Confidence            9999999999874 699999999999999999998877521  222333333332211   1123567889999999999


Q ss_pred             CcCCCCCHHHHhcCCCcccC
Q 017960          343 QPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       343 dp~~R~s~~evL~~~~~~~~  362 (363)
                      ||++|||+.|+|+|+||+.+
T Consensus       313 ~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          313 SPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             SGGGSCCHHHHHHSTTCCCC
T ss_pred             CCCcCCCHHHHhhchhhhcC
Confidence            99999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.3e-51  Score=380.20  Aligned_cols=254  Identities=26%  Similarity=0.411  Sum_probs=221.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  130 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW  130 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeEE
Confidence            4456999999999999999999999999999999997655444556678999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +||||+. |+|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS
T ss_pred             EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC
Confidence            9999996 578887754 5679999999999999999999999999999999999999   7788999999999976543


Q ss_pred             CCccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                         .....||+.|+|||++.    +.++.++|||||||++|||++|..||.+.........+........  ....+++.
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  281 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEY  281 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHH
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHH
Confidence               24568999999999984    4589999999999999999999999988887776666665543221  22457899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +.+||.+||+.||++|||+.++|+|+|+.
T Consensus       282 l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          282 FRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence            99999999999999999999999999984

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-50  Score=373.98  Aligned_cols=255  Identities=28%  Similarity=0.488  Sum_probs=213.5

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCe
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLC  174 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~  174 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...      ..+.+.+|+.+++++++||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            346799999999999999999999999999999998643      246788999999999889999999999987  677


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc-cEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-SLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-~~kl~DFG~a~~~  253 (363)
                      .++||||+.+++|.+++.   .+++..+..++.||+.||.|||++||+||||||+|||+   +.++ .+||+|||++...
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTTEEEECCCTTCEEC
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---cCCCCEEEEEeCCCceEc
Confidence            999999999999988774   48999999999999999999999999999999999999   5444 8999999999887


Q ss_pred             CCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCc-CHHHHHHH-------------HHcCC
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDA-------------VLKGH  317 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~-------------i~~~~  317 (363)
                      ..........+++.|+|||++.+  .++.++|||||||++|+|++|..||... ...+.+..             +....
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            76666677789999999999874  5899999999999999999999999543 22222221             11111


Q ss_pred             ccc--------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017960          318 IDF--------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF  363 (363)
Q Consensus       318 ~~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~~  363 (363)
                      ...                    .......+++++.+||.+||+.||++|||+.|+|+|+||..+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            111                    0111123789999999999999999999999999999998763

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.9e-51  Score=383.71  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=208.4

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--  173 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++ ||||+++++++....  
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   99 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL   99 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence            45678999999999999999999999999999999997543 34556678899999999997 999999999997654  


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          174 ----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       174 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                          ..++||||+. ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       100 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          100 EEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  173 (371)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC
T ss_pred             ccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeec
Confidence                7899999996 57888775  458999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES------  322 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------  322 (363)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+.........      
T Consensus       174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            987665545566789999999999884 5999999999999999999999999998887777766553211000      


Q ss_pred             -----------CCC--------------C-------CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 -----------DPW--------------P-------LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 -----------~~~--------------~-------~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                 ..+              +       ..++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                       000              0       014678999999999999999999999999998653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-50  Score=383.94  Aligned_cols=255  Identities=23%  Similarity=0.405  Sum_probs=214.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcC-CCceeEEeEEEecCCeEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-HKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~~~  176 (363)
                      .+.|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++++.+ ||||+++++++...+.+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            3459999999999999999999754 89999999976543 45667889999999999974 699999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   + ++.+||+|||++......
T Consensus       133 lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE---S-SSCEEECCCSSSCCC---
T ss_pred             EEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---E-CCeEEEEecCccccccCC
Confidence            99994 588999999988889999999999999999999999999999999999999   4 368999999999876443


Q ss_pred             C---ccccCccCCcccccccccc------------cCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCccc
Q 017960          257 Q---IFTDVVGSPYYVAPEVLLK------------HYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDF  320 (363)
Q Consensus       257 ~---~~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~  320 (363)
                      .   .....+||+.|+|||++.+            .++.++|||||||++|||++|..||.+.. ....+..+.......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence            2   2345689999999999853            58899999999999999999999997653 334555555544333


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+  ...++++.+||.+||+.||.+|||+.|+|+|+|++.
T Consensus       288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~  326 (390)
T 2zmd_A          288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  326 (390)
T ss_dssp             CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence            322  235789999999999999999999999999999853

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-51  Score=374.80  Aligned_cols=260  Identities=23%  Similarity=0.375  Sum_probs=215.4

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--  173 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.++++++ ||||+++++++....  
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCc
Confidence            456779999999999999999999999999999999975432  233567889999999998 999999999987655  


Q ss_pred             eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeee-CCCCccEEEeecCc
Q 017960          174 CVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN-KDDDFSLKAIDFGL  249 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~-~~~~~~~kl~DFG~  249 (363)
                      ..++||||+++++|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+.. .+.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            78999999999999999976433   899999999999999999999999999999999999833 34567899999999


Q ss_pred             ceecCCCCccccCccCCccccccccc---------ccCCCcccHHHHHHHHHHHHhCCCCCCCcC----HHHHHHHHHcC
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLL---------KHYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKG  316 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i~~~  316 (363)
                      +.............||+.|+|||++.         ..++.++|||||||++|||++|..||....    ..+....+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            99877666666788999999999885         458999999999999999999999996422    23444444443


Q ss_pred             Cccc-------------------C--CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          317 HIDF-------------------E--SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       317 ~~~~-------------------~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ....                   +  ......+++.+.+||.+||+.||++|||++|+|+|+.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            3210                   0  0111123467899999999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-50  Score=386.90  Aligned_cols=261  Identities=24%  Similarity=0.334  Sum_probs=218.4

Q ss_pred             ccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc-----CCCceeEEe
Q 017960           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-----GHKNIVTIK  166 (363)
Q Consensus        92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~  166 (363)
                      ...+.+.++|++.+.||+|+||.||+|.+..+++.||||++..    .......+.+|+.+++.++     +|+||++++
T Consensus        90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~  165 (429)
T 3kvw_A           90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML  165 (429)
T ss_dssp             CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred             cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence            3455677889999999999999999999999999999999964    3344567888999999885     477999999


Q ss_pred             EEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc--E
Q 017960          167 GAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS--L  242 (363)
Q Consensus       167 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~--~  242 (363)
                      +++.....+++||||+. ++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.  +
T Consensus       166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~v  241 (429)
T 3kvw_A          166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSGI  241 (429)
T ss_dssp             EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCCE
T ss_pred             eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcce
Confidence            99999999999999995 69999887754  48999999999999999999999999999999999999   66655  9


Q ss_pred             EEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          243 KAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       243 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      ||+|||++.....  .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+.+..+.......+
T Consensus       242 kL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~  319 (429)
T 3kvw_A          242 KVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS  319 (429)
T ss_dssp             EECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            9999999977543  3446789999999999884 699999999999999999999999998887776655543100000


Q ss_pred             ------------------------------------------------C--C-----CCCCCCHHHHHHHHHhcccCcCC
Q 017960          322 ------------------------------------------------S--D-----PWPLISDSAKDLIRKMLCSQPSE  346 (363)
Q Consensus       322 ------------------------------------------------~--~-----~~~~~~~~~~~li~~~l~~dp~~  346 (363)
                                                                      .  .     .....++++.+||.+||++||++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~  399 (429)
T 3kvw_A          320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV  399 (429)
T ss_dssp             HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence                                                            0  0     00123688999999999999999


Q ss_pred             CCCHHHHhcCCCcccC
Q 017960          347 RLTAHEVLCMYNLPVL  362 (363)
Q Consensus       347 R~s~~evL~~~~~~~~  362 (363)
                      |||+.|+|+||||+..
T Consensus       400 Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          400 RMTPGQALRHPWLRRR  415 (429)
T ss_dssp             SCCHHHHHTSTTTC--
T ss_pred             CCCHHHHhCChhhccC
Confidence            9999999999999753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-51  Score=383.48  Aligned_cols=257  Identities=31%  Similarity=0.516  Sum_probs=216.8

Q ss_pred             cceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ++|++.+.||+|+||.||+|.+.   .+++.||||++.+.... .....+.+.+|+.+++++.+||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            56999999999999999999984   58899999998654321 112335577899999999769999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCeecc
Confidence            99999999999999999988899999999999999999999999999999999999999   888899999999998754


Q ss_pred             CCC--ccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcC----HHHHHHHHHcCCcccCCCCC
Q 017960          255 PGQ--IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAET----QQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       255 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~  325 (363)
                      ...  .....+||+.|+|||++.+   .++.++|||||||++|||++|..||....    ...+...+......+    .
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~  286 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----P  286 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC----C
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC----C
Confidence            322  2334679999999999873   37899999999999999999999996433    334444444433322    2


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          326 PLISDSAKDLIRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      ..++..+.+||.+||..||.+||     ++.|+++|+||+.+
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            45789999999999999999999     99999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-52  Score=394.78  Aligned_cols=251  Identities=15%  Similarity=0.161  Sum_probs=206.4

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEe-------
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIK-------  166 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~-------  166 (363)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.++  +||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            34577999999999999999999998999999999998665555666788999995555553  499999998       


Q ss_pred             EEEecCC-----------------eEEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcE
Q 017960          167 GAYEDSL-----------------CVHIVMELCAGGELFDRIIQRGHYSE-------RKAAELTRIIVGVVEACHSLGVM  222 (363)
Q Consensus       167 ~~~~~~~-----------------~~~iv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~~l~~~l~~lH~~~ii  222 (363)
                      +++.+.+                 ..|+||||+ +|+|.+++...+.+++       ..+..++.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            7666554                 288999999 6799999987655555       78888999999999999999999


Q ss_pred             ecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCccccccccc-c-----------cCCCcccHHHHHHH
Q 017960          223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-K-----------HYGPEADVWTAGVI  290 (363)
Q Consensus       223 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~~Di~slG~i  290 (363)
                      ||||||+|||+   +.++.+||+|||+|....  ......+| +.|+|||++. .           .++.++|||||||+
T Consensus       229 HrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            99999999999   778899999999998643  34456678 9999999987 4           59999999999999


Q ss_pred             HHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          291 LYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       291 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +|||++|+.||.+.........+.        ..+..+++++.+||.+||+.||++|||+.|+|+|+||..
T Consensus       303 l~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            999999999997655433332222        223568999999999999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-50  Score=376.53  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=216.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.++++++ ||||+++++++.+....++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEE
Confidence            456999999999999999999999999999999986543 24555677889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-C
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-G  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~  256 (363)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..... .
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCc
Confidence            99999998888877777789999999999999999999999999999999999999   7888999999999976543 2


Q ss_pred             CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc---------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------------  319 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------  319 (363)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+......               
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            33455678999999999874  5899999999999999999999999888776655544321000               


Q ss_pred             ----cCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          320 ----FES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       320 ----~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                          .+.        ..++.+++++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence                000        012357899999999999999999999999999999963

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.2e-50  Score=364.22  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=220.5

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEE
Confidence            3467999999999999999999999999999999997554  2344578899999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      +||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCC
Confidence            999999999999998877789999999999999999999999999999999999999   77889999999999765322


Q ss_pred             ---CccccCccCCcccccccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCcccCCCCCCCCCH
Q 017960          257 ---QIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       257 ---~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                         .......||+.|+|||++.+ . ++.++||||||+++|+|++|..||.+.... .....+......  ...+..+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDS  236 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--STTGGGSCH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--cCchhhcCH
Confidence               22345678999999999874 3 477899999999999999999999776543 233333332221  223456899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ++.+||.+||+.||.+|||+.|+++|+||+..
T Consensus       237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          237 APLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            99999999999999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.2e-51  Score=382.48  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=204.1

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ....+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+.+++.++ ||||+++++++...
T Consensus        23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  100 (367)
T 2fst_X           23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPA  100 (367)
T ss_dssp             EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred             cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence            33456678999999999999999999999999999999986532 34556778899999999998 99999999998654


Q ss_pred             ------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          173 ------LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       173 ------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                            ...++|||++ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~D  175 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILD  175 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEee
Confidence                  5689999999 7899887765 579999999999999999999999999999999999999   7888999999


Q ss_pred             cCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-----
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----  319 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----  319 (363)
                      ||++.....  .....+||+.|+|||++.+  .++.++|||||||++|||++|+.||.+....+.+..+.+....     
T Consensus       176 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          176 FGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987543  2456789999999999874  5899999999999999999999999988877766665442110     


Q ss_pred             ------------------cCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ------------------FESD----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ------------------~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                        .+..    .++.+++++.+||.+||..||.+|||+.|+|+|+||..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                              0000    123568899999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.3e-50  Score=362.05  Aligned_cols=256  Identities=21%  Similarity=0.316  Sum_probs=214.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+..+..+.+||||+++++++.+.+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            356779999999999999999999999999999999976433 3345567889999999995599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC--------------
Q 017960          176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--------------  237 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~--------------  237 (363)
                      ++||||+++++|.+++...    +.+++..+..++.||+.||.|||++||+||||||+|||+..++              
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999764    6689999999999999999999999999999999999994322              


Q ss_pred             --CCccEEEeecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHH
Q 017960          238 --DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (363)
Q Consensus       238 --~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i  313 (363)
                        ....+||+|||++.......   ...||+.|+|||++.+  .++.++|||||||++|+|++|.+|+....   ....+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~  240 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI  240 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred             cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence              45589999999998765432   3468999999999975  35679999999999999999998775433   34444


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+....   ....+++++.+||.+||+.||++|||+.|+|+|+||..
T Consensus       241 ~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          241 RQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             HTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             HcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            4444322   22467899999999999999999999999999999964

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-50  Score=367.89  Aligned_cols=251  Identities=26%  Similarity=0.368  Sum_probs=208.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||+||+|.+  ++..||||++..... .....+.+.+|+.++++++ ||||+++++++.+....+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceE
Confidence            346799999999999999999985  688999999875543 4556678999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          177 IVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      +||||+++++|.+++...+.   +++..+..++.||+.||.|||+.|  |+||||||+|||+   +.++.+||+|||++.
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCc
Confidence            99999999999999977553   899999999999999999999999  9999999999999   888899999999997


Q ss_pred             ecCCCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          252 FFKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       252 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      ...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+........  ....++
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  265 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLN  265 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CCTTSC
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCccCC
Confidence            644332 2345679999999999984 589999999999999999999999998888877776654332222  224688


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +++.+||.+||+.||.+|||+.++++.
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~ll~~  292 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATIMDL  292 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999974

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.4e-50  Score=377.44  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=218.4

Q ss_pred             cccceeecceecccCCeEEEEEEEc-------cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-------ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~  169 (363)
                      ..++|++++.||+|+||.||+|.+.       .++..||||++....  .....+.+.+|+.+++.+.+||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3467999999999999999999875       345679999997543  4556778999999999995599999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEe
Q 017960          170 EDSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (363)
Q Consensus       170 ~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll  233 (363)
                      .+.+.+|+||||+++|+|.+++...+                .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence            99999999999999999999997653                47899999999999999999999999999999999999


Q ss_pred             eeCCCCccEEEeecCcceecCCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHH
Q 017960          234 VNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (363)
Q Consensus       234 ~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~  308 (363)
                         +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|||++ |..||.+....+
T Consensus       237 ---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          237 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             ---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             ---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence               888899999999998765432   2234566789999999874 59999999999999999999 999999988888


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+..+...   .....+++++.+||.+||+.||++|||+.|+++++
T Consensus       314 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L  359 (370)
T 2psq_A          314 LFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  359 (370)
T ss_dssp             HHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            88877766432   22246789999999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-50  Score=382.03  Aligned_cols=254  Identities=27%  Similarity=0.407  Sum_probs=211.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-----  171 (363)
                      ..++|++++.||+|+||+||+|.+..+++.||||++.....       ...+|+.+++.++ ||||+++++++..     
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD-HVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCC-CTTBCCEEEEEEEC----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcC-CCCccchhheeeecCccc
Confidence            34679999999999999999999999999999999865421       2236999999997 9999999999843     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 017960          172 ---------------------------------SLCVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVE  214 (363)
Q Consensus       172 ---------------------------------~~~~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~  214 (363)
                                                       ...+++||||++ ++|.+.+.    ....+++..+..++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             345899999997 57766664    3567999999999999999999


Q ss_pred             HHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHH
Q 017960          215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILY  292 (363)
Q Consensus       215 ~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~  292 (363)
                      |||++||+||||||+|||++  ..++.+||+|||+|.............+|+.|+|||++.+  .++.++|||||||++|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            99999999999999999993  2577999999999998766666677889999999998874  4899999999999999


Q ss_pred             HHHhCCCCCCCcCHHHHHHHHHcCCc-----------------ccCC---C-----CCCCCCHHHHHHHHHhcccCcCCC
Q 017960          293 ILLSGVPPFWAETQQGIFDAVLKGHI-----------------DFES---D-----PWPLISDSAKDLIRKMLCSQPSER  347 (363)
Q Consensus       293 ell~g~~pf~~~~~~~~~~~i~~~~~-----------------~~~~---~-----~~~~~~~~~~~li~~~l~~dp~~R  347 (363)
                      ||++|+.||.+....+.+..+.+...                 .++.   .     ....+++++.+||.+||+.||.+|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999999888777666643110                 0000   0     112478899999999999999999


Q ss_pred             CCHHHHhcCCCccc
Q 017960          348 LTAHEVLCMYNLPV  361 (363)
Q Consensus       348 ~s~~evL~~~~~~~  361 (363)
                      ||+.|+|+|+||..
T Consensus       314 ~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          314 INPYEAMAHPFFDH  327 (383)
T ss_dssp             CCHHHHHTSGGGHH
T ss_pred             CCHHHHhcCHHHHH
Confidence            99999999999964

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.2e-50  Score=378.13  Aligned_cols=259  Identities=28%  Similarity=0.412  Sum_probs=218.7

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC---
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS---  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---  172 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.++++++ ||||+++++++...   
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcc
Confidence            34568999999999999999999999999999999996432  4555678999999999998 99999999998654   


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          173 --LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       173 --~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                        ...++||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  175 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcce
Confidence              46899999996 589888765 568999999999999999999999999999999999999   78889999999999


Q ss_pred             eecCCCCc----cccCccCCccccccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC---
Q 017960          251 VFFKPGQI----FTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE---  321 (363)
Q Consensus       251 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  321 (363)
                      ........    ....+||+.|+|||++. . .++.++|||||||++|+|++|+.||.+....+.+..+........   
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  255 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  255 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            87643321    34568999999999875 3 489999999999999999999999998887776666543111000   


Q ss_pred             -----------------C-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          322 -----------------S-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       322 -----------------~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                       .       ...+.+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                             0       0124578999999999999999999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-50  Score=377.65  Aligned_cols=260  Identities=27%  Similarity=0.375  Sum_probs=213.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS--REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.......  ......+.+|+.+++.++ ||||+++++++.+...
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCc
Confidence            3467999999999999999999999999999999997543211  111346789999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceec
Confidence            9999999975 888888664 358999999999999999999999999999999999999   78889999999999876


Q ss_pred             CC-CCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCC------
Q 017960          254 KP-GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP------  324 (363)
Q Consensus       254 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------  324 (363)
                      .. ........||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+.+..+...........      
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            43 234456789999999999863  489999999999999999999999999888877777655322111111      


Q ss_pred             ------------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          325 ------------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       325 ------------------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                        +..+++++.+||.+||+.||.+|||+.|+|+|+||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence                              1346789999999999999999999999999999964

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.6e-50  Score=373.03  Aligned_cols=256  Identities=23%  Similarity=0.404  Sum_probs=210.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeEEEecCCeE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSLCV  175 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~  175 (363)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.++.++.+| |||+++++++.+...+
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            356799999999999999999997 5688999999975542 455667899999999999832 9999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   + ++.+||+|||++.....
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll---~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---E-TTEEEECCCSSSCCC--
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---E-CCcEEEeecccccccCc
Confidence            999995 588999999998899999999999999999999999999999999999999   3 46799999999987643


Q ss_pred             CC---ccccCccCCccccccccc------------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCcc
Q 017960          256 GQ---IFTDVVGSPYYVAPEVLL------------KHYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHID  319 (363)
Q Consensus       256 ~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~  319 (363)
                      ..   .....+||+.|+|||++.            ..++.++|||||||++|||++|+.||..... ......+......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  239 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  239 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence            32   234568999999999985            3488899999999999999999999976433 3344444443322


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..  .....++++.+||.+||+.||.+|||+.|+|+|||++.
T Consensus       240 ~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          240 IE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             CC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             cC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            22  22345789999999999999999999999999999853

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.9e-50  Score=378.80  Aligned_cols=266  Identities=23%  Similarity=0.322  Sum_probs=219.4

Q ss_pred             eecccccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-----cee
Q 017960           89 VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-----NIV  163 (363)
Q Consensus        89 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-----niv  163 (363)
                      ......+.+.++|++.+.||+|+||+||+|.+..+++.||||++..    .......+.+|+.+++.+..|+     +|+
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEE
Confidence            3344556677889999999999999999999999999999999964    3344567888999999887555     499


Q ss_pred             EEeEEEecCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEecCCCCCceEeeeCCCC
Q 017960          164 TIKGAYEDSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACH--SLGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       164 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~iiHrDlkp~NIll~~~~~~  239 (363)
                      .+++++...+..++||||+. ++|.+++...  +.+++..+..++.||+.||.|||  +.||+||||||+|||+.. +.+
T Consensus       120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~  197 (382)
T 2vx3_A          120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKR  197 (382)
T ss_dssp             CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTS
T ss_pred             EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCC
Confidence            99999999999999999995 5999998775  45899999999999999999999  579999999999999943 236


Q ss_pred             ccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc
Q 017960          240 FSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  318 (363)
                      +.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+.+..+.....
T Consensus       198 ~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~  275 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG  275 (382)
T ss_dssp             CCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             CcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            7899999999987643  3456789999999999985 699999999999999999999999999888777766654211


Q ss_pred             ccC------------------CCCC-----------------CC-------------------------CCHHHHHHHHH
Q 017960          319 DFE------------------SDPW-----------------PL-------------------------ISDSAKDLIRK  338 (363)
Q Consensus       319 ~~~------------------~~~~-----------------~~-------------------------~~~~~~~li~~  338 (363)
                      ..+                  ...|                 ..                         .++++.+||.+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  355 (382)
T 2vx3_A          276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR  355 (382)
T ss_dssp             SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence            100                  0000                 00                         01378999999


Q ss_pred             hcccCcCCCCCHHHHhcCCCcccC
Q 017960          339 MLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ||+.||++|||+.|+|+||||...
T Consensus       356 mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          356 MLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             hcCCChhhCCCHHHHhcCcccccC
Confidence            999999999999999999999753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.8e-50  Score=370.27  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=216.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..++|++.+.||+|+||.||+|.+..++.   .||||++....  .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            34679999999999999999999886555   49999996543  4556678999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ..++||||+++++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence            999999999999999999654 579999999999999999999999999999999999999   8888999999999987


Q ss_pred             cCCCC----ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          253 FKPGQ----IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       253 ~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      .....    ......+|+.|+|||++. ..++.++|||||||++|||++ |..||.+....+....+..+...   ....
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  277 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL---PAPM  277 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---CCCT
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC---CCCC
Confidence            64432    122344577899999998 569999999999999999999 99999999988888888776322   2234


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+++++.+||.+||..||++|||+.++++.+
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L  308 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVL  308 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            6889999999999999999999999998754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.9e-50  Score=379.77  Aligned_cols=255  Identities=28%  Similarity=0.426  Sum_probs=209.7

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-  173 (363)
                      .....+|++.+.||+|+||+||+|.+..+++ ||+|++.....       ...+|+.+++.++ ||||+++++++.... 
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~-h~niv~l~~~~~~~~~  106 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVK-HPNVVDLKAFFYSNGD  106 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEESS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCC-CCCcceEEEEEEecCC
Confidence            3455679999999999999999999876665 88888754321       1236999999998 999999999985433 


Q ss_pred             -----eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC-CCccEE
Q 017960          174 -----CVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLK  243 (363)
Q Consensus       174 -----~~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~~k  243 (363)
                           .+++||||+++ ++...+.    ....+++..+..++.||+.||.|||++||+||||||+|||+   + .++.+|
T Consensus       107 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~~k  182 (394)
T 4e7w_A          107 KKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL---DPPSGVLK  182 (394)
T ss_dssp             SSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---ETTTTEEE
T ss_pred             CCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEE---cCCCCcEE
Confidence                 38899999976 4444443    25679999999999999999999999999999999999999   5 678999


Q ss_pred             EeecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc---
Q 017960          244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI---  318 (363)
Q Consensus       244 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---  318 (363)
                      |+|||+|.....+.......+|+.|+|||++.+  .|+.++|||||||++|||++|+.||.+....+.+..+.+...   
T Consensus       183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999999998766666667889999999999864  589999999999999999999999999887776665544110   


Q ss_pred             --------------ccCC--------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          319 --------------DFES--------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       319 --------------~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                    .++.        ...+.+++++.+||.+||+.||.+|||+.|+|+|+||..+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence                          0000        0112478999999999999999999999999999999754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-50  Score=378.11  Aligned_cols=258  Identities=23%  Similarity=0.280  Sum_probs=219.2

Q ss_pred             ccccceeecceecccCCeEEEEEE-----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ...++|++.+.||+|+||+||+|.     +..+++.||||++....  .......+.+|+.++++++ ||||+++++++.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  144 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSL  144 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEe
Confidence            345679999999999999999999     44577899999986432  4555678899999999997 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEE
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRG-------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                      +....++||||+++++|.+++...+       .+++..+..++.||+.||.|||++||+||||||+|||+..++.+..+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999997653       489999999999999999999999999999999999995433555799


Q ss_pred             EeecCcceecCCC---CccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCc
Q 017960          244 AIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       244 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  318 (363)
                      |+|||++......   .......+|+.|+|||++. ..++.++|||||||++|||++ |..||.+....+....+..+..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999999754221   2233456789999999987 569999999999999999998 9999999998888888887653


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ...   ...+++++.+||.+||+.||++|||+.+++++++.
T Consensus       305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            322   34678999999999999999999999999998764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3e-49  Score=361.98  Aligned_cols=255  Identities=27%  Similarity=0.414  Sum_probs=223.5

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ...+.|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.+. ||||+++++++.+....
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeE
Confidence            34566999999999999999999999999999999997654  2345678999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++||||+++++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++.....
T Consensus        96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBT
T ss_pred             EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCc
Confidence            999999999999988754 578999999999999999999999999999999999999   7888999999999987654


Q ss_pred             CC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......   .....++.++.
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  248 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLK  248 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHH
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHH
Confidence            33 2345678999999999874 6899999999999999999999999888877777666654432   22246789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +||.+||+.||.+|||+.++|+|+|+.
T Consensus       249 ~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          249 EFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhhChhhh
Confidence            999999999999999999999999984

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.6e-50  Score=376.33  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=218.8

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++ ||||+++++++.+.+.
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCE
Confidence            345577999999999999999999999999999999997643  4556678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||+   +.++.+||+|||++...
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence            999999999999999999888899999999999999999999996 99999999999999   78889999999998654


Q ss_pred             CCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHH--------------------
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDA--------------------  312 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~--------------------  312 (363)
                      .. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........                    
T Consensus       183 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          183 ID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             cc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            32 22345688999999999884 589999999999999999999999977665443222                    


Q ss_pred             ----------------------HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          313 ----------------------VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       313 ----------------------i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                            +.....  .......++.++.+||.+||+.||++|||+.|+|+|+||+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                                  111111  11112346889999999999999999999999999999853

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.3e-49  Score=379.19  Aligned_cols=254  Identities=28%  Similarity=0.399  Sum_probs=209.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec------
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------  171 (363)
                      ...|++.+.||+|+||.||+|.+..+++.||||++.....       ...+|+++++.++ ||||+++++++..      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTT
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcC-CCCccceeeEEeccCCCCc
Confidence            3469999999999999999999999999999999865321       2346999999998 9999999998843      


Q ss_pred             CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          172 SLCVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      ...+++||||+++ +|.+.+..    ...+++..+..++.||+.||.|||++||+||||||+|||+.  .+.+.+||+||
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DF  201 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCC
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccc
Confidence            2247799999965 66665542    46799999999999999999999999999999999999993  24467899999


Q ss_pred             CcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG---------  316 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~---------  316 (363)
                      |+++....+......+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+....+.+..+.+.         
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99998766655667789999999999864  5999999999999999999999999988876666555431         


Q ss_pred             --------CcccCC---C-----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          317 --------HIDFES---D-----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       317 --------~~~~~~---~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                              .+.++.   .     ..+.+++++.+||.+||..||.+|||+.|+|+|+||..+
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence                    001110   0     012468999999999999999999999999999999653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-49  Score=360.02  Aligned_cols=255  Identities=26%  Similarity=0.439  Sum_probs=220.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe--cCCeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--DSLCV  175 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~~~~~  175 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++.  .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceE
Confidence            3569999999999999999999999999999999976543 4556778999999999997 999999999874  46789


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEecCCCCCceEeeeCCCCccEEEee
Q 017960          176 HIVMELCAGGELFDRIIQR----GHYSERKAAELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~-----iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                      ++||||+++++|.+++...    ..+++..+..++.||+.||.|||+.|     |+||||||+||++   +.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence            9999999999999998753    34899999999999999999999999     9999999999999   7888999999


Q ss_pred             cCcceecCCCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCC
Q 017960          247 FGLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP  324 (363)
Q Consensus       247 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  324 (363)
                      ||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+..+.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---  236 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---  236 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---
Confidence            99997654332 2234578999999999874 589999999999999999999999999888888888877654322   


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ...+++++.++|.+||+.||.+|||+.|+|+++|+.
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            235789999999999999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.6e-50  Score=374.41  Aligned_cols=253  Identities=24%  Similarity=0.348  Sum_probs=211.8

Q ss_pred             cccceeecceecccCCeEEEEEE-----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++++.||+|+||.||+|.     +..+++.||||++....  .....+.+.+|+.++.++.+||||+++++++.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~   97 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK   97 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence            45679999999999999999998     55677899999997543  455567899999999999669999999999887


Q ss_pred             CC-eEEEEEeccCCCChHHHHHhcCC------------------------------------------------------
Q 017960          172 SL-CVHIVMELCAGGELFDRIIQRGH------------------------------------------------------  196 (363)
Q Consensus       172 ~~-~~~iv~e~~~~~~L~~~l~~~~~------------------------------------------------------  196 (363)
                      .+ .+++||||+++|+|.+++.....                                                      
T Consensus        98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3vhe_A           98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE  177 (359)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred             CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence            55 48999999999999999976533                                                      


Q ss_pred             ------------CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC---cccc
Q 017960          197 ------------YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTD  261 (363)
Q Consensus       197 ------------~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~  261 (363)
                                  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......   ....
T Consensus       178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccchhccc
Confidence                        8899999999999999999999999999999999999   778899999999998654332   2334


Q ss_pred             CccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHH-HHHHcCCcccCCCCCCCCCHHHHHHHHH
Q 017960          262 VVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIF-DAVLKGHIDFESDPWPLISDSAKDLIRK  338 (363)
Q Consensus       262 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~li~~  338 (363)
                      ..||+.|+|||++. ..++.++|||||||++|||++ |..||.+....+.. ..+..+.. .  .....+++++.++|.+
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l~~li~~  331 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-M--RAPDYTTPEMYQTMLD  331 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-C--CCCTTCCHHHHHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-C--CCCCCCCHHHHHHHHH
Confidence            66788999999987 468999999999999999998 99999876644433 33333322 1  1224578999999999


Q ss_pred             hcccCcCCCCCHHHHhcCC
Q 017960          339 MLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       339 ~l~~dp~~R~s~~evL~~~  357 (363)
                      ||+.||.+|||+.|+++++
T Consensus       332 ~l~~dP~~Rps~~ell~~L  350 (359)
T 3vhe_A          332 CWHGEPSQRPTFSELVEHL  350 (359)
T ss_dssp             HTCSSGGGSCCHHHHHHHH
T ss_pred             HccCChhhCCCHHHHHHHH
Confidence            9999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-49  Score=362.97  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=217.9

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++ ||||+++++++...+.
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-C
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCe
Confidence            34667899999999999999999999999999999998654   3344678899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccc
Confidence            9999999999999988876 4669999999999999999999999999999999999999   77889999999987542


Q ss_pred             CCC-CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          254 KPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       254 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      ... .......||+.|+|||++.      ..++.++||||||+++|+|++|..||...........+........ ....
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  246 (302)
T 2j7t_A          168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPS  246 (302)
T ss_dssp             HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGG
T ss_pred             cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCcc
Confidence            211 1223457899999999983      3588999999999999999999999988887777766665543221 1223


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .++.++.+||.+||+.||++|||+.++++|+|+..+
T Consensus       247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            578999999999999999999999999999999764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-50  Score=380.23  Aligned_cols=257  Identities=17%  Similarity=0.136  Sum_probs=197.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc-CCCceeEEe-------EEEe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-GHKNIVTIK-------GAYE  170 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~-------~~~~  170 (363)
                      ..|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.+++.|+ +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            44999999999999999999999999999999998765545556678888876666664 499988755       4444


Q ss_pred             cC-----------------CeEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCcEecCC
Q 017960          171 DS-----------------LCVHIVMELCAGGELFDRIIQR-GHYSERKA------AELTRIIVGVVEACHSLGVMHRDL  226 (363)
Q Consensus       171 ~~-----------------~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~------~~i~~~l~~~l~~lH~~~iiHrDl  226 (363)
                      ..                 ..+|+||||++ ++|.+++... ..+++..+      ..++.||+.||+|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999997 8999999764 33455555      677799999999999999999999


Q ss_pred             CCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCC
Q 017960          227 KPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWA  303 (363)
Q Consensus       227 kp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~  303 (363)
                      ||+|||+   +.++.+||+|||+|.....  ......+|+.|+|||++.+   .++.++|||||||++|||++|+.||.+
T Consensus       221 kp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          221 TPDNLFI---MPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             SGGGEEE---CTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CHHHEEE---CCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9999999   7888999999999987643  2224567799999999874   599999999999999999999999976


Q ss_pred             cCHHHH--HHH---HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          304 ETQQGI--FDA---VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       304 ~~~~~~--~~~---i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ......  ...   ............++.+++++.+||.+||+.||++|||+.++|+|+||..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            643210  000   0111112223334578999999999999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9e-50  Score=371.14  Aligned_cols=257  Identities=38%  Similarity=0.629  Sum_probs=188.2

Q ss_pred             ccccceeecc-eecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec---
Q 017960           96 NIRDLYTLGR-KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (363)
Q Consensus        96 ~~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---  171 (363)
                      .+.++|++.+ +||+|+||.||+|.+..+++.||||++...    .    ...+|+..+.++.+||||+++++++..   
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----P----KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----H----HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            4667799955 699999999999999999999999998642    1    223344443344459999999999876   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          172 -SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       172 -~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                       ...+++||||+++++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||+..++.++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             556899999999999999998754  59999999999999999999999999999999999999655556779999999


Q ss_pred             cceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHH----HHHHHcCCcccCCC
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI----FDAVLKGHIDFESD  323 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~  323 (363)
                      ++...... ......+|+.|+|||++. ..++.++|||||||++|+|++|..||........    ...+......++..
T Consensus       177 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             cceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            99875432 334567899999999987 4589999999999999999999999976655443    33333444445555


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+..+++++.+||.+||+.||.+|||+.|+|+|+||..
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            56678999999999999999999999999999999853

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.1e-49  Score=365.77  Aligned_cols=262  Identities=28%  Similarity=0.398  Sum_probs=216.7

Q ss_pred             cccccccceeecceecccCCeEEEEEEE-ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC------ceeEE
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTE-IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK------NIVTI  165 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~------niv~~  165 (363)
                      ..+.+.++|++.+.||+|+||.||+|.+ ..+++.||||++..    .....+.+.+|+.+++.+. |+      +|+++
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~   82 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLN-TTDPNSTFRCVQM   82 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCE
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----CCchhHHHHHHHHHHHHhh-hcCCCCceeeEee
Confidence            3455678899999999999999999998 56889999999864    3345677889999999987 55      59999


Q ss_pred             eEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC-----
Q 017960          166 KGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-----  238 (363)
Q Consensus       166 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~-----  238 (363)
                      ++++...+..++||||+ +++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||+...+.     
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 889999998765  5889999999999999999999999999999999999943211     


Q ss_pred             -----------CccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH
Q 017960          239 -----------DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ  306 (363)
Q Consensus       239 -----------~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~  306 (363)
                                 ++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|..||.....
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             CccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                       56799999999987543  3345789999999999874 699999999999999999999999988777


Q ss_pred             HHHHHHHHcCCcccCC----------------------------------------CCCCCCCHHHHHHHHHhcccCcCC
Q 017960          307 QGIFDAVLKGHIDFES----------------------------------------DPWPLISDSAKDLIRKMLCSQPSE  346 (363)
Q Consensus       307 ~~~~~~i~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~  346 (363)
                      .+....+.......+.                                        ......++++.+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            6655444321111000                                        001123467899999999999999


Q ss_pred             CCCHHHHhcCCCcccC
Q 017960          347 RLTAHEVLCMYNLPVL  362 (363)
Q Consensus       347 R~s~~evL~~~~~~~~  362 (363)
                      |||+.|+|+|+||..+
T Consensus       320 Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          320 RITLREALKHPFFDLL  335 (339)
T ss_dssp             SCCHHHHTTSGGGGGG
T ss_pred             ccCHHHHhcCHHHHHH
Confidence            9999999999999754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=383.03  Aligned_cols=261  Identities=24%  Similarity=0.413  Sum_probs=196.3

Q ss_pred             ccccccceee-cceecccCCeEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           94 TDNIRDLYTL-GRKLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        94 ~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ...+.+.|++ +++||+|+||+||+|.++  .+++.||||++.....     ...+.+|+.+|+.|+ ||||+++++++.
T Consensus        15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~-hpniv~~~~~~~   88 (405)
T 3rgf_A           15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELK-HPNVISLQKVFL   88 (405)
T ss_dssp             CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCC-CTTBCCCCEEEE
T ss_pred             hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcC-CCCeeeEeeEEe
Confidence            3456677887 568999999999999965  5788999999965432     246788999999998 999999999994


Q ss_pred             --cCCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC-CC
Q 017960          171 --DSLCVHIVMELCAGGELFDRIIQR---------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK-DD  238 (363)
Q Consensus       171 --~~~~~~iv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~-~~  238 (363)
                        ....+++||||+. ++|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+... +.
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           89 SHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             ETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred             cCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence              4778999999995 5888877532         248999999999999999999999999999999999999543 45


Q ss_pred             CccEEEeecCcceecCCC----CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-----
Q 017960          239 DFSLKAIDFGLSVFFKPG----QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQ-----  307 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----  307 (363)
                      ++.+||+|||+|......    ......+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....     
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            679999999999876432    23345788999999999874  4899999999999999999999999765432     


Q ss_pred             ----HHHHHHHcCCcccCCCCC----------------------------------CCCCHHHHHHHHHhcccCcCCCCC
Q 017960          308 ----GIFDAVLKGHIDFESDPW----------------------------------PLISDSAKDLIRKMLCSQPSERLT  349 (363)
Q Consensus       308 ----~~~~~i~~~~~~~~~~~~----------------------------------~~~~~~~~~li~~~l~~dp~~R~s  349 (363)
                          +.+..+...........|                                  ...++++.+||.+||+.||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence                333333221111111111                                  112678999999999999999999


Q ss_pred             HHHHhcCCCccc
Q 017960          350 AHEVLCMYNLPV  361 (363)
Q Consensus       350 ~~evL~~~~~~~  361 (363)
                      +.|+|+|+||..
T Consensus       328 a~e~L~hp~f~~  339 (405)
T 3rgf_A          328 SEQAMQDPYFLE  339 (405)
T ss_dssp             HHHHHTSGGGTS
T ss_pred             HHHHhcChhhcc
Confidence            999999999964

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-49  Score=373.94  Aligned_cols=260  Identities=27%  Similarity=0.416  Sum_probs=216.2

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ....+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+++.+|+.+++.++ ||||+++++++...
T Consensus        36 ~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  113 (371)
T 4exu_A           36 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPA  113 (371)
T ss_dssp             EEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSC
T ss_pred             ceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcC-CCCchhhhhheecc
Confidence            33456778999999999999999999999999999999997543 34556678999999999998 99999999999877


Q ss_pred             CeE------EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          173 LCV------HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       173 ~~~------~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                      +..      ++||||+. ++|.+.+  ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~D  187 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILD  187 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECS
T ss_pred             CCcccceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEe
Confidence            654      99999996 6887766  3458999999999999999999999999999999999999   8888999999


Q ss_pred             cCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc----
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF----  320 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----  320 (363)
                      ||++.....  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.......    
T Consensus       188 fg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          188 FGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             TTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            999986543  3455788999999999874  58999999999999999999999999888776666654311100    


Q ss_pred             -------------------CC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          321 -------------------ES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       321 -------------------~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                         ..    ..++.+++++.+||.+||+.||++|||+.|+|+|+||..+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                               00    0123568999999999999999999999999999999754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.5e-49  Score=367.75  Aligned_cols=261  Identities=29%  Similarity=0.407  Sum_probs=216.5

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-  172 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-  172 (363)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++....  ......++.+|+.++++++ ||||+++++++... 
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFK-HENIITIFNIQRPDS   82 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSC
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccc
Confidence            3456778999999999999999999999999999999996432  4555678889999999998 99999999987654 


Q ss_pred             ----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          173 ----LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       173 ----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                          ...++||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg  157 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFG  157 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCT
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecc
Confidence                67999999996 589887765 578999999999999999999999999999999999999   788899999999


Q ss_pred             cceecCCCC-----------ccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Q 017960          249 LSVFFKPGQ-----------IFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK  315 (363)
Q Consensus       249 ~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  315 (363)
                      ++.......           ......||+.|+|||++.  ..++.++|||||||++|+|++|..||.+....+....+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            998764321           122357899999999875  4589999999999999999999999988876655544432


Q ss_pred             CCcc------------------------cCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          316 GHID------------------------FESD----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       316 ~~~~------------------------~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ....                        ....    .++.+++++.+||.+||+.||++|||+.|+|+|+||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            1000                        0000    124678999999999999999999999999999999753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-49  Score=359.31  Aligned_cols=255  Identities=25%  Similarity=0.240  Sum_probs=196.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+..+...++.+. ||||+++++++.+.+..++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCEEE
Confidence            4679999999999999999999999999999999965431 2222333444444456565 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          178 VMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ||||++ ++|.+++..    ...+++..+..++.||+.||.|||++ ||+||||||+||++   +.++.+||+|||++..
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence            999996 488776653    46799999999999999999999998 99999999999999   7788999999999987


Q ss_pred             cCCCCccccCccCCcccccccc----c-ccCCCcccHHHHHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCcccCCCCCC
Q 017960          253 FKPGQIFTDVVGSPYYVAPEVL----L-KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       253 ~~~~~~~~~~~gt~~y~aPE~~----~-~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      ...........||+.|+|||++    . ..++.++|||||||++|+|++|..||.. ................  .....
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  237 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP--QLPAD  237 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC--CCCTT
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC--Ccccc
Confidence            7655555556899999999996    2 3588999999999999999999999975 3333333333333221  12224


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+++++.+||.+||+.||++|||+.|+++||||+
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence            5789999999999999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-49  Score=371.40  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=219.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccC-------CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~  169 (363)
                      ..++|++++.||+|+||.||+|.+...       +..||||++....  ......++.+|+.+++++.+||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            446799999999999999999997543       3579999997543  5566788999999999995599999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEe
Q 017960          170 EDSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (363)
Q Consensus       170 ~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll  233 (363)
                      .+.+..++||||+++++|.+++....                .+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999999999999998754                48999999999999999999999999999999999999


Q ss_pred             eeCCCCccEEEeecCcceecCCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHH
Q 017960          234 VNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (363)
Q Consensus       234 ~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~  308 (363)
                         +.++.+||+|||++.......   ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+
T Consensus       225 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          225 ---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             ---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence               788899999999998764432   2334567889999999874 58999999999999999999 999999988888


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+..+....   ....+++++.+||.+||+.||++|||+.|+++++
T Consensus       302 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  347 (382)
T 3tt0_A          302 LFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  347 (382)
T ss_dssp             HHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            888887764322   2246889999999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.1e-49  Score=365.31  Aligned_cols=261  Identities=24%  Similarity=0.348  Sum_probs=217.5

Q ss_pred             cccceeecceecccCCeEEEEEEEc-cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEe---
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYE---  170 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~---  170 (363)
                      ..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+.+|+.+++.+.  +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc-cccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4467999999999999999999985 6788999999975432 2222235667888887773  4999999999987   


Q ss_pred             --cCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          171 --DSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       171 --~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                        .....++||||+. ++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEec
Confidence              5677999999996 69999987753  48999999999999999999999999999999999999   7888999999


Q ss_pred             cCcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-----c
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----F  320 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~  320 (363)
                      ||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......     +
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            99998765544556678999999999987 46999999999999999999999999988887777666532110     0


Q ss_pred             ------------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          321 ------------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       321 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                        .......+++++.+||.+||+.||++|||+.|+|+|+||..+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                              001124578999999999999999999999999999999754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-49  Score=363.55  Aligned_cols=256  Identities=24%  Similarity=0.402  Sum_probs=213.9

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-----  171 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....    ...+.+.+|+.+++++.+||||+++++++..     
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            4567999999999999999999999999999999986542    2346788999999999669999999999976     


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          172 -SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       172 -~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                       ....++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg  174 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFG  174 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCc
Confidence             56899999999999999999764  568999999999999999999999999999999999999   788899999999


Q ss_pred             cceecCCC-CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          249 LSVFFKPG-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       249 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      ++...... .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.........+....... 
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  253 (326)
T 2x7f_A          175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR-  253 (326)
T ss_dssp             TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-
T ss_pred             CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc-
Confidence            99765432 2234567899999999985      348999999999999999999999998887776666655543321 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                       .....+++++.+||.+||..||.+||++.++++|+||..
T Consensus       254 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          254 -LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             -CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             -CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence             223467899999999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.4e-50  Score=366.59  Aligned_cols=245  Identities=22%  Similarity=0.325  Sum_probs=208.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|.+..+++.||+|++...   .....+.+.+|+.++++++ ||||+++++++.+....++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEE
Confidence            5699999999999999999999999999999988543   5666788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccc
Confidence            999999999999987 5679999999999999999999999999999999999999   888899999999998764332


Q ss_pred             cc---------------ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH-----HHHHHHcC
Q 017960          258 IF---------------TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQG-----IFDAVLKG  316 (363)
Q Consensus       258 ~~---------------~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-----~~~~i~~~  316 (363)
                      ..               ....||+.|+|||++.+ .++.++||||||+++|||++|..||.......     ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            21               14679999999999984 58999999999999999999999985432211     01111111


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                            ...+.+++++.+||.+||+.||++|||+.++++.
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~  276 (310)
T 3s95_A          243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW  276 (310)
T ss_dssp             ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                  1123578899999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.5e-50  Score=365.02  Aligned_cols=258  Identities=28%  Similarity=0.411  Sum_probs=198.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.++ ||||+++++++...+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCC-CTTBCCEEEEEESSSCEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCcEE
Confidence            456999999999999999999998899999999986543  2334567889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          178 VMELCAGGELFDRIIQ--------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                      ||||+++++|.+++..        .+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccc
Confidence            9999999999998864        3558999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCC------ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          250 SVFFKPGQ------IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       250 a~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      +.......      ......||+.|+|||++.+  .++.++||||||+++|+|++|..||....................
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            87654321      2234578999999999873  589999999999999999999999988776666555554433211


Q ss_pred             ------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 ------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 ------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                            ......+++++.+||.+||+.||.+|||+.++++|+||..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence                  1223467899999999999999999999999999999975

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-49  Score=375.35  Aligned_cols=251  Identities=25%  Similarity=0.334  Sum_probs=217.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.++++++ ||||+++++++......++
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEE
Confidence            457999999999999999999999899999999986432  4455667889999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCC
Confidence            999999999999997654 58999999999999999999999999999999999999   78889999999999875433


Q ss_pred             Cccc---cCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          257 QIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       257 ~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ....   ...++..|+|||++. +.++.++|||||||++|||++ |..||.+.........+..+...   .....++++
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  343 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL---PCPELCPDA  343 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC---CCCTTCCHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHH
Confidence            2211   123467899999987 569999999999999999998 99999998888877777665422   222357899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.+||.+||+.||++|||+.++++.+
T Consensus       344 l~~li~~cl~~dP~~Rps~~~i~~~L  369 (377)
T 3cbl_A          344 VFRLMEQCWAYEPGQRPSFSTIYQEL  369 (377)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            99999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1e-48  Score=352.07  Aligned_cols=248  Identities=26%  Similarity=0.381  Sum_probs=215.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEE
Confidence            466999999999999999999864 577899999975432    2367889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+++++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTT
T ss_pred             EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchh
Confidence            999999999999997754 49999999999999999999999999999999999999   88889999999999876544


Q ss_pred             Cc--cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 QI--FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+..+......   ..+++++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  234 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTI  234 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHH
Confidence            32  223445678999999884 68999999999999999999 99999988888888877766543332   3468999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .++|.+||+.||.+|||+.++++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~L  259 (268)
T 3sxs_A          235 YQIMYSCWHELPEKRPTFQQLLSSI  259 (268)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-49  Score=371.02  Aligned_cols=260  Identities=23%  Similarity=0.404  Sum_probs=223.8

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhh--------------HHHHHHHHHHHHHhcCCCc
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--------------VEDVRREIQIMHHLAGHKN  161 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l~~h~n  161 (363)
                      .+.++|++.+.||+|+||.||+|.+  +++.||||++..........              .+.+.+|+.++++++ |||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~  104 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEY  104 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTT
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCC
Confidence            3456799999999999999999997  89999999997654322211              278899999999998 999


Q ss_pred             eeEEeEEEecCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceE
Q 017960          162 IVTIKGAYEDSLCVHIVMELCAGGELFDR------IIQ--RGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFL  232 (363)
Q Consensus       162 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIl  232 (363)
                      |+++++++.+.+..++||||+++++|.++      +..  ...+++..+..++.||+.||.|||+ .||+||||||+||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999888      655  5679999999999999999999999 99999999999999


Q ss_pred             eeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccccc--cCCC-cccHHHHHHHHHHHHhCCCCCCCcCH-HH
Q 017960          233 LVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGP-EADVWTAGVILYILLSGVPPFWAETQ-QG  308 (363)
Q Consensus       233 l~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~Di~slG~il~ell~g~~pf~~~~~-~~  308 (363)
                      +   +.++.+||+|||++...... ......|++.|+|||++.+  .++. ++|||||||++|+|++|..||..... .+
T Consensus       185 ~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 M---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             E---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             E---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9   78889999999999876443 4456789999999999974  3555 99999999999999999999988776 77


Q ss_pred             HHHHHHcCCcccCCCC---------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          309 IFDAVLKGHIDFESDP---------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ....+..+...++...               ...+++++.+||.+||+.||.+|||+.|+|+|+||...
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            7777777665544211               14578999999999999999999999999999999753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-49  Score=367.43  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=218.5

Q ss_pred             cccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||||++....  .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAV  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcc
Confidence            4467999999999999999999987     345889999997543  4556678999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR------------------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLK  227 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlk  227 (363)
                      .+..++||||+++++|.+++...                        ..+++..+..++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999763                        568999999999999999999999999999999


Q ss_pred             CCceEeeeCCCCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCC
Q 017960          228 PENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFW  302 (363)
Q Consensus       228 p~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~  302 (363)
                      |+|||+   +.++.+||+|||++.......   ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.
T Consensus       202 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          202 TRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             GGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            999999   788899999999997654322   223456788999999987 469999999999999999999 999999


Q ss_pred             CcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       303 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +....+....+..+.....   ...+++++.+||.+||+.||++|||+.++++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L  330 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRIL  330 (343)
T ss_dssp             TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence            9988888888877654322   236789999999999999999999999998754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=361.79  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=217.9

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHHhcCCCceeEEeEEE--ecCC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAY--EDSL  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~--~~~~  173 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++ ||||+++++++  .+..
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence            346799999999999999999999999999999999764321 1234578999999999997 99999999998  4556


Q ss_pred             eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          174 CVHIVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ..++||||+.++ |.+.+..  ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAE  157 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeecccccc
Confidence            899999999766 7777765  4568999999999999999999999999999999999999   788899999999998


Q ss_pred             ecCCC---CccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          252 FFKPG---QIFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       252 ~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      .....   .......||+.|+|||++.+   .++.++||||||+++|+|++|..||.+.........+.++....+    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----  233 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----  233 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence            76432   23345678999999999874   247899999999999999999999999888888888887765433    


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+++++.+||.+||+.||.+|||+.|+++|+||..
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence            357899999999999999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-49  Score=368.98  Aligned_cols=250  Identities=18%  Similarity=0.215  Sum_probs=208.7

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....     .+.+.+|+.+++.|.+||||+++++++......+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            45679999999999999999999999999999999875432     2357889999999955999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc-----EEEeecCcc
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-----LKAIDFGLS  250 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~-----~kl~DFG~a  250 (363)
                      +||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.     +||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI---GRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CCGGGTCTTSEEECCCTTC
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---ccCCCCCCceEEEEEcccc
Confidence            999999 9999999886 4679999999999999999999999999999999999999   66665     999999999


Q ss_pred             eecCCCCc--------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCc
Q 017960          251 VFFKPGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHI  318 (363)
Q Consensus       251 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~  318 (363)
                      ........        .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+..   ..+.+..+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            87643322        246789999999999985 58999999999999999999999998743   3344444443332


Q ss_pred             ccCCCC-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          319 DFESDP-WPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       319 ~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ..+... ...++ ++.+||..||+.||.+||++.++++.
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~  275 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKL  275 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHH
Confidence            222111 12234 99999999999999999999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-49  Score=371.20  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=208.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC--------ChhhHHHHHHHHHHHHHhcCCCceeEEeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI--------SREDVEDVRREIQIMHHLAGHKNIVTIKG  167 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~~~~  167 (363)
                      .+.++|++.+.||+|+||.||+|.+. +++.||||++......        .....+.+.+|+.++++++ ||||+++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~   96 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRD   96 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceee
Confidence            45678999999999999999999974 4899999998654321        2334578999999999998 999999999


Q ss_pred             EEe-----cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc
Q 017960          168 AYE-----DSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       168 ~~~-----~~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      ++.     ....+++||||+. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~  172 (362)
T 3pg1_A           97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNND  172 (362)
T ss_dssp             EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCC
T ss_pred             eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCC
Confidence            984     3447899999996 6888887654 368999999999999999999999999999999999999   78889


Q ss_pred             EEEeecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc
Q 017960          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID  319 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  319 (363)
                      +||+|||++.............+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+....+....+......
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999999987655555566789999999998874  5899999999999999999999999988877766655431110


Q ss_pred             ------------------------cCCC----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccCC
Q 017960          320 ------------------------FESD----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVLF  363 (363)
Q Consensus       320 ------------------------~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~~  363 (363)
                                              .+..    ..+.+++.+.+||.+||+.||.+|||+.|+|+||||+.++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                                    0000    1234688999999999999999999999999999998753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.7e-49  Score=360.26  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=214.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ...+.|++.+.||+|+||.||+|.+..+++.||+|++....     ..+.+.+|+.+++.+. ||||+++++++...+..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence            45567999999999999999999999999999999997532     2467889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++. ....+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECB
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhh
Confidence            99999999999999986 45679999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          255 PGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       255 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......+++++
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l  255 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNF  255 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHH
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHH
Confidence            432 2345678999999999874 5899999999999999999999999887766655554443221 111223478999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+||.+||..||.+|||+.++|+|+|+..
T Consensus       256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          256 TDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence            99999999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.9e-49  Score=374.99  Aligned_cols=258  Identities=23%  Similarity=0.349  Sum_probs=209.6

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc-------CCCceeEE
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-------GHKNIVTI  165 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~niv~~  165 (363)
                      ..+.+.++|++.+.||+|+||+||+|.+..+++.||||++..    .....+.+.+|+.+++.++       +|+||+++
T Consensus        31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            445567889999999999999999999999999999999964    3445678899999999996       27889999


Q ss_pred             eEEEe----cCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCC
Q 017960          166 KGAYE----DSLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       166 ~~~~~----~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~  238 (363)
                      ++++.    ....+++||||+ +++|.+.+...  +.+++..+..++.||+.||.|||++ ||+||||||+|||+   +.
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll---~~  182 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL---SV  182 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE---CC
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE---ec
Confidence            99987    566899999999 67787777664  4699999999999999999999998 99999999999999   44


Q ss_pred             Cc-------------------------------------------------cEEEeecCcceecCCCCccccCccCCccc
Q 017960          239 DF-------------------------------------------------SLKAIDFGLSVFFKPGQIFTDVVGSPYYV  269 (363)
Q Consensus       239 ~~-------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~gt~~y~  269 (363)
                      ++                                                 .+||+|||++.....  ......||+.|+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~  260 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYR  260 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGC
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCccc
Confidence            43                                                 799999999987643  345678999999


Q ss_pred             ccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH------HHHHHHHHc--CC----------cc---cC------
Q 017960          270 APEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ------QGIFDAVLK--GH----------ID---FE------  321 (363)
Q Consensus       270 aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~i~~--~~----------~~---~~------  321 (363)
                      |||++.+ .++.++|||||||++|||++|+.||.+...      ......+..  +.          ..   +.      
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            9999884 599999999999999999999999975442      222222211  00          00   00      


Q ss_pred             ----C-------------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          322 ----S-------------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       322 ----~-------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                          .             ......++++.+||.+||+.||++|||+.|+|+|+||.
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                0             00012245788999999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.2e-49  Score=358.09  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=211.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-----
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-----  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-----  171 (363)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++..    .....+.+.+|+.+++.++ ||||+++++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchh
Confidence            45679999999999999999999999999999999964    3455678899999999997 9999999998865     


Q ss_pred             --------CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccE
Q 017960          172 --------SLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSL  242 (363)
Q Consensus       172 --------~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~  242 (363)
                              ....++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~  155 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV  155 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCE
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCE
Confidence                    457899999999999999998644 57889999999999999999999999999999999999   788899


Q ss_pred             EEeecCcceecCCC---------------CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCC-c
Q 017960          243 KAIDFGLSVFFKPG---------------QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWA-E  304 (363)
Q Consensus       243 kl~DFG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~-~  304 (363)
                      ||+|||++......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||.. .
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999999765421               12345678999999999873  58999999999999999998   5543 3


Q ss_pred             CHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       305 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ........+......++.......++.+.+||.+||+.||.+|||+.++++|+||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            344556666665555555555567888999999999999999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.2e-49  Score=361.26  Aligned_cols=252  Identities=21%  Similarity=0.315  Sum_probs=218.1

Q ss_pred             cccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++.+.||+|+||.||+|.+.     .++..||||++....  .....+.+.+|+.+++.++ ||||+++++++.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence            3467999999999999999999973     455889999997543  5566788999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcEecCCC
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGH------------------------YSERKAAELTRIIVGVVEACHSLGVMHRDLK  227 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlk  227 (363)
                      .+..++||||+++++|.+++.....                        +++..+..++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            9999999999999999999987543                        8899999999999999999999999999999


Q ss_pred             CCceEeeeCCCCccEEEeecCcceecCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCC
Q 017960          228 PENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFW  302 (363)
Q Consensus       228 p~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~  302 (363)
                      |+|||+   +.++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.
T Consensus       178 p~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          178 ARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             GGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999   7788999999999987644332   233456788999999874 58999999999999999999 999999


Q ss_pred             CcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          303 AETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       303 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.........+..+...   .....+++++.+||.+||+.||++|||+.++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l  306 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL  306 (314)
T ss_dssp             TCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            88888888777765432   22346889999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.3e-49  Score=353.76  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=214.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+....++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEE
Confidence            56999999999999999999975 577899999975432    2357889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+||++   +.++.+||+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEeccccccccccccc
Confidence            9999999999999654 458999999999999999999999999999999999999   778899999999998654332


Q ss_pred             --ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          258 --IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                        ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+.....   ...+++++.
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  237 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY  237 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHHH
Confidence              223345677899999997 569999999999999999999 9999999988888888877643222   235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++|.+||+.||.+|||+.++++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~ll~~l  261 (269)
T 4hcu_A          238 QIMNHCWRERPEDRPAFSRLLRQL  261 (269)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHHH
Confidence            999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.3e-49  Score=371.29  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe---
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC---  174 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---  174 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....    ...+..+++..+..++ ||||+++++++.....   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCT
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcC-CCCcccHHHhhhccccccc
Confidence            3569999999999999999999999999999999865332    2245667888888887 9999999999865333   


Q ss_pred             ----EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCcEecCCCCCceEeeeCCC-CccEE
Q 017960          175 ----VHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVEACH--SLGVMHRDLKPENFLLVNKDD-DFSLK  243 (363)
Q Consensus       175 ----~~iv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~lH--~~~iiHrDlkp~NIll~~~~~-~~~~k  243 (363)
                          +++||||+++ +|.+.+.    ....+++..+..++.||+.||.|||  ++||+||||||+|||+   +. ++.+|
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~~k  172 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---NEADGTLK  172 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE---ETTTTEEE
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE---eCCCCcEE
Confidence                8899999976 5544443    4567899999999999999999999  9999999999999999   54 78999


Q ss_pred             EeecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC
Q 017960          244 AIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE  321 (363)
Q Consensus       244 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  321 (363)
                      |+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+......+..+.+......
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            999999988776666667789999999999863  489999999999999999999999999888777766654211000


Q ss_pred             ----------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          322 ----------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       322 ----------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                                  .......++++.+||.+||+.||.+|||+.|+|+|+||..+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                                        00111256789999999999999999999999999999754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.8e-49  Score=360.20  Aligned_cols=255  Identities=25%  Similarity=0.344  Sum_probs=211.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++ ||||+++++++...+..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCeEEE
Confidence            356999999999999999999999999999999997665545566788999999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC--------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccccccc
Confidence            99999999999999988889999999999999999999999999999999999999   778899999999997654332


Q ss_pred             --ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          258 --IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.. .........+.+++++.+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-CCCCGGGTSTTCCTHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-CCCCccccCCCCCHHHHH
Confidence              2335678999999999874 589999999999999999999999988776544444433 332233334568999999


Q ss_pred             HHHHhcccCcCCCC-CHHHHhcCC
Q 017960          335 LIRKMLCSQPSERL-TAHEVLCMY  357 (363)
Q Consensus       335 li~~~l~~dp~~R~-s~~evL~~~  357 (363)
                      ||.+||+.||++|| +++++++.+
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~~l  291 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSAAA  291 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHHHH
Confidence            99999999999999 899888643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=364.91  Aligned_cols=261  Identities=28%  Similarity=0.399  Sum_probs=212.4

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe---
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE---  170 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---  170 (363)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+.+.+|+.+++.++ ||||+++++++.   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSG   81 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTS
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccc
Confidence            445678899999999999999999999999999999998653   4556778999999999997 999999999873   


Q ss_pred             -----------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC
Q 017960          171 -----------DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD  239 (363)
Q Consensus       171 -----------~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~  239 (363)
                                 +....++||||+. ++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||+.  .++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~  157 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TED  157 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTT
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCC
Confidence                       4468899999996 589888754 5789999999999999999999999999999999999994  246


Q ss_pred             ccEEEeecCcceecCCC----CccccCccCCccccccccc--ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHH
Q 017960          240 FSLKAIDFGLSVFFKPG----QIFTDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (363)
Q Consensus       240 ~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i  313 (363)
                      +.+||+|||++......    .......+|+.|+|||++.  ..++.++|||||||++|||++|+.||.+....+....+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            78999999999865422    1223456789999999886  45899999999999999999999999988877766665


Q ss_pred             HcCCccc----------------------CC----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          314 LKGHIDF----------------------ES----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       314 ~~~~~~~----------------------~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .......                      ..    ...+.+++++.+||.+||+.||++|||+.|+|+|+||..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            5432110                      00    0123578999999999999999999999999999999753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-48  Score=364.94  Aligned_cols=263  Identities=27%  Similarity=0.375  Sum_probs=216.6

Q ss_pred             ccccccccceeecceecccCCeEEEEEEEccCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc------eeE
Q 017960           92 HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATG-IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN------IVT  164 (363)
Q Consensus        92 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n------iv~  164 (363)
                      ...+.+.++|++.+.||+|+||.||+|.+..++ +.||+|++..    .....+.+.+|+.+++.+. |++      ++.
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~   86 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIK-EKDKENKFLCVL   86 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHH-HHCTTSCSCBCC
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHh-hcCCCCceeEEE
Confidence            345567788999999999999999999998777 6899999964    3345677889999999997 655      999


Q ss_pred             EeEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC------
Q 017960          165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK------  236 (363)
Q Consensus       165 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~------  236 (363)
                      +++++...+..++||||+ +++|.+.+....  .+++..+..++.||+.||.|||++||+||||||+|||+...      
T Consensus        87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence            999999999999999999 778888887654  68999999999999999999999999999999999999432      


Q ss_pred             ----------CCCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC
Q 017960          237 ----------DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET  305 (363)
Q Consensus       237 ----------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~  305 (363)
                                +.++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+..
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                      2467899999999987543  3355789999999999874 69999999999999999999999998877


Q ss_pred             HHHHHHHHHcCCcccCC----------------------------------------CCCCCCCHHHHHHHHHhcccCcC
Q 017960          306 QQGIFDAVLKGHIDFES----------------------------------------DPWPLISDSAKDLIRKMLCSQPS  345 (363)
Q Consensus       306 ~~~~~~~i~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~  345 (363)
                      ..+....+.+.....+.                                        ......+.++.+||.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            76655444332111100                                        00011235789999999999999


Q ss_pred             CCCCHHHHhcCCCcccC
Q 017960          346 ERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       346 ~R~s~~evL~~~~~~~~  362 (363)
                      +|||+.|+|+|+||..+
T Consensus       324 ~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          324 QRITLAEALLHPFFAGL  340 (355)
T ss_dssp             TSCCHHHHTTSGGGGGC
T ss_pred             hCcCHHHHhcChhhcCC
Confidence            99999999999999754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.6e-49  Score=362.50  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=199.1

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..++|++.+.||+|+||.||+|.+..++.   .||||++..... .....+.+.+|+.++++++ ||||+++++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCC-CCceehhhceeeccc
Confidence            34679999999999999999999877765   899999975433 3445678999999999997 999999999998776


Q ss_pred             eE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc
Q 017960          174 CV------HIVMELCAGGELFDRIIQRG------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       174 ~~------~iv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      ..      ++||||+.+++|.+++....      .+++..+..++.||+.||.|||++||+||||||+|||+   ++++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCC
Confidence            55      99999999999999986543      58999999999999999999999999999999999999   78889


Q ss_pred             EEEeecCcceecCCCCcc---ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcC
Q 017960          242 LKAIDFGLSVFFKPGQIF---TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKG  316 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~  316 (363)
                      +||+|||++.........   ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            999999999876443322   23456778999999874 58999999999999999999 99999998888888887766


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcccCcCCCCC-------HHHHhcCCCcc
Q 017960          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLT-------AHEVLCMYNLP  360 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s-------~~evL~~~~~~  360 (363)
                      ....   ..+.+++++.+||.+||+.||++|||       +++++.++|+.
T Consensus       256 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          256 NRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             CCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence            5322   23467899999999999999999999       77778888875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.8e-49  Score=359.34  Aligned_cols=255  Identities=20%  Similarity=0.313  Sum_probs=212.0

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++....     ..+.+.+|+.+++.+.+|+||+++++++.+..
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            3446678999999999999999999999999999999986432     22457889999999977999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc-----EEEeec
Q 017960          174 CVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS-----LKAIDF  247 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~-----~kl~DF  247 (363)
                      ..++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.     +||+||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI---GRPNSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CCSSSTTTTCEEECCC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---ccCCCCCCCeEEEEEC
Confidence            999999999 999999998754 59999999999999999999999999999999999999   44444     999999


Q ss_pred             CcceecCCCCc--------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCc---CHHHHHHHHHc
Q 017960          248 GLSVFFKPGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAE---TQQGIFDAVLK  315 (363)
Q Consensus       248 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~~i~~  315 (363)
                      |++........        .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.   .....+..+..
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            99987654322        345679999999999874 5899999999999999999999999774   33344444433


Q ss_pred             CCcccC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          316 GHIDFE-SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       316 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .....+ ......+++++.+||.+||+.||++||++.++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l  278 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF  278 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence            222111 111235789999999999999999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-49  Score=365.37  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=211.5

Q ss_pred             cccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..+.|++.+.||+|+||.||+|.+.     .++..||||++....  .....+.+.+|+.++.++.+||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            3467999999999999999999973     456789999997543  334457899999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCC
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRG-----------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKP  228 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp  228 (363)
                      .+..++||||+++++|.+++....                       .+++..+..++.||+.||.|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            999999999999999999997643                       278999999999999999999999999999999


Q ss_pred             CceEeeeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 017960          229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWA  303 (363)
Q Consensus       229 ~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~  303 (363)
                      +|||+   +.++.+||+|||++........   .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+
T Consensus       201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          201 RNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             GGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999   7788999999999986543321   23445688999999987 569999999999999999998 9999988


Q ss_pred             cCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       304 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      .........+........  ....+++++.+||.+||+.||.+|||+.++++++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            765555544444433222  22457899999999999999999999999998764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=365.03  Aligned_cols=257  Identities=28%  Similarity=0.421  Sum_probs=213.7

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe-
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC-  174 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-  174 (363)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+.+++.++ ||||+++++++..... 
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   98 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSL   98 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcC-CCCcccHhheEeccccc
Confidence            45678999999999999999999999999999999996543 34555678999999999998 9999999999987654 


Q ss_pred             -----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          175 -----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       175 -----~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                           +++||||+. ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~  172 (353)
T 3coi_A           99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGL  172 (353)
T ss_dssp             GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTC
T ss_pred             ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccc
Confidence                 599999996 58877663  358999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc---------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI---------  318 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------  318 (363)
                      +.....  ......+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.+...         
T Consensus       173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            976532  2345678999999999874  589999999999999999999999988877666555543110         


Q ss_pred             --------------c----cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          319 --------------D----FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       319 --------------~----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                    .    .....++.+++++.+||.+||+.||++|||+.++|+|+||..+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                          0    0011234678999999999999999999999999999999754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-48  Score=354.61  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=204.8

Q ss_pred             ccccceeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|++....  .....+.+.+|+.++++++ ||||+++++++. .
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-S
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-c
Confidence            3456799999999999999999998654   4569999886432  4556678999999999997 999999999874 4


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      +..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSR  164 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-----
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccccc
Confidence            56899999999999999997654 68999999999999999999999999999999999999   667799999999998


Q ss_pred             ecCCCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          252 FFKPGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       252 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .......  .....+++.|+|||++. ..++.++||||||+++|||++ |..||.+....+....+..+...   ...+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~  241 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN  241 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTT
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---CCCCC
Confidence            7654332  22345678899999987 568999999999999999996 99999988888888887765432   22346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++++.++|.+||+.||++|||+.++++++
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  271 (281)
T 1mp8_A          242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQL  271 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            899999999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-48  Score=358.86  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=214.3

Q ss_pred             cccceeecceecccCCeEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||||++....  .....+.+.+|+.+++++.+||||+++++++.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            446799999999999999999985     4567899999997543  445567899999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEe
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRG------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll  233 (363)
                      .+..++||||+++++|.+++....                  .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            999999999999999999997654                  38999999999999999999999999999999999999


Q ss_pred             eeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHH
Q 017960          234 VNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (363)
Q Consensus       234 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~  308 (363)
                         +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.....
T Consensus       179 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          179 ---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             ---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence               7788999999999987654432   23345678899999887 468999999999999999999 999998766544


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ............  .....+++++.+||.+||+.||.+|||+.|+++++
T Consensus       256 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  302 (313)
T 1t46_A          256 KFYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (313)
T ss_dssp             HHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhccCCCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            444443333222  22245789999999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.7e-49  Score=363.28  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=212.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEE--EEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEF--ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ++|++.+.||+|+||.||+|.+..++..+  |+|.+....  .....+.+.+|+.+++++.+||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            45999999999999999999999888865  999886432  34455678999999999955999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          177 IVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      +||||+++++|.+++...+                .+++..+..++.||+.||.|||++||+||||||+|||+   +.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence            9999999999999997654                68999999999999999999999999999999999999   7788


Q ss_pred             cEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCc
Q 017960          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  318 (363)
                      .+||+|||++.............+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            999999999975433333344567889999999874 58999999999999999998 9999999888887777765532


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                         ......+++++.+||.+||+.||.+|||+.++++++
T Consensus       260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence               222346789999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-48  Score=353.73  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=212.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.++++++ ||||+++++++.+....++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEE
Confidence            356999999999999999999864 677899999975432    2367889999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCH
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccc
Confidence            9999999999999976 4679999999999999999999999999999999999999   78889999999999865433


Q ss_pred             C--ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 Q--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      .  ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+......   ..+++++
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  250 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV  250 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHH
Confidence            2  122345677899999988 569999999999999999998 99999998888888888776433222   3568999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+||.+||+.||.+|||+.++++++
T Consensus       251 ~~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          251 YTIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHHHHH
Confidence            9999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.6e-48  Score=359.93  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=217.0

Q ss_pred             cccceeecceecccCCeEEEEEEEc-------cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEI-------ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY  169 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~  169 (363)
                      ..++|++++.||+|+||.||+|.+.       .++..||||++....  .....+.+.+|+.+++++.+||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            3467999999999999999999975       456789999997543  4556778999999999995599999999999


Q ss_pred             ecCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEe
Q 017960          170 EDSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLL  233 (363)
Q Consensus       170 ~~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll  233 (363)
                      .+.+..++||||+++++|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            99999999999999999999997654                38899999999999999999999999999999999999


Q ss_pred             eeCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHH
Q 017960          234 VNKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQG  308 (363)
Q Consensus       234 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~  308 (363)
                         +.++.+||+|||++........   .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+
T Consensus       191 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          191 ---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             ---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence               7888999999999987654332   23345678899999987 458999999999999999999 999999988888


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+..+...   .....+++++.++|.+||+.||.+|||+.|+++++
T Consensus       268 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  313 (334)
T 2pvf_A          268 LFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  313 (334)
T ss_dssp             HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            88777765432   22246789999999999999999999999999764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.9e-48  Score=352.60  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=208.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhh----HHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED----VEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..........    .+.+.+|+.++++++ ||||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            3467999999999999999999999999999999986544322222    167899999999997 99999999998776


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCcc-----EEE
Q 017960          173 LCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFS-----LKA  244 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~-----~kl  244 (363)
                      .  ++||||+++++|.+.+... ..+++..+..++.|++.||.|||++|  |+||||||+|||+   +.++.     +||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~---~~~~~~~~~~~kl  170 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFL---QSLDENAPVCAKV  170 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEE---SCCCTTCSCCEEE
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEE---eccCCCCceeEEe
Confidence            6  6999999999998888654 46899999999999999999999999  9999999999999   44444     999


Q ss_pred             eecCcceecCCCCccccCccCCccccccccc---ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHH--HHHHHcCCcc
Q 017960          245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGI--FDAVLKGHID  319 (363)
Q Consensus       245 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~  319 (363)
                      +|||++....  .......||+.|+|||++.   ..++.++|||||||++|+|++|+.||........  ...+......
T Consensus       171 ~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  248 (287)
T 4f0f_A          171 ADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR  248 (287)
T ss_dssp             CCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred             CCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence            9999997543  2345678999999999984   3478999999999999999999999976554332  3444333322


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                        ......+++++.+||.+||+.||.+|||+.++++.+
T Consensus       249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  284 (287)
T 4f0f_A          249 --PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL  284 (287)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             --CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence              222346889999999999999999999999999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.6e-49  Score=362.81  Aligned_cols=257  Identities=28%  Similarity=0.490  Sum_probs=216.5

Q ss_pred             cccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHHhc-CCCceeEEeEE
Q 017960           93 KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLA-GHKNIVTIKGA  168 (363)
Q Consensus        93 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~niv~~~~~  168 (363)
                      ..+.+.++|++.+.||+|+||.||+|.+..+++.||||++........   ....++.+|+.+++++. +|+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            344567789999999999999999999999999999999976543221   12245678999999997 37999999999


Q ss_pred             EecCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          169 YEDSLCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       169 ~~~~~~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      +...+..++|||++.+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++  .+++.+||+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Df  194 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF  194 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeC
Confidence            9999999999999976 89999999888999999999999999999999999999999999999993  16779999999


Q ss_pred             CcceecCCCCccccCccCCcccccccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      |++...... ......||+.|+|||++.+ . ++.++|||||||++|||++|..||....      .+......+    .
T Consensus       195 g~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~----~  263 (320)
T 3a99_A          195 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF----R  263 (320)
T ss_dssp             TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC----S
T ss_pred             ccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc----c
Confidence            999876543 3455779999999999874 3 4788999999999999999999996532      122232222    2


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      ..+++++.+||.+||+.||++|||+.|+++|+||+.+
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence            3578999999999999999999999999999999765

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.4e-49  Score=369.29  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=205.5

Q ss_pred             ccceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      .+.|++.+.||+|+||.||+|.+.   .++..||||++....  .....+.+.+|+.++++++ ||||+++++++.+...
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCc
Confidence            356999999999999999999976   467789999996542  4556678999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccc
Confidence            999999999999999997654 69999999999999999999999999999999999999   88889999999999876


Q ss_pred             CCCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          254 KPGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       254 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .....    .....+++.|+|||++. ..++.++|||||||++|||++ |+.||.+....+....+..+...   .....
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~  274 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---PPPMD  274 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC---CCCTT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence            43321    11234567899999987 569999999999999999998 99999998888888877765322   22235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.++.+||.+||+.||.+||++.++++.+
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L  304 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVSIL  304 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence            789999999999999999999999998753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.3e-48  Score=350.18  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=202.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC-hhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS-REDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ++|++.+.||+|+||.||+|.+  ++..||||++....... ....+.+.+|+.+++.++ ||||+++++++.+.+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceEE
Confidence            4699999999999999999996  48899999986543222 233578899999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cEecCCCCCceEeeeCC-----CCccEEEeecCc
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG---VMHRDLKPENFLLVNKD-----DDFSLKAIDFGL  249 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---iiHrDlkp~NIll~~~~-----~~~~~kl~DFG~  249 (363)
                      ||||+++++|.+++. .+.+++..+..++.|++.||.|||++|   |+||||||+|||+....     .++.+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999988774 557899999999999999999999999   99999999999994311     267899999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      +....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.........+.........  ...+
T Consensus       163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  239 (271)
T 3dtc_A          163 AREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PSTC  239 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTTC
T ss_pred             cccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--Cccc
Confidence            98654433 335678999999999874 5899999999999999999999999988887777777665543332  2467


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++++.++|.+||+.||.+|||+.|+++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L  268 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQL  268 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            89999999999999999999999999865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-48  Score=356.20  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=204.7

Q ss_pred             cccceeecceecccCCeEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-  171 (363)
                      ..++|++.+.||+|+||+||+|.    +..+++.||||++...   .....+.+.+|+.++++++ ||||+++++++.. 
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC
Confidence            45679999999999999999998    5678999999998643   4556678999999999998 9999999999854 


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 -SLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 -~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                       ...+++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGL  160 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCS
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCcc
Confidence             456899999999999999997754 48999999999999999999999999999999999999   6678999999999


Q ss_pred             ceecCCCC----ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH----------------H
Q 017960          250 SVFFKPGQ----IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ----------------G  308 (363)
Q Consensus       250 a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----------------~  308 (363)
                      +.......    ......++..|+|||++. ..++.++||||||+++|+|++|..||......                .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            98764432    223345677899999987 46999999999999999999999998543321                1


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+....   .......+++++.+||.+||+.||++|||+.|+++.+
T Consensus       241 ~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L  286 (295)
T 3ugc_A          241 LIELLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV  286 (295)
T ss_dssp             HHHHHHTTC---CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhccC---cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            222222221   1222346889999999999999999999999998754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-48  Score=353.62  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=207.0

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      |.....||+|+||.||+|.+..+++.||||.+...   .....+.+.+|+.+++.+. ||||+++++++.+.+..++|||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEE
Confidence            34445899999999999999999999999999754   2344577899999999997 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC-CccEEEeecCcceecCCC
Q 017960          181 LCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~-~~~~kl~DFG~a~~~~~~  256 (363)
                      |+++++|.+++....   .+++..+..++.||+.||.|||++||+||||||+||++   +. ++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI---NTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE---ECCCCCEEEeecccccccCCC
Confidence            999999999987652   46789999999999999999999999999999999999   44 779999999999876432


Q ss_pred             C-ccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHH-HHHHHcCCcccCCCCCCCCCHH
Q 017960          257 Q-IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGI-FDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       257 ~-~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      . ......|++.|+|||++.+   .++.++||||||+++|+|++|..||........ ......  ..........++++
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  254 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKVHPEIPESMSAE  254 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCCCCCCCTTSCHH
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--ccccccccccCCHH
Confidence            2 2345678999999999873   388999999999999999999999975433221 111111  11122223467899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||+.||++|||+.++|+|+||..
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~~~~~~  284 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVDEFLKV  284 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence            999999999999999999999999999964

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.6e-48  Score=361.39  Aligned_cols=250  Identities=21%  Similarity=0.290  Sum_probs=205.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEE----EEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEF----ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .++|++.+.||+|+||+||+|.+..+++.+    |+|.+....  .....+.+.+|+.++++++ ||||+++++++.+..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC
Confidence            356999999999999999999988887765    666664322  3345678999999999998 999999999998765


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                       .++|+||+.+++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence             7789999999999999987 4569999999999999999999999999999999999999   6778999999999987


Q ss_pred             cCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          253 FKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       253 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ......   .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.+.........+..+....   ....
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCcc
Confidence            654332   22345678999999987 469999999999999999999 999999888887777776654322   2245


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.++.+++.+||+.||.+|||+.++++++
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l  273 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIEF  273 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            789999999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.4e-48  Score=353.83  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=205.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++ ||||+++++++...+..+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence            3356999999999999999999999999999999998655556667788999999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          177 IVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +||||+++++|.+++..    ...+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceee
Confidence            99999999999998864    4568999999999999999999999999999999999999   7888999999999976


Q ss_pred             cCCCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--HHHHHHHHHcCCcccCCCCCCCC
Q 017960          253 FKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       253 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ..... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+..  .......+......  ......+
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  263 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHY  263 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTS
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCccccc
Confidence            54332 2334678999999999874 58999999999999999999999997643  33445555544332  2223467


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++++.+||.+||+.||++|||+.++++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l  292 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYDVA  292 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence            89999999999999999999999999754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-48  Score=360.42  Aligned_cols=257  Identities=24%  Similarity=0.295  Sum_probs=215.1

Q ss_pred             cccceeecceecccCCeEEEEEE-----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++.+.||+|+||.||+|.     +..++..||||++....  ......++.+|+.+++++. ||||+++++++.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC
Confidence            45679999999999999999999     55678899999996432  4556678999999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEE
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRG-------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                      ....++||||+++++|.+++....       .+++..+..++.||+.||.|||++||+||||||+|||+..++++..+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998753       4889999999999999999999999999999999999954345667999


Q ss_pred             eecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcc
Q 017960          245 IDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHID  319 (363)
Q Consensus       245 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~  319 (363)
                      +|||++.......   ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||......+....+..+...
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  264 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  264 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence            9999987543222   223456788999999987 468999999999999999998 99999988888888877766432


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .   ....+++.+.+||.+||+.||.+|||+.++++++|.
T Consensus       265 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          265 D---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            2   234678999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.7e-48  Score=351.24  Aligned_cols=250  Identities=23%  Similarity=0.346  Sum_probs=217.9

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++...    ....+.+.+|+.++++++ ||||+++++++.+....+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEE
Confidence            346699999999999999999999999999999999643    344678899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceecc
Confidence            999999999999999864  348999999999999999999999999999999999999   778899999999998754


Q ss_pred             CCC--ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ...  ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+......   .....+++
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~  239 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPE  239 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCCCCCH
Confidence            333  223345678899999987 568999999999999999999 99999888877777777665322   22346889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+||.+||+.||.+|||+.++++.+
T Consensus       240 ~l~~li~~~l~~dp~~Rps~~~~~~~l  266 (288)
T 3kfa_A          240 KVYELMRACWQWNPSDRPSFAEIHQAF  266 (288)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence            999999999999999999999998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=372.10  Aligned_cols=258  Identities=23%  Similarity=0.385  Sum_probs=212.8

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--  173 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.....  ....+.+.+|+.++++++ ||||+++++++.+..  
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCC
Confidence            456779999999999999999999999999999999975432  233567889999999998 999999999998655  


Q ss_pred             eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeee-CCCCccEEEeecCc
Q 017960          174 CVHIVMELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN-KDDDFSLKAIDFGL  249 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~-~~~~~~~kl~DFG~  249 (363)
                      ..++||||+++++|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+.. .+.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            78999999999999999876433   899999999999999999999999999999999999833 34566799999999


Q ss_pred             ceecCCCCccccCccCCccccccccc---------ccCCCcccHHHHHHHHHHHHhCCCCCCC----cCHHHHHHHHHcC
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLL---------KHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKG  316 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~il~ell~g~~pf~~----~~~~~~~~~i~~~  316 (363)
                      +.............||+.|+|||++.         ..++.++|||||||++|||++|+.||..    ....+....+..+
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            99877666666788999999999985         3478899999999999999999999964    2234455555544


Q ss_pred             CcccC---------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          317 HIDFE---------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       317 ~~~~~---------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      .....                     ......+++.+.++|.+||..||++||++.++++.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            32110                     00011234678899999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.2e-49  Score=362.92  Aligned_cols=250  Identities=21%  Similarity=0.317  Sum_probs=208.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIE----FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .++|++.+.||+|+||.||+|.+..+++.    ||+|.+....  .......+.+|+.+++.++ ||||+++++++. ..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GS   87 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CC
Confidence            35699999999999999999999888876    6666664322  2233356778999999997 999999999886 45


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ..++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence            688999999999999999764 578999999999999999999999999999999999999   7888999999999987


Q ss_pred             cCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          253 FKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       253 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .....   ......++..|+|||++. ..++.++|||||||++|+|++ |..||.+.........+..+......   ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~  241 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QI  241 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TT
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---Cc
Confidence            64332   234556788999999998 569999999999999999999 99999988888887777765432222   34


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.++.+||.+||..||.+|||+.++++++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l  271 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANEF  271 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            678899999999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-47  Score=353.02  Aligned_cols=256  Identities=22%  Similarity=0.396  Sum_probs=210.2

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcC-CCceeEEeEEEecCCeE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-HKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~~  175 (363)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.++.++.+ ||||+++++++......
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            345699999999999999999997 4588999999975432 45567889999999999984 69999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   + ++.+||+|||++.....
T Consensus       104 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          104 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---E-TTEEEECCCSSSCC---
T ss_pred             EEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---E-CCeEEEeeccccccccC
Confidence            999995 588999999988889999999999999999999999999999999999999   3 36899999999987643


Q ss_pred             CC---ccccCccCCcccccccccc------------cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHcCCcc
Q 017960          256 GQ---IFTDVVGSPYYVAPEVLLK------------HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLKGHID  319 (363)
Q Consensus       256 ~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~  319 (363)
                      ..   ......||+.|+|||++.+            .++.++||||||+++|+|++|..||..... ......+......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            32   1234578999999999863            578899999999999999999999976533 3344444443322


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          320 FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..  .....++++.+||.+||+.||.+|||+.|+|+|+||+.
T Consensus       259 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          259 IE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             CC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             cC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            22  12345789999999999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.7e-48  Score=355.89  Aligned_cols=253  Identities=21%  Similarity=0.303  Sum_probs=218.1

Q ss_pred             ccccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .......+.+|+.+++.+. ||||+++++++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   98 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVS   98 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEEC
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEc
Confidence            34567999999999999999999876     357889999996543  4455677899999999997 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQR----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      +.+..++||||+++++|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCC
Confidence            999999999999999999998653          356899999999999999999999999999999999999   7888


Q ss_pred             cEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHc
Q 017960          241 SLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLK  315 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~  315 (363)
                      .+||+|||++.......   ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            99999999997654332   122345688999999987 468999999999999999999 8999999888888888777


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.....   ...+++++.+||.+||+.||.+|||+.|+++++
T Consensus       256 ~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L  294 (322)
T 1p4o_A          256 GGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  294 (322)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            654322   246789999999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-48  Score=353.83  Aligned_cols=245  Identities=19%  Similarity=0.244  Sum_probs=204.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCC-------cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      .++|++.+.||+|+||.||+|.+..++       ..||+|++...   .....+.+.+|+.++++++ ||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLS-HKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEE
Confidence            467999999999999999999988877       46999998654   3445678999999999998 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc--------
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS--------  241 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~--------  241 (363)
                      +.+..++||||+++++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||+.   .++.        
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~~  159 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPPF  159 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCCE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccce
Confidence            99999999999999999999987654 89999999999999999999999999999999999994   3333        


Q ss_pred             EEEeecCcceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCC-CCCCcCHHHHHHHHHcCCc
Q 017960          242 LKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVP-PFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~-pf~~~~~~~~~~~i~~~~~  318 (363)
                      +||+|||++......   ....+|+.|+|||++.+  .++.++|||||||++|||++|.. ||............ ....
T Consensus       160 ~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~~  235 (289)
T 4fvq_A          160 IKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRH  235 (289)
T ss_dssp             EEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTTC
T ss_pred             eeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hccC
Confidence            999999998754322   33457889999999874  58999999999999999999554 55444444433333 3322


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+    ...++++.+||.+||+.||++|||+.++++++
T Consensus       236 ~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          236 QLP----APKAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             CCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             CCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            222    24578899999999999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.8e-48  Score=358.55  Aligned_cols=255  Identities=23%  Similarity=0.279  Sum_probs=189.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ-IMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  ......++..|+. +++.+ +||||+++++++.+.+..++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCceEE
Confidence            56999999999999999999999999999999997543  3444556667776 44445 49999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          178 VMELCAGGELFDRIIQ-----RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ||||+.+ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+|||+   +.++.+||+|||++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCce
Confidence            9999965 78777753     56789999999999999999999999 99999999999999   778899999999998


Q ss_pred             ecCCCCccccCccCCccccccccc-----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCc-ccCCCC
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLL-----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHI-DFESDP  324 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~-~~~~~~  324 (363)
                      ............||+.|+|||++.     ..++.++|||||||++|+|++|..||.+.... +....+..+.. .+....
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE  254 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence            765554445567999999999983     35899999999999999999999999764321 22222222111 112222


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ...+++++.+||.+||+.||++|||+.++++|+|+.
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            345889999999999999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.9e-48  Score=357.58  Aligned_cols=254  Identities=23%  Similarity=0.380  Sum_probs=213.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCc-----EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGI-----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..+.|++.+.||+|+||.||+|.+..++.     .||+|.+....  .....+.+.+|+.+++.+.+||||+++++++.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            34669999999999999999999877664     79999996543  445567899999999999449999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR--------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~  237 (363)
                      .+..++||||+++++|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||+   +
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---T  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---E
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---C
Confidence            99999999999999999998653              357999999999999999999999999999999999999   6


Q ss_pred             CCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHH
Q 017960          238 DDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDA  312 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~  312 (363)
                      .++.+||+|||++........   .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+.........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            778999999999986543321   23345678899999987 468999999999999999998 9999987665555544


Q ss_pred             HHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          313 VLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       313 i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +........  ....+++++.+||.+||+.||.+|||+.++++++
T Consensus       279 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  321 (333)
T 2i1m_A          279 LVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL  321 (333)
T ss_dssp             HHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence            444333222  2235789999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.4e-48  Score=355.89  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=211.2

Q ss_pred             cccceeecceecccCCeEEEEEEE-----ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTE-----IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||||++....  .....+.+.+|+.++.++.+||||+++++++..
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            346799999999999999999985     3567899999997543  445567899999999999669999999999876


Q ss_pred             CC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          172 SL-CVHIVMELCAGGELFDRIIQRGH----------------YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       172 ~~-~~~iv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                      .+ .+++||||+++++|.+++.....                +++..+..++.||+.||.|||++||+||||||+||++ 
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-  181 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-  181 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE-
Confidence            54 59999999999999999987543                7899999999999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHH-H
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQ-G  308 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~-~  308 (363)
                        +.++.+||+|||++........   .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+.... .
T Consensus       182 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          182 --SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             --CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             --CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence              7788999999999986543322   23456788999999987 468999999999999999998 99999776543 3


Q ss_pred             HHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          309 IFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       309 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+..+...   .....+++++.++|.+||+.||.+|||+.++++++
T Consensus       260 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          260 FCRRLKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             HHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhccCccC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            33444433221   12235789999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-48  Score=359.37  Aligned_cols=248  Identities=20%  Similarity=0.239  Sum_probs=199.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC----e
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL----C  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~  174 (363)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++...    ........+|+.++++++ ||||+++++++....    .
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG----GHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC----chHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCce
Confidence            46999999999999999999854  789999999653    233445667999999997 999999999997744    4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEecCCCCCceEeeeCCCCccEEE
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL----------GVMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~----------~iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                      +++||||+++++|.+++.. ..+++..+..++.||+.||.|||+.          ||+||||||+|||+   +.++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEE
Confidence            7999999999999998866 4589999999999999999999999          99999999999999   78889999


Q ss_pred             eecCcceecCCCCc---cccCccCCcccccccccc------cCCCcccHHHHHHHHHHHHhCCCCCCCcCH---------
Q 017960          245 IDFGLSVFFKPGQI---FTDVVGSPYYVAPEVLLK------HYGPEADVWTAGVILYILLSGVPPFWAETQ---------  306 (363)
Q Consensus       245 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~il~ell~g~~pf~~~~~---------  306 (363)
                      +|||++........   .....||+.|+|||++.+      .++.++|||||||++|||++|+.||.+...         
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654332   334678999999999874      366788999999999999999999965321         


Q ss_pred             -------HHHHHHHHcCCcccCCCC-C--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          307 -------QGIFDAVLKGHIDFESDP-W--PLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       307 -------~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                             ......+........... +  ...++++.+||.+||+.||++|||+.|+++.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  313 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI  313 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                   222333322222111110 0  01234599999999999999999999999854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.2e-48  Score=376.63  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=216.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|+||.||+|.+..++..||||++....    ...+.+.+|+.++++++ ||||+++++++.+...++|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEE
Confidence            456999999999999999999999889999999997542    23578999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccC
Confidence            99999999999999864  458999999999999999999999999999999999999   7788999999999987654


Q ss_pred             CCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ...  .....++..|+|||++. +.++.++|||||||+||||++ |..||.+.........+..+..   ......++++
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  447 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEK  447 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHH
Confidence            322  22344567899999987 569999999999999999999 9999998888877777765432   2223468899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +.+||.+||+.||++|||+.++++.+
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~~L  473 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQAF  473 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHHH
Confidence            99999999999999999999998753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-47  Score=349.77  Aligned_cols=250  Identities=23%  Similarity=0.270  Sum_probs=211.4

Q ss_pred             cceeecc-eecccCCeEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGR-KLGQGQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++|++.+ .||+|+||.||+|.+  ..+++.||||++..... .....+.+.+|+.+++.++ ||||+++++++ ..+..
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSSE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCCc
Confidence            4688888 999999999999954  56678999999975432 3444678999999999997 99999999998 56678


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeecc
Confidence            9999999999999999988889999999999999999999999999999999999999   6677999999999987654


Q ss_pred             CCcc----ccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          256 GQIF----TDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       256 ~~~~----~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      ....    ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+..+...   .....++
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  246 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCP  246 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCC
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            4321    22345788999999874 58999999999999999999 99999998888888777765432   2224678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.++|.+||+.||++|||+.++++.+
T Consensus       247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L  274 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPGFAAVELRL  274 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999998743

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-47  Score=344.38  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=214.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEE
Confidence            56999999999999999999975 677899999975432    2367889999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccccc
Confidence            9999999999999765 568999999999999999999999999999999999999   778899999999998654322


Q ss_pred             --ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          258 --IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                        ......+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+..+....   ....+++++.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~  235 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVY  235 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHH
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHHH
Confidence              123345678899999998 568999999999999999999 999999888888888877664322   2235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++|.+||+.||++|||+.++++++
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~L  259 (267)
T 3t9t_A          236 QIMNHCWRERPEDRPAFSRLLRQL  259 (267)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHHH
Confidence            999999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=352.05  Aligned_cols=256  Identities=24%  Similarity=0.286  Sum_probs=195.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhH-HHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDV-EDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ..... +.+..+..+++.+. ||||+++++++.+.+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEE
Confidence            356999999999999999999999999999999997543  22333 33444445566665 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||+ ++.+...... .+.+++..+..++.||+.||.|||+. ||+||||||+||++   +.++.+||+|||++....
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC----
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhcc
Confidence            999999 5555544443 46799999999999999999999995 99999999999999   788899999999998765


Q ss_pred             CCCccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCcccCCCCCCC
Q 017960          255 PGQIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWA-ETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .........+|+.|+|||++.      ..++.++|||||||++|+|++|..||.. .........+........ .....
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  255 (318)
T 2dyl_A          177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMG  255 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSC
T ss_pred             CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCC
Confidence            555555678999999999984      3588999999999999999999999976 345555666655443222 22235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +++++.+||.+||+.||.+|||+.++|+|+||..
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            7899999999999999999999999999999853

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.6e-48  Score=349.23  Aligned_cols=246  Identities=28%  Similarity=0.451  Sum_probs=211.1

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec---
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---  171 (363)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||+|++....       +.+.+|+.+++.++ ||||+++++++..   
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~   78 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD-HVNIVHYNGCWDGFDY   78 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCC-CCCEEEEeeeEecccc
Confidence            346677999999999999999999999899999999997542       34678999999998 9999999998854   


Q ss_pred             -------------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC
Q 017960          172 -------------SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK  236 (363)
Q Consensus       172 -------------~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~  236 (363)
                                   ...+++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   
T Consensus        79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---  155 (284)
T 2a19_B           79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---  155 (284)
T ss_dssp             C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred             CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---
Confidence                         45589999999999999999754  578999999999999999999999999999999999999   


Q ss_pred             CCCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Q 017960          237 DDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK  315 (363)
Q Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  315 (363)
                      ++++.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...  ......+..
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~  233 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD  233 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred             cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence            6677999999999988766655566789999999999874 5899999999999999999999987432  233344443


Q ss_pred             CCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          316 GHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ...      ...+++++.+||.+||+.||.+|||+.|++++++.
T Consensus       234 ~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          234 GII------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             TCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            322      13578999999999999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.9e-48  Score=351.46  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             ccceeecceecccCCeEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC-
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS-  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-  172 (363)
                      .+.|++.+.||+|+||.||+|.    +..+++.||+|++....  .....+.+.+|+.+++.++ ||||+++++++.+. 
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLY-HENIVKYKGICTEDG   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCC
Confidence            3559999999999999999998    56789999999997543  3345678999999999998 99999999999876 


Q ss_pred             -CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          173 -LCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       173 -~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                       ..+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLT  173 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccc
Confidence             678999999999999999954 4569999999999999999999999999999999999999   66779999999999


Q ss_pred             eecCCCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcC--------------H-HHHH
Q 017960          251 VFFKPGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET--------------Q-QGIF  310 (363)
Q Consensus       251 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~--------------~-~~~~  310 (363)
                      ........    .....+|..|+|||++. ..++.++||||||+++|+|++|..|+....              . ....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87654432    23456788899999987 468899999999999999999998863221              1 1222


Q ss_pred             HHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       311 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+..+.   .......+++++.+||.+||+.||.+|||+.++++.+
T Consensus       254 ~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  297 (302)
T 4e5w_A          254 NTLKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF  297 (302)
T ss_dssp             HHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhccC---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            2332222   1222346889999999999999999999999999754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-47  Score=369.74  Aligned_cols=244  Identities=24%  Similarity=0.321  Sum_probs=209.7

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-eEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-CVH  176 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~  176 (363)
                      .+.|++.+.||+|+||.||+|.+  +++.||||+++...     ..+.+.+|+.++++++ ||||+++++++.+.. .++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceE
Confidence            35699999999999999999985  47799999997532     3467899999999998 999999999986654 799


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||+++|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccc
Confidence            99999999999999987654  7999999999999999999999999999999999999   788899999999998653


Q ss_pred             CCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..  .....++..|+|||++. ..++.++|||||||++|||++ |..||.+....+....+.++..   ......+++++
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~~l  415 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAV  415 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCHHH
T ss_pred             cc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHHH
Confidence            32  23346788999999997 469999999999999999998 9999998888888887776532   22234689999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+||.+||+.||++|||+.++++.+
T Consensus       416 ~~li~~cl~~dp~~Rpt~~~l~~~L  440 (450)
T 1k9a_A          416 YDVMKNCWHLDAATRPTFLQLREQL  440 (450)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHH
Confidence            9999999999999999999998743

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.7e-47  Score=345.24  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=209.9

Q ss_pred             cccceeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..++|++.+.||+|+||.||+|.+...   +..||+|++....  .....+.+.+|+.+++.++ ||||+++++++.+. 
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-
Confidence            346799999999999999999986543   3469999987543  4556788999999999997 99999999988654 


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCcc
Confidence            568999999999999999765 458999999999999999999999999999999999999   6677999999999987


Q ss_pred             cCCCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          253 FKPGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       253 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ......  .....+++.|+|||++. ..++.++||||||+++|+|++ |+.||......+....+..+....   ....+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  239 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDLC  239 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTTC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCCC
Confidence            544322  23345678899999987 468999999999999999998 999998877777777766654322   22357


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+.++|.+||+.||++|||+.|+++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L  268 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCSL  268 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence            89999999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-47  Score=347.17  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=212.8

Q ss_pred             cceeecc-eecccCCeEEEEEEEc--cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGR-KLGQGQFGTTYLCTEI--ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++|.+.+ .||+|+||.||+|.+.  .++..||||++....  .....+.+.+|+.+++.++ ||||+++++++ ..+..
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESSSE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCCCc
Confidence            4566665 9999999999999854  467789999997542  4566788999999999997 99999999998 45568


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++   +.++.+||+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeeec
Confidence            9999999999999988654 459999999999999999999999999999999999999   667899999999998765


Q ss_pred             CCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ....    .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+...   .....+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~  238 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPEC  238 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTC
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCCCc
Confidence            4332    12345678999999997 468999999999999999998 99999988888888877765432   222468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ++++.+||.+||+.||.+||++.+++++++
T Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999999998764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-47  Score=344.60  Aligned_cols=247  Identities=18%  Similarity=0.256  Sum_probs=211.9

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--CeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--LCV  175 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~  175 (363)
                      .++|++.+.||+|+||.||+|.+  +++.||||++..... .....+.+.+|+.++++++ ||||+++++++.+.  ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCe
Confidence            35699999999999999999996  488999999976432 4556678999999999997 99999999999877  788


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          176 HIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      ++||||+++++|.+++....  .+++..+..++.||+.||.|||++|  |+||||||+||++   +.++.++|+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKF  161 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCC
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecccee
Confidence            99999999999999998765  4899999999999999999999999  9999999999999   788899999998876


Q ss_pred             ecCCCCccccCccCCcccccccccc-cC---CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLK-HY---GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~---~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ....    ....||+.|+|||++.+ .+   +.++|||||||++|||++|..||.+.........+........  ....
T Consensus       162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  235 (271)
T 3kmu_A          162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPG  235 (271)
T ss_dssp             TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCTT
T ss_pred             eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCCC
Confidence            5322    34578999999999874 23   3479999999999999999999998888777766665543322  2346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++++.++|.+||+.||++|||+.++++.+
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~L  265 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVPIL  265 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            899999999999999999999999999754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=354.06  Aligned_cols=252  Identities=20%  Similarity=0.346  Sum_probs=209.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      ..+.|++.+.||+|+||.||+|.+..++    ..||||++....  .......+.+|+.+++.++ ||||+++++++.+.
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKY  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecC
Confidence            3456999999999999999999976553    359999986543  4555678999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          173 LCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      +..++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence            9999999999999999999764 569999999999999999999999999999999999999   788899999999998


Q ss_pred             ecCCCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          252 FFKPGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       252 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      .......    .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.+....+....+..+...   ...
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~  272 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTP  272 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---CCc
Confidence            7643321    12234577899999987 468999999999999999999 99999988888888887765322   222


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+++++.+||.+||+.||++||++.++++++
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L  304 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSIL  304 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            45789999999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9e-48  Score=356.33  Aligned_cols=250  Identities=21%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEE----EEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEF----ACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .++|++.+.||+|+||.||+|.+..+++.+    |+|.+....  .....+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC
Confidence            356999999999999999999998888766    555553322  3345678999999999998 999999999998765


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                       .++|+||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence             78899999999999999774 569999999999999999999999999999999999999   6677999999999987


Q ss_pred             cCCCCc---cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          253 FKPGQI---FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       253 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ......   .....+|+.|+|||++.+ .++.++|||||||++|||++ |..||.+.........+..+....   ....
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            643322   223456778999999884 68999999999999999999 999999888888877777654322   2245


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.++.+||.+||+.||.+|||+.|+++.+
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L  273 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIEF  273 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            789999999999999999999999999753

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.8e-48  Score=351.37  Aligned_cols=255  Identities=22%  Similarity=0.289  Sum_probs=207.5

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc-eeEEeEEEecCCe
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-IVTIKGAYEDSLC  174 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~  174 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.....     .+.+.+|+.+++.+. |++ +..+..++.....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQ-GGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHT-TSTTCCCEEEEEEETTE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhh-cCCCCCccccccCCCCc
Confidence            356789999999999999999999999999999999865432     235789999999998 555 5555555577888


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..++++.+||+|||++...
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999999 9999999874 456999999999999999999999999999999999999954446778999999999876


Q ss_pred             CCCCc--------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCCcccC
Q 017960          254 KPGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFE  321 (363)
Q Consensus       254 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~  321 (363)
                      .....        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..   ....+..+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            54332        245679999999999885 58999999999999999999999997632   2233333333222222


Q ss_pred             C-CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          322 S-DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       322 ~-~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      . .....+++++.+||.+||+.||++|||+.++++.+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  275 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  275 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence            1 11235789999999999999999999999998753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-48  Score=359.74  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=207.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++...   .....+.+.+|+.+++.++ ||||+++++++.+.+..+
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTCCE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEE
Confidence            446699999999999999999995 57899999988654   3345678999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          177 IVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      +||||+++++|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeecccccc
Confidence            9999999999999886543    48999999999999999999999999999999999999   8888999999999986


Q ss_pred             cCCC---CccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHH-------HHHHcCCcccC
Q 017960          253 FKPG---QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIF-------DAVLKGHIDFE  321 (363)
Q Consensus       253 ~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~~~~  321 (363)
                      ....   .......||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+..       .....+.....
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            4322   2233456899999999987 56999999999999999999999999765432211       11111111110


Q ss_pred             --C----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          322 --S----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       322 --~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                        .    ...+..+.++.+++.+||+.||++|||+.|+++++.
T Consensus       269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence              0    111223467899999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.5e-48  Score=365.27  Aligned_cols=257  Identities=15%  Similarity=0.165  Sum_probs=195.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccC-----CcEEEEEEeeccccCChhh--------HHHHHHHHHHHHHhcCCCcee
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIAT-----GIEFACKSISKRKLISRED--------VEDVRREIQIMHHLAGHKNIV  163 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~~h~niv  163 (363)
                      ..+.|++.+.||+|+||.||+|.+..+     ++.||||++..........        ...+..|+..+..+. ||||+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~~iv  111 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLK-YLGVP  111 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCS-CCCSC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhcc-CCCCC
Confidence            445799999999999999999998664     5789999986542100000        011233444455555 99999


Q ss_pred             EEeEEEecC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC
Q 017960          164 TIKGAYEDS----LCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD  238 (363)
Q Consensus       164 ~~~~~~~~~----~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~  238 (363)
                      ++++++...    ...+|||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++. +.
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence            999998764    5589999999 99999999875 67999999999999999999999999999999999999942 16


Q ss_pred             CccEEEeecCcceecCCCCc--------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHH
Q 017960          239 DFSLKAIDFGLSVFFKPGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGI  309 (363)
Q Consensus       239 ~~~~kl~DFG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  309 (363)
                      ++.+||+|||++........        .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            78999999999987643321        133559999999999985 599999999999999999999999975432222


Q ss_pred             HHHHHcCC----c-ccCCC--CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          310 FDAVLKGH----I-DFESD--PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       310 ~~~i~~~~----~-~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ........    . .....  ....+++++.+||..||..||.+||++.++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            11111100    0 00000  113578999999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-48  Score=354.44  Aligned_cols=254  Identities=28%  Similarity=0.514  Sum_probs=205.3

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHHhc---CCCceeEEeE
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---EDVEDVRREIQIMHHLA---GHKNIVTIKG  167 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~niv~~~~  167 (363)
                      .+.+.++|++.+.||+|+||.||+|.+..+++.||||++........   .....+.+|+.++.++.   +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34466789999999999999999999999999999999975543221   22345667999999993   3999999999


Q ss_pred             EEecCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC-CCccEEEe
Q 017960          168 AYEDSLCVHIVMEL-CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAI  245 (363)
Q Consensus       168 ~~~~~~~~~iv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~~kl~  245 (363)
                      ++...+..++|||+ +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++   + .++.+||+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~kl~  182 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI---DLRRGCAKLI  182 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE---ETTTTEEEEC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE---eCCCCeEEEE
Confidence            99999999999999 7899999999988889999999999999999999999999999999999999   5 67899999


Q ss_pred             ecCcceecCCCCccccCccCCcccccccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC
Q 017960          246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (363)
Q Consensus       246 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  323 (363)
                      |||++...... ......|++.|+|||++.+ .+ +.++||||||+++|+|++|+.||....      .+......+   
T Consensus       183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~---  252 (312)
T 2iwi_A          183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF---  252 (312)
T ss_dssp             CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC---
T ss_pred             EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC---
Confidence            99999876543 3456779999999999874 34 458999999999999999999996532      122222222   


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                       ...+++++.+||.+||+.||++|||+.|+++|+||+.
T Consensus       253 -~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~  289 (312)
T 2iwi_A          253 -PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT  289 (312)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence             2357899999999999999999999999999999974

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-47  Score=371.06  Aligned_cols=247  Identities=22%  Similarity=0.333  Sum_probs=212.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||+|+||.||+|.+. ++..||||++....    ...+.+.+|+.+++.++ ||||+++++++. ....+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCccE
Confidence            4467999999999999999999974 57789999997532    34678999999999998 999999999886 56789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcC
Confidence            999999999999999754  368999999999999999999999999999999999999   788899999999998764


Q ss_pred             CCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ....  .....++..|+|||++. +.++.++|||||||++|||++ |+.||.+....+....+..+...   .....+++
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~  412 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPE  412 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTSCH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            3321  12344577899999997 569999999999999999999 99999998888888887765322   22346889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ++.+||.+||+.||++|||+.+|++.
T Consensus       413 ~l~~li~~cl~~dp~~RPt~~~i~~~  438 (454)
T 1qcf_A          413 ELYNIMMRCWKNRPEERPTFEYIQSV  438 (454)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-47  Score=348.82  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=200.9

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .+...++|++.+.||+|+||.||+|.+..   .||+|++.... ......+.+.+|+.++++++ ||||++++++. ...
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAP   92 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSS
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCC
Confidence            34456679999999999999999998533   59999986543 25566788999999999998 99999999954 556


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATE  169 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceeccc
Confidence            68999999999999999864 3568999999999999999999999999999999999999   7778999999999976


Q ss_pred             cCC---CCccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-HHHHHHHcCCcccCC-C
Q 017960          253 FKP---GQIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-GIFDAVLKGHIDFES-D  323 (363)
Q Consensus       253 ~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~-~  323 (363)
                      ...   ........||+.|+|||++.    ..++.++||||||+++|+|++|..||.+.... .....+..+...... .
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            532   22334567899999999985    34788999999999999999999999875544 444444444433222 2


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....+++++.+||.+||+.||.+|||+.++++.+
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L  283 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI  283 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            2346789999999999999999999999999754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.3e-47  Score=351.05  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=205.0

Q ss_pred             ccceeecceecccCCeEEEEEEEcc---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-  173 (363)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++..... .....+.+.+|+.++++++ ||||+++++++.+.. 
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC---
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccc
Confidence            3569999999999999999998765   455899999875432 4556678999999999998 999999999987654 


Q ss_pred             ----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEE
Q 017960          174 ----CVHIVMELCAGGELFDRIIQ------RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       174 ----~~~iv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                          ..++||||+++++|.+++..      ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEE
Confidence                35999999999999999843      3568999999999999999999999999999999999999   7888999


Q ss_pred             EeecCcceecCCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCc
Q 017960          244 AIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       244 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~  318 (363)
                      |+|||++.......   ......+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..+..
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            99999998654332   1233456789999999874 58999999999999999999 9999998888888887776643


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .   .....+++++.+||.+||..||.+|||+.++++++
T Consensus       268 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  303 (313)
T 3brb_A          268 L---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL  303 (313)
T ss_dssp             C---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             C---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            2   22246789999999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.5e-47  Score=353.06  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=209.2

Q ss_pred             ccceeecceecccCCeEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe--c
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE--D  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~  171 (363)
                      .++|++.+.||+|+||.||+|.    +..+++.||||++...   .....+.+.+|+.++++++ ||||+++++++.  +
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCC
Confidence            3579999999999999999998    5678899999999654   4555678999999999997 999999999886  5


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          172 SLCVHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      ....++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA  174 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence            6679999999999999999976 4569999999999999999999999999999999999999   67789999999999


Q ss_pred             eecCCCC----ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH---------------HHH
Q 017960          251 VFFKPGQ----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------------GIF  310 (363)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~---------------~~~  310 (363)
                      .......    ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||......               ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            8765433    2234567888999999874 5899999999999999999999998654332               222


Q ss_pred             HHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       311 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ..+..+.   .......+++++.+||.+||+.||.+|||+.++++++
T Consensus       255 ~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  298 (327)
T 3lxl_A          255 ELLEEGQ---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL  298 (327)
T ss_dssp             HHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhhccc---CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            2333222   1222346889999999999999999999999997654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=351.53  Aligned_cols=250  Identities=25%  Similarity=0.321  Sum_probs=205.1

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe----cCC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE----DSL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~  173 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.+++.+. ||||+++++++.    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCc
Confidence            35699999999999999999999999999999998653   4556778999999999997 999999999986    345


Q ss_pred             eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          174 CVHIVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                      ..++||||+.+++|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCc
Confidence            78999999999999998876    4669999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCC----------ccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCH--HHHHHHH
Q 017960          250 SVFFKPGQ----------IFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQ--QGIFDAV  313 (363)
Q Consensus       250 a~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i  313 (363)
                      +.......          ......||+.|+|||++..    .++.++||||||+++|+|++|..||.....  ......+
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            87643211          0123457999999999863    379999999999999999999999943211  1222222


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .. ..  .......+++++.+||.+||+.||.+|||+.++++++
T Consensus       261 ~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          261 QN-QL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HC-C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hc-cC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            22 22  2222346789999999999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-47  Score=361.36  Aligned_cols=258  Identities=21%  Similarity=0.350  Sum_probs=206.6

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcC----------CCceeEEeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG----------HKNIVTIKG  167 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~----------h~niv~~~~  167 (363)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..    .....+.+.+|+.+++++..          ||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            4579999999999999999999999999999999964    33445678899999998862          789999999


Q ss_pred             EEecCC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEecCCCCCceEeeeC---C
Q 017960          168 AYEDSL----CVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSL-GVMHRDLKPENFLLVNK---D  237 (363)
Q Consensus       168 ~~~~~~----~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~-~iiHrDlkp~NIll~~~---~  237 (363)
                      ++...+    .+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++ ||+||||||+|||+...   +
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            987654    789999999 88999998763  4589999999999999999999998 99999999999999532   3


Q ss_pred             CCccEEEeecCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH------HHHH
Q 017960          238 DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ------QGIF  310 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~  310 (363)
                      ..+.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+...      ....
T Consensus       173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            445899999999987643  3445688999999999985 589999999999999999999999975542      2222


Q ss_pred             HHHHcCCcccC--------------------------------------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHH
Q 017960          311 DAVLKGHIDFE--------------------------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHE  352 (363)
Q Consensus       311 ~~i~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~e  352 (363)
                      ..+.......+                                      ......+++++.+||.+||+.||++|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            22221000000                                      0001123568899999999999999999999


Q ss_pred             HhcCCCcccC
Q 017960          353 VLCMYNLPVL  362 (363)
Q Consensus       353 vL~~~~~~~~  362 (363)
                      +|+|+||...
T Consensus       331 ll~hp~f~~~  340 (373)
T 1q8y_A          331 LVNHPWLKDT  340 (373)
T ss_dssp             HHTCGGGTTC
T ss_pred             HhhChhhhcc
Confidence            9999999754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-47  Score=347.19  Aligned_cols=253  Identities=24%  Similarity=0.314  Sum_probs=205.2

Q ss_pred             ccceeecceecccCCeEEEEEEEcc-CCc--EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA-TGI--EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      .++|++.+.||+|+||.||+|.+.. ++.  .||||++...........+.+.+|+.++++++ ||||+++++++.... 
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-
Confidence            4569999999999999999998643 333  68999987655445566788999999999997 999999999988765 


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++...
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccccc
Confidence            88999999999999998764 568999999999999999999999999999999999999   66779999999999876


Q ss_pred             CCCCc----cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          254 KPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       254 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .....    .....+|..|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+.......+  ....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  249 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPED  249 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTT
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCcC
Confidence            54332    223456778999999874 58999999999999999999 9999999888888888876654333  2346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++++.++|.+||..||++|||+.++++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  279 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFL  279 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence            889999999999999999999999999854

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.1e-47  Score=341.99  Aligned_cols=249  Identities=21%  Similarity=0.310  Sum_probs=212.3

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ...++|++.+.||+|+||.||+|.+ .++..||+|.+....    ...+.+.+|+.+++.++ ||||+++++++.+ +..
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~   82 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPI   82 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCc----ccHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CCc
Confidence            3456799999999999999999996 456789999986532    23467899999999997 9999999998764 458


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          176 HIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||++   ++++.+||+|||++...
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccc
Confidence            99999999999999886543  68999999999999999999999999999999999999   78889999999999876


Q ss_pred             CCCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          254 KPGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       254 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      .....  .....++..|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..+...   .....++
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~  236 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCP  236 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCC
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCccccc
Confidence            54332  22345678899999997 468999999999999999999 99999988888888877765322   2224678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.+||.+||+.||++|||+.++++.+
T Consensus       237 ~~l~~li~~~l~~~p~~Rps~~~l~~~l  264 (279)
T 1qpc_A          237 EELYQLMRLCWKERPEDRPTFDYLRSVL  264 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            9999999999999999999999998743

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=352.87  Aligned_cols=248  Identities=28%  Similarity=0.433  Sum_probs=189.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe-------
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-------  170 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-------  170 (363)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.++.++.+||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34699999999999999999999999999999998544   45556788999999999977999999999983       


Q ss_pred             -cCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEE
Q 017960          171 -DSLCVHIVMELCAGGELFDRIIQ---RGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       171 -~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                       ....+++||||+. |+|.+++..   .+.+++..+..++.||+.||.|||+.|  |+||||||+|||+   +.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEE
Confidence             4456899999995 689888865   456999999999999999999999999  9999999999999   78889999


Q ss_pred             eecCcceecCCCCcc-------------ccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH
Q 017960          245 IDFGLSVFFKPGQIF-------------TDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQ  307 (363)
Q Consensus       245 ~DFG~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  307 (363)
                      +|||++.........             ....||+.|+|||++.    ..++.++|||||||++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876433221             1456899999999983    35889999999999999999999999765443


Q ss_pred             HHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          308 GIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       308 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ....    ....  .......+..+.+||.+||+.||.+|||+.|++++++
T Consensus       260 ~~~~----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 RIVN----GKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             Hhhc----Cccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            3222    2221  2223456788999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-47  Score=348.49  Aligned_cols=255  Identities=22%  Similarity=0.289  Sum_probs=202.2

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++.....     ...+.+|+.+++.+.+|++|..+..++......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            456789999999999999999999999999999998764432     235788999999998444455555556788899


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+...++++.+||+|||++....
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999999 9999999875 4569999999999999999999999999999999999999544567789999999998765


Q ss_pred             CCCc--------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH---HHHHHHHcCCcccCC
Q 017960          255 PGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---GIFDAVLKGHIDFES  322 (363)
Q Consensus       255 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~  322 (363)
                      ....        .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....   .....+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            4322        235678999999999884 6899999999999999999999999764322   223333222222211


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          323 -DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       323 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                       .....+++++.+||.+||+.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  274 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHH
Confidence             1123578999999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.5e-47  Score=346.01  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=208.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEE-ecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAY-EDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-~~~~~  174 (363)
                      .+|++.+.||+|+||.||+|.+..++   ..+|+|.+....  .....+.+.+|+.++++++ ||||+++++++ ...+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCCc
Confidence            45999999999999999999965433   358999886432  5566788999999999998 99999999985 55678


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++...
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccc
Confidence            89999999999999999763 458999999999999999999999999999999999999   78889999999999865


Q ss_pred             CCCC-----ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          254 KPGQ-----IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       254 ~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      ....     ......+|+.|+|||++. ..++.++||||||+++|+|++ |.+||.+....+....+..+......   .
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  255 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---E  255 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---T
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---c
Confidence            4332     123456778899999997 468999999999999999999 67777777777777777666543332   3


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+++++.++|.+||+.||++|||+.++++.+
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L  286 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI  286 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            5789999999999999999999999999753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-47  Score=349.25  Aligned_cols=249  Identities=24%  Similarity=0.316  Sum_probs=197.3

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHH--hcCCCceeEEeEEEec--
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH--LAGHKNIVTIKGAYED--  171 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~--  171 (363)
                      .+.++|++.+.||+|+||+||+|.+  +++.||||++...      ....+.+|.+++..  ++ ||||+++++++..  
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLR-HENILGFIASDMTSR   75 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhcc-CcCeeeEEEeecccc
Confidence            4567899999999999999999985  7889999998543      23556677777777  55 9999999998643  


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEecCCCCCceEeeeCCCCcc
Q 017960          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH--------SLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH--------~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                        ....++||||+++++|.+++. ...+++..+..++.||+.||.|||        +.||+||||||+|||+   +.++.
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~  151 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQ  151 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSC
T ss_pred             CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCC
Confidence              356899999999999999885 456899999999999999999999        9999999999999999   78889


Q ss_pred             EEEeecCcceecCCCCc-----cccCccCCcccccccccc-------cCCCcccHHHHHHHHHHHHhC----------CC
Q 017960          242 LKAIDFGLSVFFKPGQI-----FTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSG----------VP  299 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~ell~g----------~~  299 (363)
                      +||+|||++........     .....||+.|+|||++.+       .++.++|||||||++|||++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            99999999976544332     233579999999999874       345789999999999999999          88


Q ss_pred             CCCCcCH----HHHHHHHHcCCcccCCCC----CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          300 PFWAETQ----QGIFDAVLKGHIDFESDP----WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       300 pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ||.....    ..............+..+    ...+++++.+||.+||+.||++|||+.++++.+
T Consensus       232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  297 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL  297 (301)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence            8854322    222222222111111110    012346799999999999999999999999754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=343.53  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=208.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE-
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV-  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~-  175 (363)
                      .|++.+.||+|+||.||+|.+..++.   .||+|++....  .....+.+.+|+.+++.++ ||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCCc
Confidence            47788999999999999999765554   79999986432  5566788999999999997 99999999999766655 


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCccccc
Confidence            999999999999999976 4568999999999999999999999999999999999999   788899999999997654


Q ss_pred             CCC-----ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          255 PGQ-----IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       255 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ...     ......+++.|+|||.+.+ .++.++||||||+++|+|++ |.+||...........+.......   ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  252 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPEY  252 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CCTT
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CCcc
Confidence            322     2234567889999999984 68999999999999999999 555566666666666666654322   2245


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++++.+||.+||+.||.+|||+.++++.+
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l  282 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEV  282 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            789999999999999999999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=361.54  Aligned_cols=257  Identities=18%  Similarity=0.162  Sum_probs=198.8

Q ss_pred             cccceeecceecccCCeEEEEEEEcc---CCcEEEEEEeeccccCChh--------hHHHHHHHHHHHHHhcCCCceeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISRE--------DVEDVRREIQIMHHLAGHKNIVTI  165 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~niv~~  165 (363)
                      ..++|++.+.||+|+||.||+|.+..   ++..||||++.........        ....+.+|+..++.+. ||||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence            34679999999999999999999887   7889999998754311000        1123567888888887 9999999


Q ss_pred             eEEEec----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc-
Q 017960          166 KGAYED----SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF-  240 (363)
Q Consensus       166 ~~~~~~----~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~-  240 (363)
                      ++++..    ....++||||+ +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~  189 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL---GYKNP  189 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---ESSST
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE---ccCCC
Confidence            999987    78899999999 99999999887789999999999999999999999999999999999999   4444 


Q ss_pred             -cEEEeecCcceecCCCC--------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--HHH
Q 017960          241 -SLKAIDFGLSVFFKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQG  308 (363)
Q Consensus       241 -~~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~  308 (363)
                       .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.+..  ...
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             89999999998754321        1245679999999999885 58999999999999999999999996532  222


Q ss_pred             HHHHHHcCCcccCC-----CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          309 IFDAVLKGHIDFES-----DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       309 ~~~~i~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      ............+.     .....+++++.+||.+||+.||++|||+.++++.+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  324 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN  324 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            21111111000110     011257899999999999999999999999998654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-47  Score=353.53  Aligned_cols=257  Identities=23%  Similarity=0.265  Sum_probs=204.9

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++.....  ......+.+|+.+++.+. ||||+++++++......
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSCC
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC--chHHHHHHHHHHHHHhcc-CCCccceEEEEecCCce
Confidence            3456799999999999999999984 5789999999975432  222236889999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          176 HIVMELCAGGELFDRIIQRG----HYSERKAAELTRIIVGVVEACHSL---GVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                      ++||||+.+++|.+++....    .+++..+..++.|++.||.|||++   ||+||||||+|||+   +.++.+||+|||
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg  179 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFG  179 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCS
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCc
Confidence            99999999999999997643    389999999999999999999999   99999999999999   788899999999


Q ss_pred             cceecCCC--CccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCc-----CHHHHHHHHHcCCccc
Q 017960          249 LSVFFKPG--QIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAE-----TQQGIFDAVLKGHIDF  320 (363)
Q Consensus       249 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~  320 (363)
                      ++......  .......||+.|+|||++. ..++.++|||||||++|+|++|..||...     ......+.+.......
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  259 (326)
T 3uim_A          180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK  259 (326)
T ss_dssp             SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred             cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence            99876433  2334556999999999987 46899999999999999999999999421     1111112111110000


Q ss_pred             CC----------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          321 ES----------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       321 ~~----------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ..          ......++++.+++.+||+.||.+|||+.|++++++-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            00          0011123679999999999999999999999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.6e-47  Score=349.61  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=205.9

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      |..++.||+|+||.||+|.+  +++.||||++..... ......+.+.+|+.+++.++ ||||+++++++.+.+..++||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEE
Confidence            66679999999999999984  688999999865432 23445678999999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          180 ELCAGGELFDRIIQ---RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||++||+||||||+||++   +.++.+||+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence            99999999999864   3458999999999999999999999999999999999999   78889999999999875432


Q ss_pred             C---ccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHH----HHHHHHcCCccc-------CC
Q 017960          257 Q---IFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQG----IFDAVLKGHIDF-------ES  322 (363)
Q Consensus       257 ~---~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~-------~~  322 (363)
                      .   ......||+.|+|||++.+.++.++||||||+++|+|++|..||.+.....    ....+.......       ..
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence            2   223457899999999998889999999999999999999999997654332    222222211110       01


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ......++.+.+++.+||+.||.+|||+.++++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L  301 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL  301 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            11122346789999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.6e-47  Score=349.57  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=205.9

Q ss_pred             cccce-eecceecccCCeEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLY-TLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y-~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      +.++| ++++.||+|+||+||+|.    +..+++.||||++....  .....+.+.+|+.++++++ ||||+++++++.+
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY-HEHIIKYKGCCED  104 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCC-CcchhhEEEEEec
Confidence            44555 999999999999998775    34578899999997542  4556778999999999998 9999999999987


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                        ...+++||||+++++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL  180 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred             CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence              46789999999999999988654 48999999999999999999999999999999999999   7888999999999


Q ss_pred             ceecCCCCc----cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH---------------HH
Q 017960          250 SVFFKPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ---------------GI  309 (363)
Q Consensus       250 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~---------------~~  309 (363)
                      +........    .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||......               ..
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            988754432    234567888999999984 6889999999999999999999998654321               12


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+..+.   .......+++++.+||.+||+.||.+|||+.|+++.+
T Consensus       261 ~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  305 (318)
T 3lxp_A          261 TELLERGE---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL  305 (318)
T ss_dssp             HHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhccc---CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            22222222   1222346889999999999999999999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.4e-47  Score=365.15  Aligned_cols=247  Identities=24%  Similarity=0.347  Sum_probs=207.2

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.++++++ ||||+++++++.+ ...+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceE
Confidence            34679999999999999999999754 4679999997543    22467899999999998 9999999999876 6789


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecC
Confidence            99999999999999964  3568999999999999999999999999999999999999   778899999999998764


Q ss_pred             CCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          255 PGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       255 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                      ....  .....++..|+|||++. +.++.++|||||||++|||++ |..||.+....+....+..+...   .....+++
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~  408 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPE  408 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCH
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCH
Confidence            3321  22345677899999987 569999999999999999999 99999998888888888765322   22346889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ++.+||.+||+.||++|||+.++++.
T Consensus       409 ~l~~li~~cl~~dP~~Rpt~~~l~~~  434 (452)
T 1fmk_A          409 SLHDLMCQCWRKEPEERPTFEYLQAF  434 (452)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-47  Score=358.60  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             ceeecceecccCCeEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe-cCCeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE-DSLCV  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~~~  175 (363)
                      .|++.+.||+|+||.||+|.+..++   ..||+|.+...  ......+++.+|+.++++++ ||||+++++++. ..+..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCCe
Confidence            4888999999999999999976443   46899988643  24556788999999999997 999999999864 45678


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccc
Confidence            9999999999999999765 358899999999999999999999999999999999999   788899999999998654


Q ss_pred             CCCc-----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          255 PGQI-----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       255 ~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ....     .....+|+.|+|||++. ..++.++|||||||++|||++ |.+||.+....+....+..+.....   ...
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~~  320 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEY  320 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CTT
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CCC
Confidence            3221     23345678899999987 469999999999999999999 7888887777777777766553322   235


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++++.++|.+||+.||++|||+.|+++++
T Consensus       321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~L  350 (373)
T 3c1x_A          321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRI  350 (373)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            789999999999999999999999999854

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.6e-47  Score=342.66  Aligned_cols=244  Identities=23%  Similarity=0.311  Sum_probs=201.8

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-CCeEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVH  176 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~  176 (363)
                      .++|++.+.||+|+||.||+|.+  +++.||||++...     ...+.+.+|+.++++++ ||||+++++++.+ .+..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----hHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceE
Confidence            35699999999999999999985  5889999998643     24567899999999998 9999999998754 45789


Q ss_pred             EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +||||+++++|.+++...+.  +++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----
T ss_pred             EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccc
Confidence            99999999999999976543  8999999999999999999999999999999999999   788899999999997654


Q ss_pred             CCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..  .....+++.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..+..   ......+++++
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  243 (278)
T 1byg_A          169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAV  243 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHH
T ss_pred             cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHH
Confidence            32  23446788999999987 468999999999999999998 9999988887777777765532   22234678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .++|.+||+.||++|||+.++++.+
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~~L  268 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLREQL  268 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHHHH
Confidence            9999999999999999999998753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.9e-46  Score=342.96  Aligned_cols=238  Identities=34%  Similarity=0.569  Sum_probs=192.5

Q ss_pred             ccccceeec-ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec---
Q 017960           96 NIRDLYTLG-RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED---  171 (363)
Q Consensus        96 ~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---  171 (363)
                      .+.+.|.+. +.||+|+||.||+|.+..+++.||+|++...        ..+.+|+.++.++.+||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            445567776 7899999999999999999999999998642        3567899988666669999999999876   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          172 -SLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       172 -~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                       ...+++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998764  59999999999999999999999999999999999999543337899999999


Q ss_pred             cceecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcC----CcccCCCC
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG----HIDFESDP  324 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~  324 (363)
                      ++.....                    ..++.++|||||||++|||++|..||.+.........+...    ...++...
T Consensus       166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (299)
T 3m2w_A          166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  225 (299)
T ss_dssp             TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred             ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence            9876432                    34678999999999999999999999776544332211111    11111111


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          325 WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       325 ~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +..+++++.+||.+||+.||.+|||+.|+|+|+||..
T Consensus       226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence            2457899999999999999999999999999999853

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.2e-46  Score=377.09  Aligned_cols=245  Identities=22%  Similarity=0.248  Sum_probs=208.2

Q ss_pred             cceecccCCeEEEEEEE--ccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEec
Q 017960          104 GRKLGQGQFGTTYLCTE--IATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      .+.||+|+||.||+|.+  ..+++.||||+++... ......+.+.+|+.++++++ ||||+++++++.. ...++||||
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~  450 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEM  450 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEEC
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEc
Confidence            35899999999999954  4566889999997543 24455688999999999998 9999999999865 458899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc---
Q 017960          182 CAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI---  258 (363)
Q Consensus       182 ~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---  258 (363)
                      +++++|.+++...+.+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||++........   
T Consensus       451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC------
T ss_pred             cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCccccc
Confidence            9999999999988889999999999999999999999999999999999999   6778999999999987644321   


Q ss_pred             -cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHH
Q 017960          259 -FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL  335 (363)
Q Consensus       259 -~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  335 (363)
                       .....+|+.|+|||++.. .++.++|||||||++|||++ |+.||.+....+....+..+....   ....+++++.+|
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~l  604 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDL  604 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHH
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHH
Confidence             223456788999999984 69999999999999999998 999999999888888888765332   224688999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCC
Q 017960          336 IRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       336 i~~~l~~dp~~R~s~~evL~~~  357 (363)
                      |.+||+.||++||++.+|++.+
T Consensus       605 i~~cl~~dP~~RPs~~~l~~~L  626 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVELRL  626 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHH
Confidence            9999999999999999998753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-46  Score=360.34  Aligned_cols=256  Identities=26%  Similarity=0.374  Sum_probs=199.1

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++...      ..+.+.+|+.++.++.+||||+++++++.+...
T Consensus        11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            3456678889999999999998754 578999999998643      235678899999988559999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC----------C
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYS-------ERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK----------D  237 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~-------~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~----------~  237 (363)
                      +++|||||. ++|.+++.......       +..+..++.||+.||.|||++||+||||||+|||++..          +
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence            999999995 69999997654332       23457899999999999999999999999999999532          2


Q ss_pred             CCccEEEeecCcceecCCCCc-----cccCccCCcccccccccc--------cCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 017960          238 DDFSLKAIDFGLSVFFKPGQI-----FTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLS-GVPPFWA  303 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~il~ell~-g~~pf~~  303 (363)
                      .++.+||+|||++........     .....||+.|+|||++.+        .++.++|||||||++|||++ |..||..
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            456899999999987654321     234679999999999853        48999999999999999999 9999976


Q ss_pred             cCHHHHHHHHHcCCcccCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          304 ETQQGIFDAVLKGHIDFESDP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       304 ~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .....  ..+..+........   ...+++++.+||.+||+.||.+|||+.++|+||||.
T Consensus       243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence            54433  23334333322211   112457899999999999999999999999999995

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-46  Score=365.17  Aligned_cols=255  Identities=22%  Similarity=0.278  Sum_probs=211.0

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.++|+++++||+|+||.||+|.+..+++.||||++.....     ...+.+|+.+++.|.+|++|..+..++.+....
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            356789999999999999999999999999999998865432     234778999999999668888888888889999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +|||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+||||...+.++.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 9999999975 5679999999999999999999999999999999999999544567899999999998765


Q ss_pred             CCCc--------cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH---HHHHHHHHcCCcccCC
Q 017960          255 PGQI--------FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDFES  322 (363)
Q Consensus       255 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~  322 (363)
                      ....        .....||+.|+|||++.+ .++.++|||||||+||||++|+.||.+...   ...+..+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            4332        125689999999999884 699999999999999999999999976433   3333333332221111


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          323 -DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       323 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                       .....+++++.+||.+||+.||++||++.+|++.
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~  272 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL  272 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence             1113578999999999999999999999998874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-47  Score=355.59  Aligned_cols=247  Identities=14%  Similarity=0.150  Sum_probs=201.8

Q ss_pred             ccceeecceecccCCeEEEEEEEcc--------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeE-----
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA--------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVT-----  164 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~-----  164 (363)
                      .++|++.+.||+|+||.||+|.+..        .++.||||++...        +.+.+|+.++++++ ||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~-h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAA-KPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHC-CHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhc-ccchhhhhhhh
Confidence            4679999999999999999999887        4889999998643        35788999999998 999887     


Q ss_pred             ----------EeEEEec-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCce
Q 017960          165 ----------IKGAYED-SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENF  231 (363)
Q Consensus       165 ----------~~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NI  231 (363)
                                +++++.. ....++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6677765 78899999999 99999999875  7799999999999999999999999999999999999


Q ss_pred             EeeeCCCCc--cEEEeecCcceecCCCC--------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCC
Q 017960          232 LLVNKDDDF--SLKAIDFGLSVFFKPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPP  300 (363)
Q Consensus       232 ll~~~~~~~--~~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~p  300 (363)
                      |+   +.++  .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|||++|+.|
T Consensus       191 l~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          191 FV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             EE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             EE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99   6666  89999999997654322        1234579999999999985 689999999999999999999999


Q ss_pred             CCCcC--HHHHHHHHH---cCCcccC--CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          301 FWAET--QQGIFDAVL---KGHIDFE--SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       301 f~~~~--~~~~~~~i~---~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      |.+..  .........   .....+.  ...+..+++++.+||.+||+.||++|||+.++++.+
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  331 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL  331 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence            97653  222322222   1111111  112235789999999999999999999999998753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=364.03  Aligned_cols=253  Identities=26%  Similarity=0.329  Sum_probs=196.8

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|.+.+.||+|+||+||. ....+++.||||++.....      ..+.+|+.+|+.+.+||||+++++++.+....||||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            488999999999999764 3357899999999865322      235679999999956999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC--CCccEEEeecCcceecCCC
Q 017960          180 ELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD--DDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~--~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||. ++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||+..++  ....+||+|||+|......
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            9995 69999887654 356667789999999999999999999999999999995322  3346889999999876543


Q ss_pred             C----ccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          257 Q----IFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       257 ~----~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      .    .....+||+.|+|||++.    ..++.++|||||||++|||++ |..||...........+...... .......
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~  255 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD-CLHPEKH  255 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT-TSCTTCH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc-ccCcccc
Confidence            2    234567999999999986    347889999999999999999 99999655444333222221111 1111122


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+..+.+||.+||+.||.+|||+.|+|+||||..
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            3566899999999999999999999999999964

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=342.10  Aligned_cols=241  Identities=27%  Similarity=0.383  Sum_probs=194.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||.||+|.+  .++.||||++..     ....+.+.+|+.++++++ ||||+++++++.+  ..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES-----ESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS-----TTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC-----hhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEE
Confidence            4599999999999999999985  478899999853     234578899999999997 9999999998764  47899


Q ss_pred             EeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCcEecCCCCCceEeeeCCCCcc-EEEeecCcce
Q 017960          179 MELCAGGELFDRIIQRGH---YSERKAAELTRIIVGVVEACHS---LGVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSV  251 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~l~~~l~~lH~---~~iiHrDlkp~NIll~~~~~~~~-~kl~DFG~a~  251 (363)
                      |||+++++|.+++.....   ++...+..++.|++.||.|||+   +||+||||||+|||+   +.++. +||+|||++.
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL---VAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE---ETTTTEEEECCCCC--
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE---eCCCCEEEEccccccc
Confidence            999999999999986553   7889999999999999999999   899999999999999   45554 8999999997


Q ss_pred             ecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcC--HHHHHHHHHcCCcccCCCCCCCC
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAET--QQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      .....  .....||+.|+|||++.+ .++.++||||||+++|||++|+.||....  .......+..+..   ......+
T Consensus       155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  229 (307)
T 2eva_A          155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNL  229 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTC
T ss_pred             ccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCccccc
Confidence            65432  334578999999999985 69999999999999999999999997543  2333333433322   2223468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++.+.+||.+||+.||++|||+.++++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L  258 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKIM  258 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            89999999999999999999999999853

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.5e-46  Score=368.60  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=211.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.|++.+.||+|+||.||+|.+.. +..||||++....    ...+.+.+|+.+|++|+ ||||+++++++.+ ...+|
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccceE
Confidence            4669999999999999999999754 4679999997543    22467899999999998 9999999999876 67899


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||||+.+++|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||+   ++++.+||+|||++.....
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIED  415 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCC
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCC
Confidence            9999999999999974  3568999999999999999999999999999999999999   7788999999999986543


Q ss_pred             CCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ...  .....++..|+|||++. +.++.++|||||||+||||++ |..||.+....+....+..+...   .....++++
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~  492 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPES  492 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHH
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHH
Confidence            221  12344677899999987 569999999999999999999 99999998888888888765322   223468899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.+||.+||+.||++|||+.+|++.
T Consensus       493 l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=371.29  Aligned_cols=248  Identities=24%  Similarity=0.321  Sum_probs=206.8

Q ss_pred             cceeecc-eecccCCeEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGR-KLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~-~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +.+.+.+ .||+|+||.||+|.+..  ++..||||+++...  .....+.+.+|+.++++++ ||||+++++++.. +.+
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CCe
Confidence            3455555 89999999999998753  55679999997542  3345678999999999997 9999999999876 568


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCccccc
Confidence            9999999999999998754 459999999999999999999999999999999999999   677899999999998654


Q ss_pred             CCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ....    .....+++.|+|||++. +.++.++|||||||+||||++ |+.||.+....+....+..+...   .....+
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~  564 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPEC  564 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTTC
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence            3321    12234568899999997 569999999999999999998 99999998888888888776432   222468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ++++.+||.+||+.||++||++.++++.
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~  592 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTVEQR  592 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999999999999999999999999764

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.6e-47  Score=378.69  Aligned_cols=260  Identities=27%  Similarity=0.395  Sum_probs=211.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec------C
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------S  172 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~  172 (363)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.++++++ ||||+++++++..      .
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence            56999999999999999999999999999999986542  5566788999999999997 9999999998765      6


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG---HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                      +..++||||++|++|.+++....   .+++..+..++.||+.||.|||+.||+||||||+||++..++....+||+|||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            77899999999999999997654   589999999999999999999999999999999999996544555699999999


Q ss_pred             ceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHH---------H-----H
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDA---------V-----L  314 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~---------i-----~  314 (363)
                      +.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........         +     .
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            99877666667788999999999998 4699999999999999999999999976533221100         0     0


Q ss_pred             cCCcccC------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          315 KGHIDFE------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       315 ~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      .+...+.      ......+++++.+||.+||..||++|||+.++++|+||..
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            1111111      1112235688999999999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=350.32  Aligned_cols=242  Identities=20%  Similarity=0.227  Sum_probs=193.9

Q ss_pred             ccceeecceecccCCeEEEEE-----EEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcC--CCceeEEeEEEe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLC-----TEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG--HKNIVTIKGAYE  170 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--h~niv~~~~~~~  170 (363)
                      .++|++.+.||+|+||+||+|     .+..+++.||||++...      ....+..|+.++..+..  |+||+.+++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            466999999999999999999     46788999999998643      23467778888887753  899999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeee--------CC
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQ-----RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN--------KD  237 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~--------~~  237 (363)
                      ..+..++||||+++|+|.+++..     ...+++..+..++.||+.||+|||++|||||||||+|||++.        .+
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999999974     456999999999999999999999999999999999999932        11


Q ss_pred             CCccEEEeecCcceecC---CCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHH
Q 017960          238 DDFSLKAIDFGLSVFFK---PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAV  313 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i  313 (363)
                      .++.+||+|||+|....   ........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.......     
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----  292 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----  292 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence            17899999999997543   3445567789999999999985 59999999999999999999999996543211     


Q ss_pred             HcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 017960          314 LKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV  353 (363)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ev  353 (363)
                        ......... ...++.+.+++.+||+.+|.+|++..+.
T Consensus       293 --~~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~  329 (365)
T 3e7e_A          293 --CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDL  329 (365)
T ss_dssp             --EEECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHH
T ss_pred             --eeechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHH
Confidence              000001111 1246789999999999999999654333

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.5e-46  Score=343.53  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             ccceeecceecccCCeEEEEEE----EccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCT----EIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .+.|++.+.||+|+||.||+|.    +..+++.||||++...   .....+.+.+|+.++++++ ||||+++++++...+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC--
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecC
Confidence            4569999999999999999998    4678999999998653   4455678999999999997 999999999886544


Q ss_pred             --eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          174 --CVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       174 --~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                        ..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT  192 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcch
Confidence              789999999999999999875 458999999999999999999999999999999999999   66789999999999


Q ss_pred             eecCCCCc----cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHH----------------HH
Q 017960          251 VFFKPGQI----FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQ----------------GI  309 (363)
Q Consensus       251 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~----------------~~  309 (363)
                      ........    .....++..|+|||++.+ .++.++||||||+++|+|++|..||......                .+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654432    223456778999999874 5899999999999999999999998543111                11


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+..+.   .......+++++.+||.+||+.||++|||+.|+++.+
T Consensus       273 ~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L  317 (326)
T 2w1i_A          273 IELLKNNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV  317 (326)
T ss_dssp             HHHHHTTC---CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHhhcCC---CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            22222221   1122346889999999999999999999999998753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-45  Score=342.40  Aligned_cols=251  Identities=21%  Similarity=0.284  Sum_probs=195.0

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc-CCCceeEEeEEEecC-
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA-GHKNIVTIKGAYEDS-  172 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~-  172 (363)
                      ..+.++|++.+.||+|+||.||+|.+  +++.||||++....      .....+|.+++..+. +||||+++++++... 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            34567899999999999999999986  48899999985432      234455666655541 499999999999877 


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEecCCCCCceEeeeCCCCcc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL--------GVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~--------~iiHrDlkp~NIll~~~~~~~~  241 (363)
                         ...++||||+++++|.+++... .+++..+..++.|++.||.|||+.        ||+||||||+|||+   +.++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGT  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCC
Confidence               7899999999999999998654 689999999999999999999999        99999999999999   78889


Q ss_pred             EEEeecCcceecCCCCcc-----ccCccCCccccccccccc-CCCc------ccHHHHHHHHHHHHhC----------CC
Q 017960          242 LKAIDFGLSVFFKPGQIF-----TDVVGSPYYVAPEVLLKH-YGPE------ADVWTAGVILYILLSG----------VP  299 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------~Di~slG~il~ell~g----------~~  299 (363)
                      +||+|||++.........     ....||+.|+|||++.+. +...      +|||||||++|||++|          ..
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999999999765433221     245799999999999743 4443      8999999999999999          77


Q ss_pred             CCCCcC-----HHHHHHHHHcCCcccCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          300 PFWAET-----QQGIFDAVLKGHIDFESDP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       300 pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ||....     .......+...........   ...+++++.+||.+||+.||++|||+.++++++
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence            775432     1222222222221111110   113456799999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-45  Score=344.02  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=202.9

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHH--hcCCCceeEEeEEEecCC
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH--LAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~~~  173 (363)
                      .+.++|++.+.||+|+||.||+|.+  +++.||||++...      ....+.+|++++..  ++ ||||+++++++....
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLR-HENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcC-CCcEEEEEeeecccC
Confidence            4567799999999999999999996  5889999998543      24567889999988  55 999999999998776


Q ss_pred             ----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEecCCCCCceEeeeCCCCcc
Q 017960          174 ----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACH--------SLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       174 ----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH--------~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                          ..++||||+++++|.+++.+ ..+++..+..++.||+.||.|||        +.||+||||||+|||+   +.++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~  185 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGT  185 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSC
T ss_pred             CccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCC
Confidence                79999999999999999865 46899999999999999999999        8999999999999999   78889


Q ss_pred             EEEeecCcceecCCCC-----ccccCccCCccccccccccc-------CCCcccHHHHHHHHHHHHhC----------CC
Q 017960          242 LKAIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLLKH-------YGPEADVWTAGVILYILLSG----------VP  299 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~il~ell~g----------~~  299 (363)
                      +||+|||++.......     ......||+.|+|||++.+.       ++.++|||||||++|||++|          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            9999999998765443     22456799999999998743       33689999999999999999          78


Q ss_pred             CCCCcC-----HHHHHHHHHcCCcccCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          300 PFWAET-----QQGIFDAVLKGHIDFESDP---WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       300 pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ||....     .......+...........   ...+++.+.+||.+||+.||++|||+.++++++
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence            986542     2334444433322211110   012345789999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=348.09  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=186.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHH--HHHhcCCCceeEEeEEEe-----c
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI--MHHLAGHKNIVTIKGAYE-----D  171 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~~h~niv~~~~~~~-----~  171 (363)
                      ++|++.+.||+|+||.||+|.+  +++.||||++....      ...+..|.++  +..+. ||||+++++.+.     .
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLME-HDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTTS
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhcc-CcchhhheecccccccCC
Confidence            5699999999999999999974  78899999996432      2334444444  44465 999999998553     2


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEecCCCCCceEeeeCCCCccE
Q 017960          172 SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL---------GVMHRDLKPENFLLVNKDDDFSL  242 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~---------~iiHrDlkp~NIll~~~~~~~~~  242 (363)
                      ...+++||||+++++|.+++.... .++..+..++.||+.||.|||+.         ||+||||||+|||+   +.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcE
Confidence            346789999999999999886654 58999999999999999999999         99999999999999   788899


Q ss_pred             EEeecCcceecCCCC---------ccccCccCCcccccccccc--------cCCCcccHHHHHHHHHHHHhCCCCCCCcC
Q 017960          243 KAIDFGLSVFFKPGQ---------IFTDVVGSPYYVAPEVLLK--------HYGPEADVWTAGVILYILLSGVPPFWAET  305 (363)
Q Consensus       243 kl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~il~ell~g~~pf~~~~  305 (363)
                      ||+|||++.......         ......||+.|+|||++.+        .++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998764322         2234579999999999864        36778999999999999999977763321


Q ss_pred             H------------------HHHHHHHHcCCcccC-CCCC---CCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          306 Q------------------QGIFDAVLKGHIDFE-SDPW---PLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       306 ~------------------~~~~~~i~~~~~~~~-~~~~---~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      .                  ......+........ ...+   ..+++++.+||.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            1                  111111111111111 1111   1234579999999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=345.51  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=207.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||.||+|.+..   .||+|++..... .....+.+.+|+.++++++ ||||+++++++.+....++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCEEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCceEE
Confidence            3569999999999999999999643   599999875432 2333456778999999997 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-
Q 017960          178 VMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-  255 (363)
                      ||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   + ++.+||+|||++..... 
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCccccccc
Confidence            999999999999987654 68999999999999999999999999999999999999   5 56899999999865421 


Q ss_pred             -----CCccccCccCCcccccccccc----------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc
Q 017960          256 -----GQIFTDVVGSPYYVAPEVLLK----------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF  320 (363)
Q Consensus       256 -----~~~~~~~~gt~~y~aPE~~~~----------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  320 (363)
                           ........|++.|+|||++..          .++.++|||||||++|+|++|..||.+.........+..+....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                 122334568999999999863          37889999999999999999999999888888877777654332


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .  ....++.++.++|.+||..||++|||+.++++.+
T Consensus       263 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l  297 (319)
T 2y4i_B          263 L--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML  297 (319)
T ss_dssp             C--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred             C--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            2  2235788999999999999999999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-45  Score=367.71  Aligned_cols=251  Identities=25%  Similarity=0.334  Sum_probs=211.2

Q ss_pred             cccceeecceecccCCeEEEEEEEccC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.++++++ ||||+++++++.+ +
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~-~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVITE-N  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec-C
Confidence            456799999999999999999997654   4579999886432  4555678999999999998 9999999998854 5


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          174 CVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      ..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCS
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCee
Confidence            6899999999999999997654 68999999999999999999999999999999999999   6678999999999987


Q ss_pred             cCCCCc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          253 FKPGQI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       253 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ......  .....+|+.|+|||++. ..++.++|||||||++|||++ |..||.+....+....+..+....   ..+.+
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~  617 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNC  617 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence            644332  22345678999999987 469999999999999999997 999999988888888877654322   23468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ++++.+||.+||..||++|||+.++++.+
T Consensus       618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L  646 (656)
T 2j0j_A          618 PPTLYSLMTKCWAYDPSRRPRFTELKAQL  646 (656)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            89999999999999999999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5e-46  Score=355.30  Aligned_cols=247  Identities=17%  Similarity=0.171  Sum_probs=194.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-Cce---------e-----
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNI---------V-----  163 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~ni---------v-----  163 (363)
                      ..|++++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+. | +++         +     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchhh
Confidence            45888999999999999999999999999999987554434445678999999999887 4 221         1     


Q ss_pred             -------EEeEEEec-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEec
Q 017960          164 -------TIKGAYED-----SLCVHIVMELCAGGELFDRIIQ-------RGHYSERKAAELTRIIVGVVEACHSLGVMHR  224 (363)
Q Consensus       164 -------~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHr  224 (363)
                             .+..++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                   11111111     23467888876 6799888742       2336788999999999999999999999999


Q ss_pred             CCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccc----------cc-cCCCcccHHHHHHHHHH
Q 017960          225 DLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL----------LK-HYGPEADVWTAGVILYI  293 (363)
Q Consensus       225 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~~Di~slG~il~e  293 (363)
                      ||||+|||+   +.++.+||+|||++.....  .....+| +.|+|||++          .. .++.++|||||||++||
T Consensus       236 DiKp~NILl---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVL---DQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEE---CTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEE---ecCCeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999   8888999999999987543  2456678 999999998          32 48889999999999999


Q ss_pred             HHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          294 LLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       294 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |++|+.||.+.........+.        ..+..+++++.+||.+||+.||++||++.++|+|+||..
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999999998766544333222        223467899999999999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.4e-46  Score=345.51  Aligned_cols=251  Identities=19%  Similarity=0.189  Sum_probs=196.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHHhc--------CCCceeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----SREDVEDVRREIQIMHHLA--------GHKNIVT  164 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~niv~  164 (363)
                      .++|++.+.||+|+||+||+|++  +++.||||++......     .....+.+.+|+.+++.++        +||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35699999999999999999996  7899999999865421     2334578899999999986        4777777


Q ss_pred             EeEEEe------------------------------cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 017960          165 IKGAYE------------------------------DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE  214 (363)
Q Consensus       165 ~~~~~~------------------------------~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~  214 (363)
                      +.+++.                              +...+||||||+++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            776542                              26789999999999987777644 56899999999999999999


Q ss_pred             HHH-hCCcEecCCCCCceEeeeCC-----------------CCccEEEeecCcceecCCCCccccCccCCcccccccccc
Q 017960          215 ACH-SLGVMHRDLKPENFLLVNKD-----------------DDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLK  276 (363)
Q Consensus       215 ~lH-~~~iiHrDlkp~NIll~~~~-----------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  276 (363)
                      ||| ++||+||||||+|||+..++                 ....+||+|||+|+.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999995432                 1238999999999876543    3579999999999987


Q ss_pred             cCCCcccHHHHHHH-HHHHHhCCCCCCCcCH-HHHHHHHHcCC-ccc--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHH
Q 017960          277 HYGPEADVWTAGVI-LYILLSGVPPFWAETQ-QGIFDAVLKGH-IDF--ESDPWPLISDSAKDLIRKMLCSQPSERLTAH  351 (363)
Q Consensus       277 ~~~~~~Di~slG~i-l~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~  351 (363)
                      ..+.++||||||++ .+++++|..||.+... ....+.+.... ...  ....++.+++++.+||.+||+.|     |+.
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            67889999998777 7788899999843211 12233333211 111  11112246789999999999977     999


Q ss_pred             HHh-cCCCcc
Q 017960          352 EVL-CMYNLP  360 (363)
Q Consensus       352 evL-~~~~~~  360 (363)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.8e-45  Score=332.39  Aligned_cols=230  Identities=14%  Similarity=0.071  Sum_probs=191.2

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.++|++.+.||+|+||.||+|.+..+++.||||++...........+.+.+|+.++..+. ||||+++++++.+.+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence            45677999999999999999999999999999999998766555667788999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |+||||++|++|.+++.. + ....++..++.||+.||.|||++||+||||||+|||+   +.++.+||+++|       
T Consensus       107 ~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC-------
T ss_pred             EEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc-------
Confidence            999999999999998854 3 4667889999999999999999999999999999999   778889998543       


Q ss_pred             CCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHH---HHHcCCcccCCCCCCCCCHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD---AVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~  332 (363)
                                  |++      .++.++|||||||++|||++|+.||.+......+.   ....+.........+.+++++
T Consensus       175 ------------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 ------------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             ------------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             ------------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                        333      26889999999999999999999998765432110   001111111111224688999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+||.+||+.||++| |+.|+++.+
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~L  260 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNLM  260 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHHH
Confidence            999999999999999 999999854

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.9e-45  Score=368.26  Aligned_cols=244  Identities=26%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             ccccccceeecceecccCCeEEEEEEEcc-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIA-TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .+.+.++|++.+.||+|+||.||+|.+.. +++.||||++....  .......+.+|+.++.+++ ||||+++++++...
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHT  151 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEE
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeec
Confidence            34566889999999999999999999876 78999999986532  4556678899999999998 99999999999876


Q ss_pred             Ce-----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeec
Q 017960          173 LC-----VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       173 ~~-----~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      +.     .||||||++|++|.+.+..  .+++..+..++.||+.||.|||++|||||||||+|||+   +.+ .+||+||
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll---~~~-~~kl~DF  225 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML---TEE-QLKLIDL  225 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSS-CEEECCC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE---eCC-cEEEEec
Confidence            55     7999999999999887754  78999999999999999999999999999999999999   543 8999999


Q ss_pred             CcceecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          248 GLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       248 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      |++......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+.....         .. .......
T Consensus       226 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~~-~~~~~~~  292 (681)
T 2pzi_A          226 GAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------LP-EDDPVLK  292 (681)
T ss_dssp             TTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------CC-TTCHHHH
T ss_pred             ccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc---------cc-ccccccc
Confidence            999876543   4567999999999998778999999999999999999999886532110         00 0001112


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      .++.+.+||.+||+.||.+||+..+++.+.|.
T Consensus       293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             cCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            45789999999999999999988887776654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.5e-37  Score=307.13  Aligned_cols=190  Identities=17%  Similarity=0.151  Sum_probs=140.3

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccC-------ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-------SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      ..++.|++|.+..+.....|+.||+|++.+....       .+...+++.+|+++|+++..|+||++++++++++..+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3477889998888888889999999999765322       234456799999999999779999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-  256 (363)
                      ||||++|++|.+.|.+.+++++.   .|+.||+.||+|+|++|||||||||+|||+   ++++.+||+|||+|+..... 
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence            99999999999999998888765   478999999999999999999999999999   88899999999999876433 


Q ss_pred             CccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCC
Q 017960          257 QIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPP  300 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~p  300 (363)
                      ....+.+||+.|||||++.+.+..++|+||+|+++++|.++..+
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            34456789999999999998888999999999998877665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.97  E-value=4.7e-31  Score=259.34  Aligned_cols=184  Identities=19%  Similarity=0.153  Sum_probs=146.0

Q ss_pred             eecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          102 TLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR-----EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       102 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ...++||+|+||.||+|.  ..+..+|+|..........     ...+++.+|+.++++++ ||||+++..++......|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence            345789999999999995  6678999998755433222     12456899999999998 999996666666777789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||+   +.  .+||+|||+|+.....
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEECCCc
Confidence            99999999999998854        67899999999999999999999999999999   55  8999999999987543


Q ss_pred             Cc--------cccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCC
Q 017960          257 QI--------FTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPF  301 (363)
Q Consensus       257 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf  301 (363)
                      ..        .....||+.|||||++..   .|+..+|+|+..+-..+-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            22        235789999999999973   5888999999999888888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.95  E-value=1.3e-27  Score=216.18  Aligned_cols=159  Identities=22%  Similarity=0.271  Sum_probs=123.9

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh---------------hhHHHHHHHHHHHHHhcCCCceeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR---------------EDVEDVRREIQIMHHLAGHKNIVT  164 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~niv~  164 (363)
                      .|.+++.||+|+||.||+|.+ .+|+.||||++........               .....+.+|+.+++++. |++++ 
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~-  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVP-  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSC-
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcC-
Confidence            466779999999999999998 8899999999864321110               23567899999999997 54444 


Q ss_pred             EeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEE
Q 017960          165 IKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKA  244 (363)
Q Consensus       165 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl  244 (363)
                        +++.. +..++||||++|++|.+ +      .......++.|++.||.|||++||+||||||+|||+   + ++.+||
T Consensus       168 --~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~vkl  233 (282)
T 1zar_A          168 --KVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGIWI  233 (282)
T ss_dssp             --CEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEEEE
T ss_pred             --eEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcEEE
Confidence              44433 45699999999999977 4      123455799999999999999999999999999999   6 789999


Q ss_pred             eecCcceecCCCCccccCccCCccccccccc-----------ccCCCcccHHHH
Q 017960          245 IDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-----------KHYGPEADVWTA  287 (363)
Q Consensus       245 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----------~~~~~~~Di~sl  287 (363)
                      +|||+|..            +..++|||.+.           +.|...+|+|.+
T Consensus       234 ~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          234 IDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             CCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             EECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            99999974            34578999874           235666677653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=1.9e-23  Score=186.42  Aligned_cols=141  Identities=15%  Similarity=0.150  Sum_probs=108.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcE--EEEEEeeccccCC---------------------hhhHHHHHHHHHHHHHh
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLIS---------------------REDVEDVRREIQIMHHL  156 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l  156 (363)
                      .|++.+.||+|+||.||+|.+..+|+.  ||||+++......                     ......+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            378899999999999999998788999  9999875432110                     01123678999999999


Q ss_pred             cCCCce--eEEeEEEecCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCC
Q 017960          157 AGHKNI--VTIKGAYEDSLCVHIVMELCAG-G----ELFDRIIQRGHYSERKAAELTRIIVGVVEACH-SLGVMHRDLKP  228 (363)
Q Consensus       157 ~~h~ni--v~~~~~~~~~~~~~iv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~iiHrDlkp  228 (363)
                      . |++|  +.+++.    ...++||||+.+ |    +|.+....   .++..+..++.||+.||.||| +.||+||||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            8 7654  444432    356899999932 3    56554322   245678899999999999999 99999999999


Q ss_pred             CceEeeeCCCCccEEEeecCcceec
Q 017960          229 ENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       229 ~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      +|||+   ++  .++|+|||+|...
T Consensus       200 ~NILl---~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMY---ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEE---SS--SEEECCCTTCEET
T ss_pred             HHEEE---cC--cEEEEECcccccC
Confidence            99999   55  8999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.82  E-value=6.8e-21  Score=177.27  Aligned_cols=144  Identities=17%  Similarity=0.216  Sum_probs=101.1

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC-----------C---h-hh----HHHHHHHHHHHHHhcCCC
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI-----------S---R-ED----VEDVRREIQIMHHLAGHK  160 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~---~-~~----~~~~~~E~~~l~~l~~h~  160 (363)
                      .|++++.||+|+||.||+|.+ .+|+.||||+++.....           .   . ..    .....+|...|.++. +.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            399999999999999999997 57999999987542110           0   0 00    112346777888875 44


Q ss_pred             ceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCC--
Q 017960          161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDD--  238 (363)
Q Consensus       161 niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~--  238 (363)
                      ++....-+....  .+|||||++|++|....      .......++.||+.+|.+||++|||||||||.|||+..+++  
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            432221111222  36999999988875432      22345678899999999999999999999999999954221  


Q ss_pred             -----CccEEEeecCcceec
Q 017960          239 -----DFSLKAIDFGLSVFF  253 (363)
Q Consensus       239 -----~~~~kl~DFG~a~~~  253 (363)
                           ...+.|+||+-+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                 114899999988764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.56  E-value=2.2e-14  Score=127.67  Aligned_cols=140  Identities=19%  Similarity=0.155  Sum_probs=112.3

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++...+|.|+.+.||++.  ..+..+++|+......   .....+.+|+.+++.|.++..++++++++...+..|+||
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             cceeEeeccCCCCCeEEEEE--CCCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            48888889999999999997  3467999999864321   112358899999999976788899999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-----------------------------------------  218 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-----------------------------------------  218 (363)
                      ||++|.+|.+.+     .+......++.+++.+|..||+                                         
T Consensus        90 e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           90 SEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             EecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            999999887652     1223345788899999999998                                         


Q ss_pred             ------------------CCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          219 ------------------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       219 ------------------~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                                        ..++|+|++|.||++   +++..+.|+||+.+..
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEEEEEEchhccc
Confidence                              458999999999999   5555667999998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.41  E-value=6.6e-13  Score=117.51  Aligned_cols=134  Identities=15%  Similarity=0.147  Sum_probs=98.5

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc-eeEEeEEEecCCeEEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN-IVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~~~iv~  179 (363)
                      |.+..+.+.|..+.||++. ..+|..+++|+....      ....+.+|+.+++.+..+.- +++++++....+..++||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            4554444466679999996 456778999987542      12457789999999985522 566888888888899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 017960          180 ELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG---------------------------------------  220 (363)
Q Consensus       180 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---------------------------------------  220 (363)
                      ||++|.+|.  .   ....   ...++.+++.+|..||+..                                       
T Consensus        95 e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999998873  2   1112   2356677777777777643                                       


Q ss_pred             -------------------cEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          221 -------------------VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       221 -------------------iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                                         ++|+|++|.||++   +++..+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEEEEEcchhccc
Confidence                               9999999999999   5555677999998865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.33  E-value=7.3e-12  Score=116.57  Aligned_cols=141  Identities=22%  Similarity=0.337  Sum_probs=104.5

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEee--ccccCChhhHHHHHHHHHHHHHhcC-CCceeEEeEEEecC---CeEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSIS--KRKLISREDVEDVRREIQIMHHLAG-HKNIVTIKGAYEDS---LCVHI  177 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~---~~~~i  177 (363)
                      .+.|+.|.++.||++..  .+..+++|+..  ....  ......+.+|+.+++.|.. +..+++++.++.+.   +..|+
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            46789999999999884  34688898775  3221  1223567889999999974 34578888888766   45899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS---------------------------------------  218 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~---------------------------------------  218 (363)
                      ||||++|..+.+..  ...++......++.+++.+|..||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999988774321  2246788889999999999999997                                       


Q ss_pred             -------------------CCcEecCCCCCceEeeeCCCC--ccEEEeecCcceec
Q 017960          219 -------------------LGVMHRDLKPENFLLVNKDDD--FSLKAIDFGLSVFF  253 (363)
Q Consensus       219 -------------------~~iiHrDlkp~NIll~~~~~~--~~~kl~DFG~a~~~  253 (363)
                                         ..++|+|++|.|||+   +.+  ..+.|+||+.+...
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~---~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMF---HPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEE---CSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEE---eCCCCcEEEEECccccccC
Confidence                               369999999999999   443  34689999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.33  E-value=5.4e-12  Score=114.72  Aligned_cols=185  Identities=16%  Similarity=0.199  Sum_probs=124.2

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCc--eeEEeEEEecCC---eEEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKN--IVTIKGAYEDSL---CVHIV  178 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~n--iv~~~~~~~~~~---~~~iv  178 (363)
                      .+.++.|....||++.     ..+++|+...     ......+.+|..+|+.+..+..  +..++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            3568999999999864     4688997642     2445788999999999853433  445555443333   35889


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS----------------------------------------  218 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~----------------------------------------  218 (363)
                      ||+++|.+|.+...  ..++..+...++.+++..|..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988865433  246777888888888888888885                                        


Q ss_pred             ------------------CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccCccCCccccccccc---cc
Q 017960          219 ------------------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL---KH  277 (363)
Q Consensus       219 ------------------~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~  277 (363)
                                        ..++|+|++|.||++..+ +...+.|+||+.+....+............-..|+...   ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                              137999999999999421 15678899999987653321111111000002333221   22


Q ss_pred             CCC------------cccHHHHHHHHHHHHhCCCCC
Q 017960          278 YGP------------EADVWTAGVILYILLSGVPPF  301 (363)
Q Consensus       278 ~~~------------~~Di~slG~il~ell~g~~pf  301 (363)
                      |..            ..+.|+++.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222            258999999999999999887

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.93  E-value=2.4e-08  Score=90.64  Aligned_cols=139  Identities=18%  Similarity=0.223  Sum_probs=95.0

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC--ceeEEeEEEe-cCCeEEEEEe
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK--NIVTIKGAYE-DSLCVHIVME  180 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~--niv~~~~~~~-~~~~~~iv~e  180 (363)
                      .+.++.|....||+.     +..+++|+-.     .......+.+|..+|+.|..+-  .+.+++.+.. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            356888999999987     5678898742     2344578899999999998442  3566666664 4556789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL-----------------------------------------  219 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-----------------------------------------  219 (363)
                      +++|.++.+...  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988865321  1234445555555555555555432                                         


Q ss_pred             -------------------CcEecCCCCCceEeeeCCCCcc-EEEeecCcceecC
Q 017960          220 -------------------GVMHRDLKPENFLLVNKDDDFS-LKAIDFGLSVFFK  254 (363)
Q Consensus       220 -------------------~iiHrDlkp~NIll~~~~~~~~-~kl~DFG~a~~~~  254 (363)
                                         .++|+|++|.||++...+.++. +.|+||+.+....
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                               3599999999999942111344 5899999887643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.92  E-value=2.9e-08  Score=88.21  Aligned_cols=134  Identities=19%  Similarity=0.200  Sum_probs=96.3

Q ss_pred             ecccCCe-EEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCC
Q 017960          107 LGQGQFG-TTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGG  185 (363)
Q Consensus       107 lG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~  185 (363)
                      +..|..| .||+......+..+++|+-..      .....+.+|...|+.|..+--+.+++.++.+.+..++|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            4445444 699988767778899998643      234578899999999986656888999999999999999999998


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 017960          186 ELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL----------------------------------------------  219 (363)
Q Consensus       186 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~----------------------------------------------  219 (363)
                      ++.+.....    ......+..++...|..||..                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            776654321    122233444444444444421                                              


Q ss_pred             ------------CcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          220 ------------GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       220 ------------~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                                  .++|+|+.|.||++   ++++.+-|+||+.+...
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECcccccC
Confidence                        27899999999999   66666779999988753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.67  E-value=1.2e-07  Score=89.18  Aligned_cols=80  Identities=13%  Similarity=0.101  Sum_probs=51.3

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeecccc-CC---hhhHHHHHHHHHHHHHhcCC-C-ceeEEeEEEecCCeEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-IS---REDVEDVRREIQIMHHLAGH-K-NIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~i  177 (363)
                      .+.||.|..+.||++.....++.++||....... ..   .....++..|..+++.+..+ + .+++++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4579999999999997656678899998653211 00   11235677899999988643 3 34456543  3344689


Q ss_pred             EEeccCCC
Q 017960          178 VMELCAGG  185 (363)
Q Consensus       178 v~e~~~~~  185 (363)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.55  E-value=7.5e-08  Score=89.16  Aligned_cols=84  Identities=6%  Similarity=0.032  Sum_probs=55.7

Q ss_pred             ccee-cccCCeEEEEEEEc--c----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC--CceeEEeEEEecC--
Q 017960          104 GRKL-GQGQFGTTYLCTEI--A----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDS--  172 (363)
Q Consensus       104 ~~~l-G~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~--  172 (363)
                      .+.| +.|....+|++...  .    ++..+++|+..............+.+|+.+++.|..+  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88999999988743  1    2567899976532200000113567888899888744  3577788876654  


Q ss_pred             -CeEEEEEeccCCCCh
Q 017960          173 -LCVHIVMELCAGGEL  187 (363)
Q Consensus       173 -~~~~iv~e~~~~~~L  187 (363)
                       +..++|||+++|..+
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence             356899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.40  E-value=5.8e-06  Score=75.57  Aligned_cols=136  Identities=15%  Similarity=0.109  Sum_probs=78.3

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeE------EEecCCeEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKG------AYEDSLCVHI  177 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~------~~~~~~~~~i  177 (363)
                      +.|+.|..+.||++.. . +..+++|+....    .   ..+..|..+++.|..+ -.+++++.      +....+..++
T Consensus        38 ~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~  108 (346)
T 2q83_A           38 DVIQGNQMALVWKVHT-D-SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV  108 (346)
T ss_dssp             EECC----CEEEEEEE-T-TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred             eeccccccCcEEEEEe-C-CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence            4567778899999874 3 345899988642    1   3344566666666521 12344443      1234667899


Q ss_pred             EEeccCCCChH--------------HHHHh-cCCC-------------CHHH----------------------------
Q 017960          178 VMELCAGGELF--------------DRIIQ-RGHY-------------SERK----------------------------  201 (363)
Q Consensus       178 v~e~~~~~~L~--------------~~l~~-~~~~-------------~~~~----------------------------  201 (363)
                      +|||++|..+.              ..++. ...+             .+..                            
T Consensus       109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  188 (346)
T 2q83_A          109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY  188 (346)
T ss_dssp             EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred             EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence            99999986531              11121 1111             1100                            


Q ss_pred             ---HHHHHHHHHHHHHHHH-------------hCCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          202 ---AAELTRIIVGVVEACH-------------SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       202 ---~~~i~~~l~~~l~~lH-------------~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                         +..+..++..++.+|+             ...++|+|+++.|||+   +.++.+.|+||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLL---GENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEE---CGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEE---eCCCcEEEEehhhccc
Confidence               1111122334555664             3579999999999999   6567899999998865

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.32  E-value=5.4e-06  Score=78.49  Aligned_cols=77  Identities=9%  Similarity=0.042  Sum_probs=45.7

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeecccc-CChh-----hHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKL-ISRE-----DVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .+.||.|..+.||++.  .++..++||....... ....     ....+..|+..+..-.....+++++.+.  ....++
T Consensus        39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            4578999999999996  3567899995432111 0110     1223333333322211135677777665  456789


Q ss_pred             EEecc-CC
Q 017960          178 VMELC-AG  184 (363)
Q Consensus       178 v~e~~-~~  184 (363)
                      ||||+ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.26  E-value=9e-06  Score=73.67  Aligned_cols=76  Identities=16%  Similarity=0.097  Sum_probs=61.0

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC--CceeEEeEEEecCCeEEEEEec
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHIVMEL  181 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~iv~e~  181 (363)
                      .+.|+.|....+|+..  .++..+++|+....      ....+..|...|+.|..+  ..+++++.+....+..++||||
T Consensus        41 ~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIN--DEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             EEEECCSSSSEEEEEE--SSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eEEeCCccceeeeEEE--ECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            4678999999999988  35678999987532      256788999999988643  5688898888888899999999


Q ss_pred             cCCCCh
Q 017960          182 CAGGEL  187 (363)
Q Consensus       182 ~~~~~L  187 (363)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.03  E-value=2e-05  Score=70.88  Aligned_cols=72  Identities=8%  Similarity=-0.062  Sum_probs=45.9

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEecc-
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC-  182 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~-  182 (363)
                      .+.|+.|....+|++      ..+++|+.....   .. .....+|+.+++.+..+.-..+++....+  .-++++||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCc---cc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecC
Confidence            567889999999998      568999875421   11 11234588888877644333566654332  346899999 


Q ss_pred             CCCCh
Q 017960          183 AGGEL  187 (363)
Q Consensus       183 ~~~~L  187 (363)
                      +|.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.91  E-value=2.2e-05  Score=71.23  Aligned_cols=139  Identities=19%  Similarity=0.129  Sum_probs=78.6

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEeEE------EecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGA------YEDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~------~~~~~~~~  176 (363)
                      .+.|+.|....||++.. .++ .+++|+.....     ....+..|+.++..|..+. .+.+++..      ....+..+
T Consensus        27 ~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            45688888899999874 334 68899886421     1234567888888876331 13334321      12345678


Q ss_pred             EEEeccCCCChH----H----------HHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHh
Q 017960          177 IVMELCAGGELF----D----------RIIQR-GHY--------SERKAAEL---------------TRIIVGVVEACHS  218 (363)
Q Consensus       177 iv~e~~~~~~L~----~----------~l~~~-~~~--------~~~~~~~i---------------~~~l~~~l~~lH~  218 (363)
                      ++|+|++|..+.    .          .++.. ..+        ........               ...+...+..+++
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999886531    0          11211 011        11111110               0113344555542


Q ss_pred             -------CCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          219 -------LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       219 -------~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                             .+++|+|+++.|||+   +++..+.|+||+.+..
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~---~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFF---LGDELSGLIDFYFACN  217 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             hCcccCCcccCCCCCCccCEEE---eCCceEEEecchhccC
Confidence                   369999999999999   5555568999998865

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.85  E-value=3.7e-05  Score=71.55  Aligned_cols=142  Identities=15%  Similarity=0.129  Sum_probs=83.9

Q ss_pred             cceecccCCeEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      .+.|..|-...+|++....       ++..+++|+....    ........+|..+++.|..+.-..++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            3567778888999988532       3578999986431    11244566899999998855555677776654    2


Q ss_pred             EEEeccCCCChH--------------HHH---Hhc----C-CC--CHHHHHHHHHHHHH-------------------HH
Q 017960          177 IVMELCAGGELF--------------DRI---IQR----G-HY--SERKAAELTRIIVG-------------------VV  213 (363)
Q Consensus       177 iv~e~~~~~~L~--------------~~l---~~~----~-~~--~~~~~~~i~~~l~~-------------------~l  213 (363)
                      +||||++|..|.              +.|   +..    + ..  -+.++..+..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            899999875442              111   111    0 11  13455555544422                   22


Q ss_pred             HHHH----h----CCcEecCCCCCceEeeeC-CCCccEEEeecCcceec
Q 017960          214 EACH----S----LGVMHRDLKPENFLLVNK-DDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       214 ~~lH----~----~~iiHrDlkp~NIll~~~-~~~~~~kl~DFG~a~~~  253 (363)
                      ..|.    .    ..++|+|+.+.||++..+ +..+.+.|+||..+...
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence            3332    2    259999999999999532 12368999999988753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.82  E-value=6.5e-05  Score=68.54  Aligned_cols=138  Identities=12%  Similarity=0.076  Sum_probs=72.9

Q ss_pred             ceecccCCeE-EEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEeEEEecCCeEEEEEecc
Q 017960          105 RKLGQGQFGT-TYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       105 ~~lG~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      +.|+.|+... +|+... .++..+++|......      ...+..|+.+++.|..+. .+++++.+..+.+  +++||++
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l   94 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL   94 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence            4566665554 667652 236677777654321      023456777777776432 3556666543333  6899999


Q ss_pred             CCCChHHHHHhc--------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHH
Q 017960          183 AGGELFDRIIQR--------------------------GHYSERKAA-------E-L------------TRIIVGVVEAC  216 (363)
Q Consensus       183 ~~~~L~~~l~~~--------------------------~~~~~~~~~-------~-i------------~~~l~~~l~~l  216 (363)
                      .+..+.+.+...                          ..+......       . +            ...+..++..+
T Consensus        95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l  174 (333)
T 3csv_A           95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI  174 (333)
T ss_dssp             CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred             CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence            766665433211                          011111110       0 0            01111222223


Q ss_pred             ------HhCCcEecCCCCCceEeeeCCCC----ccEEEeecCcceecC
Q 017960          217 ------HSLGVMHRDLKPENFLLVNKDDD----FSLKAIDFGLSVFFK  254 (363)
Q Consensus       217 ------H~~~iiHrDlkp~NIll~~~~~~----~~~kl~DFG~a~~~~  254 (363)
                            +...++|+|+.+.||++   +.+    ..+.|+||+.+....
T Consensus       175 ~~~~~~~~~~lvHgD~~~~Nil~---~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          175 LSAQLEGDMVFVHRDFHAQNLLW---LPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HHHHCCSCCEEECSCCSGGGEEE---CTTSCGGGGEEECCCTTCEEEC
T ss_pred             HHhcccCCCeeEeCCcCcccEEe---ccCcCCCCCeEEEeCCCcCcCC
Confidence                  23469999999999999   432    679999999987754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.82  E-value=0.00011  Score=66.78  Aligned_cols=76  Identities=12%  Similarity=0.110  Sum_probs=49.0

Q ss_pred             ceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEeEE-----EecCCeEEEE
Q 017960          105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKGA-----YEDSLCVHIV  178 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~-----~~~~~~~~iv  178 (363)
                      ..|+ |....||++.. .+|+.+++|+.....    .....+..|..++..|..+. .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            3566 88889998763 456689999886321    12346677888888886331 24444442     1224567889


Q ss_pred             EeccCCCC
Q 017960          179 MELCAGGE  186 (363)
Q Consensus       179 ~e~~~~~~  186 (363)
                      |++++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998744

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.81  E-value=0.00016  Score=64.45  Aligned_cols=79  Identities=14%  Similarity=0.072  Sum_probs=55.2

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC--CceeEEeEEEecCCeEEEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~iv  178 (363)
                      ..-.+.+|.|..+.||++. ..+|+.|++|+......   .....+..|...|+.|...  --+++++++.  .  -++|
T Consensus        17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv   88 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA   88 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred             eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence            4456789999999999998 47889999997653321   1224578899999998633  2345555542  2  3689


Q ss_pred             EeccCCCCh
Q 017960          179 MELCAGGEL  187 (363)
Q Consensus       179 ~e~~~~~~L  187 (363)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.80  E-value=5.5e-05  Score=71.71  Aligned_cols=74  Identities=11%  Similarity=0.084  Sum_probs=50.9

Q ss_pred             cceecccCCeEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      .+.|+.|....||++....       .+..+++|+.....  .   ...+.+|..+++.|..+.-.+++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            4568889899999998532       35789999884311  1   13455799999998755444677776543    3


Q ss_pred             EEEeccCCCC
Q 017960          177 IVMELCAGGE  186 (363)
Q Consensus       177 iv~e~~~~~~  186 (363)
                      +||||++|.+
T Consensus       149 ~v~e~l~G~~  158 (429)
T 1nw1_A          149 RLEEYIPSRP  158 (429)
T ss_dssp             EEECCCCEEE
T ss_pred             EEEEEeCCcc
Confidence            8999998643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.76  E-value=0.00027  Score=59.67  Aligned_cols=135  Identities=16%  Similarity=0.064  Sum_probs=90.0

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCccccC
Q 017960          185 GELFDRIIQ-RGHYSERKAAELTRIIVGVVEACH-SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDV  262 (363)
Q Consensus       185 ~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH-~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~  262 (363)
                      .+|.+.|.. ..++++++++.++.|.+.+|.-+- ...-..+=+.|..|++   ..+|.|-+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------
Confidence            478888875 467999999999999999987762 1111233445688888   6777776653 1110           


Q ss_pred             ccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhccc
Q 017960          263 VGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCS  342 (363)
Q Consensus       263 ~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~  342 (363)
                      .....+.|||......+.+.=|||||+++|.-+--..|                     ...-+.+|+.+..||..|..-
T Consensus        98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence            11335678888765567788999999999998863333                     111236899999999999866


Q ss_pred             C-------------------------cCCCCCHHHHhc
Q 017960          343 Q-------------------------PSERLTAHEVLC  355 (363)
Q Consensus       343 d-------------------------p~~R~s~~evL~  355 (363)
                      +                         +..|++.++|++
T Consensus       157 ~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          157 VEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             CC--------------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            2                         457899999986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.67  E-value=0.00013  Score=67.65  Aligned_cols=75  Identities=8%  Similarity=0.073  Sum_probs=45.3

Q ss_pred             cceecccCCeEEEEEEEcc--------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960          104 GRKLGQGQFGTTYLCTEIA--------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.|+.|....+|++....        .+..+++|+.....    ........|..+++.|..+.-++++++.+  .  -
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence            3568888889999988543        13688999875421    11112357888888887443355676654  2  2


Q ss_pred             EEEEeccCCCC
Q 017960          176 HIVMELCAGGE  186 (363)
Q Consensus       176 ~iv~e~~~~~~  186 (363)
                      ++||||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.55  E-value=0.0009  Score=61.20  Aligned_cols=69  Identities=12%  Similarity=0.024  Sum_probs=44.1

Q ss_pred             cccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC--CceeEEeEE------EecCCeEEEEE
Q 017960          108 GQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH--KNIVTIKGA------YEDSLCVHIVM  179 (363)
Q Consensus       108 G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~------~~~~~~~~iv~  179 (363)
                      |.|....||++.. .+| .+++|+......         ..|+.++..|..+  |.+++++..      ....+..+++|
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~  100 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY  100 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence            4444689999873 445 899998764321         3566667666522  334555432      23356789999


Q ss_pred             eccCCCCh
Q 017960          180 ELCAGGEL  187 (363)
Q Consensus       180 e~~~~~~L  187 (363)
                      +|++|..+
T Consensus       101 ~~i~G~~~  108 (339)
T 3i1a_A          101 PFIHAPNG  108 (339)
T ss_dssp             ECCCCCBT
T ss_pred             eccCCCcC
Confidence            99988655

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.50  E-value=0.00073  Score=64.42  Aligned_cols=76  Identities=13%  Similarity=0.093  Sum_probs=49.2

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccC
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCA  183 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~  183 (363)
                      .+.|+.|-...+|++.....+..+++|+.....   .... .-.+|..++..|..+.-.+++++.+.  +  .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            456888989999999854435789999875321   1111 12579999999985544567777763  2  25999998


Q ss_pred             CCCh
Q 017960          184 GGEL  187 (363)
Q Consensus       184 ~~~L  187 (363)
                      |.+|
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.83  E-value=0.0024  Score=60.19  Aligned_cols=75  Identities=11%  Similarity=0.134  Sum_probs=49.3

Q ss_pred             cceecccCCeEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ++.|..|....+|++....       .+..+++++.....   .. .-...+|..+++.|..+.-..++++.+.  +  +
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--G  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence            4567778889999988542       15789999864321   11 1123568888888875544566666442  2  6


Q ss_pred             EEEeccCCCC
Q 017960          177 IVMELCAGGE  186 (363)
Q Consensus       177 iv~e~~~~~~  186 (363)
                      +||||++|..
T Consensus       147 ~I~efI~G~~  156 (424)
T 3mes_A          147 RIEEFIDGEP  156 (424)
T ss_dssp             EEEECCCSEE
T ss_pred             EEEEEeCCcc
Confidence            8999998865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.11  E-value=0.027  Score=52.53  Aligned_cols=33  Identities=30%  Similarity=0.465  Sum_probs=26.9

Q ss_pred             cEecCCCCCceEeee---CCCCccEEEeecCcceec
Q 017960          221 VMHRDLKPENFLLVN---KDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       221 iiHrDlkp~NIll~~---~~~~~~~kl~DFG~a~~~  253 (363)
                      ++|+|+.+.|||+..   ++++..+.++||..|...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            689999999999953   235668999999988764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.59  E-value=0.023  Score=54.11  Aligned_cols=63  Identities=10%  Similarity=0.067  Sum_probs=17.8

Q ss_pred             ecceecccCCeEEEEEEEccCCcEEEE------EEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960          103 LGRKLGQGQFGTTYLCTEIATGIEFAC------KSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus       103 ~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      +.+.||   ||.||+|....+..+||+      |...... ...+....+.+|..+++.+. |||+++.+++-.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~-H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQ-IPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCcccccccc-cccccccccccccccccccc-ccccCCCcceEE
Confidence            355676   999999997666678888      6554322 23344556788888888887 999999988653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.37  E-value=3.1  Score=34.81  Aligned_cols=122  Identities=12%  Similarity=0.092  Sum_probs=79.0

Q ss_pred             HHHHHHHhcCCCceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCC
Q 017960          149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKP  228 (363)
Q Consensus       149 E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp  228 (363)
                      |+.+|..  .||+++.. .+-.+.+.+.+.++.-+.+-=+..+   ..++....+.++..|+....+  ...=+|-=|.|
T Consensus        36 el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~P  107 (215)
T 4ann_A           36 LMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEV--NRTRYTFVLAP  107 (215)
T ss_dssp             GGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGG--GGSSEECCCSG
T ss_pred             HHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHH--hcCceEEEEec
Confidence            4555543  48988876 5566677777777765433222223   346788999999999887643  34457888999


Q ss_pred             CceEeeeCCCCccEEEeecCcceecCCCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCC
Q 017960          229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPF  301 (363)
Q Consensus       229 ~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf  301 (363)
                      +||++   +.++.+++.--|+-....+..                    ++...=.-.+=|++..+++++..|
T Consensus       108 ~NL~f---~~~~~p~i~~RGik~~l~P~~--------------------~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          108 DELFF---TRDGLPIAKTRGLQNVVDPLP--------------------VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GGEEE---CTTSCEEESCCEETTTBSCCC--------------------CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             ceEEE---cCCCCEEEEEccCccCCCCCC--------------------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999   899999999888654332211                    011112224456777778777776

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.30  E-value=4.3  Score=34.06  Aligned_cols=86  Identities=15%  Similarity=0.086  Sum_probs=63.1

Q ss_pred             CCCceeEEeEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC
Q 017960          158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD  237 (363)
Q Consensus       158 ~h~niv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~  237 (363)
                      .||++  -...-.+.+.+.+.++.-+++.-+..+   ..++....++++.+|+.... -|...-+|-=|.|+||++   +
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f---~  118 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMF---N  118 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEE---C
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEE---e
Confidence            47888  344457778888888876554444445   34688999999999988654 133556788899999999   8


Q ss_pred             CCccEEEeecCccee
Q 017960          238 DDFSLKAIDFGLSVF  252 (363)
Q Consensus       238 ~~~~~kl~DFG~a~~  252 (363)
                      .++.++|.-.|+-..
T Consensus       119 ~~~~p~i~hRGi~~~  133 (219)
T 4ano_A          119 RALEPFFLHVGVKES  133 (219)
T ss_dssp             TTCCEEESCCEETTT
T ss_pred             CCCcEEEEEcCCccc
Confidence            899999998886543

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=83.64  E-value=24  Score=34.32  Aligned_cols=81  Identities=23%  Similarity=0.249  Sum_probs=49.9

Q ss_pred             eEEeEEEecCCeEEEEEeccCCCChHHHHHhcCC-----------------CCHHHHHHHHHHHHH--HHHHHHhCCcEe
Q 017960          163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-----------------YSERKAAELTRIIVG--VVEACHSLGVMH  223 (363)
Q Consensus       163 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~i~~~l~~--~l~~lH~~~iiH  223 (363)
                      +..+.+........+ +|++++.++.+.+...+.                 ..+.....+++.++.  .+.|+  .||  
T Consensus       402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI--LGi--  476 (614)
T 3ls8_A          402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYI--LGV--  476 (614)
T ss_dssp             CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred             eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhhee--eec--
Confidence            445566655555555 477776555554432211                 113345555555543  34444  333  


Q ss_pred             cCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          224 RDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       224 rDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      +|=.++|||+   +.+|++.=+|||.+-
T Consensus       477 gDRH~~NILl---d~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          477 GDRHLDNLLL---TKTGKLFHIDFGYIL  501 (614)
T ss_dssp             CCCCTTSEEE---CTTSCEEECCCSSCT
T ss_pred             cCCCCcceeE---cCCCCEeeeehHHhh
Confidence            5889999999   789999999999874

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=81.13  E-value=28  Score=34.49  Aligned_cols=81  Identities=23%  Similarity=0.301  Sum_probs=47.6

Q ss_pred             eEEeEEEecCCeEEEEEeccCCCChHHHHHhcCC---------------C--CHHHHHHHHHHHHH--HHHHHHhCCcEe
Q 017960          163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---------------Y--SERKAAELTRIIVG--VVEACHSLGVMH  223 (363)
Q Consensus       163 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~---------------~--~~~~~~~i~~~l~~--~l~~lH~~~iiH  223 (363)
                      +..+.+........+| |+++..+|.+.+...+.               +  .......+++.++.  .+.|+  .||  
T Consensus       476 i~~Y~Vipls~~~GLI-E~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YI--LGl--  550 (696)
T 2x6h_A          476 LTPYKVLATSSKHGFL-QYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYL--LGV--  550 (696)
T ss_dssp             CCCCCEEESSTTCEEE-ECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred             EeccEEEeccCCCCee-eeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHH--ccC--
Confidence            3344555444444444 66665555555433221               1  12334455555543  34444  233  


Q ss_pred             cCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          224 RDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       224 rDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      +|-.++||||   +.+|++.=+|||.+-
T Consensus       551 GDRH~~NILi---d~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLL---TTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEE---CTTSCEEECCCCSCT
T ss_pred             CCCCCcceEE---eCCCCEEEEeehhhh
Confidence            6999999999   779999999999874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	363
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-84
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-81
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-80
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-80
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-79
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-78
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-78
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-75
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-74
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-74
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-72
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-71
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-69
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-68
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-66
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-66
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-65
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-63
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-59
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-59
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-59
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-58
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-58
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-57
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-57
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-55
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-55
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-55
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-54
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-52
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-52
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-51
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	2e-04

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  256 bits (656), Expect = 2e-84
 Identities = 107/263 (40%), Positives = 153/263 (58%), Gaps = 4/263 (1%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           + ++IRD+Y     LG G F    L  +  T    A K I+K+ L  +E    +  EI +
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAV 60

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H +  H NIV +   YE    ++++M+L +GGELFDRI+++G Y+ER A+ L   ++  
Sbjct: 61  LHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           V+  H LG++HRDLKPEN L  + D+D  +   DFGLS    PG + +   G+P YVAPE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           VL  K Y    D W+ GVI YILL G PPF+ E    +F+ +LK   +F+S  W  ISDS
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 332 AKDLIRKMLCSQPSERLTAHEVL 354
           AKD IR ++   P +R T  + L
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQAL 262

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  248 bits (634), Expect = 1e-81
 Identities = 97/267 (36%), Positives = 142/267 (53%), Gaps = 16/267 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS------REDVEDVRREIQIMH 154
           Y     LG+G       C    T  E+A K I      S      +E  E   +E+ I+ 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            ++GH NI+ +K  YE +    +V +L   GELFD + ++   SE++  ++ R ++ V+ 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           A H L ++HRDLKPEN LL   DDD ++K  DFG S    PG+   +V G+P Y+APE++
Sbjct: 125 ALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 275 L-------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
                     YG E D+W+ GVI+Y LL+G PPFW   Q  +   ++ G+  F S  W  
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            SD+ KDL+ + L  QP +R TA E L
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEAL 268

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  248 bits (633), Expect = 2e-80
 Identities = 94/264 (35%), Positives = 134/264 (50%), Gaps = 7/264 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D++ D Y +  +LG G FG  +  TE ATG  FA K +         D E VR+EIQ 
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQT 76

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVG 211
           M  L  H  +V +  A+ED   + ++ E  +GGELF+++  +    SE +A E  R +  
Sbjct: 77  MSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            +   H    +H DLKPEN +   K  +  LK IDFGL+    P Q      G+  + AP
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           EV   K  G   D+W+ GV+ YILLSG+ PF  E        V     + +   +  IS+
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             KD IRK+L + P+ R+T H+ L
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQAL 278

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  247 bits (632), Expect = 3e-80
 Identities = 85/264 (32%), Positives = 134/264 (50%), Gaps = 7/264 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K  ++ D Y +  +LG G FG  + C E ATG  F  K I+    + +  V   + EI I
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISI 79

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVG 211
           M+ L  H  ++ +  A+ED   + +++E  +GGELFDRI    +  SE +     R    
Sbjct: 80  MNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 138

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            ++  H   ++H D+KPEN +        S+K IDFGL+    P +I      +  + AP
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           E++  +  G   D+W  GV+ Y+LLSG+ PF  E        V +   +F+ D +  +S 
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
            AKD I+ +L  +P +RLT H+ L
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDAL 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (617), Expect = 2e-79
 Identities = 80/255 (31%), Positives = 131/255 (51%), Gaps = 10/255 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + +GR LG+G+FG  YL  E  +    A K + K +L        +RRE++I  HL  H 
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHP 66

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NI+ + G + D+  V++++E    G ++  + +   + E++ A     +   +  CHS  
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           V+HRD+KPEN LL        LK  DFG SV     +  T + G+  Y+ PE++  + + 
Sbjct: 127 VIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMHD 182

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
            + D+W+ GV+ Y  L G PPF A T Q  +  + +    F       +++ A+DLI ++
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISRL 238

Query: 340 LCSQPSERLTAHEVL 354
           L   PS+R    EVL
Sbjct: 239 LKHNPSQRPMLREVL 253

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 2e-78
 Identities = 101/267 (37%), Positives = 156/267 (58%), Gaps = 6/267 (2%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED---VEDVRRE 149
           + +N+ D Y  G +LG GQF     C E +TG+++A K I KR+  S       ED+ RE
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 150 IQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
           + I+  +  H N++T+   YE+   V +++EL AGGELFD + ++   +E +A E  + I
Sbjct: 64  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDD-DFSLKAIDFGLSVFFKPGQIFTDVVGSPYY 268
           +  V   HSL + H DLKPEN +L++++     +K IDFGL+     G  F ++ G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           VAPE++  +  G EAD+W+ GVI YILLSG  PF  +T+Q     V   + +FE + +  
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            S  AKD IR++L   P +R+T  + L
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSL 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 9e-78
 Identities = 84/258 (32%), Positives = 126/258 (48%), Gaps = 12/258 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +  G+ LG+G F T  L  E+AT  E+A K + KR +I    V  V RE  +M  L  H 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 68

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             V +   ++D   ++  +     GEL   I + G + E      T  IV  +E  H  G
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-K 276
           ++HRDLKPEN LL   ++D  ++  DFG +    P          VG+  YV+PE+L  K
Sbjct: 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
                +D+W  G I+Y L++G+PPF A  +  IF  ++K   DF           A+DL+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FFPKARDLV 241

Query: 337 RKMLCSQPSERLTAHEVL 354
            K+L    ++RL   E+ 
Sbjct: 242 EKLLVLDATKRLGCEEME 259

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (609), Expect = 3e-77
 Identities = 72/260 (27%), Positives = 131/260 (50%), Gaps = 8/260 (3%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + + Y +   LG+G+FG  + C E ++   +  K +  +      D   V++EI I++  
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA 58

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEA 215
             H+NI+ +  ++E    + ++ E  +G ++F+RI       +ER+       +   ++ 
Sbjct: 59  -RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL 275
            HS  + H D++PEN +        ++K I+FG +   KPG  F  +  +P Y APEV  
Sbjct: 118 LHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 276 -KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD 334
                   D+W+ G ++Y+LLSG+ PF AET Q I + ++     F+ + +  IS  A D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 335 LIRKMLCSQPSERLTAHEVL 354
            + ++L  +   R+TA E L
Sbjct: 237 FVDRLLVKERKSRMTASEAL 256

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  236 bits (602), Expect = 2e-76
 Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 13/264 (4%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           D+   L++  R++G G FG  Y   ++      A K +S     S E  +D+ +E++ + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  H N +  +G Y       +VME C G       + +    E + A +T   +  + 
Sbjct: 71  KLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
             HS  ++HRD+K  N LL    +   +K  DFG +    P       VG+PY++APEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVI 183

Query: 275 L----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
           L      Y  + DVW+ G+    L    PP +          + +   +  +      S+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSE 241

Query: 331 SAKDLIRKMLCSQPSERLTAHEVL 354
             ++ +   L   P +R T+  +L
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLL 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 1e-75
 Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 16/271 (5%)

Query: 92  HKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
            +  N  D + +  +LG G FG  Y      T +  A K I  +   S E++ED   EI 
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEID 61

Query: 152 IMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIV 210
           I+     H NIV +  A+     + I++E CAGG +   +++     +E +   + +  +
Sbjct: 62  ILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 211 GVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYV 269
             +   H   ++HRDLK  N L      D  +K  DFG+S    +  Q     +G+PY++
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177

Query: 270 APEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD 323
           APEV++      + Y  +ADVW+ G+ L  +    PP        +   + K      + 
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237

Query: 324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           P    S + KD ++K L      R T  ++L
Sbjct: 238 P-SRWSSNFKDFLKKCLEKNVDARWTTSQLL 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 6e-74
 Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 12/259 (4%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G +G   L     T    A K +  ++  + +  E++++EI I   L  H+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKML-NHE 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           N+V   G   +    ++ +E C+GGELFDRI       E  A      ++  V   H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEVLL-- 275
           + HRD+KPEN LL   D+  +LK  DFGL+  F+     ++   + G+  YVAPE+L   
Sbjct: 124 ITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 276 KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
           + +    DVW+ G++L  +L+G  P+   +      +  K    +  +PW  I  +   L
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL-NPWKKIDSAPLAL 239

Query: 336 IRKMLCSQPSERLTAHEVL 354
           + K+L   PS R+T  ++ 
Sbjct: 240 LHKILVENPSARITIPDIK 258

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 8e-74
 Identities = 77/262 (29%), Positives = 126/262 (48%), Gaps = 11/262 (4%)

Query: 95  DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
            + +  YT   K+GQG  GT Y   ++ATG E A + ++ ++   +   E +  EI +M 
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMR 72

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
               + NIV    +Y     + +VME  AGG L D ++      E + A + R  +  +E
Sbjct: 73  EN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALE 130

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK-PGQIFTDVVGSPYYVAPEV 273
             HS  V+HRD+K +N LL     D S+K  DFG            + +VG+PY++APEV
Sbjct: 131 FLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 274 LL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
           +  K YGP+ D+W+ G++   ++ G PP+  E        +       E      +S   
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIF 246

Query: 333 KDLIRKMLCSQPSERLTAHEVL 354
           +D + + L     +R +A E+L
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELL 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 9e-72
 Identities = 93/274 (33%), Positives = 138/274 (50%), Gaps = 20/274 (7%)

Query: 93  KTDNIRDLYT-LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQ 151
           K + I D Y    + LG G  G         T  +FA K +              RRE++
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 56

Query: 152 IMHHLAGHKNIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGH--YSERKAAEL 205
           +    +   +IV I   YE+      C+ IVME   GGELF RI  RG   ++ER+A+E+
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 206 TRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGS 265
            + I   ++  HS+ + HRD+KPEN L  +K  +  LK  DFG +         T    +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 266 PYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWA----ETQQGIFDAVLKGHIDF 320
           PYYVAPEVL  + Y    D+W+ GVI+YILL G PPF++        G+   +  G  +F
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
            +  W  +S+  K LIR +L ++P++R+T  E +
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 9e-71
 Identities = 59/261 (22%), Positives = 112/261 (42%), Gaps = 14/261 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
                ++G+G F T Y   +  T +E A   +  RKL ++ + +  + E +++  L  H 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HP 68

Query: 161 NIVTIKGAYEDSL----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
           NIV    ++E ++    C+ +V EL   G L   + +      +      R I+  ++  
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128

Query: 217 HSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
           H+    ++HRDLK +N  +       S+K  D GL+   K       V+G+P ++APE+ 
Sbjct: 129 HTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY 185

Query: 275 LKHYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            + Y    DV+  G+ +  + +   P+   +    I+  V  G      D         K
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV--AIPEVK 243

Query: 334 DLIRKMLCSQPSERLTAHEVL 354
           ++I   +     ER +  ++L
Sbjct: 244 EIIEGCIRQNKDERYSIKDLL 264

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 2e-69
 Identities = 70/256 (27%), Positives = 120/256 (46%), Gaps = 9/256 (3%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + L + LG+G FG  +L     T   FA K++ K  ++  +DVE    E +++     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +   ++    +  VME   GG+L   I     +   +A      I+  ++  HS G
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIFTDVVGSPYYVAPEVLL-KHY 278
           +++RDLK +N L    D D  +K  DFG+      G        G+P Y+APE+LL + Y
Sbjct: 124 IVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
               D W+ GV+LY +L G  PF  + ++ +F ++   +  +       +   AKDL+ K
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVK 236

Query: 339 MLCSQPSERLTAHEVL 354
           +   +P +RL     +
Sbjct: 237 LFVREPEKRLGVRGDI 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  216 bits (550), Expect = 4e-69
 Identities = 61/266 (22%), Positives = 104/266 (39%), Gaps = 8/266 (3%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++ D Y LG  LG G     +L  ++    + A K +              RRE Q    
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 156 LAGHKNIVTIKGAYED----SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           L  H  IV +    E         +IVME   G  L D +   G  + ++A E+      
Sbjct: 64  L-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG-LSVFFKPGQIFTDVVGSPYYVA 270
            +   H  G++HRD+KP N ++   +    +       ++           V+G+  Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           PE          +DV++ G +LY +L+G PPF  ++   +    ++      S     +S
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

Query: 330 DSAKDLIRKMLCSQPSERL-TAHEVL 354
                ++ K L   P  R  TA E+ 
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMR 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 7e-68
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 21/267 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +   +G G +G        + G     K +     ++  + + +  E+ ++  L  H 
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK-HP 63

Query: 161 NIVTIKGAYEDSL--CVHIVMELCAGGELFDRII----QRGHYSERKAAELTRIIVGVVE 214
           NIV       D     ++IVME C GG+L   I     +R +  E     +   +   ++
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 215 ACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF-TDVVGSPYY 268
            CH        V+HRDLKP N  L   D   ++K  DFGL+        F    VG+PYY
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           ++PE +    Y  ++D+W+ G +LY L + +PPF A +Q+ +   + +G           
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYR 237

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVL 354
            SD   ++I +ML  +   R +  E+L
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (537), Expect = 5e-67
 Identities = 61/269 (22%), Positives = 115/269 (42%), Gaps = 19/269 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T+G+++G G FGT Y         + A K ++     + + ++  + E+ ++    
Sbjct: 7   DGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTR 62

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEAC 216
            H NI+   G Y  +  + IV + C G  L+  + I    +   K  ++ R     ++  
Sbjct: 63  -HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG---QIFTDVVGSPYYVAPEV 273
           H+  ++HRDLK  N  L    +D ++K  DFGL+           F  + GS  ++APEV
Sbjct: 121 HAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 274 LL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE--SDPWPL 327
           +       Y  ++DV+  G++LY L++G  P+     +     ++         S     
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
              + K L+ + L  +  ER    ++L  
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 2e-66
 Identities = 64/304 (21%), Positives = 112/304 (36%), Gaps = 53/304 (17%)

Query: 93  KTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           K D+    +    +LG G  G  +  +   +G+  A K I     I       + RE+Q+
Sbjct: 4   KDDD----FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQV 57

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           +H       IV   GA+     + I ME   GG L   + + G   E+   +++  ++  
Sbjct: 58  LHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 116

Query: 213 VEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
           +        +MHRD+KP N L+   +    +K  DFG+S            VG+  Y++P
Sbjct: 117 LTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSP 172

Query: 272 EVLL-KHYGPEADVWTAGVILYILLSGVPPFWAET---QQGIFDAVLKGHIDFESD---- 323
           E L   HY  ++D+W+ G+ L  +  G  P         + +F   ++G           
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 324 ---------------------------------PWPLISDSAKDLIRKMLCSQPSERLTA 350
                                            P  + S   +D + K L   P+ER   
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

Query: 351 HEVL 354
            +++
Sbjct: 293 KQLM 296

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  211 bits (538), Expect = 3e-66
 Identities = 67/263 (25%), Positives = 118/263 (44%), Gaps = 14/263 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA--G 158
           +++ R +G+G FG  Y C +  TG  +A K + K+++  ++       E  ++  ++   
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
              IV +  A+     +  +++L  GG+L   + Q G +SE         I+  +E  H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL--K 276
             V++RDLKP N LL   D+   ++  D GL+  F   +     VG+  Y+APEVL    
Sbjct: 126 RFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGV 181

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI 336
            Y   AD ++ G +L+ LL G  PF     +     + +  +    +     S   + L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLL 240

Query: 337 RKMLCSQPSERLT-----AHEVL 354
             +L    + RL      A EV 
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVK 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  209 bits (534), Expect = 3e-66
 Identities = 69/260 (26%), Positives = 125/260 (48%), Gaps = 16/260 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           + + R LG G FG  +L      G  +A K + K  ++  + VE    E  ++  +  H 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 64

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            I+ + G ++D+  + ++M+   GGELF  + +   +    A      +   +E  HS  
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYG 279
           +++RDLKPEN LL   D +  +K  DFG + +     +   + G+P Y+APEV+  K Y 
Sbjct: 125 IIYRDLKPENILL---DKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKM 339
              D W+ G+++Y +L+G  PF+       ++ +L   + F     P  ++  KDL+ ++
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSRL 235

Query: 340 LCSQPSERL-----TAHEVL 354
           +    S+RL        +V 
Sbjct: 236 ITRDLSQRLGNLQNGTEDVK 255

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 5e-65
 Identities = 71/265 (26%), Positives = 127/265 (47%), Gaps = 20/265 (7%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED---VRREIQIM 153
           +   Y +G  LG G FG+ Y    ++  +  A K + K ++    ++ +   V  E+ ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 154 HHL-AGHKNIVTIKGAYEDSLCVHIVMELCAGG-ELFDRIIQRGHYSERKAAELTRIIVG 211
             + +G   ++ +   +E      +++E      +LFD I +RG   E  A      ++ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            V  CH+ GV+HRD+K EN L+    +   LK IDFG     K   ++TD  G+  Y  P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E +   +++G  A VW+ G++LY ++ G  PF  + +      +++G + F       +S
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR----VS 228

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVL 354
              + LIR  L  +PS+R T  E+ 
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQ 253

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 2e-63
 Identities = 82/261 (31%), Positives = 129/261 (49%), Gaps = 15/261 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +   + LG+G FG   L  E ATG  +A K + K  +I++++V     E +++ +   H 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHP 65

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            +  +K A++    +  VME   GGELF  + +   ++E +A      IV  +E  HS  
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL-KHY 278
           V++RD+K EN +L   D D  +K  DFGL       G       G+P Y+APEVL    Y
Sbjct: 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 279 GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRK 338
           G   D W  GV++Y ++ G  PF+ +  + +F+ +L   I F       +S  AK L+  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLAG 238

Query: 339 MLCSQPSERL-----TAHEVL 354
           +L   P +RL      A EV+
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVM 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-59
 Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 17/269 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMH 154
                L  KLG G FG        A     +  A K +    L   E ++D  RE+  MH
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVV 213
            L  H+N++ + G       + +V EL   G L DR+ +  GH+     +     +   +
Sbjct: 67  SL-DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPYYV 269
               S   +HRDL   N LL        +K  DFGL            +         + 
Sbjct: 125 GYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           APE L  + +   +D W  GV L+ + + G  P+       I   + K            
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED-- 239

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
                 +++ +    +P +R T   +   
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 70/279 (25%), Positives = 107/279 (38%), Gaps = 33/279 (11%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED--VEDVRREIQIMHHLAGHKNI 162
             LG+GQF T Y   +  T    A K I        +D       REI+++  L  H NI
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62

Query: 163 VTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVM 222
           + +  A+     + +V +                 +         + +  +E  H   ++
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 223 HRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--KHYG 279
           HRDLKP N LL   D++  LK  DFGL+  F  P + +T  V + +Y APE+L   + YG
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 280 PEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP------------- 326
              D+W  G IL  LL  VP    ++       + +       + WP             
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 327 -----------LISDSAKDLIRKMLCSQPSERLTAHEVL 354
                         D   DLI+ +    P  R+TA + L
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (489), Expect = 4e-59
 Identities = 81/305 (26%), Positives = 151/305 (49%), Gaps = 24/305 (7%)

Query: 56  SKENPKKDNSAPRISPSKKDNIMRRGIDNQTYYVLGHKTDNIRDLYTLGRKLGQGQFGTT 115
           +K+  ++++    ++ +K+D + +    +Q    L        D +   + LG G FG  
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL--------DQFDRIKTLGTGSFGRV 57

Query: 116 YLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV 175
            L     +G  +A K + K+K++  + +E    E +I+  +     +V ++ +++D+  +
Sbjct: 58  MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNL 116

Query: 176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN 235
           ++VME  AGGE+F  + + G +SE  A      IV   E  HSL +++RDLKPEN L+  
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI-- 174

Query: 236 KDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYIL 294
            D    ++  DFG +   K       + G+P  +APE++L K Y    D W  GV++Y +
Sbjct: 175 -DQQGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231

Query: 295 LSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERL-----T 349
            +G PPF+A+    I++ ++ G + F        S   KDL+R +L    ++R       
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287

Query: 350 AHEVL 354
            +++ 
Sbjct: 288 VNDIK 292

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  190 bits (484), Expect = 1e-58
 Identities = 72/297 (24%), Positives = 128/297 (43%), Gaps = 49/297 (16%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
             +D Y L RKLG+G++   +    I    +   K +           + ++REI+I+ +
Sbjct: 32  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 85

Query: 156 LAGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVV 213
           L G  NI+T+    +D  S    +V E     +           ++         I+  +
Sbjct: 86  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 142

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEV 273
           + CHS+G+MHRD+KP N ++ +  +   L+ ID+GL+ F+ PGQ +   V S Y+  PE+
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

Query: 274 LL--KHYGPEADVWTAGVILYILLSGVPPFWAET--------------QQGIFDAVLKGH 317
           L+  + Y    D+W+ G +L  ++    PF+                  + ++D + K +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 318 ID--------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
           I+                      S+   L+S  A D + K+L      RLTA E +
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-58
 Identities = 77/268 (28%), Positives = 134/268 (50%), Gaps = 17/268 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIA---TGIEFACKSISKRKLISRED-VEDVRREIQIMHHL 156
           + L + LG G +G  +L  +I+   TG  +A K + K  ++ +    E  R E Q++ H+
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
                +VT+  A++    +H++++   GGELF  + QR  ++E +       IV  +E  
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 145

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP--GQIFTDVVGSPYYVAPEVL 274
           H LG+++RD+K EN LL   D +  +   DFGLS  F     +   D  G+  Y+AP+++
Sbjct: 146 HKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 275 L---KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
                 +    D W+ GV++Y LL+G  PF  + ++     + +  +  E      +S  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262

Query: 332 AKDLIRKMLCSQPSERL-----TAHEVL 354
           AKDLI+++L   P +RL      A E+ 
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIK 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-58
 Identities = 69/296 (23%), Positives = 112/296 (37%), Gaps = 44/296 (14%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
           ++   YT    +G+G +G      +    +  A K IS  +   +   +   REI+I+  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62

Query: 156 LAGHKNIVTIKGAYEDSLCVH----IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
              H+NI+ I                ++    G +L+  +++  H S          I+ 
Sbjct: 63  FR-HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILR 120

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVVGSPY 267
            ++  HS  V+HRDLKP N LL   +    LK  DFGL+    P        T+ V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 268 YVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           Y APE++L    Y    D+W+ G IL  +LS  P F  +      + +L        +  
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 326 ---------------------------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                                      P     A DL+ KML   P +R+   + L
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 5e-58
 Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 24/274 (8%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
                 +G+G FG          G+         ++  S++D  D   E++++  L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAE 204
           NI+ + GA E    +++ +E    G L D + +                    S ++   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 205 LTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVG 264
               +   ++       +HRDL   N L+    +++  K  DFGLS   +     T    
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 265 SPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFES 322
              ++A E L    Y   +DVW+ GV+L+ ++S G  P+   T   +++ + +G   +  
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRL 245

Query: 323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           +      D   DL+R+    +P ER +  ++L  
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 9e-58
 Identities = 54/292 (18%), Positives = 108/292 (36%), Gaps = 40/292 (13%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+    G+ LG G FG     T     +    I+ A K + ++      + E +  E+++
Sbjct: 36  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKM 93

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---------------- 196
           M  L  H+NIV + GA   S  ++++ E C  G+L + +  +                  
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 197 -------YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 249
                   +          +   +E       +HRDL   N L+        +K  DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGL 210

Query: 250 SVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAE 304
           +          +  +      ++APE L    Y  ++DVW+ G++L+ + S GV P+   
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
                F  +++     +   +   ++    +++        +R +   +   
Sbjct: 271 PVDANFYKLIQNGFKMDQPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 9e-58
 Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 21/264 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
                L + +G+G+FG   L      G + A K I           +    E  +M  L 
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLR 58

Query: 158 GHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGH--YSERKAAELTRIIVGVVE 214
            H N+V + G   E+   ++IV E  A G L D +  RG          + +  +   +E
Sbjct: 59  -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVL 274
                  +HRDL   N L+    +D   K  DFGL+      Q          + APE L
Sbjct: 118 YLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEAL 172

Query: 275 L-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
             K +  ++DVW+ G++L+ + S G  P+     + +   V KG   ++ D       + 
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAV 229

Query: 333 KDLIRKMLCSQPSERLTAHEVLCM 356
            ++++       + R +  ++   
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQ 253

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-57
 Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 48/297 (16%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y    K+GQG FG  +      TG + A K +               REI+I+  L  H+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HE 69

Query: 161 NIVTIKGAYEDSL--------CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGV 212
           N+V +                 +++V + C              ++  +   + ++++  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-----IFTDVVGSPY 267
           +   H   ++HRD+K  N L+     D  LK  DFGL+  F   +      +T+ V + +
Sbjct: 130 LYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 268 YVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW 325
           Y  PE+LL  + YGP  D+W AG I+  + +  P     T+Q     + +       + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 326 PLI----------------------------SDSAKDLIRKMLCSQPSERLTAHEVL 354
           P +                               A DLI K+L   P++R+ + + L
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (471), Expect = 4e-57
 Identities = 56/271 (20%), Positives = 95/271 (35%), Gaps = 18/271 (6%)

Query: 97  IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHL 156
           + + Y LGRK+G G FG  YL T+IA G E A K    +          +  E +I   +
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMM 59

Query: 157 AGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEAC 216
            G   I TI+    +     +VMEL               +S +    L   ++  +E  
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--------TDVVGSPYY 268
           HS   +HRD+KP+NFL+        +  IDFGL+  ++  +           ++ G+  Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 269 VAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP--- 324
            +    L        D+ + G +L     G  P+             +      S P   
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 325 -WPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                       +      +  ++     + 
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-57
 Identities = 65/304 (21%), Positives = 122/304 (40%), Gaps = 44/304 (14%)

Query: 86  TYYVLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVED 145
               +      +R +Y   + +G G +G      +  TG + A K +  R   S    + 
Sbjct: 5   YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKR 63

Query: 146 VRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGHYSE 199
             RE++++ H+  H+N++ +   +      +D    ++VM     G    ++++     E
Sbjct: 64  AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE 120

Query: 200 RKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF 259
            +   L   ++  +   H+ G++HRDLKP N  +   ++D  LK +DFGL+         
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEM 175

Query: 260 TDVVGSPYYVAPEVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGH 317
           T  V + +Y APEV+L    Y    D+W+ G I+  +++G   F           ++K  
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 318 IDFESDPWPLI---------------------------SDSAKDLIRKMLCSQPSERLTA 350
               ++    +                           S  A +L+ KML     +R+TA
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

Query: 351 HEVL 354
            E L
Sbjct: 296 GEAL 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 7e-56
 Identities = 63/267 (23%), Positives = 104/267 (38%), Gaps = 18/267 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT---GIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R+   LGR +G+GQFG  +    ++     +  A K+   +   S    E   +E   M 
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMR 63

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVV 213
               H +IV + G   ++  V I+MELC  GEL   +  R               +   +
Sbjct: 64  QF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--TDVVGSPYYVAP 271
               S   +HRD+   N L+     +  +K  DFGLS + +    +  +       ++AP
Sbjct: 122 AYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 272 EVLL-KHYGPEADVWTAGVILY-ILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS 329
           E +  + +   +DVW  GV ++ IL+ GV PF       +   +  G         P   
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCP 235

Query: 330 DSAKDLIRKMLCSQPSERLTAHEVLCM 356
            +   L+ K     PS R    E+   
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  182 bits (463), Expect = 7e-56
 Identities = 57/290 (19%), Positives = 108/290 (37%), Gaps = 22/290 (7%)

Query: 82  IDNQTYYVLGHKTDNI-----RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK-R 135
           ID  T+                    + + +G G+FG          G      +I   +
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 136 KLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR- 194
              + +   D   E  IM     H N++ ++G    S  V I+ E    G L   + Q  
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND 122

Query: 195 GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
           G ++  +   + R I   ++    +  +HRDL   N L+   + +   K  DFGLS F +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE 179

Query: 255 PGQIFTDV------VGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQ 306
                              + APE +  + +   +DVW+ G++++ ++S G  P+W  T 
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239

Query: 307 QGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           Q + +A+ +   D+   P      +   L+        + R    +++  
Sbjct: 240 QDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 8e-56
 Identities = 60/268 (22%), Positives = 95/268 (35%), Gaps = 18/268 (6%)

Query: 98  RDLYTLG-RKLGQGQFGTTYLCT--EIATGIEFACKSISKRKLISREDVEDVRREIQIMH 154
           R L TL  ++LG G FGT               A K + K +       +++  E  +M 
Sbjct: 5   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQ 63

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVE 214
            L  +  IV + G  E      +VME+   G L   + Q  H  ++   EL   +   ++
Sbjct: 64  QL-DNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121

Query: 215 ACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYVA 270
                  +HRDL   N LL         K  DFGLS   +  + +    T       + A
Sbjct: 122 YLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI 328
           PE +    +  ++DVW+ GV+++   S G  P+       +   + KG            
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGC 235

Query: 329 SDSAKDLIRKMLCSQPSERLTAHEVLCM 356
                DL+          R     V   
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELR 263

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (461), Expect = 1e-55
 Identities = 62/286 (21%), Positives = 107/286 (37%), Gaps = 35/286 (12%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAG-- 158
           Y    ++G+G +G  +   ++  G  F      + +           RE+ ++ HL    
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 159 HKNIVTIKGAYEDS-----LCVHIVMELCAGGEL-FDRIIQRGHYSERKAAELTRIIVGV 212
           H N+V +      S       + +V E        +   +           ++   ++  
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 213 VEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPE 272
           ++  HS  V+HRDLKP+N L+        +K  DFGL+  +      T VV + +Y APE
Sbjct: 129 LDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 273 VLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL---- 327
           VLL   Y    D+W+ G I   +    P F   +       +L        + WP     
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 328 -------------------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                              I +  KDL+ K L   P++R++A+  L
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-55
 Identities = 61/265 (23%), Positives = 108/265 (40%), Gaps = 19/265 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  KLGQG FG  ++ T   T    A K++           E   +E Q+M  L 
Sbjct: 16  RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKL- 69

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +     +   ++IV E  + G L D +      +    +  ++   I   +  
Sbjct: 70  RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 128

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--IFTDVVGSPYYVAPEV 273
              +  +HRDL+  N L+    ++   K  DFGL+   +  +            + APE 
Sbjct: 129 VERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
            L   +  ++DVW+ G++L  L + G  P+     + + D V +G   +     P   +S
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 242

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCM 356
             DL+ +    +P ER T   +   
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAF 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 2e-55
 Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 17/265 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R   T+  KLG GQ+G  Y        +  A K++ +       +VE+  +E  +M  + 
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIK 71

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY--SERKAAELTRIIVGVVEA 215
            H N+V + G        +I+ E    G L D + +      S      +   I   +E 
Sbjct: 72  -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEV 273
                 +HRDL   N L+    ++  +K  DFGLS                   + APE 
Sbjct: 131 LEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           L    +  ++DVW  GV+L+ + + G+ P+       +++ + K   D+  +      + 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEK 244

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCM 356
             +L+R      PS+R +  E+   
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQA 269

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-55
 Identities = 58/261 (22%), Positives = 106/261 (40%), Gaps = 17/261 (6%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
            T  ++LG GQFG            + A K I +  +   E       E ++M +L+ H+
Sbjct: 6   LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLS-HE 59

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRI-IQRGHYSERKAAELTRIIVGVVEACHSL 219
            +V + G       + I+ E  A G L + +   R  +  ++  E+ + +   +E   S 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI--FTDVVGSPYYVAPEVLL-K 276
             +HRDL   N L+   +D   +K  DFGLS +    +            +  PEVL+  
Sbjct: 120 QFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 277 HYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDL 335
            +  ++D+W  GV+++ + S G  P+   T     + + +G          L S+    +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTI 233

Query: 336 IRKMLCSQPSERLTAHEVLCM 356
           +      +  ER T   +L  
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-55
 Identities = 56/264 (21%), Positives = 104/264 (39%), Gaps = 17/264 (6%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
               T  +++G GQFG  +L   +    + A K+I +         ED   E ++M  L 
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE----GAMSEEDFIEEAEVMMKL- 57

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEAC 216
            H  +V + G   +   + +V E    G L D +  +   ++      +   +   +   
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 217 HSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ--IFTDVVGSPYYVAPEVL 274
               V+HRDL   N L+    ++  +K  DFG++ F    Q    T       + +PEV 
Sbjct: 118 EEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 275 L-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA 332
               Y  ++DVW+ GV+++ + S G  P+   +   + + +  G   F      L S   
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHV 231

Query: 333 KDLIRKMLCSQPSERLTAHEVLCM 356
             ++      +P +R     +L  
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 4e-55
 Identities = 66/283 (23%), Positives = 108/283 (38%), Gaps = 34/283 (12%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y    K+G+G +GT +      T    A K +               REI ++  L  HK
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK-HK 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +         + +V E C            G             ++  +  CHS  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--KH 277
           V+HRDLKP+N L+   + +  LK  +FGL+  F  P + ++  V + +Y  P+VL   K 
Sbjct: 122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 278 YGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPW----------- 325
           Y    D+W+AG I   L +   P F           + +       + W           
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 326 --------------PLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                         P ++ + +DL++ +L   P +R++A E L
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  180 bits (456), Expect = 6e-55
 Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 34/282 (12%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y    K+G+G +G  Y       G  FA K I   K           REI I+  L  H 
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HS 60

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
           NIV +         + +V E           +  G      A      ++  +  CH   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 221 VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--KH 277
           V+HRDLKP+N L+   + +  LK  DFGL+  F  P + +T  + + +Y AP+VL+  K 
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 278 YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI--------- 328
           Y    D+W+ G I   +++G P F   ++      + +      S  WP +         
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 329 ----------------SDSAKDLIRKMLCSQPSERLTAHEVL 354
                            +S  DL+ KML   P++R+TA + L
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 8e-55
 Identities = 62/269 (23%), Positives = 103/269 (38%), Gaps = 20/269 (7%)

Query: 98  RDLYTLG-RKLGQGQFGTTYLCTEIAT--GIEFACKSISKRKLISREDVEDVRREIQIMH 154
           RD   +   +LG G FG+            I+ A K + +     + D E++ RE QIMH
Sbjct: 7   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMH 64

Query: 155 HLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVV 213
            L  +  IV + G  +    + +VME+  GG L   ++ +R        AEL   +   +
Sbjct: 65  QL-DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 214 EACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF----TDVVGSPYYV 269
           +       +HRDL   N LL    +    K  DFGLS        +    +       + 
Sbjct: 123 KYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 270 APEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPL 327
           APE +  + +   +DVW+ GV ++  LS G  P+       +   + +G      +  P 
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPE 236

Query: 328 ISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
                  L+      +  +R     V   
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQR 265

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-54
 Identities = 71/301 (23%), Positives = 111/301 (36%), Gaps = 47/301 (15%)

Query: 91  GHKTDNIRDL-YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE 149
           G   D  +++ YT  + +G G FG  Y      +G   A K + +       D     RE
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRE 63

Query: 150 IQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGG---ELFDRIIQRGHYSER 200
           +QIM  L  H NIV ++  +      +D + +++V++                +      
Sbjct: 64  LQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122

Query: 201 KAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFT 260
                   +   +   HS G+ HRD+KP+N LL    D   LK  DFG +     G+   
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNV 180

Query: 261 DVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKG-- 316
             + S YY APE++     Y    DVW+AG +L  LL G P F  ++       ++K   
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240

Query: 317 -----------------------HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEV 353
                                     +     P     A  L  ++L   P+ RLT  E 
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

Query: 354 L 354
            
Sbjct: 301 C 301

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-54
 Identities = 53/265 (20%), Positives = 101/265 (38%), Gaps = 19/265 (7%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA 157
           R+   L  +LG GQFG  ++        + A KS+ +         +    E  +M  L 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQ 66

Query: 158 GHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEA 215
            H+ +V +         ++I+ E    G L D +        +  K  ++   I   +  
Sbjct: 67  -HQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 216 CHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIF--TDVVGSPYYVAPEV 273
                 +HRDL+  N L+    D  S K  DFGL+   +  +            + APE 
Sbjct: 125 IEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 274 LL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS 331
           +    +  ++DVW+ G++L  +++ G  P+   T   +   + +G   +         + 
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEE 238

Query: 332 AKDLIRKMLCSQPSERLTAHEVLCM 356
              L+R     +P +R T   +  +
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSV 263

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 6e-53
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 34/283 (12%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           +    K+G+G +G  Y      TG   A K I      +        REI ++  L  H 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKEL-NHP 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCA-GGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSL 219
           NIV +         +++V E      + F                    ++  +  CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 220 GVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF-KPGQIFTDVVGSPYYVAPEVLL--K 276
            V+HRDLKP+N L+   + + ++K  DFGL+  F  P + +T  V + +Y APE+LL  K
Sbjct: 122 RVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 277 HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPL--------- 327
           +Y    D+W+ G I   +++    F  +++      + +     +   WP          
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 328 ----------------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                           + +  + L+ +ML   P++R++A   L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-52
 Identities = 58/287 (20%), Positives = 105/287 (36%), Gaps = 35/287 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+  + G+ LG G FG     T     +    +  A K +         + E +  E+++
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKV 79

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH---------------- 196
           + +L  H NIV + GA        ++ E C  G+L + + ++                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 197 --YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
                      +  +   +    S   +HRDL   N LL         K  DFGL+   K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIK 196

Query: 255 PGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
                 +  +      ++APE +    Y  E+DVW+ G+ L+ L S G  P+        
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           F  ++K      S           D+++    + P +R T  +++ +
Sbjct: 257 FYKMIKEGFRMLSPEH--APAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  173 bits (439), Expect = 2e-52
 Identities = 46/271 (16%), Positives = 99/271 (36%), Gaps = 20/271 (7%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
           Y +GR++G+G FG  +  T +    + A K   +R      D   +R E +    LAG  
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 61

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
            I  +    ++ L   +V++L          +    +S +  A   + ++  V++ H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 221 VMHRDLKPENFLLVNKDDDFS--LKAIDFGLSVFFKPG--------QIFTDVVGSPYYVA 270
           +++RD+KP+NFL+   +   +  +  +DFG+  F++          +   ++ G+  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 271 PEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDP----W 325
               L +      D+   G +    L G  P+             +     +S P     
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
               +     +                +  +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-52
 Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 36/287 (12%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCTEIAT-------GIEFACKSISKRKLISREDVEDVRREI 150
           RD   LG+ LG+G FG   L   I           + A K +      + +D+ D+  E+
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEM 69

Query: 151 QIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRG--------------- 195
           ++M  +  HKNI+ + GA      +++++E  + G L + +  R                
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 196 -HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK 254
              S +        +   +E   S   +HRDL   N L+    +D  +K  DFGL+    
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIH 186

Query: 255 PGQIFT---DVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI 309
               +    +      ++APE L  + Y  ++DVW+ GV+L+ + + G  P+     + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

Query: 310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           F  + +GH     D     ++    ++R    + PS+R T  +++  
Sbjct: 247 FKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-52
 Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 40/292 (13%)

Query: 96  NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHH 155
            + + Y     +G G +G+     +  TG+  A K +S+    S    +   RE++++ H
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 73

Query: 156 LAGHKNIVTIKGAYEDSLCV----HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVG 211
           +  H+N++ +   +  +  +     + +     G   + I++    ++     L   I+ 
Sbjct: 74  MK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132

Query: 212 VVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAP 271
            ++  HS  ++HRDLKP N      ++D  LK +DFGL+         T  V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187

Query: 272 EVLL--KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE-------- 321
           E++L   HY    D+W+ G I+  LL+G   F           +L+              
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247

Query: 322 -------------------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVL 354
                              ++ +   +  A DL+ KML     +R+TA + L
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 8e-52
 Identities = 50/263 (19%), Positives = 94/263 (35%), Gaps = 14/263 (5%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISK--RKLISREDVEDVRREIQIMHHLAG 158
           +   + LG G FGT Y    I  G +       K  R+  S +  +++  E  +M  +  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-D 69

Query: 159 HKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS 218
           + ++  + G    S    I   +  G  L      + +   +        I   +     
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL 275
             ++HRDL   N L+        +K  DFGL+      +             ++A E +L
Sbjct: 130 RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 276 -KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK 333
            + Y  ++DVW+ GV ++ L++ G  P+       I   + KG         P+ +    
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPICTIDVY 243

Query: 334 DLIRKMLCSQPSERLTAHEVLCM 356
            ++ K        R    E++  
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (433), Expect = 2e-51
 Identities = 55/293 (18%), Positives = 105/293 (35%), Gaps = 43/293 (14%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+     R +G+G FG  +                A K + +    S +   D +RE  +
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAAL 69

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHY--------------- 197
           M     + NIV + G       + ++ E  A G+L + +     +               
Sbjct: 70  MAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 198 ---------SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG 248
                    S  +   + R +   +        +HRDL   N L+    ++  +K  DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFG 185

Query: 249 LSVFFKPGQIF---TDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLS-GVPPFWA 303
           LS        +    +      ++ PE +  + Y  E+DVW  GV+L+ + S G+ P++ 
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245

Query: 304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
              + +   V  G+I               +L+R      P++R +   +  +
Sbjct: 246 MAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (435), Expect = 4e-51
 Identities = 71/317 (22%), Positives = 127/317 (40%), Gaps = 54/317 (17%)

Query: 84  NQTYYV-LGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRED 142
           NQ Y V +G  T  +   Y   + +G G  G      +       A K +S+    ++  
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTH 59

Query: 143 VEDVRREIQIMHHLAGHKNIVTIKGAY------EDSLCVHIVMELCAGGELFDRIIQRGH 196
            +   RE+ +M  +  HKNI+++   +      E+   V++VMEL            +  
Sbjct: 60  AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QME 115

Query: 197 YSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG 256
               + + L   ++  ++  HS G++HRDLKP N ++     D +LK +DFGL+      
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 172

Query: 257 QIFTDVVGSPYYVAPEVLLKH-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK 315
            + T  V + YY APEV+L   Y    D+W+ G I+  ++     F        ++ V++
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Query: 316 G--------------------------------------HIDFESDPWPLISDSAKDLIR 337
                                                      +S+   L +  A+DL+ 
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 292

Query: 338 KMLCSQPSERLTAHEVL 354
           KML   P++R++  + L
Sbjct: 293 KMLVIDPAKRISVDDAL 309

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 8e-49
 Identities = 53/275 (19%), Positives = 109/275 (39%), Gaps = 21/275 (7%)

Query: 94  TDNI-RDLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRR 148
           T  I     T  + +G G+FG  Y      +     +  A K++      + +   D   
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLG 58

Query: 149 EIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQR-GHYSERKAAELTR 207
           E  IM     H NI+ ++G       + I+ E    G L   + ++ G +S  +   + R
Sbjct: 59  EAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117

Query: 208 IIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ----IFTDVV 263
            I   ++   ++  +HRDL   N L+   + +   K  DFGLS   +         +   
Sbjct: 118 GIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174

Query: 264 GSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFE 321
               + APE +  + +   +DVW+ G++++ +++ G  P+W  +   +  A+  G   F 
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FR 231

Query: 322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
                    +   L+ +    + + R    +++ +
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 6e-48
 Identities = 55/279 (19%), Positives = 109/279 (39%), Gaps = 29/279 (10%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           R+  T+ R+LGQG FG  Y        +       A K++++    S  +  +   E  +
Sbjct: 19  REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASV 76

Query: 153 MHHLAGHKNIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGH----------YSERKA 202
           M       ++V + G         ++MEL   G+L   +                S  K 
Sbjct: 77  MKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 203 AELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IF 259
            ++   I   +   ++   +HRDL   N ++    +DF++K  DFG++            
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 260 TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGH 317
              +    +++PE L    +   +DVW+ GV+L+ + +    P+   + + +   V++G 
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252

Query: 318 IDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
           +    D      D   +L+R      P  R +  E++  
Sbjct: 253 LL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 6e-46
 Identities = 57/297 (19%), Positives = 98/297 (32%), Gaps = 51/297 (17%)

Query: 101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK 160
             L   +G+G+FG  +       G E A K  S R+    E       EI     L  H+
Sbjct: 5   IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHE 57

Query: 161 NIVTIKGAYEDS----LCVHIVMELCAGGELFDRIIQRGHYSERK-------AAELTRII 209
           NI+    A          + +V +    G LFD + +     E         A+ L  + 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTD-----VVG 264
           + +V       + HRDLK +N L+     + +    D GL+V         D      VG
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 265 SPYYVAPEVLL-------KHYGPEADVWTAGVILYILLSGVPPFWAE------------- 304
           +  Y+APEVL              AD++  G++ + +                       
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234

Query: 305 --TQQGIFDAVLKGHIDFESDPWPL---ISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
             + + +   V +  +                   ++R+   +  + RLTA  +   
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 7e-46
 Identities = 57/266 (21%), Positives = 106/266 (39%), Gaps = 21/266 (7%)

Query: 103 LGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH 159
               +G+G FG  Y  T +      I  A KS+++       +V     E  IM   + H
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFS-H 87

Query: 160 KNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGH-YSERKAAELTRIIVGVVEACH 217
            N++++ G          +V+     G+L + I    H  + +        +   ++   
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147

Query: 218 SLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI-----FTDVVGSPYYVAPE 272
           S   +HRDL   N +L   D+ F++K  DFGL+      +       T       ++A E
Sbjct: 148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 273 VLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISD 330
            L  + +  ++DVW+ GV+L+ L++ G PP+       I   +L+G             D
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCPD 261

Query: 331 SAKDLIRKMLCSQPSERLTAHEVLCM 356
              +++ K    +   R +  E++  
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-45
 Identities = 60/286 (20%), Positives = 110/286 (38%), Gaps = 34/286 (11%)

Query: 98  RDLYTLGRKLGQGQFGTTYLCT-----EIATGIEFACKSISKRKLISREDVEDVRREIQI 152
           RD   LG+ LG+G FG           + AT    A K + +    +  +   +  E++I
Sbjct: 12  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKI 69

Query: 153 MHHLAGHKNIVTIKGA-YEDSLCVHIVMELCAGGELFDRIIQRGHY-------------- 197
           + H+  H N+V + GA  +    + +++E C  G L   +  + +               
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 198 --SERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP 255
             +       +  +   +E   S   +HRDL   N LL    +   +K  DFGL+     
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYK 186

Query: 256 GQIF---TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGV-PPFWAETQQGIF 310
              +    D      ++APE +  + Y  ++DVW+ GV+L+ + S    P+        F
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246

Query: 311 DAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM 356
              LK      +  +   +      +      +PS+R T  E++  
Sbjct: 247 CRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  136 bits (342), Expect = 1e-37
 Identities = 64/334 (19%), Positives = 119/334 (35%), Gaps = 74/334 (22%)

Query: 87  YY--VLGHKTDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVE 144
           Y+    G    + R  Y L RKLG G F T +L  ++      A K +   K+ +    E
Sbjct: 1   YHPAFKGEPYKDAR--YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----E 54

Query: 145 DVRREIQIMHHL----------AGHKNIVTIKGAYED--SLCVHIVMELCAGGELFDRII 192
               EI+++  +           G  +I+ +   +       VH+VM     GE    +I
Sbjct: 55  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114

Query: 193 QRGHYSERKAAELTRIIVGVVEACHSL----GVMHRDLKPENFLLVNKD---DDFSLKAI 245
           ++  +       + +I   ++     +    G++H D+KPEN L+   D   +   +K  
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 174

Query: 246 DFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAE 304
           D G + ++      +    +  Y +PEVLL   +G  AD+W+   +++ L++G   F  +
Sbjct: 175 DLGNACWYDEHYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232

Query: 305 TQQG-------------------------------IFDAVLKGHIDFESDPWPL------ 327
                                               F++        +   WPL      
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292

Query: 328 -------ISDSAKDLIRKMLCSQPSERLTAHEVL 354
                   +    D +  ML   P +R  A  ++
Sbjct: 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 1e-20
 Identities = 37/211 (17%), Positives = 70/211 (33%), Gaps = 37/211 (17%)

Query: 100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACK-----SISKRKLISREDVEDVR-REIQIM 153
           +  +G+ +G+G+    + C       E   K       S +K+  + D  D+    + I 
Sbjct: 1   VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 154 HHLAGHKNIVTIKGAYE----DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRII 209
                 + +  ++G             ++MEL           +          E+  +I
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMI 112

Query: 210 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFTDVVGSPYYV 269
           +  V   +  G++H DL   N L+     +  +  IDF  SV            G    +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSV-------EVGEEGWREIL 161

Query: 270 APEV------LLKHYGPEADVWTAGVILYIL 294
             +V        + Y  E D+ +   I  IL
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINS--AIDRIL 190

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 15/139 (10%), Positives = 39/139 (28%), Gaps = 4/139 (2%)

Query: 105 RKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE----DVEDVRREIQIMHHLAGHK 160
           +++G G     +   +         K       +  E     ++  R E   +     H 
Sbjct: 32  QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91

Query: 161 NIVTIKGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG 220
             +  +  Y D+     VME  +  ++  + +  G      +  +   +   +       
Sbjct: 92  PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151

Query: 221 VMHRDLKPENFLLVNKDDD 239
           +  +  K       N +  
Sbjct: 152 LEPKVKKQLVKQFTNPELC 170

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	363
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.92
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.61
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.36
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.77
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.72
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.1

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-65  Score=467.95  Aligned_cols=264  Identities=40%  Similarity=0.716  Sum_probs=224.0

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL  173 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~  173 (363)
                      .+++.+.|++.+.||+|+||+||+|+++.+++.||||++.+....  .....+.+|+.+|++++ |||||++++++.+.+
T Consensus         4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIK-HPNIVALDDIYESGG   80 (307)
T ss_dssp             CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCC-CTTBCCEEEEEECSS
T ss_pred             CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECC
Confidence            456788899999999999999999999999999999999765432  23456889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          174 CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .+|||||||+||+|.+++.+.+.+++..+..++.||+.||+|||++|||||||||+|||+...++++.+||+|||+|...
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999999999999889999999999999999999999999999999999999976567889999999999887


Q ss_pred             CCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          254 KPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       254 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      .........+||+.|||||++.+ .|+.++|||||||++|||++|..||.+....+....+.+....++.+.++.+|+++
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            76666677899999999999985 59999999999999999999999999999999999999988887777778899999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+||.+||++||++|||+.|+|+||||+
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            9999999999999999999999999996

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-65  Score=454.45  Aligned_cols=254  Identities=31%  Similarity=0.544  Sum_probs=232.0

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+|||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            45999999999999999999999999999999997655434445678899999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||||++|+|.+++.+.+.+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|...... .
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS-R  160 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-C
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC-c
Confidence            9999999999999998899999999999999999999999999999999999999   78889999999999876543 3


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+.+....++    ..+++++++||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence            456789999999999985 589999999999999999999999999999999999988776544    358999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCccc
Q 017960          338 KMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||++||++|||++|+|+||||+.
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999999863

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-64  Score=452.48  Aligned_cols=258  Identities=29%  Similarity=0.495  Sum_probs=219.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.++|++++.||+|+||+||+|.++.+|+.||||++.+..  .....+.+.+|+.++++++ ||||+++++++.+.+.+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~   79 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQY   79 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeE
Confidence            3467999999999999999999999999999999997654  2334467899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|+.....
T Consensus        80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEET
T ss_pred             EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccC
Confidence            999999999999999888889999999999999999999999999999999999999   78889999999999876433


Q ss_pred             C---ccccCccCCcccccccccc-cC-CCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          257 Q---IFTDVVGSPYYVAPEVLLK-HY-GPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       257 ~---~~~~~~gt~~y~aPE~~~~-~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      .   .....+||+.|||||++.+ .+ +.++|||||||++|||++|+.||.................. ....+..++++
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~  235 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-YLNPWKKIDSA  235 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-TSTTGGGSCHH
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-CCCccccCCHH
Confidence            2   3456789999999999974 44 67899999999999999999999776544333222222221 22344578999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +.+||.+||+.||++|||++|+|+||||+.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         236 PLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            999999999999999999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-63  Score=452.97  Aligned_cols=267  Identities=38%  Similarity=0.646  Sum_probs=240.3

Q ss_pred             ccccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           94 TDNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS---REDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        94 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      ..++.++|++++.||+|+||+||+|.++.+|+.||||++.+.....   ....+.+.+|+.+|++++ |||||+++++|.
T Consensus         5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~   83 (293)
T d1jksa_           5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE   83 (293)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence            3457788999999999999999999999999999999997654322   224678999999999998 999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCC-CCccEEEeecCc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKD-DDFSLKAIDFGL  249 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~-~~~~~kl~DFG~  249 (363)
                      +.+.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+...+ ....+||+|||+
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999999999999888999999999999999999999999999999999999994322 123699999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      |.....+.......||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+.+..+......++...++.+
T Consensus       164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            998877777777899999999999985 5999999999999999999999999999999999999888776665555678


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      |+++++||.+||+.||++|||++|+|+|+||+.
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-63  Score=451.48  Aligned_cols=256  Identities=32%  Similarity=0.543  Sum_probs=229.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|.++.+++.||||++.+.........+.+.+|++++++++ ||||+++++++.+.+.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEEE
Confidence            56999999999999999999999999999999998655444455678999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      ||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+   ++++.+||+|||+|+...... 
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   888999999999998765332 


Q ss_pred             --ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          258 --IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       258 --~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                        .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+++..+.+....++    ..+++++++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  239 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD  239 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence              3345789999999999985 699999999999999999999999999999999999988876554    358999999


Q ss_pred             HHHHhcccCcCCCCCHHH------HhcCCCcccC
Q 017960          335 LIRKMLCSQPSERLTAHE------VLCMYNLPVL  362 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~e------vL~~~~~~~~  362 (363)
                      ||.+||++||.+|||++|      +++||||+.+
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999999988      5789998653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-62  Score=443.01  Aligned_cols=263  Identities=37%  Similarity=0.653  Sum_probs=241.0

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCC------hhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLIS------REDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      |.++|++.+.||+|+||+||+|+++.+++.||||++.+.....      ....+++.+|+.++++|+.||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            4578999999999999999999999999999999997654332      2234578899999999988999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                      +++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a  157 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFS  157 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhe
Confidence            999999999999999999999999999999999999999999999999999999999999999   88899999999999


Q ss_pred             eecCCCCccccCccCCcccccccccc-------cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC
Q 017960          251 VFFKPGQIFTDVVGSPYYVAPEVLLK-------HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD  323 (363)
Q Consensus       251 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  323 (363)
                      .....+......+||+.|+|||++.+       .++.++||||+||++|||++|+.||.+.+.......+..+...++..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            98877666677889999999999852       37889999999999999999999999999999999999888777777


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          324 PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       324 ~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      .++.+|+++++||.+||+.||.+|||++|||+|+||+.+
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            777899999999999999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-63  Score=448.68  Aligned_cols=255  Identities=31%  Similarity=0.457  Sum_probs=225.0

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..++|++.+.||+|+||+||+|.++.+|+.||||++.....   ...+.+.+|+.++++++ |||||+++++|.+.+.+|
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENK-NPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEE
Confidence            45679999999999999999999999999999999976543   23467899999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus        94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCST
T ss_pred             EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccc
Confidence            99999999999887654 579999999999999999999999999999999999999   77889999999999876543


Q ss_pred             -CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                       ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+...... ....+..+++++++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  248 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD  248 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence             34556789999999999985 5999999999999999999999999988877776666554322 12233568999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ||.+||++||++|||+.|+|+|+||+
T Consensus       249 li~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         249 FLNRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhC
Confidence            99999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-63  Score=459.88  Aligned_cols=261  Identities=35%  Similarity=0.553  Sum_probs=238.0

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+-++|++++.||+|+||.||+|.++.+|+.||||++.+.   .....+.+.+|+.+|++|+ |||||++++++.+.+.+
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            3556799999999999999999999999999999999654   3455678899999999998 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |||||||+||+|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||+.. +.++.+||+|||+|....
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecc
Confidence            999999999999999854 467999999999999999999999999999999999999943 235789999999999887


Q ss_pred             CCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .........||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..+.+..+......++...++.++++++
T Consensus       178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            7777777899999999999985 599999999999999999999999999999999999998887777666678999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||.+||+.||++|||+.|+|+||||+.
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~  285 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTP  285 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999964

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.1e-63  Score=458.34  Aligned_cols=261  Identities=33%  Similarity=0.555  Sum_probs=238.5

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      .+.+.|++++.||+|+||+||+|.++.+|+.||||++.+.   .....+.+.+|+.+|++|+ |||||+++++|.+.+.+
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            3456799999999999999999999999999999999764   3344567889999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |||||||+||+|.+.+...+ .+++.+++.++.||+.||.|||++|||||||||+|||+.. ..++.+||+|||+|....
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecC
Confidence            99999999999998876654 6999999999999999999999999999999999999932 256789999999999988


Q ss_pred             CCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .........||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....+.+..+.+....++...++.+++++.
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            7777777899999999999985 599999999999999999999999999999999999999888888777788999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      +||.+||++||.+|||+.|+|+|+||+.
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            9999999999999999999999999964

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-63  Score=446.79  Aligned_cols=257  Identities=28%  Similarity=0.415  Sum_probs=226.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ..+.|++++.||+|+||+||+|.++.+++.||||++.+.   .....+.+.+|+++|++++ |||||++++++.+.+.++
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEE
Confidence            346799999999999999999999999999999999754   3345577889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|.....
T Consensus        86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCC
Confidence            99999999999998765 4569999999999999999999999999999999999999   7888999999999976533


Q ss_pred             C-CccccCccCCccccccccc------ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          256 G-QIFTDVVGSPYYVAPEVLL------KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       256 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      . ......+||+.|+|||++.      ..|+.++|||||||++|||++|+.||.+.+..+.+..+.++..... .....+
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~  241 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRW  241 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGS
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccC
Confidence            2 2334678999999999984      2489999999999999999999999999888888888887654322 223468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ++++.+||.+||++||++|||+.|+|+||||+.
T Consensus       242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999999963

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-62  Score=452.24  Aligned_cols=256  Identities=32%  Similarity=0.520  Sum_probs=234.4

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++ ||||++++++|.+.+.+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccc
Confidence            45999999999999999999999999999999998765444556788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC-CC
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP-GQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~-~~  257 (363)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+.... ..
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCCc
Confidence            9999999999999999999999999999999999999999999999999999999   8889999999999987543 34


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+.+..++.+.+..+...++    ..+++++++||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  236 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            5567899999999999984 699999999999999999999999999999999999988876654    35899999999


Q ss_pred             HHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          337 RKMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      .+||++||.+|++     ++|+++|+||..+
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HhhccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999994     9999999999653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-62  Score=438.36  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=220.1

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec----CCeEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----SLCVH  176 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~  176 (363)
                      |++.++||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+++|++++ |||||+++++|.+    ...+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEE
Confidence            4778899999999999999999999999999976543 5556778999999999998 9999999999865    45689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLG--VMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ||||||++|+|.+++.+.+.+++..+..++.||+.||+|||+++  |+||||||+|||++  ++++.+||+|||+|+...
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc
Confidence            99999999999999999889999999999999999999999999  99999999999993  246789999999998643


Q ss_pred             CCCccccCccCCcccccccccccCCCcccHHHHHHHHHHHHhCCCCCCCcC-HHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          255 PGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAET-QQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       255 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      . ......+||+.|||||++.+.|+.++|||||||++|||++|+.||.+.. ...+.+.+..+....  .....+++++.
T Consensus       167 ~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~  243 (270)
T d1t4ha_         167 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIPEVK  243 (270)
T ss_dssp             T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG--GGGGCCCHHHH
T ss_pred             C-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc--ccCccCCHHHH
Confidence            3 3445688999999999998889999999999999999999999997654 445556665543322  12235789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      +||.+||++||++|||+.|+|+||||+
T Consensus       244 ~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         244 EIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-63  Score=449.69  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=228.6

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.+.|++.+.||+|+||+||+|++..+++.||||++.+.........+.+.+|+.+|++|+ |||||++++++.+.+.+|
T Consensus        13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEE
Confidence            3456999999999999999999999999999999998766555666788999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          177 IVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||||.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|..... 
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS-
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC-
Confidence            999999999988777778889999999999999999999999999999999999999   7788999999999987543 


Q ss_pred             CccccCccCCccccccccc----ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 QIFTDVVGSPYYVAPEVLL----KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                        ....+||+.|||||++.    +.|+.++|||||||++|||++|..||.+....+.+..+..+......  ...+++++
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~~~  243 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYF  243 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCHHH
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCHHH
Confidence              34578999999999985    34899999999999999999999999998888888777766543322  24579999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      .+||.+||+.||.+|||+.|+|+|+|+.
T Consensus       244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence            9999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-62  Score=440.20  Aligned_cols=253  Identities=27%  Similarity=0.460  Sum_probs=214.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCeEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCVH  176 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~  176 (363)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|++++++++ |||||++++++.+  .+.+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEE
Confidence            569999999999999999999999999999999976544 5566788999999999998 9999999999864  56689


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEecCCCCCceEeeeCCCCccEEEeec
Q 017960          177 IVMELCAGGELFDRIIQ----RGHYSERKAAELTRIIVGVVEACHSLG-----VMHRDLKPENFLLVNKDDDFSLKAIDF  247 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-----iiHrDlkp~NIll~~~~~~~~~kl~DF  247 (363)
                      ||||||+||+|.+++.+    .+.+++..++.++.||+.||.|||+.|     ||||||||+|||+   +.++.+||+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF  158 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF  158 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence            99999999999998854    457999999999999999999999976     9999999999999   78889999999


Q ss_pred             CcceecCCCC-ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCC
Q 017960          248 GLSVFFKPGQ-IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPW  325 (363)
Q Consensus       248 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  325 (363)
                      |+|....... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..++...+..+.....   .
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            9998765433 3456789999999999974 699999999999999999999999999999999888887765422   2


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 017960          326 PLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNL  359 (363)
Q Consensus       326 ~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~  359 (363)
                      ..+++++.+||.+||+.||++|||+.|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            3689999999999999999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-61  Score=443.21  Aligned_cols=254  Identities=27%  Similarity=0.517  Sum_probs=232.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.++ ||||+++++++.+.+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            35999999999999999999999999999999997655434455678999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      ||||+||+|...+.....+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|.....  .
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~--~  157 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD--V  157 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS--C
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecc--c
Confidence            9999999999999999999999999999999999999999999999999999999   8889999999999988653  3


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      ....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+..+....+.++...++    +.+++++.++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            456889999999999985 599999999999999999999999999999999999988766543    358999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          338 KMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       338 ~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      +||.+||.+|+     |++++|+||||+.+
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999996     99999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-62  Score=446.58  Aligned_cols=258  Identities=28%  Similarity=0.525  Sum_probs=235.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +-++|++++.||+|+||+||+|.++.+++.||||++.+..    .....+.+|+++|+.++ |||||+++++|.+.+.+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~   77 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIAR-HRNILHLHESFESMEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence            5577999999999999999999999999999999997642    33456889999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||||||+|++|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||+.. ++...+||+|||++.....
T Consensus        78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhcccc
Confidence            9999999999999997665 6999999999999999999999999999999999999943 2455899999999998877


Q ss_pred             CCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKD  334 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  334 (363)
                      ........+|+.|+|||.+.+ .|+.++|||||||++|+|++|..||.+.+..+.+..+.+....++...++.+++++++
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            666677889999999999874 5999999999999999999999999999999999999998887776666789999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          335 LIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       335 li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ||.+||..||.+|||++|+|+||||+
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhc
Confidence            99999999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-62  Score=447.76  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=216.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++....  .....+++.+|+.+|++++ |||||+++++|.+.+.+||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEE
Confidence            467999999999999999999999999999999997643  3445678999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||||+||+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||+   ++++.+||+|||+|..... 
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH-
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC-
Confidence            99999999999999998899999999999999999999997 599999999999999   8888999999999987543 


Q ss_pred             CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHH------------------------
Q 017960          257 QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFD------------------------  311 (363)
Q Consensus       257 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~------------------------  311 (363)
                      ....+.+||+.|+|||++.+ .|+.++||||+||++|||++|+.||.+.+......                        
T Consensus       158 ~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            23456799999999999985 69999999999999999999999997654322110                        


Q ss_pred             ------------------HHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          312 ------------------AVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       312 ------------------~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                        .+....  .+..+...++.++++||.+||+.||++|||++|+|+||||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                              000000  000111236789999999999999999999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-61  Score=445.42  Aligned_cols=253  Identities=30%  Similarity=0.533  Sum_probs=231.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.........+.+.+|+.+|+.++ ||||+++++++.+...+++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeecccccccccccccc
Confidence            56999999999999999999999999999999997655444455678999999999997 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI  258 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~  258 (363)
                      |||+.||+|..++.+.+.+++..+..++.||+.||.|||++|||||||||+|||+   +.++.+||+|||+|+.....  
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc--
Confidence            9999999999999999999999999999999999999999999999999999999   78889999999999986533  


Q ss_pred             cccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIR  337 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  337 (363)
                      .....||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+....+..+..+...++    ..+++++.+||.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHH
Confidence            356789999999999985 599999999999999999999999999999999999988765543    358999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCCCccc
Q 017960          338 KMLCSQPSERL-----TAHEVLCMYNLPV  361 (363)
Q Consensus       338 ~~l~~dp~~R~-----s~~evL~~~~~~~  361 (363)
                      +||++||.+|+     |++|+++|+||+.
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccC
Confidence            99999999995     9999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-61  Score=438.75  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=229.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+..|+.++.+..+||||+++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            46999999999999999999999999999999998654433445667778888776533499999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-C
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-Q  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~  257 (363)
                      ||||++|+|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|...... .
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccccc
Confidence            9999999999999999999999999999999999999999999999999999999   88899999999999865433 3


Q ss_pred             ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          258 IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      ......||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..++...+..+...++    ..+++++.+||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  234 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLL  234 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHH
Confidence            4455789999999999985 699999999999999999999999999999999999987765443    35799999999


Q ss_pred             HHhcccCcCCCCCHH-HHhcCCCcccC
Q 017960          337 RKMLCSQPSERLTAH-EVLCMYNLPVL  362 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~-evL~~~~~~~~  362 (363)
                      .+||++||.+|||+. ++++||||+.+
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999995 89999999753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-61  Score=444.15  Aligned_cols=259  Identities=35%  Similarity=0.576  Sum_probs=219.5

Q ss_pred             ccccccceeecc-eecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-
Q 017960           94 TDNIRDLYTLGR-KLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (363)
Q Consensus        94 ~~~~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-  171 (363)
                      ...+.+.|++.+ .||+|+||+||+|.+..+++.||||++...        ..+.+|+.++.++.+|||||+++++|++ 
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            344556798864 699999999999999999999999998642        4577899998777669999999999875 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEee
Q 017960          172 ---SLCVHIVMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAID  246 (363)
Q Consensus       172 ---~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~D  246 (363)
                         +..+|||||||+||+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||+...+..+.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               46799999999999999999874  3689999999999999999999999999999999999996555677899999


Q ss_pred             cCcceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHH----cCCcccC
Q 017960          247 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVL----KGHIDFE  321 (363)
Q Consensus       247 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~  321 (363)
                      ||+|+...........+||+.|+|||++.+ .|+.++|||||||+||+|++|+.||.+.........+.    .....++
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            999998877777778899999999999985 59999999999999999999999998766554444333    3333444


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 017960          322 SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLP  360 (363)
Q Consensus       322 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~  360 (363)
                      ...+..+++++.+||.+||+.||++|||+.|+|+|+||.
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence            444456899999999999999999999999999999984

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.4e-60  Score=441.69  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=217.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHH---HHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRRE---IQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|   +.+++.+. |||||+++++|.+.+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCEE
Confidence            459999999999999999999999999999999976543333333344444   55555555 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence            9999999999999999999999999999999999999999999999999999999999   8889999999999988754


Q ss_pred             CCccccCccCCccccccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .. ....+||+.|+|||++. + .|+.++|||||||+||||++|+.||.+......... .+.........+..++++++
T Consensus       160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~  237 (364)
T d1omwa3         160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVELPDSFSPELR  237 (364)
T ss_dssp             SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSSSCCCCCCSSSCHHHH
T ss_pred             Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcccCCCCCCCCCCHHHH
Confidence            43 45578999999999986 3 489999999999999999999999987654433322 22222223333456899999


Q ss_pred             HHHHHhcccCcCCCCC-----HHHHhcCCCcccC
Q 017960          334 DLIRKMLCSQPSERLT-----AHEVLCMYNLPVL  362 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s-----~~evL~~~~~~~~  362 (363)
                      +||.+||+.||.+|||     ++|+++|+||+.+
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999999     7999999999753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7e-59  Score=418.86  Aligned_cols=256  Identities=25%  Similarity=0.367  Sum_probs=220.6

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--  173 (363)
                      .+.++|++.+.||+|+||+||+|.+..+++.||||++.+....+....+++.+|+.+++.++ ||||+++++++...+  
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            35678999999999999999999999999999999998776666677788999999999998 999999999987643  


Q ss_pred             --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          174 --CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       174 --~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                        .+|||||||+|++|.+++...+.+++.++..++.||+.||+|||++|||||||||+|||+   +.++.++|+|||.+.
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR  159 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence              489999999999999999999999999999999999999999999999999999999999   778899999999987


Q ss_pred             ecCCC----CccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          252 FFKPG----QIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       252 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      .....    ......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+.+..+....+.......+...++
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE  239 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence            65332    23445789999999999985 59999999999999999999999999999888888887776665555667


Q ss_pred             CCCHHHHHHHHHhcccCcCCCC-CHHHHhc
Q 017960          327 LISDSAKDLIRKMLCSQPSERL-TAHEVLC  355 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~-s~~evL~  355 (363)
                      .+|+++.+||.+||++||++|| |++++++
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~  269 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRA  269 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence            8999999999999999999999 6666654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=427.96  Aligned_cols=255  Identities=26%  Similarity=0.350  Sum_probs=213.9

Q ss_pred             ecceecccCCeEEEEEEEccCCcEEEEEEeeccccCCh--hhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEe
Q 017960          103 LGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISR--EDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVME  180 (363)
Q Consensus       103 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e  180 (363)
                      .+++||+|+||+||+|.++.+|+.||||++........  ...+.+.+|+.++++++ |||||++++++.+.+.+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            45789999999999999999999999999965432211  12356889999999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC-Ccc
Q 017960          181 LCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG-QIF  259 (363)
Q Consensus       181 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~  259 (363)
                      |+.++++.........+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|...... ...
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcccc
Confidence            99888776666666779999999999999999999999999999999999999   88899999999999775443 334


Q ss_pred             ccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC--------------
Q 017960          260 TDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD--------------  323 (363)
Q Consensus       260 ~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------  323 (363)
                      ...+||+.|+|||++..  .|+.++|||||||++|||++|..||.+....+.+..+.+........              
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            56789999999999863  48999999999999999999999999999888887776431111110              


Q ss_pred             ----------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          324 ----------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       324 ----------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                .++.+++++++||.+||+.||++|||+.|+|+|+||+.
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence                      01346889999999999999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-59  Score=418.78  Aligned_cols=253  Identities=28%  Similarity=0.498  Sum_probs=216.8

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChh---hHHHHHHHHHHHHHhc-CCCceeEEeEEEecC
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISRE---DVEDVRREIQIMHHLA-GHKNIVTIKGAYEDS  172 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~  172 (363)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++.+.......   ...++.+|+.++++++ +|||||++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            456799999999999999999999999999999999765433221   2244678999999996 489999999999999


Q ss_pred             CeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcce
Q 017960          173 LCVHIVMELCAG-GELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSV  251 (363)
Q Consensus       173 ~~~~iv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~  251 (363)
                      +..++||||+.+ +++.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+.  .+++.+||+|||+|.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA  159 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccce
Confidence            999999999976 57888888888999999999999999999999999999999999999993  245789999999998


Q ss_pred             ecCCCCccccCccCCcccccccccc-c-CCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          252 FFKPGQIFTDVVGSPYYVAPEVLLK-H-YGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       252 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      .... ...+...||+.|+|||++.+ . ++.++|||||||++|||++|+.||.+..      .+.++...++    ..+|
T Consensus       160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s  228 (273)
T d1xwsa_         160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS  228 (273)
T ss_dssp             ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred             eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCC
Confidence            7543 34567889999999999874 3 4678999999999999999999997632      3444444333    3589


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                      +++++||.+||++||++|||++|+|+||||+.+
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999999865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-58  Score=419.41  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=215.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      |+|++++.||+|+||+||+|++..+++.||||++..... .....+++.+|+++|++++ |||||+++++|.+.+.+|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEE
Confidence            569999999999999999999999999999999965432 3344578899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||+.+ ++...+..  ...+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|......
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCC
Confidence            999965 55555543  3569999999999999999999999999999999999999   78889999999999876543


Q ss_pred             -CccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCC----------
Q 017960          257 -QIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESD----------  323 (363)
Q Consensus       257 -~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------  323 (363)
                       .......||+.|+|||++..  .++.++|||||||++|+|++|+.||.+.+..+.+..+.+........          
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             34456689999999998763  36899999999999999999999999988877766654321111110          


Q ss_pred             ---------------CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          324 ---------------PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       324 ---------------~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                     ..+.+++++++||.+||+.||++|||++|+|+|+||+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence                           023567899999999999999999999999999999764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-58  Score=422.14  Aligned_cols=253  Identities=21%  Similarity=0.344  Sum_probs=213.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCc-----EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGI-----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|+++++||+|+||+||+|.+...++     .||+|.+....  .......+.+|+.++.++.+|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3679999999999999999999876554     69999886543  3344567899999999995599999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCC
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG-----------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPE  229 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~  229 (363)
                      +.+++|||||++|+|.+++....                       .+++..+..++.||+.||+|||+++||||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            99999999999999999997542                       4789999999999999999999999999999999


Q ss_pred             ceEeeeCCCCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCc
Q 017960          230 NFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAE  304 (363)
Q Consensus       230 NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~  304 (363)
                      |||+   +.++.+||+|||+|+......   ......||+.|||||++. +.|+.++|||||||++|||+| |..||.+.
T Consensus       194 Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         194 NVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            9999   788899999999998754433   223566899999999987 569999999999999999998 89999887


Q ss_pred             CHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          305 TQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       305 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .....+..+.......  +....+++++.+||.+||+.||++|||++||+++|
T Consensus       271 ~~~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  321 (325)
T d1rjba_         271 PVDANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  321 (325)
T ss_dssp             CCSHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            7666555555554332  22346899999999999999999999999999876

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-58  Score=416.54  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=206.6

Q ss_pred             cceeecceecccCCeEEEEEEEccCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGI---EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +.|++.++||+|+||+||+|.++.+++   .||||.+....  .....+.+.+|+.+|++++ |||||++++++.+.+.+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEE
Confidence            569999999999999999999877664   58888875433  5566778999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++|||||++|+|.+++... +.+++.++..++.||+.||.|||+++|+||||||+|||+   +.++.+||+|||+|+...
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEcc
Confidence            9999999999999988764 568999999999999999999999999999999999999   888999999999998765


Q ss_pred             CCCcc------ccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCC
Q 017960          255 PGQIF------TDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWP  326 (363)
Q Consensus       255 ~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  326 (363)
                      .....      ....||+.|||||++. +.|+.++|||||||+||||+| |+.||.+....++...+..+...   +...
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~  256 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPPM  256 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCc
Confidence            43221      1245789999999987 569999999999999999998 89999999998888888775432   2334


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          327 LISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       327 ~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      .+++++.+||.+||+.||++|||+.||++.+
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L  287 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL  287 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            6899999999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-58  Score=414.76  Aligned_cols=247  Identities=22%  Similarity=0.301  Sum_probs=212.8

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.+.||+|+||+||+|.++.+++.||||++....    ...+++.+|+.+|++++ |||||++++++.+.+.++||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEEE
Confidence            56999999999999999999999999999999986532    33567899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      ||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||+   ++++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCC
Confidence            9999999999999764  468999999999999999999999999999999999999   78889999999999876543


Q ss_pred             Cc--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCC-CCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 QI--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPF-WAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      ..  .....|++.|+|||++. +.|+.++|||||||++|||++|..|| .+.....+.+.+..+.   ..+....+++++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~l  245 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEKV  245 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---CCCCCTTCCHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC---CCCCCccchHHH
Confidence            32  23345789999999987 57999999999999999999966655 4555566666655542   223334689999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      .+||.+||+.||++|||+.|+++.
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~~  269 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQA  269 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=414.10  Aligned_cols=252  Identities=24%  Similarity=0.401  Sum_probs=207.0

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++++.||+|+||+||+|+..   ..||||++..... .....+.+.+|+.++++++ |||||++++++. .+.++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~~~l   80 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAI   80 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccEEEE
Confidence            356999999999999999999843   3699999975543 4556788999999999997 999999999765 456899


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          178 VMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||||++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||+   +.++.+||+|||+|......
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeecccc
Confidence            99999999999999764 569999999999999999999999999999999999999   78889999999999775432


Q ss_pred             ---CccccCccCCcccccccccc----cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHH-HHHHcCCcccC-CCCCCC
Q 017960          257 ---QIFTDVVGSPYYVAPEVLLK----HYGPEADVWTAGVILYILLSGVPPFWAETQQGIF-DAVLKGHIDFE-SDPWPL  327 (363)
Q Consensus       257 ---~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~-~~~~~~  327 (363)
                         .......||+.|||||++..    .|+.++|||||||+||||+||+.||.+....... ..+.++..... ......
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  237 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN  237 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence               23356789999999999862    4899999999999999999999999886655444 34444332211 223456


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMYN  358 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~~  358 (363)
                      +++++.+||.+||+.||++|||+.|+++++.
T Consensus       238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         238 CPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            8899999999999999999999999998753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-58  Score=417.15  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=216.1

Q ss_pred             ccceeecceecccCCeEEEEEEEccC-CcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc--CCCceeEEeEEEec---
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIAT-GIEFACKSISKRKLISREDVEDVRREIQIMHHLA--GHKNIVTIKGAYED---  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~---  171 (363)
                      .++|++++.||+|+||+||+|.+..+ ++.||||++..... .......+.+|+.+++.|.  +||||++++++|..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhc-cchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            36799999999999999999999765 66799999976433 2222345667888887774  49999999999853   


Q ss_pred             --CCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          172 --SLCVHIVMELCAGGELFDRII-QRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                        ...++++|||+.++.+..... ....+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence              357899999998776644333 34568999999999999999999999999999999999999   888899999999


Q ss_pred             cceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc-------
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF-------  320 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------  320 (363)
                      ++.............||+.|+|||++. ..|+.++|||||||++|||++|+.||.+.+..+.+..+.......       
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            998776666667889999999999987 469999999999999999999999999998888777765421100       


Q ss_pred             ----------------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          321 ----------------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       321 ----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                      .......+++++.+||.+||++||++|||+.|+|+||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                            001124578999999999999999999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=406.39  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=204.9

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|.+. ++..||||++....    ...+++.+|++++++++ |||||++++++.+.+.+++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEE
Confidence            35899999999999999999974 57789999987533    23467899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+   ++++.+||+|||+|+......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCC
Confidence            9999999999988654 558999999999999999999999999999999999999   888999999999998765433


Q ss_pred             c--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          258 I--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       258 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .  .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||......++...+..+.....   ...+++++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHH
Confidence            2  23467899999999998 469999999999999999999 5777777777788888877643322   245789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +||.+||+.||++|||++||++++
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~L  256 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQL  256 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHH
Confidence            999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-57  Score=406.31  Aligned_cols=248  Identities=25%  Similarity=0.322  Sum_probs=212.6

Q ss_pred             cceeecce-ecccCCeEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRK-LGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~-lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +.|.+.+. ||+|+||+||+|.++.  ++..||||++....  .....+++.+|+++|++++ |||||++++++.+ +.+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-CeE
Confidence            45777774 9999999999998654  44579999996543  5566788999999999998 9999999999875 458


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      |+|||||++|+|.+++.. ++.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+|+...
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccc
Confidence            999999999999998765 4579999999999999999999999999999999999999   677899999999998765


Q ss_pred             CCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ....    .....||+.|+|||++. +.++.++|||||||++|||+| |+.||.+....++...+.++...   +..+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~  237 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPEC  237 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcC
Confidence            4332    23456889999999987 569999999999999999998 99999998888888888876532   223468


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ++++.+||.+||+.||++|||+.+|++.
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~  265 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQR  265 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3e-57  Score=410.03  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=215.7

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++.++||+|+||+||+|+++ +++.||||++..... .....+++.+|+.+|++++ ||||+++++++...+..+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEE
Confidence            57999999999999999999984 789999999976542 3344578999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      |||+.++.+.......+.+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||.|....... 
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc
Confidence            9999777666666667789999999999999999999999999999999999999   888999999999998765433 


Q ss_pred             ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccC--------------
Q 017960          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFE--------------  321 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------  321 (363)
                      ......+++.|+|||.+.+  .++.++|||||||++|||++|+.||.+.+..+.+..+........              
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            2345578999999999873  479999999999999999999999998888777666543211110              


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          322 -----------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       322 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                                 ....+.+++++.+||.+||++||++|||+.|+|+||||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                       0112357889999999999999999999999999999973

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-57  Score=400.70  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=217.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      +.|+++++||+|+||+||+|++ .+++.||||++++...    ..+.+.+|+.++++++ ||||+++++++.+.+.+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEE
Confidence            3588999999999999999997 4778999999976432    2457899999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      |||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||+   ++++.+||+|||+|.......
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSS
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCC
Confidence            999999999888655 4568999999999999999999999999999999999999   888999999999998655433


Q ss_pred             c--cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          258 I--FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       258 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                      .  .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+.+..++...+..+....   ....+++++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccHHHH
Confidence            2  23467899999999998 569999999999999999998 899999999999988888764322   2346789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +||.+||+.||++|||++++|+++
T Consensus       232 ~li~~cl~~dP~~RPt~~eil~~L  255 (258)
T d1k2pa_         232 TIMYSCWHEKADERPTFKILLSNI  255 (258)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHh
Confidence            999999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-57  Score=405.72  Aligned_cols=242  Identities=23%  Similarity=0.264  Sum_probs=206.3

Q ss_pred             ceecccCCeEEEEEEEcc--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEEecc
Q 017960          105 RKLGQGQFGTTYLCTEIA--TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVMELC  182 (363)
Q Consensus       105 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~e~~  182 (363)
                      ++||+|+||+||+|.+..  +++.||||++..... +....+++.+|+.+|++++ |||||++++++..+ ..+||||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~~-~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEESS-SEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCC-CCCCceEEEEeccC-CEEEEEEcC
Confidence            579999999999998643  457899999965432 4455678999999999997 99999999998654 578999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCCc----
Q 017960          183 AGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQI----  258 (363)
Q Consensus       183 ~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~----  258 (363)
                      ++|+|.+++.+...+++..+..++.||+.||+|||+++||||||||+|||+   +.++.+||+|||+|+.......    
T Consensus        90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccccc
Confidence            999999999998899999999999999999999999999999999999999   7778999999999987654322    


Q ss_pred             cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHH
Q 017960          259 FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAKDLI  336 (363)
Q Consensus       259 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  336 (363)
                      .....||+.|+|||++. ..++.++|||||||++|||++ |+.||.+....++...+.++...   +....+|+++.+||
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li  243 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM  243 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHH
Confidence            23457899999999987 569999999999999999998 89999999888888888776432   22346899999999


Q ss_pred             HHhcccCcCCCCCHHHHhc
Q 017960          337 RKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       337 ~~~l~~dp~~R~s~~evL~  355 (363)
                      .+||+.||++|||+.+|+.
T Consensus       244 ~~cl~~dp~~RPs~~~i~~  262 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVEL  262 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=402.98  Aligned_cols=246  Identities=21%  Similarity=0.305  Sum_probs=210.5

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~i  177 (363)
                      .++|++.+.||+|+||+||+|.++ ++..||||++....    ...+.+.+|+.++++++ |||||++++++.+ +.+++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEE
Confidence            457999999999999999999964 67789999996532    23467999999999997 9999999998755 56789


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQR--GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      |||||++|+|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+||||   ++++.+||+|||+|+....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccC
Confidence            99999999999877543  358999999999999999999999999999999999999   8889999999999988754


Q ss_pred             CC--ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHH
Q 017960          256 GQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPWPLISDS  331 (363)
Q Consensus       256 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  331 (363)
                      ..  ......||+.|+|||++. +.|+.++|||||||++|||+|| .+||......+....+..+.....   ...++++
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~  238 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCPEE  238 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHH
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccChHH
Confidence            43  234567899999999988 5699999999999999999994 566677777788888876643222   2468899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          332 AKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       332 ~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      +.+||.+||+.||++|||+++|++.
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~  263 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSV  263 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999983

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=414.39  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=214.8

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC-
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL-  173 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-  173 (363)
                      ..+.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+++|++++ |||||+++++|...+ 
T Consensus        14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~   91 (346)
T d1cm8a_          14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDET   91 (346)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSS
T ss_pred             eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcc
Confidence            347789999999999999999999999999999999997543 35566788999999999997 999999999997654 


Q ss_pred             -----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecC
Q 017960          174 -----CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFG  248 (363)
Q Consensus       174 -----~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG  248 (363)
                           .+|+||||| +.+|... .+.+.+++..++.++.||+.||+|||++|||||||||+|||+   +.++.+||+|||
T Consensus        92 ~~~~~~~~lv~e~~-~~~l~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg  166 (346)
T d1cm8a_          92 LDDFTDFYLVMPFM-GTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFG  166 (346)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCT
T ss_pred             ccccceEEEEEecc-cccHHHH-HHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---cccccccccccc
Confidence                 579999999 6666554 455679999999999999999999999999999999999999   888999999999


Q ss_pred             cceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCccc------
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDF------  320 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------  320 (363)
                      +|....  ...+...||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+.+..+.+..+.......      
T Consensus       167 ~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         167 LARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             TCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            998764  33466889999999999874  47999999999999999999999998887766655544321110      


Q ss_pred             -----------------C----CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          321 -----------------E----SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       321 -----------------~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                       .    ......+++++.+||.+||..||++|||++|+|+||||+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                             0    11234578999999999999999999999999999999754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=412.32  Aligned_cols=251  Identities=28%  Similarity=0.399  Sum_probs=210.9

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec------CC
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------SL  173 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~~  173 (363)
                      .|+..++||+|+||+||+|+++.+|+.||||++.+...       ...+|+.+|++++ ||||++++++|..      ..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCce
Confidence            48999999999999999999999999999999976432       2346999999997 9999999999843      34


Q ss_pred             eEEEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCC-ccEEEeecC
Q 017960          174 CVHIVMELCAGGELFDRI----IQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDD-FSLKAIDFG  248 (363)
Q Consensus       174 ~~~iv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~-~~~kl~DFG  248 (363)
                      +++||||||+++ +.+.+    .....+++..++.++.||+.||+|||++||+||||||+|||+   +.+ ..+||+|||
T Consensus        93 ~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl---~~~~~~~kl~DFG  168 (350)
T d1q5ka_          93 YLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFG  168 (350)
T ss_dssp             EEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTTCCEEECCCT
T ss_pred             EEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE---ecCCCceeEeccc
Confidence            589999999765 43333    345579999999999999999999999999999999999999   654 489999999


Q ss_pred             cceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCc--------
Q 017960          249 LSVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHI--------  318 (363)
Q Consensus       249 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------  318 (363)
                      ++............+||+.|+|||.+.+  .|+.++|||||||++|||++|+.||.+....+.+..+.+...        
T Consensus       169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            9998877777778899999999998763  589999999999999999999999998888777666543100        


Q ss_pred             ---------ccC--------CCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          319 ---------DFE--------SDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       319 ---------~~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                               .++        ....+.+++++.+||.+||..||++|||+.|+|+|+||+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                     000        01123578999999999999999999999999999999754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=408.71  Aligned_cols=259  Identities=25%  Similarity=0.366  Sum_probs=214.3

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec------
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED------  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------  171 (363)
                      .++|++++.||+|+||+||+|++..+|+.||||++..... ......++.+|+.+|++++ ||||+++++++..      
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccccc
Confidence            3679999999999999999999999999999999876543 3344577889999999998 9999999998854      


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                        .+.+++||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~  163 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGL  163 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTT
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecce
Confidence              45689999999777665555556779999999999999999999999999999999999999   8888999999999


Q ss_pred             ceecCCCC-----ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC
Q 017960          250 SVFFKPGQ-----IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES  322 (363)
Q Consensus       250 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  322 (363)
                      +.......     .....+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.+.........+.+....+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97664322     2334679999999999873  5899999999999999999999999998888777766554333222


Q ss_pred             CCCCC----------------------------CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 017960          323 DPWPL----------------------------ISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPV  361 (363)
Q Consensus       323 ~~~~~----------------------------~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~  361 (363)
                      ..+..                            .++++++||.+||+.||++|||++|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            21111                            3678899999999999999999999999999974

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=398.71  Aligned_cols=250  Identities=20%  Similarity=0.342  Sum_probs=206.1

Q ss_pred             cceeecceecccCCeEEEEEEEccCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATG----IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      +.|++.++||+|+||+||+|.++.++    ..||||++....  .......+.+|+.++++++ |||||++++++.+.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCc
Confidence            45889999999999999999977654    469999986543  4555677999999999998 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      .++|||||.++++.+.+... +.+++..+..++.||+.||+|||+++|+||||||+||||   +.++.+||+|||+|+..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhcc
Confidence            99999999999998877654 569999999999999999999999999999999999999   88899999999999876


Q ss_pred             CCCC----ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCcCHHHHHHHHHcCCcccCCCCCCC
Q 017960          254 KPGQ----IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPWPL  327 (363)
Q Consensus       254 ~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  327 (363)
                      ....    ......||+.|+|||++. +.++.++|||||||++|||++| .+||.+....++.+.+..+...   +....
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~  237 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPMD  237 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---CCchh
Confidence            4432    223356899999999987 4699999999999999999995 5556666777777777765432   22346


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          328 ISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       328 ~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++++.+||.+||+.||++|||+.||++.+
T Consensus       238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L  267 (283)
T d1mqba_         238 CPSAIYQLMMQCWQQERARRPKFADIVSIL  267 (283)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence            889999999999999999999999998754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-55  Score=407.27  Aligned_cols=254  Identities=28%  Similarity=0.486  Sum_probs=212.1

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec--CCeE
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED--SLCV  175 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~  175 (363)
                      .++|+++++||+|+||+||+|+++.+++.||||++.+..      .+++.+|+.+|+.+.+||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            367999999999999999999999999999999986432      46788999999999779999999999874  4569


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          176 HIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ++|||||.+++|....   +.+++..++.++.||+.||.|||++||+||||||+|||++  .++..+||+|||+|.....
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCT
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccC
Confidence            9999999999986643   5699999999999999999999999999999999999994  2345799999999998877


Q ss_pred             CCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCH-HHHHHHHHc-------------CCcc
Q 017960          256 GQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQ-QGIFDAVLK-------------GHID  319 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~i~~-------------~~~~  319 (363)
                      .......++|+.|+|||.+.+  .++.++||||+||++|||++|..||..... .+....+..             ....
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            777778889999999999874  489999999999999999999999965443 222211111             0000


Q ss_pred             --------------------cCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 --------------------FESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 --------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                          ........+++++++||.+||+.||++|||++|+|+||||+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                                0111223478899999999999999999999999999999865

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=397.43  Aligned_cols=259  Identities=24%  Similarity=0.368  Sum_probs=221.2

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|++..+++.||||+++.... ......++.+|+.+|+.++ ||||+++++++.+....++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEE
Confidence            479999999999999999999999999999999976543 4556788999999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC-
Q 017960          179 MELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ-  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-  257 (363)
                      ||++.+++|...+...+.+++..+..++.|++.||+|||++||+||||||+|||+   +.++.+||+|||.|....... 
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence            9999999888888888889999999999999999999999999999999999999   778899999999998865433 


Q ss_pred             ccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCC-CcCHHHHHHHHHcCCccc--------------
Q 017960          258 IFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFW-AETQQGIFDAVLKGHIDF--------------  320 (363)
Q Consensus       258 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~--------------  320 (363)
                      ......+++.|+|||++..  .++.++|||||||++|||++|+.||. +.+..+.+..+.......              
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            3344567889999998874  37999999999999999999999864 455555555543311111              


Q ss_pred             -----------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          321 -----------ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       321 -----------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                 .....+.+++++.+||.+||+.||.+|||++|+|+||||+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                       011223567899999999999999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=409.76  Aligned_cols=259  Identities=28%  Similarity=0.425  Sum_probs=212.4

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCC--
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSL--  173 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--  173 (363)
                      ++.++|++++.||+|+||+||+|.++.+|+.||||++.+..  .....+++.+|+.+|++|+ ||||+++++++....  
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~   81 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE   81 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence            35578999999999999999999999999999999997543  4556778999999999998 999999999986543  


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcc
Q 017960          174 ---CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLS  250 (363)
Q Consensus       174 ---~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a  250 (363)
                         .++++ +|+.+++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||+   ++++.+||+|||+|
T Consensus        82 ~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a  156 (345)
T d1pmea_          82 QMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA  156 (345)
T ss_dssp             TCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTC
T ss_pred             ccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCce
Confidence               34555 55569999998865 469999999999999999999999999999999999999   78889999999999


Q ss_pred             eecCCCC----ccccCccCCccccccccc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc-----
Q 017960          251 VFFKPGQ----IFTDVVGSPYYVAPEVLL-K-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID-----  319 (363)
Q Consensus       251 ~~~~~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----  319 (363)
                      .......    .....+||+.|+|||++. . .++.++||||+||++|+|++|+.||.+....+...........     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            8754332    234567999999999986 3 4889999999999999999999999887765555444321100     


Q ss_pred             ---------------cCC-------CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 ---------------FES-------DPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 ---------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                     .+.       ..++.+++++++||.+||+.||.+|||+.|+|+||||+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                           000       1134578899999999999999999999999999999754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=410.02  Aligned_cols=261  Identities=30%  Similarity=0.489  Sum_probs=222.2

Q ss_pred             cceeecceecccCCeEEEEEEEc---cCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEI---ATGIEFACKSISKRKLI-SREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      ++|++++.||+|+||+||+|.+.   .+|+.||||++.+.... .....+++.+|+++++++++||||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999873   46899999998754332 223356788999999999855899999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          175 VHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++++|||+.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||+|....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999   788899999999998764


Q ss_pred             CCC--ccccCccCCcccccccccc---cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          255 PGQ--IFTDVVGSPYYVAPEVLLK---HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       255 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      ...  ......|++.|+|||.+..   .++.++|||||||+||||++|..||.+....+....+.+............++
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            332  3345779999999999863   37889999999999999999999998876665555555444333333345689


Q ss_pred             HHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccC
Q 017960          330 DSAKDLIRKMLCSQPSERL-----TAHEVLCMYNLPVL  362 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~-----s~~evL~~~~~~~~  362 (363)
                      +++.+||.+||++||++||     |++|+|+||||+.+
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            9999999999999999999     58999999999753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-56  Score=398.09  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=205.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLC  174 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~  174 (363)
                      .++|++++.||+|+||+||+|.+..++   ..||||.+....  .....+.+.+|+.++++++ ||||+++++++. .+.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCe
Confidence            467999999999999999999976543   458888875432  5556778999999999997 999999999986 467


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceec
Q 017960          175 VHIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       175 ~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  253 (363)
                      +++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++||||||||+||++   +.++.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence            8999999999999988765 4568999999999999999999999999999999999999   67789999999999876


Q ss_pred             CCCC--ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          254 KPGQ--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       254 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      ....  ......||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+....++...+..+...   +.++.+|
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~  235 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCP  235 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence            4332  234567899999999998 569999999999999999998 89999999999998888876532   2345789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.+||.+||+.||++|||+.||++++
T Consensus       236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L  263 (273)
T d1mp8a_         236 PTLYSLMTKCWAYDPSRRPRFTELKAQL  263 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            9999999999999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=403.96  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=212.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcE--EEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIE--FACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ++|++.++||+|+||+||+|.++.++..  ||||.+....  .....+.+.+|+++|.++.+|||||++++++.+++.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            4589999999999999999999888875  6667664332  44456789999999999955999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCc
Q 017960          177 IVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDF  240 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~  240 (363)
                      +||||+++|+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||+   +.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence            999999999999998654                568999999999999999999999999999999999999   7888


Q ss_pred             cEEEeecCcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCC-CCCCCcCHHHHHHHHHcCCc
Q 017960          241 SLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGV-PPFWAETQQGIFDAVLKGHI  318 (363)
Q Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~-~pf~~~~~~~~~~~i~~~~~  318 (363)
                      .+||+|||+|.............||..|+|||.+. +.|+.++|||||||++|||++|. +||.+.+..++...+.++..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            99999999998765444445567899999999997 56999999999999999999965 67888888888888776532


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          319 DFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                         .+....+++++.+||.+||+.||++|||+.||++++
T Consensus       245 ---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L  280 (309)
T d1fvra_         245 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  280 (309)
T ss_dssp             ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence               223346899999999999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=398.23  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=201.9

Q ss_pred             ccceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-  171 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-  171 (363)
                      .++|++++.||+|+||+||+|.+..     +++.||||++....  .....+.+.+|..++.++.+|+||+.+++++.+ 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            4679999999999999999999754     34689999986543  455567788999999999779999999998765 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeee
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR----------------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVN  235 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~  235 (363)
                      ...+++|||||++|+|.+++...                ..+++.++..++.||+.||.|||++|||||||||+|||+  
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl--  167 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--  167 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence            45689999999999999999653                247899999999999999999999999999999999999  


Q ss_pred             CCCCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCcCHHHH-
Q 017960          236 KDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG-VPPFWAETQQGI-  309 (363)
Q Consensus       236 ~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~-  309 (363)
                       ++++.+||+|||+|+......   ......||+.|+|||++. +.++.++|||||||++|||++| .+||.+....+. 
T Consensus       168 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 -SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             -CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             -CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence             788899999999998654332   234567999999999998 4699999999999999999986 567876654443 


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+..+..   ......+++++.+||.+||+.||++|||+.|+++|+
T Consensus       247 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L  291 (299)
T d1ywna1         247 CRRLKEGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  291 (299)
T ss_dssp             HHHHHHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHhcCCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            344444332   222346889999999999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=400.86  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=206.6

Q ss_pred             ceeecceecccCCeEEEEEEEccCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGI----EFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      +|+++++||+|+||+||+|.+..+|+    .||+|.+....  .....+++.+|+.++++++ |||||++++++.+.. .
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~-~   85 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-V   85 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESSS-E
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC-e
Confidence            49999999999999999999888876    47777775432  3445678999999999998 999999999998754 6


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQR-GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      +++|||+.+++|.+.+... ..+++..+..++.||+.||+|||++|||||||||+|||+   +.++.+||+|||+|+...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecc
Confidence            7788888899999888764 568999999999999999999999999999999999999   778899999999998765


Q ss_pred             CCCc---cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCC
Q 017960          255 PGQI---FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLIS  329 (363)
Q Consensus       255 ~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  329 (363)
                      ....   .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+....++...+.++...   +..+.++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~~  239 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICT  239 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTTBC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccC
Confidence            4332   23456899999999987 569999999999999999998 89999988888888877765432   2224688


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          330 DSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       330 ~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +++.+||.+||+.||.+|||+.|++.++
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-55  Score=397.78  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=217.0

Q ss_pred             ccceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|++++.||+|+||+||+|+.+.     +++.||||++....  .....+++.+|+.++++++ ||||+++++++.+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFD-NPNIVKLLGVCAVG   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcC-CCCcccceeeeccC
Confidence            4679999999999999999999753     56789999987543  4555678999999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCC
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG------------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKP  228 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp  228 (363)
                      +..++||||+++|+|.+++....                        .+++..+..++.||+.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999986532                        378899999999999999999999999999999


Q ss_pred             CceEeeeCCCCccEEEeecCcceecCCCC---ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCC-CCCCC
Q 017960          229 ENFLLVNKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGV-PPFWA  303 (363)
Q Consensus       229 ~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~-~pf~~  303 (363)
                      +|||+   +.++.+||+|||+|.......   ......||+.|+|||++.+ .|+.++|||||||++|||++|. +||.+
T Consensus       169 ~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         169 RNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            99999   888999999999997654332   2345678899999999984 6999999999999999999985 68999


Q ss_pred             cCHHHHHHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          304 ETQQGIFDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       304 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ....++...+.++....   ....+++++.+||.+||+.||++|||+.||++.+
T Consensus       246 ~~~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L  296 (301)
T d1lufa_         246 MAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL  296 (301)
T ss_dssp             SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            99999999988876432   2346889999999999999999999999998743

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-55  Score=392.91  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=204.6

Q ss_pred             cceeecceecccCCeEEEEEEEccC-C--cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIAT-G--IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCV  175 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~  175 (363)
                      ++|++.+.||+|+||.||+|+...+ +  ..||||++.+.........+++.+|+.+|++++ ||||+++++++.+ ...
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cch
Confidence            4599999999999999999986533 3  368999997766556666788999999999997 9999999999976 467


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecC
Q 017960          176 HIVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFK  254 (363)
Q Consensus       176 ~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  254 (363)
                      ++||||++++++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhcc
Confidence            899999999999987765 4569999999999999999999999999999999999999   667799999999999865


Q ss_pred             CCCc----cccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCC
Q 017960          255 PGQI----FTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLI  328 (363)
Q Consensus       255 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  328 (363)
                      ....    .....|+..|+|||++. ..++.++|||||||++|||+| |..||.+.+..+....+.+.....+  ....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~  240 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC  240 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence            4432    23346788999999998 469999999999999999998 8999999999999988887654432  33568


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          329 SDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       329 ~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      |+++.+||.+||+.||++|||+.||++.
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~  268 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRDF  268 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=392.53  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=206.5

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIV  178 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv  178 (363)
                      ++|++++.||+|+||+||+|.+..+ +.||||++....    ...+.+.+|+.++++++ |||||++++++.+ +.+++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEEE
Confidence            5699999999999999999997544 579999996543    23467899999999998 9999999999865 557899


Q ss_pred             EeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCC
Q 017960          179 MELCAGGELFDRIIQ--RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPG  256 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~  256 (363)
                      |||+++|+|.+.+..  .+.+++.++..++.||+.||.|||++||+||||||+||||   ++++.+||+|||+|+.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCC
Confidence            999999999888754  3569999999999999999999999999999999999999   78899999999999876433


Q ss_pred             C--ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHH
Q 017960          257 Q--IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSA  332 (363)
Q Consensus       257 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  332 (363)
                      .  ......||+.|+|||++. +.++.++|||||||++|||++| .+|+.+....+.+..+.++..   .+....+++++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l  243 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPESL  243 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHHH
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHHH
Confidence            3  233467899999999998 5699999999999999999995 555667777778888776542   22335689999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc--CCCccc
Q 017960          333 KDLIRKMLCSQPSERLTAHEVLC--MYNLPV  361 (363)
Q Consensus       333 ~~li~~~l~~dp~~R~s~~evL~--~~~~~~  361 (363)
                      .+||.+||+.||++|||+++|++  +.|+..
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            99999999999999999999988  556643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=405.96  Aligned_cols=260  Identities=24%  Similarity=0.391  Sum_probs=216.2

Q ss_pred             cccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC--
Q 017960           95 DNIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS--  172 (363)
Q Consensus        95 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--  172 (363)
                      .++.++|++++.||+|+||+||+|.+..+|+.||||++.+.. .+....+++.+|+.+|++|+ |||||++++++...  
T Consensus        14 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~   91 (348)
T d2gfsa1          14 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS   91 (348)
T ss_dssp             EEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred             ccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccc
Confidence            345688999999999999999999999999999999997543 35556678999999999998 99999999998532  


Q ss_pred             ---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          173 ---LCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       173 ---~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                         ...+++|+|+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||+
T Consensus        92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~  167 (348)
T d2gfsa1          92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGL  167 (348)
T ss_dssp             TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC--
T ss_pred             cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccch
Confidence               334556677779999987754 579999999999999999999999999999999999999   8889999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc--cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcccCC-----
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK--HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHIDFES-----  322 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-----  322 (363)
                      |....  .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+.+.......     
T Consensus       168 a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         168 ARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             --CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            97643  34456789999999998764  4789999999999999999999999998887777666543221110     


Q ss_pred             ------------------C----CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          323 ------------------D----PWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       323 ------------------~----~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                        .    .+..+++++++||.+||+.||.+|||+.|+|+||||+.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                              0    123578999999999999999999999999999999753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=394.03  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=214.4

Q ss_pred             ccceeecceecccCCeEEEEEEEccCC-------cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEe
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATG-------IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYE  170 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~  170 (363)
                      .++|++++.||+|+||.||+|++..++       ..||||++.+..  .......+.+|...+.++.+|||||++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            467999999999999999999976554       479999997543  55567789999999999966999999999999


Q ss_pred             cCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          171 DSLCVHIVMELCAGGELFDRIIQRG----------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       171 ~~~~~~iv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                      +++.+++|||||++|+|.+++....                .+++..+..++.||+.||+|||+++||||||||+|||+ 
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl-  168 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-  168 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence            9999999999999999999997543                48999999999999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHH
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~  309 (363)
                        +.++.+||+|||++.......   ......+|+.|+|||.+. +.|+.++|||||||++|||++ |.+||.+.....+
T Consensus       169 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 --TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             --CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             --cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence              888899999999998765433   234467899999999987 579999999999999999998 7999999898888


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      ...+..+...   +....+++++.+||.+||+.||.+|||+.||++.+
T Consensus       247 ~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L  291 (299)
T d1fgka_         247 FKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL  291 (299)
T ss_dssp             HHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHcCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence            8888765432   22346899999999999999999999999999854

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=404.21  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=205.3

Q ss_pred             ccccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec----
Q 017960           96 NIRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED----  171 (363)
Q Consensus        96 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----  171 (363)
                      .+.++|+++++||+|+||+||+|.++.+|+.||||++.+... +.....++.+|+.++++++ ||||++++++|..    
T Consensus        14 ~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~   91 (355)
T d2b1pa1          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL   91 (355)
T ss_dssp             EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred             eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence            455789999999999999999999999999999999976543 5666778999999999997 9999999999953    


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCc
Q 017960          172 --SLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL  249 (363)
Q Consensus       172 --~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~  249 (363)
                        ...+|+|||||.+ ++.+.+  ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+|++|||+
T Consensus        92 ~~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~  165 (355)
T d2b1pa1          92 EEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGL  165 (355)
T ss_dssp             TTCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred             ccCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhh
Confidence              4689999999965 555555  3568999999999999999999999999999999999999   7788999999999


Q ss_pred             ceecCCCCccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCcc---------
Q 017960          250 SVFFKPGQIFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGHID---------  319 (363)
Q Consensus       250 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------  319 (363)
                      +............++|+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+......         
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            988777667777889999999999984 6999999999999999999999999888776665554321111         


Q ss_pred             -------------cCCCC----------------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccC
Q 017960          320 -------------FESDP----------------WPLISDSAKDLIRKMLCSQPSERLTAHEVLCMYNLPVL  362 (363)
Q Consensus       320 -------------~~~~~----------------~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~~~~~~  362 (363)
                                   .....                ....++++.+||.+||..||++|||++|||+||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                         00000                01135678999999999999999999999999999753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=387.38  Aligned_cols=243  Identities=23%  Similarity=0.310  Sum_probs=203.3

Q ss_pred             cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-CCeEEE
Q 017960           99 DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVHI  177 (363)
Q Consensus        99 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~i  177 (363)
                      ++|++++.||+|+||.||+|.+  +|..||||++++.     ...+.+.+|++++++++ ||||+++++++.+ .+.+++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-----HHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEE
Confidence            4589999999999999999996  5779999999643     23467899999999997 9999999998854 566899


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          178 VMELCAGGELFDRIIQRG--HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       178 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      ||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+|+||||||+|||+   +.++.+||+|||++.....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCC
Confidence            999999999999986643  48999999999999999999999999999999999999   8889999999999987543


Q ss_pred             CCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHHHHHHHcCCcccCCCCCCCCCHHHH
Q 017960          256 GQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGIFDAVLKGHIDFESDPWPLISDSAK  333 (363)
Q Consensus       256 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  333 (363)
                        ......+|..|+|||++. +.++.++|||||||++|||+| |++||......++...+..+...   +....+++++.
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~  230 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHH
T ss_pred             --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHH
Confidence              234567889999999987 569999999999999999998 79999988888888888765332   22345789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCC
Q 017960          334 DLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       334 ~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +||.+||+.||++|||+.++++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~~L  254 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLREQL  254 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHHHH
Confidence            999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=390.13  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=214.3

Q ss_pred             ccceeecceecccCCeEEEEEEEc-----cCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecC
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEI-----ATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDS  172 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~  172 (363)
                      .++|+++++||+|+||.||+|++.     .+++.||||++....  .......+.+|+.+++++.+|||||++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            467999999999999999999863     466789999997543  4556678999999999997799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEee
Q 017960          173 LCVHIVMELCAGGELFDRIIQRG------------------HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLV  234 (363)
Q Consensus       173 ~~~~iv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~  234 (363)
                      ...++|||||++|+|.+++....                  .+++..+..++.||+.||+|||+++||||||||+|||+ 
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~-  178 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-  178 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence            99999999999999999987643                  58899999999999999999999999999999999999 


Q ss_pred             eCCCCccEEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCcCHHHH
Q 017960          235 NKDDDFSLKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLS-GVPPFWAETQQGI  309 (363)
Q Consensus       235 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~  309 (363)
                        +.++.+||+|||.++......   ......||+.|+|||++. +.++.++|||||||++|||+| |.+||.+....+.
T Consensus       179 --~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 --THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             --ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             --cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence              778899999999998765432   223467899999999998 568999999999999999998 6666766666555


Q ss_pred             HHHHHcCCcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          310 FDAVLKGHIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       310 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                      +..+........  ....+++++.+||.+||+.||.+|||+.|||+.+
T Consensus       257 ~~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L  302 (311)
T d1t46a_         257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI  302 (311)
T ss_dssp             HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            554444333222  2245789999999999999999999999999754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=386.59  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=217.5

Q ss_pred             cccceeecceecccCCeEEEEEEEcc-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIA-----TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED  171 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~  171 (363)
                      ..++|++++.||+|+||+||+|.++.     +++.||||++....  .......+.+|+.+++++. ||||+++++++..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEec
Confidence            34779999999999999999998753     35789999997543  5556678999999999998 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCcc
Q 017960          172 SLCVHIVMELCAGGELFDRIIQR----------GHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFS  241 (363)
Q Consensus       172 ~~~~~iv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~  241 (363)
                      ....++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||+   ++++.
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCce
Confidence            99999999999999999988642          236889999999999999999999999999999999999   88999


Q ss_pred             EEEeecCcceecCCCC---ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCcCHHHHHHHHHcC
Q 017960          242 LKAIDFGLSVFFKPGQ---IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSG-VPPFWAETQQGIFDAVLKG  316 (363)
Q Consensus       242 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~i~~~  316 (363)
                      +||+|||+|+......   ......||+.|+|||.+. +.++.++|||||||++|||+|| .+||.+.+..+.+..+.++
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            9999999998654332   233457899999999988 4689999999999999999998 5889899999999888876


Q ss_pred             CcccCCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          317 HIDFESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ....   ....+++++.+||.+||+.||++|||+.+|+++
T Consensus       252 ~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         252 GLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5432   234688999999999999999999999999983

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-52  Score=381.90  Aligned_cols=252  Identities=23%  Similarity=0.274  Sum_probs=202.3

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.....     .+++..|+++++.+++|++|+.+.+++.+.+..+
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~   79 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   79 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence            45679999999999999999999999999999999875432     2357789999999985666777778888999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCC
Q 017960          177 IVMELCAGGELFDRIIQ-RGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKP  255 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~  255 (363)
                      +||||+ +++|.+.+.. .+.+++..+..++.|++.||+|||++|||||||||+|||+...+.+..+||+|||+|+....
T Consensus        80 ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999999 5667666654 56799999999999999999999999999999999999996555667899999999987654


Q ss_pred             CC--------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHc---CCcccC-C
Q 017960          256 GQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLK---GHIDFE-S  322 (363)
Q Consensus       256 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~-~  322 (363)
                      ..        ......||+.|||||++.+ .++.++|||||||++|||++|..||...........+.+   .....+ .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            32        2245689999999999985 599999999999999999999999977655433322211   111111 1


Q ss_pred             CCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 017960          323 DPWPLISDSAKDLIRKMLCSQPSERLTAHEVL  354 (363)
Q Consensus       323 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL  354 (363)
                      .....+|+++.+||.+||+.||++||++.++.
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~  270 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR  270 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            12346889999999999999999999987654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=379.19  Aligned_cols=245  Identities=22%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             ecceecccCCeEEEEEEEccCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEec-CCeEEEE
Q 017960          103 LGRKLGQGQFGTTYLCTEIATG---IEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYED-SLCVHIV  178 (363)
Q Consensus       103 ~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~iv  178 (363)
                      ..++||+|+||+||+|.+..++   ..||||++.+.  .+....+++.+|+++|++++ ||||+++++++.+ ++..++|
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEE
Confidence            3578999999999999976543   35899998643  26667789999999999998 9999999998765 5689999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEeecCcceecCCCC
Q 017960          179 MELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQ  257 (363)
Q Consensus       179 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~  257 (363)
                      ||||++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||+   ++++.+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccccc
Confidence            99999999999887543 47788999999999999999999999999999999999   888999999999998764432


Q ss_pred             -----ccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCCcccCCCCCCCCCH
Q 017960          258 -----IFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAE-TQQGIFDAVLKGHIDFESDPWPLISD  330 (363)
Q Consensus       258 -----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~  330 (363)
                           ......||+.|+|||.+. +.++.++||||||+++|||++|..||... ...+....+..+....   ....+++
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~---~p~~~~~  261 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPEYCPD  261 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC---CCTTCCH
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CcccCcH
Confidence                 223356899999999987 57999999999999999999977776543 4445566666654322   2245789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcC
Q 017960          331 SAKDLIRKMLCSQPSERLTAHEVLCM  356 (363)
Q Consensus       331 ~~~~li~~~l~~dp~~R~s~~evL~~  356 (363)
                      ++.+||.+||+.||++|||+.||+++
T Consensus       262 ~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         262 PLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.9e-51  Score=370.09  Aligned_cols=253  Identities=19%  Similarity=0.278  Sum_probs=207.4

Q ss_pred             cccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960           97 IRDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus        97 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.....     ...+.+|++.++.|.+|+||+.+++++.+....+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            45679999999999999999999999999999999865431     2356789999999986799999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeC--CCCccEEEeecCcceec
Q 017960          177 IVMELCAGGELFDRIIQRG-HYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNK--DDDFSLKAIDFGLSVFF  253 (363)
Q Consensus       177 iv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~--~~~~~~kl~DFG~a~~~  253 (363)
                      +||||+ +++|.+.+...+ .++...+..++.|++.||+|||++|||||||||+|||++..  ..++.+||+|||+|+..
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 789999887654 69999999999999999999999999999999999999532  23568999999999876


Q ss_pred             CCCC--------ccccCccCCcccccccccc-cCCCcccHHHHHHHHHHHHhCCCCCCCcCH---HHHHHHHHcCCccc-
Q 017960          254 KPGQ--------IFTDVVGSPYYVAPEVLLK-HYGPEADVWTAGVILYILLSGVPPFWAETQ---QGIFDAVLKGHIDF-  320 (363)
Q Consensus       254 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~-  320 (363)
                      ....        .....+||+.|||||++.+ .++.++|||||||++|||++|..||.+...   ......+....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            4321        2345689999999999985 599999999999999999999999975433   23333332222111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 017960          321 ESDPWPLISDSAKDLIRKMLCSQPSERLTAHEVLC  355 (363)
Q Consensus       321 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~evL~  355 (363)
                      ..+..+.+|+++.+++..|+..+|++||+++.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            11123457899999999999999999999876654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-51  Score=371.89  Aligned_cols=247  Identities=22%  Similarity=0.263  Sum_probs=191.2

Q ss_pred             ccceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHH--HHHHHHHHhcCCCceeEEeEEEecCC--
Q 017960           98 RDLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVR--REIQIMHHLAGHKNIVTIKGAYEDSL--  173 (363)
Q Consensus        98 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--~E~~~l~~l~~h~niv~~~~~~~~~~--  173 (363)
                      .+.|.+.+.||+|+||.||+|++  +|+.||||++....      ...+.  .|+..+..++ ||||+++++++.+.+  
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR-HENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCc
Confidence            45689999999999999999984  68899999986432      23333  4555555676 999999999987543  


Q ss_pred             --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEecCCCCCceEeeeCCCCccEE
Q 017960          174 --CVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHS--------LGVMHRDLKPENFLLVNKDDDFSLK  243 (363)
Q Consensus       174 --~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~--------~~iiHrDlkp~NIll~~~~~~~~~k  243 (363)
                        .+++|||||++|+|.+++.+. .+++..+..++.|++.||.|||+        +|||||||||+||||   ++++.+|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred             ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeE
Confidence              689999999999999999764 68999999999999999999996        599999999999999   8889999


Q ss_pred             EeecCcceecCCCC-----ccccCccCCccccccccccc-------CCCcccHHHHHHHHHHHHhCCCCCCCc-------
Q 017960          244 AIDFGLSVFFKPGQ-----IFTDVVGSPYYVAPEVLLKH-------YGPEADVWTAGVILYILLSGVPPFWAE-------  304 (363)
Q Consensus       244 l~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~il~ell~g~~pf~~~-------  304 (363)
                      |+|||++.......     ......||+.|+|||++.+.       ++.++|||||||+||||+||..||...       
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999998765432     22356899999999998642       577899999999999999998876321       


Q ss_pred             --------CHHHHHHHHHcCCcccCCC-CC--CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 017960          305 --------TQQGIFDAVLKGHIDFESD-PW--PLISDSAKDLIRKMLCSQPSERLTAHEVLCMY  357 (363)
Q Consensus       305 --------~~~~~~~~i~~~~~~~~~~-~~--~~~~~~~~~li~~~l~~dp~~R~s~~evL~~~  357 (363)
                              ......+.+.........+ .+  .....++.+|+.+||+.||++|||+.||++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L  292 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence                    1222333333322211110 00  11224589999999999999999999998754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-47  Score=354.90  Aligned_cols=263  Identities=22%  Similarity=0.390  Sum_probs=197.9

Q ss_pred             ccccc-cceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhc----------CCCce
Q 017960           94 TDNIR-DLYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLA----------GHKNI  162 (363)
Q Consensus        94 ~~~~~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~ni  162 (363)
                      ++.|. .+|+++++||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.+.          +|+||
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            44455 4699999999999999999999999999999999753    334567788999998885          26889


Q ss_pred             eEEeEEEec--CCeEEEEEeccCCCChHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEecCCCCCceEeeeC
Q 017960          163 VTIKGAYED--SLCVHIVMELCAGGELFDRII---QRGHYSERKAAELTRIIVGVVEACHS-LGVMHRDLKPENFLLVNK  236 (363)
Q Consensus       163 v~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~~l~~~l~~lH~-~~iiHrDlkp~NIll~~~  236 (363)
                      +++++++..  ....+++|+++..+.......   ....+++..+..++.||+.||+|||+ .||+||||||+|||+...
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            999998754  456677777765554333322   23568999999999999999999998 899999999999999532


Q ss_pred             CC---CccEEEeecCcceecCCCCccccCccCCccccccccc-ccCCCcccHHHHHHHHHHHHhCCCCCCCcCHH-----
Q 017960          237 DD---DFSLKAIDFGLSVFFKPGQIFTDVVGSPYYVAPEVLL-KHYGPEADVWTAGVILYILLSGVPPFWAETQQ-----  307 (363)
Q Consensus       237 ~~---~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-----  307 (363)
                      +.   ...++|+|||.|....  ......+||+.|+|||++. ..|+.++||||+||++++|++|+.||......     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcccccceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence            21   1259999999998754  3345678999999999887 46999999999999999999999999654321     


Q ss_pred             -HHHHHHHc--CCc----------------------cc--------------CCCCCCCCCHHHHHHHHHhcccCcCCCC
Q 017960          308 -GIFDAVLK--GHI----------------------DF--------------ESDPWPLISDSAKDLIRKMLCSQPSERL  348 (363)
Q Consensus       308 -~~~~~i~~--~~~----------------------~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~R~  348 (363)
                       +.......  +..                      ..              ........++++++||.+||+.||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             11111100  000                      00              0000112357899999999999999999


Q ss_pred             CHHHHhcCCCcccC
Q 017960          349 TAHEVLCMYNLPVL  362 (363)
Q Consensus       349 s~~evL~~~~~~~~  362 (363)
                      |++|+|+||||+..
T Consensus       321 ta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         321 DAGGLVNHPWLKDT  334 (362)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHhcCcccCCC
Confidence            99999999999753

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=2e-28  Score=206.78  Aligned_cols=166  Identities=20%  Similarity=0.227  Sum_probs=122.8

Q ss_pred             eeecceecccCCeEEEEEEEccCCcEEEEEEeeccccC---------------ChhhHHHHHHHHHHHHHhcCCCceeEE
Q 017960          101 YTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI---------------SREDVEDVRREIQIMHHLAGHKNIVTI  165 (363)
Q Consensus       101 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~~h~niv~~  165 (363)
                      +.++++||+|+||+||+|.+ .+|+.||||+++.....               .........+|...+.++. |++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            45789999999999999997 57899999987532110               0111234567889999997 9999988


Q ss_pred             eEEEecCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEecCCCCCceEeeeCCCCccEEEe
Q 017960          166 KGAYEDSLCVHIVMELCAGGELFDRIIQRGHYSERKAAELTRIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAI  245 (363)
Q Consensus       166 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~iiHrDlkp~NIll~~~~~~~~~kl~  245 (363)
                      +++..    .+++|||+++..+.       .++...+..++.|++.+|.|||++||+||||||+|||+   +++ .++|+
T Consensus        80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv---~~~-~~~li  144 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---SEE-GIWII  144 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---ETT-EEEEC
T ss_pred             EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee---eCC-CEEEE
Confidence            76532    36999999876543       24566778899999999999999999999999999999   443 48999


Q ss_pred             ecCcceecCCCCccccCccCCcccc------cccccccCCCcccHHHHHHH
Q 017960          246 DFGLSVFFKPGQIFTDVVGSPYYVA------PEVLLKHYGPEADVWTAGVI  290 (363)
Q Consensus       246 DFG~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~Di~slG~i  290 (363)
                      |||.|.........       .|..      .+.+.+.|+.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            99999875432211       1211      12334678999999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.92  E-value=4e-09  Score=91.20  Aligned_cols=86  Identities=15%  Similarity=0.081  Sum_probs=63.7

Q ss_pred             ceeecceecccCCeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEEEEE
Q 017960          100 LYTLGRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVHIVM  179 (363)
Q Consensus       100 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~iv~  179 (363)
                      .|++.+..+.++.+.||+..  .++..+++|+......   .....+.+|...+..|..+--+.+++.+..+.+..++||
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~   89 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence            46666666556668999886  5667788998764432   223456789999988876655788888888889999999


Q ss_pred             eccCCCChHHH
Q 017960          180 ELCAGGELFDR  190 (363)
Q Consensus       180 e~~~~~~L~~~  190 (363)
                      ++++|.++.+.
T Consensus        90 ~~l~G~~~~~~  100 (263)
T d1j7la_          90 SEADGVLCSEE  100 (263)
T ss_dssp             ECCSSEEHHHH
T ss_pred             Eeccccccccc
Confidence            99988776543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.61  E-value=1.2e-07  Score=86.94  Aligned_cols=82  Identities=12%  Similarity=0.105  Sum_probs=52.9

Q ss_pred             cceecccCCeEEEEEEEccCCcEEEEEEeeccccC----ChhhHHHHHHHHHHHHHhcCC--CceeEEeEEEecCCeEEE
Q 017960          104 GRKLGQGQFGTTYLCTEIATGIEFACKSISKRKLI----SREDVEDVRREIQIMHHLAGH--KNIVTIKGAYEDSLCVHI  177 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~i  177 (363)
                      .+.||.|....||++.+...++.++||.-......    ......+...|...|+.+..+  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            35689999999999997777889999975432111    112345667788888887644  345666654  3445578


Q ss_pred             EEeccCCCCh
Q 017960          178 VMELCAGGEL  187 (363)
Q Consensus       178 v~e~~~~~~L  187 (363)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.36  E-value=6.4e-07  Score=76.44  Aligned_cols=74  Identities=9%  Similarity=0.056  Sum_probs=52.2

Q ss_pred             ecccC-CeEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCC-CceeEEeEEEecCCeEEEEEeccCC
Q 017960          107 LGQGQ-FGTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGH-KNIVTIKGAYEDSLCVHIVMELCAG  184 (363)
Q Consensus       107 lG~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~iv~e~~~~  184 (363)
                      +..|. .+.||+... ..+..+++|......      ...+..|...++.|..+ -.+.+++.+..+.+..++||++++|
T Consensus        18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            44454 468999873 556678889765432      23467788888887743 2366778888888889999999987


Q ss_pred             CCh
Q 017960          185 GEL  187 (363)
Q Consensus       185 ~~L  187 (363)
                      .++
T Consensus        91 ~~~   93 (255)
T d1nd4a_          91 QDL   93 (255)
T ss_dssp             EET
T ss_pred             ccc
Confidence            654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.77  E-value=5e-05  Score=67.00  Aligned_cols=68  Identities=12%  Similarity=0.128  Sum_probs=44.6

Q ss_pred             eEEEEEEEccCCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCC-ceeEEeE-----EEecCCeEEEEEeccCCC
Q 017960          113 GTTYLCTEIATGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHK-NIVTIKG-----AYEDSLCVHIVMELCAGG  185 (363)
Q Consensus       113 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~-----~~~~~~~~~iv~e~~~~~  185 (363)
                      -.||++.. .+|..|++|+.....    ...+++..|...+..|..+. -++..+.     .+...+..+.+++++.|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            58999984 788899999986432    23456778999888887221 1111111     234566788999999763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.72  E-value=7.4e-05  Score=67.74  Aligned_cols=75  Identities=12%  Similarity=0.101  Sum_probs=52.0

Q ss_pred             cceecccCCeEEEEEEEcc-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHHhcCCCceeEEeEEEecCCeEE
Q 017960          104 GRKLGQGQFGTTYLCTEIA-------TGIEFACKSISKRKLISREDVEDVRREIQIMHHLAGHKNIVTIKGAYEDSLCVH  176 (363)
Q Consensus       104 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~  176 (363)
                      ++.|+.|-.-.+|++....       ....|.+++.....  .   .-...+|..+++.+..+.-.+++++++.+    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            3578889999999988542       34567787765221  1   23455799999998866556688887653    5


Q ss_pred             EEEeccCCCCh
Q 017960          177 IVMELCAGGEL  187 (363)
Q Consensus       177 iv~e~~~~~~L  187 (363)
                      +||||++|..+
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.10  E-value=0.00089  Score=58.18  Aligned_cols=31  Identities=32%  Similarity=0.373  Sum_probs=26.6

Q ss_pred             CCcEecCCCCCceEeeeCCCCccEEEeecCccee
Q 017960          219 LGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVF  252 (363)
Q Consensus       219 ~~iiHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  252 (363)
                      .|+||+|+.++||++   +++...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFF---LGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhc---ccccceeEeccccccc
Confidence            479999999999999   6666678999998864